Citrus Sinensis ID: 013973
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 433 | 2.2.26 [Sep-21-2011] | |||||||
| P51567 | 427 | Serine/threonine-protein | yes | no | 0.979 | 0.992 | 0.829 | 0.0 | |
| P51566 | 467 | Serine/threonine-protein | no | no | 0.965 | 0.895 | 0.699 | 1e-180 | |
| P51568 | 400 | Serine/threonine-protein | no | no | 0.889 | 0.962 | 0.594 | 1e-143 | |
| Q10156 | 690 | Dual specificity protein | yes | no | 0.861 | 0.540 | 0.424 | 2e-92 | |
| O35491 | 499 | Dual specificity protein | yes | no | 0.773 | 0.671 | 0.474 | 1e-89 | |
| P49760 | 499 | Dual specificity protein | yes | no | 0.775 | 0.673 | 0.472 | 2e-89 | |
| P49762 | 832 | Serine/threonine-protein | no | no | 0.787 | 0.409 | 0.455 | 6e-87 | |
| Q9HAZ1 | 481 | Dual specificity protein | no | no | 0.771 | 0.694 | 0.469 | 3e-85 | |
| O35493 | 481 | Dual specificity protein | no | no | 0.771 | 0.694 | 0.461 | 3e-83 | |
| P49759 | 484 | Dual specificity protein | no | no | 0.771 | 0.690 | 0.455 | 8e-83 |
| >sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 753 bits (1943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/429 (82%), Positives = 397/429 (92%), Gaps = 5/429 (1%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDV-PQVPKAQVGLFCGQEVGNVTSFAPPRAPSDH 59
MEMERV EFP +++DRRPRKRARLGWDV PQ KAQVG+FCGQE+GN++SFA APSD+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQVGMFCGQEIGNISSFASSGAPSDN 60
Query: 60 VTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR 119
SSSL VKGVARNGSPPWREDDKDGHY+F LG++LT RYKI+SKMGEGTFGQVLECWDR
Sbjct: 61 --SSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 120 ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 179
ERKEMVA+KIVRG+KKYREAAMIEIE+LQQL KHDKGGNRCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 180 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239
LGSSLYDFLRKNNYRSFPIDLVREI QLLEC+AFMHDL MIHTDLKPEN+LLVSS+Y+K
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 299
+P+YK S +D Y KR+PKSSAIKVIDFGSTTYER DQ YIVSTRHYRAPEVILGLG
Sbjct: 239 IPEYKGS-RLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296
Query: 300 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 359
W+YPCD+WSVGCI+VELCTGEALFQTHENLEHLAMMERVLGP PQ MLK+VDRH+EKYVR
Sbjct: 297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356
Query: 360 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 419
RGRLDWP+GA SR+S+K+V+KLPRLQNLIMQHVDHSAG+L +++QGLLR+DP++R+TARE
Sbjct: 357 RGRLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQGLLRFDPSERITARE 416
Query: 420 ALRHPFFTR 428
ALRHPFF R
Sbjct: 417 ALRHPFFAR 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 631 bits (1628), Expect = e-180, Method: Compositional matrix adjust.
Identities = 307/439 (69%), Positives = 350/439 (79%), Gaps = 21/439 (4%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQVPKA--------QVGLFCGQEV--GNVTSF 50
+E +R EFP +D+RPRKR RL WD Q L+ G E G V +F
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 51 APPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTF 110
P ++F G+ R GSPPWR DDKDGHY+F +G+ LT RY+I SKMGEGTF
Sbjct: 77 VYP----------NMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTF 126
Query: 111 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170
GQVLEC+D + KE+VAIK++R I KYREAAMIEI+VLQ+L +HD GG+RCVQIRNWFDYR
Sbjct: 127 GQVLECFDNKNKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYR 186
Query: 171 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 230
NHICIVFEKLG SLYDFLRKN+YRSFPIDLVRE+ RQLLE +A+MHDL +IHTDLKPEN+
Sbjct: 187 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENI 246
Query: 231 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR 290
LLVSSEYIK+PDYK KD SYFK +PKSSAIK+IDFGSTT+E D NYIVSTRHYR
Sbjct: 247 LLVSSEYIKIPDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYR 306
Query: 291 APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRV 350
APEVILG+GW YPCD+WS+GCILVELC+GEALFQTHENLEHLAMMERVLGPLP HM+ R
Sbjct: 307 APEVILGVGWNYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRA 366
Query: 351 DRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409
DR +EKY RRG +LDWPEGA SR+S+K+V KLPRL NLIMQHVDHSAGDL LLQGLLRY
Sbjct: 367 DRRSEKYFRRGAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRY 426
Query: 410 DPTDRLTAREALRHPFFTR 428
DPT+R AREAL HPFFTR
Sbjct: 427 DPTERFKAREALNHPFFTR 445
|
Activator of yeast transcription factor, STE12. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1311), Expect = e-143, Method: Compositional matrix adjust.
Identities = 251/422 (59%), Positives = 316/422 (74%), Gaps = 37/422 (8%)
Query: 11 FSNLDR-RPRKRARLGWD-VPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVK 68
F ++D+ R RKR R+ WD P P+A+ + +K
Sbjct: 6 FESMDKERVRKRPRMTWDEAPAEPEAKRAV----------------------------IK 37
Query: 69 GVARNG---SPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMV 125
G +G SPP R+DD+DGHY+F+L +NLT RYKI SKMGEGTFG+VLECWDR+ KE V
Sbjct: 38 GHGSDGRILSPPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYV 97
Query: 126 AIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLY 185
AIKI+R IKKYR+AAMIEI+VLQ+L K DKG RCVQ++NWFDYRNHICIVFEKLG SL+
Sbjct: 98 AIKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLF 157
Query: 186 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245
DFL++N Y +FP+ LVR+ QLLE +A+MH+L ++HTDLKPEN+LLVSSE +K+PD K
Sbjct: 158 DFLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNKR 217
Query: 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 305
S + ++F+ +PKSSAIK+IDFGST + + IV TRHYR+PEVILGLGW+Y CD
Sbjct: 218 S---AANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCD 274
Query: 306 IWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLD 364
+WS+GCIL ELCTGEALFQTH+NLEHLAMMER LGPLP+HM ++ R AEKY RRG RL+
Sbjct: 275 LWSIGCILFELCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKASRGAEKYFRRGCRLN 334
Query: 365 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 424
WPEGA SRESI++V +L RL++++ +HVD++ LL GLL YDP++RLTA EAL HP
Sbjct: 335 WPEGANSRESIRAVKRLDRLKDMVSKHVDNTRSRFADLLYGLLAYDPSERLTANEALDHP 394
Query: 425 FF 426
FF
Sbjct: 395 FF 396
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 177/417 (42%), Positives = 255/417 (61%), Gaps = 44/417 (10%)
Query: 16 RRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGS 75
R P+KR R W P +V V + T+F P S F
Sbjct: 308 RPPKKRKRAAWP----PYKKVDRVNVPVVHDTTAFDP-----------STF--------- 343
Query: 76 PPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK 135
DD DGHY +RY + +G GTFG+V++C+D+ AIK+ R I K
Sbjct: 344 -----DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPK 398
Query: 136 YREAAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYR 194
YREA++IE+ VLQ +A D N+C+Q+R++FDYR HICIV + G S++DFL+ NNY
Sbjct: 399 YREASLIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYI 458
Query: 195 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS--SEYIKVPDYKSSLHTPKD 252
FP+ ++ +++QL + +AF+H L ++HTDLKPENVLLVS S I++P Y++
Sbjct: 459 PFPLKHIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YRN------- 510
Query: 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312
Y +++ S I++IDFGS T+E + +VSTRHYRAPE+ILGLGW+YPCD+WS+GCI
Sbjct: 511 --YSQKVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSIGCI 568
Query: 313 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR-GRLDWPEGAAS 371
LVEL TG+ALFQTHE+ EHL MME++LGP ++M+ R R ++++ + G++ +P
Sbjct: 569 LVELFTGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLSNTP 628
Query: 372 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
++SI + L L+ + A L LL+ + YDP R+TA+EAL HPFFT+
Sbjct: 629 KKSINYLQSLQTLEQIFAVSSPEVAL-LLDLLKKVFVYDPKRRITAKEALWHPFFTQ 684
|
Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (845), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 166/350 (47%), Positives = 235/350 (67%), Gaps = 15/350 (4%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD +GH ++ +G+ L RY+I S +GEGTFG+V++C D R VA+KI++ ++KY+E
Sbjct: 143 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKE 202
Query: 139 AAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + D N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +P
Sbjct: 203 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 262
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I VR +A QL + + F+HD + HTDLKPEN+L V+S+Y + +L +D +
Sbjct: 263 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 314
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R KS+A++V+DFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 315 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 374
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTH+N EHLAMMER+LGP+P M+++ + +KY RGRLDW E ++ ++
Sbjct: 375 VGFTLFQTHDNREHLAMMERILGPVPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 432
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
K P + L + DH L L++ +L Y+P RLT EAL+HPFF
Sbjct: 433 NCK-PLRRYLTSEAEDHHQ--LFDLIENMLEYEPAKRLTLGEALQHPFFA 479
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 166/351 (47%), Positives = 236/351 (67%), Gaps = 15/351 (4%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD +GH ++ +G+ L RY+I S +GEGTFG+V++C D R VA+KI++ ++KY+E
Sbjct: 144 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 203
Query: 139 AAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + D N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +P
Sbjct: 204 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 263
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I VR +A QL + + F+HD + HTDLKPEN+L V+S+Y + +L +D +
Sbjct: 264 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 315
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R KS+A++V+DFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 316 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 375
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTH+N EHLAMMER+LGP+P M+++ + +KY RGRLDW E ++ ++
Sbjct: 376 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 433
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
K P + L + +H L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 434 NCK-PLRRYLTSEAEEHHQ--LFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 162/356 (45%), Positives = 231/356 (64%), Gaps = 15/356 (4%)
Query: 77 PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 136
P +DD DGH ++ G+ L RYKI + +GEGTFG+V++ D ER +A+KI++ ++KY
Sbjct: 457 PVIQDDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKY 516
Query: 137 REAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS 195
REAA +EI L+++A+ D + CV++ +WFDY H+CIVFE LG S++DFLR+NNY
Sbjct: 517 REAAKLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEP 576
Query: 196 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255
+P+D VR +A QL + F+HD + HTDLKPEN+L V S+Y ++K +
Sbjct: 577 YPLDQVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHKINREV------ 630
Query: 256 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315
R K++ +++IDFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCIL E
Sbjct: 631 --RRVKNTDVRLIDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFE 688
Query: 316 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKR---VDRHAEKYVRRGRLDWPEGAASR 372
L G LFQTH+N EHLAMMER+LG +P M + + KY G+LDW E +++
Sbjct: 689 LYLGITLFQTHDNREHLAMMERILGQIPYRMARNHTLYSKTKTKYFYHGKLDWDEKSSAG 748
Query: 373 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
++ K P + DH +L L++ +L Y+P+ R+T EAL HPFF R
Sbjct: 749 RYVRDHCK-PLFLCQLSDSEDHC--ELFSLIKKMLEYEPSSRITLGEALHHPFFDR 801
|
Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9HAZ1|CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 164/349 (46%), Positives = 232/349 (66%), Gaps = 15/349 (4%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYRE 138
EDD++GH + G+ L +RY+I +GEG FG+V+EC D M VA+KIV+ + +YRE
Sbjct: 140 EDDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYRE 199
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA EI+VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++N++ F
Sbjct: 200 AARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQ 259
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
ID +R++A Q+ + I F+H + HTDLKPEN+L V S+Y V Y S + +D +
Sbjct: 260 IDHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDY--VVKYNSKM--KRD----E 311
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R K++ IKV+DFGS TY+ + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 312 RTLKNTDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 371
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G +FQTH++ EHLAMMER+LGP+PQHM+++ + KY +LDW E +++ ++
Sbjct: 372 LGFTVFQTHDSKEHLAMMERILGPIPQHMIQKTRK--RKYFHHNQLDWDEHSSAGRYVRR 429
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
K L+ ++ H D L L++ +L YDPT R+T EAL+HPFF
Sbjct: 430 RCKP--LKEFMLCH-DEEHEKLFDLVRRMLEYDPTQRITLDEALQHPFF 475
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35493|CLK4_MOUSE Dual specificity protein kinase CLK4 OS=Mus musculus GN=Clk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 161/349 (46%), Positives = 230/349 (65%), Gaps = 15/349 (4%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYRE 138
EDD++GH + G+ L +RY+I +GEG FG+V+EC D + VA+KIV+ + +YRE
Sbjct: 140 EDDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYRE 199
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA EI+VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++N++ F
Sbjct: 200 AARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQ 259
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
ID +R++A Q+ + I F+H + HTDLKPEN+L V S+Y V Y S + +D +
Sbjct: 260 IDHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDY--VVKYNSKM--KRD----E 311
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R K++ IKV+DFGS TY+ + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 312 RTLKNTDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 371
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G +FQTH++ EHLAMMER+LGP+P HM+++ + KY +LDW E +++ ++
Sbjct: 372 LGFTVFQTHDSKEHLAMMERILGPIPAHMIQKTRK--RKYFHHNQLDWDEHSSAGRYVRR 429
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
K L+ ++ H D L L++ +L YDP R+T EAL+HPFF
Sbjct: 430 RCKP--LKEFMLCH-DEEHEKLFDLVRRMLEYDPARRITLDEALQHPFF 475
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49759|CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 8e-83, Method: Compositional matrix adjust.
Identities = 159/349 (45%), Positives = 228/349 (65%), Gaps = 15/349 (4%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD++GH + G+ L++RY+I +GEG FG+V+EC D + VA+KIV+ + +Y E
Sbjct: 142 EDDEEGHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE 201
Query: 139 AAMIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA EI+VL+ L D RCVQ+ WF++ HICIVFE LG S YDF+++N + F
Sbjct: 202 AARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFR 261
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
+D +R++A Q+ + + F+H + HTDLKPEN+L V S+Y + + K +D +
Sbjct: 262 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK----IKRD----E 313
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R + IKV+DFGS TY+ + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 314 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 373
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G +F TH++ EHLAMMER+LGPLP+HM+++ + KY RLDW E +++ +
Sbjct: 374 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSR 431
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
K P + ++ Q V+H L L+Q +L YDP R+T REAL+HPFF
Sbjct: 432 RCK-PLKEFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFF 477
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 433 | ||||||
| 255540473 | 435 | afc, putative [Ricinus communis] gi|2235 | 1.0 | 0.995 | 0.901 | 0.0 | |
| 225456860 | 435 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.993 | 0.898 | 0.0 | |
| 363806778 | 430 | uncharacterized protein LOC100804452 [Gl | 0.993 | 1.0 | 0.882 | 0.0 | |
| 363807284 | 430 | uncharacterized protein LOC100804022 [Gl | 0.993 | 1.0 | 0.875 | 0.0 | |
| 224135977 | 427 | predicted protein [Populus trichocarpa] | 0.983 | 0.997 | 0.875 | 0.0 | |
| 147767048 | 421 | hypothetical protein VITISV_035275 [Viti | 0.965 | 0.992 | 0.871 | 0.0 | |
| 449469580 | 433 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.997 | 0.857 | 0.0 | |
| 224121850 | 422 | predicted protein [Populus trichocarpa] | 0.974 | 1.0 | 0.869 | 0.0 | |
| 356516617 | 425 | PREDICTED: serine/threonine-protein kina | 0.981 | 1.0 | 0.859 | 0.0 | |
| 357461735 | 426 | Serine/threonine protein kinase AFC2 [Me | 0.983 | 1.0 | 0.849 | 0.0 |
| >gi|255540473|ref|XP_002511301.1| afc, putative [Ricinus communis] gi|223550416|gb|EEF51903.1| afc, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2122), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/435 (90%), Positives = 411/435 (94%), Gaps = 2/435 (0%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHV 60
MEMERVTEFP +LDRRPRKRARLGWDVP VPKAQVG+FC QEVGNV S+A A SDH
Sbjct: 1 MEMERVTEFPLPHLDRRPRKRARLGWDVPLVPKAQVGMFCAQEVGNVASYASSGANSDHT 60
Query: 61 T-SSSLFVKGVA-RNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 118
T SSS+F+KGVA RNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD
Sbjct: 61 TTSSSVFLKGVAPRNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 120
Query: 119 RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178
RERKEMVAIKIVRGIKKYREAAMIEI+VLQQL KHDKGGNRCVQIRNWFDYRNHICIVFE
Sbjct: 121 RERKEMVAIKIVRGIKKYREAAMIEIDVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFE 180
Query: 179 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 238
KLG SLYDFLRKNNYRSFPIDLVREI RQLLECIAFMHDL +IHTDLKPEN+LLVS +Y+
Sbjct: 181 KLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECIAFMHDLHLIHTDLKPENILLVSPDYV 240
Query: 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 298
KVPDYK S +PKDSSYFKR+PKSSA+KVIDFGSTTYER DQNYIVSTRHYRAPEVILGL
Sbjct: 241 KVPDYKGSTRSPKDSSYFKRVPKSSAVKVIDFGSTTYERQDQNYIVSTRHYRAPEVILGL 300
Query: 299 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 358
GW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKR+DRHAEKYV
Sbjct: 301 GWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRIDRHAEKYV 360
Query: 359 RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 418
RRGRLDWPEGA SRESIK+V+KLPRLQNL+MQHVDHSAGDL HLLQGLLRYDP+DRLTAR
Sbjct: 361 RRGRLDWPEGATSRESIKAVLKLPRLQNLVMQHVDHSAGDLIHLLQGLLRYDPSDRLTAR 420
Query: 419 EALRHPFFTRDHLRR 433
EALRHPFF RDHLRR
Sbjct: 421 EALRHPFFARDHLRR 435
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456860|ref|XP_002279764.1| PREDICTED: serine/threonine-protein kinase AFC2 [Vitis vinifera] gi|297733679|emb|CBI14926.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2108), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/435 (89%), Positives = 412/435 (94%), Gaps = 3/435 (0%)
Query: 1 MEM-ERVTEFPFSNLDRRPRKRARLGWDV-PQVPKAQVGLFCGQEVGNVTSFAPPRAPSD 58
MEM ERVTEFP +++DRRPRKR RLGWDV PQ PKAQ+G+FCGQEVGNV SFAP +A SD
Sbjct: 1 MEMVERVTEFPHTHMDRRPRKRPRLGWDVLPQAPKAQLGMFCGQEVGNVASFAPSKAHSD 60
Query: 59 HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 118
T+SS+FVKGVARNGSPPWREDDKDGHY+FALGENLTSRYKI+SKMGEGTFGQVLECWD
Sbjct: 61 Q-TTSSMFVKGVARNGSPPWREDDKDGHYIFALGENLTSRYKINSKMGEGTFGQVLECWD 119
Query: 119 RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178
RERKEMVA+KIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE
Sbjct: 120 RERKEMVAVKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 179
Query: 179 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 238
KLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL +IHTDLKPEN+LLVS EY+
Sbjct: 180 KLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLRLIHTDLKPENILLVSPEYV 239
Query: 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 298
KVPDYK S +PKD SYFKR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGL
Sbjct: 240 KVPDYKVSSRSPKDGSYFKRVPKSSAIKVIDFGSTTYERQDQNYIVSTRHYRAPEVILGL 299
Query: 299 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 358
GW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV
Sbjct: 300 GWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 359
Query: 359 RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 418
RRGRLDWPEGA SRESIK+V+KLPRLQNLIMQHVDHSAGDL HLLQGLLRYDP+DRLTA
Sbjct: 360 RRGRLDWPEGATSRESIKAVLKLPRLQNLIMQHVDHSAGDLIHLLQGLLRYDPSDRLTAL 419
Query: 419 EALRHPFFTRDHLRR 433
ALRHPFFTRDHLRR
Sbjct: 420 GALRHPFFTRDHLRR 434
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363806778|ref|NP_001242280.1| uncharacterized protein LOC100804452 [Glycine max] gi|255635653|gb|ACU18176.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2043), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/433 (88%), Positives = 405/433 (93%), Gaps = 3/433 (0%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHV 60
MEMERV EFP +++DRRPRKRARLGWD+P+VPKAQVGLFCGQ+VG ++SFAP R PS++
Sbjct: 1 MEMERVFEFPHTHMDRRPRKRARLGWDIPEVPKAQVGLFCGQDVGTISSFAPSRGPSEN- 59
Query: 61 TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 120
T+SSLFVK VARNGSPPWR+DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE
Sbjct: 60 TTSSLFVKPVARNGSPPWRDDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 119
Query: 121 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180
RKEMVA+KIVRGIKKYREAAMIEIEVLQQL KHDKGGNRCVQIRNWFDYRNHICIV EKL
Sbjct: 120 RKEMVAVKIVRGIKKYREAAMIEIEVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVLEKL 179
Query: 181 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240
G SLYDFLRKNNYRSFPIDLVREI RQLLECIAFMHDL MIHTDLKPEN+LLVS EY+KV
Sbjct: 180 GPSLYDFLRKNNYRSFPIDLVREIGRQLLECIAFMHDLRMIHTDLKPENILLVSPEYVKV 239
Query: 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 300
PDYKSS + SSYFKR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGLGW
Sbjct: 240 PDYKSSSRS--PSSYFKRVPKSSAIKVIDFGSTTYEREDQNYIVSTRHYRAPEVILGLGW 297
Query: 301 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360
+YPCDIWSVGCILVELCTG ALFQTHENLEHLAMMERVLGPLPQ MLKRVDRHAEKYVRR
Sbjct: 298 SYPCDIWSVGCILVELCTGGALFQTHENLEHLAMMERVLGPLPQPMLKRVDRHAEKYVRR 357
Query: 361 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 420
GRLDWPEGA SRESIK+VM LPRLQNL+MQHVDHSAGDL HLLQGLLRYDP++RLTA+EA
Sbjct: 358 GRLDWPEGATSRESIKAVMNLPRLQNLVMQHVDHSAGDLIHLLQGLLRYDPSERLTAKEA 417
Query: 421 LRHPFFTRDHLRR 433
LRH FF RD RR
Sbjct: 418 LRHSFFMRDQFRR 430
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807284|ref|NP_001242619.1| uncharacterized protein LOC100804022 [Glycine max] gi|255634850|gb|ACU17784.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/433 (87%), Positives = 404/433 (93%), Gaps = 3/433 (0%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHV 60
MEMERV EFP + +DRRPRKRARLGWD+P+VPKAQVGLFCGQ+VG ++SFAP R PS+H
Sbjct: 1 MEMERVFEFPHTYMDRRPRKRARLGWDIPEVPKAQVGLFCGQDVGTISSFAPSRGPSEH- 59
Query: 61 TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 120
T+SSLFVK VARNGSPPWR+DDKDGHYMF LGENLTSRYKIH+KMGEGTFGQVLECWDRE
Sbjct: 60 TTSSLFVKPVARNGSPPWRDDDKDGHYMFTLGENLTSRYKIHTKMGEGTFGQVLECWDRE 119
Query: 121 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180
RKEMVA+KIVRGIKKYREAAMIEIEVLQQL KHDKGGNRCVQIRNWFDYRNHICIVFEKL
Sbjct: 120 RKEMVAVKIVRGIKKYREAAMIEIEVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEKL 179
Query: 181 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240
G SLYDFLRKNNYRSFPIDLVREI +QLLECIAFMHDL MIHTDLKPEN+LLVS EY+KV
Sbjct: 180 GPSLYDFLRKNNYRSFPIDLVREIGKQLLECIAFMHDLRMIHTDLKPENILLVSPEYVKV 239
Query: 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 300
PDYKSS + SYFKR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGLGW
Sbjct: 240 PDYKSSSRS--SCSYFKRVPKSSAIKVIDFGSTTYEREDQNYIVSTRHYRAPEVILGLGW 297
Query: 301 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360
+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG LPQ M+KRVDRHAEKYVRR
Sbjct: 298 SYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGSLPQTMMKRVDRHAEKYVRR 357
Query: 361 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 420
GRLDWPEGA SRESIK+VMKLPRLQNL+MQHVD SAGDL HLLQGLLRYDP++RLTA+EA
Sbjct: 358 GRLDWPEGATSRESIKAVMKLPRLQNLVMQHVDRSAGDLIHLLQGLLRYDPSERLTAKEA 417
Query: 421 LRHPFFTRDHLRR 433
LRH FF R+H RR
Sbjct: 418 LRHSFFMREHFRR 430
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135977|ref|XP_002322208.1| predicted protein [Populus trichocarpa] gi|222869204|gb|EEF06335.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/432 (87%), Positives = 403/432 (93%), Gaps = 6/432 (1%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHV 60
MEME VT FP ++LDR PRKR R GWDVPQ AQVG FCGQEVGNV S+A A SDH
Sbjct: 1 MEMEHVTIFPITHLDR-PRKRPRFGWDVPQ---AQVGNFCGQEVGNVASYASSGAISDH- 55
Query: 61 TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 120
+SSLFVKGVA+NGSPPWREDDKDGHYMFALG+NLTSRYKIH+KMGEGTFGQVLECWDRE
Sbjct: 56 -TSSLFVKGVAQNGSPPWREDDKDGHYMFALGDNLTSRYKIHNKMGEGTFGQVLECWDRE 114
Query: 121 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180
RKEMVAIKIVRGIKKY+EAAMIEIEVLQQL KHDKGGNRCVQIRNWFDYRNHICIVFEKL
Sbjct: 115 RKEMVAIKIVRGIKKYKEAAMIEIEVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEKL 174
Query: 181 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240
G SLYDFLRKNNYRSFPID VREI RQLLEC+AFMHDL MIHTDLKPEN+LLVSS+Y+KV
Sbjct: 175 GPSLYDFLRKNNYRSFPIDHVREIGRQLLECVAFMHDLHMIHTDLKPENILLVSSDYVKV 234
Query: 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 300
PDYK+S +PKDSSY+KR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGLGW
Sbjct: 235 PDYKNSTRSPKDSSYYKRVPKSSAIKVIDFGSTTYERQDQNYIVSTRHYRAPEVILGLGW 294
Query: 301 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360
+YPCD+WSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ+MLKRVDRHAEK+VRR
Sbjct: 295 SYPCDVWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPMPQNMLKRVDRHAEKFVRR 354
Query: 361 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 420
GRLDWPEGAASRESIK+V+KLPRLQNL+MQHVDHSAGDL HLLQGLLRYDP DRLTAREA
Sbjct: 355 GRLDWPEGAASRESIKAVLKLPRLQNLVMQHVDHSAGDLIHLLQGLLRYDPMDRLTAREA 414
Query: 421 LRHPFFTRDHLR 432
LRHPFF +DH R
Sbjct: 415 LRHPFFAKDHRR 426
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767048|emb|CAN67679.1| hypothetical protein VITISV_035275 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/435 (87%), Positives = 399/435 (91%), Gaps = 17/435 (3%)
Query: 1 MEM-ERVTEFPFSNLDRRPRKRARLGWDV-PQVPKAQVGLFCGQEVGNVTSFAPPRAPSD 58
MEM ERVTEFP +++DRRPRKR RLGWDV PQ PKAQ+G+FCGQEVGNV SFAP +A SD
Sbjct: 1 MEMVERVTEFPHTHMDRRPRKRPRLGWDVLPQAPKAQLGMFCGQEVGNVASFAPSKAHSD 60
Query: 59 HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 118
T+SS+FVKGVARNGSPPWREDDKDGHY+FALGENLTSRYKI+SKMGEGTFGQVLECWD
Sbjct: 61 Q-TTSSMFVKGVARNGSPPWREDDKDGHYIFALGENLTSRYKINSKMGEGTFGQVLECWD 119
Query: 119 RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178
RERKEMVA+KIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE
Sbjct: 120 RERKEMVAVKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 179
Query: 179 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 238
KLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL +IHTDLKPEN+LLVS EY+
Sbjct: 180 KLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLRLIHTDLKPENILLVSPEYV 239
Query: 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 298
KVPDYK S +PKD VIDFGSTTYER DQNYIVSTRHYRAPEVILGL
Sbjct: 240 KVPDYKVSSRSPKD--------------VIDFGSTTYERQDQNYIVSTRHYRAPEVILGL 285
Query: 299 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 358
GW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV
Sbjct: 286 GWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 345
Query: 359 RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 418
RRGRLDWPEGA SRESIK+V+KLPRLQNLIMQHVDHSAGDL HLLQGLLRYDP+DRLTA
Sbjct: 346 RRGRLDWPEGATSRESIKAVLKLPRLQNLIMQHVDHSAGDLIHLLQGLLRYDPSDRLTAJ 405
Query: 419 EALRHPFFTRDHLRR 433
ALRHPFFTRDHLRR
Sbjct: 406 GALRHPFFTRDHLRR 420
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469580|ref|XP_004152497.1| PREDICTED: serine/threonine-protein kinase AFC2-like [Cucumis sativus] gi|449487736|ref|XP_004157775.1| PREDICTED: serine/threonine-protein kinase AFC2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2012), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/434 (85%), Positives = 401/434 (92%), Gaps = 2/434 (0%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDV-PQVPKAQVGLFCGQEVGNVTSFAPPRAPSDH 59
MEMER+ EFP ++LDRRPRKRARLGWDV P+ PKAQVG+ CGQE+ N+ SFA RAPSDH
Sbjct: 1 MEMERMIEFPHTHLDRRPRKRARLGWDVVPEAPKAQVGICCGQEIANIPSFASTRAPSDH 60
Query: 60 VTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR 119
+S+ LFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR
Sbjct: 61 -SSNPLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR 119
Query: 120 ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 179
E+KEMVAIKIVRGI+KYR+AAMIEIEVLQQL KHDKGGNRCVQIRNWFDYRNHICIVFEK
Sbjct: 120 EKKEMVAIKIVRGIRKYRDAAMIEIEVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 179
Query: 180 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239
LG SLYDFLRKNNYRSFPIDLVR+I RQLLEC+AFMHDL MIHTDLKPEN+LLVS +Y+K
Sbjct: 180 LGPSLYDFLRKNNYRSFPIDLVRDIGRQLLECVAFMHDLRMIHTDLKPENILLVSGDYVK 239
Query: 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 299
V DYK+ +P+DSS FKR+PKSSAIKVIDFGSTTY+R DQNYIVSTRHYRAPEVILGLG
Sbjct: 240 VHDYKNLSRSPRDSSNFKRVPKSSAIKVIDFGSTTYDRQDQNYIVSTRHYRAPEVILGLG 299
Query: 300 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 359
W +PCDIWSVGCILVELC+GEALFQTHENLEHLAMMERVLGPLPQ MLK+VDRHAEKYVR
Sbjct: 300 WRFPCDIWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPQEMLKKVDRHAEKYVR 359
Query: 360 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 419
RGRLDWPEGA SR+SIK+V KL RL NLIMQHVDHS G+L HL+QGLLRYDP RLTARE
Sbjct: 360 RGRLDWPEGATSRDSIKAVQKLARLPNLIMQHVDHSGGELIHLVQGLLRYDPLLRLTARE 419
Query: 420 ALRHPFFTRDHLRR 433
ALRHPFFTRD LRR
Sbjct: 420 ALRHPFFTRDSLRR 433
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121850|ref|XP_002318688.1| predicted protein [Populus trichocarpa] gi|222859361|gb|EEE96908.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2009), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/428 (86%), Positives = 395/428 (92%), Gaps = 6/428 (1%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHV 60
ME+E VT FP ++LDR PRKRAR WDVPQ AQVG+FCGQEVGNV S+A A SDH
Sbjct: 1 MELEHVTVFPITHLDR-PRKRARFAWDVPQ---AQVGIFCGQEVGNVASYASSGAISDH- 55
Query: 61 TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 120
+SSLFVKGVARNGSPPWREDDKDGHYMFALG+NLTSRYKIHSKMGEGTFGQVLECWDRE
Sbjct: 56 -TSSLFVKGVARNGSPPWREDDKDGHYMFALGDNLTSRYKIHSKMGEGTFGQVLECWDRE 114
Query: 121 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180
RKEMVAIKIVRGIKKYREAAMIEIEVLQ L KHDKG NRCVQIRNWFDYRNHICIVFEKL
Sbjct: 115 RKEMVAIKIVRGIKKYREAAMIEIEVLQNLGKHDKGSNRCVQIRNWFDYRNHICIVFEKL 174
Query: 181 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240
G SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL MIHTDLKPEN+LLVSS+Y+KV
Sbjct: 175 GPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLRMIHTDLKPENILLVSSDYVKV 234
Query: 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 300
PDYK+S +PKD SY+KR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGLGW
Sbjct: 235 PDYKNSSRSPKDISYYKRVPKSSAIKVIDFGSTTYERQDQNYIVSTRHYRAPEVILGLGW 294
Query: 301 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360
+YPCDIWS GCILVELCTGEALFQTHENLEHLAMMERVLGP+PQH+LKRVDRHA KYVRR
Sbjct: 295 SYPCDIWSAGCILVELCTGEALFQTHENLEHLAMMERVLGPMPQHILKRVDRHAGKYVRR 354
Query: 361 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 420
GRLDWPEGAASRES+K+V+KLPRLQNL+MQHVD SAGDL HLLQGLLRYDP DRLTAREA
Sbjct: 355 GRLDWPEGAASRESMKAVLKLPRLQNLVMQHVDQSAGDLIHLLQGLLRYDPLDRLTAREA 414
Query: 421 LRHPFFTR 428
LRHPF +
Sbjct: 415 LRHPFLAK 422
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516617|ref|XP_003526990.1| PREDICTED: serine/threonine-protein kinase AFC2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2000), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/433 (85%), Positives = 397/433 (91%), Gaps = 8/433 (1%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHV 60
MEMER+ EFP + +DR PRKRARLGWD+ +VPKAQVGLFCGQEV N++SFAP P
Sbjct: 1 MEMERIVEFPHTYMDRPPRKRARLGWDIAEVPKAQVGLFCGQEVENISSFAPSEHPP--- 57
Query: 61 TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 120
SSLF KGVARNGSPPWR+DDKDGHYMF LG+NLTSRYKIH KMGEGTFGQVLECWDRE
Sbjct: 58 --SSLF-KGVARNGSPPWRDDDKDGHYMFELGDNLTSRYKIHGKMGEGTFGQVLECWDRE 114
Query: 121 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180
RKEMVAIKIVRGIKKYREAAM+EIEVLQQL KHDKG NRCVQIRNWFDYRNHICIVFEKL
Sbjct: 115 RKEMVAIKIVRGIKKYREAAMVEIEVLQQLGKHDKGSNRCVQIRNWFDYRNHICIVFEKL 174
Query: 181 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240
G SLYDFLRKN+YRSFPIDLVREI QLLEC+AFMHDL MIHTDLKPEN+LLVS EY+K+
Sbjct: 175 GPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLHMIHTDLKPENILLVSPEYLKI 234
Query: 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 300
PDYKS+ +P SS+FKR+PKSSAIKVIDFGSTTYER DQ YIVSTRHYRAPEVILGLGW
Sbjct: 235 PDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYEREDQTYIVSTRHYRAPEVILGLGW 292
Query: 301 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360
+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ MLKRVDRHAEKYVRR
Sbjct: 293 SYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPIPQQMLKRVDRHAEKYVRR 352
Query: 361 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 420
GRLDWPEGAASRESIK+VMKLPRLQN+IMQHVDHSAGDL HLLQGLLRYDP +RLTAR+A
Sbjct: 353 GRLDWPEGAASRESIKAVMKLPRLQNIIMQHVDHSAGDLIHLLQGLLRYDPFERLTARDA 412
Query: 421 LRHPFFTRDHLRR 433
LRH FFTRD LRR
Sbjct: 413 LRHSFFTRDQLRR 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461735|ref|XP_003601149.1| Serine/threonine protein kinase AFC2 [Medicago truncatula] gi|355490197|gb|AES71400.1| Serine/threonine protein kinase AFC2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1997), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/433 (84%), Positives = 399/433 (92%), Gaps = 7/433 (1%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHV 60
MEMER+ EF + +DR PRKRARLGWD+P+ PKAQVGLFCGQEV N++S+AP S+H
Sbjct: 1 MEMERMAEFSRNYMDRPPRKRARLGWDIPETPKAQVGLFCGQEVENISSYAP----SEHN 56
Query: 61 TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 120
+SSLF KGVARNGSPPWR+DDKDGHYMF LG+NLTSRY++H KMGEGTFGQVLECWDRE
Sbjct: 57 ITSSLF-KGVARNGSPPWRDDDKDGHYMFELGDNLTSRYRVHGKMGEGTFGQVLECWDRE 115
Query: 121 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180
RKEMVAIK+VR IKKYREAAMIEIE+LQQL KHDKGGNRCVQIRNWFDYRNHICIVFEKL
Sbjct: 116 RKEMVAIKVVRAIKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEKL 175
Query: 181 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240
G SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL MIHTDLKPEN+LLVSSEY+K+
Sbjct: 176 GPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLHMIHTDLKPENILLVSSEYLKI 235
Query: 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 300
PDYKSS P S++KR+PKSSAIKVIDFGSTTYER +QNYIVSTRHYRAPEVILGLGW
Sbjct: 236 PDYKSSSRAP--CSFYKRVPKSSAIKVIDFGSTTYERENQNYIVSTRHYRAPEVILGLGW 293
Query: 301 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360
+YPCD+WSVGCILVELCTGEALFQTHENLEHLAMMERVLG LPQ +LKRVDRHAEKYVRR
Sbjct: 294 SYPCDVWSVGCILVELCTGEALFQTHENLEHLAMMERVLGLLPQQLLKRVDRHAEKYVRR 353
Query: 361 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 420
GRLDWPEGA SRESIK+VMKLPRLQNLIMQHVDHSAGDL HLLQGLLRYDP +R+TAR+A
Sbjct: 354 GRLDWPEGANSRESIKAVMKLPRLQNLIMQHVDHSAGDLIHLLQGLLRYDPFERVTARDA 413
Query: 421 LRHPFFTRDHLRR 433
LRHPFF RDHLRR
Sbjct: 414 LRHPFFMRDHLRR 426
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 433 | ||||||
| TAIR|locus:2121984 | 427 | FC2 "FUS3-complementing gene 2 | 0.979 | 0.992 | 0.829 | 2.2e-199 | |
| TAIR|locus:2084006 | 467 | FC1 "FUS3-complementing gene 1 | 0.983 | 0.912 | 0.705 | 2e-166 | |
| TAIR|locus:2125622 | 400 | AME3 [Arabidopsis thaliana (ta | 0.849 | 0.92 | 0.640 | 9.1e-132 | |
| POMBASE|SPAC1D4.11c | 690 | lkh1 "dual specificity protein | 0.778 | 0.488 | 0.463 | 3.5e-86 | |
| UNIPROTKB|E1B9Q2 | 500 | CLK2 "Uncharacterized protein" | 0.775 | 0.672 | 0.472 | 8.9e-86 | |
| UNIPROTKB|F1P919 | 612 | CLK2 "Uncharacterized protein" | 0.775 | 0.549 | 0.472 | 8.9e-86 | |
| UNIPROTKB|B1AVT0 | 497 | CLK2 "Dual-specificity protein | 0.775 | 0.676 | 0.472 | 8.9e-86 | |
| UNIPROTKB|P49760 | 499 | CLK2 "Dual specificity protein | 0.775 | 0.673 | 0.472 | 8.9e-86 | |
| UNIPROTKB|F1RLJ5 | 500 | CLK2 "Uncharacterized protein" | 0.775 | 0.672 | 0.472 | 8.9e-86 | |
| MGI|MGI:1098669 | 499 | Clk2 "CDC-like kinase 2" [Mus | 0.771 | 0.669 | 0.475 | 1.1e-85 |
| TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1930 (684.5 bits), Expect = 2.2e-199, P = 2.2e-199
Identities = 356/429 (82%), Positives = 397/429 (92%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDV-PQVPKAQVGLFCGQEVGNVTSFAPPRAPSDH 59
MEMERV EFP +++DRRPRKRARLGWDV PQ KAQVG+FCGQE+GN++SFA APSD+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQVGMFCGQEIGNISSFASSGAPSDN 60
Query: 60 VTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR 119
SSSL VKGVARNGSPPWREDDKDGHY+F LG++LT RYKI+SKMGEGTFGQVLECWDR
Sbjct: 61 --SSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 120 ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 179
ERKEMVA+KIVRG+KKYREAAMIEIE+LQQL KHDKGGNRCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 180 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239
LGSSLYDFLRKNNYRSFPIDLVREI QLLEC+AFMHDL MIHTDLKPEN+LLVSS+Y+K
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 299
+P+YK S +D Y KR+PKSSAIKVIDFGSTTYER DQ YIVSTRHYRAPEVILGLG
Sbjct: 239 IPEYKGS-RLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296
Query: 300 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 359
W+YPCD+WSVGCI+VELCTGEALFQTHENLEHLAMMERVLGP PQ MLK+VDRH+EKYVR
Sbjct: 297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356
Query: 360 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 419
RGRLDWP+GA SR+S+K+V+KLPRLQNLIMQHVDHSAG+L +++QGLLR+DP++R+TARE
Sbjct: 357 RGRLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQGLLRFDPSERITARE 416
Query: 420 ALRHPFFTR 428
ALRHPFF R
Sbjct: 417 ALRHPFFAR 425
|
|
| TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1619 (575.0 bits), Expect = 2.0e-166, P = 2.0e-166
Identities = 304/431 (70%), Positives = 348/431 (80%)
Query: 1 MEMERVTEFPFSNLDRRPRKRARLGWDV--PQVPKAQVGLFCGQEVGNVTSFAPPRAPSD 58
+E +R EFP +D+RPRKR RL WD P +P + FA P+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPN- 75
Query: 59 HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 118
++F G+ R GSPPWR DDKDGHY+F +G+ LT RY+I SKMGEGTFGQVLEC+D
Sbjct: 76 -FVYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFD 134
Query: 119 RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178
+ KE+VAIK++R I KYREAAMIEI+VLQ+L +HD GG+RCVQIRNWFDYRNHICIVFE
Sbjct: 135 NKNKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFE 194
Query: 179 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 238
KLG SLYDFLRKN+YRSFPIDLVRE+ RQLLE +A+MHDL +IHTDLKPEN+LLVSSEYI
Sbjct: 195 KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYI 254
Query: 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 298
K+PDYK KD SYFK +PKSSAIK+IDFGSTT+E D NYIVSTRHYRAPEVILG+
Sbjct: 255 KIPDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGV 314
Query: 299 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 358
GW YPCD+WS+GCILVELC+GEALFQTHENLEHLAMMERVLGPLP HM+ R DR +EKY
Sbjct: 315 GWNYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYF 374
Query: 359 RRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 417
RRG +LDWPEGA SR+S+K+V KLPRL NLIMQHVDHSAGDL LLQGLLRYDPT+R A
Sbjct: 375 RRGAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKA 434
Query: 418 REALRHPFFTR 428
REAL HPFFTR
Sbjct: 435 REALNHPFFTR 445
|
|
| TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1292 (459.9 bits), Expect = 9.1e-132, P = 9.1e-132
Identities = 241/376 (64%), Positives = 303/376 (80%)
Query: 55 APSDHVTSSSLFVKGVARNG---SPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFG 111
AP++ ++ +KG +G SPP R+DD+DGHY+F+L +NLT RYKI SKMGEGTFG
Sbjct: 25 APAEPEAKRAV-IKGHGSDGRILSPPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFG 83
Query: 112 QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171
+VLECWDR+ KE VAIKI+R IKKYR+AAMIEI+VLQ+L K DKG RCVQ++NWFDYRN
Sbjct: 84 RVLECWDRDTKEYVAIKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRN 143
Query: 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231
HICIVFEKLG SL+DFL++N Y +FP+ LVR+ QLLE +A+MH+L ++HTDLKPEN+L
Sbjct: 144 HICIVFEKLGPSLFDFLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENIL 203
Query: 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRA 291
LVSSE +K+PD K S + ++F+ +PKSSAIK+IDFGST + + IV TRHYR+
Sbjct: 204 LVSSENVKLPDNKRSA---ANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRS 260
Query: 292 PEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVD 351
PEVILGLGW+Y CD+WS+GCIL ELCTGEALFQTH+NLEHLAMMER LGPLP+HM ++
Sbjct: 261 PEVILGLGWSYQCDLWSIGCILFELCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKAS 320
Query: 352 RHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410
R AEKY RRG RL+WPEGA SRESI++V +L RL++++ +HVD++ LL GLL YD
Sbjct: 321 RGAEKYFRRGCRLNWPEGANSRESIRAVKRLDRLKDMVSKHVDNTRSRFADLLYGLLAYD 380
Query: 411 PTDRLTAREALRHPFF 426
P++RLTA EAL HPFF
Sbjct: 381 PSERLTANEALDHPFF 396
|
|
| POMBASE|SPAC1D4.11c lkh1 "dual specificity protein kinase Lkh1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 840 (300.8 bits), Expect = 3.5e-86, Sum P(2) = 3.5e-86
Identities = 163/352 (46%), Positives = 237/352 (67%)
Query: 81 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 140
DD DGHY +RY + +G GTFG+V++C+D+ AIK+ R I KYREA+
Sbjct: 344 DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREAS 403
Query: 141 MIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 199
+IE+ VLQ +A D N+C+Q+R++FDYR HICIV + G S++DFL+ NNY FP+
Sbjct: 404 LIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLK 463
Query: 200 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS--SEYIKVPDYKSSLHTPKDSSYFK 257
++ +++QL + +AF+H L ++HTDLKPENVLLVS S I++P Y++ Y +
Sbjct: 464 HIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YRN---------YSQ 513
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
++ S I++IDFGS T+E + +VSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL
Sbjct: 514 KVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVELF 573
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR-GRLDWPEGAASRESIK 376
TG+ALFQTHE+ EHL MME++LGP ++M+ R R ++++ + G++ +P ++SI
Sbjct: 574 TGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKSIN 633
Query: 377 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ L L+ + A L LL+ + YDP R+TA+EAL HPFFT+
Sbjct: 634 YLQSLQTLEQIFAVSSPEVAL-LLDLLKKVFVYDPKRRITAKEALWHPFFTQ 684
|
|
| UNIPROTKB|E1B9Q2 CLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 166/351 (47%), Positives = 236/351 (67%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD +GH ++ +G+ L RY+I S +GEGTFG+V++C D R VA+KI++ ++KY+E
Sbjct: 144 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 203
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + D N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +P
Sbjct: 204 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 263
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I VR +A QL + + F+HD + HTDLKPEN+L V+S+Y + +L +D +
Sbjct: 264 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 315
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R KS+A++V+DFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 316 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 375
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTH+N EHLAMMER+LGP+P M+++ + +KY RGRLDW E ++ ++
Sbjct: 376 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 433
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
K P + L + +H L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 434 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|F1P919 CLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 166/351 (47%), Positives = 236/351 (67%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD +GH ++ +G+ L RY+I S +GEGTFG+V++C D R VA+KI++ ++KY+E
Sbjct: 256 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 315
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + D N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +P
Sbjct: 316 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 375
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I VR +A QL + + F+HD + HTDLKPEN+L V+S+Y + +L +D +
Sbjct: 376 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 427
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R KS+A++V+DFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 428 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 487
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTH+N EHLAMMER+LGP+P M+++ + +KY RGRLDW E ++ ++
Sbjct: 488 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 545
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
K P + L + +H L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 546 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 593
|
|
| UNIPROTKB|B1AVT0 CLK2 "Dual-specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 166/351 (47%), Positives = 236/351 (67%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD +GH ++ +G+ L RY+I S +GEGTFG+V++C D R VA+KI++ ++KY+E
Sbjct: 142 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 201
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + D N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +P
Sbjct: 202 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 261
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I VR +A QL + + F+HD + HTDLKPEN+L V+S+Y + +L +D +
Sbjct: 262 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 313
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R KS+A++V+DFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 314 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 373
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTH+N EHLAMMER+LGP+P M+++ + +KY RGRLDW E ++ ++
Sbjct: 374 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 431
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
K P + L + +H L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 432 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 479
|
|
| UNIPROTKB|P49760 CLK2 "Dual specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 166/351 (47%), Positives = 236/351 (67%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD +GH ++ +G+ L RY+I S +GEGTFG+V++C D R VA+KI++ ++KY+E
Sbjct: 144 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 203
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + D N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +P
Sbjct: 204 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 263
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I VR +A QL + + F+HD + HTDLKPEN+L V+S+Y + +L +D +
Sbjct: 264 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 315
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R KS+A++V+DFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 316 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 375
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTH+N EHLAMMER+LGP+P M+++ + +KY RGRLDW E ++ ++
Sbjct: 376 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 433
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
K P + L + +H L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 434 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|F1RLJ5 CLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 166/351 (47%), Positives = 236/351 (67%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD +GH ++ +G+ L RY+I S +GEGTFG+V++C D R VA+KI++ ++KY+E
Sbjct: 144 EDDAEGHLIYHVGDWLQERYEIISTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 203
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + D N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +P
Sbjct: 204 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 263
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I VR +A QL + + F+HD + HTDLKPEN+L V+S+Y + +L +D +
Sbjct: 264 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 315
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R KS+A++V+DFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 316 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 375
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTH+N EHLAMMER+LGP+P M+++ + +KY RGRLDW E ++ ++
Sbjct: 376 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 433
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
K P + L + +H L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 434 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| MGI|MGI:1098669 Clk2 "CDC-like kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 857 (306.7 bits), Expect = 1.1e-85, P = 1.1e-85
Identities = 166/349 (47%), Positives = 235/349 (67%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 138
EDD +GH ++ +G+ L RY+I S +GEGTFG+V++C D R VA+KI++ ++KY+E
Sbjct: 143 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKE 202
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + D N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +P
Sbjct: 203 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 262
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I VR +A QL + + F+HD + HTDLKPEN+L V+S+Y + +L +D +
Sbjct: 263 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 314
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
R KS+A++V+DFGS T++ + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 315 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 374
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTH+N EHLAMMER+LGP+P M+++ + +KY RGRLDW E ++ ++
Sbjct: 375 VGFTLFQTHDNREHLAMMERILGPVPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 432
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
K P + L + DH L L++ +L Y+P RLT EAL+HPFF
Sbjct: 433 NCK-PLRRYLTSEAEDHH--QLFDLIENMLEYEPAKRLTLGEALQHPFF 478
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P51567 | AFC2_ARATH | 2, ., 7, ., 1, 2, ., 1 | 0.8298 | 0.9792 | 0.9929 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pg.C_LG_XV0599 | hypothetical protein (428 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 433 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-73 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-59 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-55 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-50 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-49 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-47 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-37 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-37 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-37 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-37 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-37 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-37 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-36 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-35 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-31 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-30 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-29 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-29 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-28 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-28 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-27 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-26 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-25 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-25 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-24 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-24 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-23 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-23 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-21 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-15 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.001 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.001 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.003 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 230 bits (590), Expect = 1e-73
Identities = 99/333 (29%), Positives = 148/333 (44%), Gaps = 84/333 (25%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 156
Y+I K+GEG+FG+V D++ ++VAIK+++ IKK RE + EI++L++L KH
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPN- 58
Query: 157 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
V++ + F+ + + +V E G L+D L+K D R RQ+L + ++
Sbjct: 59 ---IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYL 113
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
H ++H DLKPEN+LL + +K+ DFG
Sbjct: 114 HSKGIVHRDLKPENILLDEDGH---------------------------VKLADFGLARQ 146
Query: 276 ERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
P + V T Y APEV+LG G+ DIWS+G IL EL TG+ F + L
Sbjct: 147 LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL--E 204
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ +++ P P PE S E+
Sbjct: 205 LFKKIGKPKPP------------------FPPPEWDISPEAK------------------ 228
Query: 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
L++ LL DP RLTA EAL+HPFF
Sbjct: 229 -------DLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 6e-68
Identities = 129/354 (36%), Positives = 197/354 (55%), Gaps = 36/354 (10%)
Query: 83 KDGHYMFALGENL---TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA 139
++GH+ LGE++ T R+KI S +GEGTFG+V+E WDR+RKE A+KIVR + KY
Sbjct: 112 EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRD 171
Query: 140 AMIEIEVLQQLAKHDKGGN-RCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKN---NYR 194
A IEI+ ++++ + D ++I+ +F + H+CIV K G L D++ K+ ++R
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR 231
Query: 195 SFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253
+I Q + + H +L ++HTDLKPEN+L+ +S+ V D ++ P
Sbjct: 232 HLA-----QIIFQTGVALDYFHTELHLMHTDLKPENILMETSD--TVVDPVTNRALP--- 281
Query: 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 313
P +++ D G ER + IVSTRHYR+PEV+LGLGW Y D+WS+GCI+
Sbjct: 282 ------PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335
Query: 314 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEK--YVRRGRLDWPEGAAS 371
EL TG+ L+ TH+NLEHL +ME+ LG LP R + Y G+L
Sbjct: 336 YELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQL---RPCTD 392
Query: 372 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+ + + + ++ +I + L L+ GLL YD RL AR+ HP+
Sbjct: 393 PKHLARIARARPVREVIRDDL------LCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 2e-59
Identities = 89/336 (26%), Positives = 147/336 (43%), Gaps = 84/336 (25%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 155
Y++ K+G G+FG V + + ++VA+KI++ K + A EI +L++L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V++ + F+ ++H+ +V E G L+D+L + D ++IA Q+L + +
Sbjct: 60 I----VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEY 113
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 273
+H +IH DLKPEN+LL + +K+ DFG +
Sbjct: 114 LHSNGIIHRDLKPENILLDENGVVKI---------------------------ADFGLAK 146
Query: 274 TYERPDQNY--IVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
+ + V T Y APEV+L G G+ D+WS+G IL EL TG+ F L+
Sbjct: 147 KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD 206
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
L ++ R+LGP D P+ ++ E
Sbjct: 207 QLQLIRRILGPPL------------------EFDEPKWSSGSE----------------- 231
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ L++ L DP+ R TA E L+HP+F
Sbjct: 232 -------EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 104/340 (30%), Positives = 161/340 (47%), Gaps = 69/340 (20%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMI--EIEVLQQLAKHD 154
YK+ ++G+GTFG V ++E E+VAIK + KK+ E M E++ L++L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V+++ F + + VFE + +LY ++ + F ++R I Q+L+ +A
Sbjct: 59 N----IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--S 272
+H H DLKPEN LLVS + +K+ DFG
Sbjct: 115 IHKHGFFHRDLKPEN-LLVSGPEV--------------------------VKIADFGLAR 147
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLE 330
RP VSTR YRAPE++L Y P DIW++GCI+ EL T LF ++
Sbjct: 148 EIRSRPPYTDYVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
Query: 331 HLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGA--ASRESIKSVMKLPRL-QN 386
L + VLG P Q DWPEG AS+ + P+
Sbjct: 207 QLYKICSVLGTPTKQ-------------------DWPEGYKLASKLGF----RFPQFAPT 243
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ Q + +++ + L++ +LR+DP R TA +AL+HP+F
Sbjct: 244 SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 3e-50
Identities = 97/350 (27%), Positives = 157/350 (44%), Gaps = 90/350 (25%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAK 152
Y+ K+GEGT+G V + D++ E+VA+K +R GI A+ EI +L++L K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS---TALREISLLKEL-K 56
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
H N V++ + + +VFE L +L +L++ I QLL +
Sbjct: 57 HP---N-IVKLLDVIHTERKLYLVFEYCDMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGL 111
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
A+ H ++H DLKP+N +L++ + + +K+ DFG
Sbjct: 112 AYCHSHRILHRDLKPQN-ILINRDGV--------------------------LKLADFGL 144
Query: 272 STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
+ + P + Y V T YRAPE++LG ++ DIWSVGCI E+ TG+ LF
Sbjct: 145 ARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204
Query: 329 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
++ L + ++LG P + WP V KLP +
Sbjct: 205 IDQLFKIFQILGTPTEE-------------------SWPG----------VTKLPDYKPT 235
Query: 388 IMQH-----------VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ +D D LL +L+Y+P R++A+EAL+HP+F
Sbjct: 236 FPKFPPKDLEKVLPRLDPEGID---LLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-49
Identities = 100/337 (29%), Positives = 164/337 (48%), Gaps = 58/337 (17%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHD 154
+Y++ +GEG +G VL+C ++ E+VAIK + ++ A+ E++VL+QL +H+
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHE 60
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V ++ F + + +VFE + +L + L + P D VR QLL+ IA+
Sbjct: 61 N----IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAY 115
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
H +IH D+KPEN +LVS +S +K+ DFG
Sbjct: 116 CHSHNIIHRDIKPEN-ILVS--------------------------ESGVLKLCDFGFAR 148
Query: 275 Y--ERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
RP V+TR YRAPE+++G + P D+W++GCI+ EL GE LF ++
Sbjct: 149 ALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
+ L ++++ LGPLP + + R + +PE + ES++ R +
Sbjct: 209 DQLYLIQKCLGPLPPSHQELFSSNP----RFAGVAFPE-PSQPESLER-----RYPGKV- 257
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ L+ LR DP +RLT E L+HP+F
Sbjct: 258 ------SSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 9e-47
Identities = 100/343 (29%), Positives = 153/343 (44%), Gaps = 75/343 (21%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAK 152
Y+ K+GEGT+G V + D+ E+VAIK ++ GI K A+ EI++L++L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK---TALREIKLLKEL-N 56
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
H +++ + F ++ + +VFE + + LY ++ R P L++ QLL+ +
Sbjct: 57 HPN----IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGL 111
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
AF H ++H DLKPEN+L+ +K+ DFG
Sbjct: 112 AFCHSHGILHRDLKPENLLI---------------------------NTEGVLKLADFGL 144
Query: 273 TTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 328
V TR YRAPE++LG G++ P DIWSVGCI EL + LF
Sbjct: 145 ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204
Query: 329 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGA----ASRESIKSVMKLPR 383
++ L + R LG P P+ WP+ + S +P
Sbjct: 205 IDQLFKIFRTLGTPDPEV-------------------WPKFTSLARNYKFSFPKKAGMP- 244
Query: 384 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ + A D LL +L YDP R+TA +AL HP+F
Sbjct: 245 -LPKLFPNASPQALD---LLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-44
Identities = 100/346 (28%), Positives = 153/346 (44%), Gaps = 76/346 (21%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHD 154
RYKI ++GEG G V + DRE E VA+K + R A+ EI+ LQ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHP 59
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V++ + F + + +V E + S L + LR + R P V+ R LL+ +A+
Sbjct: 60 ----YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAY 114
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGS 272
MH ++H DLKP N+L+ + +K+ D+ + + Y +
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-------------- 160
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331
V+TR YRAPE++ G + D+W+VGCI EL G LF ++E
Sbjct: 161 -----------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ 209
Query: 332 LAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM- 389
LA++ R LG P + WP + LP +
Sbjct: 210 LAIVFRTLGTPNEE-------------------TWPG----------LTSLPDYNKITFP 240
Query: 390 --------QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
+ ++ + LL+GLL YDP+ RL+A EALRHP+FT
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-44
Identities = 73/218 (33%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
GEG FG V D++ + VAIKI++ E + EIE+L++L H V++
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHP----NIVKL 56
Query: 164 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 222
F+ NH+ +V E G SL D L++N + D + I Q+LE + ++H +IH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 223 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 282
DLKPEN+LL S +K+ DFG + D++
Sbjct: 116 RDLKPENILLDSDNGK--------------------------VKLADFGLSKLLTSDKSL 149
Query: 283 ---IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVEL 316
IV T Y APEV+LG G ++ DIWS+G IL EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 90/343 (26%), Positives = 148/343 (43%), Gaps = 71/343 (20%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMI-EIEVLQQLA 151
Y+ +++GEG +G V + D VA+K VR GI + + EI +L+QL
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP----LSTLREIALLKQLE 56
Query: 152 KHDKGGNRCVQIR----NWFDYRN-HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 206
+ V++ R + +VFE + L +L K P + ++++ R
Sbjct: 57 SFEH--PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR 114
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
QLL + F+H ++H DLKP+N+L+ S +K+ D+ + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA-------------------R 155
Query: 267 VIDFGS--TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
+ F T+ +V T YRAPEV+L + P D+WSVGCI EL LF+
Sbjct: 156 IYSFEMALTS--------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207
Query: 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPR 383
+ L + V+G + +WP + R S S PR
Sbjct: 208 GTSEADQLDKIFDVIGLPSEE------------------EWPRNVSLPRSSFPS--YTPR 247
Query: 384 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ + D LL+ +L ++P R++A EAL+HP+F
Sbjct: 248 SFKSFVPEICEEGLD---LLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 100/343 (29%), Positives = 169/343 (49%), Gaps = 72/343 (20%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIK---------IVRGIKKYREAAMIEIEVLQ 148
+Y+ SK+GEG++G V +C +RE ++VAIK +++ I A+ EI +L+
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI------ALREIRMLK 55
Query: 149 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 208
QL KH V + F + + +VFE ++ + L KN R P L+++I Q
Sbjct: 56 QL-KH----PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQT 109
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
L+ + F H IH D+KPEN+L+ K IK+
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---------------------------KQGQIKLC 142
Query: 269 DFG-STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 324
DFG + P +Y V+TR YRAPE+++G + P D+W++GC+ EL TG+ L+
Sbjct: 143 DFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202
Query: 325 THENLEHLAMMERVLGPL-PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 383
+++ L ++ + LG L P+H +++ ++ + + PE +RE ++ K P
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRH--QQIFS-TNQFFKGLSIPEPE---TREPLE--SKFPN 254
Query: 384 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ + + L+G L+ DPT+RL+ E L HP+F
Sbjct: 255 ISSPALS-----------FLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 96/355 (27%), Positives = 153/355 (43%), Gaps = 81/355 (22%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHD 154
RY++ +G G +G V D+ VAIK I +A I EI++L+ L +H+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHE 59
Query: 155 KGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR--- 206
N + + + + N + IV E + + L+ ++ P L + +
Sbjct: 60 ---N-IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFL 109
Query: 207 -QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
Q+L + ++H +IH DLKP N+L+ S+ +
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILVNSN---------------------------CDL 142
Query: 266 KVIDFG----STTYERPDQN---YIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 317
K+ DFG E Y+V TR YRAPE++L +T DIWSVGCI EL
Sbjct: 143 KICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
T + LF + ++ L ++ VLG + LK + +R +KS
Sbjct: 202 TRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI----------------TSEKARNYLKS 245
Query: 378 VMKLPRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ K P+ + L + A D LL+ +L +DP R+TA EAL HP+ + H
Sbjct: 246 LPKKPK-KPLSKLFPGASPEAID---LLEKMLVFDPKKRITADEALAHPYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 101/336 (30%), Positives = 154/336 (45%), Gaps = 62/336 (18%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 154
YKI K+GEGTF +VL+ R+ + AIK K ++ + EI+ L++L+ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPH- 57
Query: 155 KGGNRCVQIRNWFDYR-NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
N I FD + + +VFE + +LY+ + K R P V+ QLL+ +
Sbjct: 58 --PNILRLIEVLFDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS- 272
MH + H D+KPEN+L+ K +K+ DFGS
Sbjct: 115 HMHRNGIFHRDIKPENILI----------------------------KDDILKLADFGSC 146
Query: 273 -TTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLE 330
Y +P +STR YRAPE +L G + DIW+VGC+ E+ + LF L+
Sbjct: 147 RGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
+A + VLG +LK+ + ++P K L +L +
Sbjct: 207 QIAKIHDVLGTPDAEVLKKFRKSRHM-----NYNFPS--------KKGTGLRKL----LP 249
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ D LL+ LL YDP +R+TA++ALRHP+F
Sbjct: 250 NASAEGLD---LLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 4e-37
Identities = 90/341 (26%), Positives = 153/341 (44%), Gaps = 66/341 (19%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA------AMIEIEVLQQLA 151
RY+ K+GEGT+ V + D+E +VAIK ++ ++ A+ EI++LQ+L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
KH + + + F ++++I +VFE + + L ++ + P D ++ L
Sbjct: 60 KHPN----IIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTLRG 114
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ ++H ++H DLKP N LL++S+ + +K+ DFG
Sbjct: 115 LEYLHSNWILHRDLKPNN-LLIASDGV--------------------------LKLADFG 147
Query: 272 -STTYERPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 327
+ ++ P++ V TR YRAPE++ G + D+WSVGCI EL
Sbjct: 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207
Query: 328 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+++ L + LG P + +WP G S P
Sbjct: 208 DIDQLGKIFEALGTPTEE-------------------NWP-GVTSLPDYVEFKPFPPTP- 246
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
+ Q ++ D LLQ LL +P R+TAR+AL HP+F+
Sbjct: 247 -LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 103/357 (28%), Positives = 156/357 (43%), Gaps = 76/357 (21%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEI 144
+++ +Y+I K+G+G +G V + DR KE+VA+K + + +RE I
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE-----I 57
Query: 145 EVLQQLAKHDKGGNRCVQIRNWFDYRNH--ICIVFEKLGSSLYDFLRKNNYRSFPIDLVR 202
LQ+L H V++ N N I +VFE + + L+ +R N R
Sbjct: 58 MFLQELGDHPN----IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED---VHKR 110
Query: 203 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 262
I QLL+ + ++H +IH DLKP N+LL +S
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILL-------------------NSDCR------ 145
Query: 263 SAIKVIDFG--------STTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCIL 313
+K+ DFG E P V+TR YRAPE++LG T D+WSVGCIL
Sbjct: 146 --VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203
Query: 314 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 373
E+ G+ LF L L + V+GP ++ + P A +
Sbjct: 204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS-------------PFAATMLD 250
Query: 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
S+ S + P + ++ A D LL+ LL ++P RLTA EAL HP+ + H
Sbjct: 251 SLPSRPRKPLDE--LLPKASDDALD---LLKKLLVFNPNKRLTAEEALEHPYVAQFH 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 94/358 (26%), Positives = 149/358 (41%), Gaps = 101/358 (28%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHD 154
Y+ +++GEGT+GQV + +++ E+VA+K +R ++ +E A+ EI++LQ+L +H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKL-RHP 58
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLY--------DF---LRKNNYRSFPIDLVRE 203
V++ IV K S+Y D L + F ++
Sbjct: 59 N----IVRL---------KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKC 104
Query: 204 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
+QLLE + ++H ++H D+K N+L+ + L
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILI---------NNDGVL---------------- 139
Query: 264 AIKVIDFG-STTYE---RPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 318
K+ DFG + Y D V T YR PE++LG + D+WSVGCIL EL
Sbjct: 140 --KLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197
Query: 319 GEALFQTHENLEHLAMMERVLGP----------LPQHMLKRVDRHAEKYVRRGRLDWPEG 368
G+ +FQ LE L + + G + + Y RR
Sbjct: 198 GKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF--ENLKPKKPYKRR-------- 247
Query: 369 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
RE K ++ D SA D LL LL DP R++A +AL+H +F
Sbjct: 248 --LREFFKHLI-------------DPSALD---LLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 94/335 (28%), Positives = 163/335 (48%), Gaps = 53/335 (15%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 153
+++++ +GEG +G VL+C +E KE+VAIK + ++ +E + E+++L+ L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
+ V+++ F R + +VFE + ++ + L + P + VR QL++ I
Sbjct: 61 N-----IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIH 114
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+ H ++H D+KPEN+L+ ++ +K+ D+ F
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDF-------------------------GFARN 149
Query: 274 TYERPDQNYI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331
E + NY V+TR YR+PE++LG + D+WSVGCIL EL G+ LF ++
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209
Query: 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391
L +++VLGPLP +K + R L +P ++ L R I+
Sbjct: 210 LFTIQKVLGPLPAEQMKLFYSNP----RFHGLRFP-------AVNHPQSLERRYLGILS- 257
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
G L L++ LL+ +PTDR + L HP F
Sbjct: 258 -----GVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 92/348 (26%), Positives = 139/348 (39%), Gaps = 93/348 (26%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNR 159
++GEGT+G V D E+VA+K VR + R+ I EI +L L +H
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNL-RHPN---- 67
Query: 160 CVQIRNWF--DYRNHICIVFE----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V+++ + + I +V E L S L N F V+ + QLL +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQ 122
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 272
++H+ +IH DLK N+L + +K+ DFG +
Sbjct: 123 YLHENFIIHRDLKVSNLL---------------------------LTDKGCLKIADFGLA 155
Query: 273 TTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
TY P + V T YRAPE++LG +T D+W+VGCIL EL + L +
Sbjct: 156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
E L ++ ++LG + + WP LP + +
Sbjct: 216 EQLDLIIQLLGTPNESI------------------WP----------GFSDLPLVGKFTL 247
Query: 390 QHVDHSAGDLTH-----------LLQGLLRYDPTDRLTAREALRHPFF 426
++ +L H LL LL YDP R TA EAL +F
Sbjct: 248 PKQPYN--NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-33
Identities = 88/345 (25%), Positives = 138/345 (40%), Gaps = 71/345 (20%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHD 154
Y+I K+GEG+FG+V DR+ VA+K++ K E + EI++L L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP- 57
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-SFPIDLVREIARQLLECI 212
V++ ++F + +V E + G SL D L+K + I Q+L +
Sbjct: 58 ---PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEY-IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
++H +IH D+KPEN+LL +K+ D+ A + D G
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDF------------------GLAKLLPDPG 156
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPC---DIWSVGCILVELCTGEALFQTHEN 328
ST+ + V T Y APEV+LGL Y DIWS+G L EL TG F+ +N
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
+ +++ LP L L
Sbjct: 217 SSATSQTLKIILELPTPSLA------------------------------------SPLS 240
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 433
+ + + + LL+ LL DP +RL++ L H L+
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285
|
Length = 384 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-33
Identities = 91/342 (26%), Positives = 151/342 (44%), Gaps = 69/342 (20%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHD 154
Y+ +++ EGT+G V D++ E+VA+K ++ ++K +E ++ EI +L +L +H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKL-QHP 64
Query: 155 KGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
V ++ + I +V E + L + + + F V+ + QLL +
Sbjct: 65 N----IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGV 119
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
A +HD ++H DLK N+L + +K+ DFG
Sbjct: 120 AHLHDNWILHRDLKTSNLL---------------------------LNNRGILKICDFGL 152
Query: 272 STTYERPDQNY--IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHEN 328
+ Y P + Y +V T YRAPE++LG ++ D+WSVGCI EL T + LF
Sbjct: 153 AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
++ L + ++LG P EK WP G + K N +
Sbjct: 213 IDQLNKIFKLLG-TPT----------EK-------IWP-GFSELPGAKKKTFTKYPYNQL 253
Query: 389 MQHVDHSAGDLTH----LLQGLLRYDPTDRLTAREALRHPFF 426
+ L+ LL LL YDP R++A +AL+HP+F
Sbjct: 254 RKKFPA--LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 100/335 (29%), Positives = 156/335 (46%), Gaps = 69/335 (20%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 157
K+GEGT+G V + ++ E+VA+K +R G+ A+ EI +L++L H
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL-NHPN-- 60
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V++ + N + +VFE L L F+ + P+ L++ QLL+ +AF H
Sbjct: 61 --IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 276
++H DLKP+N LL+++E AIK+ DFG + +
Sbjct: 119 HRVLHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFG 151
Query: 277 RPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
P + Y V T YRAPE++LG ++ DIWS+GCI E+ T ALF ++ L
Sbjct: 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 391
+ R LG P ++ WP + + S K R Q+ ++
Sbjct: 212 RIFRTLGT-PDEVV-----------------WPGVTSLPDYKPSFPKWAR-QDFSKVVPP 252
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+D D LL +L YDP R++A+ AL HPFF
Sbjct: 253 LDEDGRD---LLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 90/333 (27%), Positives = 152/333 (45%), Gaps = 55/333 (16%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 156
+K K+GEGT+ V + +R E+VA+K + + A+ EI ++++L KH+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHEN- 59
Query: 157 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFM 215
V++ + N + +VFE + L ++ + + + V+ QLL+ IAF
Sbjct: 60 ---IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
H+ ++H DLKP+N+L+ +K+ D+ + ++ I V F +
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFG--------------LARAFGIPVNTFSNE-- 160
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPC--DIWSVGCILVELCTGEALFQTHENLEHLA 333
V T YRAP+V+LG TY DIWSVGCI+ E+ TG LF N + L
Sbjct: 161 --------VVTLWYRAPDVLLG-SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ R++G + + + E + +P LQ L
Sbjct: 212 KIFRIMGTPTESTWPGISQLPEY-----KPTFPRYPPQ-----------DLQQLF----P 251
Query: 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
H+ LL LL+ +P R++A +AL+HP+F
Sbjct: 252 HADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 82/331 (24%), Positives = 137/331 (41%), Gaps = 83/331 (25%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGG 157
++I K+G+G FG+V + + + VAIK+++ K+ +E + EI++L++ KH
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KH---P 57
Query: 158 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
N V+ + ++ + IV E G SL D L K+ ++ + + ++LL+ + ++H
Sbjct: 58 N-IVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 275
+IH D+K N+LL S +K+IDFG S
Sbjct: 116 SNGIIHRDIKAANILLTS---------------------------DGEVKLIDFGLSAQL 148
Query: 276 E-RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334
+N +V T ++ APEVI G + Y DIWS+G +EL G+ + E A+
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--SELPPMKAL 206
Query: 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
+ P L PE S E
Sbjct: 207 FKIATNGPP------------------GLRNPE-KWSDE--------------------- 226
Query: 395 SAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
L+ L+ +P R TA + L+HPF
Sbjct: 227 ----FKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 99/342 (28%), Positives = 164/342 (47%), Gaps = 70/342 (20%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHD 154
+Y+ +GEG++G V++C +E ++VAIK K ++ AM EI +L+QL +H+
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHE 60
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL----VREIARQLLE 210
V + F + + +VFE + ++ D L K +P L VR+ Q+L
Sbjct: 61 N----LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-----YPNGLDESRVRKYLFQILR 111
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
I F H +IH D+KPEN+L VS +S +K+ DF
Sbjct: 112 GIEFCHSHNIIHRDIKPENIL-VS--------------------------QSGVVKLCDF 144
Query: 271 G-STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 326
G + T P + Y V+TR YRAPE+++G + DIW+VGC++ E+ TGE LF
Sbjct: 145 GFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+++ L + + LG L + RH E + + + + M+LP ++
Sbjct: 205 SDIDQLYHIIKCLGNL-------IPRHQEIF-------------QKNPLFAGMRLPEVKE 244
Query: 387 L--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ + + +G + L + LR DP DR ++ + L H FF
Sbjct: 245 IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 80/339 (23%), Positives = 132/339 (38%), Gaps = 72/339 (21%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHD 154
+K +GEG+F V+ ++E + AIKI+ + +E IE EVL +L H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH- 61
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
G +++ F ++ V E L ++RK Y S R A ++L +
Sbjct: 62 PG---IIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALE 116
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++H +IH DLKPEN+LL +IK+ D+ ++ +SS S +
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS------PESNKGDATNIDS 170
Query: 274 TYERPDQN--YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331
E+ + V T Y +PE++ D+W++GCI+ ++ TG+ F+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR------- 223
Query: 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391
G +++ E +P P ++LI
Sbjct: 224 --------GSNEYLTFQKI-LKLE-------YSFPPNFP-----------PDAKDLI--- 253
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRLTA----REALRHPFF 426
+ LL DP DRL E HPFF
Sbjct: 254 ------------EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 65/258 (25%), Positives = 111/258 (43%), Gaps = 54/258 (20%)
Query: 106 GEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 162
G G+FG V D++ E++A+K + ++ EA EI +L L +H V+
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QH----PNIVR 63
Query: 163 IR--NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
+ +N + I E + G SL L+K + P ++R+ RQ+LE +A++H
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
++H D+K N+L+ S +K+ DFG D
Sbjct: 122 IVHRDIKGANILVDSD---------------------------GVVKLADFGCAK-RLGD 153
Query: 280 QNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
T R APEVI G + DIWS+GC ++E+ TG+ + E +A
Sbjct: 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMA 211
Query: 334 MMERVLG-----PLPQHM 346
+ ++ +P+H+
Sbjct: 212 ALYKIGSSGEPPEIPEHL 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 98/345 (28%), Positives = 157/345 (45%), Gaps = 68/345 (19%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMI--EIEVLQQLAKHD 154
RYKI +G+G++G V D E VAIK + + ++ +A I EI++L+ L D
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 155 KGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE----I 204
V+I++ ++++ I +VFE + S L+ ++ N+ DL E
Sbjct: 61 -----IVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQFF 108
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
QLL + ++H + H DLKP+N+L + +K+ D+ + D+ +A
Sbjct: 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--------TA 160
Query: 265 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEAL 322
I D+ V+TR YRAPE+ +T DIWS+GCI E+ TG+ L
Sbjct: 161 IFWTDY-------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
F + L ++ +LG + RV + A +Y+ R P + K
Sbjct: 208 FPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP--------VPFSQKF 259
Query: 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
P L ++ LL+ LL +DP DR TA EAL P+F
Sbjct: 260 PNADPLALR-----------LLERLLAFDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 95/336 (28%), Positives = 150/336 (44%), Gaps = 71/336 (21%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 157
K+GEGT+G V + D+ E+VA+K +R G+ A+ EI +L++L H
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP---STAIREISLLKEL-NHPN-- 59
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V++ + N + +VFE L L ++ + L++ QLL+ IA+ H
Sbjct: 60 --IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 276
++H DLKP+N+L+ + A+K+ DFG + +
Sbjct: 118 HRVLHRDLKPQNLLI---------------------------DREGALKLADFGLARAFG 150
Query: 277 RPDQNYI--VSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHL 332
P + Y V T YRAPE++LG Y P DIWS+GCI E+ LF ++ L
Sbjct: 151 VPVRTYTHEVVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209
Query: 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQ 390
+ R LG + + WP G S K Q+L ++
Sbjct: 210 FRIFRTLGTPDEDV------------------WP-GVTSLPDYKPTFPKWARQDLSKVVP 250
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
++D D LL +L YDP R++A+ AL+HP+F
Sbjct: 251 NLDEDGLD---LLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 92/355 (25%), Positives = 155/355 (43%), Gaps = 75/355 (21%)
Query: 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLA 151
+ SRYK +G G +G V D + VAIK I A + E+++L+
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF- 61
Query: 152 KHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 206
KHD + IR+ D++ + +V + + S L+ + + + + +R
Sbjct: 62 KHDN----IIAIRDILRPPGADFK-DVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLY 114
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSS 263
QLL + ++H +IH DLKP N+L+ +++ D+ + +P + YF M
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF--M---- 168
Query: 264 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL 322
T Y V+TR YRAPE++L L +T D+WSVGCI E+ L
Sbjct: 169 ---------TEY--------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLK-----RVDRHAEKYVRRGRLDWPE--GAASRESI 375
F + L ++ VLG + +L RV ++ + R+ + W + AS E++
Sbjct: 212 FPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEAL 271
Query: 376 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
LL +L++DP +R+T +AL+HPF + H
Sbjct: 272 D-------------------------LLSQMLQFDPEERITVEQALQHPFLAQYH 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 97/375 (25%), Positives = 155/375 (41%), Gaps = 105/375 (28%)
Query: 98 RYKIHSKMGEGTFGQVLECW--DRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLA 151
+Y+I +G GT+G+V + + + + AIK +G K+ +A EI +L++L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL- 59
Query: 152 KHDKGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFL------RKNNYRSFPIDLVRE 203
KH+ V + F + ++F+ + +D R+ S P +V+
Sbjct: 60 KHEN----VVSLVEVFLEHADKSVYLLFD---YAEHDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 204 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
+ Q+L + ++H ++H DLKP N+L++ P+
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEG-----------------------PERG 149
Query: 264 AIKVIDFG-STTYERP-----DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVEL 316
+K+ D G + + P D + +V T YRAPE++LG +T DIW++GCI EL
Sbjct: 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
Query: 317 CTGEALFQTHE------NLEHLAMMER---VLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 367
T E +F+ E N +ER VLG P EK DWP+
Sbjct: 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT-PT----------EK-------DWPD 251
Query: 368 GAASRESIKSVMKLPRLQNLIMQH------------VDHSAGDLT----HLLQGLLRYDP 411
+ K+P L+ LL+ LL YDP
Sbjct: 252 ----------IKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301
Query: 412 TDRLTAREALRHPFF 426
T R+TA EAL HP+F
Sbjct: 302 TKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 98/347 (28%), Positives = 152/347 (43%), Gaps = 74/347 (21%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAK 152
Y+ K+GEGT+G+V + D+ ++VA+K R GI A+ EI +LQ L+
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPP---TALREISLLQMLS- 58
Query: 153 HDKGGNRCVQIRNWFDYRNHICI--VFEKLGSSLYDFL---RKNNYRSFPIDLVREIARQ 207
R + + + + + VFE L S L F+ + R P ++ Q
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
LL+ +A H ++H DLKP+N+L+ + + +K+
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--------------------------LKI 152
Query: 268 IDFG-STTYERPDQNYI--VSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEAL 322
D G + P ++Y + T YRAPEV+LG Y P DIWSVGCI E+ + L
Sbjct: 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPL 211
Query: 323 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
F L+ L + ++LG P Q WP + R+ +
Sbjct: 212 FPGDSELQQLLHIFKLLGTPTEQ-------------------VWPGVSKLRDWHEFPQWK 252
Query: 382 PRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
P Q+L + + D LLQ +LRYDP R++A+ AL HP+F
Sbjct: 253 P--QDLSRAVPDLSPEGLD---LLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 95/335 (28%), Positives = 159/335 (47%), Gaps = 68/335 (20%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 157
K+GEGT+G V + +++ ++VA+K +R G+ A+ EI +L++L +H
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKEL-QHPN-- 60
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSL---YDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V +++ + + ++FE L L D L K Y +LV+ Q+L+ I F
Sbjct: 61 --IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGILF 116
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
H ++H DLKP+N+L+ + IK+ D+ + ++ I V + T
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFG--------------LARAFGIPVRVY---T 159
Query: 275 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
+E V T YRAPEV+LG ++ P DIWS+G I E+ T + LF ++ L
Sbjct: 160 HE-------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 391
+ R+LG P WP G S K+ + +L +++
Sbjct: 213 RIFRILGT-PTE-----------------DVWP-GVTSLPDYKNTFPKWKKGSLRSAVKN 253
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+D D LL+ +L YDP R++A++AL HP+F
Sbjct: 254 LDEDGLD---LLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 95/355 (26%), Positives = 153/355 (43%), Gaps = 76/355 (21%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVL 147
G+ ++ I ++GEGT+GQV + D++ E+VA+K VR + +E A+ EI++L
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKIL 60
Query: 148 QQLAKHDKGGNRC---VQIRNWFDYRNH---ICIVFEKLGSSLYDFLRKNNYRSFPIDLV 201
+QL H N ++ D++ +VFE + L L ++ F D +
Sbjct: 61 RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDHI 118
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
+ +QLLE + + H +H D+K N+LL + IK+ D+ + + S
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES------- 171
Query: 262 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPC-DIWSVGCILVELCTGE 320
RP N ++ T YR PE++LG P D+WS GCIL EL T +
Sbjct: 172 ---------------RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
Query: 321 ALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 379
+FQ ++ L L ++ R+ G P P WP+ V+
Sbjct: 216 PIFQANQELAQLELISRLCGSPCPA-------------------VWPD----------VI 246
Query: 380 KLPRLQNL---------IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
KLP + + + LL +L DP+ R TA EAL P+
Sbjct: 247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 81/329 (24%), Positives = 134/329 (40%), Gaps = 88/329 (26%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 161
G+G+FG+VL ++ ++ A+K+++ I K +E E +L ++ H V
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHP----FIV 56
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
++ F + +V E G L+ L K F + R A +++ + ++H L +
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
I+ DLKPEN+LL + +IK+ D+ A ++ GS T
Sbjct: 115 IYRDLKPENILLDADGHIKLTDF------------------GLAKELSSEGSRTNT---- 152
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 340
T Y APEV+LG G+ D WS+G +L E+ TG+ F + E + E++L
Sbjct: 153 --FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKIL- 206
Query: 341 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400
+ L +PE + +
Sbjct: 207 -------------------KDPLRFPEFLSP--------------------------EAR 221
Query: 401 HLLQGLLRYDPTDRLTAREA---LRHPFF 426
L+ GLL+ DPT RL + A HPFF
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 86/337 (25%), Positives = 142/337 (42%), Gaps = 57/337 (16%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 154
+Y+ +++G G +G V + D VA+K VR + + E+ +L++L D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 155 -----KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
+ + C R D + +VFE + L +L K P + ++++ RQ L
Sbjct: 61 HPNIVRLMDVCATSRT--DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ F+H C++H DLKPEN+L+ S +K+ D+ + Y +M +
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA------RIYSCQMALTP------ 166
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
+V T YRAPEV+L + P D+WSVGCI E+ + LF +
Sbjct: 167 -------------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
+ L + ++G P+ DWP S PR +
Sbjct: 214 DQLGKIFDLIGLPPED------------------DWPRDVTLPRGAFS----PRGPRPVQ 251
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
V LL +L ++P R++A AL+HPFF
Sbjct: 252 SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 81/328 (24%), Positives = 129/328 (39%), Gaps = 78/328 (23%)
Query: 108 GTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRCVQI 163
G +G+V + ++ AIK+++ R+ + E ++L Q V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-----SPYVVKL 58
Query: 164 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 222
F + ++ +V E L G L L N S D+ R +++ + ++H +IH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 223 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 282
DLKP+N+L+ S+ ++K+ D+ L S + + + +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDF--GL------SKVGLVRRQINLNDDEKEDKR-------- 160
Query: 283 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 342
IV T Y APEVILG G + D WS+GCIL E G F H E +
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF--HGETP-----EEIF--- 210
Query: 343 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402
Q++L G+++WPE V +LI
Sbjct: 211 -QNILN------------GKIEWPED---------VEVSDEAIDLI-------------- 234
Query: 403 LQGLLRYDPTDRLTAR---EALRHPFFT 427
LL DP RL A+ E HPFF
Sbjct: 235 -SKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 81/340 (23%), Positives = 143/340 (42%), Gaps = 93/340 (27%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHD 154
+Y+I ++G+G+FG+V + ++ +K + +K RE A+ E+++L++L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLVREIARQLLEC 211
N ++ F+ + +CIV E G L + +K + FP + + + QL
Sbjct: 60 ---N-IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ ++H ++H D+KP+N+ L +S + +K+ DFG
Sbjct: 116 LKYLHSRKILHRDIKPQNIFL-TSNGL--------------------------VKLGDFG 148
Query: 272 -STTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
S +V T +Y +PE+ + Y DIWS+GC+L ELCT + F+ EN
Sbjct: 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GEN 207
Query: 329 LEHLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
L LA+ ++ P+P Y S E L+N
Sbjct: 208 LLELALKILKGQYPPIPSQ-----------Y-------------SSE----------LRN 233
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
L+ LL+ DP +R + + L+ PF
Sbjct: 234 LV---------------SSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 85/349 (24%), Positives = 144/349 (41%), Gaps = 62/349 (17%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLA 151
Y+I K+GEGTFG+V + + +VA+K + + ++ A+ EI++L++L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL-MHNEKDGFPITALREIKILKKLK 65
Query: 152 -------------KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI 198
+ DK + R + +V + L L + +
Sbjct: 66 HPNVVPLIDMAVERPDKSKRK----------RGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 199 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258
++ QLLE I ++H+ ++H D+K N+L+ + +K+ D+ L P D
Sbjct: 116 Q-IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF--GLARPYDGP--PP 170
Query: 259 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 317
PK G R N +V TR YR PE++LG +T DIW +GC+ E+
Sbjct: 171 NPKG--------GGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
T + Q +++ L ++ ++ G + WP G S +
Sbjct: 222 TRRPILQGKSDIDQLHLIFKLCGTPTEE------------------TWP-GWRSLPGCEG 262
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
V + + + LL LL DP RLTA +AL HP+F
Sbjct: 263 VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 84/370 (22%), Positives = 155/370 (41%), Gaps = 83/370 (22%)
Query: 93 ENLTSRYK-IHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYRE------- 138
+++ RY + +GEGT+G+V + +D ++VAIK V+ + K R+
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 139 --AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSF 196
+ E++++ ++ + G V + F I +V + + S L + +
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDF-----INLVMDIMASDLKKVV--DRKIRL 116
Query: 197 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDS 253
V+ I Q+L + +H +H DL P N+ + S K+ D+ + + P
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCI 312
+ K ++ T + V T YRAPE+++G + + D+WSVGCI
Sbjct: 177 TLSKDETMQRREEM------TSK-------VVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223
Query: 313 LVELCTGEALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEG--- 368
EL TG+ LF ++ L + +LG P +WP+
Sbjct: 224 FAELLTGKPLFPGENEIDQLGRIFELLGTPNED-------------------NWPQAKKL 264
Query: 369 -------AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 421
+ +K++ +++ D LLQ LL+ +P +R++A+EAL
Sbjct: 265 PLYTEFTPRKPKDLKTIFP-------------NASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 422 RHPFFTRDHL 431
+H +F D L
Sbjct: 312 KHEYFKSDPL 321
|
Length = 335 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 92/339 (27%), Positives = 157/339 (46%), Gaps = 64/339 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKH 153
+Y+ K+GEGT+G V + DR E +A+K +R +++ E A+ EI +L+++ +H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEM-QH 60
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V++++ + +VFE L L + + + L++ Q+L IA
Sbjct: 61 GN----IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 272
+ H ++H DLKP+N+L+ ++A+K+ DFG +
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRR--------------------------TNALKLADFGLA 150
Query: 273 TTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
+ P + + V T YRAPE++LG ++ P DIWSVGCI E+ + LF +
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL-- 387
+ L + R+LG + WP G S KS ++L
Sbjct: 211 DELFKIFRILGTPNEET------------------WP-GVTSLPDYKSAFPKWPPKDLAT 251
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
++ ++ + D LL +LR DP+ R+TAR AL H +F
Sbjct: 252 VVPTLEPAGVD---LLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 97/349 (27%), Positives = 152/349 (43%), Gaps = 85/349 (24%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLA 151
+Y+ K+GEGT+G V + +RE E+VA+K VR G+ +A+ EI +L++L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKEL- 56
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
KH V++ + + +VFE L + N P ++V+ QLL+
Sbjct: 57 KH----KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP-EIVKSFMFQLLKG 111
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+AF H ++H DLKP+N+L+ K+ +K+ DFG
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLI---------------------------NKNGELKLADFG 144
Query: 272 -STTYERPDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT-GEALFQTH 326
+ + P + Y V T YR P+V+ G ++ D+WS GCI EL G LF +
Sbjct: 145 LARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204
Query: 327 ENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
+ + L + R+LG P + WP V KLP +
Sbjct: 205 DVDDQLKRIFRLLGTPTEE-------------------SWP----------GVSKLPDYK 235
Query: 386 NLIMQHVDHSAGDLT--------HLLQGLLRYDPTDRLTAREALRHPFF 426
M S ++ LLQ LL +P R++A EAL+HP+F
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 87/348 (25%), Positives = 150/348 (43%), Gaps = 72/348 (20%)
Query: 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQ 149
+T+RY +G G FG V D+ + VAIK + +K + + E+++L+
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI--MKPFSTPVLAKRTYRELKLLKH 65
Query: 150 LAKHDKGGNRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 208
L +H+ + + + F I V E LG+ L+ L R ++ Q+
Sbjct: 66 L-RHEN----IISLSDIFISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQI 117
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
L + ++H ++H DLKP N+L+ ++ +K+
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILI---------------------------NENCDLKIC 150
Query: 269 DFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE 327
DFG + P VSTR+YRAPE++L + DIWS GCI E+ G+ LF +
Sbjct: 151 DFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR---- 383
++ +++ +LG P ++ + S +++ V LP+
Sbjct: 211 HVNQFSIITDLLGTPPDDVINTI-------------------CSENTLRFVQSLPKREPV 251
Query: 384 -LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
++ D SA D LL+ +L +DP R++A EAL HP+ H
Sbjct: 252 PFSEKF-KNADPSAID---LLEKMLVFDPQKRISAAEALAHPYLAPYH 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---AMIEIEVLQQLAKHD 154
Y++ +G G FG V + + E + VAIK + K EA M EI++L+ L KH
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KH- 58
Query: 155 KGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V+ + + + I+ E SL ++K FP LV Q+L+ +A
Sbjct: 59 ---PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLA 113
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++H+ +IH D+K N+L K +K+ DFG
Sbjct: 114 YLHEQGVIHRDIKAANIL---------------------------TTKDGVVKLADFGVA 146
Query: 274 TY---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
T D +V T ++ APEVI G + DIWS+GC ++EL TG
Sbjct: 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 93/346 (26%), Positives = 153/346 (44%), Gaps = 67/346 (19%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--------EAAMIEIEVLQ 148
RY+ ++G G +G V DR VAIK K YR + A E+ +L+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 69
Query: 149 QLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 206
+ KH+ G D + +V +G+ L ++ + D ++ +
Sbjct: 70 HM-KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVY 125
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+L+ + ++H +IH DLKP N L V+ + +K
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGN-LAVNED--------------------------CELK 158
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 325
++DFG + V TR YRAPEVIL + +T DIWSVGCI+ E+ TG+ LF+
Sbjct: 159 ILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
H++L+ L + +V G + ++++ S ++ V KLPR +
Sbjct: 219 HDHLDQLMEIMKVTGTPSKEFVQKLQ-------------------SEDAKNYVKKLPRFR 259
Query: 386 NLIMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ + +A L ++L+ +L D R+TA EAL HP+F H
Sbjct: 260 KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 89/337 (26%), Positives = 153/337 (45%), Gaps = 47/337 (13%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQL 150
++ RY+ S +GEG +G V + VAIK + + + + + EI++L++
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
+ G + F+ N + IV E + + LY ++ + + D ++ Q+L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN---DHIQYFLYQILR 117
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++H ++H DLKP N+LL ++ +K+ D+ + + + +
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL----------- 166
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 329
T Y V+TR YRAPE++L G+T DIWSVGCIL E+ + LF + L
Sbjct: 167 --TEY--------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLI 388
L ++ VLG Q L + +R IKS+ P++ N +
Sbjct: 217 HQLNLILGVLGTPSQEDLNCI----------------ISLRARNYIKSLPFKPKVPWNKL 260
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+ D A D LL +L ++P R+T EAL HP+
Sbjct: 261 FPNADPKALD---LLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 98/348 (28%), Positives = 146/348 (41%), Gaps = 76/348 (21%)
Query: 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKK--YREAAMIEIEVLQQLA 151
L RY ++G G +G V D+ E VAIK + R + + + A E+ +L+ +
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDF----------LRKNNYRSFPIDLV 201
+ G V G DF L+K D V
Sbjct: 73 HENVIGLLDVF-------------TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV 119
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
+ + Q+L + ++H +IH DLKP N L V+ +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGN-LAVNED------------------------- 153
Query: 262 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGE 320
+K++DFG + + V TR YRAPEVIL + + DIWSVGCI+ E+ TG+
Sbjct: 154 -CELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
Query: 321 ALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 379
LF+ + L+ L + +V G P P+ + K D+ A+ Y IKS+
Sbjct: 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY-----------------IKSLP 255
Query: 380 KLPRLQ-NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
K PR + + A D LL+ +L D RLTA EAL HP+F
Sbjct: 256 KYPRKDFSTLFPKASPQAVD---LLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 92/355 (25%), Positives = 151/355 (42%), Gaps = 87/355 (24%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
RY+ S +G G +GQV +D + VAIK K R Q A H K
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-----KLSRPF---------QSAIHAKRT 61
Query: 158 NRCVQIRNWFDYRNHIC------------------IVFEKLGSSLYDFLRKNNYRSFPID 199
R +++ D+ N I +V +G+ L + ++ + D
Sbjct: 62 YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDD 118
Query: 200 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
++ + Q+L + ++H +IH DLKP N+ + +K+ D+ + HT + M
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------M 172
Query: 260 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCT 318
T Y V+TR YRAPE++L + + DIWSVGCI+ EL T
Sbjct: 173 -------------TGY--------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 319 GEALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G+ LF ++++ L + ++G P + + K A Y I+S
Sbjct: 212 GKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY-----------------IQS 254
Query: 378 VMKLPR--LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ ++P+ + + + A D LL+ +L DP R+TA EAL HP+ H
Sbjct: 255 LPQMPKKDFKEVFSGA-NPLAID---LLEKMLVLDPDKRITAAEALAHPYLAEYH 305
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 84/355 (23%), Positives = 145/355 (40%), Gaps = 81/355 (22%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAK 152
S+Y+ +K+G+GTFG+V + ++ K++VA+K V ++ +E A+ EI++LQ L K
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL-MENEKEGFPITALREIKILQLL-K 69
Query: 153 HD-------------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 199
H+ NR Y+ +VFE L L N F +
Sbjct: 70 HENVVNLIEICRTKATPYNR---------YKGSFYLVFEFCEHDLAGLL-SNKNVKFTLS 119
Query: 200 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
++++ + LL + ++H ++H D+K N+L+
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT-------------------------- 153
Query: 260 PKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGC 311
K +K+ DFG S + V T YR PE++LG + P D+W GC
Sbjct: 154 -KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC 212
Query: 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS 371
I+ E+ T + Q + L ++ ++ G + + VD K +++ P+G
Sbjct: 213 IMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD----KLELFKKMELPQGQKR 268
Query: 372 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ + + L L+ LL DP R+ A AL H FF
Sbjct: 269 KVKERLKPYVKDPHAL-------------DLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 87/353 (24%), Positives = 153/353 (43%), Gaps = 83/353 (23%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 149
RY+ S +G G +G V +D + VA+K I+ + YRE +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 68
Query: 150 LAKHDKGGN-----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 204
L KH K N + N + +V +G+ L + ++ + D V+ +
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 125
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
Q+L + ++H +IH DLKP N+ + +
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAV---------------------------NEDCE 158
Query: 265 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 323
+K++DFG + + V+TR YRAPE++L + + DIWSVGCI+ EL TG LF
Sbjct: 159 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
Query: 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 383
++++ L ++ R++G +LK++ ++R I+S+ ++P+
Sbjct: 219 PGTDHIDQLKLILRLVGTPGAELLKKISSE----------------SARNYIQSLTQMPK 262
Query: 384 L--QNLIM----QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ N+ + VD LL+ +L D R+TA +AL H +F + H
Sbjct: 263 MNFANVFIGANPLAVD--------LLEKMLVLDSDKRITAAQALAHAYFAQYH 307
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 86/340 (25%), Positives = 147/340 (43%), Gaps = 62/340 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAK 152
+Y+ +++GEG +G+V + D + VA+K VR ++ E + + E+ VL+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 60
Query: 153 HDKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
+ + C R D + +VFE + L +L K P + ++++ Q
Sbjct: 61 FEHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
LL + F+H ++H DLKP+N+L+ SS IK+ D+ + ++
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-------------------RI 159
Query: 268 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
F +V T YRAPEV+L + P D+WSVGCI E+ + LF+
Sbjct: 160 YSFQMAL------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213
Query: 328 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+++ L + V+G P + DWP A ++
Sbjct: 214 DVDQLGKILDVIGLPGEE-------------------DWPRDVALPRQAFHSKSAQPIEK 254
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ +D D LL L ++P R++A AL HP+F
Sbjct: 255 FV-TDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 83/340 (24%), Positives = 129/340 (37%), Gaps = 101/340 (29%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNR 159
K+G GTFG+V + + E++A+K +R I+ + E++VL+ L KH
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELL-KHP----- 59
Query: 160 CVQIRNWFDY------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
N Y R + I E G +L + L + R ++R QLLE +
Sbjct: 60 -----NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGL 112
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
A++H ++H D+KP N+ L + IK+ D+ + + +
Sbjct: 113 AYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA-------------------VKLKNNT 153
Query: 273 TTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTG----EALFQT 325
TT Q+ T Y APEVI G G DIWS+GC+++E+ TG L
Sbjct: 154 TTMGEEVQSL-AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
+ + H+ + P+P + PEG
Sbjct: 213 FQIMFHVGAGHK--PPIPDSLQLS----------------PEG----------------- 237
Query: 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+D L DP R TA E L+HPF
Sbjct: 238 ---KDFLDRC-----------LESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 51/270 (18%)
Query: 168 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 227
D I +V E + S L+ + + D V+ Q+L + ++H ++H D+KP
Sbjct: 74 DPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP 131
Query: 228 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI---- 283
N LLV+S + +K+ DFG E PD++
Sbjct: 132 GN-LLVNSNCV--------------------------LKICDFGLARVEEPDESKHMTQE 164
Query: 284 VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 342
V T++YRAPE+++G +T DIWSVGCI EL LFQ ++ L ++ +LG
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 343 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402
++ A ++ R K P L L + + HL
Sbjct: 225 SLEAMRSACEGARAHILR----------------GPHKPPSLPVLYT-LSSQATHEAVHL 267
Query: 403 LQGLLRYDPTDRLTAREALRHPFFTRDHLR 432
L +L +DP R++A +AL HP+ LR
Sbjct: 268 LCRMLVFDPDKRISAADALAHPYLDEGRLR 297
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 90/350 (25%), Positives = 155/350 (44%), Gaps = 77/350 (22%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 149
RY+ + +G G +G V +D ++ VA+K ++ + YRE +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYREL---------R 66
Query: 150 LAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 203
L KH K N + + + F + N + +V +G+ L + ++ + + V+
Sbjct: 67 LLKHMKHEN-VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQF 122
Query: 204 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
+ QLL + ++H +IH DLKP NV + +
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAV---------------------------NEDC 155
Query: 264 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 322
++++DFG + V+TR YRAPE++L + + DIWSVGCI+ EL G+AL
Sbjct: 156 ELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
Query: 323 FQTHENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
F ++ ++ L +ME V P P+ + K HA KY++ L
Sbjct: 216 FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ--------------------SL 255
Query: 382 PRLQNLIMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
P + ++ + A L LL+ +L D R++A EAL HP+F++ H
Sbjct: 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 78/332 (23%), Positives = 125/332 (37%), Gaps = 89/332 (26%)
Query: 103 SKMGEGTFGQVLECWDRERKEMVAIKI--VRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+ G V + + ++ A+K V G +++R+ + E++ L+ +
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESPY----V 61
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DL 218
V+ F I IV E + G SL D L+K P ++ IARQ+L+ + ++H
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 277
+IH D+KP N+L+ S +K+ DFG S E
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIA---------------------------DFGISKVLEN 152
Query: 278 ---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334
+ V T Y +PE I G ++Y DIWS+G L+E G+ F +
Sbjct: 153 TLDQCNTF-VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 335 MERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
M+ + GP P P S E
Sbjct: 212 MQAICDGPPP--------------------SLPAEEFSPE-------------------- 231
Query: 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+ L+ DP R +A E L+HPF
Sbjct: 232 -----FRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 5e-23
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 39/261 (14%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 161
G G FG+V + + A+K V R I + + I E E+L++ H V
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HP----FIV 56
Query: 162 QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
++ F + +I ++ E LG L+ LR F R ++ ++H+ +
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
I+ DLKPEN+LL S+ Y+K+ D+ + K + G T+
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFA-------------------KKLKSGQKTWT---- 151
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 340
T Y APE+IL G+ + D WS+G +L EL TG F ++ + + + +L
Sbjct: 152 --FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE-DDEDPMEIYNDILK 208
Query: 341 PLPQHML-KRVDRHAEKYVRR 360
+ +D+ A+ +++
Sbjct: 209 GNGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 94/330 (28%), Positives = 146/330 (44%), Gaps = 60/330 (18%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 159
K+GEGT+ V + + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNL-KH----AN 64
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + + + +VFE L S L +L N + V+ QLL +++ H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
++H DLKP+N+L+ +K+ D+ + K +P + TY
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADF--------GLARAKSVP-----------TKTYSNE- 163
Query: 280 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 338
V T YR P+V+LG ++ P D+W VGCIL E+ TG +F E L ++ R+
Sbjct: 164 ----VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219
Query: 339 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP--RLQNLIMQHVDHSA 396
LG + WP G S E +S + P R Q LI H
Sbjct: 220 LGTPTEE------------------TWP-GITSNEEFRSYL-FPQYRAQPLI-NHAPRLD 258
Query: 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
D LL LL Y+ R++A ALRH +F
Sbjct: 259 TDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 94/351 (26%), Positives = 155/351 (44%), Gaps = 70/351 (19%)
Query: 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLA 151
+ ++Y +G G +G V + E E VAIK I +A + EI++L+ L
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL- 61
Query: 152 KHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 206
H+ + I++ + N + IV+E + + L+ +R + ++ D +
Sbjct: 62 DHEN----VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLY 115
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
QLL + ++H ++H DLKP N+LL ++ +K
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNAN---------------------------CDLK 148
Query: 267 VIDFG--STTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA 321
+ DFG TT E+ D Y+V TR YRAPE++L +T D+WSVGCI EL +
Sbjct: 149 ICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
Query: 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
LF + + L ++ +LG L + +R I+S+
Sbjct: 208 LFPGKDYVHQLKLITELLGS----------------PSEEDLGFIRNEKARRYIRSLPYT 251
Query: 382 PRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
PR Q+ + H + A D LL+ +L +DP+ R+T EAL HP+ H
Sbjct: 252 PR-QSFARLFPHANPLAID---LLEKMLVFDPSKRITVEEALAHPYLASLH 298
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 91/347 (26%), Positives = 155/347 (44%), Gaps = 69/347 (19%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA---KHDK 155
YK+ + +G G+FG V E + E VAIK V +Y+ ++ ++ L + D
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 156 GGNRCVQI--RNWFDYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLEC 211
C + +N F + +V E + +++ +++ N + P+ LV+ + QL
Sbjct: 128 YYTECFKKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+A++H + H DLKP+N+L+ P + +K+ DFG
Sbjct: 183 LAYIHSKFICHRDLKPQNLLI--------------------------DPNTHTLKLCDFG 216
Query: 272 STTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 327
S Q +YI S R YRAPE++LG +T D+WS+GCI+ E+ G +F
Sbjct: 217 SAKNLLAGQRSVSYICS-RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
+++ L + +VLG + LK ++ P A +K P ++
Sbjct: 276 SVDQLVRIIQVLGTPTEDQLKEMN--------------PNYAD--------IKFPDVKPK 313
Query: 388 IMQHV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 432
++ V + D + + L+Y+P RL EAL PFF D LR
Sbjct: 314 DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF--DDLR 358
|
Length = 440 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-22
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV------RGIKKYREAAMIEIEVLQQLAKHDKGGN 158
+G+G FG+V C+D + +A+K V KK A EI++L+ L +H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QH----E 64
Query: 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
R VQ + I E + G S+ D L+ Y + + R+ RQ+LE + ++H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHS 122
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
++H D+K N+L S+ +K+ D+ +S KR+ I S T +
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGAS----------KRL---QTICS----SGTGMK 165
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+ T ++ +PEVI G G+ D+WSVGC +VE+ T
Sbjct: 166 S----VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 79/331 (23%), Positives = 132/331 (39%), Gaps = 91/331 (27%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMI---EIEVLQQLAKHDKGGN 158
+G G+FG V E + + + A+K V + +EA EI +L +L +H
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPN--- 63
Query: 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
VQ +++ I E + G SL L+K Y SFP ++R RQ+L + ++HD
Sbjct: 64 -IVQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+H D+K N+L+ ++ +K+ D+ + KS
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQ-----VVEFSFAKS--------------- 160
Query: 278 PDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
+ ++ APEVI G + DIWS+GC ++E+ TG+ + E + + +
Sbjct: 161 -----FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
Query: 337 R--VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
R L P+P H+ S E ++ I++
Sbjct: 216 RSKELPPIPDHL------------------------SDE----------AKDFILK---- 237
Query: 395 SAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
L+ DP+ R TA E L HPF
Sbjct: 238 -----------CLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 154
+K+ K+G+G++G V + + A+K V +K RE A+ EI +L + +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 155 KGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNY--RSFPIDLVREIARQLLEC 211
+ + F N +CIV E L + K + P + I QLL
Sbjct: 61 -----IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ +H+ ++H DLK N+LLV+++ +K+ D S K + K+ A I
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGIS----------KVLKKNMAKTQI--- 162
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
T HY APEV G ++Y DIWS+GC+L E+ T F+
Sbjct: 163 -------------GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 87/359 (24%), Positives = 155/359 (43%), Gaps = 79/359 (22%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMIEIEVLQQLAK 152
+L SRY +G G+ G V D + + VA+K IV + + A+ EI+++++L
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-D 60
Query: 153 HD-----------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLV 201
HD G + + + + + + IV E + + L + L + +
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQG---PLSEEHA 116
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
R QLL + ++H ++H DLKP NV + + + +
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV----------------------- 153
Query: 262 SSAIKVIDFGSTTYERPD---QNYI---VSTRHYRAPEVILG-LGWTYPCDIWSVGCILV 314
+K+ DFG P + Y+ + T+ YR+P ++L +T D+W+ GCI
Sbjct: 154 ---LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 210
Query: 315 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHA-----EKYVRRGRLDWPEGA 369
E+ TG+ LF LE M+ +L +P +++ DR+ +VR +G
Sbjct: 211 EMLTGKPLFAGAHELE---QMQLILESVP--VVREEDRNELLNVIPSFVRN------DGG 259
Query: 370 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
R ++ ++ V+ A D L+ +L ++P DRLTA EAL HP+ +
Sbjct: 260 EPRRPLRDLLP----------GVNPEALD---FLEQILTFNPMDRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 84/341 (24%), Positives = 140/341 (41%), Gaps = 97/341 (28%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
YK K+GEG G+V + DR + VAIK +R K+ +E + EI +++ KH
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHP---- 75
Query: 159 RCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVRE----IARQLLE 210
I +++D + + +V E + G SL D + +N + + + R++L+
Sbjct: 76 ---NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQ 127
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++H +IH D+K +N+LL KD S +K+ DF
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILL-----------------SKDGS----------VKLADF 160
Query: 271 G---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
G T E+ +N +V T ++ APEVI + DIWS+G + +E+ GE
Sbjct: 161 GFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE------- 213
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
P ++ R P A + K +P L+N
Sbjct: 214 ---------------PPYL---------------REP-PLRALFLITTK---GIPPLKNP 239
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ + + L L DP R +A E L+HPF +
Sbjct: 240 -----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+L I +H +IH DLKP N+++ S D + +K
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKS-----------------DCT----------LK 158
Query: 267 VIDFG-----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321
++DFG T++ Y+V TR+YRAPEVILG+G+ DIWSVGCI+ E+ G
Sbjct: 159 ILDFGLARTAGTSFMMTP--YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
Query: 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR-RGRLDWPEGAASRESIKSVMK 380
LF ++++ + LG + R+ YV R + G + E V+
Sbjct: 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY---AGYSFEELFPDVLF 272
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
P ++ H A LL +L DP R++ +AL+HP+
Sbjct: 273 PPDSES----HNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 92/360 (25%), Positives = 157/360 (43%), Gaps = 88/360 (24%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERK--EMVAIKIVRGI---KKYREAAMIEIEVLQQLAK 152
RY++ ++G+G +G V + E E VAIK + + K + A+ E+++L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 153 HDKGGNRCVQIRNWFDYR-------NHICIVFEKLGSSLYDFLRKN------NYRSFPID 199
H I +D N + + E + + L+ +R +++SF
Sbjct: 61 HK-------NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF--- 110
Query: 200 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
Q+L + ++H ++H DLKP N LLV+++
Sbjct: 111 -----IYQILCGLKYIHSANVLHRDLKPGN-LLVNAD----------------------- 141
Query: 260 PKSSAIKVIDFG-STTY-ERPDQN--YI---VSTRHYRAPEVILGL-GWTYPCDIWSVGC 311
+K+ DFG + + E P +N ++ V+TR YRAPE++L +T D+WSVGC
Sbjct: 142 ---CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAA 370
IL EL + +F+ + ++ L + +VLG + L R+ A+ Y+R L
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR--SLPNIPK-- 254
Query: 371 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
I + + A D LL+ LL +DPT R++ EAL HP+ H
Sbjct: 255 --------KPFES----IFPNANPLALD---LLEKLLAFDPTKRISVEEALEHPYLAIWH 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 81/348 (23%), Positives = 133/348 (38%), Gaps = 108/348 (31%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAK 152
+ + +G+G+FG+V + D+ ++VAIK++ E A EIE +QQ L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQ 55
Query: 153 HDKGGNRCVQIRNWF-----DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 206
R I ++ + + I+ E G S D L+ + I R
Sbjct: 56 C-----RSPYITKYYGSFLKGSK--LWIIMEYCGGGSCLDLLK---PGKLDETYIAFILR 105
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
++L + ++H+ IH D+K N+LL + +K
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLS---------------------------EEGDVK 138
Query: 267 VIDFG------STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
+ DFG ST +R N V T + APEVI G+ DIWS+G +EL GE
Sbjct: 139 LADFGVSGQLTSTMSKR---NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
Query: 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380
L L M RVL +P++ ++ + K+ + +
Sbjct: 196 P------PLSDLHPM-RVLFLIPKNNPPSLEGN--KFSKPFK------------------ 228
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
D L L DP +R +A+E L+H F +
Sbjct: 229 -----------------DFVSL---CLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 85/328 (25%), Positives = 141/328 (42%), Gaps = 56/328 (17%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 159
K+GEGT+ V + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KHAN---- 65
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + + + +VFE L L +L + S + V+ QLL + + H
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
++H DLKP+N+L+ +K+ D+ + ++ +I + TY
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFG--------------LARAKSIP-----TKTYSNE- 164
Query: 280 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 338
V T YR P+++LG ++ D+W VGCI E+ TG LF E L + R+
Sbjct: 165 ----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220
Query: 339 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398
LG + WP G S E KS + + H D
Sbjct: 221 LGTPTEET------------------WP-GILSNEEFKSYNYPKYRADCLHNHAPRLDSD 261
Query: 399 LTHLLQGLLRYDPTDRLTAREALRHPFF 426
LL LL+++ R++A EA++HP+F
Sbjct: 262 GAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 89/342 (26%), Positives = 142/342 (41%), Gaps = 71/342 (20%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHD 154
YK K+GEG++ V + + ++VA+K +R ++ E A+ E +L+ L KH
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLKDL-KH- 62
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V + + + + +VFE L + L ++ + VR QLL +A+
Sbjct: 63 ---ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAY 118
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 271
H ++H DLKP+N LL+S + +K+ DFG
Sbjct: 119 CHQRRVLHRDLKPQN-LLIS--------------------------ERGELKLADFGLAR 151
Query: 272 -----STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 325
S TY N +V T YR P+V+LG ++ D+W VGCI E+ TG LF
Sbjct: 152 AKSVPSKTY----SNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206
Query: 326 HEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 384
+ + L + RVLG + V + E P + PRL
Sbjct: 207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINH--------APRL 258
Query: 385 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ L L+Y+P R++A EA++HP+F
Sbjct: 259 DRIP---------HGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+L I +H +IH DLKP N+++ S +K+ D+ + +++
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--------------LARTACT- 175
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
+F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ EL G +FQ
Sbjct: 176 --NFMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
++++ + LG + R+ YV R +P S E + P
Sbjct: 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV-ENRPQYP--GISFEELFPDWIFPSES- 281
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
+ LL +L DP R++ EALRHP+ T
Sbjct: 282 ---ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 75/349 (21%), Positives = 125/349 (35%), Gaps = 80/349 (22%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAA-MIEIEVLQQLAK 152
+++ +G G FG+V D++ ++ A+K++R IK+ + A E ++L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL----- 55
Query: 153 HDKGGNRCVQIRN-W-------FDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVRE 203
+ W F H+ +V E + D + FP + R
Sbjct: 56 --------ADADSPWIVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARF 105
Query: 204 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFK--RM 259
+L+ + +H L IH D+KP+N+L+ + +IK+ D+ ++ KD Y+
Sbjct: 106 YIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 260 PKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
V+ +R N V T Y APEV+ G + CD WS+G IL E+
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 378
G F Q ++
Sbjct: 226 GFPPF---------------YSDTLQETYNKIINW------------------------- 245
Query: 379 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT-AREALRHPFF 426
++L + + L+ LL DP DRL E HPFF
Sbjct: 246 -----KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVR----GIK-KYREAAMI-----EIEVLQQLAKHD 154
+G G+FG V + E++A+K V K R+ +M+ EI +L++L +H+
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
VQ +H+ I E + G S+ L NNY +F LVR RQ+L+ +
Sbjct: 67 N----IVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++H+ +IH D+K N+L+ + IK+ D+ S K++ +S T
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGIS----------KKLEANSLS-----TKT 165
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
RP + + + APEV+ +T DIWS+GC++VE+ TG
Sbjct: 166 NGARPS---LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
+ I K+GEG++G V + +E ++VAIK+V +++ + + EI +L+Q
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQ-CDSP---- 58
Query: 159 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V+ + + IV E G S+ D ++ N ++ + + I Q L+ + ++H
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS 117
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST--T 274
IH D+K N+LL + K+ DFG S T
Sbjct: 118 NKKIHRDIKAGNILL---------------------------NEEGQAKLADFGVSGQLT 150
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
+N ++ T + APEVI +G+ DIWS+G +E+ G+
Sbjct: 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 68/310 (21%), Positives = 109/310 (35%), Gaps = 90/310 (29%)
Query: 121 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180
+ +M+A V +K R MI+ E ++ F ++++ +V E L
Sbjct: 31 KSDMIAKNQVTNVKAERAIMMIQGE-----------SPYVAKLYYSFQSKDYLYLVMEYL 79
Query: 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239
G ++ P D ++ +++ + +H +IH D+KPEN+L+ + ++K
Sbjct: 80 NGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137
Query: 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 299
+ D+ S R E V T Y APE ILG+G
Sbjct: 138 LTDFGLS-----------RN--------------GLENKK---FVGTPDYLAPETILGVG 169
Query: 300 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 359
D WS+GC++ E G F P + +
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAVFDNIL-------- 206
Query: 360 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-- 417
R++WPE S P +LI + LL DP RL A
Sbjct: 207 SRRINWPEEVKEFCS-------PEAVDLINR---------------LLCMDPAKRLGANG 244
Query: 418 -REALRHPFF 426
+E HPFF
Sbjct: 245 YQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-17
Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 44/225 (19%)
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+L I +H +IH DLKP N+++ S +K+ D+ R +S
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 172
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ + LF
Sbjct: 173 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 327 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 384
+ ++ ++E++ P P+ M K++ YV + P+ A + P+L
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 268
Query: 385 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+L +H+ A LL +L DP R++ EAL+HP+
Sbjct: 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 85/335 (25%), Positives = 143/335 (42%), Gaps = 67/335 (20%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIV-----RGI--KKYREAAMIEIEVLQQLAKHDKG 156
K+GEG++ V + R ++VA+K++ G+ REA+++ K K
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLL---------KGLKH 62
Query: 157 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
N V + + + + VFE + + L ++ ++ P + VR QLL +A++H
Sbjct: 63 AN-IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYIH 120
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 275
++H DLKP+N+L+ SY +K+ DFG +
Sbjct: 121 GQHILHRDLKPQNLLI---------------------SYL------GELKLADFGLARAK 153
Query: 276 ERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ-THENLEH 331
P Q Y V T YR P+V+LG ++ DIW GCI +E+ G+ F + E
Sbjct: 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213
Query: 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391
L + VLG + V + Y L + R K + + P+ ++L Q
Sbjct: 214 LEKIWTVLGVPTEDTWPGVSK-LPNYKPEWFL-PCKPQQLRVVWKRLSRPPKAEDLASQ- 270
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+L P DR++A++AL HP+F
Sbjct: 271 --------------MLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+L I +H +IH DLKP N+++ S +K+ D+ R +S
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 179
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ G LF
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 327 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 384
++++ ++E++ P P+ M K++ YV + P+ A S E + + P
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 283
Query: 385 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+H A LL +L D + R++ EAL+HP+
Sbjct: 284 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 70/338 (20%), Positives = 121/338 (35%), Gaps = 79/338 (23%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---EAAMIEIEVLQQLAKH 153
Y++ +G G V E VAIK + ++K + + E++ + Q H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCN-H 58
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR-KNNYRSFPIDLVREIARQLLEC 211
V+ F + + +V L G SL D ++ ++ + +++L+
Sbjct: 59 PN----VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSAIKVID 269
+ ++H IH D+K N+LL +K+ D+ +SL D + R
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR----------- 163
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
V T + APEV+ G+ + DIWS G +EL TG A + +
Sbjct: 164 -----------KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
++ +M + P +KY + R+ I
Sbjct: 213 MK--VLMLTLQNDPPSL---ETGADYKKY----------SKSFRKMISLC---------- 247
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
L+ DP+ R TA E L+H FF
Sbjct: 248 ------------------LQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 76/339 (22%), Positives = 130/339 (38%), Gaps = 95/339 (28%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 154
++ +G G+FG+V+ + + A+KI+ I K ++ + E +LQ + +H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61
Query: 155 KGGNRCVQIRNWF-DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
V + F D N + +V E + G L+ LRK+ FP + R A Q++ +
Sbjct: 62 ----FLVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLAL 114
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
++H L +++ DLKPEN+LL S Y IK+ DFG
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGY---------------------------IKITDFGF 147
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332
+ + T Y APE+IL G+ D W++G ++ E+ G F +
Sbjct: 148 AKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD---NPI 204
Query: 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392
+ E++L G++ +P
Sbjct: 205 QIYEKILE--------------------GKVRFP-----------------------SFF 221
Query: 393 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
D L++ LL+ D T RL + HP+F
Sbjct: 222 S---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 82/330 (24%), Positives = 145/330 (43%), Gaps = 60/330 (18%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 159
K+GEGT+ V + + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KHAN---- 65
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDL 218
V + + + +VFE L L ++ N S + V+ Q+L +A+ H
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS--MHNVKIFLYQILRGLAYCHRR 123
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
++H DLKP+N+L+ +K+ D+ + K +P + TY
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADF--------GLARAKSVP-----------TKTYSNE 164
Query: 279 DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337
V T YR P+V+LG ++ D+W VGCI E+ +G LF + L ++ R
Sbjct: 165 -----VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219
Query: 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHSA 396
+LG + WP G +S + K+ P+ + ++ H
Sbjct: 220 LLGTPTEE------------------TWP-GISSNDEFKN-YNFPKYKPQPLINHAPRLD 259
Query: 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ LL L+Y+ R++A EA++H +F
Sbjct: 260 TEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 88/354 (24%), Positives = 152/354 (42%), Gaps = 75/354 (21%)
Query: 104 KMGEGTFGQVLECWDRERKEM--VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 161
K+G GT+G V + ++ K+ A+K + G +A EI +L++L K N
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-TGISMSACREIALLREL----KHPNVIA 62
Query: 162 QIRNWFDYRNH-ICIVFEKLGSSLYDFLR-----KNNYR--SFPIDLVREIARQLLECIA 213
+ + + + + ++F+ L+ ++ K N + P +V+ + Q+L+ I
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 272
++H ++H DLKP N+L++ P+ +K+ D G +
Sbjct: 123 YLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMGFA 159
Query: 273 TTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 326
+ P D + +V T YRAPE++LG +T DIW++GCI EL T E +F
Sbjct: 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ- 385
+ E + P H ++DR DW E I+ + + P LQ
Sbjct: 220 Q--------EDIKTSNPFHH-DQLDRIFSVMGFPADKDW-------EDIRKMPEYPTLQK 263
Query: 386 -------------NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ +H + LLQ LL DPT R+T+ +AL+ P+F
Sbjct: 264 DFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 1e-15
Identities = 83/333 (24%), Positives = 152/333 (45%), Gaps = 51/333 (15%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQLAKHDKG 156
Y+ K+GEG++ V + + ++VA+K++R ++ A+ E +L+ L KH
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHAN- 64
Query: 157 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
V + + + + +VFE + + L ++ K+ P + V+ QLL ++++H
Sbjct: 65 ---IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIH 120
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
++H DLKP+N+L+ + +K+ D+ + ++ ++ S TY
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFG--------------LARAKSVP-----SHTYS 161
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPC-DIWSVGCILVELCTGEALFQTHENLE-HLAM 334
V T YR P+V+LG C D+W VGCI VE+ G A F ++++ L
Sbjct: 162 NE-----VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216
Query: 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
+ VLG + V P R ++ S L + N + +V+H
Sbjct: 217 IFLVLGTPNEDTWPGVH------------SLPHFKPERFTLYSPKNLRQAWNK-LSYVNH 263
Query: 395 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
+ L LL+ P +RL+A+ AL H +F+
Sbjct: 264 A----EDLASKLLQCFPKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 88/349 (25%), Positives = 151/349 (43%), Gaps = 65/349 (18%)
Query: 104 KMGEGTFGQVLECWDRERKEM--VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 161
K+G GT+G V + ++ K+ A+K + G +A EI +L++L KH +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEG-TGISMSACREIALLREL-KHPN----VI 61
Query: 162 QIRNWF--DYRNHICIVFEKLGSSLYDFLR-----KNNYR--SFPIDLVREIARQLLECI 212
++ F + ++F+ L+ ++ K N + P +V+ + Q+L+ I
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
++H ++H DLKP N+L++ P+ +K+ D G
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMGF 158
Query: 272 STTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 325
+ + P D + +V T YRAPE++LG +T DIW++GCI EL T E +F
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-- 383
+ E + P H ++DR DW + E ++MK R
Sbjct: 219 RQ--------EDIKTSNPYHH-DQLDRIFNVMGFPADKDWEDIKKMPEH-STLMKDFRRN 268
Query: 384 ------LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
L + +H HLLQ LL DP R+T+ +A++ P+F
Sbjct: 269 TYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 53/236 (22%), Positives = 87/236 (36%), Gaps = 55/236 (23%)
Query: 100 KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKH 153
+ K+GEG FG+V + ++ VA+K ++ ++ E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 154 D-----KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 206
G C + + IV E G L D+LRKN + + + A
Sbjct: 61 PNIVKLLGV--CTE-------EEPLMIVMEYMPGGD-LLDYLRKNRPKELSLSDLLSFAL 110
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+ + ++ IH DL N L V + +K
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCL-VGENLV--------------------------VK 143
Query: 267 VIDFGSTTYERPDQNYIVSTRH--YR--APEVILGLGWTYPCDIWSVGCILVELCT 318
+ DFG + D Y V R APE + +T D+WS G +L E+ T
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 74/336 (22%), Positives = 130/336 (38%), Gaps = 83/336 (24%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD 154
Y++ ++G GT+G V + D E+VAIK+++ ++ + +I EI +L++ +H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFEIIQQEISMLKE-CRH- 59
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V + R+ + IV E G SL D + + + R+ L+ +A
Sbjct: 60 ---PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLA 115
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++H+ IH D+K N+LL +K+ D+ S ++ KR
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATIAKR--------------- 158
Query: 274 TYERPDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGE-ALFQTHENL 329
+ T ++ APEV G+ CDIW++G +EL + +F H
Sbjct: 159 -------KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH--- 208
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
M R L + KS P+L++
Sbjct: 209 ---PM--RALFLIS--------------------------------KSNFPPPKLKD--- 228
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+ + ++ L DP R TA + L+HPF
Sbjct: 229 --KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 67/268 (25%)
Query: 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 225
F+ + H+C+V E + G L+ N + P+D+ R + + + ++H+ ++H DL
Sbjct: 70 FETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALEYLHNYGIVHRDL 127
Query: 226 KPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 282
KP+N+L+ S +IK+ D+ K L + + Y + K T E D+
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD-----------TREFLDKQ- 175
Query: 283 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 342
+ T Y APEVIL G+ P D W++G IL E G F G
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---------------FGDT 220
Query: 343 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402
P+ + + V ++WPEG + LP D L
Sbjct: 221 PEELFGQ--------VISDDIEWPEGDEA---------LP--------------ADAQDL 249
Query: 403 LQGLLRYDPTDRL---TAREALRHPFFT 427
+ LLR +P +RL A E +H FF
Sbjct: 250 ISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 7e-15
Identities = 62/301 (20%), Positives = 107/301 (35%), Gaps = 82/301 (27%)
Query: 100 KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKH 153
++ K+GEG FG+V + + VA+K ++ ++ RE + E ++++L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SH 60
Query: 154 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 206
G C Q + IV E G L DFLRK+ + + ++A
Sbjct: 61 PNIVRLLGV--CTQ-------GEPLYIVTEYMPGGD-LLDFLRKHG-EKLTLKDLLQMAL 109
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+ + + ++ +H DL N L+ +L +K
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLV-----------TENLV----------------VK 142
Query: 267 VIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321
+ DFG + D Y + APE + +T D+WS G +L E+ T
Sbjct: 143 ISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202
Query: 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMK 380
P P + V + + G RL PE + + +M
Sbjct: 203 Q------------------PYPGMSNEEV----LELLEDGYRLPRPENCP--DELYELML 238
Query: 381 L 381
Sbjct: 239 Q 239
|
Length = 258 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 68/273 (24%), Positives = 124/273 (45%), Gaps = 39/273 (14%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQL 150
+ +++ +G+G FG+V C+D + +A+K V+ K A EI++L+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 151 AKHDKGGNRCVQIRNWF-DYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQ 207
R VQ D +F + G S+ D L+ +Y + ++ R+ RQ
Sbjct: 62 LHE-----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQ 114
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+LE ++++H ++H D+K N+L S +K+ D+ +S KR+ +
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS----------KRL------QT 158
Query: 268 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
I T + + T ++ +PEVI G G+ DIWSVGC +VE+ T + + E
Sbjct: 159 ICLSGTGMKS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360
+ A+ + P + V H +++R
Sbjct: 214 AMA--AIFKIATQPTNPVLPPHVSDHCRDFLKR 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 78/347 (22%), Positives = 130/347 (37%), Gaps = 94/347 (27%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 154
++I +++G+G +GQV ++ E+VA+K + + K E + E ++L K +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSE 61
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V++ F ++ + E + G L NN D R ++ E +
Sbjct: 62 ----WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVD 115
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+H+L IH DLKPEN L+ +S +IK+ DFG +
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKL---------------------------TDFGLS 148
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF------QTHE 327
N +V + Y APEV+ G G+ + D WS+GC+L E G F +T E
Sbjct: 149 KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
NL++ L P R ++
Sbjct: 209 NLKYWKET---------------------------LQRPVYDDPRFNLS----------- 230
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR-HPFFTRDHLRR 433
D + +T L+ DP+ R + E ++ HPFF
Sbjct: 231 -----DEAWDLITKLIN-----DPSRRFGSLEDIKNHPFFKEVDWNE 267
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 44/246 (17%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDK 155
Y++ +G+G+FG V + + +++ K I G +E + E+ +L++L KH
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPN 60
Query: 156 GGNRCVQIRNWF-DYRNH-ICIVFEKLG----SSLYDFLRKNNYRSFPIDLVREIARQLL 209
V+ + D N + IV E + L +K + + + I QLL
Sbjct: 61 ----IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLL 115
Query: 210 ECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+ H+ ++H DLKP N+ L ++ +K+ D+ + K + S
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA----------KILGHDS- 164
Query: 265 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
+ TY V T +Y +PE + + + DIWS+GC++ ELC F
Sbjct: 165 -----SFAKTY--------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
Query: 325 THENLE 330
L+
Sbjct: 212 ARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 33/252 (13%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIE-VLQQLAKHDKG 156
+Y + +GEG+FG+ L + A+K +R K E VL KH
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN- 59
Query: 157 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
V + F+ H+ IV E G L ++ + FP D + + Q+ + +
Sbjct: 60 ---IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
H+ ++H D+K +N+ L + +K+ D+ S+ +Y + TY
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY----------------ACTY 160
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLA 333
V T +Y PE+ + + DIWS+GCIL ELCT + FQ + +NL L
Sbjct: 161 --------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-LK 211
Query: 334 MMERVLGPLPQH 345
+ + PLP H
Sbjct: 212 VCQGSYKPLPSH 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 43/236 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHD 154
+Y K+GEG+FG+ + +E + IK I + K RE + E+ VL + KH
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHP 59
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
VQ + F+ ++ IV + G LY + FP D + + Q+ +
Sbjct: 60 N----IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-- 271
+HD ++H D+K +N+ L K IK+ DFG
Sbjct: 116 HVHDRKILHRDIKSQNIFLT---------------------------KDGTIKLGDFGIA 148
Query: 272 ---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
++T E + T +Y +PE+ + DIW++GC+L E+CT + F+
Sbjct: 149 RVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 84/335 (25%), Positives = 128/335 (38%), Gaps = 83/335 (24%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKH 153
RY + ++G+G+FG V D++ +K+++ I E E Q L+K
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA-QLLSKL 59
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLE 210
D V+ F R+ CI+ E G L L K+ ++ + V E QLL
Sbjct: 60 DHPA--IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ +MH ++H DLK +N+ L + +K+ D+ S R+ S D
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVS-----------RLLMGSC----DL 161
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
+T T +Y +PE + G+ DIWS+GCIL E+C F+ L
Sbjct: 162 ATT---------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
++ V GP P PE R N IMQ
Sbjct: 213 --VVLRIVEGPTPS--------------------LPE------------TYSRQLNSIMQ 238
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+L DP+ R +A E LR+PF
Sbjct: 239 S--------------MLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 79/343 (23%), Positives = 128/343 (37%), Gaps = 83/343 (24%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLA 151
N ++I ++G+G FG+V + +E A KI++ ++ E M+EI++L +
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC- 59
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
KH V + + Y N + I+ E D + R +R + RQ+LE
Sbjct: 60 KHPN----IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ F+H +IH DLK N+LL +K+ D+ S
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVS------------------------A 151
Query: 272 STTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTH 326
++ + T ++ APEV+ + Y DIWS+G L+EL E H
Sbjct: 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PH 208
Query: 327 ENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
L + ++ ++L P LD P +S
Sbjct: 209 HELNPMRVLLKILKSEPPT------------------LDQPSKWSS-------------- 236
Query: 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
L+ L DP DR TA E L+HPF +
Sbjct: 237 ------------SFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 47/269 (17%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 158
+G+G FG+V C+D + +A K V+ K A EI++L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHE---- 64
Query: 159 RCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
R VQ R+ + I E + G S+ D L+ Y + + R+ RQ+LE ++
Sbjct: 65 RIVQYYGCL--RDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMS 120
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++H ++H D+K N+L S+ +K+ D+ +S KR+ + I T
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS----------KRL------QTICMSGT 164
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
+ T ++ +PEVI G G+ D+WS+GC +VE+ T + + +E + +
Sbjct: 165 GIRS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219
Query: 334 MM--ERVLGPLPQHMLKRVDRHAEKYVRR 360
+ + LP H + HA ++
Sbjct: 220 KIATQPTNPQLPSH----ISEHARDFLGC 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 71/340 (20%), Positives = 121/340 (35%), Gaps = 98/340 (28%)
Query: 103 SKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRC 160
++G G G V + R +++A+K +R + ++ + E+++L +C
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH----------KC 56
Query: 161 -----VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
V F I I E + D + K P ++ +IA +L+ + ++
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL 116
Query: 216 H-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
H +IH D+KP N+L+ S IK+ D+ S ++ S A
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----------GQLVNSLA---------- 156
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334
V T Y APE I G ++ DIWS+G L+EL T
Sbjct: 157 ------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT---------------- 194
Query: 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL------PRLQNLI 388
GR +P + I +++ PRL +
Sbjct: 195 --------------------------GRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-- 226
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ D + L DP +R + +E L HPF +
Sbjct: 227 ----GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 161
+G+G FG+ E +V K V R +K R A+ EI +L L +H +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN----II 62
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
N F N + I E G +LYD + + + F ++V Q++ ++++H +
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
+H D+K N+ L + IK+ D+ S K M ++
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGIS----KILGSEYSMAET------------------ 160
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+V T +Y +PE+ G+ + + DIW++GC+L EL T
Sbjct: 161 --VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ-------LAKHDKGGN 158
G G FG+V ++ + A+K +R ++ M+E E + LA+ D
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKKLR------KSEMLEKEQVAHVRAERDILAEAD--NP 61
Query: 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR-EIARQLLECIAFMH 216
V++ F N++ ++ E L G + L K +F + R IA +L I +H
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETIL-AIDSIH 118
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
L IH D+KP+N+LL + +IK+ D+ + L + +++ + + +DF S
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 275 YERPD--QNY----------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
+ + V T Y APEV L G+ CD WS+G I+ E+ G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 71/248 (28%), Positives = 106/248 (42%), Gaps = 53/248 (21%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164
+G+GT+G V D + +AIK + + R + E+ L + K N VQ
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYVQPLHEEIA--LHSYLKHRN-IVQYL 71
Query: 165 NWFDYRNHICIVFEKL-GSSLYDFLR------KNNYRSFPIDLVREIARQLLECIAFMHD 217
I E++ G SL LR K+N + +Q+LE + ++HD
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-----QTIIFYTKQILEGLKYLHD 126
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
++H D+K +NVL+ ++Y S +K+ DFG T +R
Sbjct: 127 NQIVHRDIKGDNVLV--------------------NTY------SGVVKISDFG--TSKR 158
Query: 278 -----PDQNYIVSTRHYRAPEVI-LGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
P T Y APEVI G G+ P DIWS+GC +VE+ TG+ F E E
Sbjct: 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGE 216
Query: 331 HLAMMERV 338
A M +V
Sbjct: 217 PQAAMFKV 224
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 38/161 (23%), Positives = 81/161 (50%), Gaps = 26/161 (16%)
Query: 192 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLHTP 250
Y +F ++ QLL ++++H+ +IH D+K N+L+ S+ + +++ D+
Sbjct: 96 KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF------- 148
Query: 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 310
+A ++ G+ E Q ++ T + APEV+ G + CD+WSVG
Sbjct: 149 -----------GAAARLAAKGTGAGEFQGQ--LLGTIAFMAPEVLRGEQYGRSCDVWSVG 195
Query: 311 CILVELCTGEALFQTHENLEHLAMMERVLG-----PLPQHM 346
C+++E+ T + + ++ HLA++ ++ +P+H+
Sbjct: 196 CVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 78/340 (22%), Positives = 128/340 (37%), Gaps = 96/340 (28%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMI-----EIEVLQQLAKH 153
+G+GT+G+V + EM+A+K V G R+ M+ EIE L+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
+ VQ + ++ I E + G S+ LR Y F LVR Q+LE +
Sbjct: 69 N-----IVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVLEGL 121
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
A++H ++H DLK +N+L+ + K+ D+ S +
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS----------------------D 159
Query: 273 TTYERPDQNYIVSTRHYRAPEVI--LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
Y+ + + + APEVI G++ DIWS+GC+++E+ G + + E
Sbjct: 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR---RPWSDEE 216
Query: 331 HLAMM-----ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
+A M +R P+P + + P
Sbjct: 217 AIAAMFKLGNKRSAPPIPPDVSMNLS--------------PVAL---------------- 246
Query: 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
L +P +R TARE L+HPF
Sbjct: 247 ---------------DFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 35/224 (15%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 157
++I ++G+G FG+V + ++E + A K++ + E M+EIE+L
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP---- 69
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V++ F + + I+ E D + R ++ I RQ+LE + ++H
Sbjct: 70 -YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+ +IH DLK NVLL IK+ D+ S K T +R
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK----------------------TLQR 166
Query: 278 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 316
D + T ++ APEV++ + Y DIWS+G L+E+
Sbjct: 167 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 68/332 (20%), Positives = 129/332 (38%), Gaps = 85/332 (25%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYR--EAAMIEIEVLQQLAKHDKGGNRC 160
+G+G FG+V C + +M A K + + +KK + + A+ E ++L++++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + F+ ++ +C+V + G L + FP A Q++ + +H
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ DLKPENVLL +++ D ++ G R
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKG-------------------GKKIKGR-- 154
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 339
T Y APEV+ G + + D +++GC L E+ G + F+ +
Sbjct: 155 ----AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK------------ 198
Query: 340 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399
++V++ K R +++ ++ P D + +
Sbjct: 199 --------EKVEKEELK---------------RRTLEMAVEYP----------DKFSPEA 225
Query: 400 THLLQGLLRYDPTDRL-----TAREALRHPFF 426
L + LL+ DP RL +A E HP F
Sbjct: 226 KDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 39/224 (17%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV------RGIKKYREAAMIEIEVLQQLAKHDKGGN 158
+G G FG+V C+D + +A+K V + K A EI++L+ L +HD
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHD---- 64
Query: 159 RCVQ----IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
R VQ +R+ + + I + + G S+ D L+ Y + ++ R RQ+L+ +++
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMP-GGSIKDQLKA--YGALTENVTRRYTRQILQGVSY 121
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H ++H D+K N+L S+ +K+ D+ +S KR I+ I T
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS----------KR------IQTICMSGTG 165
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+ + T ++ +PEVI G G+ D+WSV C +VE+ T
Sbjct: 166 IKS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 43/234 (18%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGI-KKYREAAMIEIEVLQQLAKHDK 155
++I +K+G+G+FG V + + K + A+K + + ++ RE A+ E VL +L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL----- 56
Query: 156 GGNRCVQIRNW--FDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
+ IR + F + + IV E L+ L+ R P D V Q+L +
Sbjct: 57 --DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
A +H ++H D+K N+ L Y V K+ D G
Sbjct: 115 AHLHSKKILHRDIKSLNLFL--DAYDNV-------------------------KIGDLGV 147
Query: 273 TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
+ N+ IV T +Y +PE+ + D+W++G +L E CTG+ F
Sbjct: 148 AKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 74/264 (28%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD- 154
T +++ +GEGT+G+V + ++ ++VAIKI+ I+ E E +L++ + H
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 155 ---------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF---LRKNNYRSFPIDLV 201
K + W V E G S+ D LRK + + +
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWL--------VMELCGGGSVTDLVKGLRKKG-KRLKEEWI 115
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
I R+ L +A++H+ +IH D+K +N+LL K
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLT---------------------------K 148
Query: 262 SSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVG 310
++ +K++DFG ST R N + T ++ APEVI + D+WS+G
Sbjct: 149 NAEVKLVDFGVSAQLDSTLGRR---NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205
Query: 311 CILVELCTGE----------ALFQ 324
+EL G+ ALF+
Sbjct: 206 ITAIELADGKPPLCDMHPMRALFK 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 66/250 (26%), Positives = 109/250 (43%), Gaps = 40/250 (16%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ---LAKHDKGGNRCV 161
+G+G +G V C + +++A+K V AA E E LQ+ L K K N
Sbjct: 8 LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+ D N I I E + G S+ L N + P + + +Q+L+ +A++H+ C+
Sbjct: 67 YLGTCLD-DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 221 IHTDLKPENVLLVSSEYIKVPDYK-------SSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+H D+K NV+L+ + IK+ D+ LH S+ K M
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH-SNMLKSMH------------- 169
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
T ++ APEVI G+ DIWS+GC + E+ TG+ + + L +
Sbjct: 170 -----------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
Query: 334 MMERVLGPLP 343
+ G +P
Sbjct: 219 YIGAHRGLMP 228
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 157
++I ++G+G FG+V + ++E + A K++ + E M+EI++L +
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN--- 63
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V++ + F Y N++ I+ E D + R +R + +Q LE + ++H+
Sbjct: 64 --IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+IH DLK N+L IK+ D+ S + T +R
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----------------------TIQR 159
Query: 278 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 316
D + T ++ APEV++ + Y D+WS+G L+E+
Sbjct: 160 RDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 6e-13
Identities = 54/236 (22%), Positives = 88/236 (37%), Gaps = 56/236 (23%)
Query: 100 KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKH 153
+ K+GEG FG+V + ++K VA+K ++ ++ E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 154 D-----KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 206
G C + + IV E + G L +LRKN + DL+ A
Sbjct: 61 PNVVKLLGV--CTE-------EEPLYIVMEYMEGGD-LLSYLRKNRPKLSLSDLL-SFAL 109
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+ + ++ IH DL N L V + +K
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL-VGENLV--------------------------VK 142
Query: 267 VIDFGSTTYERPDQNYIVSTRH--YR--APEVILGLGWTYPCDIWSVGCILVELCT 318
+ DFG + D Y R APE + +T D+WS G +L E+ T
Sbjct: 143 ISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 40/227 (17%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHD 154
+KI K+G+G F V + +VA+K V+ K R+ + EI++L+QL H
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHP 62
Query: 155 KGGNRCVQIRNWFDYRNHICIVFE-----KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
++ F N + IV E L + F K R P + + QL
Sbjct: 63 N----VIKYLASFIENNELNIVLELADAGDLSRMIKHF--KKQKRLIPERTIWKYFVQLC 116
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ MH ++H D+KP NV + ++ +K+ D R
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG-----------LGRF---------- 155
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316
F S T + +V T +Y +PE I G+ + DIWS+GC+L E+
Sbjct: 156 FSSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 83/330 (25%), Positives = 131/330 (39%), Gaps = 87/330 (26%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
++G+G+FG+V + D KE+VAIKI+ E A EIE +QQ +
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 164 RNWFDY--RNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDL 218
R + Y + I+ E LG S D L+ P++ + I R++L+ + ++H
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE 120
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
IH D+K NVLL +K+ D+ + G T +
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQI 156
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 338
+N V T + APEVI + + DIWS+G +EL GE + +L + RV
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP---PNSDLHPM----RV 209
Query: 339 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398
L +P++ P L+ Q+ +
Sbjct: 210 LFLIPKN----------------------------------SPPTLEG---QY----SKP 228
Query: 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
++ L DP R TA+E L+H F TR
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 75/334 (22%), Positives = 125/334 (37%), Gaps = 94/334 (28%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC---- 160
+G+GTFG+V+ ++ + A+KI++ +E + + EV L + N
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILK-----KEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
++ F + +C V E G L+ L + R F D R +++ + ++H
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ DLK EN++L +IK+ D+ + K I G+T
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFG--------------LCKEG----ISDGATM----- 152
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 337
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
Query: 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
+ + PR L +
Sbjct: 212 I-----------------------------------------RFPR--TL--------SP 220
Query: 398 DLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
+ LL GLL+ DP RL A+E + H FF
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 36/261 (13%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAM-IEIEVLQ 148
GE+ + Y++ K+G G FG+V + +E K + RG+K+ ++ + IE+ V++
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67
Query: 149 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI------DLVR 202
+L KH + N + + +I + F G L +N + + + +
Sbjct: 68 EL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGD-----LSRNIQKCYKMFGKIEEHAIV 121
Query: 203 EIARQLLECIAFMHDLC-------MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255
+I RQLL +A+ H+L ++H DLKP+N+ L S I+ H K ++
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL--STGIR--------HIGKITAQ 171
Query: 256 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTY--PCDIWSVGC 311
+ K+ DFG + + + V T +Y +PE++L +Y D+W++GC
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 312 ILVELCTGEALFQTHENLEHL 332
I+ ELC+G+ F N L
Sbjct: 232 IIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 39/258 (15%)
Query: 105 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
+G G+FG+V L + E VAIK K ++ + + +++ + CV +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNL 96
Query: 164 RNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 222
F +++ +V E +G + FLR+N + FP D+ A Q++ ++ L +++
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 223 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 282
DLKPEN+LL +IK+ D+ + KV+D + TY
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFA-------------------KVVD--TRTYT------ 187
Query: 283 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-------EALFQTHENLEHLAMM 335
+ T Y APE++L +G D W++G + E+ G E L + LE +
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247
Query: 336 ERVLGPLPQHMLKRVDRH 353
+ L +H++K++ H
Sbjct: 248 PKFLDNNCKHLMKKLLSH 265
|
Length = 340 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 34/204 (16%)
Query: 192 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHT 249
Y +F D+ R + + I +H L IH D+KP+N+L+ +IK+ D+ S H
Sbjct: 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153
Query: 250 PKDSSYFKRMPKSSAIK---------VIDFGSTTYERPDQ-----------NY-IVSTRH 288
DS+Y++++ + + K +D + T DQ Y V T
Sbjct: 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213
Query: 289 YRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF---QTHENL-------EHLAMMERV 338
Y APE+ L G+ CD WS+G I+ E G F +HE E L + +
Sbjct: 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI 273
Query: 339 -LGPLPQHMLKRVDRHAEKYVRRG 361
L + +++R+ +AE + RG
Sbjct: 274 HLSVEAEDLIRRLITNAENRLGRG 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKGGNR 159
++G+G+FG+V + D +++VAIKI+ E A EIE +QQ L++ D
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDS--PY 63
Query: 160 CVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
+ + + I+ E LG S D LR + F I + +++L+ + ++H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLHSE 120
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
IH D+K NVLL +K+ D+ + G T +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQI 156
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
+N V T + APEVI + DIWS+G +EL GE
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 38/262 (14%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
K+GEG+ G V ++ + VA+K + K+ R + V+ + H+ V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN----VVDM 84
Query: 164 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 222
N + + + +V E L G +L D + + + + +L ++++H+ +IH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHNQGVIH 141
Query: 223 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 282
D+K +++LL S IK+ D+ K E P +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSK------------------------EVPKRKS 177
Query: 283 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 342
+V T ++ APEVI L + DIWS+G +++E+ GE + N L M R+ L
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYFNEPPLQAMRRIRDNL 234
Query: 343 PQHMLKRVDRHAEKYVRRGRLD 364
P + D H V RG LD
Sbjct: 235 PPRV---KDSHKVSSVLRGFLD 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 62/255 (24%), Positives = 109/255 (42%), Gaps = 38/255 (14%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHD 154
+Y+ +G G FG V C + +++V IK + + K R AA E +VL+ L+ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
++ F + IV E G +L ++++K D + Q+L +
Sbjct: 61 -----IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
+H ++H DLK +N+LL + + K+ D+ S K++ S
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS-------------------KILSSKS 156
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332
Y +V T Y +PE+ G + DIW++GC+L EL + + F+ NL L
Sbjct: 157 KAYT------VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPAL 209
Query: 333 AM--MERVLGPLPQH 345
+ M P+
Sbjct: 210 VLKIMSGTFAPISDR 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 45/259 (17%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---KGGNRCV 161
+G G FG+V + K + A+K +R ++ ++ +V A+ D + N V
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLR-----KKDVLLRNQVAHVKAERDILAEADNEWV 63
Query: 162 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS-------FPIDLVREIARQLLECIAF 214
+R ++ +++ + F + D++ + S FP DL R +L +
Sbjct: 64 -VRLYYSFQDKDNLYF------VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVES 116
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPD---------------YKSSLHTPKDSSYFKRM 259
+H + IH D+KP+N+L+ +IK+ D Y+S H +DS F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 260 PKSSA-------IKVIDF-GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311
A +K ++ + ++R + +V T +Y APEV+L G+T CD WSVG
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 312 ILVELCTGEALFQTHENLE 330
IL E+ G+ F LE
Sbjct: 237 ILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 57/262 (21%), Positives = 114/262 (43%), Gaps = 35/262 (13%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 154
++ + +G+G FG+V C R +M A K + + IKK + +M E ++L+++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV---- 57
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V + ++ ++ +C+V + G L + F A ++ +
Sbjct: 58 -NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+H +++ DLKPEN+LL +I++ D ++H P+ + R
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--------------- 161
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
V T Y APEV+ +T+ D W++GC+L E+ G++ FQ +
Sbjct: 162 ----------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211
Query: 334 MMERVLGPLPQHMLKRVDRHAE 355
+ER++ + + ++ A
Sbjct: 212 EVERLVKEVQEEYSEKFSPDAR 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 103 SKMGEGTFGQV-LECWDRER---KEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 156
++GEG FG+V L +D E VA+K + G +++R EIE+L+ L H+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN- 67
Query: 157 GNRCVQIRNWFD--YRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V+ + + + ++ E L S SL D+L+++ + L+ + Q+ + +
Sbjct: 68 ---IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQICKGMD 123
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDFGS 272
++ IH DL N+L+ S + +K+ D+ + P+D Y+ + P S I
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF------ 177
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+ APE + ++ D+WS G L EL T
Sbjct: 178 ----------------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 54/235 (22%)
Query: 104 KMGEGTFGQVLEC-WDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGN 158
K+GEG FG+V + + VA+K ++ ++ R+ + E V+++L H
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPN--- 57
Query: 159 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN-NYRSFPI-------DLVREIARQL 208
V++ + +V E + G L D+LRK+ P DL+ A Q+
Sbjct: 58 -VVRLLGVCTEEEPLYLVLEYMEGGD-LLDYLRKSRPVFPSPEKSTLSLKDLLS-FAIQI 114
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
+ + ++ +H DL N L V + + +K+
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCL-VGEDLV--------------------------VKIS 147
Query: 269 DFGSTTYERPDQNYIVSTR---HYR--APEVILGLGWTYPCDIWSVGCILVELCT 318
DFG + D Y T R APE + +T D+WS G +L E+ T
Sbjct: 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 55/230 (23%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKG--- 156
K+G+G+FG+V + D +++VAIKI+ E A EIE +QQ L++ D
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 157 ---GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLE 210
G+ + W I+ E LG S D L P+D + I R++L+
Sbjct: 66 KYYGSYLKDTKLW--------IIMEYLGGGSALDLLEPG-----PLDETQIATILREILK 112
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++H IH D+K NVLL +K+ D+ +
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------ 148
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
G T + +N V T + APEVI + DIWS+G +EL GE
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 74/327 (22%), Positives = 130/327 (39%), Gaps = 84/327 (25%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
K+GEG+ G V D+ VA+K + K+ R + V+ + +H V++
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN----IVEM 81
Query: 164 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 222
+ + + + +V E L G +L D + + + + +L+ ++F+H +IH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLAVLKALSFLHAQGVIH 138
Query: 223 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYERPD 279
D+K +++LL S +K+ DFG + E P
Sbjct: 139 RDIKSDSILLTSD---------------------------GRVKLSDFGFCAQVSKEVPR 171
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 339
+ +V T ++ APEVI L + DIWS+G +++E+ GE + N L M+R+
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP---PYFNEPPLQAMKRIR 228
Query: 340 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399
LP + ++ K PRL++ + +
Sbjct: 229 DNLPPKL-----KNLHKVS-----------------------PRLRSFLDR--------- 251
Query: 400 THLLQGLLRYDPTDRLTAREALRHPFF 426
+L DP R TA E L HPF
Sbjct: 252 ------MLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 63/272 (23%), Positives = 103/272 (37%), Gaps = 61/272 (22%)
Query: 167 FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 225
F ++C+V + G L+ L++ + ++ R A ++L + ++H L +++ DL
Sbjct: 70 FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDL 129
Query: 226 KPENVLLVSSEYIKVPDYKSSLHTP-------KDSSYFKRMPKSSAIKVIDFGSTTYERP 278
KPEN+LL S +I + D+ S + K R ++I F R
Sbjct: 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR- 188
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 338
N V T Y APEVI G G D W++G +L E+ G F+
Sbjct: 189 -SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK-------------- 233
Query: 339 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398
G+ E+ +++K S+
Sbjct: 234 -----------------------------GSNRDETFSNILKKEV---TFPGSPPVSS-S 260
Query: 399 LTHLLQGLLRYDPTDRL----TAREALRHPFF 426
L++ LL DP+ RL A E +HPFF
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 19/147 (12%)
Query: 196 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD------------- 242
F DL R +L I +H + IH D+KP+N+L+ +IK+ D
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 243 --YKSSLHTPKDS-SYFKRM--PKSSAIKVID-FGSTTYERPDQNYIVSTRHYRAPEVIL 296
Y+ H +DS + +K ++ ++R + +V T +Y APEV+L
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 297 GLGWTYPCDIWSVGCILVELCTGEALF 323
G+T CD WSVG IL E+ G+ F
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 61/251 (24%), Positives = 105/251 (41%), Gaps = 52/251 (20%)
Query: 96 TSRYKIH-----SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEV 146
TS +K+ +G G+FG+V + E AIK ++ + K + E +
Sbjct: 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI 71
Query: 147 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIA 205
L +L+ V + F N + + E +G L+ LRK FP D+ +
Sbjct: 72 LMELSH-----PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYH 124
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
+L+ ++H +I+ DLKPEN+LL + ++KV D+ + K++
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF----------GFAKKV------ 168
Query: 266 KVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG----- 319
PD+ + + T Y APEVI G D W++G +L E G
Sbjct: 169 ------------PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
Query: 320 -EALFQTHENL 329
+ F+ +E +
Sbjct: 217 DDTPFRIYEKI 227
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 3e-11
Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 46/246 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 156
+Y + K+G+G G V D + VAIK + K+ ++ +I EI V+++L +
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN-- 77
Query: 157 GNRCVQIRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
I N+ D + + +V E L G SL D + + I V R+ L+ +
Sbjct: 78 ------IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQAL 128
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
F+H +IH D+K +NVLL ++K+ DFG
Sbjct: 129 EFLHANQVIHRDIKSDNVLL---------------------------GMDGSVKLTDFGF 161
Query: 272 --STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
T E+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 330 EHLAMM 335
L ++
Sbjct: 222 RALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 70/337 (20%), Positives = 131/337 (38%), Gaps = 88/337 (26%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD 154
S Y+ +G G +G V +VA+KI+ + + I E+ +L QL +
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQL-RQS 59
Query: 155 KGGNRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLL 209
+ N + + Y + I+ E G S+ ++ PI + I R++L
Sbjct: 60 QPPN---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVL 111
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ ++H + +IH D+K N+L+ ++ +K+ D+ + ++SS KR
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KR----------- 158
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
+T+ V T ++ APEVI G + DIWS+G + E+ TG + +
Sbjct: 159 ---STF--------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
R + +P+ K PRL++
Sbjct: 208 F-------RAMMLIPKS----------------------------------KPPRLED-- 224
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+ + L + L +P +RL+A E L+ +
Sbjct: 225 ----NGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 94/335 (28%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 160
+G+GTFG+V+ ++ + A+KI++ +E + + EV L + N
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILK-----KEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
++ F ++ +C V E + G L+ L + R F D R +++ + ++H
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ DLK EN++L +IK+ D+ D++ K
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-------------------- 155
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 337
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
Query: 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
+ K PR +
Sbjct: 212 I-----------------------------------------KFPRTL----------SA 220
Query: 398 DLTHLLQGLLRYDPTDRL-----TAREALRHPFFT 427
D LL GLL DP RL A+E +RH FFT
Sbjct: 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 73/326 (22%), Positives = 130/326 (39%), Gaps = 78/326 (23%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
K+GEG+ G V + ++VA+K + K+ R + V+ + +H+ V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEM 82
Query: 164 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 222
N + + + +V E L G +L D + + + + +L+ ++ +H +IH
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLKALSVLHAQGVIH 139
Query: 223 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 282
D+K +++LL +K+ D+ K E P +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSK------------------------EVPRRKS 175
Query: 283 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 342
+V T ++ APE+I L + DIWS+G +++E+ GE + L+ + M+
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------- 228
Query: 343 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402
R + P P+L+NL V S L
Sbjct: 229 -------------------RDNLP---------------PKLKNL--HKVSPS---LKGF 249
Query: 403 LQGLLRYDPTDRLTAREALRHPFFTR 428
L LL DP R TA E L+HPF +
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 74/338 (21%), Positives = 126/338 (37%), Gaps = 101/338 (29%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-------EAAMIEIEVLQQLAKHDKGG 157
+G+G+FG+VL + E+ A+K++ KK E M E VL KH
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAGKHP--- 56
Query: 158 NRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
Q+ + F ++ + V E + G ++ R F R A +++ + F+
Sbjct: 57 -FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFL 112
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
H+ +I+ DLK +NVLL S +IK+ D+ M K I G TT
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFG--------------MCKEG----ILGGVTT- 153
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLA 333
+ T Y APE++ + D W++G +L E+ G++ F + L
Sbjct: 154 -----STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ + V P+ + S+E+
Sbjct: 209 LEDEVR--YPRWL------------------------SKEAKS----------------- 225
Query: 394 HSAGDLTHLLQGLLRYDPTDRL----TAREALR-HPFF 426
+L+ L +P RL T + ++ HPFF
Sbjct: 226 --------ILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 35/249 (14%)
Query: 100 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++ K+G+G FG+V + W+ K VAIK ++ EA + E +++++L +HDK
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVP 65
Query: 159 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
+ I IV E +G SL DFL++ + + + + ++A Q+ + +A++
Sbjct: 66 LYAVVS-----EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+ IH DL+ N+L+ + K+ D+ + +D+ Y R IK
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLA-RLIEDNEYTARQGAKFPIK----------- 168
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 336
+ APE L +T D+WS G +L EL T G + N E L +E
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
Query: 337 R-VLGPLPQ 344
R P PQ
Sbjct: 218 RGYRMPCPQ 226
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 34/237 (14%)
Query: 104 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 162
K+G G FG+V + W+ K VA+K ++ E+ + E +++++L +HDK VQ
Sbjct: 13 KLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKL-RHDK----LVQ 65
Query: 163 IRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 221
+ I IV E + SL DFL+ R+ + + ++A Q+ +A++ + I
Sbjct: 66 LYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 222 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 281
H DL+ N+L+ K+ D+ + +D+ Y R IK
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLA-RLIEDNEYTARQGAKFPIK--------------- 168
Query: 282 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 337
+ APE L +T D+WS G +L EL T G + N E L +ER
Sbjct: 169 -------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 96/335 (28%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+VL + + A+K++ + I K +E M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + F + + V + + G L+ L++ RSFP R A ++ + ++H L
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116
Query: 220 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+I+ DLKPEN+LL S ++ + D+ K + K +S F P+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE--------------- 161
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
Y APEV+ + D W +G +L E+ G F + + E M +
Sbjct: 162 ------------YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYD 206
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH-VDHS 395
+L + L ++ + S
Sbjct: 207 NILN--------------------------------------------KPLRLKPNISVS 222
Query: 396 AGDLTHLLQGLLRYDPTDRLTAREALR----HPFF 426
A HLL+GLL+ D T RL A++ H FF
Sbjct: 223 A---RHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 84/347 (24%), Positives = 134/347 (38%), Gaps = 108/347 (31%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+V++ R+ + + A+K +R + + E VL Q+ C
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV--------NC 52
Query: 161 ---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRK----NNYRSFPIDLVREIARQLLECI 212
V ++ F + +V + G L+ L++ + R+ R +LL +
Sbjct: 53 PFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYTAELLCAL 106
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
+H +I+ DLKPEN+LL DY+ I + DFG
Sbjct: 107 ENLHKFNVIYRDLKPENILL---------DYQGH------------------IALCDFGL 139
Query: 273 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
D N T Y APE++LG G+T D W++G +L E+ TG
Sbjct: 140 CKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG---------- 189
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
LP + V+ K ++ L +P+G
Sbjct: 190 ------------LPPFYDENVNEMYRKILQE-PLRFPDG--------------------- 215
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRDHLRR 433
D A D LL GLL DPT RL A+E HPFF++ ++
Sbjct: 216 --FDRDAKD---LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKK 257
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 58/236 (24%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164
+G GT+GQV + + ++ AIK++ + E +EI +L++ + H R
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH----------R 73
Query: 165 NWFDY------------RNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLEC 211
N Y + + +V E G+ S+ D ++ + D + I R++L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+A +H +IH D+K +NVLL +++ +K++DFG
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFG 166
Query: 272 -STTYERP--DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG 319
S +R +N + T ++ APEVI + Y DIWS+G +E+ G
Sbjct: 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 78/345 (22%), Positives = 134/345 (38%), Gaps = 85/345 (24%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 154
++ + +G+G FG+V C R +M A K + + IKK + +M E ++L+++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV---- 57
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V + ++ ++ +C+V + G L + F + A ++L +
Sbjct: 58 -NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+H ++ DLKPEN+LL +I++ D ++ P+ S R
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--------------- 161
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
V T Y APEV+ +T D W +GC++ E+ G++ F+
Sbjct: 162 ----------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR--------G 203
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
E+V + + +RV E Y A E KS+ K+
Sbjct: 204 RKEKV---KREEVDRRVLETEEVY----------SAKFSEEAKSICKM------------ 238
Query: 394 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 433
LL DP RL A E RHPFF + +R
Sbjct: 239 ------------LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 75/280 (26%), Positives = 109/280 (38%), Gaps = 84/280 (30%)
Query: 174 CIVFEKLGSSLYDFLRKNNYRSFPIDL--VREIARQLLECIAFMHDLCMIHTDLKPENVL 231
C+V K S LY +L R P+ L V +ARQLL I ++H +IH D+K ENVL
Sbjct: 236 CLVLPKYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292
Query: 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-----PDQNYIVST 286
++ P+D I + DFG+ + R P I T
Sbjct: 293 ---------------VNGPED------------ICLGDFGAACFARGSWSTPFHYGIAGT 325
Query: 287 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHLAMMERVLGPLPQH 345
APEV+ G +T DIWS G ++ E A LF E ++L
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL------ 379
Query: 346 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG-------- 397
R+ R A+ +V ++P+ A SR L+ Q+ +A
Sbjct: 380 ---RIIRQAQVHVD----EFPQHAGSR--------------LVSQYRHRAARNRRPAYTR 418
Query: 398 -----------DLTHLLQGLLRYDPTDRLTAREALRHPFF 426
D+ +L+ L +D R +A E LR P F
Sbjct: 419 PAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458
|
Length = 461 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 57/228 (25%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
++G G+FG V D E+VAIK K + E Q + K + +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIK------KMSYSGKQSNEKWQDIIKEVRFLQQLRH- 74
Query: 164 RNWFDY-----RNHIC-IVFEK-LGSS--LYDFLRKNNYRSFPIDLVREIA---RQLLEC 211
N +Y R H +V E LGS+ + + +K P+ V EIA L+
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK------PLQEV-EIAAICHGALQG 127
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+A++H IH D+K N+LL + +K+ DFG
Sbjct: 128 LAYLHSHERIHRDIKAGNILLT---------------------------EPGTVKLADFG 160
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 316
S + P ++ V T ++ APEVIL + + D+WS+G +EL
Sbjct: 161 SASLVSPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 43/227 (18%)
Query: 97 SRYKIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 155
S + ++G G FG V L W +RK VAIK +R E + E +V+ +L+
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK--VAIKTIREGAMSEEDFIEEAQVMMKLSH--- 58
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
+ VQ+ R+ IC+VFE + L D+LR F + + + + E +A+
Sbjct: 59 --PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAY 115
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+ +IH DL N L+ ++ +KV DFG T
Sbjct: 116 LESSNVIHRDLAARNCLV---------------------------GENQVVKVSDFGMTR 148
Query: 275 YERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVEL 316
+ DQ Y ST + +PEV ++ D+WS G ++ E+
Sbjct: 149 FVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 35/242 (14%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHD 154
RY+I K+GEG+FG++ + E IK + K K +EA+ E+ +L ++ KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHP 59
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V F + IV E G L + + F D + Q+ +
Sbjct: 60 N----IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
+HD ++H D+K +N+ L + + K+ D+ + DS
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA-RQLNDSMELAYT------------- 161
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332
V T +Y +PE+ + DIWS+GC+L ELCT + F+ + NL L
Sbjct: 162 ----------CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQL 210
Query: 333 AM 334
+
Sbjct: 211 VL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 79/335 (23%), Positives = 133/335 (39%), Gaps = 53/335 (15%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
Y + + G+ G+V + + V +KI G K +IE +LQ + H
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--GQKG---TTLIEAMLLQNV-NHPS--- 118
Query: 159 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
+++++ C+V S LY +L K + R PID I +Q+LE + ++H
Sbjct: 119 -VIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+IH D+K EN+ + + + + D ++ + P V+ P
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAA-----------QFP------VVA--------P 211
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 338
+ T APEV+ + DIWS G +L E+ A T E V
Sbjct: 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML---AYPSTIFEDPPSTPEEYV 268
Query: 339 LGPLPQHMLKRVDR---HAEKYVRRGRLDWPEGAASRESIK--SVMKLPRLQNLIMQHVD 393
H+LK + H E++ R P R I+ S+ + P + Q V+
Sbjct: 269 KSC-HSHLLKIISTLKVHPEEFPRD-----PGSRLVRGFIEYASLERQPYTRYPCFQRVN 322
Query: 394 -HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
G+ L+ +L +D R +A E L +P F
Sbjct: 323 LPIDGEF--LVHKMLTFDAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 46/225 (20%)
Query: 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA-----KHDKGG 157
S++GEG G V +C + + A+K + ++ ++L++L K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCKSP--- 59
Query: 158 NRCVQIRNWF--DYRNHICIVFEKLGS----SLYDFLRKNNYRSFPIDLVREIARQLLEC 211
V+ F + + I I E S+Y ++K R L + IA +L+
Sbjct: 60 -YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK-IAESVLKG 117
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
++++H +IH D+KP N+LL +K+ D+ S ++++
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG------------------ELVNSL 159
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316
+ T+ T Y APE I G ++ D+WS+G L+E+
Sbjct: 160 AGTF--------TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 38/235 (16%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAK 152
+ ++I K+G G F +V ++ VA+K V+ + K R+ + EI++L+QL
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLG----SSLYDFLRKNNYRSFPIDLVREIARQL 208
+ ++ + F N + IV E S + + +K R P V + QL
Sbjct: 62 PN-----VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK-RLIPERTVWKYFVQL 115
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
+ MH ++H D+KP NV + ++ +K+ D R
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-----------LGRF--------- 155
Query: 269 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
F S T + +V T +Y +PE I G+ + DIWS+GC+L E+ ++ F
Sbjct: 156 -FSSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 46/246 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 156
+Y K+G+G G V D + VAIK + ++ ++ +I EI V+++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE------- 72
Query: 157 GNRCVQIRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
N+ I N+ D + + +V E L G SL D + + I V R+ L+ +
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 128
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
F+H +IH D+K +N+LL ++K+ DFG
Sbjct: 129 DFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 161
Query: 272 --STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
T E+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 330 EHLAMM 335
L ++
Sbjct: 222 RALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 23/151 (15%)
Query: 196 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDS 253
FP L R +L I +H + IH D+KP+N+L+ +IK+ D+ + +S
Sbjct: 98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157
Query: 254 SYFKR--------MPKS------SAIKVIDFGSTTYERPDQNY-------IVSTRHYRAP 292
Y+++ M S S + D T +R + + +V T +Y AP
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217
Query: 293 EVILGLGWTYPCDIWSVGCILVELCTGEALF 323
EV+L G+T CD WSVG IL E+ G+ F
Sbjct: 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 60/246 (24%), Positives = 107/246 (43%), Gaps = 46/246 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 156
+Y K+G+G G V D + VAI+ + ++ ++ +I EI V+++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73
Query: 157 GNRCVQIRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
N+ I N+ D + + +V E L G SL D + + I V R+ L+ +
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
F+H +IH D+K +N+LL ++K+ DFG
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 162
Query: 272 --STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
T E+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 330 EHLAMM 335
L ++
Sbjct: 223 RALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 68/257 (26%), Positives = 105/257 (40%), Gaps = 54/257 (21%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164
+G+G+FG+V +VR I + ++VL++ + R R
Sbjct: 4 LGQGSFGKVF--------------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER 49
Query: 165 NWFDYRNHICIV-----FEKLGSSLY---DFLRKNNYRS-------FPIDLVREIARQLL 209
+ NH IV F+ G LY DFLR + + F + V+ +L
Sbjct: 50 DILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 108
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ +H L +I+ DLKPEN+LL +IK+ D+ S K+S ID
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES--------------ID 150
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
Y T Y APEV+ G T D WS G ++ E+ TG FQ +
Sbjct: 151 HEKKAYS------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204
Query: 330 EHLAMMERVLGPLPQHM 346
E + M+ + +PQ +
Sbjct: 205 ETMTMILKAKLGMPQFL 221
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 52/227 (22%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGG 157
+ S +G G G V + ++A K+V R+ + E++++ H+
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM-----HECRS 62
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V F N+IC+ E + D + K P++++ +IA ++E + ++++
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 218 -LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
++H D+KP N+L+ S IK+ D+ S ++I+ + T+
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG------------------ELINSIADTF- 162
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
V T Y +PE I G +T D+WS+G ++EL G+ F
Sbjct: 163 -------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 98 RY-KIHSKMGEGTFGQV-LECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQL 150
RY K +GEG FG+V L C+D EMVA+K ++ ++ EI +L+ L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 151 AKHD---------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLV 201
+ + G + +Q+ + + LGS L D+L K+ + L
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQL----------IMEYVPLGS-LRDYLPKHKLNLAQLLL- 111
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
A+Q+ E +A++H IH DL NVLL + +K+ D+ + P+ Y+
Sbjct: 112 --FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----- 164
Query: 262 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+V + G S + A E + ++Y D+WS G L EL T
Sbjct: 165 ----RVREDGD------------SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 35/228 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREA-AMIEIEVLQQLAKHDKGGNRC 160
+G+G FG+V + +M A K + R KK E A++E E+L+++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP-----FI 55
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + F+ + H+C+V + G L + R ++ V + Q+ I +H +
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ D+KPENVLL ++ D ++ G T +R
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-------------------GKTITQR-- 154
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
T Y APE++ ++YP D +++GC + E+ G F+ H+
Sbjct: 155 ----AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 161
+G+G++G+V R + IK + ++ R+AA E ++L QL KH N
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHP---NIVA 63
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+W + IV G LY L++ + P + V E Q+ + ++H+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
+H DLK +NV L + IKV D R+ ++ D ST
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLG-----------IARVLENQC----DMAST------- 161
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL- 339
++ T +Y +PE+ + Y D+W++GC + E+ T + F + +++ R++
Sbjct: 162 --LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK---DMNSLVYRIIE 216
Query: 340 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
G LP M K + + PE R S+KS+++ P
Sbjct: 217 GKLPP-MPKDYSPELGELIATMLSKRPE---KRPSVKSILRQP 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 41/228 (17%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+VL + + E A+K ++ I E M+E VL ++
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMH 216
+ F + H+ V E L G ++ K + DL R A +++ + F+H
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-----DLYRATFYAAEIVCGLQFLH 113
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+I+ DLK +NV+L +IK+ D+ M K + D ++T+
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFG--------------MCKENVFG--DNRASTF- 156
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
T Y APE++ GL +T+ D WS G +L E+ G++ F
Sbjct: 157 -------CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 54/261 (20%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-- 162
+G+GTFG+V+ ++ A+KI++ +E + + EV L + NR +Q
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTE-----NRVLQNS 52
Query: 163 -------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
++ F + +C V E G L+ L + R F D R +++ + +
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDY 110
Query: 215 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+H + +++ DLK EN++L +IK+ D+ KD + K
Sbjct: 111 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-------------- 156
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEH 331
T Y APEV+ + D W +G ++ E+ G F Q HE L
Sbjct: 157 ----------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206
Query: 332 LAMME-----RVLGPLPQHML 347
L +ME R L P + +L
Sbjct: 207 LILMEEIRFPRTLSPEAKSLL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 52/242 (21%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
+ + S +G G FG+V ++ ++ A+K+ +KK + ++ E + +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKV---MKK---SVLLAQETVSFFEEE----R 52
Query: 159 RCVQIRN--W-------FDYRNHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQ 207
+ I N W F ++++ +V E G L L N Y F D+ + +
Sbjct: 53 DILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAE 110
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
L+ I +H + +H D+KPENVL+ + +IK+ D+ S+ + ++P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP------- 163
Query: 268 IDFGSTTYERPDQNYIVSTRHYRAPEVILGL----GWTY--PCDIWSVGCILVELCTGEA 321
V T Y APEV+ + TY CD WS+G I E+ G +
Sbjct: 164 ----------------VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
Query: 322 LF 323
F
Sbjct: 208 PF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 46/231 (19%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 156
+Y K+G+G G V D + VAIK + ++ ++ +I EI V+++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE------- 72
Query: 157 GNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
N+ I N+ D + + +V E L G SL D + + I V R+ L+ +
Sbjct: 73 -NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 128
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
F+H +IH D+K +N+LL ++K+ DFG
Sbjct: 129 EFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 161
Query: 273 TTYERPDQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
P+Q+ +V T ++ APEV+ + DIWS+G + +E+ GE
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 49/248 (19%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNR 159
+G G FG+V ++ + A+KI+R +A M+E E + + A+ D G
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILVEADGAW 62
Query: 160 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL-----LECIA 213
V++ F + ++ ++ E L G + L K D + E A Q + I
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAID 115
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPD---------------YKSSLHTPKDSSYFKR 258
+H L IH D+KP+N+LL + ++K+ D Y++ H P F+
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 259 MPKSSAIKVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315
M + T+++ + V T Y APEV + G+ CD WS+G I+ E
Sbjct: 176 MNSKRK-------AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 316 LCTGEALF 323
+ G F
Sbjct: 229 MLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 76/339 (22%), Positives = 131/339 (38%), Gaps = 85/339 (25%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 160
+G+G FG+V C R +M A K + + IKK + AM E ++L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFV 62
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + ++ ++ +C+V + G L + F + A ++ + +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ DLKPEN+LL +I++ D ++ P+ G T R
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPE-------------------GETIRGR-- 161
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 339
V T Y APEV+ +T+ D W +GC++ E+ G++ F+ + +ER
Sbjct: 162 ----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-- 215
Query: 340 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399
RV E+Y + + E A S
Sbjct: 216 ---------RVKEDQEEYSEK----FSEAARS---------------------------- 234
Query: 400 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 433
+ + LL DP RL A E HPFF + +R
Sbjct: 235 --ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 100 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++ K+G+G FG+V + W+ + VAIK ++ EA + E +V+++L +H+K
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 62
Query: 159 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
VQ+ I IV E + SL DFL+ + + + ++A Q+ +A++
Sbjct: 63 -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+ +H DL+ N+L+ + KV D+ + +D+ Y R IK
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 168
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 336
+ APE L +T D+WS G +L EL T G + N E L +E
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217
Query: 337 R 337
R
Sbjct: 218 R 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 59/238 (24%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKI--VRGIKKYREAAMI--EIEVLQQL-- 150
+ +G GTFG+V DR + A+K+ + + + ++ + E VL+++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 151 --------AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLV 201
+HD+ + ++ E + G L+ +LR N F
Sbjct: 61 PFIIRLFWTEHDQ---------------RFLYMLMEYVPGGELFSYLR--NSGRFSNSTG 103
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
A +++ + ++H +++ DLKPEN+LL +IK+ D+
Sbjct: 104 LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDF------------------ 145
Query: 262 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
A K+ D T + T Y APEVI G D W++G ++ E+ G
Sbjct: 146 GFAKKLRDRTWT---------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 75/332 (22%), Positives = 129/332 (38%), Gaps = 86/332 (25%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 160
+G+GTFGQV + ++ + + A+K++ + I +E A E +L + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE--SPFI 58
Query: 161 VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V ++ F + + +V + G L+ L+K F D + +L+ + +H
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ DLKPEN+LL ++ +I + D+ S D+ TT
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDN------------------KTT----- 153
Query: 280 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 338
N T Y APEV+L G+T D WS+G ++ E+C G + F
Sbjct: 154 -NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--------------- 197
Query: 339 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398
Q M + + G++ +P+ S E
Sbjct: 198 YAEDTQQMYRN--------IAFGKVRFPKNVLSDEG------------------------ 225
Query: 399 LTHLLQGLLRYDPTDRL----TAREALRHPFF 426
++GLL +P RL A E HPFF
Sbjct: 226 -RQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 60/289 (20%), Positives = 123/289 (42%), Gaps = 43/289 (14%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI- 163
+G GT+GQV + + ++ AIK++ E EI +L++ + H
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 164 -RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 221
+N + + +V E G+ S+ D ++ + + + I R++L ++ +H +I
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 222 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP-- 278
H D+K +NVLL +++ +K++DFG S +R
Sbjct: 134 HRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQLDRTVG 166
Query: 279 DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
+N + T ++ APEVI + + D+WS+G +E+ G + L
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
++ R P P+ K+ + + ++ + + + R + + +MK P
Sbjct: 227 LIPR--NPAPRLKSKKWSKKFQSFIESCLV---KNHSQRPTTEQLMKHP 270
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 68/324 (20%), Positives = 124/324 (38%), Gaps = 78/324 (24%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
K+GEG+ G V ++ VA+K++ K+ R + V+ + +H V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----QNVVEM 83
Query: 164 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 222
+ + ++ E L G +L D + + I V E +L+ + ++H +IH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---SVLQALCYLHSQGVIH 140
Query: 223 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 282
D+K +++LL +K+ D+ KD P +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDV------------------------PKRKS 176
Query: 283 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 342
+V T ++ APEVI + DIWS+G +++E+ GE + +
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--------------- 221
Query: 343 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402
P +KR+ R P + I V++
Sbjct: 222 PVQAMKRL-----------RDSPPPKLKNAHKISPVLR--------------------DF 250
Query: 403 LQGLLRYDPTDRLTAREALRHPFF 426
L+ +L +P +R TA+E L HPF
Sbjct: 251 LERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 76/335 (22%), Positives = 121/335 (36%), Gaps = 94/335 (28%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMI-EIEVLQQLAKHDKGGNRC 160
+G+GTFG+V+ ++ A+KI+R I K A + E VLQ +H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP----FL 57
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
++ F + +C V E G L+ L + R F + R +++ + ++H
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ D+K EN++L +IK+ D+ D + K
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-------------------- 155
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 337
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
+ P R PE +
Sbjct: 212 IRFP--------------------RTLSPEAKS--------------------------- 224
Query: 398 DLTHLLQGLLRYDPTDRL-----TAREALRHPFFT 427
LL GLL+ DP RL A+E + H FF
Sbjct: 225 ----LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 64/259 (24%), Positives = 103/259 (39%), Gaps = 70/259 (27%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 155
T ++I +G+GT+G+V + +++ + A+KI+ I E E +LQ L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC---- 211
V+ F Y+ + G L+ L N S V E+ + LL C
Sbjct: 81 ----VVKFYGMF-YKADKLV-----GGQLWLVLELCNGGS-----VTELVKGLLICGQRL 125
Query: 212 ----IAF-----------MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256
I++ +H+ +IH D+K N+LL +
Sbjct: 126 DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---------------------- 163
Query: 257 KRMPKSSAIKVIDFGST---TYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWS 308
+K++DFG + T R +N V T + APEVI + CD+WS
Sbjct: 164 -----EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS 218
Query: 309 VGCILVELCTGE-ALFQTH 326
+G +EL G+ LF H
Sbjct: 219 LGITAIELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 38/245 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+VL + + A+K+++ +K ++ M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + F + V + + G L+ L++ RSFP R A ++ + ++H +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ DLKPEN+LL S ++ + D+ I D +T
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLC---------------KEGIAQSDTTTT------ 155
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF---QTHENLEHLAMME 336
T Y APEVI + D W +G +L E+ G F E +++
Sbjct: 156 ---FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 337 RVLGP 341
VL P
Sbjct: 213 LVLRP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 52/236 (22%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMI-EIEVLQQLAKHD 154
+++ +G+G FG+V R+ K+M A+K + ++K ++ E +LQ+L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NH- 59
Query: 155 KGGNRCVQIRNWFDYRNHICIVFE-KLGSSL-YDFLRKNNYRSFPIDLVREIARQLLECI 212
V + F ++ +V + LG L Y +K F + V+ +++ +
Sbjct: 60 ---PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLAL 113
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
++H +IH D+KP+N+LL ++ + D+ + D+ +
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----------------T 156
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
T+ T Y APEV+ G++ D WS+G E G+ ++ H
Sbjct: 157 TST--------SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 108 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167
G G C D + E V IK + R E +L+ + H +Q++ F
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPS----IIQLKGTF 152
Query: 168 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 227
Y C++ + + LY +L R+ I + I R +L I ++H+ +IH D+K
Sbjct: 153 TYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKA 210
Query: 228 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR 287
EN+ + + P D + + DFG+ + I + +
Sbjct: 211 ENIFI---------------NHPGD------------VCLGDFGAACFPVD----INANK 239
Query: 288 HY--------RAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALFQ 324
+Y APE++ + DIWS G +L E+ T +LF+
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 36/234 (15%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAK 152
+ ++I K+G G F +V VA+K V+ K R + EI++L+QL
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLL 209
+ ++ F N + IV E L ++ K R P V + QL
Sbjct: 62 PN-----VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ MH ++H D+KP NV + ++ +K+ D +F K++A
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS--KTTA----- 162
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
+ +V T +Y +PE I G+ + DIWS+GC+L E+ ++ F
Sbjct: 163 ----------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 51/240 (21%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++I +G+GT+G+V + +++ A+KI+ I E E +L+ L+ H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN--- 76
Query: 159 RCVQIRNWF---DYRN--HICIVFEKL-GSSLYD----FLRKNNYRSFPIDLVREIARQL 208
V+ + D +N + +V E G S+ D FL++ PI + I +
Sbjct: 77 -VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEA 133
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
L + +H IH D+K N+LL + +K++
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTT---------------------------EGGVKLV 166
Query: 269 DFGST---TYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 320
DFG + T R +N V T + APEVI L + CD+WS+G +EL G+
Sbjct: 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 160
+G+G FG+V C R +M A K + + IKK + AM E +L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-----NSRFV 62
Query: 161 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMHDL 218
V + ++ ++ +C+V + F N + D R I A +L + +
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+++ DLKPEN+LL +I++ D ++ P+ G T R
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE-------------------GETVRGR- 161
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
V T Y APEVI +T+ D W +GC++ E+ G++ F+ +
Sbjct: 162 -----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIV----RGIKKYREAAMIEIEVLQQLAKHDKGGNR 159
++G G+FG V + E+VA+K + + + + + E++ LQQL KH
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPN---- 82
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
++ + + + +V E S D L + +++ I L+ +A++H
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSHN 141
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
MIH D+K N+LL + +K+ DFGS + P
Sbjct: 142 MIHRDIKAGNILLT---------------------------EPGQVKLADFGSASKSSP- 173
Query: 280 QNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 316
N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 57/248 (22%)
Query: 105 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIE------IEVLQQLAKHDKGG 157
+G G FG V L W + VAIK++R E AM E +V+ +L+ H
Sbjct: 12 LGSGQFGVVHLGKWRGKID--VAIKMIR------EGAMSEDDFIEEAKVMMKLS-HPN-- 60
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
VQ+ + I IV E + + L ++LR+ + + + ++ + E + ++
Sbjct: 61 --LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE 117
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
IH DL N LV + + +KV DFG Y
Sbjct: 118 SNGFIHRDLAARNC-LVGEDNV--------------------------VKVSDFGLARYV 150
Query: 277 RPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331
DQ Y S + PEV ++ D+WS G ++ E+ + + +E +
Sbjct: 151 LDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM--PYERFSN 207
Query: 332 LAMMERVL 339
++E V
Sbjct: 208 SEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 65/319 (20%), Positives = 129/319 (40%), Gaps = 77/319 (24%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164
+G G++ +VL ++ ++ A+K+V+ + + + ++ + + + V +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 165 NWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 222
+ F + + +V E + G ++ R+ R P + R A ++ + F+H+ +I+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 223 TDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
DLK +NVLL + +IK+ DY K L +S F P
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP------------------- 160
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 339
NYI APE++ G + + D W++G ++ E+ G + F
Sbjct: 161 -NYI-------APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI-------------- 198
Query: 340 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399
+ D + E Y+ + L+ P +++PR ++ HV
Sbjct: 199 ------ITDNPDMNTEDYLFQVILEKP------------IRIPRFLSVKASHV------- 233
Query: 400 THLLQGLLRYDPTDRLTAR 418
L+G L DP +RL +
Sbjct: 234 ---LKGFLNKDPKERLGCQ 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 74/348 (21%), Positives = 141/348 (40%), Gaps = 77/348 (22%)
Query: 98 RYKIHSKMGEGTFGQVLEC--WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 155
+Y I S + G+ G+V C E+++ V +K V G K EI++L+ +
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR----EIDILKTI----- 143
Query: 156 GGNRCVQIR--NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
+ I + + +++ +C+V K L+ ++ ++ P++ I R+LLE +A
Sbjct: 144 --SHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALA 199
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS------SLHTPKDSSYFKRMPKSSAIKV 267
++H +IH D+K EN+ L E + D+ + TP+ +
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW------------ 247
Query: 268 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALF--Q 324
T +PE++ + DIWS G +L E+ LF Q
Sbjct: 248 ----------------SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
Query: 325 THENLEHLAMMERVLG--PL--PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380
+ L + R + PL PQ+ + +H ++Y R + ++
Sbjct: 292 VKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY-----------TIPP 340
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ R + M D+ +L+ +L +D R +A++ L P FT+
Sbjct: 341 VIRKYGMHM--------DVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380
|
Length = 392 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 37/232 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+V + + AIK ++ + E M+E VL +H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMHDL 218
+ F + ++ V E L F ++ ++ DL R A +++ + F+H
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSK 115
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+++ DLK +N+LL + +IK+ D+ M K + + D + T+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFG--------------MCKENMLG--DAKTCTF--- 156
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
T Y APE++LG + D WS G +L E+ G++ F H+ E
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 34/241 (14%)
Query: 100 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
K+ K+G G FG+V + +++ K VA+K ++ EA + E V++ L +HDK
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHDK--- 62
Query: 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V++ + + I I+ E + SL DFL+ + P+ + + + Q+ E +AF+
Sbjct: 63 -LVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
IH DL+ N+L+ +S K+ D+ + +D+ Y R IK
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIK----------- 168
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 336
+ APE I +T D+WS G +L+E+ T G + N E + +E
Sbjct: 169 -----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 217
Query: 337 R 337
R
Sbjct: 218 R 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 35/241 (14%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNR 159
+G G FG+V ++ + A+KI+R +A M+E E + + A+ D
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILR------KADMLEKEQVGHIRAERDILVEADSLW 62
Query: 160 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL-----LECIA 213
V++ F + ++ ++ E L G + L K D + E Q + I
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAID 115
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDSSYFKRMPKS--SAIKVID 269
+H L IH D+KP+N+LL S ++K+ D+ + L + +++ + S S +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 270 FGST----TYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
S T++R + V T Y APEV + G+ CD WS+G I+ E+ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 323 F 323
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 34/153 (22%)
Query: 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPE 228
I I E + G SL L+K P +++ +I+ +L + ++ + ++H D+KP
Sbjct: 72 GEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 229 NVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVST 286
N+L+ S IK+ D+ S L DS N V T
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLI---DSM-------------------------ANSFVGT 161
Query: 287 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
R Y +PE + G +T DIWS+G LVE+ G
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 100 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
K+ K+G G FG+V + ++ K VAIK ++ EA + E +++QL +H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTK--VAIKSLKQGSMSPEAFLAEANLMKQL-QH----P 61
Query: 159 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
R V++ + I I+ E + + SL DFL+ I+ + ++A Q+ E +AF+
Sbjct: 62 RLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
IH DL+ N+L+ + K+ D+ + +D+ Y R IK
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLA-RLIEDNEYTAREGAKFPIK----------- 168
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 336
+ APE I +T D+WS G +L E+ T G + N E + +E
Sbjct: 169 -----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE 217
Query: 337 R 337
R
Sbjct: 218 R 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 56/268 (20%), Positives = 115/268 (42%), Gaps = 52/268 (19%)
Query: 99 YKIHSKMGEGTFGQVLECWDRER-KEMVAIKIV-------RGIKKYREAA---MI-EIEV 146
Y + +G G FG V + + + ++A+K + K+ R+ + ++ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 147 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVRE 203
+++ +H V+ F + + IV + + G+ L + K + F + +
Sbjct: 62 IKEQLRHPN----IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 204 IARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 262
I Q++ + ++H + ++H DL P N++L +
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-------------------------- 151
Query: 263 SAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
+ + DFG ++P+ +V T Y PE++ + D+W+ GCIL ++CT +
Sbjct: 152 -KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
Query: 321 ALFQTHENLEHLAM--MERVLGPLPQHM 346
F + N+ LA +E V PLP+ M
Sbjct: 211 PPFYS-TNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 6e-08
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 47/186 (25%)
Query: 184 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243
L+D L+K V++I RQL+E + +H +IH D+K ENVL
Sbjct: 96 LFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL------------ 141
Query: 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVIL 296
Y + + I + D+G + Y+ T Y +PE I
Sbjct: 142 -----------YDRAKDR---IYLCDYGLCKIIGTPSCYDG--------TLDYFSPEKIK 179
Query: 297 GLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHA 354
G + D W+VG + EL TG+ F+ E L+ ++++R LP +K V ++A
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP--FIKNVSKNA 237
Query: 355 EKYVRR 360
+V+
Sbjct: 238 NDFVQS 243
|
Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 7e-08
Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 45/222 (20%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 163
++G G+FG V D E+VAIK K + E Q + K K R ++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIK------KMSYSGKQSNEKWQDIIKEVKFLQR-IKH 84
Query: 164 RNWFDY-----RNHIC-IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
N +Y R H +V E S D L + +++ I L+ +A++H
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS 143
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
MIH D+K N+LL + +K+ DFGS +
Sbjct: 144 HNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASIAS 176
Query: 278 PDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 316
P N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 177 P-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 65/262 (24%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD--KGGNRCVQ 162
+G G FG V + + ++A+K +R + E E + L D + C
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRST-------VDEKEQKRLLMDLDVVMRSSDCPY 64
Query: 163 IRNWFDYRNH-----IC-----IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
I ++ IC I +K +Y+ L+ P +++ +IA ++ +
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV----IPEEILGKIAVATVKAL 120
Query: 213 AFM-HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
++ +L +IH D+KP N+LL ++ IK+ DFG
Sbjct: 121 NYLKEELKIIHRDVKPSNILL---------------------------DRNGNIKLCDFG 153
Query: 272 STTYERPDQNYIVSTRH-----YRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALF 323
+ + I TR Y APE I G+ D+WS+G L E+ TG+ +
Sbjct: 154 ISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
Query: 324 QTHENL-EHLAMMERVLGPLPQ 344
++ + L + V G P
Sbjct: 211 PKWNSVFDQLTQV--VKGDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 41/234 (17%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+VL + ++ A+K++ + I K +E M E VL + KH
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + F + + V + + G L+ L++ R F R A ++ + ++H L
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116
Query: 220 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+++ DLKPEN+LL S +I + D+ K ++ +S F P+
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE--------------- 161
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
Y APEV+ + D W +G +L E+ G F + E
Sbjct: 162 ------------YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++I +G G FG+V + + + A+KI + K+ E ++ G+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKI---LNKWEMLKRAETACFREERNVLVNGD 59
Query: 159 RCVQIRNW---FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
C I F N++ +V + +G L L K R P D+ R +++ I
Sbjct: 60 -CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHS 117
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H L +H D+KP+NVLL + +I++ D+ S L +D + +SS
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-----QSSV---------- 162
Query: 275 YERPDQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHENL 329
V T Y +PE++ G+G P CD WS+G + E+ GE F +
Sbjct: 163 --------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 330 E 330
E
Sbjct: 215 E 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 41/242 (16%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+V+ + E AIK ++ E M+E VL +H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+ F + H+ V E L F +++ R F R A +++ + F+H +
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGI 117
Query: 221 IHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
I+ DLK +NVLL +IK+ D+ K +++ +S F
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--------------------- 156
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMM 335
T Y APE++ G + D WS G +L E+ G++ F + + L +
Sbjct: 157 ------CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
Query: 336 ER 337
+R
Sbjct: 211 DR 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 41/243 (16%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 154
++I +G G FG+V + ++ A+KI+ + + A E +VL
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----- 57
Query: 155 KGGNRCVQIRNW-FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
G N+ + ++ F N++ +V + +G L L K R P D+ R +++ I
Sbjct: 58 -GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAI 115
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
+H L +H D+KP+N+L+ + +I++ D+ S L +D +
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----------------- 158
Query: 273 TTYERPDQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHE 327
+ V T Y +PE++ G G P CD WS+G + E+ GE F
Sbjct: 159 ------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
Query: 328 NLE 330
+E
Sbjct: 213 LVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 45/243 (18%)
Query: 104 KMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 162
K+G G FG+V W+ K VA+K ++ EA + E +++++L +HDK VQ
Sbjct: 13 KLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKL-RHDK----LVQ 65
Query: 163 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 221
+ I IV E + SL DFL+ + + + ++A Q+ E +A++ I
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125
Query: 222 HTDLKPENVLLVSSEYIKVPDY------KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
H DL N+L+ + K+ D+ + +T ++ + + P IK
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA---KFP----IK--------- 169
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 334
+ APE +T D+WS G +L E+ T G + N E L
Sbjct: 170 -------------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216
Query: 335 MER 337
+ER
Sbjct: 217 VER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 162
+G G G V + + + ++A+K++ + ++ M E+E+L + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-----PYIIG 63
Query: 163 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 221
F N I I E + G SL + YR P ++ IA +++ + ++ L ++
Sbjct: 64 FYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKIL 117
Query: 222 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 281
H D+KP N+L+ + +K+ D+ S ++++ + TY
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVS------------------TQLVNSIAKTY------ 153
Query: 282 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
V T Y APE I G + D+WS+G +EL G
Sbjct: 154 --VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 35/242 (14%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++ K+G G FG+V E W+ VA+K ++ + + E +++++L +H K
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKL-RHPK--- 62
Query: 159 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
+Q+ I IV E K GS L ++L+ R+ + + ++A Q+ +A++
Sbjct: 63 -LIQLYAVCTLEEPIYIVTELMKYGS-LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
IH DL NVL+ + KV D+ + K+ Y R IK
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLA-RVIKEDIYEAREGAKFPIK---------- 169
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 335
+ APE L ++ D+WS G +L E+ T G + N E L +
Sbjct: 170 ------------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
Query: 336 ER 337
++
Sbjct: 218 DQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 158
+G G++ +VL ++ + + A+K+V+ + + ++ E V +Q + H G +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 159 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
C Q + R I + G ++ R+ R P + R + ++ + ++H+
Sbjct: 63 SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 115
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
+I+ DLK +NVLL S +IK+ DY K L +S F P
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP--------------- 160
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
NYI APE++ G + + D W++G ++ E+ G + F
Sbjct: 161 -----NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 105 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 157
+G G FG+V+E + M VA+K+++ REA M E++++ L H+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99
Query: 158 NRCVQIRNWFDYRNH---ICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
I N I ++ E L +FLR+ ++ + + Q+ + +A
Sbjct: 100 ----NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
F+ IH DL NVLL + +K+ DFG
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGK---------------------------IVKICDFGLA 188
Query: 274 TYERPDQNYIV--STR---HYRAPEVILGLGWTYPCDIWSVGCILVEL 316
D NY+V + R + APE I +T+ D+WS G +L E+
Sbjct: 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIV----RGIKKYREAAMIEIEVLQQLAKHDKGGNR 159
++G G+FG V D E+VAIK + + + + + E+ LQ+L +H
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPN---- 76
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
+Q R + + +V E S D L + +++ + L+ +A++H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHSHN 135
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
MIH D+K N+LL + +K+ DFGS + P
Sbjct: 136 MIHRDVKAGNILLS---------------------------EPGLVKLGDFGSASIMAP- 167
Query: 280 QNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 316
N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 155
Y++ +G G FG+V + +++ A+K++ IK+ A E + A
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--- 101
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
VQ+ F ++ +V E + G L + + +NY P R +++ +
Sbjct: 102 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY-DVPEKWARFYTAEVVLALDA 157
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H + IH D+KP+N+LL S ++K+ D+ + + +M K ++
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMNKEGMVRC------- 200
Query: 275 YERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 323
+ V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 201 ------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 44/242 (18%)
Query: 104 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 162
++G G FG V L W + K VAIK + E + E +V+ +L+ H K VQ
Sbjct: 11 ELGSGQFGVVHLGKWRAQIK--VAIKAINEGAMSEEDFIEEAKVMMKLS-HPK----LVQ 63
Query: 163 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 221
+ + + IV E + L ++LR+ D++ + + + E + ++ I
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 222 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 281
H DL N LVSS + +KV DFG T Y D+
Sbjct: 123 HRDLAARNC-LVSSTGV--------------------------VKVSDFGMTRYVLDDE- 154
Query: 282 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 335
Y S+ + PEV ++ D+WS G ++ E+ T G+ F+ N E + M+
Sbjct: 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
Query: 336 ER 337
R
Sbjct: 215 SR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 53/240 (22%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 153
N +++ ++G GT+G V + + E+ AIK+++ ++ + A+++ E++ + K
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEII--MMKD 62
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLE 210
K N ++ R+ + I E G SL D + + P+ + ++R+ L+
Sbjct: 63 CKHSNIVAYFGSYLR-RDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQ 117
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++H +H D+K N+LL + ++K+ D+ S
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQ---------------------I 156
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGE-ALFQTH 326
+T +R + T ++ APEV G+ CDIW+VG +EL + +F H
Sbjct: 157 TATIAKRKS---FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 64/304 (21%), Positives = 110/304 (36%), Gaps = 94/304 (30%)
Query: 129 IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF 187
I++G++K E + + ++ + V + + + + +V + G L+
Sbjct: 22 ILKGLRKSSEYSRERLTIIPHCVPN------MVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75
Query: 188 LRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247
+ K + + P + V+ A +++ + +H ++ DL P N+LL +I++
Sbjct: 76 ISK--FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL------- 126
Query: 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 307
+YF R S + D + Y APEV T CD W
Sbjct: 127 ------TYFSRW------------SEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWW 166
Query: 308 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 367
S+G IL EL TG+ L + H P
Sbjct: 167 SLGAILFELLTGKTLVECH---------------------------------------PS 187
Query: 368 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA-----LR 422
G + ++ I + V A LLQ LL+++PT+RL A A
Sbjct: 188 GINTHTTLN-----------IPEWVSEEARS---LLQQLLQFNPTERLGAGVAGVEDIKS 233
Query: 423 HPFF 426
HPFF
Sbjct: 234 HPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+VL + A+K+++ KK + M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V + F + V + + G L+ L++ R F R A ++ I ++H L
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 220 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+I+ DLKPEN+LL S ++ + D+ K + + +S F P+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPE--------------- 161
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF------QTHENLE 330
Y APEV+ + D W +G +L E+ G F Q ++N+
Sbjct: 162 ------------YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209
Query: 331 H 331
H
Sbjct: 210 H 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 33/241 (13%)
Query: 100 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
K+ K+G G FG+V + ++ K VA+K ++ +A + E +++ L +HDK
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTL-QHDK--- 62
Query: 159 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V++ I I+ E + SL DFL+ + + + + + Q+ E +A++
Sbjct: 63 -LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
IH DL+ NVL+ S K+ D+ + +D+ Y R IK
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIK----------- 169
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 336
+ APE I +T D+WS G +L E+ T G+ + N + ++ ++
Sbjct: 170 -----------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218
Query: 337 R 337
R
Sbjct: 219 R 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 73/334 (21%), Positives = 135/334 (40%), Gaps = 83/334 (24%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 158
+G G++ +VL ++ + + A+K+++ + + ++ E V + + H G +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 159 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
C Q + R I F G ++ R+ R P + R + ++ + F+H+
Sbjct: 63 SCFQTES----RLFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER 115
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+I+ DLK +NVLL + +IK+ DY M K I+ D ST P
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYG--------------MCK-EGIRPGDTTSTFCGTP 160
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 338
NYI APE++ G + + D W++G ++ E+ G + F ++
Sbjct: 161 --NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN------- 204
Query: 339 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398
D++ E Y+ + L+ +++PR ++ V
Sbjct: 205 -----------PDQNTEDYLFQVILEKQ------------IRIPRSLSVKASSV------ 235
Query: 399 LTHLLQGLLRYDPTDRLTA------REALRHPFF 426
L+G L DP +RL R+ HPFF
Sbjct: 236 ----LKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 27/121 (22%)
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
+++ + +H + IH D+KP+N+LL S ++K+ D+ + + +M + ++
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMDANGMVR 199
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEAL 322
T PD Y +PEV+ G + CD WSVG L E+ G+
Sbjct: 200 C----DTAVGTPD---------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 323 F 323
F
Sbjct: 247 F 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 52/233 (22%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 155
Y + +G G FG+V + +++ A+K++ IK+ A E + A
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--- 101
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
VQ+ F ++ +V E + G L + + +NY P + +++ +
Sbjct: 102 -SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY-DVPEKWAKFYTAEVVLALDA 157
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H + +IH D+KP+N+LL ++K+ D+ + + +M ++ ++
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM----------KMDETGMVRC------- 200
Query: 275 YERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 323
+ V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 201 ------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 56/259 (21%), Positives = 95/259 (36%), Gaps = 83/259 (32%)
Query: 200 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
+++ I RQ+L + +H ++H D+KP+N++
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF--------------------------S 289
Query: 260 PKSSAIKVIDFGSTT------------------YERPDQNYIVSTRHYRAPEVILGLG-- 299
S + K+ID G+ Y P+Q YI+ST+ AP +
Sbjct: 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ-YIMSTQTPSAPSAPVATALS 348
Query: 300 ---WTYPC----DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDR 352
W DI+S G I +++ F + +L R LKR D
Sbjct: 349 PVLWQLNLPDRFDIYSAGLIFLQMA-----FPNLRSDSNLIQFNR--------QLKRNDY 395
Query: 353 HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412
+ R ++ R + V+ L D AG LL+ ++R+
Sbjct: 396 DLVAW--RKLVEPRASPDLRRGFE-VLDL-----------DGGAG--WELLKSMMRFKGR 439
Query: 413 DRLTAREALRHPFFTRDHL 431
R++A+ AL HP+F R+ L
Sbjct: 440 QRISAKAALAHPYFDREGL 458
|
Length = 566 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 55/232 (23%), Positives = 103/232 (44%), Gaps = 38/232 (16%)
Query: 91 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL 150
L N Y++ ++G GT+G V + + E+ A+KI++ ++ + ++I+ E+ +
Sbjct: 3 LRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIF--M 59
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQ 207
K K N ++ R + I E G SL D + + P+ + + R+
Sbjct: 60 VKECKHCNIVAYFGSYLS-REKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRE 114
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
L+ +A++H +H D+K N+LL + +K+ D+ A K+
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADF------------------GVAAKI 156
Query: 268 IDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVEL 316
+T +R + T ++ APEV G+ CDIW+VG +EL
Sbjct: 157 T---ATIAKRKS---FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 57/251 (22%), Positives = 100/251 (39%), Gaps = 56/251 (22%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDR------ERKEMVAI------KIVRGIKKY-----REA 139
+ +++ + G FG++ C R E + V K R I K R A
Sbjct: 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 140 AMIEIEVLQ-QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN--NYRSF 196
+E E+L H+ ++I + ++ +K LY F+ +++
Sbjct: 208 IQLENEILALGRLNHEN----ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263
Query: 197 P-IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255
P + R I +QLL + ++HD +IH D+K EN+ L D K L
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC-------DGKIVLG------- 309
Query: 256 FKRMPKSSAIKVIDFGS-TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGC 311
DFG+ +E+ + + V T +PE++ G G+ DIWS G
Sbjct: 310 -------------DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGL 356
Query: 312 ILVELCTGEAL 322
IL+++ + +
Sbjct: 357 ILLDMLSHDFC 367
|
Length = 501 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 103 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 160
S++G G G V + + ++A K++ IK R + E++VL H+
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 65
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V F I I E + G SL L++ + P +++ +++ +L +A++ +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 220 MI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
I H D+KP N+L+ S IK+ D+ S ++ID + ++
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 162
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
V TR Y +PE + G ++ DIWS+G LVEL G
Sbjct: 163 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 32/152 (21%)
Query: 175 IVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVL 231
I E + +SL F +K + + P D++ +IA +++ + ++H L +IH D+KP NVL
Sbjct: 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136
Query: 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRA 291
+ + +K+ D+ S + S K ID G + Y A
Sbjct: 137 INRNGQVKLCDFGISGYL-----------VDSVAKTIDAGC--------------KPYMA 171
Query: 292 PEVILG----LGWTYPCDIWSVGCILVELCTG 319
PE I G+ D+WS+G ++EL TG
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 68/255 (26%)
Query: 105 MGEGTFGQVLECWDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 159
+G G FG V++ + VA+K ++ I ++ + E V+ QL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53
Query: 160 CVQIRNWFDYRNHICIV----------------FEKLGSSLYDFLRKNNYRSFPIDLVRE 203
+H CIV LG L +L+K R P+ ++E
Sbjct: 54 -----------DHPCIVRLIGVCKGEPLMLVMELAPLGP-LLKYLKKR--REIPVSDLKE 99
Query: 204 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
+A Q+ +A++ +H DL NVLLV+ K+ D+ S S Y++
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR------ 153
Query: 264 AIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 321
+TT R P + Y APE I ++ D+WS G L E + G
Sbjct: 154 --------ATTAGRWPLKWY--------APECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
Query: 322 LFQTHENLEHLAMME 336
+ + E +AM+E
Sbjct: 198 PYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G G FG+V C + +M A+K + +K+ A+ E +L ++ D C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
+ F + +C + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 62 MTYA--FHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF 117
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ DLKP N+LL ++++ D + + K+ P +S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------------- 155
Query: 280 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
V T Y APEV+ G + D +S+GC+L +L G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 103 SKMGEGTFGQV-LECWD---RERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGG 157
++G+G FG V L +D E+VA+K ++ ++ EIE+L+ L +HD
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDN-- 66
Query: 158 NRCVQIRN--WFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V+ + + R ++ +V E L SL D+L+K+ R L+ A Q+ + + +
Sbjct: 67 --IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEY 123
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDFGST 273
+ +H DL N+L+ S +K+ D+ + P+D Y+K R P S I
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI-------- 175
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+ APE + ++ D+WS G +L EL T
Sbjct: 176 --------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 46/246 (18%)
Query: 104 KMGEGTFGQVLECWDRERK--EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 161
++G G FG V + + +K + VA+KI +K ++ E+L + N
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKI---LKNDNNDPALKDELL-------REANVMQ 51
Query: 162 QIRNWFDYRN-HIC------IVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
Q+ N + R IC +V E +LG L FL+KN + + E+ Q+ +
Sbjct: 52 QLDNPYIVRMIGICEAESWMLVMELAELGP-LNKFLQKN--KHVTEKNITELVHQVSMGM 108
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
++ + +H DL NVLLV+ Y K+ D+ S D +Y+K
Sbjct: 109 KYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-------------AK 155
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEH 331
T + P + Y APE + ++ D+WS G ++ E G+ ++ + E
Sbjct: 156 THGKWPVKWY--------APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207
Query: 332 LAMMER 337
M+E
Sbjct: 208 TQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 42/236 (17%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+V+ +E + A+K+++ + E M E +L H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
Q+ F + + V E + G L ++K+ R F R A ++ + F+HD
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG 116
Query: 220 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+I+ DLK +NVLL + K+ D+ K + K +S F
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-------------------- 156
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332
T Y APE++ + + D W++G +L E+ G A F+ EN + L
Sbjct: 157 -------CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 57/205 (27%)
Query: 183 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242
SL D LRK+ F I + + A Q+ + ++ IH DL N+LL S + +K+ D
Sbjct: 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGD 140
Query: 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------APEVIL 296
+ + +P++ + +Y V H + APE +
Sbjct: 141 FGLM----------RALPQN----------------EDHY-VMEEHLKVPFAWCAPESLR 173
Query: 297 GLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE 355
+++ D+W G L E+ T GE E G +LK++D+ E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGE---------------EPWAGLSGSQILKKIDKEGE 218
Query: 356 KYVRRGRLDWPEGAASRESIKSVMK 380
RL+ PE A + I +VM
Sbjct: 219 ------RLERPE--ACPQDIYNVML 235
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 57/245 (23%), Positives = 108/245 (44%), Gaps = 41/245 (16%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYR--EAAMIEIEVLQQLAKHDKGGNRC 160
+G+G FG+V C R ++ A K + + +KK + E AM+E +L ++ H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSR---FI 55
Query: 161 VQIRNWFDYRNHICIVFEKLGSS-----LYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
V + F + +C+V + +Y+ +N FP Q++ + +
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHL 113
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
H +I+ DLKPENVLL + +++ D A+++ D S T
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDL------------------GLAVELKDGQSKT- 154
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAM 334
+ Y T + APE++ G + + D +++G L E+ F+ E +E+ +
Sbjct: 155 ----KGY-AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209
Query: 335 MERVL 339
+R+L
Sbjct: 210 KQRIL 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 39/226 (17%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+V+ + E+ AIKI++ + E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----FL 63
Query: 161 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 217
Q+ + F + + V E + G +Y + ++ + EI+ L F+H
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF----FLHR 119
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+I+ DLK +NV+L S +IK+ D+ M K + G TT
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFG--------------MCKEHMVD----GVTT--- 158
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
T Y APE+I + D W+ G +L E+ G+ F
Sbjct: 159 ---RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMI--EIEVLQQLAKHDKGGNRC 160
+G G FG+V + ++ A+KI+ + K E A E +VL G R
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLV------NGDRRW 62
Query: 161 V-QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
+ + F N++ +V + +G L L K R P D+ R +++ I +H L
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQL 121
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+H D+KP+NVLL + +I++ D+ S L D +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV----------------------- 158
Query: 279 DQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALF 323
N V T Y +PE++ G G P CD WS+G + E+ GE F
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 56/239 (23%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 104 KMGEGTFGQVLECWDRERKEM--VAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNR 159
++G G FG V + + RK+ VAIK+++ K R+ M E E++ QL
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN-----PY 56
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V++ + + ++ G L FL + V E+ Q+ + ++
Sbjct: 57 IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+H DL NVLLV+ Y K+ D+ S D SY+K + + P
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-------------ARSAGKWPL 162
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 337
+ Y APE I ++ D+WS G + E G+ ++ + E ++ +E+
Sbjct: 163 KWY--------APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 159
+ ++G GT GQV + ++ ++A+K +R E I +++ L HD
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD----- 72
Query: 160 C---VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
C V+ +F + + I E + + L D L K P D++ ++ +++ + ++
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 217 DL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
+ +IH D+KP N+LL +S +K+ D+ S R+ S A K G Y
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGIS----------GRLVDSKA-KTRSAGCAAY 180
Query: 276 ---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332
ER D RA D+WS+G LVEL TG+ F
Sbjct: 181 MAPERIDPPDPNPKYDIRA-------------DVWSLGISLVELATGQ--FPYKNCKTEF 225
Query: 333 AMMERVLGPLP 343
++ ++L P
Sbjct: 226 EVLTKILQEEP 236
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 37/245 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+V+ + E+ AIK+++ + + M E +L AKH
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP----FL 58
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
+ F ++ + V E + G L ++++ R F R A ++ + F+H
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+I+ DLK +N+LL + + K+ D+ M K + G TT
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFG--------------MCKEGILN----GVTT----- 153
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT--HENLEHLAMMER 337
T Y APE++ L + D W++G ++ E+ G+ F+ ++L + +
Sbjct: 154 -TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212
Query: 338 VLGPL 342
VL P+
Sbjct: 213 VLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G G FG+V C + +M A+K + +K+ A+ E +L ++ D C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
+ F + + + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 62 MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNRF 117
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+++ DLKP N+LL ++++ D + + K+ P +S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------------- 155
Query: 280 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 37/221 (16%)
Query: 103 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 160
S++G G G V + + ++A K++ IK R + E++VL H+
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 65
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
V F I I E + G SL L+K P ++ +++ +++ + ++ +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 220 MI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
I H D+KP N+L+ S IK+ D+ S ++ID + ++
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 162
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
V TR Y +PE + G ++ DIWS+G LVE+ G
Sbjct: 163 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 52/246 (21%), Positives = 92/246 (37%), Gaps = 61/246 (24%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA--------MIEIEVLQQLAKHD-- 154
+GEG FG+V++ K V +K +E A + E +L+Q+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTV-AVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN----------------------N 192
K C Q D + + + K GS L FLR++ +
Sbjct: 67 KLYGACSQ-----DGPLLLIVEYAKYGS-LRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 193 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252
R+ + + A Q+ + ++ ++ ++H DL NVL+ +K+ D+ S ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312
SY KR +K + A E + +T D+WS G +
Sbjct: 181 DSYVKRSKGRIPVK----------------------WMAIESLFDHIYTTQSDVWSFGVL 218
Query: 313 LVELCT 318
L E+ T
Sbjct: 219 LWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 51/232 (21%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAKHDKGG 157
+G+G+FG+V+ + E+ AIKI +KK E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKI---LKKDVIIQDDDVECTMVEKRVLALPGK----P 60
Query: 158 NRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAF 214
Q+ + F + + V E + G +Y + ++ + EIA L F
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF----F 116
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+H +I+ DLK +NV+L + +IK+ D+ K ++ K + F P
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP----------- 165
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
+YI APE+I + D W+ G +L E+ G+ F
Sbjct: 166 ---------DYI-------APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQ 149
S KI +G G FG+V C R +R+ VAIK ++ +K R + E ++ Q
Sbjct: 4 SCIKIEKVIGAGEFGEV--CSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQ 61
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
+ + + + IV E + SL FLRK++ + I LV + R +
Sbjct: 62 FDHPN-----IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV-GMLRGI 115
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIK 266
+ ++ D+ +H DL N+L+ S+ KV D+ S L +++Y R K
Sbjct: 116 ASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK----- 170
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316
+ R + APE I +T D+WS G ++ E+
Sbjct: 171 -----------------IPIR-WTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 41/252 (16%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+V+ + E+ AIKI++ + E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP----FL 63
Query: 161 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 217
Q+ + F + + V E + G +Y + ++ + EIA L F+H
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF----FLHS 119
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+I+ DLK +NV+L S +IK+ D+ M K + G TT
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFG--------------MCKENMWD----GVTT--- 158
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL-AMME 336
T Y APE+I + D W+ G +L E+ G+A F+ + E ++ME
Sbjct: 159 ---KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
Query: 337 RVLGPLPQHMLK 348
+ P+ M K
Sbjct: 216 HNVA-YPKSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 51/226 (22%), Positives = 93/226 (41%), Gaps = 34/226 (15%)
Query: 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ-----LAKHDKGG 157
+ +G G FG+VL ++ E+ AIK +KK A E+E L + +
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKA---LKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V + F +H+C V E D + + F A ++ + ++H+
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+++ DLK +N+LL + ++K+ D+ + K + FG T
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFG--------------LCKEG----MGFGDRT--- 158
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
+ T + APEV+ +T D W +G ++ E+ GE+ F
Sbjct: 159 ---STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 31/117 (26%)
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+H +I+ DLKPEN+LL + ++K+ D+ K S+H G
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---------------------G 154
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
+ T+ T Y APE+++ G D WS+G ++ ++ TG F T EN
Sbjct: 155 TVTHT------FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 29/138 (21%)
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H L +I+ D+K EN+LL S+ ++ + D+ S +F
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK---------------------EFHEDE 159
Query: 275 YERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEH 331
ER T Y AP+++ G G D WS+G ++ EL TG + F E
Sbjct: 160 VERAYS--FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
Query: 332 LAMMERVLG---PLPQHM 346
+ R+L P PQ M
Sbjct: 218 AEISRRILKSEPPYPQEM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 26/140 (18%)
Query: 183 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242
SL FLR+N+ + LV + R + + ++ ++ +H DL N+L+ S+ KV D
Sbjct: 91 SLDKFLRENDGKFTVGQLVG-MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 243 YKSSLHT-PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT 301
+ S +++Y + K + APE I +T
Sbjct: 150 FGLSRRLEDSEATYTTKGGKIPI-----------------------RWTAPEAIAYRKFT 186
Query: 302 YPCDIWSVGCILVELCT-GE 320
D+WS G ++ E+ + GE
Sbjct: 187 SASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 43/185 (23%)
Query: 181 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240
G ++ L + + F D VR + +++ + +H L +++ D+K EN+LL S ++ +
Sbjct: 89 GGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVL 146
Query: 241 PDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG 297
D+ K L K+ +Y F T Y APE+I G
Sbjct: 147 TDFGLSKEFLSEEKERTY-------------SFCGTI-------------EYMAPEIIRG 180
Query: 298 -LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER-----------VLGPLPQH 345
G D WS+G ++ EL TG + F + + R +GP Q
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240
Query: 346 MLKRV 350
+L ++
Sbjct: 241 LLHKL 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 61/254 (24%), Positives = 108/254 (42%), Gaps = 57/254 (22%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK------HDKGG 157
++G G FG V++ + VAIK+++ E +M E E +++ AK H+K
Sbjct: 11 ELGTGQFG-VVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEE-AKVMMKLSHEK-- 60
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
VQ+ + I IV E + + L ++LR++ R P L+ E+ + + E +A++
Sbjct: 61 --LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLE 117
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
IH DL N L+ +KV DFG + Y
Sbjct: 118 SKQFIHRDLAARNCLVDD---------------------------QGCVKVSDFGLSRYV 150
Query: 277 RPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA---LFQTHE 327
D+ Y S + PEV+L ++ D+W+ G ++ E+ + G+ F E
Sbjct: 151 LDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209
Query: 328 NLEHLAMMERVLGP 341
+E ++ R+ P
Sbjct: 210 TVEKVSQGLRLYRP 223
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 34/125 (27%), Positives = 53/125 (42%), Gaps = 25/125 (20%)
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H M+H DLK N+ L+ + IK+ D+ S S +D S+
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-------------LDVASS- 230
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334
T +Y APE+ ++ D+WS+G IL EL T F+ E +
Sbjct: 231 --------FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---I 279
Query: 335 MERVL 339
M++VL
Sbjct: 280 MQQVL 284
|
Length = 478 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 36/132 (27%), Positives = 54/132 (40%), Gaps = 25/132 (18%)
Query: 196 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255
F VR +++ + +H L +I+ D+K EN+LL S ++ + D+ S
Sbjct: 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK-------- 153
Query: 256 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCIL 313
+F + ER T Y APEVI G G D WS+G +
Sbjct: 154 -------------EFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 314 VELCTGEALFQT 325
EL TG + F
Sbjct: 199 FELLTGASPFTV 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 40/225 (17%)
Query: 105 MGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD--KG 156
+GEG FG+V C +D E E VA+K ++ A + EIE+L+ L + K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 157 GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREI--ARQLLECIA 213
C + D N I ++ E L S SL ++L +N + I+L +++ A Q+ + +
Sbjct: 72 KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMD 123
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++ +H DL NVL+ S +K+ D+ + D Y+ T
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----------------T 167
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+ D S + APE ++ + D+WS G L EL T
Sbjct: 168 VKDDLD-----SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 40/254 (15%)
Query: 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA--KHDKGGN 158
+ K+G G +G+V E ++ VA+K ++ E M E L++ A K K N
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 159 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
VQ+ I+ E + +L D+LR+ N + ++ +A Q+ + ++
Sbjct: 64 -LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
IH DL N L+ + +KV D+ S +Y IK
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK----------- 170
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLE 330
+ APE + ++ D+W+ G +L E+ T G L Q +E LE
Sbjct: 171 -----------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
Query: 331 HLAMMERVLGPLPQ 344
MER G P+
Sbjct: 220 KGYRMERPEGCPPK 233
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 29/141 (20%)
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+L + +H MIH D+K N+LL S+ +K+ D+ F +M +A
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG-----------FSKM--YAATV 197
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
D G T T +Y APE+ ++ D++S+G +L EL T + F
Sbjct: 198 SDDVGRT---------FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG- 247
Query: 327 ENLEHLAMMERVLG----PLP 343
EN+E + M + L PLP
Sbjct: 248 ENMEEV--MHKTLAGRYDPLP 266
|
Length = 496 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 51/239 (21%)
Query: 101 IHSKMGEGTFGQVL--ECWD---RERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHD 154
+ ++GEG FG+V EC++ + K +VA+K ++ R+ E E+L L +H+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHE 67
Query: 155 ---KGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSF-------PIDLVR- 202
K CV+ + + +VFE + L FLR + + P +L +
Sbjct: 68 HIVKFYGVCVE-------GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 203 ---EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
IA+Q+ + ++ +H DL N L+ + +K+ D+ S
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------ 168
Query: 260 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
D ST Y R + ++ R + PE I+ +T D+WS+G +L E+ T
Sbjct: 169 ---------DVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 100 KIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAK 152
KI +G G FG+V C R +R+ VAIK ++ +K R + E ++ Q
Sbjct: 7 KIEEVIGAGEFGEV--CRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
+ + + + I+ E + +L FLR+N+ + I LV + R +
Sbjct: 65 PN-----IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV-GMLRGIAAG 118
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ ++ ++ +H DL N+L+ S+ KV D+ S D+S
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS----------------- 161
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316
TY I + APE I +T D+WS G ++ E+
Sbjct: 162 DPTYTSSLGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 50/233 (21%)
Query: 97 SRYKIHSKMGEGTFGQVLE-CWDRERKEMVAIKIV-RGIKKYREAAMIEIEVLQQLAKHD 154
+ + K+G G FG+V E W + VAIKI+ ++ E++ L++L +H
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-RHK 62
Query: 155 K--------GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 206
V I I + EK SL FLR + P+ + ++A
Sbjct: 63 HLISLFAVCSVGEPVYI---------ITELMEK--GSLLAFLRSPEGQVLPVASLIDMAC 111
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAI 265
Q+ E +A++ + IH DL N+ LV + + KV D+ + K+ Y + I
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNI-LVGEDLVCKVADFGLA-RLIKEDVY---LSSDKKI 166
Query: 266 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+ APE ++ D+WS G +L E+ T
Sbjct: 167 PY--------------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 45/231 (19%)
Query: 17 RPRKRARLGWDVPQV-PKAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGS 75
RPR+R L +PQ P V L PP + S +SSS G A + +
Sbjct: 23 RPRRRPDLTLPLPQRDPSLAVPL----------PLPPPSSSSSSSSSSS--ASGSAPSAA 70
Query: 76 PPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK 135
E ++ +++G G G V + R + A+K++ G +
Sbjct: 71 KSLSELERV------------------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE 112
Query: 136 --YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN 192
R EIE+L+ H V+ + FD+ I ++ E + G SL
Sbjct: 113 DTVRRQICREIEILRD-VNHPN----VVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIA 165
Query: 193 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243
F D+ ARQ+L IA++H ++H D+KP N+L+ S++ +K+ D+
Sbjct: 166 DEQFLADV----ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212
|
Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 42/176 (23%), Positives = 69/176 (39%), Gaps = 46/176 (26%)
Query: 197 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256
+ R + Q+L+ +A H+ ++H DLKP+N+++ +
Sbjct: 78 AGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTG-------------------- 116
Query: 257 KRMPKSSAIKVIDFGSTT----YERPDQNYI------VSTRHYRAPEVILGLGWTYPCDI 306
KV+DFG T D + + T Y APE + G T D+
Sbjct: 117 ----VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 307 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGP----LPQ----HMLKRVDRHA 354
++ G I +E TG+ + Q E ++ + L P LP H L +V R A
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAE---ILYQQLSPVDVSLPPWIAGHPLGQVLRKA 225
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 36/234 (15%)
Query: 105 MGEGTFGQVLECWDRE--RKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 159
+G G FG+V + RKE+ VAIK ++ +K R+ + E ++ Q + H+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN----- 67
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
+++ I+ E + + D +LR ++ LV + R + + ++ D+
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV-GMLRGIAAGMKYLSDM 126
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI-DFGSTTYER 277
+H DL N+L+ S+ KV D+ S +V+ D TY
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLS-------------------RVLEDDPEGTYTT 167
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330
+ + APE I +T D+WS G ++ E+ + GE + N E
Sbjct: 168 SGGKIPI---RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 48/230 (20%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 160
++G+G +G V + R +A+K +R K+ + M E+++L H
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDIL-----HKAVSPYI 61
Query: 161 VQIRNWFDYRN--HICIVFEKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFM- 215
V F ++C+ + GS LY P D++R I +++ + F+
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYA--GGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
+ +IH D+KP NVL+ + +K+ D+ S + + K++
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN------------ 161
Query: 276 ERPDQNYIVSTRHYRAPEVILGLG------WTYPCDIWSVGCILVELCTG 319
+ + Y APE I G +T D+WS+G ++E+ G
Sbjct: 162 --------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS--SAIKVID 269
I ++H ++H DLKP+N+LL + + D+ +++ FK++ + I V +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI--------FKKLEEEDLLDIDVDE 177
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
IV T Y APE +LG+ + DI+++G IL ++ T
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 66/268 (24%), Positives = 103/268 (38%), Gaps = 58/268 (21%)
Query: 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 162
+ +G+G FG V+ R +K VA+K ++ +A + E V+ L +H VQ
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTL-RHPN----LVQ 64
Query: 163 IRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 221
+ N + IV E + SL D+LR + A + E + ++ + +
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV 124
Query: 222 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 281
H DL NV LVS + + KV DFG Q+
Sbjct: 125 HRDLAARNV-LVSEDLVA--------------------------KVSDFGLAKEASQGQD 157
Query: 282 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 341
+ APE + ++ D+WS G +L E+ + RV P
Sbjct: 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS----------------FGRV--P 199
Query: 342 LPQHMLKRVDRHAEK-YVRRGRLDWPEG 368
P+ LK V H EK Y R++ PEG
Sbjct: 200 YPRIPLKDVVPHVEKGY----RMEAPEG 223
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 14/50 (28%), Positives = 34/50 (68%)
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247
I++++ + RQ+L + +H + ++H D+KPEN+L+ +K+ D+ +++
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAV 357
|
Length = 507 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 32/137 (23%), Positives = 58/137 (42%), Gaps = 25/137 (18%)
Query: 183 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242
SL D +R++ P + Q+ + + ++ + M+H +L N+LL S +++ D
Sbjct: 94 SLLDHVRQHRDSLDP-QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152
Query: 243 YK-SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT 301
+ + L P D YF K+ IK + A E IL +T
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTP-IK----------------------WMALESILFGRYT 189
Query: 302 YPCDIWSVGCILVELCT 318
+ D+WS G + E+ +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 54/248 (21%), Positives = 97/248 (39%), Gaps = 54/248 (21%)
Query: 98 RYKIHSKMGEGTFGQVLECWDR--------------ERKEMVAIKIVRG--IKKYREAAM 141
+ ++ K+GEG FG+V C + +VA+K++R K R +
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 142 IEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRK---------- 190
EI+++ +L + V + + + +C++ E + L FL +
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 191 NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250
NN S I + +A Q+ + ++ L +H DL N L+ + IK+ D+ S
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR--- 177
Query: 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 310
+ S Y R ++ R + A E IL +T D+W+ G
Sbjct: 178 ------------------NLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTTASDVWAFG 218
Query: 311 CILVELCT 318
L E+ T
Sbjct: 219 VTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 199 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258
D+++ +A ++ + ++H IH+DL N L + +K+ DY +L + Y +
Sbjct: 100 DVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159
Query: 259 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
+ ++ + P+ +V R +L T +IWS+G + EL T
Sbjct: 160 DCHAVPLRWLA--------PE---LVEIRGQD----LLPKDQTKKSNIWSLGVTMWELFT 204
Query: 319 -GEALFQTHENLEHLA--MMERVLG-PLPQHMLKRVDRHAE 355
+ + + + L + E+ + P PQ LK DR E
Sbjct: 205 AADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 34/142 (23%), Positives = 67/142 (47%), Gaps = 14/142 (9%)
Query: 108 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNRCVQ 162
G FG+V + ++ A+K+V+ +A MI ++ Q+ A+ D V
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAERDALALSKSPFIVH 68
Query: 163 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 221
+ N++ +V E L G + L Y F ++ + ++ + ++H +I
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGII 126
Query: 222 HTDLKPENVLLVSSEYIKVPDY 243
H DLKP+N+L+ + +IK+ D+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 37/219 (16%)
Query: 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 159
K+ +G+G FG V+ R K VA+K ++ +A + E V+ QL +H
Sbjct: 9 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSN---- 60
Query: 160 CVQIRNWF-DYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
VQ+ + + + IV E + SL D+LR D + + + + E + ++
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+H DL NV LVS + + KV DFG T
Sbjct: 121 NNFVHRDLAARNV-LVSEDNVA--------------------------KVSDFGLTKEAS 153
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316
Q+ + APE + ++ D+WS G +L E+
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 433 | |||
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.35 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.06 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.06 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.97 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.72 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.62 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.58 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.52 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.36 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.14 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.12 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.03 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.71 | |
| PLN02236 | 344 | choline kinase | 96.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.66 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.65 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.99 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.95 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.66 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.56 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 95.32 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.24 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.96 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.72 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 94.48 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-62 Score=450.62 Aligned_cols=350 Identities=60% Similarity=1.025 Sum_probs=315.4
Q ss_pred cCCCCCCCCcCCCCCCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHH
Q 013973 71 ARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL 150 (433)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l 150 (433)
++...+++..++..|++.+..++.+.++|.++.++|+|.||.|..|.+..++..||||+++...+.++....|+++|+++
T Consensus 63 ~~~~~~~~~~dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki 142 (415)
T KOG0671|consen 63 ARLESRPGRPDDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKI 142 (415)
T ss_pred ccccCCCCCCCCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 56667788889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcC-CCCCceEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 013973 151 AKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 229 (433)
Q Consensus 151 ~~~~-~~~~~i~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~N 229 (433)
.++. ++...|+++.+||+..++.|||+|.+|-++.++|..++..+++...++.++.|++.+++|||+.+++|-||||+|
T Consensus 143 ~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN 222 (415)
T KOG0671|consen 143 NESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN 222 (415)
T ss_pred HhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence 7766 455669999999999999999999999999999999988999999999999999999999999999999999999
Q ss_pred eEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHH
Q 013973 230 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV 309 (433)
Q Consensus 230 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 309 (433)
||+.+..+.++-+.+-. .++.+..++..++++|||.|+......+.++.|..|.|||++++-+++.++||||+
T Consensus 223 ILfvss~~~~~~~~k~~-------~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 223 ILFVSSEYFKTYNPKKK-------VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred EEEeccceEEEeccCCc-------cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceee
Confidence 99999888777665543 12233356778999999999999888899999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 310 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 310 Gv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
||||+||.+|...|+..++.+.+++|..++|++|..+..+.. .++|...|.++||+...... .+.+.+.........
T Consensus 296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~--~~Kyf~~~rldw~e~~~~~~-~k~v~~~ckpl~~~~ 372 (415)
T KOG0671|consen 296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR--KEKYFRRGRLDWPEVSSKGK-SKYVFEPCKPLKKYM 372 (415)
T ss_pred eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh--hHhhhhcccccCcccccccc-chhhhcCCccHHHHh
Confidence 999999999999999999999999999999999999988765 78888889999999887664 445555555555666
Q ss_pred hhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
...+....++.|||++||..||.+|+|+.|+|.||||+...
T Consensus 373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred ccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 66677778899999999999999999999999999998754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-60 Score=437.20 Aligned_cols=262 Identities=29% Similarity=0.516 Sum_probs=220.1
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh--------hHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
.+.+.|.+.+.||+|+||.|-+|..+.||+.||||++.+.+. ......+|+++|+++ +||+||++++
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-----~HP~IV~~~d 243 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-----SHPNIVRIKD 243 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-----CCCCEEEEee
Confidence 356779999999999999999999999999999999974321 122346899999999 8899999999
Q ss_pred eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 166 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 166 ~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
+|+..+..||||||+ ||+|.+++..++ .+.+...+.+++|++.||.|||++||+||||||+|||+..+
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~--------- 312 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND--------- 312 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC---------
Confidence 999999999999999 999999998875 79999999999999999999999999999999999999643
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCC---CCCcchhHHHHHHHHHHHhC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg 319 (433)
.++..+||+|||+|...+... .+.|||+.|.|||++.+.. +..++|+||+||+||.+++|
T Consensus 313 ---------------~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG 377 (475)
T KOG0615|consen 313 ---------------AEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG 377 (475)
T ss_pred ---------------CcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence 356789999999998876433 5689999999999998765 34588999999999999999
Q ss_pred CCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 320 EALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 320 ~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
.+||.+..... ...+ |.+|.+.+-+ ..|...+.+
T Consensus 378 ~pPFS~~~~~~sl~eQ-----------------------I~~G~y~f~p----------------------~~w~~Isee 412 (475)
T KOG0615|consen 378 YPPFSEEYTDPSLKEQ-----------------------ILKGRYAFGP----------------------LQWDRISEE 412 (475)
T ss_pred CCCcccccCCccHHHH-----------------------HhcCcccccC----------------------hhhhhhhHH
Confidence 99998654322 2222 3344333221 234567889
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
+.+||.+||.+||++|||++|+|+||||+....
T Consensus 413 a~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 413 ALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred HHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 999999999999999999999999999996653
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-57 Score=447.13 Aligned_cols=326 Identities=39% Similarity=0.701 Sum_probs=272.3
Q ss_pred CCCCCCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhc-CCCCCc
Q 013973 81 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH-DKGGNR 159 (433)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~~ 159 (433)
++..+.|.+...+.+..+|.+++.||+|+||.|.+|.+..|++.||||+++..+....+...|+.+|..+..+ ..+..|
T Consensus 170 ~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n 249 (586)
T KOG0667|consen 170 DDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYN 249 (586)
T ss_pred CCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 3455667888888888899999999999999999999999999999999998888889999999999999844 345578
Q ss_pred eEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccc
Q 013973 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239 (433)
Q Consensus 160 i~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~ 239 (433)
+|.++++|...+++|||+|.+..+|.++|+.+....|+...++.++.||+.||.+||+.||||+||||+||||.+
T Consensus 250 ~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~----- 324 (586)
T KOG0667|consen 250 IVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD----- 324 (586)
T ss_pred EEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc-----
Confidence 999999999999999999999999999999998889999999999999999999999999999999999999965
Q ss_pred cCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC
Q 013973 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 240 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg 319 (433)
.....+||+|||.+++....-.+.+-+..|.|||+|.|.+|+.+.||||||||++||++|
T Consensus 325 --------------------~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG 384 (586)
T KOG0667|consen 325 --------------------PKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG 384 (586)
T ss_pred --------------------CCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC
Confidence 334589999999999988777778899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhc-cCcccCCCCccch------h--h----Hhhhccch-hHH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR-RGRLDWPEGAASR------E--S----IKSVMKLP-RLQ 385 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~------~--~----~~~~~~~~-~~~ 385 (433)
.+.|.+.+..++++.|.+.+|.+|..+++.....-..+-. .+.+......... + . .......+ ...
T Consensus 385 ~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~ 464 (586)
T KOG0667|consen 385 EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSR 464 (586)
T ss_pred ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCc
Confidence 9999999999999999999999999999988776443333 2322211111100 0 0 00111112 122
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
.+...........+.|||.+||.+||.+|+|+.|+|+||||+...+
T Consensus 465 ~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 465 SLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred ccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 2222222244567899999999999999999999999999996544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=420.41 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=216.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||+||+++.+++++.||+|++++.. +..+....|..+|..+ +||+||.+...|++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-----~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-----KHPFIVKLIYSFQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-----CCCcEeeeEEecccCC
Confidence 367999999999999999999999999999999997543 2345567899999987 8899999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|||+||+ ||.|+.+|++.+ .|++..++.|+.+|+.||.|||++|||||||||+|||++.
T Consensus 99 kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~---------------- 160 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDE---------------- 160 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecC----------------
Confidence 999999999 999999999876 8999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+++++|+|||+++.... ...++|||+.|||||++.+.+|+.++||||||+++|||++|.+||.+.+
T Consensus 161 -----------~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 161 -----------QGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred -----------CCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 45566666666653222 2355799999999999999999999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
.......|...-.. . .+..++.++++||+++|
T Consensus 230 ~~~~~~~I~~~k~~-----------------------~-------------------------~p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 230 VKKMYDKILKGKLP-----------------------L-------------------------PPGYLSEEARDLLKKLL 261 (357)
T ss_pred HHHHHHHHhcCcCC-----------------------C-------------------------CCccCCHHHHHHHHHHh
Confidence 77666554332111 1 11247789999999999
Q ss_pred ccCCCCCC----CHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRL----TAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~----ta~ell~hp~f~~~~ 430 (433)
++||++|+ ++.++.+||||....
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccCC
Confidence 99999997 689999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-57 Score=439.20 Aligned_cols=250 Identities=32% Similarity=0.523 Sum_probs=225.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.+|+..+.||+|||+.||++++..+|+.||+|++.+ ....++....|+++.+.+ .|+|||+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-----~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-----KHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-----CCCcEEeeeeEeecCCc
Confidence 469999999999999999999999999999999975 345677888999999988 77999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|||+|+| .++|..+++.. +.++|.+++.++.||+.||.|||+++|||||||..|+|+
T Consensus 93 VYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL------------------- 151 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL------------------- 151 (592)
T ss_pred eEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee-------------------
Confidence 99999999 99999999854 489999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
+++.++||+|||+|+.... ...+.||||.|+|||++....++..+||||+||+||.||+|++||+..+.
T Consensus 152 --------~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 152 --------NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred --------cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 6778899999999987763 34678999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.+..|...-... |..++.++++||.+||+
T Consensus 224 kety~~Ik~~~Y~~-------------------------------------------------P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 224 KETYNKIKLNEYSM-------------------------------------------------PSHLSAEAKDLIRKLLR 254 (592)
T ss_pred HHHHHHHHhcCccc-------------------------------------------------ccccCHHHHHHHHHHhc
Confidence 88877765433322 23678899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
.||.+|||+++||.|+||+..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCC
Confidence 999999999999999999654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-57 Score=415.56 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=216.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEee--cchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-e
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-H 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~--~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-~ 172 (433)
.++.+.++.||+|+.|+||+|+++.|++.+|+|++. .....+++..+|+++++.+ .+|+||.+++.|..++ .
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-----~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-----QSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-----CCCCeeeEeEEEEeCCce
Confidence 356888999999999999999999999999999994 3455677889999999888 7799999999999999 5
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++|+|||| +|+|.+++...+ ++++.....++.+|++||.|||+ ++||||||||+|||+++.
T Consensus 153 isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk--------------- 215 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK--------------- 215 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC---------------
Confidence 99999999 999999998764 79999999999999999999995 999999999999999654
Q ss_pred CCCcccccCCCCCCEEEEecCCccccC-CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--C
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--E 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~--~ 327 (433)
+.+||||||.+.... ....+++||..|||||.+.+..|+.++||||||++++|+++|++||... .
T Consensus 216 ------------GeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~ 283 (364)
T KOG0581|consen 216 ------------GEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP 283 (364)
T ss_pred ------------CCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC
Confidence 456777777665332 3346679999999999999999999999999999999999999999764 2
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcC-CchhHHHHHHHhc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD-HSAGDLTHLLQGL 406 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~ 406 (433)
....+..+..++...|+. .+. .+|+++++||..|
T Consensus 284 ~~~~~~Ll~~Iv~~ppP~---------------------------------------------lP~~~fS~ef~~FV~~C 318 (364)
T KOG0581|consen 284 YLDIFELLCAIVDEPPPR---------------------------------------------LPEGEFSPEFRSFVSCC 318 (364)
T ss_pred CCCHHHHHHHHhcCCCCC---------------------------------------------CCcccCCHHHHHHHHHH
Confidence 334455554444332221 122 4889999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|++||.+|+|+.|+++|||+++..
T Consensus 319 L~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 319 LRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred hcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999998643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-56 Score=398.30 Aligned_cols=251 Identities=26% Similarity=0.446 Sum_probs=223.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||.|+||.|.+++.+.+|..||+|++++.+ +..+....|..+|+.+ .||+++.+.+.|.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-----~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-----SHPFLVKLYGTFKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-----cCceeEEEEEeeccCC
Confidence 367999999999999999999999999999999997543 2334456788899888 6799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++||||||+ ||.|+.+|++.+ +|++..+++|+.||+.||+|||+++|++|||||+||||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl------------------ 177 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL------------------ 177 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee------------------
Confidence 999999999 999999999876 89999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
|.++.+||+|||+|........+.||||.|+|||++...+|+.++|||||||++|||+.|.+||.+.+...
T Consensus 178 ---------D~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 178 ---------DQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred ---------ccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 56667888999999888777778899999999999999999999999999999999999999999988877
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
++..|.. |.+. +|..++++++|||.++|++|
T Consensus 249 iY~KI~~-----------------------~~v~--------------------------fP~~fs~~~kdLl~~LL~vD 279 (355)
T KOG0616|consen 249 IYEKILE-----------------------GKVK--------------------------FPSYFSSDAKDLLKKLLQVD 279 (355)
T ss_pred HHHHHHh-----------------------Cccc--------------------------CCcccCHHHHHHHHHHHhhh
Confidence 7766433 3333 34478889999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q 013973 411 PTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~-----ta~ell~hp~f~~~ 429 (433)
-.+|. ...++..||||+.-
T Consensus 280 ~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 280 LTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred hHhhhcCcCCCccccccCcccccc
Confidence 99995 57899999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-56 Score=424.50 Aligned_cols=269 Identities=26% Similarity=0.414 Sum_probs=225.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
..+|.+.+.||+|+|++|++|+++.+++.||||++.+.- +..+-...|.++|.+|. +||.|++++..|++..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~----~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS----GHPGIVKLYFTFQDEE 147 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh----CCCCeEEEEEEeeccc
Confidence 467999999999999999999999999999999986421 11233557888888884 6788999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+|+||+ +|+|.++|.+.+ .|++..++.|+.||+.||+|||++|||||||||+|||++.+++++|+|||-+...+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999 999999999886 89999999999999999999999999999999999999888888888888766554
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
...... + .+-.......+...++||..|.+||++.....++.+|+|+|||++|.|+.|.+||.+.++.-
T Consensus 226 ~~~~~~----~-------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl 294 (604)
T KOG0592|consen 226 PSQKSQ----E-------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL 294 (604)
T ss_pred hhhccc----c-------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence 322110 0 00000011111255799999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
++..|..+...+| ..+++.+.|||.++|.+|
T Consensus 295 iFqkI~~l~y~fp-------------------------------------------------~~fp~~a~dLv~KLLv~d 325 (604)
T KOG0592|consen 295 IFQKIQALDYEFP-------------------------------------------------EGFPEDARDLIKKLLVRD 325 (604)
T ss_pred HHHHHHHhcccCC-------------------------------------------------CCCCHHHHHHHHHHHccC
Confidence 8888776655443 467789999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~ 430 (433)
|.+|+|+.||.+||||..-.
T Consensus 326 p~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 326 PSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred ccccccHHHHhhCcccccCC
Confidence 99999999999999998643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-56 Score=424.66 Aligned_cols=281 Identities=27% Similarity=0.453 Sum_probs=226.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHH----HHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~----~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|+.+.||+.||+|++++...... -...|..+|... .++.||+++..|++..
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-----ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-----DSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-----CCCcEEEEEEEecCCC
Confidence 4689999999999999999999999999999999987654333 334566666553 7799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++||||||+ ||++..+|...+ .|++..+++|+.+++.|++-||+.|+|||||||+|+||+..||+||+|||++....
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999 999999998876 89999999999999999999999999999999999999999999999999996554
Q ss_pred CCCcccc-c----CC-CCCCEEEEecCCc--cccC-CC--------------CCceeecCcccchhhhhCCCCCCcchhH
Q 013973 251 KDSSYFK-R----MP-KSSAIKVIDFGST--TYER-PD--------------QNYIVSTRHYRAPEVILGLGWTYPCDIW 307 (433)
Q Consensus 251 ~~~~~~~-~----~~-~~~~~kl~Dfg~a--~~~~-~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 307 (433)
....... + ++ .....+-.||... .... .. ....+|||.|||||++.+.+|+..+|||
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 3322110 0 00 1112233444421 0000 00 0235899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHH
Q 013973 308 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387 (433)
Q Consensus 308 SlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
|||||+||||.|.+||.+.+..+++..|...-.. +.+|.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------------l~fP~-------------------- 411 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------------LKFPE-------------------- 411 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------------ccCCC--------------------
Confidence 9999999999999999999988888776543211 12222
Q ss_pred HhhhcCCchhHHHHHHHhccccCCCCCCC---HHHHhcCCCCCCC
Q 013973 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRD 429 (433)
Q Consensus 388 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t---a~ell~hp~f~~~ 429 (433)
...++.++.|||.+||. ||++|+. ++||.+||||+.-
T Consensus 412 ----~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 412 ----EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred ----cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 12456799999999999 9999995 8999999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=393.53 Aligned_cols=279 Identities=32% Similarity=0.590 Sum_probs=233.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|+.+.++|+|+||+||+|++++||+.||||.+... ....+-+++|+..|+++ .|+|+|.+++.|.-...+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-----kH~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-----KHENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-----ccchHHHHHHHHHhccee
Confidence 4588899999999999999999999999999998633 23456678999999999 778999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||||..++.+-|+... ..++.+.+..|+.|++.|+.|+|+++||||||||+||||
T Consensus 77 hLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi--------------------- 134 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI--------------------- 134 (396)
T ss_pred EEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---------------------
Confidence 9999999888888888765 369999999999999999999999999999999999999
Q ss_pred cccccCCCCCCEEEEecCCccccC-CCCC--ceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYER-PDQN--YIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~--~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
..++.+||||||+|+... ++.. .++.|.+|.|||.+.+ .+|++.+||||+||++.||++|.+.|.+.++.
T Consensus 135 ------t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi 208 (396)
T KOG0593|consen 135 ------TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI 208 (396)
T ss_pred ------ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence 456788999999998766 3332 2588999999999998 68999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccC-cccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
+++..|...+|.+++....-...+. +..| .+.-|+.. . ......+..+.-+.||+.+||+
T Consensus 209 DQLy~I~ktLG~L~prhq~iF~~N~---~F~Gv~lP~~~~~---------------e-pLe~k~p~~s~~~ld~~k~cL~ 269 (396)
T KOG0593|consen 209 DQLYLIRKTLGNLIPRHQSIFSSNP---FFHGVRLPEPEHP---------------E-PLERKYPKISNVLLDLLKKCLK 269 (396)
T ss_pred HHHHHHHHHHcccCHHHHHHhccCC---ceeeeecCCCCCc---------------c-chhhhcccchHHHHHHHHHHhc
Confidence 9999999999999987654332211 1111 11112111 1 1122334566789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~ 427 (433)
.||.+|++.+|+|.||||.
T Consensus 270 ~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 270 MDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred CCccccccHHHHhcChHHH
Confidence 9999999999999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-55 Score=413.34 Aligned_cols=284 Identities=31% Similarity=0.524 Sum_probs=235.6
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHH--HHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA--AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~--~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 171 (433)
+-++|.++++||.|+||.||+|+.+.+++.||||.+++.-...++ -.+|+..|+++ +.|+||+++.+.+.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kl----n~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL----NPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhc----CCCCcchhhHHHhhccCc
Confidence 346899999999999999999999999999999998743221222 35788888888 23899999999998887
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.+|+|||||..+|+++++.+ ++.|++..++.|+.||++||+|+|++|+.||||||+|||+.
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~------------------ 144 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS------------------ 144 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec------------------
Confidence 99999999999999999988 57899999999999999999999999999999999999993
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
....+||+|||+|+...... +.++.|.+|+|||+++. .-|+.+.||||+|||++|+.+-++.|.+.++
T Consensus 145 ---------~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 145 ---------GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred ---------ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 35678999999998665444 34689999999999985 4589999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+++..|..++|.+....+......+. .-.+.+|.-.. .. +....+..+.++.+||.+||.
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~----~mnf~~P~~~~-----------~~----l~~L~p~~s~~~~~li~~ll~ 276 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLAS----AMNFRFPQVKP-----------SP----LKDLLPNASSEAASLIERLLA 276 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHH----HhccCCCcCCC-----------CC----hHHhCcccCHHHHHHHHHHhc
Confidence 999999999999988776655422222 22233332111 11 122234578899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
+||.+||||.|+|+||||+..
T Consensus 277 WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 277 WDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred CCCccCccHHHHhcCcccccc
Confidence 999999999999999999854
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-54 Score=400.16 Aligned_cols=282 Identities=27% Similarity=0.383 Sum_probs=231.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+.|++++.||.|.-|+||+|+.+.++..+|+|++.+.. +...++..|.+||+.+ +||.++.+|..|+...
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-----DHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-----DHPFLPTLYASFETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-----CCCccchhhheeeccc
Confidence 467999999999999999999999999999999997532 2334566789999988 8899999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..|+||||| ||+|...++++..+.|++..+++|+.+|+.||+|||-+|||+|||||+||||.++||+.++||-++...+
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999 9999999999988999999999999999999999999999999999999999999999999999987665
Q ss_pred CCCcccccCC-----CCCCE---EEEecCCc------------------------cccCCCCCceeecCcccchhhhhCC
Q 013973 251 KDSSYFKRMP-----KSSAI---KVIDFGST------------------------TYERPDQNYIVSTRHYRAPEVILGL 298 (433)
Q Consensus 251 ~~~~~~~~~~-----~~~~~---kl~Dfg~a------------------------~~~~~~~~~~~gt~~y~aPE~~~~~ 298 (433)
..++...... ..... .+.-|... ...+.....++||-.|+|||++.++
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 5433322110 00000 01111111 1111122457999999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhh
Q 013973 299 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 378 (433)
Q Consensus 299 ~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (433)
..+.++|||+|||++|||+.|..||++.+..+++..|...--.+ |+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F-----------------------p~----------- 356 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF-----------------------PE----------- 356 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC-----------------------CC-----------
Confidence 99999999999999999999999999999988887654332222 22
Q ss_pred ccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCC----HHHHhcCCCCCCC
Q 013973 379 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT----AREALRHPFFTRD 429 (433)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----a~ell~hp~f~~~ 429 (433)
....+..++|||+++|.+||.+|+. |+||.+||||+.-
T Consensus 357 -------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 357 -------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred -------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 1245678999999999999999998 9999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-54 Score=408.90 Aligned_cols=286 Identities=28% Similarity=0.467 Sum_probs=237.3
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
....+.|+.+++||+|+||.||+|++..+|+.||+|.++... ....-..+||.||+++ +|+||+++.+....
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-----~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-----DHPNIIKLEEIVTS 187 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-----CCCcccceeeEEEe
Confidence 334567999999999999999999999999999999997432 2344567899999999 88999999999876
Q ss_pred C--CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 R--NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 ~--~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
. +.+|||||||..+|..++...+ -.|++.++..|+.||+.||+|||.+||+|||||.+||||
T Consensus 188 ~~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi--------------- 251 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI--------------- 251 (560)
T ss_pred cCCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---------------
Confidence 6 7999999999999999988654 479999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~P 322 (433)
|.++.+||+|||+|++..... +..+-|.+|.|||+++|. .|+.++|+||.||||.||++|++.
T Consensus 252 ------------dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI 319 (560)
T KOG0600|consen 252 ------------DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI 319 (560)
T ss_pred ------------cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC
Confidence 556678888888887655443 234679999999999986 599999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|++.++.+++..|.+++|.+.+..|+ +... .+...... ...+...+.+....++..+.+|
T Consensus 320 ~~G~tEveQl~kIfklcGSP~e~~W~-~~kL----------P~~~~~kp---------~~~y~r~l~E~~~~~~~~~l~L 379 (560)
T KOG0600|consen 320 LQGRTEVEQLHKIFKLCGSPTEDYWP-VSKL----------PHATIFKP---------QQPYKRRLRETFKDFPASALDL 379 (560)
T ss_pred cCCccHHHHHHHHHHHhCCCChhccc-cccC----------CcccccCC---------CCcccchHHHHhccCCHHHHHH
Confidence 99999999999999999999988766 2111 11111111 1111223333456788899999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
+..||..||.+|.||.++|+|+||+..++
T Consensus 380 l~~lL~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 380 LEKLLSLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred HHHHhccCccccccHHHHhcCcccccCCC
Confidence 99999999999999999999999965543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=396.34 Aligned_cols=262 Identities=29% Similarity=0.511 Sum_probs=223.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|.+.+.||+|+||+||+|+++.++..||||.+.+ .++..+....|+.+|+.+ .|+|||.+++++++.++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-----~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-----KHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-----CCcceeeEEEEEecCCe
Confidence 4679999999999999999999999999999999864 345667778999999999 68999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||| ||+|.+||+..+ .+++..++.++.||+.||++||+++||||||||.||||+....
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~-------------- 147 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR-------------- 147 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC--------------
Confidence 99999999 999999999876 8999999999999999999999999999999999999964310
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.+....+||+|||+|+...+.. .+.||++.|||||++....|+.|+|+||+|+++|++++|..||...+..
T Consensus 148 -------~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 148 -------NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred -------CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 0122679999999999877654 5679999999999999999999999999999999999999999988877
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+. ++....|. .+...+....+|+..+|++
T Consensus 221 eL~~~~~-----------------------k~~~~~~~-----------------------~~~~~s~~~~~Ll~~ll~~ 254 (429)
T KOG0595|consen 221 ELLLYIK-----------------------KGNEIVPV-----------------------LPAELSNPLRELLISLLQR 254 (429)
T ss_pred HHHHHHh-----------------------ccccccCc-----------------------hhhhccCchhhhhhHHHhc
Confidence 7665332 22211111 1234455677899999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~~~ 431 (433)
||..|.+..+-+.|+++.....
T Consensus 255 ~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 255 NPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred CccccCchHHhhhhhhcccCcc
Confidence 9999999999999999876643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=375.78 Aligned_cols=281 Identities=29% Similarity=0.503 Sum_probs=235.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+|..++.||+|.||+||+|++..||+.||||.++..+ .......+|+..|+.+ +|+||+.+++.|...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-----~h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-----KHPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-----cCcchhhhhhhccCCCce
Confidence 46888999999999999999999999999999997432 2345678899999999 679999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
.||+||+..+|...++... ..|+...+..|+.++++||+|||++.|+||||||.|+||++
T Consensus 77 ~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~------------------- 136 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS------------------- 136 (318)
T ss_pred EEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC-------------------
Confidence 9999999999999998765 57999999999999999999999999999999999999955
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.+||+|||+|+...+.. ...+-|.+|.|||.+.|. .|+..+||||.||++.||+.|.+-|.+.++.
T Consensus 137 --------~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 137 --------DGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred --------CCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 4567777777777655433 223789999999999875 5999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+++..|.+.+|.+.++.|+.+.....+...+ .+.. +...+ .....+.++.||+.+||..
T Consensus 209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~-~~P~----------------~~~~~----lf~aas~d~ldLl~~m~~y 267 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-QFPK----------------PPLNN----LFPAASSDALDLLSKMLTY 267 (318)
T ss_pred HHHHHHHHHcCCCCcccCccccccccHHHHh-cCCC----------------Ccccc----ccccccHHHHHHHHhhhcc
Confidence 9999999999998887766654433322111 1111 11111 3345677889999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~~~ 431 (433)
||.+|+||.|+|+|+||+..+.
T Consensus 268 nP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 268 NPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred CchhcccHHHHhcchhhhcCCC
Confidence 9999999999999999997653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-53 Score=414.83 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=214.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|.++++||+|+||+|++|..+.+++.||||++++. +...+..+.|..|+..+. .||.++.++..|++..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~----~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN----RHPFLVNLFSCFQTKE 442 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc----cCCeEeecccccccCC
Confidence 46899999999999999999999999999999999864 345677788888887773 6899999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++|+||||+ ||++..+.+ .+.|++..++.|+++|+.||.|||++||||||||.+|||++.+|+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh------------- 506 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH------------- 506 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc-------------
Confidence 999999999 888433332 247999999999999999999999999999999999999955555
Q ss_pred CCCcccccCCCCCCEEEEecCCccc---cCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTY---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+||+|||+++. .+...+++||||.|||||++.+..|+.++|||||||+|||||+|.+||.+++
T Consensus 507 --------------~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 507 --------------VKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred --------------EEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 55555555542 2234467899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
+.+.+..|...-. .+|..++.++.++++++|
T Consensus 573 Eee~FdsI~~d~~-------------------------------------------------~yP~~ls~ea~~il~~ll 603 (694)
T KOG0694|consen 573 EEEVFDSIVNDEV-------------------------------------------------RYPRFLSKEAIAIMRRLL 603 (694)
T ss_pred HHHHHHHHhcCCC-------------------------------------------------CCCCcccHHHHHHHHHHh
Confidence 9988876543211 134577889999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCCCCC
Q 013973 408 RYDPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~t-----a~ell~hp~f~~~ 429 (433)
.+||++|+. +.+|..||||+..
T Consensus 604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 604 RKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ccCcccccCCCCCCchhhhhCCccccC
Confidence 999999995 6899999999865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=404.39 Aligned_cols=252 Identities=31% Similarity=0.527 Sum_probs=216.5
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----h--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----K--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
..++|.+.+.||+|+||+|++|.+..+++.||+|+++.. . ...+...+|+.+++.+. +||||+++++++.
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~----~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR----SHPNIIRLLEVFA 90 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc----cCCCEeEEEEEEe
Confidence 356799999999999999999999999999999987642 1 23445567999999883 2678999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
....+|+||||+ ||+|++++...+ ++.+.+++.++.|+++|++|||++||+||||||+|||+
T Consensus 91 t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill--------------- 153 (370)
T KOG0583|consen 91 TPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL--------------- 153 (370)
T ss_pred cCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---------------
Confidence 999999999999 899999999844 89999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCC-CCEEEEecCCccccC-C--CCCceeecCcccchhhhhCCC-CC-CcchhHHHHHHHHHHHhCCC
Q 013973 248 HTPKDSSYFKRMPKS-SAIKVIDFGSTTYER-P--DQNYIVSTRHYRAPEVILGLG-WT-YPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~-~~~kl~Dfg~a~~~~-~--~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGv~l~elltg~~ 321 (433)
+.+ +++||+|||++.... . ...+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.
T Consensus 154 ------------d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~ 221 (370)
T KOG0583|consen 154 ------------DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRL 221 (370)
T ss_pred ------------cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 445 788999999888662 2 235679999999999999987 86 88999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc-hhHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS-AGDLT 400 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 400 (433)
||...+....+.. +..+.+..|. .+ +.+++
T Consensus 222 PF~d~~~~~l~~k-----------------------i~~~~~~~p~--------------------------~~~S~~~~ 252 (370)
T KOG0583|consen 222 PFDDSNVPNLYRK-----------------------IRKGEFKIPS--------------------------YLLSPEAR 252 (370)
T ss_pred CCCCccHHHHHHH-----------------------HhcCCccCCC--------------------------CcCCHHHH
Confidence 9998665554443 3344444333 44 78999
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+|+.+||+.||.+|+|+.+++.||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=408.38 Aligned_cols=249 Identities=30% Similarity=0.559 Sum_probs=221.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
+-|++.+.||.|+.|.|.+|++..||+.+|||++.+. ......+.+|+.+|+.| .|||++.+++.++...+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-----~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-----EHPNVLRLYDVWENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-----cCCCeeeeeeeeccCce
Confidence 3489999999999999999999999999999999754 22345678899999999 77999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+|.||+ ||.|+++|...+ +|++.++.+++.||+.|+.|||..+|+||||||+|+|+
T Consensus 87 lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL------------------- 145 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL------------------- 145 (786)
T ss_pred EEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh-------------------
Confidence 99999999 999999998876 89999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
+...++||+|||+|....++. .+.||++.|.|||++.|.+|+ .++||||+|||||.||||++||.+++-
T Consensus 146 --------d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi 217 (786)
T KOG0588|consen 146 --------DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI 217 (786)
T ss_pred --------hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH
Confidence 555569999999998766655 457999999999999999986 899999999999999999999997665
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
...+.+ +.+|.+..|. .++.++++||++||.
T Consensus 218 r~LLlK-----------------------V~~G~f~MPs--------------------------~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 218 RVLLLK-----------------------VQRGVFEMPS--------------------------NISSEAQDLLRRMLD 248 (786)
T ss_pred HHHHHH-----------------------HHcCcccCCC--------------------------cCCHHHHHHHHHHhc
Confidence 554443 4556666554 678899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~ 428 (433)
+||++|+|.+||++|||+..
T Consensus 249 VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 249 VDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred cCccccccHHHHhhCchhhc
Confidence 99999999999999999974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=377.07 Aligned_cols=284 Identities=27% Similarity=0.462 Sum_probs=231.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~ 171 (433)
+.|+.++.|++|+||.||+|+++.|++.||+|.++-.+. ..-...+|+.+|.++ +|+|||.+.++... -+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-----~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-----RHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-----CCCCeeeeEEEEeccccc
Confidence 569999999999999999999999999999999974321 122346899999988 67999999888764 45
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.+|||||||..+|...+.... .+|...+++.++.|+++||+|||.+.|+|||||++|+|++.
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~----------------- 212 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSH----------------- 212 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeecc-----------------
Confidence 799999999999999998775 68999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+.+||+|||+|+..+... +..+-|.+|.|||++.+. .|++++|+||+|||+.||+++.+.|.+.+
T Consensus 213 ----------~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 213 ----------KGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred ----------CCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 4567788888887666552 345779999999999986 49999999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC-chhHHHHHHHhc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGL 406 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~ 406 (433)
..+++..|.+.+|.+.+.+|+........- ...++.. ....++ ..+... ++....+|+..+
T Consensus 283 E~dQl~~If~llGtPte~iwpg~~~lp~~k----~~~f~~~-----------pyn~lr---~kF~~~~lse~g~~Lln~l 344 (419)
T KOG0663|consen 283 EIDQLDKIFKLLGTPSEAIWPGYSELPAVK----KMTFSEH-----------PYNNLR---KKFGALSLSEQGFDLLNKL 344 (419)
T ss_pred hHHHHHHHHHHhCCCccccCCCccccchhh----ccccCCC-----------Cchhhh---hhccccccchhHHHHHHHH
Confidence 999999999999999887766544332110 0011110 011111 111112 568899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
|.+||.+|.||.|.|+|+||.+.++
T Consensus 345 lt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 345 LTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred hccCccccccHHHhhcccccccCCC
Confidence 9999999999999999999998543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=378.15 Aligned_cols=282 Identities=29% Similarity=0.510 Sum_probs=235.6
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEee---cchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY- 169 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~- 169 (433)
.+...|..++.||+|+||.|..|.++.+|+.||||.+. ......++..+|+.+|+.+ .|+||+.+.+.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-----~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-----RHENIIGLLDIFRPP 93 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-----cCCCcceEEeecccc
Confidence 34566888899999999999999999999999999885 2344567778899999998 56889999988865
Q ss_pred ----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 170 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 ----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
-+.+|+|+|+|+.+|...++++. .|+.+.++.+++||++||+|+|+.+|+||||||+|+|++
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n------------ 159 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN------------ 159 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeec------------
Confidence 46799999999999999998764 699999999999999999999999999999999999995
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCC----CC-CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP----DQ-NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~-~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg 319 (433)
.+..+||||||+|+.... +. +..+-|.+|.|||++.. ..|+.++||||.|||+.||++|
T Consensus 160 ---------------~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~g 224 (359)
T KOG0660|consen 160 ---------------ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTG 224 (359)
T ss_pred ---------------cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcC
Confidence 455667777777776532 21 34678999999999875 5799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHh-hhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
++.|.+.+..+++..|...+|.++++.+..+. +.+..|+.+-.. .|.. ......+..++.
T Consensus 225 kplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~-~p~~------------------~f~~~fp~a~p~ 285 (359)
T KOG0660|consen 225 KPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQ-IPKQ------------------PFSSIFPNANPL 285 (359)
T ss_pred CCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCC-CCCC------------------CHHHHcCCCCHH
Confidence 99999999999999999999999999888876 445556654211 1110 011223477889
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+.||+.+||..||.+|+|++|+|+||||+.
T Consensus 286 AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 286 AIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 999999999999999999999999999974
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-50 Score=405.83 Aligned_cols=312 Identities=39% Similarity=0.722 Sum_probs=237.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcC-CCCCceEEecceeecC-CeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYR-NHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~~~~~~~~-~~~ 173 (433)
.++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+.. .++.+++.++.++... .++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 57899999999999999999999999999999999755455555677899998887654 2455688888888754 689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+|||++|++|.+++.+.+ .+++..+..|+.||+.||+|||+ .|||||||||+|||++.++... ++......+
T Consensus 208 ~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~--~~~~~~~~~-- 281 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVV--DPVTNRALP-- 281 (467)
T ss_pred EEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccc--ccccccccC--
Confidence 9999999999999998754 79999999999999999999998 5999999999999997765321 221111110
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~ 332 (433)
.....+||+|||.+..........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+
T Consensus 282 -------~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 282 -------PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred -------CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 2335699999998876555555678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHhh-hhhhhhc-cCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 333 AMMERVLGPLPQHMLKRVDR-HAEKYVR-RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
..+...+|.+|..+...... ....++. .+.+. + ......+........... ......+.|||.+||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~------~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLR-P--CTDPKHLARIARARPVRE------VIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhccccc-c--cCCHHHHHhhhcccchhh------hhchHHHHHHHHHhCCcC
Confidence 99999999999887654321 1111211 11110 0 000011111000000000 012457889999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|++|||++|+|+||||.+.
T Consensus 426 P~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 426 RQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhhCCCHHHHhcCcccccc
Confidence 9999999999999999863
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-53 Score=366.40 Aligned_cols=261 Identities=26% Similarity=0.454 Sum_probs=223.1
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.+.|++.+.||+|.|+.|+++.+..+|+.+|+|+++.. ....++..+|+.|-+.+ .||||+.+.+.+...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-----qHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-----CCCcEeehhhhhccc
Confidence 3457799999999999999999999999999999998632 23456677888888877 679999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+..|||+|+| |++|..-+.++. .+++..+..++.||+.||.|+|.+||||||+||+|+|+.+.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK-------------- 146 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK-------------- 146 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec--------------
Confidence 9999999999 999976665543 68999999999999999999999999999999999999653
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
++.-.+||+|||+|.....+. ...+|||+|||||++...+|+..+|||+.||+||-|+.|++||.+.+
T Consensus 147 ----------~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 147 ----------AKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred ----------cCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 344578999999998777433 23689999999999999999999999999999999999999999877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
....+..|. +|.++++. +.+++.++++++||++||
T Consensus 217 ~~rlye~I~-----------------------~g~yd~~~----------------------~~w~~is~~Ak~LvrrML 251 (355)
T KOG0033|consen 217 QHRLYEQIK-----------------------AGAYDYPS----------------------PEWDTVTPEAKSLIRRML 251 (355)
T ss_pred HHHHHHHHh-----------------------ccccCCCC----------------------cccCcCCHHHHHHHHHHh
Confidence 776666543 44444443 235688999999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
..||.+|+|+.|+|+|||+.+..
T Consensus 252 ~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 252 TVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred ccChhhhccHHHHhCCchhcchH
Confidence 99999999999999999998653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=376.67 Aligned_cols=271 Identities=25% Similarity=0.387 Sum_probs=219.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.|++...||.|..++||+|+.+.+++.||||+++-.+ ...+...+|+..+..+ +||||+..+..|..+..++
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-----~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-----DHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-----CCCCcceEEEEEEecceeE
Confidence 56999999999999999999999999999999997433 2346677899998888 8899999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||.|| +|++.+.+.......|++..+..|++++++||.|||++|.||||||+.||||+++|.+||+|||.+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa------ 174 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA------ 174 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee------
Confidence 999999 9999999998776789999999999999999999999999999999999999988888888887653
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.|.|-|....... .+++||++|||||++.. .+|+.|+||||||++..||.+|..||........
T Consensus 175 ------------~l~~~G~R~~~rf--~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv 240 (516)
T KOG0582|consen 175 ------------SLFDSGDRQVTRF--NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV 240 (516)
T ss_pred ------------eecccCceeeEee--ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH
Confidence 2333331111111 45689999999999654 4699999999999999999999999998877665
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+.+ ++-+.+|.-.. + .... +....++..++.+|..||++||
T Consensus 241 Ll~--tLqn~pp~~~t-------------~-------~~~~-----------------d~~k~~~ksf~e~i~~CL~kDP 281 (516)
T KOG0582|consen 241 LLL--TLQNDPPTLLT-------------S-------GLDK-----------------DEDKKFSKSFREMIALCLVKDP 281 (516)
T ss_pred HHH--HhcCCCCCccc-------------c-------cCCh-----------------HHhhhhcHHHHHHHHHHhhcCc
Confidence 543 33333331100 0 0000 0112455689999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~~~ 431 (433)
++||||.++|+|+||+....
T Consensus 282 ~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 282 SKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccCCCHHHHhccHHHhhccc
Confidence 99999999999999987643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=391.63 Aligned_cols=253 Identities=28% Similarity=0.450 Sum_probs=218.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhh-HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
...|....+||+|+.|.||.|....+++.||||.+...... ++-...|+.+|+.. +|+|||.+++.|...+.++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-----~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-----HHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-----cchHHHHHHHHhcccceeE
Confidence 35688999999999999999999999999999999755443 44567899999888 7799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||| ||+|.|.+... .+++.++..|..+++.||+|||.+||+|||||.+|||+
T Consensus 347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL--------------------- 402 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL--------------------- 402 (550)
T ss_pred EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---------------------
Confidence 999999 99999999875 59999999999999999999999999999999999999
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
..++.+||+|||++....... .+.+||++|||||++....|++++||||||++++||+.|++||-..+...
T Consensus 403 ------~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr 476 (550)
T KOG0578|consen 403 ------TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 476 (550)
T ss_pred ------ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH
Confidence 455678999999887665543 55799999999999999999999999999999999999999998766666
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..|... |. .. ...++.+|+.++|||.+||+.|
T Consensus 477 AlyLIa~n-g~---------------------P~------------------------lk~~~klS~~~kdFL~~cL~~d 510 (550)
T KOG0578|consen 477 ALYLIATN-GT---------------------PK------------------------LKNPEKLSPELKDFLDRCLVVD 510 (550)
T ss_pred HHHHHhhc-CC---------------------CC------------------------cCCccccCHHHHHHHHHHhhcc
Confidence 55544322 11 10 1234578999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
+++|++|.|||+||||+..
T Consensus 511 v~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 511 VEQRASAKELLEHPFLKMA 529 (550)
T ss_pred hhcCCCHHHHhcChhhhhc
Confidence 9999999999999999654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=365.94 Aligned_cols=242 Identities=29% Similarity=0.453 Sum_probs=205.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecc-eeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-WFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~-~~~~~~ 171 (433)
..+|+++++||+|+||.||++.+..+|+.+|.|.+.- ..+.+.....|+.+|++| +||||++.++ .|..++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-----~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-----NHPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-----CCchHHHHHHHhhhccc
Confidence 3569999999999999999999999999999998862 345567778899999999 8899999998 565555
Q ss_pred e-EEEEEecC-CCCHHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCceEeeccCccccCCC
Q 013973 172 H-ICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMHD--LC--MIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 172 ~-~~lV~e~~-~~~L~~~l~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~--ivHrDlKp~NILl~~~~~~~i~df 243 (433)
. ++||||+| +|+|.+.++ +...+.+++..++.++.|++.||.+||+ .. |+||||||.||+|
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl----------- 161 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL----------- 161 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE-----------
Confidence 5 99999999 999999986 3445789999999999999999999998 44 9999999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
+.++.+||+|||++++..... .+.+|||.||+||++.+.+|+.+|||||+||++|||..-+
T Consensus 162 ----------------~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~ 225 (375)
T KOG0591|consen 162 ----------------TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ 225 (375)
T ss_pred ----------------cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence 566788899999888776655 3469999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhc-CCchhHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV-DHSAGDL 399 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 399 (433)
+||.+.+-.+....|.. |.+. + .| +.+|.++
T Consensus 226 ~PF~g~n~~~L~~KI~q-----------------------gd~~--~-----------------------~p~~~YS~~l 257 (375)
T KOG0591|consen 226 SPFYGDNLLSLCKKIEQ-----------------------GDYP--P-----------------------LPDEHYSTDL 257 (375)
T ss_pred CCcccccHHHHHHHHHc-----------------------CCCC--C-----------------------CcHHHhhhHH
Confidence 99999866555554433 2211 0 11 3567889
Q ss_pred HHHHHhccccCCCCCCCH
Q 013973 400 THLLQGLLRYDPTDRLTA 417 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta 417 (433)
..||..|+..||++||+.
T Consensus 258 ~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHccCCcccCCCc
Confidence 999999999999999984
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=384.13 Aligned_cols=262 Identities=34% Similarity=0.581 Sum_probs=225.9
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
..+...|++.+.||+|.||.||+|+.+.+|+.||+|++.+... ..+...+|+.+|+++.. |+||+.+++.|+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~----hpniv~l~~~~e 106 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG----HPNIVQLKDAFE 106 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC----CCCEEEEEEEEE
Confidence 3455779999999999999999999999999999999975432 34578899999999942 789999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
+...+++|||++ ||.|++.+... .+++..+..++.||+.|+.|||+.|||||||||+|+|+....
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~----------- 172 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD----------- 172 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc-----------
Confidence 999999999999 99999999876 299999999999999999999999999999999999996432
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
..++.+|++|||++...... ....+||+.|+|||++....|+..+||||+||++|.|++|.+||.+
T Consensus 173 ------------~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 173 ------------EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred ------------CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 23468999999999887763 2457999999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+.......+. .+.+.++. +.++..+..+++||.+
T Consensus 241 ~~~~~~~~~i~-----------------------~~~~~f~~----------------------~~w~~is~~akd~i~~ 275 (382)
T KOG0032|consen 241 ETEFEIFLAIL-----------------------RGDFDFTS----------------------EPWDDISESAKDFIRK 275 (382)
T ss_pred CChhHHHHHHH-----------------------cCCCCCCC----------------------CCccccCHHHHHHHHH
Confidence 88766655332 22222222 2345778899999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||..||.+|+||.++|+|||++..
T Consensus 276 ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 276 LLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred hcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=388.20 Aligned_cols=249 Identities=29% Similarity=0.509 Sum_probs=215.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+. ++......+|+++++.+ .|+||+.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-----kHpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-----KHPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-----CCcchhhHHHhhcccceE
Confidence 4688999999999999999999999999999999643 33445577899999999 779999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
++|.||+-|+|+.+|...+ .++++.++.++.|++.||.|||+.+|+|||+||.|||+
T Consensus 77 ~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl--------------------- 133 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL--------------------- 133 (808)
T ss_pred EEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---------------------
Confidence 9999999669999999876 89999999999999999999999999999999999999
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+.+|+||||+|+...... +.+.|||.|||||++.+..|+..+|+||+||++||+++|++||...+..+
T Consensus 134 ------~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~ 207 (808)
T KOG0597|consen 134 ------EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ 207 (808)
T ss_pred ------cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence 666778888888887665544 33579999999999999999999999999999999999999998655554
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....|.. ....| ++..+..+.+|+..+|++|
T Consensus 208 Lv~~I~~-----------------------d~v~~--------------------------p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 208 LVKSILK-----------------------DPVKP--------------------------PSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred HHHHHhc-----------------------CCCCC--------------------------cccccHHHHHHHHHHhhcC
Confidence 4444322 11122 2356778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTR 428 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~ 428 (433)
|.+|+|=.+++.|||.+.
T Consensus 239 P~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred hhhcccHHHHhcChHHhh
Confidence 999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=367.16 Aligned_cols=284 Identities=31% Similarity=0.510 Sum_probs=230.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---hHHHHHHHHHHHHHHHhcCCCCCc-eEEecceeecCC-
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRN- 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~-i~~~~~~~~~~~- 171 (433)
..|+.+++||+|+||+||+|+.+.+|+.||+|.++-... ......+|+.+++.+.+ .+ |+.+.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~-----~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSH-----ANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCC-----CcceEEEEeeeeeccc
Confidence 457888999999999999999999999999999974433 34556889999999944 44 999999998876
Q ss_pred -----eEEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 172 -----HICIVFEKLGSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 172 -----~~~lV~e~~~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+++||||+.-+|..++..... ..++...++.++.||+.||+|||++||+||||||.||||+
T Consensus 86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----------- 154 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----------- 154 (323)
T ss_pred ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC-----------
Confidence 8999999999999999987653 3688899999999999999999999999999999999995
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~ 320 (433)
..+.+||+|||+|+...-+. +..++|.+|.|||++.+. .|+..+||||+||+++||++++
T Consensus 155 ----------------~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~ 218 (323)
T KOG0594|consen 155 ----------------SSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR 218 (323)
T ss_pred ----------------CCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence 45567777777776544222 335799999999999987 6999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
+.|.+..+.+++..|.+.+|.+.+..|+.+........ .++... .... .....+..+++..
T Consensus 219 ~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~-----~f~~~~-------------~~~~-l~~~~~~~~~~~~ 279 (323)
T KOG0594|consen 219 PLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA-----PFPKWP-------------GPKD-LSSILPKLDPDGI 279 (323)
T ss_pred CCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc-----cCcCCC-------------Cccc-hHHhccccCccHH
Confidence 99999999999999999999998876665543332221 111110 0001 1111233446899
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
|++.+||+.+|.+|.||..+|+||||.....
T Consensus 280 dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 280 ELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred HHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 9999999999999999999999999987754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=374.83 Aligned_cols=255 Identities=31% Similarity=0.480 Sum_probs=203.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC--eE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--~~ 173 (433)
.++...+.||+|+||.||++.+.++|..+|||.+..... ..+....|+.+|.++ .|++||++++...... .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-----~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-----NHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-----CCCCEEeeCCccccccCeee
Confidence 347888999999999999999999999999998864321 145578899999999 5789999999855444 69
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+|+|||+ +|+|.+++...+. .|++..++.++.||+.||+|||++|||||||||+|||++..
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~----------------- 153 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS----------------- 153 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-----------------
Confidence 9999999 9999999998876 79999999999999999999999999999999999999541
Q ss_pred CcccccCCCCCCEEEEecCCccccCC------CCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERP------DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
++.+||+|||.+..... ......||+.|||||++... ....++|||||||++.||+||..||..
T Consensus 154 ---------~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 154 ---------NGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ---------CCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 34566666665553331 12336899999999999963 334599999999999999999999986
Q ss_pred C-ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 326 H-ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 326 ~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
. ...+.+..+.. .. .....++.++.++++||.
T Consensus 225 ~~~~~~~~~~ig~----------------------~~-------------------------~~P~ip~~ls~~a~~Fl~ 257 (313)
T KOG0198|consen 225 FFEEAEALLLIGR----------------------ED-------------------------SLPEIPDSLSDEAKDFLR 257 (313)
T ss_pred hcchHHHHHHHhc----------------------cC-------------------------CCCCCCcccCHHHHHHHH
Confidence 3 22221111100 00 001234578899999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||++||++||||+++|.|||.++..
T Consensus 258 ~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 258 KCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999998754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=372.38 Aligned_cols=278 Identities=29% Similarity=0.495 Sum_probs=220.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++++.||.|+||.||+|.+..+++.||+|+++... ........|+.+++.+ .|+||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-----KHANIVTLHDIIHTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-----CCCCEeeEEEEEcCCCeEE
Confidence 56999999999999999999999999999999986422 2234566799999888 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||+.++|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~------------------ 140 (288)
T cd07871 80 LVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG------------------ 140 (288)
T ss_pred EEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC------------------
Confidence 999999779999987654 3589999999999999999999999999999999999995544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 141 ---------~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~ 211 (288)
T cd07871 141 ---------ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211 (288)
T ss_pred ---------CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4556666655432211 122468999999999876 568999999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+...++..+.+.++.+....+.. . ...|.. .... ........+.++.+||.+||+.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~--------------~~~~-~~~~~~~~~~~~~dll~~mL~~d 272 (288)
T cd07871 212 ELHLIFRLLGTPTEETWPGITSNEEFR-S---YLFPQY--------------RAQP-LINHAPRLDTDGIDLLSSLLLYE 272 (288)
T ss_pred HHHHHHHHhCCCChHHhhccccchhhh-c---cccCcc--------------CCCc-hHHhCCCCCHHHHHHHHHhcCcC
Confidence 899999999988887766543221110 0 000000 0000 01122356778999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|.+|||++|+|+||||
T Consensus 273 p~~R~t~~~~l~hp~f 288 (288)
T cd07871 273 TKSRISAEAALRHSYF 288 (288)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=358.52 Aligned_cols=254 Identities=30% Similarity=0.536 Sum_probs=216.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---------chhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
-..|.-.+.||.|..++|.+|.++.+++.+|+|++.- .....+....|+.||+++. +||+|+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~----GHP~II~l~D~ 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM----GHPYIIDLQDV 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc----CCCcEEEeeee
Confidence 3568888999999999999999999999999999851 1234566778999999994 67899999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
|+.+..+++|+|.| .|.|+|||.+.- .+++.+.+.|+.|++.|++|||.++||||||||+|||+
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl------------- 156 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL------------- 156 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee-------------
Confidence 99999999999999 999999998764 79999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC------CCCCCcchhHHHHHHHHHHH
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~ell 317 (433)
+.+.++||+|||+++...++. ...||||+|+|||.+.. .+|+..+|+||+||+||.|+
T Consensus 157 --------------ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 157 --------------DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred --------------ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence 667789999999998877665 34799999999999963 36899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
.|++||-.....-.+.+ |..|++.+... -|++.+.
T Consensus 223 aGcpPFwHRkQmlMLR~-----------------------ImeGkyqF~sp----------------------eWadis~ 257 (411)
T KOG0599|consen 223 AGCPPFWHRKQMLMLRM-----------------------IMEGKYQFRSP----------------------EWADISA 257 (411)
T ss_pred cCCCchhHHHHHHHHHH-----------------------HHhcccccCCc----------------------chhhccc
Confidence 99999965444444433 33444433221 2456778
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
+.+|||.+||+.||.+|.|++|+|.||||.
T Consensus 258 ~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred cHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 899999999999999999999999999994
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=366.65 Aligned_cols=277 Identities=31% Similarity=0.551 Sum_probs=227.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-----C
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----N 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-----~ 171 (433)
-.|.-.+++|+|+||.||+|....+++.||||.+-..+.. ..+|.++|+.+ .|||||.+..+|... -
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l-----~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKL-----DHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhc-----CCcCeeeEEEEEEecCCCchh
Confidence 3588999999999999999999999999999987544433 34689999877 789999999888532 2
Q ss_pred eEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.+.+|||||..+|.++++.. .+..++.-.++-|+.||++||.|||+.||+||||||.|||++
T Consensus 96 ~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---------------- 159 (364)
T KOG0658|consen 96 YLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---------------- 159 (364)
T ss_pred HHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc----------------
Confidence 56799999999999999842 235799999999999999999999999999999999999996
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
...+.+||||||.|+....+. .+..-|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.
T Consensus 160 ----------~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 160 ----------PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred ----------CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 445789999999998765544 334669999999999986 5999999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHH--hhhcCCchhHHHHHHH
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI--MQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~ 404 (433)
+..+++..|.+.+|.++.+-...+......+ ..|. +.... .-+....++++.+|+.
T Consensus 230 s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~------~~p~----------------ik~~~~~~~~~~~~~~d~~dll~ 287 (364)
T KOG0658|consen 230 SSVDQLVEIIKVLGTPTREDIKSMNPNYTEF------KFPQ----------------IKAHPWHKVFFKRLPPDALDLLS 287 (364)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcCcccccc------cCcc----------------cccccceeecccCCCHHHHHHHH
Confidence 9999999999999999988766654432110 0110 00000 0123467889999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
++|+++|.+|.++.|+|.||||...
T Consensus 288 ~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 288 KLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HHhccChhhcCCHHHHhcchhhHHh
Confidence 9999999999999999999999753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=368.37 Aligned_cols=280 Identities=32% Similarity=0.597 Sum_probs=220.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++.+.||+|+||.||+|+++.+++.||+|+++... ...+....|+.+++.+ .|++|+++++.+...+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-----KQENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-----CCccccchhhhEecCCEE
Confidence 36999999999999999999999999999999987432 2345567788888888 668899999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|+||||+.+++.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~------------------- 135 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH------------------- 135 (287)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-------------------
Confidence 9999999555555554432 36999999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.+||+|||++....... ....||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+..
T Consensus 136 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~ 207 (287)
T cd07848 136 --------NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI 207 (287)
T ss_pred --------CCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 4456667777665432211 2346899999999999989999999999999999999999999998888
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+....+++|............. ....++.... ...........++.++.+||.+||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-------------~~~~~~~~~~~~s~~~~dll~~~L~~ 270 (287)
T cd07848 208 DQLFTIQKVLGPLPAEQMKLFYSNPRF----HGLRFPAVNH-------------PQSLERRYLGILSGVLLDLMKNLLKL 270 (287)
T ss_pred HHHHHHHHhhCCCCHHHHHhhhccchh----cccccCcccC-------------cccHHHhhhcccCHHHHHHHHHHccC
Confidence 888888888899887765543221100 0011111000 00111223345788999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013973 410 DPTDRLTAREALRHPFF 426 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f 426 (433)
||++|||++|+|+||||
T Consensus 271 ~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 271 NPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=371.10 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=208.1
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---------------hHHHHHHHHHHHHHHHhcCCCCC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------------YREAAMIEIEVLQQLAKHDKGGN 158 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~~~~~ 158 (433)
...++|++++.||+|.||.|.+|++..+++.||||++.+... ..+...+|+.+|+++ +|+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-----~H~ 168 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-----HHP 168 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-----CCc
Confidence 446789999999999999999999999999999999953211 124678899999999 779
Q ss_pred ceEEecceeecC--CeEEEEEecC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 159 RCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 159 ~i~~~~~~~~~~--~~~~lV~e~~-~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
|||+++++.++. +.+|||+||| .|.+... ..... |++.+++.|+.+++.||+|||.+|||||||||+|+||++
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence 999999999874 6899999999 6665322 22234 899999999999999999999999999999999999988
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCC----CCCcchhHHHH
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVG 310 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG 310 (433)
+|++||+|||.+...+..... + .- ..-...+|||.|+|||.+.++. .+.+.||||+|
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~------~---------~d----~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDE------G---------SD----DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred CCcEEeeccceeeecccCCcc------c---------cH----HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 777777777766544332100 0 00 0001248999999999998733 35789999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh
Q 013973 311 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390 (433)
Q Consensus 311 v~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
|+||.|+.|+.||-+....+.+..|... .+.+|+.
T Consensus 307 VTLYCllfG~~PF~~~~~~~l~~KIvn~-----------------------pL~fP~~---------------------- 341 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDFELELFDKIVND-----------------------PLEFPEN---------------------- 341 (576)
T ss_pred hhHHHhhhccCCcccchHHHHHHHHhcC-----------------------cccCCCc----------------------
Confidence 9999999999999988777777665432 2222221
Q ss_pred hcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 391 ~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
..+..+++|||.+||++||++|++..+|..|||.+..
T Consensus 342 --pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 342 --PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1356789999999999999999999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=373.15 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=210.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|.++.+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++.+.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-----SHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-----CCCcHhhhHhhhccCCe
Confidence 36999999999999999999999999999999986432 2334566788888888 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~------------------ 135 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD------------------ 135 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC------------------
Confidence 99999999 899999998754 799999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 136 ---------~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~ 206 (291)
T cd05612 136 ---------KEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206 (291)
T ss_pred ---------CCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45568888888877655444456799999999999999999999999999999999999999987665554
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.. +... .+...+..+++||.+||+.||
T Consensus 207 ~~~i~~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 207 YEKILA-----------------------GKLE--------------------------FPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred HHHHHh-----------------------CCcC--------------------------CCccCCHHHHHHHHHHcCCCH
Confidence 433221 1111 122456789999999999999
Q ss_pred CCCCC-----HHHHhcCCCCCCC
Q 013973 412 TDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~t-----a~ell~hp~f~~~ 429 (433)
.+|++ +.|+++||||+.-
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHccCCccCCHHHHhcCccccCC
Confidence 99995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=379.41 Aligned_cols=250 Identities=29% Similarity=0.459 Sum_probs=211.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.++.+++.||+|+++... .....+..|+.+++.+ .|+||+++++.+...+.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-----SHPFIVNMMCSFQDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEcCCE
Confidence 56999999999999999999999999999999997432 2334567788888888 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll------------------- 151 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL------------------- 151 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE-------------------
Confidence 99999999 899999998764 78999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 152 --------~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 152 --------DNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred --------CCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 445568888888877655544556899999999999999999999999999999999999999987665443
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+. .+.+.. +...+.++++||.+||+.||
T Consensus 224 ~~~i~-----------------------~~~~~~--------------------------p~~~~~~~~~li~~~L~~dP 254 (329)
T PTZ00263 224 YEKIL-----------------------AGRLKF--------------------------PNWFDGRARDLVKGLLQTDH 254 (329)
T ss_pred HHHHh-----------------------cCCcCC--------------------------CCCCCHHHHHHHHHHhhcCH
Confidence 33221 111111 22456688999999999999
Q ss_pred CCCCC-----HHHHhcCCCCCCC
Q 013973 412 TDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~t-----a~ell~hp~f~~~ 429 (433)
.+|++ +++++.||||++.
T Consensus 255 ~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 255 TKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHcCCCCCCCHHHHhcCCccCCC
Confidence 99997 7999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=362.45 Aligned_cols=340 Identities=32% Similarity=0.570 Sum_probs=266.2
Q ss_pred CCCCceeecCceec-CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCC---C
Q 013973 83 KDGHYMFALGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG---N 158 (433)
Q Consensus 83 ~~~~~~~~~~~~~~-~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~---~ 158 (433)
.+|.+++.+|+.+. ++|.+.++||-|.|++||+|.+.++.+.||+|+.+....+.+..+.||.+|++++.+..++ .
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 35678899999998 8999999999999999999999999999999999988888999999999999999877433 4
Q ss_pred ceEEecceeec----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEee
Q 013973 159 RCVQIRNWFDY----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLV 233 (433)
Q Consensus 159 ~i~~~~~~~~~----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~ 233 (433)
+||++++.|.. +.++|||+|++|.+|..+|...+.+.++...++.|+.||+.||.|||+ .||||-||||+|||+.
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 69999999975 469999999999999999999999999999999999999999999996 5799999999999997
Q ss_pred ccCc----------------c-------cc--------------CCC--------------------cC--CC-------
Q 013973 234 SSEY----------------I-------KV--------------PDY--------------------KS--SL------- 247 (433)
Q Consensus 234 ~~~~----------------~-------~i--------------~df--------------------g~--~~------- 247 (433)
.... . +- .++ |. ..
T Consensus 223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s 302 (590)
T KOG1290|consen 223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQES 302 (590)
T ss_pred ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccc
Confidence 5410 0 00 000 00 00
Q ss_pred -----CCCC------C--------------Cccc------------------------------c---------------
Q 013973 248 -----HTPK------D--------------SSYF------------------------------K--------------- 257 (433)
Q Consensus 248 -----~~~~------~--------------~~~~------------------------------~--------------- 257 (433)
..+. . +... +
T Consensus 303 ~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p 382 (590)
T KOG1290|consen 303 YNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNP 382 (590)
T ss_pred cccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCC
Confidence 0000 0 0000 0
Q ss_pred ---cCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC------Ch
Q 013973 258 ---RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH------EN 328 (433)
Q Consensus 258 ---~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~------~~ 328 (433)
....+..+||+|||.|++....-+.-..|..|.|||++.+.+|+..+||||++|++|||+||.+.|..+ .+
T Consensus 383 ~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD 462 (590)
T KOG1290|consen 383 DIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD 462 (590)
T ss_pred CCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence 012234689999999998776666667899999999999999999999999999999999999999643 47
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.++.|..++|..|..+.-..+-.-..|-+.|.+..=..... ..+..+......++...+.++.|||.-||+
T Consensus 463 EDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~-------WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 463 EDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKP-------WPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred HHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCC-------CcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 8899999999999999887666555555555555532111110 011111122233445667789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+|++|+||.++|+|||+..-
T Consensus 536 f~PeKR~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLKHPWLNPV 556 (590)
T ss_pred cCccccccHHHHhcCccccCC
Confidence 999999999999999999843
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=374.05 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=216.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+.|..-++||+||||.||-|+.+.||+.||+|.+.+. .+...-...|..+|.++ +.+.||.+-..|++.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-----~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-----SSPFIVSLAYAFETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-----ccCcEEEEeeeecCCC
Confidence 35789999999999999999999999999999988521 22334466789999998 6678999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||..| ||+|.-+|...+...|++..+++|+.+|+.||++||+.+||+|||||+|||+++.|+
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh------------- 325 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH------------- 325 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC-------------
Confidence 999999999 999999998888788999999999999999999999999999999999999965555
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
+.|+|+|+|....... ...+||.+|||||++.++.|+...|||||||++|||+.|+.||.....
T Consensus 326 --------------vRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 326 --------------VRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred --------------eEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 5555555555443332 234899999999999999999999999999999999999999987654
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
......+.+.. .+....+++.+|+++++|++.+|+
T Consensus 392 Kvk~eEvdrr~---------------------------------------------~~~~~ey~~kFS~eakslc~~LL~ 426 (591)
T KOG0986|consen 392 KVKREEVDRRT---------------------------------------------LEDPEEYSDKFSEEAKSLCEGLLT 426 (591)
T ss_pred hhhHHHHHHHH---------------------------------------------hcchhhcccccCHHHHHHHHHHHc
Confidence 43332222211 111223456889999999999999
Q ss_pred cCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 013973 409 YDPTDRLT-----AREALRHPFFTRDHLRR 433 (433)
Q Consensus 409 ~dP~~R~t-----a~ell~hp~f~~~~~~~ 433 (433)
+||.+|+. +++|.+||||++.+.||
T Consensus 427 Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 427 KDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred cCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 99999994 78999999999987664
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=368.01 Aligned_cols=284 Identities=26% Similarity=0.428 Sum_probs=212.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++.+.||+|+||.||+|.++.+++.||+|+++... ........|+.+++.+ .|+||+++++++.+....|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-----KHANIVLLHDIIHTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-----CCCCcCeEEEEEecCCeEE
Confidence 67999999999999999999999999999999986432 2233456789999888 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||++++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||+++++
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~------------------ 140 (303)
T cd07869 80 LVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG------------------ 140 (303)
T ss_pred EEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------------------
Confidence 999999889999987653 4689999999999999999999999999999999999995544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCh-H
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN-L 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~-~ 329 (433)
.+||+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..+ .
T Consensus 141 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 211 (303)
T cd07869 141 ---------ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211 (303)
T ss_pred ---------CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 4555555555432211 1224689999999998764 588999999999999999999999987544 3
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+...++......+........ +. ...+.. ... ..+.... .....+.++.+||.+||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~----~~~---------~~~~~~~--~~~~~~~~~~dli~~mL~~ 274 (303)
T cd07869 212 DQLERIFLVLGTPNEDTWPGVHSLPH-FK-PERFTL----YSP---------KNLRQAW--NKLSYVNHAEDLASKLLQC 274 (303)
T ss_pred HHHHHHHHHhCCCChhhccchhhccc-cc-cccccc----cCC---------ccHHHHh--hccCCChHHHHHHHHHhcc
Confidence 45555555566555443332211100 00 000000 000 0000000 0113456899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~~ 430 (433)
||++|||+.|+|+||||++.+
T Consensus 275 dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 275 FPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred CchhccCHHHHhcCcccccCC
Confidence 999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=372.29 Aligned_cols=279 Identities=32% Similarity=0.497 Sum_probs=217.6
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 170 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 170 (433)
+|++.+.||+|+||.||+|++..+++.||||++... ......+..|+.+++.+ .|+||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-----RHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-----CCCCEeeecceEeccCCCC
Confidence 589999999999999999999999999999998632 12334567899999888 678999999887532
Q ss_pred -CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 -NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 -~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
..+|+||||++++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~------------ 141 (338)
T cd07859 76 FKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK------------ 141 (338)
T ss_pred CceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc------------
Confidence 3589999999889999987654 6999999999999999999999999999999999999965554
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHHhCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|++
T Consensus 142 ---------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 142 ---------------LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred ---------------EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 555555554422111 122478999999999876 678999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhh-hhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
||.+.+....+..+....|..+......+.... ..+...-....+ ..........++++.
T Consensus 207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~ 267 (338)
T cd07859 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP-------------------VPFSQKFPNADPLAL 267 (338)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCC-------------------CchHHhcCCCChHHH
Confidence 999988888888888888888877766553321 111110000000 000111234567899
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+||.+||+.||++|||++|+|+||||++.
T Consensus 268 ~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 268 RLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 99999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=384.25 Aligned_cols=279 Identities=28% Similarity=0.523 Sum_probs=218.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec------
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------ 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~------ 169 (433)
..+|++.+.||+|+||.||+|.+..+++.||||++..... ....|+.+++.+ .|+||+++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l-----~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNL-----NHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhc-----CCCCCcceeeeEeecccccC
Confidence 4679999999999999999999999999999998864322 234688999888 67889998876632
Q ss_pred --CCeEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 170 --RNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 --~~~~~lV~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...+++||||++++|.+++.. .....+++..++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~---------- 206 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN---------- 206 (440)
T ss_pred CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCC----------
Confidence 235789999998889888753 223579999999999999999999999999999999999999532
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~P 322 (433)
...+||+|||+++...... ...+||+.|+|||++.+. .|+.++|||||||++|||++|.+|
T Consensus 207 ----------------~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~p 270 (440)
T PTZ00036 207 ----------------THTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270 (440)
T ss_pred ----------------CCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 2357888888776443222 235789999999998764 699999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+..+.+..+.+.+|..+.+.+......... +.+|.. ....+...++...+.++.+|
T Consensus 271 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~------~~~~~~--------------~~~~l~~~~p~~~~~~~~~l 330 (440)
T PTZ00036 271 FSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD------IKFPDV--------------KPKDLKKVFPKGTPDDAINF 330 (440)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc------ccCCcc--------------CchhHHHHhccCCCHHHHHH
Confidence 9999888888888888888776655433221110 111110 00112222345677899999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|.+||++||.+|||+.|+|+||||..
T Consensus 331 i~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 331 ISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHCCCChhHCcCHHHHhCChhHHh
Confidence 99999999999999999999999964
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=366.75 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=206.4
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|++++.+.+.+.+.+.++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~iv~~~~~~~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-----NSRFVVSLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-----CCCcEEEEEEEEccCCeEE
Confidence 889999999999999999999999999999986432 1223456788888888 6688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||++
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~-------------------- 136 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD-------------------- 136 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC--------------------
Confidence 999999 89999888765545799999999999999999999999999999999999994
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++.++|+|||++....... ....||..|+|||++.+..++.++|||||||++|||++|+.||...+....
T Consensus 137 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 137 -------DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred -------CCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence 44567777777765433221 234789999999999999999999999999999999999999987544222
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.... ... ....+..++.++.+||.+||+.||
T Consensus 210 ~~~~~~~~-------------------~~~--------------------------~~~~~~~~s~~~~~li~~~l~~~P 244 (285)
T cd05631 210 REEVDRRV-------------------KED--------------------------QEEYSEKFSEDAKSICRMLLTKNP 244 (285)
T ss_pred HHHHHHHh-------------------hcc--------------------------cccCCccCCHHHHHHHHHHhhcCH
Confidence 21111110 000 011233567889999999999999
Q ss_pred CCCCC-----HHHHhcCCCCCCCCC
Q 013973 412 TDRLT-----AREALRHPFFTRDHL 431 (433)
Q Consensus 412 ~~R~t-----a~ell~hp~f~~~~~ 431 (433)
++||+ ++++++||||.+...
T Consensus 245 ~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 245 KERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 99997 899999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=363.56 Aligned_cols=279 Identities=29% Similarity=0.485 Sum_probs=213.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECC-CCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---- 168 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~---- 168 (433)
++|++++.||+|+||.||+|.+.. +++.||+|+++... ........|+.+++.+... .|+||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF--EHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhccc--CCCCcceEEEEEecccC
Confidence 369999999999999999999854 56889999886322 2233456678877776432 5689999998874
Q ss_pred -cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 -YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 -~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
....+++||||++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~------------ 146 (290)
T cd07862 79 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS------------ 146 (290)
T ss_pred CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC------------
Confidence 3567999999998899999987655679999999999999999999999999999999999999544
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||.+
T Consensus 147 ---------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 147 ---------------GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred ---------------CCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 45666666666533222 2334789999999999998999999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.++.+.+..+....+......+........... .. .............+..+.+||.+
T Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-------~~---------------~~~~~~~~~~~~~~~~~~~li~~ 269 (290)
T cd07862 212 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-------HS---------------KSAQPIEKFVTDIDELGKDLLLK 269 (290)
T ss_pred CCHHHHHHHHHHHhCCCChhhchhhhcccchhc-------cC---------------CCCCCHHHHccCCCHHHHHHHHH
Confidence 888888888877776554432221110000000 00 00000111223567789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f 426 (433)
||+.||++|||+.|+|+||||
T Consensus 270 ~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 270 CLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HhccCchhcCCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=342.97 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=216.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|-||.||+|+.+.++-.||+|++.+..- ...+..+|++|-..| .||||++++++|.+...
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-----~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-----RHPNILRLYGYFHDSKR 96 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-----CCccHHhhhhheeccce
Confidence 669999999999999999999999999999999975432 223445566665555 78999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||++||. .|+|+..|+.....++++..+..|+.|++.||.|+|..+||||||||+|+|+..
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~----------------- 159 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS----------------- 159 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC-----------------
Confidence 99999999 999999999777778999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccC-CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.+.+||+|||.+.... ....+.|||..|.+||++.+..++..+|+|++|++.||++.|.+||......+
T Consensus 160 ----------~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 160 ----------AGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred ----------CCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 4556777777665543 23456799999999999999999999999999999999999999999888777
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..|.+.--. +++.++.+++|||..||.++
T Consensus 230 tYkrI~k~~~~-------------------------------------------------~p~~is~~a~dlI~~ll~~~ 260 (281)
T KOG0580|consen 230 TYKRIRKVDLK-------------------------------------------------FPSTISGGAADLISRLLVKN 260 (281)
T ss_pred HHHHHHHcccc-------------------------------------------------CCcccChhHHHHHHHHhccC
Confidence 77766554322 23467889999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|.+|++..|++.|||....
T Consensus 261 p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 261 PIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ccccccHHHHhhhHHHHhc
Confidence 9999999999999998653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=374.80 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=208.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC-eEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|++.+.||+|+||.||+|.++.++ ..||+|++.... ...+.+..|+.+++.+ +|+||+++++.+.+.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-----NHPFCVNLYGSFKDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCCcceEEEEEeC
Confidence 356999999999999999999876654 689999986432 2334566788888888 679999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+|+||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---------------- 165 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---------------- 165 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----------------
Confidence 9999999999 899999998764 799999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 166 -----------~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 234 (340)
T PTZ00426 166 -----------KDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234 (340)
T ss_pred -----------CCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH
Confidence 455677777777765544445568999999999999989999999999999999999999999876654
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+.. +... .+...+.++.+||++||+.
T Consensus 235 ~~~~~i~~-----------------------~~~~--------------------------~p~~~~~~~~~li~~~l~~ 265 (340)
T PTZ00426 235 LIYQKILE-----------------------GIIY--------------------------FPKFLDNNCKHLMKKLLSH 265 (340)
T ss_pred HHHHHHhc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHccc
Confidence 44333211 1111 1234567889999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCCC
Q 013973 410 DPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~-----ta~ell~hp~f~~~ 429 (433)
||++|+ +++++++||||++.
T Consensus 266 dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 266 DLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999996 89999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=373.00 Aligned_cols=244 Identities=25% Similarity=0.431 Sum_probs=201.2
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.++.+++.||+|+++... ........|+.+++.+ .|++|+.+++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-----RHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCCEEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999997432 2234456788888877 67899999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~----------------------- 130 (323)
T cd05571 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK----------------------- 130 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC-----------------------
Confidence 99 899999998754 7999999999999999999999999999999999999954
Q ss_pred cCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
++.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......
T Consensus 131 ----~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~ 206 (323)
T cd05571 131 ----DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (323)
T ss_pred ----CCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 45577777776653221 12345799999999999999999999999999999999999999987655443332
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.. +... .+..++.++.+||.+||+.||++|
T Consensus 207 ~~~-----------------------~~~~--------------------------~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 207 ILM-----------------------EEIR--------------------------FPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred HHc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHccCCHHHc
Confidence 211 1111 123567789999999999999999
Q ss_pred C-----CHHHHhcCCCCCCC
Q 013973 415 L-----TAREALRHPFFTRD 429 (433)
Q Consensus 415 ~-----ta~ell~hp~f~~~ 429 (433)
| ++.++++||||+..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=374.66 Aligned_cols=279 Identities=22% Similarity=0.311 Sum_probs=210.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||+||+|.++.+++.||+|+++... .....+..|+.++..+ +|++|+++++.+.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-----~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-----DSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCe
Confidence 36999999999999999999999999999999997432 2234456688888777 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+++++|+|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999 999999998754 799999999999999999999999999999999999999989999999988764432
Q ss_pred CCcc-cccCCCCCCEEEEecCCccccC------------CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh
Q 013973 252 DSSY-FKRMPKSSAIKVIDFGSTTYER------------PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 252 ~~~~-~~~~~~~~~~kl~Dfg~a~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 318 (433)
.... +.+ ........|+....... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 154 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 154 AHRTEFYR--NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccc--cccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 1100 000 00000011111110000 00123579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||.+.+..+....+..... .+..|+ ...++.+
T Consensus 232 G~~Pf~~~~~~~~~~~i~~~~~---------------------~~~~p~------------------------~~~~s~~ 266 (363)
T cd05628 232 GYPPFCSETPQETYKKVMNWKE---------------------TLIFPP------------------------EVPISEK 266 (363)
T ss_pred CCCCCCCCCHHHHHHHHHcCcC---------------------cccCCC------------------------cCCCCHH
Confidence 9999988766555444322110 011111 1135678
Q ss_pred HHHHHHhccccCCC---CCCCHHHHhcCCCCCCCC
Q 013973 399 LTHLLQGLLRYDPT---DRLTAREALRHPFFTRDH 430 (433)
Q Consensus 399 ~~~li~~~L~~dP~---~R~ta~ell~hp~f~~~~ 430 (433)
+++||.+|+. +|. .||+++|+++||||+...
T Consensus 267 ~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 267 AKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred HHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 9999998775 444 468999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=374.77 Aligned_cols=282 Identities=27% Similarity=0.466 Sum_probs=223.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--- 171 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--- 171 (433)
+|++++.||+|+||.||+|.+..+++.||||.+... ......+..|+.+++.+ .|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-----KHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-----CCCCcCCHhheecCCCccc
Confidence 378999999999999999999999999999988632 12334567788888887 6788999999998776
Q ss_pred --eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 172 --HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 172 --~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.+|+||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~------------- 140 (372)
T cd07853 76 FEEIYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC------------- 140 (372)
T ss_pred cceEEEEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-------------
Confidence 899999999889999887654 799999999999999999999999999999999999995544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.+||+|||++....... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 141 --------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 141 --------------VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred --------------CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 55666666554332211 223678999999999875 47899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+.+..+...+|..+.+.+.........++.......+. ...........+.++.+||.
T Consensus 207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~ 269 (372)
T cd07853 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS-----------------LPVLYTLSSQATHEAVHLLC 269 (372)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc-----------------hHHhcccCCCCCHHHHHHHH
Confidence 9999999999999999888766655544444444322111110 00111122355778999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||+.||++|||+.|+|+||||....
T Consensus 270 ~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 270 RMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 99999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.29 Aligned_cols=278 Identities=21% Similarity=0.352 Sum_probs=213.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
..+|++++.||+|+||.||+|.+..+++.||+|... ......|+.+++.+ .|+||+++++++......|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-----NHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-----CCCCCCCEeEEEEECCeeEE
Confidence 357999999999999999999999999999999754 23457799999998 67999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 176 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 176 V~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+++++|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 161 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~--------------------- 217 (391)
T PHA03212 161 ILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH--------------------- 217 (391)
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC---------------------
Confidence 99999889999987654 6899999999999999999999999999999999999944
Q ss_pred cccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC-----
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH----- 326 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~----- 326 (433)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||-..
T Consensus 218 ------~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~ 291 (391)
T PHA03212 218 ------PGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG 291 (391)
T ss_pred ------CCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence 455777777776532211 12347999999999999999999999999999999999999877432
Q ss_pred --ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhh-c--cCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 327 --ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV-R--RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 327 --~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
.....+..+....|..|.+............. . ......+.....+. .....+.++.+
T Consensus 292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~l~~ 354 (391)
T PHA03212 292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWT-----------------NLYELPIDLEY 354 (391)
T ss_pred cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHH-----------------HHhhhhhhHHH
Confidence 23456677777777766543211111111000 0 00000000000000 01134568899
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||.+||++||++||||.|+|+||||+..
T Consensus 355 Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 355 LICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 9999999999999999999999999874
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.72 Aligned_cols=291 Identities=27% Similarity=0.469 Sum_probs=224.6
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... .........|+.+++.+ +|+||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 92 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-----NHKNIISLLNVFTPQ 92 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-----CCCCEeeeeeeeccC
Confidence 3467899999999999999999999999999999998632 23345566788888887 678999999988644
Q ss_pred ------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 171 ------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 171 ------~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
..+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~---------- 158 (359)
T cd07876 93 KSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------- 158 (359)
T ss_pred CCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC----------
Confidence 35799999998888887753 5889999999999999999999999999999999999954
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 221 (359)
T cd07876 159 -----------------DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVI 221 (359)
T ss_pred -----------------CCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 445666666666533221 1234789999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+..+.+..+...++..+..+..........+..... .++.... .+.+.... . ..........+.++++|
T Consensus 222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~-~----~~~~~~~~~~~~~~~~l 294 (359)
T cd07876 222 FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRP-QYPGISF-EELFPDWI-F----PSESERDKLKTSQARDL 294 (359)
T ss_pred CCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCC-CCCCcch-hhhccccc-c----ccccccccccchhHHHH
Confidence 9998888888888888898888877776655555543211 1111000 00000000 0 00001122346789999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
|.+||+.||++|||+.|+|+||||+
T Consensus 295 i~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 295 LSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHhccCcccCCCHHHHhcCchhh
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=368.96 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=212.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|++..+++.||+|+++... .....+..|+.++..+ .|++|+++++.+...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-----KSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-----CCCCCccEEEEEEcCCE
Confidence 36999999999999999999999999999999997432 2234456788888777 57899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||+ |++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~------------------ 135 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID------------------ 135 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC------------------
Confidence 99999999 999999997654 799999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.
T Consensus 136 ---------~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 206 (333)
T cd05600 136 ---------ASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206 (333)
T ss_pred ---------CCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence 45568888888777555444556899999999999999999999999999999999999999988766555
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+...... +..|.... ....++.++.+||.+||+.+|
T Consensus 207 ~~~i~~~~~~---------------------~~~~~~~~--------------------~~~~~s~~~~~li~~~l~~~~ 245 (333)
T cd05600 207 WENLKYWKET---------------------LQRPVYDD--------------------PRFNLSDEAWDLITKLINDPS 245 (333)
T ss_pred HHHHHhcccc---------------------ccCCCCCc--------------------cccccCHHHHHHHHHHhhChh
Confidence 4433221100 00010000 002457789999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
.+|+++.|+++||||++.
T Consensus 246 ~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 246 RRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred hhcCCHHHHHhCcccCCC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=359.72 Aligned_cols=250 Identities=28% Similarity=0.488 Sum_probs=218.2
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.+..+|++.+.||+|.||+|-+|+....|+.||||.+++.+. ..-.+.+|++||..| +||||+++++.|+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-----NHPhII~IyEVFEN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-----NHPHIIQIYEVFEN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-----CCCceeehhhhhcC
Confidence 445689999999999999999999999999999999975432 223356799999998 88999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+.+.|||||. +|.|+||+...+ .|++.+++.++.||.+|+.|||++++||||||.+|||+
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---------------- 186 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---------------- 186 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheee----------------
Confidence 99999999999 999999998876 89999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCC-CcchhHHHHHHHHHHHhCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
|.++++||+|||++..+.... .++||++-|.+||++.+.+|. +.+|.|||||+||.|+.|..||++
T Consensus 187 -----------D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 187 -----------DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred -----------cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 677789999999887665544 568999999999999999985 899999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+....+.+| ..|.+.-| .-+.++..||++
T Consensus 256 ~Dhk~lvrQI-----------------------s~GaYrEP---------------------------~~PSdA~gLIRw 285 (668)
T KOG0611|consen 256 RDHKRLVRQI-----------------------SRGAYREP---------------------------ETPSDASGLIRW 285 (668)
T ss_pred chHHHHHHHh-----------------------hcccccCC---------------------------CCCchHHHHHHH
Confidence 8776655543 33333222 234478889999
Q ss_pred ccccCCCCCCCHHHHhcCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~ 427 (433)
||-+||++|.|+.++-.|=|+.
T Consensus 286 mLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHhcCcccchhHHHHhhhheee
Confidence 9999999999999999998875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=373.58 Aligned_cols=280 Identities=24% Similarity=0.383 Sum_probs=212.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|++..+++.||||+++... .....+..|+.++..+ +|++|+++++.+.+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-----DNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCe
Confidence 36999999999999999999999999999999997432 2233456788888887 67999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999 899999998754 699999999999999999999999999999999999999999999999998765432
Q ss_pred CCcc--cccCCCCCCEEEEecCCccccCC------------CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHH
Q 013973 252 DSSY--FKRMPKSSAIKVIDFGSTTYERP------------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 252 ~~~~--~~~~~~~~~~kl~Dfg~a~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 317 (433)
.... ..........-..++........ .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1110 00000000000011111100000 011247999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
+|..||.+.+..+....+..... .+..|. ...+++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~---------------------~~~~~~------------------------~~~~s~ 268 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKE---------------------TLQFPD------------------------EVPLSP 268 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC---------------------ccCCCC------------------------CCCCCH
Confidence 99999987766554433221100 000110 114567
Q ss_pred HHHHHHHhccccCCCCCCC---HHHHhcCCCCCCC
Q 013973 398 DLTHLLQGLLRYDPTDRLT---AREALRHPFFTRD 429 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~t---a~ell~hp~f~~~ 429 (433)
++.+||.+||. +|.+|++ +.|+++||||+..
T Consensus 269 ~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 269 EAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred HHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 89999999997 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=353.72 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=212.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
-++|..+++||+|.||+|-+|+.+.+++.||||++++. +....-...|-.+|+.. .||.+..+...|+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-----~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-----RHPFLTSLKYSFQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-----cCcHHHHhhhhhccCc
Confidence 36799999999999999999999999999999999753 23334455688888877 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++|+||||. ||.|+-+|... +.|+++.+++|-.+|+.||.|||+++||+||||.+|+|++.
T Consensus 242 rlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDk---------------- 303 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDK---------------- 303 (516)
T ss_pred eEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheecc----------------
Confidence 999999999 99999888765 48999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCcccc---CCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
++++||+|||++... +....++||||.|+|||++....|+.++|||.+||+||||++|++||...+
T Consensus 304 -----------DGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 304 -----------DGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred -----------CCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 455566666665422 223356899999999999999999999999999999999999999998877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
....+..|.-. ...++..++++++.|+..+|
T Consensus 373 h~kLFeLIl~e-------------------------------------------------d~kFPr~ls~eAktLLsGLL 403 (516)
T KOG0690|consen 373 HEKLFELILME-------------------------------------------------DLKFPRTLSPEAKTLLSGLL 403 (516)
T ss_pred hhHHHHHHHhh-------------------------------------------------hccCCccCCHHHHHHHHHHh
Confidence 66655544321 12245588999999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCCCCC
Q 013973 408 RYDPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~t-----a~ell~hp~f~~~ 429 (433)
.+||.+|+. |.|+.+|+||..-
T Consensus 404 ~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 404 KKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred hcChHhhcCCCchhHHHHHhhhhhccC
Confidence 999999994 8999999999864
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=373.45 Aligned_cols=280 Identities=24% Similarity=0.368 Sum_probs=209.6
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.|++++.||+|+||+||+|++..+++.||||+++... .....+..|+.+++.+ .|++|+++++.+.+.+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-----DNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-----CCCCeeeeEEEEecCCEE
Confidence 5899999999999999999999999999999997432 2234566788888887 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ ||+|.+++.... .+++..++.++.||+.||+|||+.|||||||||+|||++.+++++|+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999 999999998754 7999999999999999999999999999999999999999999999999987533211
Q ss_pred Cc--cccc------CCCC-----CCEEEEecCCc-------ccc---CCCCCceeecCcccchhhhhCCCCCCcchhHHH
Q 013973 253 SS--YFKR------MPKS-----SAIKVIDFGST-------TYE---RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV 309 (433)
Q Consensus 253 ~~--~~~~------~~~~-----~~~kl~Dfg~a-------~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 309 (433)
.. .... .... .....+.++.. ... .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 0000 0000 00000111100 000 001123579999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 310 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 310 Gv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
||++|||++|..||...+..+....+..... .+..|.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------~~~~~~---------------------- 271 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------------TLHIPP---------------------- 271 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------------ccCCCC----------------------
Confidence 9999999999999987665443332221100 011111
Q ss_pred hhcCCchhHHHHHHHhccc--cCCCCCCCHHHHhcCCCCCCC
Q 013973 390 QHVDHSAGDLTHLLQGLLR--YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~--~dP~~R~ta~ell~hp~f~~~ 429 (433)
...+++++.+||.+||. .+|..|+++.|+++||||++.
T Consensus 272 --~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 272 --QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred --CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 12467789999999664 455569999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=365.24 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=203.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+|++++.||+|+||.||+|.+..+++.||+|+++... ...+....|..++..+. ++++++.+++.+...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~i~~~~~~~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG----KPPFLTQLHSCFQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC----CCCceeeeEEEEEcCCEE
Confidence 4899999999999999999999999999999997432 22344556777766652 445688999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~------------------ 136 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA------------------ 136 (324)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC------------------
Confidence 9999999 899999997754 6899999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 137 ---------~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (324)
T cd05587 137 ---------EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207 (324)
T ss_pred ---------CCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 4456777777654321 1123357999999999999999999999999999999999999999877665
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+... ... .+...+.++.+||.+||++
T Consensus 208 ~~~~~i~~~-----------------------~~~--------------------------~~~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 208 ELFQSIMEH-----------------------NVS--------------------------YPKSLSKEAVSICKGLLTK 238 (324)
T ss_pred HHHHHHHcC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHhhc
Confidence 544333211 111 1234567899999999999
Q ss_pred CCCCCCCH-----HHHhcCCCCCCC
Q 013973 410 DPTDRLTA-----REALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta-----~ell~hp~f~~~ 429 (433)
||.+|+++ .++++||||+..
T Consensus 239 ~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 239 HPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=357.09 Aligned_cols=278 Identities=30% Similarity=0.537 Sum_probs=212.7
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 169 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----- 169 (433)
+|++++.||+|+||.||+|.++.+++.||+|.++... ........|+.+++.+.+. +|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF--DHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhc--CCCCeeeeeeeeccccCCC
Confidence 4899999999999999999999999999999986422 1223456688888777542 56899999988754
Q ss_pred CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 170 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 170 ~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
...+++||||+.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-------------- 144 (288)
T cd07863 79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-------------- 144 (288)
T ss_pred CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC--------------
Confidence 356899999998899999987655569999999999999999999999999999999999999544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+.+||+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|.+||.+..
T Consensus 145 -------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 145 -------------GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred -------------CCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 456666666655433221 23468999999999999899999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+....+......+.... ..+..... +............++.++.+||.+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L 269 (288)
T cd07863 212 EADQLGKIFDLIGLPPEDDWPRDV------------TLPRGAFS----------PRGPRPVQSVVPEIEESGAQLLLEML 269 (288)
T ss_pred HHHHHHHHHHHhCCCChhhCcccc------------cccccccC----------CCCCCchHHhCcCcCHHHHHHHHHHh
Confidence 777777777766654432221100 00000000 00000111223456778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013973 408 RYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f 426 (433)
++||++|||+.|++.||||
T Consensus 270 ~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 270 TFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=359.66 Aligned_cols=282 Identities=26% Similarity=0.460 Sum_probs=222.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|.+.+.||+|+||.||+|+++.+++.||+|.++... ........|+.+++.+ .|+||+++++++..++..|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-----CCCCcceEEEEEeeCCeEE
Confidence 56999999999999999999999999999999986332 2233456788888888 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||+.++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~------------------- 140 (309)
T cd07872 81 LVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER------------------- 140 (309)
T ss_pred EEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-------------------
Confidence 999999889999987654 358999999999999999999999999999999999999544
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.+||+|||.+....... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+
T Consensus 141 --------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 141 --------GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred --------CCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 456666666654322111 22367899999999875 458899999999999999999999999988888
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+...++..+...+..+........ ...+... ..........++.++.+||.+||+.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~L~~d 273 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFKN----YNFPKYK---------------PQPLINHAPRLDTEGIELLTKFLQYE 273 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhhh----hhcCccC---------------CCchhhhccCCCHHHHHHHHHhccCC
Confidence 8888999888888777665433221110 0000000 00001122356788999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~ 430 (433)
|.+|||+.|+|+||||+..+
T Consensus 274 p~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 274 SKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhCCCHHHHhcChhhhhcc
Confidence 99999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=367.34 Aligned_cols=290 Identities=27% Similarity=0.442 Sum_probs=223.8
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~- 170 (433)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... .........|+.+++.+ .|+||+++++.+...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-----CCCchhceeeeeeccc
Confidence 467899999999999999999999999999999998642 23345566788888888 678999999887543
Q ss_pred -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 171 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 171 -----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
..+|+||||+.++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~----------- 154 (355)
T cd07874 90 SLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS----------- 154 (355)
T ss_pred cccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC-----------
Confidence 45799999998888888754 5889999999999999999999999999999999999954
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
++.+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 155 ----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 155 ----------------DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred ----------------CCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 4557777777765443321 2347899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+..+.+..+...++....+...........++..... +...... ..... .............+.++++||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~~li 291 (355)
T cd07874 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK-YAGLTFP-KLFPD-----SLFPADSEHNKLKASQARDLL 291 (355)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCc-cccccch-hhccc-----cccccccccccccchHHHHHH
Confidence 9988888888888888887777777666555555433210 0000000 00000 000000111223456789999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
.+||+.||++|||+.|+|+||||.
T Consensus 292 ~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 292 SKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHhcCCchhcCCHHHHhcCcchh
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=364.32 Aligned_cols=242 Identities=31% Similarity=0.508 Sum_probs=200.0
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
||+|+||.||+|.+..+++.||+|+++.. ......+..|+.+++++ +|++|+++++.+...+.+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-----NCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCcEeceeeEEecCCeEEEEEcCC
Confidence 79999999999999999999999998742 22334456788888877 6789999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~-------------------------- 127 (312)
T cd05585 76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD-------------------------- 127 (312)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC--------------------------
Confidence 999999998754 799999999999999999999999999999999999994
Q ss_pred CCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 336 (433)
.++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.
T Consensus 128 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 128 -YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred -CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 4456777777776543211 233579999999999999999999999999999999999999998766544333221
Q ss_pred HHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC-
Q 013973 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 415 (433)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~- 415 (433)
. +... .+..++.++.+||.+||+.||.+||
T Consensus 207 ~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 207 Q-----------------------EPLR--------------------------FPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred c-----------------------CCCC--------------------------CCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 1 1111 1235677899999999999999997
Q ss_pred --CHHHHhcCCCCCCC
Q 013973 416 --TAREALRHPFFTRD 429 (433)
Q Consensus 416 --ta~ell~hp~f~~~ 429 (433)
++.|++.||||++.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=371.51 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=211.3
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.|..++.||+|+||.||+|.+..+++.||+|++.- .+...+....|+.+|.++ .+++|.+.|+.|..+..+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-----~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-----DSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-----CcchHHhhhhheeecccHHH
Confidence 47888999999999999999999999999999973 334456677899999988 55889999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+|||| ||++.+.|+..+ .+.+..+..++.+++.||.|||.++.+|||||+.|||+..
T Consensus 89 iMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~-------------------- 146 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE-------------------- 146 (467)
T ss_pred HHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEec--------------------
Confidence 99999 999999998764 5689999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.+.+||+|||.+...... ..+++||+.|||||++.+..|+.++||||||++.+||++|.+||.....+..
T Consensus 147 -------~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv 219 (467)
T KOG0201|consen 147 -------SGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV 219 (467)
T ss_pred -------cCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE
Confidence 456777777776554432 2567999999999999999999999999999999999999999987665433
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..|-+ +........+++.+++||..||++||
T Consensus 220 lflIpk------------------------------------------------~~PP~L~~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 220 LFLIPK------------------------------------------------SAPPRLDGDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred EEeccC------------------------------------------------CCCCccccccCHHHHHHHHHHhhcCc
Confidence 222111 00111223678899999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~~ 430 (433)
+.||+|.++|+|+|++...
T Consensus 252 ~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 252 EFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred ccCcCHHHHhhhHHHHhcC
Confidence 9999999999999998743
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=363.81 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=201.5
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+|++++.||+|+||.||+|++..+++.||+|++++... .......|..++..+ .+|++++.+++++...+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS----GKPPFLTQLHSCFQTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCeEeeEEEEEecCCEE
Confidence 48899999999999999999999999999999974321 122334455555544 3567899999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~----------------- 137 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE----------------- 137 (323)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-----------------
Confidence 9999999 899999987654 69999999999999999999999999999999999999544
Q ss_pred CcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
+.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 138 ----------~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 138 ----------GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred ----------CcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 4566666666543221 122357999999999999999999999999999999999999999887665
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+... ... .+...+.++.+|+.+||++
T Consensus 208 ~~~~~i~~~-----------------------~~~--------------------------~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 208 ELFQSIMEH-----------------------NVA--------------------------YPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred HHHHHHHhC-----------------------CCC--------------------------CCCcCCHHHHHHHHHHccc
Confidence 554433221 111 1234567899999999999
Q ss_pred CCCCCCC-----HHHHhcCCCCCCC
Q 013973 410 DPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~t-----a~ell~hp~f~~~ 429 (433)
||++|++ ..++++||||+..
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred CHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999997 4899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=373.25 Aligned_cols=278 Identities=24% Similarity=0.383 Sum_probs=210.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|.+++.||+|+||.||+|.++.+++.||||++.... .....+..|+.+++.+ +|++|+++++++.+..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-----DSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCe
Confidence 35999999999999999999999999999999986432 2234456788888776 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ |++|.+++.... .+++..++.++.|++.||+|||+.|||||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999 999999997654 799999999999999999999999999999999999999999999999998853211
Q ss_pred C--CcccccC----------CCCC-------------CEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchh
Q 013973 252 D--SSYFKRM----------PKSS-------------AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 252 ~--~~~~~~~----------~~~~-------------~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
. ...+... +... ..++.+++..... .....+||+.|+|||++.+..++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--cccccCCCccccCHHHHccCCCCCceee
Confidence 0 0000000 0000 0011111111100 0112479999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHH
Q 013973 307 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386 (433)
Q Consensus 307 wSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
|||||++|||++|.+||.+.+..+.+..+.... ..+.+|.
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------------~~~~~p~------------------- 271 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWR---------------------ETLYFPD------------------- 271 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------------CccCCCC-------------------
Confidence 999999999999999998766655444332110 0011111
Q ss_pred HHhhhcCCchhHHHHHHHhccccCCCCC---CCHHHHhcCCCCCCC
Q 013973 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDR---LTAREALRHPFFTRD 429 (433)
Q Consensus 387 ~~~~~~~~~~~~~~~li~~~L~~dP~~R---~ta~ell~hp~f~~~ 429 (433)
...++.++.+||.+||+ +|.+| +++.|+++||||+..
T Consensus 272 -----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 272 -----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred -----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 12456789999999998 77776 599999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=373.31 Aligned_cols=278 Identities=27% Similarity=0.423 Sum_probs=210.6
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+|++++.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +|++|+++++.+.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-----~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-----CCCcCCeEEEEEEeCCEE
Confidence 5899999999999999999999999999999987432 2234566788888887 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|.++|+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999 899999997754 7899999999999999999999999999999999999999999999999987533211
Q ss_pred Cc--ccccCCCCCCEEEEecCC---------------------ccc-cCCCCCceeecCcccchhhhhCCCCCCcchhHH
Q 013973 253 SS--YFKRMPKSSAIKVIDFGS---------------------TTY-ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWS 308 (433)
Q Consensus 253 ~~--~~~~~~~~~~~kl~Dfg~---------------------a~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 308 (433)
.. .... .........+|.. ... ........+||+.|+|||++.+..|+.++||||
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 155 HDSKYYQS-GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccc-ccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 0000 0000000000000 000 000112357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHH
Q 013973 309 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388 (433)
Q Consensus 309 lGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
|||++|||++|.+||.+.+..+....+..... .+..|.
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------~~~~p~--------------------- 271 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------------SLHIPP--------------------- 271 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------------CcCCCC---------------------
Confidence 99999999999999987766544333221100 000110
Q ss_pred hhhcCCchhHHHHHHHhccccCCCCCCC---HHHHhcCCCCCCC
Q 013973 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRD 429 (433)
Q Consensus 389 ~~~~~~~~~~~~~li~~~L~~dP~~R~t---a~ell~hp~f~~~ 429 (433)
...+++++.+||.+|+ .||.+|++ +.|+++||||+..
T Consensus 272 ---~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 272 ---QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred ---cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 1245778999999976 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=366.40 Aligned_cols=281 Identities=27% Similarity=0.507 Sum_probs=221.2
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~- 170 (433)
+.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-----KHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-----CCCchhhhhhhhcccc
Confidence 4578999999999999999999999999999999986422 2234456789999888 678899999887543
Q ss_pred -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 171 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 171 -----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...|++|++++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~----------- 153 (343)
T cd07878 88 SIENFNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE----------- 153 (343)
T ss_pred cccccCcEEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC-----------
Confidence 457999999999999887643 6999999999999999999999999999999999999954
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
++.+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 154 ----------------~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 154 ----------------DCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred ----------------CCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 455677777776655444445679999999999987 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhh-hhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
+.+..+.+..+....+..+.+....+..... .++.. ....+. . .........++.+.+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------------~----~~~~~~~~~~~~~~~li 278 (343)
T cd07878 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS-LPHMPQ--------------Q----DLKKIFRGANPLAIDLL 278 (343)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhc-cccccc--------------h----hHHHhccCCCHHHHHHH
Confidence 8888888888888888877766655432221 11110 000000 0 00111234566789999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+||+.||.+|||+.|+|+||||...
T Consensus 279 ~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 279 EKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHcCCChhhCCCHHHHhcCcchhcc
Confidence 99999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=366.15 Aligned_cols=244 Identities=26% Similarity=0.451 Sum_probs=199.9
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+++.||+|++.... ........|+.+++.+ .|++|+.+.+.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-----RHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999997432 2234556788888777 67899999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 y~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~----------------------- 130 (328)
T cd05593 76 YVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK----------------------- 130 (328)
T ss_pred CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC-----------------------
Confidence 99 899999987654 7999999999999999999999999999999999999954
Q ss_pred cCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus 131 ----~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 131 ----DGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred ----CCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 455677777766532211 1235799999999999999999999999999999999999999987665443332
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.. +.. ..+..++.++.+||.+||++||++|
T Consensus 207 ~~~-----------------------~~~--------------------------~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 207 ILM-----------------------EDI--------------------------KFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred hcc-----------------------CCc--------------------------cCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 110 111 1123567789999999999999999
Q ss_pred C-----CHHHHhcCCCCCCC
Q 013973 415 L-----TAREALRHPFFTRD 429 (433)
Q Consensus 415 ~-----ta~ell~hp~f~~~ 429 (433)
+ ++.|+++||||...
T Consensus 238 ~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 7 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=367.67 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=196.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|+++++||+|+||.||+|.+..+++.||||++... ......+..|+++++.+ .|+||+++++++...+.+|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-----NHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-----CCCCcceeeeEeccCCeEE
Confidence 4688999999999999999999999999999998643 23445677899999888 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+. ..+++..+..++.||+.||+|||++|||||||||+|||++.+
T Consensus 149 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~------------------ 204 (353)
T PLN00034 149 VLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA------------------ 204 (353)
T ss_pred EEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC------------------
Confidence 999999 8887542 246778888999999999999999999999999999999544
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
+.+||+|||++...... ....+||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 205 ---------~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 205 ---------KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ---------CCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 45666666665543221 123479999999998853 2345789999999999999999999974
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
....+....+....... ....+..++.++++||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~~ 310 (353)
T PLN00034 276 GRQGDWASLMCAICMSQ---------------------------------------------PPEAPATASREFRHFISC 310 (353)
T ss_pred CCCccHHHHHHHHhccC---------------------------------------------CCCCCCccCHHHHHHHHH
Confidence 33222211111110000 001123557789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
||+.||++|||+.|+|+||||.....
T Consensus 311 ~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 311 CLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred HccCChhhCcCHHHHhcCcccccCCc
Confidence 99999999999999999999987743
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=342.77 Aligned_cols=264 Identities=27% Similarity=0.491 Sum_probs=218.6
Q ss_pred eecCcEEEE-eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 94 NLTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 94 ~~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
.++++|.+. .+||-|-.|.|..|+++.|++.+|+|++.... .+.+|+++--.. ..|+|||.+++.|+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~----s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMA----SGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhh----cCCCceEEeehhhhhhcc
Confidence 456778776 57999999999999999999999999986433 345566554333 367899999998764
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
...+.+|||+| ||.|+..++..+...|++.++..|+.||..|+.|||+.+|.||||||+|+|.+..
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t------------ 197 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTT------------ 197 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecC------------
Confidence 56789999999 9999999999998899999999999999999999999999999999999999643
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCC--CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
..+..+||+|||+|+.... .-.+.|-|+.|.|||++-.++|+..+|+||+||++|-|++|.+||..
T Consensus 198 ------------~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 198 ------------SPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred ------------CCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 3566799999999986542 22456889999999999999999999999999999999999999976
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.... ..++. ++..|..|.+.+|+.. |+..|.+++|+|++
T Consensus 266 ~hg~-----------aispg--------Mk~rI~~gqy~FP~pE----------------------Ws~VSe~aKdlIR~ 304 (400)
T KOG0604|consen 266 NHGL-----------AISPG--------MKRRIRTGQYEFPEPE----------------------WSCVSEAAKDLIRK 304 (400)
T ss_pred cCCc-----------cCChh--------HHhHhhccCccCCChh----------------------HhHHHHHHHHHHHH
Confidence 4331 12222 2334667777777633 45678899999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+|..+|++|+|++|++.|||+.+..
T Consensus 305 LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 305 LLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred HhcCCchhheeHHHhhcCchhcccc
Confidence 9999999999999999999998653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=365.71 Aligned_cols=291 Identities=27% Similarity=0.433 Sum_probs=224.4
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~- 170 (433)
+.++|++.+.||+|+||.||+|++..+++.||||++... .........|+.+++.+ +|+||+.+++.+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-----CCCCccccceeecccc
Confidence 457899999999999999999999999999999998642 23344566788888877 678899998877543
Q ss_pred -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 171 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 171 -----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
..+|+||||++++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~------------ 160 (364)
T cd07875 97 SLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK------------ 160 (364)
T ss_pred cccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC------------
Confidence 46899999998899888854 488999999999999999999999999999999999994
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
.++.+||+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 161 ---------------~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 161 ---------------SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred ---------------CCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 44567777777776443321 2347899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+..+.+..+...++..+++...........+....... .. ...+.+...... ..........+.++++||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY-AG--YSFEKLFPDVLF----PADSEHNKLKASQARDLL 298 (364)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCc-CC--CChHhhCccccc----cccccccccccHHHHHHH
Confidence 99998888888888888888777776665554444321100 00 000000000000 000111123456789999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.+||+.||.+|||+.|+|+||||..
T Consensus 299 ~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 299 SKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhcCcCcccCCCHHHHhcCccccc
Confidence 9999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=369.42 Aligned_cols=280 Identities=26% Similarity=0.404 Sum_probs=211.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.+..+++.||||+++... .....+..|+.++..+ +|++|+++++.+.+.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-----DSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-----CCCCccchhhheecCCe
Confidence 36999999999999999999999999999999997432 2334566788888877 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999 899999998763 799999999999999999999999999999999999998888888888877654433
Q ss_pred CCcccccCCCCCC-EEEEec----CCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 252 DSSYFKRMPKSSA-IKVIDF----GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~-~kl~Df----g~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
............. ...... ..............||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 2211000000000 000000 00000000112347999999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+..... .+..|. ...+++++.+||.+|
T Consensus 234 ~~~~~~~~i~~~~~---------------------~~~~p~------------------------~~~~~~~~~~li~~l 268 (350)
T cd05573 234 TLQETYNKIINWKE---------------------SLRFPP------------------------DPPVSPEAIDLICRL 268 (350)
T ss_pred CHHHHHHHHhccCC---------------------cccCCC------------------------CCCCCHHHHHHHHHH
Confidence 65544433322100 001111 112577899999999
Q ss_pred cccCCCCCCC-HHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLT-AREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~t-a~ell~hp~f~~~ 429 (433)
|+ ||.+|++ +.|+++||||+..
T Consensus 269 l~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 269 LC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred cc-ChhhcCCCHHHHhcCCCcCCC
Confidence 98 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=363.10 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=198.8
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++|+++++.+...+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~iv~~~~~~~~~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA----RNHPFLTQLYCCFQTPDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc----cCCCchhceeeEEEcCCEEEEEEc
Confidence 46999999999999999999999999987432 2233445566666554 257889999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 77 y~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~----------------------- 131 (320)
T cd05590 77 FVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH----------------------- 131 (320)
T ss_pred CCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC-----------------------
Confidence 99 899999987754 7999999999999999999999999999999999999954
Q ss_pred cCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
++.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..
T Consensus 132 ----~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (320)
T cd05590 132 ----EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 207 (320)
T ss_pred ----CCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 44566666666543211 12335799999999999999999999999999999999999999988776554443
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.. +... .+...+.++.+||.+||+.||++|
T Consensus 208 i~~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 208 ILN-----------------------DEVV--------------------------YPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred Hhc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHcccCHHHC
Confidence 321 1111 122456789999999999999999
Q ss_pred CCH------HHHhcCCCCCCC
Q 013973 415 LTA------REALRHPFFTRD 429 (433)
Q Consensus 415 ~ta------~ell~hp~f~~~ 429 (433)
+++ .++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 239 LGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCHHHHHcCCCcCCC
Confidence 998 999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.98 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=199.0
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+|+.||+|+++... ........|+.+++.+ .|++|+++++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCEEEEEEe
Confidence 47999999999999999999999999997432 2233455688888877 67899999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--------------------- 132 (323)
T cd05595 76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--------------------- 132 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC---------------------
Confidence 99 899999987654 799999999999999999999999999999999999995544
Q ss_pred cCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....
T Consensus 133 ------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~ 206 (323)
T cd05595 133 ------HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206 (323)
T ss_pred ------CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5566666655432111 1234799999999999999999999999999999999999999987665544333
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.. .... .+..+++++.+||.+||+.||++|
T Consensus 207 ~~~-----------------------~~~~--------------------------~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 207 ILM-----------------------EEIR--------------------------FPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred Hhc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHccCCHHHh
Confidence 211 0001 123567789999999999999999
Q ss_pred C-----CHHHHhcCCCCCCC
Q 013973 415 L-----TAREALRHPFFTRD 429 (433)
Q Consensus 415 ~-----ta~ell~hp~f~~~ 429 (433)
+ ++.++++||||...
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=372.13 Aligned_cols=279 Identities=25% Similarity=0.378 Sum_probs=209.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|++..+++.||+|++.... .....+..|+.++..+ .|++|+++++.+.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-----DNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCE
Confidence 36999999999999999999999999999999986432 2234466788888888 67889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +++|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999 999999998754 789999999999999999999999999999999999999989999999988643211
Q ss_pred C--CcccccCCCCCCEEEEecCC---------------cc---ccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHH
Q 013973 252 D--SSYFKRMPKSSAIKVIDFGS---------------TT---YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311 (433)
Q Consensus 252 ~--~~~~~~~~~~~~~kl~Dfg~---------------a~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 311 (433)
. ...+.. .........+... .. .........+||+.|||||++.+..++.++|||||||
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 154 THDSKYYQK-GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccc-ccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 0 000000 0000000000000 00 0000112357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|||++|..||.+.+..+....+..... .+.. ..
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------------~~~~------------------------~~ 267 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVINWET---------------------TLHI------------------------PS 267 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHhccCc---------------------cccC------------------------CC
Confidence 99999999999987765544332211000 0000 01
Q ss_pred cCCchhHHHHHHHhccccCCCCCC---CHHHHhcCCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRD 429 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~---ta~ell~hp~f~~~ 429 (433)
...++.++.+||.+|+ .+|.+|+ ++.|+++||||+..
T Consensus 268 ~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 268 QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 1246778999999976 5999999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=361.27 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=201.8
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
|++++.||+|+||.||+|.+..+++.||||+++... ...+....|+.++..+.. ..|+||+++++++...+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~--l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS--ERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccc--cCCCChhceeeEEEcCCEEE
Confidence 678999999999999999999999999999997432 223345566666654432 26799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 79 lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~----------------- 138 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG----------------- 138 (324)
T ss_pred EEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-----------------
Confidence 999999 88998888653 699999999999999999999999999999999999995544
Q ss_pred cccccCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+
T Consensus 139 ----------~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~ 208 (324)
T cd05589 139 ----------FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208 (324)
T ss_pred ----------cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence 56666666554321 11234579999999999999999999999999999999999999998776655
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+... ... .+..++.++.+||.+||+.|
T Consensus 209 ~~~~i~~~-----------------------~~~--------------------------~p~~~~~~~~~li~~~L~~d 239 (324)
T cd05589 209 VFDSIVND-----------------------EVR--------------------------YPRFLSREAISIMRRLLRRN 239 (324)
T ss_pred HHHHHHhC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHhhcC
Confidence 44332211 001 12346778999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q 013973 411 PTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~-----ta~ell~hp~f~~~ 429 (433)
|.+|| ++.++++||||++.
T Consensus 240 P~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 240 PERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999 69999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=360.45 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=195.6
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.++.+++.||+|+++... ........|..++... .+|++++++++.+.+.+++|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA----WENPFLTHLYCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCCccCeeEEEEeCCEEEEEEC
Confidence 47999999999999999999999999997432 2233345566665443 256889999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~--------------------- 133 (316)
T cd05620 77 FLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--------------------- 133 (316)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---------------------
Confidence 99 899999987754 799999999999999999999999999999999999995544
Q ss_pred cCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
.++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....
T Consensus 134 ------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~ 207 (316)
T cd05620 134 ------HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207 (316)
T ss_pred ------CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45555565554211 112335799999999999999999999999999999999999999987665544333
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.... . ..+...+.++.+||.+||+.||++|
T Consensus 208 ~~~~~-----------------------~--------------------------~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 208 IRVDT-----------------------P--------------------------HYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred HHhCC-----------------------C--------------------------CCCCCCCHHHHHHHHHHccCCHHHc
Confidence 21100 0 0122456789999999999999999
Q ss_pred CCH-HHHhcCCCCCCC
Q 013973 415 LTA-REALRHPFFTRD 429 (433)
Q Consensus 415 ~ta-~ell~hp~f~~~ 429 (433)
+++ +++++||||+..
T Consensus 239 ~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 239 LGVVGNIRGHPFFKTI 254 (316)
T ss_pred CCChHHHHcCCCcCCC
Confidence 997 589999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=359.44 Aligned_cols=293 Identities=23% Similarity=0.330 Sum_probs=209.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.++|++++.||+|+||.||+|++..++..||+|++... ......+..|+++++++ +|+||+++++++...+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECCEE
Confidence 36799999999999999999999999999999998643 23445678899999888 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
++||||+ +++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--------------- 141 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG--------------- 141 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC---------------
Confidence 9999999 899999998754 689999999999999999999986 599999999999995544
Q ss_pred CCcccccCCCCCCEEEEecCCccccCC-CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus 142 ------------~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 142 ------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred ------------cEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 456666665543322 1233478999999999999899999999999999999999999998766544
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccC---cccCCCCcc---chhhHhhhccchhHHHHHhh--hcCCchhHHHHH
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRG---RLDWPEGAA---SRESIKSVMKLPRLQNLIMQ--HVDHSAGDLTHL 402 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 402 (433)
.... ++...... ............ ......... ......... ..+...... ....++.++++|
T Consensus 210 ~~~~----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l 280 (331)
T cd06649 210 LEAI----FGRPVVDG---EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELL--DYIVNEPPPKLPNGVFTPDFQEF 280 (331)
T ss_pred HHHH----hccccccc---ccCCccccCcccccccccccccccccccchhHHHHH--HHHHhCCCcCCCCccccHHHHHH
Confidence 3222 11110000 000000000000 000000000 000000000 000000000 012467889999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
|.+||++||++|||+.|+++||||+....
T Consensus 281 i~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 281 VNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred HHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 99999999999999999999999987644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=360.05 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=196.7
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+++.||+|+++.... ..+....|..++..+ .+|++|+++++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~i~~~~~~~~~~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA----WEHPFLTHLFCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCEEEEEEc
Confidence 469999999999999999999999999974321 222334455554433 267899999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ |++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~----------------------- 131 (316)
T cd05592 77 YLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK----------------------- 131 (316)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC-----------------------
Confidence 99 999999997654 7999999999999999999999999999999999999954
Q ss_pred cCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
++.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..
T Consensus 132 ----~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~ 207 (316)
T cd05592 132 ----DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS 207 (316)
T ss_pred ----CCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45567777776653221 12335799999999999999999999999999999999999999988776554433
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+..... ..+..++.++.+||.+||+.||++|
T Consensus 208 i~~~~~-------------------------------------------------~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 208 ILNDRP-------------------------------------------------HFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred HHcCCC-------------------------------------------------CCCCCCCHHHHHHHHHHccCCHHHc
Confidence 221100 0123456789999999999999999
Q ss_pred CCH-HHHhcCCCCCCC
Q 013973 415 LTA-REALRHPFFTRD 429 (433)
Q Consensus 415 ~ta-~ell~hp~f~~~ 429 (433)
+++ .++++||||...
T Consensus 239 ~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 239 LGVDGDIRQHPFFRGI 254 (316)
T ss_pred CCChHHHHcCcccCCC
Confidence 986 589999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=361.24 Aligned_cols=247 Identities=28% Similarity=0.387 Sum_probs=198.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-e
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-H 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-~ 172 (433)
..+.+.+.||+|+||+||+|..+.+. .||+|++.... ...+.+..|+.+|.++ .||||+++++.+.... .
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRL-----RHPNIVQFYGACTSPPGS 114 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCc
Confidence 34566677999999999999876432 29999997432 2255788999999998 7899999999999887 7
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++|||||+ +|+|.++|+....+.+++..+..++.||++||+|||+++ ||||||||+|||++.++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-------------- 180 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-------------- 180 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--------------
Confidence 99999999 999999998854468999999999999999999999999 99999999999995432
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhh--CCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL--GLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
..+||+|||+++.... ......||+.|||||++. ...|+.++||||||+++|||+||..||.+
T Consensus 181 ------------~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 181 ------------KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred ------------CEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 2667777777654442 223358999999999999 56899999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
....+....+ ...+..| ..+..+++.+.+||..
T Consensus 249 ~~~~~~~~~v-~~~~~Rp----------------------------------------------~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 249 LAPVQVASAV-VVGGLRP----------------------------------------------PIPKECPPHLSSLMER 281 (362)
T ss_pred CCHHHHHHHH-HhcCCCC----------------------------------------------CCCccCCHHHHHHHHH
Confidence 8773332222 1111111 1123467789999999
Q ss_pred ccccCCCCCCCHHHHhc
Q 013973 406 LLRYDPTDRLTAREALR 422 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~ 422 (433)
||+.||.+||+..+++.
T Consensus 282 CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 282 CWLVDPSRRPSFLEIVS 298 (362)
T ss_pred hCCCCCCcCCCHHHHHH
Confidence 99999999999887753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=359.32 Aligned_cols=255 Identities=26% Similarity=0.459 Sum_probs=225.7
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+.+-|.+.+.||+|.|++|-+|++.-||+.||||++.+.+. .......|+..|+.+ .|||||.+|+..++..
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-----QHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-----QHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-----cCcCeeeeeehhcccc
Confidence 45679999999999999999999999999999999986543 234566799999888 6689999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|||+|+- +|+|+|||-+.. ..+.++.+++|+.||+.|+.|+|+..+|||||||+||.+-
T Consensus 91 KlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF----------------- 152 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF----------------- 152 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe-----------------
Confidence 999999999 899999998765 4699999999999999999999999999999999999983
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+.+.+||.|||++..+.++. .+.||+..|-|||++++..|+ +++||||||||||-|++|++||+..+
T Consensus 153 ---------EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 153 ---------EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred ---------eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 466789999999997766655 567999999999999999998 78999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
+.+.+.+|...-... +++.+.+++|||..||
T Consensus 224 DSETLTmImDCKYtv-------------------------------------------------PshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 224 DSETLTMIMDCKYTV-------------------------------------------------PSHVSKECRDLIQSML 254 (864)
T ss_pred chhhhhhhhcccccC-------------------------------------------------chhhhHHHHHHHHHHH
Confidence 999888765543332 3467889999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.||.+|.+.+|+..|+|++...
T Consensus 255 vRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred hcCchhhccHHHHhccccccCCC
Confidence 99999999999999999998653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=344.08 Aligned_cols=271 Identities=26% Similarity=0.454 Sum_probs=220.3
Q ss_pred EEEE-eeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 99 YKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 99 ~~~~-~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
|++. +.||+|+|+.|--|+...++..||||++.+.. ..+.+..+|++++.++. +|+||++++++|+++..+|||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq----gh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ----GHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc----CCccHHHHHHHhcccceEEEE
Confidence 4443 67999999999999999999999999997653 45677788999998884 667899999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
||.| ||.|..+|++.. .|++.++.+++.+|+.||.|||.+||.||||||+|||..+.
T Consensus 155 fEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p-------------------- 212 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP-------------------- 212 (463)
T ss_pred EecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC--------------------
Confidence 9999 999999998865 79999999999999999999999999999999999999643
Q ss_pred cccCCCCCCEEEEecCCccccCC----------CCCceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHHHhCC
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERP----------DQNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~ 320 (433)
+.-.-+|||||.++..... .-.+.+|+..|||||++.- ..|++++|.||||||+|-||+|.
T Consensus 213 ----n~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 213 ----NKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred ----CCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 2334577888776542221 1134589999999998852 34999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
+||.+.=..+ +|=.-.+.....+.....-|..|.+.+|+.. |..+|.+++
T Consensus 289 pPFvG~Cg~d--------CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkd----------------------WahIS~eak 338 (463)
T KOG0607|consen 289 PPFVGHCGAD--------CGWDRGEVCRVCQNKLFESIQEGKYEFPDKD----------------------WAHISSEAK 338 (463)
T ss_pred CCccCccCCc--------CCccCCCccHHHHHHHHHHHhccCCcCChhh----------------------hHHhhHHHH
Confidence 9998642211 1222223334445555556778888888733 357788999
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|||+.+|.+|+.+|++|.++++|||++..
T Consensus 339 dlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 339 DLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 99999999999999999999999999864
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=366.50 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=205.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+..|+.+++.+ +|++|+.+++++.+.+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-----~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-----NSEWIVQLHYAFQDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEEecCC
Confidence 467999999999999999999999999999999996432 1223355688888777 7799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ ||+|.+++... .+++..+..++.||+.||+|||+.|||||||||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----------------- 176 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----------------- 176 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc-----------------
Confidence 999999999 99999998754 589999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCC----CCCCcchhHHHHHHHHHHHhCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL----GWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~P 322 (433)
.++.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++|..|
T Consensus 177 ----------~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 246 (370)
T cd05596 177 ----------KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (370)
T ss_pred ----------CCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence 4456777777766543322 1235799999999999754 378999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+....+..+.... ..+.+|. ....+.++.+|
T Consensus 247 f~~~~~~~~~~~i~~~~---------------------~~~~~~~------------------------~~~~s~~~~~l 281 (370)
T cd05596 247 FYADSLVGTYSKIMDHK---------------------NSLTFPD------------------------DIEISKQAKDL 281 (370)
T ss_pred cCCCCHHHHHHHHHcCC---------------------CcCCCCC------------------------cCCCCHHHHHH
Confidence 98876554443322110 0111111 12457789999
Q ss_pred HHhccccCCCC--CCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTD--RLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~--R~ta~ell~hp~f~~~ 429 (433)
|.+||+.+|.+ |+|++|+++||||++.
T Consensus 282 i~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 282 ICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999998 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=356.72 Aligned_cols=285 Identities=26% Similarity=0.474 Sum_probs=207.6
Q ss_pred EeeeeccccEEEEEEEEC--CCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeEEEEE
Q 013973 102 HSKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVF 177 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~lV~ 177 (433)
.++||+|+||.||+|+++ .+++.||+|.+.... ......+|+.+++++ .|+||+++++.+.. ...+|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLREL-----KHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhc-----CCCCCcceeeeEecCCCcEEEEEE
Confidence 368999999999999976 467889999987432 234567899999988 67899999998853 56789999
Q ss_pred ecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 178 EKLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 178 e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
||++++|.+++.... ...+++..++.++.||+.||.|||++|||||||||+|||+...+
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~-------------- 145 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-------------- 145 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC--------------
Confidence 999889999876321 12589999999999999999999999999999999999995322
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+..+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus 146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ---------CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 34457888888887654322 1235789999999999874 5899999999999999999999999
Q ss_pred CCCCh---------HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 324 QTHEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 324 ~~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
..... .+.+..+...+|..+...+.......+.......+... ... ..............
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---------~~~~~~~~~~~~~~ 285 (317)
T cd07868 217 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN--TYT---------NCSLIKYMEKHKVK 285 (317)
T ss_pred cCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhcc--ccC---------cccccchHHhcCCC
Confidence 75432 34566677777776666555443221110000000000 000 00000011111123
Q ss_pred chhHHHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
.+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 286 ~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 286 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 35678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=357.68 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=201.3
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+|++.+.||+|+||.||+|.++.+++.||+|+++... ........|..++..+ .++++++++.+++...+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ----DKPPFLTQLHSCFQTVDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCchhheeeEEecCCEE
Confidence 3788999999999999999999999999999997432 1223345566666555 2456788999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++.+
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~----------------- 137 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE----------------- 137 (323)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-----------------
Confidence 9999999 899999997754 79999999999999999999999999999999999999544
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
+.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 138 ----------~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (323)
T cd05615 138 ----------GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207 (323)
T ss_pred ----------CCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 45666666665432211 12346999999999999989999999999999999999999999877655
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+... ... .+...+.++.+|+.+||++
T Consensus 208 ~~~~~i~~~-----------------------~~~--------------------------~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 208 ELFQSIMEH-----------------------NVS--------------------------YPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred HHHHHHHhC-----------------------CCC--------------------------CCccCCHHHHHHHHHHccc
Confidence 444332211 111 1234567899999999999
Q ss_pred CCCCCCC-----HHHHhcCCCCCCC
Q 013973 410 DPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~t-----a~ell~hp~f~~~ 429 (433)
||.+|++ ..++++||||...
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 239 HPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred CHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999997 5799999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=363.26 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=198.1
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+++.||+|+++... ........|+.+++.+ .|++|+.+.+.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-----~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-----RHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCCceEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999997432 2223445677777666 67899999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
|+ +++|.+++.... .+++..+..++.||+.||.|||+ .|||||||||+|||++.
T Consensus 76 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~---------------------- 131 (325)
T cd05594 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK---------------------- 131 (325)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC----------------------
Confidence 99 899999987654 79999999999999999999997 79999999999999954
Q ss_pred ccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 132 -----~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~ 206 (325)
T cd05594 132 -----DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206 (325)
T ss_pred -----CCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH
Confidence 455677777766532211 123479999999999999999999999999999999999999998766544333
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+.. +... .+..+++++.+||.+||+.||++
T Consensus 207 ~i~~-----------------------~~~~--------------------------~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 207 LILM-----------------------EEIR--------------------------FPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred HHhc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHhhcCHHH
Confidence 2211 1111 12356778999999999999999
Q ss_pred CC-----CHHHHhcCCCCCCC
Q 013973 414 RL-----TAREALRHPFFTRD 429 (433)
Q Consensus 414 R~-----ta~ell~hp~f~~~ 429 (433)
|+ ++.++++||||...
T Consensus 238 R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCCC
Confidence 97 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=351.97 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=206.5
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+|++.+.||+|+||.||++.+..+++.||+|++.... .....+..|+.+++.+ +|++++.+++.+...+.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-----CCCCEeeeeeeecCCCeE
Confidence 4899999999999999999999999999999986432 1223456788888888 668899999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~------------------ 137 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD------------------ 137 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC------------------
Confidence 9999999 899999887655457999999999999999999999999999999999999944
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.++|+|||++....... ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...
T Consensus 138 ---------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 138 ---------YGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred ---------CCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 4556777777665432221 23478999999999999899999999999999999999999998755433
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+..... .+. ...+..++..+.+||.+||+.|
T Consensus 209 ~~~~~~~~~~-------------------~~~--------------------------~~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05605 209 KREEVERRVK-------------------EDQ--------------------------EEYSEKFSEAARSICRQLLTKD 243 (285)
T ss_pred HHHHHHHHhh-------------------hcc--------------------------cccCcccCHHHHHHHHHHccCC
Confidence 2222211110 000 0112346778999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCCCC
Q 013973 411 PTDRL-----TAREALRHPFFTRDHL 431 (433)
Q Consensus 411 P~~R~-----ta~ell~hp~f~~~~~ 431 (433)
|.+|| +++++++||||.....
T Consensus 244 P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 244 PGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred HHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 99999 8999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=367.13 Aligned_cols=277 Identities=23% Similarity=0.384 Sum_probs=210.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|.++.+++.||+|+++... .....+..|+.++..+ .|++++++++.+.+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-----DGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCE
Confidence 35999999999999999999999999999999997432 2234456688888776 67889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ |++|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|.++|+|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999 899999997654 799999999999999999999999999999999999999999999999998764432
Q ss_pred CCcc--cccCCCCCCEEEEecCCcccc------------CCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHH
Q 013973 252 DSSY--FKRMPKSSAIKVIDFGSTTYE------------RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 252 ~~~~--~~~~~~~~~~kl~Dfg~a~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 317 (433)
.... ...... ..-.++.+.... .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 154 AHRTEFYRNLTH---NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred cccccccccccc---CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence 1100 000000 000011100000 00012357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
+|..||.+.+..+....+... ...+.+|. ...++.
T Consensus 231 tG~~Pf~~~~~~~~~~~i~~~---------------------~~~~~~p~------------------------~~~~s~ 265 (360)
T cd05627 231 IGYPPFCSETPQETYRKVMNW---------------------KETLVFPP------------------------EVPISE 265 (360)
T ss_pred cCCCCCCCCCHHHHHHHHHcC---------------------CCceecCC------------------------CCCCCH
Confidence 999999877665544332210 00011111 113567
Q ss_pred HHHHHHHhccccCCCCCC---CHHHHhcCCCCCCC
Q 013973 398 DLTHLLQGLLRYDPTDRL---TAREALRHPFFTRD 429 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~---ta~ell~hp~f~~~ 429 (433)
++++||.+|+. ||.+|+ ++.|+++||||++.
T Consensus 266 ~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 266 KAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred HHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 89999999774 999999 48999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=359.74 Aligned_cols=244 Identities=22% Similarity=0.361 Sum_probs=199.1
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|+++.+++.||+|+++... ........|.+++..+. +|++|+.+++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~----~hp~i~~~~~~~~~~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA----KHPFLTALHCCFQTKDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc----CCCCccceeeEEEcCCeEEEEEe
Confidence 46999999999999999999999999997432 22334556777666542 56889999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~------------------------ 130 (321)
T cd05591 77 YVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD------------------------ 130 (321)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC------------------------
Confidence 99 899999987654 799999999999999999999999999999999999994
Q ss_pred cCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
.++.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.+..
T Consensus 131 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 207 (321)
T cd05591 131 ---AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES 207 (321)
T ss_pred ---CCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 445677777776653221 12335799999999999999999999999999999999999999988776555443
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.. +... .+..++.++.+||.+||+.||++|
T Consensus 208 i~~-----------------------~~~~--------------------------~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 208 ILH-----------------------DDVL--------------------------YPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred HHc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHhccCHHHc
Confidence 221 1111 122456789999999999999999
Q ss_pred C-------CHHHHhcCCCCCC
Q 013973 415 L-------TAREALRHPFFTR 428 (433)
Q Consensus 415 ~-------ta~ell~hp~f~~ 428 (433)
+ ++.++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 239 LGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCCCCCHHHHhcCCccCC
Confidence 9 8999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=365.54 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=204.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+.. .....+..|+.+++.+ +|++|+++++.+.++.
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFCAFQDDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCC
Confidence 467999999999999999999999999999999986422 1233455688887776 7799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ +|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----------------- 176 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----------------- 176 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC-----------------
Confidence 999999999 99999999754 589999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCC----CCCcchhHHHHHHHHHHHhCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~P 322 (433)
.++.+||+|||++....... ...+||+.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 177 ----------~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~P 246 (370)
T cd05621 177 ----------KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246 (370)
T ss_pred ----------CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCC
Confidence 44567777777776443221 2457999999999998643 78999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+....+..+.... ..+.+|. ....+..++++
T Consensus 247 f~~~~~~~~~~~i~~~~---------------------~~~~~p~------------------------~~~~s~~~~~l 281 (370)
T cd05621 247 FYADSLVGTYSKIMDHK---------------------NSLNFPE------------------------DVEISKHAKNL 281 (370)
T ss_pred CCCCCHHHHHHHHHhCC---------------------cccCCCC------------------------cccCCHHHHHH
Confidence 98776655444332210 0111221 11356789999
Q ss_pred HHhccccCCCC--CCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTD--RLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~--R~ta~ell~hp~f~~~ 429 (433)
|.+||+.++.+ |+++.|+++||||+..
T Consensus 282 i~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 282 ICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999866544 8899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=363.95 Aligned_cols=280 Identities=24% Similarity=0.419 Sum_probs=210.0
Q ss_pred eecCcEEEEeeeeccccEEEEEEEEC--CCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+..+|++++.||+|+||.||+|... .+++.||+|.+.... ....|+.+++.+ .|++|+++++.+....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l-----~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTI-----SHRAIINLIHAYRWKS 159 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhc-----CCCCccceeeeEeeCC
Confidence 34568999999999999999999764 356789999886432 345689999988 6789999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.+|+|||+++++|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~--------------- 222 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--------------- 222 (392)
T ss_pred EEEEEehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC---------------
Confidence 99999999988999999544 3799999999999999999999999999999999999995544
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++|+|||++....... ....||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 223 ------------~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 223 ------------NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ------------CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 45566666554322211 2347999999999999999999999999999999999999999764
Q ss_pred C---hHHHHHHHHHHhCCCCHHHHHHHh----hhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 327 E---NLEHLAMMERVLGPLPQHMLKRVD----RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 327 ~---~~~~~~~i~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
. ....+..+.+.++..+.+...... .....+.......++. + ... ....++.++
T Consensus 291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~---~~~--~~~~~~~~~ 351 (392)
T PHA03207 291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTI--------------P---PVI--RKYGMHMDV 351 (392)
T ss_pred CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccc--------------c---chh--hccCcchhH
Confidence 3 345556666666554433211110 0011111000000000 0 000 012346688
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||.+||+.||++|||+.|+|.||||++.+
T Consensus 352 ~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 352 EYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 9999999999999999999999999998765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=393.37 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=211.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|.+++.||+|+||.|.+++.+.+++.||+|++++- ......+..|..+|... +.+.|+++...|+++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-----ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-----NSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-----CcHHHHHHHHHhcCcc
Confidence 46899999999999999999999999999999999752 23345677788888655 5688999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++|+||||+ ||+|..+|.+.+ ++|++.+++|+.+|+.||.-||+.|+|||||||+||||+..|
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-------------- 212 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-------------- 212 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--------------
Confidence 999999999 999999998876 899999999999999999999999999999999999995555
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHHHhCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
++||+|||.+.....++ ...+|||.|++||++.. +.|+..+||||+||++|||+.|..
T Consensus 213 -------------HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T 279 (1317)
T KOG0612|consen 213 -------------HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET 279 (1317)
T ss_pred -------------cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence 55555555554433332 33589999999999973 459999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||..++-.+++..|... +..+.+|+. ...|.++++
T Consensus 280 PFYadslveTY~KIm~h---------------------k~~l~FP~~------------------------~~VSeeakd 314 (1317)
T KOG0612|consen 280 PFYADSLVETYGKIMNH---------------------KESLSFPDE------------------------TDVSEEAKD 314 (1317)
T ss_pred cchHHHHHHHHHHHhch---------------------hhhcCCCcc------------------------cccCHHHHH
Confidence 99988888887776543 112223311 246889999
Q ss_pred HHHhccccCCCCCCC---HHHHhcCCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLT---AREALRHPFFTRDH 430 (433)
Q Consensus 402 li~~~L~~dP~~R~t---a~ell~hp~f~~~~ 430 (433)
||+++|. +|+.|++ ++++..||||.+..
T Consensus 315 LI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 315 LIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 9999887 6889998 99999999998753
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=360.21 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=198.0
Q ss_pred cEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 98 RYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
+|++++.||+|+||.||+|++. .+++.||+|++.... ...+....|+.++..+. +|++|+.+++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR----QSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc----CCCCcccEEEEEec
Confidence 4899999999999999999864 578899999986432 12234556777777763 46789999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+.+++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~-------------- 140 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS-------------- 140 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC--------------
Confidence 99999999999 899999997654 6999999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
++.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++|..||
T Consensus 141 -------------~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf 207 (332)
T cd05614 141 -------------EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207 (332)
T ss_pred -------------CCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence 455677777766533211 1235799999999999875 4789999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
...........+... +.... ...+...+..+.+||
T Consensus 208 ~~~~~~~~~~~~~~~-------------------~~~~~--------------------------~~~~~~~~~~~~~li 242 (332)
T cd05614 208 TLEGERNTQSEVSRR-------------------ILKCD--------------------------PPFPSFIGPEAQDLL 242 (332)
T ss_pred CCCCCCCCHHHHHHH-------------------HhcCC--------------------------CCCCCCCCHHHHHHH
Confidence 753321111110000 00000 012235677899999
Q ss_pred HhccccCCCCCC-----CHHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~-----ta~ell~hp~f~~~ 429 (433)
.+||+.||++|| +++++++||||++.
T Consensus 243 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 243 HKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999 78899999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.13 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=196.8
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+++.||+|+++... ........|..++..+ ..|++|+++++.+.+.+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHLYCTFQTKENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCcCcceEEEEEeCCEEEEEEe
Confidence 47999999999999999999999999997432 2233345566665543 267899999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 77 y~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---------------------- 132 (316)
T cd05619 77 YLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---------------------- 132 (316)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC----------------------
Confidence 99 899999998653 78999999999999999999999999999999999999544
Q ss_pred cCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
+.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....
T Consensus 133 -----~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 133 -----GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred -----CCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 456666666654321 112335799999999999999999999999999999999999999987665544333
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+... .. ..+..++.++.+||.+||+.||++|
T Consensus 208 i~~~-----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 208 IRMD-----------------------NP--------------------------CYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred HHhC-----------------------CC--------------------------CCCccCCHHHHHHHHHHhccCHhhc
Confidence 2110 00 0112356689999999999999999
Q ss_pred CCHH-HHhcCCCCCCC
Q 013973 415 LTAR-EALRHPFFTRD 429 (433)
Q Consensus 415 ~ta~-ell~hp~f~~~ 429 (433)
+++. ++++||||+..
T Consensus 239 ~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 239 LGVKGDIRQHPFFREI 254 (316)
T ss_pred CCChHHHHcCcccCCC
Confidence 9996 99999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=360.95 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=203.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.++.+++.||+|+++.... ....+..|+.+++.+ +|++|+.+++.+.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-----NSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCe
Confidence 359999999999999999999999999999999975322 334456677777665 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~----------------- 137 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR----------------- 137 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC-----------------
Confidence 99999999 999999998753 37999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhh------CCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL------GLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
++.+||+|||++....... ....||+.|+|||++. ...++.++|||||||++|||++|..
T Consensus 138 ----------~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 138 ----------TGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred ----------CCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence 4456666666665433222 1236899999999997 4568899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||...+....+..+... ...+.+|. ....+.++.+
T Consensus 208 Pf~~~~~~~~~~~i~~~---------------------~~~~~~~~------------------------~~~~~~~~~~ 242 (330)
T cd05601 208 PFHEGTSAKTYNNIMNF---------------------QRFLKFPE------------------------DPKVSSDFLD 242 (330)
T ss_pred CCCCCCHHHHHHHHHcC---------------------CCccCCCC------------------------CCCCCHHHHH
Confidence 99876655444332211 00011111 1245678999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||.+||+ ||.+|||+.++++||||+..
T Consensus 243 li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 243 LIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999998 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=349.91 Aligned_cols=283 Identities=27% Similarity=0.458 Sum_probs=219.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++++.||+|+||.||+|.++.+++.||+|.++... ........|+.+++.+ .|+||+++++++...+.++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-----CCCCcceEEEEEecCCeEE
Confidence 56999999999999999999999999999999986332 2234566789999888 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||+.++|.+++.... ..+++..+..++.||+.||+|||+.||+|+||||+|||+++++
T Consensus 81 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~------------------ 141 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG------------------ 141 (301)
T ss_pred EEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC------------------
Confidence 999999889999987653 3689999999999999999999999999999999999996554
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++|+|||.+....... ....+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+
T Consensus 142 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 142 ---------ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred ---------cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 45555555554322111 123578899999998764 47899999999999999999999999888888
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+...++..+...+......... .....+.. ...........++.++++||.+||+.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~ml~~d 273 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEF----KSYNYPKY---------------RADCLHNHAPRLDSDGAELLSKLLQFE 273 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccc----cccccCcc---------------ccccHHhhcCCCCHHHHHHHHHHhcCC
Confidence 88888888877666554433211100 00001100 000111123456778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~~ 431 (433)
|.+|||+.|+|+||||+....
T Consensus 274 p~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 274 GRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccCcCHHHHhcCcccccccc
Confidence 999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.21 Aligned_cols=245 Identities=24% Similarity=0.433 Sum_probs=199.2
Q ss_pred EeeeeccccEEEEEEEEC---CCCeEEEEEEeecch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 102 HSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++.||+|+||.||+|++. .+++.||+|+++... ........|+.+++.+ .|+||+++++.+..++.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-----KHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-----CCCchhceeeEEecCCeE
Confidence 368999999999999864 578899999997432 2223456788888888 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~------------------ 135 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA------------------ 135 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC------------------
Confidence 9999999 899999998754 7899999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 136 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~ 206 (323)
T cd05584 136 ---------QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206 (323)
T ss_pred ---------CCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH
Confidence 455677777766432111 12357999999999999988999999999999999999999999876654
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+.. +... .+..++.++.+||.+||++
T Consensus 207 ~~~~~~~~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 207 KTIDKILK-----------------------GKLN--------------------------LPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred HHHHHHHc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHccc
Confidence 43332211 1111 1234567899999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCCC
Q 013973 410 DPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~-----ta~ell~hp~f~~~ 429 (433)
||++|| ++.++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=355.03 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=198.6
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||+||+|.+..+++.||+|++++.. ........|..++..+. +|++|+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~----~h~~i~~~~~~~~~~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG----KHPFLTQLHSCFQTKDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc----CCCCccceeeEEEcCCEEEEEEc
Confidence 47999999999999999999999999997432 22334456777766553 56889999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 77 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---------------------- 132 (318)
T cd05570 77 YVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---------------------- 132 (318)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC----------------------
Confidence 99 899999987764 79999999999999999999999999999999999999544
Q ss_pred cCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
+.+||+|||++..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....
T Consensus 133 -----~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~ 207 (318)
T cd05570 133 -----GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS 207 (318)
T ss_pred -----CcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 4566666665543211 12235799999999999999999999999999999999999999987665544332
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.. +... .+..++.++.+||.+||+.||.+|
T Consensus 208 i~~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 208 ILE-----------------------DEVR--------------------------YPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred HHc-----------------------CCCC--------------------------CCCcCCHHHHHHHHHHccCCHHHc
Confidence 211 0111 122456789999999999999999
Q ss_pred CCH-----HHHhcCCCCCCC
Q 013973 415 LTA-----REALRHPFFTRD 429 (433)
Q Consensus 415 ~ta-----~ell~hp~f~~~ 429 (433)
|++ .++++||||+..
T Consensus 239 ~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 239 LGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=356.74 Aligned_cols=253 Identities=22% Similarity=0.396 Sum_probs=194.5
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+++.||+|+++... .....+..|..++..+. +|++|+.+++++.+.+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~----~hp~Iv~~~~~~~~~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS----NHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc----CCCCCCceEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999997432 22234556777776663 56889999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 77 ~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~--------------------- 133 (329)
T cd05588 77 FVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG--------------------- 133 (329)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---------------------
Confidence 99 899999987654 799999999999999999999999999999999999995544
Q ss_pred cCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||......+.
T Consensus 134 ------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--- 204 (329)
T cd05588 134 ------HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN--- 204 (329)
T ss_pred ------CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc---
Confidence 56666666554211 112335799999999999999999999999999999999999999964221000
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+... ........+..+. ...+..++.++.+||.+||+.||.+|
T Consensus 205 --------~~~~---~~~~~~~~~~~~~--------------------------~~~p~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 205 --------PDQN---TEDYLFQVILEKQ--------------------------IRIPRSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred --------cccc---chHHHHHHHHcCC--------------------------CCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 0000 0000000011111 11234567789999999999999999
Q ss_pred CC------HHHHhcCCCCCC
Q 013973 415 LT------AREALRHPFFTR 428 (433)
Q Consensus 415 ~t------a~ell~hp~f~~ 428 (433)
++ +.++++||||..
T Consensus 248 ~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 248 LGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCC
Confidence 97 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=356.59 Aligned_cols=244 Identities=28% Similarity=0.424 Sum_probs=194.2
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHH-HHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~-l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
+.||+|+||+||+|.+..+++.||+|++..... .......|... ++.+ .|++|+++++.+...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-----~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-----KHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-----CCCCCCCeeEEEEeCCEEEEEE
Confidence 479999999999999999999999999974321 11223333332 2333 6789999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~---------------------- 131 (323)
T cd05575 76 DYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS---------------------- 131 (323)
T ss_pred cCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC----------------------
Confidence 999 899999998754 7999999999999999999999999999999999999954
Q ss_pred ccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
++.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+...
T Consensus 132 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 206 (323)
T cd05575 132 -----QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206 (323)
T ss_pred -----CCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 44566777776643211 1233579999999999999999999999999999999999999998766554433
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+.. +... .....+.++.+||.+||+.||.+
T Consensus 207 ~i~~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 207 NILN-----------------------KPLR--------------------------LKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred HHHc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHhhcCHHh
Confidence 2211 0000 12245678999999999999999
Q ss_pred CCCH----HHHhcCCCCCCC
Q 013973 414 RLTA----REALRHPFFTRD 429 (433)
Q Consensus 414 R~ta----~ell~hp~f~~~ 429 (433)
||++ .|+++||||...
T Consensus 238 R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=346.33 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=196.3
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
||+|+||+||+|.++.+++.||+|++..... ..+.+..|+.+++.+ +|++++.+.+.+.....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-----HSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-----CCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 7999999999999999999999999864321 223456788888888 6789999999999999999999999
Q ss_pred -CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 181 -GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 181 -~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
+++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~----------------------- 132 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN----------------------- 132 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-----------------------
Confidence 89999887542 2246999999999999999999999999999999999999944
Q ss_pred cCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
++.++|+|||.+....... ....||+.|+|||++.+..++.++|+|||||++|||++|+.||...+.......
T Consensus 133 ----~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 208 (280)
T cd05608 133 ----DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208 (280)
T ss_pred ----CCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 4557777777665432221 234789999999999999999999999999999999999999976443211111
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+... +..+. ...+..++.++.+|+.+||+.||++|
T Consensus 209 ~~~~-------------------~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R 243 (280)
T cd05608 209 LKQR-------------------ILNDS--------------------------VTYPDKFSPASKSFCEALLAKDPEKR 243 (280)
T ss_pred HHHh-------------------hcccC--------------------------CCCcccCCHHHHHHHHHHhcCCHHHh
Confidence 1000 00000 01123567789999999999999999
Q ss_pred C-----CHHHHhcCCCCCCC
Q 013973 415 L-----TAREALRHPFFTRD 429 (433)
Q Consensus 415 ~-----ta~ell~hp~f~~~ 429 (433)
| +++++++||||++.
T Consensus 244 ~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 244 LGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cCCCCCCHHHHhcChhhhcC
Confidence 9 89999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=354.98 Aligned_cols=254 Identities=22% Similarity=0.388 Sum_probs=194.5
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+++.||+|+++... ........|+.++..+ .+|++|+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhc----CCCCcCCceeeEEEeCCEEEEEEe
Confidence 47999999999999999999999999997432 2223345566666554 256889999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~----------------------- 131 (329)
T cd05618 77 YVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS----------------------- 131 (329)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC-----------------------
Confidence 99 899999887654 7999999999999999999999999999999999999954
Q ss_pred cCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
++.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 132 ----~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--- 204 (329)
T cd05618 132 ----EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--- 204 (329)
T ss_pred ----CCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC---
Confidence 45567777776653211 12335799999999999999999999999999999999999999953211000
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.. .........+..... ..+...+.++.+||.+||+.||++|
T Consensus 205 --------~~~---~~~~~~~~~i~~~~~--------------------------~~p~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 205 --------PDQ---NTEDYLFQVILEKQI--------------------------RIPRSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred --------ccc---ccHHHHHHHHhcCCC--------------------------CCCCCCCHHHHHHHHHHhcCCHHHc
Confidence 000 000000000011111 1234567789999999999999999
Q ss_pred CC------HHHHhcCCCCCCC
Q 013973 415 LT------AREALRHPFFTRD 429 (433)
Q Consensus 415 ~t------a~ell~hp~f~~~ 429 (433)
++ +.++++||||++.
T Consensus 248 ~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 248 LGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCCC
Confidence 98 5799999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=356.12 Aligned_cols=278 Identities=23% Similarity=0.383 Sum_probs=202.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
.+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.+ +|+||+++++++......|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV-----NHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC-----CCCCCcChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999986432 234588888887 678999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 177 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 177 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||++.++|.+++.... ..+++..+..++.||+.||.|||++|||||||||+|||++.
T Consensus 136 ~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~---------------------- 192 (357)
T PHA03209 136 LPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND---------------------- 192 (357)
T ss_pred EEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC----------------------
Confidence 9999889999987643 47999999999999999999999999999999999999944
Q ss_pred ccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC-CCCCCCh-----
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHEN----- 328 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~-Pf~~~~~----- 328 (433)
++.+||+|||.+...... .....||..|+|||++.+..++.++|||||||++|||+++.. +|.....
T Consensus 193 -----~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~ 267 (357)
T PHA03209 193 -----VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY 267 (357)
T ss_pred -----CCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence 455777777766543221 223579999999999999999999999999999999998654 4443211
Q ss_pred ----HHHHHHHHHHhCCCCHHHHHHH-hhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 329 ----LEHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 329 ----~~~~~~i~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
...+..+...++..|..+.... ......++........ ...... .......+.++.+||
T Consensus 268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~---~~~~~~~~~~~~~li 331 (357)
T PHA03209 268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQ-------------PYTRYP---CFQRVNLPIDGEFLV 331 (357)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCC-------------cccccH---HHhccCCCchHHHHH
Confidence 1222333333333332211000 0000001000000000 000000 000124566788999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.+||+.||.+||||.|||+||||++
T Consensus 332 ~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 332 HKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHcCCcccCcCHHHHhcCchhcc
Confidence 9999999999999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=358.57 Aligned_cols=256 Identities=24% Similarity=0.416 Sum_probs=203.7
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
..++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+..|+.+++.+ +|++|+++++.+...
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAFQDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEcC
Confidence 3478999999999999999999999999999999986422 1223345677777766 779999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+|+||||+ |++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---------------- 176 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---------------- 176 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----------------
Confidence 9999999999 89999998754 589999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCCC----CCCcchhHHHHHHHHHHHhCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~ 321 (433)
.++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|..
T Consensus 177 -----------~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 245 (371)
T cd05622 177 -----------KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (371)
T ss_pred -----------CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence 4456777777776544322 12457999999999997643 7899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.+....+..+..... .+.+|. ...++.++++
T Consensus 246 Pf~~~~~~~~~~~i~~~~~---------------------~~~~~~------------------------~~~~s~~~~~ 280 (371)
T cd05622 246 PFYADSLVGTYSKIMNHKN---------------------SLTFPD------------------------DNDISKEAKN 280 (371)
T ss_pred CCCCCCHHHHHHHHHcCCC---------------------cccCCC------------------------cCCCCHHHHH
Confidence 9988766554443321110 011111 1246778999
Q ss_pred HHHhccccCCCC--CCCHHHHhcCCCCCCCC
Q 013973 402 LLQGLLRYDPTD--RLTAREALRHPFFTRDH 430 (433)
Q Consensus 402 li~~~L~~dP~~--R~ta~ell~hp~f~~~~ 430 (433)
||.+||+.++.+ |++++|+++||||++..
T Consensus 281 li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 281 LICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred HHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 999999844443 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=333.62 Aligned_cols=295 Identities=28% Similarity=0.484 Sum_probs=230.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC----eEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~----~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
...|++++.||+|.||.||+|..+.++ +.||||.++..+ .....+.+|+.+++.+ .|+|++.+...|.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-----~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-----KHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-----cCCcchhHHHHHh
Confidence 356999999999999999999766554 379999997543 2345667899999999 6789999999987
Q ss_pred c-CCeEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 169 Y-RNHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 169 ~-~~~~~lV~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
. +..+++|+||...+|...++-.. .+.++...++.|+.||+.|+.|||++-|+||||||.|||+..+|
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg-------- 169 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG-------- 169 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC--------
Confidence 7 88999999999999999886322 24689999999999999999999999999999999999997766
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHH
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELC 317 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~ell 317 (433)
.+.+.+||+|||+++.....- ..++-|.+|.|||.+.+.. |+++.||||.|||+.||+
T Consensus 170 ---------------perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL 234 (438)
T KOG0666|consen 170 ---------------PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL 234 (438)
T ss_pred ---------------CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence 677999999999998765432 3357799999999999865 999999999999999999
Q ss_pred hCCCCCCCCC---------hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhcc-chhHHHH
Q 013973 318 TGEALFQTHE---------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK-LPRLQNL 387 (433)
Q Consensus 318 tg~~Pf~~~~---------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 387 (433)
|-.+.|.+.+ ..+++..|..++|.+....|+......+..-.- ..+..... ...+...
T Consensus 235 tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~l------------s~f~~~~~~n~sL~~~ 302 (438)
T KOG0666|consen 235 TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLL------------SDFRRHYYDNVSLHKY 302 (438)
T ss_pred ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHH------------HHhHHhhcCcchHHHH
Confidence 9999997643 245788899999998887777665433321000 00000000 0011111
Q ss_pred HhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 388 ~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
.. ....-++...+|+.+||++||.+|.|++|+|+|+||+.+++
T Consensus 303 ~~-~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 303 YH-KHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred HH-HhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence 11 12233455899999999999999999999999999998865
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.07 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=201.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|.+..+++.||+|++.+.. .....+..|+.++..+ +|++|+.+++.+...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-----DRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCceEEEEecCCe
Confidence 36999999999999999999999999999999997422 1233455677777665 67889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ |++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~------------------ 136 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD------------------ 136 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC------------------
Confidence 99999999 999999997643 4699999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
.++.+||+|||++....... ...+||+.|+|||++.. ..++.++|||||||++|+|++|..|
T Consensus 137 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 137 ---------KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred ---------CCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 44567777777765433221 22469999999999973 3578899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+..+....+.... ..+..+. ....++.++++|
T Consensus 208 f~~~~~~~~~~~i~~~~---------------------~~~~~~~-----------------------~~~~~~~~~~~l 243 (331)
T cd05597 208 FYAESLVETYGKIMNHK---------------------EHFQFPP-----------------------DVTDVSEEAKDL 243 (331)
T ss_pred CCCCCHHHHHHHHHcCC---------------------CcccCCC-----------------------ccCCCCHHHHHH
Confidence 98766554443322110 0001110 112357789999
Q ss_pred HHhccccCCCC--CCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTD--RLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~--R~ta~ell~hp~f~~~ 429 (433)
|++||+.++++ |+++.++++||||...
T Consensus 244 i~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 244 IRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 99999764444 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=353.00 Aligned_cols=296 Identities=21% Similarity=0.333 Sum_probs=209.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.++|++.++||+|+||.||+|.+..++..+|+|++... ......+..|+++++.+ +|+||+++++++...+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-----CCCcccceeEEEEECCEE
Confidence 36799999999999999999999999999999988643 23345677899999988 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
|+||||+ +++|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+|||+++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~----------------- 139 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS----------------- 139 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-----------------
Confidence 9999999 899999998754 689999999999999999999985 7999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC-CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+||+|||++...... .....||..|+|||++.+..++.++|+|||||++|+|++|..||......+
T Consensus 140 ----------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 140 ----------RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred ----------CCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 445677777766533221 233478999999999999899999999999999999999999998655433
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhh-hccCcccCCCCccchhhHhhhccchhHHHHHhhh-cCCchhHHHHHHHhccc
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKY-VRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH-VDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~ 408 (433)
....+.......+... ....... .......+............... .......... ...++.++++||.+||+
T Consensus 210 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~ 284 (333)
T cd06650 210 LELMFGCPVEGDPAES----ETSPRPRPPGRPLSSYGPDSRPPMAIFELLD-YIVNEPPPKLPSGVFGAEFQDFVNKCLI 284 (333)
T ss_pred HHHHhcCcccCCcccc----ccCcccCCccchhhhhcccccccccHHHHHH-HHhcCCCccCCCCCcCHHHHHHHHHhcc
Confidence 3221111000000000 0000000 00000000000000000000000 0000000000 12356789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||++|||+.|++.||||+...
T Consensus 285 ~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 285 KNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCcccCcCHHHHhhCHHHhcCc
Confidence 9999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.36 Aligned_cols=284 Identities=26% Similarity=0.484 Sum_probs=205.9
Q ss_pred eeeeccccEEEEEEEECC--CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--cCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRE--RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~--~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--~~~~~~lV~e 178 (433)
.+||+|+||.||+|.++. ++..||+|.+.... .......|+.+++.+ .|+|++++++++. ....+++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLREL-----KHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhC-----CCCCeeeEEEEEeccCCCeEEEEEe
Confidence 689999999999999754 56789999987432 234567799999988 6788999999874 4568899999
Q ss_pred cCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 179 KLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 179 ~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
|++++|.+++.... ...+++..+..++.||+.||.|||+.|||||||||+|||+..++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~--------------- 145 (317)
T cd07867 81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG--------------- 145 (317)
T ss_pred eeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC---------------
Confidence 99889988875321 13588999999999999999999999999999999999995332
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+.++.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|||++|.+||.
T Consensus 146 --------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 146 --------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred --------CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 345678888888876543221 234789999999999874 58999999999999999999999997
Q ss_pred CCCh---------HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 325 THEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 325 ~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
.... ...+..+...++......+..+............+... ..................
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 286 (317)
T cd07867 218 CRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRT-----------TYANSSLIKYMEKHKVKP 286 (317)
T ss_pred cccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhccc-----------ccCCchhhhhhhcccCCC
Confidence 5432 23455566666766655554433221110000000000 000001111111122234
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 287 ~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 287 DSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred ChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 5678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=327.43 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=204.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++.+++..||.|+.|.|++++.+.+|...|||.++.. +.+.+++...+.++... +..|.||+++++|..+..+.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s----~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhc----cCCCeeeeeeeEEeeCchHH
Confidence 4567889999999999999999999999999999743 34455566666665443 24689999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|.||.|+..+..+|.... .++++..+-.+...++.||.||.+ +||||||+||+|||+
T Consensus 168 IcMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl--------------------- 225 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL--------------------- 225 (391)
T ss_pred HHHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---------------------
Confidence 999999777777666543 579999999999999999999985 689999999999999
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCC-
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHE- 327 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf~~~~- 327 (433)
|+.+++||||||++...-+.. +...|.+.|||||.+.-. .|+.++||||||+.++||.||.+||.+.+
T Consensus 226 ------De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 226 ------DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred ------ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 556678888888775443332 345899999999999743 59999999999999999999999999865
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
+.+.+..+.. ..|+.+ | ....+|+++++|+..||
T Consensus 300 dFe~ltkvln---~ePP~L-------------------~------------------------~~~gFSp~F~~fv~~CL 333 (391)
T KOG0983|consen 300 DFEVLTKVLN---EEPPLL-------------------P------------------------GHMGFSPDFQSFVKDCL 333 (391)
T ss_pred cHHHHHHHHh---cCCCCC-------------------C------------------------cccCcCHHHHHHHHHHh
Confidence 4444444333 222110 0 11247899999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~ 428 (433)
++|+.+||...++|+|||...
T Consensus 334 ~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 334 TKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred hcCcccCcchHHHhcCcceee
Confidence 999999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=345.80 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=203.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ........|+.+++.+ .|++++.+.+.+.+.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-----NSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-----CCCCeeeeeEEEecCCEE
Confidence 3788899999999999999999999999999986432 1223456788888887 568899999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~------------------ 137 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD------------------ 137 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC------------------
Confidence 9999999 899999987655557999999999999999999999999999999999999944
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.++|+|||++....... ....||..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus 138 ---------~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~ 208 (285)
T cd05630 138 ---------HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208 (285)
T ss_pred ---------CCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence 4557777777665433222 22468999999999999999999999999999999999999997643211
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
........... .....+..+++++.+||.+||+.|
T Consensus 209 ~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05630 209 KREEVERLVKE---------------------------------------------VQEEYSEKFSPDARSLCKMLLCKD 243 (285)
T ss_pred hHHHHHhhhhh---------------------------------------------hhhhcCccCCHHHHHHHHHHhhcC
Confidence 11111000000 000122356778999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCCCC
Q 013973 411 PTDRLT-----AREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~t-----a~ell~hp~f~~~~ 430 (433)
|++||| +.|+++||||++-.
T Consensus 244 p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 244 PKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHHccCCCCCchHHHHcChhhhccC
Confidence 999999 99999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=356.46 Aligned_cols=251 Identities=27% Similarity=0.494 Sum_probs=220.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe-
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH- 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~- 172 (433)
++|..++.||+|+||.+++++++..++.||+|.++. ....+.....|+.+++++ .||+|+.+.+.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-----~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-----LHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-----cCCCeeeeccchhcCCce
Confidence 569999999999999999999999999999999963 334556778899999998 67999999999998887
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||+|| ||+|.+.+.+..+.-|+++.+..|+.|++.|+.|||++.|+|||||+.||+++
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt------------------ 140 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT------------------ 140 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc------------------
Confidence 99999999 99999999887767899999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
++..+||+|||+|+...+.. .+++||+.||.||++.+.+|+.++|||||||++|||++-+.+|++.+.
T Consensus 141 ---------k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 141 ---------KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred ---------ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 55567888888888766654 457899999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
......|.+.... +.+..++.+++.+|..||+
T Consensus 212 ~~Li~ki~~~~~~------------------------------------------------Plp~~ys~el~~lv~~~l~ 243 (426)
T KOG0589|consen 212 SELILKINRGLYS------------------------------------------------PLPSMYSSELRSLVKSMLR 243 (426)
T ss_pred HHHHHHHhhccCC------------------------------------------------CCCccccHHHHHHHHHHhh
Confidence 7776665554311 1234667899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~ 427 (433)
.+|..||+|.++|.+|.+.
T Consensus 244 ~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 244 KNPEHRPSALELLRRPHLL 262 (426)
T ss_pred cCCccCCCHHHHhhChhhh
Confidence 9999999999999998875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=352.42 Aligned_cols=292 Identities=26% Similarity=0.438 Sum_probs=224.4
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... .........|+.+++.+ .|+|++++++.+...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 87 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-----NHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-----CCCCCcceeeeeccC
Confidence 3467899999999999999999999999999999998532 22334566788888888 678899999887543
Q ss_pred ------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 171 ------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 171 ------~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
...|+||||++++|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 88 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~--------- 154 (353)
T cd07850 88 KSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--------- 154 (353)
T ss_pred CCccccCcEEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---------
Confidence 46799999998899998864 38999999999999999999999999999999999999544
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
+.+||+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 155 ------------------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 216 (353)
T cd07850 155 ------------------CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVL 216 (353)
T ss_pred ------------------CCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCC
Confidence 456666666665433221 224688999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+.......+...++..+.++..........+.......... .+....................+..+.+|
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 217 FPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGY------SFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCc------chhhhCcccccCcccccccccchhHHHHH
Confidence 999888888888889999998888777766555554332110000 00000000000000000122456678999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
|.+||+.||++|||+.|+|.||||.
T Consensus 291 i~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHcCCChhhCcCHHHHhcChhHh
Confidence 9999999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=340.47 Aligned_cols=277 Identities=31% Similarity=0.510 Sum_probs=211.6
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++++.||+|++|.||+|++..+++.||+|.++... ........|+.+++.+ .|++++++++.+..++.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-----QHPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-----CCCCEeeeEEEEeeCCeEE
Confidence 4899999999999999999999999999999986322 2234567788888888 5789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKLGSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+.++|.+++..... ..+++..+..++.||+.||.|||+.||+|+||||+|||+++++.+
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~--------------- 140 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVI--------------- 140 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcE---------------
Confidence 9999998899998875432 468999999999999999999999999999999999999665554
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
+|+|||++....... ....+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+....
T Consensus 141 ------------~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 141 ------------KLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred ------------EECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 455555443222111 122568899999998764 4789999999999999999999999988777
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+...++......++....... +... .+. ............++.++.+||.+||+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~ 268 (285)
T cd07861 209 DQLFRIFRILGTPTEDVWPGVTSLPD-YKNT----FPK---------------WKKGSLRSAVKNLDEDGLDLLEKMLIY 268 (285)
T ss_pred HHHHHHHHHhCCCChhhhhcchhhHH-HHhh----ccc---------------cCcchhHHhcCCCCHHHHHHHHHHhcC
Confidence 76666666666655444332221111 0000 000 000011112345788999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013973 410 DPTDRLTAREALRHPFF 426 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f 426 (433)
||++|||+.+|+.||||
T Consensus 269 dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 269 DPAKRISAKKALNHPYF 285 (285)
T ss_pred ChhhCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=354.81 Aligned_cols=244 Identities=28% Similarity=0.478 Sum_probs=199.6
Q ss_pred eeeeccccEEEEEEEE---CCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 103 SKMGEGTFGQVLECWD---RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~---~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
+.||+|+||.||++.+ ..+++.||+|+++... ........|+++++++ +|+||+++++.+...+.+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-----NHPFIVKLHYAFQTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-----CCCCcccEEEEEEcCCEEEEE
Confidence 6799999999999976 3578999999997432 2233456788888887 678999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---------------------- 132 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---------------------- 132 (318)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----------------------
Confidence 9999 899999997654 699999999999999999999999999999999999994
Q ss_pred cccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~ 332 (433)
.++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+..
T Consensus 133 -----~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 207 (318)
T cd05582 133 -----EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207 (318)
T ss_pred -----CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH
Confidence 4456777777776543322 12357999999999999988999999999999999999999999877665544
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
..+... ... .+..++.++.+||.+||+.||+
T Consensus 208 ~~i~~~-----------------------~~~--------------------------~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 208 TMILKA-----------------------KLG--------------------------MPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred HHHHcC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHhhcCHh
Confidence 332211 111 1234567899999999999999
Q ss_pred CCCC-----HHHHhcCCCCCCC
Q 013973 413 DRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 413 ~R~t-----a~ell~hp~f~~~ 429 (433)
+||+ +.+++.||||+..
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCC
Confidence 9999 7789999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=353.96 Aligned_cols=244 Identities=27% Similarity=0.386 Sum_probs=193.9
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHH-HHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~-l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
+.||+|+||+||+|.++.+++.||+|++.... ........|..+ ++.+ .|+||+++++.+...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-----KHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-----CCCCCccEEEEEecCCEEEEEE
Confidence 46999999999999999999999999997432 122233334333 2333 6789999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~---------------------- 131 (325)
T cd05604 76 DFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS---------------------- 131 (325)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC----------------------
Confidence 999 899999987654 7999999999999999999999999999999999999954
Q ss_pred ccCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
++.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.+.
T Consensus 132 -----~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (325)
T cd05604 132 -----QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206 (325)
T ss_pred -----CCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence 4556777777665321 11234579999999999999999999999999999999999999998766554433
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+.. +... .....+..+.++|.+||+.||.+
T Consensus 207 ~~~~-----------------------~~~~--------------------------~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 207 NILH-----------------------KPLV--------------------------LRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred HHHc-----------------------CCcc--------------------------CCCCCCHHHHHHHHHHhccCHHh
Confidence 2211 0000 11245667899999999999999
Q ss_pred CCCH----HHHhcCCCCCCC
Q 013973 414 RLTA----REALRHPFFTRD 429 (433)
Q Consensus 414 R~ta----~ell~hp~f~~~ 429 (433)
||++ .+++.||||...
T Consensus 238 R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCCCCCCHHHHhcCCCcCCC
Confidence 9976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=351.99 Aligned_cols=243 Identities=27% Similarity=0.433 Sum_probs=192.9
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhh----HHHHHHHHHH-HHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~E~~~-l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
+.||+|+||.||+|++..+++.||+|++...... ......|... ++.+ .|++|+++++.+...+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-----KHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-----CCCCCCceeEEEEcCCeEEEEE
Confidence 4799999999999999999999999999743211 1122223322 3333 6789999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~--------------------- 132 (325)
T cd05602 76 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ--------------------- 132 (325)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---------------------
Confidence 999 889999998754 68999999999999999999999999999999999999544
Q ss_pred ccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
+.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 133 ------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (325)
T cd05602 133 ------GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206 (325)
T ss_pred ------CCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence 4566666666543211 1233579999999999999999999999999999999999999998766655443
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+.... .......+.++.++|.+||+.||.+
T Consensus 207 ~i~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 207 NILNKP-------------------------------------------------LQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred HHHhCC-------------------------------------------------cCCCCCCCHHHHHHHHHHcccCHHH
Confidence 322100 0112356778999999999999999
Q ss_pred CCCHH----HHhcCCCCCC
Q 013973 414 RLTAR----EALRHPFFTR 428 (433)
Q Consensus 414 R~ta~----ell~hp~f~~ 428 (433)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=341.01 Aligned_cols=276 Identities=29% Similarity=0.480 Sum_probs=211.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++.+.||+|+||.||+|++..+|+.||+|.++... ........|+.+++.+ +|++++++++++.+...++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-----CCCCeeeHHHHhccCCceE
Confidence 4899999999999999999999999999999986421 1224456789999888 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+|+||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 76 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~----------------- 137 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE----------------- 137 (284)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc-----------------
Confidence 999999889999887643 36999999999999999999999999999999999999965554
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCCC-CCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF-QTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf-~~~~~~ 329 (433)
++|+|||.+....... ....++..|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+..
T Consensus 138 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 138 ----------LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred ----------EEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 5555555444322111 1235788999999987754 789999999999999999988774 556666
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+.+.++..+...+.......... .++... . .....+....++.++.+||.+||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~---~-----------~~~~~~~~~~~~~~~~~li~~~l~~ 267 (284)
T cd07839 208 DQLKRIFRLLGTPTEESWPGVSKLPDYK------PYPMYP---A-----------TTSLVNVVPKLNSTGRDLLQNLLVC 267 (284)
T ss_pred HHHHHHHHHhCCCChHHhHHhhhccccc------ccCCCC---C-----------cchhhhhcccCCHHHHHHHHHHhcC
Confidence 6777777777776665544333221110 000000 0 0000122345778999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013973 410 DPTDRLTAREALRHPFF 426 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f 426 (433)
||.+|||++|++.||||
T Consensus 268 ~P~~R~t~~~il~h~~f 284 (284)
T cd07839 268 NPVQRISAEEALQHPYF 284 (284)
T ss_pred ChhhcCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=351.93 Aligned_cols=323 Identities=33% Similarity=0.595 Sum_probs=259.2
Q ss_pred cCCCCCCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCC-CCC
Q 013973 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGN 158 (433)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~-~~~ 158 (433)
.++..|.|.+.+++.+.++|.+....|+|-|++|.+|.+...|..||||+|+......+.-..|+++|++|..... +-.
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhh
Confidence 3556789999999999999999999999999999999999999999999999888888888899999999976643 345
Q ss_pred ceEEecceeecCCeEEEEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 159 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 159 ~i~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
||+.++..|...+++|||||-+..+|.+.|.+.+. -.|....++.|+.|++.||..|-..||+|.||||+|||+++
T Consensus 495 Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--- 571 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--- 571 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc---
Confidence 79999999999999999999999999999987653 45888999999999999999999999999999999999964
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCc-eeecCcccchhhhhCCCCCCcchhHHHHHHHHHH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~el 316 (433)
....+||||||.|.......-+ +.-+..|.|||++.|-+|+...|+||.||+||||
T Consensus 572 -----------------------~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYEl 628 (752)
T KOG0670|consen 572 -----------------------SKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYEL 628 (752)
T ss_pred -----------------------CcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEe
Confidence 4457899999999877655432 3446789999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCc-cchhhHhhhccc----hhHHHHHhh-
Q 013973 317 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA-ASRESIKSVMKL----PRLQNLIMQ- 390 (433)
Q Consensus 317 ltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~- 390 (433)
.||+..|.+.++.+.+..+..+-|.+|..|+.+.+=.-..|-..-.+.+-+.. .+......++.. ..+...+..
T Consensus 629 YtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~ 708 (752)
T KOG0670|consen 629 YTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV 708 (752)
T ss_pred eccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc
Confidence 99999999999999999999999999999887654322222222222111111 111111111111 111111111
Q ss_pred --hcC---CchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 391 --HVD---HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 391 --~~~---~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+++ ..-..+++||.+||..||++|.|..|+|.||||+.
T Consensus 709 q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 709 QRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred CCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 111 23356899999999999999999999999999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=355.45 Aligned_cols=246 Identities=27% Similarity=0.476 Sum_probs=193.1
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
||+|+||+||+|+++.+++.||+|++..... .......|..++.... ..+|++|+.++..+.....+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL--LDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc--cCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 7999999999999999999999999864321 1122334555554442 125789999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~------------------------- 131 (330)
T cd05586 79 SGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA------------------------- 131 (330)
T ss_pred CCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC-------------------------
Confidence 899999998654 7999999999999999999999999999999999999954
Q ss_pred CCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 335 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i 335 (433)
++.++|+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+
T Consensus 132 --~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 132 --TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred --CCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 44567777776643221 12335799999999999764 4899999999999999999999999876654433322
Q ss_pred HHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC
Q 013973 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 415 (433)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 415 (433)
. .+....+. ..++.++.+||.+||+.||.+||
T Consensus 210 ~-----------------------~~~~~~~~-------------------------~~~~~~~~~li~~~L~~~P~~R~ 241 (330)
T cd05586 210 A-----------------------FGKVRFPK-------------------------NVLSDEGRQFVKGLLNRNPQHRL 241 (330)
T ss_pred H-----------------------cCCCCCCC-------------------------ccCCHHHHHHHHHHcCCCHHHCC
Confidence 1 11111111 13567889999999999999998
Q ss_pred ----CHHHHhcCCCCCCC
Q 013973 416 ----TAREALRHPFFTRD 429 (433)
Q Consensus 416 ----ta~ell~hp~f~~~ 429 (433)
++.|+++||||.+.
T Consensus 242 ~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 242 GAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCHHHHhcCccccCC
Confidence 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.72 Aligned_cols=252 Identities=22% Similarity=0.399 Sum_probs=195.3
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+++.||+|+++... .....+..|+.++.++. +|++|+.+++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~----~~~~i~~~~~~~~~~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS----SNPFLVGLHSCFQTTSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc----CCCCEeeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999999999997432 22334556777776663 46789999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~----------------------- 131 (327)
T cd05617 77 YVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA----------------------- 131 (327)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC-----------------------
Confidence 99 999999987654 7999999999999999999999999999999999999954
Q ss_pred cCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
++.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 132 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~- 206 (327)
T cd05617 132 ----DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN- 206 (327)
T ss_pred ----CCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-
Confidence 4456677777665321 11233579999999999999999999999999999999999999996432110000
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
....... .+.... ...+...+..+.++|.+||+.||.+|
T Consensus 207 -------~~~~~~~--------~~~~~~--------------------------~~~p~~~~~~~~~li~~~L~~dP~~R 245 (327)
T cd05617 207 -------TEDYLFQ--------VILEKP--------------------------IRIPRFLSVKASHVLKGFLNKDPKER 245 (327)
T ss_pred -------cHHHHHH--------HHHhCC--------------------------CCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 0000000 000000 11233567789999999999999999
Q ss_pred CC------HHHHhcCCCCCCC
Q 013973 415 LT------AREALRHPFFTRD 429 (433)
Q Consensus 415 ~t------a~ell~hp~f~~~ 429 (433)
++ ..+++.||||...
T Consensus 246 ~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 246 LGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred CCCCCCCCHHHHHcCCCCCCC
Confidence 98 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=350.23 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=200.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|+++++||+|+||.||+++++.+++.||+|++.+... ....+..|+.++..+ .|++|+.+++.+.+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-----CCCCEeeEEEEEecCCE
Confidence 369999999999999999999999999999999864221 222345566666655 67889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~------------------ 136 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD------------------ 136 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC------------------
Confidence 99999999 999999998643 3689999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
.++.+||+|||++....... ...+||+.|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 137 ---------~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 137 ---------MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred ---------CCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 44567777777665332211 2247999999999997 34588999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+..+.+..+.... ....+|. .....+.++.+|
T Consensus 208 f~~~~~~~~~~~i~~~~---------------------~~~~~p~-----------------------~~~~~s~~~~~l 243 (332)
T cd05623 208 FYAESLVETYGKIMNHK---------------------ERFQFPA-----------------------QVTDVSEDAKDL 243 (332)
T ss_pred CCCCCHHHHHHHHhCCC---------------------ccccCCC-----------------------ccccCCHHHHHH
Confidence 98776655444332110 0011111 112457789999
Q ss_pred HHhccccCCCC--CCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTD--RLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~--R~ta~ell~hp~f~~~ 429 (433)
|.+||+.++.+ |+++.|+++||||+..
T Consensus 244 i~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 244 IRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.18 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=206.2
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
|+..+.||+|+||+||+|.+..+++.||+|++.... ........|+.+++.+ .|++++.+.+.+..++..|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-----NSQFVVNLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-----CCcCceeEEEEEecCCEEE
Confidence 788899999999999999999999999999986432 1223456788998888 5688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++...+...+++..+..++.|++.||.|||+.||+||||||+||++++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~------------------- 137 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD------------------- 137 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC-------------------
Confidence 999999 889999887655557999999999999999999999999999999999999944
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
++.++|+|||++....... ....||..|+|||++.+..++.++|+|||||++|+|++|..||........
T Consensus 138 --------~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 138 --------YGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred --------CCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4457777777665432211 234789999999999998999999999999999999999999987655433
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+..... .+. ...+..++.++.+|+.+||+.||
T Consensus 210 ~~~~~~~~~-------------------~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P 244 (285)
T cd05632 210 REEVDRRVL-------------------ETE--------------------------EVYSAKFSEEAKSICKMLLTKDP 244 (285)
T ss_pred HHHHHHhhh-------------------ccc--------------------------cccCccCCHHHHHHHHHHccCCH
Confidence 322211110 000 01123456788999999999999
Q ss_pred CCCCC-----HHHHhcCCCCCCCCC
Q 013973 412 TDRLT-----AREALRHPFFTRDHL 431 (433)
Q Consensus 412 ~~R~t-----a~ell~hp~f~~~~~ 431 (433)
++||+ +.+++.|+||.+..+
T Consensus 245 ~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 245 KQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred hHcCCCcccChHHHHcChhhhcCCH
Confidence 99999 899999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=349.43 Aligned_cols=244 Identities=26% Similarity=0.379 Sum_probs=192.7
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHH-HHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIE-VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~-~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
+.||+|+||.||+|++..+++.||+|++.+... .......|.. +++.+ .|+||+++++.+.+.+.+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-----KHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-----CCCCccceeeEEEcCCEEEEEE
Confidence 479999999999999999999999999874321 1222333433 33334 6789999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~---------------------- 131 (321)
T cd05603 76 DYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS---------------------- 131 (321)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC----------------------
Confidence 999 889998887653 7899999999999999999999999999999999999954
Q ss_pred ccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
++.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+...
T Consensus 132 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (321)
T cd05603 132 -----QGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206 (321)
T ss_pred -----CCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 44566666666553211 1133579999999999999899999999999999999999999998766544333
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+.. +... .+...+.++.++|.+||+.||.+
T Consensus 207 ~i~~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 207 NILH-----------------------KPLQ--------------------------LPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred HHhc-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHccCCHhh
Confidence 2211 1111 12345668899999999999999
Q ss_pred CCCH----HHHhcCCCCCCC
Q 013973 414 RLTA----REALRHPFFTRD 429 (433)
Q Consensus 414 R~ta----~ell~hp~f~~~ 429 (433)
|+++ .|+++|+||...
T Consensus 238 R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred cCCCCCCHHHHhCCCCcCCC
Confidence 9975 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=343.63 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=211.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
..+|.++.+||+|+||+|.+|..+.+.+.||||++++. +...+..+.|..+|... ...|.++++...|++-+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~----~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP----GKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecC----CCCchHHHHHHHhhhhh
Confidence 45799999999999999999999999999999999753 23344455676666543 34578999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ ||+|--++++-+ ++.+..+..|+.+|+.||-|||++|||+||||.+|||++.+|++||+|||++...-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999 999999998876 89999999999999999999999999999999999999666655444444433221
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.......++||||.|+|||++...+|+.++||||+||+||||+.|++||.+.++.+
T Consensus 502 ------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 502 ------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred ------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 11122345799999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..|...--. ++..+|.++.+++..+|.+.
T Consensus 558 lF~aI~ehnvs-------------------------------------------------yPKslSkEAv~ickg~ltK~ 588 (683)
T KOG0696|consen 558 LFQAIMEHNVS-------------------------------------------------YPKSLSKEAVAICKGLLTKH 588 (683)
T ss_pred HHHHHHHccCc-------------------------------------------------CcccccHHHHHHHHHHhhcC
Confidence 87765443221 23467889999999999999
Q ss_pred CCCCCCH-----HHHhcCCCCCCC
Q 013973 411 PTDRLTA-----REALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta-----~ell~hp~f~~~ 429 (433)
|.+|+.+ .++-.||||+..
T Consensus 589 P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 589 PGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred CccccCCCCccccchhhCcchhhc
Confidence 9999964 699999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=354.59 Aligned_cols=256 Identities=26% Similarity=0.458 Sum_probs=219.8
Q ss_pred cEEEE--eeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 98 RYKIH--SKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 98 ~~~~~--~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
-|++. +.||+|-||+||-|.++.+|+.||||++.+. .+..+....|+.||+.+ +||.||.+...|++.+.
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-----~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-----HHPGIVNLECMFETPER 637 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-----CCCCeeEEEEeecCCce
Confidence 35543 7899999999999999999999999999643 34457788899999999 77899999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+++|||.+.|++.+.+-.....+|++....+++.||+.||.|||.++|||+||||+|||+.+.
T Consensus 638 vFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~----------------- 700 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA----------------- 700 (888)
T ss_pred EEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC-----------------
Confidence 999999999999998877777899999999999999999999999999999999999999643
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.-.++||||||+|++.+... ..++||+.|+|||++..+.|+..-|+||.||++|.-++|..||..+++..
T Consensus 701 -------~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 701 -------SPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred -------CCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh
Confidence 345689999999999887654 55799999999999999999999999999999999999999998655432
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
-. |....+-+|... |..+++++.|||.++|+..
T Consensus 774 dQ-------------------------IQNAaFMyPp~P----------------------W~eis~~AidlIn~LLqVk 806 (888)
T KOG4236|consen 774 DQ-------------------------IQNAAFMYPPNP----------------------WSEISPEAIDLINNLLQVK 806 (888)
T ss_pred HH-------------------------hhccccccCCCc----------------------hhhcCHHHHHHHHHHHHHH
Confidence 21 222233333322 3467889999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
=.+|.+.+..|.|||+++-
T Consensus 807 m~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 807 MRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHhcchHhhccchhhhcc
Confidence 9999999999999999875
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=349.49 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=201.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+++++.+++.||+|++.... .....+..|..++..+ .|++|+.+++.+...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-----DCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCE
Confidence 46999999999999999999999999999999986422 1223345566666655 67889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.|+||||+ ||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~------------------ 136 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD------------------ 136 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc------------------
Confidence 99999999 999999998643 3689999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
.++.+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 137 ---------~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 137 ---------MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred ---------CCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 44567777777765433222 22479999999999976 4688999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+..+.+..+.... ..+.+|. .....+.++++|
T Consensus 208 f~~~~~~~~~~~i~~~~---------------------~~~~~p~-----------------------~~~~~~~~~~~l 243 (331)
T cd05624 208 FYAESLVETYGKIMNHE---------------------ERFQFPS-----------------------HITDVSEEAKDL 243 (331)
T ss_pred ccCCCHHHHHHHHHcCC---------------------CcccCCC-----------------------ccccCCHHHHHH
Confidence 98766554443322110 0011111 112457789999
Q ss_pred HHhccccCCCC--CCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTD--RLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~--R~ta~ell~hp~f~~~ 429 (433)
|.+||+.++.+ |++++++++||||+..
T Consensus 244 i~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 244 IQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 99999976654 5689999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=359.36 Aligned_cols=277 Identities=27% Similarity=0.357 Sum_probs=199.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
...|.+.+.||+|+||.||+|.+..+++.||||.... .....|+.+++++ .|+||+++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L-----~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRL-----SHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHC-----CCCCCCcEEEEEEECCEEEE
Confidence 3579999999999999999999999999999996432 2346799999988 67899999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 176 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 176 V~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||++.++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 238 v~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~------------------- 297 (461)
T PHA03211 238 VLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE------------------- 297 (461)
T ss_pred EEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-------------------
Confidence 99999889999987643 3699999999999999999999999999999999999995544
Q ss_pred cccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE--- 327 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~--- 327 (433)
.+||+|||+++..... ....+||..|+|||++.+..++.++|||||||++|||++|..|+-...
T Consensus 298 --------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 298 --------DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred --------CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 4566666655432211 123469999999999999999999999999999999999876543211
Q ss_pred ----hHHHHHHHHHHhCCC----CHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 328 ----NLEHLAMMERVLGPL----PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 328 ----~~~~~~~i~~~~~~~----p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
....+..+....+.. +............... .....+. ............+.++
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~----------------~~~~~~~~~~~~~~~~ 431 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRA--ARNRRPA----------------YTRPAWTRYYKLDLDV 431 (461)
T ss_pred ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhh--hcccCCc----------------cCCcchhhhccccchH
Confidence 112222222222111 1000000000000000 0000000 0000000112345689
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 432 ~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 432 EYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 99999999999999999999999999975
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=334.48 Aligned_cols=252 Identities=36% Similarity=0.591 Sum_probs=202.3
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHH---HHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~---~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
|++++.||+|+||+||+|.+..+++.||+|++......... ...|+.+++.+ .|++|+++++++......++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-----RHPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-----TBTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-----cccccccccccccccccccc
Confidence 78999999999999999999999999999999865433332 24488888888 56889999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
|||++ +++|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+||+++
T Consensus 76 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~--------------------- 132 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD--------------------- 132 (260)
T ss_dssp EEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---------------------
T ss_pred cccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc---------------------
Confidence 99999 669999998443 799999999999999999999999999999999999994
Q ss_pred ccccCCCCCCEEEEecCCcccc---CCCCCceeecCcccchhhhh-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++.++|+|||.+... ........+|..|+|||++. +..++.++|+||||+++|+|++|..||......+
T Consensus 133 ------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 133 ------ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp ------TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred ------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 4556677777776532 11223357899999999998 7889999999999999999999999999774444
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.+........ ..........++.++|.+||+.|
T Consensus 207 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~~l~~~ 244 (260)
T PF00069_consen 207 QLEIIEKILKRPLPS------------------------------------------SSQQSREKSEELRDLIKKMLSKD 244 (260)
T ss_dssp HHHHHHHHHHTHHHH------------------------------------------HTTSHTTSHHHHHHHHHHHSSSS
T ss_pred hhhhhhhcccccccc------------------------------------------cccccchhHHHHHHHHHHHccCC
Confidence 443333222110000 00001122368999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|++||++.++++||||
T Consensus 245 p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 245 PEQRPSAEELLKHPWF 260 (260)
T ss_dssp GGGSTTHHHHHTSGGG
T ss_pred hhHCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=363.48 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=201.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 171 (433)
.++|.+.+.||+|+||+||+|.+..+++.||||++... .........|+.++..+ .|++++++...+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-----~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-----DFFSIVKCHEDFAKKDP 105 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-----CCCcEEEeecceecccc
Confidence 46899999999999999999999999999999998642 23334556677777665 6688998877664322
Q ss_pred -------eEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 172 -------HICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 172 -------~~~lV~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
.+++||||+ +|+|.++|.... ...+++..+..++.|++.||.|||++|||||||||+|||++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~------- 178 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS------- 178 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC-------
Confidence 478999999 899999987532 346899999999999999999999999999999999999954
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~el 316 (433)
++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 179 --------------------~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeL 238 (496)
T PTZ00283 179 --------------------NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYEL 238 (496)
T ss_pred --------------------CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 455777777766543221 2345799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 317 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 317 ltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
++|..||.+.+..+.+..+.. +.. ...+..++
T Consensus 239 ltG~~Pf~~~~~~~~~~~~~~-----------------------~~~-------------------------~~~~~~~~ 270 (496)
T PTZ00283 239 LTLKRPFDGENMEEVMHKTLA-----------------------GRY-------------------------DPLPPSIS 270 (496)
T ss_pred HHCCCCCCCCCHHHHHHHHhc-----------------------CCC-------------------------CCCCCCCC
Confidence 999999987665443332211 000 01123567
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+++.+||.+||+.||.+||++.++++|||++.
T Consensus 271 ~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 78999999999999999999999999999763
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=362.13 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=204.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC-CeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~-~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..|.+.+.||+|+||.||+|....+ ++.||+|.+... ......+..|+.+++.+ +|+||+++++.+...+++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-----~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-----DHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEEECCEEE
Confidence 3499999999999999999998877 788999976532 23334566788888887 7799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
|||||+ ||+|.++|... ....+++.++..++.||+.||+|||++|||||||||+|||++.
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----------------- 204 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP----------------- 204 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC-----------------
Confidence 999999 99999988642 2246899999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 205 ----------~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 205 ----------TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ----------CCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 456777777776543322 23357999999999999999999999999999999999999999876
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+.+..+... . . ...+..++.++.+||.+|
T Consensus 275 ~~~~~~~~~~~~--~---------------------~-------------------------~~~~~~~s~~~~~li~~~ 306 (478)
T PTZ00267 275 SQREIMQQVLYG--K---------------------Y-------------------------DPFPCPVSSGMKALLDPL 306 (478)
T ss_pred CHHHHHHHHHhC--C---------------------C-------------------------CCCCccCCHHHHHHHHHH
Confidence 655443332110 0 0 001224567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~ 427 (433)
|+.||++||++.+++.|+|++
T Consensus 307 L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 307 LSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred hccChhhCcCHHHHHhCHHHH
Confidence 999999999999999999985
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=349.27 Aligned_cols=298 Identities=18% Similarity=0.250 Sum_probs=205.1
Q ss_pred EEeeeecc--ccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 101 IHSKMGEG--TFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 101 ~~~~iG~G--~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
++++||+| +|++||++.++.+|+.||+|.++.. .........|+.+++.+ +|+||+++++++..++..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-----NHPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEECCEEEE
Confidence 56889999 7899999999999999999998743 22334566788888877 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.......+++..++.++.|++.||+|||++|||||||||+|||++.++.++++||+....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~------ 150 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS------ 150 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhc------
Confidence 99999 89999999765445699999999999999999999999999999999999998877777777753321
Q ss_pred ccccCCCCCCEEEEecCCccc-cCCCCCceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTY-ERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+.++|.... .........++..|+|||++.+ ..++.++|||||||++|||++|..||........
T Consensus 151 ------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 151 ------------MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred ------------cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 112221110 0111122357788999999986 4689999999999999999999999986554433
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhcc----C-cccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRR----G-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
.... ..+..+... .......+.+... + ........... .................+++++.+||.+|
T Consensus 219 ~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 290 (327)
T cd08227 219 LLEK--LNGTVPCLL-DTTTIPAEELTMKPSRSGANSGLGESTTVS-----TPRPSNGESSSHPYNRTFSPHFHHFVEQC 290 (327)
T ss_pred HHHH--hcCCccccc-cccchhhhhcccCCcccCCcCCCCcccccC-----CcCccccCCcccccccccCHHHHHHHHHH
Confidence 2221 112222110 0000000000000 0 00000000000 00000000001112234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|+.||++|||++|+++||||++.
T Consensus 291 l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 291 LQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred HhhCchhcCCHHHHhcChhhhhc
Confidence 99999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=338.66 Aligned_cols=250 Identities=23% Similarity=0.414 Sum_probs=195.7
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
||+|+||.||++.++.+|+.||+|.+.... ........|+++++.+ +|++|+++.+.++...++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-----NSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-----CCCcEEEEEEEEecCCeEEEEEecC
Confidence 799999999999999999999999986321 1223345688888887 6789999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
|++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||+++
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~------------------------- 130 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD------------------------- 130 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC-------------------------
Confidence 899999887665557899999999999999999999999999999999999954
Q ss_pred CCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 337 (433)
++.++|+|||++....... ....||..|+|||++.+..++.++|+|||||++|||++|..||...........+..
T Consensus 131 --~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05607 131 --QGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208 (277)
T ss_pred --CCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence 4456777777665433221 224689999999999998899999999999999999999999975432111111000
Q ss_pred HhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCH
Q 013973 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 417 (433)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta 417 (433)
. ........ ....++.++++||.+||+.||++||++
T Consensus 209 ~-------------------~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~~P~~R~~~ 244 (277)
T cd05607 209 R-------------------TLEDEVKF-------------------------EHQNFTEESKDICRLFLAKKPEDRLGS 244 (277)
T ss_pred H-------------------hhcccccc-------------------------ccccCCHHHHHHHHHHhccCHhhCCCC
Confidence 0 00000000 012457789999999999999999999
Q ss_pred ----HHHhcCCCCCCCC
Q 013973 418 ----REALRHPFFTRDH 430 (433)
Q Consensus 418 ----~ell~hp~f~~~~ 430 (433)
++++.||||+.-.
T Consensus 245 ~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 245 REKNDDPRKHEFFKTIN 261 (277)
T ss_pred ccchhhhhcChhhcCCC
Confidence 7788999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=335.90 Aligned_cols=277 Identities=32% Similarity=0.527 Sum_probs=216.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++++.||.|++|.||+|+++.+++.||||.++... .....+..|+++++++ .|+|++++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-----CCCCCcchhhhcccCCcEE
Confidence 4899999999999999999999999999999886322 1234567899999988 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||+.++|.+++.......+++..+..++.|++.||+|||+.||+|+||||+||+++++
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~------------------- 136 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE------------------- 136 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-------------------
Confidence 9999997799999887655679999999999999999999999999999999999999544
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.+||+|||.+....... ....++..|+|||++.+.. ++.++|+|||||++|+|+||..||...+..+
T Consensus 137 --------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 208 (284)
T cd07860 137 --------GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208 (284)
T ss_pred --------CCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 456666666654332211 2235688999999887654 6889999999999999999999999888877
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+...++..+...+............-. .+. . .........++.++.++|.+||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-----~-------------~~~~~~~~~~~~~~~~li~~~l~~~ 268 (284)
T cd07860 209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP--KWA-----R-------------QDFSKVVPPLDEDGRDLLSQMLHYD 268 (284)
T ss_pred HHHHHHHHhCCCChhhhhhhhHHHHHHhhcc--ccc-----c-------------cCHHHHcccCCHHHHHHHHHhcCCC
Confidence 7777777777776655443322211111000 000 0 0001112356778999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|++|||++|++.||||
T Consensus 269 P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 269 PNKRISAKAALAHPFF 284 (284)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=349.57 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=203.2
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
.+++++.||+|-||.||+|....+. .||+|.++......+.+..|+++|++| .|++||++++++..++.+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L-----~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKL-----RHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhC-----cccCeEEEEEEEecCCceEEEE
Confidence 4567789999999999999987553 499999986555667788999999999 6688999999999988999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||| .|+|.+||+..++..+...+.+.++.|||.|++||+++++|||||-..|||++
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----------------------- 337 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----------------------- 337 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec-----------------------
Confidence 999 99999999986667899999999999999999999999999999999999995
Q ss_pred ccCCCCCCEEEEecCCccccCCCCCce----eecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQNYI----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 331 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~ 331 (433)
++..+||+|||+|+...++.... .-..-|.|||.+....++.+||||||||+||||+| |+.||.+.+..+.
T Consensus 338 ----~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 338 ----EDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred ----cCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 45566666666666333322111 12567999999999999999999999999999999 9999999888777
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccC-cccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
+..+. +| ++. .|+.+|+++.+++..||..+
T Consensus 414 ~~~le-----------------------~GyRlp--------------------------~P~~CP~~vY~lM~~CW~~~ 444 (468)
T KOG0197|consen 414 LELLE-----------------------RGYRLP--------------------------RPEGCPDEVYELMKSCWHED 444 (468)
T ss_pred HHHHh-----------------------ccCcCC--------------------------CCCCCCHHHHHHHHHHhhCC
Confidence 66543 22 222 34578899999999999999
Q ss_pred CCCCCCHHHHh
Q 013973 411 PTDRLTAREAL 421 (433)
Q Consensus 411 P~~R~ta~ell 421 (433)
|++|||.+.+.
T Consensus 445 P~~RPtF~~L~ 455 (468)
T KOG0197|consen 445 PEDRPTFETLR 455 (468)
T ss_pred cccCCCHHHHH
Confidence 99999987553
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=340.89 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=210.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
-|.++++||+|+||.||+|.++.+|+.+|||.+. .+....+...|+.+++++ ..+++|+.|+.|-....++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP-V~sDLQEIIKEISIMQQC-----~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP-VDTDLQEIIKEISIMQQC-----KSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC-ccchHHHHHHHHHHHHHc-----CCchhhhhhhhhccCCceEeeh
Confidence 3889999999999999999999999999999986 345567788899999999 6688999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||| .|++.|.++.++ ++|++.++..++...+.||+|||...-||||||..|||++-+|+.|
T Consensus 108 EYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AK----------------- 169 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAK----------------- 169 (502)
T ss_pred hhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhh-----------------
Confidence 999 789999988764 6899999999999999999999999999999999999996665554
Q ss_pred ccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
|+|||.|....+ ..+++.||+.|||||++..-.|+.++||||||++..||..|++||.+-..+...-
T Consensus 170 ----------LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF 239 (502)
T KOG0574|consen 170 ----------LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF 239 (502)
T ss_pred ----------hhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence 555555543332 2356789999999999999999999999999999999999999998755543322
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
+|-. .++|. . ..+...+.++.|||++||.++|++
T Consensus 240 MIPT--~PPPT-------------------------F-------------------~KPE~WS~~F~DFi~~CLiK~PE~ 273 (502)
T KOG0574|consen 240 MIPT--KPPPT-------------------------F-------------------KKPEEWSSEFNDFIRSCLIKKPEE 273 (502)
T ss_pred eccC--CCCCC-------------------------C-------------------CChHhhhhHHHHHHHHHhcCCHHH
Confidence 2100 01110 0 012345778999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 013973 414 RLTAREALRHPFFTRDH 430 (433)
Q Consensus 414 R~ta~ell~hp~f~~~~ 430 (433)
|-||.++++|||.++.+
T Consensus 274 R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 274 RKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHHHhhhhhhcCCC
Confidence 99999999999998764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=364.70 Aligned_cols=293 Identities=22% Similarity=0.311 Sum_probs=203.1
Q ss_pred ecCceecCcEEEEeeeeccccEEEEEEEECCCCe-EEEEE------------------EeecchhhHHHHHHHHHHHHHH
Q 013973 90 ALGENLTSRYKIHSKMGEGTFGQVLECWDRERKE-MVAIK------------------IVRGIKKYREAAMIEIEVLQQL 150 (433)
Q Consensus 90 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~-~vAiK------------------~~~~~~~~~~~~~~E~~~l~~l 150 (433)
..+..+.++|++++.||+|+||+||+|..+.... .+++| .++........+..|+.+++.+
T Consensus 141 ~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 141 KHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred ccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 3344566789999999999999999987653322 12222 1122223344567899999888
Q ss_pred HhcCCCCCceEEecceeecCCeEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 013973 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 227 (433)
Q Consensus 151 ~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp 227 (433)
+|+||+++++++...+..|+|+++++++|.+++.... ........++.++.||+.||+|||++|||||||||
T Consensus 221 -----~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 221 -----NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred -----CCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 6789999999999999999999999889998876432 12234667889999999999999999999999999
Q ss_pred CceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCc
Q 013973 228 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYP 303 (433)
Q Consensus 228 ~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~ 303 (433)
+|||++. ++.+||+|||++....... ...+||..|+|||++.+..++.+
T Consensus 296 ~NILl~~---------------------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 348 (501)
T PHA03210 296 ENIFLNC---------------------------DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI 348 (501)
T ss_pred HHEEECC---------------------------CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH
Confidence 9999944 4567777777776443322 23479999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCC-CCCC--ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhcc
Q 013973 304 CDIWSVGCILVELCTGEAL-FQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380 (433)
Q Consensus 304 ~DvwSlGv~l~elltg~~P-f~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
+|||||||++|||++|..+ |... .....+..+...++....++.. .......++....+....
T Consensus 349 ~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~i~~~~~~~~~------------- 414 (501)
T PHA03210 349 TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD-PPCKLFDYIDSAEIDHAG------------- 414 (501)
T ss_pred HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCC-cHHHHHHHhhhhhcccCc-------------
Confidence 9999999999999998754 4322 2334444444444332222111 011111122111110000
Q ss_pred chhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
..+..... ...++.++.++|.+||++||.+|||+.|+|.||||.....
T Consensus 415 -~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~ 462 (501)
T PHA03210 415 -HSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE 462 (501)
T ss_pred -cchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence 00001110 1135667899999999999999999999999999987543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=334.80 Aligned_cols=278 Identities=28% Similarity=0.464 Sum_probs=212.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++.+.||+|++|.||+|.++.+++.||+|.+..... .......|+.+++.+ .|++|+++++++.+....|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-----KHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-----CCcceeeEEEEEecCCeEE
Confidence 569999999999999999999999999999999864321 223456799999988 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+++++.
T Consensus 80 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~----------------- 141 (291)
T cd07844 80 LVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE----------------- 141 (291)
T ss_pred EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC-----------------
Confidence 999999779999987654 36899999999999999999999999999999999999965554
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE-NL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~-~~ 329 (433)
+||+|||.+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..
T Consensus 142 ----------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 211 (291)
T cd07844 142 ----------LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211 (291)
T ss_pred ----------EEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 555555554322111 112246888999999876 458899999999999999999999997765 55
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch--hHHHHHHHhcc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA--GDLTHLLQGLL 407 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L 407 (433)
+.+..+...++.+....+..+.............. ....+ .......+ .++.++|.+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-------------~~~~~~~~~~~~~~~li~~~L 272 (291)
T cd07844 212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFY------PPRPL-------------INHAPRLDRIPHGEELALKFL 272 (291)
T ss_pred HHHHHHHHhcCCCChhhhhhhhhcccccccccccc------CChhH-------------HHhCcCCCCchhHHHHHHHHh
Confidence 66677777777766665554432221111110000 00000 01111223 67899999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013973 408 RYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f 426 (433)
+.||++|||+.|+++||||
T Consensus 273 ~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 273 QYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccCcccccCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=336.02 Aligned_cols=250 Identities=28% Similarity=0.474 Sum_probs=209.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+..|+++++++ .|+||+++++.+...+.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-----RHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCccceeeEEEcCCe
Confidence 36999999999999999999999999999999986432 2345567788888888 57899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~------------------ 135 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD------------------ 135 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC------------------
Confidence 99999999 999999998764 799999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++.+||+|||++...........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus 136 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 206 (290)
T cd05580 136 ---------SDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206 (290)
T ss_pred ---------CCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 44567888888776655444556789999999999888889999999999999999999999987664333
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.. +... .+...+..++++|.+||+.||
T Consensus 207 ~~~~~~-----------------------~~~~--------------------------~~~~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 207 YEKILE-----------------------GKVR--------------------------FPSFFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred HHHHhc-----------------------CCcc--------------------------CCccCCHHHHHHHHHHccCCH
Confidence 322211 1111 122446789999999999999
Q ss_pred CCCC-----CHHHHhcCCCCCCC
Q 013973 412 TDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~-----ta~ell~hp~f~~~ 429 (433)
.+|+ +++|+++||||...
T Consensus 238 ~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 238 TKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHccCcccCCHHHHHcCcccccC
Confidence 9999 89999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=358.44 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=212.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEee-cchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+-|.|+..||.|+||+||+|.++.++-..|-|++. +.....+.++-|++||..+ .||+|+++++.|-..+.++|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-----dHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-----DHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-----CChHHHHHHHHHhccCceEE
Confidence 45889999999999999999999999989999886 3455667788899999988 78999999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+.||| ||-....+..-+ +.|++.++..+.+|++.||.|||+++|||||||..|||++-+|.
T Consensus 107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd----------------- 168 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD----------------- 168 (1187)
T ss_pred EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc-----------------
Confidence 99999 666666655544 68999999999999999999999999999999999999976654
Q ss_pred ccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++|+|||.+..... ....+.|||+|||||++.. .+|+.++||||||++|.||..+.+|.+..
T Consensus 169 ----------irLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 169 ----------IRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred ----------EeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 55555554432221 2345789999999999864 57999999999999999999999999998
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+.+..+..|.+.-.|+- -.+..++..+.||+..|
T Consensus 239 npMRVllKiaKSePPTL----------------------------------------------lqPS~Ws~~F~DfLk~c 272 (1187)
T KOG0579|consen 239 NPMRVLLKIAKSEPPTL----------------------------------------------LQPSHWSRSFSDFLKRC 272 (1187)
T ss_pred chHHHHHHHhhcCCCcc----------------------------------------------cCcchhhhHHHHHHHHH
Confidence 88887766655332211 11345677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|.+||..||+++|+|+||||++..
T Consensus 273 L~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 273 LVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HhcCCccCCCHHHHhhCcccccCC
Confidence 999999999999999999998643
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=336.55 Aligned_cols=279 Identities=29% Similarity=0.469 Sum_probs=214.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+|++.+.||+|+||.||+|.+..+++.||+|.++.... ....+..|+++++.+ .|++++++++++.+.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-----KHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-----CCCCChhhhheeecCC
Confidence 48899999999999999999999999999999874322 234456788888887 5788999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
..++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~--------------- 139 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG--------------- 139 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC---------------
Confidence 999999999889999997654 4699999999999999999999999999999999999996554
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.++|+|||++....... ....++..|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.+
T Consensus 140 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 140 ------------VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred ------------CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 45555555554332211 12356788999999865 457899999999999999999999998887
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+...++......+................. ..........+.++.+||.+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~~l 266 (298)
T cd07841 208 DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPP---------------------TPLKQIFPAASDDALDLLQRLL 266 (298)
T ss_pred cHHHHHHHHHHcCCCchhhhhhcccccccccccccCC---------------------cchhhhcccccHHHHHHHHHHh
Confidence 7777777666666555444332211110000000000 0001122455778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.||++|||+.|+++||||++.+
T Consensus 267 ~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 267 TLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cCCcccCcCHHHHhhCccccCCC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=335.20 Aligned_cols=253 Identities=22% Similarity=0.399 Sum_probs=199.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec------
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------ 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~------ 169 (433)
.+.|++.+.||+|+||.||+|.+..+++.||+|++............|+.++..+. +|+|++++.+.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc----CCCCeeeEeeEEeecCCCCC
Confidence 46799999999999999999999999999999999765555566778888887763 46789999998864
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...+|+||||+ +++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+||+++.+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~------------- 147 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN------------- 147 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-------------
Confidence 35789999999 8899999987555579999999999999999999999999999999999999544
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
+.++|+|||++..... ......|+..|+|||++. +..++.++|||||||++|||++|.
T Consensus 148 --------------~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~ 213 (272)
T cd06637 148 --------------AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213 (272)
T ss_pred --------------CCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 4566666666543321 122357899999999986 345888999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||...........+.. ...... ....++.++.
T Consensus 214 ~p~~~~~~~~~~~~~~~----------------------~~~~~~-------------------------~~~~~~~~~~ 246 (272)
T cd06637 214 PPLCDMHPMRALFLIPR----------------------NPAPRL-------------------------KSKKWSKKFQ 246 (272)
T ss_pred CCccccCHHHHHHHHhc----------------------CCCCCC-------------------------CCCCcCHHHH
Confidence 99975543322211100 000000 0123466899
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+||.+||+.||.+|||+.|++.||||
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 247 SFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=330.16 Aligned_cols=278 Identities=31% Similarity=0.576 Sum_probs=208.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++.+.||+|+||.||+|.++.+++.||+|++.... ...+.+..|+.+++++ .|+|++.+++.+.....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-----KHPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-----CCCCEeeeeeEEeeCCEE
Confidence 36999999999999999999999999999999886322 2234567789998888 568899999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ ++.|..++... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++
T Consensus 76 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~---------------- 137 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG---------------- 137 (286)
T ss_pred EEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC----------------
Confidence 9999999 55555555443 3689999999999999999999999999999999999996544
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++|+|||++....... ....++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.
T Consensus 138 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 138 -----------QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred -----------cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 45555555554332221 12357889999999876 4578999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+....+............. .+...-....+.. ........+..+..+.+||.+||+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~ 268 (286)
T cd07847 207 VDQLYLIRKTLGDLIPRHQQIFSTN--QFFKGLSIPEPET----------------REPLESKFPNISSPALSFLKGCLQ 268 (286)
T ss_pred HHHHHHHHHHhCCCChHHhhhcccc--cccccccCCCccc----------------ccCHHHHhccCCHHHHHHHHHHhc
Confidence 7777777766666544321111000 0000000000000 000111223457889999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013973 409 YDPTDRLTAREALRHPFF 426 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f 426 (433)
.||++||++.|++.||||
T Consensus 269 ~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 269 MDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCccccCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=337.12 Aligned_cols=282 Identities=25% Similarity=0.391 Sum_probs=204.5
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+|++.+.||+|+||.||+|.+..++..||+|.+... ......+..|+++++++ .|+||+++++.+...+.+|+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-----NSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCEEEE
Confidence 599999999999999999999999999999998643 23345577899999888 66899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
||||+ +++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.
T Consensus 77 v~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~---------------- 138 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---------------- 138 (308)
T ss_pred EeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc----------------
Confidence 99999 889999998764 79999999999999999999997 68999999999999965554
Q ss_pred cccccCCCCCCEEEEecCCccccCC-CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~ 332 (433)
++|+|||.+..... .....+|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.....
T Consensus 139 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 139 -----------IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred -----------EEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 55555555433211 123347899999999998888999999999999999999999999765533322
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh----h-hcCCchhHHHHHHHhcc
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM----Q-HVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~li~~~L 407 (433)
..+ +..+......... ......+............ ...... . ....++.++++||.+||
T Consensus 208 ~~~----~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l 271 (308)
T cd06615 208 AMF----GRPVSEGEAKESH-------RPVSGHPPDSPRPMAIFEL-----LDYIVNEPPPKLPSGAFSDEFQDFVDKCL 271 (308)
T ss_pred Hhh----cCccccccccCCc-------ccccCCCCCccchhhHHHH-----HHHHhcCCCccCcCcccCHHHHHHHHHHc
Confidence 211 1111000000000 0000000000000000000 000000 0 01135678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+.||++|||+.|+++||||.+.
T Consensus 272 ~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 272 KKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cCChhhCcCHHHHhcChhhhhc
Confidence 9999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=331.67 Aligned_cols=278 Identities=35% Similarity=0.590 Sum_probs=216.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|++++++++++.....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-----QHPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-----CCCCCcceeeEEecCCeeE
Confidence 4899999999999999999999999999999986432 2345677888888888 5788999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||++++|.+++.... ..+++..+..++.||+.||+|||+.||+|+||||+||+++.
T Consensus 76 ~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~-------------------- 134 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA-------------------- 134 (286)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC--------------------
Confidence 999999999999987654 47999999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.++|+|||.+....... ....|+..|+|||++.+. .++.++|||||||++|||++|.+||.+..+.
T Consensus 135 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 207 (286)
T cd07832 135 -------DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI 207 (286)
T ss_pred -------CCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence 4456666666655433221 234689999999998754 4689999999999999999999999988888
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+...++......+......... +...++.... . ......+..+.++.+||.+||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-----------~----~~~~~~~~~~~~~~~li~~~l~~ 268 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDY----NKITFPESKP-----------I----PLEEIFPDASPEALDLLKGLLVY 268 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchh----hcccCCCCCc-----------c----hHHHhCCCccHHHHHHHHHHhcc
Confidence 877777777776655444332211100 0111111000 0 01112234567899999999999
Q ss_pred CCCCCCCHHHHhcCCCCC
Q 013973 410 DPTDRLTAREALRHPFFT 427 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~ 427 (433)
||++|||++++|+||||.
T Consensus 269 ~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 269 DPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ChhhCCCHHHHhhCcCcC
Confidence 999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=328.55 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=200.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... .....+..|+.+++++ +|++|+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-----QHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEccC
Confidence 45999999999999999999999999999999886321 1234566788888877 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
..+++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-------------- 140 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-------------- 140 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--------------
Confidence 9999999999 889999998754 68999999999999999999999999999999999999544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+.++|+|||.+....... ....|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 141 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 207 (263)
T cd06625 141 -------------GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207 (263)
T ss_pred -------------CCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 456666666654322111 2245788999999999988999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
...+.......+.... .. ...+...+.++.+||
T Consensus 208 ~~~~~~~~~~~~~~~~---------------------~~--------------------------~~~~~~~~~~~~~li 240 (263)
T cd06625 208 AEFEAMAAIFKIATQP---------------------TN--------------------------PQLPSHVSPDARNFL 240 (263)
T ss_pred cccchHHHHHHHhccC---------------------CC--------------------------CCCCccCCHHHHHHH
Confidence 7654433322111000 00 011235567899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f 426 (433)
.+||+.||.+|||+.|+++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=337.43 Aligned_cols=283 Identities=29% Similarity=0.448 Sum_probs=216.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--C
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--N 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~ 171 (433)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .......|+.+++++ .|++++++++++... +
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-----RHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-----CCCCCcceEEEEecCCCC
Confidence 569999999999999999999999999999999863321 122345789999888 668899999988654 5
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.+++||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++++++
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--------------- 145 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--------------- 145 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---------------
Confidence 789999999889999987643 4699999999999999999999999999999999999996544
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+||+|||.+...... .....++..|+|||++.+ ..++.++|+|||||++|||++|.+||...+
T Consensus 146 ------------~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 146 ------------CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred ------------CEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4555555555433221 112245788999999876 458899999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+...++..+..++........ .+.+..+.... . .........++++.+||.+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-----------~----~~~~~~~~~~~~~~~li~~ml 274 (309)
T cd07845 214 EIEQLDLIIQLLGTPNESIWPGFSDLPL----VGKFTLPKQPY-----------N----NLKHKFPWLSEAGLRLLNFLL 274 (309)
T ss_pred HHHHHHHHHHhcCCCChhhchhhhcccc----cccccccCCCC-----------C----chHHhccccCHHHHHHHHHHh
Confidence 8888888888888776665544322111 00111000000 0 000112235778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
+.||++|||+.|+++||||++..+
T Consensus 275 ~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 275 MYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cCChhhCcCHHHHhcChhhccCCC
Confidence 999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=300.32 Aligned_cols=279 Identities=30% Similarity=0.495 Sum_probs=224.4
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|.-.++||+|.||+||+|+++.+++.||+|.++-.+ .......+|+-+++.+ .|.||+++++....++.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-----khknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-----hhcceeehhhhhccCceeE
Confidence 4666789999999999999999999999999987432 3356778999999999 5578999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+|+|||..+|..|..+.+ +.++.+.++.++.|+++||.|+|++++.||||||.|+||+
T Consensus 78 lvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin--------------------- 135 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN--------------------- 135 (292)
T ss_pred EeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---------------------
Confidence 999999999999988765 4799999999999999999999999999999999999995
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.++.+|++|||+++-.+-.- +..+-|.+|.+|.++.+.+ |+...|+||.||++.|+.. |++.|.+.+..
T Consensus 136 ------~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 136 ------RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred ------cCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 45556666666665443322 1125689999999999876 8999999999999999987 89999999999
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+++..|.+.+|.+.++.|+.+.....+. .+|. ......-.+..+.+...-+||++++|.-
T Consensus 210 dqlkrif~~lg~p~ed~wps~t~lpdyk------~yp~--------------ypattswsqivp~lns~grdllqkll~c 269 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQWPSMTKLPDYK------PYPI--------------YPATTSWSQIVPKLNSTGRDLLQKLLKC 269 (292)
T ss_pred HHHHHHHHHhCCCccccCCccccCCCCc------ccCC--------------ccccchHHHHhhhhcchhHHHHHHHhcc
Confidence 9999999999998877655433221110 0000 0000111122335556779999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
+|.+|++|+++|+||||++-
T Consensus 270 np~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 270 NPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CcccccCHHHHhcCcccccc
Confidence 99999999999999999863
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=370.20 Aligned_cols=275 Identities=24% Similarity=0.438 Sum_probs=212.0
Q ss_pred cCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 91 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 91 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
.++...++|++++.||+|+||+||+|.+..+++.||+|++... ......+..|+.+++.+ .|++|++++++|
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-----~HPNIVrl~d~f 81 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-----KHKNIVRYIDRF 81 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-----CCCCcCeEEEEE
Confidence 3455668899999999999999999999999999999998632 33456677899999998 678999999987
Q ss_pred ec--CCeEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCceEeecc
Q 013973 168 DY--RNHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDL-------CMIHTDLKPENVLLVSS 235 (433)
Q Consensus 168 ~~--~~~~~lV~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-------~ivHrDlKp~NILl~~~ 235 (433)
.. ...+||||||+ +++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+..
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 43 46799999999 899999987531 24699999999999999999999985 49999999999999653
Q ss_pred CccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC--CCCCCcchhHHHHH
Q 013973 236 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGC 311 (433)
Q Consensus 236 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv 311 (433)
.. .+.+.... ....+....+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||
T Consensus 162 ~~-~lg~i~~~---------~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ 231 (1021)
T PTZ00266 162 IR-HIGKITAQ---------ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231 (1021)
T ss_pred cc-cccccccc---------ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHH
Confidence 21 11110000 0111345679999999987554322 33579999999999965 35889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|||++|..||...+....+.........+ +
T Consensus 232 ILYELLTGk~PF~~~~~~~qli~~lk~~p~l-----------------------p------------------------- 263 (1021)
T PTZ00266 232 IIYELCSGKTPFHKANNFSQLISELKRGPDL-----------------------P------------------------- 263 (1021)
T ss_pred HHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC-----------------------C-------------------------
Confidence 9999999999998665544332211100000 0
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
....+.++.+||..||+.+|.+||++.|+|.|||++.
T Consensus 264 i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 264 IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 1234668999999999999999999999999999974
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=342.81 Aligned_cols=252 Identities=26% Similarity=0.471 Sum_probs=200.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEee---cchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
..|+++++||+||.+.||++...+. ..||+|.+. ........+..|+..|.++..+ ..|++++++-..++.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~----~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGH----DKIIQLYDYEVTDGYL 435 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC----ceEEEEeeeeccCceE
Confidence 4699999999999999999986554 456666543 2345566788999999999654 5699999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
||||||-..+|..+|++... .++.-.+++|..|++.|+.++|+.||||.||||.|+|+.
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-------------------- 494 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-------------------- 494 (677)
T ss_pred EEEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE--------------------
Confidence 99999999999999998753 333348899999999999999999999999999999994
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCc-----eeecCcccchhhhhCCC-----------CCCcchhHHHHHHHHHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLG-----------WTYPCDIWSVGCILVELC 317 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGv~l~ell 317 (433)
.|.+||+|||+|.....+.+. .+||+.||+||.+.... .+.++||||||||||+|+
T Consensus 495 --------kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 495 --------KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred --------eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 367999999999877766543 48999999999997532 567899999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
.|+.||.... .....+..+..+.- .+.+|. .-+.
T Consensus 567 YgktPf~~~~--n~~aKl~aI~~P~~------------------~Iefp~--------------------------~~~~ 600 (677)
T KOG0596|consen 567 YGKTPFGQII--NQIAKLHAITDPNH------------------EIEFPD--------------------------IPEN 600 (677)
T ss_pred hcCCchHHHH--HHHHHHHhhcCCCc------------------cccccC--------------------------CCCc
Confidence 9999996432 12333333222210 112222 2222
Q ss_pred -HHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 398 -DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 398 -~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
++.++++.||.+||.+||++.+||+|||++-
T Consensus 601 ~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 601 DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3899999999999999999999999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=342.87 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=190.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ......+..|+.++..+. +|+||+++++.+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG----NHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc----cCcceeeEEeEec
Confidence 36799999999999999999975 234568999998643 233456778999988884 4578999999876
Q ss_pred c-CCeEEEEEecC-CCCHHHHHHhcC------------------------------------------------------
Q 013973 169 Y-RNHICIVFEKL-GSSLYDFLRKNN------------------------------------------------------ 192 (433)
Q Consensus 169 ~-~~~~~lV~e~~-~~~L~~~l~~~~------------------------------------------------------ 192 (433)
. .+.+++||||+ +|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 5 45689999999 999999997532
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEE
Q 013973 193 ------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266 (433)
Q Consensus 193 ------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~k 266 (433)
...+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+|
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~---------------------------~~~k 214 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN---------------------------NVVK 214 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC---------------------------CcEE
Confidence 1247888999999999999999999999999999999999544 4566
Q ss_pred EEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 013973 267 VIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLG 340 (433)
Q Consensus 267 l~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 340 (433)
|+|||+++...... ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...
T Consensus 215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~----- 289 (338)
T cd05102 215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR----- 289 (338)
T ss_pred EeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-----
Confidence 66666654332111 12245678999999999999999999999999999997 99999865432222111
Q ss_pred CCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHH
Q 013973 341 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 420 (433)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~el 420 (433)
+..+.. ...+...++++.+|+.+||+.||++|||+.|+
T Consensus 290 -----------------~~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el 327 (338)
T cd05102 290 -----------------LKDGTR-------------------------MRAPENATPEIYRIMLACWQGDPKERPTFSAL 327 (338)
T ss_pred -----------------HhcCCC-------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 001100 00123456789999999999999999999999
Q ss_pred hc
Q 013973 421 LR 422 (433)
Q Consensus 421 l~ 422 (433)
++
T Consensus 328 ~~ 329 (338)
T cd05102 328 VE 329 (338)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.44 Aligned_cols=282 Identities=30% Similarity=0.483 Sum_probs=216.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++.+.||+|++|.||+|.++.+++.||+|.+.... ...+.+..|+++++.+ .|++++++++++.....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-----QHGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-----cCCCEeeEEEEEecCCeE
Confidence 46999999999999999999999999999999886432 2234567788988888 668899999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|+||||++++|.+++.......+++..+..++.||+.||+|||++||+|+||||+||+++.+
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~------------------ 138 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR------------------ 138 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECC------------------
Confidence 99999998899998876554457889999999999999999999999999999999999632
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
+..+||+|||++....... ....|++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 139 --------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 139 --------TNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred --------CCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 2356777777765432211 223678899999998764 5789999999999999999999999988777
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+....+......+.......... .....++. ..........+.++.++|.+||+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~------------------~~~~~~~~~~~~~~~~~i~~~l~~ 270 (294)
T PLN00009 211 DELFKIFRILGTPNEETWPGVTSLPDYK--SAFPKWPP------------------KDLATVVPTLEPAGVDLLSKMLRL 270 (294)
T ss_pred HHHHHHHHHhCCCChhhccccccchhhh--hhcccCCC------------------CCHHHhCcCCChHHHHHHHHHccC
Confidence 7776666666655544433211110000 00000000 000111345677899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
||++||++.++++||||.+-
T Consensus 271 ~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 271 DPSKRITARAALEHEYFKDL 290 (294)
T ss_pred ChhhCcCHHHHhcCchHhHH
Confidence 99999999999999999764
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=338.92 Aligned_cols=287 Identities=27% Similarity=0.463 Sum_probs=213.7
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 170 (433)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... .........|+.+++.+ .|+|++++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-----KHENIIGILDIIRPPSF 77 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-----CCCCcCchhheeecccc
Confidence 346899999999999999999999999999999998632 23345567788888888 568899998876543
Q ss_pred ---CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 171 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 171 ---~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
...|+||||++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 78 ESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred cccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 468999999988998888653 69999999999999999999999999999999999999666655555555443
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
....... .........||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 155 ~~~~~~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 155 IADPEHD---------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ecccccc---------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2211000 0000112468999999998765 46889999999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhh-hhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
+.......+...++..+.+.+....... ..++...... .... ........+.++.+||.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~-~~~~~~~~~~~~~~li~~ 274 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFK------------------PKVP-WNKLFPNADPKALDLLDK 274 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcC------------------Cccc-HHHHhcccCcHHHHHHHH
Confidence 8877788888888776655444332111 1111100000 0000 001122457789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||+.||++|||+.|+++||||..-
T Consensus 275 ~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 275 MLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HcCCChhhCcCHHHHhcCcccccc
Confidence 999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=337.40 Aligned_cols=279 Identities=24% Similarity=0.384 Sum_probs=213.4
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+++++.+ .|++|+++++.+......
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-----DHPFLPTLYASFQTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-----CCCCchhheeeeecCCEE
Confidence 6999999999999999999999999999999986432 2334566788888887 568899999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++.......+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999 889999998755567999999999999999999999999999999999999998888888888877654332
Q ss_pred CcccccCCCCCC-----EE-EEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 253 SSYFKRMPKSSA-----IK-VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 253 ~~~~~~~~~~~~-----~k-l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
............ .+ ...+. ............||..|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETF-SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred ccccccccccccccccccccchhhh-cccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 211100000000 00 00000 000011112357899999999999988999999999999999999999999876
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+....+..+... ...++. ....+.++.++|.+|
T Consensus 236 ~~~~~~~~~~~~-----------------------~~~~~~------------------------~~~~~~~~~~li~~~ 268 (316)
T cd05574 236 NRDETFSNILKK-----------------------EVTFPG------------------------SPPVSSSARDLIRKL 268 (316)
T ss_pred chHHHHHHHhcC-----------------------CccCCC------------------------ccccCHHHHHHHHHH
Confidence 655443322110 011111 112567899999999
Q ss_pred cccCCCCCCC----HHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLT----AREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~t----a~ell~hp~f~~~ 429 (433)
|+.||++||| ++|+|.||||++.
T Consensus 269 l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 269 LVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred ccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 9999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=323.67 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=199.1
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-CCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-~~~~ 173 (433)
.|++.+.||+|++|.||++.++.+++.||+|.+... ....+.+..|+++++++ .|++++.+.+.+.. ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-----KHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeecCCCCEE
Confidence 489999999999999999999999999999998632 22334566788888777 56889999888764 4578
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++.......+++.++..++.|++.||+|||+.||+|+||||+||+++.+
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~----------------- 138 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT----------------- 138 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-----------------
Confidence 9999999 8899999987554579999999999999999999999999999999999999544
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
+.++|+|||.+...... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..
T Consensus 139 ----------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 208 (257)
T cd08223 139 ----------NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN 208 (257)
T ss_pred ----------CcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 45666666655433211 12346889999999999989999999999999999999999999865544
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+... ..+ ..+...+.++.+||.+||+.
T Consensus 209 ~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 209 SLVYRIIEG--KLP----------------------------------------------PMPKDYSPELGELIATMLSK 240 (257)
T ss_pred HHHHHHHhc--CCC----------------------------------------------CCccccCHHHHHHHHHHhcc
Confidence 332222110 000 01124567899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013973 410 DPTDRLTAREALRHPFF 426 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f 426 (433)
||++|||+.++++||||
T Consensus 241 ~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 241 RPEKRPSVKSILRQPYI 257 (257)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.25 Aligned_cols=280 Identities=32% Similarity=0.527 Sum_probs=210.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe-
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH- 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~- 172 (433)
++|++.+.||+|+||.||+|.+..+++.||+|.++... .....+..|+.+++.+. +|++++++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS----ESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc----CCCCccceeeeEeecCCC
Confidence 36999999999999999999999999999999876322 12345677888888874 34779999988876655
Q ss_pred ----EEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 173 ----ICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 173 ----~~lV~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
.|+||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 77 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~----------- 145 (295)
T cd07837 77 GKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK----------- 145 (295)
T ss_pred CCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-----------
Confidence 89999999779999887543 236899999999999999999999999999999999999954
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
.++.+||+|||.+....... ....+++.|+|||++.+ ..++.++|+||||+++|+|++|..
T Consensus 146 ---------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 210 (295)
T cd07837 146 ---------------QKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210 (295)
T ss_pred ---------------CCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCC
Confidence 14467777777665332211 12356889999999875 457899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.+..+.+..+....+..+...+.......... . .+. .. ........+.++.++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~-----------~~----~~~~~~~~~~~~~~~~~ 269 (295)
T cd07837 211 LFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH-E-----FPQ-----------WK----PQDLSRAVPDLSPEGLD 269 (295)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh-h-----cCc-----------cc----chhHHHhccccCHHHHH
Confidence 999888777776666655544433322111100000 0 000 00 00011122356788999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
||.+||+.||.+||++.|++.||||+
T Consensus 270 ~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 270 LLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHHccCChhhcCCHHHHhcCCCcC
Confidence 99999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=323.54 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=202.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|.+.+.||+|++|.||+|.+..+++.||+|.+... ......+..|+++++.+ .|++++++++.+...+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-----DSSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-----CCCCeehheeeeccCCEEE
Confidence 488999999999999999999999999999998632 34456677788888887 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~----------------- 138 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD----------------- 138 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-----------------
Confidence 999999 89999999876446799999999999999999999999999999999999996544
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++|+|||++....... ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 139 ----------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 208 (256)
T cd08529 139 ----------NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208 (256)
T ss_pred ----------CEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 45555665554332221 22468899999999999889999999999999999999999998766444
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. +... .....++.++.++|.+||+.+
T Consensus 209 ~~~~~~~-----------------------~~~~-------------------------~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08529 209 LILKIIR-----------------------GVFP-------------------------PVSQMYSQQLAQLIDQCLTKD 240 (256)
T ss_pred HHHHHHc-----------------------CCCC-------------------------CCccccCHHHHHHHHHHccCC
Confidence 3322111 0000 011234668999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|++||++.++++|||+
T Consensus 241 p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 241 YRQRPDTFQLLRNPSL 256 (256)
T ss_pred cccCcCHHHHhhCCCC
Confidence 9999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=331.28 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=200.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee------c
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------Y 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~------~ 169 (433)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.+++++. +|+|++++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS----HHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc----CCCcEEEEeeehhcccccCC
Confidence 36799999999999999999999999999999998765555556777888887773 4678999998874 3
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...+|+||||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~-------------- 156 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE-------------- 156 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--------------
Confidence 56899999999 789999998755556899999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
++.++|+|||.+..... ......|+..|+|||++. ...++.++|+|||||++|||++|.
T Consensus 157 -------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 157 -------------NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred -------------CCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 44577777776653321 123357899999999986 345888999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||...........+... ..... ....++.++.
T Consensus 224 ~p~~~~~~~~~~~~~~~~----------------------~~~~~-------------------------~~~~~~~~~~ 256 (282)
T cd06636 224 PPLCDMHPMRALFLIPRN----------------------PPPKL-------------------------KSKKWSKKFI 256 (282)
T ss_pred CCccccCHHhhhhhHhhC----------------------CCCCC-------------------------cccccCHHHH
Confidence 999765443322111000 00000 0123567899
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+||.+||+.||.+|||+.|+++||||
T Consensus 257 ~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 257 DFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=326.93 Aligned_cols=277 Identities=30% Similarity=0.501 Sum_probs=215.2
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+|++.+.||.|++|.||+|++..+++.||||+++... ........|+.+++++ .|+|++++++.+...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-----KHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-----cCCCEeeeeeeEeeCCcEEE
Confidence 4899999999999999999999999999999986432 2234566789999888 56889999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKLGSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+.++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+||+++++
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~------------------- 136 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR------------------- 136 (284)
T ss_pred EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-------------------
Confidence 99999779999887643 2468999999999999999999999999999999999999544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.++|+|||.+...... .....+|..|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+
T Consensus 137 --------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 208 (284)
T cd07836 137 --------GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208 (284)
T ss_pred --------CcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 45666666665432221 1223578899999998764 57899999999999999999999999888877
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+...........++.+... ..+.. ..+... ........+..+.++.++|.+||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~---------------~~~~~~~~~~~~~~~~~~i~~~l~~~ 268 (284)
T cd07836 209 QLLKIFRIMGTPTESTWPGISQL-PEYKP----TFPRYP---------------PQDLQQLFPHADPLGIDLLHRLLQLN 268 (284)
T ss_pred HHHHHHHHhCCCChhhHHHHhcC-chhcc----cccCCC---------------hHHHHHHhhhcCcHHHHHHHHHhcCC
Confidence 77777777666665554443311 11100 000000 00111122345778999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|.+||++.|+++||||
T Consensus 269 p~~R~~~~~~l~~~~f 284 (284)
T cd07836 269 PELRISAHDALQHPWF 284 (284)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=333.79 Aligned_cols=289 Identities=29% Similarity=0.495 Sum_probs=210.1
Q ss_pred cEEEEeeeeccccEEEEEEEECC--CCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRE--RKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 170 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~--~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~- 170 (433)
+|++.+.||+|+||.||+|.+.. +++.||+|.+... .........|+.+++.+ .|++++++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-----KHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-----CCCCccceEEEEeCCC
Confidence 48899999999999999999988 8899999998752 22335567788888888 678999999999888
Q ss_pred -CeEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 -NHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 -~~~~lV~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
..+++||||++++|.+++.... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~---------- 145 (316)
T cd07842 76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG---------- 145 (316)
T ss_pred CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC----------
Confidence 8899999999888888775332 13689999999999999999999999999999999999997622
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg 319 (433)
+.++.+||+|||++...... .....+|..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 146 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~ 212 (316)
T cd07842 146 -------------PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL 212 (316)
T ss_pred -------------CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence 22455666666665533221 1234688999999988764 588999999999999999999
Q ss_pred CCCCCCCChH---------HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh
Q 013973 320 EALFQTHENL---------EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390 (433)
Q Consensus 320 ~~Pf~~~~~~---------~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
.+||.+.... ..+..+...++......+.......+........... ... ...+... ..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---------~~~~~~~-~~ 280 (316)
T cd07842 213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTK--TYP---------SNSLAKW-ME 280 (316)
T ss_pred CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCC--CCC---------CccHHHH-HH
Confidence 9999865432 2344455555555544443322221110000000000 000 0000111 11
Q ss_pred hcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 391 ~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
.....+.++.++|.+||+.||++|||+.|+++||||
T Consensus 281 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 281 KHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 113567789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=327.41 Aligned_cols=275 Identities=32% Similarity=0.556 Sum_probs=213.0
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--CeEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHIC 174 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~~ 174 (433)
|+++++||+|+||.||+|.+..+++.||+|+++.... .......|+.++.++. +|+|++++++.+.+. +.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----PHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC----CCCCccceEEEEecCCCCcEE
Confidence 6789999999999999999999999999999864321 1223345776666662 468899999999887 8999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||+.++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 77 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~--------------------- 134 (282)
T cd07831 77 LVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK--------------------- 134 (282)
T ss_pred EEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---------------------
Confidence 999999889999887643 3689999999999999999999999999999999999994
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
. +.+||+|||.+....... ....++..|+|||++.. ..++.++|+|||||++|||++|.+||.+.+..+.
T Consensus 135 ------~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 135 ------D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred ------C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 3 567777777765443222 23467899999998754 4578999999999999999999999999888888
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+....+..+..+....... ....+.++.... ..+.......+.++.+||.+||++||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~P 267 (282)
T cd07831 208 IAKIHDVLGTPDAEVLKKFRKS-----RHMNYNFPSKKG---------------TGLRKLLPNASAEGLDLLKKLLAYDP 267 (282)
T ss_pred HHHHHHHcCCCCHHHHHhhccc-----ccccccCccccc---------------ccHHHHcccccHHHHHHHHHHhccCc
Confidence 8888888888777663322111 011111111110 01111223567899999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q 013973 412 TDRLTAREALRHPFF 426 (433)
Q Consensus 412 ~~R~ta~ell~hp~f 426 (433)
++||++.++++||||
T Consensus 268 ~~R~~~~~~l~~~~~ 282 (282)
T cd07831 268 DERITAKQALRHPYF 282 (282)
T ss_pred ccccCHHHHhhCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.08 Aligned_cols=281 Identities=28% Similarity=0.517 Sum_probs=221.1
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+.++|++++.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ .|++|+++++.+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----KHENVIGLLDVFTPDL 87 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCccceeeeecCCc
Confidence 467899999999999999999999999999999998532 22334567899999888 6688999999886543
Q ss_pred ------eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 172 ------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 172 ------~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
.+++||||++++|.+++... .+++..++.++.||+.||+|||+.||+||||||+||+++
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~------------ 152 (343)
T cd07880 88 SLDRFHDFYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN------------ 152 (343)
T ss_pred cccccceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc------------
Confidence 46999999999999888643 699999999999999999999999999999999999994
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.++.++|+|||.+...........+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.
T Consensus 153 ---------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 153 ---------------EDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred ---------------CCCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4456777777777655444444568999999999876 458899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhh-hhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
..+....+..+....+..+..+...+..... .++..- .... ...........+.++.++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~--~~~~~~~~~~~~~~~~~li 278 (343)
T cd07880 218 GHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL-----------------PRFR--KKDFRSLLPNANPLAVNVL 278 (343)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhc-----------------cccC--cchHHHhccCCChHHHHHH
Confidence 8887777777777777777666554432211 111000 0000 0011122346677899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+||+.||++|||+.+++.||||+..
T Consensus 279 ~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 279 EKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHcCCChhhCCCHHHHhcCccHhhh
Confidence 99999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=328.22 Aligned_cols=280 Identities=26% Similarity=0.431 Sum_probs=209.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++++.||+|+||.||+|.+..+++.||+|++.... ........|+.+++.+ .|+|++++.+++......|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-----KHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-----CCCCEeEEEEEEecCCeEE
Confidence 56999999999999999999999999999999986432 2223456788888888 6688999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-------------------- 138 (291)
T cd07870 80 FVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY-------------------- 138 (291)
T ss_pred EEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC--------------------
Confidence 999999888888876543 36888999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCh-H
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN-L 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~-~ 329 (433)
++.++|+|||.+...... .....+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+. .
T Consensus 139 -------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~ 211 (291)
T cd07870 139 -------LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211 (291)
T ss_pred -------CCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH
Confidence 445666666665432211 1223578999999998764 578999999999999999999999976543 4
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+...++.++...+..................+. .+. ...... ..+.++.+|+.+||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~-~~~~~~-~~~~~~~~ll~~~l~~ 274 (291)
T cd07870 212 EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQ---------------QLR-VVWKRL-SRPPKAEDLASQMLMM 274 (291)
T ss_pred HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCc---------------chh-hhcccc-CCChHHHHHHHHHhCc
Confidence 55666666666665555444332111100000000000 000 000000 1256789999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013973 410 DPTDRLTAREALRHPFF 426 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f 426 (433)
||.+|||+.|++.||||
T Consensus 275 dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 275 FPKDRISAQDALLHPYF 291 (291)
T ss_pred CcccCcCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.30 Aligned_cols=280 Identities=34% Similarity=0.643 Sum_probs=217.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+..|+++++.+ .|++++++++.+...+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-----RHENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-----CCCCeeehhheEEECCEE
Confidence 3699999999999999999999999999999988642 23346678899999988 568899999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
++||||+++++.+.+.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++
T Consensus 76 ~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~-------------------- 134 (288)
T cd07833 76 YLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS-------------------- 134 (288)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC--------------------
Confidence 9999999555554443332 3689999999999999999999999999999999999994
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++.+||+|||.+....... ....|+..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+.
T Consensus 135 -------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 135 -------ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred -------CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 45567777777765443322 234678999999999888 789999999999999999999999998888
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.+..+...++.++............. .+ ...++.. ........++..++.++.+||++||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~ 270 (288)
T cd07833 208 IDQLYLIQKCLGPLPPSHQELFSSNPRF---AG-VAFPEPS-------------QPESLERRYPGKVSSPALDFLKACLR 270 (288)
T ss_pred HHHHHHHHHHhCCCCHHHhhhcccCccc---cc-cccCCCC-------------CcHHHHHhcCCccchHHHHHHHHHhc
Confidence 8888888888888777554432211100 00 0000000 00111112234458899999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013973 409 YDPTDRLTAREALRHPFF 426 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f 426 (433)
.||++|||++++++||||
T Consensus 271 ~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 271 MDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCchhcccHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=332.58 Aligned_cols=287 Identities=25% Similarity=0.475 Sum_probs=211.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 170 (433)
++|++.++||+|+||.||+|.+..+++.||||.+.... ........|+.+++.+ .|++++++++++...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKATP 86 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-----CCCCccceEEEEeccccc
Confidence 56999999999999999999999999999999885321 2223445688888888 568899998887654
Q ss_pred -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 171 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 171 -----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...++||||++++|.+++.... ..+++.++..++.||+.||+|||++||+|+||||+||+++.++.++|+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 3569999999889998887653 3689999999999999999999999999999999999996665555555554
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+......... .........++..|+|||++.+. .++.++|+||||+++|+|++|..||.
T Consensus 166 ~~~~~~~~~~--------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 166 ARAFSLSKNS--------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred cccccCCccc--------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 4322111000 00001123578899999998765 47899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+.......+....+..+..+++........ . ....+.... ... .... .....+..+.+||.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~--~~~---------~~~l--~~~~~~~~~~dli~ 288 (310)
T cd07865 226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELF--K--KMELPQGQK--RKV---------KERL--KPYVKDPHALDLID 288 (310)
T ss_pred CCCHHHHHHHHHHHhCCCChhhcccccchhhh--h--hccCCCccc--hhh---------HHhc--ccccCCHHHHHHHH
Confidence 98888888888888888887665443211100 0 000111000 000 0000 01123567899999
Q ss_pred hccccCCCCCCCHHHHhcCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f 426 (433)
+||+.||.+|||++|+|+||||
T Consensus 289 ~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 289 KLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHhcCChhhccCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.86 Aligned_cols=282 Identities=27% Similarity=0.497 Sum_probs=221.7
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+.++|++.+.||+|++|.||+|++..+++.||+|++... .........|+.+++.+ .|++++.+.+.+....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-----DHENVIGLLDVFTPAS 87 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-----cCCCHHHHHHHhhccc
Confidence 457899999999999999999999999999999988632 22334566788888888 5688999888776655
Q ss_pred e------EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 172 H------ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 172 ~------~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
. .|+|+||++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||++++
T Consensus 88 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~----------- 153 (343)
T cd07851 88 SLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE----------- 153 (343)
T ss_pred cccccccEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-----------
Confidence 4 9999999999999998753 6999999999999999999999999999999999999954
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
++.++|+|||.+...........+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 154 ----------------~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 154 ----------------DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred ----------------CCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 456777777777654444444578899999999876 367899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhh-hhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
+.+..+.+..+...++..++.++..+..... .++....... ...........+.++.+||
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~s~~l~dli 278 (343)
T cd07851 218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMP-------------------KKDFKEVFSGANPLAIDLL 278 (343)
T ss_pred CCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccC-------------------CCCHHHHhccCCHHHHHHH
Confidence 8888888888888888777766655432211 1111000000 0001111234577899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||+.||++|||+.||++||||.+-.
T Consensus 279 ~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 279 EKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHhCCCChhhCCCHHHHhcCCCccccC
Confidence 999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=337.20 Aligned_cols=282 Identities=29% Similarity=0.511 Sum_probs=215.8
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~- 170 (433)
+.++|++.+.||+|+||.||+|.+..+++.||||.+... .........|+.+++.+ .|+|++++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-----DHENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-----CCCCccchHHheeccc
Confidence 346799999999999999999999999999999988632 22334556788888887 678899999887644
Q ss_pred ----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 ----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
..+|+||||++++|.+++...+ .+++..+..++.||+.||.|||+++|+||||||+||+++.++
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~---------- 145 (337)
T cd07858 78 REAFNDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---------- 145 (337)
T ss_pred ccccCcEEEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----------
Confidence 3589999999889999987654 799999999999999999999999999999999999996554
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
.+||+|||++...... .....||..|+|||.+.+ ..++.++|+|||||++|+|++|+.|
T Consensus 146 -----------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 208 (337)
T cd07858 146 -----------------DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208 (337)
T ss_pred -----------------CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence 4555555555433221 122367889999999875 4688999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHh-hhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
|.+.+.......+....+..+...+.... .....++.... .... .......+.++.++.+
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~--~~~~~~~~~~~~~~~~ 269 (337)
T cd07858 209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLP-----------------YTPR--QSFARLFPHANPLAID 269 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcC-----------------cccc--cCHHHHcccCCHHHHH
Confidence 99888777788888888877665432211 11111111000 0000 0001123457788999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||.+||+.||++|||+.|+++||||...
T Consensus 270 li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 270 LLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 9999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=338.56 Aligned_cols=289 Identities=26% Similarity=0.482 Sum_probs=218.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---- 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~---- 168 (433)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+..|+.+++.+ .|++|+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-----KHDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-----CCCCccCHHHhccccCC
Confidence 367999999999999999999999999999999986421 2344566788888888 5788999988875
Q ss_pred cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 169 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 169 ~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
....+++||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++..
T Consensus 79 ~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 79 DFKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred CCceEEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 345789999999889999987654 699999999999999999999999999999999999996655555555544322
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
....... .........|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 157 ~~~~~~~--------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 157 LSSSPTE--------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred ecccCcC--------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 2110000 0000122368899999999876 458999999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhh-hhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
....+..+...+|.++.+.+....... ..++.. ++.... ..........+.++.++|.+|
T Consensus 217 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------------~~~~~~~~~~~~~~~~li~~~ 277 (334)
T cd07855 217 YVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN----LPRKQP---------------VPWSKIFPKASPEALDLLSQM 277 (334)
T ss_pred hHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhh----cccCCC---------------CCHHHHcccCCHHHHHHHHHH
Confidence 888888888888888877765543221 111110 000000 000112234578899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|+.||++|||+.+++.||||.+.+
T Consensus 278 l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 278 LQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred ccCChhhCcCHHHHHhChhhhhcc
Confidence 999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.21 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=199.1
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+|++++.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++++ +|++++++++.+...+..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-----DSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEECCEEEE
Confidence 588999999999999999999999999999998643 23345677899988888 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~-------------------- 130 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT-------------------- 130 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC--------------------
Confidence 99999 78876542 5789999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCC-CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
++.++|+|||++...... ....+||..|+|||++.+..++.++|+|||||++|+|++|..||......+...
T Consensus 131 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 203 (279)
T cd06619 131 -------RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203 (279)
T ss_pred -------CCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc
Confidence 455777777766543222 234578999999999999899999999999999999999999996522111000
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+....... ........ .....+.++.+||.+||+.||++
T Consensus 204 --------~~~~~~~~~-------~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~ 243 (279)
T cd06619 204 --------MPLQLLQCI-------VDEDPPVL-------------------------PVGQFSEKFVHFITQCMRKQPKE 243 (279)
T ss_pred --------chHHHHHHH-------hccCCCCC-------------------------CCCcCCHHHHHHHHHHhhCChhh
Confidence 000000000 00000000 01235668999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCC
Q 013973 414 RLTAREALRHPFFTRDHL 431 (433)
Q Consensus 414 R~ta~ell~hp~f~~~~~ 431 (433)
||++.|+++||||.....
T Consensus 244 Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 244 RPAPENLMDHPFIVQYND 261 (279)
T ss_pred CCCHHHHhcCcccccccC
Confidence 999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.38 Aligned_cols=252 Identities=26% Similarity=0.432 Sum_probs=202.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ...+.+..|+.+++.+ .|+|++++++.+....+.|+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-----CCCCEeeEEEEEEeCCEEEE
Confidence 57999999999999999999999999999999886432 2345567788888877 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++... .+++.++..++.|++.||.|||+.||+||||||+|||++.++
T Consensus 95 v~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~------------------ 153 (296)
T cd06654 95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG------------------ 153 (296)
T ss_pred eecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------------------
Confidence 99999 89999998653 589999999999999999999999999999999999995444
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++|+|||.+....... ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....
T Consensus 154 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~ 224 (296)
T cd06654 154 ---------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (296)
T ss_pred ---------CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh
Confidence 56666666554332211 224688999999999988899999999999999999999999986654332
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.. .+... ...+...+..+.+||.+||+.||
T Consensus 225 ~~~~~~----------------------~~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p 258 (296)
T cd06654 225 LYLIAT----------------------NGTPE------------------------LQNPEKLSAIFRDFLNRCLDMDV 258 (296)
T ss_pred HHHHhc----------------------CCCCC------------------------CCCccccCHHHHHHHHHHCcCCc
Confidence 221110 00000 00112455678999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
++|||+.++++||||...
T Consensus 259 ~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 259 EKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ccCcCHHHHhhChhhhcc
Confidence 999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.16 Aligned_cols=254 Identities=25% Similarity=0.457 Sum_probs=201.5
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
|++.+.||+|+||.||+|.+..++..+|+|.+... ......+..|+++++.+ .|+|++.+++.+...+..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-----CCCCeeeEEEEEeeCCEEEEEE
Confidence 68889999999999999999999999999998643 23345567788888887 6789999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus 82 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-------------------- 140 (282)
T cd06643 82 EFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-------------------- 140 (282)
T ss_pred EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--------------------
Confidence 999 889988876533 4699999999999999999999999999999999999995544
Q ss_pred ccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++|+|||++...... .....||..|+|||++. +..++.++|+|||||++|+|++|.+||...+.
T Consensus 141 -------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 141 -------DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred -------CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 4555555555332211 12346899999999984 34578899999999999999999999987665
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+.....+. ...+..++.++.+||.+||+
T Consensus 214 ~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~ 247 (282)
T cd06643 214 MRVLLKIAKSEPPT----------------------------------------------LAQPSRWSSEFKDFLKKCLE 247 (282)
T ss_pred HHHHHHHhhcCCCC----------------------------------------------CCCccccCHHHHHHHHHHcc
Confidence 54433322111000 00112456689999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
.||.+||++.++++||||+....
T Consensus 248 ~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 248 KNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred CChhhCcCHHHHhcCCCEeccCC
Confidence 99999999999999999986644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=347.21 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=215.7
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.|.-++.||.|+||.||-|++..+.+.||||.+.... ..-..+..|+..|+++ .|||.+...++|..+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-----~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-----RHPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-----cCCCcccccceeeccchH
Confidence 4777899999999999999999999999999996322 2234567899999999 779999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||||-|+-.|.|.-.. +++-+.++..|..+.+.||.|||+.+.||||||..|||+
T Consensus 102 WLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL--------------------- 159 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL--------------------- 159 (948)
T ss_pred HHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---------------------
Confidence 9999999778778776543 479999999999999999999999999999999999999
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.+.+.|||+|||.|....+ .++++|||.|||||+|.. +.|+-++||||||++..||...++|+-..+.+.
T Consensus 160 ------se~g~VKLaDFGSAsi~~P-AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS 232 (948)
T KOG0577|consen 160 ------SEPGLVKLADFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 232 (948)
T ss_pred ------cCCCeeeeccccchhhcCc-hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH
Confidence 4556789999998876654 456789999999999974 569999999999999999999999998888888
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..|.+.-.|+-+ ...++..|+.||..||++-
T Consensus 233 ALYHIAQNesPtLq-----------------------------------------------s~eWS~~F~~Fvd~CLqKi 265 (948)
T KOG0577|consen 233 ALYHIAQNESPTLQ-----------------------------------------------SNEWSDYFRNFVDSCLQKI 265 (948)
T ss_pred HHHHHHhcCCCCCC-----------------------------------------------CchhHHHHHHHHHHHHhhC
Confidence 88887765444221 1245668999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|.+|||++++|.|+|+...
T Consensus 266 pqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 266 PQERPTSEELLKHRFVLRE 284 (948)
T ss_pred cccCCcHHHHhhcchhccC
Confidence 9999999999999999764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=326.85 Aligned_cols=276 Identities=31% Similarity=0.520 Sum_probs=214.6
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
|++.+.||.|++|.||+|.++.+|..||+|++.... .....+..|+++++.+ .|++++++++.+...+..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-----~~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-----NHPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-----CCCCccCHhheeccCCeEEE
Confidence 577899999999999999999999999999986432 2234567799998888 57899999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 176 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 176 V~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
||||++++|.+++.......+++..+..++.|++.||+|||+++++|+||+|+||+++.
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~--------------------- 134 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR--------------------- 134 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC---------------------
Confidence 99999889999998765456899999999999999999999999999999999999954
Q ss_pred cccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
++.++|+|||.+....... ....++..|+|||++.+. .++.++|+||||+++|+|++|.+||...+....
T Consensus 135 ------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 208 (283)
T cd07835 135 ------EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208 (283)
T ss_pred ------CCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4456666666664332111 223568899999988764 478999999999999999999999998887777
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+.+..+......+..+............ ++. .........++.++.++|.+||+.||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------------------~~~~~~~~~~~~~~~~li~~~l~~~P 268 (283)
T cd07835 209 LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK--WAR------------------QDLSKVVPNLDEDGLDLLSKMLVYDP 268 (283)
T ss_pred HHHHHHHhCCCChHHhhhhhhchhhhhhccc--ccc------------------cchhhhcCCCCHHHHHHHHHHhcCCh
Confidence 7667776666665554433222111100000 000 00111234567889999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q 013973 412 TDRLTAREALRHPFF 426 (433)
Q Consensus 412 ~~R~ta~ell~hp~f 426 (433)
++|||+.|++.||||
T Consensus 269 ~~Rpt~~~il~~~~~ 283 (283)
T cd07835 269 AKRISAKAALQHPYF 283 (283)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=342.18 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=215.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.+.|.+.++||+|.|++|.+|++..++..||||++.+.. .......+|+++++.+ +||||++++.+.+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-----~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-----NHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-----CCcceeeeeeeeeecce
Confidence 467999999999999999999999999999999997543 2334467899999999 88999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +|.+++||.+.+ ++.+..++.++.|+++|++|||+++|||||||.+|||+
T Consensus 130 lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL------------------- 188 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL------------------- 188 (596)
T ss_pred eEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc-------------------
Confidence 99999999 999999999876 77789999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
+.+.++||+|||++....... .+.||++.|.|||++.+..|. +++|+||+|+++|.|+.|.+||++.+-
T Consensus 189 --------~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 189 --------DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred --------ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 666778999999887666443 567999999999999998875 899999999999999999999987654
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.... ...|++..| -.++.++.++|+++|.
T Consensus 261 k~Lr~r-----------------------vl~gk~rIp--------------------------~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 261 KELRPR-----------------------VLRGKYRIP--------------------------FYMSCDCEDLLRKFLV 291 (596)
T ss_pred ccccch-----------------------heeeeeccc--------------------------ceeechhHHHHHHhhc
Confidence 321110 112222211 2456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||.+|++.+++..|.|....+
T Consensus 292 l~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred cCccccCCHHHhhhhcccchhh
Confidence 9999999999999999987543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.22 Aligned_cols=280 Identities=28% Similarity=0.501 Sum_probs=217.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 170 (433)
.++|.+.+.||+|+||.||+|++..+++.||+|++... ......+..|+.+++.+ .|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-----QHENVIGLLDVFTSAVS 88 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-----CCCCccchhheeccccc
Confidence 46799999999999999999999999999999998642 22234466788888887 668899999988654
Q ss_pred ----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 ----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
..+|+||||+..+|..++. ..+++..+..++.|++.||.|||+.||+||||||+|||++
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~------------- 151 (342)
T cd07879 89 GDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN------------- 151 (342)
T ss_pred CCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-------------
Confidence 3579999999778877652 2689999999999999999999999999999999999994
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
.++.++|+|||++...........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 152 --------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 152 --------------EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred --------------CCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 4556788888877654444444578999999999876 4688999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+....+..+....+..++.+.+.................+ ........+..+.++.+||.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li~~ 279 (342)
T cd07879 218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYP------------------RKDFSTLFPKASPQAVDLLEK 279 (342)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcc------------------cchHHHHhcCCCHHHHHHHHH
Confidence 88777788888888777776655543322111100000000 000111123457789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||+.||++||++.|++.||||...
T Consensus 280 ~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 280 MLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HcCCChhhCcCHHHHhcCcchhhc
Confidence 999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=335.16 Aligned_cols=282 Identities=27% Similarity=0.485 Sum_probs=218.8
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+....|+.+++++ +|+||+++.+.+...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~~iv~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-----CCCcccceeeeeeec
Confidence 45688999999999999999999999999999999986422 2234566788888888 678899998887532
Q ss_pred ------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 171 ------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 171 ------~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
...|+++++++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||++++
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~---------- 155 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE---------- 155 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC----------
Confidence 457899999999999888653 5999999999999999999999999999999999999954
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
++.++|+|||++...........||..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 156 -----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 218 (345)
T cd07877 156 -----------------DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218 (345)
T ss_pred -----------------CCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 445677777766554433344578999999999876 46889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhh-hhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
...+....+..+....+..+..+...+..... .++..- ...+. ..........++++.+|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------------~~~~~~~~~~~~~~~~l 279 (345)
T cd07877 219 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL-TQMPK------------------MNFANVFIGANPLAVDL 279 (345)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHh-cccCC------------------cchhhhcCCCCHHHHHH
Confidence 88877777778888777777766654432211 111000 00000 00011112457789999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|.+||+.||.+|+++.++++||||++-
T Consensus 280 i~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 280 LEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=330.14 Aligned_cols=255 Identities=28% Similarity=0.480 Sum_probs=203.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
++|++++.||.|+||.||+|.+..+++.||+|++... ....+.+..|+++++.+ .|++++++++.+.....+|+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-----KHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEEecCCeEEE
Confidence 5699999999999999999999989999999998643 23345677889988888 57899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++...+ ..+++..++.++.|++.||.|||++||+|+||||+||+++.++
T Consensus 80 v~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~------------------ 140 (280)
T cd06611 80 LIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG------------------ 140 (280)
T ss_pred EeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC------------------
Confidence 99999 889999987653 4699999999999999999999999999999999999995544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++|+|||.+...... .....||+.|+|||++.. ..++.++|+||||+++|+|++|.+||...
T Consensus 141 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 141 ---------DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ---------CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 5566666654432211 123468999999999853 44778999999999999999999999876
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+.. +..+ . ...+..++.++.+||.+|
T Consensus 212 ~~~~~~~~~~~--~~~~-----------------------~---------------------~~~~~~~~~~~~~li~~~ 245 (280)
T cd06611 212 NPMRVLLKILK--SEPP-----------------------T---------------------LDQPSKWSSSFNDFLKSC 245 (280)
T ss_pred CHHHHHHHHhc--CCCC-----------------------C---------------------cCCcccCCHHHHHHHHHH
Confidence 54433322111 0000 0 001224567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|+.||.+||++.++++||||.+..
T Consensus 246 l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 246 LVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred hccChhhCcCHHHHhcChhhcccc
Confidence 999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=328.28 Aligned_cols=279 Identities=28% Similarity=0.487 Sum_probs=215.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--C
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--N 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~ 171 (433)
++|++.+.||+|+||.||+|.++.+++.+|+|.++.... .......|+.++.++ .|+|++++++++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-----QHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-----CCCCEEEEEEEEEecCCC
Confidence 469999999999999999999999999999999874322 223445788888888 578999999988776 8
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.+|+||||++++|.+++.... ..+++..++.++.||+.||+|||+.||+|+||||+|||++.+
T Consensus 80 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---------------- 142 (293)
T cd07843 80 KIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR---------------- 142 (293)
T ss_pred cEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC----------------
Confidence 999999999889999987654 369999999999999999999999999999999999999544
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+.++|+|||.+...... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+
T Consensus 143 -----------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 143 -----------GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred -----------CcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 45666666665533222 12235788999999987654 6899999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC-chhHHHHHHHhc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGL 406 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~ 406 (433)
..+....+...++.++...+......... .. ..+... ........++.. .+..+.+||++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~ 273 (293)
T cd07843 212 EIDQLNKIFKLLGTPTEKIWPGFSELPGA--KK--KTFTKY--------------PYNQLRKKFPALSLSDNGFDLLNRL 273 (293)
T ss_pred hHHHHHHHHHHhCCCchHHHHHhhccchh--cc--cccccc--------------cchhhhccccccCCChHHHHHHHHH
Confidence 88888888887777666555443221110 00 000000 000111112222 577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f 426 (433)
|+.||++|||+.|+|.||||
T Consensus 274 l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 274 LTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hccCccccCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.06 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=204.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|++++.+.+.+.....+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-----RSPYITKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-----CCCCeeeeeEEEEECCeEE
Confidence 36889999999999999999999999999999986432 2334567788888888 5788999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+|+||+ +++|.+++... .+++..+..++.|++.||.|||+++|+|+||+|+||++++
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~------------------- 133 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE------------------- 133 (274)
T ss_pred EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-------------------
Confidence 999999 88999998764 6999999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.++|+|||.+...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 134 --------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~ 205 (274)
T cd06609 134 --------EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205 (274)
T ss_pred --------CCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence 445666666666543322 233468899999999999889999999999999999999999997655433
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC-chhHHHHHHHhcccc
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRY 409 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~ 409 (433)
....+.....+ ..... ++.++.+++.+||..
T Consensus 206 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 206 VLFLIPKNNPP------------------------------------------------SLEGNKFSKPFKDFVSLCLNK 237 (274)
T ss_pred HHHHhhhcCCC------------------------------------------------CCcccccCHHHHHHHHHHhhC
Confidence 32221111000 00011 566899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~~~ 431 (433)
||++|||++++++||||++...
T Consensus 238 ~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 238 DPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred ChhhCcCHHHHhhChhhcCCCc
Confidence 9999999999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.99 Aligned_cols=255 Identities=21% Similarity=0.357 Sum_probs=202.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+|++++.||+|+||.||+|.+..+++.||+|.++.. ......+..|+.+++++ .|+|++++++.+...+.+|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-----VSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-----CCCcHHhhhhheecCCeEEE
Confidence 589999999999999999999999999999988642 23345677888888887 66889999999999999999
Q ss_pred EEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 176 VFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
||||+ +++|.+++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~------------------ 138 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG------------------ 138 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC------------------
Confidence 99999 889998887631 2368999999999999999999997 59999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCC-CCCceeecCcccchhhhhCC------CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
++.++|+|||.+..... ......|+..|+|||++.+. .++.++|+|||||++|+|++|..||..
T Consensus 139 ---------~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 139 ---------NGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred ---------CCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 45677777777654322 22334688899999998654 358899999999999999999999976
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.........+.......+ ...+..++.++.+||.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~ 244 (286)
T cd06622 210 ETYANIFAQLSAIVDGDP---------------------------------------------PTLPSGYSDDAQDFVAK 244 (286)
T ss_pred cchhhHHHHHHHHhhcCC---------------------------------------------CCCCcccCHHHHHHHHH
Confidence 544333332222111100 01123467789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||+.||++||++.+++.||||...
T Consensus 245 ~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 245 CLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HcccCcccCCCHHHHhcChhhhhc
Confidence 999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.36 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=202.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..+|.+++.||+|+||.||+|.+..+++.||+|.+.... ...+.+..|+.+++.+ +|++++++++.+...+..|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCEEE
Confidence 367999999999999999999999999999999986432 2345566788888777 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus 93 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~----------------- 152 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG----------------- 152 (297)
T ss_pred EeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----------------
Confidence 999999 99999998753 589999999999999999999999999999999999995544
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++|+|||.+....... ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+...
T Consensus 153 ----------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~ 222 (297)
T cd06656 153 ----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (297)
T ss_pred ----------CEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 45666666554332221 23468899999999999889999999999999999999999997654432
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. .+. +. ...+...+..+.+|+.+||+.|
T Consensus 223 ~~~~~~~----------------------~~~---~~---------------------~~~~~~~~~~~~~li~~~l~~~ 256 (297)
T cd06656 223 ALYLIAT----------------------NGT---PE---------------------LQNPERLSAVFRDFLNRCLEMD 256 (297)
T ss_pred heeeecc----------------------CCC---CC---------------------CCCccccCHHHHHHHHHHccCC
Confidence 2111000 000 00 0012245667899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|++||++.++++||||...
T Consensus 257 p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 257 VDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred hhhCcCHHHHhcCchhccc
Confidence 9999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=326.75 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=189.8
Q ss_pred eeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 013973 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 179 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~ 179 (433)
.||+|+||.||+|.+..+++.||+|.+.... ........|..++..+.. .+|++++.+++.+...+..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh--CCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999999999999999886432 112223344444443322 2568899999999999999999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccccc
Q 013973 180 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258 (433)
Q Consensus 180 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~ 258 (433)
+ +++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++++
T Consensus 79 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~----------------------- 133 (279)
T cd05633 79 MNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH----------------------- 133 (279)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-----------------------
Confidence 9 899999987654 69999999999999999999999999999999999999544
Q ss_pred CCCCCCEEEEecCCccccCCC-CCceeecCcccchhhhh-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013973 259 MPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336 (433)
Q Consensus 259 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 336 (433)
+.++|+|||++...... .....||..|+|||.+. +..++.++|+|||||++|+|++|..||.......... +.
T Consensus 134 ----~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~ 208 (279)
T cd05633 134 ----GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID 208 (279)
T ss_pred ----CCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HH
Confidence 45666666655432221 12246899999999987 4568999999999999999999999997543211110 00
Q ss_pred HHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC-
Q 013973 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 415 (433)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~- 415 (433)
..... . ....++.++.++.++|.+||+.||++|+
T Consensus 209 ~~~~~-----------------------~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 209 RMTLT-----------------------V----------------------NVELPDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred HHhhc-----------------------C----------------------CcCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence 00000 0 0011235677899999999999999999
Q ss_pred ----CHHHHhcCCCCCCCC
Q 013973 416 ----TAREALRHPFFTRDH 430 (433)
Q Consensus 416 ----ta~ell~hp~f~~~~ 430 (433)
|+.|+++||||+...
T Consensus 244 ~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 244 CLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CCCCCHHHHHhCccccCCC
Confidence 699999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=320.33 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=204.3
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++.+.||+|+||.||++.+..+++.||+|.+... ......+..|+.+++.+ .|++++++.+.+...++.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-----KHPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-----CCCCeeeeEeeecCCCeEE
Confidence 489999999999999999999999999999998632 23345677888888888 6688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+|||++.
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~------------------- 136 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK------------------- 136 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-------------------
Confidence 999999 889999998755456899999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+..++|+|||.+....... ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus 137 --------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08218 137 --------DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208 (256)
T ss_pred --------CCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence 4456777777665432221 22458889999999998889999999999999999999999998765544
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. +..+ ..+..++.++.++|.+||+.+
T Consensus 209 ~~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08218 209 LVLKIIR--GSYP----------------------------------------------PVSSHYSYDLRNLVSQLFKRN 240 (256)
T ss_pred HHHHHhc--CCCC----------------------------------------------CCcccCCHHHHHHHHHHhhCC
Confidence 4332211 1000 012345678999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|++||++.++++||||
T Consensus 241 p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 241 PRDRPSVNSILEKNFI 256 (256)
T ss_pred hhhCcCHHHHhhCcCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=328.65 Aligned_cols=252 Identities=29% Similarity=0.453 Sum_probs=204.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.+|++.+.||.|+||.||+|.+..+++.||+|.+.... ...+.+..|+.+++.+ .|++++.+++.+.....+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-----KNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-----CCCceeeeeeeEecCceEEE
Confidence 56999999999999999999999999999999886322 2345567788888887 67889999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++... .+++..+..++.|++.||+|||+.||+|+||||+||+++.++
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~------------------ 152 (296)
T cd06655 94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG------------------ 152 (296)
T ss_pred EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------------------
Confidence 99999 89999988753 589999999999999999999999999999999999995444
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++|+|||++....... ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+....
T Consensus 153 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 153 ---------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred ---------CEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56666666554332221 234688999999999988899999999999999999999999987665443
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+... ..+ . ...+..++..+.+||.+||+.||
T Consensus 224 ~~~~~~~--~~~------------------~--------------------------~~~~~~~~~~~~~li~~~l~~dp 257 (296)
T cd06655 224 LYLIATN--GTP------------------E--------------------------LQNPEKLSPIFRDFLNRCLEMDV 257 (296)
T ss_pred HHHHHhc--CCc------------------c--------------------------cCCcccCCHHHHHHHHHHhhcCh
Confidence 3222110 000 0 00123456789999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
++||++.+++.||||...
T Consensus 258 ~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 258 EKRGSAKELLQHPFLKLA 275 (296)
T ss_pred hhCCCHHHHhhChHhhhc
Confidence 999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=323.05 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=198.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
+|++.+.||+|+||.||+|.+ .+++.+|+|.++... .....+..|+++++.+ .|+|++++.+++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-----KHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-----CCCCEeeEeeEeecC
Confidence 378889999999999999987 467889999886321 2234466788888887 568899999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+++||||+ +++|.+++.... .+++..+..++.|++.||+|||+.||+|+||||+||++++++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999 899999997654 6899999999999999999999999999999999999976666555555544322
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
...... ...........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 153 ~~~~~~------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 153 AWVGLH------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred hhcccc------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 110000 00000112236899999999999988999999999999999999999999765443
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+....+..+ ..+..++.++.+||++||+.
T Consensus 215 ~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~ 248 (265)
T cd06631 215 AAMFYIGAHRGLMP----------------------------------------------RLPDSFSAAAIDFVTSCLTR 248 (265)
T ss_pred HHHHHhhhccCCCC----------------------------------------------CCCCCCCHHHHHHHHHHhcC
Confidence 32222111111100 11235677899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013973 410 DPTDRLTAREALRHPFF 426 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f 426 (433)
||++||++.|+++||||
T Consensus 249 ~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 249 DQHERPSALQLLRHDFL 265 (265)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.61 Aligned_cols=280 Identities=25% Similarity=0.403 Sum_probs=214.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhH----HHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
-|..++.||-|+||.|.+++..+|...||+|.+++.+-.. .-...|..||... .++.||++|..|++.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-----Dn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-----CCcceEEEEEEeccCCce
Confidence 4889999999999999999999999999999997543222 2234577777766 678899999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC--CCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL--HTP 250 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~--~~~ 250 (433)
|+||+|+ ||++-.+|-+.+ .|+++.+++|+.++.+|+++.|.+|+|||||||+||||+.+|++||.|||++. +|.
T Consensus 705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999 999999988876 89999999999999999999999999999999999999999999999999875 334
Q ss_pred CCCcccccC---------------CCCCCEEEEecCCcccc-CCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHH
Q 013973 251 KDSSYFKRM---------------PKSSAIKVIDFGSTTYE-RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 314 (433)
Q Consensus 251 ~~~~~~~~~---------------~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ 314 (433)
.+..++... +....+|+..+--.+.. .-.....+||+.|+|||++....|+..+||||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 444443210 01111222111110100 00113468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 315 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 315 elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
||+.|++||...+..+....+.. | ++.. ....-..
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~n---------------------------w-------~~~l-----------~~~~~~~ 897 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVIN---------------------------W-------RNFL-----------HIPYQGN 897 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeee---------------------------h-------hhcc-----------ccccccc
Confidence 99999999988766543322111 0 0000 0111236
Q ss_pred chhHHHHHHHhccccCCCCCCC---HHHHhcCCCCCCCC
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRDH 430 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~t---a~ell~hp~f~~~~ 430 (433)
++.++.+||.+ |..+++.|+. ++||..||||+..+
T Consensus 898 ls~e~~~li~k-Lc~sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 898 LSKEALDLIQK-LCCSADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred cCHHHHHHHHH-HhcChhhhhcccchhhhhcCccccccc
Confidence 78899999988 5568899994 88999999998754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=328.53 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=200.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+.|+++++||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|++++++++.+...+.+|+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-----NHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCcEeeeEEEEEeCCeEEE
Confidence 56999999999999999999999999999999986432 3345567788888877 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|..++.+.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~------------------ 147 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG------------------ 147 (292)
T ss_pred EEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC------------------
Confidence 99999 888888876543 4689999999999999999999999999999999999995444
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++|+|||.+...... .....|+..|+|||++. ...++.++|+|||||++|+|++|..||...
T Consensus 148 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 148 ---------DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ---------CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 5666666655432111 12346889999999985 344788999999999999999999999776
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+.. ..+ +. ...+..++.++.+||.+|
T Consensus 219 ~~~~~~~~~~~---~~~----------------------~~---------------------~~~~~~~~~~~~~li~~~ 252 (292)
T cd06644 219 NPMRVLLKIAK---SEP----------------------PT---------------------LSQPSKWSMEFRDFLKTA 252 (292)
T ss_pred cHHHHHHHHhc---CCC----------------------cc---------------------CCCCcccCHHHHHHHHHH
Confidence 54433322211 000 00 001224566899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|+.||++||++.|+++||||..-
T Consensus 253 l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 253 LDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred hcCCcccCcCHHHHhcCcccccc
Confidence 99999999999999999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=328.32 Aligned_cols=269 Identities=25% Similarity=0.419 Sum_probs=204.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+|++++.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ .|+||+++++.+..++++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-----ENPFVVSMFCSFETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEecCCEE
Confidence 5999999999999999999999999999999987432 2234556788887776 668999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ |++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||++......
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999 889999997754 7999999999999999999999999999999999999977777777777655422110
Q ss_pred CcccccCCCCCCEEEEecCCcccc-CCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYE-RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.. ..+.+....... ........|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.+..+.
T Consensus 155 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~ 224 (305)
T cd05609 155 LT----------TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224 (305)
T ss_pred cc----------ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00 000000000000 0001123578899999999988899999999999999999999999987655443
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+... ...++. ....++.++.+||.+||+.||
T Consensus 225 ~~~~~~~-----------------------~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~P 258 (305)
T cd05609 225 FGQVISD-----------------------DIEWPE-----------------------GDEALPADAQDLISRLLRQNP 258 (305)
T ss_pred HHHHHhc-----------------------ccCCCC-----------------------ccccCCHHHHHHHHHHhccCh
Confidence 3322111 111111 012456789999999999999
Q ss_pred CCCCC---HHHHhcCCCCCCC
Q 013973 412 TDRLT---AREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~t---a~ell~hp~f~~~ 429 (433)
++||+ +.++|+||||...
T Consensus 259 ~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 259 LERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred hhccCccCHHHHHhCccccCC
Confidence 99997 8999999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=325.42 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=199.8
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 170 (433)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++............|+.+++++. .|+|++++++.+...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~----~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP----NHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc----CCCCeEEEEEEEEeccccC
Confidence 457899999999999999999999999999999998754444556677888887773 467899999987643
Q ss_pred -CeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 -NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 -~~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
+.+++||||+ +++|.+++... ....+++..++.++.|++.||+|||+.||+|+||||+||+++.
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~------------ 163 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT------------ 163 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC------------
Confidence 4689999999 88999988642 2246899999999999999999999999999999999999954
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-----CCCCcchhHHHHHHHHHHHh
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~ellt 318 (433)
++.+||+|||.+...... .....|+..|+|||++... .++.++|+|||||++|||++
T Consensus 164 ---------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~ 228 (291)
T cd06639 164 ---------------EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228 (291)
T ss_pred ---------------CCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh
Confidence 445677777766543321 1234688999999998653 36899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|++||...+..+.+..+... ..+ .. ..+...+..
T Consensus 229 g~~p~~~~~~~~~~~~~~~~--~~~--------------------~~------------------------~~~~~~~~~ 262 (291)
T cd06639 229 GDPPLFDMHPVKTLFKIPRN--PPP--------------------TL------------------------LHPEKWCRS 262 (291)
T ss_pred CCCCCCCCcHHHHHHHHhcC--CCC--------------------CC------------------------CcccccCHH
Confidence 99999865543333221110 000 00 001234457
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
+.+||.+||+.||++||++.|+++||||+
T Consensus 263 l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 263 FNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 89999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=326.11 Aligned_cols=278 Identities=31% Similarity=0.523 Sum_probs=210.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+..|+++++.+ .|++++++++++...+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-----RHENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-----CCcchhhHHHhcccCCeE
Confidence 36999999999999999999999999999999875322 2334566788888887 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ ++.|.++..... .+++..+..++.||+.||.|||+.||+|+||+|+||++++
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~------------------ 135 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ------------------ 135 (286)
T ss_pred EEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC------------------
Confidence 9999999 667766655433 5899999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
++.++|+|||++....... ....|+..|+|||++.+. .++.++||||||+++|||++|.+||...+.
T Consensus 136 ---------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~ 206 (286)
T cd07846 136 ---------SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206 (286)
T ss_pred ---------CCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence 4567777777665432221 224678899999998763 478899999999999999999999988877
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+....+.+.+.......... +..+ ...+... . ..........++..+.+|+.+||+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~-~-------------~~~~~~~~~~~~~~~~~li~~~l~ 268 (286)
T cd07846 207 IDQLYHIIKCLGNLIPRHQEIFQKNP---LFAG-MRLPEVK-E-------------IEPLEKRFPKLSGLVLDLAKQCLR 268 (286)
T ss_pred HHHHHHHHHHhCCCchhhHHHhccch---Hhhc-ccccccc-C-------------cchHHHhCCCcCHHHHHHHHHHhc
Confidence 77777777776665543222111000 0000 0000000 0 000111234667889999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013973 409 YDPTDRLTAREALRHPFF 426 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f 426 (433)
.||++||++.++++||||
T Consensus 269 ~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 269 IDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCcccchhHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=325.75 Aligned_cols=258 Identities=22% Similarity=0.430 Sum_probs=197.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++++.||+|+||.||+|.++.+|+.||+|.++... ........|..++.+. .+|++++++++.+...+.+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS----VDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH----cCCCCeeeeeEEEecCCcEE
Confidence 36999999999999999999999999999999987432 2233444555543332 26789999999999999999
Q ss_pred EEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 175 IVFEKLGSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||+.++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~----------------- 139 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR----------------- 139 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC-----------------
Confidence 99999988998888653 224689999999999999999999997 9999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhC----CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
++.+||+|||.+...... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 140 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 140 ----------NGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ----------CCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 445666777766543221 122468899999999865 4578999999999999999999999964
Q ss_pred CC-hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 326 HE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 326 ~~-~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
.. ..+.+..... +..+ ..+ ...++.++.+||.
T Consensus 210 ~~~~~~~~~~~~~--~~~~--------------------~~~-------------------------~~~~~~~l~~li~ 242 (283)
T cd06617 210 WKTPFQQLKQVVE--EPSP--------------------QLP-------------------------AEKFSPEFQDFVN 242 (283)
T ss_pred cccCHHHHHHHHh--cCCC--------------------CCC-------------------------ccccCHHHHHHHH
Confidence 22 2222211110 0000 000 1235678999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDHLR 432 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~~~ 432 (433)
+||..+|++||++.++++||||.....+
T Consensus 243 ~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 243 KCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHccCChhhCcCHHHHhcCchhhhcccc
Confidence 9999999999999999999999877543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.90 Aligned_cols=282 Identities=28% Similarity=0.503 Sum_probs=221.6
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-C
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-R 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-~ 170 (433)
++++|++.+.||.|+||.||+|.+..+++.||+|.+... .........|+++++.+ .|++++++.+++.. .
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~ 82 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-----RHENIISLSDIFISPL 82 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-----CCCCeeeEeeeEecCC
Confidence 467899999999999999999999999999999987531 22345566789999888 67899999998865 5
Q ss_pred CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 171 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 171 ~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
...|+||||++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+++
T Consensus 83 ~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~---------------- 143 (328)
T cd07856 83 EDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE---------------- 143 (328)
T ss_pred CcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC----------------
Confidence 689999999988999888653 5889999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.++|+|||.+...........++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..
T Consensus 144 -----------~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 144 -----------NCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred -----------CCCEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 445666677766544333334567889999998866 56899999999999999999999999988888
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhh-hhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRH-AEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
..+..+.+.++..|+++...+... ...++.......+ ..........+.++.++|.+||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~ 273 (328)
T cd07856 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREP-------------------VPFSEKFKNADPSAIDLLEKMLV 273 (328)
T ss_pred HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCC-------------------CcHHHHcCCCCHHHHHHHHHHcC
Confidence 888888888998887776543211 1111111000000 00011223567789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.||++|||+.+++.||||...+
T Consensus 274 ~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 274 FDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred CChhhCCCHHHHhcCCcccccc
Confidence 9999999999999999997553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=324.94 Aligned_cols=258 Identities=23% Similarity=0.399 Sum_probs=199.9
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee----
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF---- 167 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~---- 167 (433)
.....++|++++.||+|+||.||+|.+..+++.||+|+++........+..|+.++..+. .|+|++++++.+
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS----DHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh----cCCCeeeeeeeeeecc
Confidence 334567899999999999999999999999999999998754444556677888888874 357899999876
Q ss_pred -ecCCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 168 -DYRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 168 -~~~~~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
...+.+++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.+|+||||||+||+++++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-------- 160 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-------- 160 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC--------
Confidence 3456799999999 89999987632 22468999999999999999999999999999999999999544
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHH
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~e 315 (433)
+.++|+|||++...... .....|++.|+|||++.. ..++.++|||||||++||
T Consensus 161 -------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~e 221 (286)
T cd06638 161 -------------------GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221 (286)
T ss_pred -------------------CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHH
Confidence 44666666666533221 123468999999999853 457899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 316 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 316 lltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
|++|..||...........+... . .+. ...+...
T Consensus 222 l~~g~~p~~~~~~~~~~~~~~~~---~----------------------~~~---------------------~~~~~~~ 255 (286)
T cd06638 222 LGDGDPPLADLHPMRALFKIPRN---P----------------------PPT---------------------LHQPELW 255 (286)
T ss_pred HhcCCCCCCCCchhHHHhhcccc---C----------------------CCc---------------------ccCCCCc
Confidence 99999999765443322111000 0 000 0011234
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+.++.+||.+||+.||++|||+.|+++|+||
T Consensus 256 ~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 256 SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 5679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=318.99 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=204.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+..|+.+++.+ .|++++++++.+...+.++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-----SHPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-----CCCchhheeeeEecCCEEE
Confidence 489999999999999999999999999999998642 23345677788888888 6688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.......+++..+..++.|++.||+|||++||+|+||||+||+++.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~------------------ 137 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH------------------ 137 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC------------------
Confidence 999999 8899999987655568999999999999999999999999999999999999532
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+....
T Consensus 138 --------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 209 (256)
T cd08220 138 --------KMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL 209 (256)
T ss_pred --------CCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence 2346777777765443222 234689999999999988899999999999999999999999987654443
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.... ..+.++..+.++.+++.+||+.||
T Consensus 210 ~~~~~~~~------------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p 241 (256)
T cd08220 210 VLKIMSGT------------------------------------------------FAPISDRYSPDLRQLILSMLNLDP 241 (256)
T ss_pred HHHHHhcC------------------------------------------------CCCCCCCcCHHHHHHHHHHccCCh
Confidence 32221100 001123456789999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q 013973 412 TDRLTAREALRHPFF 426 (433)
Q Consensus 412 ~~R~ta~ell~hp~f 426 (433)
++|||+.|+++||||
T Consensus 242 ~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 242 SKRPQLSQIMAQPIC 256 (256)
T ss_pred hhCCCHHHHhhCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=320.74 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=202.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .+.+..|+++++.+ .|++++++++.+.....+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-----DSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-----CCCcEeeeeeeeecCCcEEEE
Confidence 569999999999999999999999899999999975433 56788899998888 678999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
+||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||+|+||++++++
T Consensus 77 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~------------------- 136 (256)
T cd06612 77 MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG------------------- 136 (256)
T ss_pred EecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-------------------
Confidence 9999 889999997644 4789999999999999999999999999999999999995544
Q ss_pred cccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~ 332 (433)
.++|+|||.+...... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 137 --------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~ 208 (256)
T cd06612 137 --------QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208 (256)
T ss_pred --------cEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence 4566666655433221 12345888999999999989999999999999999999999999765443221
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
..+.. . .+. ....+..++.++.++|.+||+.||+
T Consensus 209 ~~~~~---~-----------------------~~~--------------------~~~~~~~~~~~~~~~i~~~l~~~P~ 242 (256)
T cd06612 209 FMIPN---K-----------------------PPP--------------------TLSDPEKWSPEFNDFVKKCLVKDPE 242 (256)
T ss_pred hhhcc---C-----------------------CCC--------------------CCCchhhcCHHHHHHHHHHHhcChh
Confidence 11000 0 000 0001123456899999999999999
Q ss_pred CCCCHHHHhcCCCC
Q 013973 413 DRLTAREALRHPFF 426 (433)
Q Consensus 413 ~R~ta~ell~hp~f 426 (433)
+|||+.|+|+||||
T Consensus 243 ~Rps~~~il~~~~~ 256 (256)
T cd06612 243 ERPSAIQLLQHPFI 256 (256)
T ss_pred hCcCHHHHhcCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.17 Aligned_cols=298 Identities=25% Similarity=0.425 Sum_probs=219.8
Q ss_pred cCcEEE-EeeeeccccEEEEEEEECCCCeEEEEEEeecchhhH---------------HHHHHHHHHHHHHHhcCCCCCc
Q 013973 96 TSRYKI-HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---------------EAAMIEIEVLQQLAKHDKGGNR 159 (433)
Q Consensus 96 ~~~~~~-~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~---------------~~~~~E~~~l~~l~~~~~~~~~ 159 (433)
.++|.. .+.||+|+||+||+|.+..+++.||+|+++...... ..+..|+++++.+ .|++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ 81 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-----KHEN 81 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-----CCcc
Confidence 456764 577999999999999999999999999986432111 1356788888888 6789
Q ss_pred eEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccc
Q 013973 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239 (433)
Q Consensus 160 i~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~ 239 (433)
++++++++...+..|+||||+.++|.+++.... .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 999999999999999999999889999997654 699999999999999999999999999999999999998888888
Q ss_pred cCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHh
Q 013973 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 240 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~ellt 318 (433)
++|||++.....+..... .-.+.+.. .........++..|+|||++.+. .++.++|+|||||++|+|++
T Consensus 160 l~dfg~~~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDT--------LSKDETMQ--RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred ECCccceeeccccccccc--------cccccccc--ccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh
Confidence 888887654432111000 00000000 00111223578899999998764 47899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|.+||.+.++.+.+..+...++..+...+.......... +.... ............+.+
T Consensus 230 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-------------~~~~~~~~~~~~~~~ 288 (335)
T PTZ00024 230 GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYT--------EFTPR-------------KPKDLKTIFPNASDD 288 (335)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccc--------ccCcC-------------CcccHHHhCcCCChH
Confidence 999999988888887777777665544322211100000 00000 000011122355778
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
+.+||.+||+.||++|||++|+|.||||+...+
T Consensus 289 ~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 289 AIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 999999999999999999999999999997765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=325.57 Aligned_cols=237 Identities=16% Similarity=0.162 Sum_probs=191.4
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhh----HHHHHHHHHHHHHHHhcCCCCCceEEecceeec----CCeEE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHIC 174 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~~~ 174 (433)
..||+|++|.||+|.. +|+.||||.++..... .+.+..|+.++.++ .|+||+++++++.+ ...++
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-----DSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-----CCCCEEEEeeeEEecccCCCceE
Confidence 5799999999999987 6889999998754322 35566899999998 66899999998866 45789
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+||||+ +|+|.+++.+.. .+++.....++.|++.||.|||+ .+++||||||+|||++
T Consensus 99 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~------------------- 157 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT------------------- 157 (283)
T ss_pred EEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC-------------------
Confidence 999999 899999998754 78999999999999999999998 4999999999999994
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++.+||+|||++...........||..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+
T Consensus 158 --------~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~ 229 (283)
T PHA02988 158 --------ENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229 (283)
T ss_pred --------CCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence 4456777777776654433344578999999999986 679999999999999999999999998776555
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+...... +. .+...+.++++||.+||+.|
T Consensus 230 ~~~~i~~~~~~---------------------~~--------------------------~~~~~~~~l~~li~~cl~~d 262 (283)
T PHA02988 230 IYDLIINKNNS---------------------LK--------------------------LPLDCPLEIKCIVEACTSHD 262 (283)
T ss_pred HHHHHHhcCCC---------------------CC--------------------------CCCcCcHHHHHHHHHHhcCC
Confidence 44332211000 00 11245678999999999999
Q ss_pred CCCCCCHHHHhc
Q 013973 411 PTDRLTAREALR 422 (433)
Q Consensus 411 P~~R~ta~ell~ 422 (433)
|++|||+.|+++
T Consensus 263 p~~Rps~~ell~ 274 (283)
T PHA02988 263 SIKRPNIKEILY 274 (283)
T ss_pred cccCcCHHHHHH
Confidence 999999999985
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=325.48 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=197.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+..|+.+++.+ .|++++++++.+...+.+|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-----~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-----KHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEeCCEEEE
Confidence 46899999999999999999999999999999987432 2234456788888777 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++...+ .+++..+..++.|++.||.|||+.||+|+||||+||+++.++
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~------------------ 143 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG------------------ 143 (267)
T ss_pred EEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------------------
Confidence 99999 889999987654 799999999999999999999999999999999999995444
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++|+|||.+...... .....||..|+|||++. ...++.++|+|||||++|+|++|..||.....
T Consensus 144 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 144 ---------HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ---------CEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 4566666655432211 12346899999999985 44588999999999999999999999965443
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
......+.. .....+. ......++..+.+||.+||+
T Consensus 215 ~~~~~~~~~-----------------------~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~ 250 (267)
T cd06645 215 MRALFLMTK-----------------------SNFQPPK---------------------LKDKMKWSNSFHHFVKMALT 250 (267)
T ss_pred hhhHHhhhc-----------------------cCCCCCc---------------------ccccCCCCHHHHHHHHHHcc
Confidence 322211100 0000000 00011345678999999999
Q ss_pred cCCCCCCCHHHHhcCCC
Q 013973 409 YDPTDRLTAREALRHPF 425 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~ 425 (433)
.||++|||+.++++|||
T Consensus 251 ~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 251 KNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCchhCcCHHHHhcCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.19 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=196.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........|+.+++++ .|++++++++.+...+.++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-----KHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-----CCCCeeeeeEEEEeCCEEE
Confidence 357999999999999999999999999999999986432 2334566788888877 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||++++++
T Consensus 83 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~----------------- 143 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG----------------- 143 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-----------------
Confidence 999999 789999987654 789999999999999999999999999999999999995544
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.++|+|||.+...... .....|+..|+|||.+. ...++.++|+|||||++|||++|..||....
T Consensus 144 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 144 ----------DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ----------CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 4566666655432211 12346889999999985 3457889999999999999999999996543
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+ ....+..+. ......++..+.+||.+||
T Consensus 214 ~~~~~~~~-----------------------~~~~~~~~~---------------------~~~~~~~~~~~~~li~~~l 249 (267)
T cd06646 214 PMRALFLM-----------------------SKSNFQPPK---------------------LKDKTKWSSTFHNFVKISL 249 (267)
T ss_pred hhhhheee-----------------------ecCCCCCCC---------------------CccccccCHHHHHHHHHHh
Confidence 32211110 000000000 0001235678999999999
Q ss_pred ccCCCCCCCHHHHhcCCC
Q 013973 408 RYDPTDRLTAREALRHPF 425 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~ 425 (433)
+.||++|||++++++|+|
T Consensus 250 ~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 250 TKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hCChhhCcCHHHHhcCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=348.71 Aligned_cols=245 Identities=29% Similarity=0.418 Sum_probs=200.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec-chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-c-----
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-Y----- 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-~----- 169 (433)
.+++|.+.|.+|||+.||+|.+...+..||+|.+-. .+.......+|+++|+.|. +|+|||.+++... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~----gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS----GHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc----CCCceeeEeccccccccCCC
Confidence 468899999999999999999998888899998754 3445566788999999994 6788999999322 1
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
.-.++|+|||| ||+|-|++.++...+|++.++++|+.|+++|+.+||... |||||||-|||||..
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~----------- 181 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA----------- 181 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC-----------
Confidence 23688999999 799999999777678999999999999999999999988 999999999999954
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-C-----------ceeecCcccchhhhh---CCCCCCcchhHHHH
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-N-----------YIVSTRHYRAPEVIL---GLGWTYPCDIWSVG 310 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~-----------~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG 310 (433)
+++.||||||.++-.-... . ...-|+.|+|||++. +...+.|+||||||
T Consensus 182 ----------------~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALG 245 (738)
T KOG1989|consen 182 ----------------DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALG 245 (738)
T ss_pred ----------------CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHH
Confidence 4466777777665221111 1 124699999999986 56789999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh
Q 013973 311 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390 (433)
Q Consensus 311 v~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
|+||-|+....||+...... |..|.+.+|+
T Consensus 246 clLYkLCy~t~PFe~sg~la---------------------------Ilng~Y~~P~----------------------- 275 (738)
T KOG1989|consen 246 CLLYKLCYFTTPFEESGKLA---------------------------ILNGNYSFPP----------------------- 275 (738)
T ss_pred HHHHHHHHhCCCcCcCccee---------------------------EEeccccCCC-----------------------
Confidence 99999999999998653322 5566666665
Q ss_pred hcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 391 ~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.+.++..+++||+.||+.||.+||++-||+.+
T Consensus 276 -~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 276 -FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 24677889999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.31 Aligned_cols=209 Identities=25% Similarity=0.360 Sum_probs=177.5
Q ss_pred CCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhh-HHHHHHHHHHHHHHHhcCCCCCceEEe
Q 013973 85 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQI 163 (433)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~i~~~ 163 (433)
..|.+......+++|.-.+.||+|+||.||+|...++ ..||||.+...... ..++..|++++.++ +|+|++++
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-----~H~Nlv~L 136 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRL-----RHPNLVKL 136 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcC-----CCcCcccE
Confidence 3456666667789999999999999999999988655 78999988754443 45599999999999 67999999
Q ss_pred cceeecCC-eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEeeccCcc
Q 013973 164 RNWFDYRN-HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC---MIHTDLKPENVLLVSSEYI 238 (433)
Q Consensus 164 ~~~~~~~~-~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlKp~NILl~~~~~~ 238 (433)
+++|.+.+ +.+||+||| +|+|.++|+......++|..+.+|+.++|+||+|||+.. |||||||++|||+
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL------ 210 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL------ 210 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE------
Confidence 99999988 599999999 899999998765337899999999999999999999865 9999999999999
Q ss_pred ccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC-CCCc--e-eecCcccchhhhhCCCCCCcchhHHHHHHHH
Q 013973 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNY--I-VSTRHYRAPEVILGLGWTYPCDIWSVGCILV 314 (433)
Q Consensus 239 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ 314 (433)
|++..+||+|||+|..... .... . .||.+|+|||++.....+.++|||||||+|+
T Consensus 211 ---------------------D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvll 269 (361)
T KOG1187|consen 211 ---------------------DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLL 269 (361)
T ss_pred ---------------------CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHH
Confidence 5566677777777754443 2222 2 7999999999999989999999999999999
Q ss_pred HHHhCCCCCCCC
Q 013973 315 ELCTGEALFQTH 326 (433)
Q Consensus 315 elltg~~Pf~~~ 326 (433)
||+||+.|....
T Consensus 270 Elitgr~~~d~~ 281 (361)
T KOG1187|consen 270 ELITGRKAVDQS 281 (361)
T ss_pred HHHhCCcccCCC
Confidence 999999888743
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=334.20 Aligned_cols=279 Identities=29% Similarity=0.504 Sum_probs=218.7
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--- 171 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--- 171 (433)
+|++.+.||+|+||.||+|.+..+++.||||.+... ....+.+..|+.+++.+ +|++++++.+++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-----RHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-----CCcchhhhhhhhcccCccc
Confidence 589999999999999999999999999999988643 22345677889998888 5788999999987765
Q ss_pred --eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 172 --HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 172 --~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.+|+||||++++|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+|||++.++
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~------------- 140 (330)
T cd07834 76 FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC------------- 140 (330)
T ss_pred ccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------
Confidence 899999999889999987654 799999999999999999999999999999999999996555
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~P 322 (433)
.++|+|||.+...... .....+|..|+|||++.+. .++.++|+||||+++|+|++|.+|
T Consensus 141 --------------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 141 --------------DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred --------------CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence 4555555554433222 1224678999999999887 789999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHh-hhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
|.+.+..+.+..+....+..+...+.... .....++...... . ........+..+.++.+
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~-~~~~~~~~~~~~~~~~~ 267 (330)
T cd07834 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKK------------------P-KKPLSKLFPGASPEAID 267 (330)
T ss_pred cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccC------------------C-cchhHHhcccCCHHHHH
Confidence 99999888888888888877765544211 1111111110000 0 00011123456788999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||.+||++||++|||+.++++||||++-
T Consensus 268 li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 268 LLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred HHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 9999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=322.25 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=199.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----------hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+..|+.+++++ .|++++++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-----QHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEE
Confidence 3778899999999999999999999999999885321 1224566788888888 678999999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
...+..++||||+ +++|.+++...+ .+++..+..++.|++.||+|||+.||+||||||+||++++++.++|+|||.+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999 889999997754 7899999999999999999999999999999999999977666666666654
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
......... ...........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 154 KKLEANSLS------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccccccccc------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 433211000 00000112235889999999999888999999999999999999999999875
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+.......+... .. ...+...+.++.++|.+|
T Consensus 216 ~~~~~~~~~~~~--~~----------------------------------------------~~~~~~~~~~~~~li~~~ 247 (267)
T cd06628 216 TQLQAIFKIGEN--AS----------------------------------------------PEIPSNISSEAIDFLEKT 247 (267)
T ss_pred cHHHHHHHHhcc--CC----------------------------------------------CcCCcccCHHHHHHHHHH
Confidence 543322211110 00 011234567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f 426 (433)
|+.||.+||++.|+++||||
T Consensus 248 l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 248 FEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=320.70 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=201.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++.+.||.|+||+||+|....++..+|+|++.... .....+..|+++++.+ .|++++++++.+......+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-----NHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-----CCCCEEEEEEEEeeCCEEE
Confidence 36999999999999999999999899999999986322 2445677888888877 6688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+|||++ +++|.+++..... ..+++..+..++.|++.||.|||+.||+|+||||+||++++++
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~---------------- 139 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG---------------- 139 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----------------
Confidence 999999 8999999976432 4689999999999999999999999999999999999996544
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC-------CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.++|+|||.+...... .....|+..|+|||++... .++.++|+|||||++|+|++|..||.
T Consensus 140 -----------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 140 -----------SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred -----------CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 4555555554322221 1234689999999999876 78999999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
..+....+..... ..+. ..+. ......++.++.+|+.
T Consensus 209 ~~~~~~~~~~~~~---~~~~-------------------~~~~---------------------~~~~~~~~~~~~~li~ 245 (267)
T cd06610 209 KYPPMKVLMLTLQ---NDPP-------------------SLET---------------------GADYKKYSKSFRKMIS 245 (267)
T ss_pred ccChhhhHHHHhc---CCCC-------------------CcCC---------------------ccccccccHHHHHHHH
Confidence 6554432222111 0000 0000 0001255678999999
Q ss_pred hccccCCCCCCCHHHHhcCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f 426 (433)
+||+.||++||++.|+++||||
T Consensus 246 ~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 246 LCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHcCCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=320.49 Aligned_cols=249 Identities=25% Similarity=0.448 Sum_probs=193.9
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhhH----HHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..+++.||+|+++...... .....|..++. ....|++++++++.+...+.+|+|||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~----~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMM----IQGESPYVAKLYYSFQSKDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHh----hcCCCCCeeeeeeeEEcCCeEEEEEe
Confidence 57999999999999999999999999986432211 11222333222 22367899999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||++++
T Consensus 78 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~----------------------- 132 (260)
T cd05611 78 YLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ----------------------- 132 (260)
T ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-----------------------
Confidence 99 899999998754 6899999999999999999999999999999999999944
Q ss_pred cCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 337 (433)
++.++|+|||++..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus 133 ----~~~~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 133 ----TGHLKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred ----CCcEEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 45577777776654322 2234688999999999988899999999999999999999999987655443322211
Q ss_pred HhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCC-
Q 013973 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT- 416 (433)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t- 416 (433)
+...++.. ....++.++.++|.+||+.||++||+
T Consensus 208 -----------------------~~~~~~~~----------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~ 242 (260)
T cd05611 208 -----------------------RRINWPEE----------------------VKEFCSPEAVDLINRLLCMDPAKRLGA 242 (260)
T ss_pred -----------------------cccCCCCc----------------------ccccCCHHHHHHHHHHccCCHHHccCC
Confidence 11111110 11245678999999999999999995
Q ss_pred --HHHHhcCCCCCCCC
Q 013973 417 --AREALRHPFFTRDH 430 (433)
Q Consensus 417 --a~ell~hp~f~~~~ 430 (433)
++|++.||||++.+
T Consensus 243 ~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 243 NGYQEIKSHPFFKSIN 258 (260)
T ss_pred CcHHHHHcChHhhcCC
Confidence 47999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=322.46 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=199.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-----
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----- 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~----- 170 (433)
.++|++.+.||+|++|.||+|.++.+++.||+|++.......+.+..|+.+++++. .|++++++++.+...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS----NHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc----CCCChheEEEEEEecCCCCc
Confidence 47899999999999999999999999999999999865555567788999888873 357899999998654
Q ss_pred -CeEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 -NHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 -~~~~lV~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
..+++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~----------- 149 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN----------- 149 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-----------
Confidence 4589999999 889999887533 3579999999999999999999999999999999999999544
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHHHh
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~ellt 318 (433)
+.++|+|||.+...... .....|+..|+|||++.. ..++.++|||||||++|+|++
T Consensus 150 ----------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 150 ----------------AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred ----------------CeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 45666666655432211 123468999999999864 346789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||...........+... . +. .+ .....++.+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~--~-~~-------------------~~------------------------~~~~~~~~~ 247 (275)
T cd06608 214 GKPPLCDMHPMRALFKIPRN--P-PP-------------------TL------------------------KSPENWSKK 247 (275)
T ss_pred CCCCccccchHHHHHHhhcc--C-CC-------------------CC------------------------CchhhcCHH
Confidence 99999765443333221110 0 00 00 001234668
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+.+||.+||..||++|||+.|+++|||+
T Consensus 248 ~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 248 FNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=321.18 Aligned_cols=247 Identities=25% Similarity=0.427 Sum_probs=202.5
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+..|+++++++ +|+|++++++.+.....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-----NHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-----CCCChHHHHHhhcCCCeE
Confidence 4899999999999999999999999999999987432 3345677788888887 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ |++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||++++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~------------------ 135 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE------------------ 135 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC------------------
Confidence 9999999 99999999876 37999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH-
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL- 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~- 329 (433)
++.++|+|||.+...... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+..
T Consensus 136 ---------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 206 (258)
T cd05578 136 ---------QGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206 (258)
T ss_pred ---------CCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH
Confidence 445677777766544332 12346888999999999888999999999999999999999999876531
Q ss_pred -HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 330 -EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 330 -~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
+.+..... .. ....+...+.++.++|.+||+
T Consensus 207 ~~~~~~~~~----------------------~~--------------------------~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 207 RDQIRAKQE----------------------TA--------------------------DVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred HHHHHHHhc----------------------cc--------------------------cccCcccCcHHHHHHHHHHcc
Confidence 11111000 00 011123456789999999999
Q ss_pred cCCCCCCCH--HHHhcCCCC
Q 013973 409 YDPTDRLTA--REALRHPFF 426 (433)
Q Consensus 409 ~dP~~R~ta--~ell~hp~f 426 (433)
.||.+||++ .|+++||||
T Consensus 239 ~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 239 RDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CChhHcCCccHHHHhcCCCC
Confidence 999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=321.55 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=201.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
+|+..+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|++++++++.+.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-----NHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-----CCCceehhhceeccC
Confidence 3788899999999999999999999999999986322 1345677899999888 668899999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+++||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~------------- 140 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG------------- 140 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------
Confidence 9999999999 899999997654 789999999999999999999999999999999999995433
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC-------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
..++|+|||.+...... .....||..|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 141 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 207 (268)
T cd06630 141 -------------QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207 (268)
T ss_pred -------------CEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 23566666665433221 1234688999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...........+..... ..+ ....++.++.++.++
T Consensus 208 ~~~~~~~~~~~~~~~~~~------------------~~~--------------------------~~~~~~~~~~~~~~~ 243 (268)
T cd06630 208 WNAEKHSNHLALIFKIAS------------------ATT--------------------------APSIPEHLSPGLRDV 243 (268)
T ss_pred CCCCCCcchHHHHHHHhc------------------cCC--------------------------CCCCchhhCHHHHHH
Confidence 975433222211111100 000 001123456789999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
+.+||+.||++||++.|+++||||+
T Consensus 244 i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 244 TLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=343.87 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=202.3
Q ss_pred eeeccccEEEEEEEECCCCeEEEEEEeec-chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 013973 104 KMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 181 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~ 181 (433)
+||+|.||+||.|++..|....|||.+.. .....+-...|+.+-+++ .|.|||+.++++..++++-|.||-+ |
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-----rHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-----RHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-----hhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 69999999999999999999999998863 334445566788888888 4477999999999999999999999 9
Q ss_pred CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 182 SSLYDFLRKNNYRSF--PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 182 ~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
|+|.++|+..- +++ .+..+.+|.+||+.||.|||++.|||||||-+||||+
T Consensus 657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN-------------------------- 709 (1226)
T KOG4279|consen 657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN-------------------------- 709 (1226)
T ss_pred CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--------------------------
Confidence 99999998643 255 7888999999999999999999999999999999996
Q ss_pred CCCCCEEEEecCCccc---cCCCCCceeecCcccchhhhhCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTY---ERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~---~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
...+.+||+|||-++. .++-..++.||..|||||++..+ +|++++|||||||++.||.||++||......+....
T Consensus 710 TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF 789 (1226)
T KOG4279|consen 710 TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF 789 (1226)
T ss_pred eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh
Confidence 3445667777775542 22334567899999999999864 599999999999999999999999986554432211
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
- -|.+..- .+.+..++.+++.||.+|+..||.+|
T Consensus 790 k------------------------VGmyKvH----------------------P~iPeelsaeak~FilrcFepd~~~R 823 (1226)
T KOG4279|consen 790 K------------------------VGMYKVH----------------------PPIPEELSAEAKNFILRCFEPDPCDR 823 (1226)
T ss_pred h------------------------hcceecC----------------------CCCcHHHHHHHHHHHHHHcCCCcccC
Confidence 1 1111100 11234678899999999999999999
Q ss_pred CCHHHHhcCCCCCCCCC
Q 013973 415 LTAREALRHPFFTRDHL 431 (433)
Q Consensus 415 ~ta~ell~hp~f~~~~~ 431 (433)
|+|.++|+.||++..++
T Consensus 824 ~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 824 PSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred ccHHHhccCcccccCCC
Confidence 99999999999998754
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.73 Aligned_cols=280 Identities=26% Similarity=0.437 Sum_probs=205.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 170 (433)
.++|++.+.||.|+||.||+|.+..+++.||+|.+.... ...+....|+++++.+ .|++++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-----DHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-----CCCcchhhHhhhccccccc
Confidence 468999999999999999999999999999999986432 3345567789999888 668899988766543
Q ss_pred ----------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcccc
Q 013973 171 ----------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 171 ----------~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i 240 (433)
...|+||||++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~----- 150 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE----- 150 (342)
T ss_pred ccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-----
Confidence 468999999988999888643 68999999999999999999999999999999999999532
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhC-CCCCCcchhHHHHHHH
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCIL 313 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l 313 (433)
+..++|+|||.+...... .....|+..|+|||++.+ ..++.++|+|||||++
T Consensus 151 ---------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (342)
T cd07854 151 ---------------------DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 209 (342)
T ss_pred ---------------------CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHH
Confidence 234566666655432211 112357889999998765 5688999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcC
Q 013973 314 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393 (433)
Q Consensus 314 ~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|+|++|..||.+.+..+....+........................... +.. .........
T Consensus 210 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-----------------~~~~~~~~~ 270 (342)
T cd07854 210 AEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDG--GEP-----------------RRPLRDLLP 270 (342)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcc--ccc-----------------CCCHHHHcc
Confidence 9999999999887776665555444333332221111111111100000 000 000111223
Q ss_pred CchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 394 ~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
..+.++.+||.+||+.||++|||+.|++.||||+.
T Consensus 271 ~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 271 GVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 56778999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=316.21 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=203.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++++.||.|+||.||.+.+..+++.+++|.+... ......+..|+++++++ +|++++++++.+...+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-----QHPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-----CCCCeeEEEeEEecCCeEE
Confidence 489999999999999999999999999999987632 33445677899999888 6788999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~----------------- 138 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG----------------- 138 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-----------------
Confidence 999999 89999999876445789999999999999999999999999999999999996544
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.+||+|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 139 ----------~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08221 139 ----------LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208 (256)
T ss_pred ----------CEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 45555555554332221 23468999999999998889999999999999999999999998766554
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. +..+ ......+.++.++|.+||+.|
T Consensus 209 ~~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08221 209 LVVKIVQ--GNYT----------------------------------------------PVVSVYSSELISLVHSLLQQD 240 (256)
T ss_pred HHHHHHc--CCCC----------------------------------------------CCccccCHHHHHHHHHHcccC
Confidence 4433211 1000 001245678999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|.+||++.++++|||+
T Consensus 241 p~~R~s~~~ll~~~~l 256 (256)
T cd08221 241 PEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCCCHHHHhhCcCC
Confidence 9999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.32 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=191.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECC----------------CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRE----------------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGN 158 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~ 158 (433)
++|++.++||+|+||.||+|.+.. ++..||+|++... ......+..|+.++..+ .|+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ 79 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-----KDP 79 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-----CCC
Confidence 579999999999999999997532 3457999998742 23345677899999888 668
Q ss_pred ceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013973 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY-----------------RSFPIDLVREIARQLLECIAFMHDLCM 220 (433)
Q Consensus 159 ~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~i 220 (433)
||+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999 8999999865321 246788899999999999999999999
Q ss_pred eeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhh
Q 013973 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVI 295 (433)
Q Consensus 221 vHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~ 295 (433)
+||||||+|||++.++. +||+|||++....... ....++..|+|||++
T Consensus 160 vH~dlkp~Nill~~~~~---------------------------~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 160 VHRDLATRNCLVGENLT---------------------------IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred cccCcchhheEEcCCcc---------------------------EEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence 99999999999965554 4555555444322111 122457889999999
Q ss_pred hCCCCCCcchhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchh
Q 013973 296 LGLGWTYPCDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 373 (433)
Q Consensus 296 ~~~~~~~~~DvwSlGv~l~ellt--g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (433)
.+..++.++|||||||++|||++ +..||...+..+....+........ ...
T Consensus 213 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~--------- 265 (304)
T cd05096 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQG------------------RQV--------- 265 (304)
T ss_pred hcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcc------------------ccc---------
Confidence 98899999999999999999987 5678877665444332221110000 000
Q ss_pred hHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
....++.++..+.+|+.+||+.||++|||+.||.+
T Consensus 266 --------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 266 --------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred --------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 00112355678999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=328.22 Aligned_cols=288 Identities=26% Similarity=0.432 Sum_probs=215.1
Q ss_pred cEEEEeeeeccccEEEEEEEECCC--CeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRER--KEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---- 168 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~--~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~---- 168 (433)
+|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .........|+.+++++. +|++|+++++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR----GHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc----CCCChheeeeeeeeccc
Confidence 488999999999999999999888 889999988632 122345667888888773 4578898887643
Q ss_pred cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 169 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 169 ~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
....+|++||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..
T Consensus 77 ~~~~~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 77 NFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred cCCcEEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 235688999999889999987543 799999999999999999999999999999999999997666655555555432
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
....... .........||..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+
T Consensus 155 ~~~~~~~--------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 155 FSENPGE--------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ccccccc--------------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 2110000 0001123468999999998876 568999999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
....+..+...+|..+.+....+............-..+. . .........+.++.+|+.+||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~----~~~~~~~~~~~~~~~li~~~l 276 (332)
T cd07857 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPK--------------K----PFESIFPNANPLALDLLEKLL 276 (332)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCC--------------c----chHhhCCCCCHHHHHHHHHHc
Confidence 8888999999999888776555433221111000000000 0 001112345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+.||++|||+.|++.||||+.-
T Consensus 277 ~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 277 AFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred cCCcccCCCHHHHhcChhhhhh
Confidence 9999999999999999999744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=325.07 Aligned_cols=293 Identities=25% Similarity=0.398 Sum_probs=216.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... ........|+++++.+ .|++|+++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-----KHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-----CCCCccchhhheecccc
Confidence 477999999999999999999999999999999885321 1223456788988888 56889999887643
Q ss_pred -----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 170 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 170 -----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
...+++||||++++|.+.+.... ..+++..+..++.||+.||.|||++||+|+||||+|||+++++.++|+|||
T Consensus 82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 34579999999888988887543 469999999999999999999999999999999999999888888888887
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
++........... .+.. ..........|++.|+|||++.+. .++.++|||||||++|||++|.+||
T Consensus 161 ~~~~~~~~~~~~~------------~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 161 LARPYDGPPPNPK------------GGGG-GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred cchhccCCCcccc------------cCCc-ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 7654432111000 0000 000111234688999999988764 5889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+.......+....+.+++..+............... ..............+.++.+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~i 288 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSF-------------------TNYPRTLEERFGKLGPEGLDLL 288 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccC-------------------CCCCccHHHHcccCChhHHHHH
Confidence 998888888888777777665443332211110000000 0000011112234557899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f 426 (433)
.+||+.||++|||+.|++.||||
T Consensus 289 ~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 289 SKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHcccCcccCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=323.86 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=197.2
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
||+|+||+||+|.+..+++.||+|++.... .....+..|+++++.+ +|++++.+++.+...+.+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-----SSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-----CCCCEeeeeeEEecCCeEEEEEecC
Confidence 699999999999999999999999986422 2233446788888887 5789999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++++
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~------------------------ 131 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH------------------------ 131 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC------------------------
Confidence 8999999987655579999999999999999999999999999999999999544
Q ss_pred CCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 337 (433)
+.++|+|||.+....... ....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 132 ---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05577 132 ---GNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208 (277)
T ss_pred ---CCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence 456666666554332211 223578899999999988899999999999999999999999976443111111100
Q ss_pred HhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC--
Q 013973 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-- 415 (433)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-- 415 (433)
. +.. .....+..+++++.++|.+||+.||.+||
T Consensus 209 ~-------------------~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 243 (277)
T cd05577 209 R-------------------TLE--------------------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGC 243 (277)
T ss_pred c-------------------ccc--------------------------ccccCCccCCHHHHHHHHHHccCChhHccCC
Confidence 0 000 00012235677899999999999999999
Q ss_pred ---CHHHHhcCCCCCCCCC
Q 013973 416 ---TAREALRHPFFTRDHL 431 (433)
Q Consensus 416 ---ta~ell~hp~f~~~~~ 431 (433)
++.+++.||||.+...
T Consensus 244 ~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 244 RGGSADEVREHPLFKDLNW 262 (277)
T ss_pred CcccHHHHHhChhhhcCCh
Confidence 8999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=324.79 Aligned_cols=281 Identities=29% Similarity=0.484 Sum_probs=212.2
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
...++|++.+.||+|+||.||+|.++.+++.||+|+++... ........|+.+++.+ .|+|++++++++.+.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~i~~~~~~~~~~ 78 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-----NHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-----CCCCeeeeeheecCc
Confidence 34577999999999999999999999999999999986422 2234456788888888 678999999888664
Q ss_pred C----------eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcccc
Q 013973 171 N----------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 171 ~----------~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i 240 (433)
. .+++||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||++++++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---- 153 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---- 153 (302)
T ss_pred chhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----
Confidence 4 899999999778888887642 4699999999999999999999999999999999999996554
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHH
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVE 315 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~e 315 (433)
.+||+|||.+....... ....++..|+|||++.+. .++.++|||||||++|+
T Consensus 154 -----------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~e 210 (302)
T cd07864 154 -----------------------QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 210 (302)
T ss_pred -----------------------cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHH
Confidence 45555555554322211 112467889999988754 57899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 316 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 316 lltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
|++|++||...+..+.+..+.+..+..+...++.+........... ..............+
T Consensus 211 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~ 271 (302)
T cd07864 211 LFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKP-------------------KKQYRRRLREEFSFI 271 (302)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccccccc-------------------ccccccchhhhcCCC
Confidence 9999999998888888888887777665544332211110000000 000001111122345
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+..+.+||..||+.||.+||++.+++.||||
T Consensus 272 ~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 272 PTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 7789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=320.16 Aligned_cols=276 Identities=31% Similarity=0.538 Sum_probs=209.2
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe---
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH--- 172 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~--- 172 (433)
|++.+.||+|+||.||+|.++.+++.||+|.++... ........|+.+++++.. ..|++++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES--FEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc--cCCCCcceEEEEEeeccCCCC
Confidence 678999999999999999999889999999986322 223345568888877743 247899999999987776
Q ss_pred --EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 173 --ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 173 --~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++++|||++++|.+++.......+++..+..++.||+.||.|||+.+|+|+||||+||+++.
T Consensus 79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~---------------- 142 (287)
T cd07838 79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS---------------- 142 (287)
T ss_pred ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc----------------
Confidence 99999999779999988755446999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
++.++|+|||.+....... ....++..|+|||++.+..++.++|+|||||++|+|++|.+||.+.+.
T Consensus 143 -----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 143 -----------DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred -----------CCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 4566777777665432221 223578899999999998999999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCcc-chhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
.+.+..+....+...... |+.... ....+.. .............+..+.+||.+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l 268 (287)
T cd07838 212 ADQLDKIFDVIGLPSEEE------------------WPRNVSLPRSSFPS-----YTPRSFKSFVPEICEEGLDLLKKML 268 (287)
T ss_pred HHHHHHHHHHcCCCChHh------------------cCCCcccchhhccc-----ccccchhhhhhhhhHHHHHHHHHHh
Confidence 777766655544322111 110000 0000000 0000001112345678899999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013973 408 RYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f 426 (433)
+.||.+||++.|+++||||
T Consensus 269 ~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 269 TFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccCCccCCCHHHHhcCcCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.49 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=193.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY- 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~- 169 (433)
.+|++.+.||+|+||.||+|.+..++..||+|.+... ......+..|+.+++.+ .|++++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-----QHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-----CCCCeeeEEEEEEcC
Confidence 3589999999999999999999999999999988532 12334566788888888 66889999998765
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
...++++|||+ +++|.+++.... .+++.....++.|++.||+|||+.+|+|+||||+||+++.++.
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~---------- 144 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN---------- 144 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC----------
Confidence 46789999999 889999998654 6899999999999999999999999999999999999965544
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCC------CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
++|+|||++..... ......|+..|+|||++.+..++.++|+|||||++|||++|..
T Consensus 145 -----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~ 207 (266)
T cd06651 145 -----------------VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207 (266)
T ss_pred -----------------EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCC
Confidence 55555554432211 1112357889999999999889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||...+.......+.. .+.. ...+...+..+.+
T Consensus 208 pf~~~~~~~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~~~~ 240 (266)
T cd06651 208 PWAEYEAMAAIFKIAT-QPTN----------------------------------------------PQLPSHISEHARD 240 (266)
T ss_pred CccccchHHHHHHHhc-CCCC----------------------------------------------CCCchhcCHHHHH
Confidence 9976543332221110 0000 0011234567888
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
|+ +||..||++||+++|+++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 88 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=317.03 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=195.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY- 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~- 169 (433)
.+|++.+.||+|+||.||+|.+..+++.||||.+... ......+..|+.+++.+ .|++++++++.+.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-----LHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-----CCCCeeeEEeEeccC
Confidence 4699999999999999999999999999999988532 12234567788998888 67889999998865
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
...+++||||+ +++|.+++.... .+++..+..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||.+.
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 35788999999 889999997654 68999999999999999999999999999999999999766655555555443
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
...... ..........|+..|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 155 ~~~~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 155 RLQTIC---------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred cccccc---------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 221000 00001122468899999999998889999999999999999999999997654
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
.......+. .... . ...+...+..+.++|.+||
T Consensus 214 ~~~~~~~~~---~~~~------------------~--------------------------~~~~~~~~~~~~~~i~~~l 246 (265)
T cd06652 214 AMAAIFKIA---TQPT------------------N--------------------------PVLPPHVSDHCRDFLKRIF 246 (265)
T ss_pred hHHHHHHHh---cCCC------------------C--------------------------CCCchhhCHHHHHHHHHHh
Confidence 433222111 0000 0 0012234567889999999
Q ss_pred ccCCCCCCCHHHHhcCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~ 427 (433)
. +|++||+++|+++|||+.
T Consensus 247 ~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 247 V-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred c-ChhhCCCHHHHhcCcccC
Confidence 5 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=320.94 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=190.6
Q ss_pred eeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 013973 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 179 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~ 179 (433)
.||+|+||.||+|.+..+++.||+|++.... ........|..+++.+.. .+|++++.+.+.+...+.+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh--CCCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999999999999999986421 112223344444444433 2678999999999999999999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccccc
Q 013973 180 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258 (433)
Q Consensus 180 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~ 258 (433)
+ |++|.+++...+ .+++..++.++.|++.||+|||+.+|+||||||+||+++.++
T Consensus 79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~---------------------- 134 (278)
T cd05606 79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG---------------------- 134 (278)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC----------------------
Confidence 9 899999987654 799999999999999999999999999999999999995544
Q ss_pred CCCCCCEEEEecCCccccCC-CCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013973 259 MPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336 (433)
Q Consensus 259 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 336 (433)
.++|+|||.+..... ......||..|+|||++.+. .++.++|+||+||++|+|++|..||.............
T Consensus 135 -----~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 135 -----HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred -----CEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 455566665543221 12234689999999999754 68999999999999999999999997653221111000
Q ss_pred HHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC-
Q 013973 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 415 (433)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~- 415 (433)
. ...... ..+...+.++.+++.+||+.||.+|+
T Consensus 210 ~--------------------~~~~~~--------------------------~~~~~~s~~~~~li~~~l~~~p~~R~~ 243 (278)
T cd05606 210 M--------------------TLTMAV--------------------------ELPDSFSPELRSLLEGLLQRDVNRRLG 243 (278)
T ss_pred H--------------------hhccCC--------------------------CCCCcCCHHHHHHHHHHhhcCHHhccC
Confidence 0 000000 11234577899999999999999999
Q ss_pred ----CHHHHhcCCCCCCCC
Q 013973 416 ----TAREALRHPFFTRDH 430 (433)
Q Consensus 416 ----ta~ell~hp~f~~~~ 430 (433)
++.++++||||+...
T Consensus 244 ~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 244 CLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CCCCCHHHHHhCccccCCC
Confidence 999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.37 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=194.0
Q ss_pred CcEEEEeee--eccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKM--GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~i--G~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|.+.+.+ |+|+||.||++.++.+++.+|+|++...... ..|..+...+. +|++++++++.+...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~e~~~~~~~~----~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----AIEPMVHQLMK----DNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----hhhHHHHHHhh----cCCCEEEEEEEEecCCeeE
Confidence 457777766 9999999999999999999999998643211 11333222221 5789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++
T Consensus 86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----------------- 146 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK----------------- 146 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-----------------
Confidence 999999 899999998764 799999999999999999999999999999999999995433
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH-H
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH-L 332 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~-~ 332 (433)
..++|+|||.+...... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||........ .
T Consensus 147 ---------~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 147 ---------DRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred ---------CeEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 15777777776544322 234689999999999998999999999999999999999999985443221 0
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
..+.... .. ....+...++.+.+||.+||+.||.
T Consensus 217 ~~~~~~~--------------------~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~ 250 (267)
T PHA03390 217 ESLLKRQ--------------------QK--------------------------KLPFIKNVSKNANDFVQSMLKYNIN 250 (267)
T ss_pred HHHHHhh--------------------cc--------------------------cCCcccccCHHHHHHHHHHhccChh
Confidence 1000000 00 0011235677899999999999999
Q ss_pred CCCC-HHHHhcCCCCCC
Q 013973 413 DRLT-AREALRHPFFTR 428 (433)
Q Consensus 413 ~R~t-a~ell~hp~f~~ 428 (433)
+|++ ++|+|+||||.+
T Consensus 251 ~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 251 YRLTNYNEIIKHPFLKI 267 (267)
T ss_pred hCCchHHHHhcCCcccC
Confidence 9996 599999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=334.83 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=197.7
Q ss_pred ecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 90 ALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 90 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
..++...+.+.+...||+|.||+||+|++..+ ||||+++- .....+.+..|+.++++- .|.||+-+.++
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-----RH~NIlLFMG~ 456 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKT-----RHENILLFMGA 456 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhc-----chhhheeeehh
Confidence 44555667788999999999999999988654 99999973 344567788999999887 55789999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
+..... .||..+| |.+|+.+|+... .+|.+...+.|+.||++|+.|||.++|||||||..||++.
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~------------ 522 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH------------ 522 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc------------
Confidence 988777 9999999 889999998765 5799999999999999999999999999999999999994
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhC---CCCCCcchhHHHHHHHHHHH
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~ell 317 (433)
+++.|||+|||++.....- .....|...|||||++.. .+|++.+||||||+++|||+
T Consensus 523 ---------------~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl 587 (678)
T KOG0193|consen 523 ---------------EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL 587 (678)
T ss_pred ---------------cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH
Confidence 4466777777776532211 122357889999999974 36999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
+|..||......+++-++- +|. -.|+ .......++.
T Consensus 588 tg~lPysi~~~dqIifmVG-----------------------rG~-l~pd--------------------~s~~~s~~pk 623 (678)
T KOG0193|consen 588 TGELPYSIQNRDQIIFMVG-----------------------RGY-LMPD--------------------LSKIRSNCPK 623 (678)
T ss_pred hCcCCcCCCChhheEEEec-----------------------ccc-cCcc--------------------chhhhccCHH
Confidence 9999999444333222111 110 0000 0011235677
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhc
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
++++|+..||..++++||...+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999988876
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.46 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=198.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
.+|.+.+.||+|+||.||+|.++.+++.||+|++.........+..|+++++.+ .|++++++++.+...+.+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-----CCCChhheEEEEcCCCCcEEE
Confidence 459999999999999999999999999999999876555556678899999888 668899999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||+++++.++
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k---------------- 144 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK---------------- 144 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEE----------------
Confidence 9999 89999999876555789999999999999999999999999999999999996655544
Q ss_pred cccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus 145 -----------l~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 213 (263)
T cd05052 145 -----------VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213 (263)
T ss_pred -----------eCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 45555443322111 11134567999999999899999999999999999998 999998765544
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.... . ...+...+.++.++|.+||+.|
T Consensus 214 ~~~~~~~~~----------------------~--------------------------~~~~~~~~~~~~~li~~cl~~~ 245 (263)
T cd05052 214 VYELLEKGY----------------------R--------------------------MERPEGCPPKVYELMRACWQWN 245 (263)
T ss_pred HHHHHHCCC----------------------C--------------------------CCCCCCCCHHHHHHHHHHccCC
Confidence 332221100 0 0112345678999999999999
Q ss_pred CCCCCCHHHHhc
Q 013973 411 PTDRLTAREALR 422 (433)
Q Consensus 411 P~~R~ta~ell~ 422 (433)
|++|||+.++++
T Consensus 246 p~~Rp~~~~l~~ 257 (263)
T cd05052 246 PSDRPSFAEIHQ 257 (263)
T ss_pred cccCCCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=320.56 Aligned_cols=276 Identities=33% Similarity=0.599 Sum_probs=217.1
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
|++.+.||+|++|.||+|.+..+++.+|+|.++... ........|+.+++.+ .|++++++++.+.....+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-----NHPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-----cCCCcchHHHhhccCCCEEE
Confidence 567899999999999999999999999999986432 2345667788888888 56889999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 176 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 176 V~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++
T Consensus 76 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---------------------- 132 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---------------------- 132 (283)
T ss_pred EEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----------------------
Confidence 99999779999887753 4799999999999999999999999999999999999994
Q ss_pred cccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+.
T Consensus 133 -----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 207 (283)
T cd05118 133 -----TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207 (283)
T ss_pred -----CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 44567777777665443322 123578899999999876 789999999999999999999999998888877
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+...++......+........... ...+..... ......+..+.++.+||.+||+.||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~~P 268 (283)
T cd05118 208 LFKIFRTLGTPDPEVWPKFTSLARNYK----FSFPKKAGM---------------PLPKLFPNASPQALDLLSQMLHYDP 268 (283)
T ss_pred HHHHHHHcCCCchHhcccchhhhhhhh----hhhcccccc---------------CHHHhhhhhCHHHHHHHHHHhccCc
Confidence 777777776665554444332211111 111110000 0011223567889999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q 013973 412 TDRLTAREALRHPFF 426 (433)
Q Consensus 412 ~~R~ta~ell~hp~f 426 (433)
.+||++.+++.||||
T Consensus 269 ~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 269 HKRITAEQALAHPYF 283 (283)
T ss_pred ccCcCHHHHhhCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=319.47 Aligned_cols=278 Identities=32% Similarity=0.559 Sum_probs=214.2
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
|++.+.||+|++|.||+|....+++.||||.+..... .......|+..+.++. +|++++.+++.+...+..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN----EHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc----CCCCchhHHHHhhcCCcEEEE
Confidence 6788999999999999999999999999998864322 2223345777776662 368899999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 177 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 177 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
|||++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||++++
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~---------------------- 134 (283)
T cd07830 77 FEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG---------------------- 134 (283)
T ss_pred EecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC----------------------
Confidence 9999999999988765457899999999999999999999999999999999999954
Q ss_pred ccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
++.++|+|||.+....... ....|+..|+|||++.+ ..++.++|+||||+++|+|++|.+||...+..+...
T Consensus 135 -----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 135 -----PEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred -----CCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 4566777777665433221 23468889999998854 457899999999999999999999999988888888
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+...++..+...+......... ....++.... ..........+.++.+||.+||+.||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~cl~~~p~~ 270 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASK----LGFRFPQFAP---------------TSLHQLIPNASPEAIDLIKDMLRWDPKK 270 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhcc----cccccccccc---------------ccHHHHcccCCHHHHHHHHHhcccCccc
Confidence 88888888776544332211111 0111111000 0001112233678999999999999999
Q ss_pred CCCHHHHhcCCCC
Q 013973 414 RLTAREALRHPFF 426 (433)
Q Consensus 414 R~ta~ell~hp~f 426 (433)
|||+.|++.||||
T Consensus 271 Rpt~~ei~~~~~~ 283 (283)
T cd07830 271 RPTASQALQHPYF 283 (283)
T ss_pred CCCHHHHhhCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.18 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=190.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC-----CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|++... ++.||+|+++.. ......+..|+.+++.+. .|+||+++++.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~----~h~nIv~~~~~~~~ 113 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG----QHKNIVNLLGACTH 113 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc----cCCceeeEeeEecC
Confidence 4699999999999999999986443 357999999643 233455678999988773 46889999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcC--------------------------------------------------------
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNN-------------------------------------------------------- 192 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~-------------------------------------------------------- 192 (433)
.+.+++||||+ +|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999 999999986431
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCC
Q 013973 193 ------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 260 (433)
Q Consensus 193 ------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~ 260 (433)
..++++..+..++.||+.||.|||++||+||||||+|||+++++
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~------------------------ 249 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR------------------------ 249 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC------------------------
Confidence 12478889999999999999999999999999999999996544
Q ss_pred CCCCEEEEecCCccccCCCCC-----ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 013973 261 KSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 334 (433)
Q Consensus 261 ~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 334 (433)
.+||+|||++........ ...++..|||||++.+..++.++|||||||++|||++ |..||...........
T Consensus 250 ---~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~ 326 (374)
T cd05106 250 ---VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326 (374)
T ss_pred ---eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH
Confidence 455555555543221111 1234567999999998899999999999999999997 9999976443222211
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+... + .. ...+...++++.+++.+||+.||++|
T Consensus 327 ~~~~----------------------~-~~------------------------~~~~~~~~~~l~~li~~cl~~dp~~R 359 (374)
T cd05106 327 MVKR----------------------G-YQ------------------------MSRPDFAPPEIYSIMKMCWNLEPTER 359 (374)
T ss_pred HHHc----------------------c-cC------------------------ccCCCCCCHHHHHHHHHHcCCChhhC
Confidence 1110 0 00 00112346789999999999999999
Q ss_pred CCHHHHhc
Q 013973 415 LTAREALR 422 (433)
Q Consensus 415 ~ta~ell~ 422 (433)
||+.++++
T Consensus 360 Ps~~~l~~ 367 (374)
T cd05106 360 PTFSQISQ 367 (374)
T ss_pred cCHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=319.15 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=192.9
Q ss_pred CcEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+|++.+.||+|+||.||+|.++ ..+..||+|+++.. ......+..|+.++.++ .|+|++++++.+...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-----DHSNIVRLEGVITRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEecCC
Confidence 56999999999999999999875 45678999998743 23345567788888777 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999 889999997643 368999999999999999999999999999999999999766655555555332110
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
... ........++..|+|||++.+..++.++|||||||++||+++ |..||...+..
T Consensus 159 ~~~-----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~ 215 (266)
T cd05064 159 SEA-----------------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215 (266)
T ss_pred ccc-----------------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 000 000011235678999999999999999999999999999775 99999876655
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+..... . ..+..++..+.+++.+||+.
T Consensus 216 ~~~~~~~~~~~------------------------~------------------------~~~~~~~~~~~~li~~c~~~ 247 (266)
T cd05064 216 DVIKAVEDGFR------------------------L------------------------PAPRNCPNLLHQLMLDCWQK 247 (266)
T ss_pred HHHHHHHCCCC------------------------C------------------------CCCCCCCHHHHHHHHHHcCC
Confidence 44333211000 0 01234567899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++||++.|+++
T Consensus 248 ~p~~RP~~~~i~~ 260 (266)
T cd05064 248 ERGERPRFSQIHS 260 (266)
T ss_pred CchhCCCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.75 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=201.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..|+.++.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ .|++++++++.+.+...+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCEEE
Confidence 3588899999999999999999999999999998743 23345566788888777 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++... .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++
T Consensus 79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~----------------- 138 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG----------------- 138 (277)
T ss_pred EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-----------------
Confidence 999999 88999998753 589999999999999999999999999999999999996554
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++|+|||.+...... .....++..|+|||++.+..++.++|+|||||++|||++|..||...+...
T Consensus 139 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06640 139 ----------DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208 (277)
T ss_pred ----------CEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence 4555555555332221 122367889999999998889999999999999999999999998655433
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. +. + ......++.++.+|+.+||+.|
T Consensus 209 ~~~~~~~-----------------------~~---~----------------------~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06640 209 VLFLIPK-----------------------NN---P----------------------PTLTGEFSKPFKEFIDACLNKD 240 (277)
T ss_pred Hhhhhhc-----------------------CC---C----------------------CCCchhhhHHHHHHHHHHcccC
Confidence 2221100 00 0 0011234667899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~~ 431 (433)
|++||++.++++|+||.+...
T Consensus 241 p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 241 PSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred cccCcCHHHHHhChHhhhcch
Confidence 999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=338.11 Aligned_cols=249 Identities=22% Similarity=0.395 Sum_probs=208.9
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEee-----cchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe--
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-- 172 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~-----~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~-- 172 (433)
+...+||+|+|-+||+|.|..+|..||.-.++ +.....+++..|+.+|+.| .|+||++++.+|.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-----~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-----KHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-----CCCceeeeeeheecCCCce
Confidence 56689999999999999999999999876554 2234457788999999998 78999999999987654
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+|+|.+ .|+|..|+.+.+ ++....++.|++||+.||.|||++. |||||||.+||+|+
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---------------- 179 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---------------- 179 (632)
T ss_pred eeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc----------------
Confidence 88999999 999999998865 8999999999999999999999986 99999999999996
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
...+.|||+|+|+|+...... ..++|||.|||||+.. +.|+..+||||||.+|+||+|+.+||..+..
T Consensus 180 ----------G~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n 248 (632)
T KOG0584|consen 180 ----------GNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN 248 (632)
T ss_pred ----------CCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence 567899999999998766554 4468999999999987 7899999999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
..++.. +......+..+. ..-.+++++||.+||.
T Consensus 249 ~AQIYK--KV~SGiKP~sl~--------------------------------------------kV~dPevr~fIekCl~ 282 (632)
T KOG0584|consen 249 PAQIYK--KVTSGIKPAALS--------------------------------------------KVKDPEVREFIEKCLA 282 (632)
T ss_pred HHHHHH--HHHcCCCHHHhh--------------------------------------------ccCCHHHHHHHHHHhc
Confidence 655432 111111111111 1224689999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
. .+.|+||.|+|.||||..+
T Consensus 283 ~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 283 T-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred C-chhccCHHHHhhChhhccc
Confidence 9 9999999999999999986
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=320.09 Aligned_cols=276 Identities=29% Similarity=0.489 Sum_probs=211.8
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--CeE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHI 173 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~ 173 (433)
|++.+.||+|+||.||+|.+..+++.||+|.+... ......+..|+.+++.+ .|++++++++.+... +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-----RHPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-----cCCCeeeheeeEecCCCCcE
Confidence 67899999999999999999999999999999754 23344567789999888 578899999999887 899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
++||||++++|.+++.... ..+++..+..++.||+.||+|||+.|++|+||||+||++++++
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~----------------- 137 (287)
T cd07840 76 YMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG----------------- 137 (287)
T ss_pred EEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-----------------
Confidence 9999999779999887653 4799999999999999999999999999999999999995544
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++|+|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|||++|..||...+.
T Consensus 138 ----------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 138 ----------VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred ----------CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 45555555554332221 22356888999998765 4578999999999999999999999998888
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC-chhHHHHHHHhcc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLL 407 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L 407 (433)
...+..+....+..+...+........ ....... ............. ++.++.++|.+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~i~~~l 268 (287)
T cd07840 208 LEQLEKIFELCGSPTDENWPGVSKLPW--FENLKPK-----------------KPYKRRLREFFKHLIDPSALDLLDKLL 268 (287)
T ss_pred HHHHHHHHHHhCCCchhhccccccchh--hhhcccc-----------------ccchhHHHHHhcccCCHHHHHHHHHHc
Confidence 877777777776665443332211100 0000000 0000111111222 4788999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013973 408 RYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f 426 (433)
+.||.+||++.++++||||
T Consensus 269 ~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 269 TLDPKKRISADQALQHEYF 287 (287)
T ss_pred CCChhhCcCHHHHhhCcCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=326.49 Aligned_cols=252 Identities=26% Similarity=0.435 Sum_probs=200.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+.|.....||+|+||.||++.+..+++.||||.+.... ...+.+..|+.+++.+ .|++++++++.+...+..|+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-----HHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-----CCCcHHHHHHheecCCeEEE
Confidence 44666788999999999999999999999999986432 3345567788888877 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++++
T Consensus 97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~------------------- 154 (292)
T cd06658 97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD------------------- 154 (292)
T ss_pred EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-------------------
Confidence 99999 88999988543 58999999999999999999999999999999999999544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+.++|+|||++...... .....|+..|+|||++.+..++.++|+||||+++|||++|..||...+..+.
T Consensus 155 --------~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 226 (292)
T cd06658 155 --------GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226 (292)
T ss_pred --------CCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45666666655432211 1234689999999999988899999999999999999999999987655443
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+........ ......+..+.+||.+||+.||
T Consensus 227 ~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~P 260 (292)
T cd06658 227 MRRIRDNLPPRV----------------------------------------------KDSHKVSSVLRGFLDLMLVREP 260 (292)
T ss_pred HHHHHhcCCCcc----------------------------------------------ccccccCHHHHHHHHHHccCCh
Confidence 332221111000 0011345678999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
.+|||+.|+++||||...
T Consensus 261 ~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 261 SQRATAQELLQHPFLKLA 278 (292)
T ss_pred hHCcCHHHHhhChhhhcc
Confidence 999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=315.29 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=201.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
++|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +|++++++++.+...+.+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-----RHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-----CCCChhceEEEEEeCCEEEE
Confidence 56999999999999999999999999999999987432 2345677888888888 77899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||++++++
T Consensus 78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~------------------ 138 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG------------------ 138 (262)
T ss_pred EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC------------------
Confidence 99999 789999987652 3799999999999999999999999999999999999995544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++|+|||.+...... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+.
T Consensus 139 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 139 ---------DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred ---------CEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 4566666655433221 1234688899999999877 789999999999999999999999987665
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+.... +..+. .......+.++.+||.+||+
T Consensus 210 ~~~~~~~~~~~-----------------------~~~~~---------------------~~~~~~~~~~~~~li~~~l~ 245 (262)
T cd06613 210 MRALFLISKSN-----------------------FPPPK---------------------LKDKEKWSPVFHDFIKKCLT 245 (262)
T ss_pred HHHHHHHHhcc-----------------------CCCcc---------------------ccchhhhhHHHHHHHHHHcC
Confidence 44332221100 00000 00011345678999999999
Q ss_pred cCCCCCCCHHHHhcCCC
Q 013973 409 YDPTDRLTAREALRHPF 425 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~ 425 (433)
.||.+|||+.+++.|+|
T Consensus 246 ~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 246 KDPKKRPTATKLLQHPF 262 (262)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=314.93 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=198.1
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+|++.+.||+|+||.||++.+..+++.||+|.++.. ....+....|+.+++.+ .|+|++++.+.+.+.+.+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-----KHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEECCEEEE
Confidence 489999999999999999999999999999998632 23445566788888777 66889999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||++++++
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~------------------ 137 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG------------------ 137 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC------------------
Confidence 99999 89999998765555789999999999999999999999999999999999995544
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++|+|||.+....... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+....
T Consensus 138 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 138 ---------KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred ---------cEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 45566666554332211 234688999999999998899999999999999999999999987554433
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.. +... ..+..++.++.+||.+||+.||
T Consensus 209 ~~~~~~-----------------------~~~~-------------------------~~~~~~~~~~~~li~~~l~~~P 240 (255)
T cd08219 209 ILKVCQ-----------------------GSYK-------------------------PLPSHYSYELRSLIKQMFKRNP 240 (255)
T ss_pred HHHHhc-----------------------CCCC-------------------------CCCcccCHHHHHHHHHHHhCCc
Confidence 322111 0000 0112355678999999999999
Q ss_pred CCCCCHHHHhcC
Q 013973 412 TDRLTAREALRH 423 (433)
Q Consensus 412 ~~R~ta~ell~h 423 (433)
++|||+.+++.-
T Consensus 241 ~~Rp~~~~il~~ 252 (255)
T cd08219 241 RSRPSATTILSR 252 (255)
T ss_pred ccCCCHHHHhhc
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=318.56 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=196.3
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-----------hHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
+|.+.+.||+|+||.||+|.+..+++.||+|.++.... ..+.+..|+.+++.+ .|+++++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-----DHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-----CCCCcceEEEE
Confidence 48889999999999999999999999999998752111 123456688888877 67889999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
+...+.+++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~--------- 145 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG--------- 145 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC---------
Confidence 99999999999999 999999998764 799999999999999999999999999999999999995544
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCC--CCCcchhHHHHHHHHHHHh
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~ellt 318 (433)
.++|+|||.+...... .....|+..|+|||++.... ++.++|+||||+++|+|++
T Consensus 146 ------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~ 207 (272)
T cd06629 146 ------------------ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207 (272)
T ss_pred ------------------eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence 4555666555432211 12246889999999988754 8899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||...+..+....+... ......+. .....++.+
T Consensus 208 g~~p~~~~~~~~~~~~~~~~---------------------~~~~~~~~----------------------~~~~~~~~~ 244 (272)
T cd06629 208 GRRPWSDEEAIAAMFKLGNK---------------------RSAPPIPP----------------------DVSMNLSPV 244 (272)
T ss_pred CCCCCcCcchHHHHHHhhcc---------------------ccCCcCCc----------------------cccccCCHH
Confidence 99999754443322111000 00000000 011245678
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+.+||.+||+.||++|||++++|+||||
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 245 ALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=336.83 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=216.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
..+++++..||-||||.|=++..+.....+|+|++++. .+..+-...|..+|..+ ..+.||++|..|.+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-----~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-----RSDFIVRLYRTFRDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-----CchHHHHHHHHhccch
Confidence 45788999999999999999987766666999999753 23344455688888777 5689999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
++|++||-| ||.|...|+.++ .|+...+++|+..++.|++|||++|||+|||||+|+|++
T Consensus 494 yvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----------------- 554 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----------------- 554 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec-----------------
Confidence 999999998 999999999876 899999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++-+||.|||+|....... .++||||.|.|||++++...+.++|.||||+++|||++|.+||.+.+.
T Consensus 555 ----------~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 555 ----------NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred ----------cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 45567777888887665544 458999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
+.++..|.+.+.- ..+|..++..+.+||+++-.
T Consensus 625 mktYn~ILkGid~-----------------------------------------------i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 625 MKTYNLILKGIDK-----------------------------------------------IEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred HHHHHHHHhhhhh-----------------------------------------------hhcccccchhHHHHHHHHHh
Confidence 8888776553211 12344667789999999999
Q ss_pred cCCCCCCC-----HHHHhcCCCCCC
Q 013973 409 YDPTDRLT-----AREALRHPFFTR 428 (433)
Q Consensus 409 ~dP~~R~t-----a~ell~hp~f~~ 428 (433)
.+|.+|+. +.++.+|.||..
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhhhc
Confidence 99999996 899999999975
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=319.31 Aligned_cols=271 Identities=27% Similarity=0.402 Sum_probs=210.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++... .........|.++++++. +|++|+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN----GHPGIIKLYYTFQDEEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc----cCCCchhHHHHhcCCce
Confidence 3699999999999999999999999999999998642 222345667778877773 37899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+++|||++ +++|.+++.+.+ .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999 999999998764 799999999999999999999999999999999999998888888888887765433
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
....... ......++..............|+..|+|||++.+..++.++|+||||+++|++++|..||...+....
T Consensus 155 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 155 NSSPESN----KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred ccccccC----CCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 2211000 000001111111111112334688999999999988899999999999999999999999987664433
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+... .. ..+..++..+.+||.+||+.||
T Consensus 231 ~~~~~~~-----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~~p 261 (280)
T cd05581 231 FQKILKL-----------------------EY--------------------------SFPPNFPPDAKDLIEKLLVLDP 261 (280)
T ss_pred HHHHHhc-----------------------CC--------------------------CCCCccCHHHHHHHHHHhcCCH
Confidence 3222110 00 1123456789999999999999
Q ss_pred CCCCCH----HHHhcCCCC
Q 013973 412 TDRLTA----REALRHPFF 426 (433)
Q Consensus 412 ~~R~ta----~ell~hp~f 426 (433)
++||++ .|+++||||
T Consensus 262 ~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 262 QDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hhCCCcccCHHHHhcCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=313.88 Aligned_cols=248 Identities=29% Similarity=0.455 Sum_probs=198.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... ...+.+..|+.+++.+ .|++++++++.+....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-----QHPNIVQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-----CCCCchheeeeEecCC
Confidence 4778899999999999999999899999999886422 2345667788888877 6788999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-------------- 139 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-------------- 139 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--------------
Confidence 999999999 889999998754 689999999999999999999999999999999999995544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+||+|||.+...... .....|+..|+|||.+.... ++.++|+|||||++|+|++|..||....
T Consensus 140 -------------~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 140 -------------VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred -------------CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 5566666655432221 12346889999999998776 8999999999999999999999997655
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+... ... ...+..++.++.+|+.+||
T Consensus 207 ~~~~~~~~~~~-~~~----------------------------------------------~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 207 GVAAVFKIGRS-KEL----------------------------------------------PPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred HHHHHHHHHhc-ccC----------------------------------------------CCcCCCcCHHHHHHHHHHh
Confidence 33322211110 000 0112345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013973 408 RYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f 426 (433)
+.||.+||++.+++.|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=321.88 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=202.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++++.||+|+||+||+|.+..+++.||+|++... ......+..|+++++.+ +|++++++++.+...+.++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-----RSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-----CCCCcceEeeeEecCCEEE
Confidence 5689999999999999999999999999999988633 23456677899988887 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+||||+ +++|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+||+++++
T Consensus 80 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~----------------- 140 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR----------------- 140 (284)
T ss_pred EEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-----------------
Confidence 999999 889999987654 68999999999999999999997 689999999999999544
Q ss_pred CcccccCCCCCCEEEEecCCccccC-CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+.++|+|||++.... ......+||..|+|||++.+..++.++|+|||||++|+|++|..||......+.
T Consensus 141 ----------~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 210 (284)
T cd06620 141 ----------GQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210 (284)
T ss_pred ----------CcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh
Confidence 456666666654321 112335789999999999888899999999999999999999999986443211
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
.. ..+..+.. .....+....... ....++.++.+|+.+||+.||
T Consensus 211 ~~-------~~~~~~~~----~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp 254 (284)
T cd06620 211 GQ-------DDPMGILD----LLQQIVQEPPPRL-------------------------PSSDFPEDLRDFVDACLLKDP 254 (284)
T ss_pred hh-------hhhhHHHH----HHHHHhhccCCCC-------------------------CchhcCHHHHHHHHHHhcCCc
Confidence 00 00000000 0000000000000 001256689999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
++|||+.|+++|+||.+.
T Consensus 255 ~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 255 TERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ccCcCHHHHhcCcccccc
Confidence 999999999999999664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=314.48 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=202.3
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|.+.+.||+|+||.||+|.++.++..||+|.+... ....+.+..|+.+++.+ .|++++++++.+......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-----KHPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-----CCCChhhhhheeccCCeEE
Confidence 488999999999999999999999999999998643 13345567888888888 5688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+|+||+ +++|.+++.......+++..+..++.|++.||.|||+.+|+|+||||+||++++++
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~----------------- 138 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG----------------- 138 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC-----------------
Confidence 999999 89999999775545689999999999999999999999999999999999996432
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
..++|+|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 139 ---------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 209 (257)
T cd08225 139 ---------MVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209 (257)
T ss_pred ---------CeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 235666666665433222 12358899999999988889999999999999999999999998655433
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. +.+. ...+..+.++.++|.+||+.+
T Consensus 210 ~~~~~~~-----------------------~~~~-------------------------~~~~~~~~~~~~~i~~~l~~~ 241 (257)
T cd08225 210 LVLKICQ-----------------------GYFA-------------------------PISPNFSRDLRSLISQLFKVS 241 (257)
T ss_pred HHHHHhc-----------------------ccCC-------------------------CCCCCCCHHHHHHHHHHhccC
Confidence 3221110 0000 011245668999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|++|||+.|++.||||
T Consensus 242 p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 242 PRDRPSITSILKRPFL 257 (257)
T ss_pred hhhCcCHHHHhhCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=335.98 Aligned_cols=245 Identities=28% Similarity=0.425 Sum_probs=203.7
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.+.|.+...+|.|+|+.|-.+.+..+++.+++|++... ......|+.++.... .|+|++++.+.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~----~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVR----DHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhc----CCCcceeecceecCCceee
Confidence 456789999999999999999999999999999999754 233445676666653 5688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+|||.+ |+.|.+.+.... ....++..|+.||+.|+.|||++|||||||||+|||++
T Consensus 393 ~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-------------------- 449 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-------------------- 449 (612)
T ss_pred eeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--------------------
Confidence 999999 888888877653 33378888999999999999999999999999999993
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL-EHL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~-~~~ 332 (433)
+..++++|+|||.+...+..-.+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... ++.
T Consensus 450 ------~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~ 523 (612)
T KOG0603|consen 450 ------GSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH 523 (612)
T ss_pred ------CCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH
Confidence 2345789999999887766644456789999999999999999999999999999999999999876554 222
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
.. ++. +. +....|.+++|||.+||+.||.
T Consensus 524 ~~----i~~-------------------~~----------------------------~s~~vS~~AKdLl~~LL~~dP~ 552 (612)
T KOG0603|consen 524 TR----IQM-------------------PK----------------------------FSECVSDEAKDLLQQLLQVDPA 552 (612)
T ss_pred Hh----hcC-------------------Cc----------------------------cccccCHHHHHHHHHhccCChh
Confidence 21 111 11 1136788999999999999999
Q ss_pred CCCCHHHHhcCCCC
Q 013973 413 DRLTAREALRHPFF 426 (433)
Q Consensus 413 ~R~ta~ell~hp~f 426 (433)
+||++.|++.||||
T Consensus 553 ~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 553 LRLGADEIGAHPWF 566 (612)
T ss_pred hCcChhhhccCcch
Confidence 99999999999999
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=317.95 Aligned_cols=275 Identities=31% Similarity=0.530 Sum_probs=217.3
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
|++.+.||+|+||.||+|.+..+++.||+|++... ....+....|+.+++.+ .|++++++++.+...+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-----KHPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-----CCCCHHHHHhhhhcCCceEE
Confidence 56788999999999999999999999999998753 23345566788888887 57889999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 176 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 176 V~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
||||++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||++++
T Consensus 76 v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~--------------------- 133 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR--------------------- 133 (282)
T ss_pred EecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC---------------------
Confidence 99999889999998753 36999999999999999999999999999999999999954
Q ss_pred cccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+|||||++|||++|.+||...+..+.
T Consensus 134 ------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 207 (282)
T cd07829 134 ------DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207 (282)
T ss_pred ------CCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 4556666666665433221 123457789999999876 789999999999999999999999999888888
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+.+.++......+..+.... +... .++... ........+..+.++.++|.+||+.||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~---------------~~~~~~~~~~~~~~~~~~i~~~l~~~P 267 (282)
T cd07829 208 LFKIFQILGTPTEESWPGVTKLP--DYKP---TFPKFP---------------PKDLEKVLPRLDPEGIDLLSKMLQYNP 267 (282)
T ss_pred HHHHHHHhCCCcHHHHHhhcccc--cccc---cccccC---------------ccchHHhcccccHHHHHHHHHhhccCc
Confidence 88888888877766655443322 0000 000000 000011123447789999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q 013973 412 TDRLTAREALRHPFF 426 (433)
Q Consensus 412 ~~R~ta~ell~hp~f 426 (433)
++||++.+++.||||
T Consensus 268 ~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 268 AKRISAKEALKHPYF 282 (282)
T ss_pred ccCCCHHHHhhCcCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=315.67 Aligned_cols=244 Identities=28% Similarity=0.457 Sum_probs=197.6
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
||.|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++.+ .|++++++++.+.++..+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-----NHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-----CCCCEeeeeeeEEcCCccEEEEecC
Confidence 699999999999999999999999986432 2345567788888877 6789999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++.+.. .+++..+..++.||+.||.|||+.|++|+||||+||+++.
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~------------------------- 128 (262)
T cd05572 76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS------------------------- 128 (262)
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC-------------------------
Confidence 899999998754 6899999999999999999999999999999999999954
Q ss_pred CCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE--NLEHLAMM 335 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~--~~~~~~~i 335 (433)
++.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+
T Consensus 129 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 206 (262)
T cd05572 129 --NGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206 (262)
T ss_pred --CCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence 456777777776544332 223468899999999988889999999999999999999999997655 22222211
Q ss_pred HHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC
Q 013973 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 415 (433)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 415 (433)
.. + ..... .+...+.++.++|.+||+.||++|+
T Consensus 207 ~~--~-------------------~~~~~--------------------------~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 207 LK--G-------------------NGKLE--------------------------FPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hc--c-------------------CCCCC--------------------------CCcccCHHHHHHHHHHccCChhhCc
Confidence 10 0 00001 1223466899999999999999999
Q ss_pred C-----HHHHhcCCCCCCC
Q 013973 416 T-----AREALRHPFFTRD 429 (433)
Q Consensus 416 t-----a~ell~hp~f~~~ 429 (433)
+ ++|+++||||++-
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999863
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=313.45 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=197.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++.+.||+|+||.||+|.+..+++.||+|.++.... ....+..|+.+++.+ +|++|+++++.+...+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-----KHPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-----CCCChhheeeeEecCCEEE
Confidence 58999999999999999999999999999999874432 456677889988888 6688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+|+||+ +++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||++++++.++|+|||.+.......
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999 899999998653 68999999999999999999999999999999999999665555554444433222111
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCC---CCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
... ........++..|+|||++.+.. ++.++||||||+++|+|++|..||...+...
T Consensus 154 ~~~--------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~ 213 (264)
T cd06626 154 TTM--------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213 (264)
T ss_pred Ccc--------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH
Confidence 000 00001235788999999998766 8899999999999999999999997653322
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
........ +..+ ..|. ....+..+.+||.+||+.|
T Consensus 214 ~~~~~~~~-~~~~--------------------~~~~------------------------~~~~~~~~~~li~~~l~~~ 248 (264)
T cd06626 214 QIMFHVGA-GHKP--------------------PIPD------------------------SLQLSPEGKDFLDRCLESD 248 (264)
T ss_pred HHHHHHhc-CCCC--------------------CCCc------------------------ccccCHHHHHHHHHHccCC
Confidence 21111110 1100 0000 1123667899999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|++|||+.|++.|||+
T Consensus 249 p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 249 PKKRPTASELLQHPFV 264 (264)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=324.35 Aligned_cols=251 Identities=24% Similarity=0.435 Sum_probs=201.1
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
|.....||+|+||.||+|.+..+++.||+|++... ....+.+..|+.++..+ .|++++++++.+..++..|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-----CCCchhhhhhheeeCCeEEEEE
Confidence 55566899999999999999999999999998632 23345566788888777 6789999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~---------------------- 152 (297)
T cd06659 98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL---------------------- 152 (297)
T ss_pred ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc----------------------
Confidence 999 88999887653 5899999999999999999999999999999999999954
Q ss_pred ccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
++.++|+|||++...... .....|+..|+|||++.+..++.++|+|||||++|||++|..||...+..+...
T Consensus 153 -----~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 153 -----DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred -----CCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 455667777766433221 123578999999999998889999999999999999999999998766544433
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+... .+. . .......+.++.++|.+||+.||++
T Consensus 228 ~~~~~---~~~--------------------~-----------------------~~~~~~~~~~l~~~i~~~l~~~P~~ 261 (297)
T cd06659 228 RLRDS---PPP--------------------K-----------------------LKNAHKISPVLRDFLERMLTREPQE 261 (297)
T ss_pred HHhcc---CCC--------------------C-----------------------ccccCCCCHHHHHHHHHHhcCCccc
Confidence 22110 000 0 0011234667899999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 013973 414 RLTAREALRHPFFTRDH 430 (433)
Q Consensus 414 R~ta~ell~hp~f~~~~ 430 (433)
||++.++++||||.+..
T Consensus 262 Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 262 RATAQELLDHPFLLQTG 278 (297)
T ss_pred CcCHHHHhhChhhccCC
Confidence 99999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=353.70 Aligned_cols=144 Identities=22% Similarity=0.365 Sum_probs=129.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|.++++||+|+||.||+|.+..+++.||||+++... .....+..|+.+++.+ .|++|+.++..+....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-----KSPFIVHLYYSLQSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-----CCCCcCeEEEEEEECCE
Confidence 56999999999999999999999999999999997432 2235566788888776 66889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
+||||||+ |++|.+++...+ .+++..++.|+.||+.||.|||+.|||||||||+||||+.++.++|+|||++.
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999 999999997654 68999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=314.40 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=195.6
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
.+.....||+|+||.||+|.+..++..||+|.+... ....+.+..|+.+++.+ .|++|+++++.+...+..++|
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-----KHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-----CCCCeeeeeeeeccCCEEEEE
Confidence 344557899999999999999999999999988643 23445677888888887 678999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 177 FEKL-GSSLYDFLRKNNYRSF--PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|||+ +++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~------------------- 143 (268)
T cd06624 84 MEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT------------------- 143 (268)
T ss_pred EecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-------------------
Confidence 9999 899999998642 235 88889999999999999999999999999999999953
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
....++|+|||.+...... .....|+..|+|||++... .++.++|+||||+++|+|++|..||.....
T Consensus 144 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 144 -------YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred -------CCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 1345777777766543221 1223578999999998764 378999999999999999999999975432
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
............ .....+..++.++.+|+.+||+
T Consensus 217 ~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~li~~~l~ 250 (268)
T cd06624 217 PQAAMFKVGMFK----------------------------------------------IHPEIPESLSAEAKNFILRCFE 250 (268)
T ss_pred hhhhHhhhhhhc----------------------------------------------cCCCCCcccCHHHHHHHHHHcC
Confidence 211100000000 0001123456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013973 409 YDPTDRLTAREALRHPFF 426 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f 426 (433)
.+|.+|||+.|++.||||
T Consensus 251 ~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 251 PDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCchhCCCHHHHHhCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=332.46 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=191.5
Q ss_pred CcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|.. ..++..||+|+++... ...+.+..|+.++..+. +|+||+++++.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~----~HpnIv~l~~~~~~ 110 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHINIVNLLGACTV 110 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc----CCcceeeeeeeecc
Confidence 5799999999999999999964 3567789999986432 33456778999988873 46889999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcC--------------------------------------------------------
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNN-------------------------------------------------------- 192 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~-------------------------------------------------------- 192 (433)
.+..++||||+ +|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999 999999987532
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 193 -----------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 193 -----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~------------------- 251 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR------------------- 251 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-------------------
Confidence 12478889999999999999999999999999999999996544
Q ss_pred cccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 252 --------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~ 323 (375)
T cd05104 252 --------ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323 (375)
T ss_pred --------cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence 45555555554332211 11234667999999999999999999999999999998 89999765433
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
....... ..+.. ...+...+.++.+||.+||+.
T Consensus 324 ~~~~~~~----------------------~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~ 356 (375)
T cd05104 324 SKFYKMI----------------------KEGYR-------------------------MLSPECAPSEMYDIMKSCWDA 356 (375)
T ss_pred HHHHHHH----------------------HhCcc-------------------------CCCCCCCCHHHHHHHHHHccC
Confidence 2221110 01000 001123456899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013973 410 DPTDRLTAREALRH 423 (433)
Q Consensus 410 dP~~R~ta~ell~h 423 (433)
||++|||+.|+++.
T Consensus 357 dP~~RPs~~eil~~ 370 (375)
T cd05104 357 DPLKRPTFKQIVQL 370 (375)
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.76 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=202.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+|++.+.||+|+||.||+|.++.+++.||+|.+... ......+..|+++++.+ .|++++++++.+...+.+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-----NSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-----CCCchhhhheeeecCCEEEE
Confidence 588899999999999999999999999999998643 23445667788888877 57889999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
||||+ +++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~-------------------- 135 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN-------------------- 135 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC--------------------
Confidence 99999 799999998653 479999999999999999999999 9999999999999994
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN--LE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~--~~ 330 (433)
.++.++|+|||.+....... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 136 -------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 136 -------SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred -------CCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 44567778887765432211 125788999999999999999999999999999999999999965421 11
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.......+ ...+ ...++.++.+||.+||..|
T Consensus 209 ~~~~~~~~~~~~~-------------------~~~~-------------------------~~~~~~~~~~li~~~l~~~ 244 (265)
T cd06605 209 IFELLQYIVNEPP-------------------PRLP-------------------------SGKFSPDFQDFVNLCLIKD 244 (265)
T ss_pred HHHHHHHHhcCCC-------------------CCCC-------------------------hhhcCHHHHHHHHHHcCCC
Confidence 1111111111000 0000 0115678999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|++|||+.|++.||||+.-
T Consensus 245 p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 245 PRERPSYKELLEHPFIKKY 263 (265)
T ss_pred chhCcCHHHHhhCchhhcc
Confidence 9999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=321.74 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=202.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
...|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+++++.+ .|+|++++.+.+...+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~~~~~~~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-----RHPNTIEYKGCYLREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEEeCC
Confidence 35699999999999999999999999999999988632 22334567788888887 6789999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
..|+||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++
T Consensus 89 ~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~------------------ 149 (307)
T cd06607 89 TAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT------------------ 149 (307)
T ss_pred eEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC------------------
Confidence 999999999888888876543 3699999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++.++|+|||++...... ....|+..|+|||++. ...++.++||||||+++|||++|..||...+.
T Consensus 150 ---------~~~~~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 150 ---------EPGTVKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred ---------CCCCEEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 4456777777776544332 2346888999999885 35688999999999999999999999987655
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
......+... ..+ ..+ ...++.++.+||.+||+
T Consensus 220 ~~~~~~~~~~--~~~--------------------~~~-------------------------~~~~~~~~~~li~~~l~ 252 (307)
T cd06607 220 MSALYHIAQN--DSP--------------------TLS-------------------------SNDWSDYFRNFVDSCLQ 252 (307)
T ss_pred HHHHHHHhcC--CCC--------------------CCC-------------------------chhhCHHHHHHHHHHhc
Confidence 4433221110 000 000 01245578999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
.||++||++.+++.||||...
T Consensus 253 ~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 253 KIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CChhhCcCHHHHhcChhhccc
Confidence 999999999999999999765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=327.23 Aligned_cols=292 Identities=32% Similarity=0.484 Sum_probs=215.1
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY- 169 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~- 169 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+... .........|+.+++++. +|+||+++++++..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~ni~~~~~~~~~~ 79 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG----DHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc----CCCCccceeeeeccC
Confidence 4567899999999999999999999999999999987431 223344566888888772 45789999998754
Q ss_pred -CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 -RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 -~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...+|+||||++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred CCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 3478999999988999998764 688999999999999999999999999999999999996655555555544332
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
....... ..........||..|+|||++.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus 157 ~~~~~~~-------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 157 LSELEEN-------------------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccccccc-------------------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 2111000 00011123468999999998765 457899999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+....+..+...+..........+... . ...... .........+.++.+||.+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----------------~~~~~~-~~~~~~~~~~~~l~~li~~~l 279 (337)
T cd07852 218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS-L----------------PSRPRK-PLDELLPKASDDALDLLKKLL 279 (337)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhh-c----------------cccccc-chhhhccCCCHHHHHHHHHhc
Confidence 8888888888777766655444432221111000 0 000000 011122346788999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+.||++|||+.++++||||++-
T Consensus 280 ~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 280 VFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred cCCcccccCHHHHhhChhhhhh
Confidence 9999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.44 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=199.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~ 172 (433)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... .....+..|+++++.+ +|++|+++++.+.. .+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-----KSPYIVKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEEccCCCe
Confidence 35899999999999999999999999999999987432 3445677899988888 67899999998754 457
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+|+||||+ +++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-------------- 141 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-------------- 141 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC--------------
Confidence 99999999 88999887542 22468999999999999999999999999999999999999544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC-CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
+.++|+|||++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 142 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (287)
T cd06621 142 -------------GQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208 (287)
T ss_pred -------------CeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence 45666666665432221 1234578899999999998999999999999999999999999976522
Q ss_pred --HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 329 --LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 329 --~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
................ ..+.. .......++.+.+||.+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~-------------------~~~~~--------------------~~~~~~~~~~~~~li~~~ 249 (287)
T cd06621 209 PPLGPIELLSYIVNMPNP-------------------ELKDE--------------------PGNGIKWSEEFKDFIKQC 249 (287)
T ss_pred CCCChHHHHHHHhcCCch-------------------hhccC--------------------CCCCCchHHHHHHHHHHH
Confidence 0000000000000000 00000 000012456789999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
|+.||.+|||+.|+++||||++...
T Consensus 250 l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 250 LEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred cCCCcccCCCHHHHHhCcccccccc
Confidence 9999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=309.51 Aligned_cols=256 Identities=22% Similarity=0.383 Sum_probs=201.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|.++++||+|+|++|.+++++.|.+.||+|++++.- ...+-...|..+..+. .++|.+|-+..+|+++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~a----sn~pflvglhscfqtes 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhc----cCCCeEEehhhhhcccc
Confidence 467999999999999999999999999999999997532 2222334455555444 47799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+++|.||+ ||+|--+++.. ++|+++.+++|..+|+.||.|||++|||+||||.+|||++..|++|+.|||+++..-
T Consensus 325 rlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999 88887666654 489999999999999999999999999999999999999777776666666554331
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE--- 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~--- 327 (433)
.+ ++..+++||||.|+|||++.+..|+..+|||+|||+|+||+.|+.||.-..
T Consensus 403 ~~------------------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 403 GP------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred CC------------------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 11 123356799999999999999999999999999999999999999996321
Q ss_pred ----hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 328 ----NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 328 ----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
..+++-++ |... + ...+..++-.+..++
T Consensus 459 ~d~ntedylfqv----------------------ilek----------------q----------iriprslsvkas~vl 490 (593)
T KOG0695|consen 459 PDMNTEDYLFQV----------------------ILEK----------------Q----------IRIPRSLSVKASHVL 490 (593)
T ss_pred cccchhHHHHHH----------------------Hhhh----------------c----------ccccceeehhhHHHH
Confidence 11111110 0000 1 112335666788899
Q ss_pred HhccccCCCCCCC------HHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRLT------AREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~t------a~ell~hp~f~~~ 429 (433)
+..|++||.+|+. ..++..|+||...
T Consensus 491 kgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 491 KGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred HHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 9999999999985 6799999999753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.37 Aligned_cols=287 Identities=27% Similarity=0.485 Sum_probs=221.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---- 169 (433)
+.|+-..+||+|.||.||+|+.+.+++.||+|++-- .........+|+.+|..+ .|+|++.+++.+..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-----kHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-----cchhHHHHHHHHhhccCC
Confidence 568888999999999999999999999999986521 122345567899999998 55778887777643
Q ss_pred ----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 170 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 ----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...+|+||.+|..+|...|.... .+|+..++..++.+++.||.|+|++.|+|||+|++|+||+.+|.
T Consensus 92 ~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi-------- 162 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI-------- 162 (376)
T ss_pred cccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--------
Confidence 34699999999999999987543 57999999999999999999999999999999999999965555
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-------CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHH
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~ell 317 (433)
+||+|||+++...... +..+-|.+|.+||.+.+. .|+++.|||..||++.||.
T Consensus 163 -------------------lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw 223 (376)
T KOG0669|consen 163 -------------------LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW 223 (376)
T ss_pred -------------------EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH
Confidence 5555555553222111 223569999999999975 5999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhh-ccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV-RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
+|.+.|++.++..++..|..++|....+.|+.+........ +... .|.... ..+.+...++ .-.
T Consensus 224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~eP--l~~~~~-----------rkv~n~~kp~--~kd 288 (376)
T KOG0669|consen 224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEP--LPKGQK-----------RKVKNRLKPY--VKD 288 (376)
T ss_pred ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCC--CCcchh-----------hhhhhhcccc--cCC
Confidence 99999999999999999999999999998887755432211 1110 111111 1111111111 124
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
.++.||+.+||..||.+|+++.++|.|.||..+..
T Consensus 289 ~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 289 DEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred hhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 57899999999999999999999999999987653
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.12 Aligned_cols=302 Identities=16% Similarity=0.188 Sum_probs=198.2
Q ss_pred eeeecc--ccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEG--TFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G--~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
..||+| +||+||+|.+..+++.||+|++.... ...+.+..|+.+++.+ +|+||+++++++..++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-----RHPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcceEeeeEecCCceEEEE
Confidence 466776 99999999999999999999986432 2335566677777666 6789999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~---- 154 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN---- 154 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc----
Confidence 999 889999998765456999999999999999999999999999999999999987776666666532211000
Q ss_pred ccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 334 (433)
.+.............++..|+|||++.+. .++.++|||||||++|+|++|..||......+....
T Consensus 155 -------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 221 (328)
T cd08226 155 -------------GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221 (328)
T ss_pred -------------CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence 00000000001112356779999999764 478999999999999999999999987655443322
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhc-cchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM-KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
........|...... ......+..+...+.. ......+.... ...............++.++.+||++||+.||++
T Consensus 222 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 298 (328)
T cd08226 222 KLKGPPYSPLDITTF--PCEESRMKNSQSGVDS-GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298 (328)
T ss_pred HhcCCCCCCcccccc--chhhhhhccchhhhhc-ccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence 221111111000000 0000000000000000 00000000000 0000000011112356778999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 013973 414 RLTAREALRHPFFTRD 429 (433)
Q Consensus 414 R~ta~ell~hp~f~~~ 429 (433)
|||+.|+|+||||.+.
T Consensus 299 Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 299 RPSASSLLSHAFFKQV 314 (328)
T ss_pred CCCHHHHhhCHHHHHH
Confidence 9999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=314.23 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=195.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|+++++||+|+||.||+|.+. ++..||+|.+.......+.+..|+.+++.+ .|++++++++.+...+..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-----QHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCcEEE
Confidence 57999999999999999999875 456699998875444556778899999888 678899999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.......+++..+..++.|++.||+|||+.+++||||||+||+++.++.+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~----------------- 142 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMC----------------- 142 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcE-----------------
Confidence 9999 8999999987555578999999999999999999999999999999999999655544
Q ss_pred cccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
+|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 143 ----------~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~ 212 (261)
T cd05072 143 ----------KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212 (261)
T ss_pred ----------EECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH
Confidence 555555444322111 11245678999999998889999999999999999998 999998765544
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.... .++ ....++.++.+++.+||+.|
T Consensus 213 ~~~~~~~~~------------------------~~~------------------------~~~~~~~~~~~li~~~l~~~ 244 (261)
T cd05072 213 VMSALQRGY------------------------RMP------------------------RMENCPDELYDIMKTCWKEK 244 (261)
T ss_pred HHHHHHcCC------------------------CCC------------------------CCCCCCHHHHHHHHHHccCC
Confidence 333221100 000 11245668999999999999
Q ss_pred CCCCCCHHHHhc
Q 013973 411 PTDRLTAREALR 422 (433)
Q Consensus 411 P~~R~ta~ell~ 422 (433)
|++||+++++++
T Consensus 245 p~~Rp~~~~i~~ 256 (261)
T cd05072 245 AEERPTFDYLQS 256 (261)
T ss_pred cccCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=319.54 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=195.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCC-----eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|.+...+ ..||+|.++.. ......+..|+.++..+ .|++++++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-----QHPNIVCLLGVCTK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-----CCcccceEEEEEcC
Confidence 46999999999999999999876655 77999998643 23345567888888887 67899999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
.+..|++|||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+|+||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999 8999999976421 35888999999999999999999999999999999999965
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHH
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSV 309 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 309 (433)
++. ++|+|||++...... .....+|+.|+|||++.+..++.++|||||
T Consensus 160 ~~~---------------------------~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 160 GLT---------------------------VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred CCc---------------------------EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 554 555555554332111 112356788999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHH
Q 013973 310 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388 (433)
Q Consensus 310 Gv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
||++|||++ |..||.+....+....+... ..
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~i~~~-----------------------~~------------------------- 244 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSR-----------------------QL------------------------- 244 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----------------------Cc-------------------------
Confidence 999999998 99999876654433322110 00
Q ss_pred hhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 389 ~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+..++.++.+|+.+||+.||.+||++.|++++
T Consensus 245 ~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 245 LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=321.99 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=201.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
++|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+..|+.+++.+ .|++++++++.+...+..|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-----KHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-----CCCCeeehhheeeeCCcEEE
Confidence 6799999999999999999999989999999998632 23345567788888777 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
|+||+ +++|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+||+++.++
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~------------------ 152 (293)
T cd06647 94 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG------------------ 152 (293)
T ss_pred EEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC------------------
Confidence 99999 89999998764 588999999999999999999999999999999999995544
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++|+|||++....... ....|++.|+|||.+.+..++.++|+|||||++|++++|..||...+..+.
T Consensus 153 ---------~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~ 223 (293)
T cd06647 153 ---------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (293)
T ss_pred ---------CEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 45666666554322221 223688899999999888899999999999999999999999987554332
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.. + +...+ ..+...+..+.+||.+||+.+|
T Consensus 224 ~~~~~~--~--------------------~~~~~------------------------~~~~~~~~~l~~li~~~l~~~p 257 (293)
T cd06647 224 LYLIAT--N--------------------GTPEL------------------------QNPEKLSAIFRDFLNRCLEMDV 257 (293)
T ss_pred eeehhc--C--------------------CCCCC------------------------CCccccCHHHHHHHHHHccCCh
Confidence 211100 0 00000 0112345678999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~~ 430 (433)
++||++.+++.|+||+...
T Consensus 258 ~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 258 EKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred hhCcCHHHHhcCHHHhcCc
Confidence 9999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.07 Aligned_cols=249 Identities=24% Similarity=0.440 Sum_probs=199.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--cCCe
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNH 172 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--~~~~ 172 (433)
+|++.+.||.|+||.||+|.+..+++.||+|++... ....+.+..|+.+++.+ .|++++++++.+. ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-----KHPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-----CCCccceeeeeeecCCCCE
Confidence 489999999999999999999999999999998632 23445567788888888 6688999988764 4567
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCceEeeccCccccCCCc
Q 013973 173 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMH-----DLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
++++|||+ +++|.+++... ....+++..+..++.||+.||.||| +.+|+|+||||+||+++++
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~--------- 146 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN--------- 146 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC---------
Confidence 89999999 88999998753 1347999999999999999999999 8899999999999999554
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
+.+||+|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 147 ------------------~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 147 ------------------NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred ------------------CCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 456666666655433222 22468999999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||...+..+....+. .+.. ...+...+.++.+
T Consensus 209 p~~~~~~~~~~~~~~-----------------------~~~~-------------------------~~~~~~~~~~~~~ 240 (265)
T cd08217 209 PFTARNQLQLASKIK-----------------------EGKF-------------------------RRIPYRYSSELNE 240 (265)
T ss_pred cccCcCHHHHHHHHh-----------------------cCCC-------------------------CCCccccCHHHHH
Confidence 998765433222211 1100 0112245678999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
++.+||+.+|++||++.+|++|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=312.84 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=193.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|++.+.||+|+||.||+|..+. +..+|+|.+.........+..|+.+++.+ +|++++++++++...+.+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKL-----SHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHC-----CCCCceeEEEEEccCCCEEEE
Confidence 458999999999999999998764 45699998875444456678899999988 678999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~----------------- 139 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV----------------- 139 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeE-----------------
Confidence 9999 899999987643 368999999999999999999999999999999999999655544
Q ss_pred cccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
||+|||.+....... ....++..|+|||++.+..++.++|+||||+++|||++ |+.||...+..+
T Consensus 140 ----------kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 140 ----------KVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred ----------EECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 555555443221111 11234568999999998889999999999999999999 999998766555
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+.... ... .+...+.++.+|+.+||+.|
T Consensus 210 ~~~~i~~~~----------------------~~~--------------------------~~~~~~~~~~~li~~c~~~~ 241 (256)
T cd05114 210 VVEMISRGF----------------------RLY--------------------------RPKLASMTVYEVMYSCWHEK 241 (256)
T ss_pred HHHHHHCCC----------------------CCC--------------------------CCCCCCHHHHHHHHHHccCC
Confidence 444332110 000 01234557899999999999
Q ss_pred CCCCCCHHHHhc
Q 013973 411 PTDRLTAREALR 422 (433)
Q Consensus 411 P~~R~ta~ell~ 422 (433)
|++||++.++++
T Consensus 242 p~~Rps~~~l~~ 253 (256)
T cd05114 242 PEGRPTFAELLR 253 (256)
T ss_pred cccCcCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=312.86 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=203.4
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+|++.+.||+|++|.||+|.+..+++.||+|++.... .....+..|+..+..+ .|++++++++.+...+.+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-----ESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEccCCeEEE
Confidence 5899999999999999999999999999999987543 3456677888888887 47889999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
||||+ +++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.+
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~------------------ 136 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK------------------ 136 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC------------------
Confidence 99999 79999999875 379999999999999999999999 999999999999999544
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 137 ---------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 207 (264)
T cd06623 137 ---------GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207 (264)
T ss_pred ---------CCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC
Confidence 456666666554332221 13468899999999999889999999999999999999999997764211
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC-chhHHHHHHHhcccc
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRY 409 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~ 409 (433)
....+...... ... ..... ++..+.++|.+||..
T Consensus 208 ~~~~~~~~~~~-------------------~~~--------------------------~~~~~~~~~~l~~li~~~l~~ 242 (264)
T cd06623 208 FFELMQAICDG-------------------PPP--------------------------SLPAEEFSPEFRDFISACLQK 242 (264)
T ss_pred HHHHHHHHhcC-------------------CCC--------------------------CCCcccCCHHHHHHHHHHccC
Confidence 11111111000 000 01122 567899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
+|++||++.|+++||||+..
T Consensus 243 ~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 243 DPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=320.78 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=197.4
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+|+..+.||+|+||.||++.+..+++.||+|.+.... .....+..|+.++.++. .|++++++++.+...+..++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS----DCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc----CCCCEeeeeeEEecCCcEEE
Confidence 4777889999999999999999999999999986432 33445667888777762 36889999999999999999
Q ss_pred EEecCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 176 VFEKLGSSLYDFL---RKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 176 V~e~~~~~L~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
||||+++++.++. .......+++..+..++.|++.||+|||+. +|+||||||+|||+++
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~----------------- 143 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR----------------- 143 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-----------------
Confidence 9999977765543 222335799999999999999999999975 9999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCC---CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.++|+|||++...... .....||..|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 144 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 144 ----------NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred ----------CCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 445777777766533222 1234688999999999876 6899999999999999999999999754
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
.. ....+.......+.. .+ ......++.++.+||.+|
T Consensus 214 ~~--~~~~~~~~~~~~~~~-------------------~~----------------------~~~~~~~~~~l~~li~~~ 250 (288)
T cd06616 214 NS--VFDQLTQVVKGDPPI-------------------LS----------------------NSEEREFSPSFVNFINLC 250 (288)
T ss_pred ch--HHHHHhhhcCCCCCc-------------------CC----------------------CcCCCccCHHHHHHHHHH
Confidence 31 111111111110000 00 001124677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|+.||++|||+.+++.||||.+..
T Consensus 251 l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 251 LIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ccCChhhCcCHHHHhcChhhhchh
Confidence 999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.17 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=200.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
.|...+.||+|++|.||++.+..+++.+|+|.+.... ...+.+..|+.+++.+ +|++++++++.+...+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-----CCCChheEEEEEEcCCeEEEE
Confidence 4666789999999999999999999999999886332 2334567788888877 678999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
+||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++
T Consensus 95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~------------------- 152 (285)
T cd06648 95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG------------------- 152 (285)
T ss_pred EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-------------------
Confidence 9999 8999999877 2689999999999999999999999999999999999995544
Q ss_pred cccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~ 332 (433)
.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+..
T Consensus 153 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~ 224 (285)
T cd06648 153 --------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224 (285)
T ss_pred --------cEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 4555566554322211 12246889999999999888999999999999999999999999765544433
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
..+.....+.. ......+..+.+||.+||+.||+
T Consensus 225 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~~p~ 258 (285)
T cd06648 225 KRIRDNLPPKL----------------------------------------------KNLHKVSPRLRSFLDRMLVRDPA 258 (285)
T ss_pred HHHHhcCCCCC----------------------------------------------cccccCCHHHHHHHHHHcccChh
Confidence 32211100000 00123566899999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q 013973 413 DRLTAREALRHPFFTRD 429 (433)
Q Consensus 413 ~R~ta~ell~hp~f~~~ 429 (433)
+||++.++++||||+..
T Consensus 259 ~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 259 QRATAAELLNHPFLAKA 275 (285)
T ss_pred hCcCHHHHccCcccccC
Confidence 99999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=316.71 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=200.5
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.|++.+.||+|+||.||+|.+..+++.||+|.++.. ......+..|+.+++.+.+ ..|++++++++.+......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc--CCCCCeeeEeeeeeeCCEEEE
Confidence 478899999999999999999999999999998642 2334566788999888854 246899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||++++++
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~------------------ 138 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG------------------ 138 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC------------------
Confidence 99999 88999998653 689999999999999999999999999999999999995544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++|+|||.+...... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+...
T Consensus 139 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 139 ---------NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred ---------CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 5666666655433222 122468899999999875 457899999999999999999999997654332
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. ..+ ...+ ....+.++.+++.+||+.|
T Consensus 210 ~~~~~~~---~~~-------------------~~~~-------------------------~~~~~~~~~~~i~~~l~~~ 242 (277)
T cd06917 210 AMMLIPK---SKP-------------------PRLE-------------------------DNGYSKLLREFVAACLDEE 242 (277)
T ss_pred hhhcccc---CCC-------------------CCCC-------------------------cccCCHHHHHHHHHHcCCC
Confidence 2111000 000 0000 0124668999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~ 430 (433)
|++||++.|++.|+||++..
T Consensus 243 p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 243 PKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred cccCcCHHHHhhChHhhccc
Confidence 99999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.60 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=198.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ......+..|+.+++.+ .|++++++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-----NHQNIVRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEc
Confidence 3569999999999999999999987 7788999988633 22334567788888887 6789999999998
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~d 242 (433)
+.+..++||||+ |++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+|||++.++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~------ 153 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG------ 153 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC------
Confidence 889999999999 9999999976532 2589999999999999999999999999999999999996543
Q ss_pred CcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCC-----ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHH
Q 013973 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 317 (433)
....+||+|||+++....... ...++..|+|||++.+..++.++|||||||++|||+
T Consensus 154 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 154 ------------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred ------------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 123577777777764422111 112356799999999889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 318 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 318 t-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
+ |..||...+..+....+... .... .+..++
T Consensus 216 ~~g~~pf~~~~~~~~~~~~~~~----------------------~~~~--------------------------~~~~~~ 247 (277)
T cd05036 216 SLGYMPYPGRTNQEVMEFVTGG----------------------GRLD--------------------------PPKGCP 247 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcC----------------------CcCC--------------------------CCCCCC
Confidence 7 99999876655433322110 0000 122456
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+.+++.+||+.||++||++.+|++|
T Consensus 248 ~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 248 GPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.80 Aligned_cols=248 Identities=30% Similarity=0.452 Sum_probs=197.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.|+..+.||+|+||.||+|.+..+++.||+|+++.. ......+..|+.+++.+ .|++++++++.+.....+|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-----CCCccHhhhcccccCCceEE
Confidence 477788999999999999999999999999998633 23345567788888877 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++... .+++..+..++.||+.||.|||++||+|+||+|+||++++++
T Consensus 80 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~------------------ 138 (277)
T cd06642 80 IMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG------------------ 138 (277)
T ss_pred EEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC------------------
Confidence 99999 88999988653 689999999999999999999999999999999999996554
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.++|+|||++....... ....|+..|+|||++.+..++.++|+|||||++|||++|..||........
T Consensus 139 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 209 (277)
T cd06642 139 ---------DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV 209 (277)
T ss_pred ---------CEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence 45555555554322211 223578899999999998899999999999999999999999975443322
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+. .+.. + ......+.++.++|.+||+.+|
T Consensus 210 ~~~~~-----------------------~~~~--~-----------------------~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 210 LFLIP-----------------------KNSP--P-----------------------TLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred Hhhhh-----------------------cCCC--C-----------------------CCCcccCHHHHHHHHHHccCCc
Confidence 21110 0000 0 0012345678999999999999
Q ss_pred CCCCCHHHHhcCCCCCC
Q 013973 412 TDRLTAREALRHPFFTR 428 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~ 428 (433)
++||++.++++||||..
T Consensus 242 ~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 242 RFRPTAKELLKHKFITR 258 (277)
T ss_pred ccCcCHHHHHHhHHHHH
Confidence 99999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=332.39 Aligned_cols=234 Identities=24% Similarity=0.362 Sum_probs=191.3
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
-++-||+|+.|.||+|+.+ ++.||||.++. .-..+|+-|++| .|+||+.+.++|.....+|||||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkL-----kH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKL-----KHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhc-----cCcceeeEeeeecCCceeEEeeecc
Confidence 3466999999999999764 67899997652 223467777777 7799999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
.|-|.+.|+... .++......|..+|+.|+.|||.+.|||||||.-||||..+
T Consensus 195 a~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~------------------------ 248 (904)
T KOG4721|consen 195 AQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD------------------------ 248 (904)
T ss_pred ccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc------------------------
Confidence 999999998764 89999999999999999999999999999999999999544
Q ss_pred CCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 337 (433)
..+||+|||-++..... ...++||..|||||+|..++.+.|+|||||||||||||||..||...+...++ -
T Consensus 249 ---d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w 321 (904)
T KOG4721|consen 249 ---DVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W 321 (904)
T ss_pred ---ceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E
Confidence 45666666666544333 23479999999999999999999999999999999999999999865432211 0
Q ss_pred HhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCH
Q 013973 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 417 (433)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta 417 (433)
..|.. .+....+..++.-++-||+.||+-.|..||+.
T Consensus 322 GVGsN-------------------------------------------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSF 358 (904)
T KOG4721|consen 322 GVGSN-------------------------------------------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSF 358 (904)
T ss_pred eccCC-------------------------------------------cccccCcccCchHHHHHHHHHHhcCCCCCccH
Confidence 01110 11233456788889999999999999999999
Q ss_pred HHHhcC
Q 013973 418 REALRH 423 (433)
Q Consensus 418 ~ell~h 423 (433)
.++|.|
T Consensus 359 rqil~H 364 (904)
T KOG4721|consen 359 RQILLH 364 (904)
T ss_pred HHHHHH
Confidence 999998
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=318.23 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=194.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++|.+.+.||+|+||.||+|.+.. +++.||+|+++.... ....+..|+++++.+ .|++++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~ 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-----QHENIVKFYGVCTE 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-----CCCCchheeeEEec
Confidence 568999999999999999998753 357899999874322 346778899999888 56889999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNN------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 236 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~ 236 (433)
....++||||+ +++|.+++...+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 99999999999 999999997643 23578899999999999999999999999999999999996655
Q ss_pred ccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHH
Q 013973 237 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311 (433)
Q Consensus 237 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 311 (433)
.++++||| .+...... .....++..|+|||++.+..++.++|||||||
T Consensus 160 ~~kl~d~g---------------------------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05049 160 VVKIGDFG---------------------------MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 212 (280)
T ss_pred eEEECCcc---------------------------cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence 55555554 44322111 11224578899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh
Q 013973 312 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390 (433)
Q Consensus 312 ~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
++|||++ |..||...+..+....+. .+... .
T Consensus 213 il~e~~~~g~~p~~~~~~~~~~~~~~-----------------------~~~~~-------------------------~ 244 (280)
T cd05049 213 VLWEIFTYGKQPWYGLSNEEVIECIT-----------------------QGRLL-------------------------Q 244 (280)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHH-----------------------cCCcC-------------------------C
Confidence 9999998 999998766554433321 11110 0
Q ss_pred hcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 391 ~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.+...+..+.+|+.+||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 245 RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11245678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.28 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=200.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
-|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.++..+ .|++++++++.+..+..+++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-----CCCCEeEEEEEEEeCCeEEE
Confidence 378899999999999999999999999999987632 23345567788888877 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++... .+++..+..++.|++.||.|||+.||+|+||||+||+++.+
T Consensus 80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~------------------- 137 (277)
T cd06641 80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH------------------- 137 (277)
T ss_pred EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-------------------
Confidence 99999 88999998653 68999999999999999999999999999999999999544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||........
T Consensus 138 --------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 209 (277)
T cd06641 138 --------GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV 209 (277)
T ss_pred --------CCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH
Confidence 45666666655433221 1224678899999999888889999999999999999999999976544332
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.. +.. + ......+.++.+++.+||+.+|
T Consensus 210 ~~~~~~--~~~-----------------------~-----------------------~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 210 LFLIPK--NNP-----------------------P-----------------------TLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred HHHHhc--CCC-----------------------C-----------------------CCCcccCHHHHHHHHHHccCCh
Confidence 222110 000 0 0112456789999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
.+||++.++++||||.+.
T Consensus 242 ~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 242 SFRPTAKELLKHKFIVRF 259 (277)
T ss_pred hhCcCHHHHHhCHHHhhh
Confidence 999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=315.36 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=195.7
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
..++|++.+.||+|+||.||+|..+. .+..||+|.++... .....+..|+.+++.+ +|++++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~ 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-----TCHHVVRLLGVV 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEE
Confidence 35689999999999999999997652 34579999886432 2233456788888877 668899999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcc
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 238 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~ 238 (433)
......|+||||+ +|+|.+++.... ...++...+..++.||+.||.|||+++|+||||||+|||+++++.
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~- 157 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT- 157 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc-
Confidence 9999999999999 899999997532 123567788999999999999999999999999999999965554
Q ss_pred ccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHH
Q 013973 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 313 (433)
Q Consensus 239 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l 313 (433)
++|+|||+++...... ....++..|+|||.+.+..++.++|+|||||++
T Consensus 158 --------------------------~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 158 --------------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred --------------------------EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 5555555544221111 112456789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhc
Q 013973 314 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392 (433)
Q Consensus 314 ~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
|||++ |..||.+....+....+.. .+... .+
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~----------------------~~~~~--------------------------~~ 243 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMD----------------------GGYLD--------------------------QP 243 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc----------------------CCCCC--------------------------CC
Confidence 99998 7899987655443332110 00000 11
Q ss_pred CCchhHHHHHHHhccccCCCCCCCHHHHhc------CCCCCCC
Q 013973 393 DHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFFTRD 429 (433)
Q Consensus 393 ~~~~~~~~~li~~~L~~dP~~R~ta~ell~------hp~f~~~ 429 (433)
...+..+.+++.+||+.||++|||+.++++ ||||...
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 234568999999999999999999999987 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.57 Aligned_cols=269 Identities=20% Similarity=0.276 Sum_probs=198.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.++||+|+||.||+|++..+++.||+|+++.. ....+.+..|+.+++.+ .|+|++++++.+.+.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-----~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-----IHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-----CCcCcCeEEEEEeeCCE
Confidence 5799999999999999999999999999999998632 23345677899999888 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNN---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~d 242 (433)
.|+||||+ |++|.+++.... ...+++..+..++.||+.||+|||++|||||||||+|||++.+|.++|+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 99999999 999999986421 12356677889999999999999999999999999999998888777777
Q ss_pred CcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
||++.......... .......-+............+||+.|||||++.+..++.++|||||||++|||++|..|
T Consensus 157 FGLAk~i~~~~~~~------~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 157 WGAAIFKKLEEEDL------LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred cCcceecccccccc------cccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 77766442211100 000000000000000111235799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+....... ... ..|.. .......++.+.++
T Consensus 231 F~~~~~~ki~~~--~~i-~~P~~-------------------------------------------~~p~~~iP~~L~~L 264 (932)
T PRK13184 231 YRRKKGRKISYR--DVI-LSPIE-------------------------------------------VAPYREIPPFLSQI 264 (932)
T ss_pred CCCcchhhhhhh--hhc-cChhh-------------------------------------------ccccccCCHHHHHH
Confidence 976443221110 000 00000 00012456788999
Q ss_pred HHhccccCCCCCCCHHHHhc
Q 013973 403 LQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~ 422 (433)
+.+||+.||++|++..+.+.
T Consensus 265 I~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 265 AMKALAVDPAERYSSVQELK 284 (932)
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999987665553
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=310.87 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=196.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++.+.||+|+||.||+|.+.. ++.||+|.++......+.+..|+.+++++ .|++++++++++...+..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKL-----RHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHC-----CCCCccceeEEEecCCCeee
Confidence 3579999999999999999998754 46799999875544456678899999988 56889999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~------------------ 140 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN------------------ 140 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC------------------
Confidence 99999 99999999876555799999999999999999999999999999999999996554
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC-Cc---eeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ-NY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~---~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.++|+|||++....... .. ..++..|+|||++.+..++.++|+||||+++|||++ |+.||.+.+..
T Consensus 141 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 141 ---------ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred ---------CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 45555555554332111 01 122457999999998899999999999999999999 99999876655
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+.... .. ..+...+..+.+++.+||+.
T Consensus 212 ~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~ 243 (261)
T cd05068 212 EVLQQVDQGY----------------------RM--------------------------PCPPGCPKELYDIMLDCWKE 243 (261)
T ss_pred HHHHHHHcCC----------------------CC--------------------------CCCCcCCHHHHHHHHHHhhc
Confidence 4443322110 00 01123466899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++||++.++++
T Consensus 244 ~P~~Rp~~~~l~~ 256 (261)
T cd05068 244 DPDDRPTFETLQW 256 (261)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=304.47 Aligned_cols=249 Identities=29% Similarity=0.502 Sum_probs=204.6
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
+|.+.+.||+|++|.||++.+..+++.|++|++..... ....+..|+++++.+ .|++++++.+.+......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-----KHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCCeEEEE
Confidence 37889999999999999999998999999999875432 556677888888888 568899999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
+||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---------------------- 132 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---------------------- 132 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----------------------
Confidence 9999 799999987753 4799999999999999999999999999999999999994
Q ss_pred cccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
.++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+...
T Consensus 133 -----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 207 (253)
T cd05122 133 -----SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207 (253)
T ss_pred -----cCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 44567888888776555443 44578999999999998889999999999999999999999998765433332
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+... ..+ ..+ ....++.++.++|.+||+.||++
T Consensus 208 ~~~~~--~~~--------------------~~~------------------------~~~~~~~~~~~~i~~~l~~~p~~ 241 (253)
T cd05122 208 KIATN--GPP--------------------GLR------------------------NPEKWSDEFKDFLKKCLQKNPEK 241 (253)
T ss_pred HHHhc--CCC--------------------CcC------------------------cccccCHHHHHHHHHHccCChhh
Confidence 21110 000 000 01123568999999999999999
Q ss_pred CCCHHHHhcCCC
Q 013973 414 RLTAREALRHPF 425 (433)
Q Consensus 414 R~ta~ell~hp~ 425 (433)
|||+.|+++|||
T Consensus 242 R~t~~~~l~~~~ 253 (253)
T cd05122 242 RPTAEQLLKHPF 253 (253)
T ss_pred CCCHHHHhcCCC
Confidence 999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=317.38 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=202.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
+.|...++||+|+||.||+|.+..+++.||+|++.... .....+..|+++++.+ .|++++++++.+.+...
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-----KHPNTIEYKGCYLKEHT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCCE
Confidence 34777889999999999999999999999999986321 2234466788888887 67889999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
.|+||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~------------------ 156 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE------------------ 156 (313)
T ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC------------------
Confidence 99999999888988887543 46899999999999999999999999999999999999944
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.++|+|||++..... .....|+..|+|||++. ...++.++|+|||||++|+|++|..||...+..
T Consensus 157 ---------~~~~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~ 226 (313)
T cd06633 157 ---------PGQVKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226 (313)
T ss_pred ---------CCCEEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 44577777776653322 23457899999999985 356889999999999999999999999876654
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+... ..+. . ....++..+++|+.+||+.
T Consensus 227 ~~~~~~~~~--~~~~--------------------~-------------------------~~~~~~~~l~~li~~~l~~ 259 (313)
T cd06633 227 SALYHIAQN--DSPT--------------------L-------------------------QSNEWTDSFRGFVDYCLQK 259 (313)
T ss_pred HHHHHHHhc--CCCC--------------------C-------------------------CccccCHHHHHHHHHHccC
Confidence 443332111 0000 0 0123455789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~~~ 431 (433)
+|.+||++.+++.||||...+.
T Consensus 260 ~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 260 IPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred ChhhCcCHHHHhcCcccCCCch
Confidence 9999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=309.95 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=193.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|.+.+.||+|+||.||+|.... +..+|+|.++......+.+..|+.+++.+ +|++|+++++++.....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-----SHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-----CCCCeeeEEEEEccCCCcEEE
Confidence 469999999999999999998754 44599998875444456678899988887 678999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~------------------ 138 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC------------------ 138 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC------------------
Confidence 9999 889999998654 36899999999999999999999999999999999999965554
Q ss_pred cccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
+||+|||.+....... ....++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+
T Consensus 139 ---------~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 139 ---------VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred ---------EEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 5555555443222111 11235677999999998889999999999999999998 999998766544
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+... .... .+...+..+.+++.+||+.|
T Consensus 210 ~~~~~~~~-----------------------~~~~-------------------------~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 210 TVEKVSQG-----------------------LRLY-------------------------RPHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred HHHHHhcC-----------------------CCCC-------------------------CCCCCCHHHHHHHHHHcCCC
Confidence 33322111 0000 01234568899999999999
Q ss_pred CCCCCCHHHHhcC
Q 013973 411 PTDRLTAREALRH 423 (433)
Q Consensus 411 P~~R~ta~ell~h 423 (433)
|.+||++.+++.+
T Consensus 242 p~~Rp~~~~ll~~ 254 (256)
T cd05113 242 AEERPTFQQLLSS 254 (256)
T ss_pred cccCCCHHHHHHh
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.99 Aligned_cols=245 Identities=27% Similarity=0.348 Sum_probs=191.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++.++||+|+||.||+|.+..++ .||+|+++......+.+..|+.+++.+ .|++++++++.+. ....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhC-----CCCCcceEEEEEC-CCCcEE
Confidence 357999999999999999999887664 599999975444456678899999887 5688999988775 456899
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.......+++..+..++.|++.||+|||+.+|+||||||+||++++++
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~------------------ 139 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------ 139 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC------------------
Confidence 99999 88999999865445689999999999999999999999999999999999996544
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.++|+|||.+....... ....++..|+|||++.+..++.++|+|||||++|+|++ |..||.+....
T Consensus 140 ---------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 140 ---------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred ---------cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 45555555554322211 11245678999999998889999999999999999999 88999876554
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.... . . ......+..+.+|+.+||+.
T Consensus 211 ~~~~~~~~~~----------------------~--~------------------------~~~~~~~~~l~~li~~~l~~ 242 (262)
T cd05071 211 EVLDQVERGY----------------------R--M------------------------PCPPECPESLHDLMCQCWRK 242 (262)
T ss_pred HHHHHHhcCC----------------------C--C------------------------CCccccCHHHHHHHHHHccC
Confidence 4333221100 0 0 00123566789999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++||++.++++
T Consensus 243 ~p~~Rp~~~~~~~ 255 (262)
T cd05071 243 EPEERPTFEYLQA 255 (262)
T ss_pred CcccCCCHHHHHH
Confidence 9999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=312.33 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=192.1
Q ss_pred ecCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
..++|++.+.||+|+||.||+|.++ .++..||+|++.... .....+..|+.+++.+ +|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~ 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGVV 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEE
Confidence 4578999999999999999999864 245679999886422 2344567788888877 678899999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcc
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNNY--------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 238 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~ 238 (433)
......++||||+ +++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+|||+++++.
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~- 157 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT- 157 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC-
Confidence 9999999999999 8999999975321 23577889999999999999999999999999999999965554
Q ss_pred ccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHH
Q 013973 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 313 (433)
Q Consensus 239 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l 313 (433)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++
T Consensus 158 --------------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 211 (277)
T cd05062 158 --------------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211 (277)
T ss_pred --------------------------EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence 4555555443221111 112457789999999998999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhc
Q 013973 314 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392 (433)
Q Consensus 314 ~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
|||++ |..||.+....+....+.. .+... .+
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~----------------------~~~~~--------------------------~~ 243 (277)
T cd05062 212 WEIATLAEQPYQGMSNEQVLRFVME----------------------GGLLD--------------------------KP 243 (277)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHc----------------------CCcCC--------------------------CC
Confidence 99999 7899987655443332111 00000 11
Q ss_pred CCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 393 DHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 393 ~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 244 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2456689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=310.97 Aligned_cols=244 Identities=30% Similarity=0.534 Sum_probs=196.1
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
||.|+||.||+|++..+++.||+|++.... .....+..|+.+++.+ .|+|++++++.+......|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-----QSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-----CCcchhHHHHheecCcEEEEEEecC
Confidence 689999999999999999999999986432 2344566778888777 5688999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++...+ .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~----------------------- 130 (265)
T cd05579 76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG----------------------- 130 (265)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-----------------------
Confidence 889999998755 799999999999999999999999999999999999996554
Q ss_pred CCCCCEEEEecCCccccCCC-----------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 260 PKSSAIKVIDFGSTTYERPD-----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++|+|||++...... .....++..|+|||.+....++.++|+||||+++|+|++|..||.....
T Consensus 131 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 131 ----HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred ----CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 4555555554432211 1234678899999999988899999999999999999999999987665
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+.. +...++.. ...+..+.+|+.+||+
T Consensus 207 ~~~~~~~~~-----------------------~~~~~~~~------------------------~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 207 EEIFQNILN-----------------------GKIEWPED------------------------VEVSDEAIDLISKLLV 239 (265)
T ss_pred HHHHHHHhc-----------------------CCcCCCcc------------------------ccCCHHHHHHHHHHhc
Confidence 444332211 11222210 0136688999999999
Q ss_pred cCCCCCCCH---HHHhcCCCCCCC
Q 013973 409 YDPTDRLTA---REALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta---~ell~hp~f~~~ 429 (433)
.||++|||+ .++|+||||++-
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 999999999 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.77 Aligned_cols=246 Identities=26% Similarity=0.357 Sum_probs=195.2
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..++|+++++||+|+||.||+|..+ +++.||+|.+.........+..|+.+++.+ .|++++++++.+. .+..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-----QHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-----CCcCeeeEEEEEc-cCCcE
Confidence 3467999999999999999999865 457799999976555556788899999888 5688999998764 56789
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.......+++..+..++.|++.||+|||+.||+||||||+||++++++.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---------------- 140 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC---------------- 140 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC----------------
Confidence 999999 899999998765567999999999999999999999999999999999999965544
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 328 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~ 328 (433)
++|+|||.+....... ....++..|+|||++.+..++.++|+||||+++|||++ |..||.+.+.
T Consensus 141 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 141 -----------CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred -----------EEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 5555555554322111 11245678999999998889999999999999999999 9999987665
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+...... ..+...+.++.++|.+||+
T Consensus 210 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05067 210 PEVIQNLERGYRM------------------------------------------------PRPDNCPEELYELMRLCWK 241 (260)
T ss_pred HHHHHHHHcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHcc
Confidence 5443332111000 0112456689999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013973 409 YDPTDRLTAREALR 422 (433)
Q Consensus 409 ~dP~~R~ta~ell~ 422 (433)
.||++|||+++++.
T Consensus 242 ~~p~~Rp~~~~l~~ 255 (260)
T cd05067 242 EKPEERPTFEYLRS 255 (260)
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=319.91 Aligned_cols=245 Identities=21% Similarity=0.290 Sum_probs=190.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeE----EEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEM----VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~----vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+|++.+.||+|+||.||+|.+..+++. ||+|+++.. ......+..|+.+++.+ .|+||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEcCC
Confidence 5699999999999999999998766654 899998632 23455677788888887 678999999988764
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
..++|+||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~------------ 147 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH------------ 147 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc------------
Confidence 577899999 999999998754 36889999999999999999999999999999999999965544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCC-----ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
+||+|||++........ ...++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 148 ---------------~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 148 ---------------VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred ---------------EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 55555555543322111 1134678999999999999999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+....+....+. .+ ...+ .+..++.++.+++
T Consensus 213 ~~~~~~~~~~~~~-----------------------~~-~~~~------------------------~~~~~~~~~~~li 244 (316)
T cd05108 213 DGIPASEISSILE-----------------------KG-ERLP------------------------QPPICTIDVYMIM 244 (316)
T ss_pred CCCCHHHHHHHHh-----------------------CC-CCCC------------------------CCCCCCHHHHHHH
Confidence 8755443222111 00 0000 1124456789999
Q ss_pred HhccccCCCCCCCHHHHhcC
Q 013973 404 QGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~h 423 (433)
.+||+.||.+||++.+++.+
T Consensus 245 ~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 245 VKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=314.38 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=205.9
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..+.|++.+.||+|+||.||+|.+..+++.||+|++.......+.+..|+++++.+ .|+|++++++.+......|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-----KHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-----CCCCeeEEEEEEEECCEEE
Confidence 45679999999999999999999998899999999975444456677899888888 6688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+|+||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~---------------- 154 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---------------- 154 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC----------------
Confidence 999999 799999998754 36999999999999999999999999999999999999965554
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++|+|||.+...... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+...
T Consensus 155 -----------~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 155 -----------VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred -----------EEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 555555544322211 122357889999999998889999999999999999999999998765544
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+... ..+ ..+ ....++.++.+||.+||+.+
T Consensus 224 ~~~~~~~~--~~~--------------------~~~------------------------~~~~~~~~l~~li~~~l~~~ 257 (286)
T cd06614 224 ALFLITTK--GIP--------------------PLK------------------------NPEKWSPEFKDFLNKCLVKD 257 (286)
T ss_pred HHHHHHhc--CCC--------------------CCc------------------------chhhCCHHHHHHHHHHhccC
Confidence 33222110 000 000 01125668999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|.+||++.++++|+||++.
T Consensus 258 p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 258 PEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred hhhCcCHHHHhhChHhhcc
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.43 Aligned_cols=245 Identities=26% Similarity=0.361 Sum_probs=192.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++.++||+|+||.||+|.+. ++..+|+|.++........+..|+.+++++ .|++++++++.+. ....++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-----RHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-----CCCceEEEEeEEC-CCCcEE
Confidence 467999999999999999999876 455699999875444456678899999988 6688999998875 456899
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~----------------- 140 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV----------------- 140 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce-----------------
Confidence 99999 889999998765557899999999999999999999999999999999999965544
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
++|+|||.+....... ....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..
T Consensus 141 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 141 ----------CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred ----------EEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 5555555554322211 11234567999999998889999999999999999999 89999876655
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.... .. +.+...+..+.+|+.+||+.
T Consensus 211 ~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05070 211 EVLEQVERGY----------------------RM--------------------------PCPQDCPISLHELMLQCWKK 242 (260)
T ss_pred HHHHHHHcCC----------------------CC--------------------------CCCCcCCHHHHHHHHHHccc
Confidence 4443322100 00 01224566899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++|||++++++
T Consensus 243 ~p~~Rpt~~~l~~ 255 (260)
T cd05070 243 DPEERPTFEYLQS 255 (260)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=310.12 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=193.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.........+..|+.+++.+ .|++++++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-----SHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-----CCCCEEEEEEEEcCCCceEEE
Confidence 35889999999999999999886 456799999875444445677899998887 678899999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++++++.
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~------------------ 138 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV------------------ 138 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc------------------
Confidence 9999 899999997654 36899999999999999999999999999999999999965554
Q ss_pred cccCCCCCCEEEEecCCccccCCCCC-c---eeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQN-Y---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~~-~---~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
+||+|||.++....... . ..++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 139 ---------~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05059 139 ---------VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209 (256)
T ss_pred ---------EEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence 55555555543221111 1 123457999999999899999999999999999999 899998766554
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+..... . ..+...+.++.+++.+||+.+
T Consensus 210 ~~~~~~~~~~----------------------~--------------------------~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 210 VVESVSAGYR----------------------L--------------------------YRPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred HHHHHHcCCc----------------------C--------------------------CCCCCCCHHHHHHHHHHhcCC
Confidence 4332211100 0 012245678999999999999
Q ss_pred CCCCCCHHHHhcC
Q 013973 411 PTDRLTAREALRH 423 (433)
Q Consensus 411 P~~R~ta~ell~h 423 (433)
|++|||+.|+++.
T Consensus 242 p~~Rpt~~~~l~~ 254 (256)
T cd05059 242 PEDRPAFKKLLSQ 254 (256)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=312.79 Aligned_cols=246 Identities=23% Similarity=0.343 Sum_probs=197.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..+|++.++||.|+||.||+|.+.. ++.+|+|++..... ....+..|+.+++.+ .|++++++++++......+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-----RHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-----CCcchhheeeeEecCCCeE
Confidence 3569999999999999999999987 78899999875433 455677888888877 6689999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||+++++.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~--------------- 143 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVC--------------- 143 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceE---------------
Confidence 999999 8899999987655679999999999999999999999999999999999999665554
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
||+|||.+....... ....++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 144 ------------kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 144 ------------KVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred ------------EEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 555555443322111 11235678999999998889999999999999999998 89999876655
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+..... ...+..++..+.+++.+||+.
T Consensus 212 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05148 212 EVYDQITAGYR------------------------------------------------MPCPAKCPQEIYKIMLECWAA 243 (261)
T ss_pred HHHHHHHhCCc------------------------------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence 54443221000 011235567899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++|||+.++++
T Consensus 244 ~p~~Rpt~~~l~~ 256 (261)
T cd05148 244 EPEDRPSFKALRE 256 (261)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=309.57 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=193.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|++..+++.||||.++. .......+..|+++++.+ .|++++++++.+.+.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-----NHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-----CCcceeeeeeeEEECCe
Confidence 569999999999999999999999999999998753 123344567799988888 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+|||++.++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~------------- 143 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG------------- 143 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-------------
Confidence 99999999 88999888632 224589999999999999999999999999999999999996544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|||++|..||...
T Consensus 144 --------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 144 --------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred --------------CEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 45556666554332211 1236888999999999888999999999999999999999999654
Q ss_pred ChH--HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 327 ENL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 327 ~~~--~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
... +....+ ...+. + .. .....+.++.++|.
T Consensus 210 ~~~~~~~~~~~-~~~~~-~-----------------------~~----------------------~~~~~~~~~~~li~ 242 (267)
T cd08228 210 KMNLFSLCQKI-EQCDY-P-----------------------PL----------------------PTEHYSEKLRELVS 242 (267)
T ss_pred cccHHHHHHHH-hcCCC-C-----------------------CC----------------------ChhhcCHHHHHHHH
Confidence 321 111111 00000 0 00 01134567899999
Q ss_pred hccccCCCCCCCHHHHhcC
Q 013973 405 GLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~h 423 (433)
+||+.+|++||++.++++.
T Consensus 243 ~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 243 MCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHCCCCcccCcCHHHHHHH
Confidence 9999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=308.17 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=192.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~l 175 (433)
.+|++.+.||+|+||.||++... +..||+|.++.. ...+.+..|+.+++.+ .|++++++++.+ ...+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhC-----CCCCeeeEEEEEEcCCCceEE
Confidence 46999999999999999999764 677999998643 3345677899999888 568899999864 55678999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++++
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~------------------- 138 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED------------------- 138 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-------------------
Confidence 99999 8899999987665568999999999999999999999999999999999999544
Q ss_pred ccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 333 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 333 (433)
+.+||+|||++...........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+...
T Consensus 139 --------~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~ 210 (256)
T cd05082 139 --------NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210 (256)
T ss_pred --------CcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 45666666665543333333345678999999998889999999999999999998 999997655433332
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+.... + ...++..+..+.+++.+||+.||++
T Consensus 211 ~~~~~~--------------------------~----------------------~~~~~~~~~~~~~li~~~l~~~p~~ 242 (256)
T cd05082 211 RVEKGY--------------------------K----------------------MDAPDGCPPVVYDVMKQCWHLDAAT 242 (256)
T ss_pred HHhcCC--------------------------C----------------------CCCCCCCCHHHHHHHHHHhcCChhh
Confidence 211100 0 0112345678999999999999999
Q ss_pred CCCHHHHhc
Q 013973 414 RLTAREALR 422 (433)
Q Consensus 414 R~ta~ell~ 422 (433)
|||+.++++
T Consensus 243 Rpt~~~l~~ 251 (256)
T cd05082 243 RPSFLQLRE 251 (256)
T ss_pred CcCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=306.06 Aligned_cols=249 Identities=28% Similarity=0.511 Sum_probs=202.5
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++.+.||.|+||.||++.+..+++.||+|++.... ........|+++++.+ .|++++++.+.+......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-----NHPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-----CCCChhheEEEEecCCEEE
Confidence 4899999999999999999999999999999986432 3455677888888888 5688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|||++ +++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~--------------- 140 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG--------------- 140 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC---------------
Confidence 999999 789999998642 35799999999999999999999999999999999999995544
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.++|+|||.+....... ....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus 141 ------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 208 (258)
T cd08215 141 ------------LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208 (258)
T ss_pred ------------cEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence 45666666554332221 234688999999999998899999999999999999999999977654
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+... .. ...+..++.++.+++.+||+
T Consensus 209 ~~~~~~~~~~-----------------------~~-------------------------~~~~~~~~~~~~~~i~~~l~ 240 (258)
T cd08215 209 LELALKILKG-----------------------QY-------------------------PPIPSQYSSELRNLVSSLLQ 240 (258)
T ss_pred HHHHHHHhcC-----------------------CC-------------------------CCCCCCCCHHHHHHHHHHcC
Confidence 4333221110 00 01122456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013973 409 YDPTDRLTAREALRHPFF 426 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f 426 (433)
.||++|||+.|+|+||||
T Consensus 241 ~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 241 KDPEERPSIAQILQSPFI 258 (258)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=306.71 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=196.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY- 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~- 169 (433)
.+|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++++ .|++++++++.+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-----RHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-----CCCCcceEEEEEEcC
Confidence 4699999999999999999999999999999987421 22334567789999888 56889999998865
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
.+.+++||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 35789999999 889999998654 58999999999999999999999999999999999999665555555555443
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
...... ..........|+..|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 155 ~~~~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 155 RIQTIC---------------------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred cccccc---------------------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 221000 00001122468899999999999889999999999999999999999998654
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
.......+. ..+.+ ...++..+..+.++|.+||
T Consensus 214 ~~~~~~~~~--~~~~~---------------------------------------------~~~p~~~~~~~~~~i~~~l 246 (264)
T cd06653 214 AMAAIFKIA--TQPTK---------------------------------------------PMLPDGVSDACRDFLKQIF 246 (264)
T ss_pred HHHHHHHHH--cCCCC---------------------------------------------CCCCcccCHHHHHHHHHHh
Confidence 443322111 00000 0123456778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013973 408 RYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f 426 (433)
+ +|.+||++.+++.|||+
T Consensus 247 ~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 247 V-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred c-CcccCccHHHHhcCCCC
Confidence 9 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.28 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=191.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeE--EEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~--vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.++.++.. +|+|.++.. ......+..|++++.++. +|++++++++++...+.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~----~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGY 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc----CCCCcceEEEEECCCCC
Confidence 5699999999999999999998877754 577776532 233455677888888873 45789999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 173 ICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
+|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+++++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~- 161 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY- 161 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-
Confidence 99999999 899999997543 13588999999999999999999999999999999999995544
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e 315 (433)
.+||+|||++...... .....++..|+|||++.+..++.++|||||||++||
T Consensus 162 --------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 215 (303)
T cd05088 162 --------------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215 (303)
T ss_pred --------------------------cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHH
Confidence 4556666655321111 111134667999999988889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 316 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 316 llt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
|+| |..||...+..+....+.. + ..+ ..+..
T Consensus 216 llt~g~~p~~~~~~~~~~~~~~~-----------------------~-~~~------------------------~~~~~ 247 (303)
T cd05088 216 IVSLGGTPYCGMTCAELYEKLPQ-----------------------G-YRL------------------------EKPLN 247 (303)
T ss_pred HHhcCCCCcccCChHHHHHHHhc-----------------------C-CcC------------------------CCCCC
Confidence 998 9999976655443322110 0 000 01123
Q ss_pred chhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.+.++.+||.+||+.||++||++.+++++
T Consensus 248 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 248 CDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 46688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=313.17 Aligned_cols=247 Identities=21% Similarity=0.324 Sum_probs=192.8
Q ss_pred CcEEEEeeeeccccEEEEEEEEC----CCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
++|++.+.||+|+||.||+|.+. .+++.||+|.++... .....+..|+.+++.+ .|+|++++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-----HHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCCeeeEEEEEecC
Confidence 46899999999999999999853 456789999986422 2234567799998888 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNN---------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
...|+||||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999 889999986332 124788999999999999999999999999999999999965
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHH
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSV 309 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 309 (433)
++ .+||+|||++...... .....++..|+|||++.+..++.++|+|||
T Consensus 160 ~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 160 QL---------------------------HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred CC---------------------------cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 44 4555555555432211 122345678999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHH
Q 013973 310 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388 (433)
Q Consensus 310 Gv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
||++|||++ |..||.+.+..+....+.. ...+
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~~~~----------------------~~~~------------------------- 245 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRK----------------------RQLL------------------------- 245 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHc----------------------CCcC-------------------------
Confidence 999999998 9999987655443322211 0000
Q ss_pred hhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 389 ~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+..++..+.+++.+||+.||++||++.+++++
T Consensus 246 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 246 -PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0123456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=304.15 Aligned_cols=247 Identities=29% Similarity=0.456 Sum_probs=201.8
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... .....+..|++++.++ .|++++++.+++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-----KHPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-----CCCCccEEEEEEEeCCEEE
Confidence 4889999999999999999999999999999987543 3455677888888887 5678999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~------------------- 134 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK------------------- 134 (254)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC-------------------
Confidence 999999 889999998763 7999999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus 135 --------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~ 206 (254)
T cd06627 135 --------DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206 (254)
T ss_pred --------CCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 4456666666665443322 23468899999999988888999999999999999999999997655433
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. ... ...+...+..+.+++.+||+.|
T Consensus 207 ~~~~~~~----------------------~~~--------------------------~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 207 ALFRIVQ----------------------DDH--------------------------PPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred HHHHHhc----------------------cCC--------------------------CCCCCCCCHHHHHHHHHHHhCC
Confidence 2221110 000 0112345678999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|++|||+.+++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=327.19 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=191.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+.. ++..||||+++.. ....+.+..|+.+++++. .|+||+++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~----~HpnIv~l~~~~~ 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG----PHLNIVNLLGACT 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC----CCCCeeeEEEEEc
Confidence 3579999999999999999998743 3457999999643 233456778999998882 3789999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcC-------------------------------------------------------
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNN------------------------------------------------------- 192 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~------------------------------------------------------- 192 (433)
..+.+||||||+ +|+|.++|.++.
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999 999999987532
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEee
Q 013973 193 ---------------------------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 233 (433)
Q Consensus 193 ---------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~ 233 (433)
...+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 12478888899999999999999999999999999999995
Q ss_pred ccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHH
Q 013973 234 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWS 308 (433)
Q Consensus 234 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwS 308 (433)
.++ .+||+|||++....... ....++..|+|||++.+..++.++||||
T Consensus 272 ~~~---------------------------~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 272 QGK---------------------------IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred CCC---------------------------EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 544 46666666654322111 1234678899999999989999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHH
Q 013973 309 VGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387 (433)
Q Consensus 309 lGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
|||++|||++ |..||............. ..+. .
T Consensus 325 lGvil~ellt~g~~P~~~~~~~~~~~~~~----------------------~~~~-~----------------------- 358 (400)
T cd05105 325 YGILLWEIFSLGGTPYPGMIVDSTFYNKI----------------------KSGY-R----------------------- 358 (400)
T ss_pred HHHHHHHHHHCCCCCCcccchhHHHHHHH----------------------hcCC-C-----------------------
Confidence 9999999997 999997643322211110 0000 0
Q ss_pred HhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 388 ~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
...+...+.++.+++.+||+.||++|||+.+|.+
T Consensus 359 -~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 359 -MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred -CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 0012345678999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.61 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=209.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
+.+.+..++||+|+||+||+|+.. +....||||.++.. .+.+.++.+|++++..+ .|+|||++++.+.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-----~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-----QHPNIVRLLGVCR 559 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-----cCCCeEEEEEEEc
Confidence 456788999999999999999764 23467999999743 34678899999999999 7899999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcC--------C----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeecc
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNN--------Y----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 235 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~--------~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~ 235 (433)
.++.+|+|+||| .|||.+||.... . ..|+..+.+.|+.||+.|++||-++.+|||||-..|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV--- 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV--- 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---
Confidence 999999999999 999999997432 1 238889999999999999999999999999999999999
Q ss_pred CccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceee-----cCcccchhhhhCCCCCCcchhHHHH
Q 013973 236 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS-----TRHYRAPEVILGLGWTYPCDIWSVG 310 (433)
Q Consensus 236 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwSlG 310 (433)
.++..|||+|||+++.....+.+.++ ...||+||.|...+|+.+|||||||
T Consensus 637 ------------------------ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~G 692 (774)
T KOG1026|consen 637 ------------------------GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFG 692 (774)
T ss_pred ------------------------ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhh
Confidence 56778888888888766555444333 6789999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 311 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 311 v~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
|+|||+.+ |..||.+.++.+.+..+ ..|.+ .
T Consensus 693 VvLWEIFsyG~QPy~glSn~EVIe~i-----------------------~~g~l-------------------------L 724 (774)
T KOG1026|consen 693 VVLWEIFSYGKQPYYGLSNQEVIECI-----------------------RAGQL-------------------------L 724 (774)
T ss_pred hhhhhhhccccCcccccchHHHHHHH-----------------------HcCCc-------------------------c
Confidence 99999999 99999999988877653 23322 2
Q ss_pred hhcCCchhHHHHHHHhccccCCCCCCCHHHH
Q 013973 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 420 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~~dP~~R~ta~el 420 (433)
..++.++.++.+|+..||+.+|++||++.||
T Consensus 725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 725 SCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 3456889999999999999999999999887
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.08 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=189.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD- 168 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~- 168 (433)
++|++.+.||+|+||.||+|.... +++.||+|+++.. ......+..|+.+++++. .|+||+++++.+.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~----~h~niv~~~~~~~~ 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG----HHLNVVNLLGACTK 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc----cCcchhheeeeEec
Confidence 579999999999999999997543 4578999998642 223345667888888773 4578999998775
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCC------------------------------------------------------
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNY------------------------------------------------------ 193 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~------------------------------------------------------ 193 (433)
....+++||||+ +++|.+++.....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 456789999999 9999999864321
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEE
Q 013973 194 -----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268 (433)
Q Consensus 194 -----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~ 268 (433)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~---------------------------~vkL~ 215 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN---------------------------VVKIC 215 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC---------------------------cEEEe
Confidence 2688999999999999999999999999999999999996544 46666
Q ss_pred ecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 013973 269 DFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPL 342 (433)
Q Consensus 269 Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 342 (433)
|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+....
T Consensus 216 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~------ 289 (337)
T cd05054 216 DFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL------ 289 (337)
T ss_pred ccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH------
Confidence 666655332111 12345678999999999999999999999999999998 999997643322211100
Q ss_pred CHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 343 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
..+... ..+...+.++.+++.+||+.+|++||++.|+++
T Consensus 290 ----------------~~~~~~-------------------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~ 328 (337)
T cd05054 290 ----------------KEGTRM-------------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE 328 (337)
T ss_pred ----------------hccCCC-------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000000 011244668999999999999999999999987
Q ss_pred C
Q 013973 423 H 423 (433)
Q Consensus 423 h 423 (433)
|
T Consensus 329 ~ 329 (337)
T cd05054 329 I 329 (337)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=304.44 Aligned_cols=249 Identities=30% Similarity=0.466 Sum_probs=202.1
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--Ce
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NH 172 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~ 172 (433)
+|.+.+.||+|++|.||+|.+..+++.|++|++.... ...+.+..|+.+++++ +|++++++++.+... ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-----QHPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEecCCCCe
Confidence 4888999999999999999999999999999987543 3456677889999888 578999999999888 89
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~----------------- 136 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS----------------- 136 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC-----------------
Confidence 99999999 999999998765 7999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 137 ----------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 137 ----------DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred ----------CCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4456666666555433321 2346889999999999888999999999999999999999999865
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
++.... +.... ... .....+...+.++.+||.+|
T Consensus 207 ~~~~~~--~~~~~-------------------~~~-------------------------~~~~~~~~~~~~l~~~i~~~ 240 (260)
T cd06606 207 GNPMAA--LYKIG-------------------SSG-------------------------EPPEIPEHLSEEAKDFLRKC 240 (260)
T ss_pred CchHHH--HHhcc-------------------ccC-------------------------CCcCCCcccCHHHHHHHHHh
Confidence 521111 10000 000 00011234567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f 426 (433)
|+.||++||++.|++.||||
T Consensus 241 l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 241 LRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=312.85 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=192.8
Q ss_pred CcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+|.+.+.||+|+||.||++.+ ..++..+|+|.+... ......+..|+++++++ .|++++++++.+...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVCVEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEecC
Confidence 4699999999999999999985 335567999998643 23445677899999888 668899999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcc
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNN-----------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 238 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~ 238 (433)
+.+++||||+ +++|.+++...+ ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999 899999997543 1248999999999999999999999999999999999999665555
Q ss_pred ccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHH
Q 013973 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 313 (433)
Q Consensus 239 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l 313 (433)
+++| ||.+....... ....++..|+|||++.+..++.++|+|||||++
T Consensus 160 kl~d---------------------------fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 160 KIGD---------------------------FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred Eecc---------------------------CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 5554 44443221111 112457789999999998999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhc
Q 013973 314 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392 (433)
Q Consensus 314 ~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
|+|++ |..||......+....+.. +.. ...+
T Consensus 213 ~~l~t~g~~p~~~~~~~~~~~~i~~-----------------------~~~-------------------------~~~~ 244 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNEVIECITQ-----------------------GRV-------------------------LQRP 244 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc-----------------------CCc-------------------------CCCC
Confidence 99998 9999987665443332211 100 0011
Q ss_pred CCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 393 DHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 393 ~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
...+.++.+|+.+||+.||.+|||+.|++.
T Consensus 245 ~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 245 RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 245678999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=307.14 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=192.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|++.+.||+|+||.||+|.+..++ .+|+|.+.......+.+..|+.+++.+ .|++++++++.+. .+..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKL-----RHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhC-----CCCCeeeEEEEEc-CCCcEEE
Confidence 56999999999999999999887664 599998875444456677899999888 6688999988875 4568899
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||++++++
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~------------------- 139 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL------------------- 139 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-------------------
Confidence 9999 78999999875545689999999999999999999999999999999999995544
Q ss_pred cccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
.++|+|||.+....... ....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+....+
T Consensus 140 --------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 211 (260)
T cd05069 140 --------VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211 (260)
T ss_pred --------eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 45556666554332211 11245678999999998889999999999999999999 999998766554
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.... .. ..+...+..+.+|+.+||++|
T Consensus 212 ~~~~~~~~~----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05069 212 VLEQVERGY----------------------RM--------------------------PCPQGCPESLHELMKLCWKKD 243 (260)
T ss_pred HHHHHHcCC----------------------CC--------------------------CCCcccCHHHHHHHHHHccCC
Confidence 433221100 00 011245668999999999999
Q ss_pred CCCCCCHHHHhc
Q 013973 411 PTDRLTAREALR 422 (433)
Q Consensus 411 P~~R~ta~ell~ 422 (433)
|++||+++++++
T Consensus 244 p~~Rp~~~~i~~ 255 (260)
T cd05069 244 PDERPTFEYIQS 255 (260)
T ss_pred cccCcCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=292.20 Aligned_cols=283 Identities=27% Similarity=0.536 Sum_probs=220.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--CeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~ 173 (433)
.++|++++++|+|.|+.||.|.+..+++.++||+++..+ .+...+|+.+|+.++ +++||+.+++...+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~----gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLR----GGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhcc----CCCCeeehhhhhcCccccCc
Confidence 478999999999999999999999999999999998544 466788999999984 578899999998764 567
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
.|++||+ +.+....- ..|+.-.++.++.|++.||.|||++||+|||+||.|++|+
T Consensus 111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId------------------- 166 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID------------------- 166 (338)
T ss_pred hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec-------------------
Confidence 8999999 54544332 2588889999999999999999999999999999999996
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCc--eeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCC-CCCCh
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF-QTHEN 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf-~~~~~ 328 (433)
.+...++|+|+|+|-+..+...+ .+.+..|--||.+..- .|+..-|+|||||++..|+..+.|| .+.++
T Consensus 167 -------h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN 239 (338)
T KOG0668|consen 167 -------HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 239 (338)
T ss_pred -------hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence 45568999999999988887754 4678899999999864 5889999999999999999988765 78899
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC-chhHHHHHHHhcc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLL 407 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L 407 (433)
.+++..|.+.+|. +....|+.+-.+..++.. +.+.....-......+..-... .++++.||+.++|
T Consensus 240 ~DQLVkIakVLGt----------~el~~Yl~KY~i~Ldp~~---~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklL 306 (338)
T KOG0668|consen 240 YDQLVKIAKVLGT----------DELYAYLNKYQIDLDPQF---EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLL 306 (338)
T ss_pred HHHHHHHHHHhCh----------HHHHHHHHHHccCCChhH---hhHhhccccccHHHhCCccccccCChHHHHHHHHHH
Confidence 9999999999997 222333333222221110 1111111111111111111122 3589999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~ 428 (433)
..|..+|+||.|++.||||..
T Consensus 307 rYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 307 RYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hhccccccchHHHhcCchHHH
Confidence 999999999999999999963
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.99 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=200.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
..|...+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+++++.+ .|++++++++++.....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-----KHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEeeCCe
Confidence 44888999999999999999999999999999986321 2234566788888877 66889999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
.++||||+.|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~------------------ 160 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE------------------ 160 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC------------------
Confidence 99999999778888876543 46899999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.++|+|||.+..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||...+..
T Consensus 161 ---------~~~~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 230 (317)
T cd06635 161 ---------PGQVKLADFGSASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230 (317)
T ss_pred ---------CCCEEEecCCCccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 44567777776554332 22346889999999984 356889999999999999999999999765544
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+.....+ .. .....+..+.+||.+||+.
T Consensus 231 ~~~~~~~~~~~~----------------------~~-------------------------~~~~~~~~l~~li~~~l~~ 263 (317)
T cd06635 231 SALYHIAQNESP----------------------TL-------------------------QSNEWSDYFRNFVDSCLQK 263 (317)
T ss_pred HHHHHHHhccCC----------------------CC-------------------------CCccccHHHHHHHHHHccC
Confidence 433332211100 00 0123456789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
+|.+||++.++++|+|+...
T Consensus 264 ~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 264 IPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CcccCcCHHHHHhChhhhcc
Confidence 99999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=307.30 Aligned_cols=239 Identities=21% Similarity=0.343 Sum_probs=187.4
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
+.||+|+||.||+|.++.+++.||+|.+... ......+..|+++++.+ .|++|+++++++.....+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEcCCCCeEEEEeec
Confidence 4699999999999999999999999987632 23345677899988887 6789999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++++|||++.
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~------------ 142 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR------------ 142 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCc------------
Confidence 889999997643 368999999999999999999999999999999999999766655555555443
Q ss_pred CCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 333 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 333 (433)
...... ....++..|+|||.+.+..++.++|+|||||++|||++ |..||......+...
T Consensus 143 ---------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~ 207 (252)
T cd05084 143 ---------------EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207 (252)
T ss_pred ---------------ccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence 211110 01123457999999998889999999999999999998 899997655433222
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+... ... ..+...+..+.+|+.+||+.||++
T Consensus 208 ~~~~~----------------------~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 208 AIEQG----------------------VRL--------------------------PCPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred HHHcC----------------------CCC--------------------------CCcccCCHHHHHHHHHHcCCChhh
Confidence 21110 000 012245678999999999999999
Q ss_pred CCCHHHHhc
Q 013973 414 RLTAREALR 422 (433)
Q Consensus 414 R~ta~ell~ 422 (433)
|||+.++++
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=305.79 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=196.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|++.+.||.|+||.||+|... ++.||+|.++......+.+..|+.+++.+ .|++++++++++......++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTL-----RHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhc-----CCcceeeeEEEEcCCCCeEEE
Confidence 56899999999999999999864 67899999976544456778899999888 568899999999989999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-------------------- 138 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-------------------- 138 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC--------------------
Confidence 9999 7899999987655579999999999999999999999999999999999999544
Q ss_pred cccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 334 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 334 (433)
+.++|+|||.+...........++..|+|||++.+..++.++|+||||+++|+|++ |..||......+....
T Consensus 139 -------~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05039 139 -------LVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211 (256)
T ss_pred -------CCEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 45666666666544332223345667999999998889999999999999999997 9999976554433222
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.. .... ..+..+++++.++|.+||+.||++|
T Consensus 212 ~~~----------------------~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R 243 (256)
T cd05039 212 VEK----------------------GYRM--------------------------EAPEGCPPEVYKVMKDCWELDPAKR 243 (256)
T ss_pred Hhc----------------------CCCC--------------------------CCccCCCHHHHHHHHHHhccChhhC
Confidence 110 0000 0122456789999999999999999
Q ss_pred CCHHHHhc
Q 013973 415 LTAREALR 422 (433)
Q Consensus 415 ~ta~ell~ 422 (433)
||+.|++.
T Consensus 244 p~~~~l~~ 251 (256)
T cd05039 244 PTFKQLRE 251 (256)
T ss_pred cCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=306.30 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=197.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|.+.+.||+|+||.||+|.+. +++.||||.+.........+..|+.+++.+ .|++++++++.+......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-----RHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-----CCCCEeeeeeeeecCCceEE
Confidence 467999999999999999999976 456799999976555556788899999888 67899999999999899999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||++++++
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~------------------ 140 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL------------------ 140 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC------------------
Confidence 99999 88999999876556799999999999999999999999999999999999996544
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..
T Consensus 141 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 141 ---------VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred ---------CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 45555555554332111 11124568999999998889999999999999999999 99999876655
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
.....+..... .+ .+...+.++.+++.+||+.
T Consensus 212 ~~~~~~~~~~~------------------------~~------------------------~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05034 212 EVLEQVERGYR------------------------MP------------------------RPPNCPEELYDLMLQCWDK 243 (261)
T ss_pred HHHHHHHcCCC------------------------CC------------------------CCCCCCHHHHHHHHHHccc
Confidence 44433221100 00 1123456899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++||+++++++
T Consensus 244 ~p~~Rp~~~~l~~ 256 (261)
T cd05034 244 DPEERPTFEYLQS 256 (261)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=292.87 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=197.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----C
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----R 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-----~ 170 (433)
++|.+.+.||+|||+.||++.+..+++.||+|.+.... +..+..++|++..+++ ++||++++++.... .
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-----~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-----NSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-----CCcchHHHHHHHHHhhccCc
Confidence 68999999999999999999999999999999987544 6677788999999888 67889888876533 3
Q ss_pred CeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...||+++|. .|+|.+.++.. .+..+++.+++.|+.+|++||++||+.. +.||||||.|||+.+
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~----------- 164 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD----------- 164 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-----------
Confidence 4699999998 89999998743 2346999999999999999999999998 999999999999954
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCC------------ceeecCcccchhhhhC---CCCCCcchhHHHH
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------------YIVSTRHYRAPEVILG---LGWTYPCDIWSVG 310 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------------~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG 310 (433)
.+.++|.|||.++...-.-. .-..|..|.|||.+.- ...+.++||||||
T Consensus 165 ----------------~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLG 228 (302)
T KOG2345|consen 165 ----------------SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLG 228 (302)
T ss_pred ----------------CCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhh
Confidence 45677777877664332110 1135889999999974 4578999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh
Q 013973 311 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390 (433)
Q Consensus 311 v~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
|++|+|+.|..||...-. .-| ...--+..+.+.||..
T Consensus 229 CtLYa~mf~~sPfe~~~~---------~Gg------------SlaLAv~n~q~s~P~~---------------------- 265 (302)
T KOG2345|consen 229 CTLYAMMFGESPFERIYQ---------QGG------------SLALAVQNAQISIPNS---------------------- 265 (302)
T ss_pred HHHHHHHHcCCcchHHhh---------cCC------------eEEEeeeccccccCCC----------------------
Confidence 999999999999963110 000 0011133455555553
Q ss_pred hcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 391 ~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+|..+.+||.+||+.||.+||++.+++.+
T Consensus 266 --~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 266 --SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred --CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2467789999999999999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=308.20 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=193.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
++|++.+.||+|+||.||+|.++.+ ...||+|+++.. ......+..|+.+++.+ .|++++++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-----DHPNIIRLEGVVTKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCcceEeEEEecCC
Confidence 5699999999999999999998654 457999998643 23345567788888887 6688999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+|||+++++.++++|||++....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999 889999997654 368999999999999999999999999999999999999766655555555443332
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
..... .. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 ~~~~~---------~~-------------~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 158 DSEAT---------YT-------------TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred ccccc---------ee-------------ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 10000 00 001134678999999998899999999999999999998 99999765554
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.... ... .+...+..+.+|+.+||+.
T Consensus 216 ~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~l~~li~~cl~~ 247 (266)
T cd05033 216 DVIKAVEDGY----------------------RLP--------------------------PPMDCPSALYQLMLDCWQK 247 (266)
T ss_pred HHHHHHHcCC----------------------CCC--------------------------CCCCCCHHHHHHHHHHcCC
Confidence 4333221100 000 0124466899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013973 410 DPTDRLTAREALRH 423 (433)
Q Consensus 410 dP~~R~ta~ell~h 423 (433)
||++||++.|++++
T Consensus 248 ~p~~Rp~~~ei~~~ 261 (266)
T cd05033 248 DRNERPTFSQIVST 261 (266)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=313.15 Aligned_cols=251 Identities=26% Similarity=0.449 Sum_probs=198.4
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
|....+||+|+||.||++.+..+++.||+|.+... ......+..|+.+++.+ +|++++++++.+...+..++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-----CCcchhheeeEEEeCCEEEEEE
Confidence 44457899999999999999999999999988532 23345567788888877 6688999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++... .+++..+..++.|++.||+|||+.||+|+||||+||+++.++
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-------------------- 153 (292)
T cd06657 97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-------------------- 153 (292)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--------------------
Confidence 999 88999887543 589999999999999999999999999999999999996544
Q ss_pred ccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
.++|+|||.+...... .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+...
T Consensus 154 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~ 226 (292)
T cd06657 154 -------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 226 (292)
T ss_pred -------CEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 4555555554322211 122468899999999988889999999999999999999999998765544433
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+....... .......+..+.+++.+||+.||.+
T Consensus 227 ~~~~~~~~~----------------------------------------------~~~~~~~~~~l~~li~~~l~~~P~~ 260 (292)
T cd06657 227 MIRDNLPPK----------------------------------------------LKNLHKVSPSLKGFLDRLLVRDPAQ 260 (292)
T ss_pred HHHhhCCcc----------------------------------------------cCCcccCCHHHHHHHHHHHhCCccc
Confidence 222111000 0001234667899999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 013973 414 RLTAREALRHPFFTRDH 430 (433)
Q Consensus 414 R~ta~ell~hp~f~~~~ 430 (433)
||++.++++||||....
T Consensus 261 R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 261 RATAAELLKHPFLAKAG 277 (292)
T ss_pred CcCHHHHhcChHHhccC
Confidence 99999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=314.25 Aligned_cols=248 Identities=22% Similarity=0.289 Sum_probs=191.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCe--EEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~--~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.+..++. .+|+|.++.. ....+.+..|+.++.++. +|++++++++.+...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG----HHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc----CCCchhheEEEEccCCc
Confidence 469999999999999999999887764 4688887632 233455677888888773 46789999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
+++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 99999999 8999999975321 25889999999999999999999999999999999999965544
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e 315 (433)
+||+|||++...... ......+..|+|||++.+..++.++|||||||++||
T Consensus 158 ---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e 210 (297)
T cd05089 158 ---------------------------SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210 (297)
T ss_pred ---------------------------EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHH
Confidence 555555554321111 111123557999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 316 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 316 llt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
|++ |..||......+....+..... ...+..
T Consensus 211 l~t~g~~pf~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~ 242 (297)
T cd05089 211 IVSLGGTPYCGMTCAELYEKLPQGYR------------------------------------------------MEKPRN 242 (297)
T ss_pred HHcCCCCCCCCCCHHHHHHHHhcCCC------------------------------------------------CCCCCC
Confidence 997 9999987655443332111000 001224
Q ss_pred chhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
++.++.+|+.+||+.||.+||+++++++.
T Consensus 243 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 243 CDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56789999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.15 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=193.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCC-----CeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.++.. +..||+|.+.... .....+..|+.+++.+ .|++++++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-----NCHHVVRLLGVVS 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEEc
Confidence 46799999999999999999988654 3789999986432 2334566788888777 6788999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccc
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~ 239 (433)
.....++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~-- 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT-- 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--
Confidence 999999999999 899999997532 124788899999999999999999999999999999999965554
Q ss_pred cCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHH
Q 013973 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 314 (433)
Q Consensus 240 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ 314 (433)
+||+|||+++..... .....+|..|+|||.+.+..++.++|||||||++|
T Consensus 158 -------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 158 -------------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred -------------------------EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 555555554322211 11234678899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcC
Q 013973 315 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393 (433)
Q Consensus 315 ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
||++ |..||.+.+..+....+.. + ... ..+.
T Consensus 213 el~t~g~~p~~~~~~~~~~~~~~~--~--------------------~~~--------------------------~~~~ 244 (277)
T cd05032 213 EMATLAEQPYQGLSNEEVLKFVID--G--------------------GHL--------------------------DLPE 244 (277)
T ss_pred HhhccCCCCCccCCHHHHHHHHhc--C--------------------CCC--------------------------CCCC
Confidence 9998 9999987665444332210 0 000 0123
Q ss_pred CchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 394 HSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 394 ~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.++.++.+|+.+||+.+|++|||+.++++
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=311.15 Aligned_cols=255 Identities=24% Similarity=0.427 Sum_probs=197.4
Q ss_pred cEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 98 RYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
+|++.+.||+|+||.||+|.+. .+|+.||+|+++... ...+....|+.++..+. +|++|+.+++.++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc----cCCChhceeeEeec
Confidence 4889999999999999999875 478899999987422 22345667888888774 35789999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
+..+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~-------------- 140 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS-------------- 140 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC--------------
Confidence 99999999999 899999998754 6899999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCC--CCCCcchhHHHHHHHHHHHhCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~P 322 (433)
++.++|+|||++....... ....|+..|+|||.+.+. .++.++||||||+++|+|++|..|
T Consensus 141 -------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p 207 (290)
T cd05613 141 -------------NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207 (290)
T ss_pred -------------CCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence 4456666666655332211 224689999999998753 477899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...........+... +.... ...+..++..+.+|
T Consensus 208 ~~~~~~~~~~~~~~~~-------------------~~~~~--------------------------~~~~~~~~~~~~~l 242 (290)
T cd05613 208 FTVDGEKNSQAEISRR-------------------ILKSE--------------------------PPYPQEMSALAKDI 242 (290)
T ss_pred CCcCCccccHHHHHHH-------------------hhccC--------------------------CCCCccCCHHHHHH
Confidence 9643322111111110 00000 01123456788999
Q ss_pred HHhccccCCCCCC-----CHHHHhcCCCCCCCC
Q 013973 403 LQGLLRYDPTDRL-----TAREALRHPFFTRDH 430 (433)
Q Consensus 403 i~~~L~~dP~~R~-----ta~ell~hp~f~~~~ 430 (433)
+.+||+.||++|+ ++.+++.||||+...
T Consensus 243 l~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 243 IQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=311.87 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=193.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|.+.+.||+|+||.||+|.+ ..++..||+|+++... ...+.+..|+.+++++. .|+||+++++.+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~ 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG----NHENIVNLLGACT 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc----CCCCcceEEEEEe
Confidence 35799999999999999999975 3455689999987432 33455678999988873 3578999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
..+.+++||||+ +++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++++|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999 8999999986554458999999999999999999999999999999999999655555555555443
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~ 326 (433)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 190 ~~~~~~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 190 DIMNDSNY----------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred cccCCCce----------------------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 22111000 00011235778999999999899999999999999999998 99999865
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
...+.+..... .+. .. ..+...+.++.+|+.+|
T Consensus 248 ~~~~~~~~~~~----------------------~~~-~~------------------------~~~~~~~~~~~~li~~c 280 (302)
T cd05055 248 PVDSKFYKLIK----------------------EGY-RM------------------------AQPEHAPAEIYDIMKTC 280 (302)
T ss_pred CchHHHHHHHH----------------------cCC-cC------------------------CCCCCCCHHHHHHHHHH
Confidence 54332221110 000 00 01123466899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013973 407 LRYDPTDRLTAREALR 422 (433)
Q Consensus 407 L~~dP~~R~ta~ell~ 422 (433)
|+.+|++|||+.|+++
T Consensus 281 l~~~p~~Rpt~~ell~ 296 (302)
T cd05055 281 WDADPLKRPTFKQIVQ 296 (302)
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=311.67 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=194.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCC----------------eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERK----------------EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGN 158 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~----------------~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~ 158 (433)
++|++++.||+|+||.||+|.+..++ ..||+|.+... ....+.+..|+.+++++ .|+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-----~~~ 79 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-----SDP 79 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-----CCC
Confidence 57999999999999999999876544 56899998743 23456677899999988 568
Q ss_pred ceEEecceeecCCeEEEEEecC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 013973 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 228 (433)
Q Consensus 159 ~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~ 228 (433)
+++++++++...+..++|||++ +++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 8999999999999999999999 899999997643 126899999999999999999999999999999999
Q ss_pred ceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCc
Q 013973 229 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYP 303 (433)
Q Consensus 229 NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 303 (433)
||+++.++.+ +|+|||.+...... .....+|..|+|||++.+..++.+
T Consensus 160 Nili~~~~~~---------------------------~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 160 NCLVGKNYTI---------------------------KIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred ceeecCCCce---------------------------EEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc
Confidence 9999665554 55555544322111 112346788999999998889999
Q ss_pred chhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccc
Q 013973 304 CDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381 (433)
Q Consensus 304 ~DvwSlGv~l~ellt--g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (433)
+|||||||++|||++ |..||...+..+.+..+...... .+...
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~----------------- 257 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD------------------DGRQI----------------- 257 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccc------------------ccccc-----------------
Confidence 999999999999998 77888766554443332211100 00000
Q ss_pred hhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
....+..++.++.+|+.+||+.||++|||+.|+++
T Consensus 258 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 258 ------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 00012345678999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=314.19 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=198.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
..|...+.||+|+||.||+|+++.+++.+|+|.+... ......+..|+.+++.+ .|++++++.+++.....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-----CCCCcccEEEEEEcCCe
Confidence 4588889999999999999999999999999988632 22334566788888887 56889999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
.++||||+.++|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++
T Consensus 90 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~---------------- 152 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---------------- 152 (308)
T ss_pred eEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC----------------
Confidence 99999999778888876543 4689999999999999999999999999999999999995444
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.++|+|||.+...... ....|+..|+|||++. ...++.++|||||||++|+|++|..||...+..
T Consensus 153 -----------~~kl~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 220 (308)
T cd06634 153 -----------LVKLGDFGSASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (308)
T ss_pred -----------cEEECCcccceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH
Confidence 5666666655433322 2346889999999985 346788999999999999999999999765443
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+..... + .. ....++..+.+||.+||+.
T Consensus 221 ~~~~~~~~~~~--~--------------------~~-------------------------~~~~~~~~~~~li~~cl~~ 253 (308)
T cd06634 221 SALYHIAQNES--P--------------------AL-------------------------QSGHWSEYFRNFVDSCLQK 253 (308)
T ss_pred HHHHHHhhcCC--C--------------------Cc-------------------------CcccccHHHHHHHHHHhhC
Confidence 33322111000 0 00 0124566789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
+|++||++.++++|||+...
T Consensus 254 ~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 254 IPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred CcccCCCHHHHhhCcccccc
Confidence 99999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=301.81 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=200.4
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+|++.+.||+|+||.||++.++.+++.||+|.+... .........|+.+++.+ .|++++.+.+.+......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-----NHPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-----CCCCchhhhhhhccCCEEE
Confidence 489999999999999999999999999999998643 23344556788888877 5688999999999999999
Q ss_pred EEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||+ +++|.+++... ....+++..+..++.|++.||.|||+.|++|+||||+||++++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~----------------- 138 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA----------------- 138 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec-----------------
Confidence 999999 88999998762 1246899999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+||+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 139 ----------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 139 ----------NDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred ----------CCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 3456777777665433221 22357889999999999889999999999999999999999998766544
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. +.+ + ..+..++.++.+++.+||+.+
T Consensus 209 ~~~~~~~-----------------------~~~--~-----------------------~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08530 209 LRYKVQR-----------------------GKY--P-----------------------PIPPIYSQDLQNFIRSMLQVK 240 (256)
T ss_pred HHHHHhc-----------------------CCC--C-----------------------CCchhhCHHHHHHHHHHcCCC
Confidence 3322111 000 0 011234567999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013973 411 PTDRLTAREALRHPFF 426 (433)
Q Consensus 411 P~~R~ta~ell~hp~f 426 (433)
|++||++.|+++||++
T Consensus 241 p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 241 PKLRPNCDKILASPAV 256 (256)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=310.01 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=192.1
Q ss_pred CcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+|.+.+.||+|+||.||+|... .++..+|+|.+.... .....+..|+.+++.+ .|++|+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-----QHEHIVKFYGVCGDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-----CCCCcceEEEEEccC
Confidence 45999999999999999999854 355679999986433 2335577888888887 668899999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeecc
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 235 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~ 235 (433)
...++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 9999999999 999999997643 1348899999999999999999999999999999999999665
Q ss_pred CccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHH
Q 013973 236 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 310 (433)
Q Consensus 236 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 310 (433)
+.++++||| .+...... .....|+..|+|||++.+..++.++||||||
T Consensus 160 ~~~~l~dfg---------------------------~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 212 (291)
T cd05094 160 LLVKIGDFG---------------------------MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212 (291)
T ss_pred CcEEECCCC---------------------------cccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHH
Confidence 555555554 44322111 1123467889999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 311 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 311 v~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
|++|||++ |..||......+....+. .+...
T Consensus 213 ~il~el~t~g~~p~~~~~~~~~~~~~~-----------------------~~~~~------------------------- 244 (291)
T cd05094 213 VILWEIFTYGKQPWFQLSNTEVIECIT-----------------------QGRVL------------------------- 244 (291)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHh-----------------------CCCCC-------------------------
Confidence 99999999 999997765544332211 11000
Q ss_pred hhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
..+...+.++.+|+.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 245 ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 011235668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.83 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=188.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCe----EEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~----~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
..+|++++.||+|+||+||+|.+..+++ .||+|+++.. ......+..|+.+++.+ +|+|++.+++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-----GSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-----CCCCCceEEEEEcC
Confidence 3579999999999999999999877665 4899998642 23345566777777766 67889999988765
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...+++|||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+++++.
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~----------- 147 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH----------- 147 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc-----------
Confidence 4578999999 899999997643 46999999999999999999999999999999999999965444
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCC-----ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
+||+|||++........ ...++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 148 ----------------~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 211 (279)
T cd05109 148 ----------------VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ----------------EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 55555555543322111 1134678999999999899999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...........+.. +.. . ..+...+.++.++
T Consensus 212 ~~~~~~~~~~~~~~~-----------------------~~~-~------------------------~~~~~~~~~~~~l 243 (279)
T cd05109 212 YDGIPAREIPDLLEK-----------------------GER-L------------------------PQPPICTIDVYMI 243 (279)
T ss_pred CCCCCHHHHHHHHHC-----------------------CCc-C------------------------CCCccCCHHHHHH
Confidence 976554433222111 000 0 0112456688999
Q ss_pred HHhccccCCCCCCCHHHHhc
Q 013973 403 LQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~ 422 (433)
+.+||+.||++||++.+++.
T Consensus 244 i~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 244 MVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=309.37 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=191.6
Q ss_pred eeeeccccEEEEEEEECCCCe-------EEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 103 SKMGEGTFGQVLECWDRERKE-------MVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~-------~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.||+|+||.||+|.++..+. .||+|.+.... ...+.+..|..+++.+ .|+|++++++.+......+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-----SHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-----CCCChhheeeEEEeCCCcE
Confidence 468999999999998865543 38888876432 2334566677777776 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++..+++++
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~---------- 144 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNP---------- 144 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCC----------
Confidence 999999 889999998654 36899999999999999999999999999999999999988776655443
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhC-CCCCCCCChHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTG-EALFQTHENLEH 331 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg-~~Pf~~~~~~~~ 331 (433)
..++++|||.+...... ....++..|+|||++.+ ..++.++|||||||++|||++| ..||...+....
T Consensus 145 ---------~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 145 ---------PFIKLSDPGISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred ---------ceEEecccccccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 35899999988654432 33568899999999987 4589999999999999999998 466655443322
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
..... .. ...+...+.++.+||.+||+.||
T Consensus 215 ~~~~~------------------------~~--------------------------~~~~~~~~~~~~~li~~~l~~~p 244 (258)
T cd05078 215 LQFYE------------------------DR--------------------------HQLPAPKWTELANLINQCMDYEP 244 (258)
T ss_pred HHHHH------------------------cc--------------------------ccCCCCCcHHHHHHHHHHhccCh
Confidence 11100 00 01122344678999999999999
Q ss_pred CCCCCHHHHhcC
Q 013973 412 TDRLTAREALRH 423 (433)
Q Consensus 412 ~~R~ta~ell~h 423 (433)
++|||++++++.
T Consensus 245 ~~Rps~~~il~~ 256 (258)
T cd05078 245 DFRPSFRAIIRD 256 (258)
T ss_pred hhCCCHHHHHHh
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=302.42 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=194.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ......+..|+++++++ .|++++.+++.+...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-----~~~~i~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-----DHPNVIKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-----CCCCeeeeeeeeecCCe
Confidence 5699999999999999999999999999999988532 22345677899988888 66889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||+++.+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-------------- 142 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-------------- 142 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC--------------
Confidence 99999999 88999998653 23468999999999999999999999999999999999999544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
+.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 143 -------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 143 -------------GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred -------------CcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 45666666655433221 12246888999999999888999999999999999999999999654
Q ss_pred ChH--HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhc-CCchhHHHHHH
Q 013973 327 ENL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV-DHSAGDLTHLL 403 (433)
Q Consensus 327 ~~~--~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li 403 (433)
... +....+ ..+.. + ..+ ..++.++.++|
T Consensus 210 ~~~~~~~~~~~-----------------------~~~~~--~-----------------------~~~~~~~~~~~~~~i 241 (267)
T cd08224 210 KMNLYSLCKKI-----------------------EKCDY--P-----------------------PLPADHYSEELRDLV 241 (267)
T ss_pred CccHHHHHhhh-----------------------hcCCC--C-----------------------CCChhhcCHHHHHHH
Confidence 311 111100 00000 0 000 13456889999
Q ss_pred HhccccCCCCCCCHHHHhc
Q 013973 404 QGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~ 422 (433)
.+||+.+|++|||+.++++
T Consensus 242 ~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 242 SRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHcCCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=307.55 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=193.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.+..+++.||||.+... ......+..|+.+++.+ .|+|++++++.+...+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-----cCCchhhhhheeEeCCe
Confidence 4588999999999999999999999999999987532 22345667788888887 67889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+||+++.++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~------------- 143 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG------------- 143 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------------
Confidence 99999999 88999988742 224689999999999999999999999999999999999996544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++|+|||.+....... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||.+.
T Consensus 144 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 144 --------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred --------------CEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 45556666554332211 2246889999999999888999999999999999999999999754
Q ss_pred ChH--HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 327 ENL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 327 ~~~--~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
... +....+ .... ++. ......+.++.+||.
T Consensus 210 ~~~~~~~~~~~-----------------------~~~~--~~~----------------------~~~~~~~~~~~~li~ 242 (267)
T cd08229 210 KMNLYSLCKKI-----------------------EQCD--YPP----------------------LPSDHYSEELRQLVN 242 (267)
T ss_pred cchHHHHhhhh-----------------------hcCC--CCC----------------------CCcccccHHHHHHHH
Confidence 321 111110 0000 000 001245678999999
Q ss_pred hccccCCCCCCCHHHHhc
Q 013973 405 GLLRYDPTDRLTAREALR 422 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~ 422 (433)
+||+.||++|||+.+|++
T Consensus 243 ~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 243 MCINPDPEKRPDITYVYD 260 (267)
T ss_pred HhcCCCcccCCCHHHHHH
Confidence 999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=310.30 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=193.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCC-----CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||++..... ...+|+|.+... ......+..|+.+++++. .|++++++++.+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~ 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGVCT 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc----CCCCeeeEEEEEc
Confidence 36799999999999999999987644 378999998743 223345677888888773 4578999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEee
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKN--------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 233 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~ 233 (433)
..+.+++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999 89999999752 234689999999999999999999999999999999999996
Q ss_pred ccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHH
Q 013973 234 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWS 308 (433)
Q Consensus 234 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwS 308 (433)
.++. +||+|||.+....... ....++..|+|||++.+..++.++||||
T Consensus 167 ~~~~---------------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 219 (293)
T cd05053 167 EDHV---------------------------MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219 (293)
T ss_pred CCCe---------------------------EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceee
Confidence 5554 5555555554322211 1113456799999999889999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHH
Q 013973 309 VGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387 (433)
Q Consensus 309 lGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
|||++|||++ |..||......+....+.... ..
T Consensus 220 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------~~------------------------ 253 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY----------------------RM------------------------ 253 (293)
T ss_pred hhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------------cC------------------------
Confidence 9999999998 999998766544333221100 00
Q ss_pred HhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 388 ~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 254 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 254 --EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0112446689999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.23 Aligned_cols=283 Identities=20% Similarity=0.236 Sum_probs=194.5
Q ss_pred ccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CCCH
Q 013973 109 TFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSL 184 (433)
Q Consensus 109 ~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L 184 (433)
++|.||.++...+++.||+|+++.. ......+..|+.+++.+ .|+||+++++.+...+..+++|||+ +++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-----QHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-----CCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455666666778999999998643 33445677899999888 5688999999999999999999999 8899
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCC
Q 013973 185 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264 (433)
Q Consensus 185 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~ 264 (433)
.+++.......+++..+..++.|++.||+|||+++||||||||+|||++.++.++++|||.+........ ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~--------~~ 158 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK--------RQ 158 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc--------cc
Confidence 9999875445789999999999999999999999999999999999998777777777765443221100 00
Q ss_pred EEEEecCCccccCCCCCceeecCcccchhhhhCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 013973 265 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 342 (433)
Q Consensus 265 ~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 342 (433)
..+ ........++..|+|||++.+. .++.++|+|||||++|||++|..||......... +....+..
T Consensus 159 ~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 227 (314)
T cd08216 159 RVV---------HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTV 227 (314)
T ss_pred ccc---------ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccC
Confidence 000 0011223578889999999763 5889999999999999999999999865543322 12222222
Q ss_pred CHHHHHHHhhhhhhhhccCcccCCCCccchhh-HhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHh
Q 013973 343 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRES-IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 421 (433)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell 421 (433)
+..+. ... ++........ ....................++.++.+|+.+||+.||++|||+.|+|
T Consensus 228 ~~~~~------------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 228 PCLLD------------KST--YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred ccccc------------cCc--hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 11100 000 0000000000 00000000000111112234567899999999999999999999999
Q ss_pred cCCCCCCC
Q 013973 422 RHPFFTRD 429 (433)
Q Consensus 422 ~hp~f~~~ 429 (433)
+||||+..
T Consensus 294 ~~p~~~~~ 301 (314)
T cd08216 294 NHSFFKQC 301 (314)
T ss_pred cCchHhhh
Confidence 99999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=311.59 Aligned_cols=247 Identities=20% Similarity=0.258 Sum_probs=192.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC-----CeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.+|++.+.||+|+||.||+|.+..+ ++.||+|+++... ...+.+..|+.++..+ .|++|+++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-----QHPNIVCLLGVVTK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEcC
Confidence 3588899999999999999987543 5789999987432 2234566778777776 67899999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
....++++||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999 889999986321 135888899999999999999999999999999999999965
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHH
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV 309 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 309 (433)
++ .+||+|||+++...... ....+++.|+|||++.+..++.++|||||
T Consensus 160 ~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05091 160 KL---------------------------NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212 (283)
T ss_pred CC---------------------------ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence 44 45555555544322111 12245778999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHH
Q 013973 310 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388 (433)
Q Consensus 310 Gv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
||++|||++ |..||.+....+....+.... .
T Consensus 213 G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-----------------------~------------------------- 244 (283)
T cd05091 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-----------------------V------------------------- 244 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-----------------------c-------------------------
Confidence 999999998 889998766555443322110 0
Q ss_pred hhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 389 ~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+..++.++.+|+.+||+.||++||++++++..
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 245 LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 01123567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=303.62 Aligned_cols=241 Identities=25% Similarity=0.377 Sum_probs=193.7
Q ss_pred eeeeccccEEEEEEEECCC---CeEEEEEEeecchhh--HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
+.||+|+||.||+|.+... +..||+|++...... ...+..|+..+..+ .|++++++++++.....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-----GHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-----CCCChheeeeeecCCCceEEEE
Confidence 4799999999999999866 888999999754332 46677888888888 4688999999999999999999
Q ss_pred ecC-CCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 178 EKL-GSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
||+ +++|.+++.... ...+++..+..++.|++.||+|||++||+|+||||+||+++.++
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~------------- 142 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL------------- 142 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-------------
Confidence 999 999999998751 24799999999999999999999999999999999999995544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
.++|+|||.+...... .....++..|+|||.+....++.++|+||||+++|+|++ |..||
T Consensus 143 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 143 --------------VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred --------------cEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 5555555555433322 122357889999999998899999999999999999999 69999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
......+....+... .. ...+...+.++.+++
T Consensus 209 ~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~~~~~li 240 (262)
T cd00192 209 PGLSNEEVLEYLRKG----------------------YR--------------------------LPKPEYCPDELYELM 240 (262)
T ss_pred CCCCHHHHHHHHHcC----------------------CC--------------------------CCCCccCChHHHHHH
Confidence 877554443322210 00 011234567899999
Q ss_pred HhccccCCCCCCCHHHHhcC
Q 013973 404 QGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~h 423 (433)
.+||+.||++|||+.|+++|
T Consensus 241 ~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 241 LSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHccCCcccCcCHHHHHHh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.39 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=194.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++.+.||+|+||.||+|.+..+++.||||.++... ........|+.++.+. .+|++++++++++.....+|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhc----cCCCchHhhheeeecCCeEE
Confidence 56999999999999999999999999999999987432 2233344555555443 25789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||++++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+||++++++
T Consensus 91 ~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~----------------- 152 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG----------------- 152 (296)
T ss_pred EEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-----------------
Confidence 999999888888776543 379999999999999999999997 5999999999999995544
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCC----CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+||+|||.+....... ....|+..|+|||++.+.. ++.++|+||||+++|+|++|..||....
T Consensus 153 ----------~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 222 (296)
T cd06618 153 ----------NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222 (296)
T ss_pred ----------CEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence 45566666554322111 1235788999999997654 7889999999999999999999997533
Q ss_pred hH-HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 328 NL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 328 ~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
.. +.+.. .... ....++. ...++.++.+||.+|
T Consensus 223 ~~~~~~~~---~~~~-------------------~~~~~~~------------------------~~~~~~~l~~li~~~ 256 (296)
T cd06618 223 TEFEVLTK---ILQE-------------------EPPSLPP------------------------NEGFSPDFCSFVDLC 256 (296)
T ss_pred hHHHHHHH---HhcC-------------------CCCCCCC------------------------CCCCCHHHHHHHHHH
Confidence 21 11111 1100 0000000 013466899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|+.||++||++.++++||||....
T Consensus 257 l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 257 LTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred ccCChhhCCCHHHHhcChhhhccc
Confidence 999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.58 Aligned_cols=249 Identities=20% Similarity=0.323 Sum_probs=191.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC-------CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.++|.+.+.||+|+||.||+|.+.. +...+|+|+++.. ......+..|+.+++.+. .|++++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----KHKNIINLLGA 92 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc----CCCCEeeEEEE
Confidence 4679999999999999999998643 2356999998743 223345667888888773 35789999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+...+..|+||||+ +++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 99999999999999 8899999976421 25889999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.++. ++|+|||.+....... ....++..|+|||++.+..++.++|+
T Consensus 173 l~~~~~---------------------------~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 225 (307)
T cd05098 173 VTEDNV---------------------------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225 (307)
T ss_pred EcCCCc---------------------------EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHH
Confidence 965554 5555555443222110 11124568999999999889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|||||++|||++ |..||.+....+....+.. +.
T Consensus 226 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----------------------~~----------------------- 259 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-----------------------GH----------------------- 259 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc-----------------------CC-----------------------
Confidence 999999999998 8899976554433322111 00
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
....+...+.++.+|+.+||+.+|++|||+.+++++
T Consensus 260 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 260 --RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 001122456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=302.12 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=192.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++.++||+|+||.||+|.+.. +..+|+|.+.......+.+..|+.+++.+ +|++++++.+.+.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTL-----QHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhc-----CCCCcceEEEEEcC-CCeEE
Confidence 4679999999999999999998654 45699998876555556778899999888 66889999988877 78899
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~---------------- 141 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC---------------- 141 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcE----------------
Confidence 99999 8899999987655678999999999999999999999999999999999999655554
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
||+|||.+....... ....++..|+|||++....++.++|+|||||++|++++ |..||.+.+..
T Consensus 142 -----------~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 142 -----------KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred -----------EECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 455555443222111 11235677999999998889999999999999999999 99999876554
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.... . .......+.++.+++.+||+.
T Consensus 211 ~~~~~~~~~~------------------------~------------------------~~~~~~~~~~~~~~i~~~l~~ 242 (260)
T cd05073 211 EVIRALERGY------------------------R------------------------MPRPENCPEELYNIMMRCWKN 242 (260)
T ss_pred HHHHHHhCCC------------------------C------------------------CCCcccCCHHHHHHHHHHccc
Confidence 4332211100 0 001124566899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++||++.+++.
T Consensus 243 ~p~~Rp~~~~l~~ 255 (260)
T cd05073 243 RPEERPTFEYIQS 255 (260)
T ss_pred CcccCcCHHHHHH
Confidence 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=303.88 Aligned_cols=228 Identities=25% Similarity=0.379 Sum_probs=180.7
Q ss_pred cccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CCCHHH
Q 013973 108 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYD 186 (433)
Q Consensus 108 G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~ 186 (433)
|.+|.||+|+++.+++.||+|.++..... ..|...+... .|++++++++.+.....+++||||+ |++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~----~~~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY----SRERLTIIPH-----CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh----hhHHHHHHhc-----CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 89999999999999999999998754321 2233222222 5689999999999999999999999 899999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEE
Q 013973 187 FLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266 (433)
Q Consensus 187 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~k 266 (433)
++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.++
T Consensus 75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~---------------------------~~~~~ 125 (237)
T cd05576 75 HISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD---------------------------RGHIQ 125 (237)
T ss_pred HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC---------------------------CCCEE
Confidence 997654 6999999999999999999999999999999999999954 44567
Q ss_pred EEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 013973 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHM 346 (433)
Q Consensus 267 l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (433)
++|||.+...........++..|+|||.+.+..++.++|+||+|+++|||++|..||........
T Consensus 126 l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------- 190 (237)
T cd05576 126 LTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------- 190 (237)
T ss_pred EecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------
Confidence 77777655443333334567789999999888899999999999999999999988753211000
Q ss_pred HHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCH-----HHHh
Q 013973 347 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-----REAL 421 (433)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta-----~ell 421 (433)
.... ...++.++..+++||.+||+.||++|+++ +|++
T Consensus 191 ------------~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 232 (237)
T cd05576 191 ------------THTT--------------------------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232 (237)
T ss_pred ------------cccc--------------------------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHH
Confidence 0000 01123456789999999999999999986 9999
Q ss_pred cCCCC
Q 013973 422 RHPFF 426 (433)
Q Consensus 422 ~hp~f 426 (433)
.||||
T Consensus 233 ~h~~~ 237 (237)
T cd05576 233 SHPFF 237 (237)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.42 Aligned_cols=245 Identities=20% Similarity=0.276 Sum_probs=187.7
Q ss_pred EEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 013973 99 YKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 171 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 171 (433)
|++.+.||+|+||.||+|....+ +..||+|.++.. ......+..|+..++.+ .|++++++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-----DHPNVMKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEeeeccCCc
Confidence 56789999999999999987653 478999998643 22345677888888887 6788999998775544
Q ss_pred -----eEEEEEecC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 172 -----HICIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 172 -----~~~lV~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---- 151 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---- 151 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe----
Confidence 389999999 899999985432 236899999999999999999999999999999999999965544
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~el 316 (433)
+||+|||.++...... ....++..|+|||++.+..++.++|||||||++|||
T Consensus 152 -----------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el 208 (273)
T cd05035 152 -----------------------VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208 (273)
T ss_pred -----------------------EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence 5555555544322111 112346789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 317 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 317 lt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
++ |..||.+.+..+....+... ... ..+..+
T Consensus 209 ~~~g~~p~~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~ 240 (273)
T cd05035 209 ATRGQTPYPGVENHEIYDYLRHG----------------------NRL--------------------------KQPEDC 240 (273)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcC----------------------CCC--------------------------CCCcCC
Confidence 99 89999876654433222110 000 012345
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
+.++.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 241 LDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=303.16 Aligned_cols=236 Identities=23% Similarity=0.355 Sum_probs=183.1
Q ss_pred eeeccccEEEEEEEE--CCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 104 KMGEGTFGQVLECWD--RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~--~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+||+|+||.||+|.+ ..+++.+|+|+++... ...+.+..|+.+++.+ .|++++++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-----DNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEc-CCCcEEEEe
Confidence 689999999999964 4677899999986432 2345667788888887 6788999998875 456789999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~ 257 (433)
|+ +++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~------------------- 134 (257)
T cd05116 76 LAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYA------------------- 134 (257)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeE-------------------
Confidence 99 789999997654 68999999999999999999999999999999999999655554
Q ss_pred cCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 258 RMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 258 ~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
||+|||.+....... ....++..|+|||.+....++.++|+|||||++|||++ |..||...+..+
T Consensus 135 --------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 206 (257)
T cd05116 135 --------KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206 (257)
T ss_pred --------EECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 445555443322111 11134678999999988889999999999999999998 999998766554
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+... ... ..+...+.++.+||.+||+.|
T Consensus 207 ~~~~i~~~----------------------~~~--------------------------~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 207 VTQMIESG----------------------ERM--------------------------ECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred HHHHHHCC----------------------CCC--------------------------CCCCCCCHHHHHHHHHHhccC
Confidence 43332210 000 112356778999999999999
Q ss_pred CCCCCCHHHHhc
Q 013973 411 PTDRLTAREALR 422 (433)
Q Consensus 411 P~~R~ta~ell~ 422 (433)
|++||++++|.+
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.17 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=194.7
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+|.+.++||+|+||.||++.+..++..+++|+++.. .........|+.+++.+ +|+|++++++.+....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-----DHPAIVKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-----CCCcHHHHHHHHhcCC
Confidence 589999999999999999999888777777776531 11223445677777776 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||++++ +
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~------------ 142 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N------------ 142 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C------------
Confidence 999999999 88999988642 2346999999999999999999999999999999999999943 2
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 143 ---------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 143 ---------------LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred ---------------CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 36666666654332211 224578899999999888899999999999999999999999976
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.........+.. +..+ ..+...+.++.++|.+
T Consensus 208 ~~~~~~~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~~li~~ 239 (260)
T cd08222 208 QNFLSVVLRIVE--GPTP----------------------------------------------SLPETYSRQLNSIMQS 239 (260)
T ss_pred ccHHHHHHHHHc--CCCC----------------------------------------------CCcchhcHHHHHHHHH
Confidence 554333222111 1110 0112456688999999
Q ss_pred ccccCCCCCCCHHHHhcCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f 426 (433)
||+.||++||++.|+++||||
T Consensus 240 ~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 240 MLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=302.21 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=193.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
.+|++.+.||+|+||.||+|.+.. +..+|+|++.........+..|+++++++ .|++++++++.+......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKL-----SHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhC-----CCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999998754 56799999875444455678899999988 668899999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~------------------ 138 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV------------------ 138 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe------------------
Confidence 9999 889999987643 36899999999999999999999999999999999999965554
Q ss_pred cccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
++|+|||.+....... ....++..|+|||++.+..++.++|+||||+++|||++ |..||......+
T Consensus 139 ---------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05112 139 ---------VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209 (256)
T ss_pred ---------EEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 5555555443221111 11234678999999998889999999999999999998 999998765544
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.. +... ..+...+..+.+|+.+||+.+
T Consensus 210 ~~~~~~~-----------------------~~~~-------------------------~~~~~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 210 VVETINA-----------------------GFRL-------------------------YKPRLASQSVYELMQHCWKER 241 (256)
T ss_pred HHHHHhC-----------------------CCCC-------------------------CCCCCCCHHHHHHHHHHcccC
Confidence 3332211 0000 001234568999999999999
Q ss_pred CCCCCCHHHHhcC
Q 013973 411 PTDRLTAREALRH 423 (433)
Q Consensus 411 P~~R~ta~ell~h 423 (433)
|++|||+.|++++
T Consensus 242 p~~Rp~~~~~l~~ 254 (256)
T cd05112 242 PEDRPSFSLLLHQ 254 (256)
T ss_pred hhhCCCHHHHHHh
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=301.13 Aligned_cols=239 Identities=31% Similarity=0.538 Sum_probs=196.7
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
||+|+||.||++.+..+++.||+|+++.... ....+..|+.+++.+ .|++++++++.++.+...|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-----NHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-----CCCcHHHHHHHeecCCeeEEEEecC
Confidence 6999999999999998899999999874322 334667788888888 5788999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~------------------------- 128 (250)
T cd05123 76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA------------------------- 128 (250)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC-------------------------
Confidence 999999998764 6899999999999999999999999999999999999954
Q ss_pred CCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 336 (433)
++.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus 129 --~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 129 --DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred --CCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 445777777766544332 233468889999999998888999999999999999999999997665433222211
Q ss_pred HHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCC
Q 013973 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 416 (433)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 416 (433)
. ..+. .+...+.++.++|.+||..||++||+
T Consensus 207 ~-----------------------~~~~--------------------------~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 207 K-----------------------DPLR--------------------------FPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred c-----------------------CCCC--------------------------CCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 1 1111 12244678899999999999999999
Q ss_pred H---HHHhcCCCC
Q 013973 417 A---REALRHPFF 426 (433)
Q Consensus 417 a---~ell~hp~f 426 (433)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=316.85 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=188.5
Q ss_pred CcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ......+..|+.++.++. +|+||+++++.+..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~~ 82 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACTK 82 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc----CCccHhhhcceeec
Confidence 5799999999999999999984 356788999999742 223445678999988884 45789999987754
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCC------------------------------------------------------
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNY------------------------------------------------------ 193 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~------------------------------------------------------ 193 (433)
...+++||||+ +|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45789999999 9999999875321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCC
Q 013973 194 -----------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 262 (433)
Q Consensus 194 -----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~ 262 (433)
..+++..+..++.||+.||+|||++||+||||||+|||++. +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~---------------------------~ 215 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE---------------------------N 215 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC---------------------------C
Confidence 23678888999999999999999999999999999999954 4
Q ss_pred CCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 013973 263 SAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 336 (433)
Q Consensus 263 ~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~ 336 (433)
+.+||+|||++....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus 216 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~- 294 (343)
T cd05103 216 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR- 294 (343)
T ss_pred CcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-
Confidence 456666666655332111 11235677999999999899999999999999999997 99999764432211110
Q ss_pred HHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCC
Q 013973 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 416 (433)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 416 (433)
+..+.. ...+...++++.+++..||+.||++|||
T Consensus 295 ---------------------~~~~~~-------------------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps 328 (343)
T cd05103 295 ---------------------LKEGTR-------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPT 328 (343)
T ss_pred ---------------------HhccCC-------------------------CCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 000000 0001234567899999999999999999
Q ss_pred HHHHhcC
Q 013973 417 AREALRH 423 (433)
Q Consensus 417 a~ell~h 423 (433)
+.|+++|
T Consensus 329 ~~eil~~ 335 (343)
T cd05103 329 FSELVEH 335 (343)
T ss_pred HHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=300.16 Aligned_cols=288 Identities=27% Similarity=0.457 Sum_probs=230.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 170 (433)
..+|.-++.+|.|.- .|..|.+...++.||+|.+.. .....++..+|..++..+ .|+|++.++.+|...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-----~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-----NHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-----cccceeeeeeccCcccc
Confidence 457899999999999 788899999999999998742 233445667899999888 778999999998643
Q ss_pred ----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 ----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
..+|+|||+|..+|.+.+.. .++-+.+..++.|++.|++|||+.||+||||||+||+++.++
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~---------- 155 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC---------- 155 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh----------
Confidence 46899999999999999873 478888999999999999999999999999999999996554
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.+||.|||+|+..... .+-++.|..|.|||++.+..|...+||||+||++.||++|...|.
T Consensus 156 -----------------~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 156 -----------------TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred -----------------heeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 5666666666544433 123578999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+++.++.+.+|.+.+...++....+..|++.-.-. .. -++...++...+.. ..+.....+..++||+.
T Consensus 219 g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y-~~-----~~f~~~fpD~~f~~-~~e~~~~~~~~ardll~ 291 (369)
T KOG0665|consen 219 GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQY-QA-----ISFSELFPDSLFPV-VLEGSKLDCSLARDLLS 291 (369)
T ss_pred CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHh-hc-----cchhhhCCcccccc-cccCCccchHHHHHHHH
Confidence 9999999999999999999999999999998888732110 00 01111111111110 11122234567899999
Q ss_pred hccccCCCCCCCHHHHhcCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
+||..||++|.+++++|+||||+
T Consensus 292 ~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 292 KMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhccChhhcccHHHHhcCCeee
Confidence 99999999999999999999996
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.26 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=190.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|++.+.||+|+||.||++. .+++.||+|+++.. .....+..|+.++..+ .|++++++++.+... ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-VTAQAFLEETAVMTKL-----HHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-chHHHHHHHHHHHHhC-----CCCCcCeEEEEEcCC-CcEEE
Confidence 469999999999999999985 46778999998743 2345677888888887 668899999988654 47999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+|||++.+
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-------------------- 136 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-------------------- 136 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC--------------------
Confidence 9999 8999999987665578999999999999999999999999999999999999544
Q ss_pred cccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 334 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 334 (433)
+.++|+|||.+............+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....
T Consensus 137 -------~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 209 (254)
T cd05083 137 -------GVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC 209 (254)
T ss_pred -------CcEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 45666666665543322222334567999999998889999999999999999998 9999987655443222
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.+ +.. ...+...+..+.+|+.+||+.+|++|
T Consensus 210 ~~~-----------------------~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 241 (254)
T cd05083 210 VEK-----------------------GYR-------------------------MEPPEGCPADVYVLMTSCWETEPKKR 241 (254)
T ss_pred HhC-----------------------CCC-------------------------CCCCCcCCHHHHHHHHHHcCCChhhC
Confidence 111 000 00112456788999999999999999
Q ss_pred CCHHHHhc
Q 013973 415 LTAREALR 422 (433)
Q Consensus 415 ~ta~ell~ 422 (433)
|+++++++
T Consensus 242 p~~~~l~~ 249 (254)
T cd05083 242 PSFHKLRE 249 (254)
T ss_pred cCHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=301.57 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=185.2
Q ss_pred eeeeccccEEEEEEEECCCC---eEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDRERK---EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~---~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
++||+|+||.||+|....++ ..||+|.+..... ..+.+..|+.+++.+ .|++++++++++. ...+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-----DHPCIVRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEc-CCceEEEE
Confidence 47999999999999876655 7899999874433 455677888888887 6688999998776 45689999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++.... .+++..+..++.|++.||+|||..+|+|+||||+|||++.++.++++|||
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~------------ 140 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFG------------ 140 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEecccc------------
Confidence 999 889999998764 78999999999999999999999999999999999999665555555554
Q ss_pred ccCCCCCCEEEEecCCccccCCCCCc------eeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQNY------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.+......... ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus 141 ---------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 141 ---------------MSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred ---------------ccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 44322211111 123567999999998899999999999999999998 99999876554
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.... .. ..+...+..+.++|.+||+.
T Consensus 206 ~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~l~~li~~cl~~ 237 (257)
T cd05060 206 EVIAMLESGE----------------------RL--------------------------PRPEECPQEIYSIMLSCWKY 237 (257)
T ss_pred HHHHHHHcCC----------------------cC--------------------------CCCCCCCHHHHHHHHHHhcC
Confidence 4333221100 00 11234567899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++||++.++++
T Consensus 238 ~p~~Rp~~~~l~~ 250 (257)
T cd05060 238 RPEDRPTFSELES 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.15 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=191.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC--------------CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCce
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER--------------KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRC 160 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~--------------~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i 160 (433)
++|++.+.||+|+||.||+|.+..+ ...||+|.++.. ......+..|+++++++ .|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i 79 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-----KNPNI 79 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCc
Confidence 5799999999999999999987543 235999998642 23345677899999988 66889
Q ss_pred EEecceeecCCeEEEEEecC-CCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 013973 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY----------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 229 (433)
Q Consensus 161 ~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~N 229 (433)
+++++++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 99999999999999999999 8999999865321 246888999999999999999999999999999999
Q ss_pred eEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcc
Q 013973 230 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPC 304 (433)
Q Consensus 230 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~ 304 (433)
||+++++. +||+|||++....... ....++..|+|||++.+..++.++
T Consensus 160 ill~~~~~---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 212 (295)
T cd05097 160 CLVGNHYT---------------------------IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS 212 (295)
T ss_pred EEEcCCCc---------------------------EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchh
Confidence 99965554 4555555443221111 112456789999999988899999
Q ss_pred hhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccch
Q 013973 305 DIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382 (433)
Q Consensus 305 DvwSlGv~l~ellt--g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (433)
|+|||||++|+|++ |..||...+..+....+...... .+...+
T Consensus 213 DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~~----------------- 257 (295)
T cd05097 213 DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN------------------QGRQIY----------------- 257 (295)
T ss_pred hHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhh------------------cccccc-----------------
Confidence 99999999999988 67888876655443332221100 000000
Q ss_pred hHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
...+...+..+.+|+.+||+.||++||++.++++
T Consensus 258 ------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 258 ------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0112245678999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=303.17 Aligned_cols=251 Identities=21% Similarity=0.288 Sum_probs=191.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCe---EEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
++|...+.||+|+||.||+|.+..+++ .+|+|.++.. ......+..|+.+++.+ .|++++++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-----SHHNIIRLEGVVTKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEEccCC
Confidence 568999999999999999999876554 7999988643 23345667788888777 5688999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999 889999987643 468999999999999999999999999999999999999665555555555433221
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
..... .. .......+..|+|||++.+..++.++|||||||++|||++ |..||...+..
T Consensus 159 ~~~~~----------~~-----------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~ 217 (268)
T cd05063 159 DDPEG----------TY-----------TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217 (268)
T ss_pred ccccc----------ce-----------eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 10000 00 0000123457999999998889999999999999999998 99999876655
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.... .. | .....+.++.+|+.+||+.
T Consensus 218 ~~~~~i~~~~-~~-----------------------~------------------------~~~~~~~~~~~li~~c~~~ 249 (268)
T cd05063 218 EVMKAINDGF-RL-----------------------P------------------------APMDCPSAVYQLMLQCWQQ 249 (268)
T ss_pred HHHHHHhcCC-CC-----------------------C------------------------CCCCCCHHHHHHHHHHcCC
Confidence 4444332110 00 0 0123456789999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
||++||++.++++
T Consensus 250 ~p~~Rp~~~~i~~ 262 (268)
T cd05063 250 DRARRPRFVDIVN 262 (268)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=305.31 Aligned_cols=244 Identities=18% Similarity=0.275 Sum_probs=184.8
Q ss_pred EEEeeeeccccEEEEEEEECCCCe--EEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKE--MVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 169 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~--~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----- 169 (433)
.+.+.||+|+||.||+|.+..++. .||+|.++.. ....+.+..|..+++.+ .|+||+++++.+..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-----DHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEccCCccc
Confidence 467899999999999999887765 5899988642 33445667788888887 67889999886532
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
....++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~----- 151 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNV----- 151 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCE-----
Confidence 23578999999 89999987532 12358999999999999999999999999999999999999655554
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 318 (433)
+|+|||++....... ....+++.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ----------------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~ 209 (272)
T cd05075 152 ----------------------CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209 (272)
T ss_pred ----------------------EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence 455555444322111 11245778999999999899999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 319 -GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 319 -g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
|..||.+.+..+....+. .+.. ...+..++.
T Consensus 210 ~g~~p~~~~~~~~~~~~~~-----------------------~~~~-------------------------~~~~~~~~~ 241 (272)
T cd05075 210 RGQTPYPGVENSEIYDYLR-----------------------QGNR-------------------------LKQPPDCLD 241 (272)
T ss_pred CCCCCCCCCCHHHHHHHHH-----------------------cCCC-------------------------CCCCCCCCH
Confidence 899998765544332211 1100 001124566
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.+.++|.+||+.||++|||+.+++++
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 242 GLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 78999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.94 Aligned_cols=243 Identities=28% Similarity=0.425 Sum_probs=189.5
Q ss_pred EEEeeeeccccEEEEEEEEC----CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 100 KIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++.+.||.|.||.||+|... ..+..|+||+++.. ....+.+..|+..+.++ .|+||+++++++...+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-----RHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-----SBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-----cccccccccccccccccc
Confidence 57799999999999999987 45678999999642 23457788899999888 668899999999988889
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ +|+|.++|.......+++..+..++.||+.||.|||+++|+|+||+++|||++++
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~----------------- 139 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN----------------- 139 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-----------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------
Confidence 9999999 7899999998744579999999999999999999999999999999999999654
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~ 326 (433)
+.+||+|||++....... ....+...|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 140 ----------~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 140 ----------GQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp ----------TEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ----------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 456666666665442111 12346778999999999889999999999999999999 78999877
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+.... . ...+..++.++.++|..|
T Consensus 210 ~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~~~~~li~~C 241 (259)
T PF07714_consen 210 DNEEIIEKLKQGQ----------------------R--------------------------LPIPDNCPKDIYSLIQQC 241 (259)
T ss_dssp CHHHHHHHHHTTE----------------------E--------------------------TTSBTTSBHHHHHHHHHH
T ss_pred ccccccccccccc----------------------c--------------------------ceeccchhHHHHHHHHHH
Confidence 6655443321100 0 112235677899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013973 407 LRYDPTDRLTAREALR 422 (433)
Q Consensus 407 L~~dP~~R~ta~ell~ 422 (433)
|..||++|||+.++++
T Consensus 242 ~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 242 WSHDPEKRPSFQEILQ 257 (259)
T ss_dssp T-SSGGGS--HHHHHH
T ss_pred cCCChhhCcCHHHHHh
Confidence 9999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=308.06 Aligned_cols=245 Identities=19% Similarity=0.329 Sum_probs=190.2
Q ss_pred cEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .....+..|+.+++.+ .|+||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-----NHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-----CCCCEeeEEEEEecC
Confidence 47899999999999999998753 33679999886432 2345677899998888 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 227 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp 227 (433)
+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.||+||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 9999999999 899999987531 13578999999999999999999999999999999
Q ss_pred CceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCC
Q 013973 228 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTY 302 (433)
Q Consensus 228 ~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~ 302 (433)
+|||+++++ .+||+|||++....... ....++..|+|||++.+..++.
T Consensus 156 ~nill~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 208 (290)
T cd05045 156 RNVLVAEGR---------------------------KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208 (290)
T ss_pred heEEEcCCC---------------------------cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence 999996544 45555555554322111 1224567899999999888999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccc
Q 013973 303 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381 (433)
Q Consensus 303 ~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (433)
++||||||+++|||++ |..||.+....+....+.. + ..+
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----------------------~-~~~---------------- 248 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT-----------------------G-YRM---------------- 248 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------------------C-CCC----------------
Confidence 9999999999999998 9999987554433322110 0 000
Q ss_pred hhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
..+...+.++.+|+.+||+.||++||++.|+++
T Consensus 249 --------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 249 --------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred --------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 012245678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.81 Aligned_cols=261 Identities=29% Similarity=0.419 Sum_probs=206.0
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++-+++-...||.|.||.||-|.+..+|+..|+|.++.. .+....+..|..++..+ +|||+|+.+++-.+.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-----nHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-----NHPNLVRYYGVEVHR 1306 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-----cCccccccCceeecH
Confidence 3455788889999999999999999999999999988632 23344567789999988 889999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
..++|.|||| +|+|.+.++..+ ..++...+.|..|++.||.|||+.|||||||||.|||++..|.+|.+|||.|+..
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999 999999998754 6888889999999999999999999999999999999976655555555444322
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC---CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
..+. -|++ ..-...+||+.|||||++.+. +..-+.||||||||+.||+||+.||...
T Consensus 1385 ~~~~--------------~~~~------~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1385 KNNA--------------QTMP------GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred cCch--------------hcCC------HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 2110 0010 011235899999999999864 4678999999999999999999999865
Q ss_pred Ch-HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 327 EN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 327 ~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
+. ..+..+ -..|..|+ .|..++.+.+|||..
T Consensus 1445 dne~aIMy~--V~~gh~Pq----------------------------------------------~P~~ls~~g~dFle~ 1476 (1509)
T KOG4645|consen 1445 DNEWAIMYH--VAAGHKPQ----------------------------------------------IPERLSSEGRDFLEH 1476 (1509)
T ss_pred cchhHHHhH--HhccCCCC----------------------------------------------CchhhhHhHHHHHHH
Confidence 44 333222 22333331 233567889999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||+.||++|+++.|+|+|-|-+..
T Consensus 1477 Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1477 CLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHhcCchhhhHHHHHHHhhccccc
Confidence 999999999999999999997643
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.86 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=192.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|.+.+.||+|+||.||+|++. .+++.||+|+++.. ......+..|+.++.++. .|+||+.+++.+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~----~H~niv~~~~~~~ 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG----PHLNIVNLLGACT 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC----CCCCeEEEEEEEc
Confidence 356899999999999999999864 35578999999743 222345778999998872 2688999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCC------------------------------------------------------
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNY------------------------------------------------------ 193 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~------------------------------------------------------ 193 (433)
..+.+++||||+ +|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999 9999999975421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 194 ------------------------------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 194 ------------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
..+++..+..++.||+.||+|||+.+|+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 24677788899999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.++ .+||+|||++...... .....++..|+|||++.+..++.++||
T Consensus 272 l~~~~---------------------------~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 272 ICEGK---------------------------LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EeCCC---------------------------EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 96544 4555555555432111 112356788999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|||||++|||++ |..||......+....... .+. .
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~----------------------~~~-~--------------------- 360 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIK----------------------RGY-R--------------------- 360 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH----------------------cCC-C---------------------
Confidence 999999999998 8999976544332221110 000 0
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+...+.++.+|+.+||+.+|.+||++.||++.
T Consensus 361 ---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 361 ---MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00122456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=330.98 Aligned_cols=272 Identities=21% Similarity=0.334 Sum_probs=177.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCC----CeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecce-----
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRER----KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW----- 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~----~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~----- 166 (433)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+..... . |......+.+.. +.++..+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~-----e~~~~e~l~~~~--~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-V-----EIWMNERVRRAC--PNSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-h-----HHHHHHHHHhhc--hhhHHHHHHhhhccc
Confidence 46899999999999999999999988 89999998763221 1 111222221110 0111111111
Q ss_pred -eecCCeEEEEEecC-CCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013973 167 -FDYRNHICIVFEKL-GSSLYDFLRKNNYR------------------SFPIDLVREIARQLLECIAFMHDLCMIHTDLK 226 (433)
Q Consensus 167 -~~~~~~~~lV~e~~-~~~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlK 226 (433)
......+++||||+ +++|.+++...... ......+..++.||+.||+|||++||||||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 24567899999999 88999998754311 01234466899999999999999999999999
Q ss_pred CCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCC----
Q 013973 227 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL---- 298 (433)
Q Consensus 227 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~---- 298 (433)
|+|||++. .++.+||+|||++...... ....+||+.|||||.+...
T Consensus 283 P~NILl~~--------------------------~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~ 336 (566)
T PLN03225 283 PQNIIFSE--------------------------GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP 336 (566)
T ss_pred HHHEEEeC--------------------------CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCC
Confidence 99999953 2356788888877643322 2345789999999976432
Q ss_pred ------------------CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhcc
Q 013973 299 ------------------GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360 (433)
Q Consensus 299 ------------------~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 360 (433)
.++.++|||||||++|||+++..++. +....+..+....+.....+.......
T Consensus 337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~------- 407 (566)
T PLN03225 337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPR------- 407 (566)
T ss_pred CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccc-------
Confidence 23456799999999999999766643 333333332222222111111100000
Q ss_pred CcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 361 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
....... .....+.......+||.+||++||++|||+.|+|+||||+...
T Consensus 408 ----------~~~~~~~----------~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 408 ----------ASPDLRR----------GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred ----------cchhhhh----------hhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 0000000 0011233445677999999999999999999999999998754
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=305.75 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=191.9
Q ss_pred CcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+|++.++||+|+||.||+|... .++..+|+|.+... ......+..|+++++.+ .|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-----QHQHIVRFYGVCTEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-----CCCCCceEEEEEecC
Confidence 56889999999999999999743 35678999988643 33445677889888887 568899999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNY-------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 236 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~ 236 (433)
...++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999 8999999976431 2488999999999999999999999999999999999996555
Q ss_pred ccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHH
Q 013973 237 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311 (433)
Q Consensus 237 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 311 (433)
.++ |+|||++....... ....+++.|+|||++.+..++.++|||||||
T Consensus 160 ~~k---------------------------L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 160 VVK---------------------------IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred CEE---------------------------ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 544 44555443221111 1123577899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh
Q 013973 312 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390 (433)
Q Consensus 312 ~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
++|||++ |.+||......+....+.... .. .
T Consensus 213 il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------~~--------------------------~ 244 (280)
T cd05092 213 VLWEIFTYGKQPWYQLSNTEAIECITQGR----------------------EL--------------------------E 244 (280)
T ss_pred HHHHHHcCCCCCCccCCHHHHHHHHHcCc----------------------cC--------------------------C
Confidence 9999998 999997665544332211100 00 0
Q ss_pred hcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 391 ~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.+..+++.+.+||.+||+.||.+||++.||++
T Consensus 245 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 245 RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12345678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=303.00 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=192.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCC---eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~---~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
++|++.+.||+|+||.||+|.++.++ ..+|+|.++.. ......+..|+.+++++ .|+||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-----DHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCC
Confidence 56999999999999999999886444 37999988642 23445677888888887 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..|+||||+ +++|.+++.... ..+++.++..++.|++.||.|||++||+||||||+|||++.++.++++|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999 889999998654 368999999999999999999999999999999999999665555555555443221
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
..... . .......++..|+|||++.+..++.++|+|||||++||+++ |..||...+..
T Consensus 158 ~~~~~----------~-----------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 158 DDPEA----------A-----------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred cccce----------e-----------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 11000 0 00001123567999999998899999999999999999887 99999876554
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.+.. ..+ .+...+..+.+++.+||+.
T Consensus 217 ~~~~~~~~~~------------------------~~~------------------------~~~~~~~~~~~li~~~l~~ 248 (267)
T cd05066 217 DVIKAIEEGY------------------------RLP------------------------APMDCPAALHQLMLDCWQK 248 (267)
T ss_pred HHHHHHhCCC------------------------cCC------------------------CCCCCCHHHHHHHHHHccc
Confidence 4333221110 000 0123466889999999999
Q ss_pred CCCCCCCHHHHhc
Q 013973 410 DPTDRLTAREALR 422 (433)
Q Consensus 410 dP~~R~ta~ell~ 422 (433)
+|.+||++.++++
T Consensus 249 ~p~~Rp~~~~i~~ 261 (267)
T cd05066 249 DRNERPKFEQIVS 261 (267)
T ss_pred CchhCCCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.78 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=184.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeE----EEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEM----VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~----vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
++|++.+.||+|+||.||+|.+..+++. +|+|.+... ......+..|+..++.+ .|+||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-----~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-----DHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-----CCCCcceEEEEEC-C
Confidence 4699999999999999999998877763 677776422 12223444555565555 6789999999875 4
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
...++++||+ +|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~------------- 146 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS------------- 146 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-------------
Confidence 5578899998 899999997643 4689999999999999999999999999999999999995544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
.+||+|||.++...... ....|+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 147 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 147 --------------IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred --------------cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 45555555554322211 12346778999999998899999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.........+ ..+.... .+...+.++.+++
T Consensus 213 ~~~~~~~~~~~~-----------------------~~~~~~~-------------------------~~~~~~~~~~~li 244 (279)
T cd05111 213 AGMRPHEVPDLL-----------------------EKGERLA-------------------------QPQICTIDVYMVM 244 (279)
T ss_pred CCCCHHHHHHHH-----------------------HCCCcCC-------------------------CCCCCCHHHHHHH
Confidence 876543322211 1111000 0112345788899
Q ss_pred HhccccCCCCCCCHHHHhc
Q 013973 404 QGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~ 422 (433)
.+||..||++|||+.|+++
T Consensus 245 ~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 245 VKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=305.39 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=195.1
Q ss_pred cEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 98 RYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
+|++.+.||+|+||.||+|.+. .+++.||||+++... .....+..|+.++.++. +|++++.+.+.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~----~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR----RCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc----CCcchhhhheeeec
Confidence 3889999999999999999864 467889999987432 12344567888888773 45789999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...+|+||||+ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~-------------- 140 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS-------------- 140 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--------------
Confidence 99999999999 889999987653 6899999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCC--CCCcchhHHHHHHHHHHHhCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~P 322 (433)
++.++|+|||.+....... ....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..|
T Consensus 141 -------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p 207 (288)
T cd05583 141 -------------EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207 (288)
T ss_pred -------------CCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence 4456777777665432221 2246889999999987755 78899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+.......+.+. +.... ...+..++.++.++
T Consensus 208 ~~~~~~~~~~~~~~~~-------------------~~~~~--------------------------~~~~~~~~~~l~~l 242 (288)
T cd05583 208 FTVDGEQNSQSEISRR-------------------ILKSK--------------------------PPFPKTMSAEARDF 242 (288)
T ss_pred cccCcccchHHHHHHH-------------------HHccC--------------------------CCCCcccCHHHHHH
Confidence 9643321111111000 00000 01123456788999
Q ss_pred HHhccccCCCCCCC---HHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTDRLT---AREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~R~t---a~ell~hp~f~~~ 429 (433)
|.+||+.||++||| +.++|+||||+..
T Consensus 243 i~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 243 IQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999998 5688999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=308.07 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=191.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-------CCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.++|.+.+.||+|+||.||+|.+. .....||+|+++... .....+..|+.+++.+. .|++|++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~ 86 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG----KHKNIINLLGV 86 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc----CCCCeeeEEEE
Confidence 367999999999999999999763 234679999987432 23345667888887762 46889999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+...+.+|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999 899999997632 135889999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.++ .+||+|||.++...... ....++..|+|||++.+..++.++||
T Consensus 167 l~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 167 VTEDN---------------------------VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred EcCCC---------------------------cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence 96544 45555555554322111 11124567999999999889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|||||++|+|++ |..||.+....+.+..+.. +..
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----------------------~~~---------------------- 254 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLRE-----------------------GHR---------------------- 254 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------------------CCC----------------------
Confidence 999999999999 8999987655444432211 000
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 255 ---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 255 ---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0112345668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=307.08 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=190.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECC----------------CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRE----------------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGN 158 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~ 158 (433)
++|++.+.||+|+||.||+|.+.. ++..||+|+++.. ......+..|+.+++.+ .|+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-----~~~ 79 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-----KDP 79 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCC
Confidence 569999999999999999986432 3457999998743 23345677899999888 568
Q ss_pred ceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 013973 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY---------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 228 (433)
Q Consensus 159 ~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~ 228 (433)
+++++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 8999999999999999999999 8999999976431 24778899999999999999999999999999999
Q ss_pred ceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCc
Q 013973 229 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYP 303 (433)
Q Consensus 229 NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 303 (433)
|||++.++ .++|+|||++....... ....++..|+|||+..+..++.+
T Consensus 160 Nili~~~~---------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 212 (296)
T cd05095 160 NCLVGKNY---------------------------TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212 (296)
T ss_pred eEEEcCCC---------------------------CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch
Confidence 99996544 45555555554322111 11234678999999988899999
Q ss_pred chhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccc
Q 013973 304 CDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381 (433)
Q Consensus 304 ~DvwSlGv~l~ellt--g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (433)
+|+|||||++|||++ |..||...+..+......... ...+...
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~------------------~~~~~~~----------------- 257 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF------------------RDQGRQV----------------- 257 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHH------------------hhccccc-----------------
Confidence 999999999999998 778997665544332211100 0000000
Q ss_pred hhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
....+..++..+.+|+.+||+.||++||++.|+++
T Consensus 258 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 258 ------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00112345678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=319.83 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=198.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCe---E-EEEEEeec----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKE---M-VAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~---~-vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
++-.+.++||+|+||.||+|..+..+. . ||+|..+. ......++..|..+++++ +|+||++++|+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-----~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-----NHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEc
Confidence 445667999999999999999876532 3 89999874 245567788999999998 8899999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
....++||||+| ||+|.+||++... .++..+...++.+.+.||+|||++++|||||-.+|+|+...+.+||+|||++
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs- 309 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS- 309 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc-
Confidence 999999999999 9999999998763 6999999999999999999999999999999999999976665555555554
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC--C-ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--N-YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
+...... . ...-...|+|||.+....|+.++|||||||++||+.+ |..||
T Consensus 310 --------------------------~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 310 --------------------------RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred --------------------------cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC
Confidence 3221000 0 0113567999999999999999999999999999999 88999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+....+....+....... ..+...+.++..++
T Consensus 364 ~g~~~~~v~~kI~~~~~r~-----------------------------------------------~~~~~~p~~~~~~~ 396 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYRM-----------------------------------------------PIPSKTPKELAKVM 396 (474)
T ss_pred CCCCHHHHHHHHHhcCccC-----------------------------------------------CCCCCCHHHHHHHH
Confidence 9988876665543221111 11235567888999
Q ss_pred HhccccCCCCCCCHHHHhc
Q 013973 404 QGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~ 422 (433)
.+|+..||++||++.++.+
T Consensus 397 ~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 397 KQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHhccCChhhccCHHHHHH
Confidence 9999999999999987754
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=302.07 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=191.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCe---EEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+.|++.+.||+|+||.||+|.++.+++ .||||++... ......+..|+.+++.+ .|+|++++.+++....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNIIHLEGVVTKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCcCcceEEEEECCCC
Confidence 458999999999999999999887664 6999998642 33455677889888887 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+|||++.++.++++|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999 889999987653 468999999999999999999999999999999999999655555555554433221
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCce--eecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~ 327 (433)
...... ...... .++..|+|||++.+..++.++|||||||++||+++ |..||...+
T Consensus 158 ~~~~~~---------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 158 DDTSDP---------------------TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred cCcccc---------------------ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 100000 000001 12457999999998899999999999999999886 999997765
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+... ...+ .+..++..+.+++.+||
T Consensus 217 ~~~~~~~i~~~------------------------~~~~------------------------~~~~~~~~~~~li~~~l 248 (269)
T cd05065 217 NQDVINAIEQD------------------------YRLP------------------------PPMDCPTALHQLMLDCW 248 (269)
T ss_pred HHHHHHHHHcC------------------------CcCC------------------------CcccCCHHHHHHHHHHc
Confidence 54433322110 0000 11245667899999999
Q ss_pred ccCCCCCCCHHHHhc
Q 013973 408 RYDPTDRLTAREALR 422 (433)
Q Consensus 408 ~~dP~~R~ta~ell~ 422 (433)
+.||.+||++.+++.
T Consensus 249 ~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 249 QKDRNARPKFGQIVS 263 (269)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=307.13 Aligned_cols=249 Identities=18% Similarity=0.306 Sum_probs=191.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-------CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.++|.+.+.||+|+||.||+|+.. .++..||+|.+... ......+..|+.+++.+. .|+||+++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~ 89 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGA 89 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc----cCCCchheeEE
Confidence 367999999999999999999752 23457999998642 233456778888888773 45789999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+...+..|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999 889999997642 124788889999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.++. +||+|||.+....... ....++..|+|||++.+..++.++||
T Consensus 170 i~~~~~---------------------------~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (304)
T cd05101 170 VTENNV---------------------------MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222 (304)
T ss_pred EcCCCc---------------------------EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhH
Confidence 965554 4555555444322111 11235678999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
||||+++|+|++ |..||.+.+..+....+... ...
T Consensus 223 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------------------~~~---------------------- 258 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG----------------------HRM---------------------- 258 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC----------------------CcC----------------------
Confidence 999999999998 88999776554443322110 000
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+..++.++.+|+.+||+.+|.+|||+.|+++.
T Consensus 259 ----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 259 ----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 0122456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=299.23 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=193.3
Q ss_pred EEEEeeeeccccEEEEEEEECCCC----eEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~----~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
|++.+.||.|+||.||+|.+..++ ..||+|+++.... ..+.+..|+.+++.+ +|++++++++.+.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-----DHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-----CCCchheEEEEEcCCCe
Confidence 357789999999999999998766 8899999974432 456777899988888 66889999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.+++|||+ +++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||++++++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~-------------- 141 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV-------------- 141 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--------------
Confidence 99999999 899999998754333999999999999999999999999999999999999965554
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCc----eeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNY----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~ 326 (433)
++|+|||.+......... ..++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...
T Consensus 142 -------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 142 -------------VKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred -------------EEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 555555554433222111 126788999999988889999999999999999998 88999875
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+... .. ...+...+.++.+++.+|
T Consensus 209 ~~~~~~~~~~~~-----------------------~~-------------------------~~~~~~~~~~~~~~i~~~ 240 (258)
T smart00219 209 SNEEVLEYLKKG-----------------------YR-------------------------LPKPENCPPEIYKLMLQC 240 (258)
T ss_pred CHHHHHHHHhcC-----------------------CC-------------------------CCCCCcCCHHHHHHHHHH
Confidence 554443322110 00 001123567899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013973 407 LRYDPTDRLTAREALR 422 (433)
Q Consensus 407 L~~dP~~R~ta~ell~ 422 (433)
|+.||++|||+.|+++
T Consensus 241 l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 241 WAEDPEDRPTFSELVE 256 (258)
T ss_pred CcCChhhCcCHHHHHh
Confidence 9999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=298.75 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=189.3
Q ss_pred eeeeccccEEEEEEEECC-CC--eEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDRE-RK--EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~-~~--~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
+.||+|++|.||+|.+.. ++ ..||+|.+.... ...+.+..|+.+++++ .|+|++++++.+.. ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-----DHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-----CCCCccceeEEEcC-CeEEEEE
Confidence 468999999999998865 33 369999987433 3455677899998888 66889999999888 8999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +++|.+++.......+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++..........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999 8999999987643468999999999999999999999999999999999999766655555555443321110000
Q ss_pred ccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 335 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i 335 (433)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 155 ---------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 155 ---------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred ---------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 00012346788999999999899999999999999999999 99999876655544332
Q ss_pred HHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC
Q 013973 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 415 (433)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 415 (433)
...... + ..+...+.++.+++.+||+.+|++||
T Consensus 214 ~~~~~~---------------------~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 246 (257)
T cd05040 214 DKEGER---------------------L--------------------------ERPEACPQDIYNVMLQCWAHNPADRP 246 (257)
T ss_pred HhcCCc---------------------C--------------------------CCCccCCHHHHHHHHHHCCCCcccCC
Confidence 210000 0 01123466899999999999999999
Q ss_pred CHHHHhc
Q 013973 416 TAREALR 422 (433)
Q Consensus 416 ta~ell~ 422 (433)
++.++++
T Consensus 247 s~~~~~~ 253 (257)
T cd05040 247 TFAALRE 253 (257)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=300.44 Aligned_cols=244 Identities=20% Similarity=0.265 Sum_probs=184.4
Q ss_pred eeeeccccEEEEEEEECC------------CCeEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 103 SKMGEGTFGQVLECWDRE------------RKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~------------~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
+.||+|+||.||+|.... ....+|+|++..... ....+..|+.++..+ .|+||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-----~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-----SHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec
Confidence 468999999999998532 223589998764322 233455667777766 67999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
....++||||+ +++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++..+
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~--------- 145 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG--------- 145 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccC---------
Confidence 99999999999 788888887543 3689999999999999999999999999999999999997654211
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh-CCCCCCcchhHHHHHHHHHHH-hCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELC-TGEALFQTH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~ell-tg~~Pf~~~ 326 (433)
.....++++|||.+...... ....|+..|+|||++. +..++.++|||||||++|||+ +|..||...
T Consensus 146 -----------~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 146 -----------ECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred -----------CCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 12334889999987654322 2346888999999987 466899999999999999998 588888764
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
...+..... .+.. ......+.++.+||.+|
T Consensus 214 ~~~~~~~~~------------------------~~~~--------------------------~~~~~~~~~~~~li~~c 243 (262)
T cd05077 214 TLAEKERFY------------------------EGQC--------------------------MLVTPSCKELADLMTHC 243 (262)
T ss_pred chhHHHHHH------------------------hcCc--------------------------cCCCCChHHHHHHHHHH
Confidence 432221100 0000 00123356789999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 013973 407 LRYDPTDRLTAREALRH 423 (433)
Q Consensus 407 L~~dP~~R~ta~ell~h 423 (433)
|+.||++||++.+++++
T Consensus 244 l~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 244 MNYDPNQRPFFRAIMRD 260 (262)
T ss_pred cCCChhhCcCHHHHHHh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.62 Aligned_cols=237 Identities=24% Similarity=0.371 Sum_probs=182.8
Q ss_pred eeeccccEEEEEEEEC--CCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 013973 104 KMGEGTFGQVLECWDR--ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 179 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~ 179 (433)
.||+|+||.||+|.+. .++..||+|++.... ...+.+..|+.+++++ .|++++++++.++. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-----DNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEcC-CCeEEEEEe
Confidence 4899999999999765 455679999986432 2345577899999988 66889999998764 578999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccccc
Q 013973 180 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258 (433)
Q Consensus 180 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~ 258 (433)
+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--------------------- 133 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--------------------- 133 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc---------------------
Confidence 9 899999987543 46899999999999999999999999999999999999965554
Q ss_pred CCCCCCEEEEecCCccccCCCCC------ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 013973 259 MPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 331 (433)
Q Consensus 259 ~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~ 331 (433)
+||+|||++........ ...++..|+|||++....++.++|||||||++|||++ |..||......+.
T Consensus 134 ------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 207 (257)
T cd05115 134 ------AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV 207 (257)
T ss_pred ------EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 45555554432221111 1123568999999998889999999999999999996 9999987665443
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+. .+.. .+.+...+.++.++|.+||+.||
T Consensus 208 ~~~~~-----------------------~~~~-------------------------~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 208 MSFIE-----------------------QGKR-------------------------LDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred HHHHH-----------------------CCCC-------------------------CCCCCCCCHHHHHHHHHHcCCCh
Confidence 32221 1100 01123456789999999999999
Q ss_pred CCCCCHHHHhc
Q 013973 412 TDRLTAREALR 422 (433)
Q Consensus 412 ~~R~ta~ell~ 422 (433)
++||++.++++
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05115 240 EDRPNFAKVEE 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=304.77 Aligned_cols=246 Identities=20% Similarity=0.314 Sum_probs=191.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|.+.. ++..||+|++... ......+..|+.+++.+ .|++++++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~iv~~~~~~~~ 79 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DHPNIVKLLGVCAV 79 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-----CCCchheEEEEEcC
Confidence 579999999999999999998753 6788999998643 23345677899998888 67899999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNN--------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 228 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~ 228 (433)
...+++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999 889999997432 124788899999999999999999999999999999
Q ss_pred ceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCc
Q 013973 229 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYP 303 (433)
Q Consensus 229 NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 303 (433)
|||++.++. ++|+|||.+...... .....++..|+|||.+.+..++.+
T Consensus 160 nil~~~~~~---------------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (288)
T cd05050 160 NCLVGENMV---------------------------VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212 (288)
T ss_pred heEecCCCc---------------------------eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch
Confidence 999965554 455555544322111 111234667999999999899999
Q ss_pred chhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccch
Q 013973 304 CDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382 (433)
Q Consensus 304 ~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (433)
+|||||||++|||++ |..||.+....+....+. .+...
T Consensus 213 ~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~-----------------------~~~~~------------------ 251 (288)
T cd05050 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR-----------------------DGNVL------------------ 251 (288)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----------------------cCCCC------------------
Confidence 999999999999998 888997655544332211 11000
Q ss_pred hHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
..+..++.++.+||.+||+.||++|||+.|+++
T Consensus 252 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 252 -------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011245678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=326.23 Aligned_cols=203 Identities=27% Similarity=0.410 Sum_probs=176.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--- 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--- 171 (433)
..+...+.||+|+||.||+++++.+|+.||||.++. .....+.+.+|+++|+++ +|+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-----nh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-----NHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-----CchhhhhhcccCCccccCc
Confidence 347788999999999999999999999999999874 345678889999999999 6899999999876543
Q ss_pred ---eEEEEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 172 ---HICIVFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 172 ---~~~lV~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
...+||||| ||+|...|++.. ...|++.+.+.++.++..||.|||++|||||||||.||++-..+
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge---------- 157 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE---------- 157 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC----------
Confidence 578999999 999999998643 35799999999999999999999999999999999999994322
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhh-CCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+.....||+|||.|+...++. .+++||..|.+||++. .+.|+..+|.|||||++|+++||..||
T Consensus 158 -------------dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF 224 (732)
T KOG4250|consen 158 -------------DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPF 224 (732)
T ss_pred -------------CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCC
Confidence 455678999999999776665 4579999999999999 488999999999999999999999999
Q ss_pred CCCC
Q 013973 324 QTHE 327 (433)
Q Consensus 324 ~~~~ 327 (433)
....
T Consensus 225 ~p~~ 228 (732)
T KOG4250|consen 225 IPFG 228 (732)
T ss_pred CcCC
Confidence 6543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=303.28 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=187.6
Q ss_pred CcE-EEEeeeeccccEEEEEEE----ECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRY-KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~-~~~~~iG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++| ++++.||+|+||+||++. ...+++.||+|+++... .....+..|+++++.+ .|++++++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~ 77 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-----YHENIVKYKGCCSE 77 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec
Confidence 445 999999999999998864 34567889999987432 2455677899999888 67889999988754
Q ss_pred --CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 170 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 170 --~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
...+++||||+ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||+++++
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~---------- 144 (283)
T cd05080 78 QGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR---------- 144 (283)
T ss_pred CCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC----------
Confidence 34689999999 89999999764 599999999999999999999999999999999999996544
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
.++|+|||++....... ....++..|+|||++.+..++.++||||||+++|||++|.
T Consensus 145 -----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 145 -----------------LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred -----------------cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 45555555554332211 1123566799999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||....... ...+....+...... ....+..+ .....+...+.++.
T Consensus 208 ~p~~~~~~~~-~~~~~~~~~~~~~~~-------~~~~~~~~-------------------------~~~~~~~~~~~~~~ 254 (283)
T cd05080 208 DSKQSPPKKF-EEMIGPKQGQMTVVR-------LIELLERG-------------------------MRLPCPKNCPQEVY 254 (283)
T ss_pred CCCCCCcchh-hhhhcccccccchhh-------hhhhhhcC-------------------------CCCCCCCCCCHHHH
Confidence 9986533210 000000000000000 00000000 00011235677899
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q 013973 401 HLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~ 422 (433)
+++.+||+.||++|||++++++
T Consensus 255 ~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 255 ILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.65 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=194.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++|++++.||+|+||.||+|+.+. +.+.||+|.+..... ....+..|+.+++++ .|++++++++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-----SHKNVVRLLGLCRE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-----CCcceeeeEEEECC
Confidence 569999999999999999999754 346799998864322 345678899999988 56889999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNY-------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
....|+||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 99999999999 8999999986542 158999999999999999999999999999999999999766655555
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CC
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 320 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~ 320 (433)
|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 160 ~~~~~~~~~~~~-----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 160 LLSLSKDVYNSE-----------------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred ccccccccCccc-----------------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 555433211000 001122356778999999988889999999999999999999 88
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||...........+ ..+...|+ .+..++..+.
T Consensus 217 ~p~~~~~~~~~~~~~-----------------------~~~~~~~~------------------------~~~~~~~~l~ 249 (275)
T cd05046 217 LPFYGLSDEEVLNRL-----------------------QAGKLELP------------------------VPEGCPSRLY 249 (275)
T ss_pred CCccccchHHHHHHH-----------------------HcCCcCCC------------------------CCCCCCHHHH
Confidence 999765544333221 11111111 1235667899
Q ss_pred HHHHhccccCCCCCCCHHHHhcC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~h 423 (433)
+++.+||+.||++|||+.|++.+
T Consensus 250 ~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 250 KLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHcCCCcccCCCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.08 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=214.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----C
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----R 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-----~ 170 (433)
++.|++.+.||.|.+|.||+++++.+++.+|+||+.......++.+.|..+|+... +|||++.++++|-. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~----~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYS----HHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhcc----CCCCcceEEEEEEEecCCCC
Confidence 35699999999999999999999999999999999877777777888888887763 66889999998853 5
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.++|||||| ||+..|++......++.|+.+..|+.+++.||.|||++.++|||||-.|||++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---------------- 157 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---------------- 157 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----------------
Confidence 7899999999 99999999877778899999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-----CCCCcchhHHHHHHHHHHHhCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~ 321 (433)
.++.|||+|||.+...... ..+.+||+.|||||++... .|+..+|+||||++..||..|.+
T Consensus 158 -----------~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 158 -----------ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred -----------ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 5567888888877654432 3557899999999999753 47889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
|+-+......+-.| ...+|+. ...+...+.++.+
T Consensus 227 Pl~DmHPmraLF~I---pRNPPPk-------------------------------------------Lkrp~kWs~~Fnd 260 (953)
T KOG0587|consen 227 PLCDMHPMRALFLI---PRNPPPK-------------------------------------------LKRPKKWSKKFND 260 (953)
T ss_pred CccCcchhhhhccC---CCCCCcc-------------------------------------------ccchhhHHHHHHH
Confidence 99765544332221 1111111 1123456778999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
||..||.+|-++||+..++|+|||.++..+
T Consensus 261 FIs~cL~Kd~e~RP~~~~ll~hpFi~e~~~ 290 (953)
T KOG0587|consen 261 FISTCLVKDYEQRPSTEELLKHPFITEQPN 290 (953)
T ss_pred HHHHHHhhccccCcchhhhccCCccccccc
Confidence 999999999999999999999999996543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=302.15 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=183.5
Q ss_pred eeeccccEEEEEEEECCC------------------------CeEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCC
Q 013973 104 KMGEGTFGQVLECWDRER------------------------KEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGN 158 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~~~~------------------------~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~ 158 (433)
.||+|+||.||+|....+ ...||+|++..... ....+..|+.+++.+ .|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-----~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-----SHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-----CCC
Confidence 699999999999975321 23589998864322 233455666676666 679
Q ss_pred ceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 159 ~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
||+++++++......++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..+.
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 9999999999999999999999 889988887543 46899999999999999999999999999999999999975432
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~el 316 (433)
.. .....+|++|||.+...... ....++..|+|||.+.+ ..++.++|+|||||++|||
T Consensus 156 ~~--------------------~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 156 AE--------------------GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred cc--------------------CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 11 12345789999977543222 22357888999999875 5689999999999999998
Q ss_pred H-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 317 C-TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 317 l-tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
+ +|..||......+....+.. .. ..+...
T Consensus 215 ~~~g~~p~~~~~~~~~~~~~~~------------------------~~--------------------------~~~~~~ 244 (274)
T cd05076 215 CFDGEVPLKERTPSEKERFYEK------------------------KH--------------------------RLPEPS 244 (274)
T ss_pred HhCCCCCccccChHHHHHHHHh------------------------cc--------------------------CCCCCC
Confidence 5 69999976544332111000 00 011123
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
+.++.++|.+||+.||++|||+.++|++
T Consensus 245 ~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 245 CKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 4578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.36 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=191.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC-------CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
..+|++.+.||+|+||.||+|.+.. .+..||+|+++.. ......+..|+.+++++. .|+||+++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~ 86 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG----KHKNIINLLGA 86 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc----CCCCeeeeeEE
Confidence 3579999999999999999998643 2346999988642 233456778888888773 35789999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+...+.+++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 99999999999999 889999997532 134788899999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.++.+ ||+|||.++...... ....++..|+|||++.+..++.++||
T Consensus 167 l~~~~~~---------------------------kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (334)
T cd05100 167 VTEDNVM---------------------------KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219 (334)
T ss_pred EcCCCcE---------------------------EECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence 9655554 555555443222111 11134567999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|||||++|||++ |..||.+.+..+....+... ...
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----------------------~~~---------------------- 255 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG----------------------HRM---------------------- 255 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------------------CCC----------------------
Confidence 999999999998 89999876654443322110 000
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+...+.++.+|+.+||+.+|++|||+.|++++
T Consensus 256 ----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 256 ----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 0122456689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.19 Aligned_cols=238 Identities=24% Similarity=0.367 Sum_probs=187.5
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
++||+|+||.||+|.+.. ++.||+|++.... .....+..|+.+++++ .|++++++++++......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-----DHPNIVKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeEEEEEEEecCCCeEEEEEcC
Confidence 479999999999999887 8999999886432 2445677888888887 6788999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~----------------------- 130 (251)
T cd05041 75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN----------------------- 130 (251)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-----------------------
Confidence 899999997653 3688999999999999999999999999999999999996544
Q ss_pred CCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 333 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 333 (433)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||..........
T Consensus 131 ----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~ 206 (251)
T cd05041 131 ----VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE 206 (251)
T ss_pred ----cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH
Confidence 45555555554322111 11123567999999998889999999999999999999 889997665433222
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
.+.... .. ..++..+.++.+++.+||+.||++
T Consensus 207 ~~~~~~----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 207 RIESGY----------------------RM--------------------------PAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred HHhcCC----------------------CC--------------------------CCCccCCHHHHHHHHHHhccChhh
Confidence 211100 00 012345678999999999999999
Q ss_pred CCCHHHHhc
Q 013973 414 RLTAREALR 422 (433)
Q Consensus 414 R~ta~ell~ 422 (433)
|||+.|+++
T Consensus 239 Rp~~~ell~ 247 (251)
T cd05041 239 RPSFSEIYN 247 (251)
T ss_pred CcCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=296.25 Aligned_cols=286 Identities=28% Similarity=0.467 Sum_probs=227.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 170 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 170 (433)
+.+-.+.||.|+||+||.+.+..+|+.||+|.+.... ...+.+.+|+..|.-. .|.|++...++.+..
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-----kHdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-----RHDNVLSLLDILQPANPSF 128 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-----ccccHHHHHHhcCCCCchH
Confidence 3455689999999999999999999999999886332 2234556677777666 446677777666543
Q ss_pred -CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 -NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 -~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
..+|+|+|.|..+|...+.+.. .|+.+.+.-+++||++||+|||+.+|.||||||.|+|+++
T Consensus 129 FqEiYV~TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS--------------- 191 (449)
T KOG0664|consen 129 FQELYVLTELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS--------------- 191 (449)
T ss_pred HHHHHHHHHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc---------------
Confidence 3578899999889998887654 7999999999999999999999999999999999999954
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCc----eeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY----IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+..+||||||+++....+... -+-|-.|.|||++.+. .|+.++||||.||++.||+..+..|+
T Consensus 192 ------------NCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 192 ------------NCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred ------------CceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 556777777777765544322 3568899999999986 49999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
..+..+++..|..++|.+..+-.....+.++..+-++...-|+... .+. ...++.-..+..+++.
T Consensus 260 Aq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v-------LYt--------lsS~~~~~heav~~~~ 324 (449)
T KOG0664|consen 260 AAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR-------LYK--------IASPDDKNHEAVDLLQ 324 (449)
T ss_pred ccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc-------eee--------ecCCcccchHHHHHHH
Confidence 9999999999999999999888888877777777665544333110 000 0112234456788999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDHLR 432 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~~~ 432 (433)
++|..||++|.+.++++.|++..+..+|
T Consensus 325 ~~l~~d~dkris~~~A~~~~~~~e~R~r 352 (449)
T KOG0664|consen 325 KLLHFDPDKRISVEEALQHRYLEEGRLR 352 (449)
T ss_pred HHhCCCCcccccHhhhccccccccccee
Confidence 9999999999999999999998766543
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.35 Aligned_cols=266 Identities=22% Similarity=0.335 Sum_probs=190.8
Q ss_pred cEEEEeeeeccccEEEEEEEE----CCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 013973 98 RYKIHSKMGEGTFGQVLECWD----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 170 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~- 170 (433)
.|++++.||+|+||.||+|.. ..++..||+|.++.. ......+..|+.+++.+ .|++++++.+++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-----YHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEecCC
Confidence 479999999999999999974 457888999998633 23345677899999888 678899999988764
Q ss_pred -CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 171 -NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 171 -~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...++||||+ |++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 6789999999 999999997653 3589999999999999999999999999999999999997666555555554433
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
....... . .......|+..|+|||++.+..++.++|||||||++|||+++..|+.....
T Consensus 159 ~~~~~~~---------~------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 159 IETDKEY---------Y------------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred cccCccc---------e------------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 2111000 0 000123467789999999988899999999999999999998876543211
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
......++.+.+.... .....+..+. ..+.+..++.++.+|+.+||+
T Consensus 218 -----~~~~~~~~~~~~~~~~---~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~ 264 (284)
T cd05079 218 -----LFLKMIGPTHGQMTVT---RLVRVLEEGK-------------------------RLPRPPNCPEEVYQLMRKCWE 264 (284)
T ss_pred -----hhhhhcccccccccHH---HHHHHHHcCc-------------------------cCCCCCCCCHHHHHHHHHHcc
Confidence 1111112211110000 0000011110 001123567789999999999
Q ss_pred cCCCCCCCHHHHhcC
Q 013973 409 YDPTDRLTAREALRH 423 (433)
Q Consensus 409 ~dP~~R~ta~ell~h 423 (433)
.||++|||+.+++++
T Consensus 265 ~~p~~Rpt~~~il~~ 279 (284)
T cd05079 265 FQPSKRTTFQNLIEG 279 (284)
T ss_pred CCcccCcCHHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=302.78 Aligned_cols=257 Identities=16% Similarity=0.245 Sum_probs=179.9
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecchhh--HHH-------HHHHHHHHHHHHhcCCCCCceE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKY--REA-------AMIEIEVLQQLAKHDKGGNRCV 161 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~--~~~-------~~~E~~~l~~l~~~~~~~~~i~ 161 (433)
...++|++.+.||+|+||.||+|.+..+ +..+|+|+....... .+. ...++..+..+ ....|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~--~~~~h~~i~ 86 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI--HNIDHLGIP 86 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh--ccCCCCCCC
Confidence 3446899999999999999999998887 677888865321111 000 00111222222 223667888
Q ss_pred EecceeecCC----eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 162 QIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 162 ~~~~~~~~~~----~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
.+++...... ..+++++++..++.+.+.... .+++..+..++.|++.||+|||+.+|+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-- 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-- 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--
Confidence 8887654332 457889988778887776543 46888899999999999999999999999999999999544
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC----------CCCceeecCcccchhhhhCCCCCCcchhH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP----------DQNYIVSTRHYRAPEVILGLGWTYPCDIW 307 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 307 (433)
+.++|+|||+++.... ......||+.|+|||++.+..++.++|||
T Consensus 163 -------------------------~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~Diw 217 (294)
T PHA02882 163 -------------------------NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLE 217 (294)
T ss_pred -------------------------CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHH
Confidence 4566666666543221 11224699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHH
Q 013973 308 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387 (433)
Q Consensus 308 SlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
||||++|||++|..||.+.+........... ++... +..+..
T Consensus 218 SlG~~l~el~~g~~P~~~~~~~~~~~~~~~~------~~~~~--------~~~~~~------------------------ 259 (294)
T PHA02882 218 SLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC------DFIKR--------LHEGKI------------------------ 259 (294)
T ss_pred HHHHHHHHHHhCCCCCCccccchHHHHHhHH------HHHHH--------hhhhhh------------------------
Confidence 9999999999999999876432221111100 00000 001100
Q ss_pred HhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 388 ~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.....+.++.+++..||+.+|++||+..++++
T Consensus 260 ---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 260 ---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11244678999999999999999999999875
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=299.75 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=184.0
Q ss_pred eeeeccccEEEEEEEECCCCe--EEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~--~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|.+..++. .+|+|.++.. ......+..|++++.++. +|++++++++.+...+.+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc----cCCCeeeEEEEEecCCCceEEEE
Confidence 368999999999999988775 4688887632 334456778899888874 45789999999999999999999
Q ss_pred cC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 179 KL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
|+ +++|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~----- 151 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA----- 151 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeE-----
Confidence 99 899999997542 1247899999999999999999999999999999999999655554
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CC
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 320 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~ 320 (433)
||+|||++...... ......+..|+|||++.+..++.++|+|||||++|||++ |.
T Consensus 152 ----------------------kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~ 209 (270)
T cd05047 152 ----------------------KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209 (270)
T ss_pred ----------------------EECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 55555544311110 011123567999999998889999999999999999997 99
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||.+.+..+....+... ... ..+...+.++.
T Consensus 210 ~pf~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~~ 241 (270)
T cd05047 210 TPYCGMTCAELYEKLPQG----------------------YRL--------------------------EKPLNCDDEVY 241 (270)
T ss_pred CCccccCHHHHHHHHhCC----------------------CCC--------------------------CCCCcCCHHHH
Confidence 999765543333221100 000 01123456789
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q 013973 401 HLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~ 422 (433)
+|+.+||+.||.+|||+.+++.
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 242 DLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHcccChhhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=299.07 Aligned_cols=244 Identities=22% Similarity=0.292 Sum_probs=189.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCe----EEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+|++.+.||+|+||.||+|.++.+++ .||+|.+.... .....+..|+.+++.+ .|+|++++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-----DHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEec-
Confidence 569999999999999999999876654 58999886432 2345567788888887 67889999998877
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~----------- 148 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHV----------- 148 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeE-----------
Confidence 7899999999 899999998653 358999999999999999999999999999999999999655554
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCc-----eeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
||+|||.+......... ..++..|+|||.+....++.++|+|||||++||+++ |..||
T Consensus 149 ----------------kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 212 (279)
T cd05057 149 ----------------KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred ----------------EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence 55555544432211110 123567999999988889999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+....+....+... ... ..+...+.++.+++
T Consensus 213 ~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~~~~~ 244 (279)
T cd05057 213 EGIPAVEIPDLLEKG----------------------ERL--------------------------PQPPICTIDVYMVL 244 (279)
T ss_pred CCCCHHHHHHHHhCC----------------------CCC--------------------------CCCCCCCHHHHHHH
Confidence 876554433222110 000 01123456789999
Q ss_pred HhccccCCCCCCCHHHHhc
Q 013973 404 QGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~ 422 (433)
.+||..||.+||++.++++
T Consensus 245 ~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 245 VKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHcCCChhhCCCHHHHHH
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=334.10 Aligned_cols=247 Identities=22% Similarity=0.349 Sum_probs=206.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC-----eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
..+..+.+.||+|+||.||.|....-. ..||||.++.. ......+..|..+|+.+ +||||+++++++-
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-----~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-----DHPNIVSLIGVCL 765 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-----CCcceeeEEEeec
Confidence 456788999999999999999876433 34999998754 55677888999999988 8899999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNN-----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~d 242 (433)
+....+|++||| ||+|..||++.. ...|+..+...++.||++|++||++++.|||||..+|+|++
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~--------- 836 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD--------- 836 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---------
Confidence 999999999999 999999999762 24689999999999999999999999999999999999994
Q ss_pred CcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCce-----eecCcccchhhhhCCCCCCcchhHHHHHHHHHHH
Q 013973 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 317 (433)
+...+||+|||+|+.......+. .-...|||||.+....++.++|||||||++||++
T Consensus 837 ------------------~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 837 ------------------ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred ------------------ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence 45667788888877444433222 1245799999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 318 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 318 t-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
| |..||.+.++.+.+... .+.|+++.| ..++
T Consensus 899 slG~~PY~~~~n~~v~~~~----------------------~~ggRL~~P--------------------------~~CP 930 (1025)
T KOG1095|consen 899 SLGATPYPSRSNFEVLLDV----------------------LEGGRLDPP--------------------------SYCP 930 (1025)
T ss_pred hCCCCCCCCcchHHHHHHH----------------------HhCCccCCC--------------------------CCCC
Confidence 9 89999998887766532 234444433 4678
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
..+.++|..||+.+|++||+...+++
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHh
Confidence 88999999999999999999999886
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=299.46 Aligned_cols=247 Identities=18% Similarity=0.266 Sum_probs=190.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC----CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ......+..|+.+++.+ .|+|++++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-----SHQNILPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEec
Confidence 3679999999999999999999876 3578999988643 23345567788888887 67889999987654
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNY------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
....++++||+ +++|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.++++
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 57889999999 8999999976432 358999999999999999999999999999999999999665555555
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~el 316 (433)
||| +++...... ....++..|+|||++.+..++.++|||||||++||+
T Consensus 160 d~g---------------------------~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el 212 (280)
T cd05043 160 DNA---------------------------LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212 (280)
T ss_pred CCC---------------------------CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHH
Confidence 554 443221111 112356789999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 317 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 317 lt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
++ |..||...+..+....+.. + ..+ ..+..+
T Consensus 213 ~~~g~~p~~~~~~~~~~~~~~~-----------------------~-~~~------------------------~~~~~~ 244 (280)
T cd05043 213 MTLGQTPYVEIDPFEMAAYLKD-----------------------G-YRL------------------------AQPINC 244 (280)
T ss_pred hcCCCCCcCcCCHHHHHHHHHc-----------------------C-CCC------------------------CCCCcC
Confidence 99 9999987655443322111 0 000 011234
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
+.++.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 245 PDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 668899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.46 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=190.0
Q ss_pred eeeeccccEEEEEEEECCCC------eEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 103 SKMGEGTFGQVLECWDRERK------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~------~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.||+|+||.||+|.++... +.+|+|.+.... .....+..|+.+++.+ .|++|+++++++......+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-----NHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-----CCCCeeeEeeeecCCCCeE
Confidence 46899999999999886544 789999876432 3455677888888888 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNN-----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
+||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+++|+||||+||+++.++.
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~----------- 144 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY----------- 144 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCC-----------
Confidence 999999 899999997532 234788999999999999999999999999999999999976541
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
+....++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 145 -----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 145 -----------DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred -----------CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 122356666666654332111 11245678999999999899999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+..+....+... ... ..+...+.++.+|
T Consensus 214 ~~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~~~l 245 (269)
T cd05044 214 YPALNNQEVLQHVTAG----------------------GRL--------------------------QKPENCPDKIYQL 245 (269)
T ss_pred CcccCHHHHHHHHhcC----------------------Ccc--------------------------CCcccchHHHHHH
Confidence 9876655443322110 000 0123456788999
Q ss_pred HHhccccCCCCCCCHHHHhc
Q 013973 403 LQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~ 422 (433)
|.+||+.+|.+||++.++++
T Consensus 246 i~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 246 MTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=292.53 Aligned_cols=238 Identities=24% Similarity=0.348 Sum_probs=185.3
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
++||+|+||.||+|... ++..||+|+++... .....+..|+.+++.+ .|++++++++++...+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-----DHPNIVKLIGVCTQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCCcCeEEEEEecCCccEEEEECC
Confidence 46899999999999865 57789999886432 2334567788888887 6789999999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccC
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~ 259 (433)
+++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~-------------------- 133 (250)
T cd05085 75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLK-------------------- 133 (250)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEE--------------------
Confidence 899999987643 3689999999999999999999999999999999999996655544
Q ss_pred CCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 013973 260 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 334 (433)
Q Consensus 260 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 334 (433)
|+|||++....... ....++..|+|||++.+..++.++|+||||+++|++++ |..||...........
T Consensus 134 -------l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~ 206 (250)
T cd05085 134 -------ISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206 (250)
T ss_pred -------ECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 45555443221111 11234567999999998889999999999999999998 9999987654433222
Q ss_pred HHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCC
Q 013973 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 414 (433)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 414 (433)
+.... . ...+..++.++.+|+.+||+.||++|
T Consensus 207 ~~~~~----------------------~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 207 VEKGY----------------------R--------------------------MSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred HHcCC----------------------C--------------------------CCCCCCCCHHHHHHHHHHcccCcccC
Confidence 11100 0 00123456789999999999999999
Q ss_pred CCHHHHhc
Q 013973 415 LTAREALR 422 (433)
Q Consensus 415 ~ta~ell~ 422 (433)
|++.|+++
T Consensus 239 p~~~~l~~ 246 (250)
T cd05085 239 PKFSELQK 246 (250)
T ss_pred CCHHHHHH
Confidence 99999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=298.11 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=188.0
Q ss_pred CcEEEEeeeeccccEEEEEEE----ECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--c
Q 013973 97 SRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--Y 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--~ 169 (433)
.+|++++.||+|+||.||+|. +..+++.||+|.+.... .....+..|+++++.+ .|+|++++.+.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-----QHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCeeEEEEEEccCC
Confidence 469999999999999999997 34578899999986433 3345677899998888 6788999988754 3
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...+++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+++++.++|+|||++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 45789999999 899999997643 3689999999999999999999999999999999999997666555555555443
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.+..... .. ......++..|+|||++.+..++.++|+|||||++|||++|..|+.....
T Consensus 158 ~~~~~~~---------~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 158 LPQDKEY---------YK------------VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred ccCCCcc---------ee------------ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 3211100 00 00001234569999999988899999999999999999999877654321
Q ss_pred HHHHHHHHHHhCCCCH--HHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 329 LEHLAMMERVLGPLPQ--HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
. .. ...+.... ...... ...+..+. ....+..++.++.+|+.+|
T Consensus 217 ~-~~----~~~~~~~~~~~~~~~~----~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~c 262 (284)
T cd05081 217 E-FM----RMMGNDKQGQMIVYHL----IELLKNNG-------------------------RLPAPPGCPAEIYAIMKEC 262 (284)
T ss_pred h-hh----hhcccccccccchHHH----HHHHhcCC-------------------------cCCCCCCCCHHHHHHHHHH
Confidence 1 11 10111000 000000 00000000 0011235677899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013973 407 LRYDPTDRLTAREALR 422 (433)
Q Consensus 407 L~~dP~~R~ta~ell~ 422 (433)
|+.||++|||+.|+++
T Consensus 263 l~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 263 WNNDPSQRPSFSELAL 278 (284)
T ss_pred ccCChhhCCCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=296.26 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=190.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+|.+.+.||+|+||.||+|.+... ...||||..... ....+.+..|+.+++.+ .|+|++++++++.+ .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-----DHPHIVKLIGVITE-N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCchhceeEEEcC-C
Confidence 5689999999999999999987654 346999988643 23455677888888888 66889999998875 5
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+|||++.++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~------------- 145 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC------------- 145 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC-------------
Confidence 578999999 899999997654 36899999999999999999999999999999999999965554
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 325 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~ 325 (433)
++|+|||++....... ....++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 146 --------------~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 146 --------------VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred --------------eEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 5555555544322211 11134567999999988889999999999999999986 9999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+..+....+... ... ..+..++.++.++|.+
T Consensus 212 ~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~~~li~~ 243 (270)
T cd05056 212 VKNNDVIGRIENG----------------------ERL--------------------------PMPPNCPPTLYSLMTK 243 (270)
T ss_pred CCHHHHHHHHHcC----------------------CcC--------------------------CCCCCCCHHHHHHHHH
Confidence 6655443322110 000 0123456789999999
Q ss_pred ccccCCCCCCCHHHHhcC
Q 013973 406 LLRYDPTDRLTAREALRH 423 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~h 423 (433)
||..+|++|||+.+++..
T Consensus 244 ~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 244 CWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=296.81 Aligned_cols=244 Identities=22% Similarity=0.278 Sum_probs=179.8
Q ss_pred eeeeccccEEEEEEEECC--CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRE--RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~--~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
++||+|+||.||+|.... ....+|+|.+... ......+..|+.+++.+ +|+||+++++.+.....+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-----NHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-----CCCCcceEEEEECCCCceEEEEE
Confidence 368999999999996533 3457899977533 22334566788888776 67899999999999999999999
Q ss_pred cC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 179 KL-GSSLYDFLRKNNY---RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
|+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~------------------ 137 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL------------------ 137 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC------------------
Confidence 99 8999999976432 2356788899999999999999999999999999999996554
Q ss_pred ccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhC-------CCCCCcchhHHHHHHHHHHHh-CCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEA 321 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~ 321 (433)
.+||+|||.+...... .....++..|+|||++.. ..++.++|||||||++|||++ |..
T Consensus 138 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 208 (269)
T cd05042 138 ---------SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208 (269)
T ss_pred ---------cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence 4555555554322111 112245778999999853 356889999999999999999 789
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||....+.+.+...... +...++.. .....++..+.+
T Consensus 209 p~~~~~~~~~~~~~~~~----------------------~~~~~~~~---------------------~~~~~~~~~~~~ 245 (269)
T cd05042 209 PYPDLSDEQVLKQVVRE----------------------QDIKLPKP---------------------QLDLKYSDRWYE 245 (269)
T ss_pred CCCcCCHHHHHHHHhhc----------------------cCccCCCC---------------------cccccCCHHHHH
Confidence 99876655543332111 11111110 011245667888
Q ss_pred HHHhccccCCCCCCCHHHHhc
Q 013973 402 LLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~ 422 (433)
++..|+ .||++|||++||++
T Consensus 246 ~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 246 VMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHh-cCcccccCHHHHHH
Confidence 999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=296.31 Aligned_cols=242 Identities=23% Similarity=0.306 Sum_probs=186.6
Q ss_pred eeeeccccEEEEEEEECCCC----------eEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 103 SKMGEGTFGQVLECWDRERK----------EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~----------~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
+.||+|+||.||+|.+..++ ..+++|++.........+..|+.+++.+ .|++++++++.+.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-----SHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-----CCcchhheeeEEec-CC
Confidence 46899999999999998776 4588888765443356677788888877 67889999998877 77
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.++||||+ +++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.-
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~------------- 140 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN------------- 140 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc-------------
Confidence 89999999 8999999987542 68999999999999999999999999999999999999654410
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC--CCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCT-GEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~ 328 (433)
......+||+|||.+..... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||...+.
T Consensus 141 -------~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 141 -------EGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred -------cCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 01223688888888765433 2234577889999999876 78999999999999999999 5788866542
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+...... .... . +.....++.++|.+||+
T Consensus 213 ~~~~~~~~----------------------~~~~--~--------------------------~~~~~~~~~~li~~~l~ 242 (259)
T cd05037 213 SEKERFYQ----------------------DQHR--L--------------------------PMPDCAELANLINQCWT 242 (259)
T ss_pred hhHHHHHh----------------------cCCC--C--------------------------CCCCchHHHHHHHHHhc
Confidence 22111100 0000 0 01112578999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013973 409 YDPTDRLTAREALR 422 (433)
Q Consensus 409 ~dP~~R~ta~ell~ 422 (433)
.||.+|||+.++++
T Consensus 243 ~~p~~Rpt~~~il~ 256 (259)
T cd05037 243 YDPTKRPSFRAILR 256 (259)
T ss_pred cChhhCCCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.30 Aligned_cols=272 Identities=24% Similarity=0.352 Sum_probs=199.2
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
...+|+.++.||+||||.||+|+++-+|+.||||.+.-. .+......+|+..|.++ +|||||.++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-----nHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-----NHPNVVRYYSAWVESTA 551 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-----CCcceeeeehhhhccCC
Confidence 346789999999999999999999999999999998643 55566778899999999 77888887764421
Q ss_pred --------------------------------------------------------------------------------
Q 013973 170 -------------------------------------------------------------------------------- 169 (433)
Q Consensus 170 -------------------------------------------------------------------------------- 169 (433)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred ----------------------------C--------CeEEEEEecC-CCCHHHHHHhcCCCCC-CHHHHHHHHHHHHHH
Q 013973 170 ----------------------------R--------NHICIVFEKL-GSSLYDFLRKNNYRSF-PIDLVREIARQLLEC 211 (433)
Q Consensus 170 ----------------------------~--------~~~~lV~e~~-~~~L~~~l~~~~~~~l-~~~~~~~i~~qi~~~ 211 (433)
+ ..+||-|||| ...|.++++.+. .. ....+.+++.||+.|
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--FNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--cchhhHHHHHHHHHHHHH
Confidence 0 2478999999 555555665543 22 477889999999999
Q ss_pred HHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC-CCCceeecCccc
Q 013973 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYR 290 (433)
Q Consensus 212 L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~ 290 (433)
|.|+|++|||||||||.||++++++.+||.|||++....... ........+.+.-...+. ..+..+||.-|+
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~-------~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENL-------ESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhh-------hhHhhccCccccccCCCCcccccccceeeee
Confidence 999999999999999999999999999999998876422100 011112222222221222 234568999999
Q ss_pred chhhhhCCC---CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCC
Q 013973 291 APEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 367 (433)
Q Consensus 291 aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 367 (433)
|||++.+.. |+.|+|+||||+|++||+ +||. +.++-...+.. +++|.++.+.
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~--TsMERa~iL~~--------------------LR~g~iP~~~ 837 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFG--TSMERASILTN--------------------LRKGSIPEPA 837 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHh---ccCC--chHHHHHHHHh--------------------cccCCCCCCc
Confidence 999998755 999999999999999997 4575 33333322222 2233333331
Q ss_pred CccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q 013973 368 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
.++..--+.-+.+|++||+.||.+||||.|+|++.||.
T Consensus 838 ----------------------~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 838 ----------------------DFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ----------------------ccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 11223334567899999999999999999999999997
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=296.03 Aligned_cols=244 Identities=19% Similarity=0.226 Sum_probs=179.7
Q ss_pred eeeeccccEEEEEEEEC--CCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
+.||+|+||.||+|... .++..+|+|.++... .....+..|+.+++++ .|+|++++++.+.+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-----QHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEcCCCCcEEEEE
Confidence 46899999999999864 345679999886432 2334567788888888 67899999999999999999999
Q ss_pred cC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 179 KL-GSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
|+ +++|.+++.... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.++++|||+
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~--------- 146 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL--------- 146 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccc---------
Confidence 99 899999997532 12456778889999999999999999999999999999996655555555554
Q ss_pred ccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCC-------CCCCcchhHHHHHHHHHHHh-CCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGL-------GWTYPCDIWSVGCILVELCT-GEA 321 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGv~l~ellt-g~~ 321 (433)
+...... .....|+..|+|||++.+. .++.++|+||||+++|||++ |..
T Consensus 147 ------------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~ 208 (269)
T cd05087 147 ------------------SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ 208 (269)
T ss_pred ------------------cccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCC
Confidence 4321111 1123567889999998642 35789999999999999996 999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||...+..+........ .....+.. ......+..+.+
T Consensus 209 p~~~~~~~~~~~~~~~~----------------------~~~~~~~~---------------------~~~~~~~~~~~~ 245 (269)
T cd05087 209 PYRHLSDEQVLTYTVRE----------------------QQLKLPKP---------------------RLKLPLSDRWYE 245 (269)
T ss_pred CCCCCChHHHHHHHhhc----------------------ccCCCCCC---------------------ccCCCCChHHHH
Confidence 99876554433221110 00000000 001134567889
Q ss_pred HHHhccccCCCCCCCHHHHhc
Q 013973 402 LLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~ 422 (433)
++..|+ .+|++|||++||+.
T Consensus 246 l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 246 VMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHh-cCcccCCCHHHHHH
Confidence 999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=294.50 Aligned_cols=240 Identities=18% Similarity=0.232 Sum_probs=179.3
Q ss_pred eeeeccccEEEEEEEECC---CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-cCCeEEEE
Q 013973 103 SKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIV 176 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~~lV 176 (433)
+.||+|+||.||+|.+.. .+..||+|.+... ....+.+..|+.+++.+ .|++++++++.+. .++..++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-----SHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-----CCCCcceEEEEeecCCCCcEEE
Confidence 468999999999998754 3467999988532 23345666788888776 6788999999654 56678999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+++++.++++|||
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg----------- 143 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFG----------- 143 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcc-----------
Confidence 9999 899999997653 346788889999999999999999999999999999999665555555554
Q ss_pred cccCCCCCCEEEEecCCccccCCC-------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 327 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~ 327 (433)
++...... .....++..|+|||++.+..++.++|||||||++|||++ |.+||...+
T Consensus 144 ----------------~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 144 ----------------LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred ----------------ccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 44322111 112245778999999998899999999999999999999 567776654
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+. .+.. . ..+...+..+.+++.+||
T Consensus 208 ~~~~~~~~~-----------------------~~~~-~------------------------~~~~~~~~~~~~li~~cl 239 (262)
T cd05058 208 SFDITVYLL-----------------------QGRR-L------------------------LQPEYCPDPLYEVMLSCW 239 (262)
T ss_pred HHHHHHHHh-----------------------cCCC-C------------------------CCCCcCCHHHHHHHHHHc
Confidence 433222211 0000 0 001234567899999999
Q ss_pred ccCCCCCCCHHHHhcC
Q 013973 408 RYDPTDRLTAREALRH 423 (433)
Q Consensus 408 ~~dP~~R~ta~ell~h 423 (433)
+.+|++||++.|++..
T Consensus 240 ~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 240 HPKPEMRPTFSELVSR 255 (262)
T ss_pred CCChhhCCCHHHHHHH
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=294.22 Aligned_cols=248 Identities=21% Similarity=0.390 Sum_probs=189.6
Q ss_pred cEEEEeeeeccccEEEEEEEECC-CCeEEEEEEeecch-----------hhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIK-----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~-----------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........|+.++.+. ..|+|++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ----LRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc----CCCCCeeeEEe
Confidence 37889999999999999999987 67889999875211 1122334455555432 26789999999
Q ss_pred eeecCCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccC
Q 013973 166 WFDYRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 166 ~~~~~~~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
.+...+..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+ .||+|+||||+|||+++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~------- 149 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE------- 149 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-------
Confidence 999999999999999 88999987542 22468999999999999999999996 78999999999999954
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg 319 (433)
++.++|+|||.+....... ....|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 150 --------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g 209 (269)
T cd08528 150 --------------------DDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL 209 (269)
T ss_pred --------------------CCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhC
Confidence 4456667777665433221 234688999999999988899999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
..||...........+...... +. .....+.++
T Consensus 210 ~~p~~~~~~~~~~~~~~~~~~~------------------------~~-----------------------~~~~~~~~l 242 (269)
T cd08528 210 QPPFYSTNMLSLATKIVEAVYE------------------------PL-----------------------PEGMYSEDV 242 (269)
T ss_pred CCcccccCHHHHHHHHhhccCC------------------------cC-----------------------CcccCCHHH
Confidence 9999765544333221110000 00 011346689
Q ss_pred HHHHHhccccCCCCCCCHHHHhcC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.+||.+||+.||++||++.|+..+
T Consensus 243 ~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 243 TDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=300.10 Aligned_cols=245 Identities=22% Similarity=0.274 Sum_probs=186.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCe----EEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
++|+..+.||+|+||.||+|.+..+++ .||+|.+.... .....+..|+.+++.+ .|+|++++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-----DHPHLVRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEcCC
Confidence 568999999999999999999887775 47888876432 2233566788888877 678999999988654
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
..++|+||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~------------ 147 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH------------ 147 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc------------
Confidence 567999999 899999987653 36899999999999999999999999999999999999965444
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
+||+|||.+....... ....++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 148 ---------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 148 ---------------VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred ---------------eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 5555555554322111 11245778999999999899999999999999999997 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+....+....+. .+.. .+ .+...+.++.+++
T Consensus 213 ~~~~~~~~~~~~~-----------------------~~~~-~~------------------------~~~~~~~~~~~li 244 (303)
T cd05110 213 DGIPTREIPDLLE-----------------------KGER-LP------------------------QPPICTIDVYMVM 244 (303)
T ss_pred CCCCHHHHHHHHH-----------------------CCCC-CC------------------------CCCCCCHHHHHHH
Confidence 7654333222111 1000 00 0123456789999
Q ss_pred HhccccCCCCCCCHHHHhcC
Q 013973 404 QGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~h 423 (433)
.+||..||++||++.++++.
T Consensus 245 ~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 245 VKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=292.09 Aligned_cols=259 Identities=21% Similarity=0.353 Sum_probs=201.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++.+-+..||.|+||+|++-.++.+|+..|||.++... +...++..|.+...+- .+.++||++++..-.++..+
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks----~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS----SNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh----cCCcHHHHHhhhhhcCCcee
Confidence 34566789999999999999999999999999998543 4555666677665543 36688999999988899999
Q ss_pred EEEecCCCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 175 IVFEKLGSSLYDF---LRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 175 lV~e~~~~~L~~~---l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
|.||+|..+|..+ +.......+++...-.|+.-.+.||.||.+ ..||||||||+|||+
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl------------------ 201 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL------------------ 201 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE------------------
Confidence 9999997776543 333334579999999999999999999985 579999999999999
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
+..+.+||||||++...... .+.-+|...|||||.+.. .+|+.+||+||||++|||+.||..||.+-
T Consensus 202 ---------dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 202 ---------DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred ---------ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 55667888888887654332 233479999999999974 45999999999999999999999999864
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+. .+.++......-|+.+.. +. .--+++..+..||.-|
T Consensus 273 ~s--vfeql~~Vv~gdpp~l~~-----------------~~-----------------------~~~~~s~~~~~fintC 310 (361)
T KOG1006|consen 273 DS--VFEQLCQVVIGDPPILLF-----------------DK-----------------------ECVHYSFSMVRFINTC 310 (361)
T ss_pred HH--HHHHHHHHHcCCCCeecC-----------------cc-----------------------cccccCHHHHHHHHHH
Confidence 33 444444443222221100 00 0014677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|.+|-..||...+++.+||+..
T Consensus 311 l~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 311 LIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred hhcccccCcchhhhhcCchhhh
Confidence 9999999999999999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=294.24 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=190.7
Q ss_pred CcEEEEeeeeccccEEEEEEEEC----CCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY- 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~- 169 (433)
..|++.+.||+|+||.||+|... .+++.||+|+++.... ....+..|+.+++.+ .|++++++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-----~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-----DHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-----CCCChheEEeeeecC
Confidence 45888999999999999999864 3478999999975443 356778899888887 56889999998876
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
....++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+|+||||+||+++.+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~------------ 145 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE------------ 145 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC------------
Confidence 66899999999 899999997654 359999999999999999999999999999999999999554
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCC------ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
+.++|+|||.+........ ...++..|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 146 ---------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~ 210 (284)
T cd05038 146 ---------------DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210 (284)
T ss_pred ---------------CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence 4556666665554332111 1134567999999998899999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCC-HHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLP-QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
||........ ...+... ......... .+..+. . ...+..++.++.
T Consensus 211 p~~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~-~------------------------~~~~~~~~~~~~ 256 (284)
T cd05038 211 PSQSPPAEFL-----RMIGIAQGQMIVTRLLE----LLKEGE-R------------------------LPRPPSCPDEVY 256 (284)
T ss_pred Ccccccchhc-----cccccccccccHHHHHH----HHHcCC-c------------------------CCCCccCCHHHH
Confidence 9865332110 0001000 000000000 000000 0 001124457899
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q 013973 401 HLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~ 422 (433)
+|+.+||+.||++|||+.|+++
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 257 DLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.40 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=209.3
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
..+...+.++||+|-||.|.+|... .+..||+|+++.. +..+..+..|+++|.++ .||||+.+++.|..++.
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-----khPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRL-----KHPNIVELLGVCVQDDP 609 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhcc-----CCCCeeEEEeeeecCCc
Confidence 3567889999999999999999864 3688999999843 34567889999999999 66999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+++||| .|+|.+||.......+......+|+.||++|++||.+.++|||||.+.|+|+
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv------------------- 670 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV------------------- 670 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee-------------------
Confidence 99999999 9999999988753344556677899999999999999999999999999999
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCc-----eeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh--CCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT--GEALFQ 324 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~Pf~ 324 (433)
+++.++||+|||.++....+..+ .+-...|||+|.+.-.+++.++|+|+||+++||+++ ...||.
T Consensus 671 --------~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 671 --------DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred --------cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 66777888888887755544433 344788999999999999999999999999999865 679998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
...+.+........+...+.. .+...+..++..+.++|.
T Consensus 743 ~lt~e~vven~~~~~~~~~~~-----------------------------------------~~l~~P~~cp~~lyelml 781 (807)
T KOG1094|consen 743 QLTDEQVVENAGEFFRDQGRQ-----------------------------------------VVLSRPPACPQGLYELML 781 (807)
T ss_pred hhhHHHHHHhhhhhcCCCCcc-----------------------------------------eeccCCCcCcHHHHHHHH
Confidence 877776665544443322211 112235577888999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.||.+|-++||+.+++ |-+|++
T Consensus 782 ~Cw~~es~~RPsFe~l--h~~lq~ 803 (807)
T KOG1094|consen 782 RCWRRESEQRPSFEQL--HLFLQE 803 (807)
T ss_pred HHhchhhhcCCCHHHH--HHHHHH
Confidence 9999999999999998 434443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=289.46 Aligned_cols=244 Identities=21% Similarity=0.228 Sum_probs=178.2
Q ss_pred eeeeccccEEEEEEEECCC--CeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRER--KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~--~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
++||+|+||.||+|....+ ...+++|.++... ...+.+..|+.+++.+ .|+|++++++.+......|+|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-----QHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-----CCcchhheEEEecCCCccEEEEe
Confidence 3699999999999975433 2346777765332 3445677788877776 67899999999999999999999
Q ss_pred cC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 179 KL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|+ +++|.+++.+.. ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~------------------ 137 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT------------------ 137 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc------------------
Confidence 99 899999997642 234677788899999999999999999999999999999965554
Q ss_pred cccCCCCCCEEEEecCCccccCC-----CCCceeecCcccchhhhhC-------CCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
++|+|||++..... .....+|+..|+|||++.. ..++.++|||||||++|||++ |..|
T Consensus 138 ---------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 208 (268)
T cd05086 138 ---------VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208 (268)
T ss_pred ---------EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence 55555554432111 1123467889999999853 245789999999999999997 5789
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+..+.+..+..... ...+. ......++..+.++
T Consensus 209 ~~~~~~~~~~~~~~~~~~----------------------~~~~~---------------------~~~~~~~~~~~~~l 245 (268)
T cd05086 209 YSHLSDREVLNHVIKDQQ----------------------VKLFK---------------------PQLELPYSERWYEV 245 (268)
T ss_pred CCCCCHHHHHHHHHhhcc----------------------cccCC---------------------CccCCCCcHHHHHH
Confidence 977666554443221100 00000 00112356678899
Q ss_pred HHhccccCCCCCCCHHHHhc
Q 013973 403 LQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~ 422 (433)
+..|| .+|++||++.|+++
T Consensus 246 ~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 246 LQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHh-hCcccCCCHHHHHH
Confidence 99999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=306.84 Aligned_cols=271 Identities=22% Similarity=0.376 Sum_probs=183.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC----------------CCCeEEEEEEeecchh-hH--------------HHHHHHH
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR----------------ERKEMVAIKIVRGIKK-YR--------------EAAMIEI 144 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~----------------~~~~~vAiK~~~~~~~-~~--------------~~~~~E~ 144 (433)
.++|++.++||+|+||.||+|... ..++.||||.++.... .. +....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 468999999999999999999752 2346799999863221 11 1223466
Q ss_pred HHHHHHHhcCCCCCceEEecceeec--------CCeEEEEEecC-CCCHHHHHHhcCC----------------------
Q 013973 145 EVLQQLAKHDKGGNRCVQIRNWFDY--------RNHICIVFEKL-GSSLYDFLRKNNY---------------------- 193 (433)
Q Consensus 145 ~~l~~l~~~~~~~~~i~~~~~~~~~--------~~~~~lV~e~~-~~~L~~~l~~~~~---------------------- 193 (433)
..+.++.++...+.+++.+++++.. .+..+|||||+ +++|.++|+....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 6666776655445567777777643 35789999999 8999999874311
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCc
Q 013973 194 RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273 (433)
Q Consensus 194 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 273 (433)
..+++..++.++.|++.||.|||+.+|+||||||+|||++. +..+||+|||++
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~---------------------------~~~~kL~DFGla 356 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---------------------------DGQVKIIDFGAA 356 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC---------------------------CCcEEEEeCcCc
Confidence 12466788899999999999999999999999999999954 445677777766
Q ss_pred cccCCCC----CceeecCcccchhhhhCCC--------------------CC--CcchhHHHHHHHHHHHhCCC-CCCCC
Q 013973 274 TYERPDQ----NYIVSTRHYRAPEVILGLG--------------------WT--YPCDIWSVGCILVELCTGEA-LFQTH 326 (433)
Q Consensus 274 ~~~~~~~----~~~~gt~~y~aPE~~~~~~--------------------~~--~~~DvwSlGv~l~elltg~~-Pf~~~ 326 (433)
....... ....+|+.|+|||.+.... |+ .+.|+||+||++|+|++|.. ||...
T Consensus 357 ~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 357 VDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred cccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 5432211 1123488999999986422 22 34799999999999999975 77543
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
...... + ..... .... .+. +....+.++ ..+..+....||+.+|
T Consensus 437 ~~f~~~--~-~~~~~----~~~~----~r~-~~~~~~~~~------------------------~~d~~s~~~~dLi~~L 480 (507)
T PLN03224 437 RLFNTE--L-RQYDN----DLNR----WRM-YKGQKYDFS------------------------LLDRNKEAGWDLACKL 480 (507)
T ss_pred hhhhhH--H-hhccc----hHHH----HHh-hcccCCCcc------------------------cccccChHHHHHHHHH
Confidence 211100 0 00000 0000 000 011111111 1345678899999999
Q ss_pred cccCC---CCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDP---TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP---~~R~ta~ell~hp~f~~~ 429 (433)
|.++| .+|+|++|+|+||||..+
T Consensus 481 L~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 481 ITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred hccCCCCcccCCCHHHHhCCCCcCCC
Confidence 99876 689999999999999754
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=290.56 Aligned_cols=245 Identities=18% Similarity=0.249 Sum_probs=184.6
Q ss_pred EEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 013973 99 YKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 171 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 171 (433)
|.+.+.||+|+||.||+|.+. .+++.||||++... ....+.+..|+.+++.+ .|++++++++.+....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-----DHPNVIKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-----CCCCcceEEEEEccCCC
Confidence 567889999999999999865 35788999998642 23345567788888888 6788999999775432
Q ss_pred -----eEEEEEecC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 172 -----HICIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 172 -----~~~lV~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
..++++||+ +++|.+++.... ...+++..+..++.||+.||+|||+.||+||||||+||++++++
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~----- 150 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM----- 150 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-----
Confidence 347889999 899998875322 12578999999999999999999999999999999999995544
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~el 316 (433)
.+||+|||.++...... ....++..|++||.+.+..++.++|||||||++|+|
T Consensus 151 ----------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el 208 (273)
T cd05074 151 ----------------------TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208 (273)
T ss_pred ----------------------CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence 45555555554322111 122456789999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 317 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 317 lt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
++ |.+||.+.+..+....+.. ...+. .+...
T Consensus 209 ~~~g~~p~~~~~~~~~~~~~~~----------------------~~~~~--------------------------~~~~~ 240 (273)
T cd05074 209 MTRGQTPYAGVENSEIYNYLIK----------------------GNRLK--------------------------QPPDC 240 (273)
T ss_pred hhCCCCCCCCCCHHHHHHHHHc----------------------CCcCC--------------------------CCCCC
Confidence 99 8999976654433222111 00000 01234
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
+..+.+++.+||+.+|++||++.+++++
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=303.28 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=213.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
..+.....+||-|-||.||.|+++.-.-.||||.++......+++..|..+|+.| .|+|+|++++.|..+..+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-----kHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-----cCccHHHHhhhhccCCCeEE
Confidence 4456778899999999999999999999999999998888889999999999999 77999999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
|+||| .|+|.+||+..++.-++.-..+.++.||.+|++||..+++|||||...|+|+
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---------------------- 398 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---------------------- 398 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc----------------------
Confidence 99999 9999999999887788888899999999999999999999999999999999
Q ss_pred ccccCCCCCCEEEEecCCccccCCCCCc-eee---cCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQNY-IVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-~~g---t~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.++..+|++|||+++....+..+ ..| ..-|.|||-+.-..++.++|||+|||+|||+.| |..||.+.+-.
T Consensus 399 -----gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 399 -----GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred -----cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 67778899999999877655433 233 567999999999999999999999999999998 99999987765
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+.+ | .-++.+..+++...+|++.||++
T Consensus 474 qVY~LLEk-----------------------g-------------------------yRM~~PeGCPpkVYeLMraCW~W 505 (1157)
T KOG4278|consen 474 QVYGLLEK-----------------------G-------------------------YRMDGPEGCPPKVYELMRACWNW 505 (1157)
T ss_pred HHHHHHhc-----------------------c-------------------------ccccCCCCCCHHHHHHHHHHhcC
Confidence 55543221 1 11223457888999999999999
Q ss_pred CCCCCCCHHHH
Q 013973 410 DPTDRLTAREA 420 (433)
Q Consensus 410 dP~~R~ta~el 420 (433)
+|.+||+.+|+
T Consensus 506 sPsDRPsFaei 516 (1157)
T KOG4278|consen 506 SPSDRPSFAEI 516 (1157)
T ss_pred CcccCccHHHH
Confidence 99999998876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=292.15 Aligned_cols=324 Identities=24% Similarity=0.382 Sum_probs=222.3
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECC---CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+.+.|.++++||+|+|++||+|.+.. .++.||+|.+... ........|++.|..+. ++.||+.+.+.+..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~g----G~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLG----GSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhc----cchhhhcchhhhccCC
Confidence 34669999999999999999999887 7889999998743 34456888999999885 4567999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeecc-CccccCCCcCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLHT 249 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~-~~~~i~dfg~~~~~ 249 (433)
.+++||||+ .....+++. .++..+++.|+..++.||.++|.+|||||||||+|+|.+.. +...|.|||++.+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 999999999 667777765 37789999999999999999999999999999999999764 77889999998732
Q ss_pred CCCC-c-cccc------CC-CCCCEEEEec-------CCcc---ccCCC-CCceeecCcccchhhhhCCC-CCCcchhHH
Q 013973 250 PKDS-S-YFKR------MP-KSSAIKVIDF-------GSTT---YERPD-QNYIVSTRHYRAPEVILGLG-WTYPCDIWS 308 (433)
Q Consensus 250 ~~~~-~-~~~~------~~-~~~~~kl~Df-------g~a~---~~~~~-~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS 308 (433)
.... . .... .. ....+....+ |..+ ...+. .....||++|.|||++...+ .++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1110 0 0000 00 0000000000 0000 00000 12247999999999998654 689999999
Q ss_pred HHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhh----ccc-h
Q 013973 309 VGCILVELCTGEALF-QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV----MKL-P 382 (433)
Q Consensus 309 lGv~l~elltg~~Pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~ 382 (433)
.||+++.++++.+|| ...++.+.+.++..++|...-.-....-.. -.++++ -..+....-+-.+... +.- .
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~-~~l~~k--sn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGR-ILLWQK--SNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCc-eeeecc--ccccccHHHHhchhccChhhccccc
Confidence 999999999999998 455677788888888887432211111100 001110 0011111000011111 000 0
Q ss_pred hHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
..-.......+.++..+.||+.+||..||.+|.||+++|+||||...++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 0001223345667778999999999999999999999999999986543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=292.66 Aligned_cols=260 Identities=24% Similarity=0.449 Sum_probs=201.9
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhh--------HHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--------REAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--------~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
.+.++|-++.+||+|||+.||+|.+...++.||+|+-.-.+.+ .+-..+|..|-+.| .|+.||++|+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-----DHpRIVKlYD 534 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-----DHPRIVKLYD 534 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-----Ccceeeeeee
Confidence 4567899999999999999999999999999999986433322 23344566665555 8899999999
Q ss_pred eee-cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccC
Q 013973 166 WFD-YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 166 ~~~-~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~ 241 (433)
+|. +.+.+|-|+||| |.+|.-||.... .+++.+++.|+.||+.||.||.+.. |||-||||.|||+.+.
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G------ 606 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG------ 606 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC------
Confidence 986 567899999999 888888887764 8999999999999999999999865 9999999999999542
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC----------CceeecCcccchhhhhCC----CCCCcchhH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGL----GWTYPCDIW 307 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~~Dvw 307 (433)
...+.+||.|||++.....+. +...||.+|++||.+.-. ..+.++|||
T Consensus 607 ------------------tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVW 668 (775)
T KOG1151|consen 607 ------------------TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVW 668 (775)
T ss_pred ------------------cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeE
Confidence 345667777777776554432 234799999999988643 367899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHH
Q 013973 308 SVGCILVELCTGEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386 (433)
Q Consensus 308 SlGv~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
|+|||+|..+.|+-||...-.. +++.. ..+ +......+|.
T Consensus 669 SvGVIFyQClYGrKPFGhnqsQQdILqe-NTI-------------------lkAtEVqFP~------------------- 709 (775)
T KOG1151|consen 669 SVGVIFYQCLYGRKPFGHNQSQQDILQE-NTI-------------------LKATEVQFPP------------------- 709 (775)
T ss_pred eeehhhhhhhccCCCCCCchhHHHHHhh-hch-------------------hcceeccCCC-------------------
Confidence 9999999999999999643222 22211 110 1111222222
Q ss_pred HHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 387 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
-+..+.++++||++||++.-++|....|+-.||+|--
T Consensus 710 -----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 710 -----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred -----CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1356778999999999999999999999999999965
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=305.72 Aligned_cols=246 Identities=23% Similarity=0.340 Sum_probs=211.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCC---eEEEEEEeec--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~---~~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+...|.++||.|.||.|++|+.+..+ ..||||.++. ..+.+..+..|..||.++ .||||+.+.+......
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-----dHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-----DHPNIIRLEGVVTKSK 703 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-----CCCcEEEEEEEEecCc
Confidence 34678899999999999999998766 4699999984 456778899999999998 8899999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+.||.||| +|+|..||+++.+ .|++.+...+++.|+.|++||-++|+|||||...|||+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV------------------ 764 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV------------------ 764 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee------------------
Confidence 999999999 9999999998874 59999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCc----eee--cCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY----IVS--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~g--t~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
+.+..+|++|||+++...++... ..| ...|.|||.|...+++.+|||||||++|||.++ |..||
T Consensus 765 ---------NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 765 ---------NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred ---------ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 55667788888887765444311 122 467999999999999999999999999999888 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
=+.++.+.+..|.+...-+| +..++..+..|+
T Consensus 836 WdmSNQdVIkaIe~gyRLPp------------------------------------------------PmDCP~aL~qLM 867 (996)
T KOG0196|consen 836 WDMSNQDVIKAIEQGYRLPP------------------------------------------------PMDCPAALYQLM 867 (996)
T ss_pred cccchHHHHHHHHhccCCCC------------------------------------------------CCCCcHHHHHHH
Confidence 88888887777655433222 347788999999
Q ss_pred HhccccCCCCCCCHHHHhcC
Q 013973 404 QGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~h 423 (433)
..||++|-.+||...|++.+
T Consensus 868 ldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=282.39 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=202.8
Q ss_pred eeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 88 MFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 88 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
++-....+..+..+++.||+|.||.||+|..+ |+.||||++... ....+.+|.+|.+.+.. .|+||+.+++..
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmL---RHENILgFIaaD 274 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--DERSWFRETEIYQTVML---RHENILGFIAAD 274 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc--chhhhhhHHHHHHHHHh---ccchhhhhhhcc
Confidence 34444456778999999999999999999774 677999999743 34667788898888755 678899998876
Q ss_pred ecC----CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-----CC---ceeccCCCCceEeec
Q 013973 168 DYR----NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-----LC---MIHTDLKPENVLLVS 234 (433)
Q Consensus 168 ~~~----~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~---ivHrDlKp~NILl~~ 234 (433)
..+ ..++||.+|- .|+|+|||... .++.+...+++..++.||+|||- +| |.|||||..|||+..
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 543 3689999999 99999999875 69999999999999999999994 23 999999999999977
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCC----C--CCcchhHH
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG----W--TYPCDIWS 308 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwS 308 (433)
+|..-|+|+|++...+.+.. .+|. ..+..+||..|||||++...- + -..+||||
T Consensus 352 n~~C~IADLGLAv~h~~~t~------------~idi--------~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTD------------TIDI--------PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred CCcEEEeeceeeEEecccCC------------cccC--------CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 66666666665554433221 1111 123458999999999997532 1 25689999
Q ss_pred HHHHHHHHHhCC----------CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhh
Q 013973 309 VGCILVELCTGE----------ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 378 (433)
Q Consensus 309 lGv~l~elltg~----------~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (433)
||+++||++... +|| +++.+...+.+.+..+
T Consensus 412 fgLVlWEiarRc~~ggi~eey~~Py---------------------------------------yd~Vp~DPs~eeMrkV 452 (513)
T KOG2052|consen 412 FGLVLWEIARRCESGGIVEEYQLPY---------------------------------------YDVVPSDPSFEEMRKV 452 (513)
T ss_pred HHHHHHHHHHHhhcCCEehhhcCCc---------------------------------------ccCCCCCCCHHHHhcc
Confidence 999999998642 333 2455556677788888
Q ss_pred ccchhHHHHHhhhcCCch--hHHHHHHHhccccCCCCCCCHHHHh
Q 013973 379 MKLPRLQNLIMQHVDHSA--GDLTHLLQGLLRYDPTDRLTAREAL 421 (433)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~ta~ell 421 (433)
+...+++..+...+...+ ..+..+++.||..||.-|.||-.+.
T Consensus 453 VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 453 VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 888887777666665544 4567899999999999999986553
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=290.14 Aligned_cols=242 Identities=22% Similarity=0.359 Sum_probs=196.4
Q ss_pred cEEEEeeeeccccEEEEEEEECCC----CeEEEEEEeec--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRER----KEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~----~~~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
...+.++||.|-||.||+|....- .-.||||..+. .....+.+..|..+++++ .||||+++++.+.+ .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-----dHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-----DHPHIIKLIGVCVE-Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-----CCcchhheeeeeec-c
Confidence 455668999999999999986432 34599998874 334577889999999998 88999999999875 5
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..+||||.+ -|.|..||+.+. ..|+.....-|+.||+.||.|||+...|||||...|||+.+..
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-------------- 528 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-------------- 528 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--------------
Confidence 689999999 899999999765 4799999999999999999999999999999999999996544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCce----eecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 325 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~ 325 (433)
.+||+|||+++...++..+. .-..-|||||-+.-.+++.++|||-|||++||++. |..||.+
T Consensus 529 -------------CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 529 -------------CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred -------------eeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 46666666666655544221 22557999999999999999999999999999987 9999998
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
..+.+.... +++|.. .+.++.+++.+..|+.+
T Consensus 596 vkNsDVI~~-----------------------iEnGeR-------------------------lP~P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 596 VKNSDVIGH-----------------------IENGER-------------------------LPCPPNCPPALYSLMSK 627 (974)
T ss_pred ccccceEEE-----------------------ecCCCC-------------------------CCCCCCCChHHHHHHHH
Confidence 776554433 233311 12456889999999999
Q ss_pred ccccCCCCCCCHHHHh
Q 013973 406 LLRYDPTDRLTAREAL 421 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell 421 (433)
||.+||.+||...|+.
T Consensus 628 cWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 628 CWAYEPSKRPRFTEIK 643 (974)
T ss_pred HhccCcccCCcHHHHH
Confidence 9999999999987664
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=285.64 Aligned_cols=258 Identities=23% Similarity=0.278 Sum_probs=188.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC----e
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----H 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~ 172 (433)
...++.+.||+|.||.||+|.. +++.||||++. ...++.+..|.+|...... .|+||+++++.-+-.. .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp--~~~kqs~~~Ek~Iy~lp~m---~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP--EQEKQSFQNEKNIYSLPGM---KHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecC--HHHHHHHHhHHHHHhccCc---cchhHHHhhchhccCCccccc
Confidence 4578889999999999999976 45899999997 4556778889888876633 6789999998766544 8
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---------CCceeccCCCCceEeeccCccccCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD---------LCMIHTDLKPENVLLVSSEYIKVPD 242 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---------~~ivHrDlKp~NILl~~~~~~~i~d 242 (433)
+.||++|. .|+|.+||..+ .++|....+++..+++||+|||+ .+|+|||||..|||+.+|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl------ 353 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL------ 353 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC------
Confidence 99999999 99999999886 59999999999999999999996 3599999999999996555
Q ss_pred CcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCC-C-----CCcchhHHHHH
Q 013973 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG-W-----TYPCDIWSVGC 311 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwSlGv 311 (433)
...|+|||+|....+.. ...+||..|||||++.+.- + -.+.||||+|.
T Consensus 354 ---------------------TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL 412 (534)
T KOG3653|consen 354 ---------------------TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL 412 (534)
T ss_pred ---------------------cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence 45555555554433322 2258999999999998742 2 25789999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH--HHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQ--HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
+||||++...-+......++..-....+|..|. ++...+. ..+++..+|+....
T Consensus 413 VLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV------~kK~RP~~p~~W~~------------------ 468 (534)
T KOG3653|consen 413 VLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVV------RKKQRPKIPDAWRK------------------ 468 (534)
T ss_pred HHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHH------hhccCCCChhhhhc------------------
Confidence 999999987666433333333334444555442 1111110 01122222221100
Q ss_pred hhcCCchhHHHHHHHhccccCCCCCCCHH
Q 013973 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAR 418 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~~dP~~R~ta~ 418 (433)
.....-+++.+..||+.||+.|+||.
T Consensus 469 ---h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 469 ---HAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred ---CccHHHHHHHHHHHcCCchhhhhhhH
Confidence 12234589999999999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=305.97 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=190.5
Q ss_pred EEEEeeeeccccEE-EEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 99 YKIHSKMGEGTFGQ-VLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 99 ~~~~~~iG~G~~g~-V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
|.-.+.+|.|+.|+ ||+|.. .|+.||||.+- ....+.+.+|+..|+.- ..|+||++.++.-.+..+.||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll--~e~~~~A~rEi~lL~eS----D~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL--EEFFDFAQREIQLLQES----DEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh--hHhHHHHHHHHHHHHhc----cCCCceEEEEeeccCCceEEEEe
Confidence 44457899999887 799976 56789999774 34456677899888765 36789999999999999999999
Q ss_pred ecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 178 EKLGSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 178 e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|.|..+|.++++... .........+.+..|++.||+|||+.+||||||||.||||....
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~------------------- 643 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS------------------- 643 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC-------------------
Confidence 999999999998741 11112245678899999999999999999999999999996521
Q ss_pred cccCCCCCCEEEEecCCccccCCCCC------ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCh
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHEN 328 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~Pf~~~~~ 328 (433)
.+....++|+|||++.....+.+ ...||-+|+|||++....-+.++||+||||++|+.++| ..||...-.
T Consensus 644 ---~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 644 ---ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred ---CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 03445677777777765554432 34699999999999998888899999999999999996 899975322
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+ ..| ..|..+ ...+. +....++.|||.+||+
T Consensus 721 R~--~NI-----------------------l~~~~~----------------L~~L~-------~~~d~eA~dLI~~ml~ 752 (903)
T KOG1027|consen 721 RQ--ANI-----------------------LTGNYT----------------LVHLE-------PLPDCEAKDLISRMLN 752 (903)
T ss_pred hh--hhh-----------------------hcCccc----------------eeeec-------cCchHHHHHHHHHhcC
Confidence 11 110 111110 00000 0111178999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+|..||+|.+||.||||=..
T Consensus 753 ~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 753 PDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred CCcccCCCHHHHhCCCccCCh
Confidence 999999999999999999544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=269.01 Aligned_cols=238 Identities=36% Similarity=0.597 Sum_probs=189.4
Q ss_pred ccEEEEEEEECCCCeEEEEEEeecchhh--HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CCCHH
Q 013973 109 TFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY 185 (433)
Q Consensus 109 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~ 185 (433)
+||.||+|....+++.+|+|++...... .+.+..|+..++.+ .|++++++.+.+......++|||++ +++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-----KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-----CCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999999988999999998643221 46777888888888 6688999999999999999999999 66999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCE
Q 013973 186 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265 (433)
Q Consensus 186 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~ 265 (433)
+++.... .+++..+..++.+++.+|.|||+.+|+|+||+|+||+++. ++.+
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~---------------------------~~~~ 126 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE---------------------------DGHV 126 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC---------------------------CCcE
Confidence 9997754 3899999999999999999999999999999999999954 3456
Q ss_pred EEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Q 013973 266 KVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE-HLAMMERVLGPL 342 (433)
Q Consensus 266 kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~ 342 (433)
+|+|||.+...... .....|+..|++||.+.+..++.++|+||||+++|+|++|..||......+ ....+.
T Consensus 127 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~------ 200 (244)
T smart00220 127 KLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG------ 200 (244)
T ss_pred EEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh------
Confidence 66777766544332 233468889999999998889999999999999999999999997733322 222111
Q ss_pred CHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 343 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.+...... ....++.++.+++.+||..||++||++.++++
T Consensus 201 -----------------~~~~~~~~-----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 201 -----------------KPKPPFPP-----------------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -----------------ccCCCCcc-----------------------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11000000 00015668999999999999999999999999
Q ss_pred CCCC
Q 013973 423 HPFF 426 (433)
Q Consensus 423 hp~f 426 (433)
||||
T Consensus 241 ~~~~ 244 (244)
T smart00220 241 HPFF 244 (244)
T ss_pred CCCC
Confidence 9997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=291.33 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=199.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC-C--eEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER-K--EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~-~--~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
++..+.++||+|.||.|++|.+... | ..||||+++... .....+.+|+.+|.++ .|+|++++|+...+ .
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-----~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-----QHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-----cCcceeEEeeeecc-c
Confidence 3467889999999999999988643 2 358999997432 2467789999999998 77899999999887 7
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+.||||++ .|+|.+.|++-....|.......|+.||+.|+.||.++++|||||...|||+.+...
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt------------- 250 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT------------- 250 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce-------------
Confidence 788999999 999999999855567899999999999999999999999999999999999965444
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCcee------ecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV------STRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~------gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
+||+|||+.+-.......++ -...|+|||.+....++.++|||+|||++|||++ |..||
T Consensus 251 --------------VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 251 --------------VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred --------------eeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 55555555554433332221 2457999999999999999999999999999999 88999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+....+++..|.+. ..+ ..+..++.++.+++
T Consensus 317 ~G~~g~qIL~~iD~~----------------------erL--------------------------pRPk~csedIY~im 348 (1039)
T KOG0199|consen 317 VGCRGIQILKNIDAG----------------------ERL--------------------------PRPKYCSEDIYQIM 348 (1039)
T ss_pred CCCCHHHHHHhcccc----------------------ccC--------------------------CCCCCChHHHHHHH
Confidence 999888777654311 111 12457889999999
Q ss_pred HhccccCCCCCCCHHHHhc
Q 013973 404 QGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~ 422 (433)
..||..+|.+|||...|.+
T Consensus 349 k~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 349 KNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHhccCCccccccHHHHHH
Confidence 9999999999999887753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=287.35 Aligned_cols=197 Identities=28% Similarity=0.486 Sum_probs=174.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHH---------HHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA---------MIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~---------~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
.+|..++.+|.|+||.|++|.++.+...|+||.+.+..-..+.+ -.|+.||..+..| .|+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~--sH~NIlKlLdfF 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH--SHENILKLLDFF 638 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc--Cccchhhhhhee
Confidence 45999999999999999999999999999999997654333333 3599999999654 579999999999
Q ss_pred ecCCeEEEEEecC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 168 DYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 168 ~~~~~~~lV~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
++++++||+||.- |-+|++++.-.. .+++.++.-|+.||+.|+++||++||||||||-+||.+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv------------- 703 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV------------- 703 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEE-------------
Confidence 9999999999987 679999998765 89999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+.++.+||+|||.+.....+. ..++||..|.|||++.+.+| +..-|||++|++||.++....||
T Consensus 704 --------------d~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 704 --------------DSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred --------------ecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 567789999999987665544 56799999999999999987 47789999999999999999998
Q ss_pred C
Q 013973 324 Q 324 (433)
Q Consensus 324 ~ 324 (433)
.
T Consensus 770 y 770 (772)
T KOG1152|consen 770 Y 770 (772)
T ss_pred c
Confidence 5
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.91 Aligned_cols=187 Identities=20% Similarity=0.279 Sum_probs=154.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
..|...+.||+|+||.||+|.+..++..||+|.++.... ....|+++++++ +||||+++++++.+.+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l-----~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL-----QHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC-----CCCCcceEEEEEEcCCCCEEE
Confidence 346677899999999999999999999999998864332 123457777777 779999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH---DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|||+ +|+|.++++ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 762 ~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~---------------- 820 (968)
T PLN00113 762 HEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD---------------- 820 (968)
T ss_pred EeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC----------------
Confidence 9999 999999995 3889999999999999999999 66999999999999995433
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
..++. ||........ ....||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus 821 -----------~~~~~-~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 821 -----------EPHLR-LSLPGLLCTD-TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -----------ceEEE-eccccccccC-CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 33333 4433322111 223688999999999999999999999999999999999999953
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=241.85 Aligned_cols=210 Identities=21% Similarity=0.401 Sum_probs=167.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+...-+..||+|+||.|-+-++..+|...|+|.++.. .+...+...|+.+..+. ...|.+|.+++.+-..+.++
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~----~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT----VDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC----CCCCeEEEeehhhhccccEE
Confidence 4466678999999999999999999999999998743 33445555666665443 35688999999998899999
Q ss_pred EEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 175 IVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
|.||.|..+|..+-.+ ..+..+++..+-+|+..|+.||.|||++ .|||||+||+||||
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI------------------- 182 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI------------------- 182 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE-------------------
Confidence 9999998888766432 1224799999999999999999999975 69999999999999
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC-Cc-eeecCcccchhhhhC----CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NY-IVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~-~~gt~~y~aPE~~~~----~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
+..+++|+||||++....+.- .+ ..|.-.|||||.+.. ..|+.++||||||+.+.||.+++.||..
T Consensus 183 --------n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 183 --------NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred --------ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 556678888888776544332 22 468899999999864 3699999999999999999999999975
Q ss_pred -CChHHHHHHHHH
Q 013973 326 -HENLEHLAMMER 337 (433)
Q Consensus 326 -~~~~~~~~~i~~ 337 (433)
.+..+++.++.+
T Consensus 255 w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 255 WGTPFQQLKQVVE 267 (282)
T ss_pred cCCHHHHHHHHhc
Confidence 455566655443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.68 Aligned_cols=200 Identities=19% Similarity=0.228 Sum_probs=155.7
Q ss_pred CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 171 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 171 ~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..++++||+++++|.++|.... ..+++.+++.++.||+.||+|||++|||||||||+||||+..|.++++|||++....
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 4678889999999999997543 469999999999999999999999999999999999999999999999999876542
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC-------------------CCceeecCcccchhhhhCCCCCCcchhHHHHH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-------------------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 311 (433)
. +.+..+|++|||+++..... ....+||+.|||||++.+..|+.++|||||||
T Consensus 132 ~--------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGv 203 (793)
T PLN00181 132 S--------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGV 203 (793)
T ss_pred c--------cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHH
Confidence 2 34567999999998642210 01136899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+||||++|.+|+.... .....+... ..|..
T Consensus 204 iL~ELl~~~~~~~~~~--~~~~~~~~~--~~~~~---------------------------------------------- 233 (793)
T PLN00181 204 LLFELFCPVSSREEKS--RTMSSLRHR--VLPPQ---------------------------------------------- 233 (793)
T ss_pred HHHHHhhCCCchhhHH--HHHHHHHHh--hcChh----------------------------------------------
Confidence 9999999988875321 111111000 00000
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.....+...+++.+||+.||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 00112345688999999999999999999999999753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=287.18 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=206.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.++|+++..+|.|+||.||+|+++.+++..|+|+++-.. ........|+-+++.+ .|+||+.+++.+.....++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-----~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-----RHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-----CCcChHHHHhhhhhhcCcE
Confidence 367999999999999999999999999999999997432 2344556688888777 6799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
++|||| ||+|.+.-+..+ ++++.++....++.+.||+|||++|-+|||||-.|||+++.|.
T Consensus 89 icMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---------------- 150 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---------------- 150 (829)
T ss_pred EEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc----------------
Confidence 999999 889988776665 8999999999999999999999999999999999999976654
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+|++|||.+...... ...+.||+.|||||+.. ...|...+|+|++|+...|+-.-++|--..-
T Consensus 151 -----------vklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 151 -----------VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred -----------eeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 555555554433321 23458999999999885 4569999999999999999988888765555
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
.+..+..+.+.....|. . ......++-+.+|++.+|
T Consensus 220 pmr~l~LmTkS~~qpp~-l-------------------------------------------kDk~kws~~fh~fvK~al 255 (829)
T KOG0576|consen 220 PMRALFLMTKSGFQPPT-L-------------------------------------------KDKTKWSEFFHNFVKGAL 255 (829)
T ss_pred hHHHHHHhhccCCCCCc-c-------------------------------------------cCCccchHHHHHHHHHHh
Confidence 55555444333222221 0 012345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||++||+++.+|+|||.+...
T Consensus 256 tknpKkRptaeklL~h~fvs~~l 278 (829)
T KOG0576|consen 256 TKNPKKRPTAEKLLQHPFVSQTL 278 (829)
T ss_pred cCCCccCCChhhheeceeeccch
Confidence 99999999999999999998763
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=285.99 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=195.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC-------CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.++.++.+.||+|.||.|++|.... ....||||.++.. ....+.+..|+++|+.+. .|+|++.+.+.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g----~H~niv~llG~ 370 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG----KHPNIVNLLGA 370 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc----CCcchhhheee
Confidence 3455777899999999999997531 1456999998732 345677888999999985 45789999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNN------------Y--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+...+.+++|+||+ .|+|.++|+.+. . ..++......++.||+.|++||++..+|||||-..|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 99999999999999 999999998764 0 13889999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCce----ee--cCcccchhhhhCCCCCCcch
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI----VS--TRHYRAPEVILGLGWTYPCD 305 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~----~g--t~~y~aPE~~~~~~~~~~~D 305 (433)
+. .+..+||+|||+++.......+. .| ...|||||.+....|+.++|
T Consensus 451 i~---------------------------~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSD 503 (609)
T KOG0200|consen 451 IT---------------------------KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSD 503 (609)
T ss_pred ec---------------------------CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccch
Confidence 94 45567777777777544433332 12 23499999999999999999
Q ss_pred hHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchh
Q 013973 306 IWSVGCILVELCT-GEALFQTHE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 383 (433)
Q Consensus 306 vwSlGv~l~ellt-g~~Pf~~~~-~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
||||||+|||+.+ |..||.+-. ..+.+. +++.|..
T Consensus 504 VWSfGI~L~EifsLG~~PYp~~~~~~~l~~-----------------------~l~~G~r-------------------- 540 (609)
T KOG0200|consen 504 VWSFGILLWEIFTLGGTPYPGIPPTEELLE-----------------------FLKEGNR-------------------- 540 (609)
T ss_pred hhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-----------------------HHhcCCC--------------------
Confidence 9999999999999 889998743 222211 2333322
Q ss_pred HHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 384 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.+.|..++.++.++++.||+.+|++||+..|+.+
T Consensus 541 -----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 541 -----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred -----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 1223467889999999999999999999988754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=272.76 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=193.3
Q ss_pred EEEEeeeeccccEEEEEEEECCCCe----EEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~----~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.+..++||+|+||+||+|.....|+ .||||++... .+...++..|+-+|..+ .|+|++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-----dHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-----DHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-----CCchHHHHhhhcccch-
Confidence 4566899999999999998865554 5899988643 23356678888888888 8899999999988765
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+-||++|+ +|+|.||++... ..+.....+.|..||++||.|||.+++|||||-..|||+.+..
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--------------- 835 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN--------------- 835 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC---------------
Confidence 88999999 999999998754 5788999999999999999999999999999999999995544
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCce-----eecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 325 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~ 325 (433)
.+||.|||+++...++...+ .-.+.|||-|.+....|+.++|||||||++||++| |..|+.+
T Consensus 836 ------------hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 836 ------------HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred ------------eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 56666666666554443221 12567999999999999999999999999999999 9999988
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
....++-.. +++|.. ...++.++-++.-++.+
T Consensus 904 i~~~eI~dl-----------------------le~geR-------------------------LsqPpiCtiDVy~~mvk 935 (1177)
T KOG1025|consen 904 IPAEEIPDL-----------------------LEKGER-------------------------LSQPPICTIDVYMVMVK 935 (1177)
T ss_pred CCHHHhhHH-----------------------Hhcccc-------------------------CCCCCCccHHHHHHHHH
Confidence 766554332 222211 12345778889999999
Q ss_pred ccccCCCCCCCHHHHhc
Q 013973 406 LLRYDPTDRLTAREALR 422 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~ 422 (433)
||..|+..||+++++..
T Consensus 936 Cwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 936 CWMIDADSRPTFKELAE 952 (1177)
T ss_pred HhccCcccCccHHHHHH
Confidence 99999999999987753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=242.01 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=162.9
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc-eeecCCeE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-WFDYRNHI 173 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~-~~~~~~~~ 173 (433)
+.+.|.|.+.||+|-||.+-+|+++.++..+++|.+.........+.+|..---.| .+|.||+.-|+ .|++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~L----s~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFL----SPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceee----ccchhhhHHHHHHhhcCceE
Confidence 45679999999999999999999999999999999875555556666666543333 34455666555 58889999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++++||+ -|+|..-+...+ +.+.....++.|+++||.|||+.++||||||.+||||-.
T Consensus 98 vF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~------------------ 156 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD------------------ 156 (378)
T ss_pred EEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec------------------
Confidence 9999999 899998887654 889999999999999999999999999999999999943
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
....++||||||.++..+..-...--+..|.+||+.... ...+.+|+|.||+++|.++||.+||+...
T Consensus 157 -------~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 157 -------ADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred -------CCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 223489999999988655443334456789999988642 25688999999999999999999998543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=228.84 Aligned_cols=208 Identities=39% Similarity=0.620 Sum_probs=176.9
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 181 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~ 181 (433)
||+|++|.||++.+..+++.+++|++..... ..+.+..|+..++.+ .+++++++++.+......++|||++ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-----NHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-----CCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 6899999999999988899999999975433 246678899999988 4478999999999999999999999 6
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCC
Q 013973 182 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261 (433)
Q Consensus 182 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~ 261 (433)
++|.+++.... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. .
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--------------------------~ 128 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--------------------------D 128 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--------------------------C
Confidence 99999998652 36899999999999999999999999999999999999953 1
Q ss_pred CCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 013973 262 SSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337 (433)
Q Consensus 262 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 337 (433)
...++|+|||.+...... .....+...|++||.+... .++.++|+|++|+++++| .
T Consensus 129 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------~------- 188 (215)
T cd00180 129 NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------P------- 188 (215)
T ss_pred CCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------H-------
Confidence 456777777777654433 2334678899999999887 788999999999999998 0
Q ss_pred HhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCH
Q 013973 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 417 (433)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta 417 (433)
.+.+++.+||+.||++||++
T Consensus 189 ------------------------------------------------------------~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 189 ------------------------------------------------------------ELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred ------------------------------------------------------------HHHHHHHHHhhCCcccCcCH
Confidence 36778999999999999999
Q ss_pred HHHhcCC
Q 013973 418 REALRHP 424 (433)
Q Consensus 418 ~ell~hp 424 (433)
.++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=228.54 Aligned_cols=193 Identities=36% Similarity=0.620 Sum_probs=165.0
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
|.+.+.||.|++|.||+|.+..+++.+|+|.+..... ..+.+..|++.++.+ .+++++++++.+......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-----KHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-----CCCChhhheeeeecCCceEEE
Confidence 5678999999999999999998899999999874332 456677788888888 567899999999988999999
Q ss_pred EecC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 177 FEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+|++ +++|.+++.... . +++..+..++.+++.+|.+||+.+++|+||+|+||+++
T Consensus 76 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~--------------------- 132 (225)
T smart00221 76 MEYCEGGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG--------------------- 132 (225)
T ss_pred EeccCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---------------------
Confidence 9999 669999998754 3 89999999999999999999999999999999999994
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhh-hCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
.+..++|+|||.+....... ....++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus 133 ------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 133 ------MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ------CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34567888888776544332 345788899999998 666788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=237.70 Aligned_cols=247 Identities=17% Similarity=0.224 Sum_probs=186.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC-----eEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
..++++.-.+-+|.||.||.|.+++.. +.|-+|.++... .....+..|.-.+. ...|+|+..+.+...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly-----~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLY-----GASHPNLLSVLGVSI 357 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHh-----cCcCCCccceeEEEe
Confidence 467888899999999999999776433 234445443211 11122222333332 236888988888764
Q ss_pred -cCCeEEEEEecC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcccc
Q 013973 169 -YRNHICIVFEKL-GSSLYDFLRKN------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 169 -~~~~~~lV~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i 240 (433)
+....++++.++ -|+|..||... +.+.++..+...++.|++.|++|||+.||||.||...|++|
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI-------- 429 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI-------- 429 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee--------
Confidence 455677888888 68999999832 22457777888999999999999999999999999999999
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceee-----cCcccchhhhhCCCCCCcchhHHHHHHHHH
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS-----TRHYRAPEVILGLGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwSlGv~l~e 315 (433)
++..++||+|-.+++..-+.+....| ...||+||.+....|+.++|+|||||+|||
T Consensus 430 -------------------dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWE 490 (563)
T KOG1024|consen 430 -------------------DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWE 490 (563)
T ss_pred -------------------hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHH
Confidence 56688999998888866655544334 567999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 316 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 316 llt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
|+| |+.||..-+..+....+ .+|.. ...|-+
T Consensus 491 Lmtlg~~PyaeIDPfEm~~yl-----------------------kdGyR-------------------------laQP~N 522 (563)
T KOG1024|consen 491 LMTLGKLPYAEIDPFEMEHYL-----------------------KDGYR-------------------------LAQPFN 522 (563)
T ss_pred HHhcCCCCccccCHHHHHHHH-----------------------hccce-------------------------ecCCCC
Confidence 998 99999887776655443 22211 112347
Q ss_pred chhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
++.++..++..||..+|++||+.+|+..
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8889999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=220.26 Aligned_cols=167 Identities=23% Similarity=0.300 Sum_probs=123.7
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCC
Q 013973 182 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261 (433)
Q Consensus 182 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~ 261 (433)
|+|.+++...+ ..+++.++..++.||+.||.|||+++ ||+|||++.
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~--------------------------- 46 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW--------------------------- 46 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC---------------------------
Confidence 68999998653 46999999999999999999999999 999999954
Q ss_pred CCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Q 013973 262 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE-HLAMMERVLG 340 (433)
Q Consensus 262 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~-~~~~i~~~~~ 340 (433)
++.+|+ ||.+....... ..||+.|||||++.+..|+.++|||||||++|||++|..||....... .+..+.....
T Consensus 47 ~~~~~~--fG~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 47 DGLLKL--DGSVAFKTPEQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred ccceee--ccceEeecccc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 445666 77665443322 268999999999999999999999999999999999999997543321 1211111110
Q ss_pred CCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch--hHHHHHHHhccccCCCCCCCHH
Q 013973 341 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA--GDLTHLLQGLLRYDPTDRLTAR 418 (433)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~ta~ 418 (433)
... +.... .....+ .++.+||.+||+.||.+||++.
T Consensus 123 ~~~----------------------~~~~~--------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~ 160 (176)
T smart00750 123 ADD----------------------PRDRS--------------------NLESVSAARSFADFMRVCASRLPQRREAAN 160 (176)
T ss_pred cCC----------------------ccccc--------------------cHHHHHhhhhHHHHHHHHHhcccccccCHH
Confidence 000 00000 000112 2689999999999999999999
Q ss_pred HHhcCCCCCC
Q 013973 419 EALRHPFFTR 428 (433)
Q Consensus 419 ell~hp~f~~ 428 (433)
|+++|+|+..
T Consensus 161 ~ll~~~~~~~ 170 (176)
T smart00750 161 HYLAHCRALF 170 (176)
T ss_pred HHHHHHHHHH
Confidence 9999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=223.11 Aligned_cols=203 Identities=25% Similarity=0.337 Sum_probs=176.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
-.|++.++||+|+||..++|.+..+++.||||.-. .+....+...|....+.|.. .+.|.+.+.+-+++.+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g----~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGG----TEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcC----CCCCCceeeeccccchhhhh
Confidence 35999999999999999999999999999999754 34445667788888888853 35688888888888899999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 177 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 177 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
+|++|.+|.|++.-++ ++|+...+..++.|++.-++|+|++.+|+|||||+|+||...+.
T Consensus 103 idLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~------------------- 162 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGT------------------- 162 (449)
T ss_pred hhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCC-------------------
Confidence 9999999999988776 68999999999999999999999999999999999999965442
Q ss_pred ccCCCCCCEEEEecCCccccCCCCC----------ceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQN----------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~~----------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.....+.|+|||+|....+..+ ...||..||+-..-.+...+.+.|+=|||-++++.|-|.+||++.
T Consensus 163 ---k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 163 ---KDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ---CCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 4456789999999987665432 357999999999999999999999999999999999999999875
Q ss_pred C
Q 013973 327 E 327 (433)
Q Consensus 327 ~ 327 (433)
.
T Consensus 240 K 240 (449)
T KOG1165|consen 240 K 240 (449)
T ss_pred c
Confidence 4
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=226.01 Aligned_cols=208 Identities=29% Similarity=0.361 Sum_probs=170.2
Q ss_pred cEEEEeeeeccccEEEEEEEECCCC-eEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~ 174 (433)
+|.+.++||+|+||.||+|.+..++ ..+|+|+...... ....+..|..++..+.. ..+..++..++... ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeE
Confidence 7999999999999999999988775 6799998864322 12267789999999975 22345677888777 5788999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
|||+.+|.+|.++......+.|+...+..++.|++.+|++||+.|+|||||||+|+++...+.
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~----------------- 160 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSR----------------- 160 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCC-----------------
Confidence 999999999999887665678999999999999999999999999999999999999953210
Q ss_pred ccccCCCCCCEEEEecCCcc--ccC-C-------C---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTT--YER-P-------D---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~--~~~-~-------~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
.....+.|.|||+++ ... . . .....||..|+++....+...+.+.|+||++.++.+++.|..
T Consensus 161 -----~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 161 -----SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred -----cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 112468888888887 210 1 1 123469999999999999999999999999999999999999
Q ss_pred CCCCCCh
Q 013973 322 LFQTHEN 328 (433)
Q Consensus 322 Pf~~~~~ 328 (433)
||...+.
T Consensus 236 PW~~~~~ 242 (322)
T KOG1164|consen 236 PWEALEM 242 (322)
T ss_pred CCccccc
Confidence 9977654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=211.51 Aligned_cols=205 Identities=26% Similarity=0.368 Sum_probs=171.9
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..++|.++++||+|+||.+|+|....+|+.||||+-.... ......-|..+...+++. ..|..+..+..+..+-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g----~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGG----VGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccC----CCCchhhhhccccccce
Confidence 4578999999999999999999999999999999876433 334567788888888653 34666777778888999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||+.+|.+|.+++.-.. +.|+...++-++-|++.-++|+|.++.|||||||+|+|+.-.
T Consensus 88 lVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlg------------------- 147 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLG------------------- 147 (341)
T ss_pred eeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccc-------------------
Confidence 999999999999987654 579999999999999999999999999999999999999321
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.....+.++|||++....+.. ....||..|.+-....+...+.+.|+=|+|.+|.++.-|..||+
T Consensus 148 -----rh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 148 -----RHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred -----cccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 234579999999997554432 23589999999888888788899999999999999999999999
Q ss_pred CCChH
Q 013973 325 THENL 329 (433)
Q Consensus 325 ~~~~~ 329 (433)
+....
T Consensus 223 glka~ 227 (341)
T KOG1163|consen 223 GLKAA 227 (341)
T ss_pred ccchh
Confidence 86543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=252.96 Aligned_cols=238 Identities=27% Similarity=0.417 Sum_probs=173.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|..++.|..|+||.||+++++.+.+.+|+|+=+ .+ .+++.+.. ...++.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~----------lilRnilt-~a~npfvv--------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN----------LILRNILT-FAGNPFVV--------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccc-cc----------hhhhcccc-ccCCccee---------------
Confidence 56999999999999999999999999999996432 11 11111100 01222222
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 177 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 177 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
|+-...+...+ .++.+. +.+++|||+.||||||+||+|.||+.-|++|+.|||++.........
T Consensus 136 -----gDc~tllk~~g--~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at- 199 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG--PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT- 199 (1205)
T ss_pred -----chhhhhcccCC--CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc-
Confidence 34444444433 455443 67899999999999999999999999999999999988766443221
Q ss_pred ccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 336 (433)
+ -..+.++- .++.+ ....+|||+.|+|||++..+.|++.+|||++|+++||.+.|+.||.+++.++.+.+..
T Consensus 200 -n-l~eg~I~k----~t~Ef--~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 200 -N-LKEGHIEK----DTHEF--QDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred -h-hhhcchHH----HHHHh--hhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 0 01111110 11111 1234689999999999999999999999999999999999999999988888776654
Q ss_pred HHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC-
Q 013973 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 415 (433)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~- 415 (433)
.... .||+. ...++++++++|..+|+.+|..|.
T Consensus 272 sd~i-----------------------~wpE~-----------------------dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 272 SDDI-----------------------EWPEE-----------------------DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhc-----------------------ccccc-----------------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 4332 34432 135678999999999999999998
Q ss_pred --CHHHHhcCCCCCCCCC
Q 013973 416 --TAREALRHPFFTRDHL 431 (433)
Q Consensus 416 --ta~ell~hp~f~~~~~ 431 (433)
++-+|.+|+||+....
T Consensus 306 t~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 306 TGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred cchhhhhhhccceeeccc
Confidence 4789999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-28 Score=240.23 Aligned_cols=237 Identities=24% Similarity=0.376 Sum_probs=185.6
Q ss_pred eeeccccEEEEEEEE---CCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 104 KMGEGTFGQVLECWD---RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~---~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
.+|+|+||.|++++. .+.+..||+|+.++.. ..+.....|..++..+ ..++.++.+...++.+..+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~----~~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFV----HNTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhc----cCCCceeeeeeeeccccchhHhh
Confidence 379999999997743 4567889999886321 1111334566666666 24688999999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
++. ||+|...+.+.. .+++.....+..+++.+++++|+.+|+|||+|++||+++.+|++++.||
T Consensus 77 d~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdf------------- 141 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDF------------- 141 (612)
T ss_pred hhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCc-------------
Confidence 999 889998887654 7889999999999999999999999999999999999966665555555
Q ss_pred ccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 336 (433)
|.++..-..... |||..|||||++. ....++|+||||++++||++|..||.+ +....|.
T Consensus 142 --------------glske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 142 --------------GLSKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL 200 (612)
T ss_pred --------------hhhhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence 444433222222 8999999999998 578999999999999999999999987 4444443
Q ss_pred HHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCC
Q 013973 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 416 (433)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 416 (433)
+..-.. +..++..+++++..++.++|.+|+.
T Consensus 201 ~~~~~~-------------------------------------------------p~~l~~~a~~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 201 KAELEM-------------------------------------------------PRELSAEARSLFRQLFKRNPENRLG 231 (612)
T ss_pred hhccCC-------------------------------------------------chhhhHHHHHHHHHHHhhCHHHHhc
Confidence 322222 2345668899999999999999996
Q ss_pred -----HHHHhcCCCCCCC
Q 013973 417 -----AREALRHPFFTRD 429 (433)
Q Consensus 417 -----a~ell~hp~f~~~ 429 (433)
+.|+++|+||+..
T Consensus 232 ~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 232 AGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred cCcchhHHHhccchheee
Confidence 5799999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=245.98 Aligned_cols=257 Identities=20% Similarity=0.282 Sum_probs=181.3
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEee----cchhhHHH---HHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~----~~~~~~~~---~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
...+.+|.|++|.|+.+......+.++.|.++ ........ ...|..+ .....|++++.....+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i-----~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCI-----GSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheee-----cccccCCchhhhHHHHhhccc
Confidence 46688999999988888887777767777554 11111111 1122222 223367777776666666555
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
.+-+||||.++|+.++...+ .++..++..++.|++.||.|||..||.|||||++|++++..|
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g---------------- 457 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG---------------- 457 (601)
T ss_pred chhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC----------------
Confidence 55559999449999998763 699999999999999999999999999999999999996544
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC-------CceeecCcccchhhhhCCCCCC-cchhHHHHHHHHHHHhCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTY-PCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.+||+|||.+....... ..++|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.
T Consensus 458 -----------~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 458 -----------ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred -----------ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 56666666554332211 2358999999999999999985 5799999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
.....+.... .........+.. ........++.+.+.+|.
T Consensus 527 ~a~~~~~~~~--------------~~~~~~~~~~~~--------------------------~~~~~~~~lp~~~~~~~~ 566 (601)
T KOG0590|consen 527 VAKKSDNSFK--------------TNNYSDQRNIFE--------------------------GPNRLLSLLPRETRIIIY 566 (601)
T ss_pred cccccccchh--------------hhcccccccccc--------------------------ChHHHHHhchhhHHHHHH
Confidence 6543321100 000000000000 011122356778899999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||+.||.+|.|+++|++.+||+...
T Consensus 567 ~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 567 RMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHccCChhheecHHHHhhChHhhhcc
Confidence 99999999999999999999998654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=217.67 Aligned_cols=168 Identities=21% Similarity=0.231 Sum_probs=122.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECC-CCeEEEEEEeecc------hhhHHHHHHHHHHHHHHHhcCCCCCceE-Eecce
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCV-QIRNW 166 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~-~~~~~ 166 (433)
+.++|.+.+.||+|+||+||+|+++. +++.||||++... ......+.+|+++++.+. |++++ .++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-----h~~iv~~l~~- 89 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-----GIGVVPQLLA- 89 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-----CCCCCcEEEE-
Confidence 34679999999999999999998876 6788899986422 223556789999999994 34454 4443
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEeeccCccccCCCc
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL-KPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl-Kp~NILl~~~~~~~i~dfg 244 (433)
.+..||||||+ |++|.. +.. .. ...++.|++.||.|||++||||||| ||+|||++.
T Consensus 90 ---~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~---------- 147 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGP---------- 147 (365)
T ss_pred ---cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcC----------
Confidence 24579999999 888862 211 11 1467899999999999999999999 999999954
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----------CceeecCcccchhhhhCCC------CCCcchhH
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----------NYIVSTRHYRAPEVILGLG------WTYPCDIW 307 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 307 (433)
++.+||+|||+++...... ....+++.|+|||++.... .+..+|-|
T Consensus 148 -----------------~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 148 -----------------DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred -----------------CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 3456666666665333221 2357888999999986432 33446665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-24 Score=205.97 Aligned_cols=257 Identities=32% Similarity=0.499 Sum_probs=191.5
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
|.+.+.||.|+||.||++.+. ..+|+|.+..... ....+..|..++..+.++ ++++.+...+......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~----~~i~~~~~~~~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP----PNIVKLYDFFQDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCC----cceeeEEEEEecCCEEE
Confidence 778899999999999999987 6799998864322 355677788888877432 26899999998888899
Q ss_pred EEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++++++ ++++.+++..... ..++......++.|++.++.|+|+.+++||||||+||+++..+
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~---------------- 138 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG---------------- 138 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC----------------
Confidence 999999 8899877765432 2689999999999999999999999999999999999995433
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC---------CCceeecCcccchhhhhC---CCCCCcchhHHHHHHHHHHHhCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD---------QNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~ 320 (433)
..++++|||.+...... .....||..|+|||.+.+ ..+....|+||+|++++++++|.
T Consensus 139 ----------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 139 ----------RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred ----------CeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 14677777766533322 244589999999999998 57889999999999999999999
Q ss_pred CCCCCCCh----HHHHHHHHHHhCC-CCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 321 ALFQTHEN----LEHLAMMERVLGP-LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 321 ~Pf~~~~~----~~~~~~i~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
.||..... ......+.....+ ... +. ... . ....
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~--~~~--~----------------~~~~ 247 (384)
T COG0515 209 PPFEGEKNSSATSQTLKIILELPTPSLAS---------------------PL--SPS--N----------------PELI 247 (384)
T ss_pred CCCCCCCccccHHHHHHHHHhcCCccccc---------------------cc--Ccc--c----------------cchh
Confidence 99877653 2222221111111 000 00 000 0 0112
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
...+.+++..++..+|..|.+..+...++|....
T Consensus 248 ~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 248 SKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred hHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 3468899999999999999999998888766543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=195.15 Aligned_cols=202 Identities=20% Similarity=0.276 Sum_probs=124.7
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHh---------c-CCCCC-ceEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAK---------H-DKGGN-RCVQ 162 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~---------~-~~~~~-~i~~ 162 (433)
.+...+.||.|+++.||.+.+..||+.+|+|++.... ...+...+|.-....+.. + .--.| -++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4778899999999999999999999999999985211 122223333222111100 0 00001 0222
Q ss_pred ecc---eeecC---C-----eEEEEEecCCCCHHHHHH---hcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013973 163 IRN---WFDYR---N-----HICIVFEKLGSSLYDFLR---KNNYR--SFPIDLVREIARQLLECIAFMHDLCMIHTDLK 226 (433)
Q Consensus 163 ~~~---~~~~~---~-----~~~lV~e~~~~~L~~~l~---~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlK 226 (433)
+.+ ++... . +.+++|+-+.++|.+++. ..... .+.......+..|+++.+++||+.||||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 221 11111 1 347888888889988754 22211 12333445677999999999999999999999
Q ss_pred CCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC--------
Q 013973 227 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-------- 298 (433)
Q Consensus 227 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-------- 298 (433)
|+|+|+ +.++.++|+||+.....+........+..|.+||.....
T Consensus 173 ~~nfll---------------------------~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~ 225 (288)
T PF14531_consen 173 PENFLL---------------------------DQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNA 225 (288)
T ss_dssp GGGEEE----------------------------TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEE
T ss_pred eeeEEE---------------------------cCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccc
Confidence 999999 455677777776554333221112345779999987543
Q ss_pred CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 299 GWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 299 ~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++.+.|.|+||+++|.|.+|..||...
T Consensus 226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 226 PYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp EE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 4788999999999999999999999753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=194.02 Aligned_cols=192 Identities=21% Similarity=0.304 Sum_probs=144.0
Q ss_pred CCCCCceEEecceeec---------------------------CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHH
Q 013973 154 DKGGNRCVQIRNWFDY---------------------------RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 206 (433)
Q Consensus 154 ~~~~~~i~~~~~~~~~---------------------------~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~ 206 (433)
...||||+.+...|.+ +..+|+||.-...+|.+||..+. .+....+-++.
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~la 348 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILA 348 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHH
Confidence 3578999999988754 34789999988899999998763 67788888999
Q ss_pred HHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC--------
Q 013973 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------- 278 (433)
Q Consensus 207 qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------- 278 (433)
|+++|+.|||++||.|||+|.+|||+.-+. |+-..+.|+|||.+--...
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~Eldd-----------------------D~~P~LVvaDFGCcLAd~~hGlqlpy~ 405 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDD-----------------------DEIPQLVVADFGCCLADDNHGLQLPYE 405 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecC-----------------------CCCcEEEEcccceeeeccccccccccc
Confidence 999999999999999999999999995432 5566778888886532111
Q ss_pred -CCCceeecCcccchhhhhCCC-----C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHh
Q 013973 279 -DQNYIVSTRHYRAPEVILGLG-----W-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVD 351 (433)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~-----~-~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (433)
......|...-||||+....+ . -.++|.|+.|.+.||+++...||.+......-.
T Consensus 406 S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------------------ 467 (598)
T KOG4158|consen 406 SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------------------ 467 (598)
T ss_pred cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------------------
Confidence 111235778899999987543 1 257899999999999999999998643321000
Q ss_pred hhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHH
Q 013973 352 RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 418 (433)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ 418 (433)
..|- .......++.+++.+++|+..+|+.||.+|+++.
T Consensus 468 ---r~Yq--------------------------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 468 ---RTYQ--------------------------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ---hhhh--------------------------hhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 0000 0111234557788999999999999999999843
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=219.74 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=177.5
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
++...+.||++.|=+|.+|++.+ |. |+||++-+.+. .-..+..+++-++. ....+||++.+..+.......||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~---~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKF---ALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHH---HhhcCCcccchHHHHHhhHHHHH
Confidence 58889999999999999998754 33 99999854331 11222222222221 12266899999999888999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC--CCCC
Q 013973 176 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT--PKDS 253 (433)
Q Consensus 176 V~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~--~~~~ 253 (433)
|=+|...+|+|.|..+. .|..-+.+.|+.|++.||.-+|..||+|+|||.+||||++=.=+.|+||-.-++. |.++
T Consensus 99 vRqyvkhnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHHHhhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 99999999999997754 6778888999999999999999999999999999999998777888888644332 2221
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC----------C-CCCcchhHHHHHHHHHHHh-CCC
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL----------G-WTYPCDIWSVGCILVELCT-GEA 321 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGv~l~ellt-g~~ 321 (433)
=+||+.-..... --.+|+|||.+... . .+++-||||+||+++||++ |++
T Consensus 177 -------------Padf~fFFDTSr------RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P 237 (1431)
T KOG1240|consen 177 -------------PADFTFFFDTSR------RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP 237 (1431)
T ss_pred -------------cccceEEEecCC------ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence 134543332111 12369999988642 1 5678899999999999987 799
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.- .++-.....-...++.. .+. ..+..++.
T Consensus 238 lF~L----SQL~aYr~~~~~~~e~~-----------------------------Le~---------------Ied~~~Rn 269 (1431)
T KOG1240|consen 238 LFTL----SQLLAYRSGNADDPEQL-----------------------------LEK---------------IEDVSLRN 269 (1431)
T ss_pred cccH----HHHHhHhccCccCHHHH-----------------------------HHh---------------CcCccHHH
Confidence 9952 11111000000111111 111 11236788
Q ss_pred HHHhccccCCCCCCCHHHHhcC
Q 013973 402 LLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~h 423 (433)
||..|+++||++|++|++.|+-
T Consensus 270 lil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 270 LILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHccCchhccCHHHHHHh
Confidence 9999999999999999999974
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=178.37 Aligned_cols=137 Identities=19% Similarity=0.203 Sum_probs=102.6
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchh---h------------------------HHHHHHHHHHHHHHHhcC
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---Y------------------------REAAMIEIEVLQQLAKHD 154 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~------------------------~~~~~~E~~~l~~l~~~~ 154 (433)
...||+|+||.||+|.+. +|+.||||+++.... . ......|..++.++.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 899999999974311 0 112234889999997644
Q ss_pred CCCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEe
Q 013973 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPENVLL 232 (433)
Q Consensus 155 ~~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlKp~NILl 232 (433)
...|.+.. ... .+|||||+ |+++...+... ..++...+..++.|++.+|.|| |+.|||||||||+|||+
T Consensus 81 v~~p~~~~------~~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPIL------LKS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEE------ecC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 33344322 112 37999999 55555443322 3689999999999999999999 79999999999999999
Q ss_pred eccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCcccc
Q 013973 233 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 233 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
+ ++.++|+|||++...
T Consensus 152 ~----------------------------~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H----------------------------DGKLYIIDVSQSVEH 167 (190)
T ss_pred E----------------------------CCcEEEEEccccccC
Confidence 4 246899999988743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=183.53 Aligned_cols=170 Identities=14% Similarity=0.151 Sum_probs=122.5
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHH----------HHHHHHHHHHHHhcCCCCCceEEe
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----------AMIEIEVLQQLAKHDKGGNRCVQI 163 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~----------~~~E~~~l~~l~~~~~~~~~i~~~ 163 (433)
.+.++|++++.||.|+||.||++.. ++..+|+|+++......+. +.+|+..+.++.+. ++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~-----GI~~~ 100 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE-----GLASL 100 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC-----CCCcc
Confidence 3568999999999999999999755 3557999999632221111 46788888888554 34444
Q ss_pred cceee--------cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 164 RNWFD--------YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 164 ~~~~~--------~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
..++. ..+..+|||||+ |.+|.++. .+++ ....+++.+|..||+.||+|||+||+||+++
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~- 169 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS- 169 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe-
Confidence 44332 235689999999 77898773 2333 2456999999999999999999999999994
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHH
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 314 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ 314 (433)
.++ ++|+|||.......... ...++....|+.++|+||||+++.
T Consensus 170 --------------------------~~g-i~liDfg~~~~~~e~~a---------~d~~vler~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 170 --------------------------KNG-LRIIDLSGKRCTAQRKA---------KDRIDLERHYGIKNEIKDLGYYLL 213 (232)
T ss_pred --------------------------CCC-EEEEECCCcccccchhh---------HHHHHHHhHhcccccccceeEeeh
Confidence 334 88999987764422211 112445566888999999999887
Q ss_pred HHH
Q 013973 315 ELC 317 (433)
Q Consensus 315 ell 317 (433)
.+.
T Consensus 214 ~~~ 216 (232)
T PRK10359 214 IYK 216 (232)
T ss_pred HHH
Confidence 654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=171.95 Aligned_cols=182 Identities=18% Similarity=0.167 Sum_probs=131.8
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHH-----HHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE-----AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~-----~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.+...|++|+||+||++.. .+..++.+.+........ .+.+|+++|+++.++ ++++.++++ +..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~----~~vP~ll~~----~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGL----PRTPRLLHW----DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCC----CCCCEEEEE----cCEE
Confidence 4568899999999997754 566788777765443322 467899999998543 445666554 3468
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEeeccCccccCCCcCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL-KPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl-Kp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+||||+ |.+|.+.+.. . ...++.|++.+|+++|++||||||| ||+|||++.
T Consensus 75 lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~------------------ 127 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE------------------ 127 (218)
T ss_pred EEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC------------------
Confidence 999999 7788654321 1 1357889999999999999999999 799999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCC----------------ceeecCcccchhhhhCC-CCC-CcchhHHHHHHHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQN----------------YIVSTRHYRAPEVILGL-GWT-YPCDIWSVGCILV 314 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----------------~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGv~l~ 314 (433)
++.++|+|||++........ ....++.|++|+.-.-- ..+ ...++++-|+.+|
T Consensus 128 ---------~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~ 198 (218)
T PRK12274 128 ---------DGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVY 198 (218)
T ss_pred ---------CCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHH
Confidence 44567777777664433221 12358889999865432 334 6779999999999
Q ss_pred HHHhCCCCCCCCC
Q 013973 315 ELCTGEALFQTHE 327 (433)
Q Consensus 315 elltg~~Pf~~~~ 327 (433)
.++|+..|+-+++
T Consensus 199 ~~~~~~~~~~~~~ 211 (218)
T PRK12274 199 RFVTRRVLHWEDN 211 (218)
T ss_pred HHHhccCCccccC
Confidence 9999998875543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=173.35 Aligned_cols=136 Identities=17% Similarity=0.127 Sum_probs=100.7
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhh---------------------------HHHHHHHHHHHHHHHhcC
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---------------------------REAAMIEIEVLQQLAKHD 154 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~---------------------------~~~~~~E~~~l~~l~~~~ 154 (433)
.+.||+|+||.||+|.+. +|+.||||+++..... ......|...+.++.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 478999999999999987 8999999998743110 112346788888886643
Q ss_pred CCCCceEEecceeecCCeEEEEEecC-CCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceE
Q 013973 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVL 231 (433)
Q Consensus 155 ~~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NIL 231 (433)
...|... .. . ..+|||||+ |+++.. .+.. ..++...+..++.|++.+|.+||+ .||+||||||+|||
T Consensus 81 i~~p~~~---~~--~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPI---LL--K--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEE---Ee--c--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 3223222 11 1 248999999 554433 3433 258889999999999999999999 99999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCcccc
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
++ ++.++|+|||++...
T Consensus 151 l~----------------------------~~~~~liDFG~a~~~ 167 (190)
T cd05145 151 YH----------------------------DGKPYIIDVSQAVEL 167 (190)
T ss_pred EE----------------------------CCCEEEEEcccceec
Confidence 94 346888888887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-21 Score=172.59 Aligned_cols=141 Identities=18% Similarity=0.183 Sum_probs=111.2
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---eEE-EE
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---HIC-IV 176 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~---~~~-lV 176 (433)
.+.||+|+||.||. +..++.. +||++... ....+...+|+.+++.+.+....|+||++++++++++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 47899999999995 6666655 69987642 22456688999999999877778899999999998863 544 78
Q ss_pred EecC---CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 177 FEKL---GSSLYDFLRKNNYRSFPIDLVREIARQLLECI-AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 177 ~e~~---~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|||+ +++|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++..+
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~---------------- 142 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS---------------- 142 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC----------------
Confidence 9995 48999999653 46665 35688888888 999999999999999999996432
Q ss_pred CcccccCCCCCCEEEEecCCc
Q 013973 253 SSYFKRMPKSSAIKVIDFGST 273 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a 273 (433)
+.+..++|+||+.+
T Consensus 143 -------~~~~~~~LiDg~G~ 156 (210)
T PRK10345 143 -------ESEVIPVVCDNIGE 156 (210)
T ss_pred -------CCCCcEEEEECCCC
Confidence 34458999995543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=202.98 Aligned_cols=198 Identities=24% Similarity=0.387 Sum_probs=151.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
..|.|.+.||+|+||+||+|...+ |+.||+|+-+....+ ++..=.+++.+|. ...-+-|..+...+...+.-+||
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~q~~~RLk--~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICLQVMERLK--PQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehHHHHHhhc--hhhhcchHHHHHHHccCCcceee
Confidence 579999999999999999999877 999999987633221 1111122222332 00113355555556667778899
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
+||. -|+|.+++... +.+++..+..++.|++.-+++||..+|||+||||+|+||... +..|
T Consensus 773 ~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~---~~~~------------- 834 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRRE---ICAD------------- 834 (974)
T ss_pred eeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecc---cCCC-------------
Confidence 9999 89999999844 489999999999999999999999999999999999999542 1111
Q ss_pred cccCCCCCCEEEEecCCccccCC--CC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERP--DQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~--~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
.....++|+|||.+..... +. ...++|-.+--+|+..|..++..+|.|.|+.+++.||.|++
T Consensus 835 ----~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 835 ----SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ----CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 2255799999998864332 22 22578999999999999999999999999999999999964
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-21 Score=186.94 Aligned_cols=184 Identities=27% Similarity=0.424 Sum_probs=130.4
Q ss_pred CeEEEEEecC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.++||.|++| ..+|.++|... .....++...+.++.|++.|++| +|.+|||+||.||++..++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 4689999999 89999999733 33457788899999999999999 9999999999999997666666666665443
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHE 327 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~Pf~~~~ 327 (433)
.....+. .......+..+||..||+||.|.+..|+.++||||||++|+||+.- ...|
T Consensus 406 ~~~~~~~------------------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---- 463 (516)
T KOG1033|consen 406 QDKDETV------------------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---- 463 (516)
T ss_pred cccCCcc------------------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----
Confidence 3221100 0000112335899999999999999999999999999999999972 2222
Q ss_pred hHHHHHHHHHH-hCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 328 NLEHLAMMERV-LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 328 ~~~~~~~i~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+.+..+ -|..|+..+ .. -++-.+|+.+|
T Consensus 464 --er~~t~~d~r~g~ip~~~~---------------------------------------------~d-~p~e~~ll~~l 495 (516)
T KOG1033|consen 464 --ERIATLTDIRDGIIPPEFL---------------------------------------------QD-YPEEYTLLQQL 495 (516)
T ss_pred --HHHHhhhhhhcCCCChHHh---------------------------------------------hc-CcHHHHHHHHh
Confidence 111111111 111221110 11 12456899999
Q ss_pred cccCCCCCCCHHHHhcCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~ 427 (433)
|...|.+||++.+.-.|+|.+
T Consensus 496 ls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 496 LSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred cCCCcccCchHHHHhhhhhcC
Confidence 999999999999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-20 Score=168.21 Aligned_cols=142 Identities=20% Similarity=0.153 Sum_probs=106.9
Q ss_pred cEEEEeeeeccccEEEEEEE-ECCCCeEEEEEEeecchh-------------------------hHHHHHHHHHHHHHHH
Q 013973 98 RYKIHSKMGEGTFGQVLECW-DRERKEMVAIKIVRGIKK-------------------------YREAAMIEIEVLQQLA 151 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~-~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~E~~~l~~l~ 151 (433)
-|++.+.||+|+||.||+|. +..+|+.||+|+++.... .......|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37899999999999999999 677899999999874211 1123457999999996
Q ss_pred hcCCCCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCc
Q 013973 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPEN 229 (433)
Q Consensus 152 ~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlKp~N 229 (433)
+.. ..+...+.. ...++||||+ |.+|...+... ..+....+..++.||+.+|.+||+.| |+||||||+|
T Consensus 109 ~~~---i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAG---VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred hcC---CCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 532 223333332 2348999999 55666554332 24666677899999999999999999 9999999999
Q ss_pred eEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCcccc
Q 013973 230 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 230 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
|+++ .+.++|+|||.+...
T Consensus 180 Ili~----------------------------~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH----------------------------DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE----------------------------CCCEEEEEChhhhcc
Confidence 9993 346899999987743
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.4e-21 Score=168.57 Aligned_cols=240 Identities=16% Similarity=0.189 Sum_probs=176.3
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
...++-+|.+...|..|+|+...+. ++.|+++- .......+..|.-.|+.+ .||||+.+++.+....++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrif-----shpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIF-----SHPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeee-----cCCchhhhhhhccCCCCce
Confidence 4567788999999999999886544 66777652 223334455666666655 6799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
++..|| -|+|+..|+....-..+-.++.+++.+|++|+.|||+.. |.---|....++|+++-+.+|
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltari----------- 332 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARI----------- 332 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhe-----------
Confidence 999999 899999999876566788899999999999999999875 434468888999966543333
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCC---CcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT---YPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
..+|--++... .+ ..-.+.||+||.+...+-+ .++|+|||++++|||.|...||.....
T Consensus 333 --------------smad~kfsfqe-~g---r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 333 --------------SMADTKFSFQE-VG---RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred --------------ecccceeeeec-cc---cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 22332222211 01 1237889999999876533 578999999999999999999998777
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
++.-.++. + .| +-...++..+..+..|+.-|++
T Consensus 395 mecgmkia-l---------------------eg-------------------------lrv~ippgis~hm~klm~icmn 427 (448)
T KOG0195|consen 395 MECGMKIA-L---------------------EG-------------------------LRVHIPPGISRHMNKLMNICMN 427 (448)
T ss_pred hhhhhhhh-h---------------------cc-------------------------ccccCCCCccHHHHHHHHHHhc
Confidence 76533321 0 00 0011234667789999999999
Q ss_pred cCCCCCCCHHHH
Q 013973 409 YDPTDRLTAREA 420 (433)
Q Consensus 409 ~dP~~R~ta~el 420 (433)
.||.+||..+.+
T Consensus 428 edpgkrpkfdmi 439 (448)
T KOG0195|consen 428 EDPGKRPKFDMI 439 (448)
T ss_pred CCCCcCCCccee
Confidence 999999987765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-18 Score=154.99 Aligned_cols=132 Identities=22% Similarity=0.274 Sum_probs=100.5
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+.||+|++|.||+|.. .+..+++|+..... ........|+.++..+.+.....| ..++......
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p-----~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVP-----AVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCC-----eEEEEeCCCC
Confidence 6799999999999987 56678999764211 112346678889988865432222 2233445678
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ |++|.+++.... . ....++.+++.+|.+||+.|++|+|++|+|||++
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~------------------- 129 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS------------------- 129 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-------------------
Confidence 8999999 889999986532 2 7788999999999999999999999999999994
Q ss_pred CcccccCCCCCCEEEEecCCccc
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~ 275 (433)
.+.++|+|||.+..
T Consensus 130 ---------~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 ---------GGKIYLIDFGLAEF 143 (211)
T ss_pred ---------CCCEEEEECCcccC
Confidence 34688889988765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=150.18 Aligned_cols=135 Identities=24% Similarity=0.270 Sum_probs=99.3
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-----------------------hHHHHHHHHHHHHHHHhcCC
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------YREAAMIEIEVLQQLAKHDK 155 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------------------~~~~~~~E~~~l~~l~~~~~ 155 (433)
|.+.+.||+|+||.||+|... +|+.||||+++.... .......|..++..+.+...
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999875 789999998753210 11224567888888755321
Q ss_pred CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 156 ~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
.++..+. ....++||||+ |++|..... ......++.+++.++.++|+.||+||||||+||++
T Consensus 96 ---~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill-- 158 (198)
T cd05144 96 ---PVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV-- 158 (198)
T ss_pred ---CCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE--
Confidence 2233322 23458999999 778765432 13456788999999999999999999999999999
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCcccc
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
++++.++|+|||.+...
T Consensus 159 -------------------------~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 -------------------------DDDEKIYIIDWPQMVST 175 (198)
T ss_pred -------------------------cCCCcEEEEECCccccC
Confidence 44567888888887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.2e-19 Score=181.33 Aligned_cols=283 Identities=21% Similarity=0.277 Sum_probs=202.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
+.+.+.+-+-+|.++.++.+.-..++...++|+.............++..-..+ ....++|.++.....+......+||
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~-~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNI-LITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCc-cccCCCCceecccCCCCCCCCcchh
Confidence 447788888899999999998888887778877653332222111111111111 1112446667666667778899999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC-CCCc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP-KDSS 254 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~-~~~~ 254 (433)
++|. +++|...|+..+ ..+.+.++.++..+..+++|||...++|||+||.|+|+..+|+.+++|||...... ..+.
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999 889999998776 68888899999999999999999999999999999999999999999998433222 1111
Q ss_pred ccccCCCCCCEEEEecCCcccc---CC----CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYE---RP----DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~---~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.-.. ........-+++..... .. ......||+.|.|||.+.+...+..+|||++|++++|.++|.+||....
T Consensus 961 ~~~s-g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLS-GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcc-cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0000 00011111122211110 01 1233579999999999999999999999999999999999999999877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
....+.. +-.+...||+.. ...+.++++++..+|
T Consensus 1040 pq~~f~n-----------------------i~~~~~~~p~g~-----------------------~~~s~~aq~~~~~ll 1073 (1205)
T KOG0606|consen 1040 PQQIFEN-----------------------ILNRDIPWPEGP-----------------------EEGSYEAQDLINRLL 1073 (1205)
T ss_pred hhhhhhc-----------------------cccCCCCCCCCc-----------------------cccChhhhhhhhhhh
Confidence 6555432 233445566532 356778999999999
Q ss_pred ccCCCCCCCHH---HHhcCCCCCCC
Q 013973 408 RYDPTDRLTAR---EALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta~---ell~hp~f~~~ 429 (433)
..+|.+|.++. ++..|+||+..
T Consensus 1074 ~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1074 TEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred ccCchhccCcccccccccCCccCCC
Confidence 99999999887 99999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=149.09 Aligned_cols=129 Identities=21% Similarity=0.252 Sum_probs=96.5
Q ss_pred eeeccccEEEEEEEECCCCeEEEEEEeecch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.||+|+||.||+|.. ++..+++|...... ........|++++..+.+.... ++.++. ......+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~---~p~~~~--~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVN---TPVVYD--VDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCC---CCEEEE--EECCCCE
Confidence 489999999999984 56779999854211 1124456799999988764322 233332 2345668
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ |++|.+++.... . .++.|++.+|.+||+.|++|+|+||+||+++
T Consensus 74 lv~e~~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-------------------- 124 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-------------------- 124 (199)
T ss_pred EEEEEECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE--------------------
Confidence 999999 889998875532 1 7899999999999999999999999999994
Q ss_pred cccccCCCCCCEEEEecCCcccc
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
++.++++|||.+...
T Consensus 125 --------~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 125 --------DDKLYLIDFGLGKYS 139 (199)
T ss_pred --------CCcEEEEECCCCcCC
Confidence 356889999887653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-19 Score=185.13 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=183.7
Q ss_pred EEEEeeeeccccEEEEEEEECCC-CeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~-~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
|.+.+.||+|+|+.|-++.+..+ ...+|.|.+.... ........|..+-+.+ ..|.|++.+++........+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~----s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKL----SKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccc----cccccccccCCccCCCcccc
Confidence 77888899999999998877433 4456777664222 1222222344443333 23788999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeeccC-ccccCCCcCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSE-YIKVPDYKSSLHTPK 251 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlKp~NILl~~~~-~~~i~dfg~~~~~~~ 251 (433)
+++++. |+++++.+........+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l------------- 164 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSAL------------- 164 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcc-------------
Confidence 999999 999988884333235778888999999999999999 99999999999999996655 44
Q ss_pred CCcccccCCCCCCEEEEecCCccccCC-CC-----Cceee-cCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERP-DQ-----NYIVS-TRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~-----~~~~g-t~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
++.|||+|..... .. ...+| ++.|+|||...+.. ..+..|+||.|+++..+++|..|+
T Consensus 165 --------------~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~ 230 (601)
T KOG0590|consen 165 --------------KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPW 230 (601)
T ss_pred --------------cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCc
Confidence 4455555443332 11 12378 99999999999854 568899999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhcc-CcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR-GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
.......... ..++.. +.+. ...+...+....++
T Consensus 231 ~~~~~~~~~~---------------------~~~~~~~~~~~------------------------~~~~~~~~~~~~~~ 265 (601)
T KOG0590|consen 231 DFPSRKDGRY---------------------SSWKSNKGRFT------------------------QLPWNSISDQAHDL 265 (601)
T ss_pred cccccccccc---------------------eeecccccccc------------------------cCccccCChhhhhc
Confidence 7543322100 000000 0000 11234556678899
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+.++|..+|..|.+..++..+||+..
T Consensus 266 l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 266 LHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccCCchhccccccccccccccc
Confidence 99999999999999999999999987
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-17 Score=167.61 Aligned_cols=135 Identities=23% Similarity=0.264 Sum_probs=100.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEe--ec--ch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RG--IK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~--~~--~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
...|...+.||+|+||.||+|...... +++|+. +. .. ...+.+..|+.+++.+.+ ++++....+
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~i~~p~~~ 404 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR-----AGVPTPVIY 404 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc-----cCCCeeEEE
Confidence 345567899999999999999875544 344432 11 11 122456789999998854 344444444
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
+......++||||+ |++|.+++. ....++.|++.+|.|||+.||+||||||+|||++
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~------------ 462 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR------------ 462 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE------------
Confidence 44556678999999 889998875 3467899999999999999999999999999993
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccc
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 275 (433)
+..++|+|||+++.
T Consensus 463 ----------------~~~~~liDFGla~~ 476 (535)
T PRK09605 463 ----------------DDRLYLIDFGLGKY 476 (535)
T ss_pred ----------------CCcEEEEeCccccc
Confidence 23588999998865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.3e-17 Score=142.74 Aligned_cols=134 Identities=23% Similarity=0.257 Sum_probs=91.2
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhh---HH----------------------HHHHHHHHHHHHHhcCCC
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---RE----------------------AAMIEIEVLQQLAKHDKG 156 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~---~~----------------------~~~~E~~~l~~l~~~~~~ 156 (433)
.+.||+|+||.||+|.+. +++.||||+++..... .. ....|...+..+.....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~- 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV- 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC-
Confidence 468999999999999986 7889999998642211 01 01345556666644321
Q ss_pred CCceEEecceeecCCeEEEEEecC-CCCHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEee
Q 013973 157 GNRCVQIRNWFDYRNHICIVFEKL-GSSLY-DFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLV 233 (433)
Q Consensus 157 ~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~-~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~ 233 (433)
.+...+.. ...++||||+ ++.+. ..+.... .. ..+..++.+++.++.++|. .||+|+||||+||+++
T Consensus 80 --~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 --PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred --CCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 12222222 2358999999 53322 1222111 11 6678899999999999999 9999999999999994
Q ss_pred ccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccc
Q 013973 234 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 234 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 275 (433)
++.++|+|||.+..
T Consensus 150 ----------------------------~~~~~liDfg~a~~ 163 (187)
T cd05119 150 ----------------------------DGKVYIIDVPQAVE 163 (187)
T ss_pred ----------------------------CCcEEEEECccccc
Confidence 45678888887754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=160.25 Aligned_cols=196 Identities=20% Similarity=0.244 Sum_probs=140.8
Q ss_pred CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCceEee
Q 013973 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM-IHTDLKPENVLLV 233 (433)
Q Consensus 156 ~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-vHrDlKp~NILl~ 233 (433)
.|.|+.++++.+-+....++|.+|| -|+|.|.+.... ..+++.....++++|+.||.|||.-.| .|+.++..|++++
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd 83 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD 83 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee
Confidence 5678999999999999999999999 899999998743 468899999999999999999998776 9999999999995
Q ss_pred ccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC-----CCCceeecCcccchhhhhCCC-------CC
Q 013973 234 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGLG-------WT 301 (433)
Q Consensus 234 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~ 301 (433)
.. +.+||.|||+...... ......-..-|.|||.+.+.. .+
T Consensus 84 ~~---------------------------w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~ 136 (484)
T KOG1023|consen 84 SR---------------------------WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALT 136 (484)
T ss_pred ee---------------------------EEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccccccc
Confidence 54 4555555555443321 111112234699999998742 36
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhh
Q 013973 302 YPCDIWSVGCILVELCTGEALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377 (433)
Q Consensus 302 ~~~DvwSlGv~l~elltg~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (433)
.+.|+||||++++|+++...||..... .+....+.. .+..+ ..|.
T Consensus 137 ~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~--------------------~rP~---------- 185 (484)
T KOG1023|consen 137 QKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGSNP--------------------FRPS---------- 185 (484)
T ss_pred ccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-cCCCC--------------------cCcc----------
Confidence 779999999999999999999975321 222222211 00000 0010
Q ss_pred hccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHh
Q 013973 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 421 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell 421 (433)
+... ....+++..++..||..+|++||+++++-
T Consensus 186 ----------i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 186 ----------IELL-NELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ----------hhhh-hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 0000 02334688899999999999999998774
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.2e-15 Score=138.83 Aligned_cols=134 Identities=20% Similarity=0.187 Sum_probs=95.9
Q ss_pred eeee-ccccEEEEEEEECCCCeEEEEEEeecc--------------hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 103 SKMG-EGTFGQVLECWDRERKEMVAIKIVRGI--------------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 103 ~~iG-~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
..|| .||.|+||.+... +..++||.+... ........+|+.++..+.+.... ++..++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~---vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLP---VPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCC---CceeEeee
Confidence 5677 7888889888764 567999987421 11234567799999999764432 33333332
Q ss_pred ec-CC---eEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 168 DY-RN---HICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 168 ~~-~~---~~~lV~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
.. .. ..++|||++ | .+|.+++... .+++.. +.||+.+|.+||+.||+||||||+|||++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~-------- 176 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD-------- 176 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc--------
Confidence 22 22 235999999 5 5898888653 455543 57899999999999999999999999994
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccc
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 275 (433)
.++.++|+|||.+..
T Consensus 177 -------------------~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 177 -------------------PDGKFWLIDFDRGEL 191 (239)
T ss_pred -------------------CCCCEEEEECCCccc
Confidence 445799999998765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=129.88 Aligned_cols=133 Identities=24% Similarity=0.314 Sum_probs=105.5
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
+++.||+|.++.||++.... ..+++|....... ...+..|..+++.+.++ ...+++++.+++..+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~---~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK---GLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc---CCCCCeEEEEcCCCCccEEEEEec
Confidence 45789999999999998754 6799999865433 45678899999999775 245677777777778899999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL---CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
|+.+..+ +......++.+++.+|.+||.. +++|+|+||+|||++
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----------------------- 123 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----------------------- 123 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-----------------------
Confidence 5555432 4566678899999999999985 699999999999994
Q ss_pred ccCCCCCCEEEEecCCccc
Q 013973 257 KRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~ 275 (433)
..+.++++|||.+..
T Consensus 124 ----~~~~~~l~Df~~~~~ 138 (155)
T cd05120 124 ----DGKILGIIDWEYAGY 138 (155)
T ss_pred ----CCcEEEEEecccccC
Confidence 345688888887764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3e-16 Score=155.05 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=184.4
Q ss_pred cCcEEEEeeeec--cccEEEEEEEE--CCCCeEEEEEEeec--c-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGE--GTFGQVLECWD--RERKEMVAIKIVRG--I-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~--G~~g~V~~~~~--~~~~~~vAiK~~~~--~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
...|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+. . ......-.+|+....++ ..|++++..+..++
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i----~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKI----DSHENPVRDSPAWE 188 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhccccc----CccccccccCcccc
Confidence 456888999999 99999999988 88899999997321 1 11122223344433333 35677888888899
Q ss_pred cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCceEeecc-CccccCCC
Q 013973 169 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE----CIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDY 243 (433)
Q Consensus 169 ~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~ivHrDlKp~NILl~~~-~~~~i~df 243 (433)
..+..++-+|+++.+|..+.+... ..++...+..++.+... ||.++|+.+|+|-|+||+||++..+ ...++.||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 999999999999999999987654 35888999999999999 9999999999999999999999766 55555555
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
|+.. +|.|.+++...... ....|..-|++||...+ -++..+|++++|.++.+..+|..++
T Consensus 268 ~~v~------------------~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 268 GLVS------------------KISDGNFSSVFKVS-KRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred ceeE------------------EccCCccccceeee-ecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 5332 22222222211111 01145667999998766 6789999999999999999987666
Q ss_pred CCC--ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 324 QTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 324 ~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
... +.+.++..+. .| .++....+.++..
T Consensus 328 ~~g~~~~W~~~r~~~-----ip---------------------------------------------~e~~~~~s~~l~~ 357 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGY-----IP---------------------------------------------LEFCEGGSSSLRS 357 (524)
T ss_pred cCCCCCCcccccccc-----Cc---------------------------------------------hhhhcCcchhhhh
Confidence 543 2222111100 01 1122234455666
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+..|++.+|..|++++.++.|++....
T Consensus 358 ~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 358 VTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred HHHHhcCcchhhhhHHHHHhccccccch
Confidence 8999999999999999999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.5e-14 Score=138.93 Aligned_cols=142 Identities=18% Similarity=0.215 Sum_probs=94.4
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhh--H---------------------------------------HHHH
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--R---------------------------------------EAAM 141 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--~---------------------------------------~~~~ 141 (433)
+.||.|++|.||+|+.+ +|+.||||+.+..-.. . -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 6788999998532100 0 0123
Q ss_pred HHHHHHHHHHhcCCCCCceEEeccee-ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHHC
Q 013973 142 IEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE-CIAFMHDL 218 (433)
Q Consensus 142 ~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~ 218 (433)
.|...+.++.....+++++ .+...+ +.....+|||||+ |++|.+++..... .++ ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555565444344433 222222 2344579999999 8898887653211 122 2345566655 47889999
Q ss_pred CceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccC
Q 013973 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277 (433)
Q Consensus 219 ~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 277 (433)
|++|+|+||.||++ ..++.++++|||++....
T Consensus 277 g~~H~D~hPgNilv---------------------------~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFV---------------------------LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEE---------------------------CCCCcEEEEeCCCeeECC
Confidence 99999999999999 445678888888876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=140.08 Aligned_cols=150 Identities=19% Similarity=0.306 Sum_probs=95.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-----------------------------------hHH---
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------------------YRE--- 138 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------------------------------~~~--- 138 (433)
..|.. +.||+|++|.||+|+.+.+|+.||||+.+.... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999998899999999863210 011
Q ss_pred ---HHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEEEEEecC-CCCHHHH--HHhcCC--CCCCHHHHHHHHHHHH
Q 013973 139 ---AAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKL-GSSLYDF--LRKNNY--RSFPIDLVREIARQLL 209 (433)
Q Consensus 139 ---~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~lV~e~~-~~~L~~~--l~~~~~--~~l~~~~~~~i~~qi~ 209 (433)
.+..|...+.++.....+.+ .+.+...+ +.....+|||||+ |+.+.++ +...+. ..+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~-~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSD-MLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCC-CeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 12334444555544332222 23333333 2345678999999 8898774 333221 1234444445555554
Q ss_pred HHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC
Q 013973 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278 (433)
Q Consensus 210 ~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~ 278 (433)
..|++|+|+||.||+++.+| ...+.++++|||+......
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g-----------------------~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDP-----------------------PENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCC-----------------------CCCCeEEEEecceEEECCH
Confidence 58999999999999996554 2334788888887765543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.1e-12 Score=115.99 Aligned_cols=136 Identities=18% Similarity=0.193 Sum_probs=97.6
Q ss_pred eeeeccccEEEEEEEECC------CCeEEEEEEeecc-------------h----------hhH----HHHHHHHHHHHH
Q 013973 103 SKMGEGTFGQVLECWDRE------RKEMVAIKIVRGI-------------K----------KYR----EAAMIEIEVLQQ 149 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~------~~~~vAiK~~~~~-------------~----------~~~----~~~~~E~~~l~~ 149 (433)
..||.|--+.||.|.... .+..+|||+.+.. + ... .....|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998654 3578999987410 0 011 122379999999
Q ss_pred HHhcCCCCCceEEecceeecCCeEEEEEecCCC-CHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCC
Q 013973 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS-SLY-DFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLK 226 (433)
Q Consensus 150 l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~~~-~L~-~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlK 226 (433)
+.......|.++. . ..-+|||||+++ ++. ..|... .++...+..+..+++.+|..| |+.||||+||+
T Consensus 83 l~~~Gv~vP~pi~---~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVV---L----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEE---e----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9887655554443 2 445799999954 332 223221 356667778899999999999 89999999999
Q ss_pred CCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCcccc
Q 013973 227 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 227 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
+.|||+. ++.+.|+|||.+...
T Consensus 153 ~~NIL~~----------------------------~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH----------------------------DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE----------------------------CCcEEEEECCCceeC
Confidence 9999994 245899999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=8e-13 Score=115.33 Aligned_cols=128 Identities=16% Similarity=0.085 Sum_probs=91.4
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 180 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~- 180 (433)
++.|+.|.++.||++... ++.|++|+.............|..+++.+..... +.+++.... ...++|||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~----~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGI----GPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCC----CCceEEEeC--CCCeEEEEecC
Confidence 477899999999999864 6779999876433223345678999998866432 233444332 2347999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 181 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM-----IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 181 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-----vHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|.++.+. ......++.+++.+|..||+.++ +|+|+||.||+++
T Consensus 75 G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~---------------------- 122 (170)
T cd05151 75 GSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD---------------------- 122 (170)
T ss_pred CCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----------------------
Confidence 6665432 01123457899999999999885 9999999999994
Q ss_pred cccCCCCCCEEEEecCCccc
Q 013973 256 FKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~ 275 (433)
++.++++|||.+..
T Consensus 123 ------~~~~~liDf~~a~~ 136 (170)
T cd05151 123 ------DGRLWLIDWEYAGM 136 (170)
T ss_pred ------CCeEEEEecccccC
Confidence 34588999987753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.9e-13 Score=134.05 Aligned_cols=249 Identities=21% Similarity=0.171 Sum_probs=167.9
Q ss_pred ecCcEEEEeeeeccccEEEEEEEEC-CCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDR-ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
...+|..+..||.|.|+.|+.+... .++..|++|.+.+. ...+.....|+.+...+.. |.+++.....|...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~----~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGS----HLPSVGKNSSWSQL 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhc----ccccCCCCCCcccc
Confidence 4567999999999999999988755 67788999976522 2222333456666655543 23456656666666
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
...|+=.||| ++++...+... ..+++...+++..|++.++.++|+..++|+|+||+||++.++|
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~------------- 403 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG------------- 403 (524)
T ss_pred ccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-------------
Confidence 7777999999 77776555322 2588889999999999999999999999999999999996642
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCccc--chhhhhCCCCCCcchhHHHHHHHHHHHhCCCC-CCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR--APEVILGLGWTYPCDIWSVGCILVELCTGEAL-FQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P-f~~~ 326 (433)
...++.|||..+...-......++..++ +++......+..+.|++|||.-+.+.++|... ..+.
T Consensus 404 -------------~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~ 470 (524)
T KOG0601|consen 404 -------------FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV 470 (524)
T ss_pred -------------hhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccc
Confidence 2345555555432111111112233334 55555566788999999999999999998642 2211
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
.. ..+..+...- ......++..+...+
T Consensus 471 ~~---------------------------~~i~~~~~p~--------------------------~~~~~~~~q~~~kv~ 497 (524)
T KOG0601|consen 471 QS---------------------------LTIRSGDTPN--------------------------LPGLKLQLQVLLKVM 497 (524)
T ss_pred cc---------------------------eeeecccccC--------------------------CCchHHhhhhhhhhh
Confidence 10 0111221110 112235677888999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+..++..|+.+.++..|.=|-.
T Consensus 498 ~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cCCccccchhhhhhcccchhhh
Confidence 9999999999999988876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.4e-12 Score=119.89 Aligned_cols=200 Identities=18% Similarity=0.279 Sum_probs=132.6
Q ss_pred CCceEEecceeecC-----CeEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCC
Q 013973 157 GNRCVQIRNWFDYR-----NHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLK 226 (433)
Q Consensus 157 ~~~i~~~~~~~~~~-----~~~~lV~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlK 226 (433)
|.|++++..++.+. ....++.||| .|+|..+|+... ...+......+|..||+.||.|||+.. |+|+.+.
T Consensus 126 HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlT 205 (458)
T KOG1266|consen 126 HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLT 205 (458)
T ss_pred HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcc
Confidence 45688998888754 3588999999 999999998532 356888888999999999999999876 9999999
Q ss_pred CCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchh
Q 013973 227 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 227 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
.+-|++..+|-+||.---.... ...++.+ .........|-++|.|||.=.....+.++||
T Consensus 206 c~tifiq~ngLIkig~~ap~s~-------------h~s~~~~-------~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dI 265 (458)
T KOG1266|consen 206 CDTIFIQHNGLIKIGSVAPDST-------------HPSVNST-------REAEKSVNTSLPGFSAPESGTTTNTTGASDI 265 (458)
T ss_pred hhheeecCCceEEecccCcccc-------------chhhhhh-------hHhhhhccccCCccccCCcCcccccccchhh
Confidence 9999996655554421000000 0000000 0001122346788999998776677889999
Q ss_pred HHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCTGEAL-FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~elltg~~P-f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|+||....||..|..- -.+.+..+.-..+... +
T Consensus 266 y~fgmcAlemailEiq~tnseS~~~~ee~ia~~-------------------i--------------------------- 299 (458)
T KOG1266|consen 266 YKFGMCALEMAILEIQSTNSESKVEVEENIANV-------------------I--------------------------- 299 (458)
T ss_pred hhhhHHHHHHHHheeccCCCcceeehhhhhhhh-------------------e---------------------------
Confidence 9999999999887632 2221111000000000 0
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.. -....-++++.+||+-.|..||+|.++|.||-+-+
T Consensus 300 ---~~---len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 300 ---IG---LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ---ee---ccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 00 00112356899999999999999999999997643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-10 Score=96.84 Aligned_cols=145 Identities=23% Similarity=0.174 Sum_probs=105.8
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEee-c--------chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVR-G--------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~-~--------~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+..|-+|+-+.|+++.. .|+.+.||.-. + .+-.+.+...|+.+|.++.......|.+ + +.+..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l---~--~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRL---I--FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceE---E--EEecC
Confidence 567888999999999965 57777777431 1 1233556678999999997765444433 2 23334
Q ss_pred eEEEEEecCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 172 HICIVFEKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 172 ~~~lV~e~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.-.|+|||+.| ++.+++...............++..|=..|.-||..+|||+||..+||++.++|
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~------------- 150 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG------------- 150 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-------------
Confidence 45688999955 889998876543344444477888888899999999999999999999997653
Q ss_pred CCCCcccccCCCCCCEEEEecCCcccc
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
....+.++|||++...
T Consensus 151 -----------~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 151 -----------NQITPILIDFGLSSVS 166 (229)
T ss_pred -----------CcCceEEEeecchhcc
Confidence 3456799999998653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=106.03 Aligned_cols=107 Identities=17% Similarity=0.141 Sum_probs=73.4
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---CeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~~lV~ 177 (433)
+.||.|..+.||++.... |+.|++|+...... .......|.++++.+...... +.+++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~---vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVP---VPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCC---CCCEEEECCCCCccCCceEEE
Confidence 678999999999998754 57799998764332 345678899999999764322 34444444432 3678999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH 216 (433)
||+ |.++.+.+.. ..++......++.+++.+|..||
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALH 116 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHh
Confidence 999 6666554321 14666666777777777777777
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.1e-09 Score=99.23 Aligned_cols=142 Identities=18% Similarity=0.063 Sum_probs=97.5
Q ss_pred EEEEEEECCCCeEEEEEEeecchh------------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeEEEEE
Q 013973 112 QVLECWDRERKEMVAIKIVRGIKK------------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVF 177 (433)
Q Consensus 112 ~V~~~~~~~~~~~vAiK~~~~~~~------------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~lV~ 177 (433)
.|+++.. .|+.|.||....... ....+..|...+.++.......|.++-+...-.. ...-+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555533 466788886643221 0113678999999998876665655444221111 34578999
Q ss_pred ecCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 178 EKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 178 e~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|++++ +|.+++........+......++.+++..+.-||..||+|+|+++.|||++.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~------------------ 176 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFP------------------ 176 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEecccc------------------
Confidence 99944 7999986533235667778899999999999999999999999999999963100
Q ss_pred cccCCCCCCEEEEecCCccc
Q 013973 256 FKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~ 275 (433)
...+...+.++||+.+..
T Consensus 177 --~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 177 --GREEDLKLSVIDLHRAQI 194 (268)
T ss_pred --CCCCCceEEEEECCcccc
Confidence 002356799999998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.7e-09 Score=92.79 Aligned_cols=130 Identities=20% Similarity=0.202 Sum_probs=91.2
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEe-ec--------chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIV-RG--------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~-~~--------~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
..|++|+-+.+|.+... |..+++|.= ++ .+-.......|..++.++.....+.| .++.+ +....
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P---~v~dv--D~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVP---IVYDV--DPDNG 74 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCC---eEEEE--cCCCC
Confidence 45789999999998653 333666642 11 11224556779999999877654433 33333 34556
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
.|+|||+ |..|.+++... ...++..|=.-+.-||..||||+||.++||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~------------------ 127 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG------------------ 127 (204)
T ss_pred EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC------------------
Confidence 7999999 66777788764 1345566666678899999999999999999942
Q ss_pred CcccccCCCCCCEEEEecCCcccc
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
..+.++|||++...
T Consensus 128 ----------~~i~~IDfGLg~~s 141 (204)
T COG3642 128 ----------GRIYFIDFGLGEFS 141 (204)
T ss_pred ----------CcEEEEECCccccc
Confidence 34899999998753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.1e-09 Score=108.05 Aligned_cols=182 Identities=16% Similarity=0.260 Sum_probs=122.0
Q ss_pred EEEEeeeeccccEEEE-EEEECCCCeEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 99 YKIHSKMGEGTFGQVL-ECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~-~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
|.+ ....-++.+ +| .|..+.++..|.|...+.... ..+...+-++.|+.+ .||+|++++..++..+.+|||
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-----RHP~Il~yL~t~e~~~~~ylv 87 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-----RHPNILSYLDTTEEEGTLYLV 87 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-----cCchhhhhhhhhcccCceEEE
Confidence 444 333344444 34 466677788888888764333 223344456666666 679999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
+|-+. -|..++.. +.......-+.||+.||.||| ..+++|++|.-+-|+++..|.+||.+|.+....+
T Consensus 88 TErV~-Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~----- 156 (690)
T KOG1243|consen 88 TERVR-PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS----- 156 (690)
T ss_pred eeccc-cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc-----
Confidence 99873 35556654 336677788999999999998 4569999999999999887777776654332111
Q ss_pred cccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg 319 (433)
+|+- ......---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 157 -------------~~~~------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 157 -------------GFNA------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -------------cCCc------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1110 001111112356666543322 457999999999999999
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-09 Score=96.27 Aligned_cols=127 Identities=26% Similarity=0.304 Sum_probs=79.1
Q ss_pred EEEEEEECCCCeEEEEEEeecc---------------------------hhhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 112 QVLECWDRERKEMVAIKIVRGI---------------------------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 112 ~V~~~~~~~~~~~vAiK~~~~~---------------------------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
.||.|... .|..+|+|+.+.. .........|...|.++.......| ..+
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP---~p~ 76 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP---KPY 76 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-----EE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC---cEE
Confidence 38989874 5678999987410 0112345678899998876543334 443
Q ss_pred ceeecCCeEEEEEecCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCceEeeccCccccC
Q 013973 165 NWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIARQLLECIAF-MHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
.+. .-+|||||++ |.....|.... ++......++.+++..+.. +|+.||||+||.+.|||++.
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~------- 142 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD------- 142 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET-------
T ss_pred EEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec-------
Confidence 332 2369999996 64444444332 3345567788888886665 57999999999999999942
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccC
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 277 (433)
+ .+.|+|||.+....
T Consensus 143 --------------------~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 143 --------------------G-KVYIIDFGQAVDSS 157 (188)
T ss_dssp --------------------T-CEEE--GTTEEETT
T ss_pred --------------------c-eEEEEecCcceecC
Confidence 2 79999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=9.8e-11 Score=117.92 Aligned_cols=166 Identities=20% Similarity=0.326 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCcee
Q 013973 206 RQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 284 (433)
Q Consensus 206 ~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 284 (433)
.+++.||.|+|+ .++||+.|.|++|.++..|.+||+-|+.+.-...... .-...-|+++.-.. .
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--------~p~~~yd~~lp~~~-------~ 170 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--------YPFSEYDPPLPLLL-------Q 170 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--------cccccCCCCCChhh-------c
Confidence 344589999995 5799999999999998888888887775544332211 11222233322211 2
Q ss_pred ecCcccchhhhhCCCCCCcchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcc
Q 013973 285 STRHYRAPEVILGLGWTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL 363 (433)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 363 (433)
-...|.|||++.....+.++|++|+||++|.+. .|..-+...+...... ....... .+.+
T Consensus 171 ~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~------------------~~~~ 231 (700)
T KOG2137|consen 171 PHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLN------------------AGAF 231 (700)
T ss_pred cCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccc------------------cccc
Confidence 345799999999988899999999999999998 4555554432221111 1111000 0000
Q ss_pred cCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 364 DWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
. ....++.++++=|.++|..++.-||++.+++..|||.+.-+
T Consensus 232 ~--------------------------~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 232 G--------------------------YSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred c--------------------------ccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence 0 11467789999999999999999999999999999987543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.4e-08 Score=96.69 Aligned_cols=165 Identities=17% Similarity=0.226 Sum_probs=120.7
Q ss_pred cEEEEEEEECCCCeEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----CCeEEEEEecC--CC
Q 013973 110 FGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL--GS 182 (433)
Q Consensus 110 ~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~~~lV~e~~--~~ 182 (433)
-.+-|+|....+|..|++|.+...+. .......-++..+++ .|.|+|++.+.|.+ +..+++|++|. .+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-----~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-----CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-----ccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 45789999999999999999843221 111233346677777 66889999999874 45789999997 66
Q ss_pred CHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 183 SLYDFLRKN-------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 183 ~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+|.++.... .+...+++.++.|+.|+..||.++|+.|+.-+-|.|.+||+
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv----------------- 426 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV----------------- 426 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe-----------------
Confidence 888765321 12357889999999999999999999999989999999999
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
.++.+++|..-|+.-....+. + |-+. --.+-|.-.||.+++.|.||.
T Consensus 427 ----------~G~~RIriS~C~i~Dvl~~d~----~-------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 427 ----------TGKMRIRISGCGIMDVLQEDP----T-------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred ----------eCcceEEEecccceeeecCCC----C-------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 444467776666544332222 0 1111 134579999999999999995
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1e-07 Score=91.16 Aligned_cols=129 Identities=17% Similarity=0.297 Sum_probs=91.9
Q ss_pred eEEEEEecC-CC-CHHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 172 HICIVFEKL-GS-SLYDFLRK----NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 172 ~~~lV~e~~-~~-~L~~~l~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...+.|..+ |. .+.+++.- ....-..|..+++.+..++.+..-||+.|.+-+|+.++|+|+.+++.+.+.|-
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds-- 161 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS-- 161 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc--
Confidence 367888887 32 44444431 12234689999999999999999999999999999999999976665554431
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhC-
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG- 319 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg- 319 (433)
....|++-|.- ....+|...|.+||.-. +..-+...|.|.|||++++|+.|
T Consensus 162 -----------------Dsfqi~~ng~~------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~gg 218 (637)
T COG4248 162 -----------------DSFQINANGTL------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGG 218 (637)
T ss_pred -----------------cceeeccCCce------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcC
Confidence 01112211111 01236889999999865 23456789999999999999886
Q ss_pred CCCCCC
Q 013973 320 EALFQT 325 (433)
Q Consensus 320 ~~Pf~~ 325 (433)
+.||.+
T Consensus 219 rHPysG 224 (637)
T COG4248 219 RHPYSG 224 (637)
T ss_pred CCCCCc
Confidence 999986
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.8e-07 Score=81.96 Aligned_cols=141 Identities=11% Similarity=0.107 Sum_probs=101.6
Q ss_pred eccccEEEEEEEECCCCeEEEEEEeec----c---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeEEEE
Q 013973 106 GEGTFGQVLECWDRERKEMVAIKIVRG----I---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIV 176 (433)
Q Consensus 106 G~G~~g~V~~~~~~~~~~~vAiK~~~~----~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~lV 176 (433)
|+||.+.|+..... |+.|=+|.-.+ . ......+..|+..+.++.....+.|.++ +.+.-.. .-..+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56888889886543 23466665431 1 2245668899999999988776555544 2221111 2346899
Q ss_pred EecCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 177 FEKLG--SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 177 ~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+|-++ .+|.+++......+.+......++.+++..|.-||+.|+.|+|+-+.|||++.+|
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g------------------ 165 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG------------------ 165 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC------------------
Confidence 99885 6899998775444567788889999999999999999999999999999995321
Q ss_pred ccccCCCCCCEEEEecCCcc
Q 013973 255 YFKRMPKSSAIKVIDFGSTT 274 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~ 274 (433)
...++++||.-++
T Consensus 166 -------~~~v~lIDlEk~r 178 (216)
T PRK09902 166 -------KAEAGFLDLEKSR 178 (216)
T ss_pred -------CeeEEEEEhhccc
Confidence 2348999998665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-07 Score=85.25 Aligned_cols=113 Identities=26% Similarity=0.305 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCceEEecceeec-CCeEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 013973 137 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213 (433)
Q Consensus 137 ~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-~~~~~lV~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~ 213 (433)
......|...+..+......-|..+-+...-.. ....+||+|++ + .+|.+++.... .++......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 445778999999998876655555444322111 13568999999 4 37999988644 2667778899999999999
Q ss_pred HHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccc
Q 013973 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 214 ~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 275 (433)
-||+.||+|+|+++.|||++.++ ....+.++||+.+..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~------------------------~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDD------------------------GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCC------------------------CceeEEEEcchhcee
Confidence 99999999999999999996432 234789999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4e-07 Score=82.97 Aligned_cols=134 Identities=28% Similarity=0.336 Sum_probs=92.4
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeec-------ch----------------hhHHHHHHHHHHHHHHHhcCC
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-------IK----------------KYREAAMIEIEVLQQLAKHDK 155 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~----------------~~~~~~~~E~~~l~~l~~~~~ 155 (433)
..+..+||-|--+.||.|.+. .|..+|||.-+. .+ -.+..+.+|.++|+++.....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457789999999999999886 567799997531 00 113445679999999865422
Q ss_pred CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 156 ~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
. +..-++ .+...+|||++ |-.|... +++.+.+..++..|+.-+.-+-..||||+|+.+=|||+
T Consensus 172 ~---VP~P~~----~nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV-- 235 (304)
T COG0478 172 K---VPKPIA----WNRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV-- 235 (304)
T ss_pred C---CCCccc----cccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE--
Confidence 2 222222 24557999999 5444321 23455566666667666666668999999999999999
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCcc
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~ 274 (433)
++++.+.++||-.+.
T Consensus 236 -------------------------~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 -------------------------TEDGDIVVIDWPQAV 250 (304)
T ss_pred -------------------------ecCCCEEEEeCcccc
Confidence 455678888886554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.1e-09 Score=107.39 Aligned_cols=246 Identities=15% Similarity=0.057 Sum_probs=162.7
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCc-eEEecceeecCCeEEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRNHICIV 176 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~-i~~~~~~~~~~~~~~lV 176 (433)
.+.....+++|+++++++.+...+...+ .+.+... .....++++|.++ ++|+ .+..++.++.+.+..++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~-----n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKV-----NNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHc-----cCCCCcccccccCCcccccchh
Confidence 4556677899999999999887776655 7766533 3345578888888 5566 66667777778899999
Q ss_pred EecC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 177 FEKL-GS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 177 ~e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
|+++ ++ +-..-..... ..+..-+...+...-.++|+++|+.-=+|+| |||..+
T Consensus 313 ~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-------------------- 367 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-------------------- 367 (829)
T ss_pred hhhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----cccccc--------------------
Confidence 9999 43 2111110000 0122333444556667889999988779998 888643
Q ss_pred ccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~ 332 (433)
...+..||+........ .....+|+.++|||++....+....|.|++|+-..++.-|.+|-...-. .
T Consensus 368 --------~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~- 436 (829)
T KOG0576|consen 368 --------EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--V- 436 (829)
T ss_pred --------cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--c-
Confidence 44677777776655544 4556899999999999999999999999999877777777766543100 0
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
...+....+...+... ..+.. ..-.++...|+..-|.
T Consensus 437 ------------------------------~~~~g~~p~s~~L~~~-----------~aw~~--~~~~~~~~~~~~g~P~ 473 (829)
T KOG0576|consen 437 ------------------------------LPMIGNGPNSPMLTDK-----------SAWSP--VFHRDFPAPCLNGLPP 473 (829)
T ss_pred ------------------------------cCCCCCCCCccccchh-----------hhcCc--ccccCCcccccCCCCC
Confidence 0000000000000000 00000 0112577899999999
Q ss_pred CCCCHHHHhcCCCCCCCCCC
Q 013973 413 DRLTAREALRHPFFTRDHLR 432 (433)
Q Consensus 413 ~R~ta~ell~hp~f~~~~~~ 432 (433)
.|+.+..++-|.+|...++|
T Consensus 474 ~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 474 TPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred CCcchhhHHHHHHhccCccc
Confidence 99999999999999998876
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.2e-07 Score=79.83 Aligned_cols=137 Identities=16% Similarity=0.137 Sum_probs=93.1
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEeecchhh-------------------------HHHHHHHHHHHHHHHhcCC
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------------------------REAAMIEIEVLQQLAKHDK 155 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-------------------------~~~~~~E~~~l~~l~~~~~ 155 (433)
+...|++|--+.||+|.. .++..+|+|+++..... ..-...|..-|+++.....
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 334677888889999975 45678999998522111 1123457888888877654
Q ss_pred CCCceEEecceeecCCeEEEEEecCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEe
Q 013973 156 GGNRCVQIRNWFDYRNHICIVFEKLGSSL--YDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLL 232 (433)
Q Consensus 156 ~~~~i~~~~~~~~~~~~~~lV~e~~~~~L--~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl 232 (433)
..| +-+.+. .-.|||||+|..- .-.|... .+..+++..+..++++.+.-|-. .++||+||..=|||+
T Consensus 131 rvP---~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 131 RVP---EPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCC---Cceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 333 222222 2359999996541 1122222 24444788889999999988876 899999999999999
Q ss_pred eccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCcccc
Q 013973 233 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 233 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
. ++.+.|+|||.+...
T Consensus 201 ~----------------------------~~~p~iID~~QaV~~ 216 (268)
T COG1718 201 H----------------------------DGEPYIIDVSQAVTI 216 (268)
T ss_pred E----------------------------CCeEEEEECcccccc
Confidence 3 456899999988643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.6e-07 Score=94.94 Aligned_cols=128 Identities=16% Similarity=0.215 Sum_probs=80.8
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchh-----------------------------------h------HHHHH
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------------------Y------REAAM 141 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------------------------------~------~~~~~ 141 (433)
+.|+.++-|.||+|+.+. |+.||||+.+..-. . .-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999875 88999999741100 0 01123
Q ss_pred HHHHHHHHHHhcCCCCCceEEecce-eecCCeEEEEEecC-CCCHHHH--HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013973 142 IEIEVLQQLAKHDKGGNRCVQIRNW-FDYRNHICIVFEKL-GSSLYDF--LRKNNYRSFPIDLVREIARQLLECIAFMHD 217 (433)
Q Consensus 142 ~E~~~l~~l~~~~~~~~~i~~~~~~-~~~~~~~~lV~e~~-~~~L~~~--l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (433)
.|...+.+++....+.+.+ .+-.. ++..+.-.|+|||+ |-.+.+. +... .++...+.....++ -+.-+=.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~--f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRA--FLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHH--HHHHHHh
Confidence 4666666666665555543 33333 34456678999999 7777776 4443 35533332222222 1333345
Q ss_pred CCceeccCCCCceEeeccCc
Q 013973 218 LCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 218 ~~ivHrDlKp~NILl~~~~~ 237 (433)
.|+.|.|.+|.||+++.+|.
T Consensus 284 dgffHaDpHpGNi~v~~~g~ 303 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGR 303 (517)
T ss_pred cCccccCCCccceEEecCCc
Confidence 89999999999999955443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.4e-06 Score=79.72 Aligned_cols=82 Identities=21% Similarity=0.213 Sum_probs=57.6
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 180 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~- 180 (433)
++.|+.|..+.||++.... + .+++|..... ........|..+++.+..+....|.++............+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 5789999999999998765 3 6999988654 4556777899999999876543344433222233445689999999
Q ss_pred CCCHHH
Q 013973 181 GSSLYD 186 (433)
Q Consensus 181 ~~~L~~ 186 (433)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 666655
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=2e-06 Score=76.82 Aligned_cols=127 Identities=19% Similarity=0.206 Sum_probs=80.4
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHH----------HHHHHHHHHHHHHhcCCCCC---ceE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----------AAMIEIEVLQQLAKHDKGGN---RCV 161 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~----------~~~~E~~~l~~l~~~~~~~~---~i~ 161 (433)
+.++|++++.+-......|.+-. ..|+.+++|..+......+ ...+++..+..+....-..+ .++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45689999999888777777664 3567799998763221111 12234444444433221111 222
Q ss_pred EecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEee
Q 013973 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 233 (433)
Q Consensus 162 ~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~ 233 (433)
.....+......+|||||+ |..|.++.. +++ .+...|..++.-||+.|++|+|.+|.|++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS 169 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence 2222333345667999999 777766532 333 2446677789999999999999999999995
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.6e-06 Score=76.24 Aligned_cols=72 Identities=11% Similarity=0.122 Sum_probs=50.7
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecCCC
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 182 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~~~ 182 (433)
..||+|..+.||+. .+..+++|+..... .......|.+++..+....... ...+.+.+..+...+|||++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpv---P~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPT---PHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCC---CceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 23457899876422 3345678999999987654333 4445555666778899999933
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-05 Score=71.38 Aligned_cols=123 Identities=15% Similarity=0.252 Sum_probs=91.8
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch-----------------hhHHHHHHHHHHHHHHH-hcCCCCCceEEec
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----------------KYREAAMIEIEVLQQLA-KHDKGGNRCVQIR 164 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------------~~~~~~~~E~~~l~~l~-~~~~~~~~i~~~~ 164 (433)
..||+|+.-.||.- ..+....||+++... ....+...|+.....+. .....+.+|..++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999999964 233447899886433 22466777888888887 6666778899999
Q ss_pred ceeecCCeEEEEEecC---C----CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeecc
Q 013973 165 NWFDYRNHICIVFEKL---G----SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 235 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~---~----~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~ 235 (433)
++.+++.-..+|+|.+ . .+|.+++... .++. .....+ -.-..||-+.+|+.+||+|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHH---HHHHHHHHHcCCeecCCCcccEEEEec
Confidence 9999999999999976 2 3688888654 3655 333333 334678889999999999999999654
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.4e-05 Score=67.54 Aligned_cols=119 Identities=19% Similarity=0.276 Sum_probs=83.9
Q ss_pred CcEEEEeeeecccc-EEEEEEEECCCCeEEEEEEeec------------ch----------hhHHHHHHHHHHHHHHHhc
Q 013973 97 SRYKIHSKMGEGTF-GQVLECWDRERKEMVAIKIVRG------------IK----------KYREAAMIEIEVLQQLAKH 153 (433)
Q Consensus 97 ~~~~~~~~iG~G~~-g~V~~~~~~~~~~~vAiK~~~~------------~~----------~~~~~~~~E~~~l~~l~~~ 153 (433)
.+++.++.||.|.- |.||++.. +|+.||+|+++. .. .....+..|.....++...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 99999975 577999999421 00 1223466788888888776
Q ss_pred CCCCCceEEecceeecC------------------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 013973 154 DKGGNRCVQIRNWFDYR------------------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215 (433)
Q Consensus 154 ~~~~~~i~~~~~~~~~~------------------~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L 215 (433)
..++---+++++|+.-. ....||.||+...- .+.. .-+.+|.+-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHH
Confidence 54333248888887211 13467888762221 1222 3356777888999
Q ss_pred HHCCceeccCCCCceE
Q 013973 216 HDLCMIHTDLKPENVL 231 (433)
Q Consensus 216 H~~~ivHrDlKp~NIL 231 (433)
|..||+-+|+|+.|..
T Consensus 181 ~k~gI~~~Dv~~~ny~ 196 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR 196 (207)
T ss_pred HHCCeeeccCcccccc
Confidence 9999999999999987
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.5e-05 Score=71.29 Aligned_cols=74 Identities=15% Similarity=0.082 Sum_probs=49.7
Q ss_pred eeecccc-EEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 013973 104 KMGEGTF-GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 181 (433)
Q Consensus 104 ~iG~G~~-g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~ 181 (433)
.|-.|.+ +.||+.... +..+.+|+..... ......|+++++.+..+ .. +.+++.+....+..++|||++ |
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~-~~---vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK-LP---VPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc-CC---CCeEEEEEecCCccEEEEEeeCC
Confidence 3445554 789998653 3568889876432 33466799999998765 22 455566666566788999999 6
Q ss_pred CCHH
Q 013973 182 SSLY 185 (433)
Q Consensus 182 ~~L~ 185 (433)
.+|.
T Consensus 77 ~~l~ 80 (244)
T cd05150 77 VPAA 80 (244)
T ss_pred ccHh
Confidence 5554
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.7e-05 Score=65.89 Aligned_cols=131 Identities=24% Similarity=0.267 Sum_probs=86.5
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
.++.+.||+|.+|.||+|... |..+|+|+-+ .+..+..+..|.++|..+..... -.+++.+-. ..++||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~----~p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGV----TPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCC----CceEEEech----hhhhhh
Confidence 456789999999999999764 5579999765 35566778889999988854332 223333322 235699
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CC-ceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK-PE-NVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlK-p~-NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|+ |-.|.+.-.. .+ ++-...++..---|-..||-|..|. |. ||++
T Consensus 93 ~i~G~~L~~~~~~-----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----------------------- 140 (201)
T COG2112 93 YIDGRPLGKLEIG-----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----------------------- 140 (201)
T ss_pred hhcCcchhhhhhc-----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe-----------------------
Confidence 99 6677665432 11 2223444555444667899998886 33 4554
Q ss_pred cccCCCCCCEEEEecCCccccC
Q 013973 256 FKRMPKSSAIKVIDFGSTTYER 277 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~ 277 (433)
.+..+.|+||..|++..
T Consensus 141 -----~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 141 -----NDRDVYIIDFDSATFKK 157 (201)
T ss_pred -----cCCcEEEEEccchhhcc
Confidence 23479999999887543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.6e-05 Score=70.89 Aligned_cols=77 Identities=13% Similarity=0.045 Sum_probs=45.2
Q ss_pred EeeeeccccE-EEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhc-CCCCCceEEecceeecCCeEEEEEec
Q 013973 102 HSKMGEGTFG-QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH-DKGGNRCVQIRNWFDYRNHICIVFEK 179 (433)
Q Consensus 102 ~~~iG~G~~g-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~~i~~~~~~~~~~~~~~lV~e~ 179 (433)
++.|+.|+.. .||+.. ..+++|+.+. .........|.+++..+... ....|.++..-..-+.....++||++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567777766 489761 2478887654 22345678899999998753 22334333221111112345889999
Q ss_pred C-CCCH
Q 013973 180 L-GSSL 184 (433)
Q Consensus 180 ~-~~~L 184 (433)
+ |.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 8 5444
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.3e-05 Score=82.98 Aligned_cols=202 Identities=24% Similarity=0.317 Sum_probs=123.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCceEEecceeecCC----eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 013973 139 AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213 (433)
Q Consensus 139 ~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~ 213 (433)
....|...+..+.| +|++..+.+--... ...+..+++ ..++.+.++..+ ..+.+.++.+..++..||.
T Consensus 228 ~~E~e~~~l~k~~~-----~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 228 TTEIELESLSKIAH-----DNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHHHhhcc-----ccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHH
Confidence 34456666666644 44554444432221 122334567 678888887765 7899999999999999999
Q ss_pred HHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEE--ecCCccccCCCCCc--eeecCcc
Q 013973 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI--DFGSTTYERPDQNY--IVSTRHY 289 (433)
Q Consensus 214 ~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~--Dfg~a~~~~~~~~~--~~gt~~y 289 (433)
|+|+... .|+.+......- ...+....+.+. ||+........... ..-+..+
T Consensus 301 ~~h~~~l-------~~v~L~~s~~~~-----------------~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~ 356 (1351)
T KOG1035|consen 301 YLHSLSL-------EHVVLSASSSKE-----------------STVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIR 356 (1351)
T ss_pred HHHHhcc-------ceeEEecccccc-----------------cccCccceeecchhhhcccccCCCcccchhhcCcccc
Confidence 9999843 444443221000 001334444444 66655543332211 2335567
Q ss_pred cchhhhhCCCCCCc--chhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCC
Q 013973 290 RAPEVILGLGWTYP--CDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 367 (433)
Q Consensus 290 ~aPE~~~~~~~~~~--~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 367 (433)
.|+|......+.++ .|+|.+|.....+..|..+-..... ....++
T Consensus 357 ~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~------~~~~l~--------------------------- 403 (1351)
T KOG1035|consen 357 NADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV------PVSLLD--------------------------- 403 (1351)
T ss_pred ccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc------hhhhhc---------------------------
Confidence 88888776665544 6999999999999888653321100 000000
Q ss_pred CccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 368 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
........+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 404 -------------------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 404 -------------------------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred -------------------------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 0111156778999999999999999999999998644
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.2e-05 Score=80.59 Aligned_cols=79 Identities=15% Similarity=0.088 Sum_probs=51.5
Q ss_pred EeeeeccccEEEEEEEECCCC--eEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---CeEE
Q 013973 102 HSKMGEGTFGQVLECWDRERK--EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHIC 174 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~--~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~~ 174 (433)
++.|+.|.+..+|+......+ ..+++|+..... .......+|..+++.+..+. + ..+.+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~-~-vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHT-D-VPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcC-C-CCCCcEEEEecCCCcCCCce
Confidence 577899999999998765433 357777654221 22345778999999996421 1 1245555555443 5678
Q ss_pred EEEecCCC
Q 013973 175 IVFEKLGS 182 (433)
Q Consensus 175 lV~e~~~~ 182 (433)
+||||+.|
T Consensus 121 lVME~v~G 128 (822)
T PLN02876 121 YIMEYLEG 128 (822)
T ss_pred EEEEecCC
Confidence 99999933
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.4e-05 Score=76.72 Aligned_cols=145 Identities=14% Similarity=0.144 Sum_probs=87.7
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecch--------------------------------hhHHH------HHHHH
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--------------------------------KYREA------AMIEI 144 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------------------------------~~~~~------~~~E~ 144 (433)
+.||.-+.|.|++|+.+. |+.||||+-+..- ...+. +..|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999886 8999999853110 00111 22344
Q ss_pred HHHHHHHhcCCCCC-----ceEEecceeecCCeEEEEEecC-CCCHH--HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 013973 145 EVLQQLAKHDKGGN-----RCVQIRNWFDYRNHICIVFEKL-GSSLY--DFLRKNNYRSFPIDLVREIARQLLECIAFMH 216 (433)
Q Consensus 145 ~~l~~l~~~~~~~~-----~i~~~~~~~~~~~~~~lV~e~~-~~~L~--~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH 216 (433)
+...++++...+-. .|.+++. .....-.|+|||| |..+. +.|.+.+ ++...+...+.+... +-|=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~--~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL--EQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH--HHHH
Confidence 44444433221111 1333332 2345678999999 65544 4566654 665544433333322 2223
Q ss_pred HCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC
Q 013973 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278 (433)
Q Consensus 217 ~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~ 278 (433)
..|++|+|=+|.||++..++ ..+..+.+.|||+......
T Consensus 319 ~~GffHaDPHPGNilv~~~~-----------------------~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNP-----------------------EGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCC-----------------------CCCccEEEEcccccccccH
Confidence 47899999999999996432 2466889999998765543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00033 Score=69.09 Aligned_cols=75 Identities=23% Similarity=0.224 Sum_probs=52.6
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeec------c--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRG------I--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~------~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.||.|.+..||++.+..+++.|+||.-.. . ....+....|.+.|+.+..... .++++++.+. ....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p--~~VPkV~~~D--~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVP--DLVPKVYHYD--EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCC--CCCCeEEEEC--CCCC
Confidence 4789999999999999876556799997431 1 1234556778888888765322 3466666653 3557
Q ss_pred EEEEecC
Q 013973 174 CIVFEKL 180 (433)
Q Consensus 174 ~lV~e~~ 180 (433)
++|||++
T Consensus 107 ~lVME~L 113 (401)
T PRK09550 107 VTVMEDL 113 (401)
T ss_pred EEEEecC
Confidence 8999998
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00043 Score=63.55 Aligned_cols=75 Identities=15% Similarity=0.309 Sum_probs=46.6
Q ss_pred EeeeeccccEEEEEEEECC-CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 102 HSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
++.|..|-...||++.... .++.|++|+........-....|..+++.+..... .| +++..+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl-~P---~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL-AP---KLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC-CC---eEEEEeCC----cEEEEee
Confidence 4667788888999987543 34678899775322221223468888888876543 23 33333322 3799998
Q ss_pred -CCCH
Q 013973 181 -GSSL 184 (433)
Q Consensus 181 -~~~L 184 (433)
|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 5443
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00061 Score=65.12 Aligned_cols=137 Identities=21% Similarity=0.253 Sum_probs=95.0
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEeec---------------------------chhhHHHHHHHHHHHHHHHh
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---------------------------IKKYREAAMIEIEVLQQLAK 152 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---------------------------~~~~~~~~~~E~~~l~~l~~ 152 (433)
.+...|..|--+.||.|.. .+|..+|||+++. .+...--+..|+.-|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3556788999999999975 4566799998741 11122334568888999877
Q ss_pred cCCCCCceEEecceeecCCeEEEEEecCCCC--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCc
Q 013973 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPEN 229 (433)
Q Consensus 153 ~~~~~~~i~~~~~~~~~~~~~~lV~e~~~~~--L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlKp~N 229 (433)
.....|--+.+. ...|||+|+|.+ -.-.|..- .++...+..+-.|++.-+.-|- ..++||.||.-=|
T Consensus 226 aGIP~PePIlLk-------~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPILLK-------NHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCceeee-------cceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 655444333332 336999999543 22223322 4777788888888888887775 4569999999999
Q ss_pred eEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccc
Q 013973 230 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 230 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 275 (433)
+|+. ++.+.|+|.+.+..
T Consensus 296 ~Lyh----------------------------dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 296 LLYH----------------------------DGKLYIIDVSQSVE 313 (520)
T ss_pred heEE----------------------------CCEEEEEEcccccc
Confidence 9983 46788898887654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0017 Score=62.66 Aligned_cols=77 Identities=13% Similarity=0.056 Sum_probs=47.8
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEec-c--eeecCCeEEEEEe
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFE 178 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lV~e 178 (433)
++.|+.|....+|+.... +| .+++|++. ....+....|..+++.+.......|.++.-. + +....+..+++|+
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456777888899998653 33 58999875 2223445567788888876544444433211 1 1123566789999
Q ss_pred cC-CC
Q 013973 179 KL-GS 182 (433)
Q Consensus 179 ~~-~~ 182 (433)
++ |.
T Consensus 103 ~l~G~ 107 (319)
T PRK05231 103 FLEGK 107 (319)
T ss_pred ecCCC
Confidence 98 44
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0018 Score=62.11 Aligned_cols=78 Identities=12% Similarity=-0.027 Sum_probs=48.1
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc---eeecCCeEEEE
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICIV 176 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~---~~~~~~~~~lV 176 (433)
..++.++.|....+|++... ++ .+++|+..... .......|.+++..|.......|.++.-.. .....+..++|
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred eeccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 44677788888899988643 33 48889875421 133455678888888665433333333211 11234678899
Q ss_pred EecC
Q 013973 177 FEKL 180 (433)
Q Consensus 177 ~e~~ 180 (433)
|+++
T Consensus 102 ~e~i 105 (307)
T TIGR00938 102 VEFL 105 (307)
T ss_pred EEeC
Confidence 9998
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00073 Score=64.63 Aligned_cols=75 Identities=16% Similarity=0.159 Sum_probs=46.8
Q ss_pred EeeeeccccEEEEEEEECC------CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 102 HSKMGEGTFGQVLECWDRE------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
++.|..|-...||++.... .++.|++|+.............|..++..+..... .| +++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~-~P---~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL-GP---KLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC-CC---ceEEEeCC----Cc
Confidence 3556667777889887543 25779999976433333445678889998876542 23 34444432 25
Q ss_pred EEecC-CCCH
Q 013973 176 VFEKL-GSSL 184 (433)
Q Consensus 176 V~e~~-~~~L 184 (433)
|+||+ |..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 78887 5443
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0013 Score=62.58 Aligned_cols=78 Identities=13% Similarity=0.069 Sum_probs=49.5
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEec-c--eeecCCeEEEEEe
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFE 178 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lV~e 178 (433)
++.|..|....+|+.... +..+++|+... ........|+.++..+..+....|.++... + +....+..++||+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 567888888899998643 33589998764 234556778999998876543323322211 1 1133456789999
Q ss_pred cC-CCC
Q 013973 179 KL-GSS 183 (433)
Q Consensus 179 ~~-~~~ 183 (433)
++ |..
T Consensus 95 ~i~G~~ 100 (296)
T cd05153 95 FLAGEH 100 (296)
T ss_pred eCCCCC
Confidence 99 544
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00058 Score=63.69 Aligned_cols=69 Identities=13% Similarity=0.037 Sum_probs=42.2
Q ss_pred eeccccEEEEEEEECCCCeEEEEEEeecchhhH-HHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CC
Q 013973 105 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 182 (433)
Q Consensus 105 iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~~ 182 (433)
+..|-.+.+|+.. .+++.+++|+........ -....|..+++.+..... .|.++. ... -++||||+ |.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~-~P~~i~---~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL-APKPIL---VNE----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC-CCceEE---EeC----CEEEEEeccCc
Confidence 4567777899886 345678889764322111 134678999999876542 344433 222 26899998 54
Q ss_pred C
Q 013973 183 S 183 (433)
Q Consensus 183 ~ 183 (433)
.
T Consensus 74 ~ 74 (256)
T TIGR02721 74 V 74 (256)
T ss_pred c
Confidence 4
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0021 Score=62.21 Aligned_cols=83 Identities=19% Similarity=0.185 Sum_probs=52.6
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEee----c----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVR----G----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~----~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.||-|....||++.+..+++.|+||.-. . -....++...|.+.|+......+ ..+++++.+. .....
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P--~~vP~vy~~D--~e~~~ 76 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVP--HLVPRIFHFD--TEMAV 76 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCc--cccCeEEEEc--cccce
Confidence 35899999999999986554689999742 1 12223445678888877654322 2455555433 34556
Q ss_pred EEEecC--CCCHHHHHH
Q 013973 175 IVFEKL--GSSLYDFLR 189 (433)
Q Consensus 175 lV~e~~--~~~L~~~l~ 189 (433)
+|||++ ...|.+.|.
T Consensus 77 ~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 77 TVMEDLSHHKIARKGLI 93 (370)
T ss_pred ehHhhCccchHHHHHHH
Confidence 999998 334555553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0026 Score=62.31 Aligned_cols=83 Identities=23% Similarity=0.281 Sum_probs=54.3
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEee----cc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVR----GI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~----~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++.||-|.-.-||++.+..+++.|+||.-. .. .-..++...|.+.|+......+ .++++++.+. .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P--~~VP~vy~~D--~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAP--GLVPKVYLFD--SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCC--CcCCeEEEEC--cHHhh
Confidence 688999999999999985445679999642 11 2234556778888887765432 3456665543 34556
Q ss_pred EEEecC--CCCHHHHH
Q 013973 175 IVFEKL--GSSLYDFL 188 (433)
Q Consensus 175 lV~e~~--~~~L~~~l 188 (433)
+|||++ ...|.+.|
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 889988 23344444
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0003 Score=77.72 Aligned_cols=127 Identities=14% Similarity=0.073 Sum_probs=94.1
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeeccCccccC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYR--SFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlKp~NILl~~~~~~~i~ 241 (433)
....+.+++++ +|.+++.|-+.-.+ .+....+.....+.+.+..-+|+.. .||++||+-|.+|
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI--------- 1373 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI--------- 1373 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---------
Confidence 34678999999 99999988754322 2333334344444477777777532 7999999999999
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCc---eeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 318 (433)
..+.++|+.++|+.+...+.... .++++.|++|++...-.++.++|+|..|+.+|++--
T Consensus 1374 ------------------Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1374 ------------------VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred ------------------ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 45566777788877744444322 467889999999998889999999999999999988
Q ss_pred CCCCC
Q 013973 319 GEALF 323 (433)
Q Consensus 319 g~~Pf 323 (433)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 87766
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0029 Score=63.05 Aligned_cols=90 Identities=24% Similarity=0.258 Sum_probs=63.5
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccc
Q 013973 302 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381 (433)
Q Consensus 302 ~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (433)
+++||||+|.++.++..|...+......+++..+.+.. ..+.+......+.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~~~~~a~e~---------------------------- 160 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY-TDDQELLSTAMEH---------------------------- 160 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchhHHHHHHHH----------------------------
Confidence 49999999999999999998888777777666655543 2222222211111
Q ss_pred hhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
...-.++..+..+..+|+...|..||...++..|+-|++
T Consensus 161 --------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 161 --------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred --------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 001123456788999999999999999999999988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00099 Score=62.73 Aligned_cols=130 Identities=20% Similarity=0.253 Sum_probs=84.8
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEee-------cchh----------------hHHHHHHHHHHHHHHHhcCC
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-------GIKK----------------YREAAMIEIEVLQQLAKHDK 155 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~-------~~~~----------------~~~~~~~E~~~l~~l~~~~~ 155 (433)
+.+.+.||-|--+-||.+.+. .|...++|+-+ ..+. .+-.+..|...|+.+..+.-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 568899999999999999875 45678888642 0000 12234568888888877543
Q ss_pred CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 156 ~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
..| +-+ +.+..|+|||++ |-.|...-+- . .+..+...+..-+--|-..|+||+|..-=||++++
T Consensus 173 pVP---kpi----D~~RH~Vvmelv~g~Pl~~v~~v-----~---d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVP---KPI----DHNRHCVVMELVDGYPLRQVRHV-----E---DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCC---Ccc----cccceeeHHHhhcccceeeeeec-----C---ChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence 322 222 235568999998 6666543221 1 12234444555566788899999999999999976
Q ss_pred cCccccCCCc
Q 013973 235 SEYIKVPDYK 244 (433)
Q Consensus 235 ~~~~~i~dfg 244 (433)
++.+.+.||.
T Consensus 238 d~~i~vIDFP 247 (465)
T KOG2268|consen 238 DDKIVVIDFP 247 (465)
T ss_pred CCCEEEeech
Confidence 6555555553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0021 Score=56.92 Aligned_cols=92 Identities=25% Similarity=0.242 Sum_probs=64.9
Q ss_pred HHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecCC-CCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013973 142 IEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDF---LRKNNYRSFPIDLVREIARQLLECIAFMHD 217 (433)
Q Consensus 142 ~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~~-~~L~~~---l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (433)
.|.-+++.+... +++++++|++.. ++|.||.+ +++... +.+. ..-+|..+.+|+.+++..+++|+.
T Consensus 8 ~E~lll~~l~~~----~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGS----EPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCC----CCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhc
Confidence 366677766432 368999998843 46889984 444321 1111 146899999999999999999997
Q ss_pred ---CCceeccCCCCceEeeccCccccCCC
Q 013973 218 ---LCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 218 ---~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
..+.-.|++++|+-++++|.+|+.|.
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDl 106 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDL 106 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEec
Confidence 34888999999999966554444443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.016 Score=56.27 Aligned_cols=76 Identities=12% Similarity=0.252 Sum_probs=43.8
Q ss_pred EEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++ +.|..|-...+|++..... +..|++|+........-....|..+++.+...... | ++++++. .+ +
T Consensus 17 i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~-P---~~l~~~~-~G---~ 87 (330)
T PLN02421 17 FSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG-A---KLLGVFG-NG---M 87 (330)
T ss_pred eEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC-C---ceeEEeC-Cc---E
Confidence 444 4444477778898865432 23688998753322222235688899988776532 3 3344443 22 5
Q ss_pred EEecC-CCC
Q 013973 176 VFEKL-GSS 183 (433)
Q Consensus 176 V~e~~-~~~ 183 (433)
|.+|+ |..
T Consensus 88 i~~fi~g~~ 96 (330)
T PLN02421 88 IQSFINART 96 (330)
T ss_pred eehhhcCCC
Confidence 78887 443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.061 Score=52.04 Aligned_cols=72 Identities=14% Similarity=0.068 Sum_probs=43.4
Q ss_pred ccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc--eeecCCeEEEEEecCC
Q 013973 109 TFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN--WFDYRNHICIVFEKLG 181 (433)
Q Consensus 109 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~--~~~~~~~~~lV~e~~~ 181 (433)
.-..||+.... ++..+++|+.+...........|.+.+..+.......+..+..-+ ....++..+.|+++++
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 33568988653 455699998864333456667889999888765432111111112 1233567788999883
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.014 Score=55.76 Aligned_cols=75 Identities=12% Similarity=0.005 Sum_probs=40.7
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC--eEE
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HIC 174 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--~~~ 174 (433)
.+++.+..|..-.+|..... ++.+++. ... .........+|..+++.+...... +...++.+..+. ..+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP---~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVP---VPRAFGLCGEGYLGTPF 101 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCC---CcccccccccCCCCCce
Confidence 45555544444445555443 6667777 321 112233345677777777543222 344455554443 779
Q ss_pred EEEecC
Q 013973 175 IVFEKL 180 (433)
Q Consensus 175 lV~e~~ 180 (433)
.||+++
T Consensus 102 ~v~~~v 107 (321)
T COG3173 102 YVMEWV 107 (321)
T ss_pred EEEEEe
Confidence 999998
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.071 Score=51.03 Aligned_cols=64 Identities=11% Similarity=0.171 Sum_probs=38.1
Q ss_pred EEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc---eeecCCeEEEEEecC
Q 013973 112 QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICIVFEKL 180 (433)
Q Consensus 112 ~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~---~~~~~~~~~lV~e~~ 180 (433)
.||++... .| .+++|++... ......|..++..+.......|.++.... +...++..++|++++
T Consensus 11 ~v~~v~t~-~g-~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i 77 (313)
T TIGR02906 11 NVYKVETD-SG-NKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWI 77 (313)
T ss_pred cEEEEEeC-CC-CeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhc
Confidence 48887643 33 5899987532 23355577888888665433333333211 112356789999998
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.016 Score=56.47 Aligned_cols=75 Identities=16% Similarity=0.076 Sum_probs=44.6
Q ss_pred EeeeeccccEEEEEEEECC----CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 102 HSKMGEGTFGQVLECWDRE----RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~----~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
+..|-.|-...+|++.... +++.|++|+........-....|..+++.+..... .|.+ ++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl-~P~~---~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQ-GPRL---LGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCC-CCce---EEEECCc----eEE
Confidence 3455557788899986432 24678999875432222223568999998877654 3333 3444332 578
Q ss_pred ecC-CCCH
Q 013973 178 EKL-GSSL 184 (433)
Q Consensus 178 e~~-~~~L 184 (433)
+|+ +.+|
T Consensus 113 efi~g~~l 120 (344)
T PLN02236 113 EFIHARTL 120 (344)
T ss_pred EeeCCCCC
Confidence 887 4443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.019 Score=54.75 Aligned_cols=108 Identities=15% Similarity=0.123 Sum_probs=72.7
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee---cCCeEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---YRNHICI 175 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~---~~~~~~l 175 (433)
..-.+.||.|..+.||+....+ + .+.+|..+. ......+..|.+.|+.+..... ..+.++++.+. ..+..+|
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~--vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGT--VRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCCC--CCcCcEEEEeccCCcCCCeEE
Confidence 3446789999999999986433 3 377787542 2234578889999999976421 22455555443 3467899
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 218 (433)
|||++ |.++.+. ..+......+..+++.+|.-||+.
T Consensus 91 VmE~i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 91 LLERLRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEeccCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999 6666541 123444566778888999999974
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.024 Score=53.47 Aligned_cols=46 Identities=28% Similarity=0.177 Sum_probs=29.5
Q ss_pred eccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhc
Q 013973 106 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 153 (433)
Q Consensus 106 G~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~ 153 (433)
++|-...|+.+.+ .+|..+++|.-+. ........+|..++..+..+
T Consensus 20 ~~g~~~~v~~i~~-~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAKD-TDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEEc-CCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhc
Confidence 4454455665532 3466788887653 23345578899999999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.049 Score=53.85 Aligned_cols=75 Identities=15% Similarity=0.098 Sum_probs=49.0
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEee-----cch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~-----~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
..+.||-|....||+..+. +..|+||.-. ... ....+...|...|+.+.... ...+++++.+.+ +.
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~--p~~VPkVy~~de--d~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC--PDHVPEVYHFDR--TM 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC--CCCCCeEEEECC--CC
Confidence 4688999999999998863 3458899753 111 12344455677777665432 134677777665 44
Q ss_pred EEEEEecCC
Q 013973 173 ICIVFEKLG 181 (433)
Q Consensus 173 ~~lV~e~~~ 181 (433)
.++|||++.
T Consensus 110 ~vlvME~L~ 118 (418)
T PLN02756 110 ALIGMRYLE 118 (418)
T ss_pred CEEEEeecC
Confidence 678899993
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.075 Score=51.28 Aligned_cols=78 Identities=18% Similarity=0.161 Sum_probs=48.0
Q ss_pred eeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCc-eEEeccee--ecCC--eEEEEEe
Q 013973 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQIRNWF--DYRN--HICIVFE 178 (433)
Q Consensus 104 ~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~-i~~~~~~~--~~~~--~~~lV~e 178 (433)
.|.+ .-..||+....+.+ +++|+.+.. ....+...|.+.++.+..+....+- +..+-+-. .-.+ +.+-|++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~--~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGR--YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCC--eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 44578988764433 599999866 5667778899999999876532211 22222211 1234 7788899
Q ss_pred cC-CCCHH
Q 013973 179 KL-GSSLY 185 (433)
Q Consensus 179 ~~-~~~L~ 185 (433)
|+ |..+.
T Consensus 109 ~l~G~~~~ 116 (331)
T COG2334 109 YLPGRPLE 116 (331)
T ss_pred ecCCcCcC
Confidence 99 54444
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.02 Score=54.21 Aligned_cols=76 Identities=17% Similarity=0.186 Sum_probs=49.8
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 178 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e 178 (433)
.+-.+.|+-|....+|+.. .+++.+-+|+-. ......+..|.+-|+.|... ..-.+++.+.+....+..+||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~--~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEA--NPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHT--TTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhc--CCCCCCeEEEEEeecCCceEEEE
Confidence 3455778889999999886 567789999865 34445678899999999553 22456777777776677799999
Q ss_pred cC
Q 013973 179 KL 180 (433)
Q Consensus 179 ~~ 180 (433)
|+
T Consensus 93 ~l 94 (288)
T PF03881_consen 93 FL 94 (288)
T ss_dssp --
T ss_pred ee
Confidence 98
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.025 Score=50.98 Aligned_cols=51 Identities=20% Similarity=0.069 Sum_probs=30.0
Q ss_pred CeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 122 KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 122 ~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
++.|++|+........-....|..+++.+..... -..+++.+... +|++|+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~----~p~~~~~~~~g----~v~e~i 52 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGL----GPKIIYFFENG----RVEEFI 52 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTS----SS-EEEEETTE----EEEE--
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCC----CCeEEEEcCCC----cEEEEe
Confidence 3568899887554444555678899988877553 23344444332 566777
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.046 Score=53.38 Aligned_cols=61 Identities=28% Similarity=0.371 Sum_probs=43.5
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEeecc
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPENVLLVSS 235 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlKp~NILl~~~ 235 (433)
...||-+|. |-++..++... ..+++....++.--+.||--+ --.+.+|.|+.|.||++.-.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 345666687 88999888765 356666666666666665443 35679999999999999643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.17 Score=56.45 Aligned_cols=81 Identities=16% Similarity=0.115 Sum_probs=46.1
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhc--CCCCCceEEec-ce----eec-CC--e
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH--DKGGNRCVQIR-NW----FDY-RN--H 172 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~--~~~~~~i~~~~-~~----~~~-~~--~ 172 (433)
+.|+ |..-.+|+... .++..|++|+.+.. ........|..++..|... ....|.++... +- ... .+ +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~-~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPS-EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCc-cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 34577888764 35667999999753 2333445567788877664 22234443322 11 111 22 5
Q ss_pred EEEEEecC-CCCHHH
Q 013973 173 ICIVFEKL-GSSLYD 186 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~ 186 (433)
++-+|+|+ |..+.+
T Consensus 108 ~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 108 LLRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEEeccCCCcHHh
Confidence 67789999 655543
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.04 Score=52.16 Aligned_cols=123 Identities=20% Similarity=0.264 Sum_probs=85.2
Q ss_pred EEeeeeccccEEEEEEEE-------CC---CCeEEEEEEeecc-------h--------------------hhHHHHHHH
Q 013973 101 IHSKMGEGTFGQVLECWD-------RE---RKEMVAIKIVRGI-------K--------------------KYREAAMIE 143 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~-------~~---~~~~vAiK~~~~~-------~--------------------~~~~~~~~E 143 (433)
|...|..|.-+.|+.|+- .. .-..+|||+++.. . ....-...|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 556888999999988843 11 1245899987411 0 011123457
Q ss_pred HHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecCCCC--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCc
Q 013973 144 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCM 220 (433)
Q Consensus 144 ~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~~~~--L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~i 220 (433)
+.-|.++..+..+.|.+|.+.. ..|||.|+|.. -.--|.. ..|+.++.+....|+...+.-|- +.-+
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~---v~l~d~E~~~aY~q~~~~M~~lY~Ec~L 405 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKN---VELTDDERRNAYDQVQSIMCRLYKECLL 405 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCccccc---cccChHHHHHHHHHHHHHHHHHHHhhhe
Confidence 7778888888878888887754 35999999532 2222332 25888888888999998888774 5669
Q ss_pred eeccCCCCceEee
Q 013973 221 IHTDLKPENVLLV 233 (433)
Q Consensus 221 vHrDlKp~NILl~ 233 (433)
||-||.--|+|..
T Consensus 406 VHADlSEyN~Lw~ 418 (531)
T KOG2269|consen 406 VHADLSEYNLLWT 418 (531)
T ss_pred eecchhhhhheec
Confidence 9999999999984
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.35 Score=47.79 Aligned_cols=76 Identities=17% Similarity=0.160 Sum_probs=42.4
Q ss_pred EEeeeeccccEEEEEEEECCCC-e-----EEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 101 IHSKMGEGTFGQVLECWDRERK-E-----MVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~-~-----~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.++.|..|-...+|++...... . .|.+++........-....|..+++.+..+.. -.++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~gl----gP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNF----GPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCC----CCeEEEecCC----E
Confidence 3456656888899998754331 1 24444432111111123458888888876553 2344555543 4
Q ss_pred EEEecC-CCCH
Q 013973 175 IVFEKL-GSSL 184 (433)
Q Consensus 175 lV~e~~-~~~L 184 (433)
+|.||+ |..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 888998 5443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.49 Score=45.34 Aligned_cols=66 Identities=14% Similarity=0.218 Sum_probs=37.3
Q ss_pred cccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEec----c--eeecCCeEEEEEecC
Q 013973 108 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR----N--WFDYRNHICIVFEKL 180 (433)
Q Consensus 108 G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~----~--~~~~~~~~~lV~e~~ 180 (433)
|.-+.||++.. ..| .+++|.+... .+.......++..+....- +.++.++ + +...++..+++|+++
T Consensus 17 ~~~~~v~~v~T-~~G-~~~Lk~~~~~---~~~l~~~~~~~~~L~~~G~--~~~~~~~~t~~G~~~~~~~~~~~~L~~wi 88 (309)
T TIGR02904 17 QVTGKLFKVYT-DQG-VFALKKLYAD---RNTIESFVSQIQVLSEKGF--SRIVPVYPTKDGSYYLFHGHFLYYLMPWL 88 (309)
T ss_pred cccCcEEEEEe-CCC-CEEEEEeccc---hHhHHHHHHHHHHHHHcCC--CcCCceeecCCCCeeeEECCEEEEEeCCc
Confidence 33568999865 344 5899988633 2233345566666655432 2223331 2 123356678999988
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.12 Score=49.96 Aligned_cols=104 Identities=14% Similarity=0.271 Sum_probs=65.6
Q ss_pred ecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCC
Q 013973 168 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 168 ~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
+...+.|++|++-|++|.-. ....++++..++.+.+.-+.-+... ..=|||+...||||
T Consensus 296 de~~y~yl~~kdhgt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI-------------- 355 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI-------------- 355 (488)
T ss_pred CCceEEEEEEecCCceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee--------------
Confidence 44567889999988876432 1345777888888777766655543 48999999999999
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHH
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWS 308 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 308 (433)
+ ++++.|+||-+++...++.. +.-...--|-.+.|.. +.+-+||-
T Consensus 356 -------------d-~GnvtLIDfklsRl~~~q~~--isy~rldhp~lF~G~d-d~QFeIYr 400 (488)
T COG5072 356 -------------D-EGNVTLIDFKLSRLSYSQGI--ISYNRLDHPDLFNGVD-DYQFEIYR 400 (488)
T ss_pred -------------e-cCceEEEEeeeeecccCCce--eeccccCchhhhcCcc-ceeeeHHH
Confidence 4 56788888887774333221 1111123344444332 45556665
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.23 Score=55.35 Aligned_cols=76 Identities=11% Similarity=0.050 Sum_probs=42.7
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhc--CCCCCceEEec-ce----e--ecCCeE
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH--DKGGNRCVQIR-NW----F--DYRNHI 173 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~--~~~~~~i~~~~-~~----~--~~~~~~ 173 (433)
..|+.+ .-.+|+..... ..|++|+.+... .......|..++..|... ....|.++.-. +- . .....+
T Consensus 37 ~~L~s~-~d~nf~v~t~~--~~yVLKi~~~~~-~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~ 112 (972)
T PRK06149 37 TELGSQ-QDRNFRVDSDG--GRFVLKICHAAY-AAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLR 112 (972)
T ss_pred EecCCc-CcceEEEEecC--CcEEEEeCCccC-ChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEE
Confidence 455433 34678776532 458999987432 234566788888888765 22333333211 11 1 122456
Q ss_pred EEEEecC-CC
Q 013973 174 CIVFEKL-GS 182 (433)
Q Consensus 174 ~lV~e~~-~~ 182 (433)
+-+++|+ |.
T Consensus 113 vrL~~~l~G~ 122 (972)
T PRK06149 113 VRLLDYLPGQ 122 (972)
T ss_pred EEEEEecCCc
Confidence 7788998 53
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 433 | ||||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-90 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-83 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-83 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-83 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-81 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-80 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-66 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-49 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-49 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-49 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-48 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-48 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-48 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-44 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-44 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-42 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-37 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-37 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-27 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-27 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-27 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-26 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-26 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-26 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-26 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-26 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-26 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-26 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-26 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-26 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-26 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-26 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-26 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-26 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-26 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-26 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-26 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-26 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-26 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-26 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-26 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-26 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-26 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-26 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-26 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-26 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-26 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-26 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-26 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-26 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-25 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-25 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-25 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-25 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-25 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-24 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-24 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-24 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-24 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-24 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-24 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-24 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-23 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-23 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-23 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-23 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-23 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-23 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-23 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-23 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-23 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-22 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-22 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-22 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-22 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-22 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-22 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-22 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-22 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-22 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-22 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-22 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-22 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-22 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-22 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-22 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-22 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-22 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-22 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-22 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-22 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-22 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-22 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-22 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-22 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-22 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-22 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-22 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-22 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-22 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-22 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-22 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-22 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-22 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-22 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-22 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-22 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-22 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-22 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-22 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-22 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-22 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-22 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-22 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-22 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-22 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-22 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-22 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-22 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-22 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-22 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-21 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-21 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-21 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-21 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-21 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-21 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-21 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-21 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-21 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-21 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-21 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-21 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-21 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-21 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-21 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-20 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-20 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-20 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-20 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-20 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-20 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-20 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-20 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-20 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-20 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-20 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-20 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-20 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-19 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-18 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-16 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-16 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-16 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-16 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-16 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-16 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-16 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-16 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-15 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-14 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-14 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-14 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-14 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-14 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-14 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-14 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-14 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-07 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 2e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-06 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 8e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 8e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-04 |
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 433 | |||
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 0.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 0.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-180 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-151 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-146 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-139 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-119 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-56 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-55 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-51 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-50 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-50 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-50 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-50 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-50 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 9e-49 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-48 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-48 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-48 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-47 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-47 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-47 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-46 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-46 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-45 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 8e-45 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-44 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-44 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-44 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-44 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-44 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 7e-44 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 9e-44 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-43 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-43 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-43 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 9e-43 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-42 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-42 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-42 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-42 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-42 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 9e-42 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-41 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-41 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 7e-41 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-41 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 7e-41 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 9e-41 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-40 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-40 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-40 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-40 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-40 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-40 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-40 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-40 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-40 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-40 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-40 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-39 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-39 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-39 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-39 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-39 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-39 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-39 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-39 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-39 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-39 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-39 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-39 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 8e-39 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-39 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-38 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-38 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-38 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-38 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-37 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-37 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-37 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-37 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-36 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-36 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-36 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-36 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-36 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-36 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-36 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-35 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-35 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-34 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-34 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-33 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-33 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-33 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-33 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 8e-33 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-32 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-32 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-31 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-29 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-28 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-28 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-26 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-26 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 9e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-26 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-25 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-25 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-25 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-24 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-24 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-23 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-23 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-23 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-23 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 7e-23 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-23 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-22 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-22 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-22 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-22 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-21 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-21 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-21 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 5e-21 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-20 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-20 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-20 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-20 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-19 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-19 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-19 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-19 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-19 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-19 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-19 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-19 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-19 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 8e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-18 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-18 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-18 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-18 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-18 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 7e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-18 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-17 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-17 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-17 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-17 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 8e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 9e-17 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-16 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-16 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-16 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-16 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-15 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-15 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-15 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-15 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-15 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-15 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-14 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-14 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-14 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-13 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-13 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-13 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-12 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-12 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-11 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-11 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-11 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-11 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-11 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-11 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-10 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-10 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-10 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-10 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-10 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 8e-10 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-09 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-08 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-08 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-08 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-07 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-06 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-06 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 3e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-06 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-05 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-05 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-05 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-05 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-05 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-04 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-04 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-04 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-04 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-04 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-04 |
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 531 bits (1370), Expect = 0.0
Identities = 135/359 (37%), Positives = 206/359 (57%), Gaps = 11/359 (3%)
Query: 71 ARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV 130
+ + ++ DD+ H+ + G L + + + KMG+GTFG+VL C + K+ A+K+V
Sbjct: 9 SGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV 68
Query: 131 RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRK 190
R IKKY +A IE ++L+++ D N V+ F Y +H+C++FE LG SLY+ + +
Sbjct: 69 RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR 128
Query: 191 NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250
NNY F I+ ++ ++L+ + ++ + + HTDLKPEN+LL + K +
Sbjct: 129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188
Query: 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 310
K KS+ IK+IDFG T++ I++TR YRAPEVIL LGW D+WS G
Sbjct: 189 KKIQI--YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 311 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRG--RLDWPE 367
C+L EL TG LF+THE++EHLAMME ++ P+P++ML + + KYV + +L WPE
Sbjct: 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306
Query: 368 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
A+S SIK V K L +I + L +L+ DPT R + E L+H F
Sbjct: 307 NASSINSIKHVKKCLPLYKIIKHEL------FCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 511 bits (1317), Expect = 0.0
Identities = 154/346 (44%), Positives = 220/346 (63%), Gaps = 15/346 (4%)
Query: 85 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIE 143
H + G+ L++RY+I +GEG FG+V+EC D + VA+KIV+ + +Y EAA E
Sbjct: 2 MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61
Query: 144 IEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVR 202
I+VL+ L D RCVQ+ WF++ HICIVFE LG S YDF+++N + F +D +R
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 203 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 262
++A Q+ + + F+H + HTDLKPEN+L V S+Y + + K +R +
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--------ERTLIN 173
Query: 263 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
IKV+DFGS TY+ + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F TH++ EHLAMMER+LGPLP+HM+++ + KY RLDW E +++ + K P
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHDRLDWDEHSSAGRYVSRACK-P 290
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ ++ Q V+H L L+Q +L YDP R+T REAL+HPFF
Sbjct: 291 LKEFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 504 bits (1301), Expect = e-180
Identities = 154/351 (43%), Positives = 223/351 (63%), Gaps = 15/351 (4%)
Query: 80 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIKKYRE 138
EDDK+GH + +G+ L RY+I +GEGTFG+V+EC D R K VA+KI+R + KYRE
Sbjct: 2 EDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE 61
Query: 139 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
AA +EI VL+++ + DK CV + +WF++ H+CI FE LG + ++FL++NN++ +P
Sbjct: 62 AARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 121
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
+ VR +A QL + F+H+ + HTDLKPEN+L V+SE+ + + S +
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE--------E 173
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
+ K+++I+V DFGS T++ IV+TRHYR PEVIL LGW PCD+WS+GCIL E
Sbjct: 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
G LFQTHEN EHL MME++LGP+P HM+ R + KY +G L W E ++ +K
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ--KYFYKGGLVWDENSSDGRYVKE 291
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
K P ++ ++H L L++ +L +DP R+T EAL HPFF
Sbjct: 292 NCK-PLKSYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 434 bits (1117), Expect = e-151
Identities = 115/359 (32%), Positives = 172/359 (47%), Gaps = 36/359 (10%)
Query: 81 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 140
DD G Y+ +++ RY++ +G+G+FGQV++ +D + + VA+K+VR K++ A
Sbjct: 81 DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 141 MIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 199
EI +L+ L K DK + + F +RNHIC+ FE L +LY+ ++KN ++ F +
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 200 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
LVR+ A +L+C+ +H +IH DLKPEN+LL
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ------------------------- 235
Query: 260 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319
S IKVIDFGS+ YE + +R YRAPEVILG + P D+WS+GCIL EL TG
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG----------A 369
L + + LA M +LG Q +L R +G +
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLN 355
Query: 370 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
R + P + L+ L +DP R+T +ALRHP+ R
Sbjct: 356 GGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-146
Identities = 118/366 (32%), Positives = 183/366 (50%), Gaps = 43/366 (11%)
Query: 81 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 140
DD + Y+ GE RY+I S +G+G+FGQV++ +DR +E VAIKI++ K + A
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 141 MIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 199
IE+ +L+ + KHD V ++ F +RNH+C+VFE L +LYD LR N+R ++
Sbjct: 98 QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN 157
Query: 200 LVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
L R+ A+Q+ + F+ +L +IH DLKPEN+LL +
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN----------------------- 194
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
PK SAIK++DFGS+ + +R YR+PEV+LG+ + D+WS+GCILVE+
Sbjct: 195 --PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
TGE LF ++ + + VLG P H+L + + + + + W +
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREY 312
Query: 378 VMKLPR-LQNLIMQHVDHSAG--------------DLTHLLQGLLRYDPTDRLTAREALR 422
R L N++ G L+ +L YDP R+ AL+
Sbjct: 313 KPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372
Query: 423 HPFFTR 428
H FF +
Sbjct: 373 HSFFKK 378
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-139
Identities = 107/370 (28%), Positives = 175/370 (47%), Gaps = 52/370 (14%)
Query: 80 EDDKDGHYMFALGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE 138
+ G++ GE +RY + K+G G F V D VA+KIVRG K Y E
Sbjct: 1 DYRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE 60
Query: 139 AAMIEIEVLQQLAKHDK------GGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFL 188
AA EI++LQ++ D G N +++ + F+++ H+ +VFE LG +L +
Sbjct: 61 AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 120
Query: 189 RKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSL 247
+K +R P+ V++I++QLL + +MH C +IHTD+KPENVL+ + +
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE-------- 172
Query: 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 307
IK+ D G+ + + TR YR+PEV+LG W DIW
Sbjct: 173 -------------NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIW 219
Query: 308 SVGCILVELCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG 361
S C++ EL TG+ LF+ E + +H+A + +LG LP ++L+ + RG
Sbjct: 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 279
Query: 362 RLDWPEGAASRESIKSVMKLPRLQNLIM---QHVDHSAGDLTHLLQGLLRYDPTDRLTAR 418
L S +K L++++ + A +++ L +L+ DP R A
Sbjct: 280 LLRN----------ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329
Query: 419 EALRHPFFTR 428
+ HP+
Sbjct: 330 GLVNHPWLKD 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 353 bits (906), Expect = e-119
Identities = 106/389 (27%), Positives = 181/389 (46%), Gaps = 49/389 (12%)
Query: 77 PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 136
+ K G+++ +G+ RY + K+G G F V WD + K+ VA+K+V+ + Y
Sbjct: 17 DPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76
Query: 137 REAAMIEIEVLQQLAKHDK---GGNRCVQIRNWFDYR----NHICIVFEKLGSSLYDFLR 189
E A+ EI +L+ + D VQ+ + F HIC+VFE LG L ++
Sbjct: 77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII 136
Query: 190 KNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSEY----------- 237
K+NY+ P+ V++I +Q+L+ + ++H C +IHTD+KPEN+LL +E
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 238 -----------IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVST 286
V ++ + + + +K+ D G+ + + T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256
Query: 287 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE------HLAMMERVLG 340
R YR+ EV++G G+ P DIWS C+ EL TG+ LF+ H E H+A++ +LG
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 341 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD-- 398
+P+ ++ E + ++G L +K L ++++ + S +
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITK----------LKPWGLFEVLVEKYEWSQEEAA 366
Query: 399 -LTHLLQGLLRYDPTDRLTAREALRHPFF 426
T L +L P R TA E LRHP+
Sbjct: 367 GFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-56
Identities = 96/349 (27%), Positives = 157/349 (44%), Gaps = 74/349 (21%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKH 153
+Y+ K+GEG++G V +C +R+ ++VAIK + A+ EI +L+QL KH
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KH 61
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
N V + F + + +VFE ++ L + R P LV+ I Q L+ +
Sbjct: 62 P---N-LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVN 116
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 272
F H IH D+KPEN +L++ K S IK+ DFG +
Sbjct: 117 FCHKHNCIHRDVKPEN-ILIT--------------------------KHSVIKLCDFGFA 149
Query: 273 TTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHEN 328
P Y V+TR YR+PE+++G Y P D+W++GC+ EL +G L+ +
Sbjct: 150 RLLTGPSDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208
Query: 329 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
++ L ++ + LG +P+H S S +K+P +++
Sbjct: 209 VDQLYLIRKTLGDLIPRH-------------------QQVF--STNQYFSGVKIPDPEDM 247
Query: 388 -----IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
++ + A L L+G L DPT+RLT + L HP+F
Sbjct: 248 EPLELKFPNISYPALGL---LKGCLHMDPTERLTCEQLLHHPYFENIRE 293
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 88/351 (25%), Positives = 145/351 (41%), Gaps = 76/351 (21%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLA 151
+Y+ +GEG++G V++C +++ +VAIK +KK AM EI++L+QL
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK---IAMREIKLLKQL- 81
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
+H+ N V + + +VFE + ++ D L +V++ Q++
Sbjct: 82 RHE---N-LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIING 136
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
I F H +IH D+KPEN +LVS +S +K+ DFG
Sbjct: 137 IGFCHSHNIIHRDIKPEN-ILVS--------------------------QSGVVKLCDFG 169
Query: 272 -STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTH 326
+ T P + Y V+TR YRAPE+++G Y D+W++GC++ E+ GE LF
Sbjct: 170 FARTLAAPGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+++ L + LG L + ++LP ++
Sbjct: 229 SDIDQLYHIMMCLGNLIPR------------------HQELFNKNPVFAG--VRLPEIKE 268
Query: 387 L-----IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 432
+ DL + L DP R E L H FF D
Sbjct: 269 REPLERRYPKLSEVVIDL---AKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-50
Identities = 97/361 (26%), Positives = 155/361 (42%), Gaps = 86/361 (23%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQ 149
GE Y +G G+FG V + E E VAIK V K++ RE +++++
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE-----LQIMRI 88
Query: 150 LAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLV 201
+ KH N V ++ +F + +V E + ++Y R ++ P+ L+
Sbjct: 89 V-KHP---N-VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
+ QLL +A++H + + H D+KP+N+LL P
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--------------------------DPP 177
Query: 262 SSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILGLGWTY---PCDIWSVGCILVEL 316
S +K+IDFGS + + + +R+YRAPE+I G T DIWS GC++ EL
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG--ATNYTTNIDIWSTGCVMAEL 235
Query: 317 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 376
G+ LF ++ L + +VLG + +K ++ + ++
Sbjct: 236 MQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH------------------- 276
Query: 377 SVMKLPR-----LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
K P+ + A DL + LL Y P+ RLTA EAL HPFF D L
Sbjct: 277 ---KFPQIRPHPFSKVFRPRTPPDAIDL---ISRLLEYTPSARLTAIEALCHPFF--DEL 328
Query: 432 R 432
R
Sbjct: 329 R 329
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 88/353 (24%), Positives = 151/353 (42%), Gaps = 85/353 (24%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAK 152
RY+ +K+GEGT+G+V + D E VAIK +R ++ E A+ E+ +L++L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-Q 91
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
H N +++++ + + + ++FE + L ++ KN + +++ QL+ +
Sbjct: 92 HR---N-IIELKSVIHHNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGV 145
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
F H +H DLKP+N LL+S ++ +K+ DFG
Sbjct: 146 NFCHSRRCLHRDLKPQN-LLLSVS---------------------DASETPVLKIGDFGL 183
Query: 272 STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHE 327
+ + P + + + T YR PE++LG Y DIWS+ CI E+ LF
Sbjct: 184 ARAFGIPIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242
Query: 328 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP---- 382
++ L + VLG P WP V LP
Sbjct: 243 EIDQLFKIFEVLGLPDDT-------------------TWPG----------VTALPDWKQ 273
Query: 383 --------RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
L+ ++ +D D LL +L DP R++A+ AL HP+F+
Sbjct: 274 SFPKFRGKTLKRVLGALLDDEGLD---LLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 87/355 (24%), Positives = 149/355 (41%), Gaps = 81/355 (22%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKH 153
Y +G G+FG V + + E+VAIK V K++ RE ++++++L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQIMRKL-DH 106
Query: 154 DKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRS--FPIDLVREIA 205
N V++R +F ++ +V + + ++Y R + P+ V+
Sbjct: 107 C---N-IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
QL +A++H + H D+KP+N+LL D P ++ +
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLL-------------------D-------PDTAVL 196
Query: 266 KVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 322
K+ DFGS + + + +R+YRAPE+I G +T D+WS GC+L EL G+ +
Sbjct: 197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F ++ L + +VLG + ++ ++ + ++ K P
Sbjct: 257 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFP 294
Query: 383 R-----LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 432
+ + A L LL Y PT RLT EA H FF D LR
Sbjct: 295 QIKAHPWTKVFRPRTPPEAIAL---CSRLLEYTPTARLTPLEACAHSFF--DELR 344
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-50
Identities = 68/352 (19%), Positives = 129/352 (36%), Gaps = 99/352 (28%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 154
Y I ++G G +V + + + K++ AIK V + ++ EI L +L +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 85
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
++ +++ ++ +I +V E L +L+K +S + + +LE +
Sbjct: 86 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 142
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H ++H+DLKP N L+V +K+IDFG
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM----------------------------LKLIDFGIAN 174
Query: 275 YERPDQNYIVS-----TRHYRAPEVILGLGW-----------TYPCDIWSVGCILVELCT 318
+PD +V T +Y PE I + + D+WS+GCIL +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 378
G+ FQ N ++ + ++ P +++P+
Sbjct: 235 GKTPFQQIIN--QISKLHAIIDP------------------NHEIEFPD----------- 263
Query: 379 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ D +L+ L+ DP R++ E L HP+
Sbjct: 264 ------------IPEKDLQD---VLKCCLKRDPKQRISIPELLAHPYVQIQT 300
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-50
Identities = 92/364 (25%), Positives = 151/364 (41%), Gaps = 88/364 (24%)
Query: 91 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEI 144
LG TSRY+ +++G G +G V + D VA+K VR G + + E+
Sbjct: 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62
Query: 145 EVLQQL--AKHDKGGN----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI 198
+L++L +H N V + D + +VFE + L +L K P
Sbjct: 63 ALLRRLEAFEHP---NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 119
Query: 199 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258
+ ++++ RQ L + F+H C++H DLKPEN +LV+S
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPEN-ILVTSG---------------------- 156
Query: 259 MPKSSAIKVIDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315
+K+ DFG + Y +V T YRAPEV+L + P D+WSVGCI E
Sbjct: 157 ----GTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 211
Query: 316 LCTGEALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES 374
+ + LF + + L + ++G P DWP
Sbjct: 212 MFRRKPLFCGNSEADQLGKIFDLIGLPPED-------------------DWPR------- 245
Query: 375 IKSVMKLPRL-------QNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
+ LPR + + ++ ++ S LL +L ++P R++A AL+H +
Sbjct: 246 ---DVSLPRGAFPPRGPRPVQSVVPEMEESGAQ---LLLEMLTFNPHKRISAFRALQHSY 299
Query: 426 FTRD 429
+D
Sbjct: 300 LHKD 303
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 9e-49
Identities = 69/354 (19%), Positives = 130/354 (36%), Gaps = 103/354 (29%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAK 152
Y I ++G G +V + + E+K++ AIK V + + + EI L +L +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN--LEEADNQTLDSYRNEIAYLNKL-Q 65
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
++ +++ ++ +I +V E L +L+K +S + + +LE +
Sbjct: 66 Q--HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAV 121
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
+H ++H+DLKP N L+V +K+IDFG
Sbjct: 122 HTIHQHGIVHSDLKPANFLIVDGM----------------------------LKLIDFGI 153
Query: 273 TTYERPDQNYI-----VSTRHYRAPEVILGLG-----------WTYPCDIWSVGCILVEL 316
+PD + V T +Y PE I + + D+WS+GCIL +
Sbjct: 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
Query: 317 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 376
G+ FQ N ++ + ++ P +++P+
Sbjct: 214 TYGKTPFQQIIN--QISKLHAIIDP------------------NHEIEFPD--------- 244
Query: 377 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ D +L+ L+ DP R++ E L HP+
Sbjct: 245 --------------IPEKDLQD---VLKCCLKRDPKQRISIPELLAHPYVQIQT 281
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 1e-48
Identities = 94/343 (27%), Positives = 152/343 (44%), Gaps = 71/343 (20%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKH 153
+Y+ K+GEGT+G V + +RE E+VA+K VR + E +A+ EI +L++L KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KH 60
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
N V++ + + +VFE L + N ++V+ QLL+ +
Sbjct: 61 K---N-IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLG 115
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 272
F H ++H DLKP+N LL++ +K+ +FG +
Sbjct: 116 FCHSRNVLHRDLKPQN-LLINRN--------------------------GELKLANFGLA 148
Query: 273 TTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCT-GEALFQTHE 327
+ P + Y V T YR P+V+ G Y D+WS GCI EL G LF ++
Sbjct: 149 RAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 328 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+ L + R+LG P + WP K P +
Sbjct: 208 VDDQLKRIFRLLGTPTEE-------------------QWP-SMTKLPDYKPYPMYPATTS 247
Query: 387 L--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
L ++ ++ + DL LQ LL+ +P R++A EAL+HP+F+
Sbjct: 248 LVNVVPKLNATGRDL---LQNLLKCNPVQRISAEEALQHPYFS 287
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 79/346 (22%), Positives = 147/346 (42%), Gaps = 60/346 (17%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 153
Y++ K+G G + +V E + E V +KI++ +KK + EI++L+ L
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGG 90
Query: 154 DKGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
N + + + +VFE + ++ DF K Y++ +R ++L+
Sbjct: 91 P---N-IITLADIVKDPVSRTPALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKA 142
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ + H + ++H D+KP NV++ D + K +++ID+G
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMI-------------------DHEHRK-------LRLIDWG 176
Query: 272 STTYERPDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG-EALFQTHE 327
+ P Q Y V++R+++ PE+++ + Y D+WS+GC+L + E F H+
Sbjct: 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR--LQ 385
N + L + +VLG Y+ + ++ + + R +
Sbjct: 237 NYDQLVRIAKVLGT-ED---------LYDYIDKYNIELD-----PRFNDILGRHSRKRWE 281
Query: 386 NLIMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ H L LLRYD RLTAREA+ HP+F
Sbjct: 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 92/342 (26%), Positives = 143/342 (41%), Gaps = 71/342 (20%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKH 153
+Y K+GEGT+G V + + E A+K +R ++K E + EI +L++L KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
N V++ + + + +VFE L L L + QLL IA
Sbjct: 60 S---N-IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIA 114
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 272
+ HD ++H DLKP+N LL++ E +K+ DFG +
Sbjct: 115 YCHDRRVLHRDLKPQN-LLINRE--------------------------GELKIADFGLA 147
Query: 273 TTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHEN 328
+ P + Y + T YRAP+V++G Y DIWSVGCI E+ G LF
Sbjct: 148 RAFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206
Query: 329 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
+ L + R+LG P + +WP +
Sbjct: 207 ADQLMRIFRILGTPNSK-------------------NWP-NVTELPKYDPNFTVYEPLPW 246
Query: 388 --IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
++ +D S D LL +L+ DP R+TA++AL H +F
Sbjct: 247 ESFLKGLDESGID---LLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 92/348 (26%), Positives = 153/348 (43%), Gaps = 70/348 (20%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVL 147
+ L +Y+ K+GEGT+G V + D + +VA+K +R + E A+ EI +L
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLL 73
Query: 148 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
++L H N V + + + +VFE + L L +N ++ Q
Sbjct: 74 KEL-HHP---N-IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQ 127
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
LL +A H ++H DLKP+N LL++S+ A+K+
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQN-LLINSD--------------------------GALKL 160
Query: 268 IDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEAL 322
DFG + + P ++Y V T YRAP+V++G Y DIWS+GCI E+ TG+ L
Sbjct: 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPL 219
Query: 323 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
F + + L + +LG P P+ +WP+ + ++
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPR-------------------EWPQVQELPLWKQRTFQV 260
Query: 382 PRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
+ I+ D LL +L +DP R++AR+A+ HP+F
Sbjct: 261 FEKKPWSSIIPGFCQEGID---LLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 78/402 (19%), Positives = 143/402 (35%), Gaps = 99/402 (24%)
Query: 48 TSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGE 107
+S PR T+++ F + + +DDK Y I ++G
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGS 66
Query: 108 GTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164
G +V + + + K++ AIK V + ++ EI L +L +H + +++
Sbjct: 67 GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD---KIIRLY 122
Query: 165 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 224
++ +I +V E L +L+K +S + + +LE + +H ++H+D
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180
Query: 225 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 284
LKP N L+V +K+IDFG +PD +V
Sbjct: 181 LKPANFLIVDGM----------------------------LKLIDFGIANQMQPDTTSVV 212
Query: 285 S-----TRHYRAPEVILGLGW-----------TYPCDIWSVGCILVELCTGEALFQTHEN 328
+Y PE I + + D+WS+GCIL + G+ FQ N
Sbjct: 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
++ + ++ P +++P
Sbjct: 273 --QISKLHAIIDP------------------NHEIEFP---------------------- 290
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
D DL +L+ L+ DP R++ E L HP+
Sbjct: 291 ----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-47
Identities = 92/355 (25%), Positives = 150/355 (42%), Gaps = 88/355 (24%)
Query: 97 SRYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQL- 150
+Y+ +++GEG +G+V + D + VA+K VR ++ E + + E+ VL+ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLE 69
Query: 151 -AKHDKGGN----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 205
+H N V + D + +VFE + L +L K P + ++++
Sbjct: 70 TFEHP---NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
QLL + F+H ++H DLKP+N +LV+S I
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQN-ILVTSS--------------------------GQI 159
Query: 266 KVIDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
K+ DFG + Y +V T YRAPEV+L + P D+WSVGCI E+ + L
Sbjct: 160 KLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 323 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
F+ +++ L + V+G P + DWP + L
Sbjct: 219 FRGSSDVDQLGKILDVIGLPGEE-------------------DWPR----------DVAL 249
Query: 382 PRL-------QNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
PR Q + + +D D LL L ++P R++A AL HP+F
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 1e-46
Identities = 93/350 (26%), Positives = 154/350 (44%), Gaps = 75/350 (21%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLA 151
S++K K+G GT+ V + ++ VA+K V+ G A+ EI ++++L
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS---TAIREISLMKEL- 60
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY----RSFPIDLVREIARQ 207
KH+ N V++ + N + +VFE + + L ++ R ++LV+ Q
Sbjct: 61 KHE---N-IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
LL+ +AF H+ ++H DLKP+N LL++ K +K+
Sbjct: 117 LLQGLAFCHENKILHRDLKPQN-LLIN--------------------------KRGQLKL 149
Query: 268 IDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEAL 322
DFG + + P + V T YRAP+V++G TY DIWS GCIL E+ TG+ L
Sbjct: 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPL 208
Query: 323 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
F + E L ++ ++G P WP ++
Sbjct: 209 FPGTNDEEQLKLIFDIMGTPNES-------------------LWP-SVTKLPKYNPNIQQ 248
Query: 382 PRLQNLIMQHVDHSAGDLT----HLLQGLLRYDPTDRLTAREALRHPFFT 427
++L H+ L L GLL+ +P RL+A++AL HP+F
Sbjct: 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 89/341 (26%), Positives = 140/341 (41%), Gaps = 68/341 (19%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAK 152
Y K+GEGT+ V + + +VA+K +R G A+ E+ +L+ L K
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC---TAIREVSLLKDL-K 58
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
H N V + + + +VFE L L +L + V+ QLL +
Sbjct: 59 HA---N-IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGL 113
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
A+ H ++H DLKP+N LL++ + +K+ DFG
Sbjct: 114 AYCHRQKVLHRDLKPQN-LLIN--------------------------ERGELKLADFGL 146
Query: 272 STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHE 327
+ P + Y V T YR P+++LG Y D+W VGCI E+ TG LF
Sbjct: 147 ARAKSIPTKTYDNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGST 205
Query: 328 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
E L + R+LG P + WP ++ E R +
Sbjct: 206 VEEQLHFIFRILGTPTEE-------------------TWPGILSNEEFKTYNYPKYRAEA 246
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
L+ H D LL LL+++ +R++A +A++HPFF
Sbjct: 247 LL-SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 92/355 (25%), Positives = 149/355 (41%), Gaps = 66/355 (18%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 152
R+++ G+GTFG V ++ VAIK V ++ E++++Q L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDL-A 74
Query: 153 HDKGGNRCVQIRNWF-----DYRNHIC--IVFEKLGSSLYDFLRKNNYR--SFPIDLVRE 203
N VQ++++F R I +V E + +L+ R R + P L++
Sbjct: 75 VLHHPN-IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 204 IARQLLECIAFMHDLCM--IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
QL+ I +H + H D+KP NVL+ +
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-------------------N-------EA 167
Query: 262 SSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCT 318
+K+ DFGS P + + + +R+YRAPE+I G +T DIWSVGCI E+
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKS 377
GE +F+ + L + RVLG + +L++++ H + +
Sbjct: 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYN----------------- 270
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 432
K N+ H A + LL LL+Y P +R+ EAL HP+F D L
Sbjct: 271 -SKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF--DELH 322
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-45
Identities = 84/350 (24%), Positives = 148/350 (42%), Gaps = 82/350 (23%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYRE----AAMIEIEVLQQL 150
RY+ +GEG F V + D+ ++VAIK ++ + ++ A+ EI++LQ+L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
H N + + + F ++++I +VF+ + + L + K+N ++ L+
Sbjct: 70 -SHP---N-IIGLLDAFGHKSNISLVFDFMETDLEVII-KDNSLVLTPSHIKAYMLMTLQ 123
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++H ++H DLKP N LL+ +K+ DF
Sbjct: 124 GLEYLHQHWILHRDLKPNN-LLLDEN--------------------------GVLKLADF 156
Query: 271 G-STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQT 325
G + ++ P++ Y V TR YRAPE++ G Y D+W+VGCIL EL
Sbjct: 157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPG 215
Query: 326 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 384
+L+ L + LG P + WP+ + LP
Sbjct: 216 DSDLDQLTRIFETLGTPTEE-------------------QWPD----------MCSLPDY 246
Query: 385 QNL-------IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
+ + DL L+QGL ++P R+TA +AL+ +F+
Sbjct: 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 76/364 (20%), Positives = 135/364 (37%), Gaps = 85/364 (23%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK------IVRGIKKYREAAMIEIEVL 147
+L SRY +G G G V D + + VAIK RE I+++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-----IKII 62
Query: 148 QQLAKHD----------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 197
++L HD G++ N + IV E + + L + L +
Sbjct: 63 RRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-- 119
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
+ R QLL + ++H ++H DLKP N+ + + +
Sbjct: 120 -EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL-------------------- 158
Query: 258 RMPKSSAIKVIDFG---STTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVG 310
+K+ DFG + ++ + T+ YR+P ++L +T D+W+ G
Sbjct: 159 ------VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 311 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWP 366
CI E+ TG+ LF LE + ++ + + + + + Y+R
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT 272
Query: 367 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ ++ + A D L+ +L + P DRLTA EAL HP+
Sbjct: 273 Q--------------------LLPGISREAVD---FLEQILTFSPMDRLTAEEALSHPYM 309
Query: 427 TRDH 430
+
Sbjct: 310 SIYS 313
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 85/375 (22%), Positives = 156/375 (41%), Gaps = 83/375 (22%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--RE------------ 138
E + +Y + +G G+FG V E +D E + A+K V +Y RE
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 139 ----------------AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 182
+ + K++ N + ++ ++ E +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 183 SLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240
+L+ L+ + RS P++L+ QL + F+H L + H D+KP+N+L+
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV-------- 174
Query: 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG- 297
+ K + +K+ DFGS P + + + +R YRAPE++LG
Sbjct: 175 -----------N-------SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA 216
Query: 298 LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKY 357
+T D+WS+GC+ EL G+ LF +++ L + +++G + + R++ H
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH---- 272
Query: 358 VRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 417
+ ++ + ++ + A D LL+ +LRY+P R+
Sbjct: 273 ------------YTEVRFPTLKAKD-WRKILPEGTPSLAID---LLEQILRYEPDLRINP 316
Query: 418 REALRHPFFTRDHLR 432
EA+ HPFF DHLR
Sbjct: 317 YEAMAHPFF--DHLR 329
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 68/345 (19%), Positives = 123/345 (35%), Gaps = 76/345 (22%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD- 154
S ++ + +G+G FGQV++ + AIK +R ++ + E+ +L L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 155 --------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 205
V+ ++ + I E +LYD + N + D +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLF 122
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF---KRMPKS 262
RQ+LE ++++H +IH DLKP N+ + S +K+ D F K + +S
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD-------------FGLAKNVHRS 169
Query: 263 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA 321
I +D + + + T Y A EV+ G G D++S+G I E+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227
Query: 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
F T ++ K +R +++P +
Sbjct: 228 -FSTGMERVNIL----------------------KKLRSVSIEFPPDFDDNKM------- 257
Query: 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ +I L+ +DP R AR L +
Sbjct: 258 KVEKKIIRL---------------LIDHDPNKRPGARTLLNSGWL 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 65/382 (17%), Positives = 114/382 (29%), Gaps = 103/382 (26%)
Query: 52 PPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFG 111
PR S +S SP + + + ++ S++G G++G
Sbjct: 27 QPRRVSFRGEASETLQ-------SPGYDPSRPESFFQ--------QSFQRLSRLGHGSYG 71
Query: 112 QVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168
+V + +E + A+K K R + E+ +++ +H CV++ ++
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP----CCVRLEQAWE 127
Query: 169 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 228
+ + E G SL S P V R L +A +H ++H D+KP
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186
Query: 229 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQNY-IVST 286
N+ L K+ DFG
Sbjct: 187 NIFL---------------------------GPRGRCKLGDFGLLVELGTAGAGEVQEGD 219
Query: 287 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHM 346
Y APE++ G + D++S+G ++E+ L E + L + +
Sbjct: 220 PRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-RQGYLPPEFTAGL 277
Query: 347 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406
S E L +L +
Sbjct: 278 ------------------------SSE-------------------------LRSVLVMM 288
Query: 407 LRYDPTDRLTAREALRHPFFTR 428
L DP R TA L P +
Sbjct: 289 LEPDPKLRATAEALLALPVLRQ 310
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 71/341 (20%), Positives = 124/341 (36%), Gaps = 78/341 (22%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 152
T Y++ +G G++ C + A+KI I K + EIE+L + +
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQ 74
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
H N + +++ +D ++ +V E + G L D + + + F + + +
Sbjct: 75 HP---N-IITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKT 128
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ ++H ++H DLKP N+L V +I++ DFG
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDES-----------------------GNPESIRICDFG 165
Query: 272 STTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
R + T ++ APEV+ G+ CDIWS+G +L + TG F +
Sbjct: 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
++ R+ G+ G +
Sbjct: 226 DTPEEILARIG--------------------SGKFSLSGGYWN----------------- 248
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
V +A D L+ +L DP RLTA LRHP+
Sbjct: 249 --SVSDTAKD---LVSKMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-44
Identities = 86/349 (24%), Positives = 162/349 (46%), Gaps = 30/349 (8%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQL 150
++ +Y++ K+G+G +G V + DR E+VA+K I + +A EI +L +L
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65
Query: 151 AKHDKGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 208
+ H+ N V + N D + +VF+ + + L+ +R N + + QL
Sbjct: 66 SGHE---N-IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP---VHKQYVVYQL 118
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY-----KSSLHTPKDSSYFKRMPKSS 263
++ I ++H ++H D+KP N+LL + ++KV D+ ++ ++ +
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 264 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEAL 322
T Y V+TR YRAPE++LG +T D+WS+GCIL E+ G+ +
Sbjct: 179 NFDDDQPILTDY--------VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
F + L + V+ ++ + A+ + + +++ I + K
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290
Query: 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
L+ + A D LL LL+++P R++A +AL+HPF + H
Sbjct: 291 LLLKINPKADCNEEALD---LLDKLLQFNPNKRISANDALKHPFVSIFH 336
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-44
Identities = 68/360 (18%), Positives = 131/360 (36%), Gaps = 85/360 (23%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 152
++L + +G G+ G V+ + VA+K + + + A++EI++L +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML--IDFCDIALMEIKLLTESDD 67
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE-----IARQ 207
H ++ + I E +L D + N + L +E + RQ
Sbjct: 68 H----PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+ +A +H L +IH DLKP+N+L+ +S + ++ + ++ I +
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSS--------------RFTADQQTGAENLRILI 169
Query: 268 IDFGSTTYERPDQNYIVSTRH-------YRAPEVILGLGW-------TYPCDIWSVGCIL 313
DFG Q+ + + +RAPE++ T DI+S+GC+
Sbjct: 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 314 -VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 372
L G+ F + +
Sbjct: 230 YYILSKGKHPF-----------------------------------------GDKYSRES 248
Query: 373 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 432
I+ + L ++ L + + A D L+ ++ +DP R TA + LRHP F +
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATD---LISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 79/343 (23%), Positives = 142/343 (41%), Gaps = 83/343 (24%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-EIEVLQQ 149
+L+ Y+ K+G G +G+VL C D+ AIKI+ + + ++ E+ VL+
Sbjct: 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
L H N +++ ++F+ + + +V E G L+D + F I +Q+
Sbjct: 93 L-DHP---N-IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQV 145
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
L + ++H ++H DLKPEN+LL S E K + IK++
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKE------------------------KDALIKIV 181
Query: 269 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
DFG + + + T +Y APEV+ + CD+WS+G IL L G F
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQ 240
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+ E ++ +V +G+ +
Sbjct: 241 TDQE---ILRKVE--------------------KGKYTFDSPE----------------- 260
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
++V A D L++ +L++D R++A++AL HP+
Sbjct: 261 --WKNVSEGAKD---LIKQMLQFDSQRRISAQQALEHPWIKEM 298
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 66/341 (19%), Positives = 125/341 (36%), Gaps = 79/341 (23%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 152
+ L +Y I +G G FG V C + K+ K V+ + EI +L +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-R 59
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
H + + F+ + ++FE + G +++ + + + + Q+ E
Sbjct: 60 H----RNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEA 114
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ F+H + H D++PEN++ + +SS IK+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQT-------------------------RRSSTIKIIEFG 149
Query: 272 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
+P N+ + + Y APEV + D+WS+G ++ L +G F N
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
+ ++E ++ + E A
Sbjct: 210 Q---IIENIM--------------------NAEYTFDEEA-------------------F 227
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ + A D + LL + R+TA EAL+HP+ +
Sbjct: 228 KEISIEAMD---FVDRLLVKERKSRMTASEALQHPWLKQKI 265
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 9e-43
Identities = 84/344 (24%), Positives = 146/344 (42%), Gaps = 84/344 (24%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQ 148
+ RYK +G+G+FG+V+ C D+ + A+K++ K +E+ + E+++L+
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 149 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
QL H N +++ +F+ + + +V E G L+D + F I RQ
Sbjct: 82 QL-DHP---N-IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQ 134
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+L I +MH ++H DLKPEN+LL S K + I++
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKS------------------------KDANIRI 170
Query: 268 IDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325
IDFG +T+ + + T +Y APEV+ G + CD+WS G IL L +G F
Sbjct: 171 IDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
+ ++++V +G+ +
Sbjct: 230 ANEYD---ILKKVE--------------------KGKYTFELPQ---------------- 250
Query: 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ V SA D L++ +L Y P+ R++AR+AL H +
Sbjct: 251 ---WKKVSESAKD---LIRKMLTYVPSMRISARDALDHEWIQTY 288
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-43
Identities = 80/343 (23%), Positives = 131/343 (38%), Gaps = 77/343 (22%)
Query: 94 NLTSRYKIHS---KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL 150
Y + +GEG+F +C ++ + A+KI+ K+ EI L+
Sbjct: 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLC 62
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 209
H N V++ F + H +V E L G L++ R + F I R+L+
Sbjct: 63 EGHP---N-IVKLHEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLV 116
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
++ MHD+ ++H DLKPEN+L + IK+ID
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDEN------------------------DNLEIKIID 152
Query: 270 FGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
FG + PD T HY APE++ G+ CD+WS+G IL + +G+ FQ+H
Sbjct: 153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+ + ++K+ +++G + A
Sbjct: 213 D--------RSLTCTSAVEIMKK--------IKKGDFSFEGEAWK--------------- 241
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+V A D L+QGLL DP RL + +
Sbjct: 242 ----NVSQEAKD---LIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 58/353 (16%), Positives = 112/353 (31%), Gaps = 66/353 (18%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLA 151
+ + +G+G V ++ ++ AIK+ + + M E EVL++L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL- 64
Query: 152 KHDKGGNRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQ 207
H V++ + H ++ E SLY L + N P + R
Sbjct: 65 NHK----NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
++ + + + ++H ++KP N++ V E S K+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKL 157
Query: 268 IDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYP--------CDIWSVGCILVELC 317
DFG+ D+ + + T Y P++ D+WS+G
Sbjct: 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
Query: 318 TGEALFQTHENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 376
TG F+ E +M +++ P + V + G +DW S+
Sbjct: 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLS 272
Query: 377 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
++ LT +L +L D +
Sbjct: 273 RGLQ----------------VLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 84/347 (24%), Positives = 139/347 (40%), Gaps = 83/347 (23%)
Query: 89 FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIE 145
RY I +G+G+FG+VL+C DR ++ A+K++ K + E+E
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 146 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
+L++L H N +++ + + IV E G L+D + K F I
Sbjct: 74 LLKKL-DHP---N-IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARI 126
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+Q+ I +MH ++H DLKPEN+LL S E K
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKE------------------------KDCD 162
Query: 265 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
IK+IDFG +T + + + T +Y APEV+ G + CD+WS G IL L +G
Sbjct: 163 IKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F + +++RV G+ +
Sbjct: 222 FYGKNEYD---ILKRVE--------------------TGKYAFDLPQ------------- 245
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ + A D L++ +L + P+ R+TA + L HP+ +
Sbjct: 246 ------WRTISDDAKD---LIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 4e-42
Identities = 67/368 (18%), Positives = 126/368 (34%), Gaps = 88/368 (23%)
Query: 75 SPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK 134
SP +DD D + + + +G G G ++ VA+K + +
Sbjct: 4 SPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LP 58
Query: 135 KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYR 194
+ A E+++L++ +H N ++ R I E ++L +++ + ++
Sbjct: 59 ECFSFADREVQLLRESDEHP---N-VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFA 114
Query: 195 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254
++ + +Q +A +H L ++H DLKP N+L+ P
Sbjct: 115 HLGLE-PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM---------------PNAHG 158
Query: 255 YFKRMPKSSAIKVIDFGSTTYERPDQNY------IVSTRHYRAPEVILGL---GWTYPCD 305
K + DFG ++ + T + APE++ TY D
Sbjct: 159 KIK-------AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211
Query: 306 IWSVGCILVE-LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 364
I+S GC+ + G F K + R A + LD
Sbjct: 212 IFSAGCVFYYVISEGSHPFG-----------------------KSLQRQANILLGACSLD 248
Query: 365 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 424
+H D A + L++ ++ DP R +A+ L+HP
Sbjct: 249 CLH--------------------PEKHEDVIARE---LIEKMIAMDPQKRPSAKHVLKHP 285
Query: 425 FFTRDHLR 432
FF +
Sbjct: 286 FFWSLEKQ 293
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-42
Identities = 57/342 (16%), Positives = 112/342 (32%), Gaps = 71/342 (20%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQL 150
T+ + K+G G FG V +C R + AIK + + A+ E+ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQ 207
+H + V+ + + +H+ I E G SL D + +N F ++++ Q
Sbjct: 68 GQHS---H-VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+ + ++H + ++H D+KP N+ + + + + K+
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKI 175
Query: 268 IDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 326
D G T + A EV+ DI+++ +V E L +
Sbjct: 176 GDLGHVT-RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+ + G LP+ +P
Sbjct: 235 DQWHEIRQ-----GRLPR------------------------------------IP---- 249
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ + T LL+ ++ DP R +A ++H
Sbjct: 250 ------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 73/354 (20%), Positives = 136/354 (38%), Gaps = 94/354 (26%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--------------GIKKYRE 138
+ Y K+G G +G+VL C ++ AIK+++ I+K+ E
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 139 AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFP 197
EI +L+ L H N +++ + F+ + + +V E G L++ + + F
Sbjct: 92 EIYNEISLLKSL-DHP---N-IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FD 144
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
I +Q+L I ++H ++H D+KPEN+LL +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN--------------------- 183
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315
IK++DFG +++ D + T +Y APEV+ + CD+WS G I+
Sbjct: 184 ---SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYI 239
Query: 316 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 375
L G F + + ++++V +G+ +
Sbjct: 240 LLCGYPPFGGQNDQD---IIKKVE--------------------KGKYYFDFND------ 270
Query: 376 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+++ A + L++ +L YD R TA EAL + +
Sbjct: 271 -------------WKNISDEAKE---LIKLMLTYDYNKRCTAEEALNSRWIKKY 308
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-42
Identities = 73/412 (17%), Positives = 133/412 (32%), Gaps = 129/412 (31%)
Query: 73 NGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR- 131
+ ++ ++ L +Y + +G+G++G V + + + + AIKI+
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61
Query: 132 -----GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY 185
K E E+ ++++L H ++ ++ +IC+V E G L
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKL-HH----PNIARLYEVYEDEQYICLVMELCHGGHLL 116
Query: 186 DFLRKNNYR--------------------------------------SFPIDLVREIARQ 207
D L L+ I RQ
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+ + ++H+ + H D+KPEN L +++ S IK+
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTNK-------------------------SFEIKL 211
Query: 268 IDFG-STTYERPDQNY------IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCT 318
+DFG S + + + T ++ APEV+ +Y CD WS G +L L
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 378
G F N + +VL +L + +
Sbjct: 272 GAVPFP-GVN--DADTISQVL--------------------NKKLCFENPNYN------- 301
Query: 379 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ A D LL LL + +R A AL+HP+ ++
Sbjct: 302 ------------VLSPLARD---LLSNLLNRNVDERFDAMRALQHPWISQFS 338
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 83/356 (23%), Positives = 141/356 (39%), Gaps = 70/356 (19%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQL 150
+ RY+ +G G G V +D VAIK + R + A A E+ +++ +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 151 AKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 204
H N + + N F + + +V E + ++L ++ + + +
Sbjct: 119 -NHK---N-IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 169
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
Q+L I +H +IH DLKP N+++ S
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---------------------------CT 202
Query: 265 IKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321
+K++DFG Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ +
Sbjct: 203 LKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
Query: 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWPE---GAASRES 374
LF + ++ + LG +K++ YV L +P+ +
Sbjct: 262 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS----- 316
Query: 375 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
L + + A D LL +L DP R++ +AL+HP+ +
Sbjct: 317 ------LFPADSEHNKLKASQARD---LLSKMLVIDPAKRISVDDALQHPYINVWY 363
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-41
Identities = 74/342 (21%), Positives = 133/342 (38%), Gaps = 80/342 (23%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLA 151
++ Y I ++G G FG V C ++ + K + + EI ++ QL
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL- 105
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
H + + + + F+ + + ++ E L G L+D + +Y V RQ E
Sbjct: 106 HHP----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACE 160
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ MH+ ++H D+KPEN++ + K+S++K+IDF
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCET-------------------------KKASSVKIIDF 195
Query: 271 GSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
G T PD+ +T + APE++ + D+W++G + L +G + F ++
Sbjct: 196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
LE ++ V R ++ E A
Sbjct: 256 LE---TLQNVK--------------------RCDWEFDEDA------------------- 273
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
V A D ++ LL+ +P RLT +AL HP+ DH
Sbjct: 274 FSSVSPEAKD---FIKNLLQKEPRKRLTVHDALEHPWLKGDH 312
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-41
Identities = 61/355 (17%), Positives = 105/355 (29%), Gaps = 99/355 (27%)
Query: 89 FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQ 148
+ + +K +G G FGQV + R + IK +K E A E++ L
Sbjct: 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALA 59
Query: 149 QLAKH------------DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 195
+L H + + I E +L ++ K
Sbjct: 60 KL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 196 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255
L E+ Q+ + + ++H +I+ DLKP N+ LV
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---------------------- 156
Query: 256 FKRMPKSSAIKVIDFG-STTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 313
+ +K+ DFG T+ + + T Y +PE I + D++++G IL
Sbjct: 157 -----DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211
Query: 314 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 373
EL + T R G + ++
Sbjct: 212 AELLH---VCDTAFETSKFFTDLR-DGIISDIF------------------------DKK 243
Query: 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ L+ + LL P DR E LR +
Sbjct: 244 ----------EKTLLQK---------------LLSKKPEDRPNTSEILRTLTVWK 273
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-41
Identities = 87/368 (23%), Positives = 149/368 (40%), Gaps = 61/368 (16%)
Query: 79 REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIK 134
R + Y +G++ + RY+ +G G G V +D + VAIK + R +
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 135 KYREA--AMIEIEVLQQLAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYD 186
A A E+ +++ + H N + + N F + + IV E + ++L
Sbjct: 64 NQTHAKRAYRELVLMKCV-NHK---N-IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 118
Query: 187 FLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246
++ + + Q+L I +H +IH DLKP N+++ S +K+ D+
Sbjct: 119 VIQMELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF--G 172
Query: 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI 306
L +S+ T Y V TR+YRAPEVILG+G+ DI
Sbjct: 173 LARTAGTSFM---------------MTPY--------VVTRYYRAPEVILGMGYKENVDI 209
Query: 307 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGR 362
WSVGCI+ E+ G LF ++++ + LG +K++ YV
Sbjct: 210 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG 269
Query: 363 LDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422
+ + L + + A D LL +L D + R++ EAL+
Sbjct: 270 YSFEK--------LFPDVLFPADSEHNKLKASQARD---LLSKMLVIDASKRISVDEALQ 318
Query: 423 HPFFTRDH 430
HP+ +
Sbjct: 319 HPYINVWY 326
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-41
Identities = 71/344 (20%), Positives = 120/344 (34%), Gaps = 80/344 (23%)
Query: 92 GENLTSRYKIHSK-MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVL 147
EN + Y + SK +G G F V +C + + A K + R + R + EI VL
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 148 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 206
+ R + + ++ + I ++ E G ++ + V + +
Sbjct: 83 ELAKSCP----RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+LE + ++H ++H DLKP+N+LL S IK
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIY------------------------PLGDIK 174
Query: 267 VIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
++DFG + I+ T Y APE++ T D+W++G I L T + F
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234
Query: 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 384
+N E + + +D+ E
Sbjct: 235 GEDNQE---TYLNIS--------------------QVNVDYSEET--------------- 256
Query: 385 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
V A D +Q LL +P R TA L H + +
Sbjct: 257 ----FSSVSQLATD---FIQSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-41
Identities = 78/364 (21%), Positives = 125/364 (34%), Gaps = 119/364 (32%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---------EAAMIEI 144
Y++ +G+G F V C +RE + A+KI + + E E
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREA 77
Query: 145 EVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLV 201
+ L KH + V++ + + +VFE + G+ L + R + + +
Sbjct: 78 SICHML-KHP---H-IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
RQ+LE + + HD +IH D+KP VLL S E
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE------------------------N 168
Query: 262 SSAIKVIDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC 317
S+ +K+ FG + V T H+ APEV+ + P D+W G IL + L
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
Query: 318 -------TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----W 365
T E LF+ + +G+ W
Sbjct: 229 GCLPFYGTKERLFEG--------------------------------IIKGKYKMNPRQW 256
Query: 366 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
H+ SA D L++ +L DP +R+T EAL HP+
Sbjct: 257 S------------------------HISESAKD---LVRRMLMLDPAERITVYEALNHPW 289
Query: 426 FTRD 429
Sbjct: 290 LKER 293
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 81/366 (22%), Positives = 146/366 (39%), Gaps = 97/366 (26%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAK 152
S+Y+ +K+G+GTFG+V + R+ + VA+K V ++ +E A+ EI++LQ L K
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLL-K 74
Query: 153 HDKGGN----RCV---QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 205
H+ N + + + + I +VF+ L L + F + ++ +
Sbjct: 75 HE---NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 130
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
+ LL + ++H ++H D+K N +L++ + + +
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAAN-VLITRDGV--------------------------L 163
Query: 266 KVIDFG-----STTYERPDQNY--IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 317
K+ DFG S Y V T YR PE++LG + P D+W GCI+ E+
Sbjct: 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223
Query: 318 TGEALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 376
T + Q + LA++ ++ G P+ WP
Sbjct: 224 TRSPIMQGNTEQHQLALISQLCGSITPE-------------------VWPN--------- 255
Query: 377 SVMKLP-------------RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
V ++++ + +V L+ LL DP R+ + +AL H
Sbjct: 256 -VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA--LDLIDKLLVLDPAQRIDSDDALNH 312
Query: 424 PFFTRD 429
FF D
Sbjct: 313 DFFWSD 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 85/352 (24%), Positives = 144/352 (40%), Gaps = 74/352 (21%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQL 150
L Y + +G G +G V D+ E VAIK + R + A A E+ +L+ +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 151 AKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 204
+H+ N + + + F +V + + L + F + ++ +
Sbjct: 81 -QHE---N-VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKIQYL 131
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
Q+L+ + ++H ++H DLKP N+ +
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---------------------------CE 164
Query: 265 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALF 323
+K++DFG + + V TR YRAPEVIL DIWSVGCI+ E+ TG+ LF
Sbjct: 165 LKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
Query: 324 QTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSV 378
+ + L+ L + +V G ++++ D+ A+ Y++ R D+ +
Sbjct: 225 KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ----------- 273
Query: 379 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ A D LL+ +L D RLTA +AL HPFF
Sbjct: 274 ---------LFPRASPQAAD---LLEKMLELDVDKRLTAAQALTHPFFEPFR 313
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 90/351 (25%), Positives = 150/351 (42%), Gaps = 59/351 (16%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLA 151
N++S +++ S +GEG +G V + E+VAIK + K A EI++L+
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66
Query: 152 KHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 206
KH+ N + I N + N + I+ E + + L+ + D ++
Sbjct: 67 KHE---N-IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIY 119
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q L + +H +IH DLKP N+L+ S+ +KV D+ L D S +
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDF--GLARIIDESAADNSEPTGQQS 177
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 325
+ + V+TR YRAPEV+L ++ D+WS GCIL EL +F
Sbjct: 178 GM----VEF--------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225
Query: 326 HENLEHLAMMERVLG-PLPQHMLKRVD-RHAEKYVR----RGRLDWPEGAASRESIKSVM 379
+ L ++ ++G P + L+ ++ A +Y++ +
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK------------ 273
Query: 380 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
P V+ DL LQ +L +DP R+TA+EAL HP+ H
Sbjct: 274 MFP--------RVNPKGIDL---LQRMLVFDPAKRITAKEALEHPYLQTYH 313
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 73/347 (21%), Positives = 125/347 (36%), Gaps = 85/347 (24%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIE 145
+ + Y I ++G G F V +C ++ A K ++ + RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 146 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
+L+Q+ H + + + ++ R + ++ E + G L+DFL + +
Sbjct: 68 ILRQV-LHH----NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+Q+L+ + ++H + H DLKPEN++L+
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPH 157
Query: 265 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
IK+IDFG + I T + APE++ D+WS+G I L +G +
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F LG Q L + D+ E
Sbjct: 218 F---------------LGDTKQETLAN--------ITSVSYDFDEEF------------- 241
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
H A D ++ LL + RLT +EALRHP+ T
Sbjct: 242 ------FSHTSELAKD---FIRKLLVKETRKRLTIQEALRHPWITPV 279
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 80/373 (21%), Positives = 136/373 (36%), Gaps = 78/373 (20%)
Query: 83 KDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA 139
K M L + S Y + + G++G V D E VAIK V
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRT 63
Query: 140 AMI------------EIEVLQQLAKHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGS 182
I EI +L H N + +R+ F + + +V E + +
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHF-HHP---N-ILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 183 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242
L + ++ +L + +H+ ++H DL P N +L++
Sbjct: 119 DLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN-ILLADN------ 170
Query: 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGL- 298
+ I + DF + D N Y V+ R YRAPE+++
Sbjct: 171 --------------------NDITICDFNLAREDTADANKTHY-VTHRWYRAPELVMQFK 209
Query: 299 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKY 357
G+T D+WS GC++ E+ +ALF+ L + V+G + A Y
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269
Query: 358 VRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 417
+R + P + +V +P D A D L+ +L ++P R++
Sbjct: 270 LRNSLSNVP-----ARAWTAV--VP--------TADPVALD---LIAKMLEFNPQRRIST 311
Query: 418 REALRHPFFTRDH 430
+ALRHP+F
Sbjct: 312 EQALRHPYFESLF 324
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 83/357 (23%), Positives = 152/357 (42%), Gaps = 83/357 (23%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIE 145
+ RY+ S +G G +G V +D + VA+K + + YRE +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LR 80
Query: 146 VLQQLAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 199
+L+ + KH+ N + + + F + N + +V +G+ L + ++ D
Sbjct: 81 LLKHM-KHE---N-VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---D 132
Query: 200 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
V+ + Q+L + ++H +IH DLKP N+ +
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED------------------------ 168
Query: 260 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 318
+K++DFG + + V+TR YRAPE++L + DIWSVGCI+ EL T
Sbjct: 169 ---CELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRE 373
G LF ++++ L ++ R++G +LK++ A Y++ ++++
Sbjct: 226 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN------ 279
Query: 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ + A D LL+ +L D R+TA +AL H +F + H
Sbjct: 280 --------------VFIGANPLAVD---LLEKMLVLDSDKRITAAQALAHAYFAQYH 319
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 78/391 (19%), Positives = 146/391 (37%), Gaps = 95/391 (24%)
Query: 52 PPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKM-GEGTF 110
PP+ P+ + P + + + YK+ S++ G G
Sbjct: 20 PPQPPTPALPHPPAQPPPPPPQQFPQFHVKSG----LQIKKNAIIDDYKVTSQVLGLGIN 75
Query: 111 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-- 168
G+VL+ +++ +E A+K+++ K R E+E+ + ++ + V+I + ++
Sbjct: 76 GKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP---H-IVRIVDVYENL 127
Query: 169 --YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 225
R + IV E L G L+ ++ ++F EI + + E I ++H + + H D+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187
Query: 226 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--I 283
KPEN+L S ++ +K+ DFG +
Sbjct: 188 KPENLLYTSKR------------------------PNAILKLTDFGFAKETTSHNSLTTP 223
Query: 284 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 343
T +Y APEV+ + CD+WS+G I+ L G F ++ L +
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----------AIS 272
Query: 344 QHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398
M R +R G+ + W V
Sbjct: 273 PGMKTR--------IRMGQYEFPNPEWS------------------------EVSEEVKM 300
Query: 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
L++ LL+ +PT R+T E + HP+ +
Sbjct: 301 ---LIRNLLKTEPTQRMTITEFMNHPWIMQS 328
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 70/359 (19%), Positives = 124/359 (34%), Gaps = 88/359 (24%)
Query: 94 NLTSRYKIHSKM-GEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLA 151
Y++ + GEG +V C + + A+KI+ R E+E+L Q
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
H N +++ +F+ + +VFEK+ G S+ + K R F + + +
Sbjct: 69 GHR---N-VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVAS 122
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ F+H+ + H DLKPEN+L + S +K+ DF
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPN------------------------QVSPVKICDF 158
Query: 271 GSTTYERPDQNY----------IVSTRHYRAPEVILGLGWTY-----PCDIWSVGCILVE 315
+ + + + + Y APEV+ CD+WS+G IL
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218
Query: 316 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAA 370
L +G F + + + ++ G+ + W
Sbjct: 219 LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES--------IQEGKYEFPDKDWA---- 266
Query: 371 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
H+ +A D L+ LL D RL+A + L+HP+
Sbjct: 267 --------------------HISCAAKD---LISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 67/346 (19%), Positives = 126/346 (36%), Gaps = 85/346 (24%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEV 146
+ Y++ ++G G F V +C + + A K ++ + RE E+ +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 147 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 205
L+++ +H + + + F+ + + ++ E + G L+DFL + D +
Sbjct: 62 LREI-RHP----NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 114
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
+Q+L+ + ++H + H DLKPEN++L+ + + I
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLD-----------------------KNVPNPRI 151
Query: 266 KVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
K+IDFG + I T + APE++ D+WS+G I L +G + F
Sbjct: 152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211
Query: 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 383
LG Q L + D+ E
Sbjct: 212 ---------------LGETKQETLTN--------ISAVNYDFDEEY-------------- 234
Query: 384 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ A D ++ LL DP R+T ++L H +
Sbjct: 235 -----FSNTSELAKD---FIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-40
Identities = 79/352 (22%), Positives = 125/352 (35%), Gaps = 89/352 (25%)
Query: 85 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-- 142
G + + K+G G FG V +R IK I K R +
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQ 66
Query: 143 ---EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSF 196
EIEVL+ L H ++I F+ +++ IV E G L + + + ++
Sbjct: 67 IEAEIEVLKSL-DHP----NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 197 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256
V E+ +Q++ +A+ H ++H DLKPEN+L +
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-------------------- 161
Query: 257 KRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 314
S IK+IDFG + D++ T Y APEV T+ CDIWS G ++
Sbjct: 162 ----PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMY 216
Query: 315 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES 374
L TG F +LE + + ++
Sbjct: 217 FLLTGCLPFT-GTSLEEVQ----------------------QKATYKEPNYAVEC----- 248
Query: 375 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ + A D LL+ +L DP R +A + L H +F
Sbjct: 249 ---------------RPLTPQAVD---LLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-40
Identities = 66/347 (19%), Positives = 124/347 (35%), Gaps = 85/347 (24%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIE 145
EN+ Y ++G G F V +C ++ A K ++ + RE E+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 146 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
+L+++ +H + + ++ + + ++ E + G L+DFL + + E
Sbjct: 67 ILKEI-QHP----NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEF 119
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+Q+L + ++H L + H DLKPEN++L+
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-----------------------VPKPR 156
Query: 265 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
IK+IDFG + I T + APE++ D+WS+G I L +G +
Sbjct: 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F E + V ++ +
Sbjct: 217 FLGDTKQE---TLANVS--------------------AVNYEFEDEY------------- 240
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ A D ++ LL DP R+T +++L+HP+
Sbjct: 241 ------FSNTSALAKD---FIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 85/356 (23%), Positives = 146/356 (41%), Gaps = 77/356 (21%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLA 151
++ RY S +GEG +G V +D K VAIK + + EI++L +
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF- 82
Query: 152 KHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 206
+H+ N + I + + + IV + + + LY L+ + D +
Sbjct: 83 RHE---N-IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLY 135
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+L + ++H ++H DLKP N LL+++ +K
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSN-LLLNTT--------------------------CDLK 168
Query: 267 VIDFG---STTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 319
+ DFG + ++ V+TR YRAPE++L G+T DIWSVGCIL E+ +
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRES 374
+F L+ L + +LG Q L + + A Y+ + ++ W
Sbjct: 229 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR------- 281
Query: 375 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
P + D A D LL +L ++P R+ +AL HP+ + +
Sbjct: 282 -----LFP--------NADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 72/348 (20%), Positives = 124/348 (35%), Gaps = 85/348 (24%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIE 145
+ + Y I ++G G F V +C ++ A K ++ + RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 146 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
+L+Q+ H + + + ++ R + ++ E + G L+DFL + +
Sbjct: 68 ILRQV-LHP----NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+Q+L+ + ++H + H DLKPEN++L+
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPH 157
Query: 265 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
IK+IDFG + I T + APE++ D+WS+G I L +G +
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F LG Q L + D+ E
Sbjct: 218 F---------------LGDTKQETLAN--------ITAVSYDFDEEF------------- 241
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
A D ++ LL + RLT +EALRHP+ T
Sbjct: 242 ------FSQTSELAKD---FIRKLLVKETRKRLTIQEALRHPWITPVD 280
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 87/358 (24%), Positives = 138/358 (38%), Gaps = 93/358 (25%)
Query: 83 KDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREA 139
G RY I +G+G+FG+VL+C DR ++ A+K++ K
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 140 AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPI 198
+ E+E+L++L H N +++ + + IV E G L+D + K F
Sbjct: 68 ILREVELLKKL-DHP---N-IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSE 120
Query: 199 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258
I +Q+ I +MH ++H DLKPEN+LL S E
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE---------------------- 158
Query: 259 MPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316
K IK+IDFG +T + + + T +Y APEV+ G + CD+WS G IL L
Sbjct: 159 --KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215
Query: 317 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAAS 371
+G F +N + K V G+ W
Sbjct: 216 LSGTPPF-YGKNEYDIL----------------------KRVETGKYAFDLPQWR----- 247
Query: 372 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ A D L++ +L + P+ R+TA + L HP+ +
Sbjct: 248 -------------------TISDDAKD---LIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 73/346 (21%), Positives = 133/346 (38%), Gaps = 91/346 (26%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLA 151
N+ + +G G F +V R ++ A+K ++ +R++++ EI VL+++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI- 63
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
KH+ N V + + ++ H +V + + G L+D + + + + +Q+L
Sbjct: 64 KHE---N-IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLS 117
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++H+ ++H DLKPEN+L ++ E ++S I + DF
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPE------------------------ENSKIMITDF 153
Query: 271 GSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQTHEN 328
G + E+ T Y APEV+ ++ D WS+G I + LC G F E
Sbjct: 154 GLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYE-ET 211
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPR 383
L E++ G + W
Sbjct: 212 ESKL--FEKIK--------------------EGYYEFESPFWD----------------- 232
Query: 384 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ SA D + LL DP +R T +AL HP+ +
Sbjct: 233 -------DISESAKD---FICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 75/342 (21%), Positives = 128/342 (37%), Gaps = 80/342 (23%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLA 151
+++ Y IH ++G G FG V +R A K V + +E EI+ + L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 211
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
+H V + + F+ N + +++E + G L++ + + D E RQ+ +
Sbjct: 212 RHPT----LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCK 266
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ MH+ +H DLKPEN++ + +S+ +K+IDF
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDF 301
Query: 271 GSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
G T + P Q+ T + APEV G Y D+WSVG + L +G + F +
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
E + V + + A
Sbjct: 362 DE---TLRNVK--------------------SCDWNMDDSA------------------- 379
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ D ++ LL DP R+T +AL HP+ T +
Sbjct: 380 FSGISEDGKD---FIRKLLLADPNTRMTIHQALEHPWLTPGN 418
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 77/345 (22%), Positives = 134/345 (38%), Gaps = 82/345 (23%)
Query: 93 ENLTSRYKIHSKM-GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA 151
+T Y++ ++ G G G+VLEC+ R + A+K++ K R+ E++ Q +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQAS 79
Query: 152 KHDKGGNRCVQIRNWFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 206
+ V I + ++ + + I+ E + G L+ +++ ++F EI R
Sbjct: 80 GGP---H-IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
+ I F+H + H D+KPEN+L S E K + +K
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKE------------------------KDAVLK 171
Query: 267 VIDFG-STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325
+ DFG + + T +Y APEV+ + CD+WS+G I+ L G F +
Sbjct: 172 LTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231
Query: 326 -HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 384
M R +R G+ +P S
Sbjct: 232 NTGQAISPGMKRR--------------------IRLGQYGFPNPEWS------------- 258
Query: 385 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
V A L++ LL+ DPT+RLT + + HP+ +
Sbjct: 259 ------EVSEDAKQ---LIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-39
Identities = 71/349 (20%), Positives = 121/349 (34%), Gaps = 97/349 (27%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQ 148
++ Y + + +G G++G+V + + A K I KY + EIE+++
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMK 61
Query: 149 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
L H +++ F+ I +V E G L++ + F I +
Sbjct: 62 SL-DH----PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKD 114
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+L +A+ H L + H DLKPEN L ++ S +K+
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDS------------------------PDSPLKL 150
Query: 268 IDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325
IDFG +P + V T +Y +P+V+ G + CD WS G ++ L G F
Sbjct: 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA 209
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMK 380
+ +R G W
Sbjct: 210 -PTDSEVM----------------------LKIREGTFTFPEKDWL-------------- 232
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+V A L++ LL P R+T+ +AL H +F +
Sbjct: 233 ----------NVSPQAES---LIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-39
Identities = 93/433 (21%), Positives = 160/433 (36%), Gaps = 89/433 (20%)
Query: 53 PRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGE---NLTSRYKIHSKMGEGT 109
A H + + V G + G + + RY+I +G G+
Sbjct: 6 AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGS 65
Query: 110 FGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLAKHDKGGN--- 158
+G V E +D+ K +VAIK + + + RE I +L +L HD +
Sbjct: 66 YGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE-----IAILNRL-NHD---HVVK 116
Query: 159 -RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
+ I + + + +V E S R Y + ++ + LL + ++H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT--ELHIKTLLYNLLVGVKYVHS 174
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
++H DLKP N L+ +KV D+ + + ++P S ++ + + +
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 278 PDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT-----------GEAL 322
+ + V TR YRAPE+IL +T D+WS+GCI EL L
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL 294
Query: 323 F--------------------QTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR-- 359
F T N + L ++ +LG + ++ + A++Y+R
Sbjct: 295 FPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF 354
Query: 360 --RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 417
R D E + P A L L+ +L ++P R+T
Sbjct: 355 PKREGTDLAE------------RFP--------ASSADAIHL---LKRMLVFNPNKRITI 391
Query: 418 REALRHPFFTRDH 430
E L HPFF
Sbjct: 392 NECLAHPFFKEVR 404
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 47/249 (18%), Positives = 94/249 (37%), Gaps = 28/249 (11%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 152
+ + +H +GEG F QV E + + + +K + A E + QL +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF-VLKVQKPANPWEFYIGTQLME 119
Query: 153 HDKGGNR--CVQIRNWFDYRNHICIVFEKL-GSSLYDFL---RKNNYRSFPIDLVREIAR 206
K + ++ + ++N +V E +L + + + + P LV A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
++L I +HD +IH D+KP+N +L + + + S +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG----------------LA 223
Query: 267 VIDFGSTTYER--PDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321
+ID G + + P + T ++ E++ W Y D + V + + G
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
Query: 322 LFQTHENLE 330
+ +E E
Sbjct: 284 MKVKNEGGE 292
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 67/340 (19%), Positives = 117/340 (34%), Gaps = 91/340 (26%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHD 154
+Y K+GEG+FG+ + E IK + K RE + E+ VL + KH
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP 83
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
VQ R F+ + IV + G L+ + F D + + Q+ +
Sbjct: 84 ----NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+HD ++H D+K +N+ L K +++ DFG
Sbjct: 140 HVHDRKILHRDIKSQNIFL---------------------------TKDGTVQLGDFGIA 172
Query: 274 TYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
+ T +Y +PE+ + DIW++GC+L ELCT + F+ +++
Sbjct: 173 RVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMK 231
Query: 331 HLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
+L + + P+ H S +
Sbjct: 232 NLVLKIISGSFPPVSLHY------------------------SYD--------------- 252
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
L L+ L + +P DR + L F +
Sbjct: 253 ----------LRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 84/356 (23%), Positives = 137/356 (38%), Gaps = 91/356 (25%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMI--E 143
+ L Y + +G G G+V ++R+ + VAI+I+ ++ A + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 144 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 202
IE+L++L H ++I+N+FD IV E + G L+D + N +
Sbjct: 191 IEILKKL-NHP----CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 242
Query: 203 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 262
Q+L + ++H+ +IH DLKPENVLL S E +
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------ED 278
Query: 263 SAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELC 317
IK+ DFG + + T Y APEV++ + G+ D WS+G IL
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
+G F H + + + G+ ++
Sbjct: 339 SGYPPFSEHRT--------------QVSLKDQ--------ITSGKYNFIP---------- 366
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 433
+ V A D L++ LL DP R T EALRHP+ + ++R
Sbjct: 367 ---------EVWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-39
Identities = 77/346 (22%), Positives = 134/346 (38%), Gaps = 95/346 (27%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQL 150
+ L+ +++ S++G G V C + ++ A+K+ +KK + ++ EI VL +L
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV---LKKTVDKKIVRTEIGVLLRL 105
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
H N ++++ F+ I +V E G L+D + + Y + + +Q+L
Sbjct: 106 -SHP---N-IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQIL 158
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
E +A++H+ ++H DLKPEN+L + + +K+ D
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPA------------------------PDAPLKIAD 194
Query: 270 FGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQTH 326
FG + + T Y APE++ G + D+WSVG I + LC G F
Sbjct: 195 FGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDE 253
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKL 381
+ M R+L W
Sbjct: 254 RGDQ--FMFRRIL--------------------NCEYYFISPWWD--------------- 276
Query: 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
V +A D L++ L+ DP RLT +AL+HP+ T
Sbjct: 277 ---------EVSLNAKD---LVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-39
Identities = 68/371 (18%), Positives = 126/371 (33%), Gaps = 110/371 (29%)
Query: 79 REDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKK 135
++ + +M + Y + ++G+G F V C + A KI+ + +
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70
Query: 136 YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR 194
+ E + ++L +H N V++ + + +VF+ + G L++ + +
Sbjct: 71 DFQKLEREARICRKL-QHP---N-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF- 124
Query: 195 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254
+ +Q+LE IA+ H ++H +LKPEN+LL S
Sbjct: 125 -YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------------ 165
Query: 255 YFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312
K +A+K+ DFG + + T Y +PEV+ ++ P DIW+ G I
Sbjct: 166 ------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
Query: 313 L-VELC--------TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL 363
L + L L+ ++ G
Sbjct: 220 LYILLVGYPPFWDEDQHRLYAQ--------------------------------IKAGAY 247
Query: 364 D-----WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 418
D W V A L+ +L +P R+TA
Sbjct: 248 DYPSPEWD------------------------TVTPEAKS---LIDSMLTVNPKKRITAD 280
Query: 419 EALRHPFFTRD 429
+AL+ P+
Sbjct: 281 QALKVPWICNR 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 9e-39
Identities = 58/343 (16%), Positives = 112/343 (32%), Gaps = 66/343 (19%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDK 155
+ + +G+G V ++ ++ AIK+ + + M E EVL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHK- 67
Query: 156 GGNRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLEC 211
V++ + H ++ E SLY L + N P + R ++
Sbjct: 68 ---NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ + + ++H ++KP N++ V E S K+ DFG
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDFG 161
Query: 272 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYP--------CDIWSVGCILVELCTGEA 321
+ D+ + + T Y P++ D+WS+G TG
Sbjct: 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
Query: 322 LFQTHENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380
F+ E +M +++ P + V + G +DW S+ ++
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLSRGLQ 276
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
LT +L +L D +
Sbjct: 277 ----------------VLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 87/352 (24%), Positives = 148/352 (42%), Gaps = 73/352 (20%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQL 150
+ + Y+ +G G +G V D VAIK + R + A A E+ +L+ +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 151 AKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 204
+H+ N + + + F D +V +G+ L ++ D ++ +
Sbjct: 82 -RHE---N-VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE---DRIQFL 133
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
Q+L+ + ++H +IH DLKP N+ +
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---------------------------CE 166
Query: 265 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 323
+K++DFG + V TR YRAPEVIL +T DIWSVGCI+ E+ TG+ LF
Sbjct: 167 LKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
Query: 324 QTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSV 378
+ ++L+ L + +V G P ++R+ A+ Y++ + D+
Sbjct: 227 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS----------- 275
Query: 379 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
I+ + A + LL+ +L D R+TA EAL HP+F H
Sbjct: 276 ---------ILTNASPLAVN---LLEKMLVLDAEQRVTAGEALAHPYFESLH 315
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 72/359 (20%), Positives = 125/359 (34%), Gaps = 111/359 (30%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQ 148
T Y++ ++G+G F V C + A I+ + + + E + +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 149 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
L KH N V++ + H ++F+ + G L++ + Y + +Q
Sbjct: 66 LL-KHP---N-IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQ 118
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+LE + H + ++H +LKPEN+LL S K +A+K+
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKL------------------------KGAAVKL 154
Query: 268 IDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC------ 317
DFG + E Q + T Y +PEV+ + P D+W+ G IL + L
Sbjct: 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214
Query: 318 --TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAA 370
L+Q ++ G D W
Sbjct: 215 DEDQHRLYQ--------------------------------QIKAGAYDFPSPEWD---- 238
Query: 371 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
V A D L+ +L +P+ R+TA EAL+HP+ +
Sbjct: 239 --------------------TVTPEAKD---LINKMLTINPSKRITAAEALKHPWISHR 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 67/357 (18%), Positives = 121/357 (33%), Gaps = 110/357 (30%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQ 149
+ Y + ++G+G F V C + A KI+ + + + E + ++
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
L +H N V++ + + +VF+ + G L++ + + + +Q+
Sbjct: 62 L-QHP---N-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQI 114
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
LE IA+ H ++H +LKPEN+LL S K +A+K+
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKA------------------------KGAAVKLA 150
Query: 269 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC-------- 317
DFG + + T Y +PEV+ ++ P DIW+ G IL + L
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASR 372
L+ ++ G D W
Sbjct: 211 DQHRLYAQ--------------------------------IKAGAYDYPSPEWD------ 232
Query: 373 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
V A L+ +L +P R+TA +AL+ P+
Sbjct: 233 ------------------TVTPEAKS---LIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 6e-38
Identities = 84/368 (22%), Positives = 143/368 (38%), Gaps = 89/368 (24%)
Query: 100 KIHSKMGEGTFGQVLECWDRERK--EMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK 155
K+G GT+G V + ++ K + A+K + GI +A EI +L++L KH
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLREL-KHP- 78
Query: 156 GGNRCVQIRNWFDYRNHICI--VFE-------KLGSSLYDFLRKNNYRSFPIDLVREIAR 206
N + ++ F + +F+ + P +V+ +
Sbjct: 79 --N-VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+L+ I ++H ++H DLKP N +LV E P+ +K
Sbjct: 136 QILDGIHYLHANWVLHRDLKPAN-ILVMGEG----------------------PERGRVK 172
Query: 267 VIDFG-STTYERPDQNY-----IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCT 318
+ D G + + P + +V T YRAPE++LG Y DIW++GCI EL T
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLT 231
Query: 319 GEALFQ---------THENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPE- 367
E +F + + L + V+G P + DW +
Sbjct: 232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK-------------------DWEDI 272
Query: 368 ------GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 421
++ ++ L + +H HLLQ LL DP R+T+ +A+
Sbjct: 273 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332
Query: 422 RHPFFTRD 429
+ P+F D
Sbjct: 333 QDPYFLED 340
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 88/367 (23%), Positives = 140/367 (38%), Gaps = 103/367 (28%)
Query: 88 MFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAA 140
M + L Y + +G G G+V ++R+ + VAIKI+ ++ A
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 141 MI--EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFP 197
+ EIE+L++L H ++I+N+FD ++ IV E + G L+D + N
Sbjct: 61 NVETEIEILKKL-NHP----CIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR--LK 112
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
+ Q+L + ++H+ +IH DLKPENVLL S E
Sbjct: 113 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE--------------------- 151
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL---GWTYPCDIWSVGCI 312
+ IK+ DFG + + T Y APEV++ + G+ D WS+G I
Sbjct: 152 ---EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
Query: 313 L-VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WP 366
L + L G F H + + + G+ + W
Sbjct: 209 LFICLS-GYPPFSEHRT--------------QVSLKDQ--------ITSGKYNFIPEVWA 245
Query: 367 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
V A D L++ LL DP R T EALRHP+
Sbjct: 246 ------------------------EVSEKALD---LVKKLLVVDPKARFTTEEALRHPWL 278
Query: 427 TRDHLRR 433
+ ++R
Sbjct: 279 QDEDMKR 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 79/361 (21%), Positives = 126/361 (34%), Gaps = 107/361 (29%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV----------RGIKKYREAAMI 142
Y+ +G G V C + + A+KI+ +++ REA +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 143 EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLV 201
E+++L++++ H N +Q+++ ++ +VF+ + L+D+L +
Sbjct: 73 EVDILRKVSGHP---N-IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKET 126
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
R+I R LLE I +H L ++H DLKPEN+LL
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDD--------------------------- 159
Query: 262 SSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCIL 313
IK+ DFG + P + + T Y APE+I G+ D+WS G I+
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 314 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEG 368
L G F H ML+ + G W
Sbjct: 220 YTLLAGSPPF-WHRK--------------QMLMLRM--------IMSGNYQFGSPEWD-- 254
Query: 369 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ D L+ L P R TA EAL HPFF +
Sbjct: 255 ----------------------DYSDTVKD---LVSRFLVVQPQKRYTAEEALAHPFFQQ 289
Query: 429 D 429
Sbjct: 290 Y 290
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 86/414 (20%), Positives = 146/414 (35%), Gaps = 111/414 (26%)
Query: 42 QEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDD---KDGHYMFALGENLTSR 98
Q + S + S ++ + + + G+ +D +A + +
Sbjct: 36 QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK 95
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 149
Y +G G V C R A+KI+ +++ REA E +L+Q
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
+A H + + + ++ + + +VF+ + L+D+L + R I R L
Sbjct: 156 VAGH----PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSL 209
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
LE ++F+H ++H DLKPEN+LL + I++
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDD---------------------------NMQIRLS 242
Query: 269 DFGSTTYERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCIL-VELCTG 319
DFG + + P + + T Y APE++ G+ D+W+ G IL L G
Sbjct: 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-G 301
Query: 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRES 374
F H ML+ + G+ W
Sbjct: 302 SPPF-WHRR--------------QILMLRM--------IMEGQYQFSSPEWD-------- 330
Query: 375 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ D L+ LL+ DP RLTA +AL+HPFF R
Sbjct: 331 ----------------DRSSTVKD---LISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 82/341 (24%), Positives = 133/341 (39%), Gaps = 82/341 (24%)
Query: 93 ENLTSRYKIHSK--MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQ 149
+ S Y + +G G FGQV +C + +A KI++ K +E EI V+ Q
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
L H +Q+ + F+ +N I +V E + G L+D + +Y + +Q+
Sbjct: 143 L-DHA----NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQI 196
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
E I MH + ++H DLKPEN+L V+ + IK+I
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVN-------------------------RDAKQIKII 231
Query: 269 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
DFG +P + T + APEV+ ++P D+WSVG I L +G + F
Sbjct: 232 DFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF--- 288
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
LG L + R D +
Sbjct: 289 ------------LGDNDAETLNN--------ILACRWDLEDEE----------------- 311
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
Q + A + + LL + + R++A EAL+HP+ +
Sbjct: 312 --FQDISEEAKE---FISKLLIKEKSWRISASEALKHPWLS 347
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 71/371 (19%), Positives = 120/371 (32%), Gaps = 89/371 (23%)
Query: 73 NGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG 132
PP + +G N + ++I K+G G F +V VA+K V+
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67
Query: 133 IK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF 187
K R + EI++L+QL H N ++ F N + IV E L
Sbjct: 68 FDLMDAKARADCIKEIDLLKQL-NHP---N-VIKYYASFIEDNELNIVLELADAGDLSRM 122
Query: 188 LR--KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245
++ K R P V + QL + MH ++H D+KP NV +
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT------------ 170
Query: 246 SLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ--NYIVSTRHYRAPEVILGLGWTY 302
+ +K+ D G + + +V T +Y +PE I G+ +
Sbjct: 171 ---------------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 215
Query: 303 PCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRG 361
DIWS+GC+L E+ ++ F + + ++ +++ P
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPP----------------- 257
Query: 362 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 421
P S E L+ L+ + DP R
Sbjct: 258 ---LPSDHYSEE----------LRQLVNM---------------CINPDPEKRPDVTYVY 289
Query: 422 RHPFFTRDHLR 432
Sbjct: 290 DVAKRMHACTA 300
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 47/424 (11%), Positives = 107/424 (25%), Gaps = 104/424 (24%)
Query: 37 GLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLT 96
G +++ + + + V+ V P E + +L
Sbjct: 7 GDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETT-----VDSLLSQGE 61
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--------IKKYREAAMIEIEVLQ 148
+ K+ + G V D ER E A+K+ +++ EA +L
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 149 QLAKHDKGGNRCVQIRNWFDYRNH-----------------ICIVFEKLGSSLYDFLRKN 191
+ + + R + + ++ ++ L
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 192 NYRS-----FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246
++ I + + QL+ A + ++H P+N+ ++
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM------------- 228
Query: 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PC 304
+ + D + Y E + T+
Sbjct: 229 --------------PDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHAL 274
Query: 305 DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 364
+ W +G + + F G + + R + + L
Sbjct: 275 NAWQLGLSIYRVWCLFLPF----------------GLVTPGIKGSWKRPSLRVPGTDSLA 318
Query: 365 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 424
+ + +K+ L+ L +D RL EA+ P
Sbjct: 319 FGSCTPLPDFVKT------------------------LIGRFLNFDRRRRLLPLEAMETP 354
Query: 425 FFTR 428
F +
Sbjct: 355 EFLQ 358
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 77/349 (22%), Positives = 128/349 (36%), Gaps = 105/349 (30%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 153
RY +G+G F + E D + KE+ A KIV + K + + EI + + L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
V +F+ + + +V E SL + ++ ++ R RQ++
Sbjct: 75 ----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 128
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
++H +IH DLK N+ L + + K+ DFG
Sbjct: 129 QYLHRNRVIHRDLKLGNLFL---------NEDLEV------------------KIGDFGL 161
Query: 272 STTYERPDQ---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
+T E + NYI APEV+ G ++ D+WS+GCI+ L G+
Sbjct: 162 ATKVEYDGERKKVLCGTPNYI-------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F+T L + R +++ P+
Sbjct: 215 FET-SCL--------------KETYLR--------IKKNEYSIPK--------------- 236
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
H++ A L+Q +L+ DPT R T E L FFT ++
Sbjct: 237 --------HINPVAAS---LIQKMLQTDPTARPTINELLNDEFFTSGYI 274
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 87/385 (22%), Positives = 146/385 (37%), Gaps = 86/385 (22%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQL 150
++ Y I +G G++G V +D+ ++ VAIK + R + + I EI +L +L
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82
Query: 151 AKHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 205
K D +++ + + + IV E S L + + + + ++ I
Sbjct: 83 -KSD---Y-IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--EEHIKTIL 135
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD------YKSSLHTPKDSSYFKRM 259
LL F+H+ +IH DLKP N LL +KV D S T + +
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 260 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 318
K + T++ V TR YRAPE+IL +T DIWS GCI EL
Sbjct: 196 EPGPHNKNLKKQLTSH--------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 319 G-----------EALFQ-----------------THENLEHLAMMERVLGPLPQHMLKRV 350
LF N + L ++ ++G + LK +
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307
Query: 351 -DRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405
KY++ R ++ + K P + +L L+
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQ------------KYP--------SISDDGINL---LES 344
Query: 406 LLRYDPTDRLTAREALRHPFFTRDH 430
+L+++P R+T +AL HP+
Sbjct: 345 MLKFNPNKRITIDQALDHPYLKDVR 369
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 82/395 (20%), Positives = 136/395 (34%), Gaps = 116/395 (29%)
Query: 52 PPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFG 111
P +A V + P D + RY +G+G F
Sbjct: 7 PGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR-----------RYVRGRFLGKGGFA 55
Query: 112 QVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQIRNWF 167
+ E D + KE+ A KIV + K + + EI + + L H V +F
Sbjct: 56 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH----QHVVGFHGFF 110
Query: 168 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 226
+ + + +V E SL + ++ ++ R RQ++ ++H +IH DLK
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 227 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ----- 280
N+ L + +K+ DFG +T E +
Sbjct: 169 LGNLFL---------NEDLE------------------VKIGDFGLATKVEYDGERKKVL 201
Query: 281 ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
NYI APEV+ G ++ D+WS+GCI+ L G+ F+T L
Sbjct: 202 CGTPNYI-------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCL------- 246
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
+ R +++ P+ H++ A
Sbjct: 247 -------KETYLR--------IKKNEYSIPK-----------------------HINPVA 268
Query: 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
L+Q +L+ DPT R T E L FFT ++
Sbjct: 269 ---ASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-36
Identities = 64/354 (18%), Positives = 113/354 (31%), Gaps = 101/354 (28%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHD 154
Y++ +G G++G+ + + +++ K + ++ + E+ +L++L KH
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 155 KGGNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLL 209
N V+ + R + IV E G L + + + V + QL
Sbjct: 66 ---N-IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 210 ECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+ H ++H DLKP NV L
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLD---------------------------GKQN 154
Query: 265 IKVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321
+K+ DFG D ++ V T +Y +PE + + + DIWS+GC+L ELC
Sbjct: 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
Query: 322 LFQTHENLEHLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 379
F + + LA E +P S E
Sbjct: 215 PFTA-FSQKELAGKIREGKFRRIPYRY------------------------SDE------ 243
Query: 380 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 433
L ++ +L R + E L +P +H
Sbjct: 244 -------------------LNEIITRMLNLKDYHRPSVEEILENPLI-LEHHHH 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-36
Identities = 65/351 (18%), Positives = 111/351 (31%), Gaps = 83/351 (23%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHD 154
+ ++ +G G FG V E ++ AIK +R + RE M E++ L +L +H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHP 63
Query: 155 KGGNRCVQIRNWFD-----------YRNHICIVFEKL--GSSLYDFLRKNNYRSFP-IDL 200
W + + ++ I + L +L D++ +
Sbjct: 64 ---GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSV 119
Query: 201 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 260
I Q+ E + F+H ++H DLKP N+ + +KV D+ M
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV----------TAMD 169
Query: 261 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
+ + + V T+ Y +PE I G +++ DI+S+G IL EL
Sbjct: 170 QDEEEQ--TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP- 226
Query: 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380
F T VR K
Sbjct: 227 --FSTQMERVRTLTD----------------------VRNL------------------K 244
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
P L ++Q +L P +R A + + F
Sbjct: 245 FPPLFTQKYP-------CEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 69/341 (20%), Positives = 112/341 (32%), Gaps = 64/341 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK 155
+++ ++G G FG VL ++ E VAIK R K RE +EI+++++L H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP- 72
Query: 156 GGN-----RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQL 208
N + + E G L +L + N +R + +
Sbjct: 73 --NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
+ ++H+ +IH DLKPEN++L + K+I
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGP------------------------QRLIHKII 166
Query: 269 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
D G + V T Y APE++ +T D WS G + E TG
Sbjct: 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF------ 220
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
P + + K + ++K LP +
Sbjct: 221 ---------------RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
L AG L LQ +L + R T + F
Sbjct: 266 LSGI----LAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 70/348 (20%), Positives = 127/348 (36%), Gaps = 104/348 (29%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 153
+K+ + +G+G+F V VAIK++ + + K + E+++ QL KH
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
+++ N+F+ N++ +V E + +L+ + F + R Q++ +
Sbjct: 71 ----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGM 125
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
++H ++H DL N+LL + IK+ DFG
Sbjct: 126 LYLHSHGILHRDLTLSNLLL---------TRNMN------------------IKIADFGL 158
Query: 272 STTYERPDQ---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
+T + P + NYI +PE+ D+WS+GC+ L G
Sbjct: 159 ATQLKMPHEKHYTLCGTPNYI-------SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F T + + ++ L + V + P
Sbjct: 212 FDT-DTV--------------KNTLNK--------VVLADYEMPS--------------- 233
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ A D L+ LLR +P DRL+ L HPF +R+
Sbjct: 234 --------FLSIEAKD---LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 65/345 (18%), Positives = 103/345 (29%), Gaps = 92/345 (26%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 155
++G G+FG+V D++ A+K VR + E+ L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSP- 110
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
R V + + I E L G SL +++ P D Q LE + +
Sbjct: 111 ---RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEY 165
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 271
+H ++H D+K +NVLL S + DFG
Sbjct: 166 LHTRRILHGDVKADNVLL--------------------------SSDGSRAALCDFGHAL 199
Query: 272 -----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
+YI T + APEV++G DIWS C+++ + G
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG------- 252
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
H P Q+ +K+
Sbjct: 253 ---CH---------PWTQY---------------------------FRGPLCLKIASEPP 273
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
I + A +Q LR +P R +A E R +
Sbjct: 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 77/398 (19%), Positives = 135/398 (33%), Gaps = 112/398 (28%)
Query: 48 TSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGE 107
+S S V S + + +K E L S+Y++ +G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEK---------EPLESQYQVGPLLGS 53
Query: 108 GTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-----EIEVLQQLAKHDKGGNRC 160
G FG V VAIK V I + E E+ +L+++ G
Sbjct: 54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV-SSGFSG--V 110
Query: 161 VQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
+++ +WF+ + ++ E+ L+DF+ + + +L R Q+LE + H+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC 168
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
++H D+K EN+L+ D + + +K+IDFGS
Sbjct: 169 GVLHRDIKDENILI-------------------DLNRGE-------LKLIDFGSGALL-K 201
Query: 279 DQNYIVS--TRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLEHLA 333
D Y TR Y PE I Y +WS+G +L ++ G+ F
Sbjct: 202 DTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGDIPF---------- 249
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
++ + RG++ +
Sbjct: 250 -------------------EHDEEIIRGQVFFR--------------------------Q 264
Query: 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
+ + HL++ L P+DR T E HP+ L
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 70/348 (20%), Positives = 130/348 (37%), Gaps = 108/348 (31%)
Query: 93 ENLTSRYKIHSKM-GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA 151
+ YK+ S++ G G G+VL+ +++ +E A+K+++ K R E+E+ + +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68
Query: 152 KHDKGGNRCVQIRNWFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 206
+ + V+I + ++ R + IV E L G L+ ++ ++F EI +
Sbjct: 69 QCP---H-IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
+ E I ++H + + H D+KPEN+L S ++ +K
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAILK 160
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
+ DFG A E G + CD+WS+G I+ L G F ++
Sbjct: 161 LTDFG------------------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKL 381
+ M R +R G+ + W
Sbjct: 202 HG-----------LAISPGMKTR--------IRMGQYEFPNPEWS--------------- 227
Query: 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
V L++ LL+ +PT R+T E + HP+ +
Sbjct: 228 ---------EVSEEVKM---LIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 70/338 (20%), Positives = 128/338 (37%), Gaps = 87/338 (25%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAK 152
++I +G+G FG V +++ K ++A+K++ ++K + E+E+ L +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 67
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
H +++ +F + ++ E ++Y L+K F +L
Sbjct: 68 HPN----ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 121
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+++ H +IH D+KPEN+LL S+ +K+ D+ S+H P +R
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT------------ 165
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331
D Y PE+I G D+WS+G + E G+ F+ +
Sbjct: 166 -DLCGTLD---------YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---- 211
Query: 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391
Q KR + R +P+
Sbjct: 212 -----------YQETYKR--------ISRVEFTFPD-----------------------F 229
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
V A D L+ LL+++P+ R RE L HP+ T +
Sbjct: 230 VTEGARD---LISRLLKHNPSQRPMLREVLEHPWITAN 264
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 56/355 (15%), Positives = 102/355 (28%), Gaps = 103/355 (29%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKG 156
Y K+GEG F V A+K + ++ RE A E ++ + H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHP-- 86
Query: 157 GNRCVQIRNWF----DYRNHICIVFE-KLGSSLYDFL--RKNNYRSFPIDLVREIARQLL 209
N +++ + ++ ++ +L++ + K+ D + + +
Sbjct: 87 -N-ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ +H H DLKP N+LL ++D
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLG---------------------------DEGQPVLMD 177
Query: 270 FGSTTYERP------------DQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILV 314
GS D T YRAPE+ D+WS+GC+L
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237
Query: 315 ELCTGEALFQ-THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 373
+ GE + + + +A+ + +L P+ R
Sbjct: 238 AMMFGEGPYDMVFQKGDSVAL-----------------------AVQNQLSIPQS--PRH 272
Query: 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
S L L+ ++ DP R L +
Sbjct: 273 S-------SALWQLL---------------NSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 66/363 (18%), Positives = 135/363 (37%), Gaps = 92/363 (25%)
Query: 79 REDDKDGHYMFALGENLTSRY-KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIK 134
++DD + A+G + R+ K ++G G+F V + D E VA ++ K
Sbjct: 7 QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 66
Query: 135 KYREAAMIEIEVLQQLAKHDKGGNRCVQ-IRNWFDY---RNHICIVFEKLGS-SLYDFLR 189
R+ E E+L+ L +H V+ +W + I +V E + S +L +L+
Sbjct: 67 SERQRFKEEAEMLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121
Query: 190 KNNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247
+ ++ I ++R RQ+L+ + F+H +IH DLK +N+ +
Sbjct: 122 R--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--------------- 164
Query: 248 HTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI 306
+ ++K+ D G +T ++ T + APE+ + D+
Sbjct: 165 -----------TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDV 212
Query: 307 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWP 366
++ G ++E+ T E + +N + RV +
Sbjct: 213 YAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKPASF------------------- 251
Query: 367 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ + P ++ +I +R + +R + ++ L H FF
Sbjct: 252 ------DKVAI----PEVKEIIEG---------------CIRQNKDERYSIKDLLNHAFF 286
Query: 427 TRD 429
+
Sbjct: 287 QEE 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 69/338 (20%), Positives = 121/338 (35%), Gaps = 87/338 (25%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAK 152
+ I +G+G FG V +++ K ++A+K++ ++K + EIE+ L +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-R 72
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
H +++ N+F R I ++ E LY L+K+ F +L +
Sbjct: 73 HPN----ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADA 126
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ + H+ +IH D+KPEN+L+ +K+ D+ S+H P +R
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRR------------ 170
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331
T D Y PE+I G D+W G + E G F + H
Sbjct: 171 -TMCGTLD---------YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP---SH 217
Query: 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391
R++ L +P
Sbjct: 218 TETHRRIV--------------------NVDLKFPP-----------------------F 234
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ + D L+ LLRY P RL + + HP+ +
Sbjct: 235 LSDGSKD---LISKLLRYHPPQRLPLKGVMEHPWVKAN 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 63/352 (17%), Positives = 115/352 (32%), Gaps = 101/352 (28%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-----EIE 145
E + Y++ +G+G FG V + VAIK++ + + + E+
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 146 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 203
+L ++ +++ +WF+ + +V E L+D++ + R
Sbjct: 87 LLWKVGAGGGHPG-VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRC 143
Query: 204 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
Q++ I H ++H D+K EN+L+ D +
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILI-------------------DL-------RRG 177
Query: 264 AIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTY---PCDIWSVGCILVELCT 318
K+IDFGS D+ Y TR Y PE I Y P +WS+G +L ++
Sbjct: 178 CAKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVC 234
Query: 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 378
G+ F ++ + L +P
Sbjct: 235 GDIPF-----------------------------ERDQEILEAELHFPA----------- 254
Query: 379 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
H + D L++ L P+ R + E L P+
Sbjct: 255 ---------------HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 68/357 (19%), Positives = 110/357 (30%), Gaps = 110/357 (30%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKG 156
R ++ + EG F V E D A+K + ++ A + E+ +++L+ H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP-- 86
Query: 157 GN------RCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQL 208
N + D ++ +L G + + + D V +I Q
Sbjct: 87 -NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 209 LECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
+ MH +IH DLK EN+LL IK
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS---------------------------NQGTIK 178
Query: 267 VIDFGSTTYERPDQNYIVS-----------TRH----YRAPEVI---LGLGWTYPCDIWS 308
+ DFGS T +Y S TR+ YR PE+I DIW+
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238
Query: 309 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG 368
+GCIL LC + F+ L + G+ P
Sbjct: 239 LGCILYLLCFRQHPFEDGAKLR---------------------------IVNGKYSIP-- 269
Query: 369 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
H L++ +L+ +P +RL+ E +
Sbjct: 270 ---------------------PHDTQYT-VFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-32
Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 41/249 (16%)
Query: 81 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREA 139
++ D + +G+GT+G V D + +AIK + +Y +
Sbjct: 6 EEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP 65
Query: 140 AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPI 198
EI + + L KH VQ F I I E++ G SL L ++ +
Sbjct: 66 LHEEIALHKHL-KHK----NIVQYLGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKD 119
Query: 199 D--LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256
+ + +Q+LE + ++HD ++H D+K +NVL+
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI------------------------ 155
Query: 257 KRMPKSSAIKVIDFGS---TTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGC 311
S +K+ DFG+ P T Y APE+I G+ DIWS+GC
Sbjct: 156 --NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213
Query: 312 ILVELCTGE 320
++E+ TG+
Sbjct: 214 TIIEMATGK 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 60/362 (16%), Positives = 123/362 (33%), Gaps = 94/362 (25%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI------------- 142
Y+I + +G F +++ C + + A+K ++K R+
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 143 ---EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY----- 193
E++++ + K++ C+ + + I++E + S+ F
Sbjct: 90 FKNELQIITDI-KNE---Y-CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 194 -RSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251
PI +++ I + +L +++H+ + H D+KP N+L+ D
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---------DKNGR----- 190
Query: 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTY--PCDIW 307
+K+ DFG + Y D+ S T + PE DIW
Sbjct: 191 -------------VKLSDFGESEY-MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 308 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 367
S+G L + F +L + +R +++P
Sbjct: 237 SLGICLYVMFYNVVPFSLKISL--------------VELFNN--------IRTKNIEYPL 274
Query: 368 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
+ K N + + D L+ LR +P +R+T+ +AL+H +
Sbjct: 275 DRNHFLYPLTNKKSTCSNN----FLSNEDID---FLKLFLRKNPAERITSEDALKHEWLA 327
Query: 428 RD 429
Sbjct: 328 DT 329
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 49/367 (13%), Positives = 108/367 (29%), Gaps = 127/367 (34%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM------IEIEVLQQLAKHDKGGNR 159
G+ LE D+E E + + ++ A+ + L + K+ K
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 160 CVQIRNWFD--------------------YRNHICIVFEKLGSSLYDFL-----RKNNYR 194
++ FD + ++ ++ S+L F + ++
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 195 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254
S ++ Q++ +A +H ++HT L+P +++L
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--------------------- 240
Query: 255 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGW-----------T 301
+ + + F D +VS +R + PE+ T
Sbjct: 241 ------QRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291
Query: 302 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG 361
+ D W++G ++ + + T + + +++ R
Sbjct: 292 FSFDAWALGLVIYWIWCADLPI-TKDAALGGS----------------------EWIFRS 328
Query: 362 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 421
+ P+ LL+G LRY DRL +A+
Sbjct: 329 CKNIPQPVR------------------------------ALLEGFLRYPKEDRLLPLQAM 358
Query: 422 RHPFFTR 428
P + +
Sbjct: 359 ETPEYEQ 365
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 72/390 (18%), Positives = 121/390 (31%), Gaps = 124/390 (31%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLA--- 151
+ ++ MG G FG V E ++ AIK +R + RE M E++ L +L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 152 ----------------------------------KHDKGGNRCVQIRNWFDYRNHICIVF 177
+ D + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 178 EKLGSS----LY------------DFLRKNNYRSFP-IDLVREIARQLLECIAFMHDLCM 220
+ SS LY D++ + + I Q+ E + F+H +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 221 IHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+H DLKP N+ + +KV D+ + ++ + MP +
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA-------------- 231
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337
V T+ Y +PE I G +++ DI+S+G IL EL F T MER
Sbjct: 232 -THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQ--------MER 279
Query: 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
V ++ VR + P K P+ ++
Sbjct: 280 V------RIITD--------VRNLKF--PLL--------FTQKYPQEHMMVQD------- 308
Query: 398 DLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
+L PT+R A + + + F
Sbjct: 309 --------MLSPSPTERPEATDIIENAIFE 330
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 72/347 (20%), Positives = 125/347 (36%), Gaps = 105/347 (30%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----------EIEVL 147
+Y S +G G FG V D+E+ + V +K ++ +K E I EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 148 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIA 205
++ +H +++ + F+ + +V EK GS L+ F+ ++ L I
Sbjct: 84 SRV-EHAN----IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIF 136
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
RQL+ + ++ +IH D+K EN+++ + I
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVI-------------------AEDF--------TI 169
Query: 266 KVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEAL 322
K+IDFGS Y + + T Y APEV++G + P ++WS+G L L E
Sbjct: 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE-- 227
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
P L+ + P
Sbjct: 228 -------------------NPFCELEE--------TVEAAIHPP---------------- 244
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ +L L+ GLL+ P R T + + P+ T+
Sbjct: 245 ----------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 64/338 (18%), Positives = 118/338 (34%), Gaps = 50/338 (14%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKG 156
++ S++G G G V + + ++A K++ K I E++VL +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE------- 87
Query: 157 GNRCVQIRNW---FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
I + F I I E + G SL L+K P ++ +++ +++ +
Sbjct: 88 -CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 144
Query: 213 AFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
++ + ++H D+KP N+L+ S IK+ DFG
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSR---------------------------GEIKLCDFG 177
Query: 272 -STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
S N V TR Y +PE + G ++ DIWS+G LVE+ G + E
Sbjct: 178 VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
M + R R + + + + +
Sbjct: 238 LELMFGCQVEGDAAETPPR----PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
S + + L +P +R ++ + H F R
Sbjct: 294 SGVFSL-EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 66/346 (19%), Positives = 117/346 (33%), Gaps = 90/346 (26%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQ 148
+ Y++ +G+G F +V VAIKI+ + + E+ +++
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 149 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
L H V++ + + ++ E G ++D+L + R RQ
Sbjct: 70 IL-NHP----NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQ 122
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
++ + + H ++H DLK EN+LL D + IK+
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLL---------DADMN------------------IKI 155
Query: 268 IDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQ 324
DFG + Y APE+ G + P D+WS+G IL L +G F
Sbjct: 156 ADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
Query: 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 384
+NL+ L + V RG+ P
Sbjct: 216 -GQNLKEL----------------------RERVLRGKYRIPF----------------- 235
Query: 385 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ + D +LL+ L +P R T + ++ + H
Sbjct: 236 ---------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 57/419 (13%), Positives = 115/419 (27%), Gaps = 131/419 (31%)
Query: 51 APPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHY-MFALGENLTSRYKIHSKMGEGT 109
+ + SL + G P E + G L G+
Sbjct: 41 VRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL----------GQED 90
Query: 110 FGQVLECWDRERKEMVAIKIVR--------GIKKYREAAMIE------------IEVLQQ 149
LE D+E E + + IK+ +E + L+
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 150 LAKHD--KGGNRCVQIRNWFDYRNH----ICIVFEKLGSSLYDFL-----RKNNYRSFPI 198
+ D K + IR D R+ ++ ++ S+L F + ++S
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 199 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258
++ Q++ +A +H ++HT L+P +++L
Sbjct: 211 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD------------------------- 245
Query: 259 MPKSSAIKVIDFGSTTYE----RPDQNYIVSTRHYRAPEVILGLG-----WTYPCDIWSV 309
+ + + F + + A ++ T+ D W++
Sbjct: 246 --QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303
Query: 310 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 369
G + + + T + L E + R + P+
Sbjct: 304 GLAIYWIWCADLPN-TDDAA--LGGSEWIF--------------------RSCKNIPQPV 340
Query: 370 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ LL+G LRY DRL +A+ P + +
Sbjct: 341 RA------------------------------LLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 69/357 (19%), Positives = 128/357 (35%), Gaps = 115/357 (32%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAK 152
+Y + +GEG++G+V E D E A+KI++ K R EI++L++L +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 153 HDKGGNRCVQIRN--------WFDYRNHICIVFE--KLGSS-LYDFLRKNNYRSFPIDLV 201
H +N + + + + +V E G + D + + + FP+
Sbjct: 65 H----------KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQA 111
Query: 202 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261
QL++ + ++H ++H D+KP N+LL +
Sbjct: 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---------TTGGT--------------- 147
Query: 262 SSAIKVIDFG-STTYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCIL 313
+K+ G + + T ++ PE+ GL T+ DIWS G L
Sbjct: 148 ---LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTL 203
Query: 314 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 373
+ TG F+ +N+ L + + +G P
Sbjct: 204 YNITTGLYPFE-GDNIYKLF----------------------ENIGKGSYAIP------- 233
Query: 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
L+ LL+G+L Y+P R + R+ +H +F + H
Sbjct: 234 -------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 73/340 (21%), Positives = 126/340 (37%), Gaps = 90/340 (26%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 153
Y I +GEG+FG+V + ++ VA+K + + +KK + EI L+ L +H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RH 68
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
+++ + I +V E G L+D++ + + D R +Q++ I
Sbjct: 69 P----HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIE 122
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+ H ++H DLKPEN+LL D + +K+ DFG +
Sbjct: 123 YCHRHKIVHRDLKPENLLL---------DDNLN------------------VKIADFGLS 155
Query: 274 TYERPDQNYIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLE 330
S + +Y APEVI G + P D+WS G +L + G F E +
Sbjct: 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-DEFI- 213
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
++ K+ V P
Sbjct: 214 -------------PNLFKK--------VNSCVYVMP------------------------ 228
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
D + L++ ++ DP R+T +E R P+F +
Sbjct: 229 --DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 57/341 (16%), Positives = 116/341 (34%), Gaps = 33/341 (9%)
Query: 96 TSRYKIHSKMGEG--TFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQL 150
Y++ + +G+G V + E V ++ + + E+ V +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 209
H N V R F N + +V + S D + + + I + +L
Sbjct: 84 -NHP---N-IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ + ++H + +H +K ++L+ + + +S+ S + +
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN------LSMISHGQRQRVVHDF- 191
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVI--LGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
Y V + +PEV+ G+ DI+SVG EL G F+
Sbjct: 192 ----------PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
+ ++E++ G +P + E + R G + + +
Sbjct: 242 ATQ--MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
H S H ++ L+ +P R +A L H FF +
Sbjct: 300 HPYHRTFSP-HFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 71/336 (21%), Positives = 111/336 (33%), Gaps = 79/336 (23%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
RY +G G FG D+ KE+VA+K + E EI + L +H
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHP--- 76
Query: 158 NRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
V+ + H+ I+ E G LY+ + F D R +QLL +++ H
Sbjct: 77 -NIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCH 133
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+ + H DLK EN LL D S R +K+ DFG +
Sbjct: 134 SMQICHRDLKLENTLL-------------------DGSPAPR------LKICDFGYSKSS 168
Query: 277 RPDQ--NYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLA 333
V T Y APEV+L + D+WS G L + G F+
Sbjct: 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPRDY 227
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
R + + + P+
Sbjct: 228 ------------------RKTIQRILSVKYSIPDDI------------------------ 245
Query: 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ + HL+ + DP R++ E H +F ++
Sbjct: 246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-24
Identities = 76/342 (22%), Positives = 124/342 (36%), Gaps = 95/342 (27%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 153
Y + +G GTFG+V + VA+KI+ + I+ I EI+ L+ +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RH 70
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
+++ +V E + G L+D++ K+ R + +Q+L +
Sbjct: 71 P----HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAV 124
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
+ H ++H DLKPENVLL D + K+ DFG
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---------DAHMN------------------AKIADFGL 157
Query: 273 TTYERPDQNYIVSTR----HYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 327
+ + + T +Y APEVI G + P DIWS G IL L G F E
Sbjct: 158 SNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DE 214
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
++ + K+ +R G P
Sbjct: 215 HV--------------PTLFKK--------IRGGVFYIP--------------------- 231
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
++ + LL +L+ DP R T ++ H +F +D
Sbjct: 232 -----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 43/242 (17%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++ +G G FG V + W R + VAIK + + R+A ++E+ L ++ H
Sbjct: 11 EVEEVVGRGAFGVVCKAKW---RAKDVAIKQIES-ESERKAFIVELRQLSRV-NHP---- 61
Query: 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMH 216
V++ N +C+V E G SLY+ L + Q + +A++H
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 217 DLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+ +IH DLKP N+LLV+ + +K+ DFG+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTV--------------------------LKICDFGTA 153
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
+ + + APEV G ++ CD++S G IL E+ T F
Sbjct: 154 CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI 213
Query: 334 MM 335
M
Sbjct: 214 MW 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 66/332 (19%), Positives = 113/332 (34%), Gaps = 89/332 (26%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
GEG+F V+ + AIKI+ I K + E +V+ +L H V
Sbjct: 39 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP----FFV 93
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
++ F + L ++RK SF R +++ + ++H +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
IH DLKPEN+LL +I++ D+ ++ K + +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTA----------KVLSP------ESKQARANS---- 191
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 340
V T Y +PE++ D+W++GCI+ +L G F N + ++++
Sbjct: 192 --FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGN--EYLIFQKII- 245
Query: 341 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400
+ D+P + A D
Sbjct: 246 -------------------KLEYDFP-----------------------EKFFPKARD-- 261
Query: 401 HLLQGLLRYDPTDRLT------AREALRHPFF 426
L++ LL D T RL HPFF
Sbjct: 262 -LVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 59/256 (23%), Positives = 94/256 (36%), Gaps = 54/256 (21%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAKH 153
+ +G G FG+V W + VA+K R + I E ++ L KH
Sbjct: 10 TLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KH 65
Query: 154 D-----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
+G C++ ++C+V E G L L + P D++ A Q
Sbjct: 66 PNIIALRGV--CLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQ 113
Query: 208 LLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+ + ++HD +IH DLK N+L+ +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILI-------------------LQKVENGDLSNKI 154
Query: 265 IKVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323
+K+ DFG + APEVI ++ D+WS G +L EL TGE F
Sbjct: 155 LKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 324 QTHENLEHLAMMERVL 339
++ LA+ V
Sbjct: 215 ---RGIDGLAVAYGVA 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 59/364 (16%), Positives = 117/364 (32%), Gaps = 112/364 (30%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDK 155
+Y + ++G+G++G V ++ A+K++ + + + + A
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 156 GGNRCV--QIRN-------------------WFDY-RNHICIVFEKL-GSSLYDFLRKNN 192
R Q+ D +H+ +VFE + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK- 132
Query: 193 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252
D R + L++ I ++H +IH D+KP N+L+
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV-------------------G 171
Query: 253 SSYFKRMPKSSAIKVIDFG-STTYERPDQNYIVSTR----HYRAPEVILGLGWTY---PC 304
IK+ DFG S ++ D ++S + APE + +
Sbjct: 172 EDG--------HIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKAL 221
Query: 305 DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 364
D+W++G L G+ F E + + + ++ L+
Sbjct: 222 DVWAMGVTLYCFVFGQCPFM-DERI--------------MCLHSK--------IKSQALE 258
Query: 365 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 424
+P+ D + DL L+ +L +P R+ E HP
Sbjct: 259 FPD-----------------------QPDIAE-DLKDLITRMLDKNPESRIVVPEIKLHP 294
Query: 425 FFTR 428
+ TR
Sbjct: 295 WVTR 298
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-23
Identities = 62/343 (18%), Positives = 118/343 (34%), Gaps = 93/343 (27%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDK 155
+ + +GEG +G+V +R +E VA+KIV + I EI + + L H+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 65
Query: 156 GGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V+ N + E G L+D + + P + QL+ + +
Sbjct: 66 ---NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVY 120
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 273
+H + + H D+KPEN+LL D +K+ DFG +T
Sbjct: 121 LHGIGITHRDIKPENLLL-------------------DERD--------NLKISDFGLAT 153
Query: 274 TYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTH 326
+ ++ +++ Y APE++ + P D+WS G +L + GE +
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQP 211
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+ + Y W
Sbjct: 212 SD--------------SCQEYSDWKE-KKTY----LNPW--------------------- 231
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ +D + LL +L +P+ R+T + + ++ +
Sbjct: 232 ---KKIDSAP---LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 81/348 (23%), Positives = 127/348 (36%), Gaps = 91/348 (26%)
Query: 88 MFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIE 145
M L + + K+G+G+FG+V + D +++VAIKI+ + E I EI
Sbjct: 13 MQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 72
Query: 146 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
VL Q + + + I+ E L G S D L + I
Sbjct: 73 VLSQC-DSPY----VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATI 124
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
R++L+ + ++H IH D+K NVLL
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSE---------------------------HGE 157
Query: 265 IKVIDFG---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321
+K+ DFG T + +N V T + APEVI + DIWS+G +EL GE
Sbjct: 158 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217
Query: 322 -LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380
+ H M +VL +P++
Sbjct: 218 PHSELH------PM--KVLFLIPKN----------------------------------N 235
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
P L+ ++S L ++ L +P+ R TA+E L+H F R
Sbjct: 236 PPTLEG------NYSK-PLKEFVEACLNKEPSFRPTAKELLKHKFILR 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 48/253 (18%), Positives = 82/253 (32%), Gaps = 56/253 (22%)
Query: 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--------EIEVLQQLA 151
+ ++G+G FG V + + K +VAIK + E MI E+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL- 80
Query: 152 KHD-----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 205
H G +V E + LY L + +
Sbjct: 81 NHPNIVKLYGL--MHN---------PPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLM 128
Query: 206 RQLLECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
+ I +M + ++H DL+ N+ L S +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD----------------------ENAPV 166
Query: 264 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEA 321
KV DFG + + ++ + APE I +Y D +S IL + TGE
Sbjct: 167 CAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 322 LFQTHENLEHLAM 334
F + + +
Sbjct: 227 PF---DEYSYGKI 236
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 76/342 (22%), Positives = 124/342 (36%), Gaps = 95/342 (27%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 153
Y + +G GTFG+V VA+KI+ + I+ I EI+ L+ +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RH 75
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
+++ + I +V E + G L+D++ KN R + +Q+L +
Sbjct: 76 P----HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGV 129
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
+ H ++H DLKPENVLL D + K+ DFG
Sbjct: 130 DYCHRHMVVHRDLKPENVLL---------DAHMN------------------AKIADFGL 162
Query: 273 TTYERPDQNYIVSTR----HYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 327
+ + + T +Y APEVI G + P DIWS G IL L G F +
Sbjct: 163 SNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DD 219
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
++ + K+ + G P
Sbjct: 220 HV--------------PTLFKK--------ICDGIFYTP--------------------- 236
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ + LL+ +L+ DP R T ++ H +F +D
Sbjct: 237 -----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 49/244 (20%), Positives = 97/244 (39%), Gaps = 54/244 (22%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD- 154
+++ +G GT+GQV + + ++ AIK++ E EI +L++ + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 155 ---------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
K + + W +V E S+ D ++ + + + I
Sbjct: 83 IATYYGAFIKKNPPGMDDQLW--------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
R++L ++ +H +IH D+K +NVLL +++
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLT---------------------------ENAE 167
Query: 265 IKVIDFG---STTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 316
+K++DFG +N + T ++ APEVI + + D+WS+G +E+
Sbjct: 168 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
Query: 317 CTGE 320
G
Sbjct: 228 AEGA 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 63/343 (18%), Positives = 119/343 (34%), Gaps = 93/343 (27%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDK 155
+ + +GEG +G+V +R +E VA+KIV + I EI + + L H+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 65
Query: 156 GGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
N V+ N + E G L+D + + P + QL+ + +
Sbjct: 66 --N-VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVY 120
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 273
+H + + H D+KPEN+LL D +K+ DFG +T
Sbjct: 121 LHGIGITHRDIKPENLLL-------------------DERD--------NLKISDFGLAT 153
Query: 274 TYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTH 326
+ ++ +++ Y APE++ + P D+WS G +L + GE +
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQP 211
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+ + Y W
Sbjct: 212 SD--------------SCQEYSDWKE-KKTY----LNPW--------------------- 231
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ +D + LL +L +P+ R+T + + ++ +
Sbjct: 232 ---KKIDSAP---LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 69/341 (20%), Positives = 123/341 (36%), Gaps = 92/341 (26%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 155
+ + K+GEG++G V + +E ++VAIK V ++ + + EI ++QQ
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQC----- 81
Query: 156 GGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
+ ++ + IV E S+ D +R N ++ D + I + L+
Sbjct: 82 ---DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKG 137
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ ++H + IH D+K N+LL + K+ DFG
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNT---------------------------EGHAKLADFG 170
Query: 272 ST---TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHE 327
T +N ++ T + APEVI +G+ DIWS+G +E+ G+ H
Sbjct: 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH- 229
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
M R + +P P +
Sbjct: 230 -----PM--RAIFMIPT----------------------------------NPPPTFRK- 247
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ + + T ++ L P R TA + L+HPF
Sbjct: 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 72/332 (21%), Positives = 121/332 (36%), Gaps = 87/332 (26%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 161
G+G FG+V C R +M A K + IKK + AM E +L++ V
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK-VNS----RFVV 247
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+ ++ ++ +C+V + G L + FP A ++ + +H +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
++ DLKPEN+LL +I++ D + + G T R
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLA-------------------VHVPEGQTIKGR--- 345
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVL 339
V T Y APEV+ +T+ D W++GC+L E+ G++ FQ + ++ + V
Sbjct: 346 ---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 340 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399
++ E S ++
Sbjct: 403 --------------------EVPEEYSER-FSPQAR------------------------ 417
Query: 400 THLLQGLLRYDPTDRL-----TAREALRHPFF 426
L LL DP +RL +ARE HP F
Sbjct: 418 -SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 46/236 (19%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLA 151
+ +Y K+G+G G V D + VAI+ + ++ ++ +I EI V+++
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN- 74
Query: 152 KHDKGGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
K+ I N+ D + + +V E L G SL D + + I + R+
Sbjct: 75 KNP-------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI---AAVCRE 124
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
L+ + F+H +IH D+K +N+LL ++K+
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGM---------------------------DGSVKL 157
Query: 268 IDFGST---TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
DFG T E+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 48/236 (20%), Positives = 97/236 (41%), Gaps = 46/236 (19%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLA 151
+ + K+GEG+ G V ++ VA+K++ K+ R + E+ +++
Sbjct: 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY- 99
Query: 152 KHDKGGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
+H + + + ++ E L G +L D + + I +
Sbjct: 100 QHF-------NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---ATVCEA 149
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+L+ +A++H +IH D+K +++LL +K+
Sbjct: 150 VLQALAYLHAQGVIHRDIKSDSILLTL---------------------------DGRVKL 182
Query: 268 IDFG---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
DFG + + P + +V T ++ APEVI + DIWS+G +++E+ GE
Sbjct: 183 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 5e-21
Identities = 66/335 (19%), Positives = 118/335 (35%), Gaps = 93/335 (27%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRC- 160
G G FG+V C + +M A+K + IK + + E +L ++ D C
Sbjct: 198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-----CP 252
Query: 161 --VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V + F + + + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN 310
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+++ DLKP N+LL ++++ D + K +
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------------------KPHAS 350
Query: 278 PDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+ + +
Sbjct: 351 ------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
L ++ P
Sbjct: 405 MTL--------------------TMAVELP-----------------------DSFSPEL 421
Query: 397 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
LL+GLL+ D RL A+E PFF
Sbjct: 422 RS---LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 67/347 (19%), Positives = 122/347 (35%), Gaps = 97/347 (27%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHD 154
++I ++G+G FG+V + ++E + A K++ + I EIE+L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHP 76
Query: 155 KGGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
I + + I+ E G ++ + + + R ++ + RQ+LE
Sbjct: 77 -------YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLE 128
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ F+H +IH DLK NVL+ I++ DF
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTL---------------------------EGDIRLADF 161
Query: 271 GST---TYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEA- 321
G + ++ + T ++ APEV++ + Y DIWS+G L+E+ E
Sbjct: 162 GVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
Query: 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381
+ + M RVL + +
Sbjct: 222 HHELN------PM--RVLLKIAKS----------------------------------DP 239
Query: 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
P L + + L+ L +P R +A + L HPF +
Sbjct: 240 PTLLT-----PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 72/348 (20%), Positives = 120/348 (34%), Gaps = 98/348 (28%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQ 148
++ + ++G G+FG V D E+VAIK + G + + I E+ LQ
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 149 QLAKHDKGGNRCVQIRNWFD---YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 205
+L R + + +V E S D L + + + +
Sbjct: 110 KL--------RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVT 160
Query: 206 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
L+ +A++H MIH D+K N+LL +
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSE---------------------------PGLV 193
Query: 266 KVIDFG-STTYERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEA 321
K+ DFG ++ N V T ++ APEVIL + + D+WS+G +EL +
Sbjct: 194 KLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
Query: 322 -LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380
LF + AM L + Q+ +
Sbjct: 252 PLFNMN------AM--SALYHIAQN----------------------------------E 269
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
P LQ+ H + + + L+ P DR T+ L+H F R
Sbjct: 270 SPALQS------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 62/336 (18%), Positives = 113/336 (33%), Gaps = 92/336 (27%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 161
G G FG+V C + ++ A K + +KK + +E +L + V
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK-VHS----RFIV 248
Query: 162 QIRNWFDYRNHICIVFE-----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
+ F+ + +C+V + +Y+ N F Q++ + +H
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLH 306
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+I+ DLKPENVLL +++ D A+++ + T
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDL------------------GLAVELKAGQTKTKG 348
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMM 335
T + APE++LG + + D +++G L E+ F+ E +E+ +
Sbjct: 349 Y------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395
+RVL + +P+ S S
Sbjct: 403 QRVL--------------------EQAVTYPDK-FSPASK-------------------- 421
Query: 396 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
+ LL+ DP RL + HP F
Sbjct: 422 -----DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
RY++ K+G G+FG + D E VAIK+ K+ + + E ++ + + +GG
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMM----QGG 64
Query: 158 NRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
IR W ++ +V E LG SL D L R F + V +A Q++ I ++H
Sbjct: 65 VGIPTIR-WCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 217 DLCMIHTDLKPENVLL 232
IH D+KP+N L+
Sbjct: 123 SKNFIHRDVKPDNFLM 138
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 50/230 (21%), Positives = 95/230 (41%), Gaps = 38/230 (16%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 156
+ +MG GT GQV + R+ ++A+K +R G K+ + +++++V+ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP-- 84
Query: 157 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
VQ F + I E +G+ ++ P ++ ++ +++ + ++
Sbjct: 85 --YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLK 141
Query: 217 D-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
+ +IH D+KP N+LL IK+ D+ S R+ A
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQIKLCDFGIS----------GRLVDDKA----------- 180
Query: 276 ERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 320
++ Y APE I + D+WS+G LVEL TG+
Sbjct: 181 ----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 8/136 (5%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
+++ K+G G FG++ + E VAIK+ + +E +QL G
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQL----GSG 64
Query: 158 NRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
+ Q+ +F + +V E LG SL D L R+F + V IA QL+ + ++H
Sbjct: 65 DGIPQVY-YFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 217 DLCMIHTDLKPENVLL 232
+I+ D+KPEN L+
Sbjct: 123 SKNLIYRDVKPENFLI 138
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 67/331 (20%), Positives = 119/331 (35%), Gaps = 93/331 (28%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G G+FG+V+ +E A+KI+ + K ++ + E +LQ + V
Sbjct: 50 GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP----FLV 104
Query: 162 QIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
++ F +++ +V E G ++ LR+ F R A Q++ ++H L +
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
I+ DLKPEN+L+ Y I+V DFG +
Sbjct: 163 IYRDLKPENLLIDQQGY---------------------------IQVTDFGFAKRVKGRT 195
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 340
+ T APE+IL G+ D W++G ++ E+ G F + + + E+++
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQ--PIQIYEKIV- 251
Query: 341 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400
G++ +P H D
Sbjct: 252 -------------------SGKVRFP-----------------------SHFSSDLKD-- 267
Query: 401 HLLQGLLRYDPTDRL-----TAREALRHPFF 426
LL+ LL+ D T R + H +F
Sbjct: 268 -LLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 62/336 (18%), Positives = 118/336 (35%), Gaps = 86/336 (25%)
Query: 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 160
++G G +G V + +++A+K +R +E + ++++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP----FT 68
Query: 161 VQIRNWFDYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD- 217
V + I E + +SL F ++ + ++ P D++ +IA +++ + +H
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
L +IH D+KP NVL+ + +K+ D+ S + A
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGIS----------GYLVDDVA-------KDID-- 169
Query: 278 PDQNYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHL 332
+ Y APE I G++ DIWS+G ++EL + + + L
Sbjct: 170 ------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223
Query: 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392
+ V P P +L P S E
Sbjct: 224 KQV--VEEPSP------------------QL--PADKFSAE------------------- 242
Query: 393 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
L+ + +R T E ++HPFFT
Sbjct: 243 ------FVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 58/250 (23%), Positives = 96/250 (38%), Gaps = 49/250 (19%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDK 155
I K+G G+FG V W VA+KI+ + + E+ ++++L +H
Sbjct: 40 NIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHP- 94
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-SFPIDLVREIARQLLECIA 213
N V ++ IV E L SLY L K+ R +A + + +
Sbjct: 95 --N-IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 214 FMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
++H + ++H +LK N+L+ D Y +KV DFG
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLV-------------------DKKY--------TVKVCDFG 184
Query: 272 STTYERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
+ + S T + APEV+ D++S G IL EL T + + N
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW---GN 241
Query: 329 LEHLAMMERV 338
L ++ V
Sbjct: 242 LNPAQVVAAV 251
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 36/136 (26%), Positives = 61/136 (44%), Gaps = 8/136 (5%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
YK+ ++GEG+FG + E + + VAIK + E + L G
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLL----AGC 65
Query: 158 NRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
+ +F H +V + LG SL D L R F + V A+Q+L + +H
Sbjct: 66 TGIPNVY-YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 217 DLCMIHTDLKPENVLL 232
+ +++ D+KP+N L+
Sbjct: 124 EKSLVYRDIKPDNFLI 139
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 72/354 (20%), Positives = 123/354 (34%), Gaps = 97/354 (27%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD 154
Y++ +G G V + +KE VAIK + K + EI+ + Q H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHP 73
Query: 155 KGGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLV---REIA-- 205
I +++ ++ + +V + L G S+ D ++ + V IA
Sbjct: 74 -------NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 206 -RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
R++LE + ++H IH D+K N+LL +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGE---------------------------DGS 159
Query: 265 IKVIDFG-----STTYERPDQ---NYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVE 315
+++ DFG +T + V T + APEV+ G+ + DIWS G +E
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 316 LCTGEA-LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES 374
L TG A + M +VL Q+ ++ + + +
Sbjct: 220 LATGAAPYHKYP------PM--KVLMLTLQNDPPSLETGVQDKEMLKKY-------GKS- 263
Query: 375 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
++ L+ DP R TA E LRH FF +
Sbjct: 264 ------------------------FRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 37/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
++++ K+G G+FG++ + + E VAIK+ K+ + E ++ + L +GG
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRIL----QGG 62
Query: 158 NRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
+R WF ++ +V + LG SL D L R + V +A Q++ + F+H
Sbjct: 63 TGIPNVR-WFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 217 DLCMIHTDLKPENVLL 232
+H D+KP+N L+
Sbjct: 121 SKSFLHRDIKPDNFLM 136
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 52/250 (20%), Positives = 94/250 (37%), Gaps = 63/250 (25%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 154
+ ++G G+FG V + W + VA+K++ + + E+ VL++ +H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLN-VTAPTPQQLQAFKNEVGVLRKT-RHV 80
Query: 155 K-----GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
G + IV + GSSLY L + F + + +IARQ
Sbjct: 81 NILLFMGY--STA--------PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQT 129
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
+ ++H +IH DLK N + + + +K+
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNN-IFLHEDNT--------------------------VKIG 162
Query: 269 DFG-----STTYERPDQNYIVSTRHYRAPEVILGLGW---TYPCDIWSVGCILVELCTGE 320
DFG S + + + APEVI ++ D+++ G +L EL TG+
Sbjct: 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
Query: 321 ALFQTHENLE 330
+ N +
Sbjct: 223 LPYSNINNRD 232
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 65/343 (18%), Positives = 115/343 (33%), Gaps = 88/343 (25%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKG 156
K ++G G +G V + + +++A+K +R +E + +++V+ + +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP-- 81
Query: 157 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRK---NNYRSFPIDLVREIARQLLECIA 213
VQ I E + +S F + P +++ +I ++ +
Sbjct: 82 --YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 214 FMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
+ + L +IH D+KP N+LL S IK+ DFG
Sbjct: 140 HLKENLKIIHRDIKPSNILLDR---------------------------SGNIKLCDFGI 172
Query: 273 TTY--ERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEA-LFQT 325
+ + + R Y APE I G+ D+WS+G L EL TG +
Sbjct: 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
+ + L + V G PQ L + E S
Sbjct: 233 NSVFDQLTQV--VKGDPPQ--LS---------------NSEEREFSPS------------ 261
Query: 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ + L D + R +E L+HPF
Sbjct: 262 -------------FINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 72/346 (20%), Positives = 119/346 (34%), Gaps = 92/346 (26%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G G F +V ++ ++ A+KI+ + K E + E +VL
Sbjct: 70 GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRR----WIT 124
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
Q+ F N++ +V E G L L K R P ++ R +++ I +H L
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGY 183
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
+H D+KP+N+LL +I++ D+ S L K+ G+
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCL------------------KLRADGTVR-----S 220
Query: 281 NYIVSTRHYRAPEVILGLGWTY-------PCDIWSVGCILVELCTGEALFQTHENLEHLA 333
V T Y +PE++ +G CD W++G E+ G+ F ++
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTA--E 277
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+++ + L P + V
Sbjct: 278 TYGKIVH------------------YKEHLSLPLVD--------------------EGVP 299
Query: 394 HSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTR---DHLRR 433
A D +Q LL P RL A + HPFF D LR
Sbjct: 300 EEARD---FIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRD 341
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 31/152 (20%), Positives = 63/152 (41%), Gaps = 22/152 (14%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
++ + K+G G FG + + + E A +V+ + E++ Q++AK D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 158 NRCVQIRN---------WF--------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL 200
+ + YR +V E+LG L +N +F
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQN--GTFKKST 152
Query: 201 VREIARQLLECIAFMHDLCMIHTDLKPENVLL 232
V ++ ++L+ + ++H+ +H D+K N+LL
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 65/333 (19%), Positives = 116/333 (34%), Gaps = 97/333 (29%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G+G+FG+V ++ + AIK ++ + + M+E VL +H
Sbjct: 26 GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FLT 81
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+ F + ++ V E L G L + F + A +++ + F+H +
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE---R 277
++ DLK +N+LL +IK+ D+ M K + + + T
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFG--------------MCKEN----MLGDAKTNTFCGT 181
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337
PD Y APE++LG + + D WS G +L E+ G++ F + E +
Sbjct: 182 PD---------YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHS 229
Query: 338 VLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
+ P+ + +E+
Sbjct: 230 IRMDNPFYPRWL------------------------EKEAK------------------- 246
Query: 395 SAGDLTHLLQGLLRYDPTDRLTAREALR-HPFF 426
LL L +P RL R +R HP F
Sbjct: 247 ------DLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 95/335 (28%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRC 160
+G+G+FG+V+ + E+ A+KI++ E M+E VL K
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FL 404
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
Q+ + F + + V E + G L F A ++ + F+
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 279
+I+ DLK +NV+L S +IK+ D+ M K + I G TT
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFG--------------MCKEN----IWDGVTT----- 499
Query: 280 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 339
T Y APE+I + D W+ G +L E+ G+A F+ + E + + ++
Sbjct: 500 -KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM 555
Query: 340 G---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
P+ M S+E++
Sbjct: 556 EHNVAYPKSM------------------------SKEAV--------------------- 570
Query: 397 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
+ +GL+ P RL R+ H FF
Sbjct: 571 ----AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 53/256 (20%), Positives = 98/256 (38%), Gaps = 59/256 (23%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVR--GIKKYREAAMIEIEV 146
G+ + +Y++ + G G + DR R V +K + G + + AM E +
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAMAMAERQF 132
Query: 147 LQQLAKHDKGGNRCVQIRNWFDYRNHIC-----IVFEKL-GSSLYDFLRKNNYRSFPIDL 200
L ++ H VQI N+ ++ + IV E + G SL + P+
Sbjct: 133 LAEV-VHP----SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAE 183
Query: 201 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 260
++L ++++H + +++ DLKPEN++L +
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ------------------------ 219
Query: 261 KSSAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
+K+ID G Y+ T ++APE++ G T DI++VG L L
Sbjct: 220 ----LKLIDLGAVSRIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALT 270
Query: 318 TGEALFQTHENLEHLA 333
++ L
Sbjct: 271 LDLPTR-NGRYVDGLP 285
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 64/332 (19%), Positives = 125/332 (37%), Gaps = 81/332 (24%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 161
G G++ +VL ++ + A+K+V+ + + E V +Q + H V
Sbjct: 18 GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH----PFLV 73
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+ + F + + V E + G L R P + R + ++ + ++H+ +
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
I+ DLK +NVLL S +IK+ DY M K + G TT
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYG--------------MCKEG----LRPGDTT------ 167
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 340
+ T +Y APE++ G + + D W++G ++ E+ G + F + ++
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--- 224
Query: 341 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400
++ + + ++ +++PR + A
Sbjct: 225 ---DYLFQVI------------------------LEKQIRIPR-------SLSVKAAS-- 248
Query: 401 HLLQGLLRYDPTDRL------TAREALRHPFF 426
+L+ L DP +RL + HPFF
Sbjct: 249 -VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 52/260 (20%), Positives = 93/260 (35%), Gaps = 60/260 (23%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 155
+I +G+G FGQV W E VAI+++ + +A E+ +Q +H+
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHEN 90
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V H+ I+ G +LY +R ++ R+IA+++++ + +
Sbjct: 91 ----VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGY 145
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H ++H DLK +NV D + + DFG +
Sbjct: 146 LHAKGILHKDLKSKNVFY---------DNGK-------------------VVITDFGLFS 177
Query: 275 YERPDQNYIVS--------TRHYRAPEVILGLGWTYP---------CDIWSVGCILVELC 317
Q + APE+I L D++++G I EL
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 318 TGEALFQTHENLEHLAMMER 337
E F+T + M
Sbjct: 238 AREWPFKTQPAEAIIWQMGT 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 29/157 (18%), Positives = 59/157 (37%), Gaps = 29/157 (18%)
Query: 98 RYKIHSKMGEGTFGQV--------LECWDRERKEMVAIKI-------VRGIKKY-REAAM 141
++K+ S G + L C +K+ ++K+ + R A
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 142 IEIEVLQQLAKHDKGG-NRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRS 195
+++ ++L C+ F YR +V LG SL L +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCM----GFGVHQDKYR---FLVLPSLGRSLQSALDVSPKHV 155
Query: 196 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 232
V ++A +LL+ + F+H+ +H ++ EN+ +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 69/340 (20%), Positives = 115/340 (33%), Gaps = 111/340 (32%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G G+FG+V R A+K+++ + + ++ E +L + H +
Sbjct: 15 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP----FII 69
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
++ F I ++ + + G L+ LRK + FP + + A ++ + ++H +
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STT 274
I+ DLKPEN+LL D H IK+ DFG T
Sbjct: 128 IYRDLKPENILL---------DKNG--H----------------IKITDFGFAKYVPDVT 160
Query: 275 YER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331
Y PD Y APEV+ + D WS G ++ E+ G F N
Sbjct: 161 YTLCGTPD---------YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSN--T 208
Query: 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391
+ E++L L +P
Sbjct: 209 MKTYEKIL--------------------NAELRFP-----------------------PF 225
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
+ D LL L+ D + RL + HP+F
Sbjct: 226 FNEDVKD---LLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 37/255 (14%), Positives = 77/255 (30%), Gaps = 60/255 (23%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 154
+K+ E G++ + W + + +K+++ ++ + E L+ H
Sbjct: 13 NFLTKLNENHSGELWKGRW---QGNDIVVKVLK-VRDWSTRKSRDFNEECPRLRIF-SHP 67
Query: 155 -----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
G C H ++ + SLY+ L + + A +
Sbjct: 68 NVLPVLGA--CQS-----PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 209 LECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
+AF+H L + L +V++ D +
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMI-------------------DEDM--------TAR 153
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP---CDIWSVGCILVELCTGEALF 323
+ + + APE + D+WS +L EL T E F
Sbjct: 154 ISMADVKFSF--QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
Query: 324 QTHENLEHLAMMERV 338
+L ++ + +V
Sbjct: 212 ---ADLSNMEIGMKV 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 63/332 (18%), Positives = 125/332 (37%), Gaps = 81/332 (24%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 161
G G++ +VL ++ + A+++V+ + + E V +Q + H V
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH----PFLV 116
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+ + F + + V E + G L R P + R + ++ + ++H+ +
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
I+ DLK +NVLL S +IK+ DY M K + G TT
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYG--------------MCKEG----LRPGDTT------ 210
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 340
+ T +Y APE++ G + + D W++G ++ E+ G + F + ++
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--- 267
Query: 341 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400
++ + + ++ +++PR + A
Sbjct: 268 ---DYLFQVI------------------------LEKQIRIPR-------SLSVKAAS-- 291
Query: 401 HLLQGLLRYDPTDRL------TAREALRHPFF 426
+L+ L DP +RL + HPFF
Sbjct: 292 -VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 43/231 (18%), Positives = 91/231 (39%), Gaps = 34/231 (14%)
Query: 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDK--- 155
+G+G FGQ ++ RE E++ +K + + + + E++V++ L +H
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLK 71
Query: 156 --GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
G + + + E + G +L ++ + +P A+ + +
Sbjct: 72 FIGV--LYK-------DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGM 121
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF---KRMPKSSAIKVID 269
A++H + +IH DL N L+ ++ + V D F + M
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVAD-------------FGLARLMVDEKTQPEGL 168
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
+R + +V ++ APE+I G + D++S G +L E+
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 69/337 (20%), Positives = 119/337 (35%), Gaps = 101/337 (29%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G+G+FG+V+ + E+ A+KI++ + + + M+E VL K
Sbjct: 29 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FLT 84
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
Q+ + F + + V E + G L F A ++ + F+ +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE---R 277
I+ DLK +NV+L S +IK+ D+ M K + I G TT
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFG--------------MCKEN----IWDGVTTKTFCGT 184
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 337
PD Y APE+I + D W+ G +L E+ G+A F E+ + + +
Sbjct: 185 PD---------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDE--LFQS 232
Query: 338 VLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
++ P+ M S+E++
Sbjct: 233 IMEHNVAYPKSM------------------------SKEAV------------------- 249
Query: 395 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
+ +GL+ P RL R+ H FF
Sbjct: 250 ------AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 55/333 (16%), Positives = 113/333 (33%), Gaps = 93/333 (27%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC- 160
G+G+FG+V + K+M A+K + + E E++++Q L
Sbjct: 24 GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL--------EHP 75
Query: 161 --VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
V + F + +V + LG L L++N F + V+ +L+ + ++ +
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN 133
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+IH D+KP+N+LL ++ + D+ + ++ +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIA-------------------AMLPRETQITT- 173
Query: 278 PDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334
+ T+ Y APE+ G G+++ D WS+G EL G + + +
Sbjct: 174 -----MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228
Query: 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
+ + +P +
Sbjct: 229 VHTFE--------------------TTVVTYPSAWSQ----------------------- 245
Query: 395 SAGDLTHLLQGLLRYDPTDRL-TAREALRHPFF 426
++ LL+ LL +P R + P+
Sbjct: 246 ---EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 66/333 (19%), Positives = 119/333 (35%), Gaps = 89/333 (26%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G G FG+V + +++ A+K++ + K ++A E +++ A V
Sbjct: 78 GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSP----WVV 132
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
Q+ F ++ +V E + G L + + P R +++ + +H +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
IH D+KP+N+LL S ++K+ D+ + +M K ++ T PD
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTC----------MKMNKEGMVRCDTAVGT----PD- 234
Query: 281 NYIVSTRHYRAPEVILGLGWTYP----CDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
Y +PEV+ G CD WSVG L E+ G+ F ++L
Sbjct: 235 --------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLV--GTYS 283
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
+++ + L +P+ + K+
Sbjct: 284 KIMN------------------HKNSLTFPDDNDISKEAKN------------------- 306
Query: 397 GDLTHLLQGLLRYDPTDRLT---AREALRHPFF 426
L+ L D RL E RH FF
Sbjct: 307 -----LICAFLT-DREVRLGRNGVEEIKRHLFF 333
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 77/336 (22%), Positives = 122/336 (36%), Gaps = 100/336 (29%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC- 160
G+GTFG+V+ ++ A+KI+R I E A + E VLQ R
Sbjct: 14 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT--------RHP 65
Query: 161 --VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
++ F + +C V E G L F + R F + R +++ + ++H
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
+++ D+K EN++L +IK+ D+ + K I G+T
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDF--------------GLCKEG----ISDGATM--- 162
Query: 278 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMM 335
T Y APEV+ + D W +G ++ E+ G F Q HE L L +M
Sbjct: 163 ---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395
E + P+ + S E+
Sbjct: 220 EEI--RFPRTL------------------------SPEAK-------------------- 233
Query: 396 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
LL GLL+ DP RL A+E + H FF
Sbjct: 234 -----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 66/344 (19%), Positives = 124/344 (36%), Gaps = 90/344 (26%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G G FG+V + ++ A+KI+ + K E A E +VL
Sbjct: 83 GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSK----WIT 137
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+ F N++ +V + G L L K R P ++ R +++ I +H L
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHY 196
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
+H D+KP+N+L+ + +I++ D+ S ++ + ++ T PD
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSC----------LKLMEDGTVQSSVAVGT----PD- 241
Query: 281 NYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 335
Y +PE++ + + CD WS+G + E+ GE F E+L
Sbjct: 242 --------YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV--ETY 290
Query: 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395
+++ + R +P V
Sbjct: 291 GKIMN------------------HKERFQFP-----------------------TQVTDV 309
Query: 396 AGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTR---DHLRR 433
+ + L++ L+ RL + +HPFF+ D++R
Sbjct: 310 SENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGIDWDNIRN 352
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 96/335 (28%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G+G+FG+V+ +E ++ A+K+++ I + + M E +L H
Sbjct: 32 GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP----FLT 87
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
Q+ F + + V E + G L R F R A +++ + F+HD +
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
I+ DLK +NVLL + K+ D+ M K I G TT
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFG--------------MCKEG----ICNGVTT------ 181
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 340
T Y APE++ + + D W++G +L E+ G A F+ + + E +L
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILN 238
Query: 341 ---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
P + ++
Sbjct: 239 DEVVYPTWL------------------------HEDAT---------------------- 252
Query: 398 DLTHLLQGLLRYDPTDRL------TAREALRHPFF 426
+L+ + +PT RL LRHPFF
Sbjct: 253 ---GILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 35/188 (18%), Positives = 71/188 (37%), Gaps = 32/188 (17%)
Query: 72 RNGSPPWREDDKDGHYM---FALGENLT----SRYKIHSKMGEGTFGQVLECWDRERKEM 124
R + ++ FA+GE +T + +K+ +G+G FG + D E
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSES 61
Query: 125 VAIKIVRGIKKYREAA---MIEIEVLQQLAKHDKGGNRCVQIRN---------WF----- 167
V +K E++ Q+ AK ++ +
Sbjct: 62 VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK 121
Query: 168 ---DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 224
YR ++ ++ GS L N + F V +++ ++L+ + ++H+ +H D
Sbjct: 122 NGKSYR---FMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGD 177
Query: 225 LKPENVLL 232
+K N+LL
Sbjct: 178 IKASNLLL 185
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 77/333 (23%), Positives = 122/333 (36%), Gaps = 94/333 (28%)
Query: 106 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 161
G+G+FG+VL + + A+K+++ I K +E M E VL + KH V
Sbjct: 47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FLV 102
Query: 162 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 220
+ F + + V + + G L F R F R A ++ + ++H L +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 280
++ DLKPEN+LL S +I + D+ + K + I+ STT
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFG--------------LCKEN----IEHNSTTST---- 198
Query: 281 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL- 339
T Y APEV+ + D W +G +L E+ G F + E M + +L
Sbjct: 199 --FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN 253
Query: 340 GPL--PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
PL ++ + +
Sbjct: 254 KPLQLKPNI------------------------TNSAR---------------------- 267
Query: 398 DLTHLLQGLLRYDPTDRL----TAREALRHPFF 426
HLL+GLL+ D T RL E H FF
Sbjct: 268 ---HLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 77/335 (22%), Positives = 126/335 (37%), Gaps = 95/335 (28%)
Query: 105 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC 160
+G+GTFG+V+ ++ A+KI++ I E A + E VLQ ++H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP----FL 210
Query: 161 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DL 218
++ F + +C V E G L F + R F D R +++ + ++H +
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+++ DLK EN++L +IK+ D+ + K I G+T
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDF--------------GLCKEG----IKDGATM---- 306
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMME 336
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 307 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
+ P+ + E+
Sbjct: 365 EI--RFPRTL------------------------GPEAK--------------------- 377
Query: 397 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
LL GLL+ DP RL A+E ++H FF
Sbjct: 378 ----SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 65/360 (18%), Positives = 112/360 (31%), Gaps = 104/360 (28%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD- 154
+ ++ G FG V + E VA+KI K E+ L + KH+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHEN 79
Query: 155 ---------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
+G + V + ++ SL DFL+ N + + I
Sbjct: 80 ILQFIGAEKRGTSVDVDL----------WLITAFHEKGSLSDFLKAN---VVSWNELCHI 126
Query: 205 ARQLLECIAFMHD----------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254
A + +A++H+ + H D+K +NVLL ++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-------------------KNN 167
Query: 255 YFKRMPKSSAIKVIDFG-----STTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPC 304
+ DFG D + V TR Y APEV+
Sbjct: 168 LT--------ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219
Query: 305 DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP--QHMLKRVDRHAEKYVRRGR 362
D++++G +L EL + E++ E +G P + M + V ++ R
Sbjct: 220 DMYAMGLVLWELASRCTAA-DGPVDEYMLPFEEEIGQHPSLEDMQEVVVH------KKKR 272
Query: 363 LDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422
+ + + L I + DH D RL+A
Sbjct: 273 PVLR------DYWQKHAGMAMLCETIEECWDH---------------DAEARLSAGCVGE 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 57/285 (20%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 154
K ++G+G FG V C +D E+VA+K ++ +++ EIE+L+ L +HD
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 155 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
V+ + + R ++ ++ E GS L D+L+K+ R I L+ + Q+ +
Sbjct: 72 N----IVKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYLQKHKERIDHIKLL-QYTSQICK 125
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++ IH DL N+ LV +E +K+ DF
Sbjct: 126 GMEYLGTKRYIHRDLATRNI-LVENENR--------------------------VKIGDF 158
Query: 271 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
G T D+ + APE + ++ D+WS G +L EL T
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--- 215
Query: 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 368
++ A R++G Q + H + ++ RL P+G
Sbjct: 216 --KSKSPPAEFMRMIGNDKQGQMI--VFHLIELLKNNGRLPRPDG 256
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 66/341 (19%), Positives = 127/341 (37%), Gaps = 106/341 (31%)
Query: 106 GEGTFGQVL---ECWDRERKEMVAIKIVRG---IKKYREAA--MIEIEVLQQLAKHDKGG 157
G+G +G+V + ++ A+K+++ ++ ++ A E +L+++
Sbjct: 26 GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV------- 78
Query: 158 NRC---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
+ V + F + ++ E L G L F++ F D ++ +
Sbjct: 79 -KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
+H +I+ DLKPEN++L ++K+ D+ K+S I G+
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC----KES--------------IHDGTV 177
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
T+ T Y APE+++ G D WS+G ++ ++ TG F T EN +
Sbjct: 178 THT------FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRK--K 228
Query: 334 MMERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
++++L LP ++ ++E+
Sbjct: 229 TIDKILKCKLNLPPYL------------------------TQEAR--------------- 249
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
LL+ LL+ + RL A E HPFF
Sbjct: 250 ----------DLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 57/285 (20%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 154
K ++G+G FG V C +D E+VA+K ++ +++ EIE+L+ L +HD
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102
Query: 155 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
V+ + + R ++ ++ E GS L D+L+K+ R I L+ + Q+ +
Sbjct: 103 N----IVKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYLQKHKERIDHIKLL-QYTSQICK 156
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++ IH DL N+ LV +E +K+ DF
Sbjct: 157 GMEYLGTKRYIHRDLATRNI-LVENENR--------------------------VKIGDF 189
Query: 271 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
G T D+ Y APE + ++ D+WS G +L EL T
Sbjct: 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--- 246
Query: 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 368
++ A R++G Q + H + ++ RL P+G
Sbjct: 247 --KSKSPPAEFMRMIGNDKQGQMI--VFHLIELLKNNGRLPRPDG 287
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 54/247 (21%), Positives = 97/247 (39%), Gaps = 61/247 (24%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--------IKKY-REAAMI 142
G+ + RYKI K+G G V D VAIK + +K++ RE
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREV--- 62
Query: 143 EIEVLQQLAK--HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID 199
++ H V + + + + +V E + G +L +++ + +D
Sbjct: 63 -----HNSSQLSH----QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVD 111
Query: 200 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
Q+L+ I HD+ ++H D+KP+N+L +
Sbjct: 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNIL---------------------------I 144
Query: 260 PKSSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 313
+ +K+ DFG T+ + N+++ T Y +PE G DI+S+G +L
Sbjct: 145 DSNKTLKIFDFGIAKALSETSLTQT--NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVL 202
Query: 314 VELCTGE 320
E+ GE
Sbjct: 203 YEMLVGE 209
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 57/302 (18%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
+ +G+G FG+V W R E VA+KI ++ EI L +H+ N
Sbjct: 45 VLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREERSWFREAEIYQTVML-RHE---N 97
Query: 159 ----RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
++ + +V + SL+D+L + + ++ + ++A +A
Sbjct: 98 ILGFIAADNKD-NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLA 153
Query: 214 FMHD--------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
+H + H DLK +N+L+ + + D ++ + P
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-- 211
Query: 266 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDIWSVGCILVELCTG 319
V T+ Y APEV+ DI+++G + E+
Sbjct: 212 ------------------VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
Query: 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 379
++ HE+ + P + M K V ++ R + P S E+++ +
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMA 307
Query: 380 KL 381
K+
Sbjct: 308 KI 309
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 48/264 (18%), Positives = 82/264 (31%), Gaps = 77/264 (29%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---- 154
+ +G+G +G+V W + E VA+KI + E+ L +H+
Sbjct: 11 TLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILG 66
Query: 155 ------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
+ Q+ ++ SLYD+L+ + I
Sbjct: 67 FIASDMTSRHSSTQL----------WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLS 113
Query: 208 LLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
+ +A +H + H DLK +N+L+ K +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV-----------KKNGQ----------- 151
Query: 260 PKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDI 306
+ D G ST N V T+ Y APEV+ DI
Sbjct: 152 -----CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 307 WSVGCILVELCTGEALFQTHENLE 330
W+ G +L E+ E+ +
Sbjct: 207 WAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 75/339 (22%), Positives = 125/339 (36%), Gaps = 104/339 (30%)
Query: 106 GEGTFGQVL---ECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNR 159
G+G+FG+V + + +++ A+K+++ + R +E ++L ++
Sbjct: 33 GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV--------N 84
Query: 160 C---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
V++ F + ++ + L G L F R + F + V+ +L + +
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
H L +I+ DLKPEN+LL +IK+ D+ S K+S ID Y
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES--------------IDHEKKAY 184
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 335
T Y APEV+ G T D WS G ++ E+ TG FQ + E M
Sbjct: 185 S------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TM 235
Query: 336 ERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392
+L +PQ + S E+
Sbjct: 236 TMILKAKLGMPQFL------------------------SPEAQ----------------- 254
Query: 393 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
LL+ L + +P +RL E RH FF
Sbjct: 255 --------SLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 53/254 (20%), Positives = 90/254 (35%), Gaps = 69/254 (27%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--------IKKY-REAAMI 142
+L+ RY++ +G G +V D VA+K++R ++ REA
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA--- 63
Query: 143 EIEVLQQLAK---------HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN 192
Q A +D G + IV E + G +L D +
Sbjct: 64 -----QNAAALNHPAIVAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHTE- 110
Query: 193 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252
E+ + + F H +IH D+KP N++
Sbjct: 111 -GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM--------------------- 148
Query: 253 SSYFKRMPKSSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI 306
+ ++A+KV+DFG + ++ T Y +PE G D+
Sbjct: 149 ------ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 307 WSVGCILVELCTGE 320
+S+GC+L E+ TGE
Sbjct: 203 YSLGCVLYEVLTGE 216
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 69/338 (20%), Positives = 121/338 (35%), Gaps = 92/338 (27%)
Query: 106 GEGTFGQVL---ECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGG 157
G G +G+V + + ++ A+K+++ K E E +VL+ + +
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--- 119
Query: 158 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
V + F + ++ + + G L+ L + F V+ +++ + +H
Sbjct: 120 -FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH 176
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
L +I+ D+K EN+LL S+ ++ + D+ S K+ V D Y+
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLS----KEF-------------VADETERAYD 219
Query: 277 RPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQT-HENLEHLA 333
T Y AP+++ G G D WS+G ++ EL TG + F E
Sbjct: 220 ------FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ R+L + +P Q +
Sbjct: 274 ISRRIL--------------------KSEPPYP-----------------------QEMS 290
Query: 394 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
A D L+Q LL DP RL A E H FF
Sbjct: 291 ALAKD---LIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 65/361 (18%), Positives = 114/361 (31%), Gaps = 114/361 (31%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---- 154
++ ++G+G +G+V W R E VA+K+ ++ EI + +H+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTEEASWFRETEIYQTVLM-RHENILG 95
Query: 155 ------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 207
KG Q+ ++ + SLYD+L+ + + ++A
Sbjct: 96 FIAADIKGTGSWTQL----------YLITDYHENGSLYDYLKST---TLDAKSMLKLAYS 142
Query: 208 LLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
+ + +H + H DLK +N+L+ K +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV-----------KKNGT----------- 180
Query: 260 PKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDI 306
+ D G T N V T+ Y PEV+ D+
Sbjct: 181 -----CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 307 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV-----RRG 361
+S G IL E+ E + LP H L D E ++
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQ-----------LPYHDLVPSDPSYEDMREIVCIKKL 284
Query: 362 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 421
R +P +S E L ++ L+ + H +P RLTA
Sbjct: 285 RPSFPNRWSSDEC------LRQMGKLMTECWAH---------------NPASRLTALRVK 323
Query: 422 R 422
+
Sbjct: 324 K 324
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 49/234 (20%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHD 154
K S++G+G FG V C +D +VA+K ++ ++ EI++L+ L D
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84
Query: 155 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
V+ R + R + +V E G L DFL+++ R L+ + Q+ +
Sbjct: 85 F----IVKYRGVSYGPGRQSLRLVMEYLPSGC-LRDFLQRHRARLDASRLL-LYSSQICK 138
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++ +H DL N+ LV SE +K+ DF
Sbjct: 139 GMEYLGSRRCVHRDLAARNI-LVESEAH--------------------------VKIADF 171
Query: 271 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT 318
G D++Y V + APE + ++ D+WS G +L EL T
Sbjct: 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 52/252 (20%), Positives = 83/252 (32%), Gaps = 75/252 (29%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--------IKKY-REAAMIEIEVLQ 148
Y++ +G G G V E D R+ +VA+K++ + REA +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREA--------R 86
Query: 149 QLAK---------HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPI 198
+ HD G + + + + G L LR+
Sbjct: 87 TAGRLQEPHVVPIHDFG-----------EIDGQLYVDMRLINGVDLAAMLRRQ--GPLAP 133
Query: 199 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258
I RQ+ + H H D+KPEN+L+ + D
Sbjct: 134 PRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----------------SADD------ 171
Query: 259 MPKSSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312
++DFG + V T +Y APE TY DI+++ C+
Sbjct: 172 -----FAYLVDFGIASATTDEKLTQL--GNTVGTLYYMAPERFSESHATYRADIYALTCV 224
Query: 313 LVELCTGEALFQ 324
L E TG +Q
Sbjct: 225 LYECLTGSPPYQ 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 65/289 (22%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRER---KEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 153
K +GEG FG+V C +D E E VA+K ++ + EIE+L+ L H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82
Query: 154 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 206
+ G C + D N I ++ E G SL ++L KN + + + A
Sbjct: 83 ENIVKYKG--ICTE-----DGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQL-KYAV 133
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+ + + ++ +H DL NV LV SE+ +K
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNV-LVESEHQ--------------------------VK 166
Query: 267 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGE 320
+ DFG T D+ Y APE ++ + D+WS G L EL T
Sbjct: 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-- 224
Query: 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 368
+ ++ ++ + Q + R+ ++ G RL P
Sbjct: 225 --YCDSDSSPMALFLKMIGPTHGQMTVTRL----VNTLKEGKRLPCPPN 267
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 3e-13
Identities = 52/259 (20%), Positives = 81/259 (31%), Gaps = 62/259 (23%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---------GIKKYREAAMIEIEV 146
T + + K+GEG FG+V + VAIKI+ +K E + EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 147 LQQLAKHDKG------------GNRCVQ-------IRNWFDYRN---------------- 171
++L+ CVQ ++ W Y +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 172 -HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI-HTDLKPEN 229
I + FE G L K + + + I QL +A H DL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 230 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHY 289
VLL + K LH + + +ID+ + ER
Sbjct: 193 VLLKKTSLKK-------LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV--S 243
Query: 290 RAPEVILGLGWTYPCDIWS 308
++ G G Y DI+
Sbjct: 244 MDEDLFTGDG-DYQFDIYR 261
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 49/249 (19%), Positives = 98/249 (39%), Gaps = 42/249 (16%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 155
+ + K+G G +G+V E ++ VA+K ++ E + E V++++ KH
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNL 278
Query: 156 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
G C + I+ E G+ L D+LR+ N + ++ +A Q+
Sbjct: 279 VQLLG--VCTR-------EPPFYIITEFMTYGN-LLDYLRECNRQEVSAVVLLYMATQIS 328
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ ++ IH +L N L+ + +KV D+ S +Y IK
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIK--- 384
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 328
+ APE + ++ D+W+ G +L E+ T G + + +
Sbjct: 385 -------------------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425
Query: 329 LEHLAMMER 337
+ ++E+
Sbjct: 426 SQVYELLEK 434
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 65/349 (18%), Positives = 112/349 (32%), Gaps = 79/349 (22%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
K+ +G G +G V + + VA+K+ + I + + +HD N
Sbjct: 16 KLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHD---N 68
Query: 159 --RCV--QIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
R + R D R +V E GS L +L + + +A + +
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGS-LXKYLSLH---TSDWVSSCRLAHSVTRGL 124
Query: 213 AFMHD---------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
A++H + H DL NVL+ + + D+ S+ + ++
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 264 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-------GWTYPCDIWSVGCILVEL 316
A V T Y APEV+ G D++++G I E+
Sbjct: 185 A----------------ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 317 CTGEALFQTHENLEHLAM-MERVLGPLP--QHMLKRVDRHAEKYVRRGRLDWPEGAASRE 373
E++ M + +G P + M V R + R +PE
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR------EKQRPKFPEAWKENS 282
Query: 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422
+ + L+ I D D RLTA+ A
Sbjct: 283 -----LAVRSLKETIEDCWDQ---------------DAEARLTAQXAEE 311
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 51/261 (19%), Positives = 96/261 (36%), Gaps = 61/261 (23%)
Query: 100 KIHSKMGEGTFGQVLE-------CWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLA 151
+ +G+GTF ++ + + + + V +K++ + Y E+ ++ +L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL- 69
Query: 152 KHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREI 204
H G CV + +V E K GS L +L+KN + + E+
Sbjct: 70 SHKHLVLNYG--VCVC-------GDENILVQEFVKFGS-LDTYLKKNKNCINILWKL-EV 118
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
A+QL + F+ + +IH ++ +N+LL+ E K +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN-------------------PPF 159
Query: 265 IKVIDFGSTTYERPDQNYIVSTRHYR------APEVIL-GLGWTYPCDIWSVGCILVELC 317
IK+ D G + ++ + PE I D WS G L E+C
Sbjct: 160 IKLSDPGIS---I----TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
Query: 318 T-GEALFQTHENLEHLAMMER 337
+ G+ ++ L E
Sbjct: 213 SGGDKPLSALDSQRKLQFYED 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 53/251 (21%), Positives = 99/251 (39%), Gaps = 56/251 (22%)
Query: 104 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 159
++G G FG V + + +K++ VAIK+++ K E M E +++ QL +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPY---- 71
Query: 160 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V++ + +V E G L+ FL ++ E+ Q+ +
Sbjct: 72 IVRL-----IGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVA-ELLHQVSMGMK 124
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++ + +H DL NVLLV+ Y K+ DFG +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKIS---------------------------DFGLS 157
Query: 274 TYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326
D +Y + + APE I ++ D+WS G + E + G+ ++
Sbjct: 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
Query: 327 ENLEHLAMMER 337
+ E +A +E+
Sbjct: 218 KGPEVMAFIEQ 228
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 67/289 (23%), Positives = 107/289 (37%), Gaps = 67/289 (23%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 153
K +GEG FG+V +D EMVA+K ++ ++R EI++L+ L H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YH 92
Query: 154 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 206
+ G C + +V E LG SL D+L +++ L+ A+
Sbjct: 93 EHIIKYKG--CCED-----AGAASLQLVMEYVPLG-SLRDYLPRHSIG--LAQLL-LFAQ 141
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+ E +A++H IH DL NV L+ ++ + +K
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNV-LLDNDRL--------------------------VK 174
Query: 267 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGE 320
+ DFG Y APE + + Y D+WS G L EL T
Sbjct: 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-- 232
Query: 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 368
+E + Q + R+ + + RG RL P+
Sbjct: 233 --HCDSSQSPPTKFLELIGIAQGQMTVLRL----TELLERGERLPRPDK 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 52/254 (20%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 155
+ + K+G G +G+V E ++ VA+K ++ E + E V++++ KH
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNL 71
Query: 156 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
G C + I+ E G +L D+LR+ N + ++ +A Q+
Sbjct: 72 VQLLG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ ++ IH DL N LV ++ +KV D
Sbjct: 122 SAMEYLEKKNFIHRDLAARNC-LVGENHL--------------------------VKVAD 154
Query: 270 FGSTTYERPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323
FG + D Y + APE + ++ D+W+ G +L E+ T G + +
Sbjct: 155 FGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 324 QTHENLEHLAMMER 337
+ + ++E+
Sbjct: 214 PGIDLSQVYELLEK 227
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 44/249 (17%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 155
++ K+G+G FG+V W+ + VAIK ++ EA + E +V+++L +H+K
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK 240
Query: 156 GGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
VQ+ Y I IV E GS L DFL+ + + + ++A Q+
Sbjct: 241 ----LVQL-----YAVVSEEPIYIVTEYMSKGS-LLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+A++ + +H DL+ N+L+ + KV D+ + +D+ Y R IK
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIK--- 346
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 328
+ APE L +T D+WS G +L EL T G + N
Sbjct: 347 -------------------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387
Query: 329 LEHLAMMER 337
E L +ER
Sbjct: 388 REVLDQVER 396
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 57/252 (22%), Positives = 104/252 (41%), Gaps = 58/252 (23%)
Query: 104 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGN 158
++G G FG V + + ++ VA+KI++ ++ + E V+QQL +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPY--- 79
Query: 159 RCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
V++ +V E +LG L +L++N R + E+ Q+ +
Sbjct: 80 -IVRM-----IGICEAESWMLVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGM 130
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
++ + +H DL NVLLV+ Y K+ DFG
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKIS---------------------------DFGL 163
Query: 273 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 325
+ R D+NY + H + APE I ++ D+WS G ++ E + G+ ++
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
Query: 326 HENLEHLAMMER 337
+ E AM+E+
Sbjct: 224 MKGSEVTAMLEK 235
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 44/246 (17%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
K+ K+G G FG+V +++ K VA+K ++ EA + E V++ L +HD
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHD---- 243
Query: 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
+ V++ + I I+ E + SL DFL+ + P+ + + + Q+ E +AF+
Sbjct: 244 KLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
IH DL+ N+ LVS+ + K+ DFG
Sbjct: 303 RNYIHRDLRAANI-LVSASLV--------------------------CKIADFGLARVIE 335
Query: 278 PDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 331
D Y + APE I +T D+WS G +L+E+ T G + N E
Sbjct: 336 -DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394
Query: 332 LAMMER 337
+ +ER
Sbjct: 395 IRALER 400
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 44/249 (17%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 155
++ K+G+G FG+V W+ + VAIK ++ EA + E +V+++L +H+K
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK 323
Query: 156 GGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
VQ+ Y I IV E GS L DFL+ + + + ++A Q+
Sbjct: 324 ----LVQL-----YAVVSEEPIYIVTEYMSKGS-LLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+A++ + +H DL+ N+L+ + KV D+ + +D+ Y R IK
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIK--- 429
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 328
+ APE L +T D+WS G +L EL T G + N
Sbjct: 430 -------------------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470
Query: 329 LEHLAMMER 337
E L +ER
Sbjct: 471 REVLDQVER 479
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 55/265 (20%), Positives = 100/265 (37%), Gaps = 59/265 (22%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKEM--VAIKIVR----GIKKYREAAMIEIEVLQQLAK 152
++ K+G+G+FG V WD + VA+K ++ + + + E+ + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 79
Query: 153 HDKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 206
H +++ Y + +V E LGS L D LRK+ L A
Sbjct: 80 HRN----LIRL-----YGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLS-RYAV 128
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
Q+ E + ++ IH DL N+LL + + +K+
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG------------------------- 163
Query: 267 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-G 319
DFG + ++ V H + APE + +++ D W G L E+ T G
Sbjct: 164 --DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221
Query: 320 EALFQTHENLEHLAMMERVLGPLPQ 344
+ + + L +++ LP+
Sbjct: 222 QEPWIGLNGSQILHKIDKEGERLPR 246
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 6e-11
Identities = 63/254 (24%), Positives = 105/254 (41%), Gaps = 54/254 (21%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 155
K+ ++G G FG+V ++ K VA+K ++ +A + E +++QL +H +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQL-QHQR 69
Query: 156 GGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
V++ Y + I I+ E + GS L DFL+ + I+ + ++A Q+
Sbjct: 70 ----LVRL-----YAVVTQEPIYIITEYMENGS-LVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
E +AF+ + IH DL+ N+ LVS K+ D
Sbjct: 120 EGMAFIEERNYIHRDLRAANI-LVSDTLS--------------------------CKIAD 152
Query: 270 FGSTTYERPDQNYIVSTRH---YR--APEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323
FG D Y + APE I +T D+WS G +L E+ T G +
Sbjct: 153 FGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
Query: 324 QTHENLEHLAMMER 337
N E + +ER
Sbjct: 212 PGMTNPEVIQNLER 225
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 56/251 (22%)
Query: 104 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 159
++G G FG V + + +K++ VAIK+++ K E M E +++ QL +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPY---- 397
Query: 160 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
V++ + +V E G L+ FL ++ E+ Q+ +
Sbjct: 398 IVRL-----IGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVA-ELLHQVSMGMK 450
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++ + +H +L NVLLV+ Y K+ DFG +
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKIS---------------------------DFGLS 483
Query: 274 TYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326
D +Y + + APE I ++ D+WS G + E + G+ ++
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
Query: 327 ENLEHLAMMER 337
+ E +A +E+
Sbjct: 544 KGPEVMAFIEQ 554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 58/257 (22%)
Query: 100 KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHD 154
I +G G G+V +R VAIK ++ ++ R + E ++ Q H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHP 110
Query: 155 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
G + IV E + GS L FLR ++ + + LV + R
Sbjct: 111 NIIRLEG--VVTR-------GRLAMIVTEYMENGS-LDTFLRTHDGQFTIMQLV-GMLRG 159
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+ + ++ DL +H DL NV LV S + KV
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNV-LVDSNLV--------------------------CKV 192
Query: 268 IDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GE 320
DFG + D + +T + APE I ++ D+WS G ++ E+ GE
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 321 ALFQTHENLEHLAMMER 337
+ N + ++ +E
Sbjct: 253 RPYWNMTNRDVISSVEE 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 46/247 (18%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++G G FG V W + K VAIK +R E + E EV+ +L H K
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEEDFIEEAEVMMKL-SHPK--- 64
Query: 159 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
VQ+ + IC+V E + G L D+LR L+ + + E +A++
Sbjct: 65 -LVQLYGVCLEQAPICLVTEFMEHGC-LSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLE 121
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+ C+IH DL N LV + IKV DFG T +
Sbjct: 122 EACVIHRDLAARNC-LVGENQV--------------------------IKVSDFGMTRFV 154
Query: 277 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330
D Y ST + +PEV ++ D+WS G ++ E+ + G+ ++ N E
Sbjct: 155 -LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
Query: 331 HLAMMER 337
+ +
Sbjct: 214 VVEDIST 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 46/247 (18%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
+ ++G G FG V W + VA+K+++ + E + + +L H K
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPK--- 64
Query: 159 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
V+ I IV E G L ++LR + P L+ E+ + E +AF+
Sbjct: 65 -LVKFYGVCSKEYPIYIVTEYISNGC-LLNYLRSHGKGLEPSQLL-EMCYDVCEGMAFLE 121
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
IH DL N LV + +KV DFG T Y
Sbjct: 122 SHQFIHRDLAARNC-LVDRDLC--------------------------VKVSDFGMTRYV 154
Query: 277 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330
D Y+ S + APEV ++ D+W+ G ++ E+ + G+ + + N E
Sbjct: 155 L-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
Query: 331 HLAMMER 337
+ + +
Sbjct: 214 VVLKVSQ 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 57/255 (22%), Positives = 101/255 (39%), Gaps = 48/255 (18%)
Query: 97 SRYKIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLA 151
+ I +G G FG+V +++ VAIK ++ +K R + E ++ Q
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF- 103
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
H +++ + IV E + GS L FLRK++ + I LV + R +
Sbjct: 104 DHPN----IIRLEGVVTKSKPVMIVTEYMENGS-LDSFLRKHDAQFTVIQLV-GMLRGIA 157
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ ++ D+ +H DL N+ L++S + KV D
Sbjct: 158 SGMKYLSDMGYVHRDLAARNI-LINSNLV--------------------------CKVSD 190
Query: 270 FGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322
FG D +TR + +PE I +T D+WS G +L E+ + GE
Sbjct: 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 323 FQTHENLEHLAMMER 337
+ N + + ++
Sbjct: 251 YWEMSNQDVIKAVDE 265
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 53/254 (20%), Positives = 91/254 (35%), Gaps = 56/254 (22%)
Query: 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGG 157
+ ++G G FG+V R +VA+K R + + E +L+Q H
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPN-- 173
Query: 158 NRCVQIRNWFDY-----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
V++ + I IV E + G FLR R L+ ++
Sbjct: 174 --IVRL-----IGVCTQKQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLL-QMVGDAAA 224
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++ C IH DL N LV+ + + +K+ DF
Sbjct: 225 GMEYLESKCCIHRDLAARNC-LVTEKNV--------------------------LKISDF 257
Query: 271 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323
G + E D Y S + APE + ++ D+WS G +L E + G + +
Sbjct: 258 GMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
Query: 324 QTHENLEHLAMMER 337
N + +E+
Sbjct: 317 PNLSNQQTREFVEK 330
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 55/255 (21%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKH 153
K +G G FG V + W E +++ VAIK +R K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 154 DKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
++ + + ++ + G L D++R++ L+ Q
Sbjct: 77 PH----VCRL-----LGICLTSTVQLITQLMPFGC-LLDYVREHKDNIGSQYLL-NWCVQ 125
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSS 263
+ + + ++ D ++H DL NVL+ + +++K+ D+ + + + ++P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--- 182
Query: 264 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322
IK + A E IL +T+ D+WS G + EL T G
Sbjct: 183 -IK----------------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 323 FQTHENLEHLAMMER 337
+ E +++E+
Sbjct: 220 YDGIPASEISSILEK 234
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 46/247 (18%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++G G FG V W + VAIK+++ + + E +V+ L H+K
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEK--- 80
Query: 159 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
VQ+ + I I+ E G L ++LR+ +R L+ E+ + + E + ++
Sbjct: 81 -LVQLYGVCTKQRPIFIITEYMANGC-LLNYLREMRHRFQTQQLL-EMCKDVCEAMEYLE 137
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+H DL N LV+ + + +KV DFG + Y
Sbjct: 138 SKQFLHRDLAARNC-LVNDQGV--------------------------VKVSDFGLSRYV 170
Query: 277 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330
D+ Y S + PEV++ ++ DIW+ G ++ E+ + G+ ++ N E
Sbjct: 171 LDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
Query: 331 HLAMMER 337
+ +
Sbjct: 230 TAEHIAQ 236
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 55/261 (21%), Positives = 97/261 (37%), Gaps = 59/261 (22%)
Query: 97 SRYKIHSKMGEGTFGQVLE-CW---DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQL 150
S +G G FG+V + +++ VAIK ++ +K R + E ++ Q
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 151 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 203
H G + + I+ E + G+ L FLR+ + + LV
Sbjct: 104 -SHHNIIRLEG--VISK-------YKPMMIITEYMENGA-LDKFLREKDGEFSVLQLV-G 151
Query: 204 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
+ R + + ++ ++ +H DL N+ LV+S +
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNI-LVNSNLV------------------------- 185
Query: 264 AIKVIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELC 317
KV DFG + D +T + APE I +T D+WS G ++ E+
Sbjct: 186 -CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244
Query: 318 T-GEALFQTHENLEHLAMMER 337
T GE + N E + +
Sbjct: 245 TYGERPYWELSNHEVMKAIND 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 53/258 (20%), Positives = 98/258 (37%), Gaps = 55/258 (21%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRGI--KKYREAAMIEIEVLQQL 150
+ + +G G FG V + W E + + V IK++ ++ +A + + L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 151 AKHDKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREI 204
H V++ + + +V + LGS L D +R++ P L+
Sbjct: 73 -DHAH----IVRL-----LGLCPGSSLQLVTQYLPLGS-LLDHVRQHRGALGPQLLL-NW 120
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMP 260
Q+ + + ++ + M+H +L NVLL S ++V D+ + P D + P
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 261 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-G 319
IK + A E I +T+ D+WS G + EL T G
Sbjct: 181 ----IK----------------------WMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 320 EALFQTHENLEHLAMMER 337
+ E ++E+
Sbjct: 215 AEPYAGLRLAEVPDLLEK 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 47/250 (18%)
Query: 100 KIHSKMGEGTFGQVLE-CWDRERKE--MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 154
++ +GEG FG V + + VAIK + RE + E ++Q H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 76
Query: 155 KGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQL 208
V++ N + I+ E LG L FL+ Y L+ A QL
Sbjct: 77 H----IVKL-----IGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLI-LYAYQL 125
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
+A++ +H D+ NVL+ S++ +K+ D+ S + +DS+Y+K IK
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK-- 182
Query: 269 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 327
+ APE I +T D+W G + E+ G FQ +
Sbjct: 183 --------------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
Query: 328 NLEHLAMMER 337
N + + +E
Sbjct: 223 NNDVIGRIEN 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 31/254 (12%), Positives = 54/254 (21%), Gaps = 65/254 (25%)
Query: 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQL 150
RY++ G Q + D VA+ V + + L ++
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 209
++ + R +V E + G SL + P+ +R + L
Sbjct: 89 D-KP----GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIR-AMQSLA 139
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
H + + P V + + +
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVSI---------------------------DGDVVLAY 172
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
DI +G L L
Sbjct: 173 PA-----------------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVR 208
Query: 330 EHLAMMERVLGPLP 343
LA ER P
Sbjct: 209 SGLAPAERDTAGQP 222
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 55/255 (21%)
Query: 100 KIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKH 153
K +G G FG V + W E +++ VAIK +R K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 154 DKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
++ + + ++ + G L D++R++ L+ Q
Sbjct: 77 PH----VCRL-----LGICLTSTVQLITQLMPFGC-LLDYVREHKDNIGSQYLL-NWCVQ 125
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSS 263
+ + + ++ D ++H DL NVL+ + +++K+ D+ + + + ++P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--- 182
Query: 264 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322
IK + A E IL +T+ D+WS G + EL T G
Sbjct: 183 -IK----------------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 323 FQTHENLEHLAMMER 337
+ E +++E+
Sbjct: 220 YDGIPASEISSILEK 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 52/256 (20%), Positives = 97/256 (37%), Gaps = 59/256 (23%)
Query: 100 KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 154
++ +GEG FG+V E + + K VA+K + +E M E +++ L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHP 73
Query: 155 KGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQL 208
V++ I+ E G L +L +N + LV + Q+
Sbjct: 74 H----IVKL-----IGIIEEEPTWIIMELYPYGE-LGHYLERNKNSLKVLTLV-LYSLQI 122
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
+ +A++ + +H D+ N+ LV+S +K+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNI-LVASPEC--------------------------VKLG 155
Query: 269 DFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEA 321
DFG + Y + Y R +PE I +T D+W + E+ + G+
Sbjct: 156 DFGLSRYIEDEDYY--KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
Query: 322 LFQTHENLEHLAMMER 337
F EN + + ++E+
Sbjct: 214 PFFWLENKDVIGVLEK 229
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 20/153 (13%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 155
K+ +G+G FG V+ R K VA+K ++ +A + E V+ QL +H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQL-RHSNL 248
Query: 156 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
G V+ + + IV E GS L D+LR D + + + +
Sbjct: 249 VQLLG--VIVE------EKGGLYIVTEYMAKGS-LVDYLRSRGRSVLGGDCLLKFSLDVC 299
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242
E + ++ +H DL NVL+ KV D
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 49/251 (19%)
Query: 100 KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 154
++ +GEG FG V + + VAIK + RE + E ++Q H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 451
Query: 155 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
G + N + I+ E LG L FL+ + L+ A Q
Sbjct: 452 HIVKLIG--VITE--------NPVWIIMELCTLGE-LRSFLQVRKFSLDLASLI-LYAYQ 499
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
L +A++ +H D+ NVL+ S++ +K+ D+ S + +DS+Y+K IK
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK- 557
Query: 268 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326
+ APE I +T D+W G + E+ G FQ
Sbjct: 558 ---------------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 327 ENLEHLAMMER 337
+N + + +E
Sbjct: 597 KNNDVIGRIEN 607
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 60/253 (23%), Positives = 89/253 (35%), Gaps = 72/253 (28%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-WDRERKEM-VAIKIVRGI--KKYREAAMIEIEVLQQLAK 152
+ K +GEG FGQVL+ ++ M AIK ++ K E+EVL +L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 153 HDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIA 205
H G C R ++ + E G +L DFLRK+ +
Sbjct: 85 HPNIINLLG--ACEH-------RGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIANS 134
Query: 206 -------RQLLEC---IA----FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251
+QLL +A ++ IH DL N+ LV Y+
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI-LVGENYV------------- 180
Query: 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCD 305
K+ DFG + R Q V R A E + +T D
Sbjct: 181 -------------AKIADFGLS---R-GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD 223
Query: 306 IWSVGCILVELCT 318
+WS G +L E+ +
Sbjct: 224 VWSYGVLLWEIVS 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 54/254 (21%), Positives = 93/254 (36%), Gaps = 58/254 (22%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 155
K+ +G+G FG V+ R K VA+K ++ +A + E V+ QL +H
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNL 76
Query: 156 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
G + + + + IV E GS L D+LR D + + + +
Sbjct: 77 VQLLG---VI-----VEEKGGLYIVTEYMAKGS-LVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
E + ++ +H DL NV LVS + + KV D
Sbjct: 128 EAMEYLEGNNFVHRDLAARNV-LVSEDNV--------------------------AKVSD 160
Query: 270 FGSTTYERPDQNYIVSTRH---YR--APEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323
FG T + APE + ++ D+WS G +L E+ + G +
Sbjct: 161 FGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215
Query: 324 QTHENLEHLAMMER 337
+ + +E+
Sbjct: 216 PRIPLKDVVPRVEK 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 54/257 (21%), Positives = 80/257 (31%), Gaps = 72/257 (28%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQ 149
+R +G G FG+V+E + VA+K+++ E M E++VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 150 LAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVR 202
L H G C ++ E G L +FLR+
Sbjct: 83 LGNHMNIVNLLG--ACTI-------GGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSP 132
Query: 203 EIARQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSS 246
I + L IH DL N+ L++ I
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI-LLTHGRI-------- 183
Query: 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWT 301
K+ DFG + D NY+V APE I +T
Sbjct: 184 ------------------TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225
Query: 302 YPCDIWSVGCILVELCT 318
+ D+WS G L EL +
Sbjct: 226 FESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 61/305 (20%), Positives = 107/305 (35%), Gaps = 90/305 (29%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQ 149
+ + +G G FG+V+E + VA+K+++ +EA M E++++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 150 LAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN--NYRSFPIDL 200
L +H+ G C + ++ E G L +FLR+ + P
Sbjct: 106 LGQHENIVNLLGA--CTH-------GGPVLVITEYCCYG-DLLNFLRRKSRVLETDPAFA 155
Query: 201 VREIARQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250
+ + + F + M IH D+ NV L+++ ++
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV-LLTNGHV------------ 202
Query: 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCD 305
K+ DFG D NYIV + APE I +T D
Sbjct: 203 --------------AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248
Query: 306 IWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLD 364
+WS G +L E+ + L + P P + V+ K V+ G ++
Sbjct: 249 VWSYGILLWEIFS-------------LGLN-----PYPGIL---VNSKFYKLVKDGYQMA 287
Query: 365 WPEGA 369
P A
Sbjct: 288 QPAFA 292
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 3e-06
Identities = 26/161 (16%), Positives = 57/161 (35%), Gaps = 12/161 (7%)
Query: 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 159
KI+ ++ F ++ E E ++ + +K E L++ + G
Sbjct: 80 KIY-RIETSEFDKMDEY--LYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA---GVS 133
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
Q + Y ++ ++ L R V I ++E + ++
Sbjct: 134 VPQP---YTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA 190
Query: 220 -MIHTDLKPENVLLVSS-EYIKVPDYKSSLHTPKDSSYFKR 258
++H DL N++ + +I + + H P SY +R
Sbjct: 191 ELVHADLSEYNIMYIDKVYFIDMGQAVTLRH-PMAESYLER 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 51/255 (20%), Positives = 86/255 (33%), Gaps = 69/255 (27%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQ 149
R K+ +G G FGQV+E VA+K+++ + E M E+++L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 150 LAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN----NYRSFPI 198
+ H G + ++ E K G +L +LR
Sbjct: 87 IGHHLNVVNLLG---AC-----TKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAP 137
Query: 199 DLVREIARQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLH 248
+ + + L I + + M IH DL N+ L+S + +
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI-LLSEKNV---------- 186
Query: 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWTYP 303
+K+ DFG D +Y+ APE I +T
Sbjct: 187 ----------------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230
Query: 304 CDIWSVGCILVELCT 318
D+WS G +L E+ +
Sbjct: 231 SDVWSFGVLLWEIFS 245
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 58/339 (17%), Positives = 105/339 (30%), Gaps = 91/339 (26%)
Query: 100 KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAK 152
K+ +G G FGQV+E VA+K+++ A M E+++L +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
H N + + ++ E +L +LR R+ + + AR
Sbjct: 85 HL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--RNEFVPYKTKGARFR--- 136
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSA----- 264
+ I DLK + SS+ + + SL ++ + + K
Sbjct: 137 -QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 265 ------------------------------------IKVIDFGSTTYERPDQNYIVSTRH 288
+K+ DFG D +Y+
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 289 YR-----APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 343
APE I +T D+WS G +L E+ + LG P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------------------LGASP 295
Query: 344 -QHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMK 380
+ ++D + ++ G R+ P+ + M
Sbjct: 296 YPGV--KIDEEFCRRLKEGTRMRAPDYT--TPEMYQTML 330
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 23/155 (14%)
Query: 100 KIHSKMGEGTFGQVLEC---WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHD 154
+ +G G FG V + +K A+K + I E + + E +++ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 86
Query: 155 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
G +V K G L +F+R + DL+ Q
Sbjct: 87 NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 136
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242
+ + + ++ +H DL N +L +KV D
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 171
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 45/251 (17%), Positives = 84/251 (33%), Gaps = 58/251 (23%)
Query: 100 KIHSKMGEGTFGQVLE--CWDRERKEM-VAIKIVRGIKKYREAA--MIEIEVLQQLAKHD 154
+ +G G FG V D + K++ A+K + I E + + E +++ H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 150
Query: 155 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
G +V K G L +F+R + DL+ Q
Sbjct: 151 NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 200
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+ + + F+ +H DL N ++ ++ +KV
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNC-MLDEKFT--------------------------VKV 233
Query: 268 IDFG-STTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-G 319
DFG + + + + + + A E + +T D+WS G +L EL T G
Sbjct: 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293
Query: 320 EALFQTHENLE 330
+ +
Sbjct: 294 APPYPDVNTFD 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 31/121 (25%), Positives = 47/121 (38%), Gaps = 37/121 (30%)
Query: 204 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 263
A + F+H+ IH D+K N+LL D ++ K S
Sbjct: 142 AANGI----NFLHENHHIHRDIKSANILL-------------------DEAF---TAKIS 175
Query: 264 AIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
DFG ++++R Y APE + G T DI+S G +L+E+ T
Sbjct: 176 -----DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIIT 229
Query: 319 G 319
G
Sbjct: 230 G 230
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 51/257 (19%), Positives = 93/257 (36%), Gaps = 72/257 (28%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVL 147
R + +GEG FGQV+ R VA+K+++ ++ + + E+E++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 148 QQLAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN----NYRSF 196
+ + KH G C Q + ++ E G +L ++L+ S+
Sbjct: 129 KMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLQARRPPGLEYSY 178
Query: 197 PIDLVREIARQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSS 246
E + ++ + + M IH DL NV LV+ + +
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV-LVTEDNV-------- 229
Query: 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWT 301
+K+ DFG Y +T + APE + +T
Sbjct: 230 ------------------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271
Query: 302 YPCDIWSVGCILVELCT 318
+ D+WS G +L E+ T
Sbjct: 272 HQSDVWSFGVLLWEIFT 288
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 57/260 (21%), Positives = 90/260 (34%), Gaps = 83/260 (31%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQL 150
+ ++GEG FG+V + K +VA+K ++ + R+ E E+L L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 151 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 203
+H G C + + +VFE + G L FLR + + + +
Sbjct: 101 -QHQHIVRFFG--VCTE-------GRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGED 149
Query: 204 IARQLLECIAFMH-------------DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250
+A L + L +H DL N LV +
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC-LVGQGLV------------ 196
Query: 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------------APEVILGL 298
+K+ DFG + R I ST +YR PE IL
Sbjct: 197 --------------VKIGDFGMS---R----DIYSTDYYRVGGRTMLPIRWMPPESILYR 235
Query: 299 GWTYPCDIWSVGCILVELCT 318
+T D+WS G +L E+ T
Sbjct: 236 KFTTESDVWSFGVVLWEIFT 255
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 44/255 (17%), Positives = 83/255 (32%), Gaps = 60/255 (23%)
Query: 104 KMGEGTFGQVLEC---WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK--- 155
+G+G FG V + + AIK + I + ++ + E +++ L H
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLA 86
Query: 156 --GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
G + ++ G L F+R DL+ Q+
Sbjct: 87 LIG---IM-----LPPEGLPHVLLPYMCHGD-LLQFIRSPQRNPTVKDLI-SFGLQVARG 136
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ ++ + +H DL N ++ + +KV DFG
Sbjct: 137 MEYLAEQKFVHRDLAARNC-MLDESFT--------------------------VKVADFG 169
Query: 272 STTYERPDQNYIVSTRHYR--------APEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322
D+ Y +H A E + +T D+WS G +L EL T G
Sbjct: 170 LARDIL-DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
Query: 323 FQTHENLEHLAMMER 337
++ + + + +
Sbjct: 229 YRHIDPFDLTHFLAQ 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 51/259 (19%), Positives = 93/259 (35%), Gaps = 76/259 (29%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVL 147
+ + +GEG FGQV+ + VA+K+++ ++ + + E+E++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 148 QQLAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDL 200
+ + KH G C Q + ++ E G +L ++LR R ++
Sbjct: 95 KMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRAR--RPPGMEY 142
Query: 201 VREIARQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYK 244
+I R E + F + IH DL NV LV+ +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-LVTENNV------ 195
Query: 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLG 299
+K+ DFG Y +T + APE +
Sbjct: 196 --------------------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 300 WTYPCDIWSVGCILVELCT 318
+T+ D+WS G ++ E+ T
Sbjct: 236 YTHQSDVWSFGVLMWEIFT 254
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 55/262 (20%), Positives = 89/262 (33%), Gaps = 77/262 (29%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQ 149
+ +G G FG+V+ VA+K+++ REA M E++++ Q
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 150 LAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVR 202
L H+ G C I ++FE G L ++LR + ++
Sbjct: 105 LGSHENIVNLLGA--CTL-------SGPIYLIFEYCCYG-DLLNYLRSKREKFSEDEIEY 154
Query: 203 EIARQLLECIAF----MHDLCM-----------------IHTDLKPENVLLVSSEYIKVP 241
E ++L E DL +H DL NV LV+ +
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKV--- 210
Query: 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVIL 296
+K+ DFG D NY+V APE +
Sbjct: 211 -----------------------VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
Query: 297 GLGWTYPCDIWSVGCILVELCT 318
+T D+WS G +L E+ +
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFS 269
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 57/262 (21%), Positives = 93/262 (35%), Gaps = 86/262 (32%)
Query: 97 SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQL 150
+ ++GEG FG+V + K +VA+K ++ R+ E E+L L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 151 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSF------- 196
+H+ G C + + +VFE K G L FLR + +
Sbjct: 75 -QHEHIVKFYG--VCGD-------GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDGQP 123
Query: 197 --------PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248
++ IA Q+ + ++ +H DL N LV + +
Sbjct: 124 RQAKGELGLSQML-HIASQIASGMVYLASQHFVHRDLATRNC-LVGANLL---------- 171
Query: 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------------APEVIL 296
+K+ DFG + R + ST +YR PE I+
Sbjct: 172 ----------------VKIGDFGMS---R----DVYSTDYYRVGGHTMLPIRWMPPESIM 208
Query: 297 GLGWTYPCDIWSVGCILVELCT 318
+T D+WS G IL E+ T
Sbjct: 209 YRKFTTESDVWSFGVILWEIFT 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 76/256 (29%)
Query: 100 KIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQL 150
+ +GEG FGQV+ + VA+K+++ ++ + + E+E+++ +
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 151 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 203
KH G C Q + ++ E G +L ++LR R ++ +
Sbjct: 144 GKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRAR--RPPGMEYSYD 191
Query: 204 IARQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSSL 247
I R E + F + IH DL NV LV+ +
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-LVTENNV--------- 241
Query: 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTY 302
+K+ DFG Y +T + APE + +T+
Sbjct: 242 -----------------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284
Query: 303 PCDIWSVGCILVELCT 318
D+WS G ++ E+ T
Sbjct: 285 QSDVWSFGVLMWEIFT 300
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 66/488 (13%), Positives = 120/488 (24%), Gaps = 147/488 (30%)
Query: 10 PFSNLDRRPRKRARLGWDVPQVPKAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLF--- 66
P +R RL D K V R +L
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNV----------------SRLQPYLKLRQALLELR 148
Query: 67 -VKGVARNGSPPWREDDKDGHYMFALGEN-LTSR----YKIHSKMGEG----TFGQVLEC 116
K V +G + G+ + YK+ KM
Sbjct: 149 PAKNVLIDG-------------VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS- 194
Query: 117 WDRERKEMVAIKIVRGIKKYREAA------MIEIEVLQQLAKH---DKGGNRCVQI-RN- 165
EM+ + + + + + I +Q + K C+ + N
Sbjct: 195 -PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV 253
Query: 166 W-------FDYRNHIC-IVFEKLGSSLYDFLRKNNYRSFPID-----LVREIARQLLECI 212
F+ C I+ + DFL +D L + + LL
Sbjct: 254 QNAKAWNAFNLS---CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 213 AFMHDLCMIHTDLKPE----NVLLVS--SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
L DL E N +S +E I+ +K +
Sbjct: 311 -----LDCRPQDLPREVLTTNPRRLSIIAESIR--------DGLATWDNWKHVNCDKLTT 357
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRA----------PEVILGLGWTYPCDIWSVGCILVEL 316
+I+ S P + + + P ++L L W V ++ +L
Sbjct: 358 IIE-SSLNVLEPAEYR----KMFDRLSVFPPSAHIPTILLSLIWFDVIKS-DVMVVVNKL 411
Query: 317 CTGEALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHA---EKYVRRGRLDWPEGA 369
+ + + + + + + + H + Y D +
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELK------VKLENEYALHRSIVDHYNIPKTFDSDD-- 463
Query: 370 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF---- 425
+ P L H+ H HL + +R+ R F
Sbjct: 464 ---------LIPPYLDQYFYSHIGH------HLKNI----EHPERM---TLFRMVFLDFR 501
Query: 426 FTRDHLRR 433
F +R
Sbjct: 502 FLEQKIRH 509
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 43/267 (16%), Positives = 84/267 (31%), Gaps = 61/267 (22%)
Query: 97 SRYKIHSKMGEGTFGQVLEC---WDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQL 150
++ + +G+G FG V E + VA+K+++ E + E +++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 151 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 203
H G ++ K G L+ FL + P +L +
Sbjct: 83 -DHPHVAKLVG---VSLRSRAKGRLPIPMVILPFMKHG-DLHAFLLASRIGENPFNLPLQ 137
Query: 204 ----IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 259
+ + ++ IH DL N +++ +
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNC-MLAEDMT--------------------- 175
Query: 260 PKSSAIKVIDFGSTTYERP--DQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGC 311
+ V DFG + R +Y + A E + +T D+W+ G
Sbjct: 176 -----VCVADFGLS---RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227
Query: 312 ILVELCT-GEALFQTHENLEHLAMMER 337
+ E+ T G+ + EN E +
Sbjct: 228 TMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 433 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.01 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.81 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.68 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.26 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.07 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-64 Score=477.11 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=215.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||+||+|+++.+++.||||++.+.. ...+.+.+|+++++.+ +||||++++++|++.++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCE
Confidence 56999999999999999999999999999999997432 2345678899999888 78999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||| ||+|.++|.+.+ .+++.+++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~----------------- 167 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE----------------- 167 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-----------------
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC-----------------
Confidence 99999999 999999998765 7999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.+||+|||+|+..... ..+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 168 ----------~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 168 ----------DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp ----------TSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------CCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 455667777766644322 23468999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+.+..+... .+.+ ++.+++++++||.+|
T Consensus 238 ~~~~~~~~i~~~-----------------------~~~~--------------------------p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 238 NEGLIFAKIIKL-----------------------EYDF--------------------------PEKFFPKARDLVEKL 268 (311)
T ss_dssp SHHHHHHHHHHT-----------------------CCCC--------------------------CTTCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcC-----------------------CCCC--------------------------CcccCHHHHHHHHHH
Confidence 777666554321 1122 235678899999999
Q ss_pred cccCCCCCCCHHH------HhcCCCCCCCC
Q 013973 407 LRYDPTDRLTARE------ALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~e------ll~hp~f~~~~ 430 (433)
|++||++|||++| +++||||++-+
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 9999999999987 58999998743
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-63 Score=478.41 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=215.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
...|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+.+ +||||++++++|.+.+.+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEE
Confidence 356999999999999999999999999999999996432 3345577899999998 7799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|||||| ||+|.+++... .+++.+++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~------------------- 205 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH------------------- 205 (346)
T ss_dssp EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-------------------
T ss_pred EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC-------------------
Confidence 999999 89999999764 6999999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+
T Consensus 206 --------~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 277 (346)
T 4fih_A 206 --------DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277 (346)
T ss_dssp --------TCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred --------CCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 456777777776644322 245689999999999999999999999999999999999999999888777
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+.....+.. ..+..+++++++||.+||++|
T Consensus 278 ~~~~i~~~~~~~~----------------------------------------------~~~~~~s~~~~dli~~~L~~d 311 (346)
T 4fih_A 278 AMKMIRDNLPPRL----------------------------------------------KNLHKVSPSLKGFLDRLLVRD 311 (346)
T ss_dssp HHHHHHHSSCCCC----------------------------------------------SCGGGSCHHHHHHHHHHSCSS
T ss_pred HHHHHHcCCCCCC----------------------------------------------CccccCCHHHHHHHHHHcCCC
Confidence 6655433211100 012356789999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|++|||++|+|+||||++.
T Consensus 312 P~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 312 PAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp TTTSCCHHHHTTCGGGGGC
T ss_pred hhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-63 Score=480.40 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=212.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+++++ +||||+++++++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-----KHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-----CCCCCCcEEEEEEECCEE
Confidence 5799999999999999999999999999999999643 34456788999999998 779999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
||||||| ||+|.++|.......+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~------------------- 159 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT------------------- 159 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC-------------------
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC-------------------
Confidence 9999999 99999999877666789999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.++.+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 160 --------~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 231 (350)
T 4b9d_A 160 --------KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231 (350)
T ss_dssp --------TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred --------CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 45567777777776544321 3358999999999999999999999999999999999999999988877
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+.... .| ..+..++.++++||.+||++
T Consensus 232 ~~~~~i~~~~--~~----------------------------------------------~~~~~~s~~~~~li~~~L~~ 263 (350)
T 4b9d_A 232 NLVLKIISGS--FP----------------------------------------------PVSLHYSYDLRSLVSQLFKR 263 (350)
T ss_dssp HHHHHHHHTC--CC----------------------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHcCC--CC----------------------------------------------CCCccCCHHHHHHHHHHccC
Confidence 7665543311 10 01235678999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
||++|||++|+|+||||++.
T Consensus 264 dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 264 NPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SGGGSCCHHHHHTSHHHHTT
T ss_pred ChhHCcCHHHHhcCHHhhcC
Confidence 99999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-63 Score=463.98 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=202.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+++.+ +||||+++++++++.+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-----RHPHIIKLYDVIKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECCE
Confidence 57999999999999999999999999999999996432 2345678899999998 67999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+||||||++|+|.+++.+.+ .+++.+++.++.||+.||+|||++|||||||||+|||++.
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~------------------ 147 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE------------------ 147 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT------------------
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC------------------
Confidence 99999999999999998765 7999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.+||+|||+|+..... ..+.+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.+..
T Consensus 148 ---------~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~ 218 (275)
T 3hyh_A 148 ---------HLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218 (275)
T ss_dssp ---------TCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------CCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 455677777776544332 234689999999999999886 58999999999999999999999987766
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+... ... .+..+++++++||.+||++
T Consensus 219 ~~~~~i~~~-----------------------~~~--------------------------~p~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 219 VLFKNISNG-----------------------VYT--------------------------LPKFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp HHHHHHHHT-----------------------CCC--------------------------CCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHcC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHccC
Confidence 555443321 111 1235678899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
||++|||++|+|+||||+.+
T Consensus 250 dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 250 NPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp SGGGSCCHHHHHHCHHHHTT
T ss_pred ChhHCcCHHHHHcCcccccC
Confidence 99999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-62 Score=480.02 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=216.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.+.|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.+ +|+||++++++|.+.+.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-----CCCCCCceEEEEEECCEEE
Confidence 457999999999999999999999999999999997432 3345678899999998 7799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|||||| ||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~------------------- 282 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH------------------- 282 (423)
T ss_dssp EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT-------------------
T ss_pred EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC-------------------
Confidence 999999 99999999764 5999999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 283 --------~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 283 --------DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp --------TCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred --------CCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 456777777777644332 245699999999999999999999999999999999999999999888777
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+.....+.. ..+..+++++++||.+||++|
T Consensus 355 ~~~~i~~~~~~~~----------------------------------------------~~~~~~s~~~~dli~~~L~~d 388 (423)
T 4fie_A 355 AMKMIRDNLPPRL----------------------------------------------KNLHKVSPSLKGFLDRLLVRD 388 (423)
T ss_dssp HHHHHHHSCCCCC----------------------------------------------SCTTSSCHHHHHHHHHHSCSS
T ss_pred HHHHHHcCCCCCC----------------------------------------------cccccCCHHHHHHHHHHcCCC
Confidence 6655433211100 112356789999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|++|||++|+|+||||++.
T Consensus 389 P~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 389 PAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp TTTSCCHHHHTTCGGGGGC
T ss_pred hhHCcCHHHHhcCHHhcCC
Confidence 9999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-61 Score=455.35 Aligned_cols=253 Identities=23% Similarity=0.425 Sum_probs=206.5
Q ss_pred CcE-EEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 97 SRY-KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 97 ~~~-~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
++| ++.++||+|+||+||+|.++.+++.||+|++... ....+.+.+|+.+++++ +|||||+++++|++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEeeccC
Confidence 445 7888999999999999999999999999999642 33456678899999988 78999999999865
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
.+.+||||||| ||+|.++|.+.+ .+++..++.|+.||+.||+|||++| ||||||||+||||+.
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~----------- 166 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG----------- 166 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-----------
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-----------
Confidence 46799999999 999999998765 7999999999999999999999999 999999999999952
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.++.+||+|||+|+...... ...+||+.|||||++.+ .|+.++|||||||++|||+||+.||.
T Consensus 167 ---------------~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 167 ---------------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp ---------------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------CCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 34567888888776543332 34689999999999875 69999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+....+...... +..| ...+...++++++||.
T Consensus 231 ~~~~~~~~~~~i~~-~~~~---------------------------------------------~~~~~~~~~~~~~li~ 264 (290)
T 3fpq_A 231 ECQNAAQIYRRVTS-GVKP---------------------------------------------ASFDKVAIPEVKEIIE 264 (290)
T ss_dssp TCSSHHHHHHHHTT-TCCC---------------------------------------------GGGGGCCCHHHHHHHH
T ss_pred CCCcHHHHHHHHHc-CCCC---------------------------------------------CCCCccCCHHHHHHHH
Confidence 76554433221100 0000 0112355678999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+||++||++|||++|+|+||||+++
T Consensus 265 ~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 265 GCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHccCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-62 Score=463.04 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=207.3
Q ss_pred CcEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
++|++++.||+|+||+||+|++. .+++.||||++++.. .....+..|+.+++++ +||||++++++++++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-----NHPFIVKLHYAFQTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-----CCTTEECEEEEEEET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEEC
Confidence 57999999999999999999874 568899999996432 2233566788888777 789999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+||||||| ||+|.++|.+.+ .+++.+++.|+.||+.||+|||++|||||||||+|||++
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---------------- 160 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---------------- 160 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----------------
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc----------------
Confidence 9999999999 999999998865 799999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++.+||+|||+|+.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 161 -----------~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 161 -----------EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp -----------TTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------CCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 455677777777764322 224568999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+.+..+.... +. .+..+|+++++||.+|
T Consensus 230 ~~~~~~~~i~~~~-----------------------~~--------------------------~p~~~s~~~~~li~~~ 260 (304)
T 3ubd_A 230 DRKETMTMILKAK-----------------------LG--------------------------MPQFLSPEAQSLLRML 260 (304)
T ss_dssp SHHHHHHHHHHCC-----------------------CC--------------------------CCTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCC-----------------------CC--------------------------CCCcCCHHHHHHHHHH
Confidence 8777665543311 11 1235678999999999
Q ss_pred cccCCCCCCC-----HHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~t-----a~ell~hp~f~~~ 429 (433)
|++||++||| ++|+++||||++-
T Consensus 261 L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 261 FKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp TCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred cccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999998 5799999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=471.13 Aligned_cols=282 Identities=27% Similarity=0.471 Sum_probs=223.6
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-- 169 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-- 169 (433)
+.++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+.+ .||||+++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-----KHDNIIAIKDILRPTV 126 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-----CCCCcceEeeeeeccc
Confidence 446899999999999999999999999999999999643 23345677899999998 67999999988653
Q ss_pred ----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 170 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 ----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
.+++|||||||+|+|.+++...+ .+++..++.|+.||+.||+|||++|||||||||+|||++.+|.
T Consensus 127 ~~~~~~~~~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~-------- 196 (398)
T 4b99_A 127 PYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE-------- 196 (398)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--------
T ss_pred ccccCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--------
Confidence 47899999999889999998754 8999999999999999999999999999999999999965554
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCC-------CCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHH
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~ell 317 (433)
+||+|||+|+.... .....+||+.|||||++.+. .|+.++||||+||++|||+
T Consensus 197 -------------------~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 197 -------------------LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp -------------------EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred -------------------EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence 55555555543211 12346899999999999886 4699999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhh-hhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
+|++||.+.+..+++..|....|.++...+..+..... .++.. .+... ........+..+
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~----~~~~~---------------~~~~~~~~~~~s 318 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS----LPPRQ---------------PVPWETVYPGAD 318 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHS----SCCCC---------------CCCHHHHSTTCC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc----CCCcC---------------CCCHHHhCCCCC
Confidence 99999999999999999999999888654433221111 11110 00000 000111234678
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+++.|||.+||++||++||||+|+|+||||++-
T Consensus 319 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 319 RQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 899999999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-61 Score=459.25 Aligned_cols=251 Identities=27% Similarity=0.354 Sum_probs=207.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+++.+ +|||||++++++.+.+.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-----~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-----SSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-----CCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEE
Confidence 569999999999999999999999999999999975322 23588888877 789999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||| ||+|.++|.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|
T Consensus 129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g------------------- 187 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG------------------- 187 (336)
T ss_dssp ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS-------------------
T ss_pred EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC-------------------
Confidence 9999 999999998765 799999999999999999999999999999999999996544
Q ss_pred cccCCCCCCEEEEecCCccccCCC--------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD--------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
..+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus 188 -------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 188 -------SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp -------CCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred -------CEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 13666666666543321 123589999999999999999999999999999999999999998765
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+... +.+ ....++.+++++.+||.+||
T Consensus 261 ~~~~~~~i~~~--~~~--------------------------------------------~~~~~~~~s~~~~~li~~~L 294 (336)
T 4g3f_A 261 RGPLCLKIASE--PPP--------------------------------------------IREIPPSCAPLTAQAIQEGL 294 (336)
T ss_dssp CSCCHHHHHHS--CCG--------------------------------------------GGGSCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHcC--CCC--------------------------------------------chhcCccCCHHHHHHHHHHc
Confidence 54433332211 000 01234567889999999999
Q ss_pred ccCCCCCCCHHHH-------------hcCCCCCCCC
Q 013973 408 RYDPTDRLTAREA-------------LRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~el-------------l~hp~f~~~~ 430 (433)
++||++|||+.|+ |+|||+++-.
T Consensus 295 ~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 295 RKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred cCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 9999999999997 6899998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=449.90 Aligned_cols=321 Identities=23% Similarity=0.357 Sum_probs=222.2
Q ss_pred eecCcEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++.++||+|+||+||+|+++ .+++.||||.+.... ......+|+++|+.+. +|+||++++++|++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~----~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAG----GQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTC----SBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhc----CCCCCceEEEEEEEC
Confidence 35678999999999999999999875 467899999986533 3455778999888773 468899999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeecc-CccccCCCcCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLH 248 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~-~~~~i~dfg~~~~ 248 (433)
+++||||||+ |++|.+++. .+++.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|..
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999 899999983 59999999999999999999999999999999999999876 7888888888865
Q ss_pred CCCCCcccccC-C-CCCCEEEEecCCcc--ccCCCCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 249 TPKDSSYFKRM-P-KSSAIKVIDFGSTT--YERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 249 ~~~~~~~~~~~-~-~~~~~kl~Dfg~a~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
........... . ........+-.... .........+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43321110000 0 00000000000000 001112345899999999999876 4899999999999999999999999
Q ss_pred C-CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhcc-----ch------hHHHHHhhh
Q 013973 324 Q-THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK-----LP------RLQNLIMQH 391 (433)
Q Consensus 324 ~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~------~~~~~~~~~ 391 (433)
. +.++.+++..|...+|..+....... ......... ..|... ......... .+ .........
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~--~~~~~~~~~--~~p~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKT--FGKSILCSK--EVPAQD--LRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHH--TTEEEEESS--CCCCCC--HHHHHHHHC----------------------
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhh--ccccccccc--cCcchh--hhHHHHhhccccccccccccccccccccccc
Confidence 4 56677889999998886433221111 000000000 011000 000000000 00 000111233
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+...+++++|||.+||++||++|+||+|+|+||||++-.
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 567789999999999999999999999999999999865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=432.07 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=193.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--- 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--- 171 (433)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+++++ +||||++++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEecCccc
Confidence 5699999999999999999999999999999998632 33456678899999888 7899999999986543
Q ss_pred ---------eEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcccc
Q 013973 172 ---------HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 172 ---------~~~lV~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i 240 (433)
++||||||| ||+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 479999999 9999999987542 22456678999999999999999999999999999999987777777
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
+|||+|.....+....+ .... ..........+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 160 ~DFGla~~~~~~~~~~~--------~~~~----~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQT--------VLTP----MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp CCCCCC--------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred ccCccceecCCCccccc--------cccc----cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 77776654432211000 0000 000001133589999999999999999999999999999999996
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 321 ALFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
||.+. .+....+.... +..|+. +...++.+
T Consensus 226 -Pf~~~--~~~~~~~~~~~~~~~p~~----------------------------------------------~~~~~~~~ 256 (299)
T 4g31_A 226 -PFSTQ--MERVRTLTDVRNLKFPPL----------------------------------------------FTQKYPCE 256 (299)
T ss_dssp -CCSSH--HHHHHHHHHHHTTCCCHH----------------------------------------------HHHHCHHH
T ss_pred -CCCCc--cHHHHHHHHHhcCCCCCC----------------------------------------------CcccCHHH
Confidence 88642 22222222211 111111 11224567
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||.+||++||++|||+.|+|+||||++.+
T Consensus 257 ~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 257 YVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 8899999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=465.69 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=206.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........|..++..+.. .+||||++++++|++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~--~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh--CCCCCEeEEEEEEEECC
Confidence 467999999999999999999999999999999997432 122334455555554432 37899999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+||||||| ||+|.++|.+.+ .|++..++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~--------------- 328 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH--------------- 328 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---------------
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC---------------
Confidence 999999999 999999998865 79999999999999999999999999999999999999544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC-CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
+.+||+|||+|+..... ..+.+||+.|||||++.. ..|+.++|||||||++|||++|.+||.+.+.
T Consensus 329 ------------G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 329 ------------GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp ------------SCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred ------------CCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 45666666666543332 345699999999999974 6799999999999999999999999976432
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+........ ..... .++..+++++++||.+||+
T Consensus 397 ~~~~~i~~~i--------------------~~~~~--------------------------~~p~~~S~~a~dLI~~lL~ 430 (689)
T 3v5w_A 397 KDKHEIDRMT--------------------LTMAV--------------------------ELPDSFSPELRSLLEGLLQ 430 (689)
T ss_dssp CCHHHHHHHH--------------------HHCCC--------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhh--------------------cCCCC--------------------------CCCccCCHHHHHHHHHHcc
Confidence 2211111110 01111 1234678899999999999
Q ss_pred cCCCCCCC-----HHHHhcCCCCCCC
Q 013973 409 YDPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~t-----a~ell~hp~f~~~ 429 (433)
+||.+|++ ++||++||||++-
T Consensus 431 ~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 431 RDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp SCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred CCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999998 8999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-57 Score=465.17 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=223.5
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.+.++|++++.||+|+||+||+|+++.+|+.||+|++... ....+.+.+|+.+|+.+ +||||++++++|++.+.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-----RHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-----CCTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCE
Confidence 3457899999999999999999999999999999998743 33456678899999998 67999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||| ||+|.++|.... ..|++.+++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~----------------- 290 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT----------------- 290 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-----------------
T ss_pred EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-----------------
Confidence 99999999 999999997543 37999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
+..+.+||+|||+++...... ...+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 291 --------~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~ 362 (573)
T 3uto_A 291 --------KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362 (573)
T ss_dssp --------SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred --------CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 234678888888887665443 3468999999999999999999999999999999999999999998887
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+......++. ..+..++.++++||.+||++
T Consensus 363 ~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~dli~~~L~~ 397 (573)
T 3uto_A 363 ETLRNVKSCDWNMDD---------------------------------------------SAFSGISEDGKDFIRKLLLA 397 (573)
T ss_dssp HHHHHHHTTCCCCCS---------------------------------------------GGGTTSCHHHHHHHHTTSCS
T ss_pred HHHHHHHhCCCCCCc---------------------------------------------ccccCCCHHHHHHHHHHccC
Confidence 776655432222111 11245688999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~~ 430 (433)
||.+|||+.|+|+||||+..+
T Consensus 398 dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 398 DPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp SGGGSCCHHHHHHSTTTSCCC
T ss_pred ChhHCcCHHHHhcCcCcCCCC
Confidence 999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=425.32 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=202.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|.+.++||+|+||+||+|++. .++..||||+++.. ....+.+.+|+++++++ +||||+++++++.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVCVE 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-----CCCCCccEEEEEee
Confidence 367999999999999999999875 46789999999743 34456788999999988 78999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNN-----------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
.+.+||||||| +|+|.++|+..+ ...+++.++..|+.||+.||+|||+++||||||||+|||++++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-- 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-- 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG--
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC--
Confidence 99999999999 999999998642 3469999999999999999999999999999999999999554
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~ 312 (433)
+.+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||+
T Consensus 165 -------------------------~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvv 219 (299)
T 4asz_A 165 -------------------------LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 219 (299)
T ss_dssp -------------------------GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred -------------------------CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHH
Confidence 456666666665332221 23479999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 313 LVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 313 l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+|||+| |+.||.+.+..+....+... . .. ..
T Consensus 220 l~Ellt~G~~Pf~~~~~~~~~~~i~~~--~--------------------~~--------------------------~~ 251 (299)
T 4asz_A 220 LWEIFTYGKQPWYQLSNNEVIECITQG--R--------------------VL--------------------------QR 251 (299)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHHHHHHT--C--------------------CC--------------------------CC
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcC--C--------------------CC--------------------------CC
Confidence 999999 89999988776655543321 0 00 12
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHh
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREAL 421 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell 421 (433)
+..++.++.+||.+||+.||++|||+.||+
T Consensus 252 p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 252 PRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 345678999999999999999999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-56 Score=427.17 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=200.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|.+.++||+|+||+||+|+.+ .+++.||||+++.. ....+.+.+|+++++++ .|||||++++++.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-----QHQHIVRFFGVCTE 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEE
Confidence 367999999999999999999865 46889999999743 34556788999999988 78999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeecc
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNN-------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 235 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~ 235 (433)
.+.+||||||| +|+|.++|+... ..++++.++..|+.||+.||+|||+++||||||||+|||++++
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 99999999999 999999998643 1369999999999999999999999999999999999999665
Q ss_pred CccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHH
Q 013973 236 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 310 (433)
Q Consensus 236 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 310 (433)
+.+ ||+|||+++..... ....+||+.|||||++.+..|+.++||||||
T Consensus 195 ~~~---------------------------Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~G 247 (329)
T 4aoj_A 195 LVV---------------------------KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247 (329)
T ss_dssp TEE---------------------------EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHH
T ss_pred CcE---------------------------EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchH
Confidence 554 55555554432211 1234799999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 311 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 311 v~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
|++|||+| |+.||.+.+..+.+..+.... .+.
T Consensus 248 vvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~----------------------~~~------------------------- 280 (329)
T 4aoj_A 248 VVLWEIFTYGKQPWYQLSNTEAIDCITQGR----------------------ELE------------------------- 280 (329)
T ss_dssp HHHHHHHTTSCCTTCSSCHHHHHHHHHHTC----------------------CCC-------------------------
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------------------CCC-------------------------
Confidence 99999999 899999887766554433210 011
Q ss_pred hhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.+..+++++.+||.+||+.||++|||+.||+++
T Consensus 281 -~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 281 -RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp -CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred -CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 234567899999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-56 Score=422.19 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=196.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.+++++.++||+|+||+||+|+++. .||||+++. .....+.+.+|+.+++++ +||||+++++++.. +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-----RHVNILLFMGYMTK-DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS-SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEC-Ce
Confidence 4678999999999999999998653 499999863 234456788899999988 78999999998754 56
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||| ||+|.++|.... ..+++..+..|+.||+.||+|||+++||||||||+||||++++.+|
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~K------------ 172 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVK------------ 172 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEE------------
T ss_pred EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEE------------
Confidence 89999999 999999998654 4799999999999999999999999999999999999997655555
Q ss_pred CCcccccCCCCCCEEEEecCCccccCC-----CCCceeecCcccchhhhhCC---CCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
|+|||+|+.... .....+||+.|||||++.+. .|+.++|||||||++|||+||+.||
T Consensus 173 ---------------i~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 173 ---------------IGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp ---------------ECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ---------------EeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 555555443221 11335899999999999753 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+....+..+.......| . ....+..++.++.+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~p-----------------------~--------------------~~~~~~~~~~~l~~li 274 (307)
T 3omv_A 238 SHINNRDQIIFMVGRGYASP-----------------------D--------------------LSKLYKNCPKAMKRLV 274 (307)
T ss_dssp TTCCCHHHHHHHHHTTCCCC-----------------------C--------------------STTSCTTSCHHHHHHH
T ss_pred CCCChHHHHHHHHhcCCCCC-----------------------C--------------------cccccccchHHHHHHH
Confidence 88766554433222111100 0 0112346778999999
Q ss_pred HhccccCCCCCCCHHHH------hcCCCCC
Q 013973 404 QGLLRYDPTDRLTAREA------LRHPFFT 427 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~el------l~hp~f~ 427 (433)
.+||+.||++|||+.|| |+|++.+
T Consensus 275 ~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 275 ADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp HHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 99999999999999865 6777754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-56 Score=422.63 Aligned_cols=248 Identities=20% Similarity=0.246 Sum_probs=202.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++++++++||+|+||+||+|... .+++.||||+++.. ....+.+.+|+.+++++ .||||+++++++.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-----QHPNVVCLLGVVT 99 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-----CCCCCCCcceEEE
Confidence 456899999999999999999863 46789999999642 23456788999999998 7899999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEee
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 233 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~ 233 (433)
+.+.+||||||| +|+|.++|.... ...+++..+..|+.||+.||+|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999 999999997532 13589999999999999999999999999999999999996
Q ss_pred ccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHH
Q 013973 234 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWS 308 (433)
Q Consensus 234 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 308 (433)
+++ .+||+|||+++..... ....+||+.|||||++.+..|+.++||||
T Consensus 180 ~~~---------------------------~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwS 232 (308)
T 4gt4_A 180 DKL---------------------------NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 232 (308)
T ss_dssp GGG---------------------------CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred CCC---------------------------CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhh
Confidence 555 4555555555432211 13357999999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHH
Q 013973 309 VGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387 (433)
Q Consensus 309 lGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
|||++|||+| |..||.+.+..+....+... . ...
T Consensus 233 fGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~--~--------------------~~~----------------------- 267 (308)
T 4gt4_A 233 YGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR--Q--------------------VLP----------------------- 267 (308)
T ss_dssp HHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT--C--------------------CCC-----------------------
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C--------------------CCC-----------------------
Confidence 9999999998 89999988776655443211 0 011
Q ss_pred HhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 388 ~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.++.++.++.+|+.+||+.||++|||+.||+++
T Consensus 268 ---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 268 ---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 234667889999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-54 Score=419.90 Aligned_cols=339 Identities=39% Similarity=0.683 Sum_probs=264.8
Q ss_pred CCCCCCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCce
Q 013973 81 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 160 (433)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i 160 (433)
++....+.+..+..+.++|+++++||+|+||.||+|++..+++.||||+++...........|+.+++.+.+....|+||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 33445667788889999999999999999999999999999999999999876666777788999999997666678999
Q ss_pred EEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcccc
Q 013973 161 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 161 ~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i 240 (433)
+++++++...+.+|+||||++++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.....+-
T Consensus 99 v~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred ecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 99999999999999999999999999999876667999999999999999999999999999999999999964321000
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
. .+.... .............+.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 179 ~-~~~~~~-~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 179 L-ITVRRV-TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp E-EEEECT-TTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred c-cchhcc-cccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 0 000000 00000000002367899999999987666666678999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhh-hhhcc--CcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRR--GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
.||...+..+.+..+....++.|..+......... .+... ....||.............. .........++
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~------~~~~~~~~~~~ 330 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK------CLPLYKIIKHE 330 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHT------CCCHHHHCCCH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhh------cccccccchHH
Confidence 99999999999999999999999888776543322 22221 23345554443333222111 11112224457
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
.+.+||.+||+.||++|||+.|+|+||||+
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 899999999999999999999999999996
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=421.00 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=200.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCC-----CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
-.++|++.+.||+|+||+||+|.+..+ ++.||||+++.. ....+.+..|+.+|.++. +|||||++++++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~----hhpnIV~l~g~~ 137 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGAC 137 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEE
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC----CCCcEEEEEEEE
Confidence 357899999999999999999987654 468999999743 334566888999999993 347899999988
Q ss_pred ec-CCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 168 DY-RNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 168 ~~-~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
.. .+.+||||||| +|+|.++|+... ...+++..+..|+.||+.||+|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 65 56799999999 999999997632 235899999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
+++++. +||+|||+|+...... ...+||+.|||||++.+..|+.++||
T Consensus 218 l~~~~~---------------------------vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV 270 (353)
T 4ase_A 218 LSEKNV---------------------------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270 (353)
T ss_dssp ECGGGC---------------------------EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred eCCCCC---------------------------EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccE
Confidence 966555 5555555554332221 23579999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|||||++|||+| |..||.+.+..+.+..+... |. .+
T Consensus 271 wS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~-g~--------------------~~---------------------- 307 (353)
T 4ase_A 271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GT--------------------RM---------------------- 307 (353)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-TC--------------------CC----------------------
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc-CC--------------------CC----------------------
Confidence 999999999998 99999876543332221111 00 01
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..++.+++++.+||.+||+.||++|||+.||++|
T Consensus 308 ----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 308 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1234567899999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=424.14 Aligned_cols=321 Identities=35% Similarity=0.612 Sum_probs=254.3
Q ss_pred CCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcC-CCCCceEEe
Q 013973 85 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQI 163 (433)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~ 163 (433)
+.+.....+.+..+|++++.||+|+||.||+|.+..+++.||||+++...........|+.+++.+.+.. .+|+||+.+
T Consensus 85 ~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 85 GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp SCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred CCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 3344445667788999999999999999999999999999999999876666777888999999997653 367899999
Q ss_pred cceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 164 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 164 ~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
++.+...+++|+||||++++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 165 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~------- 237 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG------- 237 (429)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-------
T ss_pred EeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-------
Confidence 9999999999999999988999999987666799999999999999999999999999999999999995432
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
...+||+|||++..........+||+.|+|||++.+..|+.++|||||||++|||++|.+||
T Consensus 238 ------------------~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 238 ------------------RSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp ------------------SCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ------------------CcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence 12388899998877666666678999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccch-hh---------HhhhccchhHHHHHhhhcC
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR-ES---------IKSVMKLPRLQNLIMQHVD 393 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~~ 393 (433)
.+.+..+.+..+...++..+..++.........+...+...+....... .. .......+....+......
T Consensus 300 ~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 379 (429)
T 3kvw_A 300 PGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379 (429)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTT
T ss_pred CCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccc
Confidence 9999999999999999999998877655443332222211110000000 00 0000000111122222334
Q ss_pred CchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 394 ~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
..++++.+||.+||+.||++|||++|+|+||||++..
T Consensus 380 ~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp CCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred cchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 5678899999999999999999999999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=412.55 Aligned_cols=338 Identities=30% Similarity=0.549 Sum_probs=254.1
Q ss_pred CCCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCC---CCCce
Q 013973 84 DGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---GGNRC 160 (433)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~---~~~~i 160 (433)
.+.+.+..++.+.++|++++.||+|+||+||+|++..+++.||||+++......+.+..|+.+++.+.+... +|++|
T Consensus 24 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 24 GGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp --CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred CCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 345677888889999999999999999999999999999999999998766667778899999999986542 36779
Q ss_pred EEecceee----cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeecc
Q 013973 161 VQIRNWFD----YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSS 235 (433)
Q Consensus 161 ~~~~~~~~----~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~ 235 (433)
+++++.+. ....+|+||||++++|.+++.......+++..++.++.||+.||.|||++ |||||||||+|||++.+
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 99999987 56789999999999999988876656799999999999999999999998 99999999999999876
Q ss_pred CccccCCCcCCCC------CCCC----------Ccc------cccCCCCCCEEEEecCCccccCCCCCceeecCcccchh
Q 013973 236 EYIKVPDYKSSLH------TPKD----------SSY------FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPE 293 (433)
Q Consensus 236 ~~~~i~dfg~~~~------~~~~----------~~~------~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE 293 (433)
+.....+++.... .+.. ... .........+||+|||.+..........+||+.|+|||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHH
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCCh
Confidence 5322111110000 0000 000 00001234799999999987766666678999999999
Q ss_pred hhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCC
Q 013973 294 VILGLGWTYPCDIWSVGCILVELCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 367 (433)
Q Consensus 294 ~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 367 (433)
++.+..++.++|||||||++|||++|..||...+ ..+.+..+...++..|..++.........+...+.+..-.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999998654 5677888899999999887665443333322222221111
Q ss_pred CccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 368 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
........ .............+.++.+||.+||+.||++|||++|+|+||||++
T Consensus 344 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 344 KLKPWGLF-------EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCHH-------HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccCCcchh-------HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 11000000 0000011122345678999999999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=403.07 Aligned_cols=336 Identities=45% Similarity=0.847 Sum_probs=266.2
Q ss_pred CCCCCCceeecCceecCcEEEEeeeeccccEEEEEEEECCCC-eEEEEEEeecchhhHHHHHHHHHHHHHHHhcCC-CCC
Q 013973 81 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGN 158 (433)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~-~~~ 158 (433)
++..+.+....++.+.++|++++.||+|+||.||+|.+..++ +.||+|+++......+.+..|+.+++.+.+... .+.
T Consensus 3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCce
Confidence 455677888889999999999999999999999999998776 789999998766667778889999999987543 445
Q ss_pred ceEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcc
Q 013973 159 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 238 (433)
Q Consensus 159 ~i~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~ 238 (433)
+++.+.+++...+.+|+||||++++|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++..+..
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred eEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 58889999999999999999999999999887765679999999999999999999999999999999999999765543
Q ss_pred ccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh
Q 013973 239 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 239 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 318 (433)
.+.+..... ....+.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 163 ~~~~~~~~~--------~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 163 TLYNEHKSC--------EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp EEECCC-CC--------CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccc--------cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 333221111 011145678999999999876666666789999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||...+..+.+..+....++.|..+....... .+...+...|+............+.... .........+.+
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 309 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ--KYFYKGGLVWDENSSDGRYVKENCKPLK---SYMLQDSLEHVQ 309 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCG--GGEETTEECCCTTSHHHHHHHHHCCCGG---GGCSCCSHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccch--hhhcccccccccccchhccccccCCccc---ccccccchhHHH
Confidence 99999999999999999999999999887765332 2333444445443322211111111000 000111233568
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+.+||.+||+.||++|||+.|+|+||||++.
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 9999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=400.53 Aligned_cols=331 Identities=46% Similarity=0.833 Sum_probs=260.6
Q ss_pred ceeecCceecCcEEEEeeeeccccEEEEEEEE-CCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcC-CCCCceEEec
Q 013973 87 YMFALGENLTSRYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIR 164 (433)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~-~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~~ 164 (433)
.....++.+.++|++++.||+|+||.||+|.+ ..+++.||||+++......+....|+.+++.+.+.. ..++++++++
T Consensus 4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 34556778889999999999999999999998 568899999999876666777889999999998753 3456799999
Q ss_pred ceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 165 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
+++...+.+|+||||++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++..+.....+.+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 84 EWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred cccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999999999999999988766679999999999999999999999999999999999999765432221111
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
... ......++.+||+|||.+..........+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 164 ~~~--------~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKR--------DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --C--------EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccc--------ccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 000 000012567999999999876666666789999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
..+..+....+....++.|..+...... ..+.......|+................ .......+..+.++.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~ 310 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRACKPL---KEFMLSQDVEHERLFDLIQ 310 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHHHCCCG---GGGCSCCSHHHHHHHHHHH
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccc--hhHHhhccccccccccccchhhhcCcch---hhhcccchhhHHHHHHHHH
Confidence 9999999999999999999988776543 2333344455554332221111111000 0001112344678999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||+.||.+|||+.|+|+||||+...
T Consensus 311 ~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 311 KMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHhCcCcccccCHHHHhcCHHHHHHh
Confidence 99999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=408.68 Aligned_cols=319 Identities=36% Similarity=0.682 Sum_probs=247.4
Q ss_pred CCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcC-CCCCceEEe
Q 013973 85 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQI 163 (433)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~ 163 (433)
..+.+..++.+.++|++.+.||+|+||+||+|.+..+++.||||+++...........|+.+++.+.++. ..+++++.+
T Consensus 42 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 42 YDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp SCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred CcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 3456777888999999999999999999999999999999999999866666677788999999987543 234569999
Q ss_pred cceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEeeccCccccC
Q 013973 164 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 164 ~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
++.+...+.+|+||||++++|.+++.......+++..++.++.||+.||.||| +.|||||||||+|||++.
T Consensus 122 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~------- 194 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN------- 194 (382)
T ss_dssp EEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-------
T ss_pred eeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-------
Confidence 99999999999999999889999998876567999999999999999999999 579999999999999953
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
+.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 195 ------------------~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 256 (382)
T 2vx3_A 195 ------------------PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256 (382)
T ss_dssp ------------------TTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------CCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 23457899999988776665566789999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhcc---CcccCCCCc--------cchhhHhhhccc----hhHH-
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR---GRLDWPEGA--------ASRESIKSVMKL----PRLQ- 385 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~~----~~~~- 385 (433)
||.+.+..+.+..+...++..|..++...... ..++.. +.+...... .....+...... +...
T Consensus 257 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 335 (382)
T 2vx3_A 257 LFSGANEVDQMNKIVEVLGIPPAHILDQAPKA-RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335 (382)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH-HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTT
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH-HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccc
Confidence 99999999999999999999988776543322 122211 111000000 000000000000 0000
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
..........+.++.+||.+||+.||++|||++|+|+||||++.
T Consensus 336 ~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 00000000122478999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=406.58 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=220.3
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.+.++|++.+.||+|+||.||+|.++.+|+.||+|+++.... ..+.+..|+.+++.+ .||||++++++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~ 83 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-----LHPNIITLHDV 83 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-----CCTTBCCEEEE
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-----CCcCCCcEEEE
Confidence 456789999999999999999999999999999999974321 245678899999887 67999999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
+.+.+.+|+||||+ |++|.+++...+ .+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~--------- 152 (361)
T 2yab_A 84 YENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN--------- 152 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT---------
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC---------
Confidence 99999999999999 999999997654 799999999999999999999999999999999999996433
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
.....+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|+|++|..||
T Consensus 153 --------------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 153 --------------IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp --------------SSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred --------------CCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 112368888888887554332 3458999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+..+.+..+.......+.. .+...+.++++||
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li 253 (361)
T 2yab_A 219 LGDTKQETLANITAVSYDFDEE---------------------------------------------FFSQTSELAKDFI 253 (361)
T ss_dssp CCSSHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTSCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCch---------------------------------------------hccCCCHHHHHHH
Confidence 9887776665544332222211 2345677899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+||+.||.+|||+.|+|+||||+..
T Consensus 254 ~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 254 RKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 99999999999999999999999853
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=399.25 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=213.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
..++|++++.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+++.+ .|+||+++++++...+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-----NHPNIVKLFEVIETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECC
Confidence 357799999999999999999999999999999999643 23345677899999888 6799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ +++|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~----------------- 148 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD----------------- 148 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-----------------
T ss_pred EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc-----------------
Confidence 999999999 899999998765 799999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.++.+||+|||++....... ...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+
T Consensus 149 ----------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 149 ----------ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp ----------TTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------CCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 45567777777775443322 335799999999999988875 79999999999999999999999877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+.. +.+.. +...++++.+||.+||
T Consensus 219 ~~~~~~~i~~-----------------------~~~~~--------------------------p~~~s~~~~~li~~~L 249 (328)
T 3fe3_A 219 LKELRERVLR-----------------------GKYRI--------------------------PFYMSTDCENLLKRFL 249 (328)
T ss_dssp HHHHHHHHHH-----------------------CCCCC--------------------------CTTSCHHHHHHHHHHC
T ss_pred HHHHHHHHHh-----------------------CCCCC--------------------------CCCCCHHHHHHHHHHC
Confidence 6655444322 11111 1245778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+.||.+|||++|+++||||+..
T Consensus 250 ~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 250 VLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp CSSTTTSCCHHHHTTCTTTTTT
T ss_pred CCChhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=403.10 Aligned_cols=190 Identities=23% Similarity=0.306 Sum_probs=152.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHH--HHHHHhcCCCCCceEEecceeecCC---
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV--LQQLAKHDKGGNRCVQIRNWFDYRN--- 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~--l~~l~~~~~~~~~i~~~~~~~~~~~--- 171 (433)
.+|.+.++||+|+||+||+|++ +|+.||||+++.... .....|.++ +..+ +||||+++++++...+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l-----~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVML-----RHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTC-----CCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcC-----CCCCCCcEEEEEEecCCCc
Confidence 5699999999999999999987 588999999975433 233334443 3333 7899999999987653
Q ss_pred -eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeeccCccccC
Q 013973 172 -HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 172 -~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
.+||||||| +|+|.++|+.. .+++..+..++.|++.||+|||++ +||||||||+|||++.+
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~------ 144 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN------ 144 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT------
T ss_pred eEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC------
Confidence 689999999 99999999875 599999999999999999999987 89999999999999544
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-------CceeecCcccchhhhhCC------CCCCcchhHH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL------GWTYPCDIWS 308 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DvwS 308 (433)
+.+||+|||+++...... ...+||+.|||||++.+. .|+.++||||
T Consensus 145 ---------------------~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS 203 (303)
T 3hmm_A 145 ---------------------GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203 (303)
T ss_dssp ---------------------SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred ---------------------CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhh
Confidence 456666666655332221 235799999999999865 3678999999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 013973 309 VGCILVELCTGEALFQT 325 (433)
Q Consensus 309 lGv~l~elltg~~Pf~~ 325 (433)
|||++|||+||.+||..
T Consensus 204 ~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 204 MGLVFWEIARRCSIGGI 220 (303)
T ss_dssp HHHHHHHHHHTBCBTTB
T ss_pred HHHHHHHHHHCCCCCCc
Confidence 99999999999888754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=416.32 Aligned_cols=300 Identities=26% Similarity=0.449 Sum_probs=230.3
Q ss_pred CceeecCc---eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCc
Q 013973 86 HYMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNR 159 (433)
Q Consensus 86 ~~~~~~~~---~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~ 159 (433)
.+.+..++ .+.++|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.+ .|+|
T Consensus 48 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpn 122 (464)
T 3ttj_A 48 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKN 122 (464)
T ss_dssp EEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-----CCTT
T ss_pred ceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-----CCCC
Confidence 44444444 4568999999999999999999999999999999999742 33455677899999888 6799
Q ss_pred eEEecceeecC------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEee
Q 013973 160 CVQIRNWFDYR------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 233 (433)
Q Consensus 160 i~~~~~~~~~~------~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~ 233 (433)
|+++++++... ..+||||||++++|.+.+.. .+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 123 Iv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp BCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 99999998654 56899999998888888753 499999999999999999999999999999999999995
Q ss_pred ccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHH
Q 013973 234 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311 (433)
Q Consensus 234 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 311 (433)
. ++.+||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||
T Consensus 199 ~---------------------------~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 251 (464)
T 3ttj_A 199 S---------------------------DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251 (464)
T ss_dssp T---------------------------TSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred C---------------------------CCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHH
Confidence 4 455677777766644332 23458999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|||++|++||.+.+..+++..+...+|..+++.+.........++..... +... . +....... +.......
T Consensus 252 il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~-~~~~--~---~~~~~~~~-~~~~~~~~ 324 (464)
T 3ttj_A 252 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK-YAGL--T---FPKLFPDS-LFPADSEH 324 (464)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCC-CCCC--C---HHHHSCGG-GSCCSSHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccc-cCCC--C---hHHhCccc-cccccccc
Confidence 9999999999999999999999999999999998887776666666543211 0000 0 00000000 00000000
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
....++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 325 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0112668999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=397.73 Aligned_cols=288 Identities=28% Similarity=0.503 Sum_probs=222.5
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch------hhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
+..+.++|++++.||+|+||+||+|++..+++.||||++.... ........|+.+++.+... .|+||+++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~niv~~~~ 81 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF--EHPNVVRLMD 81 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH--CCTTBCCEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc--CCCCeEEeee
Confidence 4456788999999999999999999999999999999986321 1234566788888877532 4689999999
Q ss_pred eeecCC-----eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcccc
Q 013973 166 WFDYRN-----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 166 ~~~~~~-----~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i 240 (433)
++.... .+++||||++++|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~------ 155 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS------ 155 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT------
T ss_pred eeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC------
Confidence 987654 689999999889999999876566999999999999999999999999999999999999954
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 318 (433)
++.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 156 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 214 (308)
T 3g33_A 156 ---------------------GGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214 (308)
T ss_dssp ---------------------TSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTT
T ss_pred ---------------------CCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHh
Confidence 4567777777765443322 33579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||.+.+..+....+....+..+...+....... ...++.. ...........++.+
T Consensus 215 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-------~~~~~~~---------------~~~~~~~~~~~~~~~ 272 (308)
T 3g33_A 215 RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP-------RGAFPPR---------------GPRPVQSVVPEMEES 272 (308)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSC-------GGGSCCC---------------CCCCHHHHSCSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcc-------ccccCCC---------------CCCcHHHhCccccHH
Confidence 999999999999988888888876653221100000 0000000 001112234567889
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 273 ~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 273 GAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 99999999999999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=416.11 Aligned_cols=310 Identities=26% Similarity=0.460 Sum_probs=217.7
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee---
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--- 168 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--- 168 (433)
+.++|++++.||+|+||+||+|+++.+++.||||++... ....+.+.+|+.+++.+ .|+||+++++++.
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-----NHDHVVKVLDIVIPKD 125 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-----CCCCCCceEEEEecCC
Confidence 457899999999999999999999999999999998642 23446677899999998 6799999999983
Q ss_pred --cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 169 --YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 169 --~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
....+|+||||++++|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus 126 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 126 VEKFDELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp TTTCCCEEEEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccCceEEEEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence 446899999999999999998654 7999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCcccc---cCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh-CCCCCCcchhHHHHHHHHHHHh----
Q 013973 247 LHTPKDSSYFK---RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCT---- 318 (433)
Q Consensus 247 ~~~~~~~~~~~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~ellt---- 318 (433)
........... .........+.+|+............+||+.|+|||++. +..|+.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 76543221100 001112334455554443333344568999999999874 5679999999999999999999
Q ss_pred -------CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHHHHhhhh-hhhhccCcccCCCCcc
Q 013973 319 -------GEALFQTHE--------------------NLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAA 370 (433)
Q Consensus 319 -------g~~Pf~~~~--------------------~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 370 (433)
|.++|.+.+ ..+++..+...+|..+.+.+..+.... ..++..- +...
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~----~~~~- 358 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF----PKRE- 358 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTS----CCCC-
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhc----CCCC-
Confidence 778886644 357788888999999887766543222 2222110 0000
Q ss_pred chhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 371 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.......++..++++.+||.+||+.||++|||++|+|+||||++-+
T Consensus 359 --------------~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 359 --------------GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp --------------CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred --------------CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 0001122345688999999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=395.34 Aligned_cols=286 Identities=29% Similarity=0.441 Sum_probs=224.7
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
++.+.++|++++.||+|+||+||+|.+. +++.||+|+++... .....+..|+.+++.+ .|+||+++++++.
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~ 89 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-----HHPNIVSLIDVIH 89 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-----CCCCEeeeeeEEc
Confidence 3456688999999999999999999986 48899999986432 2345677899999988 6789999999999
Q ss_pred cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 169 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 169 ~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
+.+.+++||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~-------------- 154 (311)
T 3niz_A 90 SERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS-------------- 154 (311)
T ss_dssp CSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--------------
T ss_pred cCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC--------------
Confidence 999999999999889999987654 46999999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 155 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 155 -------------DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp -------------TCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -------------CCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 456777777777644322 123478999999999987 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+....+.+..+...++..+...+............. +.... ........+.++.++.+||.
T Consensus 222 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~~~~~li~ 282 (311)
T 3niz_A 222 GVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT--FQVFE-----------------KKPWSSIIPGFCQEGIDLLS 282 (311)
T ss_dssp CSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC--CCCCC-----------------CCCHHHHSTTCCHHHHHHHH
T ss_pred CCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc--ccccc-----------------CCcHHHhCcccCHHHHHHHH
Confidence 988888888888888776654333322211110000 00000 00011223467789999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||+.||++|||++|+|+||||++..
T Consensus 283 ~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 283 NMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred HHcCCChhHCCCHHHHhcCcccccCC
Confidence 99999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=398.69 Aligned_cols=259 Identities=23% Similarity=0.402 Sum_probs=221.4
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.+++.+ .|+||+++++++.+.+.++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-----RHRNILHLHESFESMEELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-----CCTTBCCEEEEEEETTEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-----CCCCCCeEeEEEecCCEEE
Confidence 46789999999999999999999999999999999976555666778899999988 6799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ |++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~------------------- 137 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT------------------- 137 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-------------------
Confidence 999999 889999997643 46999999999999999999999999999999999999953
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 138 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 211 (321)
T 1tki_A 138 ------RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211 (321)
T ss_dssp ------SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ------CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 124678888888887654433 235799999999999998899999999999999999999999998877766
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+.......+.. .+..++.++.+||.+||+.||
T Consensus 212 ~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dp 246 (321)
T 1tki_A 212 IENIMNAEYTFDEE---------------------------------------------AFKEISIEAMDFVDRLLVKER 246 (321)
T ss_dssp HHHHHHTCCCCCHH---------------------------------------------HHTTSCHHHHHHHHTTSCSSG
T ss_pred HHHHHcCCCCCChh---------------------------------------------hhccCCHHHHHHHHHHcCCCh
Confidence 65544432222211 123567789999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
.+|||+.|+|+||||++.
T Consensus 247 ~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 247 KSRMTASEALQHPWLKQK 264 (321)
T ss_dssp GGSCCHHHHHHSHHHHSC
T ss_pred hHCcCHHHHhcChhhccC
Confidence 999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=404.29 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=207.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||+||+|+++.+++.||||++++.. ........|..++..+. +|++|+++++++.+.+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~----~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR----NHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc----CCCceeeEEEEEEeCC
Confidence 367999999999999999999999999999999997432 23345567888877663 5688999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ ||+|.+++.... .+++..++.|+.||+.||+|||++|||||||||+|||++.+
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~--------------- 160 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE--------------- 160 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------------
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC---------------
Confidence 999999999 899999998764 79999999999999999999999999999999999999554
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 161 ------------g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 161 ------------GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp ------------SCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------------CCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 4566666666553221 1234589999999999999899999999999999999999999999887
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+... ...+ +..++.++.+||.+||
T Consensus 229 ~~~~~~~i~~~-----------------------~~~~--------------------------p~~~~~~~~~li~~lL 259 (353)
T 3txo_A 229 EDDLFEAILND-----------------------EVVY--------------------------PTWLHEDATGILKSFM 259 (353)
T ss_dssp HHHHHHHHHHC-----------------------CCCC--------------------------CTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHcC-----------------------CCCC--------------------------CCCCCHHHHHHHHHHh
Confidence 77665554321 1111 2346778999999999
Q ss_pred ccCCCCCCCH------HHHhcCCCCCCC
Q 013973 408 RYDPTDRLTA------REALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta------~ell~hp~f~~~ 429 (433)
++||.+||++ .|+++||||++.
T Consensus 260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 260 TKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp CSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred hhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999998 899999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=397.91 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=209.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||+||+|+++.+++.||+|++++.. ........|+.+++.+ .|++|+++++.+.+.+.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-----CCCcCcceEEEEEeCCE
Confidence 67999999999999999999999999999999997432 2344567788888766 67999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------------- 141 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---------------- 141 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT----------------
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC----------------
Confidence 99999999 899999998764 79999999999999999999999999999999999999554
Q ss_pred CCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
+.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.
T Consensus 142 -----------g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 142 -----------GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp -----------SCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -----------CCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 4566666666543221 12346899999999999999999999999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+... ... ++..+++++.+||.+||+
T Consensus 211 ~~~~~~i~~~-----------------------~~~--------------------------~p~~~s~~~~~li~~lL~ 241 (337)
T 1o6l_A 211 ERLFELILME-----------------------EIR--------------------------FPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp HHHHHHHHHC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHcC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHhh
Confidence 5554433211 111 123567889999999999
Q ss_pred cCCCCCC-----CHHHHhcCCCCCCC
Q 013973 409 YDPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~-----ta~ell~hp~f~~~ 429 (433)
.||++|| ++.|+++||||+..
T Consensus 242 ~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999 89999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=395.58 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=213.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|+++.+|+.||+|++++.. ...+....|+.+++.+ .|+||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-----CCCCCceEeEEEEeCC
Confidence 367999999999999999999999999999999997432 2234556788887776 6799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----------------- 140 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----------------- 140 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC-----------------
T ss_pred EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc-----------------
Confidence 999999999 899999998764 799999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++.+||+|||++..........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+
T Consensus 141 ----------~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 210 (318)
T 1fot_A 141 ----------KNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210 (318)
T ss_dssp ----------TTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ----------CCCCEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 4556777777777655544455689999999999999999999999999999999999999998877665
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+... ... ++..++.++.+||.+||+.|
T Consensus 211 ~~~~i~~~-----------------------~~~--------------------------~p~~~~~~~~~li~~lL~~d 241 (318)
T 1fot_A 211 TYEKILNA-----------------------ELR--------------------------FPPFFNEDVKDLLSRLITRD 241 (318)
T ss_dssp HHHHHHHC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHTCSC
T ss_pred HHHHHHhC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHhccC
Confidence 55443221 111 12356778999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q 013973 411 PTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~-----ta~ell~hp~f~~~ 429 (433)
|++|| +++|+++||||++.
T Consensus 242 p~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 242 LSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHcCCCcCCCHHHHhcCccccCC
Confidence 99999 89999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=401.28 Aligned_cols=281 Identities=27% Similarity=0.499 Sum_probs=225.5
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~- 170 (433)
+.++|++++.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+++.+ .|+||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----RHENVIGLLDVFTPDE 97 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CBTTBCCCSEEECSCS
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-----CCcCCCCceeeEecCC
Confidence 457899999999999999999999999999999998532 23455677899999988 578999999998765
Q ss_pred -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 171 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 171 -----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
..+|+||||++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~------------ 162 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN------------ 162 (367)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC------------
T ss_pred ccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc------------
Confidence 356999999999999999873 699999999999999999999999999999999999994
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.++.+||+|||+++.........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 163 ---------------~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 163 ---------------EDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp ---------------TTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------------CCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 4556777777777765554555689999999999987 679999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhh-hhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
+.+..+++..+....|..+.+....+.... ..++..- ...+. ..........++++.+||
T Consensus 228 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------------~~~~~~~~~~~~~~~~ll 288 (367)
T 1cm8_A 228 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL-PELEK------------------KDFASILTNASPLAVNLL 288 (367)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS-CCCCC------------------CCGGGTCTTCCHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhC-CCCCC------------------CCHHHHCCCCCHHHHHHH
Confidence 999999999999999999988776553222 1221110 00000 001112345678999999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+||+.||++|||+.|+|+||||++.
T Consensus 289 ~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 289 EKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHccCChhHCCCHHHHhcChHHHhh
Confidence 99999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=397.50 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=210.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++.+.||+|+||.||+|+++.+++.||||++++.. ........|..++..+. .|++|+++++++.+.+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~----~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW----EHPFLTHMFCTFQTKE 91 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT----TCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC----CCCCCCcEEEEEEeCC
Confidence 467999999999999999999999999999999997532 23445667888887662 5688999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ ||+|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||++.+|
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-------------- 155 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-------------- 155 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--------------
Confidence 999999999 899999998764 799999999999999999999999999999999999995544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 156 -------------~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 156 -------------HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp -------------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------------CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 566666665543221 2234689999999999999999999999999999999999999999877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+... ... .+..++.++.+||.+||
T Consensus 223 ~~~~~~~i~~~-----------------------~~~--------------------------~p~~~s~~~~~li~~lL 253 (345)
T 1xjd_A 223 EEELFHSIRMD-----------------------NPF--------------------------YPRWLEKEAKDLLVKLF 253 (345)
T ss_dssp HHHHHHHHHHC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHS
T ss_pred HHHHHHHHHhC-----------------------CCC--------------------------CCcccCHHHHHHHHHHh
Confidence 66655443221 111 12346778999999999
Q ss_pred ccCCCCCCCHH-HHhcCCCCCCC
Q 013973 408 RYDPTDRLTAR-EALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta~-ell~hp~f~~~ 429 (433)
+.||++||++. |+++||||+..
T Consensus 254 ~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 254 VREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTTC
T ss_pred cCCHhHcCCChHHHHcCccccCC
Confidence 99999999998 99999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=392.20 Aligned_cols=262 Identities=25% Similarity=0.458 Sum_probs=219.8
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.+.++|++.+.||+|+||.||+|.++.+++.||+|+++.... ..+.+..|+.+++.+ .|+||++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~ 82 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-----QHPNVITLHEV 82 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-----CCCCCCcEEEE
Confidence 455789999999999999999999999999999999864321 346678899999998 67999999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
+.....+++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~--------- 151 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN--------- 151 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS---------
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC---------
Confidence 99999999999999 899999997654 799999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
.....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 152 --------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 152 --------------VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp --------------SSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred --------------CCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 12336888888888654322 23457999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+....+.+..+.......+.. .+...+..+.+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li 252 (326)
T 2y0a_A 218 LGDTKQETLANVSAVNYEFEDE---------------------------------------------YFSNTSALAKDFI 252 (326)
T ss_dssp CCSSHHHHHHHHHHTCCCCCHH---------------------------------------------HHTTSCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCcCcc---------------------------------------------ccccCCHHHHHHH
Confidence 9877766655544322222211 1235677899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||+.||++|||+.|+|+||||+...
T Consensus 253 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 253 RRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHHccCChhhCCCHHHHhcCCCccCCc
Confidence 999999999999999999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=397.49 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=214.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|+++.+++.||+|+++... ...+....|+.+++.+ +|++|+++++++.+.+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEcCC
Confidence 467999999999999999999999999999999997432 2234566788888766 7799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ |++|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----------------- 175 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----------------- 175 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-----------------
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC-----------------
Confidence 999999999 899999998765 799999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+
T Consensus 176 ----------~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 245 (350)
T 1rdq_E 176 ----------QQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp ----------TTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ----------CCCCEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence 4556777777777665555556789999999999999999999999999999999999999999877666
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+.. +...+ +..++.++.+||.+||+.|
T Consensus 246 ~~~~i~~-----------------------~~~~~--------------------------p~~~~~~~~~li~~lL~~d 276 (350)
T 1rdq_E 246 IYEKIVS-----------------------GKVRF--------------------------PSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp HHHHHHH-----------------------CCCCC--------------------------CTTCCHHHHHHHHHHSCSC
T ss_pred HHHHHHc-----------------------CCCCC--------------------------CCCCCHHHHHHHHHHhhcC
Confidence 5544332 11111 2356778999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCCC
Q 013973 411 PTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~t-----a~ell~hp~f~~~ 429 (433)
|.+||+ ++|+++||||+..
T Consensus 277 p~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 277 LTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhccCCccCCHHHHHhCcCcCCC
Confidence 999998 9999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=386.63 Aligned_cols=280 Identities=28% Similarity=0.481 Sum_probs=220.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++++.||+|+||+||+|.++.+++.||+|+++.. ......+..|+.+++.+ .|+||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-----CCCCEeeEEeEEEeCCEE
Confidence 5799999999999999999999999999999999643 23345667888888877 678999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~------------------- 136 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR------------------- 136 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-------------------
T ss_pred EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-------------------
Confidence 9999999888888877643 47999999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCC-CCCCCh
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL-FQTHEN 328 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~P-f~~~~~ 328 (433)
++.+||+|||.+...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.
T Consensus 137 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~ 208 (292)
T 3o0g_A 137 --------NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp --------TSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred --------CCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH
Confidence 456677777776543322 23347899999999998766 89999999999999999987766 667777
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.+..+....+..+...+......... . ..+... ...........++.++.+||.+||+
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~ 268 (292)
T 3o0g_A 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDY----K--PYPMYP--------------ATTSLVNVVPKLNATGRDLLQNLLK 268 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTC----C--CCCCCC--------------TTCCCTTTSTTCCHHHHHHHHHHSC
T ss_pred HHHHHHHHHHhCCCChhhhhhhcccccc----c--cccccc--------------CCcchhhcccccChHHHHHHHHHhc
Confidence 7888888888887665433322211100 0 000000 0000112234577899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
.||++|||++|+|+||||++-
T Consensus 269 ~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 269 CNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp SSGGGSCCHHHHHTSGGGTTC
T ss_pred cChhhCCCHHHHhcCcccccC
Confidence 999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=404.13 Aligned_cols=314 Identities=25% Similarity=0.454 Sum_probs=220.2
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
..+.++|++++.||+|+||.||+|.++.+++.||||++... ........+|+.++..+. +|+||+++++++..
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS----GHENIVNLLNVLRA 80 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEEC
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc----CCCCCCeeeeEEec
Confidence 34568899999999999999999999999999999998532 334455677888888873 37889999999865
Q ss_pred C--CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 R--NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 ~--~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
. ..+|+||||++++|.+++... .+++..+..++.||+.||+|||+.|||||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 81 DNDRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp TTSSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 4 479999999988999999874 69999999999999999999999999999999999999887777777777765
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.................-....+. .........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFD---DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccc---cccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 432211100000000000000000 00011133589999999999987 67999999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhh-hhhcc-------CcccCCCCccchhhHhhhccchhHHHHH--hhhcCCch
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRR-------GRLDWPEGAASRESIKSVMKLPRLQNLI--MQHVDHSA 396 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 396 (433)
+..+++..+...++.++.+.+..+..... .++.. ....+.. ..+...... .......+
T Consensus 235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~ 302 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRD------------IFTKWKNLLLKINPKADCN 302 (388)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCC------------CHHHHHHHHHHHCTTCCCC
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHH------------hCcchhhhcccccccccCC
Confidence 99999999999999888766543321110 00000 0000000 001111111 11223678
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 303 ~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence 89999999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=386.70 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=211.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++++...+.+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-----CCCCCCeEeEEEEECCEEE
Confidence 467999999999999999999999999999999986432 3345677899998887 6799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~------------------- 151 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM------------------- 151 (297)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-------------------
T ss_pred EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC-------------------
Confidence 999999 99999999875 5999999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 152 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 223 (297)
T 3fxz_A 152 --------DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (297)
T ss_dssp --------TCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred --------CCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4567777777665443322 33579999999999999999999999999999999999999998877665
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.....+. + ..+..++..+.+||.+||+.|
T Consensus 224 ~~~~~~~~~~~~--------------------~--------------------------~~~~~~~~~~~~li~~~l~~d 257 (297)
T 3fxz_A 224 ALYLIATNGTPE--------------------L--------------------------QNPEKLSAIFRDFLNRCLEMD 257 (297)
T ss_dssp HHHHHHHHCSCC--------------------C--------------------------SCGGGSCHHHHHHHHHHSCSS
T ss_pred HHHHHHhCCCCC--------------------C--------------------------CCccccCHHHHHHHHHHccCC
Confidence 544432211110 0 012345678999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|++|||+.|+|+||||+..
T Consensus 258 p~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 258 VEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp TTTSCCHHHHTTCGGGGGC
T ss_pred hhHCcCHHHHhhChhhccc
Confidence 9999999999999999854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=399.70 Aligned_cols=264 Identities=24% Similarity=0.414 Sum_probs=219.0
Q ss_pred eecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 89 FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 89 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
......+.++|++.+.||+|+||.||+|.++.+++.||+|++... ....+.+..|+.+++.+ .|+||+++++
T Consensus 21 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~ 95 (362)
T 2bdw_A 21 MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHD 95 (362)
T ss_dssp ---CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred ecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEE
Confidence 334455677899999999999999999999999999999999743 23445677899999988 6799999999
Q ss_pred eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 166 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 166 ~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
++.+.+..|+||||+ |++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-------- 165 (362)
T 2bdw_A 96 SIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-------- 165 (362)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS--------
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC--------
Confidence 999999999999999 889999997654 799999999999999999999999999999999999996432
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
....+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|+|++|..|
T Consensus 166 ----------------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P 229 (362)
T 2bdw_A 166 ----------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229 (362)
T ss_dssp ----------------TTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------CCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 23468888888887654333 235899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+..+....+...... ++. ..++.++.++.+|
T Consensus 230 f~~~~~~~~~~~i~~~~~~-----------------------~~~----------------------~~~~~~~~~~~~l 264 (362)
T 2bdw_A 230 FWDEDQHRLYAQIKAGAYD-----------------------YPS----------------------PEWDTVTPEAKSL 264 (362)
T ss_dssp SCCSSHHHHHHHHHHTCCC-----------------------CCT----------------------TGGGGSCHHHHHH
T ss_pred CCCCCHHHHHHHHHhCCCC-----------------------CCc----------------------ccccCCCHHHHHH
Confidence 9887766655544322111 111 0123457789999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|.+||+.||++|||+.|+|+||||..
T Consensus 265 i~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=395.22 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=207.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|+++.+++.||||++++.. ...+....|..++..+ .+|++|+++++++++.+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP----GKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCT----TCCTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhc----CCCCEEeeEEEEEEcCC
Confidence 367999999999999999999999999999999997532 2234455666666544 36789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-------------- 158 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-------------- 158 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--------------
Confidence 999999999 899999998765 799999999999999999999999999999999999995544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 159 -------------~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 159 -------------HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp -------------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------------cEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 556666665543211 2234589999999999999999999999999999999999999999877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+... .+. ++..++.++.+||.+||
T Consensus 226 ~~~~~~~i~~~-----------------------~~~--------------------------~p~~~s~~~~~li~~lL 256 (353)
T 2i0e_A 226 EDELFQSIMEH-----------------------NVA--------------------------YPKSMSKEAVAICKGLM 256 (353)
T ss_dssp HHHHHHHHHHC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHh
Confidence 76655443321 111 12356778999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCCCCC
Q 013973 408 RYDPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~t-----a~ell~hp~f~~~ 429 (433)
+.||.+||+ +.|+++||||+..
T Consensus 257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 257 TKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp CSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred hcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999994 7999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=400.25 Aligned_cols=261 Identities=20% Similarity=0.366 Sum_probs=205.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||+||+|+++.+++.||+|++++.. ........|..++.++. +||+|+++++++.+.+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~----~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS----NHPFLVGLHSCFQTES 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT----TCTTBCCEEEEEECSS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC----CCCCcCeeEEEEEECC
Confidence 367999999999999999999999999999999997532 22234567888887763 5688999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ ||+|.+++...+ .+++..++.|+.||+.||+|||++|||||||||+|||++.+
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~--------------- 189 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE--------------- 189 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------------
T ss_pred EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC---------------
Confidence 999999999 899999998764 79999999999999999999999999999999999999544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+.+||+|||+++... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus 190 ------------g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 190 ------------GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp ------------SCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred ------------CCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 456666666665321 12234689999999999999999999999999999999999999997533
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.... ... ......+..+.+ ..+..++.++.+||.+||
T Consensus 258 ~~~~~~~-------~~~-------~~~~~~i~~~~~--------------------------~~p~~~s~~~~~li~~lL 297 (396)
T 4dc2_A 258 SSDNPDQ-------NTE-------DYLFQVILEKQI--------------------------RIPRSLSVKAASVLKSFL 297 (396)
T ss_dssp C-------------CCH-------HHHHHHHHHCCC--------------------------CCCTTSCHHHHHHHHHHT
T ss_pred cccccch-------hhH-------HHHHHHHhcccc--------------------------CCCCcCCHHHHHHHHHHh
Confidence 2110000 000 000000111111 123467889999999999
Q ss_pred ccCCCCCCCH------HHHhcCCCCCCC
Q 013973 408 RYDPTDRLTA------REALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta------~ell~hp~f~~~ 429 (433)
++||.+||++ +|+++||||++.
T Consensus 298 ~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 298 NKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999985 799999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=406.06 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=217.4
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++.... ...+.+..|+.+++.+ .||||+++++++.+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-----KHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-----CBTTBCCEEEEEECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCcCCCeEEEEEEEC
Confidence 45678999999999999999999999999999999986432 3445677899999988 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+..|+||||+ ||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++.+
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~-------------- 146 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK-------------- 146 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS--------------
T ss_pred CEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc--------------
Confidence 9999999999 899999998765 79999999999999999999999999999999999999642
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
..++.+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.
T Consensus 147 ----------~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 147 ----------LKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp ----------STTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ----------CCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 134678888888886554432 2357999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+....... +. ..++.+++++.+||.+|
T Consensus 217 ~~~~~~~~i~~~~~~~-----------------------~~----------------------~~~~~~s~~~~~li~~~ 251 (444)
T 3soa_A 217 DQHRLYQQIKAGAYDF-----------------------PS----------------------PEWDTVTPEAKDLINKM 251 (444)
T ss_dssp SHHHHHHHHHHTCCCC-----------------------CT----------------------TTTTTSCHHHHHHHHHH
T ss_pred cHHHHHHHHHhCCCCC-----------------------Cc----------------------cccccCCHHHHHHHHHH
Confidence 7766665543322211 11 11235678899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|+.||++|||+.|+|+||||+.
T Consensus 252 L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 252 LTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp SCSSTTTSCCHHHHHHSCTTHH
T ss_pred cCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999963
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=401.43 Aligned_cols=301 Identities=27% Similarity=0.424 Sum_probs=223.9
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~- 170 (433)
+.++|++++.||+|+||.||+|.++.+++.||||+++.. ....+.+.+|+.+++.+ .|+||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-----KSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-----CCCCcceEEEEEecCC
Confidence 457899999999999999999999999999999999642 23446677899999998 578999999998765
Q ss_pred ----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 ----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
..+|+||||++++|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 99 LLKFDELYIVLEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCcCCeEEEEEecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6799999999889999998654 7999999999999999999999999999999999999987777777777766
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCc-------cccCCCCCceeecCcccchhhhh-CCCCCCcchhHHHHHHHHHHHh
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGST-------TYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a-------~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~ellt 318 (433)
.......... ...++... ..........+||+.|+|||++. +..|+.++|||||||++|||++
T Consensus 177 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 177 RTINSEKDTN---------IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp EEC----------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred cccccccccc---------ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 5443211100 00000000 00001123458999999999874 5669999999999999999998
Q ss_pred -----------CCCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHHHHhhh-hhhhhccCcccCCCCc
Q 013973 319 -----------GEALFQTHE-----------------NLEHLAMMERVLGPLPQHMLKRVDRH-AEKYVRRGRLDWPEGA 369 (433)
Q Consensus 319 -----------g~~Pf~~~~-----------------~~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 369 (433)
|.++|.+.+ ..+++..+...+|..+.+.+..+... ...++.......+.
T Consensus 248 g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 325 (432)
T 3n9x_A 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPI-- 325 (432)
T ss_dssp TCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCC--
T ss_pred cccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCC--
Confidence 455555433 36788889999999988776654221 22222211110000
Q ss_pred cchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 370 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
......+..++++.+||.+||+.||++|||++|+|+||||++-+
T Consensus 326 -----------------~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 326 -----------------NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp -----------------CHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred -----------------CHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 01122346788999999999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=383.72 Aligned_cols=279 Identities=29% Similarity=0.469 Sum_probs=216.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++++.||+|+||.||+|.+ .+++.||+|++..... ....+.+|+.+++.+ .|+||+++++++...+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-----CCCCEeeeeeEEccCCeE
Confidence 5799999999999999999998 6788999999864322 235667888888877 678999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
++||||+.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-------------------- 134 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-------------------- 134 (288)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------------------
T ss_pred EEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc--------------------
Confidence 9999999889999998653 4699999999999999999999999999999999999994
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.++.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 135 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (288)
T 1ob3_A 135 -------REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (288)
T ss_dssp -------TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -------CCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4456777777776543322 1234789999999999764 5899999999999999999999999998888
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+...++..+...+........ +.. .+.... . .........++.++.+||.+||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~------------~-----~~~~~~~~~~~~~~~~li~~~L~~ 267 (288)
T 1ob3_A 208 DQLMRIFRILGTPNSKNWPNVTELPK-YDP--NFTVYE------------P-----LPWESFLKGLDESGIDLLSKMLKL 267 (288)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTT-CCT--TCCCCC------------C-----CCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHCCCChhhchhhhcccc-ccc--cccccc------------C-----ccHHHHhhhcCHHHHHHHHHHcCC
Confidence 88888888777665433222111100 000 000000 0 000112345788999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
||++|||++|+|+||||++.
T Consensus 268 dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 268 DPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTTSCCHHHHHTSGGGGC-
T ss_pred CcccCCCHHHHhcCcchhhc
Confidence 99999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=393.18 Aligned_cols=306 Identities=33% Similarity=0.554 Sum_probs=238.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCC------CCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~------~~~~i~~~~~~~~~ 169 (433)
.++|++++.||+|+||.||+|.+..+++.||||++............|+.+++++.+... .|+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 468999999999999999999999999999999998766667778899999999875421 26789999999876
Q ss_pred CC----eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCc
Q 013973 170 RN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 170 ~~----~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+ .+++|||+++++|.+++.......+++..+..++.||+.||+|||++ |||||||||+|||++.++.
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~------- 170 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS------- 170 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET-------
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC-------
Confidence 54 89999999999999999886656799999999999999999999998 9999999999999965431
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.+....+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 171 --------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 171 --------------PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp --------------TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred --------------CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 023346899999988766655556689999999999999999999999999999999999999998
Q ss_pred CCC------hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 325 THE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 325 ~~~------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
..+ ..+.+..+...++.+|..++.........+...+.+......... ............+...+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 309 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW-------PLEDVLTEKYKFSKDEAKE 309 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC-------CHHHHHHHTTCCCHHHHHH
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccccccc-------chhhhhhhcccCCcchHHH
Confidence 654 566788888999999988876554332222222211111000000 0000111111223456778
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+.+||.+||+.||++|||++|+|+||||++.
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 9999999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=390.75 Aligned_cols=286 Identities=29% Similarity=0.498 Sum_probs=211.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++++.||+|+||.||+|.++.+++.||+|+++... .....+.+|+.+++.+ .|+||+++++++...+.+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-----KHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-----CBTTBCCEEEEECCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-----CCCCcceEEEEEEECCeEE
Confidence 57999999999999999999999999999999987432 2335677899998887 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 175 IVFEKLGSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
+||||+.++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~---------------- 143 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK---------------- 143 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT----------------
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC----------------
Confidence 999999889999987542 135899999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.
T Consensus 144 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 144 -----------RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp -----------TCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----------CCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 455677777766543322 1234789999999999874 6899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+.+..+...++..+...+..+....... . ..+.. ....+. ..........++.++.+||.+|
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~--~~~~~~--------~~~~~~~~~~~~~~l~~li~~~ 277 (317)
T 2pmi_A 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYN-P----NIQQR--PPRDLR--------QVLQPHTKEPLDGNLMDFLHGL 277 (317)
T ss_dssp SHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC-T----TCCCC--CCCCSH--------HHHGGGCSSCCCHHHHHHHHHH
T ss_pred ChHHHHHHHHHHhCCCChhHhhhhhhhhhcc-c----ccccc--cchhHH--------HhhcccccccCCHHHHHHHHHH
Confidence 9999999988888887765544332211100 0 00000 000000 0111122346788999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|+.||++|||+.|+|+||||++-
T Consensus 278 L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 278 LQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp SCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCCCcccCCCHHHHhCChhhhcc
Confidence 99999999999999999999853
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=393.16 Aligned_cols=287 Identities=27% Similarity=0.462 Sum_probs=220.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++++.||+|+||+||+|.+..+++.||||+++.... ....+..|+.+++.+ .|+||+++++++.+.+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-----QHRNIIELKSVIHHNHR 107 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-----CCTTBCCEEEEEEETTE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-----CCCCcceEEEEEecCCE
Confidence 4679999999999999999999999999999999964322 234456788888877 67899999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+|+||||+.++|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++.++.
T Consensus 108 ~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~--------------- 170 (329)
T 3gbz_A 108 LHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA--------------- 170 (329)
T ss_dssp EEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC------------------
T ss_pred EEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC---------------
Confidence 99999999889999998765 6999999999999999999999999999999999999965432
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
+....+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.
T Consensus 171 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 171 -------SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp ---------CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -------CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 34456899999988654422 2335789999999999875 489999999999999999999999999998
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.+..+...++..+...+......... ...++.. .... ........++.++.+||.+||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-----------~~~~---~~~~~~~~~~~~~~~li~~~L~ 304 (329)
T 3gbz_A 244 IDQLFKIFEVLGLPDDTTWPGVTALPDW-----KQSFPKF-----------RGKT---LKRVLGALLDDEGLDLLTAMLE 304 (329)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTC-----CTTCCCC-----------CCCC---HHHHHGGGSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHHhCCCchhhhhhhhhhhhh-----hhhhhhh-----------cccc---HhhhcccccCHHHHHHHHHHcc
Confidence 8888888888776654332221110000 0000000 0000 1111223467889999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.||++|||+.|+|+||||++..
T Consensus 305 ~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 305 MDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp SSGGGSCCHHHHHTSGGGSSSC
T ss_pred CChhhCCCHHHHhCCcccCCCC
Confidence 9999999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=396.31 Aligned_cols=282 Identities=27% Similarity=0.487 Sum_probs=213.0
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.+ .|+||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEecC
Confidence 3467899999999999999999999999999999998632 23455677899999888 678999999988653
Q ss_pred ------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 171 ------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 171 ------~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
..+|+|||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----------- 166 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----------- 166 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-----------
T ss_pred CccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC-----------
Confidence 67899999999999999875 3699999999999999999999999999999999999994
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
.++.+||+|||+++.........+||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 167 ----------------~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 230 (367)
T 2fst_X 167 ----------------EDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230 (367)
T ss_dssp ----------------TTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ----------------CCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 4456777777777655444455689999999999987 67999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhh-hhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
.+.+..+++..+.+.+|.++.+.+..+.... ..++..- ...+.. .........++++.+|
T Consensus 231 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~dL 291 (367)
T 2fst_X 231 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL-TQMPKM------------------NFANVFIGANPLAVDL 291 (367)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTS-CCCCCC------------------CHHHHTTTCCHHHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhcc-CCCCCC------------------CHHHHCCCCCHHHHHH
Confidence 9999999999999999998887766543221 1222110 000000 0111234567889999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|.+||+.||.+|||+.|+|+||||++.
T Consensus 292 l~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 292 LEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=392.20 Aligned_cols=282 Identities=27% Similarity=0.472 Sum_probs=218.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhH--HHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~--~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++|++++.||+|+||.||+|.+..+++.||+|+++...... ..+..|+.+++.+ .|+||+++++++...+.++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-----CCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-----CCCCCCeeeeEEeeCCEEE
Confidence 56999999999999999999999999999999986432211 1234588888777 6789999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||++++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-------------------- 135 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE-------------------- 135 (324)
T ss_dssp EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT--------------------
T ss_pred EEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC--------------------
Confidence 999999889999998764 46999999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+
T Consensus 136 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 136 -------RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp -------TCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -------CCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4456777777665433221 23478999999999987 568999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+...++..+...+........... +.++.. ...........++.++.+||.+||+.|
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~L~~d 269 (324)
T 3mtl_A 209 QLHFIFRILGTPTEETWPGILSNEEFKT----YNYPKY---------------RAEALLSHAPRLDSDGADLLTKLLQFE 269 (324)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCHHHHH----TCCCCC---------------CCCCHHHHCTTSCHHHHHHHHHHSCSS
T ss_pred HHHHHHHHhCCCChHhchhhhcchhhcc----cccccc---------------cchhhhhhcCCCCHHHHHHHHHHcCcC
Confidence 9999999888876654332211110000 000000 001112234567889999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~ 430 (433)
|++|||++|+|+||||++..
T Consensus 270 P~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 270 GRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp GGGSCCHHHHTTSGGGGGGC
T ss_pred cccCCCHHHHhcChhhhhcc
Confidence 99999999999999997654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=389.15 Aligned_cols=261 Identities=21% Similarity=0.369 Sum_probs=205.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|+++.+++.||+|++++.. ........|..+++++. +|++|+++++++.+.+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~----~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS----NHPFLVGLHSCFQTES 83 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC----CCCccCeEEEEEEeCC
Confidence 367999999999999999999999999999999997432 23345667888877652 5688999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ |++|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~--------------- 146 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE--------------- 146 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---------------
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---------------
Confidence 999999999 899999998764 79999999999999999999999999999999999999544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus 147 ------------g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 147 ------------GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp ------------SCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred ------------CCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 4566666666653211 1234589999999999999999999999999999999999999997532
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
....... .........+..+... .+..++.++.+||.+||
T Consensus 215 ~~~~~~~--------------~~~~~~~~~i~~~~~~--------------------------~p~~~s~~~~~li~~lL 254 (345)
T 3a8x_A 215 SSDNPDQ--------------NTEDYLFQVILEKQIR--------------------------IPRSLSVKAASVLKSFL 254 (345)
T ss_dssp C---------------------CHHHHHHHHHHCCCC--------------------------CCTTSCHHHHHHHHHHT
T ss_pred ccccccc--------------ccHHHHHHHHHcCCCC--------------------------CCCCCCHHHHHHHHHHh
Confidence 1110000 0000000001111111 23356788999999999
Q ss_pred ccCCCCCCCH------HHHhcCCCCCCC
Q 013973 408 RYDPTDRLTA------REALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta------~ell~hp~f~~~ 429 (433)
+.||.+||++ .|+++||||++.
T Consensus 255 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 255 NKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred cCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 9999999995 899999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=401.20 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=210.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||+||+|+++.+++.||+|++++... ....+..|+.+++.+ +|++|+++++++.+.+
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAFQDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECC
Confidence 4689999999999999999999999999999999974321 223366788888887 7799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+||||||+ ||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~--------------- 204 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS--------------- 204 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---------------
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC---------------
Confidence 999999999 99999999764 59999999999999999999999999999999999999544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCC----CCCcchhHHHHHHHHHHHhCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~P 322 (433)
+.+||+|||++....... ...+||+.|+|||++.+.. |+.++|||||||++|||++|..|
T Consensus 205 ------------g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 272 (410)
T 3v8s_A 205 ------------GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272 (410)
T ss_dssp ------------SCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred ------------CCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence 456666666665433322 2458999999999998765 88999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+..+.+..+..... .+.+|. ...++.++++|
T Consensus 273 f~~~~~~~~~~~i~~~~~---------------------~~~~p~------------------------~~~~s~~~~~l 307 (410)
T 3v8s_A 273 FYADSLVGTYSKIMNHKN---------------------SLTFPD------------------------DNDISKEAKNL 307 (410)
T ss_dssp TCCSSHHHHHHHHHTHHH---------------------HCCCCT------------------------TCCCCHHHHHH
T ss_pred CCCCChhhHHHHHHhccc---------------------cccCCC------------------------cccccHHHHHH
Confidence 998877766655432110 001111 12567899999
Q ss_pred HHhccccCCCC--CCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTD--RLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~--R~ta~ell~hp~f~~~ 429 (433)
|.+||+.+|.+ |++++|+++||||+..
T Consensus 308 i~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 308 ICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999998 9999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=394.42 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=202.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhh----HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|+++.+++.||||++++.... ......|..++ .....|++|+++++.+.+.+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l----l~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL----LKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CC----BCCCCCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH----HHhCCCCCCCCEEEEEEeCC
Confidence 46799999999999999999999999999999999754321 12223333331 12347899999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~---------------- 174 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS---------------- 174 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT----------------
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC----------------
Confidence 999999999 899999998764 7999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
++.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 175 -----------~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 175 -----------QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp -----------TSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred -----------CCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 4456666666665322 12244689999999999999999999999999999999999999999877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+... .+. .+..++.++.+||.+||
T Consensus 244 ~~~~~~~i~~~-----------------------~~~--------------------------~~~~~~~~~~~li~~lL 274 (373)
T 2r5t_A 244 TAEMYDNILNK-----------------------PLQ--------------------------LKPNITNSARHLLEGLL 274 (373)
T ss_dssp HHHHHHHHHHS-----------------------CCC--------------------------CCSSSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhc-----------------------ccC--------------------------CCCCCCHHHHHHHHHHc
Confidence 66655443321 111 12356778999999999
Q ss_pred ccCCCCCCCH----HHHhcCCCCCCC
Q 013973 408 RYDPTDRLTA----REALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta----~ell~hp~f~~~ 429 (433)
+.||.+||++ .|+++||||+..
T Consensus 275 ~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 275 QKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp CSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999986 699999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=390.93 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=212.3
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh------hHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
.+.++|++.+.||+|+||.||+|.++.+++.||||++..... ..+.+.+|+.+++.+ .|+||+++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~ 95 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-----KHPHIVELLETY 95 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-----CCCCCCcEEEEE
Confidence 345789999999999999999999999999999999863221 246678899999988 679999999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+.+.+|+||||+ |++|.+++... ....+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~-------- 167 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-------- 167 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS--------
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC--------
Confidence 9999999999999 89999887643 223589999999999999999999999999999999999996432
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
....+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 168 ----------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 231 (351)
T 3c0i_A 168 ----------------NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231 (351)
T ss_dssp ----------------TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCC
Confidence 23458888888886554332 23579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.. .+....+.......+. ..+..++.++.+
T Consensus 232 pf~~~~-~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~ 265 (351)
T 3c0i_A 232 PFYGTK-ERLFEGIIKGKYKMNP---------------------------------------------RQWSHISESAKD 265 (351)
T ss_dssp SSCSSH-HHHHHHHHHTCCCCCH---------------------------------------------HHHTTSCHHHHH
T ss_pred CCCCcH-HHHHHHHHcCCCCCCc---------------------------------------------cccccCCHHHHH
Confidence 998643 2222222111111110 112356788999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
||.+||+.||++|||+.|+|+||||++
T Consensus 266 li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 266 LVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=402.56 Aligned_cols=258 Identities=23% Similarity=0.387 Sum_probs=211.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
..++|+++++||+|+||+||+|+++.+++.||+|++++... ....+..|+.++..+ +|++|+++++++.+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DSKWITTLHYAFQDD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-----CTTTBCCEEEEEECS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEeeC
Confidence 35789999999999999999999999999999999974321 122367788888877 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+||||||+ ||+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~--------------- 210 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--------------- 210 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---------------
T ss_pred CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcC---------------
Confidence 9999999999 999999998743 47999999999999999999999999999999999999954
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
++.+||+|||++....... ...+||+.|+|||++. ...|+.++|||||||++|||++|.
T Consensus 211 ------------~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 211 ------------NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp ------------TSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred ------------CCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 4456666666664333222 2358999999999997 456999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||.+.+..+.+..+..... .+.+|. ....++++++
T Consensus 279 ~Pf~~~~~~~~~~~i~~~~~---------------------~~~~p~-----------------------~~~~~s~~~~ 314 (437)
T 4aw2_A 279 TPFYAESLVETYGKIMNHKE---------------------RFQFPT-----------------------QVTDVSENAK 314 (437)
T ss_dssp CTTCCSSHHHHHHHHHTHHH---------------------HCCCCS-----------------------SCCCSCHHHH
T ss_pred CCCCCCChhHHHHhhhhccc---------------------cccCCc-----------------------ccccCCHHHH
Confidence 99998887776655432110 011111 1134678999
Q ss_pred HHHHhccccCCCC--CCCHHHHhcCCCCCCC
Q 013973 401 HLLQGLLRYDPTD--RLTAREALRHPFFTRD 429 (433)
Q Consensus 401 ~li~~~L~~dP~~--R~ta~ell~hp~f~~~ 429 (433)
+||.+||+.+|++ |++++|+++||||+..
T Consensus 315 dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 315 DLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred HHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 9999999999888 9999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=395.83 Aligned_cols=260 Identities=26% Similarity=0.485 Sum_probs=217.3
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+.++|++++.||+|+||.||+|.++.+++.||+|++.... .....+..|+.+++.+ .|+||+++++++.+...+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-----CCcCCCeEEEEEEeCCEE
Confidence 4578999999999999999999999999999999997532 3345677899998877 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ |++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~------------------ 184 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET------------------ 184 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS------------------
T ss_pred EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec------------------
Confidence 9999999 899999987543 46999999999999999999999999999999999999953
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+..+.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+
T Consensus 185 -------~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 257 (387)
T 1kob_A 185 -------KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257 (387)
T ss_dssp -------TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred -------CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH
Confidence 234568888888887654433 23579999999999999999999999999999999999999999877766
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+..... ..+. ..+..++.++.+||.+||+.|
T Consensus 258 ~~~~i~~~~~-----------------------~~~~----------------------~~~~~~s~~~~~li~~~L~~d 292 (387)
T 1kob_A 258 TLQNVKRCDW-----------------------EFDE----------------------DAFSSVSPEAKDFIKNLLQKE 292 (387)
T ss_dssp HHHHHHHCCC-----------------------CCCS----------------------STTTTSCHHHHHHHHTTSCSS
T ss_pred HHHHHHhCCC-----------------------CCCc----------------------cccccCCHHHHHHHHHHcCCC
Confidence 5544332111 1111 012356778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~ 430 (433)
|++|||+.|+|+||||+...
T Consensus 293 P~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 293 PRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp GGGSCCHHHHHTSTTTSSCC
T ss_pred hhHCcCHHHHhhCccccCCc
Confidence 99999999999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=377.48 Aligned_cols=282 Identities=31% Similarity=0.552 Sum_probs=221.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++++ .|+||+++++++...+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-----KHPNLVNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-----CCCCccchhheeecCCe
Confidence 367999999999999999999999999999999885432 2345567899999988 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~------------------ 136 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT------------------ 136 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred EEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc------------------
Confidence 99999999 677777776543 799999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.++.+||+|||.+....... ...+||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus 137 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 137 ---------KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp ---------TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 44567777777765443222 23478999999999986 568999999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+...++..++......... .+........+..... ........+.++.+||.+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~li~~~L 269 (311)
T 4agu_A 208 DVDQLYLIRKTLGDLIPRHQQVFSTN--QYFSGVKIPDPEDMEP----------------LELKFPNISYPALGLLKGCL 269 (311)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHHHTC--GGGTTCCCCCCSSCCC----------------HHHHCTTCCHHHHHHHHHHC
T ss_pred HHHHHHHHHHHhcccccccccccccc--cccccCcCCCccccch----------------hhhhcccccHHHHHHHHHHc
Confidence 99999999998888877654433221 1111111111111100 01122467788999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+.||++|||++|+|+||||++.
T Consensus 270 ~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 270 HMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCChhhcCCHHHHhcChHHHhc
Confidence 9999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=392.13 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=208.3
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .|+||+++++++..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-----RHPHIIKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-----CCTTBCCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEe
Confidence 34578999999999999999999999999999999997432 1234577889888877 67999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 170 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 170 ~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.+.+++||||++|+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 81 ~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---------------- 142 (336)
T 3h4j_B 81 PTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---------------- 142 (336)
T ss_dssp SSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC----------------
T ss_pred CCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc----------------
Confidence 99999999999999999998765 799999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++.+||+|||++....... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 143 -----------~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 143 -----------DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp -----------TTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred -----------CCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 44567777777765443322 34579999999999998776 68999999999999999999999764
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
...+.. ..+..+... .++.+++++.+||.+|
T Consensus 212 ~~~~~~-----------------------~~i~~~~~~--------------------------~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 212 FIPNLF-----------------------KKVNSCVYV--------------------------MPDFLSPGAQSLIRRM 242 (336)
T ss_dssp SSTTCB-----------------------CCCCSSCCC--------------------------CCTTSCHHHHHHHHTT
T ss_pred cHHHHH-----------------------HHHHcCCCC--------------------------CcccCCHHHHHHHHHH
Confidence 321110 011111111 2335678899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|+.||.+|||++|+++||||+..
T Consensus 243 L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=390.39 Aligned_cols=293 Identities=28% Similarity=0.489 Sum_probs=230.4
Q ss_pred CCCCceeecCc---eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCC
Q 013973 83 KDGHYMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKG 156 (433)
Q Consensus 83 ~~~~~~~~~~~---~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~ 156 (433)
..+.+...... .+.++|.+.+.||+|+||.||+|.++.+++.||||++... ......+..|+.+++.+ .
T Consensus 25 ~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~ 99 (371)
T 4exu_A 25 KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-----Q 99 (371)
T ss_dssp CTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-----C
T ss_pred cccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-----C
Confidence 34444444433 3578999999999999999999999999999999999742 33456677899999888 6
Q ss_pred CCceEEecceeecCCeE------EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 013973 157 GNRCVQIRNWFDYRNHI------CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 230 (433)
Q Consensus 157 ~~~i~~~~~~~~~~~~~------~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NI 230 (433)
|+||+++++++...+.. |+||||++++|.+++.. .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 100 h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 175 (371)
T 4exu_A 100 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 175 (371)
T ss_dssp CTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCchhhhhheeccCCcccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHe
Confidence 78999999999877654 99999998899888732 599999999999999999999999999999999999
Q ss_pred EeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHH
Q 013973 231 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSV 309 (433)
Q Consensus 231 Ll~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSl 309 (433)
|++ .++.+||+|||++..........+||+.|+|||++.+ ..++.++|||||
T Consensus 176 ll~---------------------------~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (371)
T 4exu_A 176 AVN---------------------------EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 228 (371)
T ss_dssp EEC---------------------------TTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHH
T ss_pred EEC---------------------------CCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHH
Confidence 994 4556777777777655555555689999999999987 679999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 310 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 310 Gv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
||++|+|++|..||.+.+..+.+..+....+..+.++...+...............+ .....
T Consensus 229 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~ 290 (371)
T 4exu_A 229 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP------------------RKDFT 290 (371)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCC------------------CCCHH
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCc------------------chhHH
Confidence 999999999999999999999999999999998887765543222111111000000 00112
Q ss_pred hhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
..++..++++.+||.+||+.||++|||+.|+|+||||+.-
T Consensus 291 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 291 QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 2345678899999999999999999999999999999853
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=403.00 Aligned_cols=262 Identities=27% Similarity=0.481 Sum_probs=200.5
Q ss_pred ecCcEEEE-eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 013973 95 LTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 169 (433)
Q Consensus 95 ~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---- 169 (433)
+.++|.+. +.||+|+||+||+|.++.+++.||||+++.. .....|+.++.++. +|+||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~----~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhc----CCCCcceEeEEEeecccC
Confidence 34668877 7899999999999999999999999999743 33556777776553 56889999998875
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...+||||||+ ||+|.+++.......+++..+..++.||+.||.|||++|||||||||+|||++..
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~------------- 197 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK------------- 197 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-------------
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecC-------------
Confidence 67899999999 8899999987655679999999999999999999999999999999999999642
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
..++.+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 198 -----------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 198 -----------RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp -----------STTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred -----------CCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 124678888888876544322 3458999999999999999999999999999999999999999765
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
...... ..+.. .+..+.+..+. ..+..++.++.+||.+|
T Consensus 267 ~~~~~~-----------~~~~~--------~i~~~~~~~~~----------------------~~~~~~s~~~~~li~~~ 305 (400)
T 1nxk_A 267 HGLAIS-----------PGMKT--------RIRMGQYEFPN----------------------PEWSEVSEEVKMLIRNL 305 (400)
T ss_dssp TTCSSC-----------CSHHH--------HHHHTCCCCCT----------------------TTTTTSCHHHHHHHHTT
T ss_pred cccccc-----------HHHHH--------HHHcCcccCCC----------------------cccccCCHHHHHHHHHH
Confidence 432100 00000 01112122111 01235678899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|+.||++|||+.|+|+||||.+.
T Consensus 306 L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 306 LKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=384.68 Aligned_cols=258 Identities=23% Similarity=0.332 Sum_probs=201.8
Q ss_pred eeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 88 MFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 88 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
+...++.+.++|+++++||+|+||+||+|++..+++.||||++... .........|+..+..+ ..|+||++++
T Consensus 48 p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~----~~h~~iv~l~ 123 (311)
T 3p1a_A 48 PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV----GQHPCCVRLE 123 (311)
T ss_dssp TTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHH----CCCTTBCCEE
T ss_pred CCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHh----cCCCcEEEEE
Confidence 3444556678899999999999999999999999999999998532 22233334455444444 2568899999
Q ss_pred ceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 165 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
+++.+.+.+|+||||++++|.+++...+ ..+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 124 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-------- 194 (311)
T 3p1a_A 124 QAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-------- 194 (311)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG--------
T ss_pred EEEEeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--------
Confidence 9999999999999999999999988764 4699999999999999999999999999999999999995544
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
.+||+|||++....... ....||+.|+|||++.+ .++.++|||||||++|||++|..|
T Consensus 195 -------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~ 254 (311)
T 3p1a_A 195 -------------------RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL 254 (311)
T ss_dssp -------------------CEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred -------------------CEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 56666666655433222 23469999999999886 799999999999999999999776
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+....+. .+..+ ...+..++.++.+|
T Consensus 255 ~~~~~~~~~~~-----~~~~~---------------------------------------------~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 255 PHGGEGWQQLR-----QGYLP---------------------------------------------PEFTAGLSSELRSV 284 (311)
T ss_dssp CSSHHHHHHHT-----TTCCC---------------------------------------------HHHHTTSCHHHHHH
T ss_pred CCCccHHHHHh-----ccCCC---------------------------------------------cccccCCCHHHHHH
Confidence 65422211110 00001 01224567899999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|.+||+.||++|||+.|+|+||||++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=391.66 Aligned_cols=300 Identities=27% Similarity=0.461 Sum_probs=223.8
Q ss_pred CceeecCc---eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCc
Q 013973 86 HYMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNR 159 (433)
Q Consensus 86 ~~~~~~~~---~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~ 159 (433)
.+.+..++ .+.++|++++.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+ .|+|
T Consensus 11 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpn 85 (371)
T 2xrw_A 11 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKN 85 (371)
T ss_dssp EEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-----CCTT
T ss_pred ceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-----CCCC
Confidence 34444444 3568999999999999999999999999999999998642 23445677899999888 6789
Q ss_pred eEEecceeecCC------eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEee
Q 013973 160 CVQIRNWFDYRN------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 233 (433)
Q Consensus 160 i~~~~~~~~~~~------~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~ 233 (433)
|+++++++...+ .+|+||||+.++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 86 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp BCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred ccceEEeeccccccccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 999999987654 8999999998899998863 589999999999999999999999999999999999995
Q ss_pred ccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHH
Q 013973 234 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311 (433)
Q Consensus 234 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 311 (433)
. ++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||
T Consensus 162 ~---------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 214 (371)
T 2xrw_A 162 S---------------------------DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 214 (371)
T ss_dssp T---------------------------TSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred C---------------------------CCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHH
Confidence 4 445666666666543322 12357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|+|++|..||.+.+..+.+..+...++..+++...........++..... +... ..+........+. ....
T Consensus 215 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~----~~~~ 287 (371)
T 2xrw_A 215 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK-YAGY--SFEKLFPDVLFPA----DSEH 287 (371)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCC-CCCC--CHHHHSCGGGSCC----SSHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcc-cccc--chhhhcccccCcc----cccc
Confidence 9999999999999999999999888888888887776665555444433210 1000 0000000000000 0000
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
....+.++++||.+||+.||++|||++|+|+||||+.
T Consensus 288 ~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 1123668999999999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=396.44 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=208.5
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
..++|++++.||+|+||.||+|+++.+++.||||++++... ....+..|..++..+ +|++|+++++++.+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-----DRRWITQLHFAFQDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-----CTTTBCCEEEEEECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeC
Confidence 35789999999999999999999999999999999974321 223466788888776 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+||||||+ ||+|.+++.+.+ ..+++..++.|+.||+.||+|||++|||||||||+|||++.+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-------------- 198 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-------------- 198 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT--------------
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC--------------
Confidence 9999999999 999999998753 369999999999999999999999999999999999999554
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhh-------CCCCCCcchhHHHHHHHHHHHh
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-------GLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGv~l~ellt 318 (433)
+.+||+|||++....... ...+||+.|+|||++. ...|+.++|||||||++|||++
T Consensus 199 -------------g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt 265 (412)
T 2vd5_A 199 -------------GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265 (412)
T ss_dssp -------------SCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH
T ss_pred -------------CCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh
Confidence 456666666655433222 2358999999999998 3568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|+.||.+.+..+.+..+...... +.+| .....++.+
T Consensus 266 G~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~p-----------------------~~~~~~s~~ 301 (412)
T 2vd5_A 266 GQTPFYADSTAETYGKIVHYKEH---------------------LSLP-----------------------LVDEGVPEE 301 (412)
T ss_dssp SSCTTCCSSHHHHHHHHHTHHHH---------------------CCCC---------------------------CCCHH
T ss_pred CCCCCCCCCHHHHHHHHHhcccC---------------------cCCC-----------------------ccccCCCHH
Confidence 99999988777665554321000 0000 012357789
Q ss_pred HHHHHHhccccCCCCCC---CHHHHhcCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRL---TAREALRHPFFTRD 429 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~---ta~ell~hp~f~~~ 429 (433)
+++||.+||+ +|.+|+ +++|+++||||+..
T Consensus 302 ~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 302 ARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999 999985 89999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=394.21 Aligned_cols=307 Identities=18% Similarity=0.234 Sum_probs=210.8
Q ss_pred CcEEEEeeeecc--ccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSKMGEG--TFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G--~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
++|++++.||+| +||.||+|+++.+++.||||+++.. ....+.+..|+.+++.+ .|+||+++++++.+.+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-----NHPNIVPYRATFIADN 99 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETT
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-----CCCCCCcEeEEEEECC
Confidence 679999999999 9999999999999999999999743 23445667799999988 6799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ +++|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.++|+|||.+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~--- 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL--- 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE---
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce---
Confidence 999999999 8999999988755679999999999999999999999999999999999999766666666665432
Q ss_pred CCCcccccCCCCCCEEEEecCCcccc-CCCCCceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYE-RPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+.+.|..... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+
T Consensus 177 ---------------~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 177 ---------------SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp ---------------ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ---------------eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22222221111 112233478999999999987 579999999999999999999999998766
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhcc-chhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK-LPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
..+....+... ..+. +........+.+.......... ......+..... ...........+..+++++.+||.+|
T Consensus 242 ~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 242 ATQMLLEKLNG--TVPC-LLDTSTIPAEELTMSPSRSVAN-SGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp STTHHHHC------------------------------------------------------------CCHHHHHHHHHH
T ss_pred HHHHHHHHhcC--CCCc-cccccccccccccccccccccc-cccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 55443322211 1110 0000000000000000000000 000000000000 00001111224456788999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|+.||++|||+.|+|+||||++..
T Consensus 318 L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 318 LQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp TCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred hhcCcccCCCHHHHhcCHHHHHHh
Confidence 999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=393.06 Aligned_cols=258 Identities=26% Similarity=0.465 Sum_probs=209.5
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.++|++.+.||+|+||.||+|.++.+++.||||+++.... ....|++++.++. .|+||+++++++.+.+.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~----~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG----QHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT----TSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc----CCCCcCeEEEEEEcCCEE
Confidence 346789999999999999999999999999999999975432 2345788887773 468899999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ ||+|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||+.++.
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~---------------- 153 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES---------------- 153 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS----------------
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC----------------
Confidence 9999999 899999998754 799999999999999999999999999999999999984321
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE-- 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~-- 327 (433)
.....+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+..
T Consensus 154 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 226 (342)
T 2qr7_A 154 -------GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226 (342)
T ss_dssp -------CSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS
T ss_pred -------CCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC
Confidence 122458888888887544322 34579999999999998889999999999999999999999997632
Q ss_pred -hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 328 -NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 328 -~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
..+.+..+. .+.+..+. ..+..++.++.+||.+|
T Consensus 227 ~~~~~~~~i~-----------------------~~~~~~~~----------------------~~~~~~s~~~~~li~~~ 261 (342)
T 2qr7_A 227 TPEEILARIG-----------------------SGKFSLSG----------------------GYWNSVSDTAKDLVSKM 261 (342)
T ss_dssp CHHHHHHHHH-----------------------HCCCCCCS----------------------TTTTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHc-----------------------cCCcccCc----------------------cccccCCHHHHHHHHHH
Confidence 222222211 11111111 12245678999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|+.||++|||+.|+++||||.+
T Consensus 262 L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 262 LHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TCSSTTTSCCHHHHTTSHHHHT
T ss_pred CCCChhHCcCHHHHhcCCeecC
Confidence 9999999999999999999954
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=388.98 Aligned_cols=261 Identities=25% Similarity=0.449 Sum_probs=202.0
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
+.+.++|++.+.||+|+||.||+|.+..+++.||||+++... ..+.+..|+.+++.+ .|+||+++++++...+.
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-----SHPNIIKLKEIFETPTE 122 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-----CCTTBCCEEEEEECSSE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-----CCCCCcceeeeEecCCe
Confidence 345678999999999999999999999999999999997543 345677899999988 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+++||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++..
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~---------------- 184 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP---------------- 184 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS----------------
T ss_pred EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC----------------
Confidence 99999999 899999997654 69999999999999999999999999999999999999531
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
+.++.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 185 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 185 --------APDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp --------STTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred --------CCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 235678888888776543322 3457999999999999999999999999999999999999999876554
Q ss_pred HH-HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 330 EH-LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 330 ~~-~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
+. +..+.. +....+. ..++.++.++.+||.+||+
T Consensus 257 ~~~~~~i~~-----------------------~~~~~~~----------------------~~~~~~~~~~~~li~~~L~ 291 (349)
T 2w4o_A 257 QFMFRRILN-----------------------CEYYFIS----------------------PWWDEVSLNAKDLVRKLIV 291 (349)
T ss_dssp HHHHHHHHT-----------------------TCCCCCT----------------------TTTTTSCHHHHHHHHTTSC
T ss_pred HHHHHHHHh-----------------------CCCccCC----------------------chhhhCCHHHHHHHHHHcc
Confidence 32 222111 1111100 1123567789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.||++|||+.|+|+||||+...
T Consensus 292 ~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 292 LDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp SSGGGSCCHHHHHHSTTTTSTT
T ss_pred CChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=392.33 Aligned_cols=254 Identities=22% Similarity=0.406 Sum_probs=207.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|+||+++++++.+.+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-----EHPFLVNLWYSFQDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeCC
Confidence 477999999999999999999999999999999997432 2235567899998887 6799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ ||+|.+++.... .+++..++.|+.||+.||.|||++|||||||||+|||++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~---------------- 150 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE---------------- 150 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT----------------
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECC----------------
Confidence 999999999 999999998754 7999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC---CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
++.+||+|||++....... ...+||+.|+|||++.+ ..|+.++|||||||++|||++|..||..
T Consensus 151 -----------~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 151 -----------HGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp -----------TSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------CCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 4556677777665443222 34689999999999974 4589999999999999999999999975
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.........+... ..... ..+..++.++.+||.+
T Consensus 220 ~~~~~~~~~~~~~--------------------~~~~~--------------------------~~p~~~s~~~~~li~~ 253 (384)
T 4fr4_A 220 RSSTSSKEIVHTF--------------------ETTVV--------------------------TYPSAWSQEMVSLLKK 253 (384)
T ss_dssp CTTSCHHHHHHHH--------------------HHCCC--------------------------CCCTTSCHHHHHHHHH
T ss_pred CCCccHHHHHHHH--------------------hhccc--------------------------CCCCcCCHHHHHHHHH
Confidence 4322111111100 00111 1233567889999999
Q ss_pred ccccCCCCCCC-HHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLT-AREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~t-a~ell~hp~f~~~ 429 (433)
||+.||.+||+ ++++++||||++.
T Consensus 254 lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 254 LLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HhcCCHhHhcccHHHHHcChhhhcC
Confidence 99999999998 9999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=392.15 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=201.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++++.||+|+||+||+|+++.+++.||||++.......+.+.+|+.+++.+ .|+||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-----RHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-----CCCCCCcEEEEEeeCCEEEE
Confidence 3679999999999999999999999999999999986655567788899999888 67999999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 94 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~------------------ 153 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP------------------ 153 (361)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS------------------
T ss_pred EEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------------------
Confidence 99999 899999998765 799999999999999999999999999999999999995432
Q ss_pred ccccCCCCCCEEEEecCCccccCC--CCCceeecCcccchhhhhCCCCCCc-chhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERP--DQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
...+||+|||++..... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....
T Consensus 154 -------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 226 (361)
T 3uc3_A 154 -------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226 (361)
T ss_dssp -------SCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred -------CceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence 23478888887763222 2234579999999999998888755 8999999999999999999986543221
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+... +.......|. ...+++++.+||.+||+.||
T Consensus 227 ~~~~~~~-------------------~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP 263 (361)
T 3uc3_A 227 YRKTIQR-------------------ILSVKYSIPD------------------------DIRISPECCHLISRIFVADP 263 (361)
T ss_dssp HHHHHHH-------------------HHTTCCCCCT------------------------TSCCCHHHHHHHHHHSCSCT
T ss_pred HHHHHHH-------------------HhcCCCCCCC------------------------cCCCCHHHHHHHHHHccCCh
Confidence 1111110 0011111111 12457789999999999999
Q ss_pred CCCCCHHHHhcCCCCCC
Q 013973 412 TDRLTAREALRHPFFTR 428 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~ 428 (433)
++|||+.|+++||||.+
T Consensus 264 ~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 264 ATRISIPEIKTHSWFLK 280 (361)
T ss_dssp TTSCCHHHHHTSHHHHT
T ss_pred hHCcCHHHHHhCcchhc
Confidence 99999999999999954
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=382.98 Aligned_cols=251 Identities=23% Similarity=0.390 Sum_probs=202.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
.++|++++.||+|+||.||+|++. .+++.||+|+++... .....+..|+.+++.+ .|+||+++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~ 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-----KHPFIVDLIYAF 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-----CCTTBCCEEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-----CCCCccceeEEE
Confidence 467999999999999999999985 688999999997432 2334466789999888 679999999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
...+.+|+||||+ |++|.+++...+ .+++..+..++.||+.||.|||++|||||||||+|||++.+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~----------- 157 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ----------- 157 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-----------
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-----------
Confidence 9999999999999 899999998764 79999999999999999999999999999999999999544
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 158 ----------------~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 221 (327)
T 3a62_A 158 ----------------GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221 (327)
T ss_dssp ----------------SCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ----------------CcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence 45666666665432211 23357999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+..+....+..... . .+..++.++.+||
T Consensus 222 ~~~~~~~~~~~i~~~~~-----------------------~--------------------------~p~~~~~~~~~li 252 (327)
T 3a62_A 222 TGENRKKTIDKILKCKL-----------------------N--------------------------LPPYLTQEARDLL 252 (327)
T ss_dssp CCSSHHHHHHHHHHTCC-----------------------C--------------------------CCTTSCHHHHHHH
T ss_pred CCCCHHHHHHHHHhCCC-----------------------C--------------------------CCCCCCHHHHHHH
Confidence 98776655544332111 1 1234577899999
Q ss_pred HhccccCCCCCC-----CHHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~-----ta~ell~hp~f~~~ 429 (433)
.+||+.||.+|| ++.|+++||||+..
T Consensus 253 ~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999 89999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=391.45 Aligned_cols=280 Identities=28% Similarity=0.549 Sum_probs=222.1
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee------
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------ 168 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~------ 168 (433)
..++|++++.||+|+||+||+|.+..+++.||||++...... ..+|+.+++.+ .|+||+++++++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVL-----DHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTC-----CCTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHc-----CCCCccchhheeeecCccc
Confidence 346899999999999999999999999999999998644322 23588888877 6799999999883
Q ss_pred --------------------------------cCCeEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHH
Q 013973 169 --------------------------------YRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAF 214 (433)
Q Consensus 169 --------------------------------~~~~~~lV~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~ 214 (433)
...++++||||+.++|.+.+.. .....+++..+..++.||+.||.|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3445899999998898888764 223579999999999999999999
Q ss_pred HHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccch
Q 013973 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAP 292 (433)
Q Consensus 215 LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aP 292 (433)
||++||+||||||+|||++. .++.+||+|||++...... .....||+.|+||
T Consensus 157 LH~~gi~H~Dikp~Nil~~~--------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP 210 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNS--------------------------KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP 210 (383)
T ss_dssp HHTTTEECSCCCGGGEEEET--------------------------TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred HHHCcCccCccCHHHEEEcC--------------------------CCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence 99999999999999999952 3456777777777644322 2345789999999
Q ss_pred hhhhCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccc
Q 013973 293 EVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS 371 (433)
Q Consensus 293 E~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (433)
|++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+...+|..+.+.+......... ..+|...
T Consensus 211 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~------~~~~~~~-- 282 (383)
T 3eb0_A 211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE------VRFPTLK-- 282 (383)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--------CCCCCCC--
T ss_pred HHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc------ccCCccC--
Confidence 9998754 899999999999999999999999999999999999999999887766554322111 1111100
Q ss_pred hhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 372 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
...+....+...+.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 283 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 283 ------------AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp ------------CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred ------------cccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 011122234567889999999999999999999999999999963
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=379.03 Aligned_cols=262 Identities=26% Similarity=0.458 Sum_probs=218.6
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
..+.++|++.+.||+|+||.||+|.++.+++.||+|+++.... ..+.+..|+.+++.+ .|+||+++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~ 82 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-----LHHNVITLHD 82 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-----CCCCcceEEE
Confidence 3456789999999999999999999999999999999964321 346678899999988 6789999999
Q ss_pred eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 166 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 166 ~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
++...+.+++||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~-------- 152 (321)
T 2a2a_A 83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-------- 152 (321)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT--------
T ss_pred EEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC--------
Confidence 999999999999999 899999998654 799999999999999999999999999999999999996543
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
.....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 153 ---------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 217 (321)
T 2a2a_A 153 ---------------IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (321)
T ss_dssp ---------------SSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred ---------------CCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCC
Confidence 112268888888876544332 335799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+....+....+.......+.. .+...+..+.+|
T Consensus 218 f~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l 252 (321)
T 2a2a_A 218 FLGDTKQETLANITSVSYDFDEE---------------------------------------------FFSHTSELAKDF 252 (321)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcccccChh---------------------------------------------hhcccCHHHHHH
Confidence 98877766555443322222211 123567789999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|.+||+.||++|||+.|+++||||+..
T Consensus 253 i~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 253 IRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=385.24 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=204.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.++|++++.||+|+||+||+|++..+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++++.+.+..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-----CCTTBCCEEEEEECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCCeE
Confidence 467999999999999999999999999999999986432 2335677899999888 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~------------------ 140 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE------------------ 140 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT------------------
T ss_pred EEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeC------------------
Confidence 9999999 889999987653 6999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 141 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 141 ---------RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp ---------TCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred ---------CCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 455677777766533211 123579999999999998775 77899999999999999999999765
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
........... ... .. ...+..++.++.+||.+|
T Consensus 212 ~~~~~~~~~~~---------------------~~~-~~------------------------~~~~~~~~~~~~~li~~~ 245 (323)
T 3tki_A 212 SDSCQEYSDWK---------------------EKK-TY------------------------LNPWKKIDSAPLALLHKI 245 (323)
T ss_dssp CTTSHHHHHHH---------------------TTC-TT------------------------STTGGGSCHHHHHHHHHH
T ss_pred chHHHHHHHHh---------------------ccc-cc------------------------CCccccCCHHHHHHHHHH
Confidence 44221111000 000 00 001124567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|+.||++|||+.|+++||||++..
T Consensus 246 L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 246 LVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp SCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=384.44 Aligned_cols=280 Identities=29% Similarity=0.518 Sum_probs=224.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 170 (433)
.++|++++.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+ .|+||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-----RHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-----CCTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-----CCCCCccceeEEecCCcc
Confidence 46899999999999999999999999999999999742 33446677899999988 678999999988654
Q ss_pred --CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 171 --NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 171 --~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
..+|+||||++++|.+++... .+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-------------- 163 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-------------- 163 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--------------
T ss_pred ccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC--------------
Confidence 479999999988999999764 5999999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 164 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 164 -------------TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp -------------TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------CCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCC
Confidence 445666666666543322 123479999999998765 458999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhh-hhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
||.+.+..+.+..+...++..+.+.+........ .+... .+.... ..........+.++.
T Consensus 231 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------------~~~~~~~~~~~~~~~ 291 (364)
T 3qyz_A 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS----LPHKNK---------------VPWNRLFPNADSKAL 291 (364)
T ss_dssp SSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT----SCCCCC---------------CCHHHHCTTSCHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh----cCCccC---------------CCHHHhCCCCCHHHH
Confidence 9999999999999999999988776554321111 11100 000000 001122346678999
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+||.+||+.||++|||+.|+|+||||++.
T Consensus 292 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 292 DLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 99999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=395.60 Aligned_cols=279 Identities=28% Similarity=0.498 Sum_probs=220.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec------
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------ 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~------ 169 (433)
..+|++.+.||+|+||.||+|++..+++.||||++..... ...+|+++++.+ .|+||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l-----~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-----DHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTC-----CCTTBCCEEEEEEEEETTTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHc-----CCCCccceeeEEeccCCCCc
Confidence 3469999999999999999999999999999999864332 234688998887 67899999888743
Q ss_pred CCeEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 RNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 ~~~~~lV~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
..++++||||+.++|.+.+.. .....+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 125 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~------------ 192 (420)
T 1j1b_A 125 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD------------ 192 (420)
T ss_dssp EEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETT------------
T ss_pred ceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCC------------
Confidence 235789999998888877653 223579999999999999999999999999999999999999632
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
...+||+|||+++..... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.
T Consensus 193 --------------~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 193 --------------TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp --------------TTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------CCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 234677777777643322 2345789999999999875 79999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+.+..+.+.+|..+.+.+......... +.+|.... ..+...+....+.++.+||.
T Consensus 259 ~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~------~~~p~~~~--------------~~~~~~~~~~~~~~~~~Li~ 318 (420)
T 1j1b_A 259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTE------FKFPQIKA--------------HPWTKVFRPRTPPEAIALCS 318 (420)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC------CCCCCCCC--------------CCHHHHSCTTSCHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh------hccCccCC--------------CCHHHhcCCCCCHHHHHHHH
Confidence 99999999999999998887766544322111 11111000 01111223456789999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+||++||.+|||+.|+|+||||++
T Consensus 319 ~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 319 RLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HhccCChhHCCCHHHHhCCHhhcc
Confidence 999999999999999999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=400.52 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=202.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|.+..+++.||||+++... .....+..|+.+++.+ .|+||+.+++++...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-----RHPFLTALKYSFQTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-----SCTTSCCEEEEEEETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-----CCCeEeeEEEEEeeCC
Confidence 467999999999999999999999999999999997432 2223344566666555 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.+||||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .|||||||||+|||++.+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-------------- 285 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-------------- 285 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS--------------
T ss_pred EEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC--------------
Confidence 999999999 889999998764 79999999999999999999998 999999999999999544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
+.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 286 -------------~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 286 -------------GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp -------------SCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -------------CCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 45666666666532221 23458999999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+.... .. .+..+++++.+||.+|
T Consensus 353 ~~~~~~~~i~~~~-----------------------~~--------------------------~p~~~~~~~~~li~~~ 383 (446)
T 4ejn_A 353 DHEKLFELILMEE-----------------------IR--------------------------FPRTLGPEAKSLLSGL 383 (446)
T ss_dssp SHHHHHHHHHHCC-----------------------CC--------------------------CCTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHhCC-----------------------CC--------------------------CCccCCHHHHHHHHHH
Confidence 7665554432211 11 1235677899999999
Q ss_pred cccCCCCCC-----CHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~-----ta~ell~hp~f~~~ 429 (433)
|+.||.+|| ++.|+++||||+..
T Consensus 384 L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 384 LKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999999 99999999999865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=403.14 Aligned_cols=267 Identities=26% Similarity=0.452 Sum_probs=219.7
Q ss_pred CCceeecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--------------hhHHHHHHHHHHHHHH
Q 013973 85 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--------------KYREAAMIEIEVLQQL 150 (433)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------------~~~~~~~~E~~~l~~l 150 (433)
+.+.......+.++|+++++||+|+||+||+|.++.+++.||+|++.... ...+.+..|+.+++.+
T Consensus 24 ~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 103 (504)
T 3q5i_A 24 GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103 (504)
T ss_dssp GGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC
T ss_pred hheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC
Confidence 33444455567789999999999999999999999999999999997432 2345677899999888
Q ss_pred HhcCCCCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 013973 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 229 (433)
Q Consensus 151 ~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~N 229 (433)
.||||+++++++.+...+|+||||+ |++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|
T Consensus 104 -----~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 176 (504)
T 3q5i_A 104 -----DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176 (504)
T ss_dssp -----CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -----CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHH
Confidence 6799999999999999999999999 889999998764 79999999999999999999999999999999999
Q ss_pred eEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhH
Q 013973 230 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIW 307 (433)
Q Consensus 230 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvw 307 (433)
||++.++ ....+||+|||++....... ...+||+.|+|||++.+ .|+.++|||
T Consensus 177 il~~~~~------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diw 231 (504)
T 3q5i_A 177 ILLENKN------------------------SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVW 231 (504)
T ss_dssp EEESSTT------------------------CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHH
T ss_pred EEEecCC------------------------CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHH
Confidence 9996432 22468899999887554432 34579999999999874 699999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHH
Q 013973 308 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387 (433)
Q Consensus 308 SlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 232 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------------------------- 268 (504)
T 3q5i_A 232 SCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF------------------------------------------- 268 (504)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-------------------------------------------
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-------------------------------------------
Confidence 9999999999999999988877766554432211111
Q ss_pred HhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 388 ~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
..+..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 269 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 269 --NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp --HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred --cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 112356789999999999999999999999999999964
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=383.85 Aligned_cols=264 Identities=28% Similarity=0.529 Sum_probs=192.1
Q ss_pred cCcEEEE---eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIH---SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~---~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++. +.||+|+||.||+|.++.+++.||||++... .......|+.+++.+. +|+||+++++++.+...
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~----~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCE----GHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSSE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhc----CCCCeeEEEEEEEcCCE
Confidence 3568876 7899999999999999999999999999743 3456678899988873 47899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--------------- 143 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN--------------- 143 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----------------
T ss_pred EEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC---------------
Confidence 99999999 889999998764 799999999999999999999999999999999999996532
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
....+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.
T Consensus 144 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 144 ---------DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp -----------CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred ---------CcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 22367888888876543322 335789999999999999999999999999999999999999986443
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.... ....+.. ..+..+.+.++. ..+..++.++.+||.+||+
T Consensus 215 ~~~~--------~~~~~~~--------~~i~~~~~~~~~----------------------~~~~~~s~~~~~li~~~L~ 256 (325)
T 3kn6_A 215 SLTC--------TSAVEIM--------KKIKKGDFSFEG----------------------EAWKNVSQEAKDLIQGLLT 256 (325)
T ss_dssp ---C--------CCHHHHH--------HHHTTTCCCCCS----------------------HHHHTSCHHHHHHHHHHHC
T ss_pred cccc--------ccHHHHH--------HHHHcCCCCCCc----------------------ccccCCCHHHHHHHHHHCC
Confidence 1100 0000000 111222222111 1123567889999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
.||.+|||+.|+++||||++.
T Consensus 257 ~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 257 VDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCTTTCCCTTTSTTCGGGCTT
T ss_pred CChhHCCCHHHHhcChhhccC
Confidence 999999999999999999865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=371.41 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=217.8
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+..|+.+++.+ .|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-----CCCCcCeEEEEEEcC
Confidence 34678999999999999999999999999999999986432 3345667899999888 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------------- 142 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------- 142 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-------------
T ss_pred CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-------------
Confidence 9999999999 889999988764 799999999999999999999999999999999999996432
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
....+||+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+
T Consensus 143 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 143 -----------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp -----------TTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----------CCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 23458888888886544333 23579999999999999999999999999999999999999998877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+.......+ . ..+..+++++.+||.+||
T Consensus 212 ~~~~~~~~~~~~~~~~-----------------------~----------------------~~~~~~~~~~~~li~~~l 246 (284)
T 3kk8_A 212 QHRLYAQIKAGAYDYP-----------------------S----------------------PEWDTVTPEAKSLIDSML 246 (284)
T ss_dssp HHHHHHHHHHTCCCCC-----------------------T----------------------TTTTTSCHHHHHHHHHHS
T ss_pred hhHHHHHHHhccccCC-----------------------c----------------------hhhcccCHHHHHHHHHHc
Confidence 6665554433221111 1 012356778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.||++|||+.|+|+||||++..
T Consensus 247 ~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 247 TVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp CSSTTTSCCHHHHTTSHHHHSCC
T ss_pred ccChhhCCCHHHHhcCccccCCh
Confidence 99999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=383.98 Aligned_cols=272 Identities=24% Similarity=0.374 Sum_probs=221.5
Q ss_pred ceeecCceecCcEEEE-eeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEE
Q 013973 87 YMFALGENLTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQ 162 (433)
Q Consensus 87 ~~~~~~~~~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~ 162 (433)
..+...+.+.++|.+. +.||+|+||.||+|.++.+++.||+|+++... .....+..|+.+++.+. +|++|++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~iv~ 93 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK----SCPRVIN 93 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT----TCTTBCC
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc----CCCCEEE
Confidence 4455566778889998 89999999999999999999999999987432 23456778898888874 4578999
Q ss_pred ecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 163 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 163 ~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
+++++...+.+++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++..
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~------ 167 (327)
T 3lm5_A 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI------ 167 (327)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB------
T ss_pred EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC------
Confidence 999999999999999999 8899999876555679999999999999999999999999999999999999541
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg 319 (433)
..++.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 168 ------------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 168 ------------------YPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp ------------------TTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ------------------CCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence 124578888888887544332 335799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
..||.+.+..+....+.......+. ..+..++..+
T Consensus 230 ~~pf~~~~~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~~~~~ 264 (327)
T 3lm5_A 230 TSPFVGEDNQETYLNISQVNVDYSE---------------------------------------------ETFSSVSQLA 264 (327)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCT---------------------------------------------TTTTTSCHHH
T ss_pred CCCCCCCCchHHHHHHHhcccccCc---------------------------------------------hhhcccCHHH
Confidence 9999988777665554433222111 1123567789
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
.+||.+||+.||.+|||++|+|+||||++...
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 99999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=414.72 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=210.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++++.||+|+||.||+|+++.+++.||||++++.. ...+....|..++..+ .+|++|+.+++++++.+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~----~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP----GKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCT----TCCTTBCCEEEECBCSS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhc----cCCCeEEEEEEEEEeCC
Confidence 468999999999999999999999999999999997432 2234455666666544 36788999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+||||||+ ||+|.+++...+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~--------------- 478 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE--------------- 478 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS---------------
T ss_pred EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC---------------
Confidence 999999999 899999998765 79999999999999999999999999999999999999544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC---CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 479 ------------g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 479 ------------GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp ------------SCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------------CcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 4566666666653221 2234689999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+.. +.+.+ +..++.++.+||.+||
T Consensus 547 ~~~~~~~i~~-----------------------~~~~~--------------------------p~~~s~~~~~li~~lL 577 (674)
T 3pfq_A 547 EDELFQSIME-----------------------HNVAY--------------------------PKSMSKEAVAICKGLM 577 (674)
T ss_dssp HHHHHHHHHS-----------------------SCCCC--------------------------CTTSCHHHHHHHHHHS
T ss_pred HHHHHHHHHh-----------------------CCCCC--------------------------CccCCHHHHHHHHHHc
Confidence 7666554432 11112 2356789999999999
Q ss_pred ccCCCCCCCH-----HHHhcCCCCCCC
Q 013973 408 RYDPTDRLTA-----REALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta-----~ell~hp~f~~~ 429 (433)
++||++||++ +||++||||+..
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred cCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999997 999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=378.11 Aligned_cols=251 Identities=24% Similarity=0.429 Sum_probs=199.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---------------------------hHHHHHHHHHHHH
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------------------------YREAAMIEIEVLQ 148 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------------------------~~~~~~~E~~~l~ 148 (433)
.++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+..|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4679999999999999999999999999999999864321 1234677999988
Q ss_pred HHHhcCCCCCceEEecceeec--CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 013973 149 QLAKHDKGGNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 225 (433)
Q Consensus 149 ~l~~~~~~~~~i~~~~~~~~~--~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 225 (433)
.+ .|+||+++++++.+ .+.+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||
T Consensus 92 ~l-----~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 92 KL-----DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp TC-----CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hC-----CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 88 67899999999886 67899999999 7888776532 36999999999999999999999999999999
Q ss_pred CCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCC---
Q 013973 226 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG--- 299 (433)
Q Consensus 226 Kp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~--- 299 (433)
||+|||++. ++.+||+|||++....... ....||+.|+|||++.+..
T Consensus 164 kp~Nil~~~---------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 216 (298)
T 2zv2_A 164 KPSNLLVGE---------------------------DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF 216 (298)
T ss_dssp CGGGEEECT---------------------------TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCE
T ss_pred CHHHEEECC---------------------------CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCC
Confidence 999999954 4456677777665443222 2347999999999998765
Q ss_pred CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhc
Q 013973 300 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 379 (433)
Q Consensus 300 ~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
++.++|||||||++|+|++|..||...+.......+.. +...++.
T Consensus 217 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----------------------~~~~~~~------------ 261 (298)
T 2zv2_A 217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS-----------------------QALEFPD------------ 261 (298)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------------------CCCCCCS------------
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc-----------------------ccCCCCC------------
Confidence 37889999999999999999999987665443332221 1111111
Q ss_pred cchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 380 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
...++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 262 ------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 262 ------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp ------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 1356778999999999999999999999999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=389.33 Aligned_cols=257 Identities=30% Similarity=0.456 Sum_probs=208.2
Q ss_pred CcEEE--EeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKI--HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~--~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+.|.+ .+.||+|+||.||+|.+..+++.||+|+++... ...+.+..|+.+++++ .|+||+++++++...+.+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-----DHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEE
Confidence 44555 678999999999999999999999999997533 3456678899998887 679999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+|||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|||+..
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------------------ 222 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN------------------ 222 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE------------------
T ss_pred EEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec------------------
Confidence 9999999 889999987643 36999999999999999999999999999999999999953
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.++.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+
T Consensus 223 -------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 295 (373)
T 2x4f_A 223 -------RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295 (373)
T ss_dssp -------TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 234567888888776544332 23479999999999999899999999999999999999999999888776
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+.......+. ..+..++.++.+||.+||+.|
T Consensus 296 ~~~~i~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~L~~d 330 (373)
T 2x4f_A 296 TLNNILACRWDLED---------------------------------------------EEFQDISEEAKEFISKLLIKE 330 (373)
T ss_dssp HHHHHHHTCCCSCS---------------------------------------------GGGTTSCHHHHHHHHTTSCSS
T ss_pred HHHHHHhccCCCCh---------------------------------------------hhhccCCHHHHHHHHHHcCCC
Confidence 66554332111110 112356778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|.+|||+.|+|+||||++.
T Consensus 331 p~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 331 KSWRISASEALKHPWLSDH 349 (373)
T ss_dssp GGGSCCHHHHHHSHHHHCH
T ss_pred hhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=402.81 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=210.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
..++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. .....+..|+.+++.+ +|++|+++++.+.+.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYETK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEeeC
Confidence 3467999999999999999999999999999999996432 2234567899999888 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+|+||||+ ||+|.+++...+...+++..++.|+.||+.||+|||++|||||||||+|||++.+
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-------------- 322 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-------------- 322 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT--------------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC--------------
Confidence 9999999999 9999999987765569999999999999999999999999999999999999544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+.+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+..
T Consensus 323 -------------g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 323 -------------GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp -------------SCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred -------------CCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 456666666665443322 23489999999999999999999999999999999999999998653
Q ss_pred h----HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 328 N----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 328 ~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
. .+....+. .... .++..++.++.+||
T Consensus 390 ~~~~~~~i~~~i~-----------------------~~~~--------------------------~~p~~~s~~~~dLI 420 (576)
T 2acx_A 390 KKIKREEVERLVK-----------------------EVPE--------------------------EYSERFSPQARSLC 420 (576)
T ss_dssp SCCCHHHHHHHHH-----------------------HCCC--------------------------CCCTTSCHHHHHHH
T ss_pred cchhHHHHHHHhh-----------------------cccc--------------------------cCCccCCHHHHHHH
Confidence 2 11111111 0001 12235678999999
Q ss_pred HhccccCCCCCC-----CHHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~-----ta~ell~hp~f~~~ 429 (433)
.+||+.||.+|| +++|+++||||+..
T Consensus 421 ~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 999999999999 79999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=384.24 Aligned_cols=286 Identities=27% Similarity=0.460 Sum_probs=220.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
.++|++++.||+|+||.||+|+++.+++.||+|++.... .....+..|+.+++.+ .|+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-----CCTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-----cCCCcccHhheeecccc
Confidence 367999999999999999999999999999999985322 2234567899999988 67899999998876
Q ss_pred -----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 170 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 170 -----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+.+|+||||++++|.+.+.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 91 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-------- 161 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-------- 161 (351)
T ss_dssp ------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--------
T ss_pred ccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--------
Confidence 45799999999889998887653 4699999999999999999999999999999999999995544
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCC-------CCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHH
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~el 316 (433)
.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 162 -------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 222 (351)
T 3mi9_A 162 -------------------VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222 (351)
T ss_dssp -------------------CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred -------------------CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHH
Confidence 566666665543221 1123478999999999986 4589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 317 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 317 ltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
++|..||.+.+..+....+....+..+...+......... .. +....... ......... ...+
T Consensus 223 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~-----------~~~~~~~~~--~~~~ 285 (351)
T 3mi9_A 223 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY--EK--LELVKGQK-----------RKVKDRLKA--YVRD 285 (351)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGG--TS--SCCCSSCC-----------CCHHHHHHH--HHCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhh--cc--cccccccc-----------cCHHHHhhh--ccCC
Confidence 9999999999999999999999988877654433221100 00 00000000 000000000 0135
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
+++.+||.+||+.||++|||++|+|+||||++...
T Consensus 286 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 286 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 67899999999999999999999999999987653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=399.49 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=211.4
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
...++|.+.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ .|+||+++++++..
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-----RHPHIIKLYQVIST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEEC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEE
Confidence 34578999999999999999999999999999999997432 2235677888888777 67999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+.+|+||||+ |++|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~--------------- 150 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD--------------- 150 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---------------
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---------------
Confidence 99999999999 899999997654 799999999999999999999999999999999999994
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
.++.+||+|||++....... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+
T Consensus 151 ------------~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 151 ------------AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp ------------TTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------------cCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 44567777777766543322 34589999999999998776 6899999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+..+....+.. +.+.. +..+++++.+||.+
T Consensus 219 ~~~~~~~~~i~~-----------------------~~~~~--------------------------p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 219 DHVPTLFKKICD-----------------------GIFYT--------------------------PQYLNPSVISLLKH 249 (476)
T ss_dssp SSSHHHHHHHHT-----------------------TCCCC--------------------------CTTCCHHHHHHHHH
T ss_pred CCHHHHHHHHhc-----------------------CCcCC--------------------------CccCCHHHHHHHHH
Confidence 766554443321 11111 22456789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||+.||.+|||+.|+++||||++.
T Consensus 250 ~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 250 MLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=384.76 Aligned_cols=280 Identities=27% Similarity=0.474 Sum_probs=215.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|++++.||+|+||.||+|.+..+++.||||+++.... ....+..|+.+++.+ .|+||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----SHPNIIGLLDAFGH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-----CCTTBCCEEEEECC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-----CCCCCCeEEEEEee
Confidence 4679999999999999999999999999999999863221 123566899999888 67899999999999
Q ss_pred CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 170 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 170 ~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.+.+++||||+.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~--------------- 147 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--------------- 147 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---------------
T ss_pred CCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC---------------
Confidence 99999999999779999987643 46899999999999999999999999999999999999954
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
++.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+
T Consensus 148 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 148 ------------NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp ------------TCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------------CCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 445666666666543222 1235789999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+..+.+..+....+..+...+......... +.... .+. ..........+.++.+||.+
T Consensus 216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~------------------~~~~~~~~~~~~~~~~li~~ 274 (346)
T 1ua2_A 216 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDY-VTFKS--FPG------------------IPLHHIFSAAGDDLLDLIQG 274 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC-CCCCC--CCC------------------CCHHHHCTTCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHHcCCCChhhhhhhccCccc-ccccc--cCC------------------CChHHhhccCCHHHHHHHHH
Confidence 9988888888877776654322211110000 00000 000 00111234667899999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||+.||++|||+.|+|+||||++.
T Consensus 275 ~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 275 LFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp HHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HhccChhhCCCHHHHhcChhhhcC
Confidence 999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=396.74 Aligned_cols=298 Identities=26% Similarity=0.482 Sum_probs=211.8
Q ss_pred eecCcEEEE-eeeeccccEEEEEEEEC--CCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee--e
Q 013973 94 NLTSRYKIH-SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--D 168 (433)
Q Consensus 94 ~~~~~~~~~-~~iG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~--~ 168 (433)
.+.+.|++. ++||+|+||+||+|.++ .+++.||||++.... ....+.+|+.+++.+ .|+||+++++++ .
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLREL-----KHPNVISLQKVFLSH 90 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHC-----CCTTBCCCCEEEEET
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhc-----CCCCeeeEeeEEecC
Confidence 445678874 58999999999999966 568899999997432 334577899999998 678999999999 4
Q ss_pred cCCeEEEEEecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 169 YRNHICIVFEKLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 169 ~~~~~~lV~e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
....+|+||||++++|.+++.... ...+++..++.++.||+.||.|||++|||||||||+|||+..++
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~----- 165 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG----- 165 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS-----
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC-----
Confidence 578999999999889999886321 12499999999999999999999999999999999999995332
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILV 314 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~ 314 (433)
+.++.+||+|||++...... ....+||+.|+|||++.+. .|+.++|||||||++|
T Consensus 166 ------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 227 (405)
T 3rgf_A 166 ------------------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227 (405)
T ss_dssp ------------------TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred ------------------CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence 34567888888887654322 1335799999999999875 4899999999999999
Q ss_pred HHHhCCCCCCCCCh---------HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 315 ELCTGEALFQTHEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 315 elltg~~Pf~~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
||++|.+||.+... .+++..+...+|..+...+..+............+. ..........
T Consensus 228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~ 296 (405)
T 3rgf_A 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR-----------RNTYTNCSLI 296 (405)
T ss_dssp HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCC-----------GGGGTTCCHH
T ss_pred HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhcc-----------ccCCCcchhh
Confidence 99999999976554 467778888888776554333321111100000000 0000001111
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
..........+.++.+||.+||+.||.+|||++|+|+||||++..+
T Consensus 297 ~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 297 KYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred hhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 1222223344778999999999999999999999999999987643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=383.16 Aligned_cols=286 Identities=30% Similarity=0.468 Sum_probs=214.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC----
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---- 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~---- 171 (433)
.++|++.+.||+|+||.||+|.+..+++.||||++............|+..+..+ .|+||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-----~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-----HHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-----CCTTBCCEEEEEEEECSSCT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-----CCCCcccHHHhhhccccccc
Confidence 4679999999999999999999999999999999875544444556667777777 6789999999986533
Q ss_pred ---eEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEeeccCccccCCCc
Q 013973 172 ---HICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 172 ---~~~lV~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+++||||+.++|.+.+.. .....+++..+..++.||+.||.||| ++|||||||||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---------- 166 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE---------- 166 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET----------
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC----------
Confidence 3899999997787776653 23357899999999999999999999 999999999999999963
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~ 321 (433)
.++.+||+|||++....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 167 ----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~ 230 (360)
T 3e3p_A 167 ----------------ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230 (360)
T ss_dssp ----------------TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 23456777777665443322 2347899999999997654 8999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.+..+.+..+.+.++..+.+.+.........+.... . ................+.++.+
T Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~------------~~~~~~~~~~~~~~~~~~~~~~ 293 (360)
T 3e3p_A 231 IFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYN-----S------------KGIPWSNVFSDHSLKDAKEAYD 293 (360)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGC-----C------------CCCCHHHHTTTCCCTTHHHHHH
T ss_pred CcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccc-----c------------ccCCcccccchhhccccHHHHH
Confidence 9999999999999999999999888776543221111000 0 0001112222233456889999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||.+||+.||.+|||+.|+|+||||++.
T Consensus 294 li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 294 LLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHhccCccccCCHHHHhcCcccccc
Confidence 9999999999999999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=368.93 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=215.2
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+.++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+..|+.+++.+ .|+||+++++++.+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-----DHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCeE
Confidence 457899999999999999999999999999999998643 23456678899999888 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+..+
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~----------------- 142 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD----------------- 142 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-----------------
T ss_pred EEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC-----------------
Confidence 9999999 889999998764 79999999999999999999999999999999999999321
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.++.+||+|||.+....... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+
T Consensus 143 -------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (277)
T 3f3z_A 143 -------SPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214 (277)
T ss_dssp -------STTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH
Confidence 234568888888776544332 335799999999998764 8999999999999999999999999887766
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.......|... ...+++++.+||.+||+.|
T Consensus 215 ~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~li~~~l~~d 249 (277)
T 3f3z_A 215 VMLKIREGTFTFPEKD---------------------------------------------WLNVSPQAESLIRRLLTKS 249 (277)
T ss_dssp HHHHHHHCCCCCCHHH---------------------------------------------HTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCCchh---------------------------------------------hhcCCHHHHHHHHHHccCC
Confidence 6555443332222211 1245778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTR 428 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~ 428 (433)
|++|||+.|+|+||||++
T Consensus 250 p~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 250 PKQRITSLQALEHEWFEK 267 (277)
T ss_dssp TTTSCCHHHHTTSHHHHH
T ss_pred hhhCcCHHHHhcCHHHhc
Confidence 999999999999999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=387.82 Aligned_cols=282 Identities=30% Similarity=0.518 Sum_probs=219.6
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 170 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 170 (433)
+....+|++++.||+|+||+||+|.+..+++ ||+|.+...... ..+|+.+++.+ .|+||+++++++...
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l-----~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIV-----KHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTC-----CCTTBCCEEEEEEEESS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhC-----CCCCcceEEEEEEecCC
Confidence 3455689999999999999999999988777 777776533221 23588888887 679999999998543
Q ss_pred ----CeEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 171 ----NHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 171 ----~~~~lV~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
..+++||||+.+++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~---------- 176 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP---------- 176 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET----------
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC----------
Confidence 34899999997777665542 22347999999999999999999999999999999999999961
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~ 321 (433)
.++.+||+|||++...... ....+||+.|+|||++.+. .|+.++|||||||++|||++|..
T Consensus 177 ----------------~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 177 ----------------PSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp ----------------TTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------CCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 3445777777777543222 2345789999999999875 59999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.+..+.+..+.+.+|..+.+.+.......... ..+... .......+....++++.+
T Consensus 241 pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~------~~~~~~--------------~~~~~~~~~~~~~~~~~~ 300 (394)
T 4e7w_A 241 LFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH------KFPQIR--------------PHPFSKVFRPRTPPDAID 300 (394)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSS------CCCCCC--------------CCCHHHHSCTTCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh------cccccc--------------CCcHHHhccccCCHHHHH
Confidence 999999999999999999999887766543322111 011100 001111233457889999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||.+||+.||.+|||+.|+|+||||++.
T Consensus 301 li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 301 LISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 9999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=369.45 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=208.2
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++++.+.+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-----DHPNIIKIFEVFEDYH 93 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-----CCchHHhHHHheecCC
Confidence 34578999999999999999999999999999999987433 2346678899999888 6799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~------------- 160 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT------------- 160 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS-------------
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC-------------
Confidence 999999999 88999998643 12479999999999999999999999999999999999999532
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
+.++.+||+|||++....... ....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.
T Consensus 161 -----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 161 -----------SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp -----------STTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------CCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 234568888888886543322 3457999999999986 46899999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+...... .+. .....++++.+||.+|
T Consensus 229 ~~~~~~~~~~~~~~~-----------------------~~~-----------------------~~~~~~~~~~~li~~~ 262 (285)
T 3is5_A 229 SLEEVQQKATYKEPN-----------------------YAV-----------------------ECRPLTPQAVDLLKQM 262 (285)
T ss_dssp SHHHHHHHHHHCCCC-----------------------CCC-------------------------CCCCHHHHHHHHHH
T ss_pred CHHHHHhhhccCCcc-----------------------ccc-----------------------ccCcCCHHHHHHHHHH
Confidence 655443322111000 000 0123567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|+.||++|||+.|+|+||||++
T Consensus 263 L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 263 LTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp TCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccCChhhCcCHHHHhcCHHhhc
Confidence 9999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=401.70 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=213.8
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
...+.++|++++.||+|+||+||+|+++.++..||+|++.... .....+..|+.+++.+ .||||+++++++.
T Consensus 32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~ 106 (494)
T 3lij_A 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-----DHPNIMKLYDFFE 106 (494)
T ss_dssp BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-----CCTTBCCEEEEEE
T ss_pred CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-----CCCCCCeEEEEEE
Confidence 3455678999999999999999999999999999999997432 2345677899998887 6799999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
+.+.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++..
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~------------ 172 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK------------ 172 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS------------
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC------------
Confidence 999999999999 899999988764 79999999999999999999999999999999999999542
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
+....+||+|||++....... ...+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+
T Consensus 173 ------------~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 173 ------------EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp ------------STTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------------CCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 234568899999887554332 3457999999999986 4699999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+..+.+..+.......+ . ..+..++.++.+||.+
T Consensus 240 ~~~~~~~~~i~~~~~~~~-----------------------~----------------------~~~~~~s~~~~~li~~ 274 (494)
T 3lij_A 240 QTDQEILRKVEKGKYTFD-----------------------S----------------------PEWKNVSEGAKDLIKQ 274 (494)
T ss_dssp SSHHHHHHHHHHTCCCCC-----------------------S----------------------GGGTTSCHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCC-----------------------c----------------------hhcccCCHHHHHHHHH
Confidence 887766655433222111 1 1123567789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
||+.||.+|||+.|+|+||||++
T Consensus 275 ~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 275 MLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HCCCChhhCccHHHHhcCccccc
Confidence 99999999999999999999964
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=398.50 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=208.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+.. .....+..|+.+++.+ +|++|+++++++.+..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-----HSRFIVSLAYAFETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-----CCCCEeeEEEEEeeCC
Confidence 478999999999999999999999999999999997432 2234567899999888 6799999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+|+||||+ ||+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~-------------- 324 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD-------------- 324 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--------------
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC--------------
Confidence 999999999 899999998653 346999999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
++.+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+
T Consensus 325 -------------~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 325 -------------DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp -------------TSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -------------CCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence 4456666666665433222 234899999999999999999999999999999999999999986
Q ss_pred CCh----HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 326 HEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 326 ~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
.+. .+....+.. +.. .++..++.++.+
T Consensus 392 ~~~~~~~~~~~~~i~~-----------------------~~~--------------------------~~p~~~s~~~~~ 422 (543)
T 3c4z_A 392 RGEKVENKELKQRVLE-----------------------QAV--------------------------TYPDKFSPASKD 422 (543)
T ss_dssp TTCCCCHHHHHHHHHH-----------------------CCC--------------------------CCCTTSCHHHHH
T ss_pred CccchhHHHHHHHHhh-----------------------ccc--------------------------CCCcccCHHHHH
Confidence 532 222211111 111 123456789999
Q ss_pred HHHhccccCCCCCCC-----HHHHhcCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 402 li~~~L~~dP~~R~t-----a~ell~hp~f~~~ 429 (433)
||.+||++||++||+ ++++++||||+..
T Consensus 423 li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 999999999999995 5899999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=379.82 Aligned_cols=282 Identities=28% Similarity=0.484 Sum_probs=222.2
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|.+.+.||+|+||.||+|.++.+|+.||||++... ......+..|+.+++.+ .|+||+++++++...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-----QHENVIGLLDVFTPA 95 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCcccHhheEecc
Confidence 3467899999999999999999999999999999998642 23345677899999888 678999999998876
Q ss_pred Ce------EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 171 NH------ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 171 ~~------~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.. +|+||||++++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~----------- 160 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----------- 160 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC-----------
T ss_pred cccccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC-----------
Confidence 53 599999998888877642 599999999999999999999999999999999999995
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
.++.+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 161 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 224 (353)
T 3coi_A 161 ----------------EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224 (353)
T ss_dssp ----------------TTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ----------------CCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 4456777777776655444445678999999999987 67899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+..+.+..+....|..+.++...+...............+. ..........+.++.+||
T Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~li 286 (353)
T 3coi_A 225 KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR------------------KDFTQLFPRASPQAADLL 286 (353)
T ss_dssp BSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSS------------------CCTTTTCTTSCHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCC------------------ccHHHhcCCcCHHHHHHH
Confidence 99999999999999999888877655433221111100000000 000112345678999999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+||+.||++|||++|+|+||||+.-
T Consensus 287 ~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 287 EKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHcCCCcccCCCHHHHhcCcchhhc
Confidence 99999999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=402.45 Aligned_cols=260 Identities=30% Similarity=0.506 Sum_probs=218.6
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
...+.++|++.+.||+|+||.||+|.++.+++.||||++... ......+..|+.+++++ .||||+++++++
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~ 95 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-----DHPNIMKLYEFF 95 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-----CCCCCCcEEEEE
Confidence 345668899999999999999999999999999999998632 23456678899999888 679999999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
.+.+.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++..
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~----------- 162 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK----------- 162 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-----------
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC-----------
Confidence 9999999999999 999999998754 79999999999999999999999999999999999999532
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+.++.+||+|||++....... ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.
T Consensus 163 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 163 -------------SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp -------------STTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------CCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 245678999999887654433 23579999999999987 69999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+.+..+...... .+. +.+..+++++++||.
T Consensus 229 ~~~~~~~~~~i~~~~~~-----------------------~~~----------------------~~~~~~s~~~~~li~ 263 (484)
T 3nyv_A 229 GANEYDILKKVEKGKYT-----------------------FEL----------------------PQWKKVSESAKDLIR 263 (484)
T ss_dssp CSSHHHHHHHHHHCCCC-----------------------CCS----------------------GGGGGSCHHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCC-----------------------CCC----------------------cccccCCHHHHHHHH
Confidence 88877666554332111 110 112346778999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+||+.||.+|||+.|+|+||||+.
T Consensus 264 ~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 264 KMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred HHCCCChhHCcCHHHHhhChhhcc
Confidence 999999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=374.13 Aligned_cols=275 Identities=24% Similarity=0.414 Sum_probs=203.0
Q ss_pred ecCcEEEE-eeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 95 LTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 95 ~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
+.++|++. +.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++.++. .|+||+++++++.+.+.
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~----~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ----GHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC----CCTTBCCEEEEEEETTE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc----CCCCeeeEEEEEeeCCE
Confidence 45679996 78999999999999999999999999997432 33566778999888752 57899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-------------- 149 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ-------------- 149 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS--------------
T ss_pred EEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC--------------
Confidence 99999999 899999998764 7999999999999999999999999999999999999965432
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhC-----CCCCCcchhHHHHHHHHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~el 316 (433)
...+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 150 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l 219 (316)
T 2ac3_A 150 ----------VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219 (316)
T ss_dssp ----------SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHH
T ss_pred ----------cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHH
Confidence 123666666665432211 123469999999999975 4588999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 317 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 317 ltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
++|..||.+....+..... .... ..........+..+...++. .....++
T Consensus 220 ~~g~~pf~~~~~~~~~~~~----~~~~----~~~~~~~~~~i~~~~~~~~~----------------------~~~~~~~ 269 (316)
T 2ac3_A 220 LSGYPPFVGRCGSDCGWDR----GEAC----PACQNMLFESIQEGKYEFPD----------------------KDWAHIS 269 (316)
T ss_dssp HHSSCSCCCCCCSCSCC--------CC----HHHHHHHHHHHHHCCCCCCH----------------------HHHTTSC
T ss_pred HHCCCCCcccccccccccc----cccc----hhHHHHHHHHHhccCcccCc----------------------hhcccCC
Confidence 9999999765321100000 0000 00000000011111111111 1123567
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 270 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 270 CAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 789999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=399.91 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=215.8
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++++.||+|+||+||+|.++.+++.||||++... ......+..|+.+++++ .||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-----CCCCcCeEEEEEEcC
Confidence 3557899999999999999999999999999999998632 22346678899999998 679999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-------------- 157 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK-------------- 157 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS--------------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC--------------
Confidence 9999999999 899999988764 79999999999999999999999999999999999999542
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
+.++.+||+|||++....... ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+
T Consensus 158 ----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 158 ----------EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp ----------STTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------CCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234568888888886544332 33579999999999986 59999999999999999999999999887
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+.......+ . +.+..++.++++||.+||
T Consensus 227 ~~~~~~~i~~~~~~~~-----------------------~----------------------~~~~~~s~~~~~li~~~L 261 (486)
T 3mwu_A 227 EYDILKRVETGKYAFD-----------------------L----------------------PQWRTISDDAKDLIRKML 261 (486)
T ss_dssp HHHHHHHHHHTCCCSC-----------------------S----------------------GGGGGSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCC-----------------------C----------------------cccCCCCHHHHHHHHHHc
Confidence 7766655433211111 0 112346778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~ 428 (433)
+.||.+|||+.|+|+||||+.
T Consensus 262 ~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 262 TFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp CSSTTTSCCHHHHHHCHHHHH
T ss_pred CCChhhCcCHHHHhcCHhhcc
Confidence 999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=373.96 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=207.6
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
.|...+.||+|+||.||+|.++.+|+.||||++.... ...+.+..|+.+++.+ .|+||+++++++...+..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEECCEEEEE
Confidence 4888899999999999999999999999999987433 3345677889888877 678999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--------------------- 176 (321)
T 2c30_A 121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--------------------- 176 (321)
T ss_dssp ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---------------------
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---------------------
Confidence 9999 89999998653 6999999999999999999999999999999999999954
Q ss_pred cccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~ 332 (433)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus 177 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~ 250 (321)
T 2c30_A 177 ------DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250 (321)
T ss_dssp ------TCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ------CCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 445677777766543322 23357999999999999999999999999999999999999999877665544
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
..+.....+. . .....+++++.+||.+||+.||+
T Consensus 251 ~~~~~~~~~~----------------------~------------------------~~~~~~~~~l~~li~~~l~~dp~ 284 (321)
T 2c30_A 251 KRLRDSPPPK----------------------L------------------------KNSHKVSPVLRDFLERMLVRDPQ 284 (321)
T ss_dssp HHHHHSSCCC----------------------C------------------------TTGGGSCHHHHHHHHHHSCSSTT
T ss_pred HHHhcCCCCC----------------------c------------------------CccccCCHHHHHHHHHHccCChh
Confidence 3332210000 0 00123567899999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 013973 413 DRLTAREALRHPFFTRDH 430 (433)
Q Consensus 413 ~R~ta~ell~hp~f~~~~ 430 (433)
+|||+.|+|+||||.+..
T Consensus 285 ~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 285 ERATAQELLDHPFLLQTG 302 (321)
T ss_dssp TSCCHHHHHTSGGGGGCC
T ss_pred hCcCHHHHhcChhhccCC
Confidence 999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=377.37 Aligned_cols=282 Identities=28% Similarity=0.465 Sum_probs=221.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++++.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ .|+||+++++++...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-----RHENLVNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-----CCCCEeeEEEEeecCCE
Confidence 46799999999999999999999999999999998533 23345567899999988 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~----------------- 159 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ----------------- 159 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-----------------
T ss_pred EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcC-----------------
Confidence 99999999 666666655443 6999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
++.+||+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+
T Consensus 160 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 160 ----------SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp ----------TSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----------CCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4456677777665433221 234789999999999875 68999999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+....+..++............ .....+.... ........+.++.++.+||.+||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~L 291 (331)
T 4aaa_A 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVF----AGVRLPEIKE--------------REPLERRYPKLSEVVIDLAKKCL 291 (331)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHHHHCGGG----TTCCCCCCSS--------------CCCHHHHSTTSCHHHHHHHHHHT
T ss_pred cHHHHHHHHHHhCCCChhhhhHhhhcccc----ccccCccccc--------------cchhhhcccchhHHHHHHHHHHh
Confidence 99999888888888887655443322111 0111111000 00111223467889999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+.||++|||+.|+|+||||+..
T Consensus 292 ~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 292 HIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccCcccCCCHHHHhcCchhccC
Confidence 9999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=367.96 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=207.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|+||+++++++.+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-----CCCCCcchhheEecCC
Confidence 467999999999999999999999999999999986432 1234566788887777 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~---------------- 144 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS---------------- 144 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECT----------------
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcC----------------
Confidence 999999999 889999998764 7999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.++|+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 145 -----------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 213 (279)
T 3fdn_A 145 -----------AGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213 (279)
T ss_dssp -----------TSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -----------CCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence 4456666666654332222 3357899999999999999999999999999999999999999987766
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+...... .+...+.++.+||.+||+.
T Consensus 214 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~ 244 (279)
T 3fdn_A 214 ETYKRISRVEFT-------------------------------------------------FPDFVTEGARDLISRLLKH 244 (279)
T ss_dssp HHHHHHHHTCCC-------------------------------------------------CCTTSCHHHHHHHHHHCCS
T ss_pred HHHHHHHhCCCC-------------------------------------------------CCCcCCHHHHHHHHHHhcc
Confidence 555443322111 1234567899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
||.+|||+.|+|+||||+..
T Consensus 245 ~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 245 NPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp SGGGSCCHHHHHHCHHHHHH
T ss_pred ChhhCCCHHHHhhCccccCC
Confidence 99999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=366.92 Aligned_cols=259 Identities=24% Similarity=0.460 Sum_probs=214.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
+.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+..|+.+++.+ .|+||+++++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~ 77 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-----RHPNIITLHDIF 77 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-----CCCCeeehhhee
Confidence 3467999999999999999999999999999999986432 1356678899999988 578999999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~---------- 145 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN---------- 145 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----------
T ss_pred cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC----------
Confidence 9999999999999 899999998754 799999999999999999999999999999999999996543
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.....+||+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 146 -------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 146 -------------VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp -------------SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred -------------CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 223478888888886543322 33478999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+....+.......+. ..+...+..+.+||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~ 247 (283)
T 3bhy_A 213 GETKQETLTNISAVNYDFDE---------------------------------------------EYFSNTSELAKDFIR 247 (283)
T ss_dssp CSSHHHHHHHHHTTCCCCCH---------------------------------------------HHHTTCCHHHHHHHH
T ss_pred CcchHHHHHHhHhcccCCcc---------------------------------------------hhcccCCHHHHHHHH
Confidence 87766555443222111111 112356778999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+||+.||++|||+.|+++||||+.
T Consensus 248 ~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 248 RLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp TTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHccCCHhHCcCHHHHHhCHHHHH
Confidence 999999999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=371.20 Aligned_cols=285 Identities=25% Similarity=0.495 Sum_probs=213.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~ 173 (433)
.++|++++.||+|+||.||+|.+..+++.||||+++.. ..+.+..|+.+++.+. +|+||+++++++.. ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR----GGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHT----TSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcC----CCCCEEEeeeeeccCCCCce
Confidence 47899999999999999999999999999999999743 3456788999999994 36889999999987 6789
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ +++|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 109 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---------------- 167 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---------------- 167 (330)
T ss_dssp EEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT----------------
T ss_pred EEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC----------------
Confidence 9999999 889988874 489999999999999999999999999999999999996432
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCC-CCCh
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ-THEN 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~-~~~~ 328 (433)
..+||+|||++....... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.
T Consensus 168 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 237 (330)
T 3nsz_A 168 ----------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237 (330)
T ss_dssp ----------TEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred ----------CEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch
Confidence 357777777776443322 33578999999999987 679999999999999999999999994 4555
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH-HHHhhhcCCchhHHHHHHHhcc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L 407 (433)
.+.+..+...++.. .....+ .......+.. ...+.......... .........++.++.+||.+||
T Consensus 238 ~~~l~~~~~~~~~~--~~~~~~--------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 304 (330)
T 3nsz_A 238 YDQLVRIAKVLGTE--DLYDYI--------DKYNIELDPR---FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 304 (330)
T ss_dssp HHHHHHHHHHHCHH--HHHHHH--------HHTTCCCCTH---HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTS
T ss_pred HHHHHHHHHhcCCc--hhhhHH--------HHhccccccc---hhhhhhhccccchhhhccccccccCCHHHHHHHHHHh
Confidence 66666666665531 111111 1111110000 00000000000000 0001112336789999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.||++|||++|+|+||||++..
T Consensus 305 ~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 305 RYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cCCcccCCCHHHHhcCccHhhhc
Confidence 99999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=370.47 Aligned_cols=284 Identities=29% Similarity=0.482 Sum_probs=221.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-CCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee---
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--- 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--- 168 (433)
.++|++++.||+|+||.||+|.+. .+++.||+|+++... ........|+.+++.+... .|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF--EHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT--CCTTBCCEEEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhcc--CCCCeEeeeeeeeecc
Confidence 478999999999999999999995 678999999986322 1223456788888887542 5688999999886
Q ss_pred --cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 169 --YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 169 --~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
....+++||||++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~----------- 156 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS----------- 156 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-----------
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-----------
Confidence 5678999999998899999988765679999999999999999999999999999999999999544
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 157 ----------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 157 ----------------GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp ----------------CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ----------------CCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 45666666666543321 123478999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+.+..+....+..+...+ +........... .............++.++.+||.
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~------------------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~ 278 (326)
T 1blx_A 221 GSSDVDQLGKILDVIGLPGEEDW------------------PRDVALPRQAFH----SKSAQPIEKFVTDIDELGKDLLL 278 (326)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGS------------------CTTCSSCGGGSC----CCCCCCGGGTCCSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHHcCCCCcccC------------------ccccccchhhhc----ccCcchhhhccccCCHHHHHHHH
Confidence 98888888888777766553321 111000000000 00000112234567889999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||+.||++|||+.|+|+||||++..
T Consensus 279 ~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 279 KCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHcCCCcccCCCHHHHhcCccccccc
Confidence 99999999999999999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=375.47 Aligned_cols=257 Identities=30% Similarity=0.524 Sum_probs=209.9
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
.+.++|++.+.||+|+||.||+|.++.+|+.||||+++... ...+.+..|+.+++.+. +|+||+.++
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~ 166 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA----GHPHIITLI 166 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeEEE
Confidence 44578999999999999999999999999999999986422 12445677889888883 468899999
Q ss_pred ceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 165 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
+++...+..|+||||+ |++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~--------- 235 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--------- 235 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---------
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---------
Confidence 9999999999999999 889999998754 7999999999999999999999999999999999999954
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC------CCCCCcchhHHHHHHHHH
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~e 315 (433)
++.+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 236 ------------------~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 297 (365)
T 2y7j_A 236 ------------------NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297 (365)
T ss_dssp ------------------TCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHH
T ss_pred ------------------CCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHH
Confidence 4566777777665443322 33579999999999974 358899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 316 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 316 lltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
|++|..||...+.......+.......+. ..+...
T Consensus 298 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~ 332 (365)
T 2y7j_A 298 LLAGSPPFWHRRQILMLRMIMEGQYQFSS---------------------------------------------PEWDDR 332 (365)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCH---------------------------------------------HHHSSS
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCCCCC---------------------------------------------cccccC
Confidence 99999999887665554443322111110 112356
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 333 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 778999999999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=377.24 Aligned_cols=284 Identities=24% Similarity=0.421 Sum_probs=218.6
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch------------hhHHHHHHHHHHHHHHHhcCCCCCceE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------------KYREAAMIEIEVLQQLAKHDKGGNRCV 161 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~~~~i~ 161 (433)
.+.++|++.+.||+|+||.||+|.+.. ++.||||++.... ...+.+..|+.+++.+ .|+||+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv 92 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-----HHPNIL 92 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-----CCTTBC
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-----CCcCcc
Confidence 456789999999999999999999865 8889999885321 1236678899999988 678999
Q ss_pred Eecceee-----cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccC
Q 013973 162 QIRNWFD-----YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 236 (433)
Q Consensus 162 ~~~~~~~-----~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~ 236 (433)
++++++. ....+|+||||++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~-- 169 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD-- 169 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--
T ss_pred ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC--
Confidence 9999983 445799999999889999988543 47999999999999999999999999999999999999954
Q ss_pred ccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhC-CCCCCcchhHHHHHHH
Q 013973 237 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCIL 313 (433)
Q Consensus 237 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l 313 (433)
++.+||+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 170 -------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 170 -------------------------NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp -------------------------TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred -------------------------CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHH
Confidence 455677777766533222 233578999999999987 6799999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhh-hhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhc
Q 013973 314 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392 (433)
Q Consensus 314 ~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
|+|++|..||.+.+..+.+..+....+..+......... ....++.......+.. ......
T Consensus 225 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~ 286 (362)
T 3pg1_A 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR------------------AWTAVV 286 (362)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC------------------CHHHHS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh------------------hHHhhC
Confidence 999999999999999999999999888877654433221 1122222211111110 011233
Q ss_pred CCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 393 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 393 ~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
...++.+.+||.+||+.||++|||+.|+|+||||++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 287 PTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 4667889999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=374.25 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=210.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+..|+.+++.+ .|+||+++++++.+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCC
Confidence 46799999999999999999999999999999998643 23455677788888877 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---------------- 176 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE---------------- 176 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT----------------
T ss_pred eEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC----------------
Confidence 999999999 889999988754 7999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 177 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 177 -----------DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp -----------TCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----------CCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 445677777766543321 233579999999999999999999999999999999999999998776
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+... ... .+..++.++.+||.+||
T Consensus 246 ~~~~~~~~~~~-----------------------~~~--------------------------~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 246 LKETYLRIKKN-----------------------EYS--------------------------IPKHINPVAASLIQKML 276 (335)
T ss_dssp HHHHHHHHHHT-----------------------CCC--------------------------CCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHhcC-----------------------CCC--------------------------CCccCCHHHHHHHHHHc
Confidence 55544332211 111 12345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.||++|||+.|+|+||||+...
T Consensus 277 ~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 277 QTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTSC
T ss_pred cCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=366.86 Aligned_cols=274 Identities=21% Similarity=0.293 Sum_probs=205.8
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+.++|++++.||+|+||.||+|.+..+++.||+|+++.. .........|+..+..+. .|+||+++++++.+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~----~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG----QHSHVVRYFSAWAED 83 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC----SCTTBCCEEEEEEET
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC----CCCCeeeeeeeeecC
Confidence 4567899999999999999999999999999999998742 233455666777776662 568899999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
+.+++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999 8899999976421 469999999999999999999999999999999999999877755544332111
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.. .......+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...
T Consensus 164 ~~--------~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 164 DD--------WASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cc--------ccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 00 01345689999999987665433 34699999999999876 5668999999999999999999887543
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
...... ..+.. ...+..++.++.+||.+|
T Consensus 235 ~~~~~~--------------------------~~~~~-------------------------~~~~~~~~~~~~~li~~~ 263 (289)
T 1x8b_A 235 DQWHEI--------------------------RQGRL-------------------------PRIPQVLSQEFTELLKVM 263 (289)
T ss_dssp HHHHHH--------------------------HTTCC-------------------------CCCSSCCCHHHHHHHHHH
T ss_pred hHHHHH--------------------------HcCCC-------------------------CCCCcccCHHHHHHHHHH
Confidence 221111 01100 011235678899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
|+.||++|||+.|+++||||++...
T Consensus 264 l~~dp~~Rps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 264 IHPDPERRPSAMALVKHSVLLSASR 288 (289)
T ss_dssp TCSSGGGSCCHHHHHTCTTC-----
T ss_pred hCCCcccCCCHHHHhhChHhhhhcc
Confidence 9999999999999999999997654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=375.80 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=199.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++++.||+|+||.||+|.+. +++.||||++... ....+.+..|+.+++.+.+ ++++|+++++++...+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh---cCCceEEEeeeEeeCCE
Confidence 467999999999999999999884 5888999998643 2334567789999999965 34789999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+|+|||+.+++|.+++.... .+++.++..++.||+.||+|||++|||||||||+|||++ ++
T Consensus 84 ~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~---------------- 144 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG---------------- 144 (343)
T ss_dssp EEEEECCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT----------------
T ss_pred EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC----------------
Confidence 99999977999999998764 799999999999999999999999999999999999994 23
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhC-----------CCCCCcchhHHHHHHHHHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~el 316 (433)
.+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 145 -----------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~el 213 (343)
T 3dbq_A 145 -----------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213 (343)
T ss_dssp -----------EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHH
T ss_pred -----------cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHH
Confidence 46666666665443222 23479999999999975 6789999999999999999
Q ss_pred HhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 317 CTGEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 317 ltg~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
++|..||...... ..+.. ...+ ..... .+...
T Consensus 214 l~g~~pf~~~~~~~~~~~~---~~~~------------------~~~~~--------------------------~~~~~ 246 (343)
T 3dbq_A 214 TYGKTPFQQIINQISKLHA---IIDP------------------NHEIE--------------------------FPDIP 246 (343)
T ss_dssp HHSSCTTTTCCSHHHHHHH---HHCT------------------TSCCC--------------------------CCCCS
T ss_pred HhCCCcchhhhhHHHHHHH---HhcC------------------CcccC--------------------------CcccC
Confidence 9999999764332 11111 1100 00111 12345
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 668999999999999999999999999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=376.92 Aligned_cols=255 Identities=26% Similarity=0.375 Sum_probs=208.6
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
..+.|++++.||+|+||.||+|++..+++.||||++... ....+.+..|+.+++.+ .|+||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEET
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEEC
Confidence 346799999999999999999999999999999998632 22335677899999988 678999999999999
Q ss_pred CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 171 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 171 ~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
+..++||||+.|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------------- 191 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-------------- 191 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--------------
T ss_pred CeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--------------
Confidence 9999999999889999886543 4799999999999999999999999999999999999996544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
.+||+|||++...... ...+||+.|+|||++. ...++.++|||||||++|||++|..||...+
T Consensus 192 -------------~~kL~DfG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 192 -------------LVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp -------------EEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -------------CEEEeeccCceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5666666666544322 2347999999999996 4678999999999999999999999998877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+.....+ .. ....++..+.+||.+||
T Consensus 258 ~~~~~~~~~~~~~~----------------------~~-------------------------~~~~~~~~l~~li~~~l 290 (348)
T 1u5q_A 258 AMSALYHIAQNESP----------------------AL-------------------------QSGHWSEYFRNFVDSCL 290 (348)
T ss_dssp HHHHHHHHHHSCCC----------------------CC-------------------------CCTTSCHHHHHHHHHHT
T ss_pred hHHHHHHHHhcCCC----------------------CC-------------------------CCCCCCHHHHHHHHHHc
Confidence 65544332221000 00 01245678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.||++|||++|+++||||....
T Consensus 291 ~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 291 QKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp CSSGGGSCCHHHHTTCHHHHSCC
T ss_pred ccChhhCcCHHHHhhChhhhccC
Confidence 99999999999999999997653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=381.75 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=200.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+|++++.||+|+||.||+|.+.. ++.||||++... ....+.+..|+.+++.+.+ +|+||+++++++...+.+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~---~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc---CCCeEEEEEEEEecCCEE
Confidence 469999999999999999999875 889999998643 2345667889999999965 458899999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|||||+.+++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++ +
T Consensus 132 ~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~------------------ 190 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D------------------ 190 (390)
T ss_dssp EEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S------------------
T ss_pred EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C------------------
Confidence 9999977999999998765 799999999999999999999999999999999999993 2
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhC-----------CCCCCcchhHHHHHHHHHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~ell 317 (433)
+.+||+|||++....... ...+||+.|+|||++.+ ..|+.++|||||||++|||+
T Consensus 191 ---------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell 261 (390)
T 2zmd_A 191 ---------GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261 (390)
T ss_dssp ---------SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred ---------CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence 346666666665443221 23479999999999976 36899999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 318 TGEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 318 tg~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
+|..||...... ..+..+ ..+ ..... .+...+
T Consensus 262 ~G~~Pf~~~~~~~~~~~~~---~~~------------------~~~~~--------------------------~~~~~~ 294 (390)
T 2zmd_A 262 YGKTPFQQIINQISKLHAI---IDP------------------NHEIE--------------------------FPDIPE 294 (390)
T ss_dssp HSSCTTTTCCCHHHHHHHH---HCT------------------TSCCC--------------------------CCCCSC
T ss_pred HCCCcchhhhHHHHHHHHH---hCc------------------cccCC--------------------------CCccch
Confidence 999999764332 221111 100 00011 122446
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 295 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 295 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 689999999999999999999999999999643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=371.68 Aligned_cols=296 Identities=27% Similarity=0.417 Sum_probs=217.7
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
..+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+ .|+||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-----KHENIITIFNIQRPD 81 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCS
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-----cCCCcCCeeeeeccc
Confidence 34568899999999999999999999999999999999632 23445667899999988 678999999877653
Q ss_pred -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 171 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 171 -----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...|+||||++++|.+++... .+++..+..++.||+.||.|||++|||||||||+|||++.++.++|+|||+
T Consensus 82 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CSTTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ccCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 789999999988999999874 699999999999999999999999999999999999997666555555555
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+........... . ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 159 a~~~~~~~~~~~----------~----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 159 ARIIDESAADNS----------E----PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp CEECC------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccc----------C----ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 433321110000 0 0000001122478999999999875 678999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHH--hhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRV--DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
+.+..+.+..+....+..+....... ......++..- ...+ .......+..++.++.+|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~------------------~~~~~~~~~~~~~~~~~l 285 (353)
T 2b9h_A 225 GRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSL-PMYP------------------AAPLEKMFPRVNPKGIDL 285 (353)
T ss_dssp CSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTS-CCCC------------------CCCHHHHSTTSCHHHHHH
T ss_pred CCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcc-cCCC------------------CcchhhhcccCCHHHHHH
Confidence 99888888888877776542110000 00000000000 0000 000112334678899999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|.+||+.||++|||+.|+|+||||+..
T Consensus 286 i~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 286 LQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhcCcCcccCCCHHHHhcCcccccc
Confidence 999999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=368.49 Aligned_cols=286 Identities=27% Similarity=0.441 Sum_probs=218.1
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee---
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--- 167 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~--- 167 (433)
+..+.++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-----DHDNIVKVFEILGPS 80 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECTT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-----CCCCeeEEEEecccc
Confidence 3456789999999999999999999999999999999986432 3456677899998888 678999998876
Q ss_pred -----------ecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccC
Q 013973 168 -----------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 236 (433)
Q Consensus 168 -----------~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~ 236 (433)
.....+|+||||++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-- 155 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-- 155 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--
T ss_pred ccccccccccccccCceeEEeeccCCCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--
Confidence 34578999999998899999965 36999999999999999999999999999999999999963
Q ss_pred ccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhC-CCCCCcchhHHH
Q 013973 237 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSV 309 (433)
Q Consensus 237 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSl 309 (433)
.++.+||+|||.+...... .....||..|+|||++.+ ..++.++|||||
T Consensus 156 ------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 211 (320)
T 2i6l_A 156 ------------------------EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211 (320)
T ss_dssp ------------------------TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred ------------------------CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence 2235566666665543221 123467999999999876 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 310 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 310 Gv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
||++|||++|..||.+.+..+....+....+................++.... ..+. ....
T Consensus 212 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~------------------~~~~ 272 (320)
T 2i6l_A 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDM-TEPH------------------KPLT 272 (320)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHT-TSCC------------------CCHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccc-cCCC------------------CChh
Confidence 99999999999999999888888888777776666554443332222211100 0000 0011
Q ss_pred hhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.....++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 273 QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 23346788999999999999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=365.39 Aligned_cols=252 Identities=24% Similarity=0.427 Sum_probs=209.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|+||+++++++.+.+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-----RHPNILRMYNYFHDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-----CCCCEeeEEEEEEcCC
Confidence 467999999999999999999999999999999986432 1235567788888887 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---------------- 149 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY---------------- 149 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT----------------
T ss_pred EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC----------------
Confidence 999999999 789999998765 7999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC-CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.+||+|||.+...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 150 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 218 (284)
T 2vgo_A 150 -----------KGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218 (284)
T ss_dssp -----------TCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -----------CCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence 445667777766543322 23357899999999999999999999999999999999999999877665
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.. .... .+..++.++.+||.+||+.
T Consensus 219 ~~~~~~~~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 219 ETHRRIVN-----------------------VDLK--------------------------FPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp HHHHHHHT-----------------------TCCC--------------------------CCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHhc-----------------------cccC--------------------------CCCcCCHHHHHHHHHHhhc
Confidence 54433221 1111 1234567899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~~ 430 (433)
||.+|||+.|+++||||+...
T Consensus 250 ~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 250 HPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp SGGGSCCHHHHHTCHHHHHHC
T ss_pred CHhhCCCHHHHhhCHHHHhhc
Confidence 999999999999999997543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=371.94 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=195.1
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 171 (433)
+.++|++++.||+|+||.||+|+++.+++.||||+++.. ....+.+..|+.+++++ .|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-----CCTTBCCEEEEEEECCS
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEEecc
Confidence 346799999999999999999999999999999998732 33456778899999888 6799999999875432
Q ss_pred --------------------------------------------------------eEEEEEecC-CCCHHHHHHhcCC-
Q 013973 172 --------------------------------------------------------HICIVFEKL-GSSLYDFLRKNNY- 193 (433)
Q Consensus 172 --------------------------------------------------------~~~lV~e~~-~~~L~~~l~~~~~- 193 (433)
.+++||||+ +++|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 489999999 8999999987542
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCc
Q 013973 194 RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273 (433)
Q Consensus 194 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 273 (433)
...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........... ....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~--------~~~~---- 226 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT--------VLTP---- 226 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC---------------------
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcc--------cccc----
Confidence 2356667899999999999999999999999999999996666555555555443322110000 0000
Q ss_pred cccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHHHHhh
Q 013973 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV-LGPLPQHMLKRVDR 352 (433)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~ 352 (433)
..........+||+.|+|||++.+..++.++|||||||++|||++|..|+.. ....+... .+..|..
T Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~------- 294 (332)
T 3qd2_B 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLL------- 294 (332)
T ss_dssp -----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHH-------
T ss_pred ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCcc-------
Confidence 0000011234799999999999999999999999999999999998776521 11111111 0111110
Q ss_pred hhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 353 HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
....++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 295 ---------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 295 ---------------------------------------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp ---------------------------------------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ---------------------------------------cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 1123457789999999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=369.31 Aligned_cols=260 Identities=23% Similarity=0.418 Sum_probs=212.6
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|+++.... ....+..|+.+++.+ .|+||+++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-----KHENIVTLEDIYESTTH 80 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-----CCTTBCCEEEEEECSSE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-----CCCCeeehhhhcccCCE
Confidence 345789999999999999999999999999999999975432 334567899999888 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+..+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~---------------- 142 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP---------------- 142 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS----------------
T ss_pred EEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC----------------
Confidence 99999999 889999998764 79999999999999999999999999999999999999321
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.++.+||+|||.+....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||......+
T Consensus 143 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 214 (304)
T 2jam_A 143 --------EENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214 (304)
T ss_dssp --------STTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred --------CCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 234567777777765443322 23479999999999999999999999999999999999999998877655
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+..... .++. ..++.++.++.+||.+||+.|
T Consensus 215 ~~~~i~~~~~-----------------------~~~~----------------------~~~~~~~~~~~~li~~~l~~d 249 (304)
T 2jam_A 215 LFEKIKEGYY-----------------------EFES----------------------PFWDDISESAKDFICHLLEKD 249 (304)
T ss_dssp HHHHHHHCCC-----------------------CCCT----------------------TTTTTSCHHHHHHHHHHHCSS
T ss_pred HHHHHHcCCC-----------------------CCCc----------------------cccccCCHHHHHHHHHHcCCC
Confidence 5444332111 1110 112356778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|++|||+.|+|+||||+..
T Consensus 250 p~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 250 PNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTSCCHHHHHTSHHHHSS
T ss_pred hhHCcCHHHHhcCccccCC
Confidence 9999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=377.00 Aligned_cols=247 Identities=27% Similarity=0.463 Sum_probs=205.6
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---------hHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
.+.++|++++.||+|+||.||+|+++.+++.||||+++.... ....+..|+.+++.+ .|+||++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~~~ 95 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-----EHANIIKVL 95 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-----CCTTBCCEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-----CCCCEeeEE
Confidence 456789999999999999999999999999999999975321 223456789998888 678999999
Q ss_pred ceeecCCeEEEEEecC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCC
Q 013973 165 NWFDYRNHICIVFEKL-GS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~d 242 (433)
+++...+.+++||||+ +| +|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--------- 164 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA--------- 164 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---------
Confidence 9999999999999998 44 9999998764 799999999999999999999999999999999999994
Q ss_pred CcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhC
Q 013973 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg 319 (433)
.++.+||+|||++....... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus 165 ------------------~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 226 (335)
T 3dls_A 165 ------------------EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226 (335)
T ss_dssp ------------------TTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred ------------------CCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhC
Confidence 45567777777776544333 34579999999999998876 7899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
..||...... . .... ..+..++.++
T Consensus 227 ~~pf~~~~~~----------------------------~-~~~~--------------------------~~~~~~~~~l 251 (335)
T 3dls_A 227 ENPFCELEET----------------------------V-EAAI--------------------------HPPYLVSKEL 251 (335)
T ss_dssp SCSCSSGGGG----------------------------T-TTCC--------------------------CCSSCCCHHH
T ss_pred CCchhhHHHH----------------------------H-hhcc--------------------------CCCcccCHHH
Confidence 9999642110 0 0000 0123467789
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+||.+||+.||++|||+.|+++||||++.
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=389.05 Aligned_cols=261 Identities=31% Similarity=0.499 Sum_probs=202.5
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh---------hHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
.+.++|.+.+.||+|+||.||+|.++.+++.||||++..... ....+..|+.+++++ .|+||++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~ 206 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKIK 206 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-----CCTTBCCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-----CCCCEeeEE
Confidence 446789999999999999999999999999999999874321 122467899999998 678999999
Q ss_pred ceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 165 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
+++.. +.+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||++..+
T Consensus 207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~------- 276 (419)
T 3i6u_A 207 NFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------- 276 (419)
T ss_dssp EEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-------
T ss_pred EEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC-------
Confidence 99864 5589999999 899999887654 799999999999999999999999999999999999995432
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC---CCCCCcchhHHHHHHHHHHHh
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~ellt 318 (433)
.+..+||+|||++....... ...+||+.|+|||++.+ ..|+.++|||||||++|+|++
T Consensus 277 -----------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt 339 (419)
T 3i6u_A 277 -----------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339 (419)
T ss_dssp -----------------SSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred -----------------CcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence 23468888888887654332 34689999999999864 568899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||........+... +..+...+. ...+..++.+
T Consensus 340 g~~pf~~~~~~~~~~~~----------------------i~~~~~~~~----------------------~~~~~~~~~~ 375 (419)
T 3i6u_A 340 GYPPFSEHRTQVSLKDQ----------------------ITSGKYNFI----------------------PEVWAEVSEK 375 (419)
T ss_dssp SSCSSCCCSSSCCHHHH----------------------HHTTCCCCC----------------------HHHHTTSCHH
T ss_pred CCCCCCCCcchHHHHHH----------------------HhcCCCCCC----------------------chhhcccCHH
Confidence 99999764432111110 111111110 1123456788
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.+||.+||+.||++|||++|+|+||||++..
T Consensus 376 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred HHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 99999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=379.46 Aligned_cols=262 Identities=24% Similarity=0.384 Sum_probs=209.4
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+..|+.+++.+ .|+||+++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~ 97 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-----HHPNIARLYEVY 97 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-----CCCCcceeehhh
Confidence 3457899999999999999999999999999999998643 23346678899999988 579999999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHH
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNN--------------------------------------YRSFPIDLVREIARQL 208 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi 208 (433)
.+.+.+++||||+ |++|.+++.... ...+++..+..++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999 999999985210 1124677888999999
Q ss_pred HHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-------CC
Q 013973 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QN 281 (433)
Q Consensus 209 ~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~ 281 (433)
+.||+|||++||+||||||+|||++.++ ...+||+|||++...... ..
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 232 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNK-------------------------SFEIKLVDFGLSKEFYKLNNGEYYGMT 232 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSS-------------------------SCCEEECCCTTCEEGGGTTCC------
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCC-------------------------CceEEEeeccccccccccCcccccccc
Confidence 9999999999999999999999995432 236788888877643221 12
Q ss_pred ceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhc
Q 013973 282 YIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 359 (433)
Q Consensus 282 ~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 359 (433)
...||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+.......+
T Consensus 233 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 296 (345)
T 3hko_A 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE---------------- 296 (345)
T ss_dssp --CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT----------------
T ss_pred ccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC----------------
Confidence 3579999999999975 6789999999999999999999999998877665544332111100
Q ss_pred cCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 360 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
. .....+++++.+||.+||+.||.+|||+.|+|+||||++-.
T Consensus 297 -------~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 297 -------N----------------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp -------S----------------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred -------C----------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 0 01123567899999999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=361.97 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=184.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.+++.+ .|+||+++++++.+.+.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-----KHPSILELYNYFEDSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-----CCTTBCCEEEEEECSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-----CCCCeEeEEEEEccCCe
Confidence 579999999999999999999999999999999964321 235567788888777 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
.++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~----------------- 147 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR----------------- 147 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT-----------------
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-----------------
Confidence 99999999 889999998653 47999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
++.+||+|||.+...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 148 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 148 ----------NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ----------TCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred ----------CCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 455677777766543321 1235789999999999998999999999999999999999999986543
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.... +...... .+..++.++.+||.+||+
T Consensus 218 ~~~~~~-----------------------~~~~~~~--------------------------~~~~~~~~~~~li~~~l~ 248 (278)
T 3cok_A 218 KNTLNK-----------------------VVLADYE--------------------------MPSFLSIEAKDLIHQLLR 248 (278)
T ss_dssp C----------------------------CCSSCCC--------------------------CCTTSCHHHHHHHHHHSC
T ss_pred HHHHHH-----------------------HhhcccC--------------------------CccccCHHHHHHHHHHcc
Confidence 222111 0000011 123467789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.||++|||+.|+++||||++..
T Consensus 249 ~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 249 RNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SSGGGSCCHHHHTTSTTTC---
T ss_pred cCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=362.18 Aligned_cols=258 Identities=29% Similarity=0.504 Sum_probs=210.8
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----------hhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
+.++|++.+.||+|+||.||+|.++.+++.||||+++... ...+.+..|+.+++++. +|+||++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~ 90 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS----GHPNIIQLK 90 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeeee
Confidence 4578999999999999999999999999999999986431 23455678999998883 368899999
Q ss_pred ceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 165 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
+++...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--------- 159 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--------- 159 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---------
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC---------
Confidence 9999999999999999 889999998754 7999999999999999999999999999999999999954
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhh------CCCCCCcchhHHHHHHHHH
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL------GLGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~e 315 (433)
++.+||+|||.+....... ....||+.|+|||++. ...++.++||||||+++|+
T Consensus 160 ------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~ 221 (298)
T 1phk_A 160 ------------------DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221 (298)
T ss_dssp ------------------TCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred ------------------CCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence 4456777777665443322 2347899999999986 4568899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 316 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 316 lltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
|++|..||...+..+....+..... ..+. ..+..+
T Consensus 222 l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------~~~~----------------------~~~~~~ 256 (298)
T 1phk_A 222 LLAGSPPFWHRKQMLMLRMIMSGNY-----------------------QFGS----------------------PEWDDY 256 (298)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCC-----------------------CCCT----------------------TTGGGS
T ss_pred HHHCCCCCcCccHHHHHHHHhcCCc-----------------------ccCc----------------------cccccc
Confidence 9999999988776555443322111 1110 011245
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 67899999999999999999999999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=380.43 Aligned_cols=293 Identities=22% Similarity=0.340 Sum_probs=211.7
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++...++|++++.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ .|+||+++++++..
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYS 102 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEEEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-----CCCCEEEEeEEEEE
Confidence 344567899999999999999999999999999999999743 33455677888888777 67999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
.+.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+|||++
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~-------------- 166 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-------------- 166 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC--------------
T ss_pred CCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC--------------
Confidence 99999999999 889999998765 799999999999999999999996 999999999999994
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccC-CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 167 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 167 -------------SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp -------------TTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred -------------CCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 45567888888775332 1223457999999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh-----hcCCchhHHHH
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ-----HVDHSAGDLTH 401 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 401 (433)
+..+....+.......+.............+...+....+. ..... ........ ....++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 303 (360)
T 3eqc_A 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP-----MAIFE-----LLDYIVNEPPPKLPSGVFSLEFQD 303 (360)
T ss_dssp CHHHHHHHHC------------------------------C-----CCHHH-----HHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred CHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCc-----ccchh-----hhhHHhccCCCCCCcccccHHHHH
Confidence 76554333222111111111000000000000000000000 00000 00000000 11246788999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
||.+||+.||++|||++|+|+||||++
T Consensus 304 li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 304 FVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=363.07 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=209.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+..|+.+++.+ .|+||+++++++.+.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFEDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeeeccCC
Confidence 46799999999999999999999999999999998643 23455667788888877 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..++||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---------------- 150 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE---------------- 150 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT----------------
T ss_pred EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC----------------
Confidence 999999999 899999988754 7999999999999999999999999999999999999954
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
++.+||+|||.+...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 151 -----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 151 -----------DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp -----------TCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----------CCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 445666666666543221 223478999999999999899999999999999999999999998776
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+.. +... .+...+..+.+||.+||
T Consensus 220 ~~~~~~~~~~-----------------------~~~~--------------------------~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 220 LKETYLRIKK-----------------------NEYS--------------------------IPKHINPVAASLIQKML 250 (294)
T ss_dssp HHHHHHHHHT-----------------------TCCC--------------------------CCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHhh-----------------------ccCC--------------------------CccccCHHHHHHHHHHc
Confidence 5544332211 1111 12345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.||++|||+.|+++||||++..
T Consensus 251 ~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 251 QTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ccChhhCcCHHHHhhChheecCC
Confidence 99999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=368.02 Aligned_cols=259 Identities=22% Similarity=0.407 Sum_probs=205.8
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 169 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---- 169 (433)
...++|++++.||+|+||.||+|.+..+++.||||++.........+..|+.+++++. .|+||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC----CSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc----CCCCeeeeeeEEeeccCc
Confidence 3457899999999999999999999999999999999765555677888999998883 46889999999876
Q ss_pred --CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 170 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 170 --~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
.+.+++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~------------ 164 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE------------ 164 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT------------
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC------------
Confidence 56899999999 779999998765457999999999999999999999999999999999999954
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHh
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~ellt 318 (433)
++.+||+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 165 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 229 (326)
T 2x7f_A 165 ---------------NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229 (326)
T ss_dssp ---------------TCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH
T ss_pred ---------------CCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh
Confidence 445666666665543221 23347899999999997 5568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||...+.......+... ..+ . .....++..
T Consensus 230 g~~p~~~~~~~~~~~~~~~~--~~~-----------------------~----------------------~~~~~~~~~ 262 (326)
T 2x7f_A 230 GAPPLCDMHPMRALFLIPRN--PAP-----------------------R----------------------LKSKKWSKK 262 (326)
T ss_dssp SSCTTTTSCHHHHHHHHHHS--CCC-----------------------C----------------------CSCSCSCHH
T ss_pred CCCCCCCCcHHHHHHHhhcC--ccc-----------------------c----------------------CCccccCHH
Confidence 99999876665443322111 000 0 001345778
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.+||.+||+.||.+|||+.|+++||||++..
T Consensus 263 l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 263 FQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 99999999999999999999999999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=360.20 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=202.2
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-----RHPHIIKLYQVIS 81 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-----CCCCEeEEEEEEe
Confidence 344578999999999999999999999999999999986432 2234567788888877 6789999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
..+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~------------- 146 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA------------- 146 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT-------------
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC-------------
Confidence 999999999999 889999998764 6999999999999999999999999999999999999954
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
++.+||+|||.+....... ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.
T Consensus 147 --------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 147 --------------HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp --------------TSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------CCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 4456777777665443322 23478999999999988765 589999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
.....+....+... ... .+..++.++.+||.
T Consensus 213 ~~~~~~~~~~~~~~-----------------------~~~--------------------------~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 213 DEHVPTLFKKIRGG-----------------------VFY--------------------------IPEYLNRSVATLLM 243 (276)
T ss_dssp CSSHHHHHHHHHHC-----------------------CCC--------------------------CCTTSCHHHHHHHH
T ss_pred CCcHHHHHHHhhcC-----------------------ccc--------------------------CchhcCHHHHHHHH
Confidence 76655444332211 111 12245678999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+||+.||.+|||+.|+++||||++.
T Consensus 244 ~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHccCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=380.06 Aligned_cols=259 Identities=14% Similarity=0.121 Sum_probs=190.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc-------
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN------- 165 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~------- 165 (433)
.+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+..|+.+++.+.. .|||+++++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~---~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG---ESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-------------CBCCCCE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc---cChhhhhhceeEEeeeh
Confidence 4599999999999999999999999999999999753 3445566778888888865 5678776443
Q ss_pred eeecC-----------------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHHCCcee
Q 013973 166 WFDYR-----------------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLV------REIARQLLECIAFMHDLCMIH 222 (433)
Q Consensus 166 ~~~~~-----------------~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~ivH 222 (433)
.+... ..+||||||+.++|.+++...+ ..+++... ..++.||+.||+|||++||||
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 22221 4589999999999999998653 23555555 677799999999999999999
Q ss_pred ccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC--CCC
Q 013973 223 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGW 300 (433)
Q Consensus 223 rDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 300 (433)
|||||+|||++ .++.+||+|||++...........||+.|+|||++.+ ..|
T Consensus 218 rDikp~NIll~---------------------------~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 270 (371)
T 3q60_A 218 GHFTPDNLFIM---------------------------PDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATF 270 (371)
T ss_dssp TTCSGGGEEEC---------------------------TTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEEC
T ss_pred CcCCHHHEEEC---------------------------CCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCc
Confidence 99999999994 4556788888877755443334567899999999987 679
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhh--hhccCcccCCCCccchhhHhhh
Q 013973 301 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEK--YVRRGRLDWPEGAASRESIKSV 378 (433)
Q Consensus 301 ~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 378 (433)
+.++|||||||++|||++|..||.+...... ..... ........
T Consensus 271 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--------------------~~~~~~~~~~~~~~~-------------- 316 (371)
T 3q60_A 271 THALNAWQLGLSIYRVWCLFLPFGLVTPGIK--------------------GSWKRPSLRVPGTDS-------------- 316 (371)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT--------------------TCCCBCCTTSCCCCS--------------
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCcCcccc--------------------cchhhhhhhhccccc--------------
Confidence 9999999999999999999999976532100 00000 00000000
Q ss_pred ccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 379 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
........++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 317 --------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 317 --------LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp --------CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred --------cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 000112466889999999999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=359.06 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=203.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---- 169 (433)
..|++.+.||+|+||.||+|.+..++..||+|++... ....+.+..|+.+++.+ .|+||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEESSS
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeeccccCC
Confidence 3489999999999999999999999999999998643 33445667788888877 67899999998765
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
...+++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~------------- 165 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT------------- 165 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-------------
T ss_pred CceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE-------------
Confidence 46799999999 889999998754 7999999999999999999999999 99999999999994
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
..++.+||+|||++....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 166 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 166 -------------GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp -------------STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -------------CCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 144567888888776544332 23579999999998875 599999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
........... ..+.. ........++++.+||.+
T Consensus 232 ~~~~~~~~~~~----------------------~~~~~------------------------~~~~~~~~~~~l~~li~~ 265 (290)
T 1t4h_A 232 CQNAAQIYRRV----------------------TSGVK------------------------PASFDKVAIPEVKEIIEG 265 (290)
T ss_dssp CSSHHHHHHHH----------------------TTTCC------------------------CGGGGGCCCHHHHHHHHH
T ss_pred cCcHHHHHHHH----------------------hccCC------------------------ccccCCCCCHHHHHHHHH
Confidence 55443322110 00000 001123456789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
||+.||.+|||+.|+|+||||+++
T Consensus 266 ~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 266 CIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HccCChhhCCCHHHHhhCcccccC
Confidence 999999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=370.73 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=201.5
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
..+.++|++.+.||+|+||.||+|.+..+++.||||+++... .....+..|+.+++.+ .|+||+++++++.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~ 82 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTGE 82 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-----CCTTBCCEEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-----CCCCcceEEEeee
Confidence 456788999999999999999999999999999999997432 2234456677766665 6799999999887
Q ss_pred cCC----eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 169 YRN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 169 ~~~----~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
... ..|+||||+ |++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------- 153 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN------- 153 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-------
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-------
Confidence 644 459999999 899999998765 799999999999999999999999999999999999996555
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHH
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 317 (433)
.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 --------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 213 (311)
T 3ork_A 154 --------------------AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213 (311)
T ss_dssp --------------------CEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred --------------------CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence 4555555555432221 12346999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
+|..||.+.+..+....+.... ..+. ......++.
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~-~~~~--------------------------------------------~~~~~~~~~ 248 (311)
T 3ork_A 214 TGEPPFTGDSPVSVAYQHVRED-PIPP--------------------------------------------SARHEGLSA 248 (311)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCC-CCCH--------------------------------------------HHHSTTCCH
T ss_pred hCCCCCCCCChHHHHHHHhcCC-CCCc--------------------------------------------ccccCCCCH
Confidence 9999998877665443322211 1110 011235678
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
++.+||.+||+.||++||++.+++.|+|++
T Consensus 249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 249 DLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 899999999999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=361.38 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=188.8
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHH--HHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~--~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
..++|++++.||+|+||.||+|.+..+++.||+|+++....... ....|...+ + ....|+||+++++++...+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~--~--~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS--M--RTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHH--H--TTCCCTTBCCEEEEEECSSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHH--H--HhCCCCeEEEEeeeeeccCC
Confidence 35789999999999999999999999999999999974322222 222222221 1 22378999999999999999
Q ss_pred EEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
.++||||++++|.+++.. .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~------------- 147 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG------------- 147 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-------------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-------------
Confidence 999999998899888764 1235799999999999999999999998 999999999999995444
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhh----hCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
.+||+|||.+....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 148 --------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 148 --------------QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp --------------CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred --------------CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 56666666654333222 224689999999997 4567899999999999999999999999
Q ss_pred CCCCh-HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 324 QTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 324 ~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
..... ......... ......+ ...++.++.+|
T Consensus 214 ~~~~~~~~~~~~~~~----------------------~~~~~~~-------------------------~~~~~~~~~~l 246 (290)
T 3fme_A 214 DSWGTPFQQLKQVVE----------------------EPSPQLP-------------------------ADKFSAEFVDF 246 (290)
T ss_dssp CCCSCHHHHHHHHHH----------------------SCCCCCC-------------------------TTTSCHHHHHH
T ss_pred cccCchHHHHHHHhc----------------------cCCCCcc-------------------------cccCCHHHHHH
Confidence 86433 222221111 0000000 12457789999
Q ss_pred HHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 403 LQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|.+||+.||++|||+.|+++||||+.
T Consensus 247 i~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 247 TSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHhhcChhhCcCHHHHHhCccccc
Confidence 99999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=361.33 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=203.2
Q ss_pred cCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 91 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 91 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.++.+.++|++++.||+|+||.||+|.+..+++.||+|++.. .....+.+..|+.+++.+ .|+||++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~ 79 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-----SHQNIVSMIDV 79 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CBTTBCCEEEE
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-----CCCCCceEEEe
Confidence 456778899999999999999999999999999999999853 223345667788888777 67899999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
+...+.+|+||||+ |++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~----------- 146 (294)
T 4eqm_A 80 DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS----------- 146 (294)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-----------
T ss_pred eeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-----------
Confidence 99999999999999 889999998765 7999999999999999999999999999999999999954
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
++.+||+|||++....... ...+||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 147 ----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 210 (294)
T 4eqm_A 147 ----------------NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210 (294)
T ss_dssp ----------------TSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ----------------CCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 4456666666665433221 23479999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.+..+...... ....+. ........++..+.+
T Consensus 211 pf~~~~~~~~~~~~~--~~~~~~------------------------------------------~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 211 PFNGETAVSIAIKHI--QDSVPN------------------------------------------VTTDVRKDIPQSLSN 246 (294)
T ss_dssp SSCSSCHHHHHHHHH--SSCCCC------------------------------------------HHHHSCTTSCHHHHH
T ss_pred CCCCCChHHHHHHHh--hccCCC------------------------------------------cchhcccCCCHHHHH
Confidence 998876654332211 111110 011223456788999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPF 425 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~ 425 (433)
+|.+||+.||.+||+..+.+.+.|
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHhcCCHhHccccHHHHHHHH
Confidence 999999999999996555555544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=387.79 Aligned_cols=248 Identities=18% Similarity=0.247 Sum_probs=195.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec----chhhHHHHHHHHHHHHHHHhcCCCCCceEEec-------
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR------- 164 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~------- 164 (433)
.++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+..|+.+++.+.. ..|+||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG--IKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT--CCSHHHHHHHHCBCCCS
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc--cCCHHHHHHHhhhhhhh
Confidence 4679999999999999999999999999999999863 22345667788876665533 2679999888
Q ss_pred ceeecCC-----------------eEEEEEecCCCCHHHHHHhcCCCCCCH-------HHHHHHHHHHHHHHHHHHHCCc
Q 013973 165 NWFDYRN-----------------HICIVFEKLGSSLYDFLRKNNYRSFPI-------DLVREIARQLLECIAFMHDLCM 220 (433)
Q Consensus 165 ~~~~~~~-----------------~~~lV~e~~~~~L~~~l~~~~~~~l~~-------~~~~~i~~qi~~~L~~LH~~~i 220 (433)
++++..+ ..||||||++|+|.+++...+ .+++ ..+..++.||+.||+|||++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4444443 389999999999999998653 3444 7888899999999999999999
Q ss_pred eeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC--
Q 013973 221 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-- 298 (433)
Q Consensus 221 vHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-- 298 (433)
|||||||+|||++ .++.+||+|||++..........+| +.|+|||++.+.
T Consensus 228 vHrDikp~NIll~---------------------------~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 228 VHTYLRPVDIVLD---------------------------QRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp ECSCCCGGGEEEC---------------------------TTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTS
T ss_pred ecCCCCHHHEEEc---------------------------CCCCEEEEechhheecCCcccCCCC-cCccChhhhccccc
Confidence 9999999999994 4456777777777654443344578 999999999987
Q ss_pred ---------CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCc
Q 013973 299 ---------GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 369 (433)
Q Consensus 299 ---------~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (433)
.|+.++|||||||++|||++|..||.+.+..+...
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~------------------------------------ 323 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE------------------------------------ 323 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG------------------------------------
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh------------------------------------
Confidence 89999999999999999999999997533211000
Q ss_pred cchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 370 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
........++.++.+||.+||+.||++|||+.|+++||||++
T Consensus 324 -----------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 324 -----------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp -----------------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred -----------------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 000112356788999999999999999999999999999964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=371.66 Aligned_cols=281 Identities=20% Similarity=0.323 Sum_probs=208.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 171 (433)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+..|+.+++.+ .|+||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEEETTT 81 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECTTT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCCcceEEEEeecCCC
Confidence 3467999999999999999999999999999999997432 2345667899999988 6789999999887654
Q ss_pred -eEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 172 -HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 172 -~~~lV~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
..|+||||+ +++|.+++..... ..+++..+..++.||+.||+|||++|||||||||+|||+....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------------ 149 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE------------ 149 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT------------
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC------------
Confidence 889999999 8999999986532 2399999999999999999999999999999999999983221
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhh--------CCCCCCcchhHHHHHHHHHHHh
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL--------GLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGv~l~ellt 318 (433)
+..+.+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|||++
T Consensus 150 -----------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~ 218 (319)
T 4euu_A 150 -----------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (319)
T ss_dssp -----------TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH
T ss_pred -----------CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh
Confidence 334567888888886544333 2357999999999997 5678999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 319 GEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 319 g~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
|..||...... .....+...+...|...+..+. ....+.+.|........ .....++.
T Consensus 219 g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~----------------~~~~~~~~ 277 (319)
T 4euu_A 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ-----KAENGPIDWSGDMPVSC----------------SLSRGLQV 277 (319)
T ss_dssp SSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEE-----CSTTCCEEEESSCCTTC----------------SSCHHHHH
T ss_pred CCCCCCCCCccchhHHHHHHHhcCCCcccchhhh-----cccCCccccCccCCccc----------------ccchhHHH
Confidence 99999753321 1122222222222211100000 00111222221111000 11224566
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhcCC
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALRHP 424 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~hp 424 (433)
.+.+||.+||+.||++|||++|+|+||
T Consensus 278 ~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 278 LLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HhHHHHHHhccCChhhhccHHHhhhcc
Confidence 889999999999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=367.29 Aligned_cols=260 Identities=31% Similarity=0.508 Sum_probs=206.0
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.+++.+ .|+||++++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~ 81 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKIK 81 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-----CCTTBCCEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-----CCCCCceEe
Confidence 45578999999999999999999999999999999986432 1223467899999988 678999999
Q ss_pred ceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 165 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
+++.... +|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------- 151 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------- 151 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-------
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC-------
Confidence 9987665 89999999 889999997653 799999999999999999999999999999999999995432
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHh
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~ellt 318 (433)
.+..+||+|||++....... ....||+.|+|||++. ...++.++|||||||++|+|++
T Consensus 152 -----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~ 214 (322)
T 2ycf_A 152 -----------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214 (322)
T ss_dssp -----------------SSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence 23458999999887654332 2347899999999985 4568999999999999999999
Q ss_pred CCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 319 GEALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 319 g~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
|..||....... ....+.. +.... ....+..++.
T Consensus 215 g~~pf~~~~~~~~~~~~~~~-----------------------~~~~~----------------------~~~~~~~~~~ 249 (322)
T 2ycf_A 215 GYPPFSEHRTQVSLKDQITS-----------------------GKYNF----------------------IPEVWAEVSE 249 (322)
T ss_dssp SSCSSCSTTCSSCHHHHHHH-----------------------TCCCC----------------------CHHHHTTSCH
T ss_pred CCCCCcccchHHHHHHHHHh-----------------------Ccccc----------------------CchhhhhcCH
Confidence 999997644321 1111111 10000 0111235677
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 250 ~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 899999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=358.51 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=204.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++++.+.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-----CCCCceeeeeEEEcCCEE
Confidence 467999999999999999999999999999999986432 3446677888888877 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~------------------ 140 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE------------------ 140 (276)
T ss_dssp EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT------------------
T ss_pred EEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc------------------
Confidence 9999999 78999998654 37999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.+||+|||.+...... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 141 ---------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 141 ---------RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp ---------TCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred ---------CCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 445666666666433211 123478999999999988765 68899999999999999999999865
Q ss_pred ChHHH-HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 327 ENLEH-LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 327 ~~~~~-~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
..... ...+.. . .... ..+...+.++.+||.+
T Consensus 212 ~~~~~~~~~~~~----------------------~-~~~~------------------------~~~~~~~~~~~~li~~ 244 (276)
T 2yex_A 212 SDSCQEYSDWKE----------------------K-KTYL------------------------NPWKKIDSAPLALLHK 244 (276)
T ss_dssp CTTSHHHHHHHT----------------------T-CTTS------------------------TTGGGSCHHHHHHHHH
T ss_pred chHHHHHHHhhh----------------------c-cccc------------------------CchhhcCHHHHHHHHH
Confidence 43211 111000 0 0000 0112456789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCCCC
Q 013973 406 LLRYDPTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~hp~f~~~~~ 431 (433)
||+.||++|||+.|+++||||++...
T Consensus 245 ~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 245 ILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HCCCCchhCCCHHHHhcCccccChhh
Confidence 99999999999999999999987654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=372.38 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=201.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
.++|++++.||+|+||.||+|++. .+++.||||+++... ...+.+..|+.+++.+. +|++|+.+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~ 128 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAF 128 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH----TCTTBCCEEEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc----CCCceeEEEEEE
Confidence 368999999999999999999984 588999999986321 23345667899999885 357899999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
...+.+++||||+ +++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------------ 194 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS------------ 194 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT------------
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC------------
Confidence 9999999999999 889999998764 7999999999999999999999999999999999999954
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHHhCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~ 320 (433)
++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 195 ---------------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~ 259 (355)
T 1vzo_A 195 ---------------NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259 (355)
T ss_dssp ---------------TSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------CCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 445666666666533221 123579999999999986 34789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||...........+... +.... ...+..++..+.
T Consensus 260 ~pf~~~~~~~~~~~~~~~-------------------~~~~~--------------------------~~~~~~~~~~~~ 294 (355)
T 1vzo_A 260 SPFTVDGEKNSQAEISRR-------------------ILKSE--------------------------PPYPQEMSALAK 294 (355)
T ss_dssp CTTSCTTSCCCHHHHHHH-------------------HHHCC--------------------------CCCCTTSCHHHH
T ss_pred CCCccCCccchHHHHHHH-------------------HhccC--------------------------CCCCcccCHHHH
Confidence 999754321111111000 00000 012235677899
Q ss_pred HHHHhccccCCCCCC-----CHHHHhcCCCCCCC
Q 013973 401 HLLQGLLRYDPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 401 ~li~~~L~~dP~~R~-----ta~ell~hp~f~~~ 429 (433)
+||.+||+.||.+|| ++.|+++||||+..
T Consensus 295 ~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 999999999999999 99999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=370.88 Aligned_cols=263 Identities=29% Similarity=0.490 Sum_probs=183.0
Q ss_pred eecCcEEEEe-eeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 94 NLTSRYKIHS-KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 94 ~~~~~~~~~~-~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
.+.++|++++ .||+|+||.||+|.++.+++.||||++...... ..|+..+.+. ..|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~----~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQA----SGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHH----TTSTTBCCEEEEEEEEET
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHh----cCCCChHHHHHHHhhccC
Confidence 4567899965 699999999999999999999999999754332 2233333222 166889999998876
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
...+++||||+ |++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~------------ 164 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK------------ 164 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS------------
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEec------------
Confidence 56699999999 8899999998766679999999999999999999999999999999999999543
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
+.++.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 165 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 165 ------------EKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp ------------STTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ------------CCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 234568999999887544332 3457899999999998888999999999999999999999999765
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
........+.. .+..+....+. ..+..++.++.+||.+|
T Consensus 233 ~~~~~~~~~~~-------------------~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~ 271 (336)
T 3fhr_A 233 TGQAISPGMKR-------------------RIRLGQYGFPN----------------------PEWSEVSEDAKQLIRLL 271 (336)
T ss_dssp -------------------------------------CCCT----------------------TTSTTCCHHHHHHHHHH
T ss_pred cchhhhhhHHH-------------------hhhccccccCc----------------------hhhccCCHHHHHHHHHH
Confidence 43322111000 01111111111 11235678899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|+.||.+|||+.|+|+||||++.
T Consensus 272 L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 272 LKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CCCChhHCcCHHHHhcCcccccc
Confidence 99999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=362.36 Aligned_cols=255 Identities=25% Similarity=0.466 Sum_probs=203.6
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee--
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-- 167 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-- 167 (433)
+.++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+..|+.+++.+ .|+||+++++++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~ 77 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-----RHKNVIQLVDVLYN 77 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-----CCCCeeEEEEEEEc
Confidence 4578999999999999999999999999999999997432 2345677888888877 678999999988
Q ss_pred ecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 168 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 168 ~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
.....+|+||||+.++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~------------ 145 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG------------ 145 (305)
T ss_dssp C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT------------
T ss_pred CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC------------
Confidence 55678999999996669898887666689999999999999999999999999999999999999544
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCC--CCCcchhHHHHHHHHHHHhCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~ 320 (433)
+.+||+|||.+....... ....||+.|+|||++.+.. ++.++||||||+++|+|++|.
T Consensus 146 ---------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 210 (305)
T 2wtk_C 146 ---------------GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210 (305)
T ss_dssp ---------------CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSS
T ss_pred ---------------CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCC
Confidence 456666666655432211 2346899999999998754 378999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||.+.+..+....+.. +... .+..++.++.
T Consensus 211 ~p~~~~~~~~~~~~i~~-----------------------~~~~--------------------------~~~~~~~~l~ 241 (305)
T 2wtk_C 211 YPFEGDNIYKLFENIGK-----------------------GSYA--------------------------IPGDCGPPLS 241 (305)
T ss_dssp CSCCCSSHHHHHHHHHH-----------------------CCCC--------------------------CCSSSCHHHH
T ss_pred CCCCCchHHHHHHHHhc-----------------------CCCC--------------------------CCCccCHHHH
Confidence 99988765554433221 1111 1234567899
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||.+||+.||.+|||+.|+++||||++..
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 999999999999999999999999997653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=358.82 Aligned_cols=258 Identities=24% Similarity=0.421 Sum_probs=205.8
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
...++|++++.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ .|+||+++++++...+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-----DHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECC-C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-----CCCCEeeeeeeeeeCCe
Confidence 4567899999999999999999999999999999998643 23446677899999887 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~------------------ 151 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT------------------ 151 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC------------------
T ss_pred EEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC------------------
Confidence 99999999 889999987643 4699999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCEEEEecCCccccC---CCCCceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
.++.+||+|||++.... .......||+.|+|||++. +..++.++||||||+++|+|++|..||
T Consensus 152 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 222 (302)
T 2j7t_A 152 ---------LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222 (302)
T ss_dssp ---------TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ---------CCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCC
Confidence 44567777777653211 1123347899999999984 567899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
...+..+....+.....+. . ..+..++.++.+||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~----------------------~------------------------~~~~~~~~~l~~li 256 (302)
T 2j7t_A 223 HELNPMRVLLKIAKSDPPT----------------------L------------------------LTPSKWSVEFRDFL 256 (302)
T ss_dssp TTSCHHHHHHHHHHSCCCC----------------------C------------------------SSGGGSCHHHHHHH
T ss_pred ccCCHHHHHHHHhccCCcc----------------------c------------------------CCccccCHHHHHHH
Confidence 8876655443322110000 0 01124567899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||+.||++|||+.|+++||||++..
T Consensus 257 ~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 257 KIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHcccChhhCCCHHHHhcChHHhhhc
Confidence 999999999999999999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=360.97 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=204.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+ .|+||+++++++...+.+|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-----DSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCCEEE
Confidence 4567999999999999999999999999999999997533 345677899998887 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.
T Consensus 101 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~------------------- 160 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT------------------- 160 (314)
T ss_dssp EEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-------------------
T ss_pred EEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC-------------------
Confidence 999999 779999997433 47999999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+||+|||.+...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 161 --------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 161 --------EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp --------TCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred --------CCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 445667777766543322 123478999999999999999999999999999999999999998766554
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+.....+ .+ ..+..++.++.+||.+||+.|
T Consensus 233 ~~~~~~~~~~~----------------------~~------------------------~~~~~~~~~l~~li~~~l~~d 266 (314)
T 3com_A 233 AIFMIPTNPPP----------------------TF------------------------RKPELWSDNFTDFVKQCLVKS 266 (314)
T ss_dssp HHHHHHHSCCC----------------------CC------------------------SSGGGSCHHHHHHHHHHTCSC
T ss_pred HHHHHhcCCCc----------------------cc------------------------CCcccCCHHHHHHHHHHccCC
Confidence 33322111000 00 001234678999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~ 430 (433)
|.+|||+.|+++||||+...
T Consensus 267 p~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 267 PEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp TTTSCCHHHHTTSHHHHTCC
T ss_pred hhhCcCHHHHHhCHHHhcCC
Confidence 99999999999999998653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=352.73 Aligned_cols=259 Identities=19% Similarity=0.240 Sum_probs=206.3
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+..|+.+++.+.+ |++++.+++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~~----~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAG----CTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTT----CTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHhc----CCCCCeEEeecCCCc
Confidence 345678899999999999999999999999999999998643 233456778998888843 466888888999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
..++||||++++|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 80 ~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-------------- 144 (298)
T 1csn_A 80 HNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS-------------- 144 (298)
T ss_dssp EEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS--------------
T ss_pred eeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC--------------
Confidence 999999999999999998754 46999999999999999999999999999999999999976543
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
.....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 145 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 145 --------KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp --------TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred --------CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCC
Confidence 23345778888877644322 133579999999999999999999999999999999999999
Q ss_pred CCCCCC---hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 322 LFQTHE---NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 322 Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
||.+.+ ..+.+..+....... ........++.+
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~ 252 (298)
T 1csn_A 217 PWQGLKAATNKQKYERIGEKKQST--------------------------------------------PLRELCAGFPEE 252 (298)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHS--------------------------------------------CHHHHTTTSCHH
T ss_pred CcchhhccccHHHHHHHHhhccCc--------------------------------------------cHHHHHhhCcHH
Confidence 998743 222222221111000 011122356789
Q ss_pred HHHHHHhccccCCCCCCCHHHHhc
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
+.+||.+||+.||++|||+.++++
T Consensus 253 l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 253 FYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCcccCCCHHHHHH
Confidence 999999999999999999998875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=360.38 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=202.5
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+. +|++|+.+++++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLG----SGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHC----SCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhh----CCCCCCEEEEEEecCCccE
Confidence 4578999999999999999999999999999999987432 2345778999999984 4578999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||++++|.+++.... ..+++..+..++.||+.||+|||+.|||||||||+|||++.++.
T Consensus 82 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~----------------- 143 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN----------------- 143 (330)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG-----------------
T ss_pred EEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC-----------------
Confidence 999999999999998753 47999999999999999999999999999999999999976553
Q ss_pred ccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 144 -----~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~ 218 (330)
T 2izr_A 144 -----KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218 (330)
T ss_dssp -----TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence 11223677777766543221 134579999999999999999999999999999999999999998
Q ss_pred CCChH---HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 325 THENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 325 ~~~~~---~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
+.+.. +.+..+.....+.+. ......++ ++.+
T Consensus 219 ~~~~~~~~~~~~~i~~~~~~~~~--------------------------------------------~~~~~~~p-~~~~ 253 (330)
T 2izr_A 219 GLKADTLKERYQKIGDTKRATPI--------------------------------------------EVLCENFP-EMAT 253 (330)
T ss_dssp TCCCSSHHHHHHHHHHHHHHSCH--------------------------------------------HHHTTTCH-HHHH
T ss_pred ccccccHHHHHHHHHhhhccCCH--------------------------------------------HHHhccCh-HHHH
Confidence 74332 222222111111110 01112345 8999
Q ss_pred HHHhccccCCCCCCCHHHHhc
Q 013973 402 LLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~ 422 (433)
||..||+.||.+||++.++++
T Consensus 254 li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 254 YLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHhCCCCCCCCHHHHHH
Confidence 999999999999999998876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=366.88 Aligned_cols=249 Identities=19% Similarity=0.320 Sum_probs=199.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-------CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ....+.+..|+.+++.+. .|+||++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~~~ 155 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGA 155 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC----CCTTBCCEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc----CCCCEeeEEEE
Confidence 478999999999999999999874 35568999999743 234456788999998873 46889999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+...+.+|+||||+ +|+|.+++..... ..+++..+..++.||+.||+|||++|||||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 99999999999999 8899999987531 35899999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.+ +.+||+|||++....... ....||+.|+|||++.+..|+.++||
T Consensus 236 l~~~---------------------------~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv 288 (370)
T 2psq_A 236 VTEN---------------------------NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288 (370)
T ss_dssp ECTT---------------------------CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHH
T ss_pred ECCC---------------------------CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHH
Confidence 9544 456666666665332211 22357889999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|||||++|||++ |..||.+....+....+.. +..
T Consensus 289 wslG~il~ellt~g~~p~~~~~~~~~~~~~~~-----------------------~~~---------------------- 323 (370)
T 2psq_A 289 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-----------------------GHR---------------------- 323 (370)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----------------------TCC----------------------
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-----------------------CCC----------------------
Confidence 999999999999 9999987665443332211 100
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 324 ---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 324 ---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123567789999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=355.72 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=195.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++.+.||+|+||+||+|.+ +++.||+|++... ....+.+..|+.+++++ .|+||+++++++...+.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-----RHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSTTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCc
Confidence 46899999999999999999976 5788999998643 23345677899999998 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
+++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++| ||||||||+|||++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~-------------- 174 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK-------------- 174 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT--------------
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC--------------
Confidence 99999999 8899999986531 23999999999999999999999999 999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 175 -------------~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 175 -------------KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp -------------TCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred -------------CCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 455666666666543322 2335799999999999999999999999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+..+....+.... ... ..+..+++++.+||.+
T Consensus 242 ~~~~~~~~~~~~~~---------------------~~~--------------------------~~~~~~~~~l~~li~~ 274 (309)
T 3p86_A 242 LNPAQVVAAVGFKC---------------------KRL--------------------------EIPRNLNPQVAAIIEG 274 (309)
T ss_dssp SCHHHHHHHHHHSC---------------------CCC--------------------------CCCTTSCHHHHHHHHH
T ss_pred CCHHHHHHHHHhcC---------------------CCC--------------------------CCCccCCHHHHHHHHH
Confidence 77655443321110 001 1123567789999999
Q ss_pred ccccCCCCCCCHHHHhc
Q 013973 406 LLRYDPTDRLTAREALR 422 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~ 422 (433)
||+.||.+|||+.|+++
T Consensus 275 ~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 275 CWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=356.60 Aligned_cols=259 Identities=31% Similarity=0.539 Sum_probs=213.3
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
..+.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ .|++|+++++++..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILED 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEEC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----cCCCccEEEEEEeC
Confidence 345678999999999999999999999999999999986432 2356677899998887 67899999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+.+++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~------------ 158 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------ 158 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS------------
T ss_pred CCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC------------
Confidence 99999999999 899999987754 799999999999999999999999999999999999995432
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.+..+||+|||++....... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.
T Consensus 159 ------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 159 ------------KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp ------------TTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------CcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 24568888998876544332 23468999999999876 4899999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+... ....+. ..+..++.++.+||.+|
T Consensus 226 ~~~~~~~~~~~~-----------------------~~~~~~----------------------~~~~~~~~~~~~li~~~ 260 (287)
T 2wei_A 226 NEYDILKRVETG-----------------------KYAFDL----------------------PQWRTISDDAKDLIRKM 260 (287)
T ss_dssp SHHHHHHHHHHC-----------------------CCCCCS----------------------GGGTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHcC-----------------------CCCCCc----------------------hhhhhcCHHHHHHHHHH
Confidence 765544433221 111100 01235677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|+.||++|||+.|+|+||||++
T Consensus 261 l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 261 LTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp TCSSGGGSCCHHHHHHSHHHHH
T ss_pred cccChhhCcCHHHHhcCHHHhc
Confidence 9999999999999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=365.22 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=205.8
Q ss_pred cCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEe
Q 013973 91 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQI 163 (433)
Q Consensus 91 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~ 163 (433)
..+.+.++|++.+.||+|+||.||+|.+..+++.||||+++.... ....+..|+.+++++.+ .|++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~i~~~ 113 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRL 113 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc---CCCCceEE
Confidence 344567889999999999999999999999999999999974321 22345678999999854 46889999
Q ss_pred cceeecCCeEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 164 RNWFDYRNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 164 ~~~~~~~~~~~lV~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
++++...+..++|||++ + ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~------- 184 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL------- 184 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-------
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC-------
Confidence 99999999999999999 4 89999998754 7999999999999999999999999999999999999961
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhC
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg 319 (433)
.++.+||+|||++....... ....||+.|+|||++.+..+ +.++|||||||++|||++|
T Consensus 185 -------------------~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 245 (320)
T 3a99_A 185 -------------------NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245 (320)
T ss_dssp -------------------TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred -------------------CCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHC
Confidence 33456777777665443322 33479999999999987765 6889999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
..||...+. .. .+... ....++.++
T Consensus 246 ~~pf~~~~~--~~---------------------------~~~~~--------------------------~~~~~~~~~ 270 (320)
T 3a99_A 246 DIPFEHDEE--II---------------------------RGQVF--------------------------FRQRVSSEC 270 (320)
T ss_dssp SCSCCSHHH--HH---------------------------HCCCC--------------------------CSSCCCHHH
T ss_pred CCCCCChhh--hh---------------------------ccccc--------------------------ccccCCHHH
Confidence 999964211 00 00000 123567789
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||.+||+.||++|||+.|+++||||++..
T Consensus 271 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 9999999999999999999999999998764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=357.25 Aligned_cols=272 Identities=24% Similarity=0.368 Sum_probs=198.4
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 169 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----- 169 (433)
+.++|++++.||+|+||.||+|.+..+++.||||+++......+.+..|+.+++.+ .|+||+++++.+.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-----NHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-----CchHHHHHHHHHHhhcchh
Confidence 34679999999999999999999999999999999986666667778899998887 67899999887754
Q ss_pred --------CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcccc
Q 013973 170 --------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 170 --------~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i 240 (433)
.+.+|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 56789999999 889999998653 46888999999999999999999999999999999999977776666
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhC
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg 319 (433)
+|||++.......... .+ +-..............||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 158 ~dfg~~~~~~~~~~~~---------~~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDIL---------KL-DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp CCCCCCSCTTC-----------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred eeCcchhhcccccchh---------cc-ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 6666655432211000 00 000000000111234789999999999865 68999999999999999998
Q ss_pred CCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 320 EALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 320 ~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
||..... .+....+ ......+|. ......+..
T Consensus 227 --p~~~~~~~~~~~~~~-----------------------~~~~~~~~~----------------------~~~~~~~~~ 259 (303)
T 1zy4_A 227 --PFSTGMERVNILKKL-----------------------RSVSIEFPP----------------------DFDDNKMKV 259 (303)
T ss_dssp --CCSSHHHHHHHHHHH-----------------------HSTTCCCCT----------------------TCCTTTSHH
T ss_pred --ccCCchhHHHHHHhc-----------------------cccccccCc----------------------cccccchHH
Confidence 5643211 1111111 111111111 112345667
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 260 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 89999999999999999999999999998654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=355.91 Aligned_cols=251 Identities=28% Similarity=0.415 Sum_probs=208.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.|++++.||+|+||.||+|.+..+++.||||++... ....+.+..|+.+++.+ .|++|+++++++.....+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCCeE
Confidence 35699999999999999999999999999999999643 23456678899998887 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ +++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~------------------ 154 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE------------------ 154 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT------------------
T ss_pred EEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC------------------
Confidence 9999999 78999998653 6999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
++.+||+|||.+...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 155 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 225 (303)
T 3a7i_A 155 ---------HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 225 (303)
T ss_dssp ---------TSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ---------CCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH
Confidence 455677777766543322 13357899999999999999999999999999999999999999876655
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.... . ......++.++.+||.+||+.
T Consensus 226 ~~~~~~~~~~-----------------------~-------------------------~~~~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 226 KVLFLIPKNN-----------------------P-------------------------PTLEGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp HHHHHHHHSC-----------------------C-------------------------CCCCSSCCHHHHHHHHHHCCS
T ss_pred HHHHHhhcCC-----------------------C-------------------------CCCccccCHHHHHHHHHHcCC
Confidence 4433221100 0 001235677899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~ 429 (433)
||.+|||+.|+++||||...
T Consensus 258 dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 258 EPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp SGGGSCCHHHHTTCHHHHHH
T ss_pred ChhhCcCHHHHhhChhhhcC
Confidence 99999999999999999643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=352.42 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=206.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee--ecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--DYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~--~~~ 170 (433)
.++|++++.||+|+||.||+|.++.+++.||+|++... ....+.+..|+.+++.+ .|+||+++++++ ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-----KHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEecCCC
Confidence 36799999999999999999999999999999999642 33456677899999988 678999999977 456
Q ss_pred CeEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeeccCccccCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPD 242 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlKp~NILl~~~~~~~i~d 242 (433)
..+++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.| |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~--------- 150 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--------- 150 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---------
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---------
Confidence 7899999999 789999997532 245999999999999999999999999 99999999999994
Q ss_pred CcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC
Q 013973 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg 319 (433)
.++.+||+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 151 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 212 (279)
T 2w5a_A 151 ------------------GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212 (279)
T ss_dssp ------------------SSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred ------------------CCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 45567888888776544332 124789999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
..||...+..+....+... ... ..+..++.++
T Consensus 213 ~~p~~~~~~~~~~~~i~~~-----------------------~~~-------------------------~~~~~~~~~l 244 (279)
T 2w5a_A 213 MPPFTAFSQKELAGKIREG-----------------------KFR-------------------------RIPYRYSDEL 244 (279)
T ss_dssp SCSSCCSSHHHHHHHHHHT-----------------------CCC-------------------------CCCTTSCHHH
T ss_pred CCCCcccCHHHHHHHHhhc-----------------------ccc-------------------------cCCcccCHHH
Confidence 9999887655444332211 000 0123457789
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.+||.+||+.||++|||+.|+++|+|+++.
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 999999999999999999999999999865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=365.34 Aligned_cols=275 Identities=20% Similarity=0.389 Sum_probs=211.1
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhh------------------HHHHHHHHHHHHHHHhc
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY------------------REAAMIEIEVLQQLAKH 153 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~------------------~~~~~~E~~~l~~l~~~ 153 (433)
.....++|++.+.||+|+||.||+|.+ +++.||+|++...... .+.+..|+.+++.+
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--- 100 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI--- 100 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC---
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC---
Confidence 445568899999999999999999998 8999999999743221 16778899998888
Q ss_pred CCCCCceEEecceeecCCeEEEEEecC-CCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccC
Q 013973 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF------LRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDL 225 (433)
Q Consensus 154 ~~~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~------l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDl 225 (433)
.|+||+++++++.+.+.+++||||+ +++|.++ +.......+++..+..++.||+.||.|||+ .||+||||
T Consensus 101 --~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl 178 (348)
T 2pml_X 101 --KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178 (348)
T ss_dssp --CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCC
T ss_pred --CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCC
Confidence 6789999999999999999999999 7899998 665435689999999999999999999999 99999999
Q ss_pred CCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-CCceeecCcccchhhhhCC-CCCC-
Q 013973 226 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGL-GWTY- 302 (433)
Q Consensus 226 Kp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~- 302 (433)
||+|||++ .++.+||+|||.+...... .....||+.|+|||++.+. .++.
T Consensus 179 ~p~Nil~~---------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (348)
T 2pml_X 179 KPSNILMD---------------------------KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGA 231 (348)
T ss_dssp CGGGEEEC---------------------------TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHH
T ss_pred ChHhEEEc---------------------------CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcc
Confidence 99999994 4456777777776543322 2334789999999999887 6666
Q ss_pred cchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccc
Q 013973 303 PCDIWSVGCILVELCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 381 (433)
Q Consensus 303 ~~DvwSlGv~l~elltg~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (433)
++|||||||++|+|++|..||..... .+....+. .+...++....... .
T Consensus 232 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~-----------------------~~~~~~~~~~~~~~---~---- 281 (348)
T 2pml_X 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR-----------------------TKNIEYPLDRNHFL---Y---- 281 (348)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT-----------------------SCCCCCCCSSSSST---T----
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-----------------------ccCcCCccchhhhh---c----
Confidence 99999999999999999999987665 44333321 12222221110000 0
Q ss_pred hhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 382 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.............++.++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 282 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 282 PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp TTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 0000000112246788999999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=353.39 Aligned_cols=265 Identities=17% Similarity=0.228 Sum_probs=200.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec-chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+..|+.+++.+ .|+||+++++++.+.+..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-----EHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCcCcccEEEEEecCCeeE
Confidence 3679999999999999999999999999999998854 344566778899998887 6799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999 889999998753 479999999999999999999999999999999999999766666666666554332111
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~ 333 (433)
..... . ..............+||+.|+|||++.+..++.++||||||+++|||++|..||.........
T Consensus 163 ~~~~~--------~--~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~- 231 (310)
T 3s95_A 163 TQPEG--------L--RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD- 231 (310)
T ss_dssp ---------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-
T ss_pred ccccc--------c--ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-
Confidence 00000 0 000000000112457999999999999999999999999999999999999998653211000
Q ss_pred HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCC
Q 013973 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 413 (433)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 413 (433)
. ............+..+++++.+||.+||+.||++
T Consensus 232 -------------------------------~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 266 (310)
T 3s95_A 232 -------------------------------F--------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEK 266 (310)
T ss_dssp -------------------------------S--------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGG
T ss_pred -------------------------------H--------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhh
Confidence 0 0000000111224567788999999999999999
Q ss_pred CCCHHHHhc
Q 013973 414 RLTAREALR 422 (433)
Q Consensus 414 R~ta~ell~ 422 (433)
|||+.|+++
T Consensus 267 Rps~~~l~~ 275 (310)
T 3s95_A 267 RPSFVKLEH 275 (310)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999876
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=349.61 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=203.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++++.||+|+||.||+|.+. +++.||+|++.......+.+..|+.+++++ .|+||+++++++.+.+..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCceEE
Confidence 367999999999999999999987 466799999986555567788999999988 57899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~------------------- 142 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN------------------- 142 (269)
T ss_dssp EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-------------------
T ss_pred EEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-------------------
Confidence 99999 889999997654 469999999999999999999999999999999999999544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
+.+||+|||.+...... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 143 --------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 143 --------QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp --------GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred --------CCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 45666667766543322 122356788999999999999999999999999999999 99999887766
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+...... ..+...+.++.+||.+||+.
T Consensus 215 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~ 246 (269)
T 4hcu_A 215 EVVEDISTGFRL------------------------------------------------YKPRLASTHVYQIMNHCWRE 246 (269)
T ss_dssp HHHHHHHTTCCC------------------------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCccC------------------------------------------------CCCCcCCHHHHHHHHHHccC
Confidence 554433211000 01124567899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013973 410 DPTDRLTAREALRH 423 (433)
Q Consensus 410 dP~~R~ta~ell~h 423 (433)
||++|||+.|+++|
T Consensus 247 ~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 247 RPEDRPAFSRLLRQ 260 (269)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=355.93 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=199.6
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
...++|++++.||+|+||.||+|.+. +++.||+|++... ....+.+..|+.+++.+.+ ++++|+++++++...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITD 100 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG---GCTTBCCEEEEEECS
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccc---cCCceEEEEEEeecC
Confidence 33467999999999999999999986 4788999998632 3345667889999999965 357899999999999
Q ss_pred CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 171 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 171 ~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
+.+++|||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+++ +
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~-------------- 163 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-------------- 163 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--------------
T ss_pred CEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--------------
Confidence 9999999977999999998764 7999999999999999999999999999999999999942 4
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhC-----------CCCCCcchhHHHHHHHH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILV 314 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~ 314 (433)
.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 164 -------------~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 164 -------------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp -------------EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred -------------eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 45666666555432221 23468999999999976 46889999999999999
Q ss_pred HHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcC
Q 013973 315 ELCTGEALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393 (433)
Q Consensus 315 elltg~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
+|++|..||....... .... ...+ .... ..+.
T Consensus 231 el~~g~~pf~~~~~~~~~~~~---~~~~------------------~~~~--------------------------~~~~ 263 (313)
T 3cek_A 231 YMTYGKTPFQQIINQISKLHA---IIDP------------------NHEI--------------------------EFPD 263 (313)
T ss_dssp HHHHSSCTTTTCCSHHHHHHH---HHCT------------------TSCC--------------------------CCCC
T ss_pred HHHhCCCchhhHHHHHHHHHH---HHhc------------------cccc--------------------------CCcc
Confidence 9999999997653321 1111 1000 0000 1123
Q ss_pred CchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 394 ~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
..+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred cchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 4467899999999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=357.90 Aligned_cols=247 Identities=24% Similarity=0.308 Sum_probs=199.6
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCe---EEEEEEeec--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
..++|++.+.||+|+||.||+|.+..+++ .||||+++. .....+.+..|+.+++.+ .|+||+++++++.+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-----DHPNIIRLEGVVTR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEe
Confidence 35789999999999999999999986554 599999974 234456678899998887 67999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+.+|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-------------- 186 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS-------------- 186 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--------------
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC--------------
Confidence 99999999999 889999997653 46999999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 321 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~ 321 (433)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 187 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 187 -------------NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp -------------TCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred -------------CCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 4456666666665433221 11245778999999999999999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+....+....+.... .. ..+..++.++.+
T Consensus 254 p~~~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~l~~ 285 (325)
T 3kul_A 254 PYWNMTNRDVISSVEEGY----------------------RL--------------------------PAPMGCPHALHQ 285 (325)
T ss_dssp TTTTSCHHHHHHHHHTTC----------------------CC--------------------------CCCTTCCHHHHH
T ss_pred CcccCCHHHHHHHHHcCC----------------------CC--------------------------CCCCCcCHHHHH
Confidence 998877665544332110 00 012356778999
Q ss_pred HHHhccccCCCCCCCHHHHhc
Q 013973 402 LLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~ 422 (433)
||.+||+.||++|||+.|+++
T Consensus 286 li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 286 LMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=351.40 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=209.2
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+...++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+..|+.+++.+ .|+||+++++++.+.+
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREP 82 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCC
Confidence 34456789999999999999999999999999999999987666677788999999998 5789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-------------- 148 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-------------- 148 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG--------------
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC--------------
Confidence 999999999 79999999887666799999999999999999999999999999999999995544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 325 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~ 325 (433)
.+||+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 149 -------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 149 -------------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp -------------CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred -------------CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 56666666665443322 22357889999999999999999999999999999999 9999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+..+....+.... . ...+..++.++.+||.+
T Consensus 216 ~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~~l~~li~~ 247 (288)
T 3kfa_A 216 IDLSQVYELLEKDY----------------------R--------------------------MERPEGCPEKVYELMRA 247 (288)
T ss_dssp CCGGGHHHHHHTTC----------------------C--------------------------CCCCTTCCHHHHHHHHH
T ss_pred CCHHHHHHHHhccC----------------------C--------------------------CCCCCCCCHHHHHHHHH
Confidence 66544333221100 0 01123567789999999
Q ss_pred ccccCCCCCCCHHHHhc
Q 013973 406 LLRYDPTDRLTAREALR 422 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~ 422 (433)
||+.||.+|||+.|+++
T Consensus 248 ~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 248 CWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HhCCChhhCcCHHHHHH
Confidence 99999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=346.62 Aligned_cols=246 Identities=22% Similarity=0.302 Sum_probs=202.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++++.||+|+||.||+|.+. ++..||+|+++......+.+..|+.+++.+ .|+||+++++++...+..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-----SHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCceEE
Confidence 468999999999999999999876 567799999986555567788999999998 57899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~-------------------- 139 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR-------------------- 139 (268)
T ss_dssp EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT--------------------
T ss_pred EEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC--------------------
Confidence 99999 899999998754 35999999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
++.+||+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 140 -------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 140 -------DLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp -------TCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred -------CCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 4456666666665433322 11246778999999999899999999999999999999 99999887765
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+..... .. .+...+.++.+||.+||+.
T Consensus 213 ~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~l~~li~~~l~~ 244 (268)
T 3sxs_A 213 EVVLKVSQGHR----------------------LY--------------------------RPHLASDTIYQIMYSCWHE 244 (268)
T ss_dssp HHHHHHHTTCC----------------------CC--------------------------CCTTSCHHHHHHHHHTTCS
T ss_pred HHHHHHHcCCC----------------------CC--------------------------CCCcChHHHHHHHHHHcCC
Confidence 54433221100 00 1123466899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013973 410 DPTDRLTAREALRH 423 (433)
Q Consensus 410 dP~~R~ta~ell~h 423 (433)
||++|||+.|+++|
T Consensus 245 ~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 245 LPEKRPTFQQLLSS 258 (268)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=359.93 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=185.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+..|+.+++.+ .|+||+++++++...+..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-----HHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-----CCTTBCCEEEEEESSSCE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-----CCCCEeeEEEEEeecCCc
Confidence 467999999999999999999999999999999886432 2234455677666655 679999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 174 CIVFEKL-GSSLYDFLRKN------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---------- 158 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG---------- 158 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC----------
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC----------
Confidence 9999999 89999998741 224699999999999999999999999999999999999996554
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC--------CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHH
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~ell 317 (433)
.+||+|||.+...... .....||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 159 -----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 221 (303)
T 2vwi_A 159 -----------------SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221 (303)
T ss_dssp -----------------CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred -----------------CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence 4555555554332211 123478999999999976 56899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 318 tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
+|..||.............. +..+ .... ..........++.
T Consensus 222 ~g~~pf~~~~~~~~~~~~~~--~~~~--------------------~~~~-----------------~~~~~~~~~~~~~ 262 (303)
T 2vwi_A 222 TGAAPYHKYPPMKVLMLTLQ--NDPP--------------------SLET-----------------GVQDKEMLKKYGK 262 (303)
T ss_dssp HSSCTTTTSCGGGHHHHHHT--SSCC--------------------CTTC----------------------CCCCCCCH
T ss_pred hCCCCCccCchhhHHHHHhc--cCCC--------------------cccc-----------------ccccchhhhhhhH
Confidence 99999987655443321111 0000 0000 0000112245677
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 263 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 263 SFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 899999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=362.42 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=198.2
Q ss_pred ecCcEEEEeeeeccccEEEEEEE-----ECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
..++|++.+.||+|+||.||+|. +..+++.||||+++.. ....+.+..|+.++.++. +|+||+++++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpniv~~~~~~ 95 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGAC 95 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEE
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc----CCcceeeeeeee
Confidence 35789999999999999999998 5667799999999743 234456788999999883 468899999998
Q ss_pred ecCC-eEEEEEecC-CCCHHHHHHhcCC----------------------------------------------------
Q 013973 168 DYRN-HICIVFEKL-GSSLYDFLRKNNY---------------------------------------------------- 193 (433)
Q Consensus 168 ~~~~-~~~lV~e~~-~~~L~~~l~~~~~---------------------------------------------------- 193 (433)
...+ .+++||||+ +|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 7754 599999999 8899999986542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCC
Q 013973 194 ------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261 (433)
Q Consensus 194 ------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~ 261 (433)
..+++..+..++.||+.||.|||++|||||||||+|||++.++.
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~------------------------ 231 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV------------------------ 231 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC------------------------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc------------------------
Confidence 12899999999999999999999999999999999999965554
Q ss_pred CCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 013973 262 SSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 335 (433)
Q Consensus 262 ~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i 335 (433)
+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.....
T Consensus 232 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 308 (359)
T 3vhe_A 232 ---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308 (359)
T ss_dssp ---EEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred ---EEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH
Confidence 5555555554322111 22468999999999999999999999999999999998 99999876543332221
Q ss_pred HHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC
Q 013973 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 415 (433)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 415 (433)
..... .. ..+..+++++.+||.+||+.||.+||
T Consensus 309 ~~~~~---------------------~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rp 341 (359)
T 3vhe_A 309 LKEGT---------------------RM--------------------------RAPDYTTPEMYQTMLDCWHGEPSQRP 341 (359)
T ss_dssp HHHTC---------------------CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHcCC---------------------CC--------------------------CCCCCCCHHHHHHHHHHccCChhhCC
Confidence 11100 00 11234677899999999999999999
Q ss_pred CHHHHhcC
Q 013973 416 TAREALRH 423 (433)
Q Consensus 416 ta~ell~h 423 (433)
|+.|+++|
T Consensus 342 s~~ell~~ 349 (359)
T 3vhe_A 342 TFSELVEH 349 (359)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=366.44 Aligned_cols=256 Identities=20% Similarity=0.277 Sum_probs=207.7
Q ss_pred eecCcEEEEeeeeccccEEEEEEE-----ECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
...++|++++.||+|+||.||+|. +..+++.||||+++.. ......+..|+.+++.+ .|+||++++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~ 142 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCIGV 142 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-----CCCCCCeEEEE
Confidence 345789999999999999999999 4567789999998642 34445677899999888 67999999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCcccc
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i 240 (433)
+......++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++|||||||||+|||++.+|
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---- 218 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG---- 218 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC----
Confidence 99999999999999 8899999987532 3589999999999999999999999999999999999996433
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccC-----CCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHH
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-----PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e 315 (433)
.+..+||+|||+++... .......||+.|+|||++.+..++.++|||||||++||
T Consensus 219 --------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e 278 (367)
T 3l9p_A 219 --------------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278 (367)
T ss_dssp --------------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --------------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHH
Confidence 23468888998876321 12233568999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 316 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 316 llt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
|++ |..||...+..+....+.... ... .+..
T Consensus 279 llt~g~~pf~~~~~~~~~~~i~~~~----------------------~~~--------------------------~~~~ 310 (367)
T 3l9p_A 279 IFSLGYMPYPSKSNQEVLEFVTSGG----------------------RMD--------------------------PPKN 310 (367)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTC----------------------CCC--------------------------CCTT
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCC----------------------CCC--------------------------CCcc
Confidence 998 999998877665544332111 000 1235
Q ss_pred chhHHHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
++.++.+||.+||+.||++|||+.|+++|.++
T Consensus 311 ~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 56789999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=348.91 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=200.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++++.||+|+||.||+|.+. ++..||+|+++......+.+..|+.+++.+ .|+||+++++++.+.+.+++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-----SHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-----CCCCEeeEEEEEecCCCeEE
Confidence 467999999999999999999876 567799999986555567788899999888 57899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~--------------------- 154 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN--------------------- 154 (283)
T ss_dssp EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---------------------
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---------------------
Confidence 99999 899999997643 3699999999999999999999999999999999999994
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.++.+||+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 155 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 155 ------DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp ------TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ------CCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence 44567777777765433221 12356788999999999999999999999999999998 99999887766
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+...... . .+...+.++.+||.+||+.
T Consensus 229 ~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~l~~li~~~l~~ 260 (283)
T 3gen_A 229 ETAEHIAQGLRL----------------------Y--------------------------RPHLASEKVYTIMYSCWHE 260 (283)
T ss_dssp HHHHHHHTTCCC----------------------C--------------------------CCTTCCHHHHHHHHHTTCS
T ss_pred HHHHHHhcccCC----------------------C--------------------------CCCcCCHHHHHHHHHHccC
Confidence 554433221110 0 1124567899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013973 410 DPTDRLTAREALRH 423 (433)
Q Consensus 410 dP~~R~ta~ell~h 423 (433)
||.+|||+.|+++|
T Consensus 261 ~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 261 KADERPTFKILLSN 274 (283)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=351.52 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=199.7
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
|.....||+|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++++...+.+++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-----KHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-----CCCCEeeEeeEEEeCCcEEEEE
Confidence 334458999999999999999999999999987432 3445677888888887 6789999999999999999999
Q ss_pred ecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 178 EKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--------------------- 157 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--------------------- 157 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---------------------
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC---------------------
Confidence 999 899999998653 235678999999999999999999999999999999999964
Q ss_pred cccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCC--CCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
.++.+||+|||.+...... .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.......
T Consensus 158 -----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (295)
T 2clq_A 158 -----YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ 232 (295)
T ss_dssp -----TTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH
T ss_pred -----CCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh
Confidence 1446777777766543321 23357899999999998653 8899999999999999999999997544332
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
............ ...+..++.++.+||.+||+.|
T Consensus 233 ~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~d 266 (295)
T 2clq_A 233 AAMFKVGMFKVH----------------------------------------------PEIPESMSAEAKAFILKCFEPD 266 (295)
T ss_dssp HHHHHHHHHCCC----------------------------------------------CCCCTTSCHHHHHHHHHTTCSS
T ss_pred HHHHhhcccccc----------------------------------------------ccccccCCHHHHHHHHHHccCC
Confidence 211100000000 0112356778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDHL 431 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~~ 431 (433)
|++|||+.|+|+||||+....
T Consensus 267 p~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 267 PDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp TTTSCCHHHHHTSGGGCC---
T ss_pred hhhCCCHHHHhcChhhhhccc
Confidence 999999999999999987654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=356.75 Aligned_cols=254 Identities=24% Similarity=0.456 Sum_probs=195.7
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
+.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......|+.++.++.... .|+||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG-GHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSC-CCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccC-CCCCeeeEEE
Confidence 3456789999999999999999999999999999999964321 1223456889998885433 5789999999
Q ss_pred eeecCCeEEEEEec-C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCC
Q 013973 166 WFDYRNHICIVFEK-L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 166 ~~~~~~~~~lV~e~-~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
++...+..++|||+ + +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--------- 174 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--------- 174 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET---------
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC---------
Confidence 99999999999998 5 889999998764 6999999999999999999999999999999999999961
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCC-CcchhHHHHHHHHHHHhCCC
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~ 321 (433)
.++.+||+|||++....... ....||..|+|||++.+..+. .++|||||||++|+|++|..
T Consensus 175 -----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 175 -----------------RRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp -----------------TTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred -----------------CCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 33456777777665443322 334789999999999877764 58999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||..... .. ..... .+..++.++.+
T Consensus 238 pf~~~~~--~~---------------------------~~~~~--------------------------~~~~~~~~~~~ 262 (312)
T 2iwi_A 238 PFERDQE--IL---------------------------EAELH--------------------------FPAHVSPDCCA 262 (312)
T ss_dssp SCCSHHH--HH---------------------------HTCCC--------------------------CCTTSCHHHHH
T ss_pred CCCChHH--Hh---------------------------hhccC--------------------------CcccCCHHHHH
Confidence 9974211 00 00001 12356778999
Q ss_pred HHHhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 402 LLQGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
||.+||+.||++|||+.|+++||||+...
T Consensus 263 li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 263 LIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 99999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.74 Aligned_cols=255 Identities=18% Similarity=0.254 Sum_probs=186.4
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCe---EEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
..++|++.+.||+|+||.||+|.+..++. .||||+++.. ....+.+..|+.+++.+ .|+||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~ 95 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-----DHPHVAKLVGVSL 95 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-----CCTTBCCCCEEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-----CCCceehhhceee
Confidence 35679999999999999999999887775 7999998642 23456677888888887 6789999999998
Q ss_pred cCCeE------EEEEecC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 169 YRNHI------CIVFEKL-GSSLYDFLRKNNY----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 169 ~~~~~------~lV~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
..... ++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-- 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-- 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT--
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC--
Confidence 76655 9999999 8899999865321 258999999999999999999999999999999999999544
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~ 312 (433)
+.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||+
T Consensus 174 -------------------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 228 (323)
T 3qup_A 174 -------------------------MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228 (323)
T ss_dssp -------------------------SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred -------------------------CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHH
Confidence 456666666655432221 12356788999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 313 LVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 313 l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+|+|++ |..||.+.+..+....+... ... ..
T Consensus 229 l~ell~~g~~p~~~~~~~~~~~~~~~~----------------------~~~--------------------------~~ 260 (323)
T 3qup_A 229 MWEIMTRGQTPYAGIENAEIYNYLIGG----------------------NRL--------------------------KQ 260 (323)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTT----------------------CCC--------------------------CC
T ss_pred HHHHHhCCCCCccccChHHHHHHHhcC----------------------CCC--------------------------CC
Confidence 999999 99999877665544332110 000 01
Q ss_pred cCCchhHHHHHHHhccccCCCCCCC-------HHHHhcCCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLT-------AREALRHPFFTRD 429 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~t-------a~ell~hp~f~~~ 429 (433)
+..++.++.+||.+||+.||++||| .++++.|||+...
T Consensus 261 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 261 PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 2356678999999999999999999 7899999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.12 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=205.4
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCC-------eEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERK-------EMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~-------~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ...+.+..|+.+++.+ .|+||++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-----SHKHLVLNYGV 80 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-----CCTTBCCEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-----CCCCEeEEEEE
Confidence 3578999999999999999999998777 579999986433 4456678899999888 67999999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
+...+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++..++.|+
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~-- 157 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP-- 157 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC--
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc--
Confidence 99999999999999 899999998754 34999999999999999999999999999999999999988876665544
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhC-CCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTG-EALF 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg-~~Pf 323 (433)
..+||+|||.+...... ....||+.|+|||++.+ ..++.++|||||||++|||++| .+||
T Consensus 158 -----------------~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 158 -----------------PFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp -----------------CEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred -----------------ceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 35899999988654332 23468999999999998 6799999999999999999995 5555
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
...+........ .... ..+...+.++.+||
T Consensus 220 ~~~~~~~~~~~~-~~~~-------------------------------------------------~~~~~~~~~l~~li 249 (289)
T 4fvq_A 220 SALDSQRKLQFY-EDRH-------------------------------------------------QLPAPKAAELANLI 249 (289)
T ss_dssp TTSCHHHHHHHH-HTTC-------------------------------------------------CCCCCSSCTTHHHH
T ss_pred cccchHHHHHHh-hccC-------------------------------------------------CCCCCCCHHHHHHH
Confidence 554433322111 1000 01224456789999
Q ss_pred HhccccCCCCCCCHHHHhcC
Q 013973 404 QGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~h 423 (433)
.+||+.||++|||+.|+++|
T Consensus 250 ~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 250 NNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHSCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.97 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=196.9
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.++ +++..+..+....+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~----~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGG----VGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTS----TTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcC----CCCCccccccCCCCce
Confidence 45678999999999999999999999999999999987433 234577899999999543 2344455555778899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~------------------ 141 (296)
T 3uzp_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------ 141 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG------------------
T ss_pred EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC------------------
Confidence 9999999999999998543 479999999999999999999999999999999999999411
Q ss_pred cccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+.++.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 142 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 3uzp_A 142 ------KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------CCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 12345666666665533322 13357999999999999999999999999999999999999999
Q ss_pred CCCChH---HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 324 QTHENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 324 ~~~~~~---~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.+.+.. +.+..+..... ..........++.++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~l~ 251 (296)
T 3uzp_A 216 QGLKAATKRQKYERISEKKM--------------------------------------------STPIEVLCKGYPSEFA 251 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHH--------------------------------------------HSCHHHHTTTSCHHHH
T ss_pred CCcCchhhhhhhhhhccccc--------------------------------------------CCchHHHHhhCCHHHH
Confidence 864321 11111111000 0001112245678899
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q 013973 401 HLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~ 422 (433)
+||.+||+.||++|||+.++++
T Consensus 252 ~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 252 TYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHhcCcCcCCCHHHHHH
Confidence 9999999999999999998875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=358.50 Aligned_cols=257 Identities=14% Similarity=0.217 Sum_probs=193.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCC-----CeEEEEEEeecchhhHHHHHHHHHHHHHHHh----------cCCCCCce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIKKYREAAMIEIEVLQQLAK----------HDKGGNRC 160 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~----------~~~~~~~i 160 (433)
.++|++.+.||+|+||.||+|.+..+ ++.||||++.... .....|+.+++.+.+ ....|+||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 35899999999999999999998765 5789999987432 234456666655533 34478999
Q ss_pred EEecceeecC----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccC
Q 013973 161 VQIRNWFDYR----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 236 (433)
Q Consensus 161 ~~~~~~~~~~----~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~ 236 (433)
+++++++... .+.||||||+|++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-- 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-- 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES--
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec--
Confidence 9999998764 5689999999999999998753 47999999999999999999999999999999999999962
Q ss_pred ccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhCCCCCCcchh
Q 013973 237 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 237 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
+.++.+||+|||++...... ....+||+.|+|||++.+..++.++||
T Consensus 188 -----------------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 244 (364)
T 3op5_A 188 -----------------------KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDL 244 (364)
T ss_dssp -----------------------SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHH
T ss_pred -----------------------CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhH
Confidence 13345666666666432211 123469999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~elltg~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|||||++|||++|..||.+... .............. +.
T Consensus 245 ~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~ 283 (364)
T 3op5_A 245 EILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYREN-----------------------------------------IA 283 (364)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHC-----------------------------------------HH
T ss_pred HHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhh-----------------------------------------HH
Confidence 9999999999999999985332 22221111110000 00
Q ss_pred HHHhhh--cCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 386 NLIMQH--VDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 386 ~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
...... ...++.++.+||..||+.||++||++.++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 284 SLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111111 1356789999999999999999999998874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=356.53 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=202.5
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECC-------CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
...++|++.+.||+|+||.||+|.+.. .+..||+|+++.. ......+..|+++++.+. .|+||++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~ 141 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----KHKNIINLL 141 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc----CCchhhhhe
Confidence 345789999999999999999999753 3367999999743 334466778999999883 458899999
Q ss_pred ceeecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 013973 165 NWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 229 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~N 229 (433)
+++...+.+++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++|||||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 9999999999999999 889999998754 1359999999999999999999999999999999999
Q ss_pred eEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcc
Q 013973 230 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPC 304 (433)
Q Consensus 230 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~ 304 (433)
||++.+ +.+||+|||++...... .....||+.|+|||++.+..++.++
T Consensus 222 Ill~~~---------------------------~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 274 (382)
T 3tt0_A 222 VLVTED---------------------------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274 (382)
T ss_dssp EEECTT---------------------------CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred EEEcCC---------------------------CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchh
Confidence 999544 45666666665543321 1223678899999999999999999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchh
Q 013973 305 DIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 383 (433)
Q Consensus 305 DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
|||||||++|+|++ |..||.+.+..+....+.... ..
T Consensus 275 DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----------------------~~-------------------- 312 (382)
T 3tt0_A 275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH----------------------RM-------------------- 312 (382)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------------CC--------------------
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------CC--------------------
Confidence 99999999999999 999998876655443322110 00
Q ss_pred HHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 384 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+..++.++.+||.+||+.||++|||+.|++++
T Consensus 313 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 313 ------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp ------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123567789999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=358.02 Aligned_cols=263 Identities=21% Similarity=0.208 Sum_probs=191.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC----e
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----H 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~ 172 (433)
++|++.+.||+|+||+||+|.+. ++.||||++............|+.+++.+ .|+||+++++++.... .
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-----KHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-----CCTTBCCEEEEEEEECSSSEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-----CCCCchhhcceeccCCCCCce
Confidence 57999999999999999999875 78999999976555555556677777666 6799999999988743 5
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCceEeeccCccccC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL----------CMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
+++||||+ +++|.+++... .+++..+..++.||+.||.|||+. |||||||||+|||++.
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~------- 166 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN------- 166 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT-------
T ss_pred EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC-------
Confidence 89999999 88999999874 599999999999999999999999 9999999999999954
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCC-----CCCCcchhHHHHH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGC 311 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv 311 (433)
++.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||
T Consensus 167 --------------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 167 --------------------NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp --------------------TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred --------------------CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 445666666666433221 1235799999999999873 4567889999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|||++|+.||.+........................ ............ .. ..
T Consensus 227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------------~~--~~ 280 (322)
T 3soc_A 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQE------VVVHKKKRPVLR------------------DY--WQ 280 (322)
T ss_dssp HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHH------HHTTSCCCCCCC------------------GG--GG
T ss_pred HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhh------hhhcccCCCCcc------------------cc--cc
Confidence 99999999999986543221111111111111110000 000000000000 00 00
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
....+.++.+||.+||+.||++|||+.|+++
T Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1123456999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=346.95 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=192.4
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... .....+..|+.+++.+.++ +++..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~~~----~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQGG----VGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTS----TTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-ccchHHHHHHHHHHHhcCC----CCCCeeeeecCCCCce
Confidence 3457899999999999999999999999999999987643 2334577899999998543 3455556666788899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~------------------ 141 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------ 141 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG------------------
T ss_pred EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc------------------
Confidence 9999999999999998543 469999999999999999999999999999999999999311
Q ss_pred cccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+.++.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 142 ------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 4hgt_A 142 ------KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------CCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence 12334566666655433222 12357999999999999999999999999999999999999999
Q ss_pred CCCChHH---HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 324 QTHENLE---HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 324 ~~~~~~~---~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.+.+... ....+.... ...........++.++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~l~ 251 (296)
T 4hgt_A 216 QGLKAATKRQKYERISEKK--------------------------------------------MSTPIEVLCKGYPSEFA 251 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHH--------------------------------------------HHSCHHHHTTTSCHHHH
T ss_pred cccchhhhhhhhhhhhccc--------------------------------------------ccchhhhhhccCCHHHH
Confidence 7643221 111111000 00001112245678999
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q 013973 401 HLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~ 422 (433)
+||.+||+.||++|||+.++++
T Consensus 252 ~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 252 TYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCCHHHHHH
Confidence 9999999999999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=362.21 Aligned_cols=246 Identities=22% Similarity=0.386 Sum_probs=199.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.++|++.+.||+|+||.||+|.++.+++.||||+++.. ......+..|+.+++.+ .|+||+++++++...+.+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-----CCTTBCCEEEEECSSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEecCCCc
Confidence 46899999999999999999999999999999998743 22334567899998887 679999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +++|.+++...+ ..+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~---------------- 250 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---------------- 250 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----------------
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC----------------
Confidence 9999999 899999998653 3699999999999999999999999999999999999995544
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~ 326 (433)
.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 251 -----------~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 251 -----------VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp -----------CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred -----------cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 45555555554322211 12246788999999999899999999999999999998 99999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+.. ..... .+..++.++.+||.+|
T Consensus 320 ~~~~~~~~~~~----------------------~~~~~--------------------------~~~~~~~~l~~li~~c 351 (377)
T 3cbl_A 320 SNQQTREFVEK----------------------GGRLP--------------------------CPELCPDAVFRLMEQC 351 (377)
T ss_dssp CHHHHHHHHHT----------------------TCCCC--------------------------CCTTCCHHHHHHHHHH
T ss_pred CHHHHHHHHHc----------------------CCCCC--------------------------CCCCCCHHHHHHHHHH
Confidence 66544332211 00111 1234677899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013973 407 LRYDPTDRLTAREALR 422 (433)
Q Consensus 407 L~~dP~~R~ta~ell~ 422 (433)
|+.||++|||+.++++
T Consensus 352 l~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 352 WAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=373.57 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=205.7
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
....+|++.+.||+|+||.||+|.++.++..||||+++......+.+..|+.+++++ .|+||+++++++...+.+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-----CCCCEeeEEEEEecCCcE
Confidence 345689999999999999999999999999999999986655667788999999998 679999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
||||||+ +|+|.++|.......+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--------------- 356 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--------------- 356 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC---------------
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc---------------
Confidence 9999999 899999998866667999999999999999999999999999999999999965554
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~ 327 (433)
+||+|||+++...... ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 357 ------------~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 357 ------------VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp ------------EEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ------------EEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 5555555554332211 12346788999999999999999999999999999999 999998766
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+.... .. ..+..++.++.+||.+||
T Consensus 425 ~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~l~~li~~cl 456 (495)
T 1opk_A 425 LSQVYELLEKDY----------------------RM--------------------------ERPEGCPEKVYELMRACW 456 (495)
T ss_dssp GGGHHHHHHTTC----------------------CC--------------------------CCCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHHcCC----------------------CC--------------------------CCCCCCCHHHHHHHHHHc
Confidence 544332221100 00 112356778999999999
Q ss_pred ccCCCCCCCHHHHhc
Q 013973 408 RYDPTDRLTAREALR 422 (433)
Q Consensus 408 ~~dP~~R~ta~ell~ 422 (433)
+.||++|||+.++++
T Consensus 457 ~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 457 QWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CcChhHCcCHHHHHH
Confidence 999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.97 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=198.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-CeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-NHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-~~~~ 174 (433)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+..|+.+++++ .|+||+++++++... +.+|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTC-----CCTTBCCEEEEEECTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhc-----cCCCEEEEEEEEEcCCCceE
Confidence 468999999999999999999875 6789999997543 456788899999988 678999999987655 4899
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +|+|.+++...+...+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~------------------- 324 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE------------------- 324 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-------------------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC-------------------
Confidence 999999 889999999876556899999999999999999999999999999999999954
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 332 (433)
++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 325 --------~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 396 (450)
T 1k9a_A 325 --------DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396 (450)
T ss_dssp --------TSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred --------CCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 456677777776644333333467889999999999999999999999999999998 99999876554433
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
..+. .+.. ...+..+++++.+||.+||+.||.
T Consensus 397 ~~i~-----------------------~~~~-------------------------~~~p~~~~~~l~~li~~cl~~dp~ 428 (450)
T 1k9a_A 397 PRVE-----------------------KGYK-------------------------MDAPDGCPPAVYDVMKNCWHLDAA 428 (450)
T ss_dssp HHHH-----------------------TTCC-------------------------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHH-----------------------cCCC-------------------------CCCCCcCCHHHHHHHHHHcCCChh
Confidence 2221 1100 012245678999999999999999
Q ss_pred CCCCHHHHhc
Q 013973 413 DRLTAREALR 422 (433)
Q Consensus 413 ~R~ta~ell~ 422 (433)
+|||+.++++
T Consensus 429 ~Rpt~~~l~~ 438 (450)
T 1k9a_A 429 TRPTFLQLRE 438 (450)
T ss_dssp GSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=344.84 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=200.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhh--------HHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--------REAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--------~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... .+.+..|+.+++.+ .|+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~ 92 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-----NHPNIVKLYGLM 92 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-----CCCCchhhheee
Confidence 46799999999999999999999999999999998532211 15667888888887 678999999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCc
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+.. ++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~------- 162 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE------- 162 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT-------
T ss_pred cCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC-------
Confidence 7766 6999999 899999987654 47999999999999999999999999 999999999999965432
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhh--CCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL--GLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
+....+||+|||++...........||+.|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 163 ---------------~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 227 (287)
T 4f0f_A 163 ---------------NAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227 (287)
T ss_dssp ---------------TCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred ---------------CCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 2233488999998876555555568999999999984 45578999999999999999999999
Q ss_pred CCCCChHHH--HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 323 FQTHENLEH--LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 323 f~~~~~~~~--~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
|...+.... ...+.. .+.. ...+..+++++.
T Consensus 228 f~~~~~~~~~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~l~ 260 (287)
T 4f0f_A 228 FDEYSYGKIKFINMIRE-EGLR----------------------------------------------PTIPEDCPPRLR 260 (287)
T ss_dssp TTTCCCCHHHHHHHHHH-SCCC----------------------------------------------CCCCTTSCHHHH
T ss_pred CccccccHHHHHHHHhc-cCCC----------------------------------------------CCCCcccCHHHH
Confidence 986543322 111100 0000 011235677899
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q 013973 401 HLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~ 422 (433)
+||.+||+.||.+|||+.|+++
T Consensus 261 ~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 261 NVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=353.15 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=201.8
Q ss_pred eecCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
...++|++++.||+|+||.||+|.+. .+++.||+|+++.. ....+.+..|+.+++.+ .|+||++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~ 118 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLLGV 118 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEE
Confidence 34578999999999999999999987 45589999999743 23456678899999888 67899999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHT 223 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHr 223 (433)
+...+.+|+||||+ +++|.+++.... ...+++.++..++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999 889999998742 1469999999999999999999999999999
Q ss_pred cCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC-----CCCceeecCcccchhhhhCC
Q 013973 224 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGL 298 (433)
Q Consensus 224 DlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~ 298 (433)
||||+|||++.++ .+||+|||++..... ......||+.|+|||++.+.
T Consensus 199 Dlkp~NIl~~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 199 DLATRNCLVGENM---------------------------VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp CCSGGGEEECGGG---------------------------CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred CCCcceEEECCCC---------------------------eEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence 9999999995544 566666666543221 11234688999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhh
Q 013973 299 GWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377 (433)
Q Consensus 299 ~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (433)
.++.++|||||||++|+|++ |..||.+....+....+.. +..
T Consensus 252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-----------------------~~~-------------- 294 (343)
T 1luf_A 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-----------------------GNI-------------- 294 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-----------------------TCC--------------
T ss_pred CcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC-----------------------CCc--------------
Confidence 99999999999999999999 9999988766554433211 100
Q ss_pred hccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+..++.++.+||.+||+.||++|||+.+++++
T Consensus 295 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 295 -----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 01123567789999999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=339.23 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=193.5
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|++.+.||+|+||.||+|.+. ++.||+|+++... ...+.+..|+.+++.+ .|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-----KHPNIIALRGVCLKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-----CCTTBCCEEEEECCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-----CCCCEeeEEEEEecC
Confidence 467999999999999999999874 7889999986432 2235567889988888 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
+..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++..+.-
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~-------- 147 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN-------- 147 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS--------
T ss_pred CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc--------
Confidence 9999999999 8999999864 36999999999999999999999999 8999999999999642210
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~ 325 (433)
....++.+||+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+
T Consensus 148 -----------~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 148 -----------GDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp -----------SCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred -----------ccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 00135678999999887544332 345799999999999999999999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHh
Q 013973 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 405 (433)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 405 (433)
.+.......+.. .... ...+..++.++.+||.+
T Consensus 217 ~~~~~~~~~~~~-----------------------~~~~------------------------~~~~~~~~~~~~~li~~ 249 (271)
T 3dtc_A 217 IDGLAVAYGVAM-----------------------NKLA------------------------LPIPSTCPEPFAKLMED 249 (271)
T ss_dssp SCHHHHHHHHHT-----------------------SCCC------------------------CCCCTTCCHHHHHHHHH
T ss_pred CCHHHHHHhhhc-----------------------CCCC------------------------CCCCcccCHHHHHHHHH
Confidence 765544322111 0000 01123567789999999
Q ss_pred ccccCCCCCCCHHHHhcC
Q 013973 406 LLRYDPTDRLTAREALRH 423 (433)
Q Consensus 406 ~L~~dP~~R~ta~ell~h 423 (433)
||+.||.+|||+.|+++|
T Consensus 250 ~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 250 CWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HhcCCcccCcCHHHHHHH
Confidence 999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=369.00 Aligned_cols=256 Identities=21% Similarity=0.281 Sum_probs=193.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
.+|.+.+.||+|+||+||. ....+++.||||++.... ......|+.+++.+. .|+||+++++++.+...+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~----~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESD----EHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSC----CCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhcc----CCCCcCeEEEEEecCCEEEEE
Confidence 4699999999999999764 344678899999986422 223457888888762 578999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 177 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 177 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
|||++++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 97 ~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~------------------- 156 (432)
T 3p23_A 97 IELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA------------------- 156 (432)
T ss_dssp EECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT-------------------
T ss_pred EECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC-------------------
Confidence 9999889999998764 34566677899999999999999999999999999999954321
Q ss_pred ccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCT-GEALFQTH 326 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~ 326 (433)
+....+||+|||++...... ....+||+.|+|||++. ...++.++|||||||++|||++ |..||...
T Consensus 157 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 157 ---HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ---TTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred ---CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 23446788888888654432 12357999999999998 4567889999999999999999 99999654
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
........ .+. ....... .....+..+.+||.+|
T Consensus 234 ~~~~~~~~----~~~-------------------~~~~~~~-----------------------~~~~~~~~~~~li~~~ 267 (432)
T 3p23_A 234 LQRQANIL----LGA-------------------CSLDCLH-----------------------PEKHEDVIARELIEKM 267 (432)
T ss_dssp TTHHHHHH----TTC-------------------CCCTTSC-----------------------TTCHHHHHHHHHHHHH
T ss_pred hHHHHHHH----hcc-------------------CCccccC-----------------------ccccccHHHHHHHHHH
Confidence 43322110 000 0000000 0012345688999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|+.||.+|||+.|+++||||..
T Consensus 268 L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 268 IAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp SCSSGGGSCCHHHHHTSTTTCC
T ss_pred HhCCHhhCCCHHHHHhCccccC
Confidence 9999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=348.70 Aligned_cols=248 Identities=20% Similarity=0.340 Sum_probs=199.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+ +.+++.||+|+++.. ....+.+..|+.+++.+ .|+||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-----NHPHVIKLYGACS 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCceeeEEEEEe
Confidence 47899999999999999999988 345689999999743 23445677888888877 6799999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNY----------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDL 225 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 225 (433)
..+.+++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 999999999999 8999999987542 24899999999999999999999999999999
Q ss_pred CCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCC
Q 013973 226 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGW 300 (433)
Q Consensus 226 Kp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~ 300 (433)
||+|||++.++. +||+|||++....... ....||+.|+|||++.+..+
T Consensus 177 kp~NIli~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 177 AARNILVAEGRK---------------------------MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp SGGGEEEETTTE---------------------------EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred chheEEEcCCCC---------------------------EEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence 999999965554 5555555554332221 22357889999999999899
Q ss_pred CCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhc
Q 013973 301 TYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 379 (433)
Q Consensus 301 ~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
+.++|||||||++|+|++ |..||.+....+....+.. +..
T Consensus 230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-----------------------~~~---------------- 270 (314)
T 2ivs_A 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT-----------------------GHR---------------- 270 (314)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----------------------TCC----------------
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhc-----------------------CCc----------------
Confidence 999999999999999999 9999987655443322111 000
Q ss_pred cchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 380 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+..++.++.+||.+||+.||++|||+.|++++
T Consensus 271 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 271 ---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123567789999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=338.20 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=201.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+..|+.+++.+ .|+||+++++++...+.+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCCeEE
Confidence 367999999999999999999986 567899999986555567788899999888 67899999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~------------------ 141 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ------------------ 141 (267)
T ss_dssp EECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG------------------
T ss_pred EEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC------------------
Confidence 99999 889999998753 4689999999999999999999999999999999999995544
Q ss_pred ccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
.+||+|||.+...... .....||..|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 142 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (267)
T 3t9t_A 142 ---------VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212 (267)
T ss_dssp ---------CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ---------CEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH
Confidence 5666666666543221 122357889999999999999999999999999999999 89999887665
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+..... . ..+...+.++.+||.+||+.
T Consensus 213 ~~~~~i~~~~~----------------------~--------------------------~~~~~~~~~l~~li~~~l~~ 244 (267)
T 3t9t_A 213 EVVEDISTGFR----------------------L--------------------------YKPRLASTHVYQIMNHCWRE 244 (267)
T ss_dssp HHHHHHHTTCC----------------------C--------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCCc----------------------C--------------------------CCCccCcHHHHHHHHHHccC
Confidence 54433221100 0 01124567899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013973 410 DPTDRLTAREALRH 423 (433)
Q Consensus 410 dP~~R~ta~ell~h 423 (433)
||++|||+.|++++
T Consensus 245 ~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 245 RPEDRPAFSRLLRQ 258 (267)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=351.23 Aligned_cols=246 Identities=21% Similarity=0.279 Sum_probs=190.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEE----EEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMV----AIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~v----AiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|++++.||+|+||.||+|++..+++.+ |+|.++.. ......+..|+.+++++ .|+||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-----CBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEec
Confidence 367999999999999999999998887654 77776532 23446678899999988 67899999999987
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.. .++||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~----------- 155 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH----------- 155 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-----------
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC-----------
Confidence 65 77888888 999999998754 46999999999999999999999999999999999999966554
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 156 ----------------~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 156 ----------------VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp ----------------EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ----------------EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence 5556666554332221 12356889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+.+..+....+.... ... .+...+.++.+|
T Consensus 220 ~~~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~~l 251 (327)
T 3poz_A 220 YDGIPASEISSILEKGE----------------------RLP--------------------------QPPICTIDVYMI 251 (327)
T ss_dssp TTTCCGGGHHHHHHTTC----------------------CCC--------------------------CCTTBCHHHHHH
T ss_pred ccCCCHHHHHHHHHcCC----------------------CCC--------------------------CCccCCHHHHHH
Confidence 98766544332221100 000 123466789999
Q ss_pred HHhccccCCCCCCCHHHHhcC
Q 013973 403 LQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~h 423 (433)
+.+||+.||.+|||+.|++++
T Consensus 252 i~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 252 MVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.69 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=202.6
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
+...++|++.+.||+|+||.||+|.+.. +..||||+++......+.+..|+.+++.+ .|+||+++++++. ...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTL-----QHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhC-----CCCCEeeEEEEEe-CCc
Confidence 3445789999999999999999999864 67799999986555667788999999888 6789999999886 667
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ +|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~----------------- 319 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA----------------- 319 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT-----------------
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC-----------------
Confidence 89999999 899999998654346899999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~ 326 (433)
++.+||+|||+++..... .....+|..|+|||++....++.++|||||||++|||++ |..||.+.
T Consensus 320 ----------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 320 ----------SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp ----------TCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ----------CCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 455677777766544321 122346788999999999999999999999999999999 99999987
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+..... . ..+..++.++.+||.+|
T Consensus 390 ~~~~~~~~i~~~~~----------------------~--------------------------~~~~~~~~~l~~li~~c 421 (454)
T 1qcf_A 390 SNPEVIRALERGYR----------------------M--------------------------PRPENCPEELYNIMMRC 421 (454)
T ss_dssp CHHHHHHHHHHTCC----------------------C--------------------------CCCTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC----------------------C--------------------------CCCCCCCHHHHHHHHHH
Confidence 76665544322100 0 01235677899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013973 407 LRYDPTDRLTAREALR 422 (433)
Q Consensus 407 L~~dP~~R~ta~ell~ 422 (433)
|+.||++|||+.+|++
T Consensus 422 l~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 422 WKNRPEERPTFEYIQS 437 (454)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHHH
Confidence 9999999999998865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=368.52 Aligned_cols=279 Identities=20% Similarity=0.325 Sum_probs=205.4
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 171 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 171 (433)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+..|+++++.+ .|+||+++++++...+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEEETTT 81 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCCCCeEEEeeccCCC
Confidence 3567999999999999999999999999999999997432 2345667899999998 6789999999987654
Q ss_pred -eEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 172 -HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 172 -~~~lV~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
..|+||||+ +++|.+++..... ..+++..+..++.||+.||+|||++|||||||||+|||+....
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------------ 149 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE------------ 149 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT------------
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC------------
Confidence 889999999 8999999976432 2399999999999999999999999999999999999983221
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhC--------CCCCCcchhHHHHHHHHHHHh
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--------LGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGv~l~ellt 318 (433)
+.++.+||+|||.+....... ...+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 150 -----------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t 218 (396)
T 4eut_A 150 -----------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (396)
T ss_dssp -----------TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred -----------CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH
Confidence 334567888888876544332 23579999999999875 467889999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchh
Q 013973 319 GEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397 (433)
Q Consensus 319 g~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (433)
|..||..... ......+.......|...+..+ .....+.+.|........ .....++.
T Consensus 219 g~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~----------------~l~~~~~~ 277 (396)
T 4eut_A 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV-----QKAENGPIDWSGDMPVSC----------------SLSRGLQV 277 (396)
T ss_dssp SSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEE-----ECSTTCCEEEESSCCTTC----------------SSCHHHHH
T ss_pred CCCCCCCCCcccchHHHHHHHhcCCCcccchhh-----eeccCCCcccCccCCccc----------------ccchHHHh
Confidence 9999975332 1112222222222222111100 001122222322211110 11124566
Q ss_pred HHHHHHHhccccCCCCCCCHHHHhc
Q 013973 398 DLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 398 ~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.+.+||.+||+.||++|||+.|+++
T Consensus 278 ~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 278 LLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hchHHHHHhhccChhhhccHHHHHH
Confidence 7899999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=343.71 Aligned_cols=269 Identities=22% Similarity=0.302 Sum_probs=196.3
Q ss_pred ecCcEEEEeeeeccccEEEEEEE----ECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~----~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
..++|++++.||+|+||.||+|+ +..+++.||||++... ....+.+..|+.+++.+ .|+||+++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-----QHDNIVKYKGVCYS 82 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec
Confidence 35789999999999999999998 6678999999998743 33446678899999888 67899999998754
Q ss_pred --CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 170 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 170 --~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
...+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 46799999999 899999998754 35999999999999999999999999999999999999977666555555544
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
......... ........||..|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 162 ~~~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 162 KVLPQDKEF---------------------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp C----------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred ccccCCcce---------------------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 332211000 00011124678899999999999999999999999999999999999753
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
... .....+..+..... .............. ..+..++.++.+||.+|
T Consensus 221 ~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~ 268 (295)
T 3ugc_A 221 PAE-----FMRMIGNDKQGQMI-VFHLIELLKNNGRL--------------------------PRPDGCPDEIYMIMTEC 268 (295)
T ss_dssp HHH-----HHHHHCTTCCTHHH-HHHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHH
T ss_pred hHH-----HHhhhcCccccchh-HHHHHHHHhccCcC--------------------------CCCcCcCHHHHHHHHHH
Confidence 211 11111111110000 00000000011111 12346778999999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013973 407 LRYDPTDRLTAREALR 422 (433)
Q Consensus 407 L~~dP~~R~ta~ell~ 422 (433)
|+.||++|||+.|+++
T Consensus 269 l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 269 WNNNVNQRPSFRDLAL 284 (295)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred cCCChhhCCCHHHHHH
Confidence 9999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=345.57 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=181.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhh--HHHHHHHHH-HHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIE-VLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~E~~-~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++++.||+|+||.||+|.++.+++.||||++...... ......|.. +++.+ .|+||+++++++...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-----~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-----DCPYIVQCFGTFITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCceeeEEEEEecCCc
Confidence 36799999999999999999999999999999999743221 222222332 23322 67899999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+++||||+++.+..++... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.
T Consensus 99 ~~lv~e~~~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~----------------- 160 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE----------------- 160 (318)
T ss_dssp EEEEECCCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT-----------------
T ss_pred EEEEEeccCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC-----------------
Confidence 9999999976666665543 24799999999999999999999995 9999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
++.+||+|||.+....... ....||+.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 161 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 161 ----------RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp ----------TSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----------CCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 4456666666664332221 2347899999999994 4568899999999999999999999998
Q ss_pred CCC-hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 325 THE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 325 ~~~-~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
... ..+....+..... ...+ ....++.++.+||
T Consensus 231 ~~~~~~~~~~~~~~~~~----------------------~~~~------------------------~~~~~~~~l~~li 264 (318)
T 2dyl_A 231 NCKTDFEVLTKVLQEEP----------------------PLLP------------------------GHMGFSGDFQSFV 264 (318)
T ss_dssp TCCSHHHHHHHHHHSCC----------------------CCCC------------------------SSSCCCHHHHHHH
T ss_pred CCCccHHHHHHHhccCC----------------------CCCC------------------------ccCCCCHHHHHHH
Confidence 643 3333222211100 0000 0124677899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.+||+.||.+|||+.|+++||||++
T Consensus 265 ~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 265 KDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHccCChhHCcCHHHHhhCHHHHh
Confidence 9999999999999999999999964
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=343.31 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=199.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+ ..+++.||+|+++... ...+.+..|+.+++++. .|+||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~ 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHMNIVNLLGACT 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc----cCCCeeeEEEEEe
Confidence 46899999999999999999985 4677899999997432 34566788999999883 4688999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNY----------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
..+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 999999999999 8899999987542 24899999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.++.++|+|| |.+....... ....||+.|+|||++.+..++.++||
T Consensus 178 ~~~~~~~kl~Df---------------------------g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 230 (313)
T 1t46_A 178 LTHGRITKICDF---------------------------GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (313)
T ss_dssp EETTTEEEECCC---------------------------GGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred EcCCCCEEEccc---------------------------cccccccccccceeccCCCCcceeeChHHhcCCCCChHHHH
Confidence 976555555555 4444332221 12357889999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
||||+++|+|++ |..||.+.........+......
T Consensus 231 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------------------- 266 (313)
T 1t46_A 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-------------------------------------------- 266 (313)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC--------------------------------------------
T ss_pred HHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC--------------------------------------------
Confidence 999999999999 99999876543332221111000
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+...+.++.+||.+||+.||.+|||+.|++++
T Consensus 267 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 267 ---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 00123456789999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=349.62 Aligned_cols=250 Identities=21% Similarity=0.310 Sum_probs=197.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+..|+.+++++. .|+||+++++++.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG----SHENIVNLLGACT 119 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc----CCCCeeeEEEEEe
Confidence 47899999999999999999997 346678999999743 234466788999999883 4688999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNY---------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 226 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlK 226 (433)
..+.+++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 999999999999 8899999986542 238999999999999999999999999999999
Q ss_pred CCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCC
Q 013973 227 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWT 301 (433)
Q Consensus 227 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~ 301 (433)
|+|||++.++. +||+|||++....... ....||+.|+|||++.+..++
T Consensus 200 p~NIll~~~~~---------------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 252 (344)
T 1rjb_A 200 ARNVLVTHGKV---------------------------VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252 (344)
T ss_dssp GGGEEEETTTE---------------------------EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred hhhEEEcCCCc---------------------------EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC
Confidence 99999965554 5555555554332221 224678899999999999999
Q ss_pred CcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhcc
Q 013973 302 YPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380 (433)
Q Consensus 302 ~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
.++|||||||++|+|++ |..||.+......+..+.. .+. .
T Consensus 253 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----------------------~~~-~---------------- 293 (344)
T 1rjb_A 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ----------------------NGF-K---------------- 293 (344)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----------------------TTC-C----------------
T ss_pred hhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHh----------------------cCC-C----------------
Confidence 99999999999999998 9999987654333222111 000 0
Q ss_pred chhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...+...+.++.+||.+||+.||.+|||+.|+++|
T Consensus 294 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 294 --------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 00123457789999999999999999999999886
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=364.30 Aligned_cols=258 Identities=19% Similarity=0.285 Sum_probs=199.2
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.++ +++..+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~----~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGG----TGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTS----TTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCC----CCCCeEEEEEeeCCEE
Confidence 45688999999999999999999999999999999987432 234577899999888543 4455666667788899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+|||||++++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 79 ~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~------------------ 139 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------------------ 139 (483)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG------------------
T ss_pred EEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC------------------
Confidence 9999999999999998643 479999999999999999999999999999999999999311
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC----------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+.++.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 140 ------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf 213 (483)
T 3sv0_A 140 ------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (483)
T ss_dssp ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------CCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 123456666666665433221 2457999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.........+..... ..+..........++.++.+||
T Consensus 214 ~~~~~~~~~~~~~~i~~-----------------------------------------~~~~~~~~~l~~~~p~~l~~li 252 (483)
T 3sv0_A 214 QGLKAGTKKQKYEKISE-----------------------------------------KKVATSIEALCRGYPTEFASYF 252 (483)
T ss_dssp SSCCCSSHHHHHHHHHH-----------------------------------------HHHHSCHHHHHTTSCHHHHHHH
T ss_pred ccccchhHHHHHHHHhh-----------------------------------------ccccccHHHHhcCCcHHHHHHH
Confidence 87543221111111000 0000111122346678999999
Q ss_pred HhccccCCCCCCCHHHHhc
Q 013973 404 QGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~ 422 (433)
..||+.||++||++.+|++
T Consensus 253 ~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 253 HYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 9999999999999987764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=353.40 Aligned_cols=255 Identities=16% Similarity=0.239 Sum_probs=188.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC---CCeEEEEEEeecchhh------------HHHHHHHHHHHHHHHhcCCCCCce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKY------------REAAMIEIEVLQQLAKHDKGGNRC 160 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~------------~~~~~~E~~~l~~l~~~~~~~~~i 160 (433)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... ...+..|+..+..+ .|+||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-----~h~ni 110 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-----DYLGI 110 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-----SCCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-----cccCc
Confidence 3679999999999999999999987 7888999998743211 01122333333333 77999
Q ss_pred EEecceeec----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccC
Q 013973 161 VQIRNWFDY----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 236 (433)
Q Consensus 161 ~~~~~~~~~----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~ 236 (433)
+++++++.. ...+|+||||++++|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred ceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence 999999877 78999999999999999998765 799999999999999999999999999999999999996543
Q ss_pred ccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhCCCCCCcchh
Q 013973 237 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 237 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
.+.+||+|||++...... .....||+.|+|||++.+..++.++||
T Consensus 189 -------------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 243 (345)
T 2v62_A 189 -------------------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDV 243 (345)
T ss_dssp -------------------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHH
T ss_pred -------------------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhH
Confidence 125666677766433211 123479999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhH
Q 013973 307 WSVGCILVELCTGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 384 (433)
Q Consensus 307 wSlGv~l~elltg~~Pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
|||||++|||++|..||.+. +...............|......
T Consensus 244 ~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------- 288 (345)
T 2v62_A 244 EILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKW----------------------------------- 288 (345)
T ss_dssp HHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHH-----------------------------------
T ss_pred HHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhh-----------------------------------
Confidence 99999999999999999642 22222222222222222211110
Q ss_pred HHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 385 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 385 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.....++.++.+||.+||+.||++|||+.++++
T Consensus 289 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 289 -----APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp -----SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 001256789999999999999999999998876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.66 Aligned_cols=248 Identities=24% Similarity=0.306 Sum_probs=191.1
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
...++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ....+.+..|+.+++.+ .|+||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCccceEEEEEc
Confidence 3457899999999999999999998654 467999998642 33455677888888877 6789999999885
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
.+..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg--- 161 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG--- 161 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc---
Confidence 56789999999 789999998653 469999999999999999999999999999999999999766655555554
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 162 ------------------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p 217 (281)
T 1mp8_A 162 ------------------------LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217 (281)
T ss_dssp -----------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ------------------------cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCC
Confidence 443322211 12356789999999999999999999999999999997 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+....+....+... ... ..+..++.++.+|
T Consensus 218 f~~~~~~~~~~~i~~~----------------------~~~--------------------------~~~~~~~~~l~~l 249 (281)
T 1mp8_A 218 FQGVKNNDVIGRIENG----------------------ERL--------------------------PMPPNCPPTLYSL 249 (281)
T ss_dssp TTTCCGGGHHHHHHTT----------------------CCC--------------------------CCCTTCCHHHHHH
T ss_pred CCcCCHHHHHHHHHcC----------------------CCC--------------------------CCCCCCCHHHHHH
Confidence 9876655443322110 000 1123567789999
Q ss_pred HHhccccCCCCCCCHHHHhcC
Q 013973 403 LQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~h 423 (433)
|.+||+.||++|||+.|++++
T Consensus 250 i~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 250 MTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=351.67 Aligned_cols=246 Identities=23% Similarity=0.275 Sum_probs=192.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeE----EEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEM----VAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~----vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|++++.||+|+||.||+|.+..+++. ||+|.+.... .....+..|+.+++.+ .|+||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-----DHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-----CCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEc-
Confidence 36799999999999999999999888876 6777764321 2223456688888777 6799999999886
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.+
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~------------- 151 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP------------- 151 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-------------
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-------------
Confidence 56789999999 899999997652 469999999999999999999999999999999999999544
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
+.+||+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 152 --------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 152 --------------SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp --------------SCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred --------------CeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 456666666665433221 23467889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+....+....+... .... .+..++.++.+|
T Consensus 218 ~~~~~~~~~~~~~~~~----------------------~~~~--------------------------~~~~~~~~~~~l 249 (325)
T 3kex_A 218 YAGLRLAEVPDLLEKG----------------------ERLA--------------------------QPQICTIDVYMV 249 (325)
T ss_dssp TTTSCTTHHHHHHHTT----------------------CBCC--------------------------CCTTBCTTTTHH
T ss_pred ccccCHHHHHHHHHcC----------------------CCCC--------------------------CCCcCcHHHHHH
Confidence 9876654433322110 0000 122456678899
Q ss_pred HHhccccCCCCCCCHHHHhcC
Q 013973 403 LQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~h 423 (433)
|.+||+.||.+|||+.|+++|
T Consensus 250 i~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 250 MVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.44 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=178.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.++|++++.||+|+||.||+|.++.+++.||||+++... ........|+..+. ....|+||+++++++...+..
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~----~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM----RSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHH----SSCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHH----HcCCCCcEeeeeeEEEeCCce
Confidence 367999999999999999999999999999999997532 22233344444222 123779999999999999999
Q ss_pred EEEEecCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRK---NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
++||||+.++|.+++.. .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~------------ 164 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN------------ 164 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE------------
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC------------
Confidence 99999997798888763 2235799999999999999999999999 9999999999999965554
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhh----hCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+||+|||++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 165 ---------------~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (327)
T 3aln_A 165 ---------------IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229 (327)
T ss_dssp ---------------EEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCS
T ss_pred ---------------EEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 5555555554332221 223689999999999 4567899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
........ .+ ...........+. .....++.++.+||
T Consensus 230 ~~~~~~~~--~~-------------------~~~~~~~~~~~~~----------------------~~~~~~~~~l~~li 266 (327)
T 3aln_A 230 PKWNSVFD--QL-------------------TQVVKGDPPQLSN----------------------SEEREFSPSFINFV 266 (327)
T ss_dssp SCC----------------------------CCCCCSCCCCCCC----------------------CSSCCCCHHHHHHH
T ss_pred CCcchHHH--HH-------------------HHHhcCCCCCCCC----------------------cccccCCHHHHHHH
Confidence 76432110 00 0000000000000 01235677899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.+||+.||++|||+.|+++||||..
T Consensus 267 ~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 267 NLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp HHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHhhCChhhCcCHHHHHhChHHHH
Confidence 9999999999999999999999964
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=335.70 Aligned_cols=244 Identities=15% Similarity=0.141 Sum_probs=197.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 170 (433)
.++|++.+.||+|+||.||+|.+. ++.||+|+++.. ....+.+..|+.+++++ .|+||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-----SHPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-----SCTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCchhheEEEEccCCC
Confidence 467999999999999999999984 788999999743 23345567788777766 679999999999877
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
+.+++||||+ +++|.+++.......+++..+..++.||+.||.|||++| |+||||||+|||++
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-------------- 147 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-------------- 147 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC--------------
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc--------------
Confidence 8899999999 889999998766556999999999999999999999999 99999999999994
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCC---cchhHHHHHHHHHHHhCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.++.++|+|||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|..||.
T Consensus 148 -------------~~~~~~l~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 148 -------------EDMTARISMADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp -------------TTSCEEEEGGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred -------------CCcceeEEeccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 445567777666543222 2347899999999999866554 7999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+....+..... .. ..+..++.++.+||.
T Consensus 213 ~~~~~~~~~~~~~~~~---------------------~~--------------------------~~~~~~~~~~~~li~ 245 (271)
T 3kmu_A 213 DLSNMEIGMKVALEGL---------------------RP--------------------------TIPPGISPHVSKLMK 245 (271)
T ss_dssp TSCHHHHHHHHHHSCC---------------------CC--------------------------CCCTTCCHHHHHHHH
T ss_pred ccChHHHHHHHHhcCC---------------------CC--------------------------CCCCCCCHHHHHHHH
Confidence 8776554333211100 00 112356778999999
Q ss_pred hccccCCCCCCCHHHHhc
Q 013973 405 GLLRYDPTDRLTAREALR 422 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~ 422 (433)
+||+.||++|||+.|+++
T Consensus 246 ~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 246 ICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=363.78 Aligned_cols=270 Identities=25% Similarity=0.307 Sum_probs=197.4
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+....|+.+++++. .||||+++++.+.+.+.+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~----~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--FCDIALMEIKLLTESD----DHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHT----TSTTBCCEEEEEECSSEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--HHHHHHHHHHHHHhcc----CCCCcCeEEEEEecCCeE
Confidence 345668888999999999998754 457899999998643 3345678999888763 568899999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRS-----FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
||||||++++|.+++....... .++..+..++.||+.||+|||++|||||||||+|||++.++.......
T Consensus 85 ~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~----- 159 (434)
T 2rio_A 85 YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ----- 159 (434)
T ss_dssp EEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT-----
T ss_pred EEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc-----
Confidence 9999999889999998654211 123345789999999999999999999999999999976543221100
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC-------CceeecCcccchhhhhC-------CCCCCcchhHHHHHHHH
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILV 314 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ 314 (433)
..+.+..+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 160 ---------~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ 230 (434)
T 2rio_A 160 ---------TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230 (434)
T ss_dssp ---------TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHH
T ss_pred ---------cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHH
Confidence 00345678999999887654432 23479999999999976 56899999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcC
Q 013973 315 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393 (433)
Q Consensus 315 ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
||++ |..||......+. .+.. +....+.... ....
T Consensus 231 ellt~g~~Pf~~~~~~~~--~i~~-----------------------~~~~~~~~~~-------------------~~~~ 266 (434)
T 2rio_A 231 YILSKGKHPFGDKYSRES--NIIR-----------------------GIFSLDEMKC-------------------LHDR 266 (434)
T ss_dssp HHHTTSCCTTCSTTTHHH--HHHH-----------------------TCCCCCCCTT-------------------CCCH
T ss_pred HHHhCCCCCCCCchhhHH--HHhc-----------------------CCCCcccccc-------------------cccc
Confidence 9999 9999976543321 1111 1111111000 0011
Q ss_pred CchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 394 ~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.++.++.+||.+||+.||.+|||+.|+++||||..
T Consensus 267 ~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 267 SLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred cchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 24568999999999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=346.33 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=202.1
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 164 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~ 164 (433)
.+...++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+..|+.+++.+ .|+||++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~ 94 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLL 94 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCCEeeeE
Confidence 3445678999999999999999999876 457889999997432 3344567788888877 678999999
Q ss_pred ceeecCCeEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeecc
Q 013973 165 NWFDYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 235 (433)
Q Consensus 165 ~~~~~~~~~~lV~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~ 235 (433)
+++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~- 173 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 173 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT-
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC-
Confidence 9999999999999999 889999997532 135799999999999999999999999999999999999954
Q ss_pred CccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHH
Q 013973 236 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVG 310 (433)
Q Consensus 236 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 310 (433)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||
T Consensus 174 --------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 227 (322)
T 1p4o_A 174 --------------------------DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 227 (322)
T ss_dssp --------------------------TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred --------------------------CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHH
Confidence 4456666666665332221 223678999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHh
Q 013973 311 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389 (433)
Q Consensus 311 v~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
|++|+|++ |..||.+.+..+....+.. +.. .
T Consensus 228 ~il~el~~~g~~p~~~~~~~~~~~~~~~-----------------------~~~-------------------------~ 259 (322)
T 1p4o_A 228 VVLWEIATLAEQPYQGLSNEQVLRFVME-----------------------GGL-------------------------L 259 (322)
T ss_dssp HHHHHHHHTSCCTTTTSCHHHHHHHHHT-----------------------TCC-------------------------C
T ss_pred HHHHHHHhcCCCccccCCHHHHHHHHHc-----------------------CCc-------------------------C
Confidence 99999999 8999988766554433211 000 0
Q ss_pred hhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 390 ~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+..++.++.+||.+||+.||.+|||+.|+++|
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0123567789999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=343.09 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=196.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ......+..|+.+++.+. +|+||+++++++.
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~ 101 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACT 101 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc----cCCCeeeEEEEEe
Confidence 47899999999999999999984 457789999999743 233456778999998883 4688999999987
Q ss_pred cC-CeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q 013973 169 YR-NHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 232 (433)
Q Consensus 169 ~~-~~~~lV~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl 232 (433)
.. ..+++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 64 4599999999 8899999987542 128999999999999999999999999999999999999
Q ss_pred eccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhH
Q 013973 233 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIW 307 (433)
Q Consensus 233 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dvw 307 (433)
+.++. +||+|||++....... ....||+.|+|||++.+..++.++|||
T Consensus 182 ~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 234 (316)
T 2xir_A 182 SEKNV---------------------------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234 (316)
T ss_dssp CGGGC---------------------------EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred CCCCC---------------------------EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHH
Confidence 65554 5555555554332221 224688999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHH
Q 013973 308 SVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386 (433)
Q Consensus 308 SlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
||||++|+|++ |..||.+....+.+........ ..
T Consensus 235 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---------------------~~----------------------- 270 (316)
T 2xir_A 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------------RM----------------------- 270 (316)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC---------------------CC-----------------------
T ss_pred HHHHHHHHHHhCCCCCCcccchhHHHHHHhccCc---------------------cC-----------------------
Confidence 99999999998 9999987654332221111000 00
Q ss_pred HHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 387 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+...++++.++|.+||+.||.+|||+.|+++|
T Consensus 271 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 271 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123456789999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=343.36 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=190.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++.+ .|+||+++++++...+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-----QEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-----CCCCeeEEEEEEeeCC
Confidence 367999999999999999999999999999999986432 2235567788888777 6789999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-------------- 171 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-------------- 171 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--------------
T ss_pred eEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--------------
Confidence 999999999 789999998764 799999999999999999999999999999999999995544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 172 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 172 -------------FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp -------------CEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred -------------CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 55666666554332221 2346899999999999989999999999999999999999999875
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+.......+. ...+ . ....+..++.++.+||.+|
T Consensus 239 ~~~~~~~~~~---~~~~---------------------~----------------------~~~~~~~~~~~l~~li~~~ 272 (309)
T 2h34_A 239 QLSVMGAHIN---QAIP---------------------R----------------------PSTVRPGIPVAFDAVIARG 272 (309)
T ss_dssp HHHHHHHHHH---SCCC---------------------C----------------------GGGTSTTCCTHHHHHHHHH
T ss_pred hHHHHHHHhc---cCCC---------------------C----------------------ccccCCCCCHHHHHHHHHh
Confidence 5432211110 0000 0 0012345677899999999
Q ss_pred cccCCCCCC-CHHHHhc
Q 013973 407 LRYDPTDRL-TAREALR 422 (433)
Q Consensus 407 L~~dP~~R~-ta~ell~ 422 (433)
|+.||++|| +++++++
T Consensus 273 l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 273 MAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp TCSSGGGSCSSHHHHHH
T ss_pred ccCCHHHHHHhHHHHHH
Confidence 999999999 8887764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=337.96 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=199.4
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
...++|++++.||+|+||.||+|.+. ++..||+|+++......+.+..|+.+++.+ .|+||+++++++. .+..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-----QHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEC-SSSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-----CCcCcceEEEEEc-CCCc
Confidence 34578999999999999999999975 567799999976555567788999999998 6788999999886 4568
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~------------------ 144 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD------------------ 144 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT------------------
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC------------------
Confidence 9999999 899999997543336999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~ 327 (433)
++.+||+|||.+....... ....||..|+|||++.+..++.++||||||+++|||++ |..||.+.+
T Consensus 145 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 145 ---------TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp ---------TSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ---------CCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 4456666666665433221 22356889999999998889999999999999999999 999998876
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+.... .. ..+..++.++.+||.+||
T Consensus 216 ~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~l~~li~~~l 247 (279)
T 1qpc_A 216 NPEVIQNLERGY----------------------RM--------------------------VRPDNCPEELYQLMRLCW 247 (279)
T ss_dssp HHHHHHHHHTTC----------------------CC--------------------------CCCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHhccc----------------------CC--------------------------CCcccccHHHHHHHHHHh
Confidence 655443321100 00 012356778999999999
Q ss_pred ccCCCCCCCHHHHhc
Q 013973 408 RYDPTDRLTAREALR 422 (433)
Q Consensus 408 ~~dP~~R~ta~ell~ 422 (433)
+.||++|||+.++++
T Consensus 248 ~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 248 KERPEDRPTFDYLRS 262 (279)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred ccChhhCCCHHHHHH
Confidence 999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=343.67 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=188.0
Q ss_pred ceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 93 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
..+.++|++.+.||+|+||+||+|.+ +++.||||++... .......|.+++.... ..|+||+++++.+..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~---l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--DEKSWFRETELYNTVM---LRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHTC---CCCTTBCCEEEEEEEEET
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--cchhhHHHHHHHHHhh---ccCcCeeeEEEeeccccC
Confidence 44568899999999999999999987 6889999998743 3344566777766632 267899999988543
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEeeccCccc
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--------DLCMIHTDLKPENVLLVSSEYIK 239 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~ivHrDlKp~NILl~~~~~~~ 239 (433)
...+++||||+ +++|.++++.. .+++..+..++.||+.||+||| +.|||||||||+|||++.+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~---- 149 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN---- 149 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT----
T ss_pred CCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC----
Confidence 46799999999 88999999643 6999999999999999999999 9999999999999999544
Q ss_pred cCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-------CceeecCcccchhhhhCC------CCCCcchh
Q 013973 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL------GWTYPCDI 306 (433)
Q Consensus 240 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~Dv 306 (433)
+.+||+|||++....... ...+||+.|+|||++.+. .++.++||
T Consensus 150 -----------------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv 206 (301)
T 3q4u_A 150 -----------------------GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206 (301)
T ss_dssp -----------------------SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred -----------------------CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence 456666666654332221 223799999999999876 45579999
Q ss_pred HHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccch
Q 013973 307 WSVGCILVELCTG----------EALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 372 (433)
Q Consensus 307 wSlGv~l~elltg----------~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (433)
|||||++|||++| ..||..... .......... .......+.
T Consensus 207 wslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~----- 261 (301)
T 3q4u_A 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV--------------------DQQRPNIPN----- 261 (301)
T ss_dssp HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT--------------------SCCCCCCCG-----
T ss_pred HHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhc--------------------cCCCCCCCh-----
Confidence 9999999999999 888864321 1111111000 000000000
Q ss_pred hhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 373 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
....+..+.++.+||.+||+.||++|||+.|+++
T Consensus 262 ----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 262 ----------------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp ----------------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----------------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 0011235678999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.81 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=190.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC---CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|++.+.||+|+||.||+|+++ .++..||||+++.. ....+.+..|+.+++++ .|+||+++++++...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-----DHPNIIRLEGVVTKS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeC
Confidence 467999999999999999999887 45678999998743 34456678899998887 678999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+++||||+ +++|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------------- 184 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL------------- 184 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------------
T ss_pred CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-------------
Confidence 9999999999 899999998653 4699999999999999999999999999999999999995544
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 185 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P 250 (373)
T 2qol_A 185 --------------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250 (373)
T ss_dssp --------------CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred --------------CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCC
Confidence 45555555554332221 11235778999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+..+....+.... .. ..+..++.++.+|
T Consensus 251 ~~~~~~~~~~~~i~~~~----------------------~~--------------------------~~~~~~~~~l~~l 282 (373)
T 2qol_A 251 YWEMSNQDVIKAVDEGY----------------------RL--------------------------PPPMDCPAALYQL 282 (373)
T ss_dssp TTTCCHHHHHHHHHTTE----------------------EC--------------------------CCCTTCBHHHHHH
T ss_pred CCCCCHHHHHHHHHcCC----------------------CC--------------------------CCCccccHHHHHH
Confidence 98776655443321110 00 0122456789999
Q ss_pred HHhccccCCCCCCCHHHHhc
Q 013973 403 LQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~ 422 (433)
|.+||+.||.+||++.|+++
T Consensus 283 i~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 283 MLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCcChhhCcCHHHHHH
Confidence 99999999999999998875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=343.07 Aligned_cols=249 Identities=26% Similarity=0.327 Sum_probs=199.8
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-- 169 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-- 169 (433)
+..+.++|++++.||+|+||.||+|.+..+++.||+|+++... +.+..|+.+++.+ .|+||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-----DHVNIVHYNGCWDGFD 77 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-----CCTTBCCEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-----CCCCEEEEeeeEeccc
Confidence 3455678999999999999999999999999999999997543 3456789999888 67899999988754
Q ss_pred --------------CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 170 --------------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 170 --------------~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
...+++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 45689999999 789999998765457999999999999999999999999999999999999965
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHH
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~ 312 (433)
++. +||+|||.+...... .....||+.|+|||++.+..++.++||||||++
T Consensus 158 ~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 210 (284)
T 2a19_B 158 TKQ---------------------------VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210 (284)
T ss_dssp TTE---------------------------EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHH
T ss_pred CCC---------------------------EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHH
Confidence 554 555556655433322 123468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhc
Q 013973 313 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392 (433)
Q Consensus 313 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|+|++|..||... ...... +..+ ..+
T Consensus 211 l~~l~~~~~~~~~~--~~~~~~-----------------------~~~~----------------------------~~~ 237 (284)
T 2a19_B 211 LAELLHVCDTAFET--SKFFTD-----------------------LRDG----------------------------IIS 237 (284)
T ss_dssp HHHHHSCCSSHHHH--HHHHHH-----------------------HHTT----------------------------CCC
T ss_pred HHHHHhcCCcchhH--HHHHHH-----------------------hhcc----------------------------ccc
Confidence 99999999887421 000000 0000 012
Q ss_pred CCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 393 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 393 ~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
..++.++.+||.+||+.||.+|||+.|+++|.+.-.
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 345678999999999999999999999999977543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=347.51 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=180.4
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee--------
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-------- 167 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-------- 167 (433)
.+|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++++. +|+||+++++++
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS----GHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT----TSTTBCCEEEEEEECTTTST
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc----cCCChhhccccccccccccc
Confidence 5799999999999999999999999999999988533 334556778999998884 368899999887
Q ss_pred ecCCeEEEEEecCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCc
Q 013973 168 DYRNHICIVFEKLGSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 168 ~~~~~~~lV~e~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.....+++||||++|+|.+++... ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||
T Consensus 104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp TSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred cCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 445679999999999999998752 2346999999999999999999999999 9999999999999777776666666
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhh---hCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
++............ ..............||+.|+|||++ .+..++.++|||||||++|+|++|..
T Consensus 184 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 184 SATTISHYPDYSWS------------AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp TCBCCSSCC-------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred cceeccccCccccc------------ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 65544322110000 0000000111234689999999999 56678999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.......... +....+ .....+..+.+
T Consensus 252 p~~~~~~~~~~~---------------------------~~~~~~------------------------~~~~~~~~~~~ 280 (337)
T 3ll6_A 252 PFEDGAKLRIVN---------------------------GKYSIP------------------------PHDTQYTVFHS 280 (337)
T ss_dssp CC---------------------------------------CCCC------------------------TTCCSSGGGHH
T ss_pred CCcchhHHHhhc---------------------------CcccCC------------------------cccccchHHHH
Confidence 997543322110 000111 11244567889
Q ss_pred HHHhccccCCCCCCCHHHHhcC
Q 013973 402 LLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~h 423 (433)
||.+||+.||.+|||+.|+++|
T Consensus 281 li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 281 LIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.64 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=203.1
Q ss_pred ecCcEEEEeeeeccccEEEEEEE-----ECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
..++|++++.||+|+||.||+|. +..+++.||||++... ......+..|+.+++.+ .|+||+++++++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 102 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCIGVS 102 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-----CCCCCCeEEEEE
Confidence 35789999999999999999998 5567889999998632 34455677899998888 678999999999
Q ss_pred ecCCeEEEEEecC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccC
Q 013973 168 DYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 241 (433)
Q Consensus 168 ~~~~~~~lV~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~ 241 (433)
......|+||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~----- 177 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG----- 177 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-----
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC-----
Confidence 9999999999999 8999999987542 3589999999999999999999999999999999999996432
Q ss_pred CCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHH
Q 013973 242 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 242 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~el 316 (433)
....+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|
T Consensus 178 -------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 238 (327)
T 2yfx_A 178 -------------------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238 (327)
T ss_dssp -------------------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHH
Confidence 3446888888877633221 1234678999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCc
Q 013973 317 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395 (433)
Q Consensus 317 lt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (433)
++ |..||......+....+.... .. ..+..+
T Consensus 239 lt~g~~p~~~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~ 270 (327)
T 2yfx_A 239 FSLGYMPYPSKSNQEVLEFVTSGG----------------------RM--------------------------DPPKNC 270 (327)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTC----------------------CC--------------------------CCCTTC
T ss_pred HcCCCCCCCCcCHHHHHHHHhcCC----------------------CC--------------------------CCCCCC
Confidence 98 999998776655443322110 00 012345
Q ss_pred hhHHHHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 396 ~~~~~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+..+.+||.+||+.||.+|||+.|+++|.|+
T Consensus 271 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 271 PGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 6789999999999999999999999998765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.68 Aligned_cols=249 Identities=18% Similarity=0.304 Sum_probs=199.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-------CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++.. ......+..|+.+++.+. .|+||++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~ 109 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGA 109 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh----cCCCEeeEEEE
Confidence 478999999999999999999976 45678999999743 234456778999998883 46889999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+...+.+++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 99999999999999 8899999986531 24899999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.+ +.+||+|||++....... ....||+.|+|||++.+..++.++||
T Consensus 190 l~~~---------------------------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 242 (334)
T 2pvf_A 190 VTEN---------------------------NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242 (334)
T ss_dssp ECTT---------------------------CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred EcCC---------------------------CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHH
Confidence 9544 456666666665433221 22357889999999999899999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
||||+++|+|++ |..||.+....+....+..... .
T Consensus 243 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------~---------------------- 278 (334)
T 2pvf_A 243 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------M---------------------- 278 (334)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC----------------------C----------------------
T ss_pred HHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC----------------------C----------------------
Confidence 999999999999 9999988766554433221100 0
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
..+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 279 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 279 ----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0123566789999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.93 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=190.2
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
...++|++.+.||+|+||.||+|.+..+++.||+|+++. .......+..|+.+++.+ .|+||+++++++..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFIE 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEc
Confidence 345679999999999999999999999999999999863 233456677899988887 67899999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
.+.+++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~----------- 172 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT----------- 172 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-----------
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-----------
Confidence 99999999999 78999998742 23469999999999999999999999999999999999999544
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 173 ----------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 236 (310)
T 2wqm_A 173 ----------------GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236 (310)
T ss_dssp ----------------SCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ----------------CCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 456666666655433221 2346899999999999999999999999999999999999999
Q ss_pred CCCChH--HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 324 QTHENL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 324 ~~~~~~--~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
.+.... +....+ ..+.+ +. .....++.++.+
T Consensus 237 ~~~~~~~~~~~~~~-----------------------~~~~~--~~----------------------~~~~~~~~~l~~ 269 (310)
T 2wqm_A 237 YGDKMNLYSLCKKI-----------------------EQCDY--PP----------------------LPSDHYSEELRQ 269 (310)
T ss_dssp C---CCHHHHHHHH-----------------------HTTCS--CC----------------------CCTTTSCHHHHH
T ss_pred cccchhHHHHHHHh-----------------------hcccC--CC----------------------CcccccCHHHHH
Confidence 754321 111111 01100 00 001245778999
Q ss_pred HHHhccccCCCCCCCHHHHhcC
Q 013973 402 LLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~h 423 (433)
||.+||+.||.+|||+.+++++
T Consensus 270 li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 270 LVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=362.05 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=200.3
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
...++|++.+.||+|+||.||+|.+..+ ..||||+++......+.+..|+.+++++ .|+||+++++++.. +.+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEcC-Cce
Confidence 3457899999999999999999998754 5699999986555566788999999998 67899999999876 678
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
|+||||+ +|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--------------- 318 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--------------- 318 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---------------
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC---------------
Confidence 9999999 899999997644346999999999999999999999999999999999999965554
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~ 327 (433)
+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 319 ------------~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 319 ------------CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp ------------EEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ------------EEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 5555555554332211 12346788999999999999999999999999999999 999998877
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+.... .. ..+..++.++.+||.+||
T Consensus 387 ~~~~~~~i~~~~----------------------~~--------------------------~~~~~~~~~l~~li~~cl 418 (452)
T 1fmk_A 387 NREVLDQVERGY----------------------RM--------------------------PCPPECPESLHDLMCQCW 418 (452)
T ss_dssp HHHHHHHHHTTC----------------------CC--------------------------CCCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHcCC----------------------CC--------------------------CCCCCCCHHHHHHHHHHc
Confidence 665544322110 00 012356778999999999
Q ss_pred ccCCCCCCCHHHHhcC--CCCCC
Q 013973 408 RYDPTDRLTAREALRH--PFFTR 428 (433)
Q Consensus 408 ~~dP~~R~ta~ell~h--p~f~~ 428 (433)
+.||++|||++++++. .+++.
T Consensus 419 ~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 419 RKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cCChhhCcCHHHHHHHHHHHhcc
Confidence 9999999999998873 55543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=340.90 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=188.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|++.+.||+|+||.||+|.+. ++.||+|++.. ....+.+..|+.+++++ .|+||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-ESERKAFIVELRQLSRV-----NHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-TTHHHHHHHHHHHHHHC-----CCTTBCCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-hhHHHHHHHHHHHHhcC-----CCCCcCeEEEEEcC--CcEEE
Confidence 57999999999999999999874 68899999974 34456778899999988 67899999998874 47999
Q ss_pred EecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 177 FEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHD---LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
|||+ +++|.+++..... ..+++..+..++.||+.||+|||+ +|||||||||+|||++.++.
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-------------- 143 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-------------- 143 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--------------
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--------------
Confidence 9999 8999999986542 247899999999999999999999 89999999999999964432
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
.+||+|||++...........||+.|+|||++.+..++.++||||||+++|||++|..||........
T Consensus 144 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 144 ------------VLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp ------------EEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred ------------EEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence 25777777766544444445799999999999999999999999999999999999999975433221
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
........+.. ......++..+.+||.+||+.||
T Consensus 212 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~~l~~li~~~l~~dp 245 (307)
T 2eva_A 212 RIMWAVHNGTR----------------------------------------------PPLIKNLPKPIESLMTRCWSKDP 245 (307)
T ss_dssp HHHHHHHTTCC----------------------------------------------CCCBTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHhcCCC----------------------------------------------CCcccccCHHHHHHHHHHhcCCh
Confidence 11100000000 01123567789999999999999
Q ss_pred CCCCCHHHHhc
Q 013973 412 TDRLTAREALR 422 (433)
Q Consensus 412 ~~R~ta~ell~ 422 (433)
++|||+.|+++
T Consensus 246 ~~Rps~~ell~ 256 (307)
T 2eva_A 246 SQRPSMEEIVK 256 (307)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=349.40 Aligned_cols=260 Identities=14% Similarity=0.156 Sum_probs=189.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC--------CeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEE------
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER--------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ------ 162 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~--------~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~------ 162 (433)
++|++.+.||+|+||.||+|.+..+ ++.||+|++... +.+..|+.+++++ .|+|+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-----~h~niv~~~~~~~ 112 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-----AKPLQVNKWKKLY 112 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-----CCHHHHHHHHHHT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-----cccchhhhhhhhc
Confidence 6899999999999999999999874 788999998744 3467789999888 3455554
Q ss_pred ---------ecceeec-CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q 013973 163 ---------IRNWFDY-RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 232 (433)
Q Consensus 163 ---------~~~~~~~-~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl 232 (433)
+++++.. .+..|+||||++++|.+++.......+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 5666654 788999999999999999987634579999999999999999999999999999999999999
Q ss_pred eccC--ccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHH
Q 013973 233 VSSE--YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 310 (433)
Q Consensus 233 ~~~~--~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 310 (433)
+.++ .++|+|||++.......... ...........||+.|+|||++.+..++.++||||||
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 255 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHV-----------------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCC-----------------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred cCCCCceEEEecCcceeeccCCCccc-----------------cccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence 7655 44444444443221110000 0000011234799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC-hHHHH-HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHH
Q 013973 311 CILVELCTGEALFQTHE-NLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388 (433)
Q Consensus 311 v~l~elltg~~Pf~~~~-~~~~~-~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
|++|||++|..||.... ..+.. ..........+ ..+..
T Consensus 256 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~-------------------- 295 (352)
T 2jii_A 256 YCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPG--------------------PFVGP-------------------- 295 (352)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCC--------------------CEECT--------------------
T ss_pred HHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChh--------------------hhhhh--------------------
Confidence 99999999999998653 22222 21111111000 00000
Q ss_pred hhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 389 ~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
...+..++.++.+||.+||+.||++|||+.++++
T Consensus 296 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 296 CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 0001245788999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=338.60 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=187.9
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
++...++|++.+.||+|+||.||+|.+.. .||+|+++.. ....+.+..|+.+++.+ .|+||+.++++.
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~- 89 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYS- 89 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE-
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-----CCCcEEEEEeec-
Confidence 44556789999999999999999998643 4999998632 33445677888888877 678999999854
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
.....++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~---------- 158 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT---------- 158 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE----------
T ss_pred cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC----------
Confidence 566789999999 899999997543 46999999999999999999999999999999999999966555
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCC-----CCCceeecCcccchhhhh---CCCCCCcchhHHHHHHHHHHHhC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg 319 (433)
+||+|||++..... ......||+.|+|||++. +..++.++||||||+++|+|++|
T Consensus 159 -----------------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 221 (289)
T 3og7_A 159 -----------------VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221 (289)
T ss_dssp -----------------EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHS
T ss_pred -----------------EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHC
Confidence 55555554432221 112346899999999997 56788999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
..||......+....+.......+ . .......++.++
T Consensus 222 ~~p~~~~~~~~~~~~~~~~~~~~~--------------------~-----------------------~~~~~~~~~~~l 258 (289)
T 3og7_A 222 QLPYSNINNRDQIIEMVGRGSLSP--------------------D-----------------------LSKVRSNCPKRM 258 (289)
T ss_dssp SCTTSSCCCHHHHHHHHHHTSCCC--------------------C-----------------------TTSSCTTSCHHH
T ss_pred CCCccccchHHHHHHHhcccccCc--------------------c-----------------------hhhccccCCHHH
Confidence 999987666554433222111000 0 001123567789
Q ss_pred HHHHHhccccCCCCCCCHHHHhc
Q 013973 400 THLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.+||.+||+.||.+|||+.|+++
T Consensus 259 ~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 259 KRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=350.03 Aligned_cols=267 Identities=22% Similarity=0.242 Sum_probs=199.2
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+...++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+..|+.+++.+ .|+||+++++++...
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC-----RHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-----CCTTBCCEEEECCCT
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEcCC
Confidence 3445688999999999999999999964 6788999988643 23445677888888776 679999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~------------- 174 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE------------- 174 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT-------------
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC-------------
Confidence 9999999999 8999999865432 35899999999999999999999999999999999999954
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 175 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 175 --------------NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp --------------TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred --------------CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCc
Confidence 445666666666532211 1234699999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|......+....... .......+.+...-.. . .........+.++.+|
T Consensus 241 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~----~------------~~~~~~~~~~~~l~~l 288 (321)
T 2qkw_B 241 IVQSLPREMVNLAEW----------------AVESHNNGQLEQIVDP----N------------LADKIRPESLRKFGDT 288 (321)
T ss_dssp CSCSSSSSCCCHHHH----------------THHHHTTTCCCSSSSS----S------------CTTCSCHHHHHHHHHH
T ss_pred ccccCcHHHHHHHHH----------------hhhccccccHHHhcCh----h------------hccccCHHHHHHHHHH
Confidence 976433211100000 0000000100000000 0 0000112346678999
Q ss_pred HHhccccCCCCCCCHHHHhcC
Q 013973 403 LQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~h 423 (433)
+.+||+.||++|||+.|+++|
T Consensus 289 i~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 289 AVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=336.15 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=197.2
Q ss_pred cCcEEEEe-eeeccccEEEEEEEEC--CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHS-KMGEGTFGQVLECWDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~-~iG~G~~g~V~~~~~~--~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|.+.+ .||+|+||.||+|.+. .++..||+|+++.. ....+.+..|+.+++.+ .|+||+++++++ ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVC-QA 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEE-ES
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-----CCCCEeEEEEEe-cC
Confidence 46688887 9999999999999864 46788999999752 34456678899999988 678999999998 45
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 6799999999 789999997543 46999999999999999999999999999999999999976665555555544322
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 328 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~ 328 (433)
...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus 161 ~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 161 GADDSY---------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp TTCSCE---------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred ccCcce---------------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 111000 000112356889999999998899999999999999999998 9999987766
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+.. +.. ...+..++.++.+||.+||+
T Consensus 220 ~~~~~~i~~-----------------------~~~-------------------------~~~~~~~~~~l~~li~~~l~ 251 (287)
T 1u59_A 220 PEVMAFIEQ-----------------------GKR-------------------------MECPPECPPELYALMSDCWI 251 (287)
T ss_dssp HHHHHHHHT-----------------------TCC-------------------------CCCCTTCCHHHHHHHHHTTC
T ss_pred HHHHHHHhc-----------------------CCc-------------------------CCCCCCcCHHHHHHHHHHcC
Confidence 554433211 000 01123567789999999999
Q ss_pred cCCCCCCCHHHHhcCC
Q 013973 409 YDPTDRLTAREALRHP 424 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp 424 (433)
.||++||++.|+++|.
T Consensus 252 ~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 252 YKWEDRPDFLTVEQRM 267 (287)
T ss_dssp SSGGGSCCHHHHHHHH
T ss_pred CChhhCcCHHHHHHHH
Confidence 9999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=342.61 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=199.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCe-----EEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~-----~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+..+++ .||+|++... ....+.+..|+.+++.+. .|+||+++++++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG----QHENIVNLLGACT 120 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc----CCCCeeeEEEEEe
Confidence 4679999999999999999999877654 7999999743 234566788999999883 4688999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeecc
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNN------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 235 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~ 235 (433)
..+.+++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999 889999997532 2368999999999999999999999999999999999999877
Q ss_pred CccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHH
Q 013973 236 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 236 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e 315 (433)
+.++|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 258 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNY----------------------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTS----------------------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CeEEECccccccccccccce----------------------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHH
Confidence 76666666655422111000 00122357889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 316 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 316 llt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
|++ |..||.+.........+...... ...+..
T Consensus 259 l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~ 291 (333)
T 2i1m_A 259 IFSLGLNPYPGILVNSKFYKLVKDGYQ-----------------------------------------------MAQPAF 291 (333)
T ss_dssp HTTTSCCSSTTCCSSHHHHHHHHHTCC-----------------------------------------------CCCCTT
T ss_pred HHcCCCCCCcccchhHHHHHHHhcCCC-----------------------------------------------CCCCCC
Confidence 998 99999876543333222111000 001224
Q ss_pred chhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.+.++.+||.+||+.||.+|||+.|++++
T Consensus 292 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 292 APKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 56789999999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.52 Aligned_cols=246 Identities=23% Similarity=0.335 Sum_probs=194.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC---CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ....+.+..|+.+++.+ .|+||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-----DHPHIVKLIGIIEEE 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-----CCTTBCCEEEEECSS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-----CCCCcceEEEEEcCC
Confidence 4679999999999999999998653 3456999998743 33456678899999999 678999999998754
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df------ 157 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF------ 157 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC------
T ss_pred -CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc------
Confidence 568999999 899999998754 46999999999999999999999999999999999999976665555555
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 324 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~ 324 (433)
|.+....... ....||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 158 ---------------------g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 158 ---------------------GLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp ---------------------CGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ---------------------CCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 4443322211 22356889999999999999999999999999999998 999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
..+..+....+.... .. ..+..+++.+.+||.
T Consensus 217 ~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~l~~li~ 248 (281)
T 3cc6_A 217 WLENKDVIGVLEKGD----------------------RL--------------------------PKPDLCPPVLYTLMT 248 (281)
T ss_dssp TSCGGGHHHHHHHTC----------------------CC--------------------------CCCTTCCHHHHHHHH
T ss_pred cCChHHHHHHHhcCC----------------------CC--------------------------CCCCCCCHHHHHHHH
Confidence 665544333221110 00 012345678999999
Q ss_pred hccccCCCCCCCHHHHhcC
Q 013973 405 GLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~h 423 (433)
+||+.||++|||+.|++++
T Consensus 249 ~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 249 RCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCchhCcCHHHHHHH
Confidence 9999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=341.86 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=194.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC----eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|.+.+.||+|+||.||+|.+..++ ..||+|+++.. ......+..|+.+++.+ .|+||+++++++..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEec
Confidence 467999999999999999999887553 45999999743 23445677889888887 67899999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+.+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------------ 184 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL------------ 184 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------------
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC------------
Confidence 99999999999 789999998653 4799999999999999999999999999999999999995544
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 321 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~ 321 (433)
.+||+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 185 ---------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 185 ---------------VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp ---------------CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ---------------cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 55555555554332211 11246788999999999999999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||...+..+....+.... ... .+..++.++.+
T Consensus 250 pf~~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~l~~ 281 (333)
T 1mqb_A 250 PYWELSNHEVMKAINDGF----------------------RLP--------------------------TPMDCPSAIYQ 281 (333)
T ss_dssp TTTTCCHHHHHHHHHTTC----------------------CCC--------------------------CCTTCBHHHHH
T ss_pred CcccCCHHHHHHHHHCCC----------------------cCC--------------------------CcccCCHHHHH
Confidence 998776655443321110 000 12245778999
Q ss_pred HHHhccccCCCCCCCHHHHhcC
Q 013973 402 LLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~h 423 (433)
||.+||+.||++||++.|++++
T Consensus 282 li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 282 LMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=344.42 Aligned_cols=245 Identities=20% Similarity=0.271 Sum_probs=191.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEE----EEEEeec--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMV----AIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~v----AiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|++++.||+|+||.||+|.+..+++.| |+|.+.. .......+..|+.+++.+ .|+||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-----CBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-----CCCCeeEEEEEEec
Confidence 367999999999999999999998888765 6666542 223456678899998887 67899999999987
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.. .++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.++|+|||
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG---- 162 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---- 162 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCc----
Confidence 65 77888888 999999998754 469999999999999999999999999999999999999766655555554
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
++....... ....||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 163 -----------------------~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 219 (327)
T 3lzb_A 163 -----------------------LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp -----------------------C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred -----------------------ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence 443322111 12356889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|.+....+....+.... .. ..+..++.++.+|
T Consensus 220 ~~~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~l~~l 251 (327)
T 3lzb_A 220 YDGIPASEISSILEKGE----------------------RL--------------------------PQPPICTIDVYMI 251 (327)
T ss_dssp TTTCCGGGHHHHHHTTC----------------------CC--------------------------CCCTTBCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCC----------------------CC--------------------------CCCccCCHHHHHH
Confidence 98766544333221100 00 0123567789999
Q ss_pred HHhccccCCCCCCCHHHHhc
Q 013973 403 LQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~ 422 (433)
|.+||+.||.+|||+.|+++
T Consensus 252 i~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 252 MRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=347.40 Aligned_cols=258 Identities=20% Similarity=0.288 Sum_probs=187.7
Q ss_pred cCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 91 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 91 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
....+.++|++++.||+|+||.||+|.+. ++.||||++.... ......|.+++..+. ..|+||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~~~~~~---~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE--EASWFRETEIYQTVL---MRHENILGFIAADIKG 103 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG--HHHHHHHHHHHTSTT---CCCTTBCCEEEEEEES
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc--cchhhhHHHHHHHHh---hcCCCeeeEEEEEccC
Confidence 34455678999999999999999999875 8899999987433 233444555544332 2679999999998876
Q ss_pred ----CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeeccCc
Q 013973 171 ----NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--------CMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 171 ----~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlKp~NILl~~~~~ 237 (433)
..+|+||||+ +++|.+++... .+++..+..++.|++.||+|||+. |||||||||+|||++.++
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~- 179 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG- 179 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-
Confidence 7899999999 88999999764 599999999999999999999998 999999999999995544
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-------CceeecCcccchhhhhCCCCCCc------c
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYP------C 304 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~------~ 304 (433)
.+||+|||++....... ...+||+.|+|||++.+..+... +
T Consensus 180 --------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 233 (337)
T 3mdy_A 180 --------------------------TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233 (337)
T ss_dssp --------------------------CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHH
T ss_pred --------------------------CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcccc
Confidence 55666666554332211 23479999999999988776665 9
Q ss_pred hhHHHHHHHHHHHhC----------CCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchh
Q 013973 305 DIWSVGCILVELCTG----------EALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 373 (433)
Q Consensus 305 DvwSlGv~l~elltg----------~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (433)
|||||||++|||++| ..||....... ....+..... ........+.
T Consensus 234 DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~------ 290 (337)
T 3mdy_A 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC-----------------IKKLRPSFPN------ 290 (337)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT-----------------TSCCCCCCCG------
T ss_pred chHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHh-----------------hhccCccccc------
Confidence 999999999999999 66665321100 0000000000 0000000000
Q ss_pred hHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
....+.++.++.+||.+||+.||++|||+.|+++|
T Consensus 291 ---------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 291 ---------------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp ---------------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---------------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 00112456789999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=338.11 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=189.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-cCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~~ 174 (433)
.++|++.+.||+|+||.||+|.+. ++.||+|+++.. ...+.+..|+.+++.+ .|+||+++++++. ..+.++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTC-----CCTTBCCEEEEECCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-hHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCCceE
Confidence 467999999999999999999874 788999999753 3456677899988887 6789999999864 445899
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-------------------- 151 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-------------------- 151 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--------------------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe--------------------
Confidence 999999 77999999875433489999999999999999999999999999999999994
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 332 (433)
.++.+||+|||.+...........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 152 -------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 224 (278)
T 1byg_A 152 -------EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224 (278)
T ss_dssp -------TTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred -------CCCcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4456777777776654444444568899999999999999999999999999999998 99999875543332
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
..+. .+.. ...+..+++++.+||.+||+.||.
T Consensus 225 ~~~~-----------------------~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~ 256 (278)
T 1byg_A 225 PRVE-----------------------KGYK-------------------------MDAPDGCPPAVYEVMKNCWHLDAA 256 (278)
T ss_dssp HHHT-----------------------TTCC-------------------------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHh-----------------------cCCC-------------------------CCCcccCCHHHHHHHHHHhcCChh
Confidence 2211 1100 011235677899999999999999
Q ss_pred CCCCHHHHhc
Q 013973 413 DRLTAREALR 422 (433)
Q Consensus 413 ~R~ta~ell~ 422 (433)
+|||+.|+++
T Consensus 257 ~Rps~~~l~~ 266 (278)
T 1byg_A 257 MRPSFLQLRE 266 (278)
T ss_dssp GSCCHHHHHH
T ss_pred hCCCHHHHHH
Confidence 9999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=335.08 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=193.8
Q ss_pred cCcEEEEe-eeeccccEEEEEEE--ECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHS-KMGEGTFGQVLECW--DRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~-~iG~G~~g~V~~~~--~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|++.+ .||+|+||.||+|. ...+++.||||+++... ...+.+..|+.+++.+ .|+||+++++++ .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGIC-E 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEEEE-E
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEE-C
Confidence 36799998 99999999999994 46678899999997432 2355677899998888 678999999998 5
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+..++||||+ +++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg---- 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG---- 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT----
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCC----
Confidence 67789999999 899999998754 69999999999999999999999999999999999999766655555555
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 321 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~ 321 (433)
++....... ....||+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 163 -----------------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 219 (291)
T 1xbb_A 163 -----------------------LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219 (291)
T ss_dssp -----------------------TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----------------------cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC
Confidence 443322211 11246788999999999889999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.+..+....+.. +.. ...+..++.++.+
T Consensus 220 p~~~~~~~~~~~~~~~-----------------------~~~-------------------------~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 220 PYRGMKGSEVTAMLEK-----------------------GER-------------------------MGCPAGCPREMYD 251 (291)
T ss_dssp SSTTCCHHHHHHHHHT-----------------------TCC-------------------------CCCCTTCCHHHHH
T ss_pred CCCCCCHHHHHHHHHc-----------------------CCC-------------------------CCCCCCCCHHHHH
Confidence 9988766554333211 000 0012356778999
Q ss_pred HHHhccccCCCCCCCHHHHhc
Q 013973 402 LLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~ 422 (433)
||.+||+.||.+|||+.++++
T Consensus 252 li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=343.60 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=195.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEE--EEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMV--AIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~v--AiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.++|++.+.||+|+||.||+|.+..++..+ |+|.++.. ....+.+..|+.+++++. .|+||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRG 99 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC----CCTTBCCEEEEEEETT
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc----CCCchhhhceeeeeCC
Confidence 367999999999999999999999888865 99988642 223445677888877662 5688999999999999
Q ss_pred eEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 236 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~ 236 (433)
.+|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999 889999998643 24699999999999999999999999999999999999996544
Q ss_pred ccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCC--CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHH
Q 013973 237 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 314 (433)
Q Consensus 237 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ 314 (433)
.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|
T Consensus 180 ---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 180 ---------------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp ---------------------------CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred ---------------------------eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 456666665542221 112235788999999999988999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcC
Q 013973 315 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393 (433)
Q Consensus 315 ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
+|++ |..||.+.+..+....+. .+.. ...+.
T Consensus 233 ellt~g~~pf~~~~~~~~~~~~~-----------------------~~~~-------------------------~~~~~ 264 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCAELYEKLP-----------------------QGYR-------------------------LEKPL 264 (327)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHGG-----------------------GTCC-------------------------CCCCT
T ss_pred HHHcCCCCCCCCCcHHHHHHHhh-----------------------cCCC-------------------------CCCCC
Confidence 9998 999998776554332211 1000 00123
Q ss_pred CchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 394 ~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.++.++.+||.+||+.||.+|||+.|+++|
T Consensus 265 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 265 NCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 567789999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.78 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=195.6
Q ss_pred cCcEEEEeeeeccccEEEEEEE----ECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
..+|++++.||+|+||.||+|+ +..+++.||+|+++... .....+..|+.+++.+ .|+||+++++++..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-----YHENIVKYKGICTE 94 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-----CCTTBCCEEEEEEC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-----CCCCeeeeeeEEec
Confidence 4569999999999999999998 67789999999987432 2345677899999888 67899999999877
Q ss_pred C--CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 170 R--NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 170 ~--~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
. ..+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k------- 166 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK------- 166 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE-------
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEE-------
Confidence 6 6799999999 889999996654 4699999999999999999999999999999999999997665544
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
|+|||.+....... ....||..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 167 --------------------l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (302)
T 4e5w_A 167 --------------------IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226 (302)
T ss_dssp --------------------ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred --------------------ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence 55555444332221 1235788899999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.|+.... ..+....++........ . ....+..+ .....+..++.++.
T Consensus 227 ~p~~~~~-----~~~~~~~~~~~~~~~~~--~-~~~~~~~~-------------------------~~~~~~~~~~~~l~ 273 (302)
T 4e5w_A 227 DSDSSPM-----ALFLKMIGPTHGQMTVT--R-LVNTLKEG-------------------------KRLPCPPNCPDEVY 273 (302)
T ss_dssp CGGGSHH-----HHHHHHHCSCCGGGHHH--H-HHHHHHTT-------------------------CCCCCCTTCCHHHH
T ss_pred CCCcchh-----hHHhhccCCcccccCHH--H-HHHHHhcc-------------------------CCCCCCCCCCHHHH
Confidence 9875321 11222222222111000 0 00000000 00112346778999
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q 013973 401 HLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~ 422 (433)
+||.+||+.||.+|||+.|+++
T Consensus 274 ~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 274 QLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCCCCCCHHHHHH
Confidence 9999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=336.36 Aligned_cols=243 Identities=26% Similarity=0.499 Sum_probs=189.4
Q ss_pred ecCcEEEE-eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 013973 95 LTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 169 (433)
Q Consensus 95 ~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---- 169 (433)
+.++|.++ +.||+|+||.||+|.+..+++.||+|+++.. .....|+.++.++. .|+||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~----~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhc----cCCCchhHHhhhhhhcCC
Confidence 44678887 7899999999999999999999999999743 34566787775553 56889999999876
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
...+++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~------------- 153 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK------------- 153 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-------------
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecC-------------
Confidence 78899999999 8899999998766679999999999999999999999999999999999999542
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
..++.+||+|||++.... +..++.++|||||||++|||++|..||.....
T Consensus 154 -----------~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 154 -----------RPNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp -----------STTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred -----------CCCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 125678999999876432 23578899999999999999999999976543
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
...... ....+..+....+ ...+..++.++.+||.+||+
T Consensus 204 ~~~~~~-------------------~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~li~~~l~ 242 (299)
T 3m2w_A 204 LAISPG-------------------MKTRIRMGQYEFP----------------------NPEWSEVSEEVKMLIRNLLK 242 (299)
T ss_dssp ----CC-------------------SCCSSCTTCCSSC----------------------HHHHTTSCHHHHHHHHHHTC
T ss_pred hhhhHH-------------------HHHHHhhccccCC----------------------chhcccCCHHHHHHHHHHcc
Confidence 221100 0000111111111 01124567899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
.||.+|||+.|+|+||||++.
T Consensus 243 ~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 243 TEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SSTTTSCCHHHHHTSHHHHTG
T ss_pred cChhhCCCHHHHhcChhhccc
Confidence 999999999999999999764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=347.47 Aligned_cols=272 Identities=20% Similarity=0.219 Sum_probs=184.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-----ecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-----DYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-----~~~ 170 (433)
.++|++++.||+|+||.||+|.+ +++.||||++..... .....|.+++.. ....|+||+++++.+ ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~---~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRV---PLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTS---TTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHH---HhccCcchhhheecccccccCCC
Confidence 36799999999999999999976 688999999974332 333344443321 123778999998743 334
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEeeccCcccc
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL---------CMIHTDLKPENVLLVSSEYIKV 240 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~ivHrDlKp~NILl~~~~~~~i 240 (433)
..+++||||+ +++|.+++... .+++..+..++.||+.||.|||+. |||||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--- 158 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--- 158 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC---
T ss_pred ceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc---
Confidence 5789999999 89999999875 468999999999999999999999 9999999999999965554
Q ss_pred CCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----------CCceeecCcccchhhhhC-------CCCCC
Q 013973 241 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----------QNYIVSTRHYRAPEVILG-------LGWTY 302 (433)
Q Consensus 241 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~-------~~~~~ 302 (433)
+||+|||++...... ....+||+.|+|||++.+ ..++.
T Consensus 159 ------------------------~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 159 ------------------------CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp ------------------------EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred ------------------------EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence 555555554432211 123469999999999987 35678
Q ss_pred cchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhc--cCcccCCCCccchhhHhhhc
Q 013973 303 PCDIWSVGCILVELCTGEALFQT-HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR--RGRLDWPEGAASRESIKSVM 379 (433)
Q Consensus 303 ~~DvwSlGv~l~elltg~~Pf~~-~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 379 (433)
++|||||||++|||++|..||.. ....+....+....+..|.... . ...+. ......|+...
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~--------- 279 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED--M----QVLVSREKQRPKFPEAWK--------- 279 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHH--H----HHHHTTSCCCCCCCTTCC---------
T ss_pred ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHH--H----HhhhcccccCCCCCcccc---------
Confidence 89999999999999999766533 2221111111111222221100 0 00000 00111111000
Q ss_pred cchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHH------hcCCCCCCCC
Q 013973 380 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA------LRHPFFTRDH 430 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~el------l~hp~f~~~~ 430 (433)
.....+.++.+||.+||+.||++|||+.|+ +.++|-++..
T Consensus 280 -----------~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 280 -----------ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp -----------CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred -----------cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 011245679999999999999999999999 5578877653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=345.21 Aligned_cols=262 Identities=22% Similarity=0.274 Sum_probs=196.3
Q ss_pred cCcEEEEeeeeccccEEEEEEE----ECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--
Q 013973 96 TSRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-- 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~----~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-- 168 (433)
.++|++++.||+|+||.||+|+ +..+++.||||++... ....+.+..|+.+++++ .|+||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-----HSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-----CCCceeEEEEEEecC
Confidence 3689999999999999999998 5778999999999743 33445678899999888 6788999998875
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
....+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~k-------- 167 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK-------- 167 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE--------
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEE--------
Confidence 567799999999 999999998643 2699999999999999999999999999999999999997665555
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
|+|||.+....... ....||..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 168 -------------------l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~ 228 (327)
T 3lxl_A 168 -------------------IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228 (327)
T ss_dssp -------------------ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred -------------------EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 45555444322211 12357888999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||........... ......+.. . . ....+..+ .....+..++.++.+
T Consensus 229 p~~~~~~~~~~~~--~~~~~~~~~--~---~-~~~~~~~~-------------------------~~~~~~~~~~~~l~~ 275 (327)
T 3lxl_A 229 KSCSPSAEFLRMM--GCERDVPAL--S---R-LLELLEEG-------------------------QRLPAPPACPAEVHE 275 (327)
T ss_dssp GGGSHHHHHHHHC--C----CCHH--H---H-HHHHHHTT-------------------------CCCCCCTTCCHHHHH
T ss_pred CCccccchhhhhc--ccccccccH--H---H-HHHHhhcc-------------------------cCCCCCCcccHHHHH
Confidence 9975332211100 000000000 0 0 00000000 001123467789999
Q ss_pred HHHhccccCCCCCCCHHHHhcC
Q 013973 402 LLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~h 423 (433)
||.+||+.||++|||+.|++++
T Consensus 276 li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 276 LMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=334.07 Aligned_cols=245 Identities=17% Similarity=0.204 Sum_probs=189.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce-eecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW-FDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~-~~~~ 170 (433)
.+|++.+.||+|+||.||+|.+..+ ...||+|.++.. ....+.+..|+.+++++ .|+||++++++ +...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeEEEcCC
Confidence 4699999999999999999997544 346899998642 23445677899988888 67899999998 4667
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~------------ 166 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT------------ 166 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC------------
T ss_pred CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC------------
Confidence 7899999999 889999997643 46899999999999999999999999999999999999965554
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC-------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 321 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~ 321 (433)
+||+|||.+...... .....||+.|+|||++.+..++.++||||||+++|+|++ |.+
T Consensus 167 ---------------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 167 ---------------VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp ---------------EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ---------------EEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 555555554432211 122367889999999999999999999999999999999 677
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||...+..+....+..... . ..+..++.++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~l~~ 263 (298)
T 3f66_A 232 PYPDVNTFDITVYLLQGRR----------------------L--------------------------LQPEYCPDPLYE 263 (298)
T ss_dssp SSTTSCTTTHHHHHHTTCC----------------------C--------------------------CCCTTCCHHHHH
T ss_pred CCccCCHHHHHHHHhcCCC----------------------C--------------------------CCCccCCHHHHH
Confidence 7876554443322211100 0 012245678999
Q ss_pred HHHhccccCCCCCCCHHHHhc
Q 013973 402 LLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~ 422 (433)
||.+||+.||++|||+.|+++
T Consensus 264 li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 264 VMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999886
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.15 Aligned_cols=252 Identities=27% Similarity=0.358 Sum_probs=202.9
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
..++|++.++||+|+||.||+|.+..+ ..||||+++......+.+..|+.+++++ .|+||+++++++.. +.+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEee-ccce
Confidence 356799999999999999999998754 5699999986555567788999999998 67899999998876 6789
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|||||+ +++|.++|.......+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----------------- 400 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----------------- 400 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-----------------
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-----------------
Confidence 999999 88999999764334699999999999999999999999999999999999996544
Q ss_pred cccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 328 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~ 328 (433)
.+||+|||+++..... .....+|..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 401 ----------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 401 ----------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp ----------CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred ----------cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 4556666655443221 112246788999999999999999999999999999999 9999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.+..+.... .. ..+..++.++.+||.+||+
T Consensus 471 ~~~~~~i~~~~----------------------~~--------------------------~~~~~~~~~l~~li~~cl~ 502 (535)
T 2h8h_A 471 REVLDQVERGY----------------------RM--------------------------PCPPECPESLHDLMCQCWR 502 (535)
T ss_dssp HHHHHHHHTTC----------------------CC--------------------------CCCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHcCC----------------------CC--------------------------CCCCCCCHHHHHHHHHHcC
Confidence 65544322110 00 0123567789999999999
Q ss_pred cCCCCCCCHHHHhcC--CCCCC
Q 013973 409 YDPTDRLTAREALRH--PFFTR 428 (433)
Q Consensus 409 ~dP~~R~ta~ell~h--p~f~~ 428 (433)
.||++|||+.+|++. .+|..
T Consensus 503 ~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 503 KEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp SSGGGSCCHHHHHHHHHTSSCC
T ss_pred CChhHCcCHHHHHHHHHHHhhc
Confidence 999999999998874 55543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=336.49 Aligned_cols=248 Identities=18% Similarity=0.250 Sum_probs=189.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC---CCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.++|.+.+.||+|+||.||+|.+.. +++.||+|+++.. ....+.+..|+.+++.+ .|+||+++++++..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-----SHPNVIRLLGVCIE 107 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEC
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-----CCCCeeeeeEEEee
Confidence 4689999999999999999998765 5668999998632 33345677888888887 67999999999876
Q ss_pred CC-----eEEEEEecC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccc
Q 013973 170 RN-----HICIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239 (433)
Q Consensus 170 ~~-----~~~lV~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~ 239 (433)
.. ..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--- 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--- 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS---
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC---
Confidence 54 459999999 88999998542 235699999999999999999999999999999999999995544
Q ss_pred cCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHH
Q 013973 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 314 (433)
Q Consensus 240 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ 314 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|
T Consensus 185 ------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 240 (313)
T 3brb_A 185 ------------------------TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240 (313)
T ss_dssp ------------------------CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred ------------------------cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence 4555555555433221 12235788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcC
Q 013973 315 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393 (433)
Q Consensus 315 ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
+|++ |..||.+....+....+... ... ..+.
T Consensus 241 el~~~g~~p~~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~ 272 (313)
T 3brb_A 241 EIATRGMTPYPGVQNHEMYDYLLHG----------------------HRL--------------------------KQPE 272 (313)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTT----------------------CCC--------------------------CCBT
T ss_pred HHHhcCCCCCccCCHHHHHHHHHcC----------------------CCC--------------------------CCCc
Confidence 9999 99999876654433322110 000 1123
Q ss_pred CchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 394 ~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
.++.++.+||.+||+.||.+|||+.+++++
T Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567789999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=331.81 Aligned_cols=244 Identities=20% Similarity=0.265 Sum_probs=189.9
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCe---EEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.|.+.+.||+|+||.||+|.+..+++ .||+|++.... ...+.+..|+.+++.+ .|+||+++++++...+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-----NHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEECCSSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEecCCC
Confidence 47888999999999999999765544 79999986432 3446677899998888 67999999999976655
Q ss_pred E-EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 173 I-CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 173 ~-~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
. ++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-------------- 161 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-------------- 161 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--------------
T ss_pred CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--------------
Confidence 4 9999999 999999998643 4789999999999999999999999999999999999995544
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC-------CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC-CCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EAL 322 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~P 322 (433)
.+||+|||.+..... ......||+.|+|||.+.+..++.++||||||+++|+|++| .+|
T Consensus 162 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 162 -------------TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp -------------CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred -------------cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 455555555543211 11234678999999999999999999999999999999995 555
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+..+....+.... .. ..+..++.++.+|
T Consensus 229 ~~~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~l~~l 260 (298)
T 3pls_A 229 YRHIDPFDLTHFLAQGR----------------------RL--------------------------PQPEYCPDSLYQV 260 (298)
T ss_dssp TTTSCGGGHHHHHHTTC----------------------CC--------------------------CCCTTCCHHHHHH
T ss_pred CccCCHHHHHHHhhcCC----------------------CC--------------------------CCCccchHHHHHH
Confidence 65544433322211100 00 0123456789999
Q ss_pred HHhccccCCCCCCCHHHHhc
Q 013973 403 LQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~ 422 (433)
|.+||+.||.+|||+.++++
T Consensus 261 i~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 261 MQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999998875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.78 Aligned_cols=210 Identities=21% Similarity=0.289 Sum_probs=168.7
Q ss_pred cCcEEEEeeeeccccEEEEEE-----EECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~-----~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|.+.+.||+|+||+||+| .+..+++.||||+++.. ....+..|+.+++.+.+ ..|++++.+++.+...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~--~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP--SMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCG--GGGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhh--hhhhhhhhhheeeecC
Confidence 467999999999999999999 46778899999999743 34556778888888743 2468899999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKN---NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
+..||||||+ +|+|.+++... ....+++..+..++.||+.||+|||++|||||||||+|||++.+....
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~------- 212 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ------- 212 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-------
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc-------
Confidence 9999999999 89999999752 234799999999999999999999999999999999999996521000
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCC--C---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--D---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
. ...+.++.+||+|||++..... . ....+||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus 213 -----~----~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 213 -----D----DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp ---------------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred -----c----ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 0 0002356788888888854321 1 133579999999999999999999999999999999999999
Q ss_pred CCCC
Q 013973 322 LFQT 325 (433)
Q Consensus 322 Pf~~ 325 (433)
||..
T Consensus 284 pf~~ 287 (365)
T 3e7e_A 284 MKVK 287 (365)
T ss_dssp CCEE
T ss_pred cccc
Confidence 9964
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=363.90 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=194.2
Q ss_pred cCcEEEEe-eeeccccEEEEEEEEC--CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHS-KMGEGTFGQVLECWDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~-~iG~G~~g~V~~~~~~--~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+++.+.+ .||+|+||.||+|.++ .++..||||+++.. ....+.+..|+.+++++ .|+||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQA- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEES-
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEecc-
Confidence 45677776 8999999999999875 35667999999753 23456788899999887 67999999999876
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.++|||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++...
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5699999999 899999997643 46999999999999999999999999999999999999977666555555555433
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 328 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~ 328 (433)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 487 ~~~~~~~---------------------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 487 GADDSYY---------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp C-----------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred cCCCcee---------------------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 2110000 00011245789999999999999999999999999999998 9999998776
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+.. +.. ...+..++.++.+||.+||+
T Consensus 546 ~~~~~~i~~-----------------------~~~-------------------------~~~p~~~~~~l~~li~~cl~ 577 (613)
T 2ozo_A 546 PEVMAFIEQ-----------------------GKR-------------------------MECPPECPPELYALMSDCWI 577 (613)
T ss_dssp HHHHHHHHT-----------------------TCC-------------------------CCCCTTCCHHHHHHHHHTTC
T ss_pred HHHHHHHHc-----------------------CCC-------------------------CCCCCcCCHHHHHHHHHHcC
Confidence 665443321 100 01123567899999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013973 409 YDPTDRLTAREALR 422 (433)
Q Consensus 409 ~dP~~R~ta~ell~ 422 (433)
.||++||++.++++
T Consensus 578 ~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 578 YKWEDRPDFLTVEQ 591 (613)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999998853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=357.67 Aligned_cols=251 Identities=17% Similarity=0.208 Sum_probs=187.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCC-----------CCCceE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDK-----------GGNRCV 161 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~-----------~~~~i~ 161 (433)
..|.+.+.||+|+||+||+|.+..+|+.||||+++... ...+.+.+|+.+++.+.+..+ ....++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45899999999999999999999999999999987221 224556778888776644210 000111
Q ss_pred Ee------cceeec-----CCeEEEEEecCCCCHHHHHH-----hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 013973 162 QI------RNWFDY-----RNHICIVFEKLGSSLYDFLR-----KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 225 (433)
Q Consensus 162 ~~------~~~~~~-----~~~~~lV~e~~~~~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 225 (433)
.+ ...+.. ...++++|++++++|.+++. ......+++..+..++.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 111111 23578999999999999985 222345788899999999999999999999999999
Q ss_pred CCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhh----------
Q 013973 226 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVI---------- 295 (433)
Q Consensus 226 Kp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---------- 295 (433)
||+|||++ .++.+||+|||+++.........+| +.|+|||++
T Consensus 238 Kp~NILl~---------------------------~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 238 RPVDIVLD---------------------------QRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp CGGGEEEC---------------------------TTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred ccceEEEe---------------------------cCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccc
Confidence 99999994 4455777777777655444445578 999999999
Q ss_pred hCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhH
Q 013973 296 LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 375 (433)
Q Consensus 296 ~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (433)
.+..|+.++|||||||++|||++|+.||...+..+... .+
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-----------------------~~----------------- 329 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE-----------------------WI----------------- 329 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG-----------------------GG-----------------
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH-----------------------HH-----------------
Confidence 45568889999999999999999999997644211000 00
Q ss_pred hhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 376 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
......++.++.+||.+||+.||++|||+.|+++||||++
T Consensus 330 -------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 330 -------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp -------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 0011245678999999999999999999999999999964
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.35 Aligned_cols=245 Identities=18% Similarity=0.220 Sum_probs=186.3
Q ss_pred cEEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRN 171 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~ 171 (433)
.|++.+.||+|+||.||+|.+..+ +..||+|.++.. ....+.+..|+.+++++ .|+||+++++++ ...+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-----CCTTBCCCCEEECCCSS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCC
Confidence 589999999999999999987543 346899998642 23456677888888777 679999999975 5567
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-------------- 229 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-------------- 229 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--------------
T ss_pred CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--------------
Confidence 889999999 889999997654 4689999999999999999999999999999999999996554
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCC-------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 322 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P 322 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 230 -------------~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 230 -------------TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp -------------CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred -------------CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 4555555555432211 122357889999999999999999999999999999999 7888
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHH
Q 013973 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 402 (433)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 402 (433)
|...+..+....+. .+... ..+..++.++.+|
T Consensus 297 ~~~~~~~~~~~~~~-----------------------~~~~~-------------------------~~p~~~~~~l~~l 328 (373)
T 3c1x_A 297 YPDVNTFDITVYLL-----------------------QGRRL-------------------------LQPEYCPDPLYEV 328 (373)
T ss_dssp CTTSCSSCHHHHHH-----------------------TTCCC-------------------------CCCTTCCHHHHHH
T ss_pred CCCCCHHHHHHHHH-----------------------cCCCC-------------------------CCCCCCCHHHHHH
Confidence 87655433322211 11000 0123466789999
Q ss_pred HHhccccCCCCCCCHHHHhcC
Q 013973 403 LQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 403 i~~~L~~dP~~R~ta~ell~h 423 (433)
|.+||+.||++|||+.|++++
T Consensus 329 i~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 329 MLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=343.18 Aligned_cols=271 Identities=19% Similarity=0.213 Sum_probs=197.4
Q ss_pred cCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 91 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 91 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
......++|++.+.||+|+||.||+|.+. +++.||||++..... ....+..|+.+++.+ .|+||+++++++.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~ 97 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLRGFCM 97 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTC-----CCTTBCCCCEEEC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhc-----cCCCccceEEEEe
Confidence 33445678999999999999999999854 678899999874321 122467788887766 6799999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEeeccCccccCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDL---CMIHTDLKPENVLLVSSEYIKVPD 242 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlKp~NILl~~~~~~~i~d 242 (433)
..+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~-------- 169 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE-------- 169 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT--------
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC--------
Confidence 999999999999 8899999986532 3499999999999999999999999 9999999999999954
Q ss_pred CcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh
Q 013973 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 318 (433)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 170 -------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 230 (326)
T 3uim_A 170 -------------------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230 (326)
T ss_dssp -------------------TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH
T ss_pred -------------------CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh
Confidence 4566777777665433222 22458999999999999899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||...... ......... ................ ...........+.+
T Consensus 231 g~~pf~~~~~~----------~~~~~~~~~----~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~ 280 (326)
T 3uim_A 231 GQRAFDLARLA----------NDDDVMLLD----WVKGLLKEKKLEALVD----------------VDLQGNYKDEEVEQ 280 (326)
T ss_dssp CCCSBCHHHHT----------TTSCSBHHH----HHTTTTSSCCSTTSSC----------------TTCTTSCCHHHHHH
T ss_pred CCCcccccccc----------cccchhHHH----HHHHHhhchhhhhhcC----------------hhhccccCHHHHHH
Confidence 99999621100 000000000 0000000000000000 00001112234568
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCC
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALRHP 424 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~hp 424 (433)
+.+|+.+||+.||.+|||+.||++|-
T Consensus 281 l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 281 LIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 99999999999999999999999873
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=374.26 Aligned_cols=279 Identities=24% Similarity=0.324 Sum_probs=205.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---- 169 (433)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.. ....+.+..|+.+++.+ .|+||+.+++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-----NHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-----CBTTBCCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCceeeeecccccc
Confidence 47799999999999999999999999999999998642 34456678899999998 67899999888765
Q ss_pred --CCeEEEEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 170 --RNHICIVFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 --~~~~~lV~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
.+..|+||||+ |++|.+++.... ...+++..+..++.||+.||+|||+.|||||||||+|||++.++
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g--------- 158 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP--------- 158 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS---------
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC---------
Confidence 77889999999 999999998643 23699999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
....+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 159 ---------------~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 159 ---------------QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp ---------------SSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------------CceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 22347888888876544332 3357999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.......... ......... .....-...+...++..... .......++..+.+||
T Consensus 224 ~~~~~~~~~~------~~i~~~~~~---~~~~~~~l~g~~~~~~~lp~----------------p~~l~~~ls~~L~dLI 278 (676)
T 3qa8_A 224 LPNWQPVQWH------GKVREKSNE---HIVVYDDLTGAVKFSSVLPT----------------PNHLSGILAGKLERWL 278 (676)
T ss_dssp CSSCHHHHSS------TTCC---------CCSCCCCSSSCCCCSSSCC----------------SCCCCGGGHHHHHHHH
T ss_pred Ccccchhhhh------hhhhcccch---hhhhhhhhccccccccccCC----------------chhhchhhhHHHHHHH
Confidence 7654322110 000000000 00000001111222111100 0112234678899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.+||+.||++|||+.|+++||||+.
T Consensus 279 ~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 279 QCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp HHHSCSSCC---CCTTCCCCTTHHH
T ss_pred HHHccCCHhhCcCHHHHhcCHHHHH
Confidence 9999999999999999999999963
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=335.79 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=194.6
Q ss_pred ecCcE-EEEeeeeccccEEEEEEE----ECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 013973 95 LTSRY-KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 167 (433)
Q Consensus 95 ~~~~~-~~~~~iG~G~~g~V~~~~----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~ 167 (433)
+.++| ++++.||+|+||.||+|. +..+++.||||+++.. ......+..|+.+++.+ .|+||+++++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 102 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-----YHEHIIKYKGCC 102 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-----CCcchhhEEEEE
Confidence 34445 999999999999998775 3457899999999743 24456678899999998 578999999999
Q ss_pred ec--CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 168 DY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 168 ~~--~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+ ...+++||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~---------- 169 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN---------- 169 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT----------
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC----------
Confidence 87 46899999999 88999999765 4999999999999999999999999999999999999954
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 318 (433)
++.+||+|||.+....... ....||..|+|||++.+..++.++||||||+++|+|++
T Consensus 170 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 232 (318)
T 3lxp_A 170 -----------------DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232 (318)
T ss_dssp -----------------TCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred -----------------CCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 4456666666665443322 22357888999999999899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhH
Q 013973 319 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398 (433)
Q Consensus 319 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
|..||....... ....+........ ......+..+. ....+..++.+
T Consensus 233 g~~p~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~-------------------------~~~~~~~~~~~ 279 (318)
T 3lxp_A 233 HCDSSQSPPTKF-----LELIGIAQGQMTV---LRLTELLERGE-------------------------RLPRPDKCPAE 279 (318)
T ss_dssp TTCGGGSHHHHH-----HHHHCSCCHHHHH---HHHHHHHHTTC-------------------------CCCCCTTCCHH
T ss_pred CCCcccccchhh-----hhhhcccccchhH---HHHHHHHhccc-------------------------CCCCCccccHH
Confidence 999997532211 0011111100000 00000111110 01123466789
Q ss_pred HHHHHHhccccCCCCCCCHHHHhc
Q 013973 399 LTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 399 ~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
+.+||.+||+.||++|||+.|+++
T Consensus 280 l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 280 VYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.00 Aligned_cols=249 Identities=21% Similarity=0.288 Sum_probs=191.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeec-chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----cC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----YR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~----~~ 170 (433)
.++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+..|+.+++.+ .|+||+++++++. ..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-----NHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-----CCCCeeeEEEEEEeccCCC
Confidence 3579999999999999999999999999999998853 334456677899988887 6789999999886 34
Q ss_pred CeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
...++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~------------- 169 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD------------- 169 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-------------
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-------------
Confidence 5899999999 88999998762 2347999999999999999999999999999999999999954
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC------------CceeecCcccchhhhhCCC---CCCcchhHHHHHH
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------------NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCI 312 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------------~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~ 312 (433)
++.+||+|||.+....... ....||+.|+|||++.+.. ++.++||||||++
T Consensus 170 --------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 235 (317)
T 2buj_A 170 --------------EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235 (317)
T ss_dssp --------------TSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred --------------CCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence 4456666666654332110 1235799999999997654 6899999999999
Q ss_pred HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 313 LVELCTGEALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 313 l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+|+|++|..||....... .... .+.. ....+ .
T Consensus 236 l~el~~g~~p~~~~~~~~~~~~~----------------------~~~~-~~~~~------------------------~ 268 (317)
T 2buj_A 236 LYAMMFGEGPYDMVFQKGDSVAL----------------------AVQN-QLSIP------------------------Q 268 (317)
T ss_dssp HHHHHHSSCTTHHHHHTTSCHHH----------------------HHHC-C--CC------------------------C
T ss_pred HHHHHhCCCChhhhhcccchhhH----------------------Hhhc-cCCCC------------------------c
Confidence 999999999995210000 0000 0000 00000 1
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...++.++.+||.+||+.||.+|||+.|+++|
T Consensus 269 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 13567789999999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.29 Aligned_cols=242 Identities=23% Similarity=0.353 Sum_probs=191.8
Q ss_pred cEEEE-eeeeccccEEEEEEEE--CCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 98 RYKIH-SKMGEGTFGQVLECWD--RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 98 ~~~~~-~~iG~G~~g~V~~~~~--~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
.+.+. ++||+|+||.||+|.+ +.+++.||||+++... ...+.+..|+.+++++ .|+||++++++++. +
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEA-E 442 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-----CCTTBCCEEEEEES-S
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec-C
Confidence 34443 4899999999999954 5667899999997432 2356788999999998 67999999999865 5
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.++|||||+ +++|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~------------- 507 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY------------- 507 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-------------
T ss_pred CEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC-------------
Confidence 588999999 899999998754 7999999999999999999999999999999999999976555
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 508 --------------~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 573 (635)
T 4fl3_A 508 --------------AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573 (635)
T ss_dssp --------------EEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred --------------EEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4555555544332211 12356889999999999999999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+..+....+.... .. ..+..++.++.+||
T Consensus 574 ~~~~~~~~~~~i~~~~----------------------~~--------------------------~~p~~~~~~l~~li 605 (635)
T 4fl3_A 574 RGMKGSEVTAMLEKGE----------------------RM--------------------------GCPAGCPREMYDLM 605 (635)
T ss_dssp TTCCHHHHHHHHHTTC----------------------CC--------------------------CCCTTCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCC----------------------CC--------------------------CCCCCCCHHHHHHH
Confidence 9877766544332210 00 11235678899999
Q ss_pred HhccccCCCCCCCHHHHhc
Q 013973 404 QGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~ 422 (433)
.+||+.||++|||+++|++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=331.58 Aligned_cols=247 Identities=20% Similarity=0.262 Sum_probs=187.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC-CC--eEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE-RK--EMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~--~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|+++.. ....+.+..|+.+++.+ .|+||+++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~ 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLYGVVL 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEc
Confidence 3679999999999999999998643 33 36999988642 23446677899999888 6789999999988
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
... .++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg--- 166 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG--- 166 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT---
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc---
Confidence 765 88999999 899999998653 369999999999999999999999999999999999999766655555554
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 320 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~ 320 (433)
.+....... ....||..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 167 ------------------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 222 (291)
T 1u46_A 167 ------------------------LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222 (291)
T ss_dssp ------------------------TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred ------------------------ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 443322211 12357889999999999889999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||.+.+..+....+...... .+ .+..++.++.
T Consensus 223 ~p~~~~~~~~~~~~~~~~~~~-----------------------~~------------------------~~~~~~~~l~ 255 (291)
T 1u46_A 223 EPWIGLNGSQILHKIDKEGER-----------------------LP------------------------RPEDCPQDIY 255 (291)
T ss_dssp CTTTTCCHHHHHHHHHTSCCC-----------------------CC------------------------CCTTCCHHHH
T ss_pred CCcccCCHHHHHHHHHccCCC-----------------------CC------------------------CCcCcCHHHH
Confidence 999887765544332211000 00 1235677899
Q ss_pred HHHHhccccCCCCCCCHHHHhcC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~h 423 (433)
++|.+||+.||++|||+.+++++
T Consensus 256 ~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 256 NVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=335.03 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=191.6
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
...+.||+|+||.||+|.+ +++.||+|++... ....+.+..|+.+++.+ .|+||+++++++...+..+
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-----QHENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCE
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEecCCceE
Confidence 3448999999999999986 5778999998632 23456678899999988 6789999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
+||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~------------------ 168 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE------------------ 168 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT------------------
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC------------------
Confidence 999999 899999997432 246999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~ 327 (433)
++.+||+|||.+....... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 169 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 169 ---------AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp ---------TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred ---------CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 4456666666655433211 23478999999999876 58899999999999999999999998654
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+....+......... ....++.... .......+..+.+++.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~cl 284 (307)
T 2nru_A 239 EPQLLLDIKEEIEDEEK--------TIEDYIDKKM--------------------------NDADSTSVEAMYSVASQCL 284 (307)
T ss_dssp SSSBTTHHHHHHHTTSC--------CHHHHSCSSC--------------------------SCCCHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHhhhhhh--------hhhhhccccc--------------------------cccchHHHHHHHHHHHHHc
Confidence 43222221111100000 0000010000 0011234567899999999
Q ss_pred ccCCCCCCCHHHHhcC
Q 013973 408 RYDPTDRLTAREALRH 423 (433)
Q Consensus 408 ~~dP~~R~ta~ell~h 423 (433)
+.||.+|||+.+++++
T Consensus 285 ~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 285 HEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSSTTTSCCHHHHHHH
T ss_pred CCCcccCcCHHHHHHH
Confidence 9999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.47 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=192.4
Q ss_pred eecCceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 89 FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 89 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
+..+..+.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++..+. ..|+||+++++++.
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~---l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVM---LRHENILGFIAADN 106 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSC---CCCTTBCCEEEEEE
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhh---cCCCcEEEEEeeec
Confidence 344455667899999999999999999987 5889999999743 3455677888877642 26789999999988
Q ss_pred cCC----eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEeecc
Q 013973 169 YRN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--------DLCMIHTDLKPENVLLVSS 235 (433)
Q Consensus 169 ~~~----~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~ivHrDlKp~NILl~~~ 235 (433)
... .+++||||+ +++|.+++... .+++..+..++.||+.||.||| +.|||||||||+|||++.+
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence 765 899999999 88999999864 5999999999999999999999 8999999999999999544
Q ss_pred CccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-------CceeecCcccchhhhhCCC------CCC
Q 013973 236 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLG------WTY 302 (433)
Q Consensus 236 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~ 302 (433)
+.+||+|||++....... ....||+.|+|||++.+.. ++.
T Consensus 184 ---------------------------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 236 (342)
T 1b6c_B 184 ---------------------------GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236 (342)
T ss_dssp ---------------------------SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHH
T ss_pred ---------------------------CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCC
Confidence 456666666664433221 2347999999999998763 336
Q ss_pred cchhHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcc--cCC
Q 013973 303 PCDIWSVGCILVELCTG----------EALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL--DWP 366 (433)
Q Consensus 303 ~~DvwSlGv~l~elltg----------~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~ 366 (433)
++|||||||++|||++| ..||..... .+..... +....+ ..+
T Consensus 237 ~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~ 294 (342)
T 1b6c_B 237 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV----------------------VCEQKLRPNIP 294 (342)
T ss_dssp HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH----------------------HTTSCCCCCCC
T ss_pred cccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHH----------------------HHHHHhCCCCc
Confidence 89999999999999999 778865321 1111100 000000 000
Q ss_pred CCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 367 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
... .....+..+.+||.+||+.||++|||+.|+++|
T Consensus 295 ~~~---------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 295 NRW---------------------QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp GGG---------------------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccc---------------------cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 000 011334578999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=328.91 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=194.1
Q ss_pred cCcEEEEeeeeccccEEEEEEE----ECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~----~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|++++.||+|+||.||+|. +..+++.||+|++... ....+.+..|+.+++.+ .|+||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-----QHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEec
Confidence 3679999999999999999998 4678999999998743 33445678899999888 678999999987654
Q ss_pred --CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 171 --NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 171 --~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
..+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg--- 190 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG--- 190 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT---
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc---
Confidence 4789999999 889999998754 469999999999999999999999999999999999999766655555555
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 321 (433)
++....... ....||..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 191 ------------------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~ 246 (326)
T 2w1i_A 191 ------------------------LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246 (326)
T ss_dssp ------------------------TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred ------------------------chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence 443322211 12356788999999999889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCH-HHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQ-HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
||..... + .....+.... .... ......+..+. ....+..++.++.
T Consensus 247 ~~~~~~~-~----~~~~~~~~~~~~~~~---~~~~~~~~~~~-------------------------~~~~~~~~~~~l~ 293 (326)
T 2w1i_A 247 KSKSPPA-E----FMRMIGNDKQGQMIV---FHLIELLKNNG-------------------------RLPRPDGCPDEIY 293 (326)
T ss_dssp GGGSHHH-H----HHHHHCTTCCTHHHH---HHHHHHHHTTC-------------------------CCCCCTTCCHHHH
T ss_pred CCCCCHH-H----HHHhhccccchhhhH---HHHHHHhhcCC-------------------------CCCCCCcccHHHH
Confidence 9864211 1 1111111111 0000 00000011100 0012345678899
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q 013973 401 HLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~ 422 (433)
+||.+||+.||++|||+.|+++
T Consensus 294 ~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 294 MIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=346.65 Aligned_cols=270 Identities=20% Similarity=0.251 Sum_probs=191.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---------hhHHHHHHHHHHHHHHHhc--------CC----
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKH--------DK---- 155 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~--------~~---- 155 (433)
++|++++.||+|+||+||+|++ +++.||||+++... ...+.+..|+.+++.+... .+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999988 67999999997432 1236678899999998631 10
Q ss_pred ---------CCCceEEecceeec-------------CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 013973 156 ---------GGNRCVQIRNWFDY-------------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212 (433)
Q Consensus 156 ---------~~~~i~~~~~~~~~-------------~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L 212 (433)
.|+||+++++++.+ .+.+||||||+ +|++.+.+.+ ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 15666666766665 78999999999 7776666643 3689999999999999999
Q ss_pred HHHH-HCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccc
Q 013973 213 AFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRA 291 (433)
Q Consensus 213 ~~LH-~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~a 291 (433)
+||| ++|||||||||+|||++.++... .+++.... ..........+||+|||+++.... ...+||+.|+|
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~-~~~~~~~~------~~~~~~~~~~vkL~DFG~a~~~~~--~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKK-LHYTLNGK------SSTIPSCGLQVSIIDYTLSRLERD--GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSE-EEEEETTE------EEEEECTTEEEEECCCTTCBEEET--TEEECCCCTTC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcc-eeeeccCc------cccccCCCceEEEeeccccEecCC--CcEEEeecccC
Confidence 9999 99999999999999998765210 11110000 000001233789999999876543 34589999999
Q ss_pred hhhhhCCCCCCcchhHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCcc
Q 013973 292 PEVILGLGWTYPCDIWSVGCI-LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA 370 (433)
Q Consensus 292 PE~~~~~~~~~~~DvwSlGv~-l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (433)
||++.+.. +.++||||||++ .+++++|..||.......... .. ...... ++....
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~--~~-------------------~~~~~~--~~~~~~ 301 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLT--DK-------------------MLKQMT--FKTKCN 301 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHH--HH-------------------HHHTCC--CSSCCC
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHH--Hh-------------------hhhhhc--cCcccc
Confidence 99998766 899999998776 788889999984311101000 00 000000 000000
Q ss_pred chhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHh-cCCCCC
Q 013973 371 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL-RHPFFT 427 (433)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell-~hp~f~ 427 (433)
...+..+++++.+||.+||++| ||+|+| +||||+
T Consensus 302 ------------------~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 ------------------TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ------------------SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ------------------hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0012245778999999999987 999999 999996
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=354.54 Aligned_cols=251 Identities=24% Similarity=0.280 Sum_probs=196.6
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCC---CeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
...++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ....+.+..|+.+++.+ .|+||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEe
Confidence 3457899999999999999999998653 467999998642 33446678899999888 6799999999885
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
.+.+|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||++.
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 46689999999 899999998653 369999999999999999999999999999999999999776655555555443
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~ 326 (433)
....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 540 ~~~~~~~-----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 540 YMEDSTY-----------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp SCCC---------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ecCCCcc-----------------------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 3211000 00112356789999999999999999999999999999997 99999987
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+.... .. ..+..++.++.+||.+|
T Consensus 597 ~~~~~~~~i~~~~----------------------~~--------------------------~~~~~~~~~l~~li~~~ 628 (656)
T 2j0j_A 597 KNNDVIGRIENGE----------------------RL--------------------------PMPPNCPPTLYSLMTKC 628 (656)
T ss_dssp CHHHHHHHHHHTC----------------------CC--------------------------CCCTTCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCC----------------------CC--------------------------CCCccccHHHHHHHHHH
Confidence 7666544332210 00 01235677899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013973 407 LRYDPTDRLTAREALR 422 (433)
Q Consensus 407 L~~dP~~R~ta~ell~ 422 (433)
|+.||++|||+.|+++
T Consensus 629 l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 629 WAYDPSRRPRFTELKA 644 (656)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCChhHCcCHHHHHH
Confidence 9999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=332.31 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=188.9
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++.+.||+|+||.||+|.+.. .||+|+++... ...+.+..|+.+++.+ .|+||+++++++...+.
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-----RHENVVLFMGACMSPPH 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-----CCTTBCCCCEEEECSSC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-----CCCCEeEEEEEEecCCc
Confidence 4679999999999999999998864 39999986321 2223455678777776 67899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~-------------- 167 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK-------------- 167 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--------------
T ss_pred eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--------------
Confidence 99999999 899999997643 4699999999999999999999999999999999999995 344
Q ss_pred CCcccccCCCCCCEEEEecCCccccC--------CCCCceeecCcccchhhhhC---------CCCCCcchhHHHHHHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYER--------PDQNYIVSTRHYRAPEVILG---------LGWTYPCDIWSVGCILV 314 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~--------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGv~l~ 314 (433)
+||+|||++.... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 168 -------------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 234 (319)
T 2y4i_B 168 -------------VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234 (319)
T ss_dssp -------------CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred -------------EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence 5555555543221 11122468999999999975 35789999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 315 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 315 elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
||++|..||...........+.....+ .. ....
T Consensus 235 el~~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~-------------------------~~~~ 267 (319)
T 2y4i_B 235 ELHAREWPFKTQPAEAIIWQMGTGMKP----------------------NL-------------------------SQIG 267 (319)
T ss_dssp HHHHSSCSSSSCCHHHHHHHHHTTCCC----------------------CC-------------------------CCSS
T ss_pred HHHhCCCCCCCCCHHHHHHHhccCCCC----------------------CC-------------------------CcCC
Confidence 999999999887665544332211000 00 0123
Q ss_pred chhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
++.++.+||.+||+.||++|||+.++++
T Consensus 268 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 268 MGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 5668999999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.02 Aligned_cols=229 Identities=15% Similarity=0.047 Sum_probs=178.3
Q ss_pred cCc-eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 91 LGE-NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 91 ~~~-~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
.+. .+.++|++.+.||+|+||.||+|++..+++.||||++... ......+..|+.++..+ .|+||+++++
T Consensus 24 ~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~ 98 (286)
T 3uqc_A 24 PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-----DKPGVARVLD 98 (286)
T ss_dssp TTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-----CCTTBCCEEE
T ss_pred CCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-----CCCCcceeeE
Confidence 344 4567899999999999999999999999999999999743 22335677788887776 7789999999
Q ss_pred eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 166 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 166 ~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
++.+.+..|+||||+ |++|.+++.. .....++..++.||+.||+|||++||+||||||+|||++.+|
T Consensus 99 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-------- 166 (286)
T 3uqc_A 99 VVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-------- 166 (286)
T ss_dssp EEEETTEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS--------
T ss_pred EEEECCcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC--------
Confidence 999999999999999 8899999954 245667889999999999999999999999999999996544
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.+||++ +.|++| ++.++|||||||++|||++|+.||.
T Consensus 167 -------------------~~kl~~-----------------~~~~~~-------~~~~~Di~slG~il~elltg~~Pf~ 203 (286)
T 3uqc_A 167 -------------------DVVLAY-----------------PATMPD-------ANPQDDIRGIGASLYALLVNRWPLP 203 (286)
T ss_dssp -------------------CEEECS-----------------CCCCTT-------CCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred -------------------CEEEEe-----------------ccccCC-------CCchhHHHHHHHHHHHHHHCCCCCC
Confidence 455542 234443 7899999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+.+.. ....+ .+.. .........++.++.+||.
T Consensus 204 ~~~~~~~~~~-------------------~~~~~-~~~~----------------------~~~~~~~~~~~~~l~~li~ 241 (286)
T 3uqc_A 204 EAGVRSGLAP-------------------AERDT-AGQP----------------------IEPADIDRDIPFQISAVAA 241 (286)
T ss_dssp CCSBCCCSEE-------------------CCBCT-TSCB----------------------CCHHHHCTTSCHHHHHHHH
T ss_pred cCCcchhhHH-------------------HHHHh-ccCC----------------------CChhhcccCCCHHHHHHHH
Confidence 7543210000 00000 0000 0011223467889999999
Q ss_pred hccccCCCCCCCHHHHhc
Q 013973 405 GLLRYDPTDRLTAREALR 422 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~ 422 (433)
+||+.||++| |+.|+++
T Consensus 242 ~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 242 RSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHCTTSSCC-CHHHHHH
T ss_pred HHcccCCccC-CHHHHHH
Confidence 9999999999 9999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.03 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=194.3
Q ss_pred eecCceecCcEEEEeeeeccccEEEEEEEECC-CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 89 FALGENLTSRYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 89 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
+..++.+.++|++.+.||+|+||.||+|.+.. +++.||||++... ......+..|+.+++.+ .|+||+++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~ 146 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-----VHPSIVQIFN 146 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-----CCCCcCeEee
Confidence 34566778999999999999999999999976 7899999998632 23445667888888777 6799999999
Q ss_pred eeecCCe-----EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccc
Q 013973 166 WFDYRNH-----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239 (433)
Q Consensus 166 ~~~~~~~-----~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~ 239 (433)
++...+. .||||||+ |++|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----- 217 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----- 217 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-----
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-----
Confidence 9987655 79999999 8899887754 6999999999999999999999999999999999999942
Q ss_pred cCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC
Q 013973 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 319 (433)
Q Consensus 240 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg 319 (433)
..+||+|||++...... ...+||+.|+|||++.+. ++.++|||||||++|+|++|
T Consensus 218 -----------------------~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g 272 (681)
T 2pzi_A 218 -----------------------EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLD 272 (681)
T ss_dssp -----------------------SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSC
T ss_pred -----------------------CcEEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhC
Confidence 26888888888765443 445799999999999875 48999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHH
Q 013973 320 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 399 (433)
Q Consensus 320 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (433)
.+||.+.... .. +... + ....+..+
T Consensus 273 ~~~~~~~~~~-----------~~-----------------------~~~~------------~---------~~~~~~~l 297 (681)
T 2pzi_A 273 LPTRNGRYVD-----------GL-----------------------PEDD------------P---------VLKTYDSY 297 (681)
T ss_dssp CCEETTEECS-----------SC-----------------------CTTC------------H---------HHHHCHHH
T ss_pred CCCCcccccc-----------cc-----------------------cccc------------c---------ccccCHHH
Confidence 9988642100 00 0000 0 00123578
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 400 THLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 400 ~~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
.+||.+||+.||++||++.+.+.|+|+
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 999999999999999998888888775
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.23 Aligned_cols=185 Identities=19% Similarity=0.122 Sum_probs=126.8
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEeecc-----------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-----------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
....++.|+.|.+..++....|+.||+|++.+. ....+.+.+|+++|+++. .|+||+++++++++
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~----~~~~i~~~~~~~ed 313 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP----AGFDAPAVLAHGEN 313 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC----TTCCCCCEEEEEEC
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC----CCCCeeEEEEEEEE
Confidence 334677888888888888888999999999632 233456778999988773 56789999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
++.+||||||+ |++|.++|...+ ++++. .|+.||+.||+|||++|||||||||+||||+.
T Consensus 314 ~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~-------------- 374 (569)
T 4azs_A 314 AQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA-------------- 374 (569)
T ss_dssp SSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT--------------
T ss_pred CCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECC--------------
Confidence 99999999999 999999998765 67764 58899999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P 322 (433)
++.+||+|||+|+..... ....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 375 -------------dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 375 -------------RQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------------TSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -------------CCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 456777777776544332 234689999999999976 467889999999999887766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=250.50 Aligned_cols=179 Identities=19% Similarity=0.160 Sum_probs=137.4
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
...+.||+|+||.||+|. ..++.+|+|...... ...+.+.+|+.+++++ .|+||+.+..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-----KDFGIPAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-----GGGTCCCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-----CCCCcCceEEEEEeC
Confidence 446799999999999994 456778999764211 1134468899999999 457788555555566
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+..||||||+ |++|.+++.. +..++.||+.||+|||++|||||||||+|||++
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---------------- 465 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---------------- 465 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----------------
T ss_pred CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----------------
Confidence 7779999999 8999999865 568999999999999999999999999999993
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC----------CceeecCcccchhhhhC--CCCCCcchhHHHHHHHHHHH
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELC 317 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~ell 317 (433)
. .+||+|||+++...... ...+||+.|||||++.. ..|+..+|+||..+-..+-+
T Consensus 466 -----------~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v 532 (540)
T 3en9_A 466 -----------K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV 532 (540)
T ss_dssp -----------S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred -----------C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 3 78888888887665432 24589999999999987 67888999999999888888
Q ss_pred hCCCCCC
Q 013973 318 TGEALFQ 324 (433)
Q Consensus 318 tg~~Pf~ 324 (433)
.++.+|.
T Consensus 533 ~~r~rY~ 539 (540)
T 3en9_A 533 ERRARYV 539 (540)
T ss_dssp HTCSCCC
T ss_pred HhccccC
Confidence 8877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-26 Score=213.75 Aligned_cols=154 Identities=23% Similarity=0.301 Sum_probs=118.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-------------------hhHHHHHHHHHHHHHHHhcCCCCC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------------------KYREAAMIEIEVLQQLAKHDKGGN 158 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------------------~~~~~~~~E~~~l~~l~~~~~~~~ 158 (433)
.|.+.+.||+|+||.||+|.+ .+|+.||+|+++... .....+..|+.+++.+.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------- 162 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------- 162 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-------
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-------
Confidence 356679999999999999999 889999999986321 13456778999999984
Q ss_pred ceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 159 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 159 ~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
| +.+.+.+.. +..|+||||+ |++|.+ +. . .....++.||+.||.|||++|||||||||+|||++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~---- 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---- 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----
Confidence 2 333444433 4569999999 889977 41 1 23557999999999999999999999999999994
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC----------CCCCCcchhH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG----------LGWTYPCDIW 307 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvw 307 (433)
++.+||+|||+++ ++..|+|||++.. ..|+..+|+|
T Consensus 228 ------------------------~~~vkl~DFG~a~----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~ 273 (282)
T 1zar_A 228 ------------------------EEGIWIIDFPQSV----------EVGEEGWREILERDVRNIITYFSRTYRTEKDIN 273 (282)
T ss_dssp ------------------------TTEEEECCCTTCE----------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHH
T ss_pred ------------------------CCcEEEEECCCCe----------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChH
Confidence 4567888888775 4566899999864 3456666666
Q ss_pred H
Q 013973 308 S 308 (433)
Q Consensus 308 S 308 (433)
.
T Consensus 274 ~ 274 (282)
T 1zar_A 274 S 274 (282)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-22 Score=185.97 Aligned_cols=137 Identities=16% Similarity=0.131 Sum_probs=106.6
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeE--EEEEEeecchh-------------------------hHHHHHHHHHHHHHHH
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRGIKK-------------------------YREAAMIEIEVLQQLA 151 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~--vAiK~~~~~~~-------------------------~~~~~~~E~~~l~~l~ 151 (433)
|++.+.||+|+||.||+|.+..+|+. ||||+++.... ....+..|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778888 99998753211 1135678999999998
Q ss_pred hcCCCCCceEEecceeecCCeEEEEEecCC--C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecc
Q 013973 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLG--S----SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTD 224 (433)
Q Consensus 152 ~~~~~~~~i~~~~~~~~~~~~~~lV~e~~~--~----~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrD 224 (433)
+.....|.++.. +..+|||||++ | +|.++... .++..+..++.||+.||.||| +.||||||
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 764444444332 34689999994 3 67766432 335567899999999999999 99999999
Q ss_pred CCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCcccc
Q 013973 225 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276 (433)
Q Consensus 225 lKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 276 (433)
|||+|||+ +. .++|+|||++...
T Consensus 197 lkp~NILl---------------------------~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMY---------------------------ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEE---------------------------SS--SEEECCCTTCEET
T ss_pred CCHHHEEE---------------------------cC--cEEEEECcccccC
Confidence 99999999 33 6899999988643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=166.85 Aligned_cols=144 Identities=17% Similarity=0.180 Sum_probs=99.7
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-----------------------hhHHHHHHHHHHHHHHHhcCC
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----------------------KYREAAMIEIEVLQQLAKHDK 155 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------------------~~~~~~~~E~~~l~~l~~~~~ 155 (433)
|++.+.||+|+||.||+|.+. +|+.||||+++... ..+.....|...|.++.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999985 58889999875210 001123457788888865443
Q ss_pred CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeec
Q 013973 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 234 (433)
Q Consensus 156 ~~~~i~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~ 234 (433)
..+.. +. ... .+|||||+ |+.|.++ .....+..++.||+.+|.|||+.|||||||||.|||++.
T Consensus 176 ~vp~p---~~---~~~-~~LVME~i~G~~L~~l--------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEP---IA---QSR-HTIVMSLVDALPMRQV--------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCE---EE---EET-TEEEEECCSCEEGGGC--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred CCCee---ee---ccC-ceEEEEecCCccHhhh--------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 22222 11 112 27999999 6676432 222345678999999999999999999999999999987
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccc
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 275 (433)
+|...-.+ .....+.|+||+.+..
T Consensus 241 dgd~~d~~-----------------~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPS-----------------SITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTT-----------------SEEEEEEECCCTTCEE
T ss_pred CCCccccc-----------------ccccceEEEEeCCccc
Confidence 76322110 1122478999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=3.9e-12 Score=117.79 Aligned_cols=108 Identities=11% Similarity=0.095 Sum_probs=81.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+.|.+...+|.|+.+.||++... ++.+++|+..... .....+..|..+++.+..+ ..+.+++.+....+..|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~----~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGK----LPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTT----SCCCCEEEEEEETTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcC----CCCCeEEEEEecCCceEE
Confidence 45889999999999999999743 5779999986321 2234578899999999652 336667777778889999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (433)
|||++ |.+|.+.+. +......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhC
Confidence 99999 778876521 122345778899999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=4.5e-11 Score=110.07 Aligned_cols=105 Identities=12% Similarity=0.101 Sum_probs=70.7
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
.+.+....+.|..+.||++.. .+|..+++|+.... .......|..+++.+.++. ..+.+++.+....+..++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~---~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTG---VPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTT---CCBCCEEEEEECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCC---CCCCeEEEeccCCCCCEEEE
Confidence 466655445666799999964 45667999987643 2245678999999997642 22556667777778899999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 218 (433)
|++ |.+|. .. ..+ ...++.+++..|..||+.
T Consensus 95 e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 95 GEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp ECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTS
T ss_pred EecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCC
Confidence 999 66663 11 122 225667777777777764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=9.5e-11 Score=110.98 Aligned_cols=102 Identities=16% Similarity=0.108 Sum_probs=69.4
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcC-CCCCceEEecceeecC---CeEEEEEe
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYR---NHICIVFE 178 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~~~~~~~~---~~~~lV~e 178 (433)
+.++.|....||++. ..+++|+... .........|..+++.+..+. ...|.+ +...... ...|+||+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~---~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEV---VFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCE---EEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCce---EeecCCCCCCCcceEEEc
Confidence 558999999999863 3488998653 334566788999999885532 223333 3332222 24588999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013973 179 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217 (433)
Q Consensus 179 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (433)
++ |..|.+.... .++..+...++.|++..|..||+
T Consensus 97 ~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 97 KIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHc
Confidence 99 6676543322 47788888888888888888886
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.6e-10 Score=109.59 Aligned_cols=108 Identities=16% Similarity=0.136 Sum_probs=74.5
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEee--cch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---CeE
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHI 173 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~--~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~ 173 (433)
-++.|+.|.++.||++... +..+++|+.. ... ........|..+++.+.... ..+++++..+.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~---vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTD---VPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSS---SCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCC---CCCCcEEEECCCCCccCCe
Confidence 4578899999999998754 3568888765 322 22346778999999997633 2355666666554 568
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (433)
|+|||++ |..+.+.. ...++......++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 9999999 65553311 1247788888999999999999997
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=3.3e-07 Score=86.59 Aligned_cols=104 Identities=17% Similarity=0.101 Sum_probs=64.2
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEEEEEecC
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKL 180 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~lV~e~~ 180 (433)
++.++.|....||+. +..+++|+-.. .........|..+|+.+.++.. -.+...+.+. ...+..++|||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~--v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVK--VNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCS--SBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCC--CCCCCeEeecccCCCceEEEEecc
Confidence 356788998999988 34588998542 3345667889999999976421 1133333333 3456678999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013973 181 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217 (433)
Q Consensus 181 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (433)
|..|.+.... .++......++.++...|..||+
T Consensus 96 ~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 96 QGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp CSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhc
Confidence 6666553211 24444455555555555555553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=3e-07 Score=84.96 Aligned_cols=101 Identities=14% Similarity=0.198 Sum_probs=66.2
Q ss_pred eeeccccE-EEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 013973 104 KMGEGTFG-QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 181 (433)
Q Consensus 104 ~iG~G~~g-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~ 181 (433)
.+..|..| .||+......+..+++|+-... ....+..|..+|+.+.... | +.+++.+..+.+..++|||++ |
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~v---P-VP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFM---P-LPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTS---C-CCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCC---C-cCeEEEEEEECCeEEEEEEeeCC
Confidence 34445444 6999887777778999987633 3345678999999886532 2 566677778888999999999 6
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 013973 182 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216 (433)
Q Consensus 182 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH 216 (433)
.++.+..... ......+..++...|.-||
T Consensus 105 ~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh 133 (272)
T 4gkh_A 105 KTAFQVLEEY------PDSGENIVDALAVFLRRLH 133 (272)
T ss_dssp EEHHHHHHHC------GGGHHHHHHHHHHHHHHHH
T ss_pred ccccccccCC------HHHHHHHHHHHHHHHHHhc
Confidence 6766654321 1122334455555555555
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.3e-05 Score=76.26 Aligned_cols=76 Identities=13% Similarity=0.171 Sum_probs=45.0
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEec-c--eeecCCeEEEEEe
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFE 178 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lV~e 178 (433)
++.|+.|..+.||++... + ..+++|+.... ......|..+++.+..+....|.++... + +....+..++||+
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~-~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-S-GAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET-T-EEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC-C-CCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 356666778899998763 3 34999998752 2334467788888876543334433311 1 1234677899999
Q ss_pred cC-CC
Q 013973 179 KL-GS 182 (433)
Q Consensus 179 ~~-~~ 182 (433)
++ |.
T Consensus 112 ~i~G~ 116 (346)
T 2q83_A 112 WIEGR 116 (346)
T ss_dssp CCCCB
T ss_pred eecCc
Confidence 99 54
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=3.3e-06 Score=82.63 Aligned_cols=77 Identities=21% Similarity=0.245 Sum_probs=48.1
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchh--------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++.||.|.++.||++.+..+++.|++|....... .......|.++++.+.... ...+..++.+ +....
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~--~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC--CCCcCeEEEE--cCCcc
Confidence 5789999999999997766677899997642111 1234567899998886532 1223344433 23445
Q ss_pred EEEEecCCC
Q 013973 174 CIVFEKLGS 182 (433)
Q Consensus 174 ~lV~e~~~~ 182 (433)
++|||++.+
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 799999943
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=8.3e-06 Score=78.47 Aligned_cols=82 Identities=10% Similarity=0.098 Sum_probs=53.3
Q ss_pred EEEEeee-eccccEEEEEEEEC---C---CCeEEEEEEeecch---h-hHHHHHHHHHHHHHHHhc-CCCCCceEEecce
Q 013973 99 YKIHSKM-GEGTFGQVLECWDR---E---RKEMVAIKIVRGIK---K-YREAAMIEIEVLQQLAKH-DKGGNRCVQIRNW 166 (433)
Q Consensus 99 ~~~~~~i-G~G~~g~V~~~~~~---~---~~~~vAiK~~~~~~---~-~~~~~~~E~~~l~~l~~~-~~~~~~i~~~~~~ 166 (433)
...++.| +.|....+|+.... . ++..+++|+..... . .......|..+++.+..+ ... +.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vp---vP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVP---VPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSC---CCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCC---CCcEEEE
Confidence 3445778 88989999988653 1 15678999865322 0 124567899999999875 333 4444444
Q ss_pred eecC---CeEEEEEecC-CCC
Q 013973 167 FDYR---NHICIVFEKL-GSS 183 (433)
Q Consensus 167 ~~~~---~~~~lV~e~~-~~~ 183 (433)
..+. +..++|||++ |..
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVV 119 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBC
T ss_pred ccCCCccCCceEEEEecCCCC
Confidence 4443 4568999999 544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00016 Score=67.72 Aligned_cols=69 Identities=12% Similarity=-0.016 Sum_probs=44.0
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 180 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~- 180 (433)
++.|+.|....+|++ ..+++|+........-....|..+++.+...... |.++ .... ..-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~~~---~~~~--~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-PEVL---HVDP--ATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-CCEE---EECT--TTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-CceE---EEEC--CCCEEEEeecC
Confidence 578889999999998 3388998753221111235688889888776543 4443 3332 2336889999
Q ss_pred CC
Q 013973 181 GS 182 (433)
Q Consensus 181 ~~ 182 (433)
+|
T Consensus 91 ~g 92 (301)
T 3dxq_A 91 GA 92 (301)
T ss_dssp TC
T ss_pred CC
Confidence 55
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00044 Score=65.10 Aligned_cols=77 Identities=22% Similarity=0.227 Sum_probs=57.1
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
-++.|+.|....+|+... ++..+++|+.... ....+..|...|+.+.... ...+++.+.+....+..++|||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~--~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTN--SINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTT--SSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhC--CCCcceEEEEeecCCceEEEEEec
Confidence 457789999999999875 4567889987632 3456788999999997642 133566666666678899999999
Q ss_pred -CCC
Q 013973 181 -GSS 183 (433)
Q Consensus 181 -~~~ 183 (433)
|..
T Consensus 114 ~G~~ 117 (312)
T 3jr1_A 114 NKSK 117 (312)
T ss_dssp CCCC
T ss_pred cCCC
Confidence 543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00012 Score=72.07 Aligned_cols=75 Identities=16% Similarity=0.169 Sum_probs=43.6
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeec-----chh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRG-----IKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++.||.|..+.||++.. +++.++||.... ... .......|.+++..+.... ...+.+++.+. .+..
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~--~~~vP~v~~~~--~~~~ 112 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS--PDHVPEVYHFD--RTMA 112 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS--GGGSCCEEEEE--TTTT
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC--CCCCCeEEEEC--CCcc
Confidence 57789999999999954 456799994321 011 0122334555554443321 12344444443 4567
Q ss_pred EEEEecC-CC
Q 013973 174 CIVFEKL-GS 182 (433)
Q Consensus 174 ~lV~e~~-~~ 182 (433)
++|||++ +|
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 8999999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00056 Score=64.47 Aligned_cols=78 Identities=8% Similarity=0.010 Sum_probs=47.1
Q ss_pred EEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEec-c--eeecCCeEEEE
Q 013973 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIV 176 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lV 176 (433)
.-++.|+.|....+|++.... + .+++|+.... ........|..+++.+..+....|.++... + +....+..++|
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 445778889889999987643 3 5889988642 122345678999999887644334433221 1 11234677899
Q ss_pred EecC
Q 013973 177 FEKL 180 (433)
Q Consensus 177 ~e~~ 180 (433)
|+++
T Consensus 102 ~~~l 105 (322)
T 2ppq_A 102 ISFL 105 (322)
T ss_dssp EECC
T ss_pred EEeC
Confidence 9999
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00055 Score=64.71 Aligned_cols=78 Identities=14% Similarity=0.167 Sum_probs=48.4
Q ss_pred eeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc--eeecCCeEEEEEecC
Q 013973 103 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN--WFDYRNHICIVFEKL 180 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~--~~~~~~~~~lV~e~~ 180 (433)
..|+ |....||++... +|+.+++|+.............|..+++.+.......|.++...+ .....+..++||+++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3455 778899987543 455699999863322345567789999998775433333322211 122356778999999
Q ss_pred CC
Q 013973 181 GS 182 (433)
Q Consensus 181 ~~ 182 (433)
.|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00095 Score=63.28 Aligned_cols=78 Identities=9% Similarity=0.023 Sum_probs=39.3
Q ss_pred eeeeccccEE-EEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-
Q 013973 103 SKMGEGTFGQ-VLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 180 (433)
Q Consensus 103 ~~iG~G~~g~-V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~- 180 (433)
+.|+.|+... +|+... .++..+++|...... ......|..+++.+.......|. ++......+ ++|||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~---v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPE---IYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCC---EEEEETTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCc---eeeecCCCC--EEEEeeCC
Confidence 4555554444 666643 225567777654221 13345688888888775433343 443333334 6899999
Q ss_pred CCCHHHHH
Q 013973 181 GSSLYDFL 188 (433)
Q Consensus 181 ~~~L~~~l 188 (433)
+..+.+++
T Consensus 96 ~~~l~~~l 103 (333)
T 3csv_A 96 DALFTEVI 103 (333)
T ss_dssp SCBHHHHH
T ss_pred CcchHHHh
Confidence 44555443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0043 Score=57.43 Aligned_cols=75 Identities=11% Similarity=-0.013 Sum_probs=51.0
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcC-CCCCceEEecceeecCCeEEE
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~~~~~~~~~~~~l 175 (433)
...-++.+|.|..+.||+.... +|+.|.+|+..... .....+..|...|+.+.... ...| +++... .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP---~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVP---QVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSC---CEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcc---eEEecc----CceE
Confidence 4667889999999999999864 56789999865322 22234678999999986542 2233 333322 2368
Q ss_pred EEecC
Q 013973 176 VFEKL 180 (433)
Q Consensus 176 V~e~~ 180 (433)
|||++
T Consensus 88 v~e~l 92 (288)
T 3f7w_A 88 AMEWV 92 (288)
T ss_dssp EEECC
T ss_pred EEEee
Confidence 99998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.002 Score=63.49 Aligned_cols=71 Identities=14% Similarity=0.156 Sum_probs=47.4
Q ss_pred EEeeeeccccEEEEEEEECC-------CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 101 IHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
-++.|+.|....||++.... ++..|++|+.... ........|..+++.+..+.. .| ++++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~-~P---~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHL-GP---KLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTS-SS---CEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCC-CC---cEEEEeCC----
Confidence 35678888899999998653 2567999988431 111345579999999877553 23 34444432
Q ss_pred EEEEecC
Q 013973 174 CIVFEKL 180 (433)
Q Consensus 174 ~lV~e~~ 180 (433)
.+||||+
T Consensus 148 g~v~e~l 154 (429)
T 1nw1_A 148 GRLEEYI 154 (429)
T ss_dssp EEEECCC
T ss_pred CEEEEEe
Confidence 2899998
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.002 Score=62.37 Aligned_cols=70 Identities=14% Similarity=0.175 Sum_probs=41.8
Q ss_pred eeeeccccEEEEEEEECC-------CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 103 SKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+.|..|-...+|++.... +++.|++|+............+|..+++.+..... .| ++++.+.. .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv-~P---~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSL-GP---QLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTS-SC---CEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCC-CC---eEEEEcCC----cc
Confidence 567677788899987642 34679999864322223445689999999987654 23 34444443 28
Q ss_pred EEecC
Q 013973 176 VFEKL 180 (433)
Q Consensus 176 V~e~~ 180 (433)
||||+
T Consensus 128 v~e~i 132 (379)
T 3feg_A 128 LEQYI 132 (379)
T ss_dssp EEECC
T ss_pred EEEEe
Confidence 99998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0035 Score=60.28 Aligned_cols=71 Identities=20% Similarity=0.132 Sum_probs=41.8
Q ss_pred EeeeeccccEEEEEEEECC--------CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 102 HSKMGEGTFGQVLECWDRE--------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~--------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++.|+.|....+|++.... .+..+++|+.............|..+++.+..+.. .|.+ +..+. +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-~P~~---~~~~~--~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-APQL---LNTFN--G-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-SCCE---EEEET--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-CCce---EEecC--C--
Confidence 4677888888999997653 12578999875322211123578899998877543 3333 33331 2
Q ss_pred EEEEecC
Q 013973 174 CIVFEKL 180 (433)
Q Consensus 174 ~lV~e~~ 180 (433)
++||||+
T Consensus 110 ~~v~e~i 116 (369)
T 3c5i_A 110 GRIEEWL 116 (369)
T ss_dssp EEEEECC
T ss_pred cEEEEEe
Confidence 5899999
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.013 Score=55.71 Aligned_cols=72 Identities=13% Similarity=0.098 Sum_probs=44.0
Q ss_pred eccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCC-CCceEEec-c--eeecCCeEEEEEecC-
Q 013973 106 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG-GNRCVQIR-N--WFDYRNHICIVFEKL- 180 (433)
Q Consensus 106 G~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~-~~~i~~~~-~--~~~~~~~~~lV~e~~- 180 (433)
|.|....||++... +| .+++|+..... ...|..+++.+...... .|.++... + +....+..++||+|+
T Consensus 32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSE-SK-SYFIKLKYGYH-----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECS-SC-EEEEEEEECSS-----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeC-CC-CEEEEEecCcc-----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 33446789998753 34 79999876433 14578888888765432 23322221 1 123457889999999
Q ss_pred CCCH
Q 013973 181 GSSL 184 (433)
Q Consensus 181 ~~~L 184 (433)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 5433
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.014 Score=57.85 Aligned_cols=72 Identities=11% Similarity=0.043 Sum_probs=44.9
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 180 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~ 180 (433)
-++.|+.|-...+|++....++..|++|+........-....|..+++.+..... ..++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl----~P~ll~~~~-~---G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNI----AKKIYVFFT-N---GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSS----BCCEEEEET-T---EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCC----CCCEEEEeC-C---eEEEEee
Confidence 3567888889999999876545789999874321111112478999998876442 244555553 2 2599998
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.013 Score=51.46 Aligned_cols=97 Identities=12% Similarity=0.008 Sum_probs=58.9
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCC
Q 013973 183 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 261 (433)
Q Consensus 183 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~ 261 (433)
+|.+.|+..+ .++++++++.++.|.+.+|.-+- +..-..+=+-|..|++..+|.
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~------------------------ 88 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA------------------------ 88 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC------------------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc------------------------
Confidence 6999998765 68999999999999999987762 111112333467888865553
Q ss_pred CCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh
Q 013973 262 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318 (433)
Q Consensus 262 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 318 (433)
|.+.+ +.+. .....+.|||... ...+.+.=|||||+++|..+-
T Consensus 89 ---V~f~~-~~s~---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 89 ---VTLAP-AADD---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---EEECC-C---------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---eeccc-cccc---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 33221 0000 1123466787653 234567789999999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.038 Score=54.10 Aligned_cols=71 Identities=11% Similarity=0.030 Sum_probs=44.8
Q ss_pred EeeeeccccEEEEEEEECCC-------CeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 102 HSKMGEGTFGQVLECWDRER-------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~-------~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
++.|..|-...+|++..... ++.|++|+........-....|..+++.+..... .|.+ ++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi-~P~l---~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI-APNI---IADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS-SCCE---EEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC-CCCE---EEEcC--C--C
Confidence 46677788888999886531 4679999864322111123568999998877553 2333 33332 2 6
Q ss_pred EEEecC
Q 013973 175 IVFEKL 180 (433)
Q Consensus 175 lV~e~~ 180 (433)
+||||+
T Consensus 147 ~I~efI 152 (424)
T 3mes_A 147 RIEEFI 152 (424)
T ss_dssp EEEECC
T ss_pred EEEEEe
Confidence 889999
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.07 E-value=0.36 Score=46.66 Aligned_cols=35 Identities=26% Similarity=0.493 Sum_probs=25.8
Q ss_pred ceeccCCCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccc
Q 013973 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275 (433)
Q Consensus 220 ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 275 (433)
++|+|+.+.|||+..+.. .++...+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~---------------------~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRE---------------------NSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGG---------------------GCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcc---------------------cCcCCeEEEechHhccC
Confidence 679999999999954220 03456789999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 433 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-50 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-47 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-47 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-45 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-34 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-29 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-25 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 | |
| d1nw1a_ | 395 | d.144.1.8 (A:) Choline kinase {Caenorhabditis eleg | 8e-05 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-55
Identities = 68/338 (20%), Positives = 117/338 (34%), Gaps = 44/338 (13%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 153
++ S++G G G V + + ++A K++ R + E++VL +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NS 63
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
V F I I E + G SL L+K P ++ +++ +++ +
Sbjct: 64 P----YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 213 AFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
++ + ++H D+KP N+L+ S IK+ DFG
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFG 150
Query: 272 -STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
S N V TR Y +PE + G ++ DIWS+G LVE+ G + E
Sbjct: 151 VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
M + R G P A V + P L
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSG 268
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
D + L +P +R ++ + H F R
Sbjct: 269 VFSLEFQD---FVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 1e-52
Identities = 71/341 (20%), Positives = 130/341 (38%), Gaps = 80/341 (23%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAK 152
++ Y I ++G G FG V C ++ + K + + EI ++ QL
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-H 84
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
H + + + + F+ + + ++ E L G L+D + +Y+ V RQ E
Sbjct: 85 HP----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEG 139
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ MH+ ++H D+KPEN++ K+S++K+IDFG
Sbjct: 140 LKHMHEHSIVHLDIKPENIMC-------------------------ETKKASSVKIIDFG 174
Query: 272 STTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
T PD+ +T + APE++ + D+W++G + L +G + F ++L
Sbjct: 175 LATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
E L ++R + V A+
Sbjct: 235 ETLQNVKRCDWEFDEDAFSSVSPEAK---------------------------------- 260
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
++ LL+ +P RLT +AL HP+ DH
Sbjct: 261 -----------DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 9e-52
Identities = 77/342 (22%), Positives = 147/342 (42%), Gaps = 45/342 (13%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 153
S+Y+ +K+G+GTFG+V + R+ + VA+K V + + A+ EI++LQ L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 154 DKGGNRCV---QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
+ + + + + I +VF+ L L N F + ++ + + LL
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLN 128
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++H ++H D+K NVL+ +K+ D+ + +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-------------------RAFSL 169
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
+ N V T YR PE++LG + P D+W GCI+ E+ T + Q +
Sbjct: 170 AKNSQPNRYTNR-VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
LA++ ++ G + + VD + + + L + ++ +K+ ++ P +LI
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNY--ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
+ LL DP R+ + +AL H FF D +
Sbjct: 287 K---------------LLVLDPAQRIDSDDALNHDFFWSDPM 313
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-51
Identities = 74/344 (21%), Positives = 139/344 (40%), Gaps = 81/344 (23%)
Query: 95 LTSRYKIHSKM-GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 153
+ YK+ S++ G G G+VL+ +++ +E A+K+++ K R E+E+ + ++
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQC 64
Query: 154 DKGGNRCVQIRNWFDY----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
V+I + ++ R + IV E L G L+ ++ ++F EI + +
Sbjct: 65 P----HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
E I ++H + + H D+KPEN+L S ++ +K+
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTS------------------------KRPNAILKLT 156
Query: 269 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
DFG + T +Y APEV+ + CD+WS+G I+ L G F ++
Sbjct: 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
L M+ +R G+ ++P S S
Sbjct: 217 HGLAISPGMKT-------------------RIRMGQYEFPNPEWSEVS------------ 245
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
++ L++ LL+ +PT R+T E + HP+ +
Sbjct: 246 ----------EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 2e-51
Identities = 84/340 (24%), Positives = 142/340 (41%), Gaps = 45/340 (13%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLA 151
++ RY S +GEG +G V +D K VAIK + + Y + + EI++L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
+ G + + + +V +G+ LY L+ + D + Q+L
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRG 121
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ ++H ++H DLKP N+LL ++ +K+ D+ + D + +
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL------------ 169
Query: 272 STTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
V+TR YRAPE++L G+T DIWSVGCIL E+ + +F L+
Sbjct: 170 ---------TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
L + +LG Q L + R L P K N +
Sbjct: 221 QLNHILGILGSPSQEDLNCIIN---LKARNYLLSLPH------------KNKVPWNRLFP 265
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ D A D LL +L ++P R+ +AL HP+ + +
Sbjct: 266 NADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (442), Expect = 3e-51
Identities = 75/343 (21%), Positives = 130/343 (37%), Gaps = 80/343 (23%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLA 151
+++ Y IH ++G G FG V +R A K V + +E EI+ + L
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 80
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
+H V + + F+ N + +++E + G L++ + + + D E RQ+ +
Sbjct: 81 RHP----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK 135
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ MH+ +H DLKPEN++ + +S+ +K+IDF
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDF 170
Query: 271 GSTTYERPDQNYIVST--RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
G T + P Q+ V+T + APEV G Y D+WSVG + L +G + F +
Sbjct: 171 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
E L ++ + +
Sbjct: 231 DETLRNVKSCDWNMDDSAFSGISE------------------------------------ 254
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
D ++ LL DP R+T +AL HP+ T +
Sbjct: 255 ---------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (437), Expect = 1e-50
Identities = 105/355 (29%), Positives = 164/355 (46%), Gaps = 46/355 (12%)
Query: 91 LGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ 149
GE +RY + K+G G F V D VA+KIVRG K Y EAA EI++LQ+
Sbjct: 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 65
Query: 150 LAKHDK------GGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPID 199
+ D G N +++ + F+++ H+ +VFE LG +L ++K +R P+
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 200 LVREIARQLLECIAFMHDLCMI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258
V++I++QLL + +MH C I HTD+KPENVL+ +
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS--------------------- 164
Query: 259 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 318
IK+ D G+ + + TR YR+PEV+LG W DIWS C++ EL T
Sbjct: 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
Query: 319 GEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 372
G+ LF+ E + +H+A + +LG LP ++L+ + RG L
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR-------N 277
Query: 373 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
S L + + A +++ L +L+ DP R A + HP+
Sbjct: 278 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 4e-50
Identities = 83/338 (24%), Positives = 140/338 (41%), Gaps = 54/338 (15%)
Query: 96 TSRYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVR---GIKKYREAAMIEIEVLQQLA 151
+Y+ +++GEG +G+V + D + VA+K VR G + + + E+ VL+ L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 152 KHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 208
+ V + D + +VFE + L +L K P + ++++ QL
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
L + F+H ++H DLKP+N+L+ SS IK+ D
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD-------------------------F 160
Query: 269 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328
+ +V T YRAPEV+L + P D+WSVGCI E+ + LF+ +
Sbjct: 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
++ L + V+G + DWP A ++ +
Sbjct: 221 VDQLGKILDVIGLPGEE------------------DWPRDVALPRQAFHSKSAQPIEKFV 262
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+D D LL L ++P R++A AL HP+F
Sbjct: 263 -TDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-49
Identities = 62/334 (18%), Positives = 121/334 (36%), Gaps = 79/334 (23%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 156
++I +G+G FG V +++ K ++A+K++ + + ++ ++ H +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 157 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
N +++ +F + ++ E ++Y L+K F +L +++
Sbjct: 66 PN-ILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYC 122
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
H +IH D+KPEN+LL S+ +K+ D+ S+H P
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-------------------- 162
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 335
+ T Y PE+I G D+WS+G + E G+ F+ + E +
Sbjct: 163 ------TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216
Query: 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395
RV P + +
Sbjct: 217 SRVEFTFPDFVTE----------------------------------------------- 229
Query: 396 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
L+ LL+++P+ R RE L HP+ T +
Sbjct: 230 --GARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-49
Identities = 60/343 (17%), Positives = 117/343 (34%), Gaps = 79/343 (23%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 152
+ L +Y I +G G FG V C + K+ K V+ + EI +L +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-R 59
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
H + + F+ + ++FE + G +++ + + + + Q+ E
Sbjct: 60 HR----NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEA 114
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ F+H + H D++PEN++ + + K+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTI-------------------------KIIEFG 149
Query: 272 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
+P N+ + + Y APEV + D+WS+G ++ L +G F N
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
+ + + + K +
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISI------------------------------------- 232
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 432
+ + LL + R+TA EAL+HP+ + R
Sbjct: 233 --------EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (418), Expect = 1e-48
Identities = 69/342 (20%), Positives = 118/342 (34%), Gaps = 81/342 (23%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----------GIKKYREAAMIEIEVL 147
Y+ +G G V C + + A+KI+ +++ REA + E+++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 148 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 206
++++ H +Q+++ ++ +VF+ + L+D+L + + R+I R
Sbjct: 64 RKVSGHP----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMR 117
Query: 207 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 266
LLE I +H L ++H DLKPEN+LL IK+ D+ S
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-------------------C 158
Query: 267 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
+D G E ++ G+ D+WS G I+ L G F
Sbjct: 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+ + L M+
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSD---------------------------------- 244
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428
+ L+ L P R TA EAL HPFF +
Sbjct: 245 -----------TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-48
Identities = 89/333 (26%), Positives = 146/333 (43%), Gaps = 53/333 (15%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 154
++ K+GEGT+G V + ++ E+VA+K +R + A+ EI +L++L +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V++ + N + +VFE L L F+ + P+ L++ QLL+ +AF
Sbjct: 63 -----IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
H ++H DLKP+N+L+ + IK+ D+ + +
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------------------ 159
Query: 275 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
+ V T YRAPE++LG ++ DIWS+GCI E+ T ALF ++ L
Sbjct: 160 ------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ R LG + + WP + + S K R + V
Sbjct: 214 RIFRTLGTPDEVV------------------WPGVTSMPDYKPSFPKWARQD--FSKVVP 253
Query: 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
D LL +L YDP R++A+ AL HPFF
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 5e-48
Identities = 67/343 (19%), Positives = 124/343 (36%), Gaps = 81/343 (23%)
Query: 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQ 149
E++ Y +G G F +V+ D+ +++VAIK + ++ + EI VL +
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 208
+ KH V + + ++ H+ ++ + + G L+D + + + + + Q+
Sbjct: 64 I-KHP----NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQV 116
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
L+ + ++HDL ++H DLKPEN+L S + + S I +
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKIMIS 152
Query: 269 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326
DFG + E P T Y APEV+ ++ D WS+G I L G F
Sbjct: 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
+ + + + +
Sbjct: 213 NDAKLFEQILKAEYEFDSPYWDDISD---------------------------------- 238
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
++ L+ DP R T +AL+HP+ D
Sbjct: 239 -----------SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-47
Identities = 67/342 (19%), Positives = 124/342 (36%), Gaps = 81/342 (23%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAK 152
N ++I ++G+G FG+V + ++E + A K++ ++ E M+EI++L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-D 67
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
H V++ + F Y N++ I+ E D + R ++ + +Q L+ +
Sbjct: 68 HPN----IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
++HD +IH DLK N+L IK+ D+ S +
Sbjct: 124 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---------------- 167
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHE 327
+ + T ++ APEV++ + Y D+WS+G L+E+ E
Sbjct: 168 --------DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
+ L + + P L P +S
Sbjct: 220 PMRVLLKIAKSEPP--------------------TLAQPSRWSS---------------- 243
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
+ L+ L + R T + L+HPF T D
Sbjct: 244 ----------NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-47
Identities = 81/344 (23%), Positives = 146/344 (42%), Gaps = 65/344 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
Y +G G+FG V + + E+VAIK V K+++ E++++++L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-DHC--- 73
Query: 158 NRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLL 209
V++R +F ++ +V + + ++Y R ++ P+ V+ QL
Sbjct: 74 -NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+A++H + H D+KP+N+LL P ++ +K+ D
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCD 166
Query: 270 FGSTTYERPDQNY--IVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 326
FGS + + +R+YRAPE+I G +T D+WS GC+L EL G+ +F
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
++ L + +VLG + ++ ++ + ++ +P+ +K
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEF------KFPQ-----------IKAHPWTK 269
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ A L LL Y PT RLT EA H FF
Sbjct: 270 VFRPRTPPEAIA---LCSRLLEYTPTARLTPLEACAHSFFDELR 310
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-47
Identities = 73/335 (21%), Positives = 138/335 (41%), Gaps = 58/335 (17%)
Query: 104 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGG 157
+GEG F V + D+ ++VAIK ++ + A+ EI++LQ+L H
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHP--- 60
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
+ + + F ++++I +VF+ + + L ++ N+ P ++ L+ + ++H
Sbjct: 61 -NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEYLHQ 118
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 277
++H DLKP N+LL + +K+ D+ + + +
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------------------- 157
Query: 278 PDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
+ V TR YRAPE++ G + D+W+VGCIL EL +L+ L +
Sbjct: 158 ---THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
LG + WP+ + + + + I
Sbjct: 215 ETLGTPTEE------------------QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 256
Query: 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 431
DL +QGL ++P R+TA +AL+ +F+
Sbjct: 257 LDL---IQGLFLFNPCARITATQALKMKYFSNRPG 288
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 162 bits (410), Expect = 7e-47
Identities = 71/337 (21%), Positives = 138/337 (40%), Gaps = 56/337 (16%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
Y++ K+G G + +V E + E V +KI++ ++ EI++L+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGP--- 90
Query: 158 NRCVQIRNWF--DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
+ + + +VFE + + + +R ++L+ + +
Sbjct: 91 -NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
H + ++H D+KP NV++ + +++ID+G
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--------------------------EHRKLRLIDWGLAE 178
Query: 275 YERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE-ALFQTHENLE 330
+ P Q N V++R+++ PE+++ + Y D+WS+GC+L + + F H+N +
Sbjct: 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
L + +VLG Y+ + ++ S + R + Q
Sbjct: 239 QLVRIAKVLGT----------EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 427
H+ + L LLRYD RLTAREA+ HP+F
Sbjct: 289 HLVSP--EALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-45
Identities = 75/341 (21%), Positives = 132/341 (38%), Gaps = 40/341 (11%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQL 150
+ RY+ +G G G V +D VAIK + + + + A E+ +++ +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 151 AKHDKGGNR-CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
+ + + + +V E + ++L ++ + + + Q+L
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQML 129
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
I +H +IH DLKP N+++ S +K+ D
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD-------------------------FG 164
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329
T V TR+YRAPEVILG+G+ DIWSVGCI+ E+ + LF + +
Sbjct: 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
Query: 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 389
+ + LG +K++ YV P+ A L +
Sbjct: 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN----RPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 390 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ A D LL +L DP R++ +AL+HP+ +
Sbjct: 281 KLKASQARD---LLSKMLVIDPAKRISVDDALQHPYINVWY 318
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 4e-45
Identities = 84/356 (23%), Positives = 148/356 (41%), Gaps = 56/356 (15%)
Query: 83 KDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKY 136
+ G Y + + + + Y+ +G G +G V D VAIK + + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 137 REAAMIEIEVLQQLA-KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS 195
+ A E+ +L+ + ++ G D +V +G+ L ++
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EK 117
Query: 196 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255
D ++ + Q+L+ + ++H +IH DLKP N+ +
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----------------------- 154
Query: 256 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILV 314
+ +K++DFG + V TR YRAPEVIL + +T DIWSVGCI+
Sbjct: 155 ----NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 315 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES 374
E+ TG+ LF+ ++L+ L + +V G P ++R+ K +G + + +
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-- 268
Query: 375 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
I+ + A + LL+ +L D R+TA EAL HP+F H
Sbjct: 269 -------------ILTNASPLAVN---LLEKMLVLDAEQRVTAGEALAHPYFESLH 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 4e-45
Identities = 68/345 (19%), Positives = 118/345 (34%), Gaps = 88/345 (25%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQ 148
++ + ++G G+FG V D E+VAIK + + + + E+ LQ
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 149 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 208
+L +H +Q R + + +V E S D L + + + +
Sbjct: 71 KL-RHP----NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 124
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
L+ +A++H MIH D+K N+LL +K+
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGL---------------------------VKLG 157
Query: 269 DFGSTTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQT 325
DFGS + P ++ V T ++ APEVIL + + D+WS+G +EL +
Sbjct: 158 DFGSASIMAPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
+ L + + P Q W E
Sbjct: 217 MNAMSALYHIAQNESPALQSG-----------------HWSE------------------ 241
Query: 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ + L+ P DR T+ L+H F R+
Sbjct: 242 ------------YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-45
Identities = 67/340 (19%), Positives = 118/340 (34%), Gaps = 80/340 (23%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLA 151
+ +Y K+G+G G V D + VAI+ + + +E + EI V+++
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN- 74
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
K+ V + + + + +V E L G SL D + + + + R+ L+
Sbjct: 75 KNP----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQ 127
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ F+H +IH D+K +N+LL +K+ D+ + S M
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----------- 176
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
V T ++ APEV+ + DIWS+G + +E+ GE + L
Sbjct: 177 -------------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
L ++ P L PE ++
Sbjct: 224 ALYLIATNGTP--------------------ELQNPEKLSA------------------- 244
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
L L D R +A+E L+H F
Sbjct: 245 -------IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-45
Identities = 59/336 (17%), Positives = 113/336 (33%), Gaps = 79/336 (23%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK 155
+ + +GEG +G+V +R +E VA+KIV E EI + + L H+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 63
Query: 156 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V+ N + E G L+D + + P + QL+ + +
Sbjct: 64 ---NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H + + H D+KPEN+LL + +K+ D+ + ++
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--------------------- 157
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
N + T Y APE++ + P D+WS G +L + GE + +
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE- 215
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ + K++D
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPL-------------------------------------- 237
Query: 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429
LL +L +P+ R+T + + ++ +
Sbjct: 238 -------ALLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 8e-45
Identities = 69/344 (20%), Positives = 123/344 (35%), Gaps = 85/344 (24%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIE 145
EN+ Y ++G G F V +C ++ A K ++ + RE E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 146 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
+L+++ +H + + ++ + + ++ E + G L+DFL + S + E
Sbjct: 66 ILKEI-QHP----NVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+Q+L + ++H L + H DLKPEN++L+ R
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLD-----------------------RNVPKPR 155
Query: 265 IKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
IK+IDFG I T + APE++ D+WS+G I L +G +
Sbjct: 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F E LA + V A+
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAK--------------------------- 248
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
++ LL DP R+T +++L+HP+
Sbjct: 249 ------------------DFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-44
Identities = 77/342 (22%), Positives = 146/342 (42%), Gaps = 53/342 (15%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQL 150
+ RY+ S +G G +G V +D + VA+K + + + E+ +L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 151 A-KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 209
++ G + N + +V +G+ L + ++ + D V+ + Q+L
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQIL 131
Query: 210 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 269
+ ++H +IH DLKP N+ + + +K++D
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLA---------------------------VNEDCELKILD 164
Query: 270 FGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHEN 328
FG + + V+TR YRAPE++L + DIWSVGCI+ EL TG LF ++
Sbjct: 165 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388
++ L ++ R++G +LK++ + + + P+ + +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN---------------V 269
Query: 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+ A D LL+ +L D R+TA +AL H +F + H
Sbjct: 270 FIGANPLAVD---LLEKMLVLDSDKRITAAQALAHAYFAQYH 308
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 7e-44
Identities = 63/349 (18%), Positives = 129/349 (36%), Gaps = 92/349 (26%)
Query: 90 ALGENLTSRY-KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIE 145
A+G + R+ K ++G G+F V + D E VA ++ K R+ E E
Sbjct: 1 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60
Query: 146 VLQQLAKHDKGGNRCVQIRNWF----DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDL 200
+L+ L +H V+ + + + I +V E + +L +L++ + I +
Sbjct: 61 MLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKV 113
Query: 201 VREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 258
+R RQ+L+ + F+H +IH DLK +N+ +
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG------------------------ 149
Query: 259 MPKSSAIKVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
+ ++K+ D G T +R ++ T + APE+ + D+++ G ++E+
Sbjct: 150 --PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 206
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
T E + +N + R V+ D
Sbjct: 207 TSEYPYSECQNAAQIY------------------RRVTSGVKPASFD------------- 235
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ ++ +++G +R + +R + ++ L H FF
Sbjct: 236 ---------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-42
Identities = 64/341 (18%), Positives = 116/341 (34%), Gaps = 93/341 (27%)
Query: 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-------GIKKYREAAMIEIEVL 147
L S+Y++ +G G FG V VAIK V G +E+ +L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 148 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
++++ G +++ +WF+ + ++ E+ F + +L R Q
Sbjct: 62 KKVSSGFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+LE + H+ ++H D+K EN+L+ + +K+
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE--------------------------LKL 152
Query: 268 IDFG-STTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQT 325
IDFG + TR Y PE I +WS+G +L ++ G+ F+
Sbjct: 153 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
E + RG++ + + +S
Sbjct: 213 DEE-----------------------------IIRGQVFFRQRVSS-------------- 229
Query: 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
+ HL++ L P+DR T E HP+
Sbjct: 230 ------------ECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 147 bits (371), Expect = 1e-41
Identities = 80/333 (24%), Positives = 132/333 (39%), Gaps = 55/333 (16%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHD 154
+Y K+GEGT+G V + + E A+K +R K + EI +L++L +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V++ + + + +VFE L L L + QLL IA+
Sbjct: 62 -----IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAY 115
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
HD ++H DLKP+N+L+ +K+ D+ + +
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY------------------ 157
Query: 275 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
+ + T YRAP+V++G ++ DIWSVGCI E+ G LF + L
Sbjct: 158 ------THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ R+LG V + + P ++ +D
Sbjct: 212 RIFRILGTPNSKNWPNVTELP-----------------KYDPNFTVYEPLPWESFLKGLD 254
Query: 394 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 426
S DL L +L+ DP R+TA++AL H +F
Sbjct: 255 ESGIDL---LSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-41
Identities = 61/336 (18%), Positives = 110/336 (32%), Gaps = 81/336 (24%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
+K +GEG+F V+ + AIKI+ +E + + + +
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 158 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
V++ F + L ++RK SF R +++ + ++H
Sbjct: 69 F-FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 125
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+IH DLKPEN+LL +I++ D+ ++ +S +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA------------------ 167
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
N V T Y +PE++ D+W++GCI+ +L G F+ +
Sbjct: 168 ----NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
++ P+ +P+
Sbjct: 224 KLEYDFPEKF------------------FPK----------------------------- 236
Query: 397 GDLTHLLQGLLRYDPTDRLTAREA------LRHPFF 426
L++ LL D T RL E HPFF
Sbjct: 237 --ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 9e-41
Identities = 81/338 (23%), Positives = 143/338 (42%), Gaps = 55/338 (16%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHD 154
+Y+ K+GEGT+G V + +RE E+VA+K VR + +A+ EI +L++L +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
V++ + + +VFE L + N P ++V+ QLL+ + F
Sbjct: 63 -----IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGF 116
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
H ++H DLKP+N+L+ + +K+ ++ + +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY------------------ 158
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA-LFQTHENLEHL 332
+ V T YR P+V+ G + D+WS GCI EL LF ++ + L
Sbjct: 159 ------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392
+ R+LG + + + + K P +L+
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPD-------------------YKPYPMYPATTSLVNVVP 253
Query: 393 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 430
+A LLQ LL+ +P R++A EAL+HP+F+
Sbjct: 254 KLNA-TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-40
Identities = 63/335 (18%), Positives = 113/335 (33%), Gaps = 85/335 (25%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKH 153
+ +H +G+G+FG+V ++ + AIK ++ + E M+E VL +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
+ F + ++ V E L G L ++ F + A +++ +
Sbjct: 63 P----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 116
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 272
F+H +++ DLK +N+LL +IK+ D+ +
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---------------- 160
Query: 273 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 332
N T Y APE++LG + + D WS G +L E+ G++ F + E
Sbjct: 161 --------NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212
Query: 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 392
+R +P
Sbjct: 213 -----------------------HSIRMDNPFYPRWLEK--------------------- 228
Query: 393 DHSAGDLTHLLQGLLRYDPTDRLTAR-EALRHPFF 426
+ LL L +P RL R + +HP F
Sbjct: 229 -----EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 5e-40
Identities = 60/339 (17%), Positives = 110/339 (32%), Gaps = 64/339 (18%)
Query: 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 154
+ +RY++ K+G G+FG + D E VAIK+ +K IE ++ + +
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGG- 62
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
IR ++ +V E LG SL D + R F + V +A Q++ I +
Sbjct: 63 ---VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEY 118
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H IH D+KP+N L+ + + D K+ + + I +
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYII-------DFGLAKKYRDARTHQHIPYRENK 171
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334
+ T Y + LG+ + D+ S+G +L+ G +Q +
Sbjct: 172 N-------LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
Query: 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
ER + ++ I
Sbjct: 225 YER-----------------------------------------ISEKKMSTPIEVLCKG 243
Query: 395 SAGDLTHLLQGLLRYDPTDRLTA---REALRHPFFTRDH 430
+ L D+ R+ R+ F +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-40
Identities = 62/343 (18%), Positives = 111/343 (32%), Gaps = 96/343 (27%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDK 155
Y++ +G G++G+ + + +++ K + + ++ + E+ +L++L KH
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPN 64
Query: 156 GGNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLE 210
V+ + R + IV E G L + K + + V + QL
Sbjct: 65 ----IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 211 CIAFMHDL-----CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 265
+ H ++H DLKP NV L + +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---------------------------V 153
Query: 266 KVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 322
K+ DFG D ++ V T +Y +PE + + + DIWS+GC+L ELC
Sbjct: 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
Query: 323 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 382
F E +R G+ S E
Sbjct: 214 FTAFSQKELAGK-----------------------IREGKFRRIPYRYSDE--------- 241
Query: 383 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 425
L ++ +L R + E L +P
Sbjct: 242 ----------------LNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 137 bits (345), Expect = 7e-38
Identities = 50/252 (19%), Positives = 92/252 (36%), Gaps = 38/252 (15%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
YK+ ++GEG+FG + E + + VAIK + E + LA
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGC---- 60
Query: 158 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 217
+ + H +V + LG SL D L R F + V A+Q+L + +H+
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE 119
Query: 218 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------ 271
+++ D+KP+N L+ ++ I V+DFG
Sbjct: 120 KSLVYRDIKPDNFLIGR----------------------PNSKNANMIYVVDFGMVKFYR 157
Query: 272 ----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 327
++ + T Y + LG + D+ ++G + + G +Q +
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217
Query: 328 NLEHLAMMERVL 339
+ ER+
Sbjct: 218 AATNKQKYERIG 229
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (338), Expect = 3e-36
Identities = 67/341 (19%), Positives = 128/341 (37%), Gaps = 89/341 (26%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKH 153
+ +H +G G FG+V C + +M A+K + +K+ A+ E +L ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 212
D V + F + + + + + G L+ L ++ F +R A +++ +
Sbjct: 65 DC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGL 120
Query: 213 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 271
MH+ +++ DLKP N+LL + +++ D G
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGH---------------------------VRISDLGL 153
Query: 272 STTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
+ + + + V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+ +
Sbjct: 154 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
+ L ++ P+ +
Sbjct: 214 KHEIDRMTLTM--------------------AVELPDSFSP------------------- 234
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLT-----AREALRHPFF 426
+L LL+GLL+ D RL A+E PFF
Sbjct: 235 -------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (334), Expect = 5e-36
Identities = 62/337 (18%), Positives = 110/337 (32%), Gaps = 91/337 (27%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHD 154
++I +G G+FG+V R A+K+++ K E E +L + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 64
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
+++ F I ++ + + L + + R FP + + A ++ + +
Sbjct: 65 ----FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEY 119
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+H +I+ DLKPEN+LL + + IK+ DFG
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGH---------------------------IKITDFGFAK 152
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334
Y + T Y APEV+ + D WS G ++ E+ G F
Sbjct: 153 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY---------- 202
Query: 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
++ + L +P
Sbjct: 203 -----DSNTMKTYEK--------ILNAELRFPPFFNE----------------------- 226
Query: 395 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
D+ LL L+ D + RL + HP+F
Sbjct: 227 ---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-35
Identities = 58/329 (17%), Positives = 108/329 (32%), Gaps = 84/329 (25%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 156
K+ +G+G FG V+ R K VA+K ++ +A + E V+ QL +H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHS-- 60
Query: 157 GNRCVQIRNWF-DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 214
VQ+ + + + IV E + SL D+LR D + + + + E + +
Sbjct: 61 --NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 215 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 274
+ +H DL NVL+ + + KV DFG T
Sbjct: 119 LEGNNFVHRDLAARNVLV---------------------------SEDNVAKVSDFGLTK 151
Query: 275 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 334
Q+ + APE + ++ D+WS G +L E+ + + L+ +
Sbjct: 152 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-- 209
Query: 335 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394
+ + ++D P+G P + ++
Sbjct: 210 -------------------VPRVEKGYKMDAPDGCP-----------PAVYEVMKN---- 235
Query: 395 SAGDLTHLLQGLLRYDPTDRLTAREALRH 423
D R + +
Sbjct: 236 -----------CWHLDAAMRPSFLQLREQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-35
Identities = 62/338 (18%), Positives = 113/338 (33%), Gaps = 90/338 (26%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHD 154
+ +G+GTFG+V+ ++ A+KI+R K + E VLQ +H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RH- 64
Query: 155 KGGNRCVQIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
++ F + +C V E G L+ L + F + R +++ +
Sbjct: 65 ---PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++H +++ D+K EN++L +IK+ D+ D +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM----------------- 162
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
T Y APEV+ + D W +G ++ E+ G F ++
Sbjct: 163 -------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ + + +P +
Sbjct: 216 L-----------------------ILMEEIRFPRTLSP---------------------- 230
Query: 394 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
+ LL GLL+ DP RL A+E + H FF
Sbjct: 231 ----EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 128 bits (322), Expect = 1e-34
Identities = 51/276 (18%), Positives = 96/276 (34%), Gaps = 37/276 (13%)
Query: 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQ 149
+L+ RY++ +G G +V D VA+K++R + E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 150 LAKHDKGGNRCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 204
L H V + + + IV E + G +L D + E+
Sbjct: 64 L-NHP----AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEV 116
Query: 205 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 264
+ + F H +IH D+KP N+++ ++ +KV D+ + + +
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT----- 171
Query: 265 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324
++ T Y +PE G D++S+GC+L E+ TGE F
Sbjct: 172 ----------------AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
Query: 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 360
+ R P + + + V +
Sbjct: 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 6e-34
Identities = 62/336 (18%), Positives = 118/336 (35%), Gaps = 86/336 (25%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 153
+ + ++G G+FG V + + VA+K++ + +A E+ VL++
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT--- 61
Query: 154 DKGGNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
R V I + Y + IV + GSSLY L + F + + +IARQ +
Sbjct: 62 -----RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQ 115
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++H +IH DLK N+ L +K+ D+ + + S +
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF------------ 163
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHE 327
+ + + APEVI +++ D+++ G +L EL TG+ +
Sbjct: 164 ----------EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213
Query: 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 387
N + + M V RG L
Sbjct: 214 NRDQIIFM----------------------VGRGYLSPD--------------------- 230
Query: 388 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
+ + + + L+ L+ +R + L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 2e-33
Identities = 66/338 (19%), Positives = 111/338 (32%), Gaps = 91/338 (26%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKH 153
++ +G G+FG+V+ +E A+KI+ K K E + E +LQ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NF 100
Query: 154 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 213
++ D N ++ G ++ LR+ F R A Q++
Sbjct: 101 P---FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155
Query: 214 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 273
++H L +I+ DLKPEN+L+ Y I+V DFG
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGY---------------------------IQVTDFGFA 188
Query: 274 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 333
+ + T APE+IL G+ D W++G ++ E+ G F + ++
Sbjct: 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 393
+ P H
Sbjct: 249 KIVSGKVRFPSHFSS--------------------------------------------- 263
Query: 394 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
DL LL+ LL+ D T R + H +F
Sbjct: 264 ----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-33
Identities = 62/334 (18%), Positives = 115/334 (34%), Gaps = 80/334 (23%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 156
K+ ++G G FG+V + + VA+K ++ +A + E +++QL +H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ-- 68
Query: 157 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
R V++ + I I+ E + SL DFL+ + I+ + ++A Q+ E +AF+
Sbjct: 69 --RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
+ IH DL+ N+L+ + K+ D+ + + +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG---------------- 169
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 335
+ APE I +T D+WS G +L E+ T + +
Sbjct: 170 -------AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--- 219
Query: 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 395
+ R R+ P+
Sbjct: 220 ------------------IQNLERGYRMVRPDNCPE------------------------ 237
Query: 396 AGDLTHLLQGLLRYDPTDRLTAREALR--HPFFT 427
+L L++ + P DR T FFT
Sbjct: 238 --ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 60/333 (18%), Positives = 111/333 (33%), Gaps = 78/333 (23%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 156
++ K+G+G FG+V VAIK ++ EA + E +V+++L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHE--- 72
Query: 157 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
+ VQ+ + SL DFL+ + + + ++A Q+ +A++
Sbjct: 73 --KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+ +H DL+ N+L+ + KV D+ + + ++
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG----------------- 173
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
+ APE L +T D+WS G +L EL T +
Sbjct: 174 ------AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------- 219
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
+ +L +V+R R+ P L +L+ Q
Sbjct: 220 ------NREVLDQVERGY-------RMPCPPECP-----------ESLHDLMCQ------ 249
Query: 397 GDLTHLLQGLLRYDPTDRLTAREALR--HPFFT 427
R +P +R T +FT
Sbjct: 250 ---------CWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 5e-31
Identities = 58/327 (17%), Positives = 105/327 (32%), Gaps = 76/327 (23%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 156
S ++G G FG V + K+ VAIK +R E + E EV+ +L H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHP-- 60
Query: 157 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
+ VQ+ + IC+VFE + + F + + + + E +A++
Sbjct: 61 --KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 276
+ C+IH DL N L+ ++ IKV D+ + D
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG----------------- 161
Query: 277 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 336
+ +PEV ++ D+WS G ++ E+ + + + + +
Sbjct: 162 ------TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---- 211
Query: 337 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396
E RL P A++
Sbjct: 212 -----------------VEDISTGFRLYKPRLAST------------------------- 229
Query: 397 GDLTHLLQGLLRYDPTDRLTAREALRH 423
+ ++ + P DR LR
Sbjct: 230 -HVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (290), Expect = 4e-30
Identities = 51/297 (17%), Positives = 111/297 (37%), Gaps = 31/297 (10%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 156
+ + K+G G +G+V E ++ VA+K ++ E + E V++++ KH
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP-- 73
Query: 157 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 215
VQ+ I+ E + +L D+LR+ N + ++ +A Q+ + ++
Sbjct: 74 --NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 216 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 275
IH DL N L+ + +KV D+ S D+
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-------------------- 171
Query: 276 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL--A 333
+ APE + ++ D+W+ G +L E+ T +L +
Sbjct: 172 ---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 228
Query: 334 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
+ + P+ ++V + D P A ++ +++ + + + + +
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-30
Identities = 57/358 (15%), Positives = 110/358 (30%), Gaps = 105/358 (29%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVR--GIKKYREAAMIEIEVLQQ 149
+ +G G FG+V+ + VA+K+++ REA M E++++ Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-------------- 194
L H+ V + I ++FE L ++LR +
Sbjct: 97 LGSHE----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 195 -------SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247
+ + A Q+ + + F+ +H DL NVL+ + +K+ D+ +
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 307
DS+Y R + APE + +T D+W
Sbjct: 213 DIMSDSNYVVRG----------------------NARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 308 SVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDW 365
S G +L E+ + G + + K ++ G ++D
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANF----------------------YKLIQNGFKMDQ 288
Query: 366 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
P A ++ ++Q +D R +
Sbjct: 289 PFYATE--------------------------EIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 9e-30
Identities = 60/332 (18%), Positives = 119/332 (35%), Gaps = 85/332 (25%)
Query: 104 KMGEGTFGQVLECWDRERK--EMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGN 158
++G G FG V + + + +K + VA+KI++ ++ + E V+QQL +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP---- 68
Query: 159 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
V++ + + + ++ L +L++N R + E+ Q+ + ++ +
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES 126
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+H DL NVLLV+ Y K+ D+ S D +Y+K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ------------------- 167
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 337
+ + APE I ++ D+WS G ++ E G+ ++ + E AM+E+
Sbjct: 168 --THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
Query: 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
R+ P G
Sbjct: 226 GE----------------------RMGCPAGCPR-------------------------- 237
Query: 398 DLTHLLQGLLRYDPTDRLTARE---ALRHPFF 426
++ L+ YD +R LR+ ++
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 9e-30
Identities = 57/346 (16%), Positives = 104/346 (30%), Gaps = 95/346 (27%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRE--RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAK 152
+ K +GEG FGQVL+ ++ + AIK ++ K E+EVL +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 153 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFP 197
H + + ++R ++ + E +L DFLRK+ +
Sbjct: 70 HP----NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 198 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 257
+ A + + ++ IH DL N+L+ + K+ D+ S
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--- 182
Query: 258 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 317
+ + A E + +T D+WS G +L E+
Sbjct: 183 ----------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 220
Query: 318 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 377
+ L EK + RL+ P
Sbjct: 221 SLGGTPYCGMTCAEL---------------------YEKLPQGYRLEKPLNCDD------ 253
Query: 378 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
++ L++ R P +R + + L
Sbjct: 254 --------------------EVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-29
Identities = 58/337 (17%), Positives = 111/337 (32%), Gaps = 62/337 (18%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 157
+ +G+G FG+V + R E VA+KI ++ EI L +H+
Sbjct: 4 TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENIL 60
Query: 158 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLEC 211
+ +V + SL+D+L + + +A +E
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+ + H DLK +N+L+ + + D + V
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADL--------------------GLAVRHDS 160
Query: 272 STTYERPDQNYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELCTGEALFQT 325
+T N+ V T+ Y APEV+ DI+++G + E+ ++
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
Query: 326 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385
HE+ + P + M K V ++ R + P S E+++ + K
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAK----- 269
Query: 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422
+++ + RLTA +
Sbjct: 270 ----------------IMRECWYANGAARLTALRIKK 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-29
Identities = 62/351 (17%), Positives = 116/351 (33%), Gaps = 98/351 (27%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQ 149
+R +G G FG+V+E + VA+K+++ REA M E++VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRK----------------NN 192
L H V + ++ E L +FLR+ ++
Sbjct: 83 LGNHM----NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 193 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252
+ ++ + + Q+ + +AF+ IH DL N+LL K+ D+ + D
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312
S+Y + + APE I +T+ D+WS G
Sbjct: 199 SNYVV----------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
Query: 313 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAAS 371
L EL + + ++ K ++ G R+ PE
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFY---------------------KMIKEGFRMLSPE---- 271
Query: 372 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422
H+ ++ +++ DP R T ++ ++
Sbjct: 272 ----------------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (285), Expect = 3e-29
Identities = 58/337 (17%), Positives = 110/337 (32%), Gaps = 78/337 (23%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRG--IKKYREAAMIEIEVL 147
E S KI +G G FG+V + +R+ VAIK ++ +K R + E ++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 148 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 207
Q H + + + I+ E + + D + N F + + + R
Sbjct: 82 GQF-DHPN----VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136
Query: 208 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 267
+ + ++ D+ +H DL N+L+ S+ KV D+ S +
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS-------------------RF 177
Query: 268 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 326
++ ++ + APE I +T D+WS G ++ E+ + GE +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
N + + +E + RL P S
Sbjct: 238 TNQDVINAIE----------------------QDYRLPPPMDCPS--------------- 260
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
L L+ + D R + +
Sbjct: 261 -----------ALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-28
Identities = 51/326 (15%), Positives = 104/326 (31%), Gaps = 78/326 (23%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 158
++G G FG V R + + VAIK+++ + + E +V+ L H+
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHE---- 59
Query: 159 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
+ VQ+ + I I+ E + + + F + E+ + + E + ++
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+H DL N L+ +KV D+ S + D
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG------------------- 160
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 337
+ PEV++ ++ DIW+ G ++ E+ + G+ ++ N E + +
Sbjct: 161 ----SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
Query: 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
L RL P A+
Sbjct: 217 GL----------------------RLYRPHLASE-------------------------- 228
Query: 398 DLTHLLQGLLRYDPTDRLTAREALRH 423
+ ++ +R T + L +
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 4e-28
Identities = 62/345 (17%), Positives = 116/345 (33%), Gaps = 90/345 (26%)
Query: 98 RYKIHSKMGEGTFGQVLECWD---RERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQ 149
+++ +G G +G+V + ++ A+K+++ K E E +VL+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQL 208
+ + V + F + ++ + G L+ L + F V+ ++
Sbjct: 85 IRQS----PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEI 138
Query: 209 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 268
+ + +H L +I+ D+K EN+LL S+ ++ + D+ S
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF------------------- 179
Query: 269 DFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTH 326
E T Y AP+++ G G D WS+G ++ EL TG + F
Sbjct: 180 ----VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235
Query: 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386
A + R + + +P+ ++
Sbjct: 236 GEKNSQAEISR-------------------RILKSEPPYPQEMSA--------------- 261
Query: 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 426
L+Q LL DP RL A E H FF
Sbjct: 262 -----------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-28
Identities = 67/333 (20%), Positives = 115/333 (34%), Gaps = 85/333 (25%)
Query: 104 KMGEGTFGQVLECWDRERKE--MVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNR 159
++G G FG V + R RK+ VAIK+++ K E M E +++ QL +
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNP----Y 70
Query: 160 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
V++ + +V E G L+ FL P+ V E+ Q+ + ++ +
Sbjct: 71 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+H DL NVLLV+ Y K+ D+ S D SY+
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR------------------- 169
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 337
+ + APE I ++ D+WS G + E L G+ ++ + E +A +E+
Sbjct: 170 --SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
Query: 338 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 397
R++ P P L L+
Sbjct: 228 GK----------------------RMECPPECP-----------PELYALMSD------- 247
Query: 398 DLTHLLQGLLRYDPTDRLTARE---ALRHPFFT 427
Y DR +R +++
Sbjct: 248 --------CWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-27
Identities = 45/262 (17%), Positives = 93/262 (35%), Gaps = 34/262 (12%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQL 150
S +G G FG+V + + +++ VAIK ++ +K R + E ++ Q
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
+ H +++ + I+ E + + D + F + + + R +
Sbjct: 67 SHH-----NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++ ++ +H DL N+L+ S+ KV D+ S D
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT----------- 170
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
+ + APE I +T D+WS G ++ E+ T +
Sbjct: 171 ----------SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 331 HL--AMMERVLGPLPQHMLKRV 350
+ A+ + P P +
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAI 242
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 54/351 (15%), Positives = 106/351 (30%), Gaps = 97/351 (27%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVR--GIKKYREAAMIEIEVL 147
R + +GEG FGQV+ R VA+K+++ +K + E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 148 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--------------KNN 192
+ + KH + + + ++ E +L ++L+ N
Sbjct: 73 KMIGKH----KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 193 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252
+ A Q+ + ++ IH DL NVL+ +K+ D+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312
Y K + APE + +T+ D+WS G +
Sbjct: 189 DYYKKTT----------------------NGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 313 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 372
L E+ T +E L + R+D P +
Sbjct: 227 LWEIFTLGGSPYPGVPVEEL---------------------FKLLKEGHRMDKPSNCTN- 264
Query: 373 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
+L +++ P+ R T ++ +
Sbjct: 265 -------------------------ELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (263), Expect = 2e-26
Identities = 54/360 (15%), Positives = 101/360 (28%), Gaps = 104/360 (28%)
Query: 93 ENLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIE 145
E + + +GEG FG+V + E MVA+K+++ + E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 146 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS--------- 195
++ + V++ +C++FE + L +FLR + +
Sbjct: 69 LMAEFDNP-----NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 196 -------------FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 242
IARQ+ +A++ + +H DL N L+ + +K+ D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 243 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY 302
+ S + Y + PE I +T
Sbjct: 184 FGLSRNIYSADYYKADGN----------------------DAIPIRWMPPESIFYNRYTT 221
Query: 303 PCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGR 362
D+W+ G +L E+ + E +
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEV---------------------IYYVRDGNI 260
Query: 363 LDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422
L PE +L +L++ P DR + R
Sbjct: 261 LACPENCPL--------------------------ELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-26
Identities = 54/332 (16%), Positives = 92/332 (27%), Gaps = 81/332 (24%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLA 151
R ++ +GEG FG V + + VAIK + RE + E ++Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65
Query: 152 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 211
H V++ N + I+ E + S + + A QL
Sbjct: 66 DHP----HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 212 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 271
+A++ +H D+ NVL+ S++ +K+ D+ S + + Y
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK------------ 168
Query: 272 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331
+ APE I +T D+W G + E+
Sbjct: 169 -----------GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
Query: 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391
+ + RL P
Sbjct: 218 V---------------------IGRIENGERLPMPPNCPP-------------------- 236
Query: 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
L L+ YDP+ R E
Sbjct: 237 ------TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-26
Identities = 44/325 (13%), Positives = 83/325 (25%), Gaps = 76/325 (23%)
Query: 104 KMGEGTFGQVLECWDRE---RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGN 158
+G G FG V + +K A+K + I + E +++ H N
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP---N 89
Query: 159 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 218
+ +V + +N + + + Q+ + + F+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 219 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 278
+H DL N +L +KV D+ + +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA--------------- 194
Query: 279 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 338
+ A E + +T D+WS G +L EL T A N +
Sbjct: 195 -----KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------ 243
Query: 339 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 398
++ RL PE +
Sbjct: 244 ---------------TVYLLQGRRLLQPE--------------------------YCPDP 262
Query: 399 LTHLLQGLLRYDPTDRLTAREALRH 423
L ++ R + E +
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-25
Identities = 55/352 (15%), Positives = 111/352 (31%), Gaps = 96/352 (27%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQ 149
+ + ++G+G+FG V E + E + VAIK V + R + E V+++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 150 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS--------FPIDL 200
H V++ ++ E + L +LR +
Sbjct: 80 FNCH-----HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 201 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 260
+ ++A ++ + +A+++ +H DL N ++ +K+ D+ + + Y K
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 261 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320
+ + +PE + +T D+WS G +L E+ T
Sbjct: 195 ----------------------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
Query: 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380
+ E + + G LD P
Sbjct: 233 EQPYQGLSNEQV---------------------LRFVMEGGLLDKP-------------- 257
Query: 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFF 426
D+ L L++ +Y+P R + E + P F
Sbjct: 258 ------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-25
Identities = 42/255 (16%), Positives = 93/255 (36%), Gaps = 35/255 (13%)
Query: 98 RYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVR----GIKKYREAAMIEIEVLQQL 150
++ K+G+G+FG V + VA+K ++ + + + E+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
H +++ + +V E + + F + + A Q+ E
Sbjct: 69 -DHRN----LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++ IH DL N+LL + + +K+ D+ P++ ++
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM------------ 170
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329
Q + + APE + +++ D W G L E+ T G+ +
Sbjct: 171 ---------QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221
Query: 330 EHLAMMERVLGPLPQ 344
+ L +++ LP+
Sbjct: 222 QILHKIDKEGERLPR 236
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-25
Identities = 50/333 (15%), Positives = 97/333 (29%), Gaps = 85/333 (25%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA--------MIEIEVLQQL 150
+K +G G FG V + E V I + IK+ REA + E V+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA--IKELREATSPKANKEILDEAYVMASV 68
Query: 151 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 210
+ ++ I L D++R++ + + Q+ +
Sbjct: 69 -DNP----HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122
Query: 211 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 270
+ ++ D ++H DL NVL+ + +++K+ D+ + + +
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------------ 170
Query: 271 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330
+ A E IL +T+ D+WS G + EL T +
Sbjct: 171 ----------EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220
Query: 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390
+ + + RL P
Sbjct: 221 EI---------------------SSILEKGERLPQPPICTI------------------- 240
Query: 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
D+ ++ D R RE +
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 3e-24
Identities = 56/350 (16%), Positives = 108/350 (30%), Gaps = 95/350 (27%)
Query: 97 SRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVR--GIKKYREAAMIEIEVLQQ 149
R K+ +G G FGQV+E VA+K+++ A M E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 150 LAKHDKGGNRCVQIRN-WFDYRNHICIVFEKL-GSSLYDFLRKNNY-------------- 193
+ H V + + ++ E +L +LR
Sbjct: 73 IGHH----LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 194 RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253
++ + + Q+ + + F+ IH DL N+LL +K+ D+ + KD
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 313
Y ++ + APE I +T D+WS G +L
Sbjct: 189 DYVRK----------------------GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226
Query: 314 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 373
E+ + A + + +R+
Sbjct: 227 WEIFSLGASPYPGVK-------------IDEEFCRRLK---------------------- 251
Query: 374 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423
+ M+ D++ ++ + +P+ R T E + H
Sbjct: 252 -----------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.7 bits (162), Expect = 1e-13
Identities = 33/223 (14%), Positives = 63/223 (28%), Gaps = 39/223 (17%)
Query: 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGG 157
I MGEG V C+ + E +K + G +++ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 158 NR-CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 216
R + + + + L + + ++ E+ +LE +A +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 217 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 275
++H DL NVL+ I +IDF S
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG----------------------------IWIIDFPQSVEV 152
Query: 276 ERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVE 315
I+ R I+ + DI S +++
Sbjct: 153 GEEGWREIL----ERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} Length = 395 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Score = 42.1 bits (98), Expect = 8e-05
Identities = 24/172 (13%), Positives = 49/172 (28%), Gaps = 10/172 (5%)
Query: 100 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 159
K++ G + + E+ + + A + ++ +
Sbjct: 109 KLYGIFSGGRLEEYIPSRPLSCHEISLAHMST-----KIAKRVAKVHQLEVPIWKEPDYL 163
Query: 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 219
C ++ W + + N +DL RE+ +
Sbjct: 164 CEALQRWLKQLTGTVDAEHRFDLPEECGVSSVNC----LDLARELEFLRAHISLSKSPVT 219
Query: 220 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK-DSSYFKRMPKSSAIKVIDF 270
H DL+ N+LL + + S T +S P + +IDF
Sbjct: 220 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDF 271
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 433 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.0 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.72 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.81 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-61 Score=447.62 Aligned_cols=249 Identities=24% Similarity=0.436 Sum_probs=211.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|+.+++.+ +||||+++++++.+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEEECCE
Confidence 57999999999999999999999999999999986422 2345677899999888 77999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~---------------- 142 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---------------- 142 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT----------------
T ss_pred EEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC----------------
Confidence 99999999 899999998765 79999999999999999999999999999999999999544
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.+||+|||++....... ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 143 -----------~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 211 (263)
T d2j4za1 143 -----------GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211 (263)
T ss_dssp -----------SCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -----------CCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence 456666666665443322 33579999999999999999999999999999999999999998877666
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+.. +.+. .++.+++++++||.+||+.|
T Consensus 212 ~~~~i~~-----------------------~~~~--------------------------~p~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 212 TYKRISR-----------------------VEFT--------------------------FPDFVTEGARDLISRLLKHN 242 (263)
T ss_dssp HHHHHHT-----------------------TCCC--------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHc-----------------------CCCC--------------------------CCccCCHHHHHHHHHHccCC
Confidence 5544322 1111 12356788999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTR 428 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~ 428 (433)
|++|||++|+|+||||+.
T Consensus 243 p~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 243 PSQRPMLREVLEHPWITA 260 (263)
T ss_dssp GGGSCCHHHHHTCHHHHH
T ss_pred HhHCcCHHHHHcCcCcCC
Confidence 999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-61 Score=449.52 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=206.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-----CCTTBCCEEEEEEETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-----CCCCEeeEeeeeccCcee
Confidence 367999999999999999999999999999999986432 2345678899999888 779999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
||||||+ ||+|.++|.... .+++.+++.++.||+.||+|||++|||||||||+|||+++
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~------------------ 138 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE------------------ 138 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT------------------
T ss_pred EEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC------------------
Confidence 9999999 889999997644 7999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.+||+|||+|+..... ....+||+.|||||++.+..+ +.++|||||||++|||++|++||...
T Consensus 139 ---------~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 139 ---------RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp ---------TCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred ---------CCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 445667777766543221 234589999999999998876 57899999999999999999999765
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
............... . ...+..+++++.+||.+|
T Consensus 210 ~~~~~~~~~~~~~~~----------------------~------------------------~~~~~~~s~~~~~li~~~ 243 (271)
T d1nvra_ 210 SDSCQEYSDWKEKKT----------------------Y------------------------LNPWKKIDSAPLALLHKI 243 (271)
T ss_dssp STTSHHHHHHHTTCT----------------------T------------------------STTGGGSCHHHHHHHHHH
T ss_pred ChHHHHHHHHhcCCC----------------------C------------------------CCccccCCHHHHHHHHHH
Confidence 443222111100000 0 001234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
|+.||++|||++|+|+||||++.-
T Consensus 244 L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 244 LVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp SCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-60 Score=448.26 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=213.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++++ +||||+++++++.+.+.+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-----CCCCEeeEeEEEEECCEEEE
Confidence 57999999999999999999999999999999987433 3456678899999988 77999999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ ||+|.+++.+. .+++.+++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 95 vmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~-------------------- 151 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-------------------- 151 (293)
T ss_dssp EEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--------------------
T ss_pred EEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC--------------------
Confidence 99999 89999988764 5999999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
++.+||+|||++...... ....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+.
T Consensus 152 -------~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 224 (293)
T d1yhwa1 152 -------DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (293)
T ss_dssp -------TCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -------CCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH
Confidence 456777777777654322 2345799999999999999999999999999999999999999998777665
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+.....+. . ..+..++.++++||.+||+.||
T Consensus 225 ~~~~~~~~~~~----------------------~------------------------~~~~~~s~~~~~li~~~L~~dP 258 (293)
T d1yhwa1 225 LYLIATNGTPE----------------------L------------------------QNPEKLSAIFRDFLNRCLDMDV 258 (293)
T ss_dssp HHHHHHHCSCC----------------------C------------------------SSGGGSCHHHHHHHHHHTCSST
T ss_pred HHHHHhCCCCC----------------------C------------------------CCcccCCHHHHHHHHHHccCCh
Confidence 54433221110 0 0123567889999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
++|||++|+|+||||+..
T Consensus 259 ~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 259 EKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp TTSCCHHHHTTCGGGGGC
T ss_pred hHCcCHHHHhcCHhhCCC
Confidence 999999999999999743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-60 Score=452.24 Aligned_cols=262 Identities=25% Similarity=0.454 Sum_probs=207.5
Q ss_pred CceecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 92 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 92 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.+.+.+.|++.+.||+|+||+||+|+++.+++.||||++.... .....+.+|+.+++.+ +||||+++++++.+
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-----KHPNIVALDDIYES 78 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-----CCTTBCCEEEEEEC
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEE
Confidence 3456778999999999999999999999999999999997432 2334566899999888 67999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
++.+||||||| ||+|.++|...+ .+++.++..++.||+.||+|||++|||||||||+|||+...
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~------------- 143 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL------------- 143 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-------------
T ss_pred CCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc-------------
Confidence 99999999999 899999998754 79999999999999999999999999999999999999531
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
+.++.+||+|||++....... ...+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 144 -----------~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 144 -----------DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp -----------STTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----------CCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 345678888888887554332 3468999999999999999999999999999999999999999987
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+...... .+. ..+..+++++.+||.+|
T Consensus 213 ~~~~~~~~i~~~~~~-----------------------~~~----------------------~~~~~~s~~~~~li~~~ 247 (307)
T d1a06a_ 213 NDAKLFEQILKAEYE-----------------------FDS----------------------PYWDDISDSAKDFIRHL 247 (307)
T ss_dssp SHHHHHHHHHTTCCC-----------------------CCT----------------------TTTTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCC-----------------------CCC----------------------ccccCCCHHHHHHHHHH
Confidence 776655543321111 110 12246788999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|++||++|||++|+|+||||++.
T Consensus 248 L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 248 MEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999854
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=443.18 Aligned_cols=262 Identities=25% Similarity=0.461 Sum_probs=222.7
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.+.++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++++ +||||++++++
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~ 81 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-----QHPNVITLHEV 81 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-----CCCCCCcEEEE
Confidence 35678999999999999999999999999999999986321 2356788999999998 67999999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
+.+.+.+||||||| ||+|.++|...+ .+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~--------- 150 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN--------- 150 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS---------
T ss_pred EEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC---------
Confidence 99999999999999 899999998765 799999999999999999999999999999999999997654
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
.....+||+|||++....... ....||+.|+|||++.+..|+.++|||||||++|||++|..||
T Consensus 151 --------------~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 216 (293)
T d1jksa_ 151 --------------VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216 (293)
T ss_dssp --------------SSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred --------------CcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCC
Confidence 234468999999987654332 3468999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+..+.+..+.......+. ..+..++.++++||
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~li 251 (293)
T d1jksa_ 217 LGDTKQETLANVSAVNYEFED---------------------------------------------EYFSNTSALAKDFI 251 (293)
T ss_dssp CCSSHHHHHHHHHTTCCCCCH---------------------------------------------HHHTTSCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCc---------------------------------------------hhcCCCCHHHHHHH
Confidence 988877766554332222221 12245678999999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||+.||++|||++|+|+||||+...
T Consensus 252 ~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 252 RRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999998654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-59 Score=452.69 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=221.4
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
+.++|++++.||+|+||+||+|+++.+|+.||||++... ....+.+.+|+.+++++ .||||+++++++.+.+.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-----RHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-----CCTTBCCEEEEEEETTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEE
Confidence 456899999999999999999999999999999998643 33456678899999998 679999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
||||||| ||+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~------------------ 159 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT------------------ 159 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS------------------
T ss_pred EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc------------------
Confidence 9999999 899999996543 36999999999999999999999999999999999999953
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+.++.+||+|||++....... ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 160 -------~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 160 -------KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp -------TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 234678899999887655443 23689999999999999999999999999999999999999999888777
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+.......+. ..+..+++++++||.+||+.|
T Consensus 233 ~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~li~~~L~~d 267 (350)
T d1koaa2 233 TLRNVKSCDWNMDD---------------------------------------------SAFSGISEDGKDFIRKLLLAD 267 (350)
T ss_dssp HHHHHHHTCCCSCC---------------------------------------------GGGGGCCHHHHHHHHHHCCSS
T ss_pred HHHHHHhCCCCCCc---------------------------------------------ccccCCCHHHHHHHHHHccCC
Confidence 66655433222111 012346778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~ 430 (433)
|++|||++|+|+||||+...
T Consensus 268 P~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 268 PNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp GGGSCCHHHHHHSTTTSCTT
T ss_pred hhHCcCHHHHhcCcccCCCC
Confidence 99999999999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=442.61 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=211.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CSTTBCCEEEEEECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-----CCCCeeEEEEEEEECCE
Confidence 57999999999999999999999999999999997432 2335678899999988 77999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||+++
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~----------------- 143 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE----------------- 143 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-----------------
T ss_pred EEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC-----------------
Confidence 99999999 899999998765 7999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 144 ----------~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 144 ----------DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp ----------TSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------CceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 445666666666543321 12357999999999999999999999999999999999999999987
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+.+..+.. +.+.+ +..+++++++||.+|
T Consensus 214 ~~~~~~~~i~~-----------------------~~~~~--------------------------p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 214 NEYLIFQKIIK-----------------------LEYDF--------------------------PEKFFPKARDLVEKL 244 (288)
T ss_dssp SHHHHHHHHHT-----------------------TCCCC--------------------------CTTCCHHHHHHHHTT
T ss_pred CHHHHHHHHHc-----------------------CCCCC--------------------------CccCCHHHHHHHHHH
Confidence 77665544321 11111 235678899999999
Q ss_pred cccCCCCCCCHHH------HhcCCCCCCCC
Q 013973 407 LRYDPTDRLTARE------ALRHPFFTRDH 430 (433)
Q Consensus 407 L~~dP~~R~ta~e------ll~hp~f~~~~ 430 (433)
|+.||++|||++| +++||||++-.
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 9999999999987 58999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=443.13 Aligned_cols=254 Identities=25% Similarity=0.462 Sum_probs=212.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
+.|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++++++ +||||+++++++.+.+.+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCeEEE
Confidence 4699999999999999999999999999999999643 34456778899999998 67999999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ ||+|.+++.+.. ..+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~--------------------- 144 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT--------------------- 144 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---------------------
T ss_pred EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---------------------
Confidence 99999 899999987643 4699999999999999999999999999999999999994
Q ss_pred ccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhh-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
.++.+||+|||++...... ....+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 145 ------~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 145 ------LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp ------TTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ------CCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 4456777777776543221 13458999999999995 456899999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+.+..+.....+. ...+..+++++++||.+|
T Consensus 219 ~~~~~~~~i~~~~~~~----------------------------------------------~~~~~~~s~~~~~li~~~ 252 (288)
T d2jfla1 219 NPMRVLLKIAKSEPPT----------------------------------------------LAQPSRWSSNFKDFLKKC 252 (288)
T ss_dssp CGGGHHHHHHHSCCCC----------------------------------------------CSSGGGSCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCC----------------------------------------------CCccccCCHHHHHHHHHH
Confidence 7666554433211000 001235677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|+.||++|||++|+|+||||+.+
T Consensus 253 L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 253 LEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp SCSSTTTSCCHHHHTTSGGGCCC
T ss_pred ccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-60 Score=453.75 Aligned_cols=289 Identities=22% Similarity=0.343 Sum_probs=210.5
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
..++|++++.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.+|+.+ +||||++++++|.+.++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-----CCTTBCCEEEEEECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCE
Confidence 357899999999999999999999999999999998743 34456778899999887 67999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
+||||||+ ||+|.+++.+.+ .+++..++.++.||+.||.|||+ +|||||||||+|||++
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----------------- 139 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----------------- 139 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC-----------------
T ss_pred EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC-----------------
Confidence 99999999 899999998765 79999999999999999999997 5999999999999994
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCC-CCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.++.+||+|||+|..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 140 ----------~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 140 ----------SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp ----------TTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ----------CCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 455677778887764332 234568999999999999999999999999999999999999999876544
Q ss_pred HHH-HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh-----hcCCchhHHHHHH
Q 013973 330 EHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ-----HVDHSAGDLTHLL 403 (433)
Q Consensus 330 ~~~-~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li 403 (433)
+.. ..+....+.... ....................+. ...... ....... .....+.++.|||
T Consensus 210 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--------~~~~~~~~~~~~~~~~~s~~~~dli 278 (322)
T d1s9ja_ 210 ELELMFGCQVEGDAAE-TPPRPRTPGRPLSSYGMDSRPP--MAIFEL--------LDYIVNEPPPKLPSGVFSLEFQDFV 278 (322)
T ss_dssp HHHHHC-------------------------------CC--CCHHHH--------HHHHHTSCCCCCCBTTBCHHHHHHH
T ss_pred HHHHHHHHHhcCCccc-CCcccccccccccccccccccc--hhHHHH--------HhhhhccCCccCccccCCHHHHHHH
Confidence 322 222222221111 0000000000000000000000 000000 0000000 0124678999999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
.+||++||++||||+|+|+||||++
T Consensus 279 ~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 279 NKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHcCCChhHCcCHHHHhhCHhhCc
Confidence 9999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-59 Score=445.97 Aligned_cols=250 Identities=24% Similarity=0.421 Sum_probs=213.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|+++.+|+.||||++++.. ...+.+..|+.+|+.+ +||||+++++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEeeeccccc
Confidence 57999999999999999999999999999999997432 2345677899998887 78999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~----------------- 140 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK----------------- 140 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-----------------
T ss_pred cccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecC-----------------
Confidence 99999999 999999998865 7999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 141 ----------~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 141 ----------DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp ----------TSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------CCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 456667777766543322 2346899999999999999999999999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.+..+... .+. ++..+++++++||.+||+
T Consensus 211 ~~~~~~i~~~-----------------------~~~--------------------------~p~~~s~~~~dli~~~L~ 241 (337)
T d1o6la_ 211 ERLFELILME-----------------------EIR--------------------------FPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp HHHHHHHHHC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhcC-----------------------CCC--------------------------CCccCCHHHHHHHHhhcc
Confidence 6655443221 111 233578899999999999
Q ss_pred cCCCCCC-----CHHHHhcCCCCCCC
Q 013973 409 YDPTDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~-----ta~ell~hp~f~~~ 429 (433)
+||.+|+ ++.|+++||||++.
T Consensus 242 ~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCchhhcccccccHHHHHcCcccccC
Confidence 9999999 49999999999764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.7e-59 Score=450.04 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=220.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+++++ .||||++++++|.+++.+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEE
Confidence 367999999999999999999999999999999987533 3445667899999887 6799999999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|||||| ||+|.+++...+ .++++.+++.++.||+.||+|||++|||||||||+|||++.
T Consensus 103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~------------------- 162 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET------------------- 162 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------
T ss_pred EEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-------------------
Confidence 999999 899999876543 46999999999999999999999999999999999999953
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
..++.+||+|||+|....... ...+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+.
T Consensus 163 ------~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 236 (352)
T d1koba_ 163 ------KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236 (352)
T ss_dssp ------TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ------cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 245678999999988765544 235899999999999999999999999999999999999999998888776
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+.......+ . ..+..+++++.+||.+||++||
T Consensus 237 ~~~i~~~~~~~~-----------------------~----------------------~~~~~~s~~~~~li~~~L~~dp 271 (352)
T d1koba_ 237 LQNVKRCDWEFD-----------------------E----------------------DAFSSVSPEAKDFIKNLLQKEP 271 (352)
T ss_dssp HHHHHHCCCCCC-----------------------S----------------------STTTTSCHHHHHHHHTTSCSSG
T ss_pred HHHHHhCCCCCC-----------------------c----------------------ccccCCCHHHHHHHHHHccCCh
Confidence 665543322221 1 1123567899999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013973 412 TDRLTAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~hp~f~~~ 429 (433)
.+|||++|+|+||||+..
T Consensus 272 ~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 272 RKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp GGSCCHHHHHTSTTTSSC
T ss_pred hHCcCHHHHhcCHhhCCC
Confidence 999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=432.62 Aligned_cols=250 Identities=24% Similarity=0.432 Sum_probs=205.3
Q ss_pred CcE-EEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 97 SRY-KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 97 ~~~-~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
++| ++.++||+|+||+||+|.++.+++.||+|++... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVK 82 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEESS
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEeeccc
Confidence 445 7888999999999999999999999999998643 23445677899999888 67999999999865
Q ss_pred -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeeccCccccCCCcC
Q 013973 170 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 -~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...+||||||+ +|+|.+++.+.. .+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~------------ 148 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT------------ 148 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES------------
T ss_pred cCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee------------
Confidence 45789999999 999999998765 7999999999999999999999999 99999999999994
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+.++.+||+|||+++...... ...+||+.|||||++.+ .|+.++|||||||++|||++|+.||.
T Consensus 149 --------------~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 149 --------------GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp --------------STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred --------------CCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 234568888888887544332 34689999999999876 69999999999999999999999998
Q ss_pred CCChHHHHH-HHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 325 THENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 325 ~~~~~~~~~-~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
+......+. .+.. +..| ...+...++++++||
T Consensus 214 ~~~~~~~~~~~i~~--~~~~---------------------------------------------~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 214 ECQNAAQIYRRVTS--GVKP---------------------------------------------ASFDKVAIPEVKEII 246 (270)
T ss_dssp TCSSHHHHHHHHTT--TCCC---------------------------------------------GGGGGCCCHHHHHHH
T ss_pred CcccHHHHHHHHHc--CCCC---------------------------------------------cccCccCCHHHHHHH
Confidence 765544322 1110 0000 011235677899999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFT 427 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~ 427 (433)
.+||+.||++|||++|+|+||||+
T Consensus 247 ~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=443.58 Aligned_cols=260 Identities=23% Similarity=0.401 Sum_probs=225.0
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.++|++++.||+|+||+||+|.++.+++.||||+++........+.+|+++|+.+ .|+||++++++|++.+++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-----RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-----CCTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEE
Confidence 356789999999999999999999999999999999987666666778999999988 679999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
||||||| ||+|.+++...+ ..+++.+++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~------------------ 137 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT------------------ 137 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS------------------
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC------------------
Confidence 9999999 889999997653 36999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
+....+||+|||++....... ...+||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+
T Consensus 138 -------~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 138 -------RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 234578999999887655433 33579999999999999999999999999999999999999999988877
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+......++.. .+..++.++++||.+||+.|
T Consensus 211 ~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~d 245 (321)
T d1tkia_ 211 IIENIMNAEYTFDEE---------------------------------------------AFKEISIEAMDFVDRLLVKE 245 (321)
T ss_dssp HHHHHHHTCCCCCHH---------------------------------------------HHTTSCHHHHHHHHTTSCSS
T ss_pred HHHHHHhCCCCCChh---------------------------------------------hccCCCHHHHHHHHHHccCC
Confidence 776655433333322 12356788999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~ 429 (433)
|++|||++|+|+||||++.
T Consensus 246 p~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 246 RKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp GGGSCCHHHHHHSHHHHSC
T ss_pred hhHCcCHHHHhcCHhhccC
Confidence 9999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-58 Score=440.89 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=216.5
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+..|+.+++.+ .||||+++++++.+.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-----cCcChhheeeeEeeCCe
Confidence 56999999999999999999999999999999997432 2345677899998887 67999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+|+||||+ ||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||+
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl------------------- 137 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL------------------- 137 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE-------------------
T ss_pred eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE-------------------
Confidence 99999999 899999988765 78999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+.++.+||+|||+|..........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus 138 --------~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 209 (316)
T d1fota_ 138 --------DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209 (316)
T ss_dssp --------CTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred --------cCCCCEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence 455667888888877666666667999999999999999999999999999999999999999998777666
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+... ... .+..+++++.++|.+||++||
T Consensus 210 ~~~i~~~-----------------------~~~--------------------------~p~~~s~~~~~li~~~L~~dp 240 (316)
T d1fota_ 210 YEKILNA-----------------------ELR--------------------------FPPFFNEDVKDLLSRLITRDL 240 (316)
T ss_dssp HHHHHHC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHTCSCT
T ss_pred HHHHHcC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHhhhCH
Confidence 5543321 111 123567789999999999999
Q ss_pred CCCC-----CHHHHhcCCCCCCC
Q 013973 412 TDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~-----ta~ell~hp~f~~~ 429 (433)
.+|+ |++|+|+||||++-
T Consensus 241 ~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 241 SQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp TTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HhccccchhhHHHHHcCcccccC
Confidence 9996 89999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=431.77 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=198.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RN 171 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~ 171 (433)
++|++++.||+|+||+||+|+++.+|+.||+|+++.. ....+.+.+|+.+++++ +||||+++++++.+ .+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-----KHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-----CCTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEeCCCC
Confidence 5799999999999999999999999999999998643 23345577888888777 78999999998854 56
Q ss_pred eEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeeccCccccCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlKp~NILl~~~~~~~i~df 243 (433)
.+||||||+ ||+|.+++.+. ....+++..++.++.||+.||+|||++| ||||||||+|||++
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---------- 148 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---------- 148 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----------
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC----------
Confidence 799999999 89999998642 2347999999999999999999999976 99999999999994
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 320 (433)
.++.+||+|||++....... ...+||+.|||||++.+..|+.++|||||||++|||++|+
T Consensus 149 -----------------~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 149 -----------------GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp -----------------TTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred -----------------CCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCC
Confidence 44567777777776543322 3458999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||.+.+..+....+... .+. ..+..+++++.
T Consensus 212 ~Pf~~~~~~~~~~~i~~~-----------------------~~~-------------------------~~~~~~s~~l~ 243 (269)
T d2java1 212 PPFTAFSQKELAGKIREG-----------------------KFR-------------------------RIPYRYSDELN 243 (269)
T ss_dssp CSCCCSSHHHHHHHHHHT-----------------------CCC-------------------------CCCTTSCHHHH
T ss_pred CCCCCCCHHHHHHHHHcC-----------------------CCC-------------------------CCCcccCHHHH
Confidence 999987766655443221 000 01235678999
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFF 426 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f 426 (433)
+||.+||+.||++|||++|+|+|||+
T Consensus 244 ~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 244 EIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-58 Score=443.74 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=216.9
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-----CCCcEeecccccccccc
Confidence 67999999999999999999999999999999986422 2335567899998887 78999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+++||||+ ||+|.+++...+ .+++..++.|+.||+.||.|||++|||||||||+|||+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl------------------- 174 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI------------------- 174 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-------------------
T ss_pred cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc-------------------
Confidence 99999999 999999998765 79999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~~ 331 (433)
+.++.+||+|||+++.........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+....
T Consensus 175 --------~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 246 (350)
T d1rdqe_ 175 --------DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp --------CTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred --------CCCCCEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence 445567888888887666555667899999999999999999999999999999999999999998777665
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
+..+...... .+..+++++.+||.+||++||
T Consensus 247 ~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~L~~dP 277 (350)
T d1rdqe_ 247 YEKIVSGKVR-------------------------------------------------FPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp HHHHHHCCCC-------------------------------------------------CCTTCCHHHHHHHHHHSCSCT
T ss_pred HHHHhcCCCC-------------------------------------------------CCccCCHHHHHHHHHHhhhCH
Confidence 5544321111 123567899999999999999
Q ss_pred CCCC-----CHHHHhcCCCCCCC
Q 013973 412 TDRL-----TAREALRHPFFTRD 429 (433)
Q Consensus 412 ~~R~-----ta~ell~hp~f~~~ 429 (433)
.+|+ |++|+++||||++.
T Consensus 278 ~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 278 TKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HhccccccccHHHHHcCccccCC
Confidence 9995 89999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-58 Score=437.35 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=206.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
..|++++.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+++++ .||||+++++++.+.+.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEECCE
Confidence 45999999999999999999999999999999986432 2335577899999888 67999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||| +|+|..++.... .+++..++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--------------- 152 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--------------- 152 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT---------------
T ss_pred EEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC---------------
Confidence 99999999 777766665543 799999999999999999999999999999999999996544
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
.+||+|||++...... ...+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+.
T Consensus 153 ------------~~Kl~DFG~a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 153 ------------LVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp ------------EEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ------------CEEEeecccccccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 4566666666543322 33579999999999974 4589999999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+.+..+.....+.+ ....+++++.+||.+||+
T Consensus 220 ~~~~~~i~~~~~~~~-----------------------------------------------~~~~~s~~~~~li~~~L~ 252 (309)
T d1u5ra_ 220 MSALYHIAQNESPAL-----------------------------------------------QSGHWSEYFRNFVDSCLQ 252 (309)
T ss_dssp HHHHHHHHHSCCCCC-----------------------------------------------SCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCC-----------------------------------------------CCCCCCHHHHHHHHHHCc
Confidence 665544332110000 012467789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013973 409 YDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~ell~hp~f~~~ 429 (433)
.||++|||++|+|+||||++.
T Consensus 253 ~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 253 KIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp SSGGGSCCHHHHTTCHHHHSC
T ss_pred CChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=431.97 Aligned_cols=282 Identities=32% Similarity=0.516 Sum_probs=226.3
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++++ +||||+++++++.+.+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEEeccccccccce
Confidence 57999999999999999999999999999999996432 2345678899999888 789999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|+||||+++++.+++.......+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~-------------------- 136 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN-------------------- 136 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------------------
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec--------------------
Confidence 999999988888888766667899999999999999999999999999999999999994
Q ss_pred cccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.++.+||+|||.+....... ...+||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+..
T Consensus 137 -------~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~ 209 (298)
T d1gz8a_ 137 -------TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209 (298)
T ss_dssp -------TTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -------ccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH
Confidence 45567777788776543322 3358999999999988766 578999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+....+..++..+..+...... ....+... ..........++.++.+||.+||++
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~---------------~~~~~~~~~~~s~~~~dll~~mL~~ 269 (298)
T d1gz8a_ 210 DQLFRIFRTLGTPDEVVWPGVTSMPDY-----KPSFPKWA---------------RQDFSKVVPPLDEDGRSLLSQMLHY 269 (298)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTC-----CTTSCCCC---------------CCCHHHHSTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHhcCCCchhhcccccccccc-----cccccccc---------------ccchhhhccCCCHHHHHHHHHHccC
Confidence 888888888887665433322111100 00011000 0011223346788999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~~~ 430 (433)
||++|||+.|+|+||||++..
T Consensus 270 dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 270 DPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp STTTSCCHHHHHTSGGGTTCC
T ss_pred ChhHCcCHHHHhCCHhhccCC
Confidence 999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-57 Score=424.80 Aligned_cols=255 Identities=29% Similarity=0.517 Sum_probs=212.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 165 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~ 165 (433)
.++|++.+.||+|+||+||+|+++.+++.||||+++.. +...+.+.+|+.+++++. .|+||+++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~~ 77 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS----GHPNIIQLKD 77 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc----CCCCeEEEEe
Confidence 46899999999999999999999999999999998642 123345778999999993 2688999999
Q ss_pred eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 166 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 166 ~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
++.+++++||||||+ ||+|.++|...+ .+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----------- 144 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----------- 144 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc-----------
Confidence 999999999999999 899999998765 799999999999999999999999999999999999994
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhC------CCCCCcchhHHHHHHHHHH
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVEL 316 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~el 316 (433)
.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++||||+||++|||
T Consensus 145 ----------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem 208 (277)
T d1phka_ 145 ----------------DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 208 (277)
T ss_dssp ----------------TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred ----------------CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence 4556777777777654432 233579999999999963 3478899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCch
Q 013973 317 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 396 (433)
Q Consensus 317 ltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (433)
++|+.||.+.+..+....+...- ..++. .....+|
T Consensus 209 l~g~~Pf~~~~~~~~~~~i~~~~-----------------------~~~~~----------------------~~~~~~s 243 (277)
T d1phka_ 209 LAGSPPFWHRKQMLMLRMIMSGN-----------------------YQFGS----------------------PEWDDYS 243 (277)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTC-----------------------CCCCT----------------------TTGGGSC
T ss_pred ccCCCCCCCCCHHHHHHHHHhCC-----------------------CCCCC----------------------cccccCC
Confidence 99999999887766555443211 11111 0123567
Q ss_pred hHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 397 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 397 ~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
+++++||.+||+.||++|||++|||+||||++
T Consensus 244 ~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 89999999999999999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-58 Score=435.78 Aligned_cols=276 Identities=26% Similarity=0.462 Sum_probs=214.2
Q ss_pred EEeeeeccccEEEEEEEECCCCeEEEEEEeecchh------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 101 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 101 ~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
.+++||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+++++ +|+||+++++++.+++++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----SHPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-----CCTTBCCEEEEECCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-----CCCCEeEEEeeeccCCcee
Confidence 46899999999999999999999999999864321 123567899999998 6799999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
|||||+.+++...+... ...+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 77 ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~-------------------- 135 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE-------------------- 135 (299)
T ss_dssp EEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--------------------
T ss_pred ehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC--------------------
Confidence 99999955555544433 247999999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 330 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~~ 330 (433)
++.+||+|||++....... ...+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.++.+
T Consensus 136 -------~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 208 (299)
T d1ua2a_ 136 -------NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208 (299)
T ss_dssp -------TCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH
Confidence 4566677777665443322 335799999999999754 58999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
++..+.+.+|..+.+.+............. ..+. ..........++++.+||.+||+.|
T Consensus 209 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------------------~~~~~~~~~~s~~~~dll~~~L~~d 267 (299)
T d1ua2a_ 209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFK---SFPG------------------IPLHHIFSAAGDDLLDLIQGLFLFN 267 (299)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCC---CCCC------------------CCHHHHCTTCCHHHHHHHHHHHCSS
T ss_pred HHHHHHHhcCCCChhhccchhccchhhhhc---cCCC------------------CChHHhcccCCHHHHHHHHHHccCC
Confidence 999999988877654322111000000000 0000 0011223466789999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 013973 411 PTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 411 P~~R~ta~ell~hp~f~~~~ 430 (433)
|++||||+|+|+||||++.+
T Consensus 268 P~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 268 PCARITATQALKMKYFSNRP 287 (299)
T ss_dssp TTTSCCHHHHHTSGGGTSSS
T ss_pred hhhCcCHHHHhCCHhhCCCC
Confidence 99999999999999999765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-57 Score=428.29 Aligned_cols=284 Identities=28% Similarity=0.476 Sum_probs=220.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCC-CeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee---
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--- 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~-~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--- 168 (433)
.++|+++++||+|+||+||+|++..+ ++.||||+++.. ........+|+.+++.+... +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~--~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF--EHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT--CCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc--CCCCcceeeeeecccc
Confidence 36799999999999999999999755 678999998632 22233466788888888542 5789999999884
Q ss_pred --cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 169 --YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 169 --~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
....++++|||+.+++..++.......+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~----------- 152 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS----------- 152 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-----------
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-----------
Confidence 3468999999996666665555555689999999999999999999999999999999999999554
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.
T Consensus 153 ----------------~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 153 ----------------GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp ----------------CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ----------------CCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 45666666655433222 234589999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+.+..+...++..+...+............. .........+...++++.+||.
T Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~s~~~~dli~ 274 (305)
T d1blxa_ 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS----------------------KSAQPIEKFVTDIDELGKDLLL 274 (305)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC----------------------CCCCCGGGTCCSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHhhCCCchhcccccccchhhhhcc----------------------ccccchhhccccCCHHHHHHHH
Confidence 999999999998888876654322111000000000 0001112344567889999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||++||++||||+|+|+||||++.+
T Consensus 275 ~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 275 KCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHCcCChhHCcCHHHHhcChhhcCch
Confidence 99999999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-57 Score=438.35 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=206.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........|...++.+.+ .+||||+++++++.+.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~--~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc--CCCCcEEEEEEEEEECCE
Confidence 57999999999999999999999999999999986422 122334455555555533 267999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||+ ||+|.++|.... .+++..++.|+.||+.||+|||++|||||||||+|||++
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~------------------ 141 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD------------------ 141 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc------------------
Confidence 99999999 899999998765 799999999999999999999999999999999999995
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC-CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.++.+||+|||+|+..... ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||.+.+..
T Consensus 142 ---------~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 142 ---------EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp ---------SSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred ---------CCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 4456777777777644333 344689999999999974 56999999999999999999999999875433
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+........ ..... ..++.+++++++||.+||++
T Consensus 213 ~~~~~~~~~--------------------~~~~~--------------------------~~~~~~s~~~~~li~~~L~~ 246 (364)
T d1omwa3 213 DKHEIDRMT--------------------LTMAV--------------------------ELPDSFSPELRSLLEGLLQR 246 (364)
T ss_dssp CHHHHHHHS--------------------SSCCC--------------------------CCCSSSCHHHHHHHHHHTCS
T ss_pred HHHHHHHhc--------------------ccCCC--------------------------CCCCCCCHHHHHHHHHHccc
Confidence 222111110 01111 12346788999999999999
Q ss_pred CCCCCCC-----HHHHhcCCCCCCC
Q 013973 410 DPTDRLT-----AREALRHPFFTRD 429 (433)
Q Consensus 410 dP~~R~t-----a~ell~hp~f~~~ 429 (433)
||++||| |+|+++||||++-
T Consensus 247 dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 247 DVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp STTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred CHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999 8999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=433.10 Aligned_cols=292 Identities=27% Similarity=0.490 Sum_probs=231.7
Q ss_pred CCceeecCce---ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCC
Q 013973 85 GHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGN 158 (433)
Q Consensus 85 ~~~~~~~~~~---~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~ 158 (433)
|.+...+++. +.++|+++++||+|+||+||+|.++.+|+.||||+++.. ....+.+.+|+.+|+.+ .|+
T Consensus 3 ~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hp 77 (346)
T d1cm8a_ 3 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----RHE 77 (346)
T ss_dssp SBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CBT
T ss_pred CcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-----CCC
Confidence 4444455543 678999999999999999999999999999999999742 33456678899999998 678
Q ss_pred ceEEecceeecCC------eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q 013973 159 RCVQIRNWFDYRN------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 232 (433)
Q Consensus 159 ~i~~~~~~~~~~~------~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl 232 (433)
||++++++|...+ ++|+||||++.+|..++... .+++..++.++.||+.||+|||++|||||||||+|||+
T Consensus 78 niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~ 154 (346)
T d1cm8a_ 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 154 (346)
T ss_dssp TBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CeeEEEEEeccCccccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc
Confidence 9999999987654 67999999988888887653 69999999999999999999999999999999999999
Q ss_pred eccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC-CCCCcchhHHHHH
Q 013973 233 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGC 311 (433)
Q Consensus 233 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv 311 (433)
+.++.+||+|||++..........+||+.|+|||++.+. .++.++|||||||
T Consensus 155 ---------------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 207 (346)
T d1cm8a_ 155 ---------------------------NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207 (346)
T ss_dssp ---------------------------CTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred ---------------------------ccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchH
Confidence 455667888888887666666667899999999999874 5689999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|+|++|++||.+.+..+.+..+....+..|.+++.............+...... ......
T Consensus 208 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~ 269 (346)
T d1cm8a_ 208 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK------------------KDFASI 269 (346)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCC------------------CCGGGT
T ss_pred HHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccc------------------cchHHh
Confidence 99999999999999999999999999999999887765433322211111110000 001112
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
....++++.+||.+||+.||++||||+|+|+||||++.
T Consensus 270 ~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 270 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 34567899999999999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-57 Score=431.58 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=209.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++++.||+|+||+||+|+++.+++.||||++++. ....+....|..++.+. .+||||+++++++.+.+.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~----~~hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHMFCTFQTKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH----TTCTTBCCEEEEEECSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh----CCCCcEEEEEEEEccCCc
Confidence 5699999999999999999999999999999999743 22234456666665532 277999999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
+||||||+ +|+|.+++.... .+++.+++.++.||+.||+|||++|||||||||+|||+++
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~----------------- 138 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK----------------- 138 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-----------------
T ss_pred eeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC-----------------
Confidence 99999999 899999998765 7999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~ 328 (433)
++.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 139 ----------~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 139 ----------DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp ----------TSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------CCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 455666666666533222 2335799999999999999999999999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 408 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 408 (433)
.+....+... ... .+..+++++++||.+||+
T Consensus 209 ~~~~~~i~~~-----------------------~~~--------------------------~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 209 EELFHSIRMD-----------------------NPF--------------------------YPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp HHHHHHHHHC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHSC
T ss_pred HHHHHHHHcC-----------------------CCC--------------------------CCccCCHHHHHHHHHhcc
Confidence 6665544221 111 123567899999999999
Q ss_pred cCCCCCCCHH-HHhcCCCCCCC
Q 013973 409 YDPTDRLTAR-EALRHPFFTRD 429 (433)
Q Consensus 409 ~dP~~R~ta~-ell~hp~f~~~ 429 (433)
+||++|||+. |+++||||++-
T Consensus 240 ~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGTTC
T ss_pred cCCCCCcCHHHHHHhCchhccC
Confidence 9999999995 89999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=437.91 Aligned_cols=262 Identities=27% Similarity=0.484 Sum_probs=210.6
Q ss_pred ecCcEEEEe-eeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 013973 95 LTSRYKIHS-KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 169 (433)
Q Consensus 95 ~~~~~~~~~-~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---- 169 (433)
+.++|+++. .||+|+||+||+|+++.+++.||||+++.. ....+|+.++.++. +||||++++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~----~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhc----CCCCCCeEEEEEeecccC
Confidence 456899885 599999999999999999999999999753 34566888876652 57899999999875
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
..++||||||| ||+|.++|...+...|++.+++.|+.||+.||+|||++|||||||||+|||++..
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~------------- 147 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK------------- 147 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS-------------
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc-------------
Confidence 57899999999 8999999987766689999999999999999999999999999999999999642
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
+..+.+||+|||+++...... ...+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.
T Consensus 148 -----------~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 148 -----------RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp -----------STTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred -----------cccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 234678999999887554333 4468999999999999999999999999999999999999999875
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+....+. ..+..+...+|.. .+..+++++.+||.+|
T Consensus 217 ~~~~~~~~~~-------------------~~i~~~~~~~~~~----------------------~~~~~s~~~~~li~~~ 255 (335)
T d2ozaa1 217 HGLAISPGMK-------------------TRIRMGQYEFPNP----------------------EWSEVSEEVKMLIRNL 255 (335)
T ss_dssp TCC---------------------------CCCSCSSSCCTT----------------------HHHHSCHHHHHHHHHH
T ss_pred CHHHHHHHHH-------------------HHHhcCCCCCCCc----------------------ccccCCHHHHHHHHHH
Confidence 5433222111 1122222222220 1124677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|++||++|||+.|+|+||||++.
T Consensus 256 L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 256 LKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ccCChhHCcCHHHHHcCHHhhCC
Confidence 99999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-57 Score=421.43 Aligned_cols=249 Identities=26% Similarity=0.459 Sum_probs=205.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... .....+..|+.+++++.+ .|+||+++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~---~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRLLDWFE 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCEEEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc---CCCCccEEEEEEe
Confidence 468999999999999999999999999999999986422 112335679999999843 4789999999999
Q ss_pred cCCeEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCC
Q 013973 169 YRNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 246 (433)
Q Consensus 169 ~~~~~~lV~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~ 246 (433)
+.+.+|+||||+ + +++.+++.... .+++.+++.++.||+.||+|||++|||||||||+|||++.
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~------------ 145 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL------------ 145 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET------------
T ss_pred eCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec------------
Confidence 999999999998 4 58888887764 7999999999999999999999999999999999999963
Q ss_pred CCCCCCCcccccCCCCCCEEEEecCCccccCCCC-CceeecCcccchhhhhCCCC-CCcchhHHHHHHHHHHHhCCCCCC
Q 013973 247 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
..+.+||+|||++....... ...+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.
T Consensus 146 --------------~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 146 --------------NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp --------------TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred --------------CCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 23467777777776543332 44689999999999988765 577999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
..+. . ..+... .+..+|+++++||.
T Consensus 212 ~~~~--i---------------------------~~~~~~--------------------------~~~~~s~~~~~li~ 236 (273)
T d1xwsa_ 212 HDEE--I---------------------------IRGQVF--------------------------FRQRVSSECQHLIR 236 (273)
T ss_dssp SHHH--H---------------------------HHCCCC--------------------------CSSCCCHHHHHHHH
T ss_pred CchH--H---------------------------hhcccC--------------------------CCCCCCHHHHHHHH
Confidence 5211 0 011111 12356789999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
+||+.||++|||++|+|+||||++..
T Consensus 237 ~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 237 WCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999999999999999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-55 Score=416.40 Aligned_cols=278 Identities=28% Similarity=0.439 Sum_probs=218.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|+++++||+|+||+||+|+++ +|+.||||+++.. ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEeeeeecccCCce
Confidence 57999999999999999999986 7789999999643 22346778899999888 679999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 174 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 174 ~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
|+|||++++++...+.... ..+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 76 ~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~-------------------- 134 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-------------------- 134 (286)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------------------
T ss_pred eEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc--------------------
Confidence 9999999666665555433 4799999999999999999999999999999999999994
Q ss_pred cccccCCCCCCEEEEecCCccccCCC---CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 329 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~~~~ 329 (433)
.++.+||+|||.+...... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..
T Consensus 135 -------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 135 -------REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp -------TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -------CCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence 4556777777777654332 2334789999999999865 4689999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+++..+....+..+...+............. ... . ...........++++.|||.+||++
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~--~-------------~~~~~~~~~~~s~~~~dli~~~L~~ 267 (286)
T d1ob3a_ 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNF-----TVY--E-------------PLPWESFLKGLDESGIDLLSKMLKL 267 (286)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC-----CCC--C-------------CCCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHhhCCCChhhccchhhhhhccccc-----ccc--c-------------CcchhhhcccCCHHHHHHHHHHccC
Confidence 9888888888887655433322211110000 000 0 0001223456788999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q 013973 410 DPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 410 dP~~R~ta~ell~hp~f~~ 428 (433)
||++||||.|+|+||||++
T Consensus 268 dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 268 DPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTTSCCHHHHHTSGGGGC
T ss_pred ChhHCcCHHHHhcCcccCc
Confidence 9999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=421.52 Aligned_cols=300 Identities=26% Similarity=0.430 Sum_probs=227.9
Q ss_pred CceeecCce---ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCc
Q 013973 86 HYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNR 159 (433)
Q Consensus 86 ~~~~~~~~~---~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~ 159 (433)
.|++..++. +.++|+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+++++ +|+|
T Consensus 3 ~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpn 77 (355)
T d2b1pa1 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKN 77 (355)
T ss_dssp EEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-----CCTT
T ss_pred CEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-----CCCC
Confidence 467778884 458999999999999999999999999999999999743 33445677899999888 6789
Q ss_pred eEEecceee------cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEee
Q 013973 160 CVQIRNWFD------YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 233 (433)
Q Consensus 160 i~~~~~~~~------~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~ 233 (433)
|++++++|. ...++|+||||+.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 Iv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp BCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred eeEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence 999999985 347899999999777777664 3699999999999999999999999999999999999995
Q ss_pred ccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCCCCCCcchhHHHHH
Q 013973 234 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311 (433)
Q Consensus 234 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 311 (433)
.+ +.+|++|||.++..... ....+||+.|+|||++.+..++.++||||+||
T Consensus 154 ~~---------------------------~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~ 206 (355)
T d2b1pa1 154 SD---------------------------CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206 (355)
T ss_dssp TT---------------------------CCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred cc---------------------------cceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccc
Confidence 54 45566666655433322 23457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 312 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 312 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|+|++|++||.+.+.......+....+..+.+.+.........+........ .......... .........
T Consensus 207 ~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~ 279 (355)
T d2b1pa1 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA---GLTFPKLFPD----SLFPADSEH 279 (355)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCC---CCCHHHHSCG----GGSCCSSHH
T ss_pred hHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccc---cccccccccc----ccccccccc
Confidence 999999999999999999999999999988888887776666555544322110 0000000000 000000111
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~ 428 (433)
....++++.+||++||+.||++||||+|||+||||+.
T Consensus 280 ~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 2235778999999999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=422.19 Aligned_cols=277 Identities=28% Similarity=0.504 Sum_probs=220.2
Q ss_pred cEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec------CC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------RN 171 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~------~~ 171 (433)
+|+.+++||+|+||+||+|+++.+|+.||||+++.... ...+|+.+++++ +|+||++++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l-----~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-----DHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHC-----CCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhc-----CCCCCCcEEEEEEecCccCCce
Confidence 59999999999999999999999999999999975432 234689999988 67899999998843 44
Q ss_pred eEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 172 HICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 172 ~~~lV~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
++||||||+++++.+.+.. .....+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~-------------- 158 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD-------------- 158 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT--------------
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC--------------
Confidence 6899999997766655532 233579999999999999999999999999999999999999532
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~~~ 326 (433)
...+||+|||++...... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...
T Consensus 159 ------------~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 159 ------------TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp ------------TCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred ------------CCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 236788888887654332 234589999999999876 46899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 327 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
+..+++..+.+.+|..+.+.+........... .+.... ...........++++.+||.+|
T Consensus 227 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~--------------~~~~~~~~~~~s~~~~dLl~~m 286 (350)
T d1q5ka_ 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFK------FPQIKA--------------HPWTKVFRPRTPPEAIALCSRL 286 (350)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCC---CCC------CCCCCC--------------CCGGGTSCTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhCCChHHhhhhhccchhhcc------cccccc--------------CchhhhcccCCCHHHHHHHHHH
Confidence 99999999999999998887665433221111 111000 0000112235678999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~ 428 (433)
|++||++||||.|+|+||||++
T Consensus 287 L~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 287 LEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp SCSSGGGSCCHHHHHTSGGGGG
T ss_pred ccCChhHCcCHHHHhcCHhhcc
Confidence 9999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-55 Score=411.44 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=207.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++.+.||+|+||+||+|+++.+++.||||+++......+.+.+|+.+++++ .||||+++++++.+.+.++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-----CCCCEecCCccEeeCCeeEE
Confidence 4679999999999999999999999999999999986666677889999999998 67999999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~------------------ 152 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH------------------ 152 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------------------
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC------------------
Confidence 99999 89999999887667899999999999999999999999999999999999996555
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC-CCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ-THENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~-~~~~~ 329 (433)
.+||+|||+++...... ....||+.|+|||++.+..|+.++|||||||++|||++|..||. +.+..
T Consensus 153 ---------~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~ 223 (287)
T d1opja_ 153 ---------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223 (287)
T ss_dssp ---------CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ---------cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence 45555555555433222 12368999999999999999999999999999999999766554 44433
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.. +. ....++.+++++.+||.+||+.
T Consensus 224 ~~~~~i~~-----------------------~~-------------------------~~~~~~~~~~~l~~li~~cl~~ 255 (287)
T d1opja_ 224 QVYELLEK-----------------------DY-------------------------RMERPEGCPEKVYELMRACWQW 255 (287)
T ss_dssp HHHHHHHT-----------------------TC-------------------------CCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHhc-----------------------CC-------------------------CCCCCccchHHHHHHHHHHcCC
Confidence 33222111 00 0012346678999999999999
Q ss_pred CCCCCCCHHHHhc--CCCCCC
Q 013973 410 DPTDRLTAREALR--HPFFTR 428 (433)
Q Consensus 410 dP~~R~ta~ell~--hp~f~~ 428 (433)
||++|||++|+++ ..++++
T Consensus 256 dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 256 NPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp SGGGSCCHHHHHHHHHHTTSS
T ss_pred CHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999976 244444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=413.48 Aligned_cols=292 Identities=25% Similarity=0.436 Sum_probs=212.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--- 169 (433)
.++|+++++||+|+||+||+|+++.+|+.||||++... ......+.+|+.+|+++ .|+|++.+++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-----CCTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-----cCCCccceEeeeecccc
Confidence 37899999999999999999999999999999998532 23345678899999998 66889999888754
Q ss_pred -----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 170 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 170 -----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+++|+||||+++.+....... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+|++|||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred cccccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 4578999999966666554433 3579999999999999999999999999999999999999655554444444
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
++........ .........+||+.|+|||++.+. .|+.++|||||||++|||++|++||
T Consensus 163 ~~~~~~~~~~--------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 163 LARAFSLAKN--------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp TCEECCC-------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeeecccccc--------------------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 4432211000 000111234799999999999865 6899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.++.+....+....+..+.+............ .+...... .......... ...++++.|||
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-----------~~~~~~~~~~--~~~~~~~~dLl 285 (318)
T d3blha1 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYE----KLELVKGQ-----------KRKVKDRLKA--YVRDPYALDLI 285 (318)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-----------CCSSC-----------CBCHHHHHHH--HHCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCChhhccccchhhhhh----hhcccccc-----------cccchhhhcc--ccCCHHHHHHH
Confidence 9999999999999999887765432221111000 00000000 0000000000 12356889999
Q ss_pred HhccccCCCCCCCHHHHhcCCCCCCCC
Q 013973 404 QGLLRYDPTDRLTAREALRHPFFTRDH 430 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~hp~f~~~~ 430 (433)
.+||++||++||||+|+|+||||+.++
T Consensus 286 ~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 286 DKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred HHHCcCChhHCcCHHHHHcChhhccCC
Confidence 999999999999999999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=401.10 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=196.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|++++.||+|+||+||+|.++ +++.||||+++......+.+.+|+.+++++ +||||+++++++...+.+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-----CCCCcccccceeccCCceEEE
Confidence 57999999999999999999986 467799999986666667889999999998 679999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.
T Consensus 79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~------------------ 139 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV------------------ 139 (263)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC------------------
T ss_pred EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC------------------
Confidence 9999 999999987654 46899999999999999999999999999999999999966554
Q ss_pred cccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
+||+|||+++...... ....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+
T Consensus 140 ---------~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~ 210 (263)
T d1sm2a_ 140 ---------IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210 (263)
T ss_dssp ---------EEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred ---------eEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence 5555555554332211 22468999999999999999999999999999999999 567777666555
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
.+..+..... .. .+..+++++.+||.+||+.|
T Consensus 211 ~~~~i~~~~~----------------------~~--------------------------~p~~~~~~l~~li~~cl~~~ 242 (263)
T d1sm2a_ 211 VVEDISTGFR----------------------LY--------------------------KPRLASTHVYQIMNHCWKER 242 (263)
T ss_dssp HHHHHHHTCC----------------------CC--------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHhcCC----------------------CC--------------------------CccccCHHHHHHHHHHccCC
Confidence 5443322110 00 12355778999999999999
Q ss_pred CCCCCCHHHHhcC
Q 013973 411 PTDRLTAREALRH 423 (433)
Q Consensus 411 P~~R~ta~ell~h 423 (433)
|++|||++|+++|
T Consensus 243 p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 243 PEDRPAFSRLLRQ 255 (263)
T ss_dssp GGGSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-55 Score=407.96 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=203.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++.+.||+|+||.||+|.++ +++.||||+++......+.+.+|+.++.++ .|+||+++++++.+ +.++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-----QHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-----CCCCEeEEEeeecc-CCeEE
Confidence 468999999999999999999986 567899999986666667789999999998 67899999998754 56799
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +|+|.+++.......+++..+..++.||+.||.|||+++||||||||+|||+++
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~-------------------- 144 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD-------------------- 144 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--------------------
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec--------------------
Confidence 99999 999999876554446999999999999999999999999999999999999954
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~Pf~~~~~~ 329 (433)
++.+||+|||+|+...... ....||+.|||||++.+..|+.++|||||||++|||+|| .+||...+..
T Consensus 145 -------~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~ 217 (272)
T d1qpca_ 145 -------TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (272)
T ss_dssp -------TSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred -------ccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence 4556666666665443222 234789999999999999999999999999999999995 5566665555
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.... .. ..++.++.++.+||.+||+.
T Consensus 218 ~~~~~i~~~~----------------------~~--------------------------~~p~~~~~~l~~li~~cl~~ 249 (272)
T d1qpca_ 218 EVIQNLERGY----------------------RM--------------------------VRPDNCPEELYQLMRLCWKE 249 (272)
T ss_dssp HHHHHHHTTC----------------------CC--------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHhcC----------------------CC--------------------------CCcccChHHHHHHHHHHcCC
Confidence 4443322110 00 11235677899999999999
Q ss_pred CCCCCCCHHHHhc--CCCCCC
Q 013973 410 DPTDRLTAREALR--HPFFTR 428 (433)
Q Consensus 410 dP~~R~ta~ell~--hp~f~~ 428 (433)
||++|||++||++ |+||+.
T Consensus 250 ~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 250 RPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999998 788864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=411.72 Aligned_cols=282 Identities=29% Similarity=0.513 Sum_probs=215.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 170 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 170 (433)
+.++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+++ .|++|+++++.+...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-----RHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-----CCTTBCCCCEEECCSST
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-----CCCCCCcEEEEEeeccc
Confidence 346799999999999999999999999999999999743 33456678899999998 678899999888654
Q ss_pred ---CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 171 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 171 ---~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
.++|++|++++++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~----------- 146 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC----------- 146 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-----------
T ss_pred cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-----------
Confidence 357777777799999999764 599999999999999999999999999999999999996554
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCC------CCceeecCcccchhhhhC-CCCCCcchhHHHHHHHHHHHhCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGE 320 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~ 320 (433)
.+||+|||++...... ....+||+.|+|||++.. ..|+.++||||+||++|+|++|+
T Consensus 147 ----------------~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~ 210 (345)
T d1pmea_ 147 ----------------DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210 (345)
T ss_dssp ----------------CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred ----------------CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence 4555555555432211 233579999999999854 56789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||.+.+..+....+...++.++............. ......+... ...........++++.
T Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---------------~~~~~~~~~~~s~~~~ 272 (345)
T d1pmea_ 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR---NYLLSLPHKN---------------KVPWNRLFPNADSKAL 272 (345)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH---HHHHTSCCCC---------------CCCHHHHCTTSCHHHH
T ss_pred CCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh---cccccCCccC---------------CCCHHHhCCCCCHHHH
Confidence 999999888888888888877766543221100000 0000000000 0001122346778999
Q ss_pred HHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+||.+||++||++||||.|+|+||||++.
T Consensus 273 ~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 273 DLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999843
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-54 Score=405.72 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=197.6
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.+.++|++.+.||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-----~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTGEA 78 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-----CCCCCCcccceeee
Confidence 4668899999999999999999999999999999999643 23345677899998877 78999999999876
Q ss_pred CC----eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCc
Q 013973 170 RN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 244 (433)
Q Consensus 170 ~~----~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg 244 (433)
.+ .+||||||+ |++|.+++...+ .+++.+++.++.||+.||+|||++|||||||||+|||++.++..+++|||
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred ccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhh
Confidence 43 489999999 899999998765 79999999999999999999999999999999999999766555555554
Q ss_pred CCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 245 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.+....... .........+||+.|||||++.+..|+.++|||||||++|||+||.+||.
T Consensus 157 ~~~~~~~~~---------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 157 IARAIADSG---------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp TCEECC-------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhhhcccc---------------------ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence 332111100 00011233589999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+.+..+.......+ ....+.+|+++.+||.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~s~~l~~li~ 250 (277)
T d1o6ya_ 216 GDSPVSVAYQHVREDPIPP---------------------------------------------SARHEGLSADLDAVVL 250 (277)
T ss_dssp CSSHHHHHHHHHHCCCCCG---------------------------------------------GGTSSSCCHHHHHHHH
T ss_pred CcCHHHHHHHHHhcCCCCC---------------------------------------------chhccCCCHHHHHHHH
Confidence 8877665544332111100 0123467889999999
Q ss_pred hccccCCCCCC-CHHHHhcCCCC
Q 013973 405 GLLRYDPTDRL-TAREALRHPFF 426 (433)
Q Consensus 405 ~~L~~dP~~R~-ta~ell~hp~f 426 (433)
+||++||.+|| |++++ .|+|.
T Consensus 251 ~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 251 KALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp HHTCSSGGGSCSSHHHH-HHHHH
T ss_pred HHccCCHhHCHhHHHHH-HHHHH
Confidence 99999999999 55554 45553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-54 Score=415.85 Aligned_cols=282 Identities=26% Similarity=0.462 Sum_probs=222.3
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-- 169 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-- 169 (433)
+.++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+.+ .|+|++++++++..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPAR 90 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeecc
Confidence 367899999999999999999999999999999999643 23445677899999998 67889999998853
Q ss_pred ----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcC
Q 013973 170 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 245 (433)
Q Consensus 170 ----~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~ 245 (433)
...+++++++.||+|.+++... ++++.+++.++.||+.||+|||++|||||||||+|||++
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~------------ 155 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN------------ 155 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC------------
T ss_pred ccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc------------
Confidence 3345665555599999998653 699999999999999999999999999999999999994
Q ss_pred CCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 246 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
.++.+|++|||.+...........||+.|+|||++.+.. ++.++|||||||++|+|++|++||.
T Consensus 156 ---------------~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 156 ---------------EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp ---------------TTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ---------------ccccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 455677777777766555555668999999999987765 6899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+.......+....+..+.++...................+.. .........+++++|||.
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~s~~~~dli~ 282 (348)
T d2gfsa1 221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM------------------NFANVFIGANPLAVDLLE 282 (348)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCC------------------CHHHHSTTCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCc------------------chhhhcCCCCHHHHHHHH
Confidence 99999999999999888887765543222221111111111110 001123467889999999
Q ss_pred hccccCCCCCCCHHHHhcCCCCCCC
Q 013973 405 GLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
+||+.||++||||+|+|+||||++-
T Consensus 283 ~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 283 KMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHCcCChhhCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=402.03 Aligned_cols=278 Identities=28% Similarity=0.452 Sum_probs=218.0
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
++|+++++||+|+||+||+|+++.+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++.+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-----CcCCEEeeccccccccce
Confidence 5799999999999999999999999999999998643 23456778899999887 678999999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++|||++ +++|..++... +.+++..++.++.|++.||+|||++|||||||||+|||++
T Consensus 77 ~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~------------------- 135 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN------------------- 135 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-------------------
T ss_pred eEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc-------------------
Confidence 9999999 66777766654 4799999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCC---CceeecCcccchhhhhCCC-CCCcchhHHHHHHHHHHHhCCCCC-CCCC
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF-QTHE 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf-~~~~ 327 (433)
.++.+||+|||.+....... ....+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+
T Consensus 136 --------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 207 (292)
T d1unla_ 136 --------RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp --------TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred --------cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC
Confidence 44567777777776544322 2346788999999998765 689999999999999999999885 5566
Q ss_pred hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcc
Q 013973 328 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 407 (433)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 407 (433)
..+.+..+....+..+...+........ ........ ...........+++++.+||.+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----------------~~~~~~~~~~~~s~~~~dll~~mL 267 (292)
T d1unla_ 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPD----YKPYPMYP----------------ATTSLVNVVPKLNATGRDLLQNLL 267 (292)
T ss_dssp HHHHHHHHHHHHCCCCTTTCTTGGGSTT----CCCCCCCC----------------TTCCCTTTSTTCCHHHHHHHHHHS
T ss_pred HHHHHHHHHhhcCCCChhhhhhhhhccc----cccccccc----------------ccchhhhccccCCHHHHHHHHHHc
Confidence 6777787877777766543222111110 00000000 001111223466788999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCC
Q 013973 408 RYDPTDRLTAREALRHPFFTR 428 (433)
Q Consensus 408 ~~dP~~R~ta~ell~hp~f~~ 428 (433)
+.||.+||||+|+|+||||++
T Consensus 268 ~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 268 KCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CSSGGGSCCHHHHTTSGGGSS
T ss_pred cCChhHCcCHHHHhcChhhcC
Confidence 999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-53 Score=408.40 Aligned_cols=283 Identities=25% Similarity=0.496 Sum_probs=211.6
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHI 173 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~ 173 (433)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+.+. +|+||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~----~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR----GGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT----TSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhcc----CCCCCcEEEEEEEecCCCce
Confidence 367999999999999999999999999999999997433 456788999999984 36889999999874 4679
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||+ +++|..+. +.+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~----------------- 165 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE----------------- 165 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-----------------
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCC-----------------
Confidence 9999999 77876542 369999999999999999999999999999999999999643
Q ss_pred CcccccCCCCCCEEEEecCCccccCCC--CCceeecCcccchhhhhCC-CCCCcchhHHHHHHHHHHHhCCCCCCCC-Ch
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH-EN 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~~~-~~ 328 (433)
+..+||+|||++...... ....+||+.|+|||.+.+. .|+.++||||+||++|||++|..||... +.
T Consensus 166 ---------~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~ 236 (328)
T d3bqca1 166 ---------HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236 (328)
T ss_dssp ---------TTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred ---------CCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence 235777888877654433 2445799999999998875 4799999999999999999999999754 45
Q ss_pred HHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCC--CccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhc
Q 013973 329 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE--GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 406 (433)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 406 (433)
.++...+...+|......... .........+.. .......... .........+++++.|||.+|
T Consensus 237 ~~~~~~i~~~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~s~~~~dli~~m 302 (328)
T d3bqca1 237 YDQLVRIAKVLGTEDLYDYID------KYNIELDPRFNDILGRHSRKRWER--------FVHSENQHLVSPEALDFLDKL 302 (328)
T ss_dssp HHHHHHHHHHHCHHHHHHHHH------HTTCCCCGGGGGTCCCCCCCCGGG--------GCCTTTGGGCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCchhhhhhh------hcccccCcccchhcccccccchhh--------cccccccccCCHHHHHHHHHH
Confidence 556666666666422211110 000000000000 0000000000 000112234678999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013973 407 LRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 407 L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
|++||++||||+|+|+||||++-
T Consensus 303 L~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 303 LRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTTS
T ss_pred ccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=401.92 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=194.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
.++|++.+.||+|+||+||+|+.+ ..||||+++.. ....+.+.+|+.+++++ +||||+++++++. .+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYST-APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeEEEe-ccE
Confidence 467999999999999999999754 34999998632 34456778899999888 6799999998765 466
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 251 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~ 251 (433)
++|||||+ +|+|.++|.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~-------------- 142 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT-------------- 142 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--------------
T ss_pred EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--------------
Confidence 89999999 899999998654 46999999999999999999999999999999999999965554
Q ss_pred CCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCC---CCCCcchhHHHHHHHHHHHhCCCCC
Q 013973 252 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALF 323 (433)
Q Consensus 252 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf 323 (433)
+||+|||+++..... .....||+.|||||++.+. .|+.++|||||||++|||+||+.||
T Consensus 143 -------------~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 143 -------------VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp -------------EEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred -------------EEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 555555555432211 1235799999999999753 4899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+...............|. ....+..+++++.+||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~p~-------------------------------------------~~~~~~~~~~~l~~li 246 (276)
T d1uwha_ 210 SNINNRDQIIFMVGRGYLSPD-------------------------------------------LSKVRSNCPKAMKRLM 246 (276)
T ss_dssp TTCCCHHHHHHHHHHTSCCCC-------------------------------------------GGGSCTTCCHHHHHHH
T ss_pred CCCChHHHHHHHHhcCCCCCc-------------------------------------------chhccccchHHHHHHH
Confidence 887665544333221111110 0112345678999999
Q ss_pred HhccccCCCCCCCHHHHhcC
Q 013973 404 QGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~h 423 (433)
.+||+.||++|||+.|+++|
T Consensus 247 ~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 247 AECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=409.09 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=198.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC-----eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||+||+|++..++ ..||+|++... ......+..|+.++.++. +||||+++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG----SHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc----CCCcEeEEEEEEe
Confidence 367999999999999999999987654 36999998532 334456778999998873 5688999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNY---------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 226 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlK 226 (433)
+.+.+||||||| +|+|.++|..... ..+++..++.|+.||+.||+|||++||||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999 9999999976432 358999999999999999999999999999999
Q ss_pred CCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCC
Q 013973 227 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWT 301 (433)
Q Consensus 227 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~ 301 (433)
|+|||++.++. +||+|||+|+...... ....||+.|||||++.+..|+
T Consensus 192 p~Nill~~~~~---------------------------~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 244 (325)
T d1rjba_ 192 ARNVLVTHGKV---------------------------VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244 (325)
T ss_dssp GGGEEEETTTE---------------------------EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred hhccccccCCe---------------------------EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence 99999965554 5555555554332222 234689999999999999999
Q ss_pred CcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhcc
Q 013973 302 YPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 380 (433)
Q Consensus 302 ~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
.++|||||||++|||+| |..||.+.+..+.+..+...-. .+
T Consensus 245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~---------------------~~----------------- 286 (325)
T d1rjba_ 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF---------------------KM----------------- 286 (325)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTC---------------------CC-----------------
T ss_pred cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------------------CC-----------------
Confidence 99999999999999998 8999987665444433221100 01
Q ss_pred chhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 381 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
+.+..+++++++||.+||+.||++|||++||++|
T Consensus 287 ---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 287 ---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1223567889999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-53 Score=402.38 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=193.8
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCe---EEEEEEeec--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|++.+.||+|+||+||+|+++.+++ .||||.+.. .....+.+.+|+.+++++ .||||+++++++...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCCccEEEEEeeC
Confidence 3679999999999999999999987664 589998863 234456788999999888 679999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+|+||||| +|+|.+++.... ..+++.++..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~------------ 166 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV------------ 166 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC------------
T ss_pred CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc------------
Confidence 9999999999 899999988654 46999999999999999999999999999999999999965554
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC--------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 320 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~ 320 (433)
+||+|||+++...... ....||+.|||||++.+..|+.++|||||||++|||+| |.
T Consensus 167 ---------------~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~ 231 (299)
T d1jpaa_ 167 ---------------CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231 (299)
T ss_dssp ---------------EEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ---------------EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCC
Confidence 5555555544322211 11357999999999999999999999999999999998 89
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHH
Q 013973 321 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 400 (433)
Q Consensus 321 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (433)
.||.+.+..+....+.... ... .+..++.++.
T Consensus 232 ~Pf~~~~~~~~~~~i~~~~----------------------~~~--------------------------~~~~~~~~l~ 263 (299)
T d1jpaa_ 232 RPYWDMTNQDVINAIEQDY----------------------RLP--------------------------PPMDCPSALH 263 (299)
T ss_dssp CTTTTCCHHHHHHHHHTTC----------------------CCC--------------------------CCTTCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCC----------------------CCC--------------------------CCccchHHHH
Confidence 9999877766554432210 000 1235677899
Q ss_pred HHHHhccccCCCCCCCHHHHhcC
Q 013973 401 HLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 401 ~li~~~L~~dP~~R~ta~ell~h 423 (433)
+||.+||+.||++|||+.||+++
T Consensus 264 ~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999988764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=394.59 Aligned_cols=245 Identities=21% Similarity=0.332 Sum_probs=204.8
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 176 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV 176 (433)
++|+++++||+|+||+||+|+++ +++.||||+++......+.+.+|+.+++++ +||||+++++++.+.+.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-----~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-----SHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-----CCCceeeEEEEEeeCCceEEE
Confidence 56899999999999999999985 778899999987666677889999999988 679999999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCcc
Q 013973 177 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 255 (433)
Q Consensus 177 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~ 255 (433)
|||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~------------------- 137 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG------------------- 137 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-------------------
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-------------------
Confidence 9999 899999976553 3689999999999999999999999999999999999995544
Q ss_pred cccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 013973 256 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 330 (433)
Q Consensus 256 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~ 330 (433)
.+||+|||++....... ....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+
T Consensus 138 --------~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 138 --------VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp --------CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred --------cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 55566666554332221 12468999999999999999999999999999999998 899999888776
Q ss_pred HHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccC
Q 013973 331 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 410 (433)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 410 (433)
....+..... . ..+...++++.+||.+||+.|
T Consensus 210 ~~~~i~~~~~----------------------~--------------------------~~p~~~~~~l~~li~~cl~~d 241 (258)
T d1k2pa_ 210 TAEHIAQGLR----------------------L--------------------------YRPHLASEKVYTIMYSCWHEK 241 (258)
T ss_dssp HHHHHHTTCC----------------------C--------------------------CCCTTCCHHHHHHHHHTTCSS
T ss_pred HHHHHHhCCC----------------------C--------------------------CCcccccHHHHHHHHHHccCC
Confidence 5554332110 0 012355678999999999999
Q ss_pred CCCCCCHHHHhcC
Q 013973 411 PTDRLTAREALRH 423 (433)
Q Consensus 411 P~~R~ta~ell~h 423 (433)
|++|||+.|+++|
T Consensus 242 P~~RPt~~eil~~ 254 (258)
T d1k2pa_ 242 ADERPTFKILLSN 254 (258)
T ss_dssp GGGSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=398.39 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=199.8
Q ss_pred CcEEEEee-eeccccEEEEEEEECC--CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 013973 97 SRYKIHSK-MGEGTFGQVLECWDRE--RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 171 (433)
Q Consensus 97 ~~~~~~~~-iG~G~~g~V~~~~~~~--~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 171 (433)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ....+.+.+|+.+++++ +||||+++++++.+ +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQA-E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEES-S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-----CCCCEeeEeeeecc-C
Confidence 56888884 9999999999998764 4557999999642 34456788999999998 67999999999875 4
Q ss_pred eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCC
Q 013973 172 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 250 (433)
Q Consensus 172 ~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~ 250 (433)
.+||||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 689999999 899999986543 479999999999999999999999999999999999999776655555555543322
Q ss_pred CCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 013973 251 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~ 329 (433)
..... ........||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..
T Consensus 161 ~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 161 ADDSY---------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp TCSCE---------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred ccccc---------------------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 11100 001123468999999999999999999999999999999998 99999987766
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+....+.. |.. ...++.+++++.+||.+||+.
T Consensus 220 ~~~~~i~~-----------------------~~~-------------------------~~~p~~~~~~l~~li~~cl~~ 251 (285)
T d1u59a_ 220 EVMAFIEQ-----------------------GKR-------------------------MECPPECPPELYALMSDCWIY 251 (285)
T ss_dssp HHHHHHHT-----------------------TCC-------------------------CCCCTTCCHHHHHHHHHTTCS
T ss_pred HHHHHHHc-----------------------CCC-------------------------CCCCCcCCHHHHHHHHHHcCC
Confidence 65544321 110 012345678999999999999
Q ss_pred CCCCCCCHHHH---hcCCCC
Q 013973 410 DPTDRLTAREA---LRHPFF 426 (433)
Q Consensus 410 dP~~R~ta~el---l~hp~f 426 (433)
||++|||+.+| |+|+|+
T Consensus 252 ~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 252 KWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp SGGGSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHHH
Confidence 99999999877 667776
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=397.17 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=192.9
Q ss_pred eeeeccccEEEEEEEEC--CCCeEEEEEEeecc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 013973 103 SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 177 (433)
Q Consensus 103 ~~iG~G~~g~V~~~~~~--~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~ 177 (433)
++||+|+||+||+|.++ .+++.||||+++.. ....+.+.+|+.+++++ +||||++++++++.+ ..+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~g~~~~~-~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEAE-SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEESS-SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-----CCCCCceEEEEeccC-CEEEEE
Confidence 47999999999999864 45678999998632 23346688899999888 779999999998654 578999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCccc
Q 013973 178 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 256 (433)
Q Consensus 178 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~ 256 (433)
||+ +|+|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++.........
T Consensus 87 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~- 163 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY- 163 (277)
T ss_dssp ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-
T ss_pred EcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-
Confidence 999 899999998764 7999999999999999999999999999999999999977666555555554322111000
Q ss_pred ccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 013973 257 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 335 (433)
Q Consensus 257 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i 335 (433)
........||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..+....+
T Consensus 164 --------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 164 --------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp --------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred --------------------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 000122468999999999999999999999999999999998 89999987766554433
Q ss_pred HHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCC
Q 013973 336 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 415 (433)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 415 (433)
... . ... .+..++.++.+||.+||+.||++||
T Consensus 224 ~~~--~--------------------~~~--------------------------~p~~~~~~~~~li~~cl~~dp~~RP 255 (277)
T d1xbba_ 224 EKG--E--------------------RMG--------------------------CPAGCPREMYDLMNLCWTYDVENRP 255 (277)
T ss_dssp HTT--C--------------------CCC--------------------------CCTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred HcC--C--------------------CCC--------------------------CCcccCHHHHHHHHHHcCCCHhHCc
Confidence 210 0 011 1235678999999999999999999
Q ss_pred CHHHH---hcCCCC
Q 013973 416 TAREA---LRHPFF 426 (433)
Q Consensus 416 ta~el---l~hp~f 426 (433)
|++|| |+|+|+
T Consensus 256 s~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 256 GFAAVELRLRNYYY 269 (277)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhCHHh
Confidence 99998 566664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=394.36 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=201.3
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
.++|++.+.||+|+||.||+|+++.+ +.||||+++......+.+.+|+.+++++ +|+||+++++++.+ +.+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-----ccCCEeEEEEEEec-CCeEE
Confidence 36799999999999999999998766 5699999986666667889999999998 77899999999865 56789
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 176 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 176 V~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
||||+ +|+|..++.......+++.+++.++.||+.||+|||++|||||||||+||||+.++.
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~----------------- 151 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV----------------- 151 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-----------------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc-----------------
Confidence 99999 899999987654457999999999999999999999999999999999999965554
Q ss_pred ccccCCCCCCEEEEecCCccccCCCC----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCChH
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALFQTHENL 329 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~Pf~~~~~~ 329 (433)
+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|. +||......
T Consensus 152 ----------~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~ 221 (285)
T d1fmka3 152 ----------CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221 (285)
T ss_dssp ----------EEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ----------EEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 5555555554332211 2246899999999999999999999999999999999964 555655555
Q ss_pred HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhcccc
Q 013973 330 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 409 (433)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 409 (433)
+.+..+.... .. +.+..++.++++||.+||+.
T Consensus 222 ~~~~~i~~~~----------------------~~--------------------------~~~~~~~~~l~~li~~cl~~ 253 (285)
T d1fmka3 222 EVLDQVERGY----------------------RM--------------------------PCPPECPESLHDLMCQCWRK 253 (285)
T ss_dssp HHHHHHHTTC----------------------CC--------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHhcC----------------------CC--------------------------CCCcccCHHHHHHHHHHccc
Confidence 5544432110 00 11235678899999999999
Q ss_pred CCCCCCCHHHHhc--CCCCCCC
Q 013973 410 DPTDRLTAREALR--HPFFTRD 429 (433)
Q Consensus 410 dP~~R~ta~ell~--hp~f~~~ 429 (433)
||++|||+++|++ |+||+..
T Consensus 254 dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 254 EPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999998 8999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=384.54 Aligned_cols=246 Identities=21% Similarity=0.291 Sum_probs=191.0
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC----eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
.+.|++.++||+|+||.||+|.++.++ ..||||+++.. ......+.+|+.+++++ .|+||+++++++.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGVISK 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-----CCCCEeeeeEEEec
Confidence 356999999999999999999987654 47999998642 33445678899999888 67999999999999
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
.+.+++||||+ ++++.+++.... ..+++..+..++.||+.||+|||+++||||||||+||||+.++
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~------------ 147 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL------------ 147 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------------
T ss_pred CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC------------
Confidence 99999999999 888888877653 4799999999999999999999999999999999999995544
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCC-C
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-A 321 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~ 321 (433)
.+||+|||+++...... ....||+.|||||++.+..|+.++|||||||++|||++|. +
T Consensus 148 ---------------~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~ 212 (283)
T d1mqba_ 148 ---------------VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212 (283)
T ss_dssp ---------------CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ---------------eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence 55555555554332211 1236899999999999999999999999999999999965 4
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||...+..+.+..+.... .. +.+..++.++.+
T Consensus 213 ~~~~~~~~~~~~~i~~~~----------------------~~--------------------------~~~~~~~~~l~~ 244 (283)
T d1mqba_ 213 PYWELSNHEVMKAINDGF----------------------RL--------------------------PTPMDCPSAIYQ 244 (283)
T ss_dssp TTTTCCHHHHHHHHHTTC----------------------CC--------------------------CCCTTCBHHHHH
T ss_pred ccccCCHHHHHHHHhccC----------------------CC--------------------------CCchhhHHHHHH
Confidence 555545444333221100 00 112356778999
Q ss_pred HHHhccccCCCCCCCHHHHhc
Q 013973 402 LLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~ 422 (433)
||.+||+.||++|||+.||++
T Consensus 245 li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 245 LMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=398.48 Aligned_cols=256 Identities=24% Similarity=0.408 Sum_probs=204.5
Q ss_pred CcEEEEeeeeccccEEEEEEEE---CCCCeEEEEEEeecc-----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 97 SRYKIHSKMGEGTFGQVLECWD---RERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~---~~~~~~vAiK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
++|++++.||+|+||+||+|++ +.+|+.||||+++.. ....+.+..|+.+++++.| +|||++++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h----~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ----SPFLVTLHYAFQ 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT----CTTBCCEEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC----CCeEEEeeeeec
Confidence 6799999999999999999987 457899999998532 2234556789999999954 367999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 247 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~ 247 (433)
+...+++||||+ +++|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~------------- 164 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS------------- 164 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-------------
T ss_pred cCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecC-------------
Confidence 999999999999 999999998775 7889999999999999999999999999999999999954
Q ss_pred CCCCCCcccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCC--CCCCcchhHHHHHHHHHHHhCCC
Q 013973 248 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEA 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~ 321 (433)
++.+||+|||++...... .....||+.|+|||.+.+. .++.++|||||||++|||++|..
T Consensus 165 --------------~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 165 --------------NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp --------------TSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence 455666677766533221 1335799999999999865 46889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.+..+....+..... .+. ...+..+++++.+
T Consensus 231 PF~~~~~~~~~~~i~~~~~-------------------~~~--------------------------~~~~~~~s~~~~~ 265 (322)
T d1vzoa_ 231 PFTVDGEKNSQAEISRRIL-------------------KSE--------------------------PPYPQEMSALAKD 265 (322)
T ss_dssp TTSCTTSCCCHHHHHHHHH-------------------HCC--------------------------CCCCTTSCHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcc-------------------cCC--------------------------CCCcccCCHHHHH
Confidence 9987654333222211100 000 1123457889999
Q ss_pred HHHhccccCCCCCC-----CHHHHhcCCCCCCCC
Q 013973 402 LLQGLLRYDPTDRL-----TAREALRHPFFTRDH 430 (433)
Q Consensus 402 li~~~L~~dP~~R~-----ta~ell~hp~f~~~~ 430 (433)
||.+||++||++|| ||+|+|+||||++.+
T Consensus 266 li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 266 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 99999999999999 589999999998743
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=389.80 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=189.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.++||+|+||.||+|.+.. +++.||||+++.. ....+.+..|..++.++. +|++|+.+++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~----~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACT 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc----CCCeEEEeeeeec
Confidence 3679999999999999999999754 4578999998632 233455667777777773 4567888888765
Q ss_pred c-CCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q 013973 169 Y-RNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 232 (433)
Q Consensus 169 ~-~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl 232 (433)
. ...+++||||| +|+|.++|.... ...+++..+..++.||+.||+|||++|||||||||+|||+
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 4 56799999999 999999997542 2358999999999999999999999999999999999999
Q ss_pred eccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchhH
Q 013973 233 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIW 307 (433)
Q Consensus 233 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 307 (433)
+.++.+ ||+|||+|+..... ....+||+.|||||++.+..|+.++|||
T Consensus 168 ~~~~~~---------------------------Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 168 SEKNVV---------------------------KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp CGGGCE---------------------------EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred CCCCcE---------------------------EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCccccee
Confidence 665554 55555544322211 1235799999999999999999999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHH
Q 013973 308 SVGCILVELCTG-EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 386 (433)
Q Consensus 308 SlGv~l~elltg-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
||||++|||++| .+||.+.+..+.+......- . .
T Consensus 221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~-~--------------------~------------------------ 255 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-T--------------------R------------------------ 255 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT-C--------------------C------------------------
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-C--------------------C------------------------
Confidence 999999999986 57887765444332221110 0 0
Q ss_pred HHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 387 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 387 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
...++.+++++.+||.+||+.||++|||++|+++|
T Consensus 256 --~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 256 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01234567889999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-50 Score=395.29 Aligned_cols=315 Identities=32% Similarity=0.508 Sum_probs=239.1
Q ss_pred ceeecCceec-CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCC------CCCc
Q 013973 87 YMFALGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNR 159 (433)
Q Consensus 87 ~~~~~~~~~~-~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~------~~~~ 159 (433)
+++.+|+.+. ++|+++++||+|+||+||+|+++.+|+.||||+++......+....|+.+++.+.+... .++|
T Consensus 2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 4456778776 47999999999999999999999999999999998766666778889999999976542 3578
Q ss_pred eEEecceeec--CCeEEEEEecC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeec
Q 013973 160 CVQIRNWFDY--RNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVS 234 (433)
Q Consensus 160 i~~~~~~~~~--~~~~~lV~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlKp~NILl~~ 234 (433)
|+++++++.. ....++||+++ +++............+++..++.++.||+.||+|||+ .|||||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 9999988754 35666677665 5566666666666789999999999999999999998 89999999999999976
Q ss_pred cCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHH
Q 013973 235 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 314 (433)
Q Consensus 235 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ 314 (433)
++.. .....++++|||.+..........+||+.|+|||++.+..|+.++|+||+||+++
T Consensus 162 ~~~~---------------------~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 220 (362)
T d1q8ya_ 162 VDSP---------------------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220 (362)
T ss_dssp EETT---------------------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred cCcc---------------------cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHH
Confidence 5420 1223589999999887666666778999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHH
Q 013973 315 ELCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 388 (433)
Q Consensus 315 elltg~~Pf~~~~------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
+|++|+.||...+ ..+.+..+...+|..|.++..........+...+....-...... .........
T Consensus 221 el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 293 (362)
T d1q8ya_ 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW-------PLEDVLTEK 293 (362)
T ss_dssp HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC-------CHHHHHHHT
T ss_pred HHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCC-------chhhhcccc
Confidence 9999999997543 345677788899999988876654443333222211111100000 001111111
Q ss_pred hhhcCCchhHHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q 013973 389 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 429 (433)
Q Consensus 389 ~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 429 (433)
.......++++.|||.+||++||++||||+|+|+||||++.
T Consensus 294 ~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 294 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred cccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 22334567889999999999999999999999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=386.66 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=193.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC---eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~---~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.++|++.+.||+|+||.||+|++..++ ..||||.++.. ....+.+..|+.+++++ +||||+++++++. .
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT-E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC-S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEe-c
Confidence 468999999999999999999987553 56899988642 33456678899999888 7799999999986 4
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
+.+|+||||+ +|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||+++++.+||+|||
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG----- 153 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG----- 153 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch-----
Confidence 6789999999 899999877654 479999999999999999999999999999999999999766655555555
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCC----CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 324 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~ 324 (433)
+++..... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 154 ----------------------~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 154 ----------------------LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ----------------------hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC
Confidence 44332211 123468999999999999999999999999999999998 899998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
+.+..+....+... . .. +.+..+++++.+||.
T Consensus 212 ~~~~~~~~~~i~~~--~--------------------~~--------------------------~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 212 GVKNNDVIGRIENG--E--------------------RL--------------------------PMPPNCPPTLYSLMT 243 (273)
T ss_dssp TCCGGGHHHHHHTT--C--------------------CC--------------------------CCCTTCCHHHHHHHH
T ss_pred CCCHHHHHHHHHcC--C--------------------CC--------------------------CCCCCCCHHHHHHHH
Confidence 87765554432210 0 00 123466789999999
Q ss_pred hccccCCCCCCCHHHHhcC
Q 013973 405 GLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 405 ~~L~~dP~~R~ta~ell~h 423 (433)
+||+.||++|||+.||++|
T Consensus 244 ~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 244 KCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-52 Score=383.98 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=193.7
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEE
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHIC 174 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~ 174 (433)
.++|++++.||+|+||.||+|.++ |..||||+++.. ...+.+.+|+++++++ .|+||+++++++ +..+.+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTC-----CCTTBCCEEEEECCC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEecCCcEE
Confidence 367999999999999999999984 678999999753 4456788899999887 679999999987 4456789
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCC
Q 013973 175 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 253 (433)
Q Consensus 175 lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~ 253 (433)
+||||+ +|+|.++|.+.....+++..++.++.||+.||.|||+.+||||||||+|||+
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~--------------------- 136 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV--------------------- 136 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---------------------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---------------------
Confidence 999999 9999999987554469999999999999999999999999999999999999
Q ss_pred cccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 013973 254 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 332 (433)
+.++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||+| |++||...+..+..
T Consensus 137 ------~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~ 210 (262)
T d1byga_ 137 ------SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 210 (262)
T ss_dssp ------CTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred ------cCCCCEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 44556777777877765555556678999999999999999999999999999999998 78999876655444
Q ss_pred HHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCCC
Q 013973 333 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 412 (433)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 412 (433)
..+. .+. ..+.+..+++++.+||.+||+.||.
T Consensus 211 ~~i~-----------------------~~~-------------------------~~~~~~~~~~~~~~li~~cl~~dP~ 242 (262)
T d1byga_ 211 PRVE-----------------------KGY-------------------------KMDAPDGCPPAVYEVMKNCWHLDAA 242 (262)
T ss_dssp HHHT-----------------------TTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHH-----------------------cCC-------------------------CCCCCccCCHHHHHHHHHHcccCHh
Confidence 3321 110 0012345677899999999999999
Q ss_pred CCCCHHHHhcC
Q 013973 413 DRLTAREALRH 423 (433)
Q Consensus 413 ~R~ta~ell~h 423 (433)
+|||+.|++++
T Consensus 243 ~Rps~~~l~~~ 253 (262)
T d1byga_ 243 MRPSFLQLREQ 253 (262)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=388.61 Aligned_cols=245 Identities=21% Similarity=0.279 Sum_probs=192.7
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCe----EEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~----~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+|+++++||+|+||+||+|.+..+|+ .||+|.++.. ....+.+.+|+.+++++ +||||+++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-----CCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEecC
Confidence 469999999999999999999988876 4788887532 33456788999999998 679999999999875
Q ss_pred CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCC
Q 013973 171 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 249 (433)
Q Consensus 171 ~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~ 249 (433)
. .++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+++
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~------------ 149 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH------------ 149 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE------------
T ss_pred C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC------------
Confidence 4 56667776 999999887654 57999999999999999999999999999999999999976555
Q ss_pred CCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 013973 250 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf 323 (433)
+||+|||+++...... ....||+.|||||++.+..|+.++|||||||++|||+| |.+||
T Consensus 150 ---------------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 150 ---------------VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp ---------------EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ---------------eEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 5555555554332211 22368999999999999999999999999999999998 89999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHH
Q 013973 324 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 403 (433)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 403 (433)
.+.+..+....+.... .+ ..++.++.++.+||
T Consensus 215 ~~~~~~~~~~~i~~~~----------------------~~--------------------------~~p~~~~~~~~~li 246 (317)
T d1xkka_ 215 DGIPASEISSILEKGE----------------------RL--------------------------PQPPICTIDVYMIM 246 (317)
T ss_dssp TTSCGGGHHHHHHHTC----------------------CC--------------------------CCCTTBCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCC----------------------CC--------------------------CCCcccCHHHHHHH
Confidence 8776555443322110 01 11235678899999
Q ss_pred HhccccCCCCCCCHHHHhcC
Q 013973 404 QGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 404 ~~~L~~dP~~R~ta~ell~h 423 (433)
.+||+.||++|||+.|+++|
T Consensus 247 ~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 247 VKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCChhhCcCHHHHHHH
Confidence 99999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-50 Score=381.24 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=202.6
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+..|+++++.+.+ +++|+.+..++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~----~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQG----GVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTT----STTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccC----CCcccEEEEEEecCCEEE
Confidence 3467999999999999999999999999999999987433 33457789999988843 345777777888899999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||++++|.+.+.... ..+++..+..++.|++.||+|||++|||||||||+|||++..
T Consensus 80 ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~------------------- 139 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------- 139 (299)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG-------------------
T ss_pred EEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc-------------------
Confidence 999999999988876544 479999999999999999999999999999999999998543
Q ss_pred ccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
+.+..+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|..||.
T Consensus 140 -----~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 140 -----KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp -----GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred -----CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 23456777888877654322 133579999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHH
Q 013973 325 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 404 (433)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 404 (433)
.....+....+..... .............+++++.+||.
T Consensus 215 ~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~p~~~~~li~ 253 (299)
T d1ckia_ 215 GLKAATKRQKYERISE-----------------------------------------KKMSTPIEVLCKGYPSEFATYLN 253 (299)
T ss_dssp CCC-------HHHHHH-----------------------------------------HHHHSCHHHHTTTSCHHHHHHHH
T ss_pred ccchHHHHHHHHHhhc-----------------------------------------ccCCCChhHhccCCCHHHHHHHH
Confidence 7655443322211100 00000111223467889999999
Q ss_pred hccccCCCCCCCHH---HHhcCCCC
Q 013973 405 GLLRYDPTDRLTAR---EALRHPFF 426 (433)
Q Consensus 405 ~~L~~dP~~R~ta~---ell~hp~f 426 (433)
.||+.||++||+++ ++|+|+|.
T Consensus 254 ~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 254 FCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHccCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999986 55777654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-50 Score=382.42 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=200.1
Q ss_pred cCcEEEEeeeeccccEEEEEEEEC-----CCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++++.||+|+||+||+|+.+ .+++.||||+++.. ....+.+.+|+.+++++ .|+|++.+++++.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~ 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLLGVCA 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-----CCCCcccceeeec
Confidence 567999999999999999999875 35688999998642 33456788999999888 6799999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 225 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 225 (433)
..+..++||||+ +|+|.++|.... ...+++..+..++.||+.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 999999999999 999999997532 124889999999999999999999999999999
Q ss_pred CCCceEeeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCC
Q 013973 226 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW 300 (433)
Q Consensus 226 Kp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 300 (433)
||+|||++.+ +.+||+|||+++..... .....||+.|+|||++.+..|
T Consensus 167 Kp~NILld~~---------------------------~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (301)
T d1lufa_ 167 ATRNCLVGEN---------------------------MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219 (301)
T ss_dssp SGGGEEECGG---------------------------GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred cccceEECCC---------------------------CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC
Confidence 9999999554 45666666666432221 123478999999999999999
Q ss_pred CCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhc
Q 013973 301 TYPCDIWSVGCILVELCTGE-ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 379 (433)
Q Consensus 301 ~~~~DvwSlGv~l~elltg~-~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
+.++|||||||++|||++|. +||.+.+..+....+.. +..
T Consensus 220 t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~-----------------------~~~---------------- 260 (301)
T d1lufa_ 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-----------------------GNI---------------- 260 (301)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-----------------------TCC----------------
T ss_pred ChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHc-----------------------CCC----------------
Confidence 99999999999999999985 68888777665543221 110
Q ss_pred cchhHHHHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 380 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
...+..+++++.+||.+||+.||++|||+.||++
T Consensus 261 ---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 261 ---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112356788999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-50 Score=378.38 Aligned_cols=248 Identities=20% Similarity=0.307 Sum_probs=194.4
Q ss_pred cCcEEEEeeeeccccEEEEEEEECCCC-------eEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWDRERK-------EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~~~~~-------~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
.++|++.+.||+|+||.||+|+...++ ..||||+++.. ......+..|...+.++. .|+||++++++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~----~HpnIv~~~~~ 87 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----KHKNIINLLGA 87 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc----CCCeEEecccc
Confidence 467999999999999999999876554 47999999643 234466677888877773 56899999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+.+++.+++||||+ +|+|.++|.... ...+++.+++.++.||+.||+|||+++||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999 999999997553 235899999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-----CCceeecCcccchhhhhCCCCCCcchh
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDI 306 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv 306 (433)
++.++ .+||+|||++...... ....+||+.|+|||++.+..|+.++||
T Consensus 168 l~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Di 220 (299)
T d1fgka_ 168 VTEDN---------------------------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220 (299)
T ss_dssp ECTTC---------------------------CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHH
T ss_pred ecCCC---------------------------CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhh
Confidence 95544 5555555555433222 123478999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHH
Q 013973 307 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 385 (433)
Q Consensus 307 wSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|||||++|||++ |.+||.+.+..+.+..+... . .+.
T Consensus 221 wS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~--~--------------------~~~--------------------- 257 (299)
T d1fgka_ 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG--H--------------------RMD--------------------- 257 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--C--------------------CCC---------------------
T ss_pred HHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC--C--------------------CCC---------------------
Confidence 999999999998 79999877765544332210 0 111
Q ss_pred HHHhhhcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 386 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 386 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.+..+++++.+||.+||+.||++|||+.||++
T Consensus 258 -----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 258 -----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 12356788999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=377.06 Aligned_cols=245 Identities=21% Similarity=0.268 Sum_probs=188.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCC-C--eEEEEEEeecc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRER-K--EMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 169 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~-~--~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~ 169 (433)
++|++++.||+|+||.||+|+.... + ..||||+++.. ....+.+.+|+.+++++ +|+||+++++++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLYGVVLT 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEee
Confidence 5699999999999999999986433 2 46899988632 23345678899999998 67999999999976
Q ss_pred CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCC
Q 013973 170 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 248 (433)
Q Consensus 170 ~~~~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~ 248 (433)
..+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~----------- 149 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL----------- 149 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-----------
T ss_pred -cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc-----------
Confidence 4678999999 899998877653 36999999999999999999999999999999999999976555
Q ss_pred CCCCCcccccCCCCCCEEEEecCCccccCCCC------CceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHh-CCC
Q 013973 249 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 321 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~ 321 (433)
+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||+| |..
T Consensus 150 ----------------vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~ 213 (273)
T d1u46a_ 150 ----------------VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213 (273)
T ss_dssp ----------------EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred ----------------eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC
Confidence 4555555554332221 22367889999999999999999999999999999998 899
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 322 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 322 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
||.+.+..+....+...... + +.++.++.++.+
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~---------------------~--------------------------~~~~~~~~~l~~ 246 (273)
T d1u46a_ 214 PWIGLNGSQILHKIDKEGER---------------------L--------------------------PRPEDCPQDIYN 246 (273)
T ss_dssp TTTTCCHHHHHHHHHTSCCC---------------------C--------------------------CCCTTCCHHHHH
T ss_pred CCCCcCHHHHHHHHHhCCCC---------------------C--------------------------CCcccccHHHHH
Confidence 99988877765543221000 0 112356778999
Q ss_pred HHHhccccCCCCCCCHHHHhc
Q 013973 402 LLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell~ 422 (433)
||.+||+.||++|||+.||++
T Consensus 247 li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 247 VMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-49 Score=372.92 Aligned_cols=255 Identities=19% Similarity=0.242 Sum_probs=202.0
Q ss_pred ecCcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 013973 95 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 174 (433)
Q Consensus 95 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 174 (433)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ....+..|+++++.+.+ +++++.+++++......+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~----~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAG----CTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTT----CTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcC----CCCCCEEEEEeecCCccE
Confidence 4578999999999999999999999999999999986432 33456778888888854 356888888999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCCCc
Q 013973 175 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 254 (433)
Q Consensus 175 lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~ 254 (433)
+||||++++|.+++...+ ..+++..+..++.|++.||+|||++|||||||||+|||++....
T Consensus 78 ~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~----------------- 139 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS----------------- 139 (293)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-----------------
T ss_pred EEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc-----------------
Confidence 999999999999987654 47999999999999999999999999999999999999964221
Q ss_pred ccccCCCCCCEEEEecCCccccCCC----------CCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 013973 255 YFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 324 (433)
Q Consensus 255 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~ 324 (433)
...+.+||+|||+|+..... ....+||+.|||||++.+..++.++|||||||++|||++|..||.
T Consensus 140 -----~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 140 -----KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp -----TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred -----ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 23456888888887654321 233579999999999999999999999999999999999999997
Q ss_pred CCChH---HHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHH
Q 013973 325 THENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 401 (433)
Q Consensus 325 ~~~~~---~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (433)
+.... +....+....... ...+....+++++.+
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~--------------------------------------------~~~~l~~~~p~~l~~ 250 (293)
T d1csna_ 215 GLKAATNKQKYERIGEKKQST--------------------------------------------PLRELCAGFPEEFYK 250 (293)
T ss_dssp SCCSCCHHHHHHHHHHHHHHS--------------------------------------------CHHHHTTTSCHHHHH
T ss_pred CccchhHHHHHHHHHhccCCC--------------------------------------------ChHHhcCCCCHHHHH
Confidence 64432 2222111100000 011122456788999
Q ss_pred HHHhccccCCCCCCCHHHHh
Q 013973 402 LLQGLLRYDPTDRLTAREAL 421 (433)
Q Consensus 402 li~~~L~~dP~~R~ta~ell 421 (433)
++..|+..+|++||+.+.+.
T Consensus 251 ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 251 YMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHHhcCCcccCcCHHHHH
Confidence 99999999999999876553
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=381.76 Aligned_cols=248 Identities=22% Similarity=0.274 Sum_probs=197.1
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeE--EEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~--vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 172 (433)
++|++.+.||+|+||+||+|+++.++.. ||||.++.. ....+.+.+|++++.++. +|+||+++++++.+.+.
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC----CCTTBCCEEEEEEETTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc----CCCCEeeEEEEEecCCe
Confidence 5799999999999999999999888874 677777532 234456788999888762 47899999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 173 ICIVFEKL-GSSLYDFLRKN--------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
+++||||+ +|+|.++|+.. ....+++..+..++.||+.||.|||+++||||||||+|||++.+
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~-- 163 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-- 163 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG--
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC--
Confidence 99999999 99999999754 23579999999999999999999999999999999999999554
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC--CceeecCcccchhhhhCCCCCCcchhHHHHHHHHH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 315 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e 315 (433)
+.+||+|||+++...... ....||..|+|||.+.+..|+.++|||||||++||
T Consensus 164 -------------------------~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~e 218 (309)
T d1fvra_ 164 -------------------------YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 218 (309)
T ss_dssp -------------------------GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred -------------------------CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHH
Confidence 456666666665333222 23468999999999999999999999999999999
Q ss_pred HHhCC-CCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCC
Q 013973 316 LCTGE-ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 394 (433)
Q Consensus 316 lltg~-~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
|++|. +||.+.+..+....+.. .... ..+..
T Consensus 219 ll~~~~~p~~~~~~~~~~~~i~~----------------------~~~~--------------------------~~~~~ 250 (309)
T d1fvra_ 219 IVSLGGTPYCGMTCAELYEKLPQ----------------------GYRL--------------------------EKPLN 250 (309)
T ss_dssp HHTTSCCTTTTCCHHHHHHHGGG----------------------TCCC--------------------------CCCTT
T ss_pred HHhcCCCCCCCCCHHHHHHHHHh----------------------cCCC--------------------------CCCcc
Confidence 99965 67887766554433211 0011 11235
Q ss_pred chhHHHHHHHhccccCCCCCCCHHHHhcC
Q 013973 395 SAGDLTHLLQGLLRYDPTDRLTAREALRH 423 (433)
Q Consensus 395 ~~~~~~~li~~~L~~dP~~R~ta~ell~h 423 (433)
+++++.+||.+||+.||++|||+.||++|
T Consensus 251 ~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 251 CDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 67899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=374.68 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=199.2
Q ss_pred cCcEEEEeeeeccccEEEEEEEE-----CCCCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 013973 96 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 168 (433)
Q Consensus 96 ~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|++ ..+++.||||+++.. ......+..|+.+++++. +|+||+++++++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~----~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHMNIVNLLGACT 97 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc----CCCCEEEEEEEEe
Confidence 46899999999999999999986 356788999999743 334556778999998883 5789999999999
Q ss_pred cCCeEEEEEecC-CCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 013973 169 YRNHICIVFEKL-GSSLYDFLRKNN----------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 231 (433)
Q Consensus 169 ~~~~~~lV~e~~-~~~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NIL 231 (433)
+.+.+++||||| +|+|.++|+... ...+++..+..++.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 999999999999 899999997643 235899999999999999999999999999999999999
Q ss_pred eeccCccccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHH
Q 013973 232 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 311 (433)
Q Consensus 232 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 311 (433)
++.++.++++|||.+......... . .....+||+.|+|||++.+..++.++|||||||
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~---------~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNY---------V-------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTS---------E-------------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccCcccccccchheeccCCCcc---------e-------------EeeecccChHHcCHHHhcCCCCCCcccccchHH
Confidence 976665555555554433211100 0 012247899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhh
Q 013973 312 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 390 (433)
Q Consensus 312 ~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
++|||+| |.+||.+.+..+.+..+...-.. ..
T Consensus 236 ~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-----------------------------------------------~~ 268 (311)
T d1t46a_ 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-----------------------------------------------ML 268 (311)
T ss_dssp HHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-----------------------------------------------CC
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-----------------------------------------------CC
Confidence 9999998 67777766554443332211000 00
Q ss_pred hcCCchhHHHHHHHhccccCCCCCCCHHHHhc
Q 013973 391 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 422 (433)
Q Consensus 391 ~~~~~~~~~~~li~~~L~~dP~~R~ta~ell~ 422 (433)
.+...+.++.+||.+||+.||++|||++||++
T Consensus 269 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 269 SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12356778999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=377.01 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=205.4
Q ss_pred eecCcEEEEeeeeccccEEEEEEEECC-----CCeEEEEEEeecc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 013973 94 NLTSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 166 (433)
Q Consensus 94 ~~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~ 166 (433)
...++|++.+.||+|+||+||+|.++. ++..||||+++.. ......+.+|+.+++++ +|+||+++++.
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~ 91 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGV 91 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-----CCCCEeeeeeE
Confidence 335789999999999999999998752 3578999999743 23334567899988887 77899999999
Q ss_pred eecCCeEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCc
Q 013973 167 FDYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 237 (433)
Q Consensus 167 ~~~~~~~~lV~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~ 237 (433)
+......++||||+ +|+|.+++.... ...+++..+..++.|++.||.|||+++||||||||+|||++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld---- 167 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---- 167 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC----
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec----
Confidence 99999999999999 999999986421 13578999999999999999999999999999999999994
Q ss_pred cccCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCC-----CceeecCcccchhhhhCCCCCCcchhHHHHHH
Q 013973 238 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 312 (433)
Q Consensus 238 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~ 312 (433)
.+..+||+|||+++...... ....||+.|+|||.+.+..++.++|||||||+
T Consensus 168 -----------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 168 -----------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224 (308)
T ss_dssp -----------------------TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred -----------------------CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHH
Confidence 45566666777665433221 22478999999999999999999999999999
Q ss_pred HHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhh
Q 013973 313 LVELCTG-EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 391 (433)
Q Consensus 313 l~elltg-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+|||+|| .+||.+.+..+.+..+... .... .
T Consensus 225 l~El~t~~~~p~~~~~~~~~~~~i~~~----------------------~~~~--------------------------~ 256 (308)
T d1p4oa_ 225 LWEIATLAEQPYQGLSNEQVLRFVMEG----------------------GLLD--------------------------K 256 (308)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHHTT----------------------CCCC--------------------------C
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhC----------------------CCCC--------------------------C
Confidence 9999998 5888887776655443210 0001 1
Q ss_pred cCCchhHHHHHHHhccccCCCCCCCHHHHhc------CCCCCC
Q 013973 392 VDHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFFTR 428 (433)
Q Consensus 392 ~~~~~~~~~~li~~~L~~dP~~R~ta~ell~------hp~f~~ 428 (433)
++.+++.+.+||.+||+.||++|||+.||++ +|+|++
T Consensus 257 p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 2356778999999999999999999999998 777753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=366.22 Aligned_cols=256 Identities=16% Similarity=0.180 Sum_probs=191.6
Q ss_pred EEEeeeeccccEEEEEEEECCCC---eEEEEEEeec--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-cCCeE
Q 013973 100 KIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHI 173 (433)
Q Consensus 100 ~~~~~iG~G~~g~V~~~~~~~~~---~~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~ 173 (433)
.+.++||+|+||+||+|++..++ ..||||.++. .....+.+..|+++++++ .||||+++++++. .++.+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEETTTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCEeEEeEEEEecCCce
Confidence 34688999999999999987653 3699999863 344556788999999988 6799999999865 46789
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccccCCCcCCCCCCCC
Q 013973 174 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 252 (433)
Q Consensus 174 ~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~ 252 (433)
++||||| +++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999 899999987653 46888999999999999999999999999999999999965555444444444322211
Q ss_pred CcccccCCCCCCEEEEecCCccccCCCCCceeecCcccchhhhhCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 013973 253 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEH 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~~~~~-~~~ 331 (433)
... .........||+.|+|||++.+..++.++||||||+++|||++|..||..... .+.
T Consensus 184 ~~~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~ 243 (311)
T d1r0pa_ 184 EFD--------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243 (311)
T ss_dssp TCC--------------------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C
T ss_pred ccc--------------------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence 000 00011224689999999999999999999999999999999998777754322 221
Q ss_pred HHHHHHHhCCCCHHHHHHHhhhhhhhhccCcccCCCCccchhhHhhhccchhHHHHHhhhcCCchhHHHHHHHhccccCC
Q 013973 332 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 411 (433)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 411 (433)
...+ ..|.. ...++.+++++.+||.+||+.||
T Consensus 244 ~~~i-----------------------~~g~~-------------------------~~~p~~~~~~l~~li~~cl~~dP 275 (311)
T d1r0pa_ 244 TVYL-----------------------LQGRR-------------------------LLQPEYCPDPLYEVMLKCWHPKA 275 (311)
T ss_dssp HHHH-----------------------HTTCC-------------------------CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHH-----------------------HcCCC-------------------------CCCcccCcHHHHHHHHHHcCCCH
Confidence 1111 11110 01123567789999999999999
Q ss_pred CCCCCHHHHhcC------CCCCCC
Q 013973 412 TDRLTAREALRH------PFFTRD 429 (433)
Q Consensus 412 ~~R~ta~ell~h------p~f~~~ 429 (433)
++|||+.||++| .|..+.
T Consensus 276 ~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 276 EMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp GGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred hHCcCHHHHHHHHHHHHHhhhhhh
Confidence 999999999998 666654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=369.49 Aligned_cols=192 Identities=22% Similarity=0.295 Sum_probs=152.6
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC----e
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----H 172 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~ 172 (433)
.+|.+.+.||+|+||.||+|+. +|+.||||+++... ......|.+++... ..+|+||+++++++.+.+ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~---~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTV---MLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTST---TCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHh---hCCCCcCcceEEEEEeCCCcceE
Confidence 5699999999999999999986 67899999997443 23344454444221 126899999999987543 6
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCceEeeccCccccCCC
Q 013973 173 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD--------LCMIHTDLKPENVLLVSSEYIKVPDY 243 (433)
Q Consensus 173 ~~lV~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------~~ivHrDlKp~NILl~~~~~~~i~df 243 (433)
+|+||||+ +|+|.++|++. .+++..+..++.|++.||.|||+ +|||||||||+||||+.+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-------- 144 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-------- 144 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT--------
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC--------
Confidence 89999999 99999999875 59999999999999999999996 589999999999999554
Q ss_pred cCCCCCCCCCcccccCCCCCCEEEEecCCccccCCC-------CCceeecCcccchhhhhCCC------CCCcchhHHHH
Q 013973 244 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLG------WTYPCDIWSVG 310 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG 310 (433)
+.+||+|||++...... ....+||+.|||||++.+.. ++.++||||||
T Consensus 145 -------------------~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 145 -------------------GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp -------------------SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred -------------------CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 45566666655433221 12357999999999998643 57789999999
Q ss_pred HHHHHHHhCCCCCCC
Q 013973 311 CILVELCTGEALFQT 325 (433)
Q Consensus 311 v~l~elltg~~Pf~~ 325 (433)
|++|||+||..||..
T Consensus 206 vvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 206 LVFWEIARRCSIGGI 220 (303)
T ss_dssp HHHHHHHHTBCBTTB
T ss_pred HHHHHHhhCCCCCCc
Confidence 999999999988854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.2e-25 Score=195.75 Aligned_cols=162 Identities=21% Similarity=0.225 Sum_probs=109.8
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-------------------hhHHHHHHHHHHHHHHHhcCCCCCc
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------------------KYREAAMIEIEVLQQLAKHDKGGNR 159 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------------------~~~~~~~~E~~~l~~l~~~~~~~~~ 159 (433)
+.+.++||+|+||+||+|.+. +|+.||||+++... ........|...+.++ .+.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-----QGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-----TTSS
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-----cCCC
Confidence 357899999999999999985 68899999875211 0112233466666666 3344
Q ss_pred eEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeeccCccc
Q 013973 160 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 239 (433)
Q Consensus 160 i~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlKp~NILl~~~~~~~ 239 (433)
++..++... .++||||+++... ..++...+..++.|++.||.|||++||+||||||+|||++++
T Consensus 76 v~~~~~~~~----~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~---- 139 (191)
T d1zara2 76 VPKVYAWEG----NAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE---- 139 (191)
T ss_dssp SCCEEEEET----TEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT----
T ss_pred cceEEEecC----CEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC----
Confidence 555544321 2799999944311 135566678899999999999999999999999999999532
Q ss_pred cCCCcCCCCCCCCCcccccCCCCCCEEEEecCCccccCCCCCceeecCcccch------hhhhCCCCCCcchhHHHHHH
Q 013973 240 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAP------EVILGLGWTYPCDIWSVGCI 312 (433)
Q Consensus 240 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwSlGv~ 312 (433)
.++|+|||.|........ ..|... +. ....|+.++|+||+.--
T Consensus 140 ------------------------~~~liDFG~a~~~~~~~~-----~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 140 ------------------------GIWIIDFPQSVEVGEEGW-----REILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ------------------------EEEECCCTTCEETTSTTH-----HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred ------------------------CEEEEECCCcccCCCCCc-----HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 378888888765432221 011111 11 13568899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=8.6e-07 Score=79.21 Aligned_cols=84 Identities=8% Similarity=0.028 Sum_probs=56.2
Q ss_pred CcEEEEeeeeccccEEEEEEEECCCCeEEEEEEeecch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 013973 97 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 175 (433)
Q Consensus 97 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 175 (433)
..|++++..+-++.+.||+.. .+++.+.+|+..... ........|...+..+.... . +.+++.+...++..++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~v-p---vP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKL-P---VPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTS-C---CCCEEEEEEETTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccC-C---CCcEEEEEecCCceEE
Confidence 457777765555567899875 345567888775332 22334567888888885432 1 4566667777889999
Q ss_pred EEecC-CCCHHH
Q 013973 176 VFEKL-GSSLYD 186 (433)
Q Consensus 176 V~e~~-~~~L~~ 186 (433)
||+++ |..+.+
T Consensus 88 v~~~l~G~~~~~ 99 (263)
T d1j7la_ 88 LMSEADGVLCSE 99 (263)
T ss_dssp EEECCSSEEHHH
T ss_pred EEEecccccccc
Confidence 99999 656544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.00 E-value=1.2e-05 Score=76.32 Aligned_cols=76 Identities=20% Similarity=0.222 Sum_probs=47.4
Q ss_pred EeeeeccccEEEEEEEECCCCeEEEEEEeecc--------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 013973 102 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 173 (433)
Q Consensus 102 ~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 173 (433)
.+.||.|....||++.+..+++.|++|.-... .....+...|.+.|+.+..... ..+++++.+. ....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p--~~vP~v~~~d--~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP--HLVPRVFYSD--TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCG--GGSCCEEEEE--TTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCC--CCcceEEEEc--CCCC
Confidence 56789999999999998888888999975311 1112334568888887765321 2345555443 3345
Q ss_pred EEEEecCC
Q 013973 174 CIVFEKLG 181 (433)
Q Consensus 174 ~lV~e~~~ 181 (433)
++|||+++
T Consensus 107 ~lvmE~L~ 114 (392)
T d2pula1 107 VTVMEDLS 114 (392)
T ss_dssp EEEECCCT
T ss_pred EEEEeccC
Confidence 78999993
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=2.6e-05 Score=68.75 Aligned_cols=74 Identities=12% Similarity=0.085 Sum_probs=50.4
Q ss_pred eeeccc-cEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 013973 104 KMGEGT-FGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 181 (433)
Q Consensus 104 ~iG~G~-~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lV~e~~-~ 181 (433)
.+..|. -+.||+... .++..+++|...... ......|...++.+...... +.+++....+.+..++||+++ |
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvp---vP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCC---CCceeeecccccceEEEEEeeec
Confidence 334444 367998875 455668899876432 33467789999888765432 555666667778899999999 5
Q ss_pred CC
Q 013973 182 SS 183 (433)
Q Consensus 182 ~~ 183 (433)
.+
T Consensus 91 ~~ 92 (255)
T d1nd4a_ 91 QD 92 (255)
T ss_dssp EE
T ss_pred cc
Confidence 44
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.72 E-value=0.00012 Score=67.13 Aligned_cols=71 Identities=17% Similarity=0.205 Sum_probs=48.2
Q ss_pred EEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEec--ceeecCCeEEEEEecCCC
Q 013973 111 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR--NWFDYRNHICIVFEKLGS 182 (433)
Q Consensus 111 g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~--~~~~~~~~~~lV~e~~~~ 182 (433)
-.||++.. .+|..|++|+.+......+++..|...+..|.......+..+... ..+...+..+.|+++++|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 57999976 456779999987544445667789999999987654333222221 223456778899999843
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.16 E-value=0.00076 Score=63.37 Aligned_cols=73 Identities=14% Similarity=0.172 Sum_probs=48.6
Q ss_pred cEEEEeeeeccccEEEEEEEECC-------CCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 013973 98 RYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 170 (433)
Q Consensus 98 ~~~~~~~iG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~ 170 (433)
.+++ +.|+-|-.-.+|++.... ..+.|.+++.-.... .-....|..+++.+..+.. ..++++++..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~idr~~E~~i~~~ls~~gl----~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSERHL----GPKLYGIFSG- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHTTS----SSCEEEEETT-
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-hhHHHHHHHHHHHHHhCCC----CCeEEEEcCC-
Confidence 3444 678888889999998653 345688887653322 2335578999998877543 3455555543
Q ss_pred CeEEEEEecC
Q 013973 171 NHICIVFEKL 180 (433)
Q Consensus 171 ~~~~lV~e~~ 180 (433)
.+||||+
T Consensus 117 ---g~I~efi 123 (395)
T d1nw1a_ 117 ---GRLEEYI 123 (395)
T ss_dssp ---EEEECCC
T ss_pred ---ceEEEEe
Confidence 5889998
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.81 E-value=0.0045 Score=55.74 Aligned_cols=79 Identities=8% Similarity=0.025 Sum_probs=44.2
Q ss_pred EEEEeeeeccccEEEEEEEECCCCeEEEEEEeecchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc---eeecCCeEEE
Q 013973 99 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICI 175 (433)
Q Consensus 99 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~---~~~~~~~~~l 175 (433)
..-.+.|..|---+.|+..... |+ |++|++... ...+....|.+++..+..+....|..+.... .....+....
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~-g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~ 96 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTK-DP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 96 (316)
T ss_dssp EEEEEEECC---EEEEEEEESS-CC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ceEeecCCCCcccCeEEEEECC-Cc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence 4445667778778899987643 43 999998643 2334456688889988876544443322211 1122345566
Q ss_pred EEecC
Q 013973 176 VFEKL 180 (433)
Q Consensus 176 V~e~~ 180 (433)
++.++
T Consensus 97 ~~~~~ 101 (316)
T d2ppqa1 97 LISFL 101 (316)
T ss_dssp EEECC
T ss_pred eeeec
Confidence 66655
|